PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Wada, H; Kawakami, K				Wada, Hironori; Kawakami, Koichi			Size control during organogenesis: Development of the lateral line organs in zebrafish	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						bone remodeling; lateral line; neuromast; organ size control; Wnt signaling; zebrafish	HAIR CELL REGENERATION; POSTEMBRYONIC DEVELOPMENT; PROLIFERATION; SYSTEM; NEUROMASTS; DPP; MORPHOGENESIS; DROSOPHILA; COCHLEA; GROWTH	Many genes that play essential roles in organ growth have been identified across a range of organisms. However, the mechanisms by which growing organs can sense their sizes and stop growing when they reach their proper sizes remain poorly understood. The mechanosensory organs of the fish lateral line system (neuromasts) provide an ideal system to address this question for the following reasons. First, each superficial neuromast is composed of a small number of cells situated on the body surface, making it relatively easy to quantify organ size throughout development. Second, while the sensory cells of superficial neuromasts are continuously renewed, overall organ size is homeostatically maintained. Third, there is another type of neuromast showing an opposite mode of growth: that is, canal neuromasts increase in size in proportion to organism body size. Here, we review recent findings regarding the mechanisms that control organ size in the zebrafish lateral line.	[Wada, Hironori; Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan	Wada, H (reprint author), Grad Univ Adv Studies SOKENDAI, Natl Inst Genet, Div Mol & Dev Biol, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	hiwada@nig.ac.jp			KAKENHI Grant of Japan Society for the Promotion of Science (JSPS) [19770204, 25440118]; PRESTO program of the Japan Science and Technology Agency (JST)	We would like to thank Alain Ghysen and Miki Iwasaki for critical reading of the manuscript. We also thank members of the Kawakami lab for helpful discussions. Our studies cited in this review were supported by grants KAKENHI Grant number 19770204 and 25440118 of Japan Society for the Promotion of Science (JSPS), and by the PRESTO program of the Japan Science and Technology Agency (JST) to H.W.	Burke R, 1996, DEVELOPMENT, V122, P2261; Wada H, 2013, CURR BIOL, V23, P1559, DOI 10.1016/j.cub.2013.06.035; Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Wada H, 2014, DEV BIOL, V392, P1, DOI 10.1016/j.ydbio.2014.05.004; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Harris JA, 2003, JARO, V4, P219, DOI 10.1007/s10162-002-3022-x; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Day SJ, 2000, DEVELOPMENT, V127, P2977; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Chitnis AB, 2012, DEV NEUROBIOL, V72, P234, DOI 10.1002/dneu.20962; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Aman A, 2011, CELL ADHES MIGR, V5, P499, DOI 10.4161/cam.5.6.19113; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Wada H, 2010, DEV BIOL, V340, P583, DOI 10.1016/j.ydbio.2010.02.017; Head JR, 2013, DEV DYNAM, V242, P832, DOI 10.1002/dvdy.23973; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; Webb JF, 2003, DEV DYNAM, V228, P370, DOI 10.1002/dvdy.10385; Ledent V, 2002, DEVELOPMENT, V129, P597; Bailey SW, 1937, J EXP ZOOL, V76, P187, DOI 10.1002/jez.1400760203; Buchmann A, 2014, SEMIN CELL DEV BIOL, V35, P73, DOI 10.1016/j.semcdb.2014.06.018; Denton E.J., 1989, P229; Ghysen A., 2014, FLOW SENSING AIR WAT, P295; Grant KA, 2005, NEURON, V45, P69, DOI 10.1016/j.neuron.2004.12.020; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Lush ME, 2014, DEV DYNAM, V243, P1187, DOI [10.1002/dvdy.24167, 10.1002/DVDY.24167]; Lush ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01832; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; MERRILEES MJ, 1975, J EXP ZOOL, V192, P113, DOI 10.1002/jez.1401920112; Quilhac A, 1998, J EXP ZOOL, V281, P305, DOI 10.1002/(SICI)1097-010X(19980701)281:4<305::AID-JEZ6>3.0.CO;2-S; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Thomas E. D., 2014, WILEY INTERDISCIP RE, V4, P1; Wada H, 2013, P NATL ACAD SCI USA, V110, P5659, DOI 10.1073/pnas.1214004110	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	FEB	2015	57	2					169	178		10.1111/dgd.12196		10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CC6ML	WOS:000350479100008		
J	Ui, T; Fujii, H; Hosoya, Y; Nagase, M; Mieno, MN; Mori, M; Zuiki, T; Saito, S; Kurashina, K; Haruta, H; Matsumoto, S; Niki, T; Lefor, A; Yasuda, Y				Ui, T.; Fujii, H.; Hosoya, Y.; Nagase, M.; Mieno, M. N.; Mori, M.; Zuiki, T.; Saito, S.; Kurashina, K.; Haruta, H.; Matsumoto, S.; Niki, T.; Lefor, A.; Yasuda, Y.			Comparison of preoperative chemotherapy using docetaxel, cisplatin and fluorouracil with cisplatin and fluorouracil in patients with advanced carcinoma of the thoracic esophagus	DISEASES OF THE ESOPHAGUS			English	Article						DCF; docetaxel; esophageal carcinoma; neoadjuvant chemotherapy	LOCALLY ADVANCED ESOPHAGEAL; SQUAMOUS-CELL CARCINOMA; COMBINATION CHEMOTHERAPY; NECK-CANCER; PHASE I/II; DOCETAXEL/CISPLATIN/5-FLUOROURACIL; ADENOCARCINOMA; THERAPY; TRIAL; HEAD	We retrospectively compared preoperative docetaxel, cisplatin, and fluorouracil (DCF) with cisplatin and fluorouracil (CF) in patients with esophageal cancer. The study included patients with advanced thoracic esophageal carcinoma (excluding T4 tumors) receiving preoperative chemotherapy. In the DCF group, five patients received two courses of treatment every 4 weeks, and 33 patients received three courses every 3 weeks. In the CF group, 38 patients received two courses of treatment every 4 weeks. Patients underwent curative surgery 4-5 weeks after completing chemotherapy. Patient demographic characteristics did not differ between the two study groups. The incidence of a grade 3 or 4 hematologic toxicity was significantly higher in the DCF group (33 patients) than in the CF group (five patients; P < 0.001). Curative resection was accomplished in 79% of patients in the DCF group and 66% in the CF group (P = 0.305). There were no in-hospital deaths. The incidence of perioperative complications did not differ between the groups. A grade 2 or 3 histological response was attained in a significantly higher proportion of patients in the DCF group (63%) than in the CF group (5%; P < 0.001). Progression-free survival and overall survival were significantly higher in the DCF group (P = 0.013, hazard ratio 0.473; P = 0.001, hazard ratio 0.344). In conclusion, a grade 3 or 4 hematologic toxicity was common in the DCF group but was managed by supportive therapy. Histological response rate, progression-free survival, and overall survival were significantly higher in the DCF group compared with the CF group.	[Ui, T.; Hosoya, Y.; Zuiki, T.; Saito, S.; Kurashina, K.; Haruta, H.; Matsumoto, S.; Lefor, A.; Yasuda, Y.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan; [Fujii, H.; Nagase, M.; Mori, M.] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi 3290498, Japan; [Mieno, M. N.] Jichi Med Univ, Dept Med Informat, Shimotsuke, Tochigi 3290498, Japan; [Niki, T.] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi 3290498, Japan	Ui, T (reprint author), Jichi Med Univ, Dept Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ui@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Ando N, 2011, ESOPHAGUS-TOKYO, V8, P151, DOI 10.1007/s10388-011-0282-8; Zanoni A, 2013, ANN SURG ONCOL, V20, P1993, DOI 10.1245/s10434-012-2822-4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Watanabe M, 2011, DIGESTION, V83, P146, DOI 10.1159/000321797; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; [Anonymous], 2013, ES ES JUNCT CANC; Bayraktar UD, 2012, MED ONCOL, V29, P1707, DOI 10.1007/s12032-011-0093-8; Ferri LE, 2012, ANN ONCOL, V23, P1512, DOI 10.1093/annonc/mdr465; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; Miyata Hiroshi, 2011, Gen Thorac Cardiovasc Surg, V59, P461, DOI 10.1007/s11748-011-0780-6; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Takahashi H, 2010, J THORAC ONCOL, V5, P122, DOI 10.1097/JTO.0b013e3181c1ffd5; Ui T, 2011, ESOPHAGUS-TOKYO, V8, P59, DOI 10.1007/s10388-011-0253-0; vansHagen P, 2012, NEW ENGL J MED, V366, P2074	23	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	FEB-MAR	2015	28	2					180	187		10.1111/dote.12187		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CC6JL	WOS:000350471100010		
J	Oya, H; Kanda, M; Takami, H; Hibino, S; Shimizu, D; Niwa, Y; Koike, M; Nomoto, S; Yamada, S; Nishikawa, Y; Asai, M; Fujii, T; Nakayama, G; Sugimoto, H; Fujiwara, M; Kodera, Y				Oya, H.; Kanda, M.; Takami, H.; Hibino, S.; Shimizu, D.; Niwa, Y.; Koike, M.; Nomoto, S.; Yamada, S.; Nishikawa, Y.; Asai, M.; Fujii, T.; Nakayama, G.; Sugimoto, H.; Fujiwara, M.; Kodera, Y.			Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus	DISEASES OF THE ESOPHAGUS			English	Article						esophageal cancer; expression; MAGE-D4; progression	MAGE GENE FAMILY; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL LOCALIZATION; BIOLOGICAL FUNCTIONS; BREAST-CANCER; MYELOMA CELLS; LUNG-CANCER; EXPRESSION; IDENTIFICATION; APOPTOSIS	To pursue an urgently needed treatment target for esophageal cancer (EC), we investigated the function of the recently discovered melanoma-associated antigen (MAGE)-D4 in squamous cell EC. MAGE-D4 messenger RNA (mRNA) expression was analyzed in nine EC cell lines using quantitative reverse transcription polymerase chain reaction. In 65 surgical specimens of squamous cell EC with no prior neoadjuvant therapy, MAGE-D4mRNA expression in EC tissues and corresponding normal tissues was analyzed and compared, and evaluated in terms of clinicopathological factors. In representative cases, MAGE-D4 protein distribution was analyzed immunohistochemically. The heterogeneity of MAGE-D4mRNA expression was confirmed in EC cell lines by quantitative reverse transcription polymerase chain reaction. In surgical specimens, MAGE-D4mRNA expression was significantly higher in EC tissues than in corresponding normal tissues (P<0.001). Patients with the highest MAGE-D4mRNA expression in EC tissues (top quartile, n = 17) had significantly shorter overall survival than patients with low expression (2-year survival: 44% and 73%, respectively, P = 0.006). Univariate analysis identified age (65 years), lymphatic involvement, and high MAGE-D4mRNA expression as significant prognostic factors; high MAGE-D4mRNA expression was also an independent prognostic factor in multivariable analysis (hazard ratio: 2.194; P = 0.039) and was significantly associated with Brinkman index (P = 0.008) and preoperative carcinoembryonic antigen level (P = 0.002). Immunohistochemical MAGE-D4b expression was consistent with MAGE-D4mRNA profiling. Our results suggest that MAGE-D4 overexpression influences tumor progression, and MADE-D4 can be a prognostic marker and a potential molecular target in squamous cell EC.	[Oya, H.; Kanda, M.; Takami, H.; Hibino, S.; Shimizu, D.; Niwa, Y.; Koike, M.; Nomoto, S.; Yamada, S.; Nishikawa, Y.; Asai, M.; Fujii, T.; Nakayama, G.; Sugimoto, H.; Fujiwara, M.; Kodera, Y.] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Jang SJ, 2001, CANCER RES, V61, P7959; ROGNER UC, 1995, GENOMICS, V29, P725; Xiao J, 2004, WORLD J GASTROENTERO, V10, P1849; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI [10.3324/haematol.2009.014464, 10.3324/haemato1.2009.014464]; Tsai JR, 2007, LUNG CANCER, V56, P185, DOI 10.1016/j.lungcan.2006.12.004; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Chomez P, 2001, CANCER RES, V61, P5544; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Long MJ, 2013, ALCOHOL, V47, P473, DOI 10.1016/j.alcohol.2013.06.003; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Jager E, 1996, INT J CANCER, V67, P54, DOI 10.1002/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002; Chong CE, 2012, CANCER LETT, V321, P18, DOI 10.1016/j.canlet.2012.03.025; Dawsey SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014080; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Germano S, 2012, INT J CANCER, V130, P1991, DOI 10.1002/ijc.26200; HOON DSB, 1995, J IMMUNOL, V154, P730; Iwamoto O, 1997, INT J CANCER, V70, P287, DOI 10.1002/(SICI)1097-0215(19970127)70:3<287::AID-IJC7>3.0.CO;2-T; Kawano Y, 2001, GENE, V277, P129, DOI 10.1016/S0378-1119(01)00698-9; Lucas S, 1998, CANCER RES, V58, P743; Lurquin C, 1997, GENOMICS, V46, P397, DOI 10.1006/geno.1997.5052; Pastorcic-Grgic M, 2010, HEAD NECK-J SCI SPEC, V32, P1178, DOI 10.1002/hed.21314; Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870; Ries J, 2009, DIS MARKERS, V27, P75, DOI 10.3233/DMA-2009-0652; Sasaki M, 2001, CANCER RES, V61, P4809; Shichijo S, 1997, JPN J CANCER RES, V88, P414; Sobin LH, 2002, INT UNION CANC UICC	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	FEB-MAR	2015	28	2					188	195		10.1111/dote.12156		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CC6JL	WOS:000350471100011		
J	Miura, F; Ito, T				Miura, Fumihito; Ito, Takashi			Highly sensitive targeted methylome sequencing by post-bisulfite adaptor tagging	DNA RESEARCH			English	Article						DNA methylation; target enrichment; massively parallel sequencing	SINGLE-BASE RESOLUTION; GENOME; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; ARABIDOPSIS	The current gold standard method for methylome analysis is whole-genome bisulfite sequencing (WGBS), but its cost is substantial, especially for the purpose of multi-sample comparison of large methylomes. Shotgun bisulfite sequencing of target-enriched DNA, or targeted methylome sequencing (TMS), can be a flexible, cost-effective alternative to WGBS. However, the current TMS protocol requires a considerable amount of input DNA and hence is hardly applicable to samples of limited quantity. Here we report a method to overcome this limitation by using post-bisulfite adaptor tagging (PBAT), in which adaptor tagging is conducted after bisulfite treatment to circumvent bisulfite-induced loss of intact sequencing templates, thereby enabling TMS of a 100-fold smaller amount of input DNA with far fewer cycles of polymerase chain reaction than in the current protocol. We thus expect that the PBAT-mediated TMS will serve as an invaluable method in epigenomics.	[Miura, Fumihito; Ito, Takashi] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; [Miura, Fumihito; Ito, Takashi] Japan Sci & Technol Agcy JST, CREST, Higashi Ku, Fukuoka 8128582, Japan; [Miura, Fumihito; Ito, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan	Miura, F (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan.	tito@med.kyushu-u.ac.jp			Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); Platform for Drug Discovery, Informatics and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25129702]; MEXT	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) (to T.I.), Platform for Drug Discovery, Informatics and Structural Life Science (to T.I.) and Grant-in-Aid for Scientific Research on Innovative Areas (25129702) (to F.M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Funding to pay the Open Access publication charges for this article was provided by MEXT.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Wang JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-597; Lee EJ, 2013, CANCER LETT, V340, P171, DOI 10.1016/j.canlet.2012.10.040; Lee EJ, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr598; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Miura F., 2014, METHODS MOL IN PRESS; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439	16	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	FEB	2015	22	1					13	18		10.1093/dnares/dsu034		6	Genetics & Heredity	Genetics & Heredity	CC5YU	WOS:000350442100002		
J	Afiahayati; Sato, K; Sakakibara, Y				Afiahayati; Sato, Kengo; Sakakibara, Yasubumi			MetaVelvet-SL: an extension of the Velvet assembler to a de novo metagenomic assembler utilizing supervised learning	DNA RESEARCH			English	Article						metagenomic; de novo assembler; short read; supervised learning; microbial community	READS; IDBA	The assembly of multiple genomes from mixed sequence reads is a bottleneck in metagenomic analysis. A single-genome assembly program (assembler) is not capable of resolving metagenome sequences, so assemblers designed specifically for metagenomics have been developed. MetaVelvet is an extension of the single-genome assembler Velvet. It has been proved to generate assemblies with higher N50 scores and higher quality than single-genome assemblers such as Velvet and SOAPdenovo when applied to metagenomic sequence reads and is frequently used in this research community. One important open problem for MetaVelvet is its low accuracy and sensitivity in detecting chimeric nodes in the assembly (de Bruijn) graph, which prevents the generation of longer contigs and scaffolds. We have tackled this problem of classifying chimeric nodes using supervised machine learning to significantly improve the performance of MetaVelvet and developed a new tool, called MetaVelvet-SL. A Support Vector Machine is used for learning the classification model based on 94 features extracted from candidate nodes. In extensive experiments, MetaVelvet-SL outperformed the original MetaVelvet and other state-of-the-art metagenomic assemblers, IDBA-UD, Ray Meta and Omega, to reconstruct accurate longer assemblies with higher N50 scores for both simulated data sets and real data sets of human gut microbial sequences.	[Afiahayati; Sato, Kengo; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sakakibara, Y (reprint author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yasu@bio.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002, 23241066]	This work was supported by a Grant-in-Aid for Scientific Research in Innovative Areas No. 221S0002 and Scientific Research (A) No. 23241066 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Funding to pay the Open Access publication charges for this article was provided by Grant-in-Aid for Scientific Research in Innovative Areas No. 221S0002 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Afiahayati A., 2013, PEERJ, V1, pe196; Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Lai BB, 2012, BIOINFORMATICS, V28, P1455, DOI 10.1093/bioinformatics/bts162; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/nmeth.2066, 10.1038/NMETH.2066]; Boisvert S., 2012, GENOME BIOL, V13, pr22; Brodersen Kay H, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), DOI 10.1109/ICPR.2010.764; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Haider B, 2014, BIOINFORMATICS, V30, P2717, DOI 10.1093/bioinformatics/btu395; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	21	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	FEB	2015	22	1					69	77		10.1093/dnares/dsu041		9	Genetics & Heredity	Genetics & Heredity	CC5YU	WOS:000350442100007		
J	Iguchi, A; Iyoda, S; Kikuchi, T; Ogura, Y; Katsura, K; Ohnishi, M; Hayashi, T; Thomson, NR				Iguchi, Atsushi; Iyoda, Sunao; Kikuchi, Taisei; Ogura, Yoshitoshi; Katsura, Keisuke; Ohnishi, Makoto; Hayashi, Tetsuya; Thomson, Nicholas R.			A complete view of the genetic diversity of the Escherichia coli O-antigen biosynthesis gene cluster	DNA RESEARCH			English	Article						E. coli; O-antigen biosynthesis gene cluster; horizontal gene transfer; O serogroup; genomic diversity	SHIGA-TOXIN; STRAINS; FOOD; LIPOPOLYSACCHARIDE; EMERGENCE; O103	The O antigen constitutes the outermost part of the lipopolysaccharide layer in Gram-negative bacteria. The chemical composition and structure of the O antigen show high levels of variation even within a single species revealing itself as serological diversity. Here, we present a complete sequence set for the O-antigen biosynthesis gene clusters (O-AGCs) from all 184 recognized Escherichia coli O serogroups. By comparing these sequences, we identified 161 well-defined O-AGCs. Based on the wzx/wzy or wzm/wzt gene sequences, in addition to 145 singletons, 37 serogroups were placed into 16 groups. Furthermore, phylogenetic analysis of all the E. coli O-serogroup reference strains revealed that the nearly one-quarter of the 184 serogroups were found in the ST10 lineage, which may have a unique genetic background allowing a more successful exchange of O-AGCs. Our data provide a complete view of the genetic diversity of O-AGCs in E. coli showing a stronger association between host phylogenetic lineage and O-serogroup diversification than previously recognized. These data will be a valuable basis for developing a systematic molecular O-typing scheme that will allow traditional typing approaches to be linked to genomic exploration of E. coli diversity.	[Iguchi, Atsushi] Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 8892192, Japan; [Iyoda, Sunao; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan; [Kikuchi, Taisei] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki 8892192, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki 8892192, Japan; [Ogura, Yoshitoshi; Katsura, Keisuke; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki 8892192, Japan; [Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge CB10 1SA, England; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	Iguchi, A (reprint author), Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 8892192, Japan.	iguchi@med.miyazaki-u.ac.jp			Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan [H25-Syokuhin-Wakate-018, H24-Shinkou-Ippan-012]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency [AS242Z00217P]; Scientific Research Grant on Priority Areas from the University of Miyazaki; Program to Disseminate Tenure Tracking System from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Wellcome Trust grant [098051]; University of Miyazaki, Japan	This work was supported by Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan to A.I. (H25-Syokuhin-Wakate-018) and M.O. (H24-Shinkou-Ippan-012); Adaptable and Seamless Technology Transfer Program through Target-driven R&D (AS242Z00217P) from Japan Science and Technology Agency to A.I.; and a Scientific Research Grant on Priority Areas from the University of Miyazaki and the Program to Disseminate Tenure Tracking System from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to A.I. (http://www.miyazaki-u.ac.jp/ir/english/index.html). This work was also supported by Wellcome Trust grant (098051). Funding to pay the Open Access publication charges for this article was provided by the University of Miyazaki, Japan.	Nada RA, 2011, J CLIN MICROBIOL, V49, P1403, DOI 10.1128/JCM.02006-10; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; Iguchi A, 2012, J CLIN MICROBIOL, V50, P2894, DOI 10.1128/JCM.00789-12; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Olesen B, 2012, J CLIN MICROBIOL, V50, P3703, DOI 10.1128/JCM.01909-12; Lacher DW, 2014, APPL ENVIRON MICROB, V80, P4677, DOI 10.1128/AEM.01049-14; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; Hauser E, 2013, APPL ENVIRON MICROB, V79, P2731, DOI 10.1128/AEM.03552-12; Iguchi A, 2011, J CLIN MICROBIOL, V49, P3678, DOI 10.1128/JCM.01197-11; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023250; Jensen SO, 2004, CAN J MICROBIOL, V50, P299, DOI 10.1139/W04-010; Liu B., 2013, FEMS MICROBIOL REV, V38, P56; Monaghan AM, 2012, FOODBORNE PATHOG DIS, V9, P1088, DOI 10.1089/fpd.2012.1257; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Penner JL, 1997, J INFECT DIS, V176, pS135, DOI 10.1086/513778; Sun QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046095; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Wang Q, 2012, GLYCOBIOLOGY, V22, P281, DOI 10.1093/glycob/cwr137; Wang W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/mic.0.2007/004192-0	34	9	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	FEB	2015	22	1					101	107		10.1093/dnares/dsu043		7	Genetics & Heredity	Genetics & Heredity	CC5YU	WOS:000350442100010		
J	Abe, K; Weisz, SEM; Dunn, RL; DiGioacchino, MC; Nyentap, JA; Stanbouly, S; Theurer, JA; Bureau, Y; Affoo, RH; Martin, RE				Abe, Kimiko; Weisz, Sarah E. M.; Dunn, Rachelle L.; DiGioacchino, Martina C.; Nyentap, Jennifer A.; Stanbouly, Seta; Theurer, Julie A.; Bureau, Yves; Affoo, Rebecca H.; Martin, Ruth E.			Occurrences of Yawn and Swallow are Temporally Related	DYSPHAGIA			English	Article						Yawning; Coordination; Upper airway; Brainstem; Saliva; Deglutition; Deglutition disorders	SALIVARY FLOW; STIMULATION; HUMANS; FREQUENCY; BRAIN; MASTICATION; DYSPHAGIA; PATTERN; STROKE; REFLEX	Yawning is a stereotyped motor behavior characterized by deep inhalation and associated dilation of the respiratory tract, pronounced jaw opening, and facial grimacing. The frequency of spontaneous yawning varies over the diurnal cycle, peaking after waking and before sleep. Yawning can also be elicited by seeing or hearing another yawn, or by thinking about yawning, a phenomenon known as "contagious yawning". Yawning is mediated by a distributed network of brainstem and supratentorial brain regions, the components of which are shared with other airway behaviors including respiration, swallowing, and mastication. Nevertheless, the possibility of behavioral coordination between yawning and other brainstem-mediated functions has not been examined. Here we show, with a double-blind methodology, a greater-than-fivefold increase in rest (saliva) swallowing rate during the 10-s period immediately following contagious yawning elicited in 14 adult humans through the viewing of videotaped yawn stimuli. Sixty-five percent of yawns were followed by a swallow within 10 s and swallows accounted for 26 % of all behaviors produced during this post-yawn period. This novel finding of a tight temporal coupling between yawning and swallowing provides preliminary evidence that yawning and swallowing are physiologically related, thus extending current models of upper airway physiology and neurophysiology. Moreover, our finding suggests the possibility that yawning plays a role in eliciting rest swallowing, a view not considered in previous theories of yawning. As such, the present demonstration of a temporal association between yawning and swallowing motivates a re-examination of the longstanding question, "Why do we yawn?".	[Abe, Kimiko; Weisz, Sarah E. M.; Dunn, Rachelle L.; DiGioacchino, Martina C.; Nyentap, Jennifer A.; Stanbouly, Seta; Theurer, Julie A.; Martin, Ruth E.] Univ Western Ontario, Fac Hlth Sci, Sch Commun Sci & Disorders, London, ON N6A 5B9, Canada; [Abe, Kimiko] Nihon Univ, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Theurer, Julie A.] London Hlth Sci Ctr, London, ON N6A 5W9, Canada; [Bureau, Yves] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5C1, Canada; [Theurer, Julie A.; Affoo, Rebecca H.; Martin, Ruth E.] Univ Western Ontario, Fac Hlth Sci, London, ON N6A 5B9, Canada; [Weisz, Sarah E. M.; Martin, Ruth E.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Theurer, Julie A.; Martin, Ruth E.] Univ Western Ontario, Victoria Hosp, London Hlth Sci Ctr, Dept Otolaryngol,Schulich Sch Med & Dent, London, ON N6A 5W9, Canada; [Bureau, Yves] London Hlth Sci Ctr, Lawson Res Inst, London, ON N6C 2R5, Canada; [Bureau, Yves] St Josephs Hlth Care, London, ON N6C 2R5, Canada; [Bureau, Yves] Univ Western Ontario, Dept Psychol, Social Sci Ctr, London, ON N6A 5C2, Canada; [Martin, Ruth E.] Univ Western Ontario, Elborn Coll, London, ON N6B 1H1, Canada	Martin, RE (reprint author), Univ Western Ontario, Elborn Coll, Rm 1510, London, ON N6B 1H1, Canada.	abe.kimiko@nihon-u.ac.jp; sweisz2015@meds.uwo.ca; rachelle.aupperle@live.com; martinadigioacchino@gmail.com; jnyentap@gmail.com; sstanbouly@hotmail.com; jtheurer@LawsonResearch.Com; ybureau@lawsonimaging.ca; raffoo@uwo.ca; remartin@uwo.ca			Nihon University School of Dentistry; Canadian Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	This research was supported by funding from Nihon University School of Dentistry (KA), the Canadian Natural Sciences and Engineering Research Council of Canada (RM), and the Canadian Institutes of Health Research (RM).	PROVINE RR, 1986, ETHOLOGY, V72, P109; Steele CM, 2004, DYSPHAGIA, V19, P192, DOI 10.1007/s00455-004-0006-5; KAHRILAS PJ, 1993, GASTROENTEROLOGY, V104, P152; PROVINE RR, 1987, ETHOLOGY, V76, P152; BARBIZET J, 1958, J NEUROL NEUROSUR PS, V21, P203, DOI 10.1136/jnnp.21.3.203; Ertekin C, 2000, NEUROGASTROENT MOTIL, V12, P567, DOI 10.1046/j.1365-2982.2000.00232.x; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Davenport PW, 2011, HEAD NECK-J SCI SPEC, V33, pS8, DOI 10.1002/hed.21845; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Takatsuji H, 2012, DYSPHAGIA, V27, P473, DOI 10.1007/s00455-012-9393-1; Walusinski O, 2004, REV NEUROL-FRANCE, V160, P1011; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Steele CM, 2010, DYSPHAGIA, V25, P323, DOI 10.1007/s00455-010-9301-5; THEXTON AJ, 1992, BRIT DENT J, V173, P197, DOI 10.1038/sj.bdj.4808002; Baenninger R, 1996, PHYSIOL BEHAV, V59, P421, DOI 10.1016/0031-9384(95)02014-4; BAENNINGER R, 1991, PSYCHOL REC, V41, P453; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; Lang IM, 2009, DYSPHAGIA, V24, P333, DOI 10.1007/s00455-009-9211-6; Argiolas A, 1998, EUR J PHARMACOL, V343, P1, DOI 10.1016/S0014-2999(97)01538-0; Barlow SM, 2009, CURR OPIN OTOLARYNGO, V17, P187, DOI 10.1097/MOO.0b013e32832b312a; Bieger D, 2006, GI MOTILITY ONLINE, DOI [10.1038/gimo74, DOI 10.1038/GIMO74]; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Cattaneo L, 2006, J NEUROL NEUROSUR PS, V77, P98, DOI 10.1136/jnnp.2005.075267; Chouard C H, 1990, Ann Otolaryngol Chir Cervicofac, V107, P145; Cooper NR, 2008, MED HYPOTHESES, V71, P975, DOI 10.1016/j.mehy.2008.07.023; Crary MA, 2013, STROKE, V44, P3452, DOI 10.1161/STROKEAHA.113.003048; GRECO M, 1993, PSYCHOL REC, V43, P175; GRECO M, 1991, PHYSIOL BEHAV, V50, P1067, DOI 10.1016/0031-9384(91)90439-U; Hiraba H, 2008, SOMATOSENS MOT RES, V25, P222, DOI 10.1080/08990220802611649; Inomata K, 2005, STANDARD ORAL PATHOL, P297; Jean A, 1990, NEUROPHYSIOLOGY JAWS, P294; KAPILA YV, 1984, DIGEST DIS SCI, V29, P528, DOI 10.1007/BF01296273; Lowell SY, 2008, 16 ANN DYSPH RES SOC; Martin Ruth E., 1993, Dysphagia, V8, P195, DOI 10.1007/BF01354538; MCFARLAND DH, 1993, J NEUROPHYSIOL, V69, P95; Miller AJ, 1999, NEUROSCIENTIFIC PRIN; Peyron MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021167; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; PROVINE RR, 1989, B PSYCHONOMIC SOC, V27, P211; PROVINE RR, 1987, BEHAV NEURAL BIOL, V48, P382, DOI 10.1016/S0163-1047(87)90944-7; RUDNEY JD, 1995, ARCH ORAL BIOL, V40, P507, DOI 10.1016/0003-9969(95)00004-9; Scott BJJ, 1999, J ORAL REHABIL, V26, P791, DOI 10.1046/j.1365-2842.1999.00454.x; Sessle BJ, 1975, MASTICATION SWALLOWI; Theurer JA, 2013, ARCH PHYS MED REHAB, V94, P1088, DOI 10.1016/j.apmr.2012.11.033; Theurer JA, 2005, DYSPHAGIA, V20, P254, DOI 10.1007/s00455-005-0021-1; Theurer JA, 2009, DYSPHAGIA, V24, P302, DOI 10.1007/s00455-009-9207-2; Walusinski O, 2010, INT J STROKE, V5, P21, DOI 10.1111/j.1747-4949.2009.00394.x; Walusinski O, 2006, MED HYPOTHESES, V67, P6, DOI 10.1016/j.mehy.2006.01.020; Alóe F, 1994, Arq Neuropsiquiatr, V52, P273; Zilli I, 2007, PHYSIOL BEHAV, V91, P218, DOI 10.1016/j.physbeh.2007.02.015	51	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	FEB	2015	30	1					57	66		10.1007/s00455-014-9573-2		10	Otorhinolaryngology	Otorhinolaryngology	CC6JO	WOS:000350471400005		
J	Maeda, K; Akagi, J				Maeda, Keisuke; Akagi, Junji			Decreased Tongue Pressure is Associated with Sarcopenia and Sarcopenic Dysphagia in the Elderly	DYSPHAGIA			English	Article						Tongue pressure; Sarcopenia; Sarcopenic dysphagia; Elderly; Deglutition; Deglutition disorders	OLDER-ADULTS; ALZHEIMERS-DISEASE; BODY-COMPOSITION; PERFORMANCE; DEMENTIA; STRENGTH; AGE; GENERATION; HEALTH	The aim of this study was to clarify the association between tongue pressure and factors related to sarcopenia such as aging, activities of daily living, nutritional state, and dysphagia. One-hundred-and-four patients without a history of treatment of stroke and without a diagnosis of neurodegenerative disease (36 men and 68 women), with a mean age of 84.1 +/- A 5.6 years, hospitalized from May 2013 to June 2013 were included in this study. Maximum voluntary tongue pressure against the palate (MTP) was measured by a device consisting of a disposable oral balloon probe. Nutritional and anthropometric parameters such as serum albumin concentration, Mini-Nutritional Assessment short form (MNA-SF), body mass index, arm muscle area (AMA), and others and presence of sarcopenia and dysphagia were analyzed to evaluate their relationships. Correlation analysis and univariate or multivariate analysis were performed. Simple correlation analysis showed that MTP correlated with Barthel index (BI), MNA-SF, serum albumin concentration, body mass index, and AMA. Univariate and multivariate analysis showed that sarcopenia, BI, MNA-SF, and age were the independent explanatory factors for decreased MTP, and the propensity score for dysphagia, including causes of primary or secondary sarcopenia, and the presence of sarcopenia were significantly associated with the presence of dysphagia. Decreased MTP and dysphagia were related to sarcopenia or the causes of sarcopenia in the studied population. Furthermore, the clinical condition of sarcopenic dysphagia may be partially interpreted as the presence of sarcopenia and causal factors for sarcopenia.	[Maeda, Keisuke] Tamana Reg Hlth Med Ctr, Dept Internal Med, Taman City, Kumamoto 8650005, Japan; [Akagi, Junji] Tamana Reg Hlth Med Ctr, Dept Surg, Tamana, Kumamoto 8650005, Japan	Maeda, K (reprint author), Tamana Reg Hlth Med Ctr, Dept Internal Med, 2172 Tamana, Taman City, Kumamoto 8650005, Japan.	maeda4work@tng.bbiq.jp		Maeda, Keisuke/0000-0001-7132-7818			Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Humbert IA, 2008, PHYS MED REHABIL CLI, V19, P853, DOI 10.1016/j.pmr.2008.06.002; Youmans SR, 2006, DYSPHAGIA, V21, P102, DOI 10.1007/s00455-006-9013-z; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI [10.1016/S1470-2045(10)70218-7, 10.1016/51470-2045(10)70218-7]; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Youmans SR, 2009, DYSPHAGIA, V24, P57, DOI 10.1007/s00455-008-9171-2; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Nicosia MA, 2000, J GERONTOL A-BIOL, V55, pM634; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; GREEN CR, 1993, J AM GERIATR SOC, V41, P654; Clark HM, 2012, DYSPHAGIA, V27, P2, DOI 10.1007/s00455-011-9328-2; Hudson HM, 2000, DYSPHAGIA, V15, P31; SINGH S, 1988, AGE AGEING, V17, P21, DOI 10.1093/ageing/17.1.21; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Buehring B, 2013, J AM GERIATR SOC, V61, P418, DOI 10.1111/jgs.12124; Burge E, 2012, EUR REV AGING PHYS A, V9, P27, DOI 10.1007/s11556-011-0092-y; Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219; Guyonnet S, 1998, J Nutr Health Aging, V2, P107; Hebert LE, 2008, AGING MENT HEALTH, V12, P729, DOI 10.1080/13607860802154390; Kendall KA, 2001, DYSPHAGIA, V16, P272, DOI 10.1007/s00455-001-0086-4; Kodaira Y, 2008, RES PRACT, V7, P40; Kuroda Y, 2014, INT J SPEECH-LANG PA, V2, P20; Logemann J.A., 1983, EVALUATION TREATMENT; MAHONEY F I, 1965, Md State Med J, V14, P61; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; Moriwaki H, 2001, JPN J NUTR ASSESS, V19, P45; Palmer J B, 1989, Dysphagia, V3, P192, DOI 10.1007/BF02407223; ROBBINS J, 1995, J GERONTOL A-BIOL, V50, pM257; Robbins J, 1996, SEMIN NEUROL, V16, P309, DOI 10.1055/s-2008-1040989; Sheth N, 1988, Dysphagia, V2, P209, DOI 10.1007/BF02414428; Steeman E, 1997, ARCH PSYCHIAT NURS, V11, P295, DOI 10.1016/S0883-9417(97)80002-7; Tsuga K, 2012, GERODONTOLOGY, V29, pE1078, DOI 10.1111/j.1741-2358.2011.00615.x; Ulibarri J., 2005, NUTR HOSP, V20, P38; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; Wakabayashi H., 2014, J FRAILTY AGING, V3, P97; Wang SY, 1997, J AM GERIATR SOC, V45, P1189	44	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	FEB	2015	30	1					80	87		10.1007/s00455-014-9577-y		8	Otorhinolaryngology	Otorhinolaryngology	CC6JO	WOS:000350471400008		
J	Maeda, K; Akagi, J				Maeda, Keisuke; Akagi, Junji			Decreased Tongue Pressure is Associated with Sarcopenia and Sarcopenic Dysphagia in the Elderly (vol 30, pg 80, 2015)	DYSPHAGIA			English	Correction									[Maeda, Keisuke] Tamana Reg Hlth Med Ctr, Dept Internal Med, Taman City, Kumamoto 8650005, Japan; [Akagi, Junji] Tamana Reg Hlth Med Ctr, Dept Surg, Taman, Kumamoto 8650005, Japan	Maeda, K (reprint author), Tamana Reg Hlth Med Ctr, Dept Internal Med, 2172 Tamana, Taman City, Kumamoto 8650005, Japan.	maeda4work@tng.bbiq.jp		Maeda, Keisuke/0000-0001-7132-7818			Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	FEB	2015	30	1					88	88		10.1007/s00455-014-9583-0		1	Otorhinolaryngology	Otorhinolaryngology	CC6JO	WOS:000350471400009		
J	Saitoh, E; Matsuo, K; Inamoto, Y; Ishikawa, M; Tsubahara, A				Saitoh, Eiichi; Matsuo, Koichiro; Inamoto, Yoko; Ishikawa, Makoto; Tsubahara, Akio			Twenty Years of Trans-disciplinary Approach Development for Dysphagia Rehabilitation in Japan	DYSPHAGIA			English	Letter									[Saitoh, Eiichi] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi 47011, Japan; [Matsuo, Koichiro] Fujita Hlth Univ, Sch Med, Dept Dent, Toyoake, Aichi 47011, Japan; [Inamoto, Yoko] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi 47011, Japan; [Ishikawa, Makoto] Med Inst Kiseikai, Shibuya Ku, Tokyo, Japan; [Tsubahara, Akio] Kawasaki Univ Med Welf, Kurashiki, Okayama, Japan	Matsuo, K (reprint author), Fujita Hlth Univ, Sch Med, Dept Dent, Toyoake, Aichi 47011, Japan.	esaitoh@fujita-hu.ac.jp; kmatsuo@fujita-hu.ac.jp; yoko5usagidon5@nifty.com; m-ishikawa@hatsudai-reha.or.jp; tsuba@med.kawasaki-m.ac.jp					[Anonymous], 2013, CURR POP EST OCT 1 2	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	FEB	2015	30	1					102	103		10.1007/s00455-014-9591-0		2	Otorhinolaryngology	Otorhinolaryngology	CC6JO	WOS:000350471400012		
J	Dao, DS; Yamada, H; Yogo, K				Duc Sy Dao; Yamada, Hidetaka; Yogo, Katsunori			Response Surface Optimization of Impregnation of Blended Amines into Mesoporous Silica for High-Performance CO2 Capture	ENERGY & FUELS			English	Article							CARBON-DIOXIDE CAPTURE; SOLID SORBENTS; ADSORPTION; ADSORBENTS; METHODOLOGY; SUPPORT; CHALLENGES; DESORPTION; STABILITY; REMOVAL	We used the response surface method (RSM) to optimize the conditions for the impregnation of blended amines into mesostructured cellular silica foam (MSU-F) to prepare effective solid sorbents for CO2 capture. The effects of the amounts of tetraethylenepentamine (TEPA), diethanolamine (DEA), and methanol (MeOH) in the wet impregnation mixture on the amounts of CO2 adsorbed were investigated. The influences of these three independent variables and their interactions were determined using the RSM; the optimum amounts of TEPA, DEA, and MeOH were 1.33 g (7.03 mmol), 0.85 g (8.08 mmol), and 58.2 g, for the preparation of 3 g of sorbent, respectively. Under the adsorption conditions of 40 degrees C and 100 kPa CO2, the optimum sorbent showed fast kinetics and an excellent CO2 adsorption of 5.64 mmol/g; the value predicted by the RSM model was 5.67 mmol/g. Analysis of variance and the coefficient of determination (R-2 = 0.9525) showed the utility of the approach used in this study to optimize the conditions for preparing high-performance solid sorbents. For the optimum sorbent, the heat of adsorption was determined to be 78.9 kJ/mol CO2 at 40 degrees C and 100 kPa, using a Calvet calorimeter, indicating relatively strong chemisorption in the form of carbamate. We also found that the amounts of CO2 adsorbed by the optimum sorbent substantially depended upon the adsorption temperature. The highest CO2 adsorption, 6.86 mmol/g, was obtained at 50 degrees C and 100 kPa.	[Duc Sy Dao; Yogo, Katsunori] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Nara 6300192, Japan; [Duc Sy Dao] Vietnam Natl Univ, Hanoi VNU, Fac Chem, Hanoi Univ Sci, Hanoi, Vietnam; [Yamada, Hidetaka; Yogo, Katsunori] Res Inst Innovat Technol Earth RITE, Kyoto 6190292, Japan	Yogo, K (reprint author), Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, 8916-5 Takayama Cho, Nara 6300192, Japan.	yogo@rite.or.jp			Ministry of Economy, Trade, and Industry (METI), Japan	The authors thank Fumio Asanoma at the Nara Institute of Science and Technology (NAIST) for technical support with elemental analysis. Financial support from the Ministry of Economy, Trade, and Industry (METI), Japan, is gratefully acknowledged.	Rezaei F, 2013, IND ENG CHEM RES, V52, P12192, DOI 10.1021/ie4019116; Peng YC, 2012, ENRGY PROCED, V14, P1515; Wang JT, 2013, J ENVIRON SCI-CHINA, V25, P124, DOI 10.1016/S1001-0742(12)60011-4; Qi GG, 2012, ENERG ENVIRON SCI, V5, P7368, DOI 10.1039/c2ee21394j; Korbahti BK, 2007, J HAZARD MATER, V145, P277, DOI 10.1016/j.jhazmat.2006.11.031; Gil MV, 2013, FUEL PROCESS TECHNOL, V106, P55, DOI 10.1016/j.fuproc.2012.06.018; Yue MB, 2008, MICROPOR MESOPOR MAT, V114, P74, DOI 10.1016/j.micromeso.2007.12.016; Shafeeyan MS, 2012, FUEL, V94, P465, DOI 10.1016/j.fuel.2011.11.035; Zhang H, 2014, RSC ADV, V4, P19403, DOI 10.1039/c4ra02145b; Torrades F, 2011, DESALINATION, V268, P97, DOI 10.1016/j.desal.2010.10.003; Yamada H, 2010, IND ENG CHEM RES, V49, P2449, DOI 10.1021/ie901185v; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Wang JT, 2012, ENERG ENVIRON SCI, V5, P5742, DOI 10.1039/c2ee02272a; Zelenak V, 2008, CHEM ENG J, V144, P336, DOI 10.1016/j.cej.2008.07.025; Dao DS, 2013, IND ENG CHEM RES, V52, P13810, DOI 10.1021/ie4020588; Wang WL, 2013, ENERG FUEL, V27, P1538, DOI 10.1021/ef3021816; Samanta A, 2012, IND ENG CHEM RES, V51, P1438, DOI 10.1021/ie200686q; Fujiki J, 2014, ENERG FUEL, V28, P6467, DOI 10.1021/ef500975g; Mello MR, 2011, MICROPOR MESOPOR MAT, V143, P174, DOI 10.1016/j.micromeso.2011.02.022; Zhang XY, 2012, IND ENG CHEM RES, V51, P15163, DOI 10.1021/ie300180u; Khatri RA, 2006, ENERG FUEL, V20, P1514, DOI 10.1021/ef050402y; Tanthana J, 2010, CHEMSUSCHEM, V3, P957, DOI 10.1002/cssc.201000090; Wang QA, 2011, ENERG ENVIRON SCI, V4, P42, DOI 10.1039/c0ee00064g; Yamada H, 2011, J PHYS CHEM A, V115, P3079, DOI 10.1021/jp109851k; Hiyoshi N, 2005, MICROPOR MESOPOR MAT, V84, P357, DOI 10.1016/j.micromeso.2005.06.010; Xu XC, 2003, MICROPOR MESOPOR MAT, V62, P29, DOI 10.1016/S1387-1811(03)00388-3; Drage TC, 2012, J MATER CHEM, V22, P2815, DOI 10.1039/c2jm12592g; Ebner AD, 2011, IND ENG CHEM RES, V50, P5634, DOI 10.1021/ie2000709; Srikanth CS, 2012, CHEMSUSCHEM, V5, P1435, DOI 10.1002/cssc.201100662; Satyapal S, 2001, ENERG FUEL, V15, P250, DOI 10.1021/ef0002391; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; Aziz B, 2011, LANGMUIR, V27, P3822, DOI 10.1021/la104629m; Dao D. S., 2014, PREPR PAP AM CHEM SO, V59, P435; Dasgupta S, 2009, SEPAR SCI TECHNOL, V44, P3973, DOI 10.1080/01496390903183170; Lee D, 2011, ENVIRON SCI TECHNOL, V45, P5704, DOI 10.1021/es200680v; Mortari DA, 2013, ENERG FUEL, V27, P2890, DOI 10.1021/ef400049z; Tang HY, 2013, ORG PROCESS RES DEV, V17, P632, DOI 10.1021/op3002905; Youn HK, 2011, MATER LETT, V65, P1772, DOI 10.1016/j.matlet.2011.03.039	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	FEB	2015	29	2					985	992		10.1021/ef502656t		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CB9HT	WOS:000349943300059		
J	Zhang, Q; Wu, DY; Lin, Y; Wang, XZ; Kong, HN; Tanaka, S				Zhang, Qi; Wu, Deyi; Lin, Yan; Wang, Xinze; Kong, Hainan; Tanaka, Shuzo			Substrate and Product Inhibition on Yeast Performance in Ethanol Fermentation	ENERGY & FUELS			English	Article							SIMULTANEOUS SACCHARIFICATION; SACCHAROMYCES-CEREVISIAE; TOLERANCE; OPTIMIZATION; STUCK	A batch fermentation utilizing Saccharomyces cerevisiae BY4742 was conducted to determine the inhibitory effects of highly concentrated substrate and product levels on yeast. Experiments were performed to determine the largest dosage of substrate and the largest product concentration that the yeast could tolerate in a very high gravity fermentation process. The yeasts growth and fermentation activities were characterized by changes in the biomass and ethanol yield under different substrate and product concentrations during fermentation. All of the experiments were performed at a pH of 5.0 and a temperature of 35 degrees C with a stirring rate of 180 r/min and a fermentation time of 96 h. Furthermore, five cycles of acclimatization were conducted to improve the yeasts tolerance to ethanol. Ethanol yield was maximized at 95% with a product concentration of 39 g/L and substrate dosage of 80 g/L. The system exhibited an obvious increase in cell growth and ethanol production with increasing substrate dosage up to a critical point of 160 g/L glucose (53 g/L ethanol fermented and an ethanol yield of 65%). Above this point, cell growth and ethanol production were inhibited with the final product concentration increasing only slightly with an increase in the initial substrate concentration. The end product (ethanol) was shown to be the primary factor inhibiting yeast growth and fermentation activity because the yeast would completely stop growing and fermenting when the initial exogenous ethanol concentration exceeded 70 g/L. The endogenous ethanol exerted a greater impact on yeast performance during anaerobic fermentation than exogenous ethanol. Five cycles of acclimatization significantly improved the yeast density, cell morphology, and ethanol production during very high gravity fermentation. The ethanol yield increased from 6% to 30% under an initial exogenous ethanol concentration of 60 g/L.	[Zhang, Qi; Wu, Deyi; Lin, Yan; Wang, Xinze; Kong, Hainan] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China; [Tanaka, Shuzo] Meisei Univ, Fac Sci & Engn, Program Environm & Ecol, Tokyo 1918506, Japan	Lin, Y (reprint author), Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	linyan2002@sjtu.edu.cn			Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07105-003]; Shanghai Natural Science Foundation [11ZR1417200]	The research project was sponsored by the Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07105-003) and the Shanghai Natural Science Foundation (No. 11ZR1417200). The authors would also like to thank Dr. Hui Lin and Dr. Tyler Barzee at University of California, Davis for their discussions and help on this work.	Alexandre H, 1998, J IND MICROBIOL BIOT, V20, P20, DOI 10.1038/sj.jim.2900442; Puligundla P, 2011, J IND MICROBIOL BIOT, V38, P1133, DOI 10.1007/s10295-011-0999-3; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001; Xue C, 2008, WORLD J MICROB BIOT, V24, P2257, DOI 10.1007/s11274-008-9739-x; Li YH, 2007, ENZYME MICROB TECH, V41, P312, DOI 10.1016/j.enzmictec.2007.02.008; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Singh A, 2013, RENEW ENERG, V50, P488, DOI 10.1016/j.renene.2012.07.003; Sukumaran RK, 2009, RENEW ENERG, V34, P421, DOI 10.1016/j.renene.2008.05.008; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Zhang W, 2013, FUEL, V112, P331, DOI 10.1016/j.fuel.2013.05.064; Pereira FB, 2010, BIORESOURCE TECHNOL, V101, P7856, DOI 10.1016/j.biortech.2010.04.082; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Apweiler E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-239; DOMBEK KM, 1986, APPL ENVIRON MICROB, V51, P197; DOMBEK KM, 1986, J IND MICROBIOL, V1, P219, DOI 10.1007/BF01569275; Fan Y. F., 2008, BREEDING YEAST HIGH, P128; [Hu Chunkeng 胡纯铿], 2005, [生物工程学报, Chinese Journal of Biotechnology], V21, P809; Hu Y. Z., 1993, CHIN OPHTHALMIC RES, V11, P90; Ji HR, 2012, APPL BIOCHEM BIOTECH, V168, P21, DOI 10.1007/s12010-011-9280-5; Lv X., 2003, FOOD FERMENT IND, V29, P21; Ma L. A., 2000, J HUBEI AGR COLL, V20, P72; Pessani NK, 2011, BIORESOURCE TECHNOL, V102, P10618, DOI 10.1016/j.biortech.2011.09.011; Peterson J. D, 2009, U.S. Patent Application, Patent No. [12/990, 031, 12990031]; Rossi FG, 2003, ENZYME MICROB TECH, V32, P107, DOI 10.1016/S0141-0229(02)00242-9; Santos J, 2008, MICROBIOL-SGM, V154, P422, DOI 10.1099/mic.0.2007/011445-0; Sherman F., 2002, METHOD ENZYMOL, V35, P3; Song A. D., 2003, LIQUOR MAKING, V30, P44; Sridhar J, 2000, APPL ENVIRON MICROB, V66, P246; Tao X., 2012, PLOS ONE, V7, P31; THOMAS KC, 1992, J IND MICROBIOL, V10, P61, DOI 10.1007/BF01583635; Voorst F. van, 2006, Yeast, V23, P351, DOI 10.1002/yea.1359	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	FEB	2015	29	2					1019	1027		10.1021/ef502349v		9	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CB9HT	WOS:000349943300063		
J	Koshima, T; Okada, H				Koshima, Tetsuya; Okada, Hiroshi			Three-dimensional J-integral evaluation for finite strain elastic-plastic solid using the quadratic tetrahedral finite element and automatic meshing methodology	ENGINEERING FRACTURE MECHANICS			English	Article						J-integral; Domain integral method; Finite element method; Finite deformation; Elastic-plastic deformation	STRESS INTENSITY FACTORS; DISSIMILAR ANISOTROPIC MATERIALS; SUPERCONVERGENT PATCH RECOVERY; CRACK EXTENSION METHOD; ENERGY-RELEASE RATES; FRACTURE-MECHANICS; INTERFACE CRACK; DYNAMIC FRACTURE; GROWTH; PROPAGATION	In this paper, the three-dimensional J-integral for finite deformation problems is critically concerned when it is computed by the domain integral method for the quadratic tetrahedral finite element. When a cracked body undergoes a large elastic-plastic deformation, the domain independent property is not guaranteed. Evaluation procedures that guarantee the domain independent property by including the terms involving the spatial derivatives of the strain energy density, etc., are proposed. The proposed methodology includes a way to compute such derivatives by adopting the concept of superconvergent patch recovery method. Finally, numerical examples demonstrate that proposed procedures can guarantee the domain independent property. (C) 2015 Elsevier Ltd. All rights reserved.	[Koshima, Tetsuya] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 2788510, Japan; [Okada, Hiroshi] Tokyo Univ Sci, Fac Engn, Dept Mech Engn, Noda, Chiba 2788510, Japan	Okada, H (reprint author), Tokyo Univ Sci, Fac Engn, Dept Mech Engn, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	hokada@rs.noda.tus.ac.jp			Japan Society for the Promotion of Science (JSPS) [25390157]	The research has been performed under the support of Grant-in-Aid for Scientific Research (c) ( No. 25390157) of Japan Society for the Promotion of Science (JSPS). The authors would like to express his sincere gratitude for the support.	Allen PA, 2014, ENG FRACT MECH, V119, P173, DOI 10.1016/j.engfracmech.2014.02.021; Pop O, 2013, WOOD SCI TECHNOL, V47, P257, DOI 10.1007/s00226-012-0488-5; Belytschko T, 1999, INT J NUMER METH ENG, V45, P601, DOI 10.1002/(SICI)1097-0207(19990620)45:5<601::AID-NME598>3.0.CO;2-S; Daimon R, 2014, ENG FRACT MECH, V115, P22, DOI 10.1016/j.engfracmech.2013.11.009; Nagai M, 2007, ENG FRACT MECH, V74, P2481, DOI 10.1016/j.engfracmech.2006.12.027; ATLURI SN, 1984, ENG FRACT MECH, V20, P209, DOI 10.1016/0013-7944(84)90129-2; BRUST FW, 1985, ENG FRACT MECH, V22, P1079, DOI 10.1016/0013-7944(85)90046-3; Ural A, 2005, ENG FRACT MECH, V72, P1148, DOI 10.1016/j.engfracmech.2004.08.004; Pathak H, 2013, INT J FRACTURE, V181, P189, DOI 10.1007/s10704-013-9835-2; ZIENKIEWICZ OC, 1995, FINITE ELEM ANAL DES, V19, P11, DOI 10.1016/0168-874X(94)00054-J; SHIVAKUMAR KN, 1992, ENG FRACT MECH, V42, P935, DOI 10.1016/0013-7944(92)90134-Z; Okada H, 2013, INT J FATIGUE, V50, P33, DOI 10.1016/j.ijfatigue.2012.04.009; Pereira JPA, 2012, COMPUT MECH, V49, P99, DOI 10.1007/s00466-011-0631-4; LI FZ, 1985, ENG FRACT MECH, V21, P405, DOI 10.1016/0013-7944(85)90029-3; Lei Y, 2005, ENG FRACT MECH, V72, P577, DOI 10.1016/j.engfracmech.2004.04.003; RICE JR, 1968, J APPL MECH, V35, P379; Firmature R, 2000, ENG FRACT MECH, V66, P15, DOI 10.1016/S0013-7944(99)00135-6; Kuang JH, 1996, ENG FRACT MECH, V55, P869, DOI 10.1016/S0013-7944(96)00077-X; Duarte CA, 2001, COMPUT METHOD APPL M, V190, P2227, DOI 10.1016/S0045-7825(00)00233-4; Nishioka T, 2003, CMES-COMP MODEL ENG, V4, P119; NIKISHKOV GP, 1987, ENG FRACT MECH, V26, P851, DOI 10.1016/0013-7944(87)90034-8; Okada H, 2008, ENG FRACT MECH, V75, P4466, DOI 10.1016/j.engfracmech.2008.04.014; Moes N, 2002, INT J NUMER METH ENG, V53, P2549, DOI 10.1002/nme.429; PARKS DM, 1977, COMPUT METHOD APPL M, V12, P353, DOI 10.1016/0045-7825(77)90023-8; Carka D, 2011, J APPL MECH-T ASME, V78, DOI 10.1115/1.4001748; SHIH CF, 1986, INT J FRACTURE, V30, P79; AOKI S, 1992, INT J FRACTURE, V55, P363, DOI 10.1007/BF00035191; Atluri SN, 1986, COMPUTATIONAL METHOD, P121; BANKSSILLS L, 1991, COMPUT STRUCT, V41, P981, DOI 10.1016/0045-7949(91)90291-S; Bremberg D, 2009, INT J FRACTURE, V157, P109, DOI 10.1007/s10704-009-9313-z; Bremberg D, 2008, ENG FRACT MECH, V75, P404, DOI 10.1016/j.engfracmech.2007.01.003; BROBERG KB, 1995, ENG FRACT MECH, V50, P157, DOI 10.1016/0013-7944(94)00188-N; Carka D, 2012, J APPL MECH, V79-044502, P1; Cho DH, 2011, FATIGUE FRACT ENG M, V34, P667, DOI 10.1111/j.1460-2695.2011.01558.x; CLAYDON PW, 1992, ENG FRACT MECH, V42, P961, DOI 10.1016/0013-7944(92)90135-2; Elmeguenni M, 2013, INT J FRACTURE, V183, P119, DOI 10.1007/s10704-013-9848-x; Grabouil A, 2002, INT J NUMER METHODS, V53, P2569; Hellen T. K., 1975, International Journal for Numerical Methods in Engineering, V9, DOI 10.1002/nme.1620090114; Kaneko Shuhei, 2012, Journal of Computational Science and Technology, V6, DOI 10.1299/jcst.6.97; Kikuchi M, 1984, JPN SOC MECH ENG A, V50, P1524; KIKUCHI M, 1984, B JSME, V27, P2365; Lan WM, 2007, ENG FRACT MECH, V74, P2498, DOI 10.1016/j.engfracmech.2006.12.026; Lee CH, 2009, COMP MATER SCI, V46, P186, DOI 10.1016/j.commatsci.2009.02.021; Legrain G, 2005, INT J NUMER METH ENG, V63, P290, DOI 10.1002/nme.1291; LIEBOWITZ H, 1995, ENG FRACT MECH, V50, P653, DOI 10.1016/0013-7944(94)E0051-H; Lucht T, 2009, ENG FRACT MECH, V76, P2148, DOI 10.1016/j.engfracmech.2009.03.007; MCMEEKING RM, 1977, J MECH PHYS SOLIDS, V25, P357, DOI 10.1016/0022-5096(77)90003-5; MSC.Software, 2012, MARC 2012; Nagai M, 2007, INT J FRACTURE, V146, P233, DOI 10.1007/s10704-007-9163-5; NIKISHKOV GP, 1988, ENG FRACT MECH, V29, P81, DOI 10.1016/0013-7944(88)90008-2; Nishioka T, 2002, JSME INT J A-SOLID M, V45, P523, DOI 10.1299/jsmea.45.523; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Okada H, 2013, ENG FRACT MECH, V109, P58, DOI 10.1016/j.engfracmech.2013.06.009; Okada H, 1999, COMPUT MECH, V23, P339, DOI 10.1007/s004660050414; Rajaram H, 2000, ENG FRACT MECH, V66, P455, DOI 10.1016/S0013-7944(00)00025-4; Sukmar N, 2003, ENG FRACT MECH, V70, P29; Taniguchi T, 2006, AUTOMATIC MESH GENER; Wang L, 1997, COMPUT MECH, V19, P370, DOI 10.1007/s004660050185; Wawrzynek PA, 2009, 12 INT C FRACT ICF12; ZIENKIEWICZ OC, 1992, INT J NUMER METH ENG, V33, P1331, DOI 10.1002/nme.1620330702	60	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	FEB	2015	135						34	63		10.1016/j.engfracmech.2015.01.014		30	Mechanics	Mechanics	CC0CO	WOS:000350002800003		
J	Fukumura, N; Suzuki, T; Hamada, S; Tsuzaki, K; Noguchi, H				Fukumura, Naoki; Suzuki, Tomohiro; Hamada, Shigeru; Tsuzaki, Kaneaki; Noguchi, Hiroshi			Mechanical examination of crack length dependency and material dependency on threshold stress intensity factor range with Dugdale model	ENGINEERING FRACTURE MECHANICS			English	Article						Fatigue crack growth; Crack closure; Cohesive zone modeling; Short cracks; Crack growth threshold	SHORT FATIGUE CRACKS; GROWTH-BEHAVIOR; CURVE METHOD; PROPAGATION; CLOSURE; PLASTICITY; NOTCHES; STEEL; LIMIT; LAW	The threshold stress intensity factor range Delta K-th was analytically calculated under stress control conditions using the plasticity-induced crack closure analysis with the Dugdale model. Before obtaining Delta K-th, the accuracy of the method was verified. The characteristics of the crack closure behavior were discussed by specifying the small-scale yielding (SSY) and large-scale yielding (LSY). The analysis results of Delta K-th were discussed systematically by non-dimensionalizing them with the Dugdale model. Under the SSY condition, DKth was dependent on Young's modulus and Poisson's ratio. Under the LSY condition, Delta K-th increased when the initial crack length or yield strain increased. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukumura, Naoki] Kyushu Univ, Dept Mech Engn, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Suzuki, Tomohiro] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Hamada, Shigeru; Tsuzaki, Kaneaki; Noguchi, Hiroshi] Kyushu Univ, Dept Mech Engn, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan	Noguchi, H (reprint author), Kyushu Univ, Dept Mech Engn, Fac Engn, Nishi Ku, Moto Oka 744, Fukuoka 8190395, Japan.	nogu@mech.kyushu-u.ac.jp		Noguchi, Hiroshi/0000-0002-9439-7226			Belytschko T, 1999, INT J NUMER METH ENG, V45, P601, DOI 10.1002/(SICI)1097-0207(19990620)45:5<601::AID-NME598>3.0.CO;2-S; DUGDALE DS, 1960, J MECH PHYS SOLIDS, V8, P100, DOI 10.1016/0022-5096(60)90013-2; SURESH S, 1981, METALL TRANS A, V12, P1435, DOI 10.1007/BF02643688; NISITANI H, 1992, ENG FRACT MECH, V41, P499; Oda Y, 2002, INT J FRACTURE, V113, P213, DOI 10.1023/A:1014211617958; de Matos PFP, 2008, ENG FRACT MECH, V75, P2087, DOI 10.1016/j.engfracmech.2007.10.017; LAIRD C, 1962, PHILOS MAG, V7, P847, DOI 10.1080/14786436208212674; Solanki K, 2004, ENG FRACT MECH, V71, P149, DOI 10.1016/S0013-7944(03)00099-7; TANAKA K, 1988, ENG FRACT MECH, V30, P863, DOI 10.1016/0013-7944(88)90146-4; WALKER N, 1979, FATIGUE ENG MATER, V1, P135, DOI 10.1111/j.1460-2695.1979.tb00372.x; Suresh S., 1984, International Metals Reviews, V29; MINAKAWA K, 1981, SCRIPTA METALL MATER, V15, P633, DOI 10.1016/0036-9748(81)90041-7; Miyazaki T, 2004, INT J FRACTURE, V129, P21, DOI 10.1023/B:FRAC.0000038886.80094.59; Hamada S, 2013, INT J FATIGUE, V56, P86, DOI 10.1016/j.ijfatigue.2013.08.006; CHERMAHINI RG, 1989, ENG FRACT MECH, V34, P393, DOI 10.1016/0013-7944(89)90152-5; Akiniwa Y, 1997, FATIGUE FRACT ENG M, V20, P1387, DOI 10.1111/j.1460-2695.1997.tb01497.x; Toyosada M, 2004, INT J FATIGUE, V26, P983, DOI 10.1016/j.ijfatigue.2003.12.006; ASTM, 2011, E64711 ASTM; Budiansky B, 1978, J APPL MECH, V45, P2174; Burdekin F.M., 1966, J STRAIN ANAL, V1, P145, DOI DOI 10.1243/03093247V012145; Elbert W., 1971, ASTM STP, V486, P230; Erdogan F, 1963, J BASIC ENG, V85, P528, DOI DOI 10.1115/1.3656900; Gotoh K, 2009, C P JAP SOC NAV ARCH, V8, P449; JAMES MR, 1983, METALL TRANS A, V14, P153, DOI 10.1007/BF02643749; Kikukawa M, 1982, ADV FRACTURE RES, P1799; KUO AS, 1976, SCRIPTA METALL MATER, V10, P723, DOI 10.1016/0036-9748(76)90350-1; LIAW PK, 1983, ACTA METALL MATER, V31, P1581, DOI 10.1016/0001-6160(83)90155-4; MCCARVER JF, 1982, MATER SCI ENG, V55, P63, DOI 10.1016/0025-5416(82)90084-2; Murakami Y, 1986, BEHAV SHORT FATIGUE, P275; Murakami Y, 2002, METAL FATIGUE EFFECT; NEUMANN P, 1974, ACTA METALL MATER, V22, P1155, DOI 10.1016/0001-6160(74)90071-6; Newman Jr J C, 1981, ASTM SPEC TECH PUBL, P53; Rice J, 1967, ASTM STP, V415, P247; RITCHIE RO, 1980, J ENG MATER-T ASME, V102, P293; Sadananda K, 2004, ACTA MATER, V52, P4239, DOI 10.1016/j.actamat.2004.05.040; Stewart AT, 1980, ENG FRACT MECH, V13, P475; Tabor D., 1951, HARDNESS METALS; Tanaka K, 2010, PROCEDIA ENGINEER, V2, P27, DOI 10.1016/j.proeng.2010.03.004; Toyosada M, 2005, P 11 INT C FRACT, V2, P1062; Usami S, 1981, FATIGUE THRESHOLDS; Yokobori AT, 1981, MICRO MACROMECHANICS, P171	41	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	FEB	2015	135						168	186		10.1016/j.engfracmech.2015.01.003		19	Mechanics	Mechanics	CC0CO	WOS:000350002800010		
J	Meshii, T; Lu, K; Fujiwara, Y				Meshii, Toshiyuki; Lu, Kai; Fujiwara, Yuki			Extended investigation of the test specimen thickness (TST) effect on the fracture toughness (J(c)) of a material in the ductile-to-brittle transition temperature region as a difference in the crack tip constraint - What is the loss of constraint in the TST effects on J(c)?	ENGINEERING FRACTURE MECHANICS			English	Article						Fracture toughness; Test specimen thickness effect; Transition temperature; Stress triaxiality; Crack-tip constraint	SEMIELLIPTIC SURFACE CRACKS; NONUNIFORM STRESS DISTRIBUTIONS; ELASTIC-PLASTIC FRACTURE; ELLIPTIC CORNER CRACKS; OF-PLANE CONSTRAINT; HARDENING MATERIAL; CLEAVAGE FRACTURE; BORDER FIELD; PLATES; TENSION	This paper answers a question that was raised from our recent work [1] for the non-standard single-edge notched bend (SE(B)) specimens, which exhibited the test specimen thickness effect on J(c) (TST effect on J(c)) together with the bounded nature for increasing TST in the ductile-to-brittle transition temperature region. The question was "what is the loss of constraint in the TST effect on J(c), because the crack opening stress sigma(22) distribution scaled with CTOD at fracture load was approximately same for different TSTs?'' To answer this question, several well-known constraint parameters were investigated to determine their correlations with the TST effect and the bounded nature of J(c) for increasing TST. Based on the elastic-plastic finite element analysis results, it was demonstrated that the well-known stress triaxiality factor Theta = (hydrostatic stress)/(von Mises stress), measured at 4 delta(tc) (crack-tip opening displacement at fracture load P-c), exhibited a good correlation with the decreasing and subsequently bounded nature of J(c) for increasing TST. H started to decrease at some load level before fracture for relatively thin specimens, and this was the loss of constraint in the TST effects on J(c). (C) 2014 The Authors. Published by Elsevier Ltd.	[Meshii, Toshiyuki] Univ Fukui, Fac Engn, Fukui 910, Japan; [Lu, Kai; Fujiwara, Yuki] Univ Fukui, Grad Sch Engn, Fukui 910, Japan	Lu, K (reprint author), Univ Fukui, Grad Sch Engn, 3-9-1 Bunkyo, Fukui 910, Japan.	kai_lu@u-fukui.ac.jp	Meshii, Toshiyuki/G-2248-2010	Meshii, Toshiyuki/0000-0001-5496-6087	JSPS KAKENHI [24561038]	Part of this work was supported by JSPS KAKENHI Grant Number 24561038, and their support is greatly appreciated.	Anderson TL, 2005, FRACTURE MECH FUNDAM; She CM, 2007, INT J SOLIDS STRUCT, V44, P3021, DOI 10.1016/j.ijsolstr.2006.09.002; Wang X, 2004, ENG FRACT MECH, V71, P1477, DOI 10.1016/S0013-7944(03)00140-1; Lewis T, 2008, ENG FRACT MECH, V75, P3206, DOI 10.1016/j.engfracmech.2007.12.001; RICE JR, 1968, J MECH PHYS SOLIDS, V16, P1, DOI 10.1016/0022-5096(68)90013-6; Qu J, 2006, INT J PRES VES PIP, V83, P593, DOI 10.1016/j.ijpvp.2006.04.003; ANDERSON TL, 1994, AM SOC TEST MATER, V1207, P186, DOI 10.1520/STP13706S; KIRK MT, 1993, AM SOC TEST MATER, V1171, P79, DOI 10.1520/STP18024S; KIRK MT, 1994, AM SOC TEST MATER, V1207, P62, DOI 10.1520/STP13700S; ALANI AM, 1991, J MECH PHYS SOLIDS, V39, P23, DOI 10.1016/0022-5096(91)90029-N; Wang X, 2003, ENG FRACT MECH, V70, P731, DOI 10.1016/S0013-7944(02)00081-4; Wang X, 2004, ENG FRACT MECH, V71, P2283, DOI 10.1016/j.engfracmech.2004.02.001; Petti JP, 2004, ENG FRACT MECH, V71, P2079, DOI [10.1016/j.engfracmech.2003.08.004, 10.1016/j.engfrachmech.2003.08.004]; GUO WL, 1993, ENG FRACT MECH, V46, P93, DOI 10.1016/0013-7944(93)90306-D; Meshii T, 2010, ENG FRACT MECH, V77, P2467, DOI 10.1016/j.engfracmech.2010.06.007; Zhao JH, 2008, INT J MECH SCI, V50, P1168, DOI 10.1016/j.ijmecsci.2008.04.006; Lu K, 2014, ENG FRACT MECH, V116, P197, DOI 10.1016/j.engfracmech.2013.12.011; Matvienko YG, 2013, FATIGUE FRACT ENG M, V36, P14, DOI 10.1111/j.1460-2695.2012.01722.x; Zhao JH, 2007, INT J FATIGUE, V29, P435, DOI 10.1016/j.ijfatigue.2006.05.005; ODOWD NP, 1991, J MECH PHYS SOLIDS, V39, P989, DOI 10.1016/0022-5096(91)90049-T; Henry BS, 1997, ENG FRACT MECH, V57, P375, DOI 10.1016/S0013-7944(97)00031-3; GUO WL, 1993, ENG FRACT MECH, V46, P105, DOI 10.1016/0013-7944(93)90307-E; DODDS RH, 1991, INT J FRACTURE, V48, P1, DOI 10.1007/BF00012499; DU ZZ, 1991, J MECH PHYS SOLIDS, V39, P555, DOI 10.1016/0022-5096(91)90041-L; WALLIN K, 1985, ENG FRACT MECH, V22, P149, DOI 10.1016/0013-7944(85)90167-5; BETEGON C, 1991, J APPL MECH-T ASME, V58, P104; Bilby B. A., 1986, FINITE ELEMENT INVES, P37; Dlouhy I, 2004, ENG FRACT MECH, V71, P873, DOI 10.1016/S0013-7944(03)00027-4; GAO HJ, 1992, INT J FRACTURE, V58, P241, DOI 10.1007/BF00015618; Gonzalez-Albuixech VF, 2011, ENG FRACT MECH, V78, P412, DOI 10.1016/j.engfracmech.2010.11.003; HOM CL, 1990, INT J FRACTURE, V45, P103; HUTCHINS.JW, 1968, J MECH PHYS SOLIDS, V16, P13, DOI 10.1016/0022-5096(68)90014-8; Lu K, 2014, ADV MATER SCI ENG, DOI 10.1155/2014/269137; Meshii T, 2013, ENG FRACT MECH, V104, P184, DOI 10.1016/j.engfracmech.2013.03.025; Neimitz A, 2006, INT J PRES VES PIP, V83, P42, DOI 10.1016/j.ijpvp.2005.10.001; Sumpter JDG., 1993, STP ASTM, V1171, P495; Meshii T, 2010, ENG FRACT MECH, V77, P867, DOI 10.1016/j.engfracmech.2010.01.014; THEISS TJ, 1993, AM SOC TEST MATER, V1171, P104, DOI 10.1520/STP18025S; Zhang B, 2007, ENG FRACT MECH, V74, P386, DOI 10.1016/j.engfracmech.2006.05.011; Zhang B, 2005, INT J FRACTURE, V131, P173, DOI 10.1007/s10704-004-5105-7; Zhao J, 2007, FATIGUE FRACT ENG M, V30, P673, DOI 10.1111/j.1460-2695.2007.01114.x; Zhao JH, 2006, ACTA MECH SINICA, V22, P148, DOI 10.1007/s10409-006-0095-5	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	FEB	2015	135						286	294		10.1016/j.engfracmech.2014.07.025		9	Mechanics	Mechanics	CC0CO	WOS:000350002800018		
J	Iwasa, M; Moki, Y; Takahashi, J				Iwasa, Mitsuhiro; Moki, Yukari; Takahashi, Junichi			Effects of the Activity of Coprophagous Insects on Greenhouse Gas Emissions from Cattle Dung Pats and Changes in Amounts of Nitrogen, Carbon, and Energy	ENVIRONMENTAL ENTOMOLOGY			English	Article						CH4; CO2; dung beetle; fly larva; N2O	COW DUNG; METHANE EMISSION; UNDERLYING SOIL; RABBIT FECES; BEETLES; DECOMPOSITION; EXCRETA; DISAPPEARANCE; DIOXIDE; PASTURE	Effects of coprophagous insects on greenhouse gas emissions from cattle dung pats were investigated during the initial stage in the decomposition of dung, with accompanying changes in nitrogen, carbon, and energy content. We set up three treatments with adults of Caccobius jessoensis Harold (dung beetle) and larvae of the fly Neomyia cornicina (F.): 1) dung with dung beetles; 2) dung with fly larvae; and 3) dung without insects. In these treatments, the gas flux was measured from air flow exiting the glass containers connected with an in vitro continuous gas analysis system. Total gas fluxes from dung pats with fly larvae were lowest in carbon dioxide (CO2), methane (CH4), and nitrous oxide (N2O). The presence of dung beetles significantly increased CO2 flux from dung, but reduced CH4 flux compared with dung without insects. Fluxes of N2O from dung pats with dung beetles and without insects had distinct peaks at different times after the start of the experiment, while N2O from dung with fly larvae was emitted in extremely low levels throughout the experiment. Carbon (C) content in dung with beetles was significantly lower than that of untreated dung pats designated as fresh dung, whereas that of dung with fly larvae was higher than dung with beetles and without insects. Nitrogen (N) content was significantly lower in dung with fly larvae than the other treatments. Contents of C and N in fly pupae were 35.87 and 8.05%, respectively. During the larval growth of the fly, energy accumulated in the fly body was 2,830 J/g.	[Iwasa, Mitsuhiro; Moki, Yukari] Obihiro Univ Agr & Vet Med, Entomol Lab, Obihiro, Hokkaido 0808555, Japan; [Takahashi, Junichi] Obihiro Univ Agr & Vet Med, Dept Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan	Iwasa, M (reprint author), Obihiro Univ Agr & Vet Med, Entomol Lab, Obihiro, Hokkaido 0808555, Japan.	iwasa@obihiro.ac.jp					ADRIANO DC, 1974, J ENVIRON QUAL, V3, P258; HOLTER P, 1991, PEDOBIOLOGIA, V35, P381; Bellarby J, 2013, GLOBAL CHANGE BIOL, V19, P3, DOI 10.1111/j.1365-2486.2012.02786.x; ANGEL K, 1974, J ECOL, V62, P429; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; HOLTER P, 1979, OIKOS, V32, P393, DOI 10.2307/3544751; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513; Brown J, 2010, APPL SOIL ECOL, V46, P9, DOI 10.1016/j.apsoil.2010.05.010; van Groenigen JW, 2005, PLANT SOIL, V273, P15, DOI 10.1007/s11104-004-6261-2; YOKOYAMA K, 1991, SOIL BIOL BIOCHEM, V23, P649; BORNEMIS.GF, 1970, PEDOBIOLOGIA, V10, P1; BREYMEYER A, 1975, B ACAD POL SCI BIOL, V23, P257; GILLARD P., 1967, Journal of the Australian Institute of Agricultural Science, V33, P30; HELSEL ED, 1979, CAN ENTOMOL, V111, P213; HOLTER P, 1990, SOIL BIOL BIOCHEM, V22, P995, DOI 10.1016/0038-0717(90)90143-N; Holter P, 1997, SOIL BIOL BIOCHEM, V29, P31, DOI 10.1016/S0038-0717(96)00267-2; HOLTER P, 1994, EUR J SOIL BIOL, V30, P187; Iwasa M, 2008, APPL ENTOMOL ZOOL, V43, P271, DOI 10.1303/aez.2008.271; Jarvis SC, 1995, SOIL BIOL BIOCHEM, V27, P1581, DOI 10.1016/0038-0717(95)00092-S; Kreuzer M, 2002, GREENHOUSE GASES AND ANIMAL AGRICULTURE, PROCEEDINGS, P145; Kreuzer M., 2006, INT C SERIES, V1293, P199, DOI 10.1016/j.ics.2006.01.015; Macdiarmid B. N., 1972, BR GRASSLD SOC J, V27, P43; MACQUEEN A, 1975, ENVIRON ENTOMOL, V4, P868; Masse DI, 2002, GREENHOUSE GASES AND ANIMAL AGRICULTURE, PROCEEDINGS, P307; Mwenya B., 2006, INT C SERIES, V1293, P209, DOI 10.1016/j.ics.2006.03.027; NAKAMURA Y, 1975, PEDOBIOLOGIA, V15, P210; Papp L., 1970, ACTA ZOOL ACAD SCI H, V17, P91; Pen B, 2006, ANIM FEED SCI TECH, V129, P175, DOI 10.1016/j.anifeedsci.2006.01.002; Penttila A., 2013, PLOS ONE, V8, P1; Petersen SO, 1998, ATMOS ENVIRON, V32, P295, DOI 10.1016/S1352-2310(97)00043-5; Sherman RA, 2000, ANNU REV ENTOMOL, V45, P55, DOI 10.1146/annurev.ento.45.1.55; Shiraishi M., 2006, INT C SERIES, P303; Shiraishi M, 2004, BULLETIN, V15, P70; STEVENSON BG, 1987, PEDOBIOLOGIA, V30, P81; Takahashi J., 2004, RECENT ADV ANIMAL NU, P97; YOKOYAMA K, 1991, SOIL BIOL BIOCHEM, V23, P643; Yokoyama K., 1991, EDAPHOLOGIA, V47, P33; Yokoyama K., 1990, EDAPHOLOGIA, V43, P51	40	0	0	ENTOMOLOGICAL SOC AMER	ANNAPOLIS	3 PARK PLACE, STE 307, ANNAPOLIS, MD 21401-3722 USA	0046-225X	1938-2936		ENVIRON ENTOMOL	Environ. Entomol.	FEB	2015	44	1					106	113		10.1093/ee/nvu023		8	Entomology	Entomology	CC5ZO	WOS:000350444300013		
J	Nascimento, FX; Hasegawa, K; Mota, M; Vicente, CSL				Nascimento, Francisco X.; Hasegawa, Koichi; Mota, Manuel; Vicente, Claudia S. L.			Bacterial role in pine wilt disease development - review and future perspectives	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Review							NEMATODE BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; ENDOPHYTIC BACTERIA; PSEUDOMONAS-SYRINGAE; POPULATION-DYNAMICS; PANTOEA-AGGLOMERANS; BRENNERIA-SALICIS; INNATE IMMUNITY; PLANT; THUNBERGII	Mutualistic and beneficial relationships between nematodes and bacteria are highly present in nature, mostly occurring because of nutritional dependence and pathogen protection, and intrinsically related with the environment, the ecological conditions and the nematode life stages. Thirty-four years have passed since the first hypothesis suggesting a bacterial role in pine wilt disease (PWD), associated with the pinewood nematode (PWN), Bursaphelenchus xylophilus. In 1980, researchers reported that bacteria associated with the PWN could produce toxins that lead to PWD development in pine seedlings. It was also suggested a double vector system for PWD, where bacteria were vectored by the PWN and the PWN vectored by an insect from the Monochamus genus. Presently, the specific involvement of bacteria in such complex disease is still controversial, even though the increased number of studies focused on the potential bacteria role has increased considerably. This review is an up-to-date comprehensive perspective and brings new insights on the role of PWN-associated bacteria in PWD.	[Nascimento, Francisco X.; Mota, Manuel; Vicente, Claudia S. L.] Univ Evora, ICAAM, Dept Biol, Nucleo Mitra, P-7002554 Evora, Portugal; [Hasegawa, Koichi] Chubu Univ, Dept Environm Biol, Kasugai, Aichi 487, Japan; [Mota, Manuel] INIAV, Unidade Estrateg Invest, Oeiras, Portugal; [Mota, Manuel] INIAV, Serv Sistemas Agr & Florestais, Oeiras, Portugal; [Mota, Manuel] INIAV, Serv Saindade Vegetal, Oeiras, Portugal	Vicente, CSL (reprint author), Univ Evora, ICAAM, Dept Biol, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal.	cvicente@uevora.pt		Mota, Manuel/0000-0002-4145-5031; Vicente, Claudia/0000-0002-3865-5358	Portuguese national scientific agency FCT (Fundacao para a Ciencia e Tecnologia) [TDC/BIA-MIC/3768/2012, FCOMP-01-0124-FEDER-028368]; European Project REPHRAME - Development of improved methods for detection; EU Plant Health policy, European Union Seventh Framework Programme [FP7-KBBE-2010-4]; EDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic [PEst-C/AGR/UI0115/2011]	This work was supported by the Portuguese national scientific agency FCT (Fundacao para a Ciencia e Tecnologia)/project PTDC/BIA-MIC/3768/2012 (FCOMP-01-0124-FEDER-028368), the European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme FP7-KBBE-2010-4; and by FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The authors would like to thank Candida Sofia Trindade (INIAV, Portugal) for her contribution on Figure 1 (histological cut of Pinus pinaster).	Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Hallmann J, 1997, CAN J MICROBIOL, V43, P895; Yuan Weimin, 2011, Weishengwu Xuebao, V51, P1071; Izumi H, 2008, CAN J MICROBIOL, V54, P173, DOI 10.1139/w07-134; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; Xu ZQ, 2013, EUR J PLANT PATHOL, V136, P729, DOI 10.1007/s10658-013-0202-y; Sipponen A, 2011, APMIS, V119, P720, DOI 10.1111/j.1600-0463.2011.02791.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Zhao BG, 2007, J PHYTOPATHOL, V155, P26, DOI 10.1111/j.1439-0434.2006.01188.x; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Roriz M, 2011, EXP PARASITOL, V128, P357, DOI 10.1016/j.exppara.2011.04.008; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Murfin KE, 2012, BIOL BULL-US, V223, P85; BAKER KF, 1966, ANNU REV PHYTOPATHOL, V14, P311; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; BOLLA RI, 1982, J NEMATOL, V14, P377; Cankar K, 2005, FEMS MICROBIOL LETT, V244, P341, DOI 10.1016/j.femsle.2005.02.008; Cheng H. R., 1983, FOREST PEST DIS, V4, P1; Cheng XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01869; Dang L. D., 2011, NEMATOLOGY, V13, P521; Fielding N. J., 1996, FORESTRY, V69, P36; Guo D., 2008, RUSS J NEMATOL, V16, P151; Guo Q., 2007, J NEMATOL, V39, P243; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Hara Naoki, 2006, Japanese Journal of Nematology, V36, P23, DOI 10.3725/jjn.36.23; Hara N., 2001, Journal of the Japanese Forestry Society, V83, P285; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Hong Y. D., 2002, J NANJING FOR U, V26, P5; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Huvenne H, 2009, ENVIRON MICROBIOL, V11, P1463, DOI 10.1111/j.1462-2920.2009.01874.x; Izumi H, 2011, FOR SCI, V80, P95, DOI 10.1007/978-94-007-1599-8_6; Kawazu Kazuyoshi, 1997, Japanese Journal of Nematology, V27, P76; Kawazu K., 1999, SCI REPORTS FACULTY, V88, P1; Kawazu K., 1998, SCI REPORTS FACULTY, V87, P1; KAWAZU K, 1990, NIPPON NOGEIK KAISHI, V64, P1262; Kawazu K, 1996, BIOSCI BIOTECH BIOCH, V60, P1413; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kong L., 2010, ARCH MICROBIOL, V192, P585; Kuroda K., 2008, PINE WILT DIS 4, P202; KURODA K, 1991, EUR J FOREST PATHOL, V21, P82; KURODA K, 1988, Annals of the Phytopathological Society of Japan, V54, P606; Kusonoki M., 1987, ANN PHYTOPATHOL SOC, V53, P622; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; Langenheim J. H., 2003, PLANT RESINS CHEMIST; LUND B M, 1972, Potato Research, V15, P174, DOI 10.1007/BF02355965; Ma Liang-jin, 2009, Chinese Journal of Biological Control, V25, P220; Maes M, 2009, ENVIRON MICROBIOL, V11, P1453, DOI 10.1111/j.1462-2920.2009.01873.x; Mamiya Y, 2012, J NEMATOL, V44, P255; Martins D., 2012, THESIS U AVEIRO; Mota M. M., 2008, PINE WILT DIS, P33; MUNDT JO, 1976, APPL ENVIRON MICROB, V32, P694; MYERS RF, 1988, J NEMATOL, V20, P236; Niu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031716; OKU H, 1988, J NEMATOL, V20, P245; Oku H., 1981, P 17 IUFRO WORLD C V, P281; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Paiva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079705; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Proenca D. N., 2012, J BACTERIOL, V194, P4789; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Robertson L., 2011, NEMATOLOGY, V13, P755; Sabaratnam S, 2003, APPL ENVIRON MICROB, V69, P1220, DOI 10.1128/AEM.69.2.1220-1228.2003; Santos C. S. S., 2012, EUR J PLANT PATHOL, V132, P407; Scortichini M, 2007, J PLANT PATHOL, V89, P431; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Subramoni S., 2009, HDB HYDROCARBON LIPI, V4, P3269; Takemoto S., 2008, PINE WILT DIS, P105, DOI 10.1007/978-4-431-75655-2_12; Tamura H., 1973, Japanese Journal of Nematology., V3, P30; Tamura H., 1983, Japanese Journal of Nematology, V13, P1; Tan Jiajin, 2004, Scientia Silvae Sinicae, V40, P110; Tzean S., 1985, P 6 ROC S EL MICR, P38; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vicente CSL, 2013, FEMS MICROBIOL LETT, V347, P130, DOI 10.1111/1574-6968.12232; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; Yan X, 2012, GENE, V505, P81, DOI 10.1016/j.gene.2012.05.041; Yano S, 1913, SANRIN KOUHOU, V4, P1; Yi C.K., 1989, RES REP FOR RES I, P141; Zhang H, 1997, Z NATURFORSCH C, V52, P329; Zhang L., 2012, AFR J MICROBIOL RES, V6, P1322; Zhang QiLing, 2010, Acta Phytopathologica Sinica, V40, P381; Zhao B. G., 2004, J BEIJING FOR U, V1, P57; Zhao Bo-guang, 2000, Journal of Nanjing Forestry University, V24, P75; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2011, J NEMATOL, V43, P129; Zhao BG, 2009, J NEMATOL, V41, P11; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	102	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	FEB	2015	7	1					51	63		10.1111/1758-2229.12202		13	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CC6KP	WOS:000350474100018		
J	Kang, B; Yoon, HS				Kang, Bongmun; Yoon, Ho-Sung			The application of two-step linear temperature program to thermal analysis for monitoring the lipid induction of Nostoc sp KNUA003 in large scale cultivation	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						Two-step linear temperature program; Heat evolved; Total lipid content; Nostoc sp KNUA003; Large-scale cultivation; Lipid induction	BIODIESEL PRODUCTION; NILE RED; MICROALGAE; PHOTOBIOREACTOR; QUANTIFICATION; ACCUMULATION; STRAINS	Recently, microalgae was considered as a renewable energy for fuel production because its production is nonseasonal and may take place on nonarable land. Despite all of these advantages, microalgal oil production is significantly affected by environmental factors. Furthermore, the large variability remains an important problem in measurement of algae productivity and compositional analysis, especially, the total lipid content. Thus, there is considerable interest in accurate determination of total lipid content during the biotechnological process. For these reason, various high-throughput technologies were suggested for accurate measurement of total lipids contained in the microorganisms, especially oleaginous microalgae. In addition, more advanced technologies were employed to quantify the total lipids of the microalgae without a pretreatment. However, these methods are difficult to measure total lipid content in wet form microalgae obtained from large-scale production. In present study, the thermal analysis performed with two-step linear temeperature program was applied to measure heat evolved in temperature range from 310 to 351 degrees C of Nostoc sp. KNUA003 obtained from large-scale cultivation. And then, we examined the relationship between the heat evolved in 310-351 degrees C (H-E) and total lipid content of the wet Nostoc cell cultivated in raceway. As a result, the linear relationship was determined between H-E value and total lipid content of Nostoc sp. KNUA003. Particularly, there was a linear relationship of 98% between the H-E value and the total lipid content of the tested microorganism. Based on this relationship, the total lipid content converted from the heat evolved of wet Nostoc sp. KNUA003 could be used for monitoring its lipid induction in large-scale cultivation. (C) 2014 Elsevier Inc. All rights reserved.	[Kang, Bongmun] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Yoon, Ho-Sung] Kyungpook Natl Univ, Dept Biol, Taegu 702701, South Korea	Kang, B (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Hashigami Cho 1, Kyoto 6068585, Japan.	biobe064@gmail.com			Advanced Biomass R&D Center belonging to Ministry of Science, ICT and Future Planning of Republic of Korea	This work was supported in part by a grant-in-aid for scientific research from the Advanced Biomass R&D Center belonging to Ministry of Science, ICT and Future Planning of Republic of Korea.	Algae Biomass Organization, 2014, ALG MEAS VERS 6 0; AN XW, 1991, THERMOCHIM ACTA, V190, P241, DOI 10.1016/0040-6031(91)85250-L; GUCKERT JB, 1990, J PHYCOL, V26, P72, DOI 10.1111/j.0022-3646.1990.00072.x; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Yeh KL, 2011, BIOTECHNOL J, V6, P1358, DOI 10.1002/biot.201000433; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Talebi AF, 2013, ALGAL RES, V2, P258, DOI 10.1016/j.algal.2013.04.003; Illman AM, 2000, ENZYME MICROB TECH, V27, P631, DOI 10.1016/S0141-0229(00)00266-0; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Rawat I, 2013, APPL ENERG, V103, P444, DOI 10.1016/j.apenergy.2012.10.004; Feng GD, 2013, BIORESOURCE TECHNOL, V128, P107, DOI 10.1016/j.biortech.2012.09.123; ARSENEAU DF, 1961, CAN J CHEM, V39, P1915, DOI 10.1139/v61-257; Davey PT, 2012, ALGAL RES, V1, P166, DOI 10.1016/j.algal.2012.07.003; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Hsieh CH, 2009, BIORESOURCE TECHNOL, V100, P3921, DOI 10.1016/j.biortech.2009.03.019; Sharma K, 2014, GREEN CHEM, V16, P3539, DOI 10.1039/c4gc00552j; Praveenkumar R, 2012, BIOMASS BIOENERG, V37, P60, DOI 10.1016/j.biombioe.2011.12.035; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Lohman EJ, 2013, J MICROBIOL METH, V94, P235, DOI 10.1016/j.mimet.2013.06.007; Gao CF, 2008, J MICROBIOL METH, V75, P437, DOI 10.1016/j.mimet.2008.07.019; COOKSEY KE, 1987, J MICROBIOL METH, V6, P333, DOI 10.1016/0167-7012(87)90019-4; Cooper MS, 2012, J BIOSCI BIOENG, V109, P198; Doan TTY, 2011, BIOMASS BIOENERG, V35, P2534, DOI DOI 10.1016/J.BIOMBIOE.2011.02.021; Kang B, 2011, BIOCHEM ENG J, V57, P23, DOI 10.1016/j.bej.2011.08.002; MITCHELL BD, 1965, J EXP BOT, V16, P1, DOI 10.1093/jxb/16.1.1; Nautiyal HP, 2014, FUEL PROCESS TECHNOL, V120, P79; Passell H, 2013, J ENVIRON MANAGE, V29, P103; Patil Y, 2008, INT J MOL SCI, V9, P1188; Peng XW, 2008, BIORESOURCE TECHNOL, V99, P8869, DOI 10.1016/j.biortech.2008.04.055; Price D. M., 2000, ENCY ANAL CHEM, P8094; Silva T. L., 2008, APPL BIOCHEM BIOTECH, V159, P568	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229	1879-0909		ENZYME MICROB TECH	Enzyme Microb. Technol.	FEB	2015	69						54	61		10.1016/j.enzmictec2014.12.005		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC1DE	WOS:000350080600008		
J	Iriuchishima, H; Saitoh, T; Handa, H; Isoda, A; Matsumoto, M; Sawamura, M; Iwasaki, A; Ushie, C; Hattori, H; Sasaki, Y; Mitsui, T; Yokohama, A; Tsukamoto, N; Murakami, H; Nojima, Y				Iriuchishima, Hirono; Saitoh, Takayuki; Handa, Hiroshi; Isoda, Atsushi; Matsumoto, Morio; Sawamura, Morio; Iwasaki, Atsushi; Ushie, Chiaki; Hattori, Hikaru; Sasaki, Yoshiko; Mitsui, Takeki; Yokohama, Akihiko; Tsukamoto, Norifumi; Murakami, Hirokazu; Nojima, Yoshihisa			A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents	EUROPEAN JOURNAL OF HAEMATOLOGY			English	Article						multiple myeloma; international staging system; anemia; plasmacytoma; novel agent era; prognostic factors	CENTRAL-NERVOUS-SYSTEM; LIGHT-CHAIN RATIO; IMPROVED SURVIVAL; EXTRAMEDULLARY; BORTEZOMIB; FEATURES; CLASSIFICATION; DELETIONS; DISEASE; IMPACT	Various prognostic markers for multiple myeloma (MM) have been identified, and stratification using these markers is considered important to optimize treatment strategies. The international staging system (ISS) is now a widely accepted prognostic staging system for MM patients; however, its validity is controversial in the era of new therapeutic regimens, since ISS had been established before introduction of new agents. We retrospectively reviewed prognostic factors in order to seek out an alternative staging system more suitably applied to MM patients treated with novel agents. We analyzed 178 newly diagnosed MM patients who received either conventional chemotherapy without novel agents (CT; n = 79) or chemotherapy with novel agents (NT; n = 99). Although median overall survival (OS) of patients treated with CT is significantly different depending on stages of ISS, ISS had no effect on OS among patients treated with NT. Meanwhile, we identified hemoglobin (Hb) and plasmacytoma as independent risk factors for OS in patients who received NT. Using these two parameters, we stratified NT patients into three stages; stage 1 (Hb >= 10 g/dL and absence of plasmacytoma), stage 2 (not stage 1 or 3), and stage 3 (Hb <10 g/dL and presence of plasmacytoma). We found that there were significant differences in median OS among the three stages (8.13, 5.95, and 2.45 yr for stages 1, 2, and 3, respectively). This preliminary study suggests that this alternative staging system based on Hb and plasmacytoma is a simple and useful way to predict prognosis of MM patients in the novel agent era.	[Iriuchishima, Hirono; Handa, Hiroshi; Mitsui, Takeki; Nojima, Yoshihisa] Gunma Univ, Dept Med & Clin Sci, Maebashi, Gumma 371, Japan; [Saitoh, Takayuki; Iwasaki, Atsushi; Ushie, Chiaki; Hattori, Hikaru; Sasaki, Yoshiko; Murakami, Hirokazu] Gunma Univ, Dept Lab Sci, Grad Sch Hlth Sci, Maebashi, Gumma 371, Japan; [Isoda, Atsushi; Matsumoto, Morio; Sawamura, Morio] Nishigunma Natl Hosp, Natl Hosp Org, Dept Hematol, Shibukawa, Gunma, Japan; [Yokohama, Akihiko] Gunma Univ Hosp, Dept Blood Transfus, Maebashi, Gumma, Japan; [Tsukamoto, Norifumi] Gunma Univ Hosp, Dept Oncol Ctr, Maebashi, Gumma, Japan	Iriuchishima, H (reprint author), Showa 3-29-22, Maebashi, Gunma 3718511, Japan.	iriuchishima.h@gmail.com					Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Yang SH, 2012, ANN HEMATOL, V91, P93, DOI 10.1007/s00277-011-1251-y; Tan D, 2013, LEUKEMIA RES, V37, P1070, DOI 10.1016/j.leukres.2013.06.008; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Chang H, 2004, BRIT J HAEMATOL, V127, P280, DOI 10.1111/j.1365-2141.2004.05199.x; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Snozek CLH, 2008, LEUKEMIA, V22, P1933, DOI 10.1038/leu.2008.171; Damaj G, 2004, EUR J HAEMATOL, V73, P402, DOI 10.1111/j.1600-0609.2004.00331.x; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Varettoni M, 2010, ANN ONCOL, V21, P325, DOI 10.1093/annonc/mdp329; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Fassas ABT, 2004, LEUKEMIA LYMPHOMA, V45, P291, DOI 10.1080/10428190310001597964; Kyrtsonis MC, 2009, SEMIN HEMATOL, V46, P110, DOI 10.1053/j.seminhematol.2009.02.004; Kyrtsonis MC, 2007, BRIT J HAEMATOL, V137, P240, DOI 10.1111/j.1365-2141.2007.06561.x; BERGSAGEL D. E., 1962, CANCER CHEMOTHER REPTS, V21, P87; Billecke L, 2012, ANTICANCER RES, V32, P2031; Billecke L, 2013, BRIT J HAEMATOL, V161, P87, DOI 10.1111/bjh.12223; CAVO M, 1989, BLOOD, V74, P1774; Deng Shu-Hui, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P217; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lopez-Anglada L, 2010, EUR J HAEMATOL, V84, P359, DOI 10.1111/j.1600-0609.2009.01399.x; Maltezas D, 2013, HEMATOL ONCOL, V31, P356, DOI 10.1002/hon.2026; MERLINI G, 1980, BLOOD, V55, P1011; Oriol Albert, 2011, Adv Ther, V28 Suppl 7, P1, DOI 10.1007/s12325-011-0079-0; OSGOOD E E, 1960, Cancer Chemother Rep, V9, P1; Rasche L, 2012, ANN HEMATOL, V91, P1031, DOI 10.1007/s00277-012-1414-5; MIGUEL JFS, 1989, BRIT J CANCER, V59, P113; Terpos E, 2005, EUR J HAEMATOL, V75, P376, DOI 10.1111/j.1600-0609.2005.00531.x	33	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0902-4441	1600-0609		EUR J HAEMATOL	Eur. J. Haematol.	FEB	2015	94	2					145	151		10.1111/ejh.12407		7	Hematology	Hematology	CC1KN	WOS:000350099700009		
J	Tokuda, K; Eguchi-Ishimae, M; Iwabuki, H; Kawakami, S; Tauchi, H; Ishii, E; Eguchi, M				Tokuda, Kiriko; Eguchi-Ishimae, Minenori; Iwabuki, Hidehiko; Kawakami, Sanae; Tauchi, Hisamichi; Ishii, Eiichi; Eguchi, Mariko			Lineage-dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia	EUROPEAN JOURNAL OF HAEMATOLOGY			English	Article						KRAS; juvenile myelomonocytic leukemia; loss of heterozygosity	ACUTE LYMPHOBLASTIC-LEUKEMIA; MUTATION; PATHOGENESIS; PATIENT; NRAS	Juvenile myelomonocytic leukemia (JMML) is a clonal disease arising from abnormal hematopoietic stem cells, although the involvement of lymphoid lineage differs among reported cases. Here, we present a case of JMML with a KRAS G13D mutation. The mutation was detected in various hematopoietic lineages, including T and B lymphocytes and also in lineage(-) CD34(+)CD38(-) hematopoietic stem cells, showing a different percentage of affected cells in each lineage. Single cell-based analysis of hematopoietic cells revealed the loss of wild-type KRAS in a significant proportion of G13D-harboring cells. The percentage of loss of heterozygosity (LOH)/non-LOH cells showed lineage-dependent skewing in hematopoietic cells. The loss of the wild-type KRAS allele may be a common secondary genetic change in KRAS-related JMML and may affect the differentiation behavior of early JMML progenitors.	[Tokuda, Kiriko; Eguchi-Ishimae, Minenori; Iwabuki, Hidehiko; Kawakami, Sanae; Tauchi, Hisamichi; Ishii, Eiichi; Eguchi, Mariko] Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime 7910295, Japan	Eguchi, M (reprint author), Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime 7910295, Japan.	maeguchi@m.ehime-u.ac.jp			Japan Children's Cancer Association; Ministry of Health and Labor of Japan	The authors thank the parents for consenting to the publication of their clinical details. The authors also thank Ms. Chihiro Tanaka and Ms. Tokiko Mizushiro for technical assistance. This study was supported by the Japan Children's Cancer Association, a Grant-in-Aid for Scientific Research, and a Grant-in-Aid for Cancer Research from the Ministry of Health and Labor of Japan.	Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Pauli S, 2012, AM J MED GENET A, V158A, P652, DOI 10.1002/ajmg.a.34439; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; Matsuda K, 2007, HAEMATOL-HEMATOL J, V92, P1576, DOI 10.3324/haematol.11503; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Koike K, 2008, BRIT J HAEMATOL, V141, P567, DOI 10.1111/j.1365-2141.2008.07104.x; Loh ML, 2010, HEMATOL-AM SOC HEMAT, P357, DOI 10.1182/asheducation-2010.1.357; Ly B, 2014, PEDIATR BLOOD CANCER, V61, P946, DOI 10.1002/pbc.24797; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; Scrideli CA, 2003, LEUKEMIA RES, V27, P371, DOI 10.1016/S0145-2126(02)00178-9	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0902-4441	1600-0609		EUR J HAEMATOL	Eur. J. Haematol.	FEB	2015	94	2					177	181		10.1111/ejh.12355		5	Hematology	Hematology	CC1KN	WOS:000350099700014		
J	Singh, A; Kim, OH; Iida, A; Park, WY; Ikegawa, S; Kapoor, S				Singh, Ankur; Kim, Ok-Hwa; Iida, Aritoshi; Park, Woong-Yang; Ikegawa, Shiro; Kapoor, Seema			A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Desbuquois dysplasia; Kim type; CANT1; Novel mutation	VARIANT	Desbuquois dysplasia (DBQD) is a rare skeletal dysplasia characterized by severe short stature, laxity, dislocation of multiple joints and developmental delay. DBQD is clinically heterogeneous. Distinct radiographic hand abnormalities such as the presence of extra-ossification distal to the second metacarpal or normal hand has led to its classification into types 1 and 2. Furthermore, the third type of DBQD, Kim type has been reported which is characterized by short metacarpals and elongated phalanges. However, DBQD Kim type has been exclusively reported in Japanese and Korean and its clinical characteristics remain to be delineated. Mutations in the calcium-activated nucleotidase 1 (CANT1) gene have been reported in all three types of DBQD. Previously reported patients with DBQD Kim type had a common mutation c.676G>A (p.Val226Met), which had a common founder between Japanese and Korean. Here, we report 3 Indian patients with DBQD, Kim type from 2 families which were unrelated to each other. We identified a novel mutation of CANT1, c.467C>T (p.Ser156Phe), in all the patients in the homozygous form. Our results show that DBQD Kim type is not exclusive to East Asians and also report a novel mutation from the Indian subcontinent. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Singh, Ankur] Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul, South Korea; [Iida, Aritoshi] RIKEN Ctr Integrated Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Translat Genom Lab, Seoul, South Korea; [Ikegawa, Shiro; Kapoor, Seema] MAMC Associated Lok Nayak Hosp, Div Genet, New Delhi, India	Kapoor, S (reprint author), M-439 Ground Floor, New Delhi, India.	drseemakapoor@gmail.com					Nizon M, 2012, HUM MUTAT, V33, P1261, DOI 10.1002/humu.22104; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Bui C, 2014, AM J HUM GENET, V94, P405, DOI 10.1016/j.ajhg.2014.01.020; Faivre L, 2004, AM J MED GENET A, V124A, P48, DOI 10.1002/ajmg.a.20440; Faden M, 2010, AM J MED GENET A, V152A, P1157, DOI 10.1002/ajmg.a.33404; Furuichi T, 2011, J MED GENET, V48, P32, DOI 10.1136/jmg.2010.080226; Kim OH, 2010, AM J MED GENET A, V152A, P875, DOI 10.1002/ajmg.a.33347; Laccone F, 2011, EUR J HUM GENET, V19, P1133, DOI 10.1038/ejhg.2011.101	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	FEB	2015	58	2					105	110		10.1016/j.ejmg.2014.11.006		6	Genetics & Heredity	Genetics & Heredity	CC3EL	WOS:000350228100008		
J	Le, ST; Asahara, H; Nishiwaki, N				Song Thi Le; Asahara, Haruyasu; Nishiwaki, Nagatoshi			Tailor-Made Synthesis of N,N,2,6-Tetrasubstituted 4-Nitroanilines by Three-Component Ring Transformation of Dinitropyridone	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Nitroheterocycles; Multicomponent reactions; Ring transformation; Ketones; Synthetic methods	DIELS-ALDER REACTIONS; DERIVATIVES; KETONES; HETEROCYCLES; CONVERSION; COMPLEXES; PYRAZOLES	The ring transformation of dinitropyridone afforded various kinds of 2,6-disubstituted-4-nitroanilines upon treatment with aliphatic ketones in the presence of ammonium acetate as a nitrogen source, wherein dinitropyridone behaved as the synthetic equivalent of unstable nitromalonaldehyde. The benzene ring, as well as the amino group of the nitroaniline framework, was easily modified by only changing a ketone and the nitrogen source, which afforded N,N,2,6-tetrasubstituted 4-nitroanilines in good to excellent yields.	[Song Thi Le; Asahara, Haruyasu; Nishiwaki, Nagatoshi] Kochi Univ Technol, Sch Environm Sci & Engn, Kochi 7828502, Japan; [Asahara, Haruyasu; Nishiwaki, Nagatoshi] Kochi Univ Technol, Res Ctr Mat Sci & Engn, Kochi 7828502, Japan	Nishiwaki, N (reprint author), Kochi Univ Technol, Sch Environm Sci & Engn, Kochi 7828502, Japan.	nishiwaki.nagatoshi@kochi-tech.ac.jp			Japan Society for the Promotion of Science (JSPS) [26410123]	We sincerely thank Prof. Satoshi Minakata (Osaka University, Japan) for his kind assistance. This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (Grant Number 26410123).	Al-Khafaji S., 2003, J CHEM RES SYNOP, V388, P701; Anderson ED, 2011, ORG LETT, V13, P2492, DOI 10.1021/ol2007428; Nanjo T, 2012, ORG LETT, V14, P4270, DOI 10.1021/ol302035j; Meinhard D, 2007, J AM CHEM SOC, V129, P9182, DOI 10.1021/ja070224i; Xie HX, 2008, ORG LETT, V10, P1923, DOI 10.1021/ol800417q; Bonacorso HG, 2013, J FLUORINE CHEM, V151, P38, DOI 10.1016/j.jfluchem.2013.03.014; Kirkham JD, 2012, ANGEW CHEM INT EDIT, V51, P6402, DOI 10.1002/anie.201200917; Yoshino Y, 2009, J AM CHEM SOC, V131, P7494, DOI 10.1021/ja900805y; Jorgensen AS, 2000, BIOORG MED CHEM LETT, V10, P2383, DOI 10.1016/S0960-894X(00)00474-1; Baddeley G, 1935, J CHEM SOC, P303, DOI 10.1039/jr9350000303; BARCZYNSKI P, 1978, RECL TRAV CHIM PAY B, V97, P256; BEVAN CWL, 1957, J CHEM SOC, P3194, DOI 10.1039/jr9570003194; Birch M., 2009, PCT Int. Appl, Patent No. [WO 2009-144473, 2009144473, 2009/144473]; Carver FJ, 2002, CHEM-EUR J, V8, P2848; Chimenti F, 2004, SYNTHETIC COMMUN, V34, P2549, DOI 10.1080/SCC-200025604; Delaunay T, 2010, ORG LETT, V12, P3328, DOI 10.1021/ol101087j; GRUBER W, 1953, CAN J CHEM, V31, P1181, DOI 10.1139/v53-152; Hajos G, 2001, EUR J ORG CHEM, P3405; Henry C, 2009, J ORG CHEM, V74, P1932, DOI 10.1021/jo802439d; Jamkhandi C. M., 2013, INT J PHARM PHARM SC, V5, P225; Kirkham J. D., 2012, ANGEW CHEM, V124, P6508; Koutentis PA, 2013, ORG BIOMOL CHEM, V11, P621, DOI 10.1039/c2ob26993g; Le S, 2014, SYNTHESIS-STUTTGART, V46, P2175, DOI 10.1055/s-0033-1341237; Le S. T., 2014, ASIAN J ORG CHEM, V3, P297; Liu Y., 2014, PCT Int. Appl, Patent No. [WO 2014-151147, 2014151147]; Matheis C, 2014, ORG LETT, V16, P5984, DOI 10.1021/ol5030037; Minksztym K, 2004, J MOL STRUCT, V691, P203, DOI 10.1016/j.molstruc.2003.12.021; Miura T., 2009, CHEM COMMUN, P1470; Nishiwaki N, 2013, TETRAHEDRON LETT, V54, P956, DOI 10.1016/j.tetlet.2012.12.020; Nishiwaki N, 2006, LETT ORG CHEM, V3, P629, DOI 10.2174/157017806778559563; Nishiwaki N, 2007, TOP HETEROCYCL CHEM, V8, P43, DOI 10.1007/7081_2006_048; Nishiwaki N, 2012, HETEROCYCLES, V84, P115, DOI 10.3987/REV-11-SR(P)3; Rajendran NM, 2014, ORGANOMETALLICS, V33, P217, DOI 10.1021/om400977c; Rykowski A, 2004, ARKIVOC, P74; Sabot C, 2012, CHEM COMMUN, V48, P768, DOI 10.1039/c1cc16562c; Sagitullina GP, 2009, RUSS J ORG CHEM+, V45, P1045, DOI 10.1134/S1070428009070112; Saka H., 2002, JPN KOKAI TOKKYO KOH, Patent No. 173476; TOHDA Y, 1990, B CHEM SOC JPN, V63, P2820, DOI 10.1246/bcsj.63.2820; van der Plas HC, 2000, J HETEROCYCLIC CHEM, V37, P427; Vollhardt K. P. C., 2007, ORGANIC CHEM STURCTU; Wade Jr. L. G., 2006, ORGANIC CHEM; Wu CR, 2010, ORG LETT, V12, P2234, DOI 10.1021/ol100586r	42	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	FEB	2015		6					1203	1206		10.1002/ejoc.201403652		4	Chemistry, Organic	Chemistry	CB9SM	WOS:000349972700005		
J	Fujiwara, S; Cadou, R; Yamaoka, Y; Takasu, K; Yamada, K				Fujiwara, Shinichi; Cadou, Romain; Yamaoka, Yousuke; Takasu, Kiyosei; Yamada, Ken-ichi			Hydrostannylation-Cross-Coupling Strategy for the Stereoselective Synthesis of Alkylidenemalonates and Related alpha,beta-Unsaturated Esters	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Cross-coupling; Hydrostannylation; Diastereoselectivity; Michael acceptors; Palladium	MICHAEL ADDITION; 1,3-DIPOLAR CYCLOADDITION; CONJUGATE ADDITION; AZOMETHINE YLIDES; AMINO-ACIDS; METHYL; ROUTE; ARYL; DERIVATIVES; ORGANOSTANNANES	A method for the stereoselective synthesis of alkylidenemalonates and related alpha,beta-unsaturated esters by a hydrostannylation-cross-coupling process has been developed. Pd-catalyzed and radical hydrostannylation of propiolate derivatives stereoselectively provided a-alkoxycarbonyl (E)-and (Z)-vinylstannanes, respectively, which were then converted into alkylidenemalonates by the Stille coupling reaction. A one-pot process was also realizable for the Pd-catalyzed reactions.	[Fujiwara, Shinichi; Cadou, Romain; Yamaoka, Yousuke; Takasu, Kiyosei; Yamada, Ken-ichi] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Yamada, K (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	yamak@pharm.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors thank the Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for Young Scientist (B), Grant-in-Aid for Scientific Research (C), and Postdoctral Fellowship to R. C.] and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Platform for Drug Design, Discovery and Development) for financial support.	Albrecht L, 2008, J ORG CHEM, V73, P8337, DOI 10.1021/jo801582t; Nilsson K, 1996, J AM CHEM SOC, V118, P4194, DOI 10.1021/ja953676g; Ohmatsu K, 2014, NAT CHEM, V6, P47, DOI [10.1038/nchem.1796, 10.1038/NCHEM.1796]; Littke AF, 1999, ANGEW CHEM INT EDIT, V38, P2411, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2411::AID-ANIE2411>3.0.CO;2-T; Kano T, 2011, CHEM SCI, V2, P2311, DOI 10.1039/c1sc00453k; Wen LL, 2010, ORG LETT, V12, P4655, DOI 10.1021/ol101894h; FARINA V, 1991, J AM CHEM SOC, V113, P9585, DOI 10.1021/ja00025a025; Mukherjee H, 2011, ACS CATAL, V1, P1010, DOI 10.1021/cs2002466; Penon O, 2008, CHEM-EUR J, V14, P4788, DOI 10.1002/chem.200800440; Wang M, 2011, ANGEW CHEM INT EDIT, V50, P4897, DOI 10.1002/anie.201007960; Stevens KL, 2005, ORG LETT, V7, P4753, DOI 10.1021/ol0519745; Yamada K, 2012, J ORG CHEM, V77, P5775, DOI 10.1021/jo300944f; Karimi B, 2014, CHEMCATCHEM, V6, P212, DOI 10.1002/cctc.201300739; Aoyagi S, 1998, J ORG CHEM, V63, P8397, DOI 10.1021/jo9813078; Su C, 2003, SYNTHESIS-STUTTGART, P555; Petrovic D, 2011, ORG LETT, V13, P6524, DOI 10.1021/ol202809y; Leung LT, 2005, ORG LETT, V7, P5249, DOI 10.1021/ol052129p; Orimoto K, 2013, ORG LETT, V15, P768, DOI 10.1021/ol303381c; SCOTT WJ, 1984, J AM CHEM SOC, V106, P4630, DOI 10.1021/ja00328a063; Wang MY, 2012, ORGANOMETALLICS, V31, P7870, DOI 10.1021/om300435s; Yamada KI, 2008, J ORG CHEM, V73, P9535, DOI 10.1021/jo801541m; Hughes TV, 1999, J ORG CHEM, V64, P313, DOI 10.1021/jo981924w; Ling TT, 2013, ORG LETT, V15, P5790, DOI 10.1021/ol402842u; Antonioletti R, 2002, TETRAHEDRON, V58, P589, DOI 10.1016/S0040-4020(01)01173-5; BAKER R, 1988, J CHEM SOC PERK T 1, P471, DOI 10.1039/p19880000471; BALAS L, 1991, ORGANOMETALLICS, V10, P366, DOI 10.1021/om00047a077; BOGER DL, 1988, J ORG CHEM, V53, P3408, DOI 10.1021/jo00250a002; Carcenac Y, 2010, ADV SYNTH CATAL, V352, P949, DOI 10.1002/adsc.200900828; Carola A., 1988, SYNTHETIC COMMUN, V18, P1133, DOI 10.1080/00397918808060900; Chowdhury R., 2013, EUR J ORG CHEM, P6167; Covarrubias-Zuniga AC, 2005, SYNTHESIS-STUTTGART, P2293, DOI 10.1055/s-2005-872082; da Silva KP, 2007, ORG LETT, V9, P2815, DOI 10.1021/ol070980t; HARTKE K, 1991, LIEBIGS ANN CHEM, P903; Jankova S, 2008, EUR J ORG CHEM, P47, DOI 10.1002/ejoc.200700916; JOUCLA M, 1978, TETRAHEDRON LETT, P2885; KARMARKAR PG, 1981, SYNTHESIS-STUTTGART, P228; KUNO A, 1992, CHEM PHARM BULL, V40, P1452; Lee JI, 2011, B KOREAN CHEM SOC, V32, P1765, DOI 10.5012/bkcs.2011.32.5.1765; LEUSINK AJ, 1967, J ORGANOMET CHEM, V9, P285, DOI 10.1016/S0022-328X(00)83730-4; LEY SV, 1989, TETRAHEDRON LETT, V30, P1001, DOI 10.1016/S0040-4039(00)95301-2; Littke A. F., 1999, ANGEW CHEM, V111, P2568, DOI 10.1002/(SICI)1521-3757(19990816)111:16<2568::AID-ANGE2568>3.3.CO;2-A; LIU HJ, 1988, TETRAHEDRON LETT, V29, P6721, DOI 10.1016/S0040-4039(00)82438-7; Milite C, 2011, BIOORGAN MED CHEM, V19, P3690, DOI 10.1016/j.bmc.2011.01.013; Mitchell T. N., 2007, ADV SYNTH CATAL, P67; Ooi T, 2001, TETRAHEDRON LETT, V42, P9245, DOI 10.1016/S0040-4039(01)02035-4; Orimoto K, 2013, HETEROCYCLES, V87, P827, DOI 10.3987/COM-13-12662; RAWAL VH, 1995, TETRAHEDRON LETT, V36, P19, DOI 10.1016/0040-4039(94)02159-9; ROSSI R, 1993, J ORGANOMET CHEM, V451, P33, DOI 10.1016/0022-328X(93)83005-G; Sai H, 2006, CHEM PHARM BULL, V54, P1686, DOI 10.1248/cpb.54.1686; SANO T, 1987, CHEM PHARM BULL, V35, P479; SINGH SM, 1991, CAN J CHEM, V69, P1872, DOI 10.1139/v91-271; Soderquist J. A., 2001, ARKIVOC, P12; Tanaka K., 2004, ANGEW CHEM, V116, P6672, DOI 10.1002/ange.200461533; Tanaka K, 2004, ANGEW CHEM INT EDIT, V43, P6510, DOI 10.1002/anie.200461533; Wang M., 2011, ANGEW CHEM, V123, P4999; WILSON JW, 1968, J AM CHEM SOC, V90, P3423, DOI 10.1021/ja01015a024; Wrackmeyer B., 2008, TIN CHEM FUNDAMENTAL, P43; Zhao GL, 2008, ADV SYNTH CATAL, V350, P657, DOI 10.1002/adse.200700570; Zhong P, 2001, SYNTHETIC COMMUN, V31, P311, DOI 10.1081/SCC-100000215; Zhu JL, 2000, CHEM COMMUN, P1599, DOI 10.1039/b004297h	60	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	FEB	2015		6					1264	1272		10.1002/ejoc.201403429		9	Chemistry, Organic	Chemistry	CB9SM	WOS:000349972700013		
J	Tamura, K; Harada, Y; Kunimi, M; Takemitsu, H; Hara, Y; Nakamura, T; Tagawa, M				Tamura, Katsutoshi; Harada, Yasuji; Kunimi, Maki; Takemitsu, Hiroshi; Hara, Yasushi; Nakamura, Tatsuo; Tagawa, Masahiro			Autologous Bone Marrow Mononuclear Cell Transplant and Surgical Decompression in a Dog With Chronic Spinal Cord Injury	EXPERIMENTAL AND CLINICAL TRANSPLANTATION			English	Article						Disk herniation; Diskectomy; Paraplegia; Veterinary medicine	SOMATOSENSORY-EVOKED POTENTIALS; INTERVERTEBRAL DISC HERNIATION; STROMAL CELLS; PAIN PERCEPTION; STEM-CELLS; DYSFUNCTION; CONTUSION; SECONDARY; ISCHEMIA; DELIVERY	Objectives: In dogs with deep analgesia caused by acute spinal cord injury from thoracolumbar disk herniation, autologous bone marrow mononuclear cell transplant may improve recovery. The purpose of the present study was to evaluate autologous bone marrow mononuclear cell transplant in a dog that had paraplegia and deep analgesia caused by chronic spinal cord injury. Materials and Methods: Autologous bone marrow mononuclear cell transplant was performed in a dog having paraplegia and analgesia for 3 years that was caused by a chronic spinal cord injury secondary to Hansen type I thoracolumbar disk herniation. Functional recovery was evaluated with electrophysiologic studies and the Texas Spinal Cord Injury Scale. Results: Somatosensory evoked potentials were absent before transplant but were detected after transplant. Functional improvement was noted (Texas Spinal Cord Injury Scale: before transplant, 0; after transplant, 6). No adverse events were observed. Conclusions: Autologous bone marrow mononuclear cell transplant into the subarachnoid space may be a safe and beneficial treatment for chronic spinal cord injury in dogs.	[Harada, Yasuji; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan; [Tamura, Katsutoshi; Kunimi, Maki; Takemitsu, Hiroshi] Aikouishida Anim Hosp, Kanagawa, Japan; [Harada, Yasuji; Hara, Yasushi; Tagawa, Masahiro] Nippon Vet & Life Sci Univ, Div Vet Surg, Tokyo, Japan	Tamura, K (reprint author), 1195-4 Takamori Isehara Shi, Kanagawa 2591114, Japan.	Katsutoshi@vet.name			Aikou Ishida Animal Hospital	We greatly appreciate the staff of Aikou Ishida Animal Hospital who performed the sample collection. Public funds were not used in this work; it was supported through private funds of the Aikou Ishida Animal Hospital. The authors have no conflicts of interest to declare.	Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P330, DOI 10.3171/spi.2004.1.3.0330; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Shi EY, 2010, ANESTHESIOLOGY, V113, P1109, DOI 10.1097/ALN.0b013e3181f6970d; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Bakshi A, 2006, J NEUROTRAUM, V23, P55, DOI 10.1089/neu.2006.23.55; Itoh H, 2008, J VET MED SCI, V70, P701, DOI 10.1292/jvms.70.701; Pelosi L, 2002, CLIN NEUROPHYSIOL, V113, P1082, DOI 10.1016/S1388-2457(02)00027-5; Laitinen OM, 2005, ACTA VET SCAND, V46, P79, DOI 10.1186/1751-0147-46-79; De Lahunta A, 1983, VET NEUROANATOMY CLI, P166; Okuno S, 2005, J VET MED SCI, V67, P719, DOI 10.1292/jvms.67.719; Tamura K, 2012, EXP CLIN TRANSPLANT, V10, P263, DOI 10.6002/ect.2011.0151; UZUKA Y, 1995, J VET MED SCI, V57, P871; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zentner J, 1987, Cent Nerv Syst Trauma, V4, P197	20	0	0	BASKENT UNIV	ANKARA	TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY	1304-0855			EXP CLIN TRANSPLANT	Exp. Clin. Transplant.	FEB	2015	13	1					100	105		10.6002/ect.2013.0237		6	Transplantation	Transplantation	CC5IJ	WOS:000350392000016		
J	Nagashima, T; Inoue, N; Yumoto, N; Saeki, Y; Magi, S; Volinsky, N; Sorkin, A; Kholodenko, BN; Okada-Hatakeyama, M				Nagashima, Takeshi; Inoue, Norihiko; Yumoto, Noriko; Saeki, Yuko; Magi, Shigeyuki; Volinsky, Natalia; Sorkin, Alexander; Kholodenko, Boris N.; Okada-Hatakeyama, Mariko			Feedforward regulation of mRNA stability by prolonged extracellular signal-regulated kinase activity	FEBS JOURNAL			English	Editorial Material						EGFR; ERK; mRNA stability; signal transduction; transcriptome	EPIDERMAL-GROWTH-FACTOR; SINGLE-MOLECULE ANALYSIS; EARLY GENE-PRODUCTS; T-CELL-ACTIVATION; POSTTRANSCRIPTIONAL REGULATION; SPATIOTEMPORAL CONTROL; FACTOR RECEPTOR; LIVING CELLS; EGF RECEPTOR; C-FOS	Extracellular signal-regulated kinase (ERK) plays a central role in signal transduction networks and cell fate decisions. Sustained ERK activation induces cell differentiation, whereas transient ERK results in the proliferation of several types of cells. Sustained ERK activity stabilizes the proteins of early-response gene products. However, the effect of ERK activity duration on mRNA stability is unknown. We analyzed the quantitative relationship between the duration of four ERK activity kinetics and the mRNA expression profile in growth factor-treated cells. Time-course transcriptome analysis revealed that the cells with prolonged ERK activity generally showed sustained mRNA expression of late response genes but not early or mid genes. Selected late response genes decayed more rapidly in the presence of a specific ERK inhibitor than a general transcription inhibitor and the decay rate was not related to the number of AU-rich elements. Our results suggest that sustained ERK activity plays an important role in the lifespan of the mRNA encoded by late response genes, in addition to the previously demonstrated role in protein stabilization of early-response genes, including transcription factors regulating the transcription of mid and late genes. This double-positive regulation of ligand-induced genes, also termed feedforward regulation, is critical in cell fate decisions.	[Nagashima, Takeshi; Inoue, Norihiko; Yumoto, Noriko; Saeki, Yuko; Magi, Shigeyuki; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Volinsky, Natalia; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Kholodenko, Boris N.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland	Okada-Hatakeyama, M (reprint author), RIKEN Ctr Integrat Med Sci IMS, Tsurumi Ku, 1-7-22 W518, Yokohama, Kanagawa 2300045, Japan.	marikoh@rcai.riken.jp		Kholodenko, Boris/0000-0002-9483-4975			Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Suer S, 2009, CELL TISSUE RES, V336, P213, DOI 10.1007/s00441-009-0776-z; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Chen CY, 2000, GENE DEV, V14, P1236; Essafi-Benkhadir K, 2010, METHODS MOL BIOL, V661, P451, DOI 10.1007/978-1-60761-795-2_28; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Gupta I, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.135068; Hiroshima M, 2012, P NATL ACAD SCI USA, V109, P13984, DOI 10.1073/pnas.1200464109; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244; Kim JH, 2002, EUR J BIOCHEM, V269, P2323, DOI 10.1046/j.1432-1033.2002.02877.x; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; ROSS J, 1995, MICROBIOL REV, V59, P423; SAWICKI SG, 1971, J CELL BIOL, V50, P746, DOI 10.1083/jcb.50.3.746; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Zhai BB, 2010, J BIOL CHEM, V285, P23568, DOI 10.1074/jbc.M110.107623	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	FEB	2015	282	4					613	629		10.1111/febs.13172		17	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC3YV	WOS:000350288300001		
J	Martin, P; Kelly, N; Kahana, B; Kahana, E; Willcox, BJ; Willcox, DC; Poon, LW				Martin, Peter; Kelly, Norene; Kahana, Boaz; Kahana, Eva; Willcox, Bradley J.; Willcox, D. Craig; Poon, Leonard W.			Defining Successful Aging: A Tangible or Elusive Concept?	GERONTOLOGIST			English	Article						Successful aging; Longevity; Centenarians	EXCEPTIONAL LONGEVITY; CENTENARIANS; DEFINITIONS; OLDER; LIFE; SELF	Everyone wants to age successfully; however, the definition and criteria of successful aging remain vague for laypersons, researchers, and policymakers in spite of decades of research on the topic. This paper highlights work of scholars who made significant theoretical contributions to the topic. A thorough review and evaluation of the literature on successful aging was undertaken. Our review includes early gerontological definitions of successful aging and related concepts. Historical perspectives reach back to philosophical and religious texts, and more recent approaches have focused on both process- and outcome-oriented models of successful aging. We elaborate on Baltes and Baltes' theory of selective optimization with compensation [Baltes, P. B., & Baltes, M. M. (1990a). Psychological perspectives on successful aging: The model of selective optimization with compensation. In P. B. Baltes & M. M. Baltes (Eds.), Successful aging: Perspectives from the behavioral sciences (pp. 1-34). United Kingdom: Cambridge University Press], Kahana and Kahana's preventive and corrective proactivity model [Kahana, E., & Kahana, B. (1996). Conceptual and empirical advances in understanding aging well through proactive adaptation. In V. Bengtson (Ed.), Adulthood and aging: Research on continuities and discontinuities (pp. 18-40). New York: Springer], and Rowe and Kahn's model of successful aging [Rowe, J. W., & Kahn, R. L. (1998). Successful aging. New York: Pantheon Books], outlining their commonalities and differences. Additional views on successful aging emphasize subjective versus objective perceptions of successful aging and relate successful aging to studies on healthy and exceptional longevity. Additional theoretical work is needed to better understand successful aging, including the way it can encompass disability and death and dying. The extent of rapid social and technological change influencing views on successful aging also deserves more consideration.	[Martin, Peter; Kelly, Norene] Iowa State Univ, Dept Human Dev & Family Studies, Ames, IA 50011 USA; [Kahana, Boaz] Cleveland State Univ, Dept Psychol, Cleveland, OH 44115 USA; [Kahana, Eva] Case Western Univ, Dept Sociol, Cleveland, OH USA; [Willcox, Bradley J.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; [Willcox, Bradley J.] Kuakini Med Ctr, Honolulu, HI USA; [Willcox, D. Craig] Okinawa Int Univ, Dept Human Welf, Ginowan, Okinawa, Japan; [Poon, Leonard W.] Univ Georgia, Inst Gerontol, Athens, GA 30602 USA	Martin, P (reprint author), Iowa State Univ, Dept Human Dev & Family Studies, Ames, IA 50011 USA.	pxmartin@iastate.edu					Achenbaum W. A., 2001, PRODUCTIVE AGING CON, P19; Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727; Kahn RL, 2003, SPRING S LIF STY ISS, P55; Gondo Y, 2006, J GERONTOL A-BIOL, V61, P305; Kahana E, 2012, AGING MENT HEALTH, V16, P438, DOI 10.1080/13607863.2011.644519; Jeste DV, 2010, WORLD PSYCHIATRY, V9, P78; Glass TA, 2003, ANN INTERN MED, V139, P382; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; Holstein MB, 2003, GERONTOLOGIST, V43, P787; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Andersen-Ranberg K, 2001, J AM GERIATR SOC, V49, P900, DOI 10.1046/j.1532-5415.2001.49180.x; Ouwehand C, 2007, CLIN PSYCHOL REV, V27, P873, DOI 10.1016/j.cpr.2006.11.003; HAVIGHURST RJ, 1961, GERONTOLOGIST, V1, P8; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Baltes PB, 1997, AM PSYCHOL, V52, P366, DOI 10.1037//0003-066X.52.4.366; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; Tate RB, 2003, GERONTOLOGIST, V43, P735; Pruchno RA, 2010, GERONTOLOGIST, V50, P821, DOI 10.1093/geront/gnq041; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; POON LW, 1992, INT J AGING HUM DEV, V34, P1, DOI 10.2190/8M7H-CJL7-6K5T-UMFV; Rowe JW, 1997, GERONTOLOGIST, V37, P433; Phelan EA, 2004, J AM GERIATR SOC, V52, P211, DOI 10.1111/j.1532-5415.2004.52056.x; Phelan EA, 2002, J AM GERIATR SOC, V50, P1306, DOI 10.1046/j.1532-5415.2002.t01-1-50324.x; Arnold J., 2010, CURRENT GERONTOLOGY, DOI [10.1155/2010/989315, DOI 10.1155/2010/989315]; Aspinwall L. G., 2011, OXFORD HDB STRESS HL, P334, DOI DOI 10.1093/OXFORDHB/9780195375343.013.0017; Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI DOI 10.1017/CBO9780511665684.003; Baltes PB, 1990, SUCCESSFUL AGING PER, V1, P1, DOI DOI 10.1017/CB09780511665684.003; Bell C. L., J AM GERIATRIC SOC; Birnbaum P., 1949, DAILY PRAYER BOOK; Butler R. N., 1985, PRODUCTIVE AGING ENH, DOI [10.1016/B978-1-4160-6231-8.10032-7, DOI 10.1016/B978-1-4160-6231-8.10032-7]; Cho J., 2012, J AGING RES, V2012, P1, DOI [10.1155/2012/695854, DOI 10.1155/2012/695854]; Colbert J. A., 2013, NEW ENGL J MED, V369, P1450; Collings P, 2001, J Cross Cult Gerontol, V16, P127, DOI 10.1023/A:1010698200870; Cumming E., 1961, GROWING OLD PROCESS; Douglas Charles Noel, 1917, 40000 QUOTATIONS PRO; Emlet CA, 2011, GERONTOLOGIST, V51, P101, DOI 10.1093/geront/gnq060; Erikson E. H., 1950, CHILDHOOD SOC; Erikson E. H, 1969, GANDHIS TRUTH; Featherman D. L., 1990, SUCCESSFUL AGING PER, P50, DOI 10.1017/CBO9780511665684.005; Franke H., 1987, HOCH HOCHSTBETAGTE, DOI [10.1007/978-3-642-95542-6, DOI 10.1007/978-3-642-95542-6]; Fries J. F., 1990, SUCCESSFUL AGING PER, P35, DOI [10.1017/CBO9780511665684.004, DOI 10.1017/CBO9780511665684.004]; Fry C. L., 2007, CULTURAL CONTEXT AGI, P104; Goedeke K., 1893, GOETHES SAMTLICHE WE; Great Thoughts Treasury, 2014, GREAT THOUGHTS TREAS; Havighurst R. J., 1963, AGE FUTURE, P419; Hirose N., 2006, GLOBAL AGEING, V4, P34; Jung C., 1933, MODERN MAN SEARCH SO; Kahana E, 2003, INVITATION LIFE COUR, P225; Kahana E., PROACTIVE APPROACHES, DOI [10.1159/000360222, DOI 10.1159/000360222]; Kahana E, 2003, AGEING INT, V28, P155, DOI DOI 10.1007/S12126-003-1022-8; Kahana E, 2001, J CLIN EPIDEMIOL, V54, pS53, DOI 10.1016/S0895-4356(01)00447-4; Kahana E., 1996, ADULTHOOD AGING RES, P18; Keith J., 1994, AGING EXPERIENCE DIV; LEHR U, 1991, Z GERONTOL, V24, P227; Martin P, 2002, DEV REV, V22, P78, DOI 10.1006/drev.2001.0538; Masoro EJ, 2001, GERONTOLOGIST, V41, P415; Merriam-Webster, 2014, SI JEUNESSE SAVAIT; Moody H. R., 2005, SUCCESSFUL AGING LIF, P55; National Research Council, 1991, EXT LIF ENH LIF NAT; Neugarten B. L., 1996, THE MEANINGS OF AGE; NEUGARTE.BL, 1972, GERONTOLOGIST, V12, P9; Palmore E., 1985, NORMAL AGING 3; Peck R., 1968, MIDDLE AGE AGING, P88; Pedersen N. L., 1990, SUCCESSFUL AGING PER, P359, DOI [10.1017/CBO9780511665684.014, DOI 10.1017/CBO9780511665684.014]; Poon L. W., 2003, SUCCESSFUL AGING ADA; Quotealbum, 2013, QUOTEALBUM; Ramamurti P. V., 2010, PSYCHOL INDIA CLIN H, V3, P185; Reichard S., 1962, AGING PERSONALITY; Rowe J. W., 1998, SUCCESSFUL AGING; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Shakespeare William Hamlet, 1974, RIVERSIDE SHAKESPEAR; Silverman P., 1987, ELDERLY MODERN PIONE, P312; Sokolovsky J., 1997, CULTURAL CONTEXT AGI, P179; Taylor C., 1897, SAYINGS JEWISH FATHE; The Quotations Page, 2014, THE QUOTATIONS PAGE; Tornstam L, 2005, GEROTRANSCENDENCE DE; Willcox B. J., 2006, AGING AGE RELATED DI, P459; Willcox D Craig, 2007, J Cross Cult Gerontol, V22, P137, DOI 10.1007/s10823-006-9032-0; Wykle M. L., 2005, SUCCESSFUL AGING LIF; Wykle M. L., 2010, AGING WELL GERONTOLO; Yi Z., 2009, HLTH LONGEVITY CHINA, DOI [10.1007/978-1-4020-6752-5, DOI 10.1007/978-1-4020-6752-5]; Zubko A, 1998, TREASURY SPIRITUAL W	83	3	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-9013	1758-5341		GERONTOLOGIST	Gerontologist	FEB	2015	55	1					14	25		10.1093/geront/gnu044		12	Gerontology	Geriatrics & Gerontology	CC0QI	WOS:000350040400003		
J	Mertens, KN; Wolny, J; Carbonell-Moore, C; Bogus, K; Ellegaard, M; Limoges, A; de Vernal, A; Gurdebeke, P; Omura, T; Al-Muftah, A; Matsuoka, K				Mertens, Kenneth Neil; Wolny, Jennifer; Carbonell-Moore, Consuelo; Bogus, Kara; Ellegaard, Marianne; Limoges, Audrey; de Vernal, Anne; Gurdebeke, Pieter; Omura, Takuo; Al-Muftah, Abdulrahman; Matsuoka, Kazumi			Taxonomic re-examination of the toxic armoured dinoflagellate Pyrodinium bahamense Plate 1906: Can morphology or LSU sequencing separate P. bahamense var. compressum from var. bahamense? (vol 41, pg 1, 2015)	HARMFUL ALGAE			English	Correction									[Mertens, Kenneth Neil; Gurdebeke, Pieter] Univ Ghent, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Wolny, Jennifer] Univ S Florida, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA; [Carbonell-Moore, Consuelo] Oregon State Univ, Coll Agr Sci, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Bogus, Kara] Texas A&M Univ, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Bogus, Kara] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77845 USA; [Ellegaard, Marianne] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark; [Limoges, Audrey; de Vernal, Anne] Univ Quebec, Geotop, Montreal, PQ H3C 3P8, Canada; [Omura, Takuo] Lab Aquat Sci Consultant Co LTD LASC, Ota Ku, Tokyo 1450064, Japan; [Al-Muftah, Abdulrahman] Qatar Univ, Dept Biol & Environm Sci, Doah, Qatar; [Matsuoka, Kazumi] Inst East China Sea Res ECSER, Nagasaki 8528521, Japan	Mertens, KN (reprint author), Univ Ghent, Res Unit Palaeontol, Knjgslaan 281 S8, B-9000 Ghent, Belgium.	kenneth.mertens@ugent.be	de Vernal, Anne/D-5602-2013	de Vernal, Anne/0000-0001-5656-724X			Mertens KN, 2015, HARMFUL ALGAE, V41, P1, DOI 10.1016/j.hal.2014.09.010	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	FEB	2015	42						71	72		10.1016/j.hal.2014.12.002		2	Marine & Freshwater Biology	Marine & Freshwater Biology	CC7BG	WOS:000350522100008		
J	Kobayashi, K; Ezaki, K; Hanioka, D; Nozawa, I				Kobayashi, Kazuhiro; Ezaki, Kosuke; Hanioka, Daisuke; Nozawa, Ippei			Synthesis of 6-Aminoindolo[2,1-a] isoquinoline-5-carbonitriles by the Cu-Catalyzed Reaction of 2-(2-Bromophenyl)-1H-indoles with CH2(CN)(2)	HELVETICA CHIMICA ACTA			English	Article								A series of 6-aminoindolo[2,1-a] isoquinoline-5-carbonitriles 4 have been prepared by treatment of 2-(2-bromophenyl)-1H-indoles 1, available from 1-(2-bromophenyl) ethanones or 1-(2-bromophenyl)-propan-1-ones by using Fischer indole synthesis, with propanedinitrile in the presence of a catalytic amount of CuBr and an excess of K2CO3 in DMSO at 100 degrees.	[Kobayashi, Kazuhiro; Ezaki, Kosuke; Hanioka, Daisuke; Nozawa, Ippei] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Div Appl Chem, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Div Appl Chem, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp					Sang P, 2012, ORG LETT, V14, P3894, DOI 10.1021/ol3016435; Kobayashi K, 2013, TETRAHEDRON, V69, P10304, DOI 10.1016/j.tet.2013.10.020; DALTON L, 1983, J CHEM SOC PERK T 1, P2417, DOI 10.1039/p19830002417; Kobayashi K, 2013, HETEROCYCLES, V87, P1925, DOI 10.3987/COM-13-12777; Kraus GA, 2013, TETRAHEDRON LETT, V54, P5597, DOI 10.1016/j.tetlet.2013.07.162; Sannicolo F, 2001, SYNTHESIS-STUTTGART, P2327; Van N. T. Cam-, 1964, TETRAHEDRON, V20, P2195	7	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	FEB	2015	98	2					179	183		10.1002/hlca.201400271		5	Chemistry, Multidisciplinary	Chemistry	CB9RZ	WOS:000349971400002		
J	Kobayashi, K; Matsumoto, N; Nagashima, M; Inouchi, H				Kobayashi, Kazuhiro; Matsumoto, Naoki; Nagashima, Mika; Inouchi, Hiroki			One-Pot Synthesis of 3-Acetyl-2-aryl-3,4-dihydroquinazolines from N-[2-(Azidomethyl)phenyl]benzamides Utilizing Intramolecular Aza-Wittig Reaction	HELVETICA CHIMICA ACTA			English	Article							3,4-DIHYDROQUINAZOLINES; CYCLIZATION	A new and convenient method for the preparation of 3,4-dihydroquinazolines 5 with aryl and Ac groups at C(2) and N(3), respectively, has been developed. The key sequence is the formation of aza-phosphorane intermediates by the reaction of N-[2-(azidomethyl)phenyl]benzamides 1 with Ph3P, followed by intramolecular aza-Wittig reaction and 3-acetylation, which can be conducted in one-pot.	[Kobayashi, Kazuhiro; Matsumoto, Naoki; Nagashima, Mika; Inouchi, Hiroki] Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp			JSPS KAKENHI [26410051]	This work was supported in part by JSPS KAKENHI, grant No. 26410051. We thank Mrs. Miyuki Tanmatsu of our university for her support in recording mass spectra and performing combustion analyses.	Kumar RA, 2012, ADV SYNTH CATAL, V354, P2985, DOI 10.1002/adsc.201200679; Zhong Y, 2011, TETRAHEDRON, V67, P3714, DOI 10.1016/j.tet.2011.03.056; PLOWMAN J, 1988, INVEST NEW DRUG, V6, P147; Rohlmann R, 2013, J ORG CHEM, V78, P6050, DOI 10.1021/jo4007199; Ghosh AK, 2012, BIOORG MED CHEM LETT, V22, P5460, DOI 10.1016/j.bmcl.2012.07.043; He P., 2010, EUR J ORG CHEM, V1088; Kobayashi K, 2014, HELV CHIM ACTA, V97, P923, DOI 10.1002/hlca.201400078; Krasavin M, 2009, TETRAHEDRON LETT, V50, P5945, DOI 10.1016/j.tetlet.2009.08.031; Kumar A., 2013, J ORG CHEM, V78, P10240; Mishra A., 2009, SYNTHESIS, P3077; Murai K, 2013, ORG BIOMOL CHEM, V11, P2648, DOI 10.1039/c3ob40132d; Neue B, 2013, EUR J ORG CHEM, P4944, DOI 10.1002/ejoc.201300293; Park JY, 2013, B KOREAN CHEM SOC, V34, P482, DOI 10.5012/bkcs.2013.34.2.482; Saito T, 2012, HETEROCYCLES, V84, P893, DOI 10.3987/COM-11-S(P)70; Saito T, 2010, HETEROCYCLES, V82, P305, DOI 10.3987/COM-10-S(E)66	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	FEB	2015	98	2					184	189		10.1002/hlca.201400316		6	Chemistry, Multidisciplinary	Chemistry	CB9RZ	WOS:000349971400003		
J	Endo, Y; Noguchi, S; Hara, Y; Hayashi, YK; Motomura, K; Miyatake, S; Murakami, N; Tanaka, S; Yamashita, S; Kizu, R; Bamba, M; Goto, Y; Matsumoto, N; Nonaka, I; Nishino, I				Endo, Yukari; Noguchi, Satoru; Hara, Yuji; Hayashi, Yukiko K.; Motomura, Kazushi; Miyatake, Satoko; Murakami, Nobuyuki; Tanaka, Satsuki; Yamashita, Sumimasa; Kizu, Rika; Bamba, Masahiro; Goto, Yu-ichi; Matsumoto, Naomichi; Nonaka, Ikuya; Nishino, Ichizo			Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca2+ channels	HUMAN MOLECULAR GENETICS			English	Article							SARCOPLASMIC-RETICULUM ORIGIN; INTERACTION MOLECULE-1 STIM1; CRAC CHANNEL; PLASMA-MEMBRANE; SKELETAL-MUSCLE; CALCIUM-CHANNEL; ION SELECTIVITY; ENTRY; PROTEIN; INFLUX	The store-operated Ca2+ release-activated Ca2+ (CRAC) channel is activated by diminished luminal Ca2+ levels in the endoplasmic reticulum and sarcoplasmic reticulum (SR), and constitutes one of the major Ca2+ entry pathways in various tissues. Tubular aggregates (TAs) are abnormal structures in the skeletal muscle, and although their mechanism of formation has not been clarified, altered Ca2+ homeostasis related to a disordered SR is suggested to be one of the main contributing factors. TA myopathy is a hereditary muscle disorder that is pathologically characterized by the presence of TAs. Recently, dominant mutations in the STIM1 gene, encoding a Ca2+ sensor that controls CRAC channels, have been identified to cause tubular aggregate myopathy (TAM). Here, we identified heterozygous missense mutations in the ORAI1 gene, encoding the CRAC channel itself, in three families affected by dominantly inherited TAM with hypocalcemia. Skeletal myotubes from an affected individual and HEK293 cells expressing mutated ORAI1 proteins displayed spontaneous extracellular Ca2+ entry into cells without diminishment of luminal Ca2+ or the association with STIM1. Our results indicate that STIM1-independent activation of CRAC channels induced by dominant mutations in ORAI1 cause altered Ca2+ homeostasis, resulting in TAM with hypocalcemia.	[Endo, Yukari; Noguchi, Satoru; Hayashi, Yukiko K.; Motomura, Kazushi; Goto, Yu-ichi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Clin Dev, Translat Med Ctr, Tokyo 1878556, Japan; [Endo, Yukari; Noguchi, Satoru; Hayashi, Yukiko K.; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Endo, Yukari] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Hara, Yuji] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Hara, Yuji] Tokyo Womens Med Univ Inst Integrated Med Sci TII, Shinjuku Ku, Kyoto 1628666, Japan; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Miyatake, Satoko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Murakami, Nobuyuki] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Tanaka, Satsuki] Osaka Saiseikai Nakatsu Hosp, Dept Diabet & Endocrinol, Osaka 5300012, Japan; [Yamashita, Sumimasa] KCMC, Div Pediat Neurol, Yokohama, Kanagawa 2328555, Japan; [Kizu, Rika] Yokosuka Kyosai Hosp, Div Pediat, Yokosuka, Kanagawa 2388558, Japan; [Bamba, Masahiro] Kawasaki Municipal Hosp, Div Pediat, Kawasaki, Kanagawa 2100013, Japan	Noguchi, S (reprint author), Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878502, Japan.	noguchi@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of the NCNP [26-8, 25-5, 23-4]; Research on Applying Health Technology grant from the Ministry of Health, Labour and Welfare [H23-JITSUYOUKA(NANBYOU)-IPPAN-008, H26-ITAKU(NAN)-IPPAN-081]	This work was supported by an Intramural Research Grant (26-8, 25-5, 23-4) for Neurological and Psychiatric Disorders of the NCNP (to S.N., Y.H., I.N.) and by a Research on Applying Health Technology grant (H23-JITSUYOUKA(NANBYOU)-IPPAN-008, H26-ITAKU(NAN)-IPPAN-081) from the Ministry of Health, Labour and Welfare (to I.N.).	Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Kilch T, 2013, J BIOL CHEM, V288, P1653, DOI 10.1074/jbc.M112.417246; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008; Schiaffino S, 2012, NEUROMUSCULAR DISORD, V22, P199, DOI 10.1016/j.nmd.2011.10.005; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ihara Y, 2006, AM J PHYSIOL-CELL PH, V290, pC208, DOI 10.1152/ajpcell.00075.2005; Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Misceo D, 2014, HUM MUTAT, V35, P556, DOI 10.1002/humu.22544; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Ishikawa J, 2003, J IMMUNOL, V170, P4441; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1093/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007; DePristo M.A., 2009, NAT GENET, V43, P491; Fukumoto S, 2008, ENDOCR J, V55, P787, DOI 10.1507/endocrj.K08E-076; Jain D, 2008, J CLIN NEUROSCI, V15, P1222, DOI 10.1016/j.jocn.2007.11.010; Kiviluoto S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-16; Kumar R, 2011, J AM SOC NEPHROL, V22, P216, DOI 10.1681/ASN.2010020186; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Maniatis T, 1982, MOL CLONING LAB MANU; Pan Z., 2012, JOVE-J VIS EXP, V13, pe3415; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; Shoback D, 2008, NEW ENGL J MED, V359, P391, DOI 10.1056/NEJMcp0803050; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805	46	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	FEB 1	2015	24	3					637	648		10.1093/hmg/ddu477		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CC1XE	WOS:000350137900004		
J	Kino, Y; Washizu, C; Kurosawa, M; Oma, Y; Hattori, N; Ishiura, S; Nukina, N				Kino, Yoshihiro; Washizu, Chika; Kurosawa, Masaru; Oma, Yoko; Hattori, Nobutaka; Ishiura, Shoichi; Nukina, Nobuyuki			Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins	HUMAN MOLECULAR GENETICS			English	Article							C9ORF72 HEXANUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY TYPE-1; PRE-MESSENGER-RNA; IN-VIVO; ANTISENSE TRANSCRIPTS; MUSCLEBLIND PROTEINS; CELF PROTEINS; CAG REPEATS; FOCI; EXPANSION	In some neurological diseases caused by repeat expansions such as myotonic dystrophy, the RNA-binding protein muscleblind-like 1 (MBNL1) accumulates in intranuclear inclusions containing mutant repeat RNA. The interaction between MBNL1 and mutant RNA in the nucleus is a key event leading to loss of MBNL function, yet the details of this effect have been elusive. Here, we investigated the mechanism and significance of MBNL1 nuclear localization. We found that MBNL1 contains two classes of nuclear localization signal (NLS), a classical bipartite NLS and a novel conformational NLS. Alternative splicing of exon 7 acts as a switch between these NLS types and couples MBNL1 activity and intracellular localization. Depending on its nuclear localization, MBNL1 promoted nuclear accumulation of mutant RNA containing a CUG or CAG repeat, some of which produced proteins containing homopolymeric tracts such as polyglutamine. Furthermore, MBNL1 repressed the expression of these homopolymeric proteins including those presumably produced through repeat-associated non-ATG (RAN) translation. These results suggest that nuclear retention of expanded RNA reflects a novel role of MBNL proteins in repressing aberrant protein expression and may provide pathological and therapeutic implications for a wide range of repeat expansion diseases associated with nuclear RNA retention and/or RAN translation.	[Kino, Yoshihiro; Kurosawa, Masaru; Hattori, Nobutaka; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo 1130033, Japan; [Kino, Yoshihiro; Kurosawa, Masaru; Nukina, Nobuyuki] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Kino, Yoshihiro; Washizu, Chika; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Kino, Yoshihiro] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo 2048588, Japan; [Oma, Yoko; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Nukina, N (reprint author), Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo 1130033, Japan.	nnukina@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22110004, 22240037, 24659436, 25253066, 19790620, 21790854, 23791007, 25461299]; Ministry of Health, Welfare and Labor	This work was supported by the Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to N.N. (22110004, 22240037, 24659436 and 25253066) and to Y.K. (19790620, 21790854, 23791007 and 25461299) and by a Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor to N.N.	Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Terenzi F, 2010, RNA BIOL, V7, P43; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Chamberlain CM, 2012, HUM MOL GENET, V21, P4645, DOI 10.1093/hmg/dds306; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Gates DP, 2011, J BIOL CHEM, V286, P34224, DOI 10.1074/jbc.M111.236547; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Oma Y, 2005, BBA-PROTEINS PROTEOM, V1748, P174, DOI 10.1016/j.bbapap.2004.12.017; Querido E, 2011, J CELL SCI, V124, P1703, DOI 10.1242/jcs.073270; Smith KP, 2007, J CELL BIOL, V178, P951, DOI 10.1083/jcb.200706048; Tran H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194928; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	53	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	FEB 1	2015	24	3					740	756		10.1093/hmg/ddu492		17	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CC1XE	WOS:000350137900012		
J	Miyagawa, T; Toyoda, H; Hirataka, A; Kanbayashi, T; Imanishi, A; Sagawa, Y; Kotorii, N; Kotorii, T; Hashizume, Y; Ogi, K; Hiejima, H; Kamei, Y; Hida, A; Miyamoto, M; Imai, M; Fujimura, Y; Tamura, Y; Ikegami, A; Wada, Y; Moriya, S; Furuya, H; Kato, M; Omata, N; Kojima, H; Kashiwase, K; Saji, H; Khor, SS; Yamasaki, M; Wada, Y; Ishigooka, J; Kuroda, K; Kume, K; Chiba, S; Yamada, N; Okawa, M; Hirata, K; Uchimura, N; Shimizu, T; Inoue, Y; Honda, Y; Mishima, K; Honda, M; Tokunaga, K				Miyagawa, Taku; Toyoda, Hiromi; Hirataka, Akane; Kanbayashi, Takashi; Imanishi, Aya; Sagawa, Yohei; Kotorii, Nozomu; Kotorii, Tatayu; Hashizume, Yuji; Ogi, Kimihiro; Hiejima, Hiroshi; Kamei, Yuichi; Hida, Akiko; Miyamoto, Masayuki; Imai, Makoto; Fujimura, Yota; Tamura, Yoshiyuki; Ikegami, Azusa; Wada, Yamato; Moriya, Shunpei; Furuya, Hirokazu; Kato, Mitsuhiro; Omata, Naoto; Kojima, Hiroto; Kashiwase, Koichi; Saji, Hiroh; Khor, Seik-Soon; Yamasaki, Maria; Wada, Yuji; Ishigooka, Jun; Kuroda, Kenji; Kume, Kazuhiko; Chiba, Shigeru; Yamada, Naoto; Okawa, Masako; Hirata, Koichi; Uchimura, Naohisa; Shimizu, Tetsuo; Inoue, Yuichi; Honda, Yutaka; Mishima, Kazuo; Honda, Makoto; Tokunaga, Katsushi			New susceptibility variants to narcolepsy identified in HLA class II region	HUMAN MOLECULAR GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GRAVES-DISEASE; JAPANESE PATIENTS; CATAPLEXY; GENES; ONSET; RISK; HYPOCRETIN/OREXIN; AUTOANTIBODIES; POLYMORPHISMS	Narcolepsy, a sleep disorder characterized by excessive daytime sleepiness, cataplexy and rapid eye movement sleep abnormalities, is tightly associated with human leukocyte antigen HLA-DQB1*06:02. DQB1*06:02 is common in the general population (10-30%); therefore, additional genetic factors are needed for the development of narcolepsy. In the present study, HLA-DQB1 in 664 Japanese narcoleptic subjects and 3131 Japanese control subjects was examined to determine whether HLA-DQB1 alleles located in trans of DQB1*06:02 are associated with narcolepsy. The strongest association was with DQB1* 06:01(P = 1.4 x 10(-10), odds ratio, OR = 0.39), as reported in previous studies. Additional predisposing effects of DQB1*03:02 were also found (P = 2.5 x 10(-9), OR = 1.97). A comparison between DQB1* 06:02 heterozygous cases and controls revealed dominant protective effects of DQB1* 06:01 and DQB1*05:01. In addition, a single-nucleotide polymorphism-based conditional analysis controlling for the effect of HLA-DQB1 was performed to determine whether there were other independent HLA associations outside of HLA-DQB1. This analysis revealed associations at HLA-DPB1 in the HLA class ll region (rs3117242, P = 4.1 x 10(-5), OR = 2.45; DPB1*05:01, P = 8.1 x 10(-3), OR = 1.39). These results indicate that complex HLA class ll associations contribute to the genetic predisposition to narcolepsy.	[Miyagawa, Taku; Toyoda, Hiromi; Hirataka, Akane; Khor, Seik-Soon; Yamasaki, Maria; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Kanbayashi, Takashi; Imanishi, Aya; Sagawa, Yohei; Shimizu, Tetsuo] Akita Univ, Dept Neuropsychiat, Akita 010, Japan; [Kotorii, Nozomu; Hashizume, Yuji; Ogi, Kimihiro; Hiejima, Hiroshi; Uchimura, Naohisa] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuoka, Japan; [Kotorii, Nozomu; Kotorii, Tatayu] Kotorii Isahaya Hosp, Nagasaki, Japan; [Kamei, Yuichi] Natl Canc Ctr, Sleep Disorder Ctr, Tokyo, Japan; [Hida, Akiko; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Tokyo, Japan; [Miyamoto, Masayuki; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Imai, Makoto; Yamada, Naoto] Shiga Univ Med Sci, Dept Psychiat, Shiga, Japan; [Kume, Kazuhiko; Okawa, Masako] Shiga Univ Med Sci, Dept Sleep Med, Shiga, Japan; [Fujimura, Yota; Tamura, Yoshiyuki; Chiba, Shigeru] Asahikawa Med Univ, Dept Psychiat & Neurol, Asahikawa, Hokkaido, Japan; [Ikegami, Azusa; Kume, Kazuhiko] Kuwamizu Hosp, Sleep Ctr, Kumamoto, Japan; [Wada, Yamato; Kuroda, Kenji] Hannan Hosp, Dept Psychiat, Osaka, Japan; [Moriya, Shunpei; Ishigooka, Jun] Tokyo Womens Med Univ, Sch Med, Dept Psychiat, Tokyo, Japan; Natl Omuta Hosp, Dept Neurol, Neuromuscular Ctr, Fukuoka, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Omata, Naoto; Wada, Yuji] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Fukui 910, Japan; [Kojima, Hiroto; Saji, Hiroh] HLA Fdn Lab, Kyoto, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Dept HLA Lab, Tokyo, Japan; [Kume, Kazuhiko] Kumamoto Univ, Inst Mol Genet & Embryol, Dept Stem Cell Biol, Kumamoto, Japan; [Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Nagoya, Aichi, Japan; [Okawa, Masako] Japan Fdn Neurosci & Mental Hlth, Tokyo, Japan; [Inoue, Yuichi; Honda, Yutaka; Honda, Makoto] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Honda, Makoto] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo 113, Japan	Miyagawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyagawa-taku@umin.ac.jp	Khor, Seik-Soon/C-4700-2015	Khor, Seik-Soon/0000-0002-6809-4731	Ministry of Education, Culture, Sports, Science and Technology of Japan [23689022, 22133008]; Takeda Science Foundation; SENSHIN Medical Research Foundation; Tokyo Society of Medical Sciences	This study was supported by Grants-in-Aid for Young Scientists (A) (23689022) and Scientific Research on Innovative Areas (22133008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid from the Takeda Science Foundation, the SENSHIN Medical Research Foundation and the Tokyo Society of Medical Sciences.	Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Toyoda H, 2010, SLEEP, V33, P875; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Peyron C, 2000, NAT MED, V6, P991; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Kawashima M, 2010, SLEEP, V33, P869; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Gencik M, 2001, NEUROLOGY, V56, P115; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Dauvilliers Y, 2010, SLEEP, V33, P1428; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mignot E, 1998, NEUROLOGY, V50, pS16; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Overeem S, 2001, J CLIN NEUROPHYSIOL, V18, P78, DOI 10.1097/00004691-200103000-00002; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; DONG RP, 1992, HUM IMMUNOL, V35, P165, DOI 10.1016/0198-8859(92)90101-R; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2012, TISSUE ANTIGENS, V80, P328, DOI 10.1111/j.1399-0039.2012.01948.x; Hong SC, 2007, HUM IMMUNOL, V68, P59, DOI 10.1016/j.humimm.2006.10.006; Hungs M, 2001, NEUROLOGY, V57, P1893; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; MITSUNAGA S, 1992, HUM IMMUNOL, V34, P203, DOI 10.1016/0198-8859(92)90113-2; Miyagawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053707; Miyagawa T., 2011, SLEEP, V34, P349; Olafsdottir BR, 2001, NEUROLOGY, V57, P1896; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Roh EY, 2006, HUM IMMUNOL, V67, P749, DOI 10.1016/j.humimm.2006.03.024; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; Takahashi M, 2006, HUM IMMUNOL, V67, P47, DOI 10.1016/j.humimm.2006.02.023	40	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	FEB 1	2015	24	3					891	898		10.1093/hmg/ddu480		8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CC1XE	WOS:000350137900023		
J	Ogata, T; Narita, H; Tanaka, M				Ogata, Takeshi; Narita, Hirokazu; Tanaka, Mikiya			Adsorption behavior of rare earth elements on silica gel modified with diglycol amic acid	HYDROMETALLURGY			English	Article						Rare earth elements; Adsorption; Recovery; Separation; Solid-liquid extraction; Lanthanoid	DEEP-SEA MUD; AQUEOUS-SOLUTIONS; PHOSPHORIC-ACID; EXTRACTION; RECOVERY; LANTHANIDES; SEPARATION; RESINS; IONS	For the recovery of rare earth elements, we previously synthesized an adsorbent consisting of silica gel particles modified with diglycol amic acid groups. In the present study, we optimized the amount of diglycolic anhydride used for the synthesis of the adsorbent and evaluated the utility of the adsorbent in terms of its selectivity for rare earth metal ions, the rate of metal ion adsorption, and the desorption behavior of the ions. We also analyzed the adsorption isotherms of the metal ions. The optimum amount of diglycolic anhydride was 4.0 mmol/gram of amino silica gel, and this amount resulted in the introduction of 1.04 mmol of diglycol amic acid groups per gram of adsorbent. The introduction of the diglycol amic acid groups had little effect on the specific surface area and average pore size of the silica gel particles, and we attributed the high adsorption rate to the large pore size. Acid concentration strongly influenced the adsorbability of rare earth metal ions, which were readily desorbed by 1 mol/L mineral acid. The adsorption isotherms for the lanthanoids at an initial pH of 1.0 were determined with the Langmuir equation. The adsorption capacities of the adsorbent for the heavy rare earth metal ions were higher than those for the light ones. (C) 2015 Elsevier B.V. All rights reserved.	[Ogata, Takeshi; Narita, Hirokazu; Tanaka, Mikiya] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan	Ogata, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	t-ogata@aist.go.jp					Alakhras FA, 2005, J APPL POLYM SCI, V97, P691, DOI 10.1002/app.21825; [Anonymous], 2014, OLI AN STUD VERS 9 1; Wang FC, 2013, J CHEM TECHNOL BIOT, V88, P317, DOI 10.1002/jctb.3850; Jia Q, 2004, J ALLOY COMPD, V374, P434, DOI 10.1016/j.jallcom.2003.11.056; Dupont D, 2014, ACS APPL MATER INTER, V6, P4980, DOI 10.1021/am406027y; Xie F, 2014, MINER ENG, V56, P10, DOI 10.1016/j.mineng.2013.10.021; Kato Y, 2011, NAT GEOSCI, V4, P535, DOI [10.1038/ngeo1185, 10.1038/NGEO1185]; Binnemans K, 2013, J CLEAN PROD, V51, P1, DOI 10.1016/j.jclepro.2012.12.037; Wu DB, 2013, J HAZARD MATER, V260, P409, DOI 10.1016/j.jhazmat.2013.05.042; Wang LS, 2010, HYDROMETALLURGY, V101, P41, DOI 10.1016/j.hydromet.2009.11.017; Choi SH, 2003, J APPL POLYM SCI, V87, P328, DOI 10.1002/app.11445; Kon Y, 2014, RESOUR GEOL, V64, P47, DOI 10.1111/rge.12026; Das N, 2013, J RARE EARTH, V31, P933, DOI 10.1016/S1002-0721(12)60382-2; Bou-Maroun E, 2006, COLLOID SURFACE A, V287, P1, DOI 10.1016/j.colsurfa.2006.05.047; Araki K, 2000, J CHEM ENG JPN, V33, P665, DOI 10.1252/jcej.33.665; Chen YG, 2012, CHEM ENG J, V181, P387, DOI 10.1016/j.cej.2011.11.100; HABASHI F, 1985, J CHEM TECH BIOT A, V35, P5; Ogata T, 2014, CHEM LETT, V43, P1414, DOI 10.1246/cl.140446; Ramakrishnan K, 2006, SEPAR SCI TECHNOL, V41, P233, DOI 10.1080/01496390500446327; Shibata J, 2000, SOLVENT EXTR RES DEV, V7, P167; Shimojo K, 2014, ANAL SCI, V30, P263; Tanaka M., 2013, HDB PHYS CHEM RARE E, V43, P159; U. S. Geological Survey, 2014, RAR EARTHS MIN COMM, P128	23	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-386X	1879-1158		HYDROMETALLURGY	Hydrometallurgy	FEB	2015	152						178	182		10.1016/j.hydromet.2015.01.005		5	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CC1FK	WOS:000350086400022		
J	Kondo, K; Matsuo, T; Matsumoto, M				Kondo, Kazuo; Matsuo, Tomohiro; Matsumoto, Michiaki			Adsorptive separation of La, Ce and Pr using microcapsules containing 2-ethylhexylphosphonic acid mono-2-ethylhexyl ester	HYDROMETALLURGY			English	Article						Adsorption mechanism; Separation; Rare earth metals; Extractant; Microcapsule	RARE-EARTH-METALS; ORGANOPHOSPHORUS COMPOUNDS; EXTRACTION; COLUMN; MEMBRANE; RECOVERY; NICKEL	The adsorption of lanthanum, cerium and praseodymium onto microcapsules containing 2-ethylhexylphosphonic acid mono-2-ethylhexyl ester (EHPNA) was investigated. Through scanning electron microscopy imaging of the microcapsule-surface and neutralization titration estimation of the amount of EHPNA extractant remaining in the microcapsule, the microencapsulated extractant was characterized. As a result, it was found that the microcapsules with a mean particle diameter of 143 pm contained the extractant of 1.63 x 10(-3) mol/g-microcapsule. The adsorption behavior for each of the metals was measured from the metal adsorption equilibrium and the metal adsorption rates, from which it was estimated that the formation of a metal complex contributes to the overall adsorption rate of the metals. The separation of each of the metals was examined using a column packed with the microcapsules. It was found that the separation of the metals was most enhanced under the conditions of the microcapsule-packed column of 10 cm, the flow rate of 0.002 L/min, and the initial metal feed solution at pH 2.0. The separation of lanthanum, cerium and praseodymium from a La-Ce-Pr mixed solution was then examined in detail, with effective separation of these metals achieved within eight repetitions of the adsorption-desorption step. (C) 2015 Elsevier B.V. All rights reserved.	[Kondo, Kazuo; Matsuo, Tomohiro; Matsumoto, Michiaki] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan	Kondo, K (reprint author), Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan.	kkondo@mail.doshisha.ac.jp; mmatsumo@mail.doshisha.ac.jp					Abdeltawab AA, 2002, SEP PURIF TECHNOL, V26, P265, DOI 10.1016/S1383-5866(01)00180-0; Kamio E, 2002, J CHEM ENG JPN, V35, P178, DOI 10.1252/jcej.35.178; Kondo K, 2007, J CHEM ENG JPN, V40, P31, DOI 10.1252/jcej.40.31; Kamio E, 2002, J CHEM ENG JPN, V35, P574, DOI 10.1252/jcej.35.574; Ngomsik AF, 2006, WATER RES, V40, P1848, DOI 10.1016/j.watres.2006.02.036; Kamio E, 2002, IND ENG CHEM RES, V41, P3669, DOI 10.1021/ie010737c; Singh DK, 2005, SEP PURIF TECHNOL, V45, P1, DOI 10.1016/j.seppur.2004.10.003; Hino A, 1997, J CHEM ENG JPN, V30, P1040, DOI 10.1252/jcej.30.1040; Kondo K, 1998, SEP PURIF TECHNOL, V13, P109, DOI 10.1016/S1383-5866(97)00064-6; Atanassova M, 2004, SEP PURIF TECHNOL, V40, P171, DOI 10.1016/j.seppur.2004.02.007; Morais CA, 1998, HYDROMETALLURGY, V49, P167, DOI 10.1016/S0304-386X(98)00022-X; Cortina J.L., 1997, ION EXCHANGE SOLVENT; Fu SS, 2004, SEPAR SCI TECHNOL, V39, P517, DOI 10.1081/SS-120027993; Karnio E, 2008, CHEM ENG J, V139, P93, DOI 10.1016/j.cej.2007.07.072; Kamio E., 1999, P RES S CHEM ENG, V2, pB59; Kamio E, 2005, IND ENG CHEM RES, V44, P2266, DOI 10.1021/ie049313j; Kiyoyama S, 2007, REACT FUNCT POLYM, V67, P522, DOI 10.1016/j.reactfunctpolym.2007.03.003; Kondo K., 1996, SOLV EXTR RES DEV JA, V3, P178; Kondo K, 2014, HYDROMETALLURGY, V149, P87, DOI 10.1016/j.hydromet.2014.07.010; Kondo K, 2002, DESALINATION, V144, P249, DOI 10.1016/S0011-9164(02)00320-X; Kondo T., 1991, MICROCAPSULE; Lo T. C., 1983, HDB SOLVENT EXTRACTI; Mandar T. N., 1999, J CHEM ENG JPN, V32, P366; Nishihama S, 2002, HYDROMETALLURGY, V64, P35, DOI 10.1016/S0304-386X(02)00011-7	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-386X	1879-1158		HYDROMETALLURGY	Hydrometallurgy	FEB	2015	152						204	213		10.1016/j.hydromet.2015.01.004		10	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CC1FK	WOS:000350086400026		
J	Rahman, MRA; Yokomori, T; Ueda, T				Rahman, Mohd Rosdzimin Abdul; Yokomori, Takeshi; Ueda, Toshihisa			Model of flame dynamics of laminar premixed flame subject to the low frequency equivalence ratio oscillations	INTERNATIONAL COMMUNICATIONS IN HEAT AND MASS TRANSFER			English	Article						Laminar premixed flame; Non-uniform scalar; Flame motion hysteresis; Equivalence ratio oscillations; Integral model	STRATIFIED METHANE/AIR FLAMES; AIR MIXTURES; PROPAGATION; FLUCTUATIONS; COMBUSTION	The effect of the non-uniform profile of scalar variables, such a fuel at the upstream and temperature at the downstream of the flame zone was discussed theoretically to elucidate; (1) the deviation of motion from the steady state case and (2) the hysteresis of premixed flames response to the equivalence ratio oscillations seen in an experimental and numerical works. One-dimensional integral model for the non-uniform scalar variable profile with low frequency equivalence ratio oscillation has been developed. Here, the wavelength of the oscillation is assumed to be larger than the nominal flame thickness. Through the integral analysis, we obtained the relation of the flame propagation speed for steady and unsteady cases depending on the non-uniform scalar profile at the upstream and downstream of the flame zone. Hysteresis of the flame propagation speed is found due to the transport of fuel and heat by the non-uniform scalar profile at the upstream and downstream of the flame zone. This result qualitatively agreed with the numerical results of a response of the stagnation laminar CH4/air premixed flames for a low equivalence ratio oscillation frequency. (C) 2014 Elsevier Ltd. All rights reserved.	[Rahman, Mohd Rosdzimin Abdul] Univ Pertahanan Nasl Malaysia, Fac Engn, Dept Mech, Kuala Lumpur, Malaysia; [Yokomori, Takeshi; Ueda, Toshihisa] Keio Univ, Dept Mech Engn, Kouhoku Ku, Yokohama, Kanagawa 2238522, Japan	Ueda, T (reprint author), Keio Univ, Dept Mech Engn, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ueda@mech.keio.ac.jp			Keio Leading-edge Laboratory of Science and Technology [000020]; Ministry of Higher Education Malaysia; Universiti Pertahanan Nasional Malaysia	This work was supported in part by a Keio Leading-edge Laboratory of Science and Technology grant 000020. One of the authors (M.R.A.R) has been supported by the Ministry of Higher Education Malaysia and Universiti Pertahanan Nasional Malaysia.	Da Cruz AP, 2000, P COMBUST INST, V28, P1925; Kang T, 2007, P COMBUST INST, V31, P1075, DOI 10.1016/j.proci.2006.07.051; Birbaud AL, 2008, COMBUST FLAME, V154, P356, DOI 10.1016/j.combustflame.2008.05.017; Marzouk YM, 2000, P COMBUST INST, V28, P1859; Richardson ES, 2010, COMBUST THEOR MODEL, V14, P775, DOI 10.1080/13647830.2010.490881; Candel S, 2002, P COMBUST INST, V29, P1, DOI 10.1016/S1540-7489(02)80007-4; Zhou RG, 2013, COMBUST FLAME, V160, P1070, DOI 10.1016/j.combustflame.2013.01.023; Kang T, 2009, P COMBUST INST, V32, P979, DOI 10.1016/j.proci.2008.06.007; CHUNG SH, 1988, COMBUST FLAME, V72, P325, DOI 10.1016/0010-2180(88)90131-9; Galizzi C, 2006, COMBUST FLAME, V145, P621, DOI 10.1016/j.combustflame.2005.12.001; Kang T, 2009, COMBUST THEOR MODEL, V13, P705, DOI 10.1080/13647830903093765; Lauvergne R, 2000, P COMBUST INST, V28, P1841; Law C.K., 2006, COMBUSTION PHYS, P263; Rahman MRA, 2012, J THERM SCI TECH-JPN, V7, P16, DOI 10.1299/jtst.7.16; Rosdzimin ARM, 2013, J THERM SCI TECH-JPN, V8, P28, DOI 10.1299/jtst.8.28; Sankaran R, 2002, P COMBUST INST, V29, P77, DOI 10.1016/S1540-7489(02)80014-1; Tomita H., 2014, P COMBUST I, V35; Wu XS, 2010, J FLUID MECH, V655, P3, DOI 10.1017/S0022112010000698	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0735-1933	1879-0178		INT COMMUN HEAT MASS	Int. Commun. Heat Mass Transf.	FEB	2015	61						8	15		10.1016/j.icheatmasstransfer.2014.12.001		8	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CC1HC	WOS:000350090800002		
J	Miyaji, T; Okamoto, H; Craik, ADD				Miyaji, Tomoyuki; Okamoto, Hisashi; Craik, Alex D. D.			A Four-Leaf Chaotic Attractor of a Three-Dimensional Dynamical System	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Three-dimensional dynamical system; period-doubling cascades to chaos; numerical verification		A three-dimensional autonomous dynamical system proposed by Pehlivan is untypical in simultaneously possessing both unbounded and chaotic solutions. Here, this topic is studied in some depth, both numerically and analytically. We find, by standard methods, that four-leaf chaotic orbits result from a period-doubling cascade; we identify unstable fixed points and both stable and unstable periodic orbits; and we examine how initial data determines whether orbits approach infinity or a stable periodic orbit. Further, we describe and apply a strict numerical verification method that rigorously proves the existence of sequences of period doublings.	[Miyaji, Tomoyuki; Okamoto, Hisashi] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan; [Craik, Alex D. D.] Univ St Andrews, Sch Math & Stat, St Andrews KY16 9SS, Fife, Scotland	Miyaji, T (reprint author), Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Tokyo 101, Japan.	tmiyaji@meiji.ac.jp; okamoto@kurims.kyoto-u.ac.jp; addc@st-andrews.ac.uk			JSPS KAKENHI [24244007];  [24.5312]	T. Miyaji is supported by the Grant-in-Aid for JSPS Fellows No. 24.5312. H. Okamoto is partially supported by JSPS KAKENHI 24244007. All figures in this paper were drawn by using gnuplot version 4.6. Comments by reviewers greatly helped us to improve our paper. We thank them for their critical reading. Lastly it is our pleasure to acknowledge that Pehlivan's work was first drawn to our attention by Dr. Irene Moroz of Oxford.	Anastassiou S., 2013, INT J BIFURCAT CHAOS, V23; Craik ADD, 2002, PHYSICA D, V164, P168, DOI 10.1016/S0167-2789(02)00372-X; Wang X, 2012, COMMUN NONLINEAR SCI, V17, P1264, DOI 10.1016/j.cnsns.2011.07.017; FEIGENBAUM MJ, 1978, J STAT PHYS, V19, P25, DOI 10.1007/BF01020332; Pehlivan I, 2011, OPTOELECTRON ADV MAT, V5, P1003; Rump SM, 2010, ACTA NUMER, V19, P287, DOI 10.1017/S096249291000005X; Caprani O., 1978, BIT (Nordisk Tidskrift for Informationsbehandling), V18, DOI 10.1007/BF01947742; CRAIK ADD, 1994, P ROY SOC EDINB A, V124, P127; Doedel E. J., 2012, AUTO 07P CONTINUATIO; Galias Z., 2013, INT J BIFURCAT CHAOS, V23; Galias Z., 1998, S CIRC SYST I SCAS 9, V3, P370; Galias Z, 2006, INT J BIFURCAT CHAOS, V16, P2873, DOI 10.1142/S0218127406016513; GANTMACHER F. R., 1959, THEORY MATRICES, VII; Keller H. B., 1987, LECT NUMERICAL METHO; Kuznetsov YA, 2004, ELEMENTS APPL BIFURC; LaSalle J., 1961, STABILITY LIAPUNOVS; Li C. B., 2014, INT J BIFURCAT CHAOS, V24; Lia C., 2014, SOV PHYS JETP, V118, P494; Miyaji T., 3 DIMENSIONAL UNPUB; Moore R.E., 1966, INTERVAL ANAL; Sparrow C, 1982, LORENZ EQUATIONS BIF; Sprott J. C., 2003, CHAOS TIME SERIES AN; Sprott J. C., 2012, INT J BIFURCAT CHAOS, V23; Wilczak D, 2009, FOUND COMPUT MATH, V9, P611, DOI 10.1007/s10208-009-9040-x; Wilczak D., 2005, COMPUTER ASSISTED PR; Zgliczynski P, 2002, FOUND COMPUT MATH, V2, P429, DOI 10.1007/s102080010025	26	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	FEB	2015	25	2							1530003	10.1142/S0218127415300037		21	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	CC6OS	WOS:000350485800001		
J	Nagao, M; Baba, S; Yonezawa, M; Yamasaki, Y; Kamitani, T; Isoda, T; Kawanami, S; Maruoka, Y; Kitamura, Y; Abe, K; Higo, T; Sunagawa, K; Honda, H				Nagao, Michinobu; Baba, Shingo; Yonezawa, Masato; Yamasaki, Yuzo; Kamitani, Takeshi; Isoda, Takuro; Kawanami, Satoshi; Maruoka, Yasuhiro; Kitamura, Yoshiyuki; Abe, Kohtaro; Higo, Taiki; Sunagawa, Kenji; Honda, Hiroshi			Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2*MRI and MIBG scintigraphy	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Dilated cardiomyopathy; MIBG scintigraphy; T2*MRI; Major adverse cardiac event	CHRONIC HEART-FAILURE; SYMPATHETIC INNERVATION; PLASMA NOREPINEPHRINE; IRON; MORTALITY; RESYNCHRONIZATION; REPRODUCIBILITY; QUANTIFICATION; THALASSEMIA; CARVEDILOL	Iron deficiency and cardiac sympathetic impairment play a role in the worsening of heart failure, and these two conditions may be linked. The present study aimed to clarify the relationship between myocardial iron deficiency, cardiac sympathetic activity, and major adverse cardiac events (MACE) in patients with dilated cardiomyopathy (DCM). Cardiac T2* MRI for iron deficiency and I-123-Metaiodobenzylguanidine (MIBG) imaging for cardiac sympathetic activity were performed in 46 patients with DCM. Myocardial T2* value (M-T2*) was calculated by fitting signal intensity data for mid-left ventricular septum to a decay curve using 3-Tesla scanner. I-123-MIBG washout rate (MIBG-WR) was calculated using a polar-map technique with tomographic data. We analyze the ability of M-T2* and MIBG-WR to predict MACE. MIBG-WR and M-T2* were significantly greater in DCM patients with MACE than in patients without MACE. Receiver-operating-characteristics curve analysis showed that the optimal MIBG-WR and M-T2* thresholds of 35 % and 28.1 ms, and the two combination predict MACE with C-statics of 0.69, 0.73, and 0.82, respectively. Patients with MIBG-WR < 35 % and M-T2* < 28.1 ms had significantly lower event-free rates than those with MIBG-WR a parts per thousand yen35 % or M-T2* a parts per thousand yen28.1 ms (log-rank value = 4.35, p < 0.05). Cox hazard regression analysis showed that chi(2) and the hazard ratio were 3.99 and 2.15 for development of MACE in patients with MIBG-WR a parts per thousand yen35 % or M-T2* a parts per thousand yen28.1 ms (p < 0.05). Iron deficiency, expressed by a high M-T2*, and MIBG-WR were both independent predictors of MACE in patients with DCM. The two combination was a more powerful predictor of MACE than either parameter alone.	[Nagao, Michinobu; Kawanami, Satoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Baba, Shingo; Yonezawa, Masato; Yamasaki, Yuzo; Kamitani, Takeshi; Isoda, Takuro; Maruoka, Yasuhiro; Kitamura, Yoshiyuki; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Fukuoka 8128582, Japan; [Abe, Kohtaro; Higo, Taiki; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Fukuoka 8128582, Japan	Nagao, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	minagao@radiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25461831]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (25461831).	SUGRUE DD, 1992, ANN INTERN MED, V117, P117; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Hjalmarson A, 1999, LANCET, V353, P2001; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Takeishi Y, 1997, J NUCL MED, V38, P1085; Westwood MA, 2003, J MAGN RESON IMAGING, V18, P616, DOI 10.1002/jmri.10396; Nakata T, 1998, J NUCL CARDIOL, V5, P579, DOI 10.1016/S1071-3581(98)90112-X; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Eisenhofer G, 1996, CIRCULATION, V93, P1667; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Kirk P, 2010, J MAGN RESON IMAGING, V32, P315, DOI 10.1002/jmri.22245; WIELAND DM, 1980, J NUCL MED, V21, P349; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; Suwa M, 1997, AM HEART J, V133, P353, DOI 10.1016/S0002-8703(97)70232-1; MERLET P, 1992, J NUCL MED, V33, P471; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Nishisato K, 2010, J NUCL MED, V51, P1241, DOI 10.2967/jnumed.110.074971; Doi T, 2012, J NUCL MED, V53, P731, DOI 10.2967/jnumed.111.095786; Goldstein D, 2006, ISHLT MONOGRAPH SERI, V1, P77; Nakata T, 2005, CURR CARDIOL REV, V1, P29, DOI 10.2174/1573403052952419; Reeder SB, 1998, MAGNET RESON MED, V39, P988, DOI 10.1002/mrm.1910390617; SCHOFER J, 1988, J AM COLL CARDIOL, V12, P1252; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; van der Veen BJ, 2012, J NUCL CARDIOL, V19, P752, DOI 10.1007/s12350-012-9539-4	29	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	FEB	2015	31	2					399	407		10.1007/s10554-014-0562-1		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CC6MK	WOS:000350479000021		
J	Takahashi, T; Takeda, N				Takahashi, Toshio; Takeda, Noriyo			Insight into the Molecular and Functional Diversity of Cnidarian Neuropeptides	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							GATED ION-CHANNEL; HYDROMEDUSA POLYORCHIS-PENICILLATUS; VASOPRESSIN-LIKE IMMUNOREACTIVITY; LESS-THAN GLU-GLY-ARG-PHE-NH2; FMRFAMIDE-RELATED PEPTIDES; HYDRACTINIA-ECHINATA; ANTHO-RFAMIDE; HYDRA-MAGNIPAPILLATA; CARDIOEXCITATORY NEUROPEPTIDE; NEURON DIFFERENTIATION	Cnidarians are the most primitive animals to possess a nervous system. This phylum is composed of the classes Scyphozoa (jellyfish), Cubozoa (box jellyfish), and Hydrozoa (e.g., Hydra, Hydractinia), which make up the subphylum Medusozoa, as well as the class Anthozoa (sea anemones and corals). Neuropeptides have an early evolutionary origin and are already abundant in cnidarians. For example, from the cnidarian Hydra, a key model system for studying the peptides involved in developmental and physiological processes, we identified a wide variety of novel neuropeptides from Hydra magnipapillata (the Hydra Peptide Project). Most of these peptides act directly on muscle cells and induce contraction and relaxation. Some peptides are involved in cell differentiation and morphogenesis. In this review, we describe FMRFamide-like peptides (FLPs), GLWamide-family peptides, and the neuropeptide Hym-355; FPQSFLPRGamide. Several hundred FLPs have been isolated from invertebrate animals such as cnidarians. GLWamide-family peptides function as signaling molecules in muscle contraction, metamorphosis, and settlement in cnidarians. Hym-355; FPQSFLPRGamide enhances neuronal differentiation in Hydra. Recently, GLWamide-family peptides and Hym-355; FPQSFLPRGamide were shown to trigger oocyte maturation and subsequent spawning in the hydrozoan jellyfish Cytaeis uchidae. These findings suggest the importance of these neuropeptides in both developmental and physiological processes.	[Takahashi, Toshio] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan; [Takeda, Noriyo] Tohoku Univ, Grad Sch Life Sci, Res Ctr Marine Biol, Aomori 0393501, Japan	Takahashi, T (reprint author), Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan.	takahashi@sunbor.or.jp; ntakeda@m.tohoku.ac.jp			 [26440184];  [26840073]	The authors acknowledge a Grant-in-Aid for Scientific Research (C) to Toshio Takahashi (Grant number 26440184) and a Grant-in Aid for Young Scientists (B) to Noriyo Takeda (Grant number 26840073).	ANCTIL M, 1989, GEN PHARMACOL, V20, P381, DOI 10.1016/0306-3623(89)90277-2; Takeda N, 2013, MOL REPROD DEV, V80, P223, DOI 10.1002/mrd.22154; CAMPBELL RD, 1976, J CELL SCI, V21, P1; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Westfall JA, 2002, J MORPHOL, V251, P83, DOI 10.1002/jmor.1075; Katsukura Y, 2004, J EXP BIOL, V207, P1803, DOI 10.1242/jeb.00974; Takahashi T, 2003, COMP BIOCHEM PHYS B, V135, P309, DOI 10.1016/S1096-4959(03)00088-5; Kass-Simon G, 2007, COMP BIOCHEM PHYS A, V146, P9, DOI 10.1016/j.cbpa.2006.09.008; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LEITZ T, 1994, DEV BIOL, V163, P440, DOI 10.1006/dbio.1994.1160; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Anderson PAV, 2004, BIOL BULL-US, V207, P141, DOI 10.2307/1543588; PRICE DA, 1989, BIOL BULL, V177, P198, DOI 10.2307/1541933; Holtmann M, 2001, J COMP NEUROL, V432, P537, DOI 10.1002/cne.1118; LEITZ T, 1995, ROUX ARCH DEV BIOL, V204, P276, DOI 10.1007/BF00208495; MARCUM BA, 1978, J CELL SCI, V29, P17; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Katsukura Y, 2003, DEV GENES EVOL, V213, P579, DOI 10.1007/s00427-003-0361-5; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Fujisawa T, 2008, DEV GROWTH DIFFER, V50, pS257, DOI [10.1111/j.1440-169X.2008.00997.x, 10.1111/i.1440-169X.2008.00997.x]; Takahashi T, 2009, DEV GENES EVOL, V219, P119, DOI 10.1007/s00427-009-0272-1; KARAS M, 1987, INT J MASS SPECTROM, V78, P53, DOI 10.1016/0168-1176(87)87041-6; Shimizu H, 2003, GENESIS, V36, P182, DOI 10.1002/gene.10213; Takahashi T, 2013, PROTEIN PEPTIDE LETT, V20, P671; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Takahashi T, 2000, DEVELOPMENT, V127, P997; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; CARSTENSEN K, 1992, PEPTIDES, V13, P851, DOI 10.1016/0196-9781(92)90040-A; Cottrell GA, 1997, J EXP BIOL, V200, P2377; DARMER D, 1991, P NATL ACAD SCI USA, V88, P2555, DOI 10.1073/pnas.88.6.2555; Darmer D, 1998, BIOCHEM J, V332, P403; Espinoza E, 2000, MOL NEUROBIOL, V21, P35; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Fujisawa T, 2012, INT J DEV BIOL, V56, P543, DOI 10.1387/ijdb.113477tf; Fujisawa T., 2005, PEPTIDE SCI 2004, P21; Gajewski M, 1998, ANN NY ACAD SCI, V839, P311, DOI 10.1111/j.1749-6632.1998.tb10782.x; Gajewski M, 1996, ROUX ARCH DEV BIOL, V205, P232, DOI 10.1007/BF00365801; Glauber KM, 2013, DEVELOPMENT, V140, P4788, DOI 10.1242/dev.094490; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; Grimmelikhuijzen C. J. P., 1988, BRAIN RES, V475, P198, DOI [10.1016/0006-8993(88)90219-32905621, DOI 10.1016/0006-8993(88)90219-32905621]; GRIMMELIKHUIJZEN CJP, 1992, BIOCHEM BIOPH RES CO, V183, P375, DOI 10.1016/0006-291X(92)90491-3; GRIMMELIKHUIJZEN CJP, 1982, NEUROSCIENCE, V7, P3191, DOI 10.1016/0306-4522(82)90241-X; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; Hamaguchi-Hamada K, 2009, CELL TISSUE RES, V337, P15, DOI 10.1007/s00441-009-0808-8; Ikeda T., 1933, PEPTIDE CHEM 1992, P583; KOIZUMI O, 1991, J NEUROSCI, V11, P2011; Koizumi O., 2014, ZOOLOGY, V118, DOI [10.1016/j.zool.2014.10.001, DOI 10.1016/J.ZOOL.2014.10.001]; Krajniak KG, 2013, PROTEIN PEPTIDE LETT, V20, P647; Leitz T, 1998, ANN NY ACAD SCI, V839, P105, DOI 10.1111/j.1749-6632.1998.tb10740.x; Leitz T, 1998, BIOFOULING, V12, P173; Leviev I, 1997, J NEUROCHEM, V68, P1319; LLOYD PE, 1987, PEPTIDES, V8, P179, DOI 10.1016/0196-9781(87)90184-7; MCFARLANE ID, 1987, J EXP BIOL, V133, P157; MINAKATA H, 1993, PEPTIDE CHEMISTRY 1992, P579; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; Moosler A, 1997, BIOCHEM BIOPH RES CO, V236, P743, DOI 10.1006/bbrc.1997.7022; Morishita F, 2003, PEPTIDES, V24, P17, DOI 10.1016/S0196-9781(02)00272-3; MORRIS HR, 1982, NATURE, V300, P643, DOI 10.1038/300643a0; MUNEOKA Y, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P109; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; PLICKERT G, 1988, DEVELOPMENT, V103, P795; PRICE DA, 1977, PREP BIOCHEM, V7, P261, DOI 10.1080/00327487708061643; REINSCHEID RK, 1994, J NEUROCHEM, V62, P1214; SCHMUTZLER C, 1992, J BIOL CHEM, V267, P22534; SCHMUTZLER C, 1994, BIOCHEM J, V299, P431; Seipp S, 2010, INVERTEBR NEUROSCI, V10, P77, DOI 10.1007/s10158-010-0109-7; Takahashi T, 2010, METHODS MOL BIOL, V615, P275, DOI 10.1007/978-1-60761-535-4_21; Takahashi T., 2011, J AMINO ACIDS, V2011, DOI [10.4061/2011/42450122312468, DOI 10.4061/2011/42450122312468]; Takahashi T., 1997, PEPTIDE CHEM, P193; Takeda N, 2006, DEV BIOL, V298, P248, DOI 10.1016/j.ydbio.2006.06.034; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411; Tremblay MT, 2004, GEN COMP ENDOCR, V137, P9, DOI 10.1016/j.ygcen.2004.02.009; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9	81	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					2610	2625		10.3390/ijms16022610		16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600019		
J	Iwasaki, Y; Fujio, K; Okamura, T; Yamamoto, K				Iwasaki, Yukiko; Fujio, Keishi; Okamura, Tomohisa; Yamamoto, Kazuhiko			Interleukin-27 in T Cell Immunity	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							FOLLICULAR-HELPER-CELLS; CENTRAL-NERVOUS-SYSTEM; IL-27 RECEPTOR WSX-1; CUTTING EDGE; TH17 CELLS; TRANSCRIPTION FACTOR; LEISHMANIA-MAJOR; MICE DEFICIENT; T(H)17 CELLS; MRL/LPR MICE	Interleukin (IL)-27, a member of IL-12/IL-23 heterodimeric family of cytokines, has pleiotropic properties that can enhance or limit immune responses. IL-27 acts on various cell types, including T cells, B cells, macrophages, dendritic cells, natural killer (NK) cells and non-hematopoietic cells. Intensive studies have been conducted especially on T cells, revealing that various subsets of T cells respond uniquely to IL-27. IL-27 induces expansion of Th1 cells by activating signal transducer and activator of transcription (STAT) 1-mediated T-bet signaling pathway. On the other hand, IL-27 suppresses immune responses through inhibition of the development of T helper (Th) 17 cells and induction of IL-10 production in a STAT1- and STAT3-dependent manner. IL-27 is a potentially promising cytokine for therapeutic approaches on various human diseases. Here, we provide an overview of the biology of IL-27 related to T cell subsets, its structure, and production mechanism.	[Iwasaki, Yukiko; Fujio, Keishi; Okamura, Tomohisa; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan; [Okamura, Tomohisa] Univ Tokyo, Max Planck Univ Tokyo Ctr Integrat Inflammol, Meguro Ku, Tokyo 1538505, Japan	Fujio, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yunyan-todai@umin.ac.jp; kfujio-tky@umin.ac.jp; tomohisa-tky@umin.ac.jp; yamamoto-tky@umin.ac.jp			Japan Society for the Promotion of Science, Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in part by Global COE Program Chemical Biology of the Diseases by MEXT, Japan	This work was supported by grants from the Japan Society for the Promotion of Science, Ministry of Health, Labor and Welfare, and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (in part by Global COE Program Chemical Biology of the Diseases, by MEXT), Japan.	Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Villarino AV, 2006, J IMMUNOL, V176, P237; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Yoshimoto T, 2007, J IMMUNOL, V179, P4415; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2289, DOI 10.1002/art.30324; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Batten M, 2008, J IMMUNOL, V180, P2752; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Shimizu S, 2005, J IMMUNOL, V175, P7185; Takeda A, 2003, J IMMUNOL, V170, P4886; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Artis D, 2004, J IMMUNOL, V172, P4672; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Devergne O, 1996, J VIROL, V70, P1143; Kim G, 2013, J IMMUNOL, V190, P1510, DOI 10.4049/jimmunol.1201017; Owaki T, 2006, J IMMUNOL, V176, P2773; Artis D, 2004, J IMMUNOL, V173, P5626; Holscher C, 2005, J IMMUNOL, V174, P3534; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Morishima N, 2005, J IMMUNOL, V175, P1686; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pflanz S, 2004, J IMMUNOL, V172, P2225; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Kamiya S, 2004, J IMMUNOL, V173, P3871; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Owaki T, 2006, J IMMUNOL, V177, P7579; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6074; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Liu H, 2011, J INTERF CYTOK RES, V31, P459, DOI 10.1089/jir.2010.0115; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Pennock ND, 2014, P NATL ACAD SCI USA, V111, P16472, DOI 10.1073/pnas.1407393111; Shimozato O, 2009, IMMUNOLOGY, V128, pe816, DOI 10.1111/j.1365-2567.2009.03088.x	58	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					2851	2863		10.3390/ijms16022851		13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600034		
J	Nakanishi, A; Minami, A; Kitagishi, Y; Ogura, Y; Matsuda, S				Nakanishi, Atsuko; Minami, Akari; Kitagishi, Yasuko; Ogura, Yasunori; Matsuda, Satoru			BRCA1 and p53 Tumor Suppressor Molecules in Alzheimer's Disease	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							DNA-DAMAGE RESPONSE; CANCER CELL-LINES; NF-KAPPA-B; BREAST-CANCER; MAGNOLIA-OFFICINALIS; AMYLOID-BETA; PHOSPHORYLATED BRCA1; GENOMIC STABILITY; GENE-EXPRESSION; ETHANOL EXTRACT	Tumor suppressor molecules play a pivotal role in regulating DNA repair, cell proliferation, and cell death, which are also important processes in the pathogenesis of Alzheimer's disease. Alzheimer's disease is the most common neurodegenerative disorder, however, the precise molecular events that control the death of neuronal cells are unclear. Recently, a fundamental role for tumor suppressor molecules in regulating neurons in Alzheimer's disease was highlighted. Generally, onset of neurodegenerative diseases including Alzheimer's disease may be delayed with use of dietary neuro-protective agents against oxidative stresses. Studies suggest that dietary antioxidants are also beneficial for brain health in reducing disease-risk and in slowing down disease-progression. We summarize research advances in dietary regulation for the treatment of Alzheimer's disease with a focus on its modulatory roles in BRCA1 and p53 tumor suppressor expression, in support of further therapeutic research in this field.	Nara Womens Univ, Dept Food Sci & Nutr, Kita Uoya Nishimachi, Nara 6308506, Japan; [Nakanishi, Atsuko; Minami, Akari; Kitagishi, Yasuko; Ogura, Yasunori; Matsuda, Satoru] Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan	Matsuda, S (reprint author), Nara Womens Univ, Dept Food Sci & Nutr, Kita Uoya Nishimachi, Nara 6308506, Japan.	GAH00635@nifty.com; laa_minami@cc.nara-wu.ac.jp; y_kitagishi@live.jp; pl0okm9ijn@live.jp; smatsuda@cc.nara-wu.ac.jp			JSPS KAKENHI [25560050, 26-12035, 24240098]	This work was supported by JSPS KAKENHI Grant Number 25560050, 26-12035, 24240098.	Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Song M, 2012, PSYCHIAT INVEST, V9, P413, DOI 10.4306/pi.2012.9.4.413; Lee YJ, 2012, PHYTOTHER RES, V26, P1884, DOI 10.1002/ptr.4643; Liu JF, 2012, NEUROCHEM RES, V37, P2738, DOI 10.1007/s11064-012-0866-2; Adjakly M, 2011, EPIGENOMICS-UK, V3, P795, DOI [10.2217/epi.11.103, 10.2217/EPI.11.103]; Dagdemir A, 2013, EPIGENOMICS-UK, V5, P51, DOI [10.2217/epi.12.74, 10.2217/EPI.12.74]; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Olcina M, 2010, CLIN CANCER RES, V16, P5624, DOI 10.1158/1078-0432.CCR-10-0286; Alhebshi AH, 2013, BIOCHEM BIOPH RES CO, V433, P362, DOI 10.1016/j.bbrc.2012.11.139; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Jacobsen E, 2004, MOL BRAIN RES, V128, P1, DOI 10.1016/j.molbrainres.2004.05.023; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Lin YC, 2010, J AGR FOOD CHEM, V58, P9511, DOI 10.1021/jf1019533; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Shastry BS, 1998, AM J MED SCI, V315, P266, DOI 10.1097/00000441-199804000-00009; Hsieh TC, 2009, ANTICANCER RES, V29, P4025; Keimpema E, 2013, P NATL ACAD SCI USA, V110, P1935, DOI 10.1073/pnas.1212563110; Cousineau I, 2005, CANCER RES, V65, P11384, DOI 10.1158/0008-5472.CAN-05-2156; Lebda MA, 2012, NEUROTOXICOLOGY, V33, P98, DOI 10.1016/j.neuro.2011.12.008; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Lanni C, 2012, FREE RADICAL BIO MED, V52, P1727, DOI 10.1016/j.freeradbiomed.2012.02.034; Zhang X, 2012, NEUROSCIENCE, V220, P191, DOI 10.1016/j.neuroscience.2012.06.027; Mazza M, 2011, J ALZHEIMERS DIS, V23, P375, DOI 10.3233/JAD-2010-090700; Hoi CP, 2010, PHYTOTHER RES, V24, P1538, DOI 10.1002/ptr.3178; Khan A, 2012, MOL CELL BIOCHEM, V369, P55, DOI 10.1007/s11010-012-1368-x; Menendez JA, 2004, INT J ONCOL, V24, P591; Jhanwar-Uniyal M, 2003, FRONT BIOSCI, V8, pS1107, DOI 10.2741/1131; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Fan S, 2006, BRIT J CANCER, V94, P407, DOI 10.1038/sj.bjc.6602935; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Bradley-Whitman MA, 2014, J NEUROCHEM, V128, P294, DOI 10.1111/jnc.12444; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196; Ayi TC, 1998, ONCOGENE, V17, P2143, DOI 10.1038/sj.onc.1202123; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Bialopiotrowicz E, 2012, J ALZHEIMERS DIS, V32, P397, DOI 10.3233/JAD-2012-121129; Bosviel R, 2012, OMICS, V16, P235, DOI 10.1089/omi.2011.0105; Cabanes A, 2004, CARCINOGENESIS, V25, P741, DOI 10.1093/carcin/bgh065; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; Chalabi N, 2005, J CHROMATOGR B, V821, P188, DOI 10.1016/j.jchromb.2005.05.006; Chalabi N, 2004, EUR J CANCER, V40, P1768, DOI 10.1016/j.ejca.2004.03.028; Chavez-Perez VA, 2014, BIOCHEM BIOPH RES CO, V443, P120, DOI 10.1016/j.bbrc.2013.11.065; Chen C., 2014, METAB BRAIN DIS, DOI [10.1007/s11011-014-9601-9, DOI 10.1007/S11011-014-9601-9]; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Ding SL, 2004, BRIT J CANCER, V90, P1995, DOI 10.1038/sj.bjc.6601804; Dong LH, 2010, CELL RES, V20, P1252, DOI 10.1038/cr.2010.111; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014; Falik-Zaccai Tzipora C, 2009, Pediatr Endocrinol Rev, V7, P37; Gartel AL, 2007, CANCER BIOL THER, V6, P1171; Gehrau RC, 2011, MUTAT RES-FUND MOL M, V707, P15, DOI 10.1016/j.mrfmmm.2010.12.002; Guo XX, 2014, PROTEIN CELL, V5, P224, DOI 10.1007/s13238-014-0027-2; Hancock SM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00137; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; Heijink AM, 2013, MUTAT RES-FUND MOL M, V750, P45, DOI 10.1016/j.mrfmmm.2013.07.003; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080461; Hemstrom TH, 2005, EXP CELL RES, V305, P200, DOI 10.1016/j.yexcr.2004.12.017; House Nealia C. M., 2014, Frontiers in Genetics, V5, P296, DOI 10.3389/fgene.2014.00296; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Kim SS, 2004, MOL CELL BIOL, V24, P9498, DOI 10.1128/MCB.24.21.9498-9507.2004; Kirkland JB, 2012, MUTAT RES-FUND MOL M, V733, P14, DOI 10.1016/j.mrfmmm.2011.11.008; Lavin Martin F., 1999, Cancer Research, V59, P3845; Lee SJ, 2010, PHYTOTHER RES, V24, P1870, DOI 10.1002/ptr.3214; Lee SJ, 2007, ONCOL REP, V18, P729; Lee SJ, 2013, ONCOL REP, V29, P1609, DOI 10.3892/or.2013.2271; Le Page F, 2000, CANCER RES, V60, P5548; Lu Y, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-31; Pavard S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001206; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P1913, DOI 10.1016/j.bbadis.2013.06.012; Reedy MB, 2001, GYNECOL ONCOL, V81, P441, DOI 10.1006/gyno.2001.6190; Roccisano D, 2014, MED HYPOTHESES, V82, P250, DOI 10.1016/j.mehy.2013.11.033; Rolyan H, 2011, BRAIN, V134, P2044, DOI 10.1093/brain/awr133; Salmena Leonardo, 2012, Womens Health (Lond Engl), V8, P127, DOI 10.2217/whe.12.2; Soni M, 2014, MATURITAS, V77, P209, DOI 10.1016/j.maturitas.2013.12.010; Vissac-Sabatier Cecile, 2003, Cancer Research, V63, P6607; Ward A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087918; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Zhao TS, 2013, ONCOL REP, V30, P377, DOI 10.3892/or.2013.2407; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	87	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					2879	2892		10.3390/ijms16022879		14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600036		
J	Kitagishi, Y; Minami, A; Nakanishi, A; Ogura, Y; Matsuda, S				Kitagishi, Yasuko; Minami, Akari; Nakanishi, Atsuko; Ogura, Yasunori; Matsuda, Satoru			Neuron Membrane Trafficking and Protein Kinases Involved in Autism and ADHD	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; GLYCOGEN-SYNTHASE KINASE-3-BETA; MONOAMINE TRANSPORTER-2 VMAT2; POLYUNSATURATED FATTY-ACIDS; TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR; SPECTRUM DISORDER; IN-VIVO; SIGNALING PATHWAY	A brain-enriched multi-domain scaffolding protein, neurobeachin has been identified as a candidate gene for autism patients. Mutations in the synaptic adhesion protein cell adhesion molecule 1 (CADM1) are also associated with autism spectrum disorder, a neurodevelopmental disorder of uncertain molecular origin. Potential roles of neurobeachin and CADM1 have been suggested to a function of vesicle transport in endosomal trafficking. It seems that protein kinase B (AKT) and cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) have key roles in the neuron membrane trafficking involved in the pathogenesis of autism. Attention deficit hyperactivity disorder (ADHD) is documented to dopaminergic insufficiencies, which is attributed to synaptic dysfunction of dopamine transporter (DAT). AKT is also essential for the DAT cell-surface redistribution. In the present paper, we summarize and discuss the importance of several protein kinases that regulate the membrane trafficking involved in autism and ADHD, suggesting new targets for therapeutic intervention.	[Kitagishi, Yasuko; Minami, Akari; Nakanishi, Atsuko; Ogura, Yasunori; Matsuda, Satoru] Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan	Matsuda, S (reprint author), Nara Womens Univ, Dept Food Sci & Nutr, Kita Uoya Nishimachi, Nara 6308506, Japan.	y_kitagishi@live.jp; laa_minami@cc.nara-wu.ac.jp; GAH00635@nifty.com; pl0okm9ijn@live.jp; smatsuda@cc.nara-wu.ac.jp			JSPS KAKENHI [25560050, 26-12035, 24240098]	This work was supported by JSPS KAKENHI Grant Number 25560050, 26-12035, 24240098.	Shaikh SR, 2006, AM J CLIN NUTR, V84, P1277; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Meneses A, 2011, REV NEUROSCIENCE, V22, P365, DOI 10.1515/RNS.2011.024; Prasad HC, 2009, PHILOS T R SOC B, V364, P163, DOI 10.1098/rstb.2008.0143; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Liang MH, 2008, MOL CELL NEUROSCI, V37, P440, DOI 10.1016/j.mcn.2007.10.017; Volders K, 2011, CURR MOL MED, V11, P204; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107; Spivak B, 2004, NEUROPSYCHOBIOLOGY, V50, P157, DOI 10.1159/000079108; McDougle CJ, 1996, ARCH GEN PSYCHIAT, V53, P993; Basselin M, 2012, BRAIN RES BULL, V87, P154, DOI 10.1016/j.brainresbull.2011.12.001; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Jia D, 2014, NEUROSCIENCE, V258, P228, DOI 10.1016/j.neuroscience.2013.11.016; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Zuko A, 2013, EUR J PHARMACOL, V719, P63, DOI 10.1016/j.ejphar.2013.07.016; Montales MTE, 2013, J ENDOCRINOL, V218, P135, DOI 10.1530/JOE-12-0520; Millichap JG, 2012, PEDIATRICS, V129, P330, DOI 10.1542/peds.2011-2199; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; Rovito D, 2013, J CELL PHYSIOL, V228, P1314, DOI 10.1002/jcp.24288; Wang R, 2010, PROG NEURO-PSYCHOPH, V34, P147, DOI 10.1016/j.pnpbp.2009.10.016; Leitner Y, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00268; Julich K, 2014, PEDIATR NEUROL, V50, P290, DOI 10.1016/j.pediatrneurol.2013.12.002; Bishop NE, 2003, INT REV CYTOL, V232, P1, DOI 10.1016/S0074-7696(03)32001-7; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Gu W, 2008, CYTOGENET GENOME RES, V123, P54, DOI 10.1159/000184692; Patel J, 2003, J NEUROCHEM, V85, P898, DOI 10.1046/j.1471-4159.2003.01732.x; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133; Fosi T, 2013, EPILEPSIA, V54, P2071, DOI 10.1111/epi.12399; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Tanabe Y, 2013, CELL BIOL INT, V37, P731, DOI 10.1002/cbin.10092; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; De Lozanne A, 2003, TRAFFIC, V4, P6, DOI 10.1034/j.1600-0854.2003.40102.x; Chen PH, 2012, J NUTR, V142, P1197, DOI 10.3945/jn.112.159939; Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653; Koutelou E, 2008, J BIOL CHEM, V283, P3846, DOI 10.1074/jbc.M706974200; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Cross S, 2008, NEUROPSYCHOPHARMACOL, V33, P353, DOI 10.1038/sj.npp.1301406; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Somkuwar SS, 2013, BIOCHEM PHARMACOL, V86, P309, DOI 10.1016/j.bcp.2013.04.013; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Barth V, 2013, J PHARMACOL EXP THER, V344, P501, DOI 10.1124/jpet.112.198895; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5; Aggarwal BB, 2013, MOL NUTR FOOD RES, V57, P1529, DOI 10.1002/mnfr.201200838; Tang DM, 2013, TRENDS CELL BIOL, V23, P296, DOI 10.1016/j.tcb.2013.01.008; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Liu H, 2008, EUR J PHARMACOL, V591, P43, DOI 10.1016/j.ejphar.2008.06.026; Benammi H, 2014, ACTA HISTOCHEM, V116, P920, DOI 10.1016/j.acthis.2014.03.002; Bourque M, 2011, PSYCHONEUROENDOCRINO, V36, P955, DOI 10.1016/j.psyneuen.2010.12.007; Bowton E, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.90; Burgess JR, 2000, AM J CLIN NUTR, V71, p327S; Cai J, 2013, MED HYPOTHESES, V80, P486, DOI 10.1016/j.mehy.2013.01.012; Carnero Amancio, 2014, Front Oncol, V4, P252, DOI 10.3389/fonc.2014.00252; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Chen CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5246; Dave B, 2005, CARCINOGENESIS, V26, P1793, DOI 10.1093/carcin/bgi131; de Joussineau C, 2014, HUM MOL GENET, V23, P5418, DOI 10.1093/hmg/ddu265; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Fujita E, 2012, J NEUROCHEM, V123, P886, DOI 10.1111/jnc.12022; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Gao N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.22; Grant P, 2014, NEUROPSYCHOBIOLOGY, V69, P220, DOI 10.1159/000360367; Greenwood TA, 2013, AM J MED GENET B, V162B, P137, DOI 10.1002/ajmg.b.32108; Hall FS, 2014, NEUROPHARMACOLOGY, V76, P146, DOI 10.1016/j.neuropharm.2013.07.031; Hamidpour Mohsen, 2014, J Tradit Complement Med, V4, P82, DOI 10.4103/2225-4110.130373; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Iwata K, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-33; Kanamarlapudi V, 2005, BIOCHEM SOC T, V33, P1279; Khattak MNK, 2010, CANCER INVEST, V28, P797, DOI 10.3109/07357907.2010.494318; Kim P, 2014, J NEUROSCI RES, V92, P658, DOI 10.1002/jnr.23275; Kirshenboim N, 2004, J MOL NEUROSCI, V24, P237, DOI 10.1385/JMN:24:2:237; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt208, 10.1186/1758-9193-5-42]; Kitagishi Y, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt265; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; La Merrill M, 2010, CLIN EXP METASTAS, V27, P107, DOI 10.1007/s10585-009-9302-7; Lecuit T, 2003, CURR OPIN GENET DEV, V13, P351, DOI 10.1016/S0959-437X(03)00078-9; Liegl R, 2014, GRAEF ARCH CLIN EXP, V252, P285, DOI 10.1007/s00417-013-2524-z; Lute BJ, 2008, BIOCHEM BIOPH RES CO, V372, P656, DOI 10.1016/j.bbrc.2008.05.091; Miller AC, 2015, CURR BIOL, V25, P16, DOI 10.1016/j.cub.2014.10.071; Mizutani R, 2009, CELL SIGNAL, V21, P1586, DOI 10.1016/j.cellsig.2009.06.005; MOMOI T, 2009, CELL BIOL INT, V34, P13; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Montgomery P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066697; Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082894; Murphy CM, 2014, AM J PSYCHIAT, V171, P1107, DOI 10.1176/appi.ajp.2014.12030352; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Nuytens K, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-43; O'Brien LJ, 1998, J NUTR, V128, P927; O'Driscoll C, 2007, J NEUROCHEM, V103, P860, DOI 10.1111/j.1471-4159.2007.04827.x; OHASHI M, 1994, J BIOL CHEM, V269, P24897; Olszewski PK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002568; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Patino-Lopez G, 2006, J NEUROIMMUNOL, V171, P145, DOI 10.1016/j.jneuroim.2005.09.017; Pearlman DM, 2014, BRIT J PSYCHIAT, V205, P8, DOI 10.1192/bjp.bp.113.137018; Penedo LA, 2009, EXP NEUROL, V217, P108, DOI 10.1016/j.expneurol.2009.01.021; Pringle DR, 2014, J CLIN ENDOCR METAB, V99, pE804, DOI 10.1210/jc.2013-3101; Qi M, 2005, MOL MED, V11, P59, DOI 10.2119/2006-00007.Auborn; Ribic A, 2014, J COMP NEUROL, V522, P900, DOI 10.1002/cne.23452; Robbins TW, 2003, CURR OPIN NEUROL, V16, pS1, DOI 10.1097/00019052-200312002-00001; Savelyeva L, 2006, HUM GENET, V118, P551, DOI 10.1007/s00439-005-0083-z; Schmid CL, 2014, NEUROPSYCHOPHARMACOL, V39, P1902, DOI 10.1038/npp.2014.38; Shamloula HK, 2002, GENETICS, V161, P693; Silva SR, 2011, ANTICANCER RES, V31, P1153; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Szentandrassy N, 2007, J PHYSIOL-LONDON, V582, P349, DOI 10.1113/jphysiol.2007.132753; Tian N, 2014, BIOCHEM BIOPH RES CO, V450, P746, DOI 10.1016/j.bbrc.2014.06.041; Tordjman Sylvie, 2014, Front Psychiatry, V5, P53, DOI 10.3389/fpsyt.2014.00053; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Wang LM, 2014, BIOCHEM PHARMACOL, V92, P73, DOI 10.1016/j.bcp.2014.07.018; Wang XL, 2000, J NEUROSCI, V20, P8551; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Wojtal KA, 2008, BIOESSAYS, V30, P146, DOI 10.1002/bies.20705; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059843; Xie F, 2013, INT J MOL SCI, V14, P21215, DOI 10.3390/ijms141121215; Yoshida H, 2011, INT J APPL BOIL PHAR, V2, P316; Yu YC, 2011, J CYST FIBROS, V10, P243, DOI 10.1016/j.jcf.2011.03.001; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079	134	0	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3095	3115		10.3390/ijms16023095		21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600047		
J	Kondo, Y; Shimosegawa, T				Kondo, Yasuteru; Shimosegawa, Tooru			Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							HEPATOCELLULAR-CARCINOMA PATIENTS; TRANSCRIPTION FACTOR FOXP3; ANTIVIRAL IMMUNE-RESPONSE; CHRONIC HBV INFECTION; NATURAL-KILLER-CELLS; DENDRITIC CELLS; POOR SURVIVAL; LAMIVUDINE THERAPY; MULTIPLE-MYELOMA; PERIPHERAL-BLOOD	The adaptive immune system, including type1 helper T cells (Th1 cells), cytotoxic T lymphocytes (CTLs), and dendritic cells (DCs), plays an important role in the control of hepatitis B virus (HBV). On the other hand, regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) suppress the immune reaction in HBV and hepatocellular carcinoma (HCC). Excessive activation of immune suppressive cells could contribute to the persistent infection of HBV and the progression of HCC. The frequency and/or function of Tregs could affect the natural course in chronic hepatitis B patients and the treatment response. In addition to the suppressive function of MDSCs, MDSCs could affect the induction and function of Tregs. Therefore, we should understand in detail the mechanism by which Tregs and MDSCs are induced to control HBV persistent infection and HBV-related HCC. Immune suppressive cells, including Tregs and MDSCs, contribute to the difficulty in inducing an effective immune response for HBV persistent infection and HBV-related HCC. In this review, we focus on the Tregs and MDSCs that could be potential targets for immune therapy of chronic hepatitis B and HBV-related HCC.	[Kondo, Yasuteru; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan	Kondo, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo, Sendai, Miyagi 9808574, Japan.	yasuteru@ebony.plala.or.jp; tshimosegawa@int3.med.tohoku.ac.jp		Kondo, Yasuteru/0000-0001-5935-4346			Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Zhang Y, 2010, VIROLOGY, V397, P34, DOI 10.1016/j.virol.2009.11.007; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI [10.1053/j.gastro.2008.03.020, 10.1053/i.gastro.2008.03.020]; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Li J, 2014, DIGEST DIS SCI, V59, P1475, DOI 10.1007/s10620-013-3022-1; Aalaei-Andabili SH, 2012, VACCINE, V30, P5595, DOI 10.1016/j.vaccine.2012.06.063; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; Kondo Y, 2010, J INFECT DIS, V202, P202, DOI 10.1086/653496; Xu DP, 2006, J IMMUNOL, V177, P739; Lunardi S, 2014, ONCOTARGET, V5, P11064; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Zhang HH, 2010, J VIRAL HEPATITIS, V17, P34, DOI 10.1111/j.1365-2893.2010.01269.x; Nan XP, 2010, VIRAL IMMUNOL, V23, P63, DOI 10.1089/vim.2009.0061; Kalathil S, 2013, CANCER RES, V73, P2435, DOI 10.1158/0008-5472.CAN-12-3381; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Han YM, 2014, HEPATOLOGY, V59, P567, DOI 10.1002/hep.26694; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.012; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Natarajan S, 2010, IMMUNOBIOLOGY, V215, P698, DOI 10.1016/j.imbio.2010.05.024; Stoop JN, 2007, VIROLOGY, V361, P141, DOI 10.1016/j.virol.2006.11.018; Liu CY, 2010, J CANCER RES CLIN, V136, P35, DOI 10.1007/s00432-009-0634-0; Brimnes MK, 2010, SCAND J IMMUNOL, V72, P540, DOI 10.1111/j.1365-3083.2010.02463.x; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Ahearne MJ, 2014, VIRCHOWS ARCH, V465, P351, DOI 10.1007/s00428-014-1615-5; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751; Takata Y, 2011, CANCER LETT, V307, P165, DOI 10.1016/j.canlet.2011.03.029; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130; Martinet J, 2012, GASTROENTEROLOGY, V143, P1586, DOI 10.1053/j.gastro.2012.08.046; Schmidt K, 2013, BLOOD, V121, P1740, DOI 10.1182/blood-2012-06-436568; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Dong XJ, 2013, LIVER INT, V33, P1517, DOI 10.1111/liv.12248; Ma YJ, 2013, SCAND J IMMUNOL, V78, P387, DOI 10.1111/sji.12097; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Anthony DD, 2011, VACCINE, V29, P3558, DOI 10.1016/j.vaccine.2011.02.092; Boltjes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097006; Braga WMT, 2014, CANCER IMMUNOL IMMUN, V63, P1189, DOI 10.1007/s00262-014-1589-9; Brtnicky T, 2015, HUM IMMUNOL, V76, P187, DOI 10.1016/j.humimm.2014.12.004; Cao MD, 2007, LAB INVEST, V87, P582, DOI 10.1038/labinvest.3700540; Chen LJ, 2014, INT J CLIN EXP PATHO, V7, P6015; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chu R, 2015, MOL CELL ENDOCRINOL, V399, P228, DOI 10.1016/j.mce.2014.10.006; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Hasegawa T., 2014, MOL CLIN ONCOL, V2, P685, DOI DOI 10.3892/MC0.2014.299; Huang YW, 2014, ANTIVIR THER, V19, P637, DOI 10.3851/IMP2762; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kondo Y, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/810939; Kondo Y, 2006, WORLD J GASTROENTERO, V12, P4310; Kondo Y, 2004, J MED VIROL, V74, P425, DOI 10.1002/jmv.20194; Kondo Yasuteru, 2009, Clin J Gastroenterol, V2, P71, DOI 10.1007/s12328-009-0074-z; Kondo Y., 2013, ISRN GASTROENTEROL, V2013, DOI [10.1155/2013/935295, DOI 10.1155/2013/935295]; Kondo Y, 2012, J GASTROENTEROL, V47, P1323, DOI 10.1007/s00535-012-0596-x; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Lim KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103975; Lu LR, 2014, ASIAN PAC J CANCER P, V15, P4367, DOI 10.7314/APJCP.2014.15.10.4367; Maeshiro T, 2007, WORLD J GASTROENTERO, V13, P4560; Monk P, 2014, J IMMUNOTHER, V37, P180, DOI 10.1097/CJI.0000000000000023; Nan XP, 2012, VIRAL IMMUNOL, V25, P21, DOI 10.1089/vim.2011.0049; Niu YH, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-47; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Otano I, 2012, HEPATOLOGY, V56, P474, DOI 10.1002/hep.25667; Pinheiro D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105027; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Sayour E.J., 2015, CANCER IMMUNOL IMMUN, DOI [10.1007/s00262-014-1651-7, DOI 10.1007/S00262-014-1651-7]; Shen SL, 2011, CAN J SURG, V54, P89, DOI 10.1503/cjs.028009; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Sprengers D, 2007, ANTIVIR THER, V12, P1087; Stoop JN, 2007, HEPATOLOGY, V46, P699, DOI 10.1002/hep.21761; Tang Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-17; Tazzari M, 2014, BRIT J CANCER, V111, P1350, DOI 10.1038/bjc.2014.437; Wang FM, 2012, LIVER INT, V32, P644, DOI 10.1111/j.1478-3231.2011.02675.x; Wang QRZ, 2013, J SURG ONCOL, V107, P422, DOI 10.1002/jso.23227; Watanabe S, 2008, J IMMUNOL, V181, P3291; Xue-Song Liang, 2012, BMC Gastroenterol, V12, P43, DOI 10.1186/1471-230X-12-43; Yin Y, 2014, CELL RES, V24, P1164, DOI 10.1038/cr.2014.121; Yukawa T, 2015, ONCOL REP, V33, P74, DOI 10.3892/or.2014.3561; Zhu JK, 2011, J GASTROEN HEPATOL, V26, P1519, DOI 10.1111/j.1440-1746.2011.06765.x	101	2	3	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3307	3322		10.3390/ijms16023307		16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600062		
J	Nanashima, A; Nagayasu, T				Nanashima, Atsushi; Nagayasu, Takeshi			Current Status of Photodynamic Therapy in Digestive Tract Carcinoma in Japan	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Editorial Material							BILE-DUCT CARCINOMA; NONRESECTABLE HILAR CHOLANGIOCARCINOMA; SQUAMOUS-CELL CARCINOMA; L-ASPARTYL CHLORINE; PHASE-II; TALAPORFIN SODIUM; ENDOSCOPIC APPLICATION; SUBMUCOSAL DISSECTION; SALVAGE TREATMENT; GASTRIC-CANCER	Photodynamic therapy (PDT) is an effective local treatment modality as a cancer-specific laser ablation in malignancy of some organs including digestive tracts or bile duct. In Japan, PDT has been applied at the early period after the first clinical induction in 1980's. Although the useful efficacy was clarified, PDT has not been fully applied because of the phototoxicity of the porfimer sodium. The next generated talaporfin-sodium was used for PDT, in which phototoxicity was reduced and, however, the clinical efficacy for digestive tract malignancy has not yet been clarified. By proceeding the experimental and clinical trials, it is necessary to clarify the evidence of efficacy as a local powerful treatment with the conventional surgery, brachiotherapy and chemotherapy in the future step.	[Nanashima, Atsushi; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan	Nanashima, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	ananasm7@gmail.com; nagayasu@nagasaki-u.ac.jp					Berr F, 2000, HEPATOLOGY, V31, P291, DOI 10.1002/hep.510310205; Dumoulin FL, 2003, GASTROINTEST ENDOSC, V57, P860, DOI 10.1067/mge.2003.250; Berr F, 2000, J HEPATOL, V32, P352, DOI 10.1016/S0168-8278(00)80083-5; Nanashima A, 2012, ANTICANCER RES, V32, P4931; Shimizu Y, 2013, DIGEST ENDOSC, V25, P13, DOI 10.1111/j.1443-1661.2012.01408.x; Ortner MAEJ, 1998, GASTROENTEROLOGY, V114, P536, DOI 10.1016/S0016-5085(98)70537-2; Yano T, 2012, INT J CANCER, V131, P1228, DOI 10.1002/ijc.27320; Nonaka Y, 2013, J SURG RES, V181, P234, DOI 10.1016/j.jss.2012.06.047; Tanaka M, 2011, ANTICANCER RES, V31, P763; Kishi K, 2010, INT J ONCOL, V36, P313, DOI 10.3892/ijo_00000502; Yano T, 2005, GASTROINTEST ENDOSC, V62, P31, DOI 10.1016/S0016-5107(05)00545-6; Witzigmann H, 2006, ANN SURG, V244, P230, DOI 10.1097/01.sla.0000217639.10331.47; Rumalla A, 2001, GASTROINTEST ENDOSC, V53, P500, DOI 10.1067/mge.2001.113386; Zoepf T, 2005, AM J GASTROENTEROL, V100, P2426, DOI 10.1111/j.1572-0241.2005.00318.x; Kakushima N, 2008, WORLD J GASTROENTERO, V14, P2962, DOI 10.3748/wjg.14.2962; Tomizawa Y, 2012, DIGEST DIS SCI, V57, P274, DOI 10.1007/s10620-011-1957-7; Wiedmann M, 2003, CANCER, V97, P2783, DOI 10.1002/cncr.11401; Wiedmann M, 2004, GASTROINTEST ENDOSC, V60, P68, DOI 10.1016/S0016-5107(04)01288-X; Harvey EH, 2005, AM J SURG, V189, P302, DOI 10.1016/j.amjsurg.2004.11.016; Nanashima A, 2004, J GASTROENTEROL, V39, P1095, DOI 10.1007/s00535-004-1449-z; Tanaka M, 2014, MOL CANCER THER, V13, P767, DOI 10.1158/1535-7163.MCT-13-0393; Usuda J, 2007, LUNG CANCER, V58, P317, DOI 10.1016/j.lungcan.2007.06.026; Kasuya K, 2010, J HEPATO-BIL-PAN SCI, V17, P313, DOI 10.1007/s00534-009-0246-8; DOUGHERTY TJ, 1978, CANCER RES, V38, P2628; Gotoda T., 2014, ANN TRANSL MED, V2, DOI [10.3978/j.isn.2305-5839.2014.03.03, DOI 10.3978/J.ISSN.2305-5839.2014.03.03]; Harewood GC, 2005, J GASTROEN HEPATOL, V20, P415, DOI 10.1111/j.1400-1746.2005.03582.x; Hayashi N, 2015, MOL CANCER THER, V14, P452, DOI 10.1158/1535-7163.MCT-14-0348; Kato H, 1996, Gan To Kagaku Ryoho, V23, P8; Mimura S, 1996, LASER SURG MED, V19, P168; Nakamura Tetsuya, 2014, Laser Ther, V23, P201, DOI 10.5978/islsm.14-OR-16; Nanashima Atsushi, 2014, Ann Transl Med, V2, P23, DOI 10.3978/j.issn.2305-5839.2014.03.04; Nonaka T, 2011, J HEPATO-BIL-PAN SCI, V18, P592, DOI 10.1007/s00534-011-0377-6; OKUNAKA T, 1990, SURG ENDOSC-ULTRAS, V4, P150, DOI 10.1007/BF02336594; Saito H, 2008, J HEPATO-BILIARY-PAN, V15, P63, DOI 10.1007/s00534-007-1281-y; Suzuki S, 2004, ENDOSCOPY, V36, P83; Tanaka T, 2011, GASTROINTEST ENDOSC, V73, P1, DOI 10.1016/j.gie.2010.08.049; Tomita T, 2011, J CLIN GASTROENTEROL, V45, pE54, DOI 10.1097/MCG.0b013e3181ef3612; Yano T., 2012, RADIAT ONCOL, P7, DOI [10.1186/1748-717X-7-11310.1186/1748-717X-7-7, DOI 10.1186/1748-717X-7-113]	38	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3434	3440		10.3390/ijms16023434		7	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600070		
J	Ishino, K; Kato, T; Kato, M; Shibata, T; Watanabe, M; Wakabayashi, K; Nakagama, H; Totsuka, Y				Ishino, Kousuke; Kato, Tatsuya; Kato, Mamoru; Shibata, Tatsuhiro; Watanabe, Masatoshi; Wakabayashi, Keiji; Nakagama, Hitoshi; Totsuka, Yukari			Comprehensive DNA Adduct Analysis Reveals Pulmonary Inflammatory Response Contributes to Genotoxic Action of Magnetite Nanoparticles	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; OXYGEN SPECIES PRODUCTION; TANDEM MASS-SPECTROMETRY; LIPID-PEROXIDATION; OXIDATIVE STRESS; NALP3 INFLAMMASOME; MAMMALIAN-CELLS; NUCLEIC-ACIDS; CROSS-LINKS; IN-VIVO	Nanosized-magnetite (MGT) is widely utilized in medicinal and industrial fields; however, its toxicological properties are not well documented. In our previous report, MGT showed genotoxicity in both in vitro and in vivo assay systems, and it was suggested that inflammatory responses exist behind the genotoxicity. To further clarify mechanisms underlying the genotoxicity, a comprehensive DNA adduct (DNA adductome) analysis was conducted using DNA samples derived from the lungs of mice exposed to MGT. In total, 30 and 42 types of DNA adducts were detected in the vehicle control and MGT-treated groups, respectively. Principal component analysis (PCA) against a subset of DNA adducts was applied and several adducts, which are deduced to be formed by inflammation or oxidative stress, as the case of etheno-deoxycytidine (epsilon dC), revealed higher contributions to MGT exposure. By quantitative-LC-MS/MS analysis, epsilon dC levels were significantly higher in MGT-treated mice than those of the vehicle control. Taken together with our previous data, it is suggested that inflammatory responses might be involved in the genotoxicity induced by MGT in the lungs of mice.	[Ishino, Kousuke; Kato, Tatsuya; Nakagama, Hitoshi; Totsuka, Yukari] Natl Canc Ctr, Res Inst, Div Carcinogenesis & Prevent, Chuo Ku, Tokyo 1040045, Japan; [Kato, Mamoru; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Div Mat Sci & Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan	Totsuka, Y (reprint author), Natl Canc Ctr, Res Inst, Div Carcinogenesis & Prevent, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	kishino@ncc.go.jp; takatou1311@gmail.com; mamkato@ncc.go.jp; tashibat@ncc.go.jp; mawata@ynu.ac.jp; kwakabayashi@u-shizuoka-ken.ac.jp; hnakagam@ncc.go.jp; ytotsuka@ncc.go.jp			Ministry of Health, Labor, and Welfare of Japan [23710084]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Foundation for Promotion of Cancer Research	We thank Naoaki Uchiya, Yoko Matsumoto and Akihiro Sekine for their excellent technical assistance. This study was supported by Grants-in-Aid for Cancer Research, for the U.S.-Japan Cooperative Medical Science Program, for Research on Risk of Chemical Substances from the Ministry of Health, Labor, and Welfare of Japan, for Young Scientists (B) 23710084 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The study was also supported by a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI). Kousuke Ishino was the recipient of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research.	WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ma P, 2012, INT J NANOMED, V7, P4809, DOI 10.2147/IJN.S34349; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Crean C, 2008, NUCLEIC ACIDS RES, V36, P742, DOI 10.1093/nar/gkm1092; Szalay B, 2012, J APPL TOXICOL, V32, P446, DOI 10.1002/jat.1779; Asahi T, 2010, J BIOL CHEM, V285, P9282, DOI 10.1074/jbc.M109.054213; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Park EJ, 2010, TOXICOLOGY, V275, P65, DOI 10.1016/j.tox.2010.06.002; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; Kanaly RA, 2006, ANTIOXID REDOX SIGN, V8, P993, DOI 10.1089/ars.2006.8.993; Otteneder MB, 2006, P NATL ACAD SCI USA, V103, P6665, DOI 10.1073/pnas.0602017103; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Kasai H, 2008, MUTAT RES-REV MUTAT, V659, P56, DOI 10.1016/j.mrrev.2008.02.003; Felton C, 2014, DRUG METAB REV, V46, P142, DOI 10.3109/03602532.2013.876429; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Matsuda T, 2006, CHEM RES TOXICOL, V19, P1374, DOI 10.1021/tx060113h; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Kew MC, 2013, J GASTROINTEST LIVER, V22, P305; Konczol M, 2011, CHEM RES TOXICOL, V24, P1460, DOI 10.1021/tx200051s; Matsuda T, 2013, CARCINOGENESIS, V34, P121, DOI 10.1093/carcin/bgs327; Guichard Y, 2012, ANN OCCUP HYG, V56, P631, DOI 10.1093/annhyg/mes006; Cabrera L, 2008, ELECTROCHIM ACTA, V53, P3436, DOI 10.1016/j.electacta.2007.12.006; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Hollstein M, 2013, MUTAT RES-REV MUTAT, V753, P41, DOI 10.1016/j.mrrev.2013.02.003; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; Singh N, 2012, BIOMATERIALS, V33, P163, DOI 10.1016/j.biomaterials.2011.09.087; Delaney JC, 2008, CHEM RES TOXICOL, V21, P232, DOI 10.1021/tx700292a; Watanabe M, 2013, INT J MOL SCI, V14, P15546, DOI 10.3390/ijms140815546; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Box HC, 1998, RADIAT RES, V149, P433, DOI 10.2307/3579782; Byun J, 2003, ANAL BIOCHEM, V317, P201, DOI 10.1016/S0003-2697(03)00093-9; Cadet J, 2012, FREE RADICAL RES, V46, P367, DOI 10.3109/10715762.2012.659248; EDER E, 1993, CHEM RES TOXICOL, V6, P486, DOI 10.1021/tx00034a015; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d; Hong HZ, 2006, CHEM RES TOXICOL, V19, P614, DOI 10.1021/tx060025x; Hsiao JK, 2009, J NANOSCI NANOTECHNO, V9, P1388, DOI 10.1166/jnn.2009.C163; Ishino K, 2008, CHEM RES TOXICOL, V21, P1261, DOI 10.1021/tx800080x; Jin RR, 2014, CURR OPIN PHARMACOL, V18, P18, DOI 10.1016/j.coph.2014.08.002; Kasper J, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-6; Kawai Y, 2003, J BIOL CHEM, V278, P50346, DOI 10.1074/jbc.M309057200; Kawanishi M, 2013, J TOXICOL SCI, V38, P503; Khalili H, 2000, MUTAT RES-GEN TOX EN, V465, P39, DOI 10.1016/S1383-5718(99)00203-X; Knutson CG, 2009, BIOCHEMISTRY-US, V48, P800, DOI 10.1021/bi801654j; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Nair J, 2012, CHEM RES TOXICOL, V25, P162, DOI 10.1021/tx200392a; Niles JC, 2006, NITRIC OXIDE-BIOL CH, V14, P109, DOI 10.1016/j.niox.2005.11.001; Olsen R, 2005, CHEM RES TOXICOL, V18, P730, DOI 10.1021/tx0496688; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Raboisson P, 2002, J MED CHEM, V45, P962, DOI 10.1021/jm0104062; Ramesh V, 2012, MOL CELL BIOCHEM, V363, P225, DOI 10.1007/s11010-011-1174-x; Roberts DW, 2001, ANAL CHEM, V73, P303, DOI 10.1021/ac000866n; Salomon RG, 2011, CHEM RES TOXICOL, V24, P1803, DOI 10.1021/tx200206v; Scholdberg TA, 2005, CHEM RES TOXICOL, V18, P145, DOI 10.1021/tx049772q; Singh N., 2010, NANO REV, V1, P5358, DOI DOI 10.3402/NANO.V1I0.5358; Totsuka Y, 2014, NANOMATERIALS-BASEL, V4, P175, DOI 10.3390/nano4010175; Wang H, 2004, CHEM RES TOXICOL, V17, P144, DOI 10.1021/tx034174g; Wang MY, 2009, CANCER RES, V69, P7170, DOI 10.1158/0008-5472.CAN-09-1571; Yang IY, 2009, J BIOL CHEM, V284, P191, DOI 10.1074/jbc.M806414200; Zhong WG, 2004, BIOMED CHROMATOGR, V18, P462, DOI 10.1002/bmc.337	67	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3474	3492		10.3390/ijms16023474		19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600073		
J	Takahashi, T; Kojima, K; Zhang, W; Sasaki, K; Ito, M; Suzuki, H; Kawasaki, M; Wakatsuki, S; Takahara, T; Shibata, H; Maki, M				Takahashi, Takeshi; Kojima, Kyosuke; Zhang, Wei; Sasaki, Kanae; Ito, Masaru; Suzuki, Hironori; Kawasaki, Masato; Wakatsuki, Soichi; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi			Structural Analysis of the Complex between Penta-EF-Hand ALG-2 Protein and Sec31A Peptide Reveals a Novel Target Recognition Mechanism of ALG-2	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							RETICULUM EXIT SITES; ALTERNATIVELY SPLICED ISOFORM; LINKED GENE ALG-2; CELL-DEATH 6; CA2+-BINDING PROTEINS; BINDING-SITE; COPII CAGE; ESCRT-I; ALIX; IDENTIFICATION	ALG-2, a 22-kDa penta-EF-hand protein, is involved in cell death, signal transduction, membrane trafficking, etc., by interacting with various proteins in mammalian cells in a Ca2+-dependent manner. Most known ALG-2-interacting proteins contain proline-rich regions in which either PPYPXnYP (type 1 motif) or PXPGF (type 2 motif) is commonly found. Previous X-ray crystal structural analysis of the complex between ALG-2 and an ALIX peptide revealed that the peptide binds to the two hydrophobic pockets. In the present study, we resolved the crystal structure of the complex between ALG-2 and a peptide of Sec31A (outer shell component of coat complex II, COPII; containing the type 2 motif) and found that the peptide binds to the third hydrophobic pocket (Pocket 3). While amino acid substitution of Phe(85), a Pocket 3 residue, with Ala abrogated the interaction with Sec31A, it did not affect the interaction with ALIX. On the other hand, amino acid substitution of Tyr(180), a Pocket 1 residue, with Ala caused loss of binding to ALIX, but maintained binding to Sec31A. We conclude that ALG-2 recognizes two types of motifs at different hydrophobic surfaces. Furthermore, based on the results of serial mutational analysis of the ALG-2-binding sites in Sec31A, the type 2 motif was newly defined.	[Takahashi, Takeshi; Kojima, Kyosuke; Zhang, Wei; Sasaki, Kanae; Ito, Masaru; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Suzuki, Hironori; Kawasaki, Masato; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Struct Biol Res Ctr, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; [Suzuki, Hironori] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 8020, New Zealand; [Wakatsuki, Soichi] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Maki, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	takahashi.takeshi@a.mbox.nagoya-u.ac.jp; kojima.kiyousuke@c.mbox.nagoya-u.ac.jp; zhang.wei@i.mbox.nagoya-u.ac.jp; guinaijiang@hotmail.co.jp; kurukurumegane3310@gmail.com; hironori.suzuki@canterbury.ac.nz; masato.kawasaki@kek.jp; soichi.wakatsuki@stanford.edu; takahara@agr.nagoya-u.ac.jp; shibabou@agr.nagoya-u.ac.jp; mmaki@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23380056, 26292050]	We thank Nobuhisa Watanabe (Nagoya University Synchrotron Research Center) and Tatsutoshi Inuzuka for valuable suggestions. We also thank Ken Ueda for technical assistance. This work was supported by a Grant-In-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) to Masatoshi Maki (Project No. 23380056, 26292050).	ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Noble AJ, 2013, NAT STRUCT MOL BIOL, V20, P167, DOI 10.1038/nsmb.2467; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Sasaki-Osugi K, 2013, J BIOL CHEM, V288, P33361, DOI 10.1074/jbc.M113.497479; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Rho SB, 2012, CELL SIGNAL, V24, P131, DOI 10.1016/j.cellsig.2011.08.013; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Braun EL, 1998, J MOL EVOL, V47, P531, DOI 10.1007/PL00006409; Chen CM, 2005, BIOCHEM BIOPH RES CO, V333, P51, DOI 10.1016/j.bbrc.2005.05.074; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Krebs J, 2009, BBA-MOL CELL RES, V1793, P979, DOI 10.1016/j.bbamcr.2008.12.006; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lollike K, 2001, J BIOL CHEM, V276, P17762, DOI 10.1074/jbc.M100965200; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Maki M, 1997, BIOCHEM J, V328, P718; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okumura M, 2013, BIOSCI BIOTECH BIOCH, V77, P1715, DOI 10.1271/bbb.130280; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Osugi Kanae, 2013, Methods Mol Biol, V963, P187, DOI 10.1007/978-1-62703-230-8_12; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suzuki H, 2008, ACTA CRYSTALLOGR F, V64, P974, DOI 10.1107/S1744309108030297; Takahashi T, 2012, INT J MOL SCI, V13, P7532, DOI 10.3390/ijms13067532; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Vernarecci S, 2007, MOL MICROBIOL, V65, P1122, DOI 10.1111/j.1365-2958.2007.05852.x; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951	59	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3677	3699		10.3390/ijms16023677		23	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600084		
J	Masaki, S; Yoshimoto, R; Kaida, D; Hata, A; Satoh, T; Ohno, M; Kataoka, N				Masaki, So; Yoshimoto, Rei; Kaida, Daisuke; Hata, Asuka; Satoh, Takayuki; Ohno, Mutsuhito; Kataoka, Naoyuki			Identification of the Specific Interactors of the Human Lariat RNA Debranching Enzyme 1 Protein	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA; XENOPUS-TROPICALIS; BINDING-PROTEINS; MAMMALIAN-CELLS; INTRON; CYTOPLASM; TURNOVER; SEQUENCE; NUCLEUS	In eukaryotes, pre-mRNA splicing is an essential step for gene expression. We have been analyzing post-splicing intron turnover steps in higher eukaryotes. Here, we report protein interaction between human Debranching enzyme 1 (hDbr1) and several factors found in the Intron Large (IL) complex, which is an intermediate complex of the intron degradation pathway. The hDbr1 protein specifically interacts with xeroderma pigmentosum, complementeation group A (XPA)-binding protein 2 (Xab2). We also attempted to identify specific interactors of hDbr1. Co-immunoprecipitation experiments followed by mass spectrometry analysis identified a novel protein as one of the specific interactors of hDbr1. This protein is well conserved among many species and shows the highest similarity to yeast Drn1, so it is designated as human Dbr1 associated ribonuclease 1 (hDrn1). hDrn1 directly interacts with hDbr1 through protein-protein interaction. Furthermore, hDrn1 shuttles between the nucleus and the cytoplasm, as hDbr1 protein does. These findings suggest that hDrn1 has roles in both the nucleus and the cytoplasm, which are highly likely to involve hDbr1.	[Masaki, So; Hata, Asuka; Kataoka, Naoyuki] Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Med Innovat Ctr,Sakyo Ku, Kyoto 6068507, Japan; [Yoshimoto, Rei] RIKEN Adv Sci Inst, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Yoshimoto, Rei; Ohno, Mutsuhito; Kataoka, Naoyuki] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Yoshimoto, Rei] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Toyoake, Aichi 4701192, Japan; [Kaida, Daisuke; Satoh, Takayuki] Toyama Univ, Frontier Res Core Life Sci, Toyama 9300194, Japan; [Kataoka, Naoyuki] Tokyo Dent & Med Univ, Med Res Inst, Med Top Track Program, Tokyo 1138510, Japan	Kataoka, N (reprint author), Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Med Innovat Ctr,Sakyo Ku, Kyoto 6068507, Japan.	masaki@dsk.med.kyoto-u.ac.jp; ryoshi@fujita-hu.ac.jp; kaida@med.u-toyama.ac.jp; akusa.atah@gmail.com; tsatoh@med.u-toyama.ac.jp; hitoohno@virus.kyoto-u.ac.jp; kataoka.naoyuki.6m@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20112007, 23112706]	We are grateful to Kataoka lab members for technical assistance and critical comments on this manuscript. We also thank Gideon Dreyfuss for the gift of the Flag-pcDNA3 plasmid. This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas "Diversity and asymmetry achieved by RNA program" (No. 20112007 to Mutsuhito Ohno, No. 23112706 to Naoyuki Kataoka) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Talhouarne GJS, 2014, RNA, V20, P1476, DOI 10.1261/rna.045781.114; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; MICHAEL WM, 1995, CELL, V83, P415; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Gardner EJ, 2012, GENE DEV, V26, P2550, DOI 10.1101/gad.202184.112; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Garrey SM, 2014, RNA, V20, P1337, DOI 10.1261/rna.044602.114; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ivanov A, 2014, CELL REP, V10, P170, DOI [10.1016/j.celrep.2014.12.01925558066, DOI 10.1016/J.CELREP.2014.12.01925558066]; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Kataoka N, 2011, SCI REP-UK, V1, DOI 10.1038/srep00092; Kataoka N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01090; Kim JW, 2000, NUCLEIC ACIDS RES, V28, P3666, DOI 10.1093/nar/28.18.3666; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nam K, 1997, MOL CELL BIOL, V17, P809; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Yoshimoto R, 2009, NUCLEIC ACIDS RES, V37, P891, DOI 10.1093/nar/gkn1002; Yoshimoto R, 2014, GENES CELLS, V19, P78, DOI 10.1111/gtc.12114	41	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3705	3721		10.3390/ijms16023705		17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600086		
J	Takeshita, Y; Takakura, K; Akitsu, T				Takeshita, Yuki; Takakura, Kazuya; Akitsu, Takashiro			Multifunctional Composites of Chiral Valine Derivative Schiff Base Cu(II) Complexes and TiO2	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							UV PROTECTION; SUNSCREENS	We have prepared four new Cu(II) complexes containing valine moieties with imidazole ligands at the fourth coordination sites and examined their photo-induced reactions with TiO2 in order of understanding the reaction mechanisms. Under a nitrogen atmosphere, the intermolecular electron transfer reactions (essentially supramolecular interactions) of these systems, which resulted in the reduction of Cu(II) species to Cu(I) ones, occurred after UV light irradiation. In this study, we have investigated the conditions of the redox reactions in view of substituent effects of aldehyde moieties. The results of cyclic voltammetry (CV) on an rotating ring-disk electrode (RRDE) suggested that the substitution effects and redox potentials were correlated. Density functional theory (DFT) and time-dependent DFT (TD-DFT) calculations were also performed to simulate the UV-Vis and circular dichroism (CD) spectra; the results revealed a reasonably good correlation between the substituent effects and the highest occupied molecular orbitals and the lowest unoccupied molecular orbitals (HOMO-LUMO) gaps associated with the most intense transition bands. In addition, we summarized the substitution effects of Cu(II) complexes for their corresponding UV light-induced reactions.	[Takeshita, Yuki; Takakura, Kazuya; Akitsu, Takashiro] Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, Tokyo 1628601, Japan	Akitsu, T (reprint author), Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	jb113697@ed.tus.ac.jp; metro.user@gmail.com; akitsu@rs.kagu.tus.ac.jp			Cosmetology Research Foundation	This work was partly supported by The Cosmetology Research Foundation. This work was performed under the Cooperative Research Program of the "Network Joint Research Centre for Materials and Devices". The computation was mainly carried out using the computer facilities at the Research Institute for Information Technology, Kyushu University.	Abney JR, 1998, J CHEM EDUC, V75, P757; Akitsu T., 2010, ASIAN CHEM LETT, V14, P255; Akitsu T., 2010, ASIAN CHEM LETT, V14, P261; Akitsu T., 2010, ASIAN CHEM LETT, V14, P63; Mosconi E, 2012, J AM CHEM SOC, V134, P19438, DOI 10.1021/ja3079016; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Huang J, 2012, ANGEW CHEM INT EDIT, V51, P12711, DOI 10.1002/anie.201204341; Colombo A, 2014, ACS APPL MATER INTER, V6, P13945, DOI 10.1021/am503306f; Frisch M. J., 2009, REF MISMAT; Fujishige S, 2001, J CHEM EDUC, V78, P1678; G-Oliveros G., 2010, OPEN MAT SCI J, V4, P15; Hang H., 2010, ENVIRON SCI TECHNOL, V44, P1107, DOI [10.1021/es902912320039724, DOI 10.1021/ES902912320039724]; Kurata M., 2013, CONT ENG SCI, V6, P255; Magni M, 2014, ELECTROCHIM ACTA, V141, P324, DOI 10.1016/j.electacta.2014.07.086; Miyazawa M., 2014, COSMETIC SCI KYORITS; Moeur HP, 2006, J CHEM EDUC, V83, P769; Nakayama T., 2011, ASIAN CHEM LETT, V15, P215; Nishizuru H., 2012, ASIAN CHEM LETT, V16, P33; Sakaki S., 2002, J CHEM SOC DA, V6, P840, DOI [10.1039/b109518h, DOI 10.1039/B109518H]; Sheldrick G. M., 1996, SADABS PROGRAM EMPIR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Takeshita Y., 2015, TRENDS PHOT IN PRESS; Takeshita Y., 2014, WORLD SCI ECHO, V1, P20; Walters C, 1997, J CHEM EDUC, V74, P99; Watanabe Y., 2012, ASIAN CHEM LETT, V16, P9; Yamamoto S., 2011, ASIAN CHEM LETT, V15, P203	26	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3955	3969		10.3390/ijms16023955		15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600101		
J	Kaitsuka, T; Matsushita, M				Kaitsuka, Taku; Matsushita, Masayuki			Regulation of Translation Factor EEF1D Gene Function by Alternative Splicing	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review							NUCLEOTIDE-EXCHANGE PROTEIN; SHOCK TRANSCRIPTION FACTORS; MOLECULAR CHAPERONES; MAMMALIAN-CELLS; STRESS; DISEASE; HSF1; ELONGATION; FAMILY; GROWTH	Alternative splicing is an exquisite mechanism that allows one coding gene to have multiple functions. The alternative splicing machinery is necessary for proper development, differentiation and stress responses in a variety of organisms, and disruption of this machinery is often implicated in human diseases. Previously, we discovered a long form of eukaryotic elongation factor 1B delta (eEF1B delta; this long-form eEF1B delta results from alternative splicing of EEF1D transcripts and regulates the cellular stress response by transcriptional activation, not translational enhancement, of heat-shock responsive genes. In this review, we discuss the molecular function of EEF1D alternative splicing products and the estimated implication of human diseases.	[Kaitsuka, Taku] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto 8608556, Japan; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Nakagami, Okinawa 9030215, Japan	Matsushita, M (reprint author), Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Nakagami, Okinawa 9030215, Japan.	kaitsuka@kumamoto-u.ac.jp; masayuki@med.u-ryukyu.ac.jp			Special Account Budget for Education and Research within Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by grants-in-aid from a Special Account Budget for Education and Research within the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Noonan E, 2008, EXP CELL RES, V314, P2468, DOI 10.1016/j.yexcr.2008.05.002; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Morano KA, 1999, GENE EXPRESSION, V7, P271; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Semenza GL, 2000, GENE DEV, V14, P1983; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Rolfe DFS, 1997, PHYSIOL REV, V77, P731; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Hinnebusch A. G., 2000, TRANSLATIONAL CONTRO, P185; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187; Kaitsuka T, 2011, EMBO REP, V12, P673, DOI 10.1038/embor.2011.82; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; LEUNG TKC, 1990, BIOCHEM J, V267, P125; MORALES J, 1992, NUCLEIC ACIDS RES, V20, P4091, DOI 10.1093/nar/20.15.4091; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Parsian AJ, 2000, BBA-GENE STRUCT EXPR, V1494, P201, DOI 10.1016/S0167-4781(00)00203-7; SANDERS J, 1993, BIOCHIM BIOPHYS ACTA, V1174, P87, DOI 10.1016/0167-4781(93)90097-W; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Schulte EC, 2014, NEUROGENETICS, V15, P49, DOI 10.1007/s10048-013-0383-8; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005	58	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					3970	3979		10.3390/ijms16023970		10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600102		
J	Kashimura, A; Kimura, M; Okawa, K; Suzuki, H; Ukita, A; Wakita, S; Okazaki, K; Ohno, M; Bauer, PO; Sakaguchi, M; Sugahara, Y; Oyama, F				Kashimura, Akinori; Kimura, Masahiro; Okawa, Kazuaki; Suzuki, Hirotaka; Ukita, Atsushi; Wakita, Satoshi; Okazaki, Kana; Ohno, Misa; Bauer, Peter O.; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka			Functional Properties of the Catalytic Domain of Mouse Acidic Mammalian Chitinase Expressed in Escherichia coli	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article							SERRATIA-MARCESCENS 2170; EXTRACELLULAR EXPRESSION; GLYCOSYL HYDROLASES; CHITOTRIOSIDASE; INFLAMMATION; SYSTEM; PROTEINS; TISSUE; MACROPHAGES; ACTIVATION	Mouse acidic mammalian chitinase (AMCase) plays important physiological roles in defense and nutrition. AMCase is composed of an N-terminal catalytic domain (CatD) and a C-terminal chitin-binding domain (CBD). We expressed CatD of mouse AMCase as a recombinant fusion protein with Protein A and V5-His in Escherichia coli (Protein A-CatD-V5-His), evaluated its functional properties and compared them to the full-length AMCase (Protein A-AMCase-V5-His). Under our experimental conditions, the chitinolytic activity of both proteins against 4-nitrophenyl N,N'-diacetyl-beta-d-chitobioside was equivalent with regard to their specific enzymatic activities, optimal pH and temperature as well as to the pH and temperature stability. CatD bound to chitin beads and cleaved the N-acetylglucosamine hexamer, colloidal and crystalline chitin as well as the shrimp shell, and released primarily N,N'-diacetylchitobiose fragments at pH 2.0. These results indicate that the primary structure of CatD is sufficient to form a proper tertiary structure required for chitinolytic activity, recognize chitin substrates and degrade them in the absence of a CBD. Our recombinant proteins can be used for further studies evaluating pathophysiological roles of AMCase in different diseases.	[Kashimura, Akinori; Kimura, Masahiro; Okawa, Kazuaki; Suzuki, Hirotaka; Ukita, Atsushi; Wakita, Satoshi; Okazaki, Kana; Ohno, Misa; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan; [Bauer, Peter O.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Oyama, F (reprint author), Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan.	bd12001@ns.kogakuin.ac.jp; b411050@ns.kogakuin.ac.jp; bd14001@ns.kogakuin.ac.jp; hirotaka.suzuki@ssd.hpk.co.jp; atsushi.ukita@gmail.com; bm13028@ns.kogakuin.ac.jp; kanaokazaki@eurofins.com; bd13001@ns.kogakuin.ac.jp; Bauer.Peter@mayo.edu; bt11532@ns.kogakuin.ac.jp; bt79310@ns.kogakuin.ac.jp; f-oyama@cc.kogakuin.ac.jp			Research Institute of Science and Technology, Kogakuin University; Ministry of Education, Culture, Sport, Science and Technology, Japan [S1411005]	We are grateful to Haruko Miyazaki and Nobuyuki Nukina for their encouragement, to Shotaro Honda and Daisuke Mizutani for valuable suggestions and to Momoka Ohmizo for technical assistance. This work was supported by the Project Research Grant from the Research Institute of Science and Technology, Kogakuin University and in part by a grant of the Strategic Research Foundation Grant-aided Project for Private Universities (S1411005) from the Ministry of Education, Culture, Sport, Science and Technology, Japan.	Richter C, 1998, BIOCHEM J, V335, P481; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; BOOT RG, 1995, J BIOL CHEM, V270, P26252; Musumeci M, 2009, CORNEA, V28, P667, DOI 10.1097/ICO.0b013e31819bc308; Seibold MA, 2009, J BIOL CHEM, V284, P19650, DOI 10.1074/jbc.M109.012443; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Yang CJ, 2009, HUM GENE THER, V20, P1597, DOI 10.1089/hum.2008.092; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Watanabe T, 1997, J BACTERIOL, V179, P7111; Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Bucolo C, 2008, PHARMACOL RES, V57, P247, DOI 10.1016/j.phrs.2008.02.002; Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Bucolo C, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00043; Bueter CL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003080; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cozzarini E, 2009, EUR J GASTROEN HEPAT, V21, P1119, DOI 10.1097/MEG.0b013e328329742a; Hamid Rifat, 2013, J Pharm Bioallied Sci, V5, P21, DOI 10.4103/0975-7406.106559; JACKSON P, 1990, BIOCHEM J, V270, P705; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kashimura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078669; Kumari A, 2012, BIOTECHNOL LETT, V34, P1733, DOI 10.1007/s10529-012-0958-8; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Nookaew I, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-41; Ohno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067399; Ohno M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-23; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; OYAMA F, 1993, J BIOCHEM-TOKYO, V114, P813; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198; Sakaguchi M, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-5; Tiwary E, 2010, J AGR FOOD CHEM, V58, P8380, DOI 10.1021/jf100803g	38	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB	2015	16	2					4028	4042		10.3390/ijms16024028		15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	CC4OV	WOS:000350333600107		
J	Wikberg, EC; Ting, N; Sicotte, P				Wikberg, Eva C.; Ting, Nelson; Sicotte, Pascale			Demographic Factors Are Associated with Intergroup Variation in the Grooming Networks of Female Colobus (Colobus vellerosus)	INTERNATIONAL JOURNAL OF PRIMATOLOGY			English	Article						Colobines; Group stability; Infants; Kinship; Social network analysis; Time constraints	WHITE-FACED CAPUCHINS; SOCIAL NETWORKS; TIME CONSTRAINTS; GROUP-SIZE; KIN BIAS; REPRODUCTIVE SUCCESS; NONHUMAN-PRIMATES; NATAL ATTRACTION; ACTIVITY BUDGETS; MONKEYS	Intergroup variation in social networks can have important implications for inferring the evolution of primate social relationships, but the underpinnings of this variation remain poorly understood. To further our understanding of this topic, we investigated whether intergroup variation in colobus grooming networks was associated with group size, the proportion of female kin and infants, and stability in female group composition. Between 2008 and 2009, we collected behavioral data via focal sampling of 61 females in 8 groups at Boabeng-Fiema, Ghana, which we used to calculate grooming network metrics. We collected demographic data during the same time period to determine group sizes and group compositions, while we used longitudinal data (2000-2009) to estimate stability in group composition. We determined kinship via partial pedigrees and genetic data from 17 short tandem repeat loci. Females in larger groups had more grooming partners but did not form weaker networks than females in smaller groups. This finding suggests that time constraints linked to large group sizes do not limit sociality in this population, which is similar to findings in other folivorous black-and-white colobus but contrasts with those in many frugivorous primates. Groups with a larger proportion of infants spent more time grooming, similar to some other mammals. Group stability correlated positively with centralization, i.e., inequity, for incoming ties. Networks were not affected by kin compositions of groups, in contrast to those in some female resident-nepotistic cercopithecines. We suggest that the relative importance of demographic factors in shaping social networks may vary between populations depending on diet and social structure.	[Wikberg, Eva C.] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Wikberg, Eva C.; Sicotte, Pascale] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada; [Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Ting, Nelson] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	Wikberg, EC (reprint author), Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan.	wikberg@ib.k.u-tokyo.ac.jp			Alberta Innovates Technology Futures; American Society of Primatologists; International Primatological Society; Leakey Foundation; Natural Sciences and Engineering Research Council of Canada; Sweden-America Foundation; Wenner-Gren Foundation; University of Calgary	We thank Fernando Campos and Teresa Holmes for their research assistance. We also thank the anonymous reviewers and the editors for their helpful comments on the manuscript. The following agencies funded our research: Alberta Innovates Technology Futures (formerly Alberta Ingenuity), American Society of Primatologists, International Primatological Society, Leakey Foundation, Natural Sciences and Engineering Research Council of Canada, Sweden-America Foundation, Wenner-Gren Foundation, and the University of Calgary.	Altman J, 1974, BEHAVIOUR, V49, P223; Altmann J, 1980, BABOON MOTHERS INFAN; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941; Bergstrom ML, 2013, AM J PHYS ANTHROPOL, V150, P591, DOI 10.1002/ajpa.22231; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Schel AM, 2013, AM J PRIMATOL, V75, P254, DOI 10.1002/ajp.22101; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; Perry S, 2008, ANIM BEHAV, V76, P187, DOI 10.1016/j.anbehav.2008.01.020; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Brent LJN, 2011, AM J PRIMATOL, V73, P720, DOI 10.1002/ajp.20949; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Wikberg EC, 2013, BEHAVIOUR, V150, P295, DOI 10.1163/1568539X-00003050; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Jacoby DMP, 2010, BEHAV ECOL, V21, P808, DOI 10.1093/beheco/arq061; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; Teichroeb JA, 2003, INT J PRIMATOL, V24, P743, DOI 10.1023/A:1024672604524; Watts DP, 2000, INT J PRIMATOL, V21, P211, DOI 10.1023/A:1005421419749; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Wikberg EC, 2014, BEHAV PROCESS, V106, P27, DOI 10.1016/j.beproc.2014.04.002; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Teichroeb JA, 2009, AM J PRIMATOL, V71, P49, DOI 10.1002/ajp.20617; Olson LE, 2009, BEHAV ECOL, V20, P624, DOI 10.1093/beheco/arp040; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; ALTMANN J, 1992, BEHAV ECOL SOCIOBIOL, V29, P391; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Brent LJN, 2013, BEHAV ECOL SOCIOBIOL, V67, P349, DOI 10.1007/s00265-012-1455-8; IDANI G, 1991, FOLIA PRIMATOL, V57, P83, DOI 10.1159/000156568; Berman CM, 2010, BEHAVIOUR, V147, P1863, DOI 10.1163/000579510X539691; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Brent LJN, 2008, AM J PRIMATOL, V70, P101, DOI 10.1002/ajp.20478; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; WATTS DP, 1991, ETHOLOGY, V89, P135; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Badescu I., 2014, AM J PRIMATOL, DOI [10.1002/ajp.22353, DOI 10.1002/AJP.22353]; Berman CM, 1997, ANIM BEHAV, V53, P405, DOI 10.1006/anbe.1996.0321; Berman CM, 2008, BEHAVIOUR, V145, P863, DOI 10.1163/156853908784089252; Berman CM, 2012, DEV PRIMATOL-PROG PR, P227, DOI 10.1007/978-1-4614-1046-1_11; Borgatti S. P., 2002, UCINET WINDOWS SOFTW; Champely Stephane, 2012, PWR BASIC FUNCTIONS; Colin J., 1992, CURRENT DIRECTIONS P, V1, P98; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; DASILVA GL, 1992, J ANIM ECOL, V61, P79, DOI 10.2307/5511; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Fashing P. J., 2011, PRIMATES PERSPECTIVE, P201; Forster S, 2005, BEHAVIOUR, V142, P869, DOI 10.1163/1568539055010138; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Gero Shane, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Guan ZH, 2013, AM J PRIMATOL, V75, P1165, DOI 10.1002/ajp.22178; Guan Zhen-Hua, 2013, Zoological Research, V34, pE1, DOI 10.3724/SP.J.1141.2013.E01E01; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; Hall J. B., 1981, DISTRIBUTION ECOLOGY; Hanneman RA, 2005, INTRO SOCIAL NETWORK; Henzi SP, 1997, ANIM BEHAV, V54, P1235, DOI 10.1006/anbe.1997.0520; Hrdy Sarah B., 1976, ADV STUD BEHAV, V6, P101, DOI 10.1016/S0065-3454(08)60083-2; Ilany A, 2013, ANIM BEHAV, V85, P1397, DOI 10.1016/j.anbehav.2013.03.032; Kapsalis E, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P153; Kim S, 2012, PPCOR PARTIAL SEMIPA; Koenig Barbara, 1994, Behavioral Ecology and Sociobiology, V34, P275; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; MOSES RA, 1994, BEHAV ECOL SOCIOBIOL, V35, P131, DOI 10.1007/s002650050079; OATES JF, 1977, Z TIERPSYCHOL, V45, P1; R Core Team, 2014, R LANG ENV STAT COMP; Rendall Drew, 1995, Evolutionary Anthropology, V4, P43, DOI 10.1002/evan.1360040205; Rendall D, 2007, J HUM EVOL, V52, P504, DOI 10.1016/j.jhevol.2006.11.014; Ruan HY, 2008, P NATL ACAD SCI USA, V105, P7506, DOI 10.1073/pnas.0711127105; Saj TL, 2007, AM J PHYS ANTHROPOL, V133, P994, DOI 10.1002/ajpa.20609; Standon V, 1989, COMP SOCIOECOLOGY BE, P195; Stanley CR, 2013, ANIM BEHAV, V85, P771, DOI 10.1016/j.anbehav.2013.01.020; Strier Karen B., 1994, Yearbook of Physical Anthropology, V37, P233; Teichroeb JA, 2009, BEHAVIOUR, V146, P551, DOI 10.1163/156853909X426363; Tiddi B, 2010, ANIM BEHAV, V79, P1115, DOI 10.1016/j.anbehav.2010.02.008; Wey TW, 2013, ANIM BEHAV, V85, P1407, DOI 10.1016/j.anbehav.2013.03.035; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; WHITEHEAD H, 1992, CAN J ZOOL, V70, P2145, DOI 10.1139/z92-289; Wikberg E., 2012, THESIS U CALGARY; Wikberg EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048740; Wikberg EC, 2014, AM J PHYS ANTHROPOL, V153, P365, DOI 10.1002/ajpa.22435; Wong SNP, 2006, AM J PRIMATOL, V68, P465, DOI 10.1002/ajp.20242	93	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0164-0291	1573-8604		INT J PRIMATOL	Int. J. Primatol.	FEB	2015	36	1					124	142		10.1007/s10764-015-9816-6		19	Zoology	Zoology	CC4XI	WOS:000350358400009		
J	Hanya, G; Bernard, H				Hanya, Goro; Bernard, Henry			Different Roles of Seeds and Young Leaves in the Diet of Red Leaf Monkeys (Presbytis rubicunda): Comparisons of Availability, Nutritional Properties, and Associated Feeding Behavior	INTERNATIONAL JOURNAL OF PRIMATOLOGY			English	Article						Colobus monkeys; Dietary switch; Fallback foods; Food selection; Preferred foods	PEAT-SWAMP FOREST; FALLBACK FOODS; GROUP-SIZE; SEMNOPITHECUS-ENTELLUS; ECOLOGICAL-CONSTRAINTS; DIPTEROCARP FORESTS; INDONESIAN BORNEO; ACTIVITY PATTERNS; PATCH DEPLETION; COLOBUS MONKEYS	It is important to clarify the roles of different types of foods in the diet of primates that switch to other foods as preferred food items become rare. Using red leaf monkeys (Presbytis rubicunda) in Danum Valley, Borneo, as an example, we compare the availability and nutritional properties of young leaves and seeds, as well as the monkeys' feeding behavior, to examine food choice and how such choices may affect their competitive regime. Over 21 mo, the number of flushing trees was larger than that of fruiting trees. When we compared nutritional content for all species, including those that the monkeys did not eat, seeds contained more lipids than young leaves but young leaves did not have any nutritional advantage over seeds. However, when we compared only food species, young leaves contained more crude ash than seeds. The proportion of food species to the total available species was significantly higher for seeds than for young leaves. In addition, red leaf monkeys selected young leaf species with higher digestible protein, but no nutritional component predicted seed selection. Young leaves are nutritionally low-quality in general, so monkeys may need to select species with higher quality leaves. However, seeds generally have high-quality nutritional values, so it may not be necessary to select species with marginally higher quality. When eating seeds, the number of individuals eating in the patch was larger, and this feeding in the patch tended to last longer than when monkeys ate young leaves, suggesting more intense feeding competition when feeding on seeds. In conclusion, seeds and young leaves have different nutritional advantages as foods and red leaf monkeys were more selective when eating young leaves than when eating seeds.	[Hanya, Goro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu 88999, Sabah, Malaysia	Hanya, G (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	hanya.goro.5z@kyoto-u.ac.jp			JSPS Core-to-Core Program (HOPE); MEXT [20770195, 22687002, 25291100]; Primate Society of Japan; Global COE Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem"	This study would not have been possible without the hard work of our field assistants, Syamsudin Jail, Sharry bin Mustah, Saharudin Idos, Unding Jami, Sallehudin Jail, and Rayner Jupili. We are greatly indebted to the staff of the Danum Valley Field Centre and our colleagues there for their hospitality and help, in particular Jimmy Omar, Mike Bernadus, Glen Reynolds, Tomoko Kanamori, Noko Kuze, and Siew Te Wong. The editor and the reviewers of this journal provided helpful comments. The Economy Planning Unit of Malaysia and the State of Sabah and the Danum Valley Management Committee of Yayasan Sabah permitted our study. This study was financed by the JSPS Core-to-Core Program (HOPE), the MEXT Grant-in-Aid for JSPS Overseas Fellows, Grant-in-Aid for Young Scientists B (No. 20770195) and A (No. 22687002) and Scientific Research B (No. 25291100) to G. Hanya, Primate Society of Japan, and Global COE Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem."	Grueter CC, 2009, AM J PHYS ANTHROPOL, V140, P700, DOI 10.1002/ajpa.21024; Riek A, 2014, J ZOOL, V292, P74, DOI 10.1111/jzo.12102; Davies AG, 1999, INT J PRIMATOL, V20, P327, DOI 10.1023/A:1020596503533; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Itoh N, 2007, PRIMATES, V48, P87, DOI 10.1007/s10329-006-0031-0; Snaith TV, 2007, EVOL ANTHROPOL, V16, P94, DOI 10.1002/evan.20132; Tsuji Y, 2013, PRIMATES, V54, P201, DOI 10.1007/s10329-013-0359-1; Koenig A, 1998, BEHAV ECOL SOCIOBIOL, V42, P225, DOI 10.1007/s002650050434; Vandercone RP, 2012, INT J PRIMATOL, V33, P1382, DOI 10.1007/s10764-012-9629-9; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Sayers K, 2008, INT J PRIMATOL, V29, P509, DOI 10.1007/s10764-008-9245-x; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Matsuda I, 2009, AM J PRIMATOL, V71, P478, DOI 10.1002/ajp.20677; POND CM, 1978, ANNU REV ECOL SYST, V9, P519, DOI 10.1146/annurev.es.09.110178.002511; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Kishimoto-Yamada K, 2008, BIOTROPICA, V40, P600, DOI 10.1111/j.1744-7429.2008.00410.x; Gillespie TR, 2001, BEHAV ECOL SOCIOBIOL, V50, P329, DOI 10.1007/s002650100371; Hanya G, 2013, PRIMATES, V54, P101, DOI 10.1007/s10329-012-0341-3; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Chapman CA, 2002, COMP BIOCHEM PHYS A, V133, P861; Clutton-Brock T. H., 1977, PRIMATE ECOLOGY STUD; CLUTTONBROCK TH, 1975, FOLIA PRIMATOL, V23, P165, DOI 10.1159/000155671; DASILVA GL, 1994, INT J PRIMATOL, V15, P655, DOI 10.1007/BF02737426; Fashing PJ, 2001, INT J PRIMATOL, V22, P579, DOI 10.1023/A:1010737601922; Fujita M, 2009, ENTOMOL SCI, V12, P427, DOI 10.1111/j.1479-8298.2009.00343.x; Hanya G, 2009, INT J PRIMATOL, V30, P569, DOI 10.1007/s10764-009-9361-2; Hanya G, 2006, PRIMATES, V47, P275, DOI 10.1007/s10329-005-1076-2; Hanya G, 2013, ECOL RES, V28, P183, DOI 10.1007/s11284-012-1012-y; Hanya G, 2010, ECOL RES, V25, P1081, DOI 10.1007/s11284-010-0733-z; Hanya G, 2012, INT J PRIMATOL, V33, P322, DOI 10.1007/s10764-012-9580-9; Hanya G, 2013, TROP ECOL, V54, P383; Hanya G, 2004, INT J PRIMATOL, V25, P55, DOI 10.1023/B:IJOP.0000014645.78610.32; Janson Charles H., 1999, P237, DOI 10.1017/CBO9780511542381.015; Kay Robin N. B., 1994, P229; Kirkpatrick R. Craig, 1999, P93; KOOL KM, 1993, INT J PRIMATOL, V14, P667, DOI 10.1007/BF02192186; Kubo T., 2012, INTRO STAT MODELLING; Li ZY, 2006, INT J PRIMATOL, V27, P1551, DOI 10.1007/s10764-006-9090-8; Lingenfelder M, 2005, THESIS U BERN; LUCAS PW, 1991, FOLIA PRIMATOL, V57, P201, DOI 10.1159/000156587; MAISELS F, 1994, INT J PRIMATOL, V15, P681, DOI 10.1007/BF02737427; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Newbery DM, 1996, VEGETATIO, V122, P193, DOI 10.1007/BF00044700; NEWTON P, 1992, INT J PRIMATOL, V13, P245, DOI 10.1007/BF02547816; Norhayati A., 2001, THESIS U KEBANGSAAN; OATES JF, 1988, INT J PRIMATOL, V9, P457, DOI 10.1007/BF02736220; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1046/j.1095-8312.2002.00016.x; Simmen B, 2005, REV ECOL-TERRE VIE, V60, P297; Smith DAE, 2013, INT J PRIMATOL, V34, P957, DOI 10.1007/s10764-013-9715-7; Smith DAE, 2013, AM J PRIMATOL, V75, P848, DOI 10.1002/ajp.22148; Smythe N., 1982, ECOLOGY TROPICAL FOR, P227; Snaith TV, 2005, BEHAV ECOL SOCIOBIOL, V59, P185, DOI 10.1007/s00265-005-0023-x; Soxhlet F., 1879, POLYTECHNISCHES J, V232, P461; Standon V, 1989, COMP SOCIOECOLOGY BE, P195; STRIER KB, 1991, AM J PRIMATOL, V23, P113, DOI 10.1002/ajp.1350230205; Tombak KJ, 2012, PRIMATES, V53, P57, DOI 10.1007/s10329-011-0274-2; UNGAR PS, 1995, INT J PRIMATOL, V16, P221, DOI 10.1007/BF02735479; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Wong ST, 2005, J TROP ECOL, V21, P627, DOI 10.1017/S0266467405002622; Zhou QH, 2009, INT J PRIMATOL, V30, P583, DOI 10.1007/s10764-009-9362-1	68	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0164-0291	1573-8604		INT J PRIMATOL	Int. J. Primatol.	FEB	2015	36	1					177	193		10.1007/s10764-015-9819-3		17	Zoology	Zoology	CC4XI	WOS:000350358400012		
J	Goto, M; Nozaki, Y; Sekiguchi, K				Goto, Minori; Nozaki, Yukio; Sekiguchi, Koji			Criteria for electric determination of antivortex creation in ferromagnetic thin film	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								Antivortex creation in a cross-shaped wire was demonstrated by using magnetoresistance and magnetic force microscopy measurements. The magnetization process was stochastic and exhibited a wide variety of magnetoresistance curves. By developing a conventional method, we have achieved electrical determination criteria to distinguish antivortex creation from many other magnetization states. The electrical criteria provide a simple method without large-scale apparatus and promote further experiments such as spin-current driven antivortex dynamics. (C) 2015 The Japan Society of Applied Physics	[Goto, Minori; Nozaki, Yukio; Sekiguchi, Koji] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan; [Nozaki, Yukio] CREST JST, Chiyoda Ku, Tokyo 1020075, Japan; [Sekiguchi, Koji] PRESTO JST, Chiyoda Ku, Tokyo 1020076, Japan	Goto, M (reprint author), Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan.	mgoto@phys.keio.ac.jp					Kamionka T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.137204; Kamionka T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224422; Kim JS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104427; Haldar A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795521; Bocklage L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.180405; Gliga S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.060404; Bohlens S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2998584; Bolte M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176601; Tatara G, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031003; Drews A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3072342; Pigeau B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373833; Drews A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094413; Goto M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064406; Heyne L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187203; Hubert A, 1998, MAGNETIC DOMAINS; Kruger B, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830011; Li J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869098; Pollard SD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2025; Rossler S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174426; Shigeto K, 2002, APPL PHYS LETT, V80, P4190, DOI 10.1063/1.1483386; Yamada K., 2007, NAT MATER, V6, P270, DOI 10.1038/nmat1867	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							023001	10.7567/JJAP.54.023001		4	Physics, Applied	Physics	CC1HE	WOS:000350091000013		
J	Goto, Y; Sakai, Y; Kamihara, Y; Matoba, M				Goto, Yosuke; Sakai, Yuki; Kamihara, Yoichi; Matoba, Masanori			Electronic structure and transport properties of Cu-deficient kuramite Cu3-xSnS4	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; THERMOELECTRIC PROPERTIES; 3-DIMENSIONAL VISUALIZATION; QUATERNARY CHALCOGENIDES; MAGNETIC-PROPERTIES; PHONON-SCATTERING; BASIS-SET; STANNITE; PERFORMANCE	Electrical and thermal transport properties of Cu-deficient kuramite Cu3-xSnS4 (CTS) was examined as a possible earth-abundant thermoelectric material. Crystallographic structure of CTS was characterized by partial disorder between Cu and Sn. In contrast to semiconducting electrical transport of related compounds, such as Cu2ZnSnS4 and Cu3SbS4, metallic conduction with an electrical resistivity of 0.4 m Omega cm and a carrier concentration of 3 x 10(21) cm(-3) was observed at 300 K. Lattice thermal conductivity was calculated at similar to 2.6 W m(-1) K-1, which was probably reduced by Cu-deficiency and/or partial cation disorder. Density functional theory calculation indicates valence band was composed of hybridization between Cu 3d orbitals and S 3p orbitals. (C) 2015 The Japan Society of Applied Physics	[Goto, Yosuke; Sakai, Yuki; Kamihara, Yoichi; Matoba, Masanori] Keio Univ, Fac Sci & Technol, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan	Goto, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan.	ygoto@z8.keio.jp	Kamihara, Yoichi/C-4471-2008		Keio University; Keio Leading-edge Laboratory of Science and Technology (KLL); Japan Society for Promotion of Science (JSPS) KAKENHI Grant [26400337]; Hitachi Metals Materials Science Foundation (HMMSF)	We thank Dr. Ikuya Yamada of Osaka Prefecture University for using high-pressure apparatus. This work was partially supported by the research grants from Keio University, the Keio Leading-edge Laboratory of Science and Technology (KLL), Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number 26400337, and Hitachi Metals Materials Science Foundation (HMMSF).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Suzumura A, 2014, J ELECTRON MATER, V43, P2356, DOI 10.1007/s11664-014-3064-y; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; SCHAFER W, 1974, MATER RES BULL, V9, P645, DOI 10.1016/0025-5408(74)90135-4; GOODMAN CHL, 1958, J PHYS CHEM SOLIDS, V6, P305, DOI 10.1016/0022-3697(58)90050-7; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Chen XY, 2003, J CRYST GROWTH, V256, P368, DOI 10.1016/S0022-0248(03)01338-1; Liu ML, 2009, ADV MATER, V21, P3808, DOI 10.1002/adma.200900409; Toberer ES, 2010, CHEM MATER, V22, P624, DOI 10.1021/cm901956r; Kuznetsov VL, 2000, J APPL PHYS, V87, P7871, DOI 10.1063/1.373469; Zeier WG, 2012, J AM CHEM SOC, V134, P7147, DOI 10.1021/ja301452j; Schorr S, 2007, EUR J MINERAL, V19, P65, DOI 10.1127/0935-1221/2007/0019-0065; Yang CY, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/29/295404; Shi XY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3103604; Sales BC, 1996, SCIENCE, V272, P1325, DOI 10.1126/science.272.5266.1325; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; PAMPLIN BR, 1964, J PHYS CHEM SOLIDS, V25, P675, DOI 10.1016/0022-3697(64)90176-3; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Ibanez M, 2012, J AM CHEM SOC, V134, P4060, DOI 10.1021/ja211952z; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Chen SY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245204; Izumi F, 2007, SOL ST PHEN, V130, P15; Goto Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890302; Winkler MT, 2014, ENERG ENVIRON SCI, V7, P1029, DOI 10.1039/c3ee42541j; Kanatzidis MG, 2010, CHEM MATER, V22, P648, DOI 10.1021/cm902195j; Skoug EJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3605246; Fernandes PA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/21/215403; Mahan GD, 1996, P NATL ACAD SCI USA, V93, P7436, DOI 10.1073/pnas.93.15.7436; Su ZH, 2012, J MATER CHEM, V22, P16346, DOI 10.1039/c2jm31669b; Di Benedetto F, 2011, PHYS CHEM MINER, V38, P483, DOI 10.1007/s00269-011-0421-8; Xiong YJ, 2002, INORG CHEM, V41, P2953, DOI 10.1021/ic0200242; Ibanez M, 2012, CHEM MATER, V24, P562, DOI 10.1021/cm2031812; Zeier WG, 2013, J AM CHEM SOC, V135, P726, DOI 10.1021/ja308627v; Goto Y, 2013, INORG CHEM, V52, P9861, DOI 10.1021/ic401310c; Washio T, 2011, J APPL PHYS, V110, DOI 10.1063/1.3642993; Liu Y, 2011, J AM CHEM SOC, V133, P20112, DOI 10.1021/ja2091195; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Brockway LO, 1934, Z KRISTALLOGR, V89, P434; Chen SY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3074499; Di Benedetto F, 2009, PHYS CHEM MINER, V36, P301, DOI 10.1007/s00269-008-0278-7; EVSTIGNEEVA T.L., 2003, NEW DATA MINERAL, V38, P65; Fitsul V.I., 1969, HEAVILY DOPED SEMICO; FLEISCHER M, 1980, AM MINERAL, V65, P1065; Goldsmid H. J., 1960, APPL THERMOELECTRICI; Hiramatsu H, 2008, J APPL PHYS, V104, DOI 10.1063/1.3039167; Ioffe A.F., 1957, SEMICONDUCTOR THERMO; Kovalenker V. A., 1979, ZAP VSES MINER OBSH, V108, P564; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kubelka P., 1931, Zeitschrift fur Technische Physik, V12; Liu ML, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3130718; Rowe D.M., 1995, CRC HDB THERMOELECTR; SCROCCO M, 1979, CHEM PHYS LETT, V63, P52, DOI 10.1016/0009-2614(79)80454-6; Seebeck T. J., 1822, MAGNETISCHE PORARISA; SLACK GA, 1972, PHYS REV B, V6, P3791, DOI 10.1103/PhysRevB.6.3791; Wagner C. D., 1979, HDB XRAY PHOTOELECTR; Wei TR, 2014, J ELECTRON MATER, V43, P2229, DOI 10.1007/s11664-014-3018-4; YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6; Zalewski W, 2010, J ALLOY COMPD, V492, P35, DOI 10.1016/j.jallcom.2009.11.158	61	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							021801	10.7567/JJAP.54.021801		5	Physics, Applied	Physics	CC1HE	WOS:000350091000009		
J	Gotow, T; Fujikawa, S; Fujishiro, HI; Ogura, M; Yasuda, T; Maeda, T				Gotow, Takahiro; Fujikawa, Sachie; Fujishiro, Hiroki I.; Ogura, Mutsuo; Yasuda, Tetsuji; Maeda, Tatsuro			Effects of HCI treatment and predeposition vacuum annealing on Al2O3/GaSb/GaAs metal-oxide-semiconductor structures	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							GASB	The effects of HCI treatment and predeposition vacuum annealing (VA) on n-type GaSb/GaAs metal-oxide-semiconductor (MOS) structures with the atomic layer deposition (ALD) of Al2O3 dielectrics are studied. We obtained MOS structures with good Fermi level modulation by HCI treatment prior to the deposition of Al2O3. From X-ray photoelectron spectroscopy (XPS) analysis, we found that the Ga2O3 content increases during the Al2O3 deposition, whereas the amounts of Sb components are reduced. The excess growth of Ga2O3 is inhibited by the reductions in the amounts of Sb components by the HCI treatment. Further reductions in the amounts of Sb components are observed following predeposition VA, indicating a lower density of states (DO. However, the frequency dispersion in the capacitance voltage (C-V) characteristics increases with predeposition VA at higher temperatures. (C) 2015 The Japan Society of Applied Physics	[Gotow, Takahiro; Fujikawa, Sachie; Fujishiro, Hiroki I.; Maeda, Tatsuro] Tokyo Univ Sci, Fac Ind Sci & Technol, Katsushika, Tokyo 1258585, Japan; [Gotow, Takahiro; Ogura, Mutsuo; Yasuda, Tetsuji; Maeda, Tatsuro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan	Gotow, T (reprint author), Tokyo Univ Sci, Fac Ind Sci & Technol, Katsushika, Tokyo 1258585, Japan.	takahiro-gotou@aist.go.jp	Maeda, Tatsuro/E-7486-2015		 [24246058]	Device fabrication was carried out at the AIST Nanoprocessing Facility. This work was supported by JSPS Grants-in-Aid for Scientific Research No. 24246058.	Ali A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492847; McDonnell S, 2011, APPL SURF SCI, V257, P8747, DOI 10.1016/j.apsusc.2011.05.034; Dey AW, 2012, NANO LETT, V12, P5593, DOI 10.1021/nl302658y; Kim HS, 2007, J CRYST GROWTH, V301, P230, DOI 10.1016/j.jcrysgro.2006.11.223; Batude P, 2007, J APPL PHYS, V102, DOI 10.1063/1.2767381; Xu M, 2011, IEEE ELECTR DEVICE L, V32, P883, DOI 10.1109/LED.2011.2143689; Nainani A, 2011, J APPL PHYS, V109, DOI 10.1063/1.3590167; Greene A, 2012, SOLID STATE ELECTRON, V78, P56, DOI 10.1016/j.sse.2012.05.049; Lin CL, 1998, JPN J APPL PHYS 2, V37, pL1543, DOI 10.1143/JJAP.37.L1543; MATHUR PC, 1979, PHYS REV B, V19, P3152, DOI 10.1103/PhysRevB.19.3152; Merckling C, 2011, J APPL PHYS, V109, DOI 10.1063/1.3569618; Nainani A, 2011, IEEE T ELECTRON DEV, V58, P3407, DOI 10.1109/TED.2011.2162732; Ruppalt LB, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768693; SCHWARTZ GP, 1980, J ELECTROCHEM SOC, V127, P2488, DOI 10.1149/1.2129502; Tan Z, 2013, ECS SOLID STATE LETT, V2, pP61, DOI 10.1149/2.003308ssl; Tatebayashi J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2793186; Thomas M, 1997, J CRYST GROWTH, V175, P894, DOI 10.1016/S0022-0248(96)00920-7; Weiss E, 2007, J VAC SCI TECHNOL A, V25, P736, DOI 10.1116/1.2746045; Wiley J., 1975, SEMICONDUCT SEMIMET, V10, P91, DOI 10.1016/S0080-8784(08)60332-4; Yokoyama M., 2013, IPRM, P31; Zhemokletov D. M., 2013, APPL PHYS LETT, V102	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							021201	10.7567/JJAP.54.021201		5	Physics, Applied	Physics	CC1HE	WOS:000350091000003		
J	Gushi, T; Ito, K; Honda, S; Yasutomi, Y; Toko, K; Oosato, H; Sugimoto, Y; Asakawa, K; Ota, N; Suemasu, T				Gushi, Toshiki; Ito, Keita; Honda, Syuta; Yasutomi, Yoko; Toko, Kaoru; Oosato, Hirotaka; Sugimoto, Yoshimasa; Asakawa, Kiyoshi; Ota, Norio; Suemasu, Takashi			Fabrication of L-shaped Fe4N ferromagnetic narrow wires and position control of magnetic domain wall with magnetic field	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOTION; NANOWIRES	We grow a 15-nm-thick ferromagnetic Fe4N epitaxial film on a SrTiO3(001) substrate by molecular beam epitaxy, and process it into approximately 0.5-mu m-wide and 24-mu m-long L-shaped ferromagnetic narrow wires by electron-beam lithography and Cl-2 reactive ion etching. Their longitudinal directions are set in parallel to the magnetic easy axes, Fe4N[100] and [010]. With applying external magnetic field in the direction parallel to Fe4N[1001 or [010], the position of domain wall is controlled either on the upper side or lower side of the corner. This experiment is the preliminary step toward current-driven domain wall motion in Fe4N having a negative spin polarization. (C) 2015 The Japan Society of Applied Physics	[Gushi, Toshiki; Ito, Keita; Honda, Syuta; Yasutomi, Yoko; Toko, Kaoru; Suemasu, Takashi] Univ Tsukuba, Inst Appl Phys, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Ito, Keita] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Ito, Keita] Tohoku Univ, Grad Sch Engn, Dept Elect Engn, Sendai, Miyagi 9808579, Japan; [Honda, Syuta; Asakawa, Kiyoshi; Ota, Norio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba Nanotechnol Human Resource Dev Program, Tsukuba, Ibaraki 3058571, Japan; [Oosato, Hirotaka; Sugimoto, Yoshimasa] Natl Inst Mat Sci, NIMS Nanofabricat Platform, Tsukuba, Ibaraki 3050047, Japan	Gushi, T (reprint author), Univ Tsukuba, Inst Appl Phys, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	suemasu@bk.tsukuba.ac.jp			JSPS [26249037]; MEXT	This work was financially supported by a Grant-in-Aid for Scientific Research (A) (No. 26249037) from JSPS. Fabrication of the narrow wires was carried out in NIMS Nanofabrication Platform in "Nanotechnology Platform Project" sponsored by MEXT. MFM measurements were performed at AIST Nano-Processing Facility (AIST-NPF).	Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Ito K, 2011, J CRYST GROWTH, V336, P40, DOI 10.1016/j.jcrysgro.2011.09.038; Li Z, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207203; Beach GSD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.057203; Koyama T, 2011, NAT MATER, V10, P194, DOI [10.1038/nmat2961, 10.1038/NMAT2961]; Shibata J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.020403; Kokado S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172410; BERGER L, 1984, J APPL PHYS, V55, P1954, DOI 10.1063/1.333530; Obata K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214429; Beach GSD, 2008, J MAGN MAGN MATER, V320, P1272, DOI 10.1016/j.jmmm.2007.12.021; Ito K, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892179; Costa-Kramer JL, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144402; Yamaguchi A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077205; Tatara G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086601; Burrowes C, 2010, NAT PHYS, V6, P17, DOI 10.1038/NPHYS1436; Bang D, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.123001; Bang D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.125201; Berger L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014407; Gushi T., 2014, 61 JSAP SPRING M; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Kokado S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024705; Ngo DT, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.093002	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							028003	10.7567/JJAP.54.028003		3	Physics, Applied	Physics	CC1HE	WOS:000350091000027		
J	Hiraiwa, M; Liu, F; Shibata, S; Takeda, S; Tsusaka, Y; Kagoshima, Y; Matsui, J				Hiraiwa, Miori; Liu, Fei; Shibata, Satoshi; Takeda, Shingo; Tsusaka, Yoshiyuki; Kagoshima, Yasushi; Matsui, Junji			Evaluation of a-type screw dislocations in m-GaN film by means of X-ray diffractometry	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VAPOR-PHASE EPITAXY; TRANSMISSION ELECTRON-MICROSCOPY; PLANE GAN; DEFECT STRUCTURE; GALLIUM NITRIDE; STACKING-FAULTS; DIFFRACTION; OVERGROWTH; EPILAYERS; DENSITY	Dislocations in an epitaxial GaN film with a (1010) surface (m-GaN) were investigated by means of X-ray diffractometry. It was clarified that a-type screw dislocations existed in the sample by evaluating diffraction contrast on X-ray topographs (XRTs). In addition, local lattice inclinations of the (1010) plane toward the [0001] direction were observed with spatial intervals similar to the separation distances of those a-type screw dislocations slipping on the (0001) basal plane and also on other cross-slip planes in the sample. (C) 2015 The Japan Society of Applied Physics	[Hiraiwa, Miori; Liu, Fei; Shibata, Satoshi] Panasonic Corp, Moriguchi, Osaka 5708501, Japan; [Takeda, Shingo] SPring 8 Serv Co Ltd, Tatsuno, Hyogo 6795165, Japan; [Hiraiwa, Miori; Tsusaka, Yoshiyuki; Kagoshima, Yasushi] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Kagoshima, Yasushi; Matsui, Junji] Univ Hyogo, Synchrotron Radiat Nanotechnol Ctr, Tatsuno, Hyogo 6795165, Japan	Hiraiwa, M (reprint author), Panasonic Corp, Moriguchi, Osaka 5708501, Japan.	kobayashi.miori@jp.panasonic.com					Wu F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671113; Romanov AE, 2011, J APPL PHYS, V109, DOI [10.1063/1.3590141, 10.1063/1.359014]; Liu R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1852085; Duxbury N, 2000, APPL PHYS LETT, V76, P1600, DOI 10.1063/1.126108; Wu F, 2011, J APPL PHYS, V109, DOI 10.1063/1.3531577; Moram MA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3129307; Hsu PS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4707160; Lei HP, 2010, J APPL PHYS, V108, DOI 10.1063/1.3509147; Srinivasan S, 2003, APPL PHYS LETT, V83, P5187, DOI 10.1063/1.1633029; Haskell BA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866225; Sakai A, 1997, APPL PHYS LETT, V71, P2259, DOI 10.1063/1.120044; Fujito K, 2008, PHYS STATUS SOLIDI A, V205, P1056, DOI 10.1002/pssa.200778709; Ponce FA, 1996, APPL PHYS LETT, V69, P770, DOI 10.1063/1.117886; Wieneke M, 2009, PHYS STATUS SOLIDI C, V6, pS498, DOI 10.1002/pssc.200880964; Kong BH, 2012, APPL SURF SCI, V258, P2522, DOI 10.1016/j.apsusc.2011.10.086; FEWSTER PF, 1993, SEMICOND SCI TECH, V8, P1915, DOI 10.1088/0268-1242/8/11/001; Usui A, 1997, JPN J APPL PHYS 2, V36, pL899, DOI 10.1143/JJAP.36.L899; Wu XH, 1996, J APPL PHYS, V80, P3228, DOI 10.1063/1.363264; Chichibu SF, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/2/024008; Dasilva YAR, 2011, J CRYST GROWTH, V327, P6, DOI 10.1016/j.jcrysgro.2011.05.018; de Mierry P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3134489; Hanada T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000565; Hu YL, 2011, J CRYST GROWTH, V331, P49, DOI 10.1016/j.jcrysgro.2011.03.063; Jang JH, 2008, J APPL PHYS, V103, DOI 10.1063/1.2899964; Kuwano N, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201001126; Lei HP, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3394007; Liu ZY, 2012, J CRYST GROWTH, V343, P122, DOI 10.1016/j.jcrysgro.2012.01.001; Moram MA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3225920; Motoki K, 2001, JPN J APPL PHYS 2, V40, pL140, DOI 10.1143/JJAP.40.L140; Oshima Y, 2003, JPN J APPL PHYS 2, V42, pL1, DOI 10.1143/JJAP.42.L1; Sakai A, 1998, APPL PHYS LETT, V73, P481, DOI 10.1063/1.121907; Smalc-Koziorowska J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3369439; Takeda S, 2006, J SYNCHROTRON RADIAT, V13, P373, DOI 10.1107/S090904950602855X; Tischer I, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035314; Tokumoto Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764928; Yamada Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195202; Yoshida S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3644978	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							025503	10.7567/JJAP.54.025503		5	Physics, Applied	Physics	CC1HE	WOS:000350091000020		
J	Homma, R; Hasegawa, Y; Terakado, H; Morita, H; Komine, T				Homma, Ryoei; Hasegawa, Yasuhiro; Terakado, Hiroki; Morita, Hiroyuki; Komine, Takashi			Simultaneous measurement of the Seebeck coefficient and thermal diffusivity for bulk thermoelectric materials	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ANGSTROMS METHOD; CONDUCTIVITY	We simultaneously measured the Seebeck coefficient and thermal diffusivity of a rectangular parallelepiped bulk thermoelectric material. We used one-dimensional heat conduction equation to show that a periodic heat cycle produces not only the thermoelectromotive force but also a certain phase shift angle between the edge and intermediate points of a sample along the length of the material. Based on the equation of the modified Angstrom method, an experiment at 300K was performed using NIST standard material (SRM 3451, Bi2Te3 material) to measure the Seebeck coefficient and thermal diffusivity. The measured Seebeck coefficient was -231 +/- 3 mu V/K, which corresponds to the published value. Using the same experimental setup as that for the thermal diffusivity measurement, the dependence of the phase shift angle on frequency was measured from 5 mHz to 10 Hz for the phase shift angle from -8.2 to -450 degrees. The estimated thermal diffusivity was (1.53 +/- 0.05) x 10(-6) m(2)/s. We conclude that the modified Angstrom method can be used to measure the Seebeck coefficient and thermal diffusivity simultaneously. (C) 2015 The Japan Society of Applied Physics	[Homma, Ryoei; Hasegawa, Yasuhiro; Terakado, Hiroki] Saitama Univ, Fac Engn, Saitama 3388570, Japan; [Morita, Hiroyuki] Saitama Ind Technol Ctr, Kawaguchi, Saitama 3330844, Japan; [Komine, Takashi] Ibaraki Univ, Fac Engn, Hitachi, Ibaraki 3168511, Japan	Homma, R (reprint author), Saitama Univ, Fac Engn, Saitama 3388570, Japan.	hasegawa@mail.saitama-u.ac.jp			Leading Industrial Technology Development Project Grant Fund of NEDO; Inamori Foundation; Izumi Science and Technology Foundation; Takahashi Industrial and Economic Research Foundation	The authors thank Dr. Masayuki Murata of AIST, Japan, for his assistance in this research. This research was supported in part by the Leading Industrial Technology Development Project Grant Fund of NEDO, Inamori Foundation, Izumi Science and Technology Foundation, and Takahashi Industrial and Economic Research Foundation. This work was performed under the auspices of the National Institute for Fusion Science (NIES) Collaborative Research (NIFS14KBAS016).	Goyal V, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3494529; Martin J, 2010, J APPL PHYS, V108, DOI 10.1063/1.3503505; BELLING JM, 1987, REV SCI INSTRUM, V58, P997, DOI 10.1063/1.1139589; CAHILL DG, 1990, REV SCI INSTRUM, V61, P802, DOI 10.1063/1.1141498; Garcia-Canadas J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4871553; GREEN A, 1960, J SCI INSTRUM, V37, P349, DOI 10.1088/0950-7671/37/9/310; Hasegawa Y, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3484192; Hasegawa Y, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2126952; Jaeger J. C., 1959, CONDUCTION HEAT SOLI; Kim H. J., 2012217791 NASA; Koh YK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3078808; LOPEZBAEZA E, 1987, J PHYS D APPL PHYS, V20, P1156, DOI 10.1088/0022-3727/20/9/011; Lowhorn ND, 2009, APPL PHYS A-MATER, V96, P511, DOI 10.1007/s00339-009-5191-5; McNeill D. J., 1958, J APPL PHYS, V29, P1373; MCNEILL DJ, 1962, J APPL PHYS, V33, P597, DOI 10.1063/1.1702472; MEDDINS HR, 1969, J PHYS D APPL PHYS, V2, P691, DOI 10.1088/0022-3727/2/5/307; Nakamura D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3581211; Nolas G. S., 2001, THERMOELECTRICS BASI; Suzuki A, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1844691; TOMOKIYO A, 1968, JPN J APPL PHYS, V7, P128, DOI 10.1143/JJAP.7.128	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							026602	10.7567/JJAP.54.026602		8	Physics, Applied	Physics	CC1HE	WOS:000350091000024		
J	Iwata, M; Ando, K; Maeda, M; Ishibashi, Y				Iwata, Makoto; Ando, Kenichiro; Maeda, Masaki; Ishibashi, Yoshihiro			In-situ observations of domain walls in the electric field applied along [111] direction in BaTiO3	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC SINGLE-CRYSTALS; MORPHOTROPIC PHASE-BOUNDARY; SOLID-SOLUTION SYSTEMS; PIEZOELECTRIC PROPERTIES; OXIDE FERROELECTRICS; ELECTROMECHANICAL RESPONSE; ENHANCED PIEZOELECTRICITY; CONFIGURATIONS; DEPENDENCE; TRANSITION	In-situ observations of domain walls in an electric field applied along the [111](c) direction in BaTiO3 have been carried out. All of the observed domain walls could be assigned to the 90 and 180 degrees domain walls in the tetragonal phase. No charged domain wall was observed. The obliquely crossed stripe pattern has been found to appear as a result of back switching after removing the electric field. (C) 2015 The Japan Society of Applied Physics	[Iwata, Makoto; Ando, Kenichiro; Maeda, Masaki] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan; [Ishibashi, Yoshihiro] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan	Iwata, M (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan.				Japan Society for the Promotion of Science [25400323]	MI and KA would like to express their sincere thanks to Professor T. Ozaki of Hiroshima Institute of Technology, for his advice on the domain wall observation by SEM, and to Ms. A. Iwasaka of the Instrument and Research Technology Center of Nagoya Institute of Technology for the manipulation of SEM. This work was supported in part by a Grant-in-Aid for Scientific Research C (No. 25400323) from the Japan Society for the Promotion of Science to MI.	Wada S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957130; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Ahluwalia R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014112; Fu HX, 2000, NATURE, V403, P281; Davis M, 2004, J APPL PHYS, V95, P5679, DOI 10.1063/1.1703829; Wada S, 1999, JPN J APPL PHYS 1, V38, P5505, DOI 10.1143/JJAP.38.5505; Ishibashi Y, 1998, JPN J APPL PHYS 2, V37, pL985, DOI 10.1143/JJAP.37.L985; Park SE, 1999, J APPL PHYS, V86, P2746, DOI 10.1063/1.371120; Wada S, 2006, FERROELECTRICS, V334, P17, DOI 10.1080/00150190600689647; Budimir M, 2003, J APPL PHYS, V94, P6753, DOI 10.1063/1.1625080; Damjanovic D, 2002, APPL PHYS LETT, V80, P652, DOI 10.1063/1.1445481; Gureev MY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184104; Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140; SAPRIEL J, 1975, PHYS REV B, V12, P5128, DOI 10.1103/PhysRevB.12.5128; KUWATA J, 1982, JPN J APPL PHYS 1, V21, P1298, DOI 10.1143/JJAP.21.1298; Wada S, 2004, BRIT CERAM T, V103, P93, DOI 10.1179/096797804225012747; Erhart J, 2012, FERROELECTRICS, V426, P13, DOI 10.1080/00150193.2012.671088; Guo HY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024114; Hlinka J, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105709; Iwata M, 2001, JPN J APPL PHYS 1, V40, P703, DOI 10.1143/JJAP.40.703; Iwata M, 2002, FERROELECTRICS, V266, P57, DOI 10.1080/00150190211434; Jona F., 1962, FERROELECTRIC CRYSTA; Li JY, 2004, J MECH PHYS SOLIDS, V52, P1719, DOI 10.1016/j.jmps.2004.02.011; Liu D, 2004, APPL PHYS LETT, V84, P3930, DOI 10.1063/1.1745114; Liu G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4720150; Liu T, 2006, CONTINUUM MECH THERM, V18, P119, DOI 10.1007/s00161-006-0017-6; Ozaki T, 1996, J APPL PHYS, V80, P1697, DOI 10.1063/1.362980; Paik DS, 1999, J APPL PHYS, V85, P1080, DOI 10.1063/1.369252; Rao WF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435584; Liu SF, 1999, J APPL PHYS, V85, P2810, DOI 10.1063/1.369599; Sluka T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1751	31	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							021502	10.7567/JJAP.54.021502		5	Physics, Applied	Physics	CC1HE	WOS:000350091000007		
J	Kameda, K; Sato, D; Ito, Y; Natsukawa, H; Okano, K; Mizutani, N; Kobayashi, T				Kameda, Keigo; Sato, Daichi; Ito, Yosuke; Natsukawa, Hiroaki; Okano, Kazuhisa; Mizutani, Natsuhiko; Kobayashi, Tetsuo			Human magnetoencephalogram measurements using newly developed compact module of high-sensitivity atomic magnetometer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								In the field of biomagnetic measurements, optically pumped atomic magnetometers (OPAMs) are expected to be alternative sensors to magnetometers based on superconducting quantum interference devices (SQUIDs). In addition, miniaturized OPAMs are required for practical use. To address this issue, we developed a compact module of a high-sensitivity OPAM with a pump probe arrangement and potassium used as the sensing atom. Because the noise spectrum density of the OPAM reached 21 f T-rms/Hz(1/2) at 10 Hz, we attempted to use it to measure human magnetocardiograms (MEGs). Compared with the results obtained with SQUID-based magnetometers, we could successfully observe distinct features of event-related desynchronization in the 8-13 Hz band associated with eye opening. The results demonstrate the feasibility of using the OPAM module for neuromagnetic field measurements. (C) 2015 The Japan Society of Applied Physics	[Kameda, Keigo; Sato, Daichi; Ito, Yosuke; Natsukawa, Hiroaki; Kobayashi, Tetsuo] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Okano, Kazuhisa; Mizutani, Natsuhiko] Canon Inc, Frontier Res Ctr, Ota, Tokyo 1468501, Japan	Kameda, K (reprint author), Japan Soc Promot Sci, Tokyo, Japan.	kamada@bfe.kuee.kyoto-u.ac.jp			Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24240081, 24650221, 26560466, 24-5350]	This work was partially supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging of the Project for Developing Innovation Systems, by Grants-in-Aid for Research (24240081, 24650221, and 26560466), and by a Grant-in-Aid for JSPS Fellows (24-5350), all from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Adachi Y, 2013, IEICE T ELECTRON, VE96C, P326, DOI 10.1587/transele.E96.C.326; Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Dong HF, 2013, IEEE SENS J, V13, P186, DOI 10.1109/JSEN.2012.2216951; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Xia H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392722; Xu SJ, 2006, P NATL ACAD SCI USA, V103, P12668, DOI 10.1073/pnas.0605396103; Allred JC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130801; Johnson C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522648; Shah VK, 2013, PHYS MED BIOL, V58, P8153, DOI 10.1088/0031-9155/58/22/8153; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Sander TH, 2012, BIOMED OPT EXPRESS, V3, P981, DOI 10.1364/BOE.3.000981; Kim K, 2014, NEUROIMAGE, V89, P143, DOI 10.1016/j.neuroimage.2013.10.040; Knappe S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491548; Groeger S, 2006, EUR PHYS J D, V38, P239, DOI 10.1140/epjd/e2006-00037-y; Hansen P. C., 2010, MEG INTRO METHODS, p35 and 169; HAPPER W, 1973, PHYS REV LETT, V31, P273, DOI 10.1103/PhysRevLett.31.273; Kamada K, 2012, PHYSIOL MEAS, V33, P1063, DOI 10.1088/0967-3334/33/6/1063; Kamada K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.056602; Koch H, 2001, IEEE T APPL SUPERCON, V11, P49, DOI 10.1109/77.919284; Okano K., 2012, P IEEE SENSORS, P239; Suter D., 1997, PHYS LASER ATOM INTE, P160, DOI 10.1017/CBO9780511524172.006; Yang HC, 2003, J LOW TEMP PHYS, V131, P509, DOI 10.1023/A:1022903320064	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							026601	10.7567/JJAP.54.026601		5	Physics, Applied	Physics	CC1HE	WOS:000350091000023		
J	Kitahara, K; Shibutani, K; Okabe, Y; Meguro, T; Hara, A				Kitahara, Kuninori; Shibutani, Kazuya; Okabe, Yasunori; Meguro, Tatsuya; Hara, Akito			Highly oriented lateral growth of SiGe thin films on glass induced by constitutional undercooling	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CRYSTALLIZED POLYCRYSTALLINE SILICON; EXCIMER-LASER; AMORPHOUS-SILICON; GRAIN-GROWTH; TRANSISTORS; HYDROGENATION; TEMPERATURE; IRRADIATION; MECHANISMS; BOUNDARIES	Enhanced lateral growth of semiconductor thin films on glass was investigated. The unidirectional growth of silicon (Si) was achieved by introducing continuous-wave laser lateral crystallization. Alloying germanium (Ge) with Si led to highly oriented lateral growth (HOLG) of SiGe thin films. The HOLG and Ge segregation in these films were explained by the constitutional undercooling model. Quasi-single crystals were grown when the Ge mole fraction was 0.3. Using a single scan of the laser on SiGe causes the amorphous phase to become crystal, which tends to decrease the stability of growth. This growth stability was improved by performing multiple scans, where the growth was dominated by regrowth from crystal to crystal. (C) 2015 The Japan Society of Applied Physics	[Kitahara, Kuninori; Shibutani, Kazuya] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Okabe, Yasunori; Meguro, Tatsuya; Hara, Akito] Tohoku Gakuin Univ, Dept Elect Engn, Tagajo, Miyagi 9856537, Japan	Kitahara, K (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	akito@mail.tohoku-gakuin.ac.jp			Japan Society for the Promotion of Science [25420339]	This study was partly funded by a Grant-in-Aid for Scientific Research (C) 25420339 from the Japan Society for the Promotion of Science. EBSD measurements were conducted by the Foundation for Promotion of Material Science and Technology of Japan.	LEVINSON J, 1982, J APPL PHYS, V53, P1193, DOI 10.1063/1.330583; IM JS, 1993, APPL PHYS LETT, V63, P1969, DOI 10.1063/1.110617; Hara A, 2002, JPN J APPL PHYS 2, V41, pL311, DOI 10.1143/JJAP.41.L311; THOMPSON MO, 1984, PHYS REV LETT, V52, P2360, DOI 10.1103/PhysRevLett.52.2360; EWING RH, 1971, J CRYST GROWTH, V11, P221, DOI 10.1016/0022-0248(71)90088-1; NAKAMURA A, 1989, J APPL PHYS, V66, P4248, DOI 10.1063/1.343965; Mariucci L, 2003, THIN SOLID FILMS, V427, P91, DOI 10.1016/S0040-6090(02)01254-3; KOHYAMA M, 1994, PHYS REV B, V49, P17102, DOI 10.1103/PhysRevB.49.17102; WU IW, 1991, IEEE ELECTR DEVICE L, V12, P181, DOI 10.1109/55.75757; Chalmers B., 1964, PRINCIPLES SOLIDIFIC; Crowder M. A., 2000, MRS P, V621; CUNNINGHAM B, 1982, APPL PHYS LETT, V40, P237, DOI 10.1063/1.93058; Fujii S, 2007, JPN J APPL PHYS 1, V46, P2501, DOI 10.1143/JJAP.46.2501; Hara A, 2002, J APPL PHYS, V91, P708, DOI 10.1063/1.1420766; Hara A, 2004, JPN J APPL PHYS 1, V43, P1269, DOI 10.1143/JJAP.43.1269; Hatano M., 2002, SID INT S, V33, P158, DOI 10.1889/1.1830220; Hirose K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CA07; Ishihara R, 2000, JPN J APPL PHYS 1, V39, P3872, DOI 10.1143/JJAP.39.3872; Kitahara K., 2012, CRYSTALLIZATION SCI; Kitahara K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.115501; Kitahara K, 2008, JPN J APPL PHYS, V47, P54, DOI 10.1143/JJAP.47.541; Koh HYS, 2010, ELECTROCHEM SOLID ST, V13, pH281, DOI 10.1149/1.3436665; KURIYAMA H, 1993, JPN J APPL PHYS 1, V32, P6190, DOI 10.1143/JJAP.32.6190; MCCULLOCH DJ, 1995, APPL PHYS LETT, V66, P2060, DOI 10.1063/1.113902; Noguchi T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CA10; Olesinski R. W., 1986, BINARY ALLOY PHASE D, P1249; SAMESHIMA T, 1986, IEEE ELECTR DEVICE L, V7, P276, DOI 10.1109/EDL.1986.26372; Sameshima T., 2005, Thin Solid Films, V487, DOI 10.1016/j.tsf.2005.01.037; D'Aragona F. S., 1972, Journal of the Electrochemical Society, V119; SZYSZKO W, 1995, APPL PHYS A-MATER, V61, P141, DOI 10.1007/BF01538380; Tanaka T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.031301; THOMPSON CV, 1985, J APPL PHYS, V58, P763, DOI 10.1063/1.336194; Weizman M., 2005, MRS P, V862	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							021302	10.7567/JJAP.54.021302		7	Physics, Applied	Physics	CC1HE	WOS:000350091000005		
J	Kubo, T; Freedsman, JJ; Yoshida, Y; Egawa, T				Kubo, Toshiharu; Freedsman, Joseph J.; Yoshida, Yusuke; Egawa, Takashi			Effects of process temperature during atomic layer deposition using water and ozone as oxidants on current voltage characteristics of Al2O3/AlGaN/GaN high-electron-mobility transistors on Si substrates	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HAFNIUM OXIDE; GATE; AL2O3; GAN/ALGAN; FILMS; GAN	Atomic layer deposition (ALD) using both water (H2O) and ozone (O-3) as oxidants was performed to fabricate Al2O3/AlGaN/GaN metal-insulator-semiconductor high-electron-mobility transistors (MIS-HEMTs) on Si substrates, and the effects of deposition temperature on the electrical characteristics of these MIS-HEMTs were investigated using DC and pulsed current-voltage measurements. The MIS-HEMT with Al2O3 deposited at 250 degrees C showed less drain current degradation in pulsed measurements, which was consistent with the low minimum interface state density of 0.9 x 10(10) cm(-2) eV(-1) estimated from the photo-assisted capacitance-voltage shift. These results indicate That the Al2O3 layer for GaN-based MIS-HEMTs can be fabricated by the H2O+O-3-based ALD process at a relatively low temperature of 250 degrees C. (C) 2015 The Japan Society of Applied Physics	[Kubo, Toshiharu; Freedsman, Joseph J.; Yoshida, Yusuke; Egawa, Takashi] Nagoya Inst Technol, Res Ctr Nanodevice & Syst, Nagoya, Aichi 4668555, Japan	Kubo, T (reprint author), Nagoya Inst Technol, Res Ctr Nanodevice & Syst, Nagoya, Aichi 4668555, Japan.	kubo.toshiharu@nitech.ac.jp		Freedsman, Joseph/0000-0002-1819-7900	Japan Science and Technology Agency JST Super Cluster Program	This work was partially supported by Japan Science and Technology Agency JST Super Cluster Program.	Knoops HCM, 2011, CHEM MATER, V23, P2381, DOI 10.1021/cm2001144; Hashizume T, 2003, J VAC SCI TECHNOL B, V21, P1828, DOI 10.1116/1.1585077; Liu ZH, 2010, IEEE ELECTR DEVICE L, V31, P96, DOI 10.1109/LED.2009.2036135; Goldstein DN, 2008, J PHYS CHEM C, V112, P19530, DOI 10.1021/jp804296a; Tapajna M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3663573; Long RD, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827102; Liu ZH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3268474; Kanamura M, 2010, IEEE ELECTR DEVICE L, V31, P189, DOI 10.1109/LED.2009.2039026; Boyd AR, 2009, PHYS STATUS SOLIDI C, V6, pS1045, DOI 10.1002/pssc.200880925; Hori Y, 2013, J APPL PHYS, V114, DOI 10.1063/1.4859576; Kordos P, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2716846; Miyazaki E, 2011, SOLID STATE ELECTRON, V62, P152, DOI 10.1016/j.sse.2011.04.017; Kubo T, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/4/045004; Liu ZH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3567927; Christy D, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026501; Freedsman JJ, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DF03; Freedsman JJ, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.041003; Freedsman JJ, 2013, IEEE T ELECTRON DEV, V60, P3079, DOI 10.1109/TED.2013.2276437; Jackson CM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4808093; Liu XY, 2005, J ELECTROCHEM SOC, V152, pG213, DOI 10.1149/1.1859631; Lossy R, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4771655; Ma XH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813912; Mizue C, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021001; Nanjo T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168036; Park K., 2005, J SEMICONDUCTOR TECH, V5, P107; Selvaraj SL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2386919; Senzaki Y, 2004, J VAC SCI TECHNOL A, V22, P1175, DOI 10.1116/1.1761186; Ye PD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861122	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							020301	10.7567/JJAP.54.020301		4	Physics, Applied	Physics	CC1HE	WOS:000350091000001		
J	Matsumoto, K; Nishio, R; Nomura, T; Kamiya, K; Inada, M; Suzuki, S				Matsumoto, Kimihisa; Nishio, Ryosuke; Nomura, Takashi; Kamiya, Kazuhide; Inada, Mitsuru; Suzuki, Shinya			Marked increase in photoluminescence from porous Si aged in ethanol solution	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HIGH-PRESSURE; NANOCRYSTALLINE SILICON; HIGHLY EFFICIENT; QUANTUM DOTS; LUMINESCENCE; OXIDATION; NANOPARTICLES; DECAY; GLASS; BLUE	Photoluminescence properties of porous Si aged in ethanol solution and porous Si films aged in ambient air were studied. It was shown that the photoluminescence properties of porous Si strongly depend on aging time and environmental conditions. The photoluminescence intensity of porous Si dispersed in ethanol solution increases 50-fold with aging for 7d. This increase is accompanied by increases in Si-O bond density and lifetime, indicating that the electron hole pair is strongly confined by the formation of surface oxide thin films. The photoluminescence intensity of porous Si films decreases with aging in ambient air, suggesting that nonradiative recombination centers are formed by natural oxidation. (C) 2015 The Japan Society of Applied Physics	[Matsumoto, Kimihisa; Nishio, Ryosuke; Nomura, Takashi; Kamiya, Kazuhide] Toyama Prefectural Univ, Dept Intelligent Syst Design Engn, Imizu, Toyama 9390398, Japan; [Inada, Mitsuru] Kansai Univ, Dept Pure & Appl Phys, Suita, Osaka 5648680, Japan; [Suzuki, Shinya] Nagano Natl Coll Technol, Dept Elect & Control Engn, Nagano 3818550, Japan	Matsumoto, K (reprint author), Toyama Prefectural Univ, Dept Intelligent Syst Design Engn, Imizu, Toyama 9390398, Japan.				CASIO Science Promotion Foundation	This work was, in part, supported by the CASIO Science Promotion Foundation.	Liu SM, 2006, CHEM MATER, V18, P637, DOI 10.1021/cm0519636; Li ZF, 2004, NANO LETT, V4, P1463, DOI 10.1021/nl0492436; KANEMITSU Y, 1994, PHYS REV B, V49, P14732, DOI 10.1103/PhysRevB.49.14732; Svrcek V, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505329; Matsumoto K, 2005, JPN J APPL PHYS 1, V44, P8742, DOI 10.1143/JJAP.44.8742; Linnros J, 1999, J APPL PHYS, V86, P6128, DOI 10.1063/1.371663; Svrcek V, 2004, J APPL PHYS, V95, P3158, DOI 10.1063/1.1649817; Takeoka S, 2000, PHYS REV B, V62, P16820, DOI 10.1103/PhysRevB.62.16820; PAVESI L, 1993, PHYS REV B, V48, P17625, DOI 10.1103/PhysRevB.48.17625; Wolkin MV, 1999, PHYS REV LETT, V82, P197, DOI 10.1103/PhysRevLett.82.197; Gelloz B, 2005, J APPL PHYS, V98, DOI 10.1063/1.2147847; Yang CS, 1999, J AM CHEM SOC, V121, P5191, DOI 10.1021/ja9828509; Stewart MP, 2001, J AM CHEM SOC, V123, P7821, DOI 10.1021/ja011116d; Shen P, 2010, J MATER CHEM, V20, P1669, DOI 10.1039/b919412f; Kovalev D, 1999, PHYS STATUS SOLIDI B, V215, P871, DOI 10.1002/(SICI)1521-3951(199910)215:2<871::AID-PSSB871>3.0.CO;2-9; Sato S, 2006, CHEM MATER, V18, P4083, DOI 10.1021/cm060750t; CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561; English DS, 2002, NANO LETT, V2, P681, DOI 10.1021/n1025538c; Mihalcescu I, 1996, J APPL PHYS, V80, P2404, DOI 10.1063/1.363076; Fukuda M, 2011, OPT LETT, V36, P4026, DOI 10.1364/OL.36.004026; Gelloz B, 2007, JPN J APPL PHYS 1, V46, P2429, DOI 10.1143/JJAP.46.2429; Gelloz B, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-382; Gelloz B, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C119; Gelloz B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2001136; Li GB, 1997, APPL PHYS LETT, V70, P1284, DOI 10.1063/1.118552; MARTIN E, 1994, PHYS REV B, V50, P18258, DOI 10.1103/PhysRevB.50.18258; Matsumoto K, 2007, JPN J APPL PHYS 1, V46, P1779, DOI 10.1143/JJAP.46.1779; Roman HE, 1996, J PHYS-CONDENS MAT, V8, P5161, DOI 10.1088/0953-8984/8/28/003; Sato K, 2003, APPL SURF SCI, V216, P376, DOI 10.1016/S0169-4332(03)00445-8; Tsybeskov T., 1994, APPL PHYS LETT, V64, P1983	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2								10.7567/JJAP.54.021301		4	Physics, Applied	Physics	CC1HE	WOS:000350091000004		
J	Noyori, M; Neo, Y; Mimura, H				Noyori, Masaji; Neo, Yoichiro; Mimura, Hidenori			Single-crystalline poly(vinylidene fluoride-trifluoroethylene) nanofiber webs fabricated by electrospinning	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							COPOLYMER THIN-FILMS; VINYLIDENE FLUORIDE; TRIFLUOROETHYLENE COPOLYMERS; PIEZOELECTRIC NANOGENERATORS; FERROELECTRIC COPOLYMERS; ELECTRICITY-GENERATION; CURIE TRANSITION; PHASE-TRANSITION; NANOWIRE ARRAYS	We have fabricated P(VDF-TrFE) nanofiber webs by electrospinning. Highly aligned nanofiber webs with high uniformity and a smooth surface were fabricated. To obtain single-crystalline P(VDF-TrFE) nanofibers, we have studied the effect of stretching and annealing on the P(VDF-TrFE) nanofiber web. Three samples were fabricated: as-electrospun, annealed, and annealed after stretching. The single-crystalline P(VDF-TrFE) nanofibers were successfully obtained by stretching and annealing process. (C) 2015 The Japan Society of Applied Physics	[Noyori, Masaji; Neo, Yoichiro; Mimura, Hidenori] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan; [Neo, Yoichiro; Mimura, Hidenori] Shizuoka Univ, Res Inst Elect, Hamamatsu, Shizuoka 4328011, Japan	Noyori, M (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan.	mimura@rie.shizuoka.ac.jp					Chang CE, 2010, NANO LETT, V10, P726, DOI 10.1021/nl9040719; Chen X, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3157837; Lin YF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831901; OHIGASHI H, 1995, APPL PHYS LETT, V66, P3281, DOI 10.1063/1.113730; OHIGASHI H, 1982, JPN J APPL PHYS 2, V21, pL455, DOI 10.1143/JJAP.21.L455; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; KOGA K, 1990, J APPL PHYS, V67, P965, DOI 10.1063/1.345706; Qin Y, 2008, NATURE, V451, P809, DOI 10.1038/nature06601; Sun DH, 2006, NANO LETT, V6, P839, DOI 10.1021/nl0602701; Chang C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2975834; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; LEGRAND JF, 1989, FERROELECTRICS, V91, P303, DOI 10.1080/00150198908015747; Chang JY, 2012, NANO ENERGY, V1, P356, DOI 10.1016/j.nanoen.2012.02.003; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Chen X, 2010, NANO LETT, V10, P2133, DOI 10.1021/nl100812k; KOGA K, 1986, J APPL PHYS, V59, P2142, DOI 10.1063/1.336351; Lu MY, 2009, ACS NANO, V3, P357, DOI 10.1021/nn800804r; Hubler AC, 2012, ORG ELECTRON, V13, P2290, DOI 10.1016/j.orgel.2012.06.048; Wang XB, 2010, ADV MATER, V22, P2155, DOI 10.1002/adma.200903442; Mandal D, 2011, MACROMOL RAPID COMM, V32, P831, DOI 10.1002/marc.201100040; KIM KJ, 1994, J POLYM SCI POL PHYS, V32, P2435, DOI 10.1002/polb.1994.090321501; Kumar B, 2011, J MATER CHEM, V21, P18946, DOI 10.1039/c1jm13066h; Li JJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388874; Barique MA, 2001, POLYMER, V42, P4981, DOI 10.1016/S0032-3861(00)00937-X; OHIGASHI H, 1988, JPN J APPL PHYS 1, V27, P2144, DOI 10.1143/JJAP.27.2144; Ohigashi H, 1984, FERROELECTRICS, V60, P263, DOI 10.1080/00150198408017527; Persano L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2639; Ren GY, 2013, MACROMOL MATER ENG, V298, P541, DOI 10.1002/mame.201200218; Tajitsu Y, 1999, J MATER SCI LETT, V18, P1501, DOI 10.1023/A:1006690200490; Urayama K, 1999, J APPL PHYS, V86, P6367, DOI 10.1063/1.371699; Xia F, 2002, J APPL PHYS, V92, P3111, DOI 10.1063/1.1503395	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							021601	10.7567/JJAP.54.021601		4	Physics, Applied	Physics	CC1HE	WOS:000350091000008		
J	Okamoto, K; Yamamoto, H; Kozawa, T; Fujiyoshi, R; Umegaki, K				Okamoto, Kazunnasa; Yamamoto, Hiroki; Kozawa, Takahiro; Fujiyoshi, Ryoko; Umegaki, Kikuo			Pulse radiolysis study of polystyrene-based polymers with added photoacid generators: Reaction mechanism of extreme-ultraviolet and electron-beam chemically amplified resist	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							RADIATION-INDUCED REACTIONS; GEMINATE ION RECOMBINATION; CHARGE-TRANSFER COMPLEXES; POST-OPTICAL LITHOGRAPHY; BENZENE TRIMER CATION; DIMER RADICAL-CATION; ACID GENERATORS; X-RAY; PHOTODISSOCIATION SPECTROSCOPY; TRIPHENYLSULFONIUM SALTS	The reaction mechanism of chemically amplified resist (CAR) after irradiation with ionizing radiation is important for developing extreme-ultraviolet and electron-beam lithography. The acid generation after the ionization is an essential reaction in CAR. In this study, the intermediate of the proton source of acid (a radical cation of the base polymer) in the presence of a photoacid generator (FAG) was investigated by the pulse radiolysis method. The deprotonation kinetics of the radical cation of poly(4-hydroxystyrene) (PHS) in solutions with and without PAG shows only a small difference. However, the yield of radical cations of poly(4-methoxystyrene) (PMOS) as a model of the resist with a protecting (releasing) group increases upon adding FAG. The formation of the ion pair between the PMOS radical cation and the dissociated anion with a lifetime of approximately 30 to 40 mu s is suggested. The lower acid yield in PMOS than in PHS film is also discussed in terms of the stability of the radical cation. (C) 2015 The Japan Society of Applied Physics	[Okamoto, Kazunnasa; Fujiyoshi, Ryoko; Umegaki, Kikuo] Hokkaido Univ, Div Quantum Sci & Engn, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Yamamoto, Hiroki; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Okamoto, K (reprint author), Hokkaido Univ, Div Quantum Sci & Engn, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	kazu@eng.hokudai.ac.jp			Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24561037, 25630424]	The authors wish to express their thanks to Mr. K. Tominaga and Mr. K. Sato of Hokkaido University and Ms. K. Kubo and Mr.. S. Suemine of ISIR Osaka University for their support in the experiments. This work has also been partly supported by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" and a Grant-in-Aid for Scientific Research (Project Nos. 24561037 and 25630424) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	BUHLER RE, 1967, NATURE, V214, P1220, DOI 10.1038/2141220a0; KOZAWA T, 1992, JPN J APPL PHYS 1, V31, P4301, DOI 10.1143/JJAP.31.4301; Nakano A, 2004, JPN J APPL PHYS 1, V43, P4363, DOI 10.1143/JJAP.43.4363; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Natsuda K, 2008, JPN J APPL PHYS, V47, P4932, DOI 10.1143/JJAP.47.4932; OHASHI K, 1991, J CHEM PHYS, V95, P4002, DOI 10.1063/1.460807; [Anonymous], 2004, GAUSSIAN03 REVISION; Croft AK, 2007, PHYS CHEM CHEM PHYS, V9, P5649, DOI 10.1039/b704966h; Inokuchi Y, 1997, CHEM PHYS LETT, V269, P298, DOI 10.1016/S0009-2614(97)00281-9; Kozawa T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2909275; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Ichinose N, 2000, CHEM PHYS LETT, V322, P15, DOI 10.1016/S0009-2614(00)00382-1; BADGER B, 1968, NATURE, V219, P263, DOI 10.1038/219263a0; Berho F, 1999, J PHYS CHEM A, V103, P5501, DOI 10.1021/jp9904318; BUHLER RE, 1968, HELV CHIM ACTA, V51, P1558, DOI 10.1002/hlca.19680510709; DEKTAR JL, 1989, J PHOTOCH PHOTOBIO A, V46, P233, DOI 10.1016/1010-6030(89)80009-7; Freeman G. R., 1987, KINETICS NONHOMOGENE, P19; HACKER NP, 1991, MACROMOLECULES, V24, P2137, DOI 10.1021/ma00008a075; HAYON E, 1970, J CHEM PHYS, V53, P2353, DOI 10.1063/1.1674332; JARZEBA W, 1995, J PHYS CHEM-US, V99, P2016, DOI 10.1021/j100007a036; Komuro Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.116503; Komuro Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.014001; Kozawa T., 1995, J PHOTOPOLYM SCI TEC, V8, P37, DOI 10.2494/photopolymer.8.37; Kozawa T, 2005, JPN J APPL PHYS 1, V44, P3908, DOI 10.1143/JJAP.44.3908; Kozawa T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.056508; Kozawa T, 1997, J VAC SCI TECHNOL B, V15, P2582, DOI 10.1116/1.589689; Kozawa T, 2002, JPN J APPL PHYS 1, V41, P4208, DOI 10.1143/JJAP.41.4208; MAH S, 1983, J PHYS CHEM-US, V87, P297, DOI 10.1021/j100225a025; Matsui Y, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.036001; Mine M, 2007, CHEM PHYS LETT, V438, P157, DOI 10.1016/j.cplett.2007.02.072; Nakano A, 2006, JPN J APPL PHYS 2, V45, pL197, DOI 10.1143/JJAP.45.L197; Nakano A, 2006, JPN J APPL PHYS 1, V45, P6866, DOI 10.1143/JJAP.45.6866; OHASHI K, 1992, J PHYS CHEM-US, V96, P2931, DOI 10.1021/j100186a030; Okamoto K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FC06; Okamoto K, 2006, CHEM PHYS LETT, V426, P306, DOI 10.1016/j.cplett.2006.05.115; Okamoto K, 2001, RADIAT PHYS CHEM, V60, P417, DOI 10.1016/S0969-806X(01)00183-9; Okamoto K, 2006, J PHYS CHEM A, V110, P8073, DOI 10.1021/jp061527m; Okamoto K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106501; Okamoto K, 2008, J PHYS CHEM B, V112, P9275, DOI 10.1021/jp801949s; Okamoto K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GC04; SHIBATA T, 1994, CHEM PHYS LETT, V229, P604, DOI 10.1016/0009-2614(94)01116-8; Shibayama W, 2014, PROC SPIE, V9051, DOI 10.1117/12.2046475; Shibayama W, 2013, PROC SPIE, V8679, DOI 10.1117/12.2011441; Tabata Y., 1991, HANDBOOK OF RADIATIO, P407; Tachikawa H, 2013, THEOR CHEM ACC, V132, DOI 10.1007/s00214-013-1374-4; Tagawa S, 2000, P SOC PHOTO-OPT INS, V3999, P204, DOI 10.1117/12.388304; Tajima Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GD03; Todo M, 2004, CHEM PHYS LETT, V399, P378, DOI 10.1016/j.cplett.2004.10.044; Toriumi M, 2014, PROC SPIE, V9051, DOI 10.1117/12.2045872; Tsuji S., 2000, Journal of Photopolymer Science and Technology, V13, DOI 10.2494/photopolymer.13.733; Yamamoto H, 2004, JPN J APPL PHYS 1, V43, P3971, DOI 10.1143/JJAP.43.3971; YOSHIDA Y, 1987, RADIAT PHYS CHEM, V30, P83; YOSHIDA Y, 1986, RADIAT PHYS CHEM, V28, P201	56	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							026501	10.7567/JJAP.54.026501		6	Physics, Applied	Physics	CC1HE	WOS:000350091000022		
J	Onishi, Y; Hashimoto, Y				Onishi, Yasuhiko; Hashimoto, Yoshio			Numerical analysis of specific on-resistance for trench gate superjunction MOSFETs	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL-GROWTH; DEVICES	The numerical analysis results and theoretical limit of specific on-resistance (R-ON.A) for a parallel trench gate superjunction (SJ) MOSFET where a striped trench gate structure is parallel to a striped SJ structure and a perpendicular trench gate SJ-MOSFET where the striped trench gate structure is perpendicular to the striped SJ structure are presented. Analytical equations for relationships between breakdown voltage and R-ON.A are verified by device simulation and show good agreement with simulation results. When the MOSFET cell pitch is below half of the SJ pitch, in accordance with the numerical analysis results, the R-ON.A of the perpendicular SJ-MOSFET is smaller than that of the parallel SJ-MOSFET. This is due to the fact that the drift resistance including a current spreading effect and the channel resistance including a current narrowing effect in the perpendicular SJ-MOSFET are reduced by reducing the MOSFET cell pitch. (C) 2015 The Japan Society of Applied Physics	[Onishi, Yasuhiko] Fuji Elect Co Ltd, Corp R&D Headquarters, Elect Device Lab, Next Gen Device Dev Ctr, Hino, Tokyo 1918502, Japan; [Onishi, Yasuhiko; Hashimoto, Yoshio] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Math & Syst Dev, Nagano 3808553, Japan	Onishi, Y (reprint author), Fuji Elect Co Ltd, Corp R&D Headquarters, Elect Device Lab, Next Gen Device Dev Ctr, Hino, Tokyo 1918502, Japan.	oonishi-yasuhiko@fujielectric.co.jp					Fujihira T, 1997, JPN J APPL PHYS 1, V36, P6254, DOI 10.1143/JJAP.36.6254; HU CM, 1984, IEEE T ELECTRON DEV, V31, P1693; Chen XB, 2001, IEEE T ELECTRON DEV, V48, P344; Strollo AGM, 2001, IEEE T ELECTRON DEV, V48, P2161, DOI 10.1109/16.944211; Deboy G, 1998, INTERNATIONAL ELECTRON DEVICES MEETING 1998 - TECHNICAL DIGEST, P683, DOI 10.1109/IEDM.1998.746448; Fujihira T., 1998, Proceedings of the 10th International Symposium on Power Semiconductor Devices and ICs. ISPSD'98 (IEEE Cat. No.98CH36212), DOI 10.1109/ISPSD.1998.702736; Hower P. L., 1983, International Electron Devices Meeting 1983. Technical Digest; Hoyniak D, 2000, J APPL PHYS, V87, P876, DOI 10.1063/1.371955; Hu C., 1979, PESC'79. IEEE Power Electronics Specialists Conference 1979; Iwamoto S, 2005, INT SYM POW SEMICOND, P31; Kobayashi T., 2001, P ISPSD, P99; Minato T., 2000, P ISPSD2000, P73; Ninomiya H., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's; Nitta T., 2000, P ISPSD, P77; Onishi Y., 2002, P ISPSD, P241; Ono S., 2012, P PCIM EUR 2012, P128; Rochefort C., 2002, P ISPSD2002, P237; Saito W., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's; Saito W, 2006, INT SYM POW SEMICOND, P293; Sakakibara Jun, 2008, Proceedings of the 20th International Symposium on Power Semiconductor Devices & ICs; Shenoy P., 1999, P ISPSD, P99; Shibata T, 2007, INT SYM POW SEMICOND, P37, DOI 10.1109/ISPSD.2007.4294926; Sugi A, 2008, Proceedings of the 20th International Symposium on Power Semiconductor Devices & ICs; Takahashi K, 2006, INT SYM POW SEMICOND, P297; Vecino E., 2013, P PCIM EUR 13, P621; Yamauchi S., 2002, P ISPSD, P133; Yamauchi S., 2001, Proceedings of the 13th International Symposium on Power Semiconductor Devices & ICs. IPSD '01 (IEEE Cat. No.01CH37216), DOI 10.1109/ISPSD.2001.934630; Yamauchi S., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's; Yamauchi S., 2006, P INT S POW SEM DEV, P65; Yamauchi S., 2003, P ISPSD, P207	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							024101	10.7567/JJAP.54.024101		7	Physics, Applied	Physics	CC1HE	WOS:000350091000014		
J	Sakaue, K; Nishimura, Y; Nishiyama, M; Takahashi, T; Washio, M; Takatomi, T; Urakawa, J				Sakaue, Kazuyuki; Nishimura, Yuichi; Nishiyama, Masahiro; Takahashi, Takenoshin; Washio, Masakazu; Takatomi, Toshikazu; Urakawa, Junji			Temporal profile measurement of an electron bunch with the two-cell rf deflecting cavity at Waseda University	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							GUN; PHOTOCATHODE; DESIGN; SYSTEM	Our group at Waseda University developed an rf deflector system for measuring longitudinal. In this study we evaluated the temporal resolution of an S-band two-cell rf deflector cavity built into the system and performed a series of longitudinal profile measurements of electron bunch from an rf photocathode gun. The if deflector system achieved a temporal resolution of 147.6 fs (rms), the value gave in close agreement with the design specification. We present our experimental results and discussion how the temporal profile was influenced by the if electric field and space charge effect in the electron bunch from the if photo cathode gun. Our results agreed with the results of a beam tracking simulation. The successful results of longitudinal profile measurements in this study confirm that our deflector system will be quite useful for improving an rf electron gun cavities. (C) 2015 The Japan Society of Applied Physics	[Sakaue, Kazuyuki; Nishimura, Yuichi; Nishiyama, Masahiro; Takahashi, Takenoshin; Washio, Masakazu] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Takatomi, Toshikazu; Urakawa, Junji] High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan	Sakaue, K (reprint author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	kazuyuki.sakaue@aoni.waseda.jp			Japan Society for the Promotion of Science (JSPS) [10001690]; Quantum Beam Technology Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors are grateful to Mr. Kudo of the KEK Mechanical Engineering Center for his support in the manufacturing of rf-deflector cavity. This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) 10001690 and the Quantum Beam Technology Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Alesini D, 2006, NUCL INSTRUM METH A, V568, P488, DOI 10.1016/j.nima.2006.07.050; Siwick BJ, 2002, J APPL PHYS, V92, P1643, DOI 10.1063/1.1487437; Yang JF, 2011, NUCL INSTRUM METH A, V629, P6, DOI 10.1016/j.nima.2010.11.109; Muro'oka Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602314; Belomestnykh S, 2010, NUCL INSTRUM METH A, V614, P179, DOI 10.1016/j.nima.2009.12.063; Comacchia M., 2002, SLACPUB9225; Deshpande A, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.063501; Deshpande A, 2009, NUCL INSTRUM METH A, V600, P361, DOI 10.1016/j.nima.2008.11.142; Emma P., 2000, LCLSTN0012 SLAC; England R. J., 2005, P 2005 PART ACC C, P2627, DOI 10.1109/PAC.2005.1591207; HARTMAN SC, 1994, NUCL INSTRUM METH A, V340, P219, DOI 10.1016/0168-9002(94)91305-6; Hosaka Y, 2013, RADIAT PHYS CHEM, V84, P10, DOI 10.1016/j.radphyschem.2012.06.055; Kuroda R, 2009, RADIAT PHYS CHEM, V78, P1102, DOI 10.1016/j.radphyschem.2009.06.026; Nishimura Y, 2014, NUCL INSTRUM METH A, V764, P291, DOI 10.1016/j.nima.2014.07.035; Otake Y, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.042802; Piot P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604017; Rohrs M, 2009, PHYS REV SPEC TOP-AC, V12, DOI 10.1103/PhysRevSTAB.12.050704; Sakaue K, 2014, PHYS REV SPEC TOP-AC, V17, DOI 10.1103/PhysRevSTAB.17.023401; Sakaue K, 2011, NUCL INSTRUM METH B, V269, P2928, DOI 10.1016/j.nimb.2011.04.041; Sakaue K, 2008, RADIAT PHYS CHEM, V77, P1136, DOI 10.1016/j.radphyschem.2008.05.039; Terunuma N, 2010, NUCL INSTRUM METH A, V613, P1, DOI 10.1016/j.nima.2009.10.151; WANG XJ, 1993, PROCEEDINGS OF THE 1993 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P3000, DOI 10.1109/PAC.1993.309530; Wang XJ, 1996, PHYS REV E, V54, pR3121	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							026301	10.7567/JJAP.54.026301		6	Physics, Applied	Physics	CC1HE	WOS:000350091000021		
J	Tomita, M; Takakura, H; Kambayashi, D; Mizuno, Y; Naritsuka, S; Maruyama, T				Tomita, Masafumi; Takakura, Hiroyuki; Kambayashi, Daisuke; Mizuno, Yosuke; Naritsuka, Shigeya; Maruyama, Takahiro			Abnormal growth in super-low supersaturation microchannel epitaxy of (001) GaAs and its improvement	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LIQUID-PHASE EPITAXY; LATERAL OVERGROWTH; SI SUBSTRATE; INTERFACE-SUPERSATURATION; GAN FILMS; INP; LPE; OPTIMIZATION; TEMPERATURE; MICROSCOPY	Microchannel epitaxy (MCE) of (001) GaAs with super-low supersaturation usually provides a very thin and wide lateral growth. However, it sometimes produces abnormal growth with a very low aspect ratio. In the abnormal growth, the layer grows very thick, and accordingly, the width becomes small. The aspect ratio is less than 1. The cause of the abnormal growth is studied and the edge effect is found to be responsible. The edge effect in liquid phase epitaxy (LPE) produces a high supersaturation near the periphery. Consequently, numerous steps are produced on the surface of the edge. This forms a step source in LPE and grows a thick layer with a very low aspect ratio. To suppress the abnormal growth, two types of mask patterns are proposed, which are designed to decrease supersaturation at the periphery. With the aid of the new masks, very wide and thin MCE layers are successfully obtained with high yields. For example, the width and thickness of an MCE layer are 210 and 6 mu m, respectively, giving a high aspect ratio of 35. (C) 2015 The Japan Society of Applied Physics	[Tomita, Masafumi; Takakura, Hiroyuki; Kambayashi, Daisuke; Mizuno, Yosuke; Naritsuka, Shigeya; Maruyama, Takahiro] Meijo Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4680073, Japan	Tomita, M (reprint author), Meijo Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4680073, Japan.	narit@meijo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22360131, 26600089, 25000011]	This work was partly supported by a Grant-in-Aid for Scientific Research on Priority Areas (B) (No. 22360131) and Grants-in-Aid for Challenging Exploratory Research (No. 26600089) and Specially Promoted Research (No. 25000011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Yan Z, 1999, J CRYST GROWTH, V198, P1077, DOI 10.1016/S0022-0248(98)01125-7; Sakai A, 1997, APPL PHYS LETT, V71, P2259, DOI 10.1063/1.120044; Hiramatsu K, 2000, J CRYST GROWTH, V221, P316, DOI 10.1016/S0022-0248(00)00707-7; BERGMANN R, 1990, APPL PHYS LETT, V57, P351, DOI 10.1063/1.103689; BERGMANN R, 1991, J CRYST GROWTH, V110, P823, DOI 10.1016/0022-0248(91)90640-Q; Bertram F, 1999, APPL PHYS LETT, V74, P359, DOI 10.1063/1.123071; Chang YS, 1998, J CRYST GROWTH, V192, P18, DOI 10.1016/S0022-0248(98)00407-2; Chang YS, 1997, J CRYST GROWTH, V174, P630, DOI 10.1016/S0022-0248(97)00067-5; Chang YS, 2010, J CRYST GROWTH, V312, P629, DOI 10.1016/j.jcrysgro.2009.11.018; Hattori A., 2007, 37 ANN C JAP ASS CRY, P132; Hishida T., 2005, 59 SPRING M; Naritsuka S, 1999, J CRYST GROWTH, V203, P459, DOI 10.1016/S0022-0248(99)00136-0; Naritsuka S, 2001, J CRYST GROWTH, V222, P14, DOI 10.1016/S0022-0248(00)00859-9; Naritsuka S, 2008, J CRYST GROWTH, V310, P1642, DOI 10.1016/j.jcrysgro.2007.11.118; Naritsuka S, 1997, J CRYST GROWTH, V174, P622, DOI 10.1016/S0022-0248(97)00046-8; NARITSUKA S, 1995, JPN J APPL PHYS 2, V34, pL1432; Naritsuka S, 1999, J CRYST GROWTH, V198, P1082, DOI 10.1016/S0022-0248(98)01150-6; Naritsuka S, 2000, J CRYST GROWTH, V211, P395, DOI 10.1016/S0022-0248(99)00823-4; NISHINAGA T, 1988, JPN J APPL PHYS 2, V27, pL964, DOI 10.1143/JJAP.27.L964; Sakai A, 1998, APPL PHYS LETT, V73, P481, DOI 10.1063/1.121907; SAKAWA S, 1992, JPN J APPL PHYS 2, V31, pL359, DOI 10.1143/JJAP.31.L359; UJIIE Y, 1989, JPN J APPL PHYS 2, V28, pL337, DOI 10.1143/JJAP.28.L337; Yan Z, 1998, J CRYST GROWTH, V192, P11, DOI 10.1016/S0022-0248(98)00419-9; Yan Z, 2000, J CRYST GROWTH, V212, P1, DOI 10.1016/S0022-0248(00)00031-2; Yan Z, 1999, J CRYST GROWTH, V203, P25, DOI 10.1016/S0022-0248(99)00050-0; Zytkiewicz ZR, 1999, APPL PHYS LETT, V75, P2749, DOI 10.1063/1.125137; Zytkiewicz ZR, 1998, J APPL PHYS, V84, P6937, DOI 10.1063/1.368995	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							025502	10.7567/JJAP.54.025502		5	Physics, Applied	Physics	CC1HE	WOS:000350091000019		
J	Uchida, K; Higashi, K; Hishida, K; Hotta, A; Miki, N				Uchida, Kazuhiro; Higashi, Kazuhiko; Hishida, Koichi; Hotta, Atsushi; Miki, Norihisa			Electrospray formation of ring-shaped silica nanoparticles	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ENHANCED RAMAN-SCATTERING; SILVER NANOPARTICLES; SOLUTION DROPLETS; DEPOSITION; PARTICLES; SUBSTRATE; CATALYST; POWDERS; ARRAYS; SIZE	Electrospray is one of the processes employed for the production of silica nanoparticles (NPs). We have experimentally determined that not only spherical but also ring-shaped NPs can be manufactured by electrospray, and that the shape of the NPs is dependent on ambient humidity and the substrate on which the NPs are deposited. Although the effect of humidity that reflects the evaporation characteristics of the suspension during flight has been reported, we have experimentally determined that the affinity of the sol suspension and the substrate play a crucial role in the formation of torus silica NPs. (C) 2015 The Japan Society of Applied Physics	[Uchida, Kazuhiro; Higashi, Kazuhiko; Hotta, Atsushi; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Hishida, Koichi] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan	Uchida, K (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	miki@mech.keio.ac.jp	Miki, Norihisa/F-7659-2014		 [2122606]	This work was supported by a Grant-in-Aid for Scientific Research (S) (2122606).	Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; Farid M, 2003, CHEM ENG SCI, V58, P2985, DOI 10.1016/S0009-2509(03)00161-1; Kneuer C, 2000, INT J PHARM, V196, P257, DOI 10.1016/S0378-5173(99)00435-4; Gorr HM, 2012, J PHYS CHEM B, V116, P12213, DOI 10.1021/jp307933a; Liu GL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2031935; de Gans BJ, 2004, LANGMUIR, V20, P7789, DOI 10.1021/la049469o; Aroca RF, 2000, LANGMUIR, V16, P5425, DOI 10.1021/la991478n; Fujiwara Y, 2008, J ELECTROCHEM SOC, V155, pD377, DOI 10.1149/1.2890288; Fukai J, 2006, INT J HEAT MASS TRAN, V49, P3561, DOI 10.1016/j.ijheatmasstransfer.2006.02.049; Hanada K, 2011, SENSOR MATER, V23, P251; Hanada K, 2009, SENSOR MATER, V21, P129; Higashi K, 2014, JALA-J LAB AUTOM, V19, P75, DOI 10.1177/2211068213495205; Iskandar F, 2003, J COLLOID INTERF SCI, V265, P296, DOI 10.1016/S0021-9797(03)00519-8; Iskandar F, 2001, J NANOPART RES, V3, P263, DOI 10.1023/A:1017592817667; Maskara A, 1997, J AM CERAM SOC, V80, P1715; Park CH, 2011, J COLLOID INTERF SCI, V361, P423, DOI 10.1016/j.jcis.2011.06.003; Ramnani SP, 2008, CATAL COMMUN, V9, P756, DOI 10.1016/j.catcom.2007.O8.Oi7; Uchida K, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/2/025023	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							020302	10.7567/JJAP.54.020302		3	Physics, Applied	Physics	CC1HE	WOS:000350091000002		
J	Uchida, M; Falson, J; Segawa, Y; Kozuka, Y; Tsukazak, A; Kawasaki, M				Uchida, Masaki; Falson, Joseph; Segawa, Yusaburo; Kozuka, Yusuke; Tsukazak, Atsushi; Kawasaki, Masashi			Calibration and control of in-plane Mg doping distribution in MgxZn1-xO/ZnO heterostructures grown by molecular beam epitaxy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ZNO; POLAR; OXIDE	The in-plane Mg doping distribution in molecular beam epitaxy grown MgxZn1-xO/ZnO heterostructures is mapped by low-temperature photoluminescence measurements in an effort to evaluate and control the resultant inhomogeneity formed during the growth process. In an unrotated sample, the independent configuration effects of the 03 and Mg source cells are clearly demonstrated in a composition spread due to flux gradients, while this inhomogeneity is suppressed by sample rotation during the growth. The present mapping results provide an important means for investigating improved doping regimes with the aim of enhancing the quality of quantum transport observable at the MgxZn1-xO/ZnO heterointerface. (C) 2015 The Japan Society of Applied Physics	[Uchida, Masaki; Falson, Joseph; Kozuka, Yusuke; Kawasaki, Masashi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Uchida, Masaki; Falson, Joseph; Kozuka, Yusuke; Kawasaki, Masashi] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Segawa, Yusaburo; Kawasaki, Masashi] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Tsukazak, Atsushi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Tsukazak, Atsushi] Japan Sci & Technol Agcy JST, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	Uchida, M (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	uchida@ap.t.u-tokyo.ac.jp	Kozuka, Yusuke/E-6470-2010; Kawasaki, Masashi/B-5826-2008; Uchida, Masaki/I-1660-2014	Kozuka, Yusuke/0000-0002-2205-2421; Uchida, Masaki/0000-0002-0735-8844	Japan Society for the Promotion of Science (JSPS) [24226002]; Mizuho Foundation for the Promotion of Sciences	This work was partly supported by a Grant-in-Aid for Scientific Research (Grants No. 24226002) from the Japan Society for the Promotion of Science (JSPS), and by Mizuho Foundation for the Promotion of Sciences.	Cho MW, 2005, SEMICOND SCI TECH, V20, pS13, DOI 10.1088/0268-1242/20/4/002; Tsukazaki A, 2010, NAT MATER, V9, P889, DOI [10.1038/nmat2874, 10.1038/NMAT2874]; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Kozuka Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075302; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; Falson J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.091101; Kozuka Y, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4853535; Maryenko D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.186803; Clayhold JA, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2901622; Falson J., UNPUB; Farrow R.F., 1995, MOL BEAM EPITAXY APP; Herman M. A., 1996, MOL BEAM EPITAXY; Kozuka Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748306; Kozuka Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205411; Maeda K, 2005, SEMICOND SCI TECH, V20, pS49, DOI 10.1088/0268-1242/20/4/006; Robins LH, 2003, J APPL PHYS, V93, P3747, DOI 10.1063/1.1556554; Warusawithana MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3351; Wu J, 2013, NAT MATER, V12, P877, DOI [10.1038/nmat3719, 10.1038/NMAT3719]; Xu HZ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2337541	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2							028004	10.7567/JJAP.54.028004		3	Physics, Applied	Physics	CC1HE	WOS:000350091000028		
J	Nagai, H				Nagai, Hirokazu			Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						Hodgkin lymphoma; interim positron emission tomography; brentuximab vedotin	POSITRON-EMISSION-TOMOGRAPHY; INVOLVED-FIELD RADIOTHERAPY; BRENTUXIMAB VEDOTIN; RESPONSE ASSESSMENT; PHASE-2 TRIAL; OPEN-LABEL; INTERPRETATION CRITERIA; INTERNATIONAL WORKSHOP; PROGNOSTIC SCORE; CLINICAL-TRIALS	Hodgkin lymphoma is a highly curative lymphoid malignancy, but some patients relapse or experience adverse events from treatment. Therefore, prognostic markers are needed to allow a more patient-tailored approach to treatment. The positive-predictive value of interim positron emission tomography for progression-free survival was reported as 81%, and the negative-predictive value was reported as 97%. Interim positron emission tomography might identify high-risk patients who would benefit from more intensive treatment regimens as well as identify low-risk patients in whom even the standard treatment regimen might be a form of overtreatment. Indeed, major clinical study groups have conducted risk-adapted treatment protocols based on interim positron emission tomography. The Japan Clinical Oncology Group is also planning a Phase II trial of this concept for advanced Hodgkin lymphoma. These trials are now ongoing, but the data of them are expected soon. Molecular-targeted therapy is another important approach to improve outcomes for these patients. Brentuximab vedotin is an antibody-drug conjugate that targets CD30 on Hodgkin cells and has excellent efficacy when used as monotherapy. The combination of brentuximab vedotin and standard chemotherapies are being investigated in randomized Phase III trials. These approaches might lead to a paradigm shift in the treatment of Hodgkin lymphoma.	[Nagai, Hirokazu] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan	Nagai, H (reprint author), Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi, Japan.	nagaih@nnh.hosp.go.jp			National Cancer Center Research and Development Fund [26-A-4]	This work was supported by the National Cancer Center Research and Development Fund (26-A-4).	Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Koontz MZ, 2013, J CLIN ONCOL, V31, P592, DOI 10.1200/JCO.2012.44.5791; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Younes A, 2011, LANCET ONCOL, V12, P1222, DOI 10.1016/S1470-2045(11)70265-0; DEVITA VT, 1980, ANN INTERN MED, V92, P587; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Bonadonna G, 2004, J CLIN ONCOL, V22, P2835, DOI 10.1200/JCO.2004.12.170; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Schulz H, 2008, BLOOD, V111, P109, DOI 10.1182/blood-2007-03-078725; VIVIANI S, 1985, EUR J CANCER CLIN ON, V21, P601, DOI 10.1016/0277-5379(85)90088-4; Terasawa T, 2009, J CLIN ONCOL, V27, P1906, DOI 10.1200/JCO.2008.16.0861; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Rehwald U, 2003, BLOOD, V101, P420, DOI 10.1182/blood.V101.2.420; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hutchings M, 2005, ANN ONCOL, V16, P1160, DOI 10.1093/annonc/mdi200; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340; Barrington SF, 2010, EUR J NUCL MED MOL I, V37, P1824, DOI 10.1007/s00259-010-1490-5; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Younes A, 2012, J CLIN ONCOL, V30, P2197, DOI 10.1200/JCO.2011.38.1350; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; Engert A, 2003, J CLIN ONCOL, V21, P3601, DOI 10.1200/JCO.2003.03.023; von Tresckow B, 2012, J CLIN ONCOL, V30, P907, DOI 10.1200/JCO.2011.38.5807; Younes A, 2012, BLOOD, V119, P4123, DOI 10.1182/blood-2012-01-405456; Kasamon YL, 2012, BLOOD, V119, P4129, DOI 10.1182/blood-2012-01-402792; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Zinzani PL, 2012, EUR J NUCL MED MOL I, V39, P4, DOI 10.1007/s00259-011-1916-8; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Raemaekers JMM, 2014, J CLIN ONCOL, V32, P1188, DOI 10.1200/JCO.2013.51.9298; Eich HT, 2010, J CLIN ONCOL, V28, P4199, DOI 10.1200/JCO.2010.29.8018; Gallamini A, 2006, HAEMATOL-HEMATOL J, V91, P475; Federico M, 2009, J CLIN ONCOL, V27, P805, DOI 10.1200/JCO.2008.17.0910; LISTER TA, 1989, J CLIN ONCOL, V7, P1630; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2012, LANCET, V379, P1791, DOI 10.1016/S0140-6736(11)61940-5; Johnston PB, 2010, AM J HEMATOL, V85, P320, DOI 10.1002/ajh.21664; Gallamini A, 2011, BRIT J HAEMATOL, V152, P551, DOI 10.1111/j.1365-2141.2010.08485.x; Biggi A, 2013, J NUCL MED, V54, P683, DOI 10.2967/jnumed.112.110890; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Younes A, 2013, LANCET ONCOL, V14, P1348, DOI 10.1016/S1470-2045(13)70501-1; Juweid ME, 2005, J CLIN ONCOL, V23, P4652, DOI 10.1200/JCO.2005.01.891; BOIVIN JF, 1995, J NATL CANCER I, V87, P732, DOI 10.1093/jnci/87.10.732; Cerci JJ, 2010, J NUCL MED, V51, P1337, DOI 10.2967/jnumed.109.073197; Gallamini A, 2014, HAEMATOLOGICA, V99, P1107, DOI 10.3324/haematol.2013.103218; Gobbi PG, 2005, J CLIN ONCOL, V23, P9198, DOI 10.1200/JCO.2005.02.907; Johnson PWM, 2005, J CLIN ONCOL, V23, P9208, DOI 10.1200/JCO.2005.03.2151; Kirschbaum MH, 2012, LEUKEMIA LYMPHOMA, V53, P259, DOI 10.3109/10428194.2011.608448; Kulkarni SS, 1997, AM J CLIN ONCOL-CANC, V20, P354, DOI 10.1097/00000421-199708000-00006; Ogura M, 2014, CANCER SCI, V105, P840, DOI 10.1111/cas.12435; Unal A, 2005, LEUKEMIA LYMPHOMA, V46, P1613, DOI 10.1080/10428190500236502; Zinzani PL, 2006, ANN ONCOL, V17, P1296, DOI 10.1093/annonc/mdl122	53	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					137	145		10.1093/jjco/hyu204		9	Oncology	Oncology	CC3DJ	WOS:000350224800001		
J	Yamaguchi, T; Furukawa, Y; Nakamura, Y; Matsubara, N; Ishikawa, H; Arai, M; Tomita, N; Tamura, K; Sugano, K; Ishioka, C; Yoshida, T; Moriya, Y; Ishida, H; Watanabe, T; Sugihara, K				Yamaguchi, Tatsuro; Furukawa, Yoichi; Nakamura, Yusuke; Matsubara, Nagahide; Ishikawa, Hideki; Arai, Masami; Tomita, Naohiro; Tamura, Kazuo; Sugano, Kokichi; Ishioka, Chikashi; Yoshida, Teruhiko; Moriya, Yoshihiro; Ishida, Hideyuki; Watanabe, Toshiaki; Sugihara, Kenichi		Japanese Soc Canc Colon Rectum	Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						colorectal cancer; familial colorectal cancer type X; Lynch syndrome	MISMATCH REPAIR DEFICIENCY; GERMLINE MUTATION; GASTRIC-CANCER; TUMOR SPECTRUM; RISK; CRITERIA; HNPCC; MSH6	Objective: The characteristics of familial colorectal cancer type X are poorly defined. Here we aimed to clarify the differences in clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients. Methods: We performed germline mutation analyses of mismatch repair genes in 125 patients. Patients who met the Amsterdam Criteria I but lacked mismatch repair gene mutations were diagnosed with suspected familial colorectal cancer type X. Results: We identified 69 patients with Lynch syndrome and 25 with suspected familial colorectal cancer type X. The frequencies of gastric and extracolonic Lynch syndrome-associated cancers were lower with suspected familial colorectal cancer type X than with Lynch syndrome. The number of organs with Lynch syndrome-associated cancer was significantly lower with suspected familial colorectal cancer type X than with Lynch syndrome. The cumulative incidence of extracolonic Lynch syndrome-associated cancer was significantly lower with suspected familial colorectal cancer type X than with Lynch syndrome. We estimated that the median cancer risk in 60-year-old patients with Lynch syndrome was 89, 36 and 24% for colorectal, endometrial and gastric cancers, respectively. Analyses of family members, including probands, revealed that the median age at diagnosis of extracolonic Lynch syndrome-associated cancer was significantly older with suspected familial colorectal cancer type X than with Lynch syndrome. The frequency of extracolonic Lynch syndrome-associated cancer was significantly lower with suspected familial colorectal cancer type X than with Lynch syndrome. Conclusion: A significant difference in extracolonic Lynch syndrome-associated cancer was evident between suspected familial colorectal cancer type X and Lynch syndrome.	[Yamaguchi, Tatsuro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Genome Res, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Matsubara, Nagahide; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Ishikawa, Hideki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan; [Arai, Masami] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Tamura, Kazuo] Kinki Univ, Grad Sch Sci & Engn Res, Higashiosaka, Osaka 577, Japan; [Sugano, Kokichi] Tochigi Canc Ctr, Res Inst, Oncogene Res Unit, Canc Prevent Unit, Utsunomiya, Tochigi, Japan; [Ishioka, Chikashi] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Moriya, Yoshihiro] Natl Canc Ctr, Dept Surg, Tokyo, Japan; [Ishida, Hideyuki] Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, Kawagoe, Saitama, Japan; [Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan	Ishida, H (reprint author), Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, Kawagoe, Saitama, Japan.	05hishi@saitama-med.ac.jp			Ministry of Health, Labor and Welfare; Japanese Society for Cancer of the Colon and Rectum	The present study was supported in part by a grant-in-aid for Cancer Research from the Ministry of Health, Labor and Welfare and by Japanese Society for Cancer of the Colon and Rectum.	Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Boland CR, 2013, GASTROENTEROLOGY, V144, P868, DOI 10.1053/j.gastro.2013.03.014; Francisco I, 2011, FAM CANCER, V10, P623, DOI 10.1007/s10689-011-9473-7; Gylling A, 2007, GUT, V56, P926, DOI 10.1136/gut.2006.114876; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Nieminen TT, 2014, GASTROENTEROLOGY, V147, P595, DOI 10.1053/j.gastro.2014.06.009; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Dominguez-Valentin M, 2015, MODERN PATHOL, V28, P30, DOI 10.1038/modpathol.2014.49; Dominguez-Valentin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071755; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; National Comprehensive Cancer Network (NCCN), 2014, CLIN PRACT GUID ONC; NICOLAIDES NC, 1995, GENOMICS, V30, P195, DOI 10.1006/geno.1995.9885; Park YJ, 2000, CLIN CANCER RES, V6, P2994; Segui N, 2014, HUM MUTAT, V35, P50, DOI 10.1002/humu.22454; Therkildsen C, 2013, EUR J CANCER, V49, P1226, DOI 10.1016/j.ejca.2012.11.011; Yamaguchi T, 2006, DIS COLON RECTUM, V49, P399, DOI 10.1007/s10350-005-0293-4	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					153	159		10.1093/jjco/hyu190		7	Oncology	Oncology	CC3DJ	WOS:000350224800003		
J	Yokota, T; Onoe, T; Ogawa, H; Hamauchi, S; Iida, Y; Kamijo, T; Suda, T; Yurikusa, T; Nishimura, T; Yasui, H; Onitsuka, T				Yokota, Tomoya; Onoe, Tsuyoshi; Ogawa, Hirofumi; Hamauchi, Satoshi; Iida, Yoshiyuki; Kamijo, Tomoyuki; Suda, Toshihito; Yurikusa, Takashi; Nishimura, Tetsuo; Yasui, Hirofumi; Onitsuka, Tetsuro			Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						locally advanced squamous cell carcinoma of the head and neck; cetuximab; radiotherapy; mucositis; percutaneous endoscopic gastrostomy	SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; LARYNGEAL-CANCER; TRIAL	Objective: Prophylactic percutaneous endoscopic gastrostomy may be considered before chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma, because severe mucositis is a common complication. We evaluated the mucosal findings and necessity of prophylactic percutaneous endoscopic gastrostomy in patients with head and neck squamous cell carcinoma receiving cetuximab and radiotherapy. Methods: Fourteen consecutive patients with locally advanced head and neck squamous cell carcinoma receiving cetuximab and radiotherapy were analyzed. Results: Patients' backgrounds were as follows: male/female, 8/6; median age, 64.5 years (range, 35-83 years); performance status, 0/1, 9/5. Primary tumor sites included the oropharynx, hypopharynx and larynx in four, seven and three patients, respectively. Patients completed a median of eight cetuximab cycles. All patients received three-dimensional conformal radiotherapy (median dose, 70 Gy). Thirteen patients were treated with elective neck irradiation at the ipsilateral (n = 3) or bilateral (n = 10) nodes. Grade = 3 mucositis/stomatitis (clinical examination) occurred in 85.7% patients (n = 12). The median irradiation dose was 33 Gy at the Grade 3 mucositis onset. Eight patients showed mucositis with distinctive features, a wide range of white-coated lesions with a clear border; hypopharyngeal atresia was observed in two patients. Prophylactic percutaneous endoscopic gastrostomy was performed in 11 patients, and 11 patients (78.6%) actually required nutritional support because of Grade = 3 mucositis/stomatitis (functional/symptomatic). Conclusions: Prophylactic percutaneous endoscopic gastrostomy is recommended because most patients receiving cetuximab and radiotherapy for locally advanced head and neck squamous cell carcinoma have Grade = 3 mucositis with distinctive features.	[Yokota, Tomoya; Hamauchi, Satoshi; Yasui, Hirofumi] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Onoe, Tsuyoshi; Ogawa, Hirofumi; Nishimura, Tetsuo] Shizuoka Canc Ctr, Div Radiat Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Iida, Yoshiyuki; Kamijo, Tomoyuki; Suda, Toshihito; Onitsuka, Tetsuro] Shizuoka Canc Ctr, Div Head & Neck Surg, Nagaizumi, Shizuoka 4118777, Japan; [Yurikusa, Takashi] Shizuoka Canc Ctr, Div Dent & Oral Surg, Nagaizumi, Shizuoka 4118777, Japan	Yokota, T (reprint author), Shizuoka Canc Ctr, Div Gastrointestinal Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	t.yokota@scchr.jp			Merck Serono; Bristol-Myers Squibb	Tomoya Yokota serves in an advisory role in AstraZeneca and Merck Serono, and has received lecture fees from Merck Serono and Bristol-Myers Squibb.	Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.3.CO;2-N; Bernier J, 2011, ANN ONCOL, V22, P2191, DOI 10.1093/annonc/mdr139; VANDENBOGAERT W, 1995, RADIOTHER ONCOL, V36, P177, DOI 10.1016/0167-8140(95)01597-A; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Tarnawski R, 2002, INT J RADIAT ONCOL, V54, P229, DOI 10.1016/S0360-3016(02)02936-X; Horiuchi A, 2008, ENDOSCOPY, V40, P722, DOI 10.1055/s-2008-1077490; Silander E, 2012, HEAD NECK-J SCI SPEC, V34, P1, DOI 10.1002/hed.21700; Lawson JD, 2009, AM J OTOLARYNG, V30, P244, DOI 10.1016/j.amjoto.2008.06.010; Wong SJ, 2011, CANCER-AM CANCER SOC, V117, P1679, DOI 10.1002/cncr.25721; Chen AM, 2010, INT J RADIAT ONCOL, V78, P1026, DOI 10.1016/j.ijrobp.2009.09.036; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Budach V, 2010, ANN ONCOL, V21, P321; CHRISTENSEN ME, 1992, EUR ARCH OTO-RHINO-L, V249, P243, DOI 10.1007/BF00714485; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Garden AS, 2008, INT J RADIAT ONCOL, V71, P1351, DOI 10.1016/j.ijrobp.2008.04.006; McCloskey SA, 2009, AM J CLIN ONCOL-CANC, V32, P587, DOI 10.1097/COC.0b013e3181967dd0; Ogino Haruei, 2013, World J Gastrointest Pathophysiol, V4, P119, DOI 10.4291/wjgp.v4.i4.119; Zbaeren P, 1987, ARCH OTOLARYNGOL, V113, P762	21	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					183	188		10.1093/jjco/hyu196		6	Oncology	Oncology	CC3DJ	WOS:000350224800007		
J	Shimoyama, N; Gomyo, I; Teramoto, O; Kojima, K; Higuchi, H; Yukitoshi, N; Ohta, E; Shimoyama, M				Shimoyama, Naohito; Gomyo, Ikuo; Teramoto, Osamu; Kojima, Keisuke; Higuchi, Hitomi; Yukitoshi, Nobuyuki; Ohta, Eri; Shimoyama, Megumi			Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						breakthrough pain; cancer pain; sublingual fentanyl tablet; opioid; conversion ratio	TRANSMUCOSAL FENTANYL; CITRATE; PHARMACOKINETICS; MANAGEMENT; TOLERABILITY; TITRATION; REGIMEN	Objective: A randomized, crossover, double-blinded placebo-controlled and non-blinded active drug-controlled, comparative clinical trial was conducted to evaluate the efficacy and safety of sublingual fentanyl tablet. Methods: Subjects were patients treated with strong opioids at fixed intervals for chronic cancer pain and with oral morphine as rescue medication for breakthrough pain. Sublingual fentanyl was administered at doses that were 1/25th (high dose) and 1/50th (low dose) of the dose of rescue morphine and was compared with placebo and oral morphine. The primary endpoint was pain intensity difference at 30 min after administration. (Clinical Trials Government; NCT00684632). Results: Fifty-one patients were enrolled in the investigation. Their mean pain intensity in visual analog scale before rescue medication prior to the investigation was 60.96 (16.44, standard deviation) mm. Compared with placebo, the low and high doses of sublingual fentanyl showed significant analgesic effects (least squares mean difference, 4.54 and 8.49 mm; P = 0.014, P < 0.001, respectively). Adverse reactions were observed in 17.6%, the most common being constipation, nausea and somnolence. The incidence of adverse reactions during the high-dose administration period was higher than that during the low-dose and active control drug administration periods. Conclusions: Patients treated with strong opioid analgesics at fixed intervals for chronic cancer pain and with oral morphine at doses up to 20 mg as rescue medication were investigated. The doses of sublingual fentanyl to treat breakthrough pain were determined from rescue morphine doses by use of conversion ratios. In these patients, administration of sublingual fentanyl at doses determined by a conversion ratio of 1/50 was effective and safe. Further studies are needed to validate the use of this conversion method.	[Shimoyama, Naohito] Jikei Univ, Grad Sch Med, Dept Palliat Med, Tokyo 1058461, Japan; [Gomyo, Ikuo] Saito Yukoukai Hosp, Dept Palliat Med, Ibaraki, Japan; [Teramoto, Osamu] Omigawa Gen Hosp, Dept Surg, Katori, Japan; [Kojima, Keisuke] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan; [Higuchi, Hitomi] Showa Univ Hosp, Dept Palliat Med, Tokyo, Japan; [Yukitoshi, Nobuyuki] Kyowa Hakko Kirin Co Ltd, Dev Div, Clin Dev Dept 2, Tokyo, Japan; [Ohta, Eri] Kyowa Hakko Kirin Co Ltd, Dev Div, Clin Data Evaluat Dept, Tokyo, Japan; [Shimoyama, Megumi] Teikyo Univ, Chiba Med Ctr, Dept Anesthesiol, Ichihara, Chiba, Japan	Shimoyama, N (reprint author), Jikei Univ, Grad Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	nshimoya@jikei.ac.jp			Kyowa Hakko Kirin Co., Ltd.	This Phase III trial was sponsored by Kyowa Hakko Kirin Co., Ltd. and was conducted under the supervision of the Pharmaceuticals and Medical Devices Agency (PMDA, Japan).	Abstral SPC, 2013, DAT OF REV; Actiq SPC, 2012, DAT OF REV; Streisand JB, 1998, ANESTHESIOLOGY, V88, P305, DOI 10.1097/00000542-199802000-00006; Mercadante S, 2013, CURR MED RES OPIN, V29, P1527, DOI 10.1185/03007995.2013.826640; Lennernas B, 2005, BRIT J CLIN PHARMACO, V59, P249, DOI 10.1111/j.1365-2125.2004.02264.x; Mercadante S, 2007, BRIT J CANCER, V96, P1828, DOI 10.1038/sj.bjc.6603811; Mercadante S, 2012, CURR MED RES OPIN, V28, P963, DOI 10.1185/03007995.2012.683112; Christie JM, 1998, J CLIN ONCOL, V16, P3238; Bennett D, 2005, PHARMACOL THERAPEUT, V30, P296; Bennett D, 2005, PHARMACOL THERAPEUT, V30, P354; Bredenberg S, 2003, EUR J PHARM SCI, V20, P327, DOI 10.1016/j.ejps.2003.07.002; CHERNY NI, 1993, CANCER-AM CANCER SOC, V72, P3393, DOI 10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO;2-O; England Ruth, 2011, BMJ Support Palliat Care, V1, P349, DOI 10.1136/bmjspcare-2011-000037; Hans GH, 2013, CURR MED RES OPIN, V29, P1523, DOI 10.1185/03007995.2013.837816; Lister N, 2011, J CLIN PHARMACOL, V51, P1195, DOI 10.1177/0091270010379410; Payne R, 2001, J PAIN SYMPTOM MANAG, V22, P575, DOI 10.1016/S0885-3924(01)00306-2; Potenoy RK, 1990, PAIN, V41, P273; Simmonds MA, 1999, ONCOLOGY-NY, V13, P1103; Yamaguchi T, 2013, JPN J CLIN ONCOL, V43, P896, DOI 10.1093/jjco/hyt099	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					189	196		10.1093/jjco/hyu182		8	Oncology	Oncology	CC3DJ	WOS:000350224800008		
J	Yamaguchi, Y; Hayashi, Y; Ishizuya, Y; Takeda, K; Nakai, Y; Arai, Y; Nakayama, M; Kakimoto, K; Nishimura, K				Yamaguchi, Yuichiro; Hayashi, Yujiro; Ishizuya, Yu; Takeda, Ken; Nakai, Yasutomo; Arai, Yasuyuki; Nakayama, Masashi; Kakimoto, Ken-ichi; Nishimura, Kazuo			A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score; primary androgen deprivation therapy; prostate cancer	MEN	Objective: Japan Cancer of the Prostate Risk Assessment scores are reportedly useful for predicting progression-free survival after primary androgen deprivation therapy of prostate cancer patients. This study validated the risk assessment at a single institution. Methods: We studied 255 prostate cancer patients given primary androgen deprivation therapy. Progression-free survival, cause-specific survival and overall survival were analyzed according to Japan Cancer of the Prostate Risk Assessment score-based risk classification. Cases with lymph node or distant metastases were subdivided by the risk classification. Results: Ages ranged from 50 to 90 years (median: 76.5). Observation periods were 2-199 (median: 46.5) months. Primary androgen deprivation therapy includes combined androgen blockade in 150 cases (58.8%), uncombined luteinizing hormone-releasing hormone agonist in 97 (38.0%) and uncombined anti-androgenic agent in 8 (3.2%). Risk classified by Japan Cancer of the Prostate Risk Assessment scores was low in 104 cases (40.8%), intermediate in 86 (33.7%) and high in 65 (25.5%). The 5-year/10-year progression-free survival rates were 100%/80.8% in the low-risk, 82.3%/69.5% in the intermediate-risk and 34.7%/16.5% in the high-risk group. The 5-year/10-year cause-specific survival rates were 100%/100% in the low-risk, 90.7%/58.2% in the intermediate-risk and 63%/30.8% in the high-risk group. The 5-year/10-year overall survival rates were 87.5%/78.5% in the low-risk, 76.2%/43.1% in the intermediate-risk and 54.9%/25.4% in the high-risk group. For lymph node metastasis, cause-specific survival differed minimally between the intermediate-and high-risk groups (P = 0.1118). For distant metastasis, cause-specific survival differed significantly between the intermediate-and high-risk groups (P = 0.0264). Conclusions: Japan Cancer of the Prostate Risk Assessment score-based risk classification is useful for predicting post-primary androgen deprivation therapy progression-free survival, cause-specific survival and overall survival. Subtyping patients based on Japan Cancer of the Prostate Risk Assessment scores is particularly useful for predicting cause-specific survival with distant metastasis from prostate cancer.	[Yamaguchi, Yuichiro; Hayashi, Yujiro; Ishizuya, Yu; Takeda, Ken; Nakai, Yasutomo; Arai, Yasuyuki; Nakayama, Masashi; Kakimoto, Ken-ichi; Nishimura, Kazuo] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Urol, Higashinari Ku, Osaka 5378511, Japan	Nishimura, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Urol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	nisimura-ka2@mc.pref.osaka.jp			Osaka foundation for the prevention of cancer and cardiovascular diseases	This work was supported by Osaka foundation for the prevention of cancer and cardiovascular diseases.	Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Abrahamsson PA, 2010, EUR UROL, V57, P49, DOI 10.1016/j.eururo.2009.07.049; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Hinotsu S, 2007, JPN J CLIN ONCOL, V37, P775, DOI 10.1093/jjco/hym098; Basaria S, 2006, CANCER, V106, P581, DOI 10.1002/cncr.21642; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Akaza H, 2010, PHARMACOLOGY, V85, P110, DOI 10.1159/000274486; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Fujimoto H, 2005, INT J UROL, V12, P46; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kitagawa Y, 2013, INT J UROL, V20, P708, DOI 10.1111/iju.12037; The Medical Research Council Prostate Cancer Working Party Investigators Group, 1997, BR J UROL, V79, P235	14	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					197	201		10.1093/jjco/hyu186		5	Oncology	Oncology	CC3DJ	WOS:000350224800009		
J	Kaneko, G; Miyajima, A; Yuge, K; Yazawa, S; Mizuno, R; Kikuchi, E; Jinzaki, M; Oya, M				Kaneko, Gou; Miyajima, Akira; Yuge, Kazuyuki; Yazawa, Satoshi; Mizuno, Ryuichi; Kikuchi, Eiji; Jinzaki, Masahiro; Oya, Mototsugu			Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						visceral obesity; obesity; renal cell carcinoma; clear cell renal cell carcinoma; recurrence-free survival	BODY-MASS INDEX; COMPUTED-TOMOGRAPHY; TUMOR NEPHRECTOMY; RISK-FACTORS; PROGNOSIS; IMPACT; EPIDEMIOLOGY; OVERWEIGHT; CANCER; FAT	Objective: To investigate the prognostic significance of visceral obesity to predict recurrence after curative surgery for Japanese patients with localized renal cell carcinoma. Methods: The data of 285 patients who underwent curative surgery for localized renal cell carcinoma were retrospectively reviewed. Median follow-up was 36.7 months. The association between visceral obesity and recurrence-free survival rate was evaluated using the Kaplan-Meier method and Cox regression models. Visceral fat area at the level of the umbilicus measured using pre-operative computed tomography was used as an index of visceral obesity. Results: Twenty-nine patients (10.2%) experienced recurrence. Five-year recurrence-free survival rates were 91.3% in high visceral fat area group (>= 120 cm(2)) and 76.9% in low visceral fat area group (<120 cm(2)) (P = 0.037); however, visceral fat area was not an independent predictor of recurrence-free survival in multivariate analysis. In the patients with clear cell renal cell carcinoma, 28 patients (11.6%) experienced recurrence. Five-year recurrence-free survival rates were 88.7% in high visceral fat area group and 71.0% in low visceral fat area group (P = 0.043), and visceral fat area was an independent predictor of recurrence-free survival (hazard ratio: 1.974, P = 0.042) as well as C-reactive protein, Fuhrman nuclear grade, tumor size and microvascular invasion. In patients with organ confined clear cell renal cell carcinoma in particular, visceral fat area was also a useful and independent predictor of recurrence-free survival (hazard ratio: 2.807, P = 0.038). Body mass index was not useful in either cohort. Conclusions: High visceral fat area was a positive predictive biomarker for better recurrence-free survival after curative surgeries for localized clear cell renal cell carcinomas; however, body mass index was not a predictor.	[Kaneko, Gou; Miyajima, Akira; Yuge, Kazuyuki; Yazawa, Satoshi; Mizuno, Ryuichi; Kikuchi, Eiji; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo 1608582, Japan; [Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 1608582, Japan	Miyajima, A (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	akiram@a8.keio.jp					Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; Wen Chi Pang, 2009, Public Health Nutr, V12, P497, DOI 10.1017/S1368980008002802; KVIST H, 1988, INT J OBESITY, V12, P249; Yoshizumi T, 1999, RADIOLOGY, V211, P283; Haferkamp A, 2008, BJU INT, V101, P1243, DOI 10.1111/j.1464-410X.2007.07375.x; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P603; Naya Y, 2010, UROL INT, V85, P30, DOI 10.1159/000318988; Noshiro H, 2003, ANN SURG, V238, P680, DOI 10.1097/01.sla.0000094302.51616.2a; Klinghoffer Z, 2009, EXPERT REV ANTICANC, V9, P975, DOI [10.1586/era.09.51, 10.1586/ERA.09.51]; Kamat AM, 2004, UROLOGY, V63, P46, DOI 10.1016/j.urology.2003.08.009; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Rasmuson T, 2004, ACTA ONCOL, V43, P744, DOI 10.1080/02841860410017260; TOKUNAGA K, 1983, INT J OBESITY, V7, P437; Lowrance WT, 2010, BJU INT, V105, P16, DOI 10.1111/j.1464-410X.2009.08706.x; Donat SM, 2006, J UROLOGY, V175, P46, DOI 10.1016/S0022-5347(05)00054-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Gaujoux S, 2012, ANN SURG ONCOL, V19, P2908, DOI 10.1245/s10434-012-2301-y; Steffens S, 2011, ONCOLOGIST, V16, P1565, DOI 10.1634/theoncologist.2011-0213; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Ather MH, 2010, INT UROL NEPHROL, V42, P299, DOI 10.1007/s11255-009-9636-8; Awakura Y, 2007, UROLOGY, V70, P50, DOI 10.1016/j.urology.2007.03.034; Ballian N, 2012, J SURG ONCOL, V105, P365, DOI 10.1002/jso.22031; Jeon HG, 2010, J UROLOGY, V183, P448, DOI 10.1016/j.juro.2009.10.004; Park YH, 2014, J UROLOGY, V192, P1043, DOI 10.1016/j.juro.2014.03.107; Parker AS, 2006, UROLOGY, V68, P741, DOI 10.1016/j.urology.2006.05.024; Rickles AS, 2012, J GASTROINTEST SURG, V17, P133; Saito K, 2010, EXPERT REV ANTICANC, V10, P1979, DOI [10.1586/era.10.192, 10.1586/ERA.10.192]; Schips L, 2004, J SURG ONCOL, V88, P57, DOI 10.1002/jso.20139; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Matsuzawa Y, 2002, CIRC J, V66, P987; Waalkes S, 2010, CANCER CAUSE CONTROL, V21, P1905, DOI 10.1007/s10552-010-9618-2	31	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					210	216		10.1093/jjco/hyu193		7	Oncology	Oncology	CC3DJ	WOS:000350224800011		
J	Iwamoto, M; Kawada, K; Hida, K; Hasegawa, S; Sakai, Y				Iwamoto, Masayoshi; Kawada, Kenji; Hida, Koya; Hasegawa, Suguru; Sakai, Yoshiharu			Adenocarcinoma arising at a colostomy site with inguinal lymph node metastasis: report of a case	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						colostomy site cancer; inguinal lymph node; metastasis; lymph node dissection	ABDOMINOPERINEAL RESECTION; CARCINOMA	Inguinal lymph node metastasis from adenocarcinoma arising at a colostomy site is extremely rare, and the significance of surgical resection for metastatic inguinal lymph nodes has not been established. An 82-year-old woman who had undergone abdominoperineal resection 27 years earlier was admitted to our hospital complaining of bleeding from a colostomy. Physical examination revealed that a tumor at the colostomy site directly invaded into the peristomal skin, and that a left inguinal lymph node was firm and swollen. Positron emission tomography/computed tomography scan demonstrated accumulation of F-18-fluorodeoxy glucose into both the colostomy tumor and the left swollen inguinal lymph node, while there was no evidence of metastasis to liver or lungs. She underwent open left hemicolectomy with wide local resection of the colostomy, and dissection of left inguinal lymph nodes. Histological diagnosis was a moderately differentiated adenocarcinoma that directly invaded into the surrounding skin and metastasized to the left inguinal lymph node. The patient has been followed up for >5 years without any sign of recurrence. In general, inguinal lymph node metastasis from colorectal cancers is regarded as a systemic disease with a poor prognosis, and so systemic chemotherapy and radiotherapy, but not surgical lymph node dissection, are recommended. Considering the lymphatic drainage route in the present case, inguinal lymph node metastasis does not represent a systemic disease but rather a sentinel nodal metastasis from adenocarcinoma at a colostomy site. Surgical dissection of metastatic inguinal lymph nodes should be considered to enable a favorable prognosis in the absence of distant metastasis to other organs.	[Iwamoto, Masayoshi; Kawada, Kenji; Hida, Koya; Hasegawa, Suguru; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Kawada, K (reprint author), 54 Shogoin Kawara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kkawada@kuhp.kyoto-u.ac.jp					Shibuya T, 2002, J GASTROENTEROL, V37, P387, DOI 10.1007/s005350200054; Gerard JP, 2001, CANCER, V92, P77, DOI 10.1002/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO;2-P; Kawada K, 2011, CANCER RES, V71, P1214, DOI 10.1158/0008-5472.CAN-10-3277; Chintamani Singhal V, 2007, WORLD J SURG ONCOL, V5, P52; DIDOLKAR MS, 1975, DIS COLON RECTUM, V18, P399, DOI 10.1007/BF02587431; Hamano T, 2010, COLORECTAL DIS, V12, pE200, DOI 10.1111/j.1463-1318.2009.02134.x; Kuo YH, 2012, JPN J CLIN ONCOL, V42, P753, DOI 10.1093/jjco/hys081; Kusunoki Masato, 1996, International Journal of Clinical Oncology, V1, P121, DOI 10.1007/BF02348279; Mourra N, 2014, GASTROENTEROLOGY, V146, P2; Okamoto N, 2009, INT SURG, V94, P54; Papaziogas B, 2006, Tech Coloproctol, V10, P365; Pisanu A, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-128; Sobin LH, 2009, INT UNION CANC UICC; TAKAMI M, 1983, DIS COLON RECTUM, V26, P50, DOI 10.1007/BF02554682; Tocchi A, 1999, DIS COLON RECTUM, V42, P1464, DOI 10.1007/BF02235048; Townley W, 2005, ANN R COLL SURG ENGL, V87, P6, DOI 10.1308/147870805X60798; Uehara M, 2007, JPN J CLIN ONCOL, V37, P230, DOI 10.1093/jjco/hym010	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					217	220		10.1093/jjco/hyu192		4	Oncology	Oncology	CC3DJ	WOS:000350224800012		
J	Ikeda, S; Yoshioka, H; Arita, M; Sakai, T; Sone, N; Nishiyama, A; Niwa, T; Hotta, M; Tanaka, T; Ishida, T				Ikeda, Satoshi; Yoshioka, Hiroshige; Arita, Machiko; Sakai, Takahiro; Sone, Naoyuki; Nishiyama, Akihiro; Niwa, Takashi; Hotta, Machiko; Tanaka, Tomohiro; Ishida, Tadashi			Interstitial lung disease induced by alectinib (CH5424802/RO5424802)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						alectinib; anaplastic lymphoma kinase; non-small cell lung cancer; interstitial lung disease; adverse event	RENAL-CELL CARCINOMA; CANCER; PNEUMONITIS; CRIZOTINIB; INHIBITOR; CH5424802; THERAPY	A 75-year-old woman with anaplastic lymphoma kinase (ALK)-rearranged Stage IV lung adenocarcinoma was administered the selective anaplastic lymphoma kinase inhibitor, alectinib, as a third-line treatment in a Phase 1-2 study. On the 102nd day, chest computed tomography showed diffuse ground glass opacities. Laboratory data revealed high serum levels of KL-6, SP-D and lactate dehydrogenase without any clinical symptoms. There was no evidence of infection. Marked lymphocytosis was seen in bronchoalveolar lavage fluid analysis, and transbronchial lung biopsy showed mild thickening of alveolar septa and lymphocyte infiltration. Interstitial lung disease was judged to be related to alectinib based on improvements in imaging findings and serum biomarkers after discontinuation of alectinib. To our knowledge, this is the first reported case of alectinib-induced interstitial lung disease. Alectinib is a promising drug for ALK-rearranged non-small cell lung cancer. Clinical trials of this selective anaplastic lymphoma kinase inhibitor will facilitate the meticulous elucidation of its long-term safety profile.	[Ikeda, Satoshi; Yoshioka, Hiroshige; Arita, Machiko; Sakai, Takahiro; Sone, Naoyuki; Nishiyama, Akihiro; Niwa, Takashi; Ishida, Tadashi] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama 7108602, Japan; [Hotta, Machiko] Kurashiki Cent Hosp, Dept Pathol, Okayama, Japan; [Tanaka, Tomohiro] Chugai Pharmaceut Co Ltd, Tokyo, Japan	Ikeda, S (reprint author), Kurashiki Cent Hosp, Dept Resp Med, Miwa 1-1-1, Kurashiki, Okayama 7108602, Japan.	isatoshi0112@gmail.com00		Ikeda, Satoshi/0000-0001-5203-7911	Chugai Pharmaceutical Co., Ltd. [AF-001JP]	This patient was included in a multicenter, single-arm, open-label, Phase 1-2 trial (AF-001JP) that was sponsored by Chugai Pharmaceutical Co., Ltd.	Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Tamiya A, 2013, J CLIN ONCOL, V31, pE15, DOI 10.1200/JCO.2012.43.3730; White DA, 2010, AM J RESP CRIT CARE, V182, P396, DOI 10.1164/rccm.200911-1720OC; Maroto JP, 2011, J CLIN ONCOL, V29, P1750, DOI 10.1200/JCO.2010.29.2235; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Pfizer Japan Inc, 2014, PROGR SPEC DRUG US S	11	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					221	224		10.1093/jjco/hyu183		4	Oncology	Oncology	CC3DJ	WOS:000350224800013		
J	Yamazaki, F; Osumi, T; Shigematsu, N; Morioka, H; Shimada, H				Yamazaki, Fumito; Osumi, Tomoo; Shigematsu, Naoyuki; Morioka, Hideo; Shimada, Hiroyuki			Successful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						rhabdomyosarcoma; stem cell transplantation; chemotherapy	PROGNOSTIC-FACTORS; INTERGROUP RHABDOMYOSARCOMA	We report a case of a 21-year-old man with alveolar rhabdomyosarcoma primarily in the right hand with lymph node, lung, bone and bone marrow metastases. Complete remission was achieved after intensive chemotherapy and radiotherapy of the primary and metastatic sites, followed by allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning from a single HLA-DR locus-mismatched mother. The patient remained relapse-free for 41 months after the diagnosis. Considering that the conventional treatment for rhabdomyosarcoma with multiple risk factors (old age, bone or bone marrow involvement, unfavorable primary sites and >= 3 metastases) is associated with a poor prognosis (5% probability of a 3-year event-free survival), the graft-versus-tumor effect may have contributed to his sustained relapse-free survival. Allogeneic hematopoietic stem cell transplantation for rhabdomyosarcoma should be done by experienced clinical oncologists on properly designed controlled trials.	[Yamazaki, Fumito; Osumi, Tomoo; Shimada, Hiroyuki] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Shigematsu, Naoyuki] Keio Univ, Sch Med, Dept Radiol, Tokyo 1608582, Japan; [Morioka, Hideo] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan	Shimada, H (reprint author), Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hshimada@a5.keio.jp					Admiraal R, 2010, COCHRANE DB SYST REV, V12; CRIST W, 1995, J CLIN ONCOL, V13, P610; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; Ringden O, 2009, BRIT J HAEMATOL, V147, P614, DOI 10.1111/j.1365-2141.2009.07886.x; Thiel U, 2013, BRIT J CANCER, V109, P2523, DOI 10.1038/bjc.2013.630; Pappo AS, 2007, J CLIN ONCOL, V25, P362, DOI 10.1200/JCO.2006.07.1720; Carli M, 2004, J CLIN ONCOL, V22, P4787, DOI 10.1200/JCO.2004.04.083; Donker AE, 2009, BONE MARROW TRANSPL, V43, P179, DOI 10.1038/bmt.2008.301; Ohta H, 2011, J PEDIAT HEMATOL ONC, V33, pE35, DOI 10.1097/MPH.0b013e3181e7ddc5	10	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					225	228		10.1093/jjco/hyu189		4	Oncology	Oncology	CC3DJ	WOS:000350224800014		
J	Nagashima, K; Iwasa, S; Yanai, T; Hashimoto, H; Suzuki, K; Ohyanagi, F; Shimada, Y; Yamamoto, N				Nagashima, Kengo; Iwasa, Satoru; Yanai, Takako; Hashimoto, Hironobu; Suzuki, Kenichi; Ohyanagi, Fumiyoshi; Shimada, Yasuhiro; Yamamoto, Noboru			A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						olanzapine; highly emetogenic chemotherapy; nausea; vomiting	PLACEBO-CONTROLLED TRIAL; HIGH-DOSE CISPLATIN; ANTAGONIST APREPITANT; INDUCED NAUSEA	A randomized Phase II dose-finding trial comparing olanzapine 10 mg with olanzapine 5 mg for patients receiving highly emetogenic chemotherapy with cisplatin was started in June 2014. The purpose of the trial is to evaluate the efficacy and safety of the two olanzapine doses and to determine which is more promising as a test arm for comparison with the current standard antiemetic care (a combination of aprepitant, a 5-HT3 receptor antagonist and dexamethasone) in a subsequent Phase III trial. Patients receiving cisplatin-containing regimens will be randomized to the olanzapine 10 or 5 mg arm. A total of 150 patients will be accumulated from nine institutions over 2 years. The primary endpoint is complete response defined as no emetic episodes and no use of rescue medications in the delayed (24-120 h) phase. This trial has been registered at the UMIN Clinical Trials Registry as UMIN000014214.	[Nagashima, Kengo] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Iwasa, Satoru; Yanai, Takako; Hashimoto, Hironobu; Shimada, Yasuhiro; Yamamoto, Noboru] Natl Canc Ctr, Tokyo 1040045, Japan; [Suzuki, Kenichi; Ohyanagi, Fumiyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan	Yamamoto, N (reprint author), Natl Canc Ctr, Dept Expt Therapeut, Exploratory Oncol Res & Clin Trial Ctr, Dept Thorac Oncol,Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	nbryamam@ncc.go.jp	Nagashima, Kengo/I-1726-2013	Nagashima, Kengo/0000-0003-4529-9045	Foundation for Promotion of Cancer Research in Japan	This study is supported by the Foundation for Promotion of Cancer Research in Japan.	Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; Hashimoto H, 2013, J CLIN ONCOL S, V31; LECOUTRE B, 1995, STAT MED, V14, P1057, DOI 10.1002/sim.4780140924; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002	7	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					229	231		10.1093/jjco/hyu191		3	Oncology	Oncology	CC3DJ	WOS:000350224800015		
J	Mihara, K; Yamamoto, Y; Sasaki, K; Uesaka, K				Mihara, Kisyo; Yamamoto, Yusuke; Sasaki, Keiko; Uesaka, Katsuhiko			A case of pancreaticobiliary fistula associated with an intraductal papillary mucinous neoplasm of the pancreas	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Mihara, Kisyo; Yamamoto, Yusuke; Uesaka, Katsuhiko] Shizuoka Canc Ctr Hosp, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan; [Sasaki, Keiko] Shizuoka Canc Ctr Hosp, Div Pathol, Shizuoka, Japan	Yamamoto, Y (reprint author), Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, 1007 Shimo Nagakubo, Shizuoka 4118777, Japan.	yusu.yamamoto@scchr.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	FEB	2015	45	2					232	232		10.1093/jjco/hyu217		1	Oncology	Oncology	CC3DJ	WOS:000350224800016		
J	Takesue, Y; Ueda, T; Mikamo, H; Oda, S; Takakura, S; Kitagawa, Y; Kohno, S				Takesue, Yoshio; Ueda, Takashi; Mikamo, Hiroshige; Oda, Shigeto; Takakura, Shunji; Kitagawa, Yuko; Kohno, Shigeru		ACTIONs Project	Management bundles for candidaemia: the impact of compliance on clinical outcomes	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article						candidiasis; guidelines; intravenous catheters; invasive disease; fungal infections	LENGTH-OF-STAY; INVASIVE CANDIDIASIS; SEPTIC SHOCK; SURVIVING SEPSIS; ATTRIBUTABLE MORTALITY; AMPHOTERICIN-B; ADULT PATIENTS; CANDIDEMIA; THERAPY; SURVEILLANCE	Objectives: The Mycoses Forum in Japan has developed management bundles for candidaemia to incorporate into bedside practice. The aim of this study was to investigate nationwide compliance with the bundles and their impact on clinical outcomes. Methods: Non-neutropenic patients treated with antifungals for candidaemia were surveyed. Bundles consist of nine items to complete. Data were sent to the central office between July 2011 and April 2012. Results: Six hundred and eight patients were analysed. The compliance rate for achieving all elements was 6.9%, and it increased to 21.4% when compliance was analysed by the bundle except for oral switch. There was a significant difference in clinical success between patients with and without compliance [92.9% versus 75.8% (P = 0.011)]. Compliance with the bundles, however, failed to be an independent factor associated with favourable outcomes. When step-down oral therapy was excluded from the elements of compliance, compliance with the bundles was revealed to be an independent predictor of clinical success (OR 4.42, 95% CI 2.05-9.52) and mortality (OR 0.27, 95% CI 0.13-0.57). Independent individual elements contributing to clinical success were removal of central venous catheters within 24 h, assessment of clinical efficacy on the third to the fifth day and at least 2 weeks of therapy after clearance of candidaemia. Conclusions: Compliance with the bundles for candidaemia had a beneficial effect on clinical outcomes. Promotion of the bundles approach may have the potential to narrow the gap between clinical evidence and bedside practice.	[Takesue, Yoshio; Mikamo, Hiroshige; Oda, Shigeto; Takakura, Shunji; Kitagawa, Yuko; Kohno, Shigeru] ACT Project Comm Mycoses Forum, Minato Ku, Tokyo 1058320, Japan; [Takesue, Yoshio; Ueda, Takashi] Hyogo Coll Med, Dept Infect Prevent & Control, Nishinomiya, Hyogo 6638501, Japan	Takesue, Y (reprint author), Hyogo Coll Med, Dept Infect Prevent & Control, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	takesuey@hyo-med.ac.jp			Pfizer Japan Inc.; MSD K.K.; Astellas Pharma Inc.; Dainippon Sumitomo Pharma; Shionogi Co., Ltd; Takeda Pharmaceutical Co., Ltd; Daiichi Sankyo Co., Ltd; Meiji Seika Pharma Co., Ltd; Taisho Toyama Pharmaceutical Co., Ltd; Chugai Pharmaceutical Co., Ltd; AstraZeneca; Eisai Co., Ltd; Otsuka Pharmaceutical Co., Ltd; Ono Pharmaceutical Co., Ltd; Taiho Pharmaceutical Co.; Boehringer Ingelheim; Toyama Chemical Co., Ltd; Shionogi Co., Ltd.	Y. T. has received grant support from Pfizer Japan Inc., MSD K.K., Astellas Pharma Inc., Dainippon Sumitomo Pharma, Shionogi & Co., Ltd and Takeda Pharmaceutical Co., Ltd, and payment for lectures from Pfizer Japan Inc., Astellas Pharma Inc., Daiichi Sankyo Co., Ltd, Meiji Seika Pharma Co., Ltd, MSD K.K., Taisho Toyama Pharmaceutical Co., Ltd and Dainippon Sumitomo Pharma. S.T. has received grant support from Pfizer Japan Inc. and Shionogi & Co., Ltd, and payment for lectures from Pfizer Japan Inc., Shionogi & Co., Ltd, Astellas Pharma Inc., Daiichi Sankyo Co., Ltd, MSD K.K. and Dainippon Sumitomo Pharma. Y. K. has received grants and payment for lectures from Pfizer Japan Inc. S.K. has received grants from Pfizer Japan Inc., MSD K. K., Astellas Pharma, Inc., Dainippon Sumitomo Pharma Co., Ltd, Taisho Toyama Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, Meijiseika Pharma Co., Ltd, Takeda Pharmaceutical Company Limited, Shionigi & Co., Ltd, Chugai Pharmaceutical Co., Ltd, AstraZeneca, Eisai Co., Ltd, Otsuka Pharmaceutical Co., Ltd, Ono Pharmaceutical Co., Ltd and Taiho Pharmaceutical Co., and payment for lectures from Taisho Toyama Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, Boehringer Ingelheim, Chugai Pharmaceutical Co., Ltd, Toyama Chemical Co., Ltd and Shionogi & Co., Ltd. All other authors: none to declare.	Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Lashof AMLO, 2011, CLIN INFECT DIS, V53, P262, DOI 10.1093/cid/cir355; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Desai M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-94; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Lashof AMLO, 2003, EUR J CLIN MICROBIOL, V22, P43, DOI 10.1007/s10096-002-0854-6; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Antworth A, 2013, PHARMACOTHERAPY, V33, P137, DOI 10.1002/phar.1186; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI [10.1097/CCM.0b013e3181d455b6, 10.1097/CCM.0b0bl3e3181d455b6]; Hsu DI, 2010, J ANTIMICROB CHEMOTH, V65, P1765, DOI 10.1093/jac/dkq216; Mycoses Forum Task Force on the Guidelines of Deep-Seated Mycoses, 2007, GUID DIAGN MAN DEEP; REX JH, 1995, CLIN INFECT DIS, V21, P994; Vazquez J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-97	22	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	FEB	2015	70	2					587	593		10.1093/jac/dku414		7	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CC2YR	WOS:000350211600033		
J	Kuroda, K; Uchida, T; Nagai, S; Ozaki, R; Yamaguchi, T; Sato, Y; Brosens, JJ; Takeda, S				Kuroda, Keiji; Uchida, Toyoyoshi; Nagai, Saki; Ozaki, Rie; Yamaguchi, Takashi; Sato, Yuichi; Brosens, Jan J.; Takeda, Satoru			Elevated serum thyroid-stimulating hormone is associated with decreased anti-Mullerian hormone in infertile women of reproductive age	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Infertility; Hypothyroidism; Anti-Mullerian hormone; Ovarian reserve; Retrospective study	OVARIAN RESERVE; SUBCLINICAL HYPOTHYROIDISM; FOLLICULAR DEVELOPMENT; PREGNANCY; ENDOMETRIOSIS; FERTILIZATION; THYROTROPIN; DYSFUNCTION; OUTCOMES; RAT	Thyroid dysfunction and autoimmune thyroiditis are associated with fertility in women of reproductive age. Anti-Mullerian hormone (AMH), a known biomarker of ovarian function, may be affected by impaired thyroid function; however, the relationship between AMH and thyroid hormone has not been elucidated. In this case-control study, to identify the impact of thyroid hormone on ovarian reserve, we recruited 67 consecutive Japanese infertile patients and 27 normal fertile women aged 30-39 years without impact factors on thyroid and ovarian functions between 2012 and 2013. We assessed patient age, BMI and AMH, prolactin, TSH and FT4 levels of all study participations as independent variables. To evaluate the relationship between AMH and thyroid hormone, we matched patients by age and body mass index as confounding factors using 1:1 matching for statistical analysis of healthy fertile women and infertile patients and obtained 23 pairs. Then, independent variables were subjected to multiple regression analysis. Multiple regression analysis showed that both thyroid-stimulating hormone (TSH) levels and patient age were negatively correlated with AMH levels in infertile patients (patient age and TSH: standardized partial regression coefficient (beta), -0.534 and -0.361; p = 0.003 and 0.036, respectively), but not in normal fertile women. AMH levels were inversely correlated with TSH levels in infertile women of reproductive age.	[Kuroda, Keiji; Nagai, Saki; Ozaki, Rie; Yamaguchi, Takashi; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138421, Japan; [Uchida, Toyoyoshi] Juntendo Univ, Fac Med, Dept Metab, Bunkyo Ku, Tokyo 1138421, Japan; [Uchida, Toyoyoshi] Juntendo Univ, Fac Med, Dept Endocrinol, Bunkyo Ku, Tokyo 1138421, Japan; [Sato, Yuichi] Tatedebari Sato Hosp, Dept Obstet & Gynecol, Takasaki, Gunma 3700836, Japan; [Brosens, Jan J.] Warwick Med Sch, Div Reprod Hlth, Clin Sci Res Labs, Coventry CV2 2DX, W Midlands, England	Kuroda, K (reprint author), Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	arthur@juntendo.ac.jp					Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052; Penzias AS, 2012, FERTIL STERIL, V97, P1033, DOI 10.1016/j.fertnstert.2012.03.017; Kitajima M, 2011, FERTIL STERIL, V95, P2589, DOI 10.1016/j.fertnstert.2011.01.036; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Fedail JS, 2014, ENDOCRINE, V46, P594, DOI 10.1007/s12020-013-0092-y; Rahman AHA, 2010, ENDOCR PRACT, V16, P792, DOI 10.4158/EP09365.OR; Michalakis KG, 2011, FERTIL STERIL, V95, P2634, DOI 10.1016/j.fertnstert.2011.02.056; Hirokawa W, 2011, HUM REPROD, V26, P904, DOI 10.1093/humrep/der006; Kitajima M, 2011, FERTIL STERIL, V96, P685, DOI 10.1016/j.fertnstert.2011.06.064; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Colicchia M, 2014, HUM REPROD UPDATE, V20, P884, DOI 10.1093/humupd/dmu028; Cook-Andersen H, 2014, J CLIN ENDOCRINOL ME; Cramer DW, 2003, J ASSIST REPROD GEN, V20, P210, DOI 10.1023/A:1024151210536; Dijkstra G, 1996, EUR J ENDOCRINOL, V134, P649; GERHARD I, 1991, GYNECOL ENDOCRINOL, V5, P15, DOI 10.3109/09513599109049938; GERHARD I, 1991, HUM REPROD, V6, P338; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kuroda M, 2012, J OBSTET GYNAECOL RE, V38, P1187, DOI 10.1111/j.1447-0756.2012.01845.x; MEHENDALE RG, 1995, ENDOCRINE, V3, P215, DOI 10.1007/BF02994446; La Marca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057005; te Velde Egbert R., 2002, Human Reproduction Update, V8, P141, DOI 10.1093/humupd/8.2.141; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061947	25	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	FEB	2015	32	2					243	247		10.1007/s10815-014-0397-7		5	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CC4XP	WOS:000350359400011		
J	Takae, S; Sugishita, Y; Yoshioka, N; Hoshina, M; Horage, Y; Sato, Y; Nishijima, C; Kawamura, K; Suzuki, N				Takae, Seido; Sugishita, Yodo; Yoshioka, Nobuhito; Hoshina, Mariko; Horage, Yuki; Sato, Yorino; Nishijima, Chie; Kawamura, Kazuhiro; Suzuki, Nao			The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Combined procedure; Ovarian tissue cryopreservation; Oncofertility; Fertility preservation; In virto maturation; Breast cancer	IN-VITRO MATURATION; FERTILITY PRESERVATION; IMMATURE OOCYTES; WOMEN; RETRIEVAL; VITRIFICATION; STIMULATION; STRATEGIES; AMENORRHEA; TUMORS	To determine the factors that affect oocyte extraction efficiency when using the "combined procedure". In the present "combined procedure" ovarian tissue cryopreservation and oocyte extraction from an isolated ovary, later used in In Vitro Maturation (IVM), are performed concurrently. Data were analyzed retrospectively and obtained from the clinical records of 27 young breast cancer patients referred for fertility preservation. The patients' mean age was 33.7 (+/- 3.8) years, mean serum anti-Mullerian hormone (AMH) concentration was 3.5 (+/- 2.1) ng/ml, and mean number of extracted oocytes was 8.3 (+/- 6.1). The phase of menstruation (follicular or luteal) did not affect either the number of oocytes extracted (P = 0.99) nor oocyte survival or maturation rates. Likewise, the number of oocytes that could be extracted was not affected by the type of laparoscopic procedure (multiple-port or single-incision laparoscopy; P = 0.94) or the molecular subtype of breast cancer (either Luminal A or B; P = 0.52). Analysis revealed that the number of extracted oocytes was well-correlated with the patient's AMH serum level and age (coefficient of correlation: 0.60 and -0.48, respectively). We conclude that the outcome of the "combined procedure" primarily depends upon the patient's serum AMH level and age. Importantly, the "combined procedure" may be used during any phase of the menstrual cycle to preserve the fertility of breast cancer patients.	[Takae, Seido; Sugishita, Yodo; Yoshioka, Nobuhito; Hoshina, Mariko; Horage, Yuki; Sato, Yorino; Nishijima, Chie; Kawamura, Kazuhiro; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan	Suzuki, N (reprint author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan.	nao@marianna-u.ac.jp					Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; von Wolff M, 2009, FERTIL STERIL, V92, P1360, DOI 10.1016/j.fertnstert.2008.08.011; Huang JYJ, 2010, AM J SURG, V200, P177, DOI 10.1016/j.amjsurg.2009.04.004; Huser M, 2012, EUR J GYNAECOL ONCOL, V33, P42; Suzuki N, 2012, HUM REPROD, V27, P2420, DOI 10.1093/humrep/des178; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Chung K, 2013, FERTIL STERIL, V99, P1534, DOI 10.1016/j.fertnstert.2012.11.057; Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674; Maman E, 2011, FERTIL STERIL, V95, P64, DOI 10.1016/j.fertnstert.2010.06.064; Abusief ME, 2010, CANCER-AM CANCER SOC, V116, P791, DOI 10.1002/cncr.24835; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; von Wolff M, 2012, DTSCH ARZTEBL INT, V109, P220, DOI 10.3238/arztebl.2012.0220; Escriba MJ, 2012, J ASSIST REPROD GEN, V29, P1261, DOI 10.1007/s10815-012-9860-5; von Wolff M, 2011, ARCH GYNECOL OBSTET, V284, P427, DOI 10.1007/s00404-011-1874-1; Cakmak H, 2013, FERTIL STERIL, V100, P1673, DOI 10.1016/j.fertnstert.2013.07.1992; Fadini R, 2009, REPROD BIOMED ONLINE, V19, P343; Chian Ri-Cheng, 2002, Reprod Biomed Online, V4, P127; Huang JYJ, 2008, FERTIL STERIL, V89, P567, DOI 10.1016/j.tertnstert.2007.03.090; Kedem A, 2013, J ASSIST REPROD GEN, V30, P745, DOI 10.1007/s10815-013-9996-y; Kikuchi I, 2013, SURG INNOV, V20, P219, DOI 10.1177/1553350612449074; Shien T, 2014, BREAST CANCER-TOKYO, V21, P651, DOI 10.1007/s12282-013-0463-5; Sonmezer M, 2011, FERTIL STERIL, V95, DOI DOI 10.1016/J.FERTNSTERT.2011.01.121	22	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	FEB	2015	32	2					305	312		10.1007/s10815-014-0392-z		8	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CC4XP	WOS:000350359400020		
J	Nishidate, I; Mizushima, C; Yoshida, K; Kawauchi, S; Sato, S; Sato, M				Nishidate, Izumi; Mizushima, Chiharu; Yoshida, Keiichiro; Kawauchi, Satoko; Sato, Shunichi; Sato, Manabu			In vivo estimation of light scattering and absorption properties of rat brain using a single-reflectance fiber probe during cortical spreading depression	JOURNAL OF BIOMEDICAL OPTICS			English	Article						diffuse reflectance spectroscopy; Monte Carlo simulation; absorption coefficient; reduced scattering coefficient; tissue oxygen saturation; cortical spreading depression; local field potential; hemodynamics	TISSUE OPTICAL-PROPERTIES; DIFFUSE-REFLECTANCE; PERIINFARCT DEPOLARIZATIONS; NONINVASIVE DETERMINATION; BLOOD-FLOW; SPECTROSCOPY; SLICES; HYPOPERFUSION; REFLECTOMETRY; COEFFICIENTS	Diffuse reflectance spectroscopy using a fiber optic probe is a promising technique for evaluating the optical properties of biological tissue. We herein present a method for determining the reduced scattering coefficient, mu(s)', the absorption coefficient, mu(a), and the tissue oxygen saturation, StO(2), of in vivo brain tissue using a single-reflectance fiber probe with two source-collector geometries. We performed in vivo recordings of diffuse reflectance spectra and of the electrophysiological signals for exposed rat brain during the cortical spreading depression evoked by the topical application of KCl. The time courses of mu(a) at 500, 570, and 584 nm indicated the hemodynamic change in the cerebral cortex as well as StO(2). At 570 nm, the time course of mu(s)' was well correlated with that of mu(a), which also reflects the scattering by RBCs. On the other hand, increases in mu(s)' at 500 and 584 nm and a decrease in mu(s)' at 800 nm were observed before the profound increase in mu(a), and these occurrences were synchronized with the negative dc shift of the local field potential. The resultant change in the slope of mu(s)'(lambda) is indicative of the morphological changes in the cellular and subcellular structures induced by the depolarization due to the temporal depression of the neuronal bioelectrical activity. The results of the present study indicate the potential application of the proposed method in evaluating the pathophysiological conditions of in vivo brain. (C) The Authors.	[Nishidate, Izumi; Mizushima, Chiharu; Yoshida, Keiichiro] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan; [Sato, Manabu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Nishidate, I (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	inishi@cc.tuat.ac.jp			Japanese Society for the Promotion of Science	The present study was supported, in part, by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science.	VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Lin SP, 1997, APPL OPTICS, V36, P136, DOI 10.1364/AO.36.000136; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Kim A, 2010, OPT EXPRESS, V18, P5580, DOI 10.1364/OE.18.005580; WANG LH, 1995, APPL OPTICS, V34, P2362, DOI 10.1364/AO.34.002362; Utzinger U, 2003, J BIOMED OPT, V8, P121, DOI 10.1117/1.1528207; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Bargo PR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921907; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Friebel M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127200; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; Pifferi A, 2005, APPL OPTICS, V44, P2104, DOI 10.1364/AO.44.002104; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Lo JY, 2009, OPT EXPRESS, V17, P1372, DOI 10.1364/OE.17.001372; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; GRAAFF R, 1992, APPL OPTICS, V31, P1370, DOI 10.1364/AO.31.001370; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Bonhoeffer T., 1996, BRAIN MAPPING METHOD; Chen SB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203654; Fang H, 2003, IEEE J SEL TOP QUANT, V9, P267, DOI 10.1109/JSTQE.2003.812515; Fishkin JB, 1997, APPL OPTICS, V36, P10, DOI 10.1364/AO.36.000010; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Guiou M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852556; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Ishimaru A., 1978, WAVE PROPAGATION SCA; Jacques S. L., 2014, SOME BIOL SCATTERES; Jacques S. L., 1993, MED OPTICAL TOMOGRAP, P211; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kohl M, 1998, OPT LETT, V23, P555, DOI 10.1364/OL.23.000555; Moffitt TP, 2001, IEEE J SEL TOP QUANT, V7, P952, DOI 10.1109/2944.983299; Mulvey CS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259363; Nishidate I, 2010, APPL OPTICS, V49, P6617, DOI 10.1364/AO.49.006617; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Tuchin V. V., 2007, TISSUE OPTICS LIGHT; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yu B, 2008, OPT LETT, V33, P1783, DOI 10.1364/OL.33.001783	46	1	1	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	FEB	2015	20	2							027003	10.1117/1.JBO.20.2.027003		13	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CC6GI	WOS:000350462900020		
J	Mineta, S; Murayama, K; Sugimori, D				Mineta, Shingo; Murayama, Kazutaka; Sugimori, Daisuke			Characterization of glycerophosphoethanolamine ethanolaminephosphodiesterase from Streptomyces sanglieri	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Glycerophosphoethanolamine ethanolaminephosphodiesterase; Purification; Characterization; Molecular cloning; Expression; Streptomyces sanglieri	PHOSPHOLIPASES-C; GLYCEROPHOSPHOCHOLINE CHOLINEPHOSPHODIESTERASE; PHOSPHODIESTERASE ACTIVITY; EXTRACELLULAR PRODUCTION; MOLECULAR-CLONING; RAT-BRAIN; PROTEIN; PURIFICATION; SUPERFAMILY; LIVIDANS	Streptomyces sanglieri extracellularly produces a glycerophosphoethanolamine ethanolaminephosphodiesterase (GPE-EP). The gene encoding the enzyme was found to consist of a 2124-bp ORF, which codes for an N-terminal 48 residue signal peptide required for secretion and a 660 amino acid mature protein with a calculated molecular mass of 72,918 Da. The maximum activity for sn-glycero-3-phosphoethanolamine (GPE) was found at pH 8.4 and 65 degrees C in the presence of 0.1% (w/v) Triton X-100. The enzyme was activated in the presence of 2 mM EDTA; however, Zn2+ remarkably inhibited activity. During the hydrolysis of GPE at 65 degrees C and pH 8.4, the apparent V-max, turnover number (k(cat)) and K-m were determined to be 0.430 mmol min(-1) mg-protein(-1), 522 s(-1) and 0.785 mM, respectively. The enzyme exhibited specificity toward GPE and hydrolyzed ethanolamine-type substrates such as 1,2-dihexanoyl-sn-glycero-3-phosphoe-thanolamine, lysophosphatidylethanolamine and ethanolamine lysoplasmalogen, but not 1-pahnitoy1-2-oleoyl-snglycero-3-phosphoe-thanolamine. Moreover, the enzyme showed no activity toward other phospholipids, such as glycerophospholipids and plasmalogens, and sn-glycero-3-phosphodiesters except for sn-glycero-3-phosphoglycerol, suggesting that GPE-EP is not a phospholipase C (PLC). However, the amino acid sequence of GPE-EP shows 86% identity to that of PLC from Streptomyces sp. SirettAA-E (UniProt accession no. G2NFN1). Recombinant GPE-EP was functionally expressed in Escherichia colt using pET-24a(+). GPE hydrolysis by GPE-EP may represent a new pathway for phosphatidylethanolamine metabolism. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Mineta, Shingo; Sugimori, Daisuke] Fukushima Univ, Grad Sch Symbiot Syst Sci & Technol, Dept Symbiot Syst Sci & Technol, Fukushima 9601296, Japan; [Murayama, Kazutaka] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Aoba Ku, Sendai, Miyagi 9808575, Japan	Sugimori, D (reprint author), Fukushima Univ, Grad Sch Symbiot Syst Sci & Technol, Dept Symbiot Syst Sci & Technol, 1 Kanayagawa, Fukushima 9601296, Japan.	sugimori@sss.fukushima-u.ac.jp					ABRA RM, 1976, BIOCHIM BIOPHYS ACTA, V431, P631, DOI 10.1016/0005-2760(76)90227-7; Alauddin M, 2009, Journal of Applied Sciences, V9, DOI 10.3923/jas.2009.2301.2306; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; Felts RL, 2006, J BIOL CHEM, V281, P30289, DOI 10.1074/jbc.M606391200; Ogino C, 2004, APPL MICROBIOL BIOT, V64, P823, DOI 10.1007/s00253-003-1552-8; Sugimori D, 2014, J BIOSCI BIOENG, V117, P422, DOI 10.1016/j.jbiosc.2013.10.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; Sugimori D, 2009, J BIOSCI BIOENG, V108, P293, DOI 10.1016/j.jbiosc.2009.04.013; Sugimori D, 2012, FEBS OPEN BIO, V2, P318, DOI 10.1016/j.fob.2012.09.006; CARMAN GM, 1995, J BIOL CHEM, V270, P18711; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; Behera K, 2007, J COLLOID INTERF SCI, V307, P235, DOI 10.1016/j.jcis.2006.11.009; TITBALL RW, 1993, MICROBIOL REV, V57, P347; Costas MJ, 2010, MOL MICROBIOL, V78, P1556, DOI 10.1111/j.1365-2958.2010.07425.x; Dennis E. A., 1983, ENZYMES, V16, P307; ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V837, P325, DOI 10.1016/0005-2760(85)90056-6; KANFER JN, 1989, J NEUROSCI RES, V24, P231, DOI 10.1002/jnr.490240214; Kieser T., 2000, PRACTICAL STREPTOMYC; Liithy R, 1992, NATURE, V356, P83, DOI DOI 10.1038/356083A0; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SOK DE, 1992, BIOCHEM J, V286, P435; Sugimori D, 2011, BIOTECHNOL LETT, V33, P727, DOI 10.1007/s10529-010-0480-9	28	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					123	130		10.1016/j.jbiosc.2014.07.005		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100001		
J	Nomura, T; Suganuma, M; Higa, Y; Kataoka, Y; Funaguma, S; Okazaki, H; Suzuki, T; Kobayashi, I; Sezutsu, H; Fujiyama, K				Nomura, Tsuyoshi; Suganuma, Masatoshi; Higa, Yukiko; Kataoka, Yukiko; Funaguma, Shunsuke; Okazaki, Hironobu; Suzuki, Takeo; Kobayashi, Isao; Sezutsu, Hideki; Fujiyama, Kazuhito			Improvement of glycosylation structure by suppression of beta-N-acetylglucosaminidases in silkworm	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						beta-N-Acetylglucosaminidase; Fused lobes; Transgenic silkworm; Baculovirus; N-Glycan processing; RNA interference	NUCLEAR-POLYHEDROSIS-VIRUS; BOMBYX-MORI LARVAE; LOBES GENE ENCODES; INSECT CELLS; DROSOPHILA-MELANOGASTER; RECOMBINANT PROTEINS; EXPRESSION; PURIFICATION; SYSTEM; GLYCANS	The baculovirus-silkworm recombinant protein expression system is an excellent method for achieving high-level expression and post-translational modifications, especially glycosylation. However, the presence of paucimannosidic-type N-glycan in glycoproteins restricts their clinical use. Paucimannosidic-type N-glycan is produced by insect-specific membrane-binding-type beta-N-acetylglucosaminidase (GlcNAcase). In the silkworm, BmGlcNAcasel, BmGlcNAcase2, and BmFDL are membrane-binding-type GlcNAcases. We investigated the localization of these GlcNAcases and found that BmFDL and BmGlcNAcase2 were mainly located in the fat body and hemolymph, respectively. The fat body is the main tissue of recombinant protein expression by baculovirus, and many glycoproteins are secreted into the hemolymph. These results suggest that inhibition of BmFDL and BmGlcNAcase2 could increase GlcNAc-type N-glycan levels. We therefore injected a GlcNAcase inhibitor into silkworms to investigate changes in the N-glycan structure of the glycoprotein expressed by baculovirus; modest levels of GlcNAc-type N-glycan were observed (0.8% of total N-glycan). Next, we generated a transgenic silkworm in which RNA interference (RNAi) reduced the BmFDL transcript level and enzyme activity to 25% and 50%, respectively, of that of the control silkworm. The proportion of GlcNAc-type N-glycan increased to 4.3% in the RNAi-transgenic silkworm. We conclude that the structure of N-glycan can be changed by inhibiting the GlcNAcases in silkworm. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Nomura, Tsuyoshi; Suganuma, Masatoshi; Higa, Yukiko; Kataoka, Yukiko; Funaguma, Shunsuke; Okazaki, Hironobu; Suzuki, Takeo] Sysmex Corp, Prot Dev Ctr, Sayama, Saitama 3501332, Japan; [Kobayashi, Isao; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Nomura, Tsuyoshi; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5658071, Japan	Nomura, T (reprint author), Sysmex Corp, Prot Dev Ctr, 1548 Simo Okudomi, Sayama, Saitama 3501332, Japan.	Nomura.Tsuyoshi@sysmex.co.jp					Suzuki T, 1997, J GEN VIROL, V78, P3073; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ailor E, 2000, GLYCOBIOLOGY, V10, P837, DOI 10.1093/glycob/10.8.837; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415; Hollister JR, 2001, GLYCOBIOLOGY, V11, P1; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; NAGAMATSU Y, 1995, BIOSCI BIOTECH BIOCH, V59, P219; Geisler C, 2012, J BIOL CHEM, V287, P7084, DOI 10.1074/jbc.M111.296814; Perotti ME, 2001, MOL REPROD DEV, V60, P248, DOI 10.1002/mrd.1085; Zen KC, 1996, INSECT BIOCHEM MOLEC, V26, P435, DOI 10.1016/0965-1748(95)00111-5; ALTMANN F, 1995, J BIOL CHEM, V270, P17344; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Imamura M, 2003, GENETICS, V165, P1329; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.biotec.2006.07.012; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; BADE ML, 1962, BIOCHEM J, V83, P470; Cattaneo F, 2002, INSECT BIOCHEM MOLEC, V32, P929, DOI 10.1016/S0965-1748(02)00031-0; Cattaneo F, 2006, CINEFORUM, V46, P16; Harlow E., 1988, ANTIBODIES LAB MANUA, P139; Kamezaki Y, 2010, PROTEIN EXPRES PURIF, V70, P23, DOI 10.1016/j.pep.2009.09.024; Kanda T., 1991, B NATL I SERIC ENTOM, V2, P31; KAZNOWSKI CE, 1985, J INSECT PHYSIOL, V31, P801, DOI 10.1016/0022-1910(85)90073-3; Kobayashi Isao, 2007, Journal of Insect Biotechnology and Sericology, V76, P145; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LU Y, 1991, ARCH BIOCHEM BIOPHYS, V286, P147, DOI 10.1016/0003-9861(91)90020-J; MAEDA S, 1989, INVERTEBRATE CELL SY, V1, P167; Misaki R, 2003, BIOCHEM BIOPH RES CO, V311, P979, DOI 10.1016/j.bbrc.2003.10.094; Nagata Y, 2013, BIOTECHNOL LETT, V35, P1009, DOI 10.1007/s10529-013-1183-9; Nagaya H, 2009, METHODS MOL BIOL, V577, P109, DOI 10.1007/978-1-60761-232-2_9; Nomura T, 2010, J BIOSCI BIOENG, V110, P386, DOI 10.1016/j.jbiosc.2010.04.008; Okada T, 2007, BIOSCI BIOTECH BIOCH, V71, P1626, DOI 10.1271/bbb.60705; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; WATANABE H, 1967, J INVERTEBR PATHOL, V9, P428, DOI 10.1016/0022-2011(67)90081-X; Watanabe S, 2002, J BIOL CHEM, V277, P5090, DOI 10.1074/jbc.M110548200	37	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					131	136		10.1016/j.jbiosc.2014.07.012		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100002		
J	Tada, S; Zang, QM; Wang, W; Kawamoto, M; Liu, MZ; Iwashita, M; Uzawa, T; Kiga, D; Yamamura, M; Ito, Y				Tada, Seiichi; Zang, Qingmin; Wang, Wei; Kawamoto, Masuki; Liu, Mingzhe; Iwashita, Michiru; Uzawa, Takanori; Kiga, Daisuke; Yamamura, Masayuki; Ito, Yoshihiro			In vitro selection of a photoresponsive peptide aptamer to glutathione-immobilized microbeads	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						In vitro selection; Photoresponsive aptamer; Peptide aptamer; Photoisomerization; Ribosome display; Misacylated tRNA; Azobenzene	NONNATURAL AMINO-ACIDS; RIBOSOME DISPLAY; RNA; INHIBITORS; LIGANDS; LIBRARY; HEMIN	Photoresponsive peptide aptamer to glutathione-immobilized microbeads was in vitro selected using ribosome display incorporated with tRNA carrying an amino acid coupled with an azobenzene. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Tada, Seiichi; Zang, Qingmin; Wang, Wei; Kawamoto, Masuki; Liu, Mingzhe; Uzawa, Takanori; Kiga, Daisuke; Yamamura, Masayuki; Ito, Yoshihiro] RIKEN, Nano Med Engn Lab, Wako, Saitama 3510198, Japan; [Zang, Qingmin; Kiga, Daisuke; Yamamura, Masayuki; Ito, Yoshihiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kawamoto, Masuki; Iwashita, Michiru; Uzawa, Takanori; Ito, Yoshihiro] RIKEN, Emergent Bioengn Mat Res Team, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Ito, Y (reprint author), RIKEN, Nano Med Engn Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y-ito@riken.jp	Uzawa, Takanori/B-2980-2010; Ito, Yoshihiro/F-4370-2012		Scientific Research on Innovative Areas "Emergence in Chemistry" of Ministry of Education, Culture, Sports, Science and Technology, Japan [23111724]; JSPS KAKENHI [22220009]	The modified tRNA was prepared by Dr. R. Abe at the Protein Express Co. (Chiba, Japan). The research was partially supported by Scientific Research on Innovative Areas "Emergence in Chemistry" of Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant number 23111724). This work was also supported in part by the JSPS KAKENHI (Grant number 22220009).	Liu MZ, 2010, BIOORG MED CHEM LETT, V20, P2964, DOI 10.1016/j.bmcl.2010.02.109; Liu MZ, 2009, BIOORG MED CHEM LETT, V19, P1484, DOI 10.1016/j.bmcl.2009.01.016; Bellotto S, 2014, J AM CHEM SOC, V136, P5880, DOI 10.1021/ja501861m; Liu MZ, 2012, CHEM COMMUN, V48, P11871, DOI 10.1039/c2cc36618e; Ito Y, 2013, BIOMATERIALS, V34, P7565, DOI 10.1016/j.biomaterials.2013.06.037; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Schlippe YVG, 2012, J AM CHEM SOC, V134, P10469, DOI 10.1021/ja301017y; Wang W, 2014, CHEM COMMUN, V50, P2962, DOI 10.1039/c3cc47624c; Uzawa T, 2013, CHEM COMMUN, V49, P1786, DOI 10.1039/c2cc36348h; Hayashi Y, 2012, ACS CHEM BIOL, V7, P607, DOI 10.1021/cb200388k; Groves M, 2006, J IMMUNOL METHODS, V313, P129, DOI 10.1016/j.jim.2006.04.002; Jafari MR, 2014, ACS CHEM BIOL, V9, P443, DOI 10.1021/cb4006722; Li Z, 2014, J BIOSCI BIOENG, V117, P501, DOI 10.1016/j.jbiosc.2013.10.005; Matsuura T, 2006, J BIOSCI BIOENG, V101, P449, DOI 10.1263/jbb.101.449; Muranaka N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj003; Wang W, 2011, J BIOSCI BIOENG, V112, P515, DOI 10.1016/j.jbiosc.2011.07.011	17	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					137	139		10.1016/j.jbiosc.2014.06.018		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100003		
J	Takagi, H; Hashida, K; Watanabe, D; Nasuno, R; Ohashi, M; Iha, T; Nezuo, M; Tsukahara, M				Takagi, Hiroshi; Hashida, Keisuke; Watanabe, Daisuke; Nasuno, Ryo; Ohashi, Masataka; Iha, Tomoya; Nezuo, Maiko; Tsukahara, Masatoshi			Isolation and characterization of awamori yeast mutants with L-leucine accumulation that overproduce isoamyl alcohol	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Saccharomyces cerevisiae; Awamori; 5,5,5-Trifluoro-DL-leucine resistance; alpha-Isopropylmalate synthase; Leucine; Isoamyl alcohol	ALPHA-ISOPROPYLMALATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; SWISS-MODEL; SAKE YEAST; RESISTANT; BIOSYNTHESIS; SELECTION; ACETATE; GENE	Awamori shochu is a traditional distilled alcoholic beverage made from steamed rice in Okinawa, Japan. Although it has a unique aroma that is distinguishable from that of other types of shochu, no studies have been reported on the breeding of awamori yeasts. In yeast, isoamyl alcohol (i-AmOH), known as the key flavor of bread, is mainly produced from alpha-ketoisocaproate in the pathway of L-leucine biosynthesis, which is regulated by end-product inhibition of alpha-isopropylmalate synthase (IPMS). Here, we isolated mutants resistant to the L-leucine analog 5,5,5-trifluoro-DL-leucine (TFL) derived from diploid awamori yeast of Saccharomyces cerevisiae. Some of the mutants accumulated a greater amount of intracellular L-leucine, and among them, one mutant overproduced i-AmOH in awamori brewing. This mutant carried an allele of the LEU4 gene encoding the Ser542Phe/Ala551Val variant IPMS, which is less sensitive to feedback inhibition by L-leucine. Interestingly, we found that either of the constituent mutations (LEU4(S542F) and LEU4(A551V)) resulted in the TFL tolerance of yeast cells and desensitization to L-leucine feedback inhibition of IPMS, leading to intracellular L-leucine accumulation. Homology modeling also suggested that L-leucine binding was drastically inhibited in the Ser542Phe, Ala551Val, and Ser542Phe/Ala551Val variants due to steric hindrance in the cavity of IPMS. As we expected, awamori yeast cells expressing LEU4(S542F), LEU4(A551V), and LEU4(S542/A551V) showed a prominent increase in extracellular i-AmOH production, compared with that of cells carrying the vector only. The approach described here could be a practical method for the breeding of novel awamori yeasts to expand the diversity of awamori taste and flavor. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Takagi, Hiroshi; Hashida, Keisuke; Watanabe, Daisuke; Nasuno, Ryo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Ohashi, Masataka] Nara Prefecture Inst Ind Dev, Nara 6308031, Japan; [Iha, Tomoya; Nezuo, Maiko; Tsukahara, Masatoshi] BioJet Ltd, Uruma, Okinawa 9042231, Japan	Takagi, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	hiro@bs.naist.jp			Japan Science and Technology Agency, Japan [AS2321364E]; Ryukyu Awamori Research Study Support Project from Okinawa Prefecture	This work was supported by grants for the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency, Japan (AS2321364E) and the Ryukyu Awamori Research Study Support Project from Okinawa Prefecture to H.T. and M.T.	Oba T, 2006, BIOSCI BIOTECH BIOCH, V70, P1776, DOI 10.1271/bbb.50640; Nikawa JI, 2006, BIOSCI BIOTECH BIOCH, V70, P2604, DOI 10.1271/bbb.60146; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; WATANABE M, 1990, APPL MICROBIOL BIOT, V34, P154; ASHIDA S, 1987, AGR BIOL CHEM TOKYO, V51, P2061; Olesen K, 2000, YEAST, V16, P1035, DOI 10.1002/1097-0061(200008)16:11<1035::AID-YEA606>3.0.CO;2-P; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; Taira J, 2012, FOOD SCI TECHNOL RES, V18, P177; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; ULM EH, 1972, J BACTERIOL, V110, P1118; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asano T, 1999, J BIOSCI BIOENG, V87, P697, DOI 10.1016/S1389-1723(99)80137-6; Cavalieri D, 1999, MOL GEN GENET, V261, P152; Hino A, 2002, TOXICOL PATHOL, V30, P126, DOI 10.1080/01926230252824815; Nishiya T., 1980, Journal of the Society of Brewing, Japan [Nihon Jozo Kyokai Zasshi], V75, P641; Oba T, 2005, BIOSCI BIOTECH BIOCH, V69, P1270, DOI 10.1271/bbb.69.1270; [Anonymous], 1991, METHOD ENZYMOL; Sambrook J, 2001, MOL CLONING LAB MANU; WEBSTER TD, 1983, GENE, V26, P243, DOI 10.1016/0378-1119(83)90194-4	20	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					140	147		10.1016/j.jbiosc.2014.06.020		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100004		
J	Iwata, H; Mizushima, D; Kobayashi, Y; Ookura, T; Ogihara, J; Kato, J; Kasumi, T				Iwata, Hisashi; Mizushima, Daiki; Kobayashi, Yosuke; Ookura, Tetsuya; Ogihara, Jun; Kato, Jun; Kasumi, Takafumi			Two transaldolase isogenes from Moniliella megachiliensis behave in a different way depending on the stress class	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Transaldolase isogene; Osmotic stress; Oxidative stress; Polyol; Moniliella megachiliensis	PENTOSE-PHOSPHATE PATHWAY; SACCHAROMYCES-CEREVISIAE; TRICHOSPORONOIDES-MEGACHILIENSIS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ERYTHRITOL PRODUCTION; HYPEROSMOTIC STRESS; AUREOBASIDIUM SP; YEAST; EXPRESSION	We cloned and sequenced two transaldolase genes from Moniliella megachiliensis, a microorganism known to produce a significant amount of erythritol under hyper-osmotic stress. The amino acid sequences encoded by these two genes (MmTAL1, MmTAL2) showed 72% homology to each other. An AP-1 (ap response element) associated with oxidative stress was found in the promoter region of MmTAL1, while four STREs (stress response element) associated with osmotic stress were found in the promoter region of MmTAL2. In early-stage cultivation (up to 2 h), MmTAL1 was specifically expressed in response to oxidative stress generated by the presence of 0.15 mM menadione; expression level 3-fold higher than before stress loading. MmTAL2 was expressed in response to osmotic stress caused by 1.2 M NaCl; expression level was 21-fold higher than stress-free control. Erythritol accumulated intracellularly under osmotic and oxidative stress, approximately 30-fold and 35-fold, respectively. We therefore concluded that M. megachiliensis selectively uses two isogenes and produces erythritol during early-stage response to stress, depending on the type of environmental stress. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Iwata, Hisashi; Mizushima, Daiki; Kobayashi, Yosuke; Ogihara, Jun; Kato, Jun; Kasumi, Takafumi] Nihon Univ, Dept Chem & Life Sci, Fermentat & Appl Microbiol Lab, Fujisawa, Kanagawa 2520880, Japan; [Ookura, Tetsuya] Natl Food Res Inst, Biomol Engn Lab, Tsukuba, Ibaraki 3058642, Japan	Kasumi, T (reprint author), Nihon Univ, Dept Chem & Life Sci, Fermentat & Appl Microbiol Lab, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	kasumi@brs.nihon-u.ac.jp					Kobayashi Y, 2013, J BIOSCI BIOENG, V115, P645, DOI 10.1016/j.jbiosc.2012.12.004; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Ryu YW, 2000, J IND MICROBIOL BIOT, V25, P100, DOI 10.1038/sj.jim.7000039; Sawada K, 2009, J BIOSCI BIOENG, V108, P385, DOI 10.1016/j.jbiosc.2009.05.008; de Hoog GS, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1837, DOI 10.1016/B978-0-444-52149-1.00150-6; ISHIZUKA H, 1989, J FERMENT BIOENG, V68, P310, DOI 10.1016/0922-338X(89)90003-2; Jia J, 1997, PROTEIN SCI, V6, P119; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Yoshida J, 2013, J BIOSCI BIOENG, V115, P127, DOI 10.1016/j.jbiosc.2012.08.019; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; D'Souza CA, 2011, MBIO, V2, DOI 10.1128/mBio.00342-10; Hermann K.M., 1999, ANNU REV PLANT PHYS, V50, P473; Huang H, 2008, PROTEINS, V73, P1076, DOI 10.1002/prot.22237; ISHIZUKA H, 1992, BIOSCI BIOTECH BIOCH, V56, P941; Juhnke R., 1996, MOL GEN GENET, V252, P456; Kasumi T., 2000, Journal of Applied Glycoscience, V47, P117; Lachaise F, 2002, GENE, V299, P263, DOI 10.1016/S0378-1119(02)01051-X; LINDQVIST Y, 1993, CURR OPIN STRUC BIOL, V3, P896, DOI 10.1016/0959-440X(93)90153-C; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; NODA K, 1994, EUR J CLIN NUTR, V48, P286; Ookura T, 2005, BIOSCI BIOTECH BIOCH, V69, P944, DOI 10.1271/bbb.69.944; Raiser M, 2007, J BIOL, V6, P10; Rosa CA, 2009, INT J SYST EVOL MICR, V59, P425, DOI 10.1099/ijs.0.65117-0; Shindo T., 1988, SHOKUHIN EISEIGAKU Z, V29, P419; Slekar KH, 1996, J BIOL CHEM, V271, P28831; TOKUOKA K, 1992, J GEN APPL MICROBIOL, V38, P35, DOI 10.2323/jgam.38.35; Tsuzi D, 2004, FEBS LETT, V565, P148, DOI 10.1016/j.febslet.2004.03.091; VEIGADACUNHA M, 1993, J BACTERIOL, V175, P3941; YOSHIDA H, 1984, J JPN SOC FOOD SCI, V31, P765	33	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					148	152		10.1016/j.jbiosc.2014.07.002		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100005		
J	Abdel-Rahman, MA; Xiao, YT; Tashiro, Y; Wang, Y; Zendo, T; Sakai, K; Sonomoto, K				Abdel-Rahman, Mohamed Ali; Xiao, Yaotian; Tashiro, Yukihiro; Wang, Ying; Zendo, Takeshi; Sakai, Kenji; Sonomoto, Kenji			Fed-batch fermentation for enhanced lactic acid production from glucose/xylose mixture without carbon catabolite repression	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Glucose/xylose mixture; L.-Lactic acid production; Fed-batch fermentation; Carbon catabolite repression; Enterococcus mundtii QU 25	MUNDTII QU 25; ENTEROCOCCUS-FAECALIS; LACTOBACILLUS-BREVIS; SUGAR UTILIZATION; CO-FERMENTATION; BACTERIA; BIOMASS; XYLOSE; RHAMNOSUS	There has been tremendous growth in the production of optically pure L-lactic acid from lignocellulose-derived sugars. In this study, Enterococcus mundtii QU 25 was used to ferment a glucose/xylose mixture to L-lactic acid. Maintenance of the xylose concentration at greater than 10 g/L achieved homo-lactic acid fermentation and reduced the formation of byproducts. Furthermore, carbon catabolite repression (CCR) was avoided by maintaining the glucose concentration below 25 g/L; therefore, initial concentrations of 25 g/L glucose and 50 g/L xylose were selected. Supplementation with 5 g/L yeast extract enhanced the maximum xylose consumption rate and consequently increased lactic acid production and productivity. Finally, a 129 g/L lactic acid without byproducts was obtained with a maximum lactic acid productivity of 5.60 g/(L.h) in fed-batch fermentation with feeding a glucose/xylose mixture using ammonium hydroxide as the neutralizing agent. These results indicate a potential for lactic acid production from glucose and xylose as the main components of lignocellulosic biomasses. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Abdel-Rahman, Mohamed Ali; Xiao, Yaotian; Wang, Ying; Zendo, Takeshi; Sonomoto, Kenji] Kyushu Univ, Grad Sch, Div Syst Bioengn,Fac Agr, Lab Microbial Technol,Dept Biosci & Biotechnol,Hi, Fukuoka 8128581, Japan; [Abdel-Rahman, Mohamed Ali] Al Azhar Univ, Fac Sci Boys, Dept Bot & Microbiol, Cairo 11884, Egypt; [Tashiro, Yukihiro; Sakai, Kenji] Kyushu Univ, Grad Sch, Div Syst Bioengn,Fac Agr, Lab Soil Microbiol,Dept Biosci & Biotechnol,Higas, Fukuoka 8128581, Japan; [Tashiro, Yukihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka 8128581, Japan; [Sonomoto, Kenji] Kyushu Univ, Dept Funct Metab Design, Bioarchitecture Ctr, Lab Funct Food Design,Higashi Ku, Fukuoka 8128581, Japan	Sonomoto, K (reprint author), Kyushu Univ, Grad Sch, Div Syst Bioengn,Fac Agr, Lab Microbial Technol,Dept Biosci & Biotechnol,Hi, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	mohamedali@kyudai.jp; vacrite@hotmail.com; tashiro@agr.kyushu-u.ac.jp; wangyingcqu@gmail.com; zendo@agr.kyushu-u.ac.jp; kensak@agr.kyushu-u.ac.jp; sonomoto@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [P12088]; Sumitomo Corporation (Japan)	This study has been supported by a Grant-in-Aid (P12088) for JSPS Fellows to Mohamed Ali Abdel-Rahman from the Japan Society for the Promotion of Science (JSPS), Japan. This research was financially supported in part by the Sumitomo Corporation (Japan).	Kim JH, 2009, MICROBIOL-SGM, V155, P1351, DOI 10.1099/mic.0.024653-0; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Abdel-Rahman MA, 2011, APPL MICROBIOL BIOT, V89, P1039, DOI 10.1007/s00253-010-2986-4; Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; Abdel-Rahman MA, 2011, J BIOTECHNOL, V156, P286, DOI 10.1016/j.jbiotec.2011.06.017; Abdel-Rahman MA, 2011, APPL ENVIRON MICROB, V77, P1892, DOI 10.1128/AEM.02076-10; Abdel-Rahman MA, 2013, RSC ADV, V3, P8437, DOI 10.1039/c3ra00078h; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Nancib A, 2005, BIORESOURCE TECHNOL, V96, P63, DOI 10.1016/j.biortech.2003.09.018; Cui FJ, 2011, BIORESOURCE TECHNOL, V102, P1831, DOI 10.1016/j.biortech.2010.09.063; Adnan AFM, 2007, BIORESOURCE TECHNOL, V98, P1380, DOI 10.1016/j.biortech.2006.05.034; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Cai Y, 1997, J APPL MICROBIOL, V83, P307, DOI 10.1046/j.1365-2672.1997.00229.x; Görke Boris, 2008, Nat Rev Microbiol, V6, P613, DOI 10.1038/nrmicro1932; Leboeuf C, 2000, INT J FOOD MICROBIOL, V55, P109, DOI 10.1016/S0168-1605(00)00185-9; Nguyen CM, 2012, BIOTECHNOL LETT, V34, P2235, DOI 10.1007/s10529-012-1023-3; Oshiro M, 2009, J BIOSCI BIOENG, V108, P376, DOI 10.1016/j.jbiosc.2009.05.003; Taniguchi M, 2004, APPL MICROBIOL BIOT, V66, P160, DOI 10.1007/s00253-004-1671-x; Tashiro Y, 2011, APPL MICROBIOL BIOT, V89, P1741, DOI 10.1007/s00253-010-3011-7; Wang Y, 2014, RSC ADV, V4, P22013, DOI 10.1039/c4ra02764g; Yoshida S, 2011, APPL MICROBIOL BIOT, V92, P67, DOI 10.1007/s00253-011-3356-6; Yun JS, 2001, PROCESS BIOCHEM, V37, P235, DOI 10.1016/S0032-9592(01)00205-9	23	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					153	158		10.1016/j.jbiosc.2014.07.007		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100006		
J	Katabami, A; Li, L; Iwasaki, M; Furubayashi, M; Saito, K; Umeno, D				Katabami, Akinori; Li, Ling; Iwasaki, Miki; Furubayashi, Maiko; Saito, Kyoichi; Umeno, Daisuke			Production of squalene by squalene synthases and their truncated mutants in Escherichia coil	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Squalene synthase; Mevalonate pathway; Triterpenoid; Carotenoid; Bacterial production	SYNTHESIZE ISOPENTENYL DIPHOSPHATE; CAROTENOID BIOSYNTHETIC PATHWAYS; MEVALONIC ACID PATHWAY; SACCHAROMYCES-CEREVISIAE; ISOPRENOID BIOSYNTHESIS; OLIVE OIL; RAT-LIVER; DIMETHYLALLYL DIPHOSPHATE; CHOLESTEROL-BIOSYNTHESIS; COLI	Squalene is a precursor of thousands of bioactive triterpenoids and also has industrial value as a lubricant, health-promoting agent, and/or drop-in biofuel. To establish an efficient Escherichia coil-based system for squalene production, we tested two different squalene synthases and their mutants in combination with precursor pathways. By co-expressing a chimeric mevalonate pathway with human or Thermosynechococcus squalene synthase, E. coli accumulated squalene up to 230 mg/L or 55 mg/g-DCW in flask culture. We also determined that a significant truncation of squalene synthase at the C-terminus retains partial cellular activity. The squalene-producing strain described herein represents a convenient platform for gene discovery and the construction of the pathway toward natural and non-natural hopanoids/steroids. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Katabami, Akinori; Li, Ling; Iwasaki, Miki; Furubayashi, Maiko; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Umeno, D (reprint author), Chiba Univ, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	umeno@faculty.chiba-u.jp			PRESTO (JST); MEXT/JSPS [23108507]; JSPS; Mishima-Kaiun Memorial Foundation; Futaba Electronics Memorial Foundation; Shorai Foundation for Science and Technology	D.U. is supported by the PRESTO (JST) and the MEXT/JSPS Grant-in-Aid for Scientific Research on Innovative Areas 23108507. M.F. and M.I are supported by a JSPS fellowship for young scientists. This work is financially supported by the Mishima-Kaiun Memorial Foundation, the Futaba Electronics Memorial Foundation, and the Shorai Foundation for Science and Technology.	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; AGNEW WS, 1978, J BIOL CHEM, V253, P4574; LOGRASSO PV, 1993, ARCH BIOCHEM BIOPHYS, V307, P193, DOI 10.1006/abbi.1993.1578; YAMAMOTO S, 1970, J BIOL CHEM, V245, P1670; Moses T, 2014, P NATL ACAD SCI USA, V111, P1634, DOI 10.1073/pnas.1323369111; SHECHTER I, 1992, J BIOL CHEM, V267, P8628; Nakazawa A, 2012, BIORESOURCE TECHNOL, V109, P287, DOI 10.1016/j.biortech.2011.09.127; Jarstfer MB, 2002, J AM CHEM SOC, V124, P8834, DOI 10.1021/ja020410i; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Bentley FK, 2014, MOL PLANT, V7, P71, DOI 10.1093/mp/sst134; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486; Albrecht M, 1999, BIOTECHNOL LETT, V21, P791, DOI 10.1023/A:1005547827380; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Matthews PD, 2000, APPL MICROBIOL BIOT, V53, P396, DOI 10.1007/s002530051632; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Newmark HL, 1997, CANCER EPIDEM BIOMAR, V6, P1101; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706; Nakazawa A, 2014, J APPL PHYCOL, V26, P29, DOI 10.1007/s10811-013-0080-x; Umeno D, 2002, J BACTERIOL, V184, P6690, DOI 10.1128/JB.184.23.6690-6699.2002; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Kaya K, 2011, BIOSCI BIOTECH BIOCH, V75, P2246, DOI 10.1271/bbb.110430; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Smith TJ, 1998, CARCINOGENESIS, V19, P703, DOI 10.1093/carcin/19.4.703; Thompson JF, 1998, ARCH BIOCHEM BIOPHYS, V350, P283, DOI 10.1006/abbi.1997.0502; AIOI A, 1995, INT J PHARM, V113, P159, DOI 10.1016/0378-5173(94)00190-G; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Liu CI, 2012, J BIOL CHEM, V287, P18750, DOI 10.1074/jbc.M112.351254; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Wriessnegger T, 2013, PROG LIPID RES, V52, P277, DOI 10.1016/j.plipres.2013.03.001; Umeno D, 2004, J BACTERIOL, V186, P1531, DOI 10.1128/JB.186.5.1531-1536.2004; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331; Smith TJ, 2000, EXPERT OPIN INV DRUG, V9, P1841, DOI 10.1517/13543784.9.8.1841; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Campos N, 2001, BIOCHEM J, V353, P59; Ghimire GP, 2009, APPL ENVIRON MICROB, V75, P7291, DOI 10.1128/AEM.01402-09; Chang MH, 2008, APPL MICROBIOL BIOT, V78, P963, DOI 10.1007/s00253-008-1395-4; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; Asadollahi MA, 2010, BIOTECHNOL BIOENG, V106, P86, DOI 10.1002/bit.22668; Kajiwara S, 1997, BIOCHEM J, V324, P421; Tokuhiro K, 2009, APPL ENVIRON MICROB, V75, P5536, DOI 10.1128/AEM.00277-09; Rao CV, 1998, CARCINOGENESIS, V19, P287, DOI 10.1093/carcin/19.2.287; Urbina JA, 2002, MOL BIOCHEM PARASIT, V125, P35, DOI 10.1016/S0166-6851(02)00206-2; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Budiyanto A, 2000, CARCINOGENESIS, V21, P2085, DOI 10.1093/carcin/21.11.2085; Cervin M., 2009, World patent, Patent No. [WO2009/076676 A2, 2009076676]; EDMOND J, 1971, J BIOL CHEM, V246, P6254; Furubayashi M, 2014, FEBS LETT, V588, P436, DOI 10.1016/j.febslet.2013.12.003; Gupta D, 2014, MOL BIOTECHNOL, V56, P516, DOI 10.1007/s12033-013-9721-1; Harada Hisashi, 2012, Methods Mol Biol, V892, P133, DOI 10.1007/978-1-61779-879-5_6; Kelly G S, 1999, Altern Med Rev, V4, P29; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; Kroon PA, 1997, PHYTOCHEMISTRY, V45, P1157, DOI 10.1016/S0031-9422(97)00104-0; Ku BS, 2005, APPL ENVIRON MICROB, V71, P6578, DOI 10.1128/AEM.71.11.6578-6583.2005; KUSWIKRABIEGA G, 1987, J BIOL CHEM, V262, P1505; Liu CI, 2014, ACTA CRYSTALLOGR D, V70, P231, DOI 10.1107/S1399004713026230; Mantzouridou F, 2010, FEMS YEAST RES, V10, P699, DOI 10.1111/j.1567-1364.2010.00645.x; MIETTINEN TA, 1994, AM J CLIN NUTR, V59, P356; ONO T, 1975, J BIOL CHEM, V250, P1571; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; RITTER MC, 1971, J BIOL CHEM, V246, P1536; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; SASIAK K, 1988, ARCH BIOCHEM BIOPHYS, V260, P622, DOI 10.1016/0003-9861(88)90490-0; SHECHTER I, 1971, J BIOL CHEM, V246, P7690; Song AAL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052444; TAI HH, 1972, J BIOL CHEM, V247, P3767; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Vadali RV, 2005, BIOTECHNOL PROGR, V21, P1558, DOI 10.1021/bp0501241; Yang JM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-60; Yuan JF, 2014, BIOTECHNOL BIOENG, V111, P608, DOI 10.1002/bit.25123; Zheng YN, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-57	79	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					165	171		10.1016/j.jbiosc.2014.07.013		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100008		
J	Yoshiyama, Y; Tanaka, K; Yoshiyama, K; Hibi, M; Ogawa, J; Shima, J				Yoshiyama, Yoko; Tanaka, Koichi; Yoshiyama, Kohei; Hibi, Makoto; Ogawa, Jun; Shima, Jun			Trehalose accumulation enhances tolerance of Saccharomyces cerevisiae to acetic acid	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Stress tolerance; Trehalose accumulation; Acetic acids; Propionic acid; Saccharomyces cerevisiae; Bioethanol production	STRESS TOLERANCE; PROTEIN-KINASE; BAKERS-YEAST; RESISTANT; STRAINS; GROWTH; GENE	Trehalose confers protection against various environmental stresses on yeast cells. In this study, trehalase gene deletion mutants that accumulate trehalose at high levels showed significant stress tolerance to acetic acid. The enhancement of trehalose accumulation can thus be considered a target in the breeding of acetic acid-tolerant yeast strains. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Yoshiyama, Yoko; Tanaka, Koichi; Shima, Jun] Kyoto Univ, Res Div Microbial Sci, Sakyo Ku, Kyoto 6068502, Japan; [Yoshiyama, Kohei] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Hibi, Makoto] Kyoto Univ, Ind Microbiol, Sakyo Ku, Kyoto 6068502, Japan; [Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Shima, J (reprint author), Ryukoku Univ, Fac Law, Fushimi Ku, Fukakusatsukamoto Cho, Kyoto 6125662, Japan.	shima@agr.ryukoku.ac.jp			Institute for Fermentation, Osaka (IFO)	This work was supported by the Institute for Fermentation, Osaka (IFO).	Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Tanaka K, 2012, APPL ENVIRON MICROB, V78, P8161, DOI 10.1128/AEM.02356-12; Mira NP, 2010, OMICS, V14, P587, DOI 10.1089/omi.2010.0048; Piper PW, 2011, ADV APPL MICROBIOL, V77, P97, DOI 10.1016/B978-0-12-387044-5.00004-2; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Watanabe I, 2008, J IND MICROBIOL BIOT, V35, P1117, DOI 10.1007/s10295-008-0390-1; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Watanabe D, 2011, APPL ENVIRON MICROB, V77, P934, DOI 10.1128/AEM.01869-10; Hynes SH, 1997, J IND MICROBIOL BIOT, V18, P284, DOI 10.1038/sj.jim.2900381; Fernandes AR, 2005, BIOCHEM BIOPH RES CO, V337, P95, DOI 10.1016/j.bbrc.2005.09.010; Cheng LL, 1999, FEMS MICROBIOL LETT, V170, P89, DOI 10.1111/j.1574-6968.1999.tb13359.x; Inaba T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-74; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Shima J, 1999, APPL ENVIRON MICROB, V65, P2841; Zahringer H, 1998, EUR J BIOCHEM, V255, P544, DOI 10.1046/j.1432-1327.1998.2550544.x	18	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					172	175		10.1016/j.jbiosc.2014.06.021		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100009		
J	Kawano, Y; Ohtsu, I; Takumi, K; Tamakoshi, A; Nonaka, G; Funahashi, E; Ihara, M; Takagi, H				Kawano, Yusuke; Ohtsu, Iwao; Takumi, Kazuhiro; Tamakoshi, Ai; Nonaka, Gen; Funahashi, Eri; Ihara, Masaki; Takagi, Hiroshi			Enhancement of L-cysteine production by disruption of yciW in Escherichia coli	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Escherichia coli; L-Cysteine fermentation; In silico analysis; CysB-binding motif; yciW gene	SALMONELLA-TYPHIMURIUM; IDENTIFICATION; OVERPRODUCTION; CYSTINE; PROTEIN; REGIONS	Using in silico analysis, the yciW gene of Eschetichia coil was identified as a novel L-cysteine regulon that may be regulated by the transcriptional activator CysB for sulfur metabolic genes. We found that overexpression of yciW conferred tolerance to L-cysteine, but disruption of yciW increased L-cysteine production in E. coli. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kawano, Yusuke; Ohtsu, Iwao; Tamakoshi, Ai; Funahashi, Eri; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Takumi, Kazuhiro; Nonaka, Gen] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa 2108681, Japan; [Ihara, Masaki] Shinshu Univ, Fac Agr, Nagano 3994511, Japan; [Ihara, Masaki] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Ohtsu, I (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama Cho, Nara 6300192, Japan.	iohtsu@bs.naist.jp			KAKENHI from the Japan Society for the Promotion of Science [26450091]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	We thank Ajinomoto, Co., Inc. (Tokyo, Japan) for providing the plasmids. This work was supported by KAKENHI (Grant-in-Aid for Scientific Research (C) (26450091)) from the Japan Society for the Promotion of Science, by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry to IO.	Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; GAITONDE MK, 1967, BIOCHEM J, V104, P627; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; KARI C, 1971, J GEN MICROBIOL, V68, P349; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Awano N, 2005, APPL ENVIRON MICROB, V71, P4149, DOI 10.1128/AEM.71.7.4149-4152.2005; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; Denlc D., 1987, J GEN MICROBIOL, V133, P515; Kredich N. M., 1983, AMINO ACIDS BIOSYNTH, P115; LEYH TS, 1992, J BIOL CHEM, V267, P10405; MONROE RS, 1990, J BACTERIOL, V172, P6919; Nakatani T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-62; Nonaka G., 2012, WO patent, Patent No. [2012137689A1, 2012137689]; SORENSEN MA, 1991, J BACTERIOL, V173, P5244; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	17	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					176	179		10.1016/j.jbiosc.2014.07.006		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100010		
J	Zhang, DD; Zhang, CF; Xiao, ZX; Suzuki, D; Katayama, A				Zhang, Dongdong; Zhang, Chunfang; Xiao, Zhixing; Suzuki, Daisuke; Katayama, Arata			Humin as an electron donor for enhancement of multiple microbial reduction reactions with different redox potentials in a consortium	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Solid-phase electron donor; Humic substance; Humin; Microbial respiration; Electron acceptors	SULFATE-REDUCING BACTERIA; ANAEROBIC RESPIRATION; DEGRADING CULTURES; FERRIC IRON; AZO DYES; SP-NOV; DECHLORINATION; SUBSTANCES; DIVERSITY; MEDIATOR	A solid-phase humin, acting as an electron donor, was able to enhance multiple reductive biotransformations, including dechlorination of pentachlorophenol (PCP), dissimilatory reduction of amorphous Fe (III) oxide (FeOOH), and reduction of nitrate, in a consortium. Humin that was chemically reduced by NaBH4 served as an electron donor for these microbial reducing reactions, with electron donating capacities of 0.013 mmol e(-)/g for PCP dechlorination, 0.15 nunol e(-)/g for iron reduction, and 0.30 mmol e(-)/g for nitrate reduction. Two pairs of oxidation and reduction peaks within the humin were detected by cyclic voltanunetry analysis. 16S rRNA gene sequencing-based microbial community analysis of the consortium incubated with different terminal electron acceptors, suggested that Dehalobacter sp., Bacteroides sp., and Sulfurospirillum sp. were involved in the PCP dechlorination, dissimilatory iron reduction, and nitrate reduction, respectively. These findings suggested that humin functioned as a versatile redox mediator, donating electrons for multiple respiration reactions with different redox potentials. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Zhang, Dongdong; Xiao, Zhixing; Katayama, Arata] Nagoya Univ, Grad Sch Engn, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zhang, Chunfang; Suzuki, Daisuke; Katayama, Arata] Nagoya Univ, Ecotopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zhang, Chunfang] Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China	Katayama, A (reprint author), Nagoya Univ, Ecotopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	a-katayama@esi.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Sekisui Chemical Grant Program for Research on Manufacturing Based on Innovations Inspired by Nature;  [23310055];  [23658272];  [26281040]	This study was supported in part by Grants-in-Aid for Scientific Research (grant numbers 23310055, 23658272, and 26281040) and a university grant for "Design of a cascade utilization system for unused biological resources in the Tokai area" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by the Sekisui Chemical Grant Program for Research on Manufacturing Based on Innovations Inspired by Nature.	Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Yuan Y, 2012, BIORESOURCE TECHNOL, V116, P428, DOI 10.1016/j.biortech.2012.03.114; Nelson JL, 2011, ENVIRON SCI TECHNOL, V45, P6806, DOI 10.1021/es200480k; Yoshida N, 2009, APPL ENVIRON MICROB, V75, P2400, DOI 10.1128/AEM.02112-08; DOLFING J, 1992, ENVIRON SCI TECHNOL, V26, P2213, DOI 10.1021/es00035a021; Coates JD, 1998, APPL ENVIRON MICROB, V64, P1504; GIBSON HW, 1969, CHEM REV, V69, P673, DOI 10.1021/cr60261a005; Cervantes FJ, 2011, BIORESOURCE TECHNOL, V102, P2097, DOI 10.1016/j.biortech.2010.08.021; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Nurmi JT, 2002, ENVIRON SCI TECHNOL, V36, P617, DOI 10.1021/es0110731; Arbeli Z, 2003, BIODEGRADATION, V14, P385, DOI 10.1023/A:1027304222436; OREMLAND RS, 1994, APPL ENVIRON MICROB, V60, P3011; Wang AJ, 2010, INT J HYDROGEN ENERG, V35, P3178, DOI 10.1016/j.ijhydene.2009.12.154; Wang XJ, 2009, J SOIL SEDIMENT, V9, P568, DOI 10.1007/s11368-009-0113-x; Duhamel M, 2006, FEMS MICROBIOL ECOL, V58, P538, DOI 10.1111/j.1574-6941.2006.00191.x; Van der Zee FR, 2009, BIOTECHNOL ADV, V27, P256, DOI 10.1016/j.biotechadv.2009.01.004; Guo JB, 2007, WATER RES, V41, P426, DOI 10.1016/j.watres.2006.10.022; Grostern A, 2009, APPL ENVIRON MICROB, V75, P2684, DOI 10.1128/AEM.02037-08; Gu BH, 2003, GEOCHIM COSMOCHIM AC, V67, P3575, DOI 10.1016/S0016-7037(03)00162-5; Zhang CF, 2012, ENVIRON SCI TECHNOL, V46, P6575, DOI 10.1021/es3002025; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; Roden EE, 2003, ENVIRON SCI TECHNOL, V37, P1319, DOI 10.1021/es026038o; Schroder U, 2007, PHYS CHEM CHEM PHYS, V9, P2619, DOI [10.1039/b703627m, 10.1039/003627m]; Lovley DR, 1999, ENVIRON MICROBIOL, V1, P89, DOI 10.1046/j.1462-2920.1999.00009.x; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Lin B, 2007, ENVIRON MICROBIOL, V9, P1956, DOI 10.1111/j.1462-2920.2007.01312.x; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Watanabe K, 2009, CURR OPIN BIOTECH, V20, P633, DOI 10.1016/j.copbio.2009.09.006; Stolz JF, 1999, INT J SYST BACTERIOL, V49, P1177; Aulenta F, 2010, BIORESOURCE TECHNOL, V101, P9728, DOI 10.1016/j.biortech.2010.07.090; Costa MC, 2010, BIORESOURCE TECHNOL, V101, P105, DOI 10.1016/j.biortech.2009.08.015; EISENMANN E, 1995, ARCH MICROBIOL, V164, P180, DOI 10.1007/BF02529969; Liu HJ, 2012, BIORESOURCE TECHNOL, V107, P144, DOI 10.1016/j.biortech.2011.12.071; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683; Maurer F, 2010, ENVIRON SCI TECHNOL, V44, P5787, DOI 10.1021/es100594t; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; SOLORZAN.L, 1969, LIMNOL OCEANOGR, V14, P799; Yang S, 2009, BIOTECHNOL BIOENG, V102, P81, DOI 10.1002/bit.22032; Yoshida N, 2007, SCI TOTAL ENVIRON, V381, P233, DOI 10.1016/j.scitotenv.2007.03.021; Zhang CF, 2013, CHEMOSPHERE, V92, P1343, DOI 10.1016/j.chemosphere.2013.05.051; Zhang DD, 2014, BIORESOURCE TECHNOL, V164, P232, DOI 10.1016/j.biortech.2014.04.071	43	4	4	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					188	194		10.1016/j.jbiosc.2014.07.010		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100012		
J	Choi, HW; Sakata, Y; Ooya, T; Takeuchi, T				Choi, Hyung Woo; Sakata, Yasuhiko; Ooya, Tooru; Takeuchi, Toshifumi			Reflectometric interference spectroscopy-based immunosensing using immobilized antibody via His-tagged recombinant protein A	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Immunosensor; Immunosensing; Reflectometric interference spectroscopy; Myoglobin; Histidine-tagged recombinant protein A; Antibody	SURFACE-PLASMON RESONANCE; LABEL-FREE DETECTION; CARDIAC TROPONIN-I; BIOCHEMICAL SENSORS; MYOGLOBIN CLEARANCE; SENSING SYSTEM; IMMUNOASSAYS; FABRICATION; NANOPARTICLES; DEXTRAN	The proposed approach demonstrated in this study provides an immunosensing system based on reflectometric interference spectroscopy (RIfS) in combination with an antibody immobilization method using histidine-tagged recombinant protein A. Carboxymethyldextran (CMD) was immobilized on a 3-aminopropyltriethoxysilane-treated a silicon nitride-coated silicon wafer, followed by chelating histidine-tagged recombinant protein A with copper (II) ions. The CMD-layer was found to be advantageous in terms of not only immobilization of histidine-tagged recombinant protein A-mediated an antibody against myoglobin (anti-Myo) but also prevention of non-specific binding of myoglobin. Myoglobin was repeatedly detected, and the apparent detection limit was 0.1 mu g mL(-1). The proposed RIfS-based protein sensing system, in conjunction with the easy preparation of silicon-based inexpensive immunosensing chips, is expected to be applicable for label-free optical detection for other proteins in various fields. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Choi, Hyung Woo; Sakata, Yasuhiko; Ooya, Tooru; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp	Takeuchi, Toshifumi/E-6379-2014; Ooya, Tooru/C-5573-2012	Takeuchi, Toshifumi/0000-0002-5641-2333; 	New Energy and Industrial Technology Development Organization (NEDO); Konica Minolta, Inc. (Tokyo, Japan)	The authors thank Meito Sangyo Co. Ltd. (Nagoya, Japan) for kindly providing carbomethyldextran. This work was supported in part by the innovation promotion program of New Energy and Industrial Technology Development Organization (NEDO) and Konica Minolta, Inc. (Tokyo, Japan).	Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Albrecht C, 2010, BIOSENS BIOELECTRON, V25, P2302, DOI 10.1016/j.bios.2010.03.022; Wu J, 2007, TRAC-TREND ANAL CHEM, V26, P679, DOI 10.1016/j.trac.2007.05.007; Swift JL, 2008, BIOPHYS J, V95, P865, DOI 10.1529/biophysj.107.127688; Qi HL, 2010, MICROCHIM ACTA, V170, P33, DOI 10.1007/s00604-010-0382-5; Naka T, 2005, CRIT CARE, V9, pR90, DOI 10.1186/cc3034; Huang Y, 2010, ACTA BIOMATER, V6, P2083, DOI 10.1016/j.actbio.2009.12.035; GAUGLITZ G, 1993, SENSOR ACTUAT B-CHEM, V11, P21, DOI 10.1016/0925-4005(93)85234-2; Li XM, 2008, TRAC-TREND ANAL CHEM, V27, P543, DOI 10.1016/j.trac.2008.04.002; Kurihara Y, 2012, LANGMUIR, V28, P13609, DOI 10.1021/la302221y; WU AHB, 1994, CLIN CHEM, V40, P796; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505; Lin JH, 2012, ANAL BIOCHEM, V421, P97, DOI 10.1016/j.ab.2011.10.018; Boisen A, 2009, MATER TODAY, V12, P32, DOI 10.1016/S1369-7021(09)70249-4; BRECHT A, 1992, ANALUSIS, V20, P135; Choi HW, 2011, ANAL METHODS-UK, V3, P1366, DOI 10.1039/c0ay00762e; Choi HW, 2012, ANAL CHIM ACTA, V728, P64, DOI 10.1016/j.aca.2012.03.030; Kim JY, 2005, ANAL CHEM, V77, P2318, DOI 10.1021/ac0484326; Kim N, 2010, CURR APPL PHYS, V10, P1227, DOI 10.1016/j.cap.2010.02.048; Masson JF, 2004, TALANTA, V62, P865, DOI 10.1016/j.talanta.2003.09.032; McBride Jeffrey D., 2008, Journal of Nanobiotechnology, V6, P5, DOI 10.1186/1477-3155-6-5; McLean KM, 2000, COLLOID SURFACE B, V18, P221, DOI 10.1016/S0927-7765(99)00149-6; Moehrle B. P., 2005, ANALYST, V130, P1634, DOI DOI 10.1039/B507728A; Mu Y., 2001, SENSORS, V1, P91, DOI 10.3390/s10300091; Nagel T, 2008, SENSOR ACTUAT B-CHEM, V129, P934, DOI 10.1016/j.snb.2007.10.009; Owalcu K., 1995, ANAL CHEM, V67, P1613; Pfeifer P, 1999, SENSOR ACTUAT B-CHEM, V54, P166, DOI 10.1016/S0925-4005(98)00334-7; Weber M, 2005, CLIN BIOCHEM, V38, P1027, DOI 10.1016/j.clinbiochem.2005.07.011; Wei JY, 2003, ANAL BIOCHEM, V321, P209, DOI 10.1016/S0003-2697(03)00407-X; Zhang R, 2006, REACT FUNCT POLYM, V66, P757, DOI 10.1016/j.reactfunctpolym.2005.11.003	31	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					195	199		10.1016/j.jbiosc.2014.06.017		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100013		
J	Sasaki, S; Ooya, T; Kitayama, Y; Takeuchi, T				Sasaki, Shogo; Ooya, Tooru; Kitayama, Yukiya; Takeuchi, Toshifumi			Molecularly imprinted protein recognition thin films constructed by controlled/living radical polymerization	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Molecular imprinting; Controlled/living radical polymerization; Proteins; Surface plasmon resonance; Molecular recognition; Quartz crystal microbalance	POLYMERS; COMPLEXES; GELATION	We demonstrated the synthesis of molecularly imprinted polymers (MIPs) with binding affinity toward a target protein, ribonuclease A (RNase) by atom transfer radical polymerization (ATRP) of acrylic acid, acrylamide, and N,N'-methylenebisacrylamide in the presence of RNase. The binding activity of the MIPs was evaluated by surface plasmon resonance (SPR) of the MIP thin layers prepared on the gold-coated sensor chips. The MIPs prepared by ATRP (MIP-ATRP) had a binding affinity toward RNase with larger binding amount compared to MIPs prepared by conventional free radical polymerization methods (MIP-RP). Moreover, protein selectivity was evaluated using reference proteins (cytochrome c, myoglobin, and alpha-lactalbumin) and was confirmed in MIP-ATRP of optimum film thickness determined experimentally to be 15-30 nm; however, protein selectivity was not achieved in all MIP-RP. We have shown that ATRP is powerful technique for preparing protein recognition materials by molecular imprinting. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sasaki, Shogo; Ooya, Tooru; Kitayama, Yukiya; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp	Takeuchi, Toshifumi/E-6379-2014; Ooya, Tooru/C-5573-2012	Takeuchi, Toshifumi/0000-0002-5641-2333; 	JST PRESTO (Creation of Innovative Technology by Integration of Nanotechnology with Information, Biological, and Environmental Technologies); JSPS KAKENHI [18350087]	This work was supported in part a grant from JST PRESTO (Creation of Innovative Technology by Integration of Nanotechnology with Information, Biological, and Environmental Technologies) and JSPS KAKENHI Grant number 18350087.	Sunayama H, 2010, BIOSENS BIOELECTRON, V26, P458, DOI 10.1016/j.bios.2010.07.091; Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951; Norisuye T, 2005, POLYMER, V46, P1982, DOI 10.1016/j.polymer.2004.12.043; Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Ide N, 1999, MACROMOLECULES, V32, P95, DOI 10.1021/ma9805349; Takeuchi T, 2008, ORG BIOMOL CHEM, V6, P2459, DOI 10.1039/b715737c; Haupt K, 2000, CHEM REV, V100, P2495, DOI 10.1021/cr990099w; Boonpangrak S, 2006, BIOSENS BIOELECTRON, V22, P349, DOI 10.1016/j.bios.2006.04.014; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Min K, 2009, CENT EUR J CHEM, V7, P657, DOI 10.2478/s11532-009-0092-1; HAWKER CJ, 1995, J AM CHEM SOC, V117, P10763, DOI 10.1021/ja00148a027; Zu BY, 2009, J POLYM SCI POL CHEM, V47, P3257, DOI 10.1002/pola.23389; Gai QQ, 2010, J CHROMATOGR A, V1217, P5035, DOI 10.1016/j.chroma.2010.06.001; Kamon Y, 2014, POLYM CHEM-UK, V5, P4764, DOI 10.1039/c4py00350k; KATO M, 1995, MACROMOLECULES, V28, P1721, DOI 10.1021/ma00109a056; Komiyama M., 2004, MOL IMPRINTING; Salian VD, 2012, J MOL RECOGNIT, V25, P361, DOI 10.1002/jmr.2168; Sasaki S, 2010, POLYM CHEM-UK, V1, P1684, DOI 10.1039/c0py00140f; Sellergren B., 2000, MOL IMPRINTED POLYM; WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035; Zimmerman SC, 2004, CHEM COMMUN, P5, DOI 10.1039/b304720b	21	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					200	205		10.1016/j.jbiosc.2014.06.019		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100014		
J	Watanabe, M; Maeda, I; Koyama, M; Nakamura, K; Sasano, K				Watanabe, Masanori; Maeda, Isamu; Koyama, Masahiro; Nakamura, Kozo; Sasano, Kazuo			Simultaneous recovery and purification of rice protein and phosphorus compounds from full-fat and defatted rice bran with organic solvent-free process	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Full-fat rice bran; Machine defatted rice bran; Isoelectric precipitation; Electrolyzed water; Rice protein; Phosphorus compounds	WATER	We studied a process that enables simultaneous recovery of protein and phosphorus compounds from rice bran. Phosphorus substances in full-fat and defatted rice bran such as phytic acid and inorganic ions were solubilized under acidic conditions in the first step. After that, inorganic and/or organic phosphate salts were recovered in insoluble form under weak alkaline conditions. Furthermore, protein fractions obtained after phosphorus compounds had been removed were solubilized under alkaline conditions. After solubilization, protein fractions with high content were recovered by isoelectric precipitation (IP) followed by electrolyzed water treatment (EWT). The highest protein content (52.3 w/w%) was attained when machine defatted rice bran was treated through the process. Energy-dispersive X-ray spectroscopy (EDX) and inductively coupled plasma atomic emission spectrometry (ICP-AES) analyses demonstrated efficient desalting from the protein fractions by EWT and higher phosphorus contents (15.1-16.4 w/w% P) in the phosphorus fractions compared with commercial phosphate rock. In addition, no heavy metal ions in either protein or phosphorus fractions were detected. These results suggest that the newly developed process is suitable for practical recovery of highly concentrated protein and phosphorus compounds from rice bran without enzymes or chemicals such as organic solvents, buffering agents, and surfactants. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Watanabe, Masanori] Yamagata Univ, Dept Food Life & Environm Sci, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Maeda, Isamu] Utsunomiya Univ, Grad Sch Agr Sci, Utsunomiya, Tochigi 3218505, Japan; [Koyama, Masahiro; Nakamura, Kozo] Shinshu Univ, Grad Sch Agr, Dept Biosci & Biotechnol, Nagano 3994598, Japan; [Sasano, Kazuo] Shokkyo Co Ltd, Asakita Ku, Hiroshima 7391751, Japan	Watanabe, M (reprint author), Yamagata Univ, Dept Food Life & Environm Sci, Fac Agr, 1-23 Wakaba Machi, Tsuruoka, Yamagata 9978555, Japan.	mwata@tds1.tr.yamagata-u.ac.jp					INOUE T, 1988, ARCH HISTOL CYTOL, V51, P53; Suzuki K, 2002, WATER RES, V36, P2991, DOI 10.1016/S0043-1354(01)00536-X; Tang S, 2003, J FOOD SCI, V68, P152, DOI 10.1111/j.1365-2621.2003.tb14132.x; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Fabian C, 2011, CRIT REV FOOD SCI, V51, P816, DOI 10.1080/10408398.2010.482678; Canan C, 2012, ACTA SCI-TECHNOL, V34, P457, DOI 10.4025/actascitechnol.v34i4.16358; Huang YR, 2008, FOOD CONTROL, V19, P329, DOI 10.1016/j.foodcont.2007.08.012; Prakash J, 1996, CRIT REV FOOD SCI, V36, P537; Wang M, 1999, J AGR FOOD CHEM, V47, P411, DOI 10.1021/jf9806964; CHEN L, 1970, CEREAL CHEM, V47, P72; de Rham O., 1979, J FOOD SCI, V44, P596; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; Juliano B. O., 1985, RICE CHEM TECHNOLOGY, P17; LEW EJL, 1975, CEREAL CHEM, V52, P748; Oshima H, 2004, J FOOD HYG SOC JPN, V45, P270; Shirage H., 2005, J ENV BIOTECHNOL, V4, P109; Tamaki S., 2013, ARCH VIROL, V80, P6; Verghese M, 2006, LWT-FOOD SCI TECHNOL, V39, P1093, DOI 10.1016/j.lwt.2005.07.012; Watanabe M., 2009, J FOOD ENG, V10, P55; Watanabe M, 2013, J BIOSCI BIOENG, V115, P449, DOI 10.1016/j.jbiosc.2012.11.001; Wiboonsirikul J, 2008, BIOSCI BIOTECH BIOCH, V72, P384, DOI 10.1271/bbb.70464	21	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					206	211		10.1016/j.jbiosc.2014.07.009		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100015		
J	Shimizu, K; Araki, H; Sakata, K; Tonomura, W; Hashida, M; Konishi, S				Shimizu, Kazunori; Araki, Hiroyuki; Sakata, Kohei; Tonomura, Wataru; Hashida, Mitsuru; Konishi, Satoshi			Microfluidic devices for construction of contractile skeletal muscle microtissues	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						BioMEMS; Skeletal-muscle-on-a-chip; Myoblasts; Myotubes; Differentiation; Active tension	ACTIVE TENSION GENERATION; CELL-CULTURE; CHIP; ALIGNMENT; TISSUE; DIFFERENTIATION; MYOBLASTS; MYOTUBES; PLATFORM	Cell-culture microchips mimicking tissue/organ-specific functions are required as alternatives to animal testing for drug discovery and disease models. Although three-dimensional (3D) cell culture microfluidic devices can create more biologically relevant cellular microenvironments and higher throughput analysis platforms of cell behavior than conventional techniques, devices for skeletal muscle cells have not been developed. In the present study, we aimed to develop microfluidic devices for 3D cultures of skeletal muscle cells. Skeletal muscle cells mixed with a collagen type-I solution was introduced into the microchannel for cells (MC-C) and was gelated. Then, the medium was introduced into the microchannel for medium (MC-M). During this process, connecting microchannels (Con-MCs) prevented leakage of the collagen solution mixed with cells from MC-C to MC-M and supplied the nutrients from the medium in MC-M to the cells in MC-C. Skeletal muscle microtissues cultured in the microchannel for a week consisted of myotubes were confirmed by histological analysis and immunofluorescence staining. The skeletal muscle microtissues in the microchannel contracted in response to externally applied electrical stimulation (1 and 50 Hz). These results indicate that the functional skeletal muscle microtissues were constructed in the microchannel. Thus, the microfluidic device for culturing 3D skeletal muscle microtissues presented in this study has a potential to be used for drug discovery and toxicological tests. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Shimizu, Kazunori; Hashida, Mitsuru; Konishi, Satoshi] Kyoto Univ, Inst Innovat NanoBio Drug Discovery & Dev, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shimizu, Kazunori; Konishi, Satoshi] Ritsumeikan Univ, R GIRO, Kusatsu, Shiga 5258577, Japan; [Araki, Hiroyuki; Sakata, Kohei] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Tonomura, Wataru; Konishi, Satoshi] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan; [Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan	Shimizu, K (reprint author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	shimizu@nubio.nagoya-u.ac.jp	Shimizu, Kazunori/B-7553-2008		Ritsumeikan Global Innovation Research Organization (R-GIRO)	This study was partly supported by a grant from Ritsumeikan Global Innovation Research Organization (R-GIRO).	Hume SL, 2012, ACTA BIOMATER, V8, P2193, DOI 10.1016/j.actbio.2012.02.001; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Shimizu K, 2009, BIOTECHNOL BIOENG, V103, P631, DOI 10.1002/bit.22268; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Yamada M, 2006, LAB CHIP, V6, P179, DOI 10.1039/b514045d; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Futai N, 2006, LAB CHIP, V6, P149, DOI 10.1039/b510901a; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Sun Y, 2013, ACTA BIOMATER, V9, P7885, DOI 10.1016/j.actbio.2013.04.036; Shimizu K, 2011, SENSOR ACTUAT B-CHEM, V156, P486, DOI 10.1016/j.snb.2011.04.048; Shimizu K, 2010, BIOMED MICRODEVICES, V12, P247, DOI 10.1007/s10544-009-9379-4; Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092; Shimizu K, 2010, J BIOSCI BIOENG, V109, P174, DOI 10.1016/j.jbiosc.2009.07.016; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Sugiura S, 2010, ANAL CHEM, V82, P8278, DOI 10.1021/ac1017666; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Lam MT, 2006, BIOMATERIALS, V27, P4340, DOI 10.1016/j.biomaterials.2006.04.012; Grosberg A, 2012, J PHARMACOL TOX MET, V65, P126, DOI 10.1016/j.vascn.2012.04.001; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015; Nagamine K, 2011, LAB CHIP, V11, P513, DOI [10.1039/c0lc00364f, 10.1039/c01c00364f]; Fujita H, 2010, BIOTECHNOL BIOENG, V106, P482, DOI 10.1002/bit.22705; Fujita H, 2010, J BIOSCI BIOENG, V110, P359, DOI 10.1016/j.jbiosc.2010.02.012; Fujita H, 2009, BIOTECHNOL BIOENG, V103, P1034, DOI 10.1002/bit.22318; Fujita H, 2010, BIOTECHNOL BIOENG, V107, P894, DOI 10.1002/bit.22865; Fujita H, 2010, J MUSCLE RES CELL M, V31, P279, DOI 10.1007/s10974-010-9230-9; Anene-Nzelu CG, 2013, LAB CHIP, V13, P4124, DOI 10.1039/c3lc50730k; Nakao Y., 2011, BIOMICROFLUIDICS, V5, P29; Shimizu K, 2013, J BIOSCI BIOENG, V115, P115, DOI 10.1016/j.jbiosc.2012.08.024; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h; Wilson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011042	36	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					212	216		10.1016/j.jbiosc.2014.07.003		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100016		
J	Takitoh, T; Bessho, M; Hirose, M; Ohgushi, H; Mori, H; Hara, M				Takitoh, Takako; Bessho, Masahiko; Hirose, Motohiro; Ohgushi, Hajime; Mori, Hideki; Hara, Masayuki			Gamma-cross-linked nonfibrillar collagen gel as a scaffold for osteogenic differentiation of mesenchymal stem cells	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Collagen fibril; Bone formation; Osteoblast; Bone marrow stromal cell; Mesenchymal stem cell	IN-VITRO; HUMAN OSTEOSARCOMA; BONE; MINERALIZATION; ALPHA-2-BETA-1; VISUALIZATION; IRRADIATION; PROTEINS; FIBRILS; CULTURE	We fabricated a transparent nonfibrillar collagen gel using gamma irradiation (5 kGy) and cultured rat mesenchymal stem cells (MSCs) on both the gamma-irradiated collagen gel and on unirradiated fibrillar collagen gel. Cells attached well and proliferated with high viability on the surface of both gels. The cells cultured on the gamma-irradiated nonfibrillar gel had a unique elongated shape and adhered to each other in culture. After 21 days of culture in dexamethasone-containing culture medium, the contents of bone-specific osteocalcin and calcium on the gamma-irradiated nonfibrillar gel were 1.4 and 1.9 times higher than those on fibrillar collagen gel, respectively. These data show that osteogenic differentiation of MSCs was promoted more efficiently on the gamma-cross-linked nonfibrillar gel than on the fibrillar gel and demonstrate the potential of the gamma-irradiated collagen gel for use in bone tissue engineering. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Takitoh, Takako; Mori, Hideki; Hara, Masayuki] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998570, Japan; [Bessho, Masahiko] Akita Univ, Int Ctr Res & Educ Mineral & Energy Resources, Akita 0108502, Japan; [Hirose, Motohiro] Natl Inst Adv Ind Sci & Technol, Human Life Technol Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo 6610974, Japan	Hara, M (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.	hara@b.s.osakafu-u.ac.jp			Iketani Science and Technology Foundation	This research is partly supported by Iketani Science and Technology Foundation. We express gratitude to Mr. Yoichi Kato in AIST, Mr. Kousuke Shimizu and Mr. Akihiro Ikenaka in Osaka Prefecture University for their contribution to the experiments.	Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169; Uchimura E, 2003, CALCIFIED TISSUE INT, V73, P575, DOI 10.1007/s00223-002-1052-3; Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0; Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Kihara T, 2004, BIOCHEM BIOPH RES CO, V316, P943, DOI 10.1016/j.bbrc.2004.02.134; Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Koshimizu N, 2009, BIOSCI BIOTECH BIOCH, V73, P1915, DOI 10.1271/bbb.80771; Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T; Inoue N, 2006, J BIOMAT SCI-POLYM E, V17, P837, DOI 10.1163/156856206777996835; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Badylak S. F., 2002, METHODS TISSUE ENG, P503; Bruder S. P., 2000, PRINCIPLES TISSUE EN, V2nd, P683, DOI 10.1016/B978-012436630-5/50052-0; Hara M, 2006, J ORAL TISSUE ENG, V3, P118; Jansen JHW, 2004, J CELL BIOCHEM, V93, P542, DOI 10.1002/jcb.20162; Kihara T, 2006, BIOCHEM BIOPH RES CO, V341, P1029, DOI 10.1016/j.bbrc.2006.01.059; MCALLIST.RM, 1971, CANCER, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; Miyata T., 1980, US-patent, Patent No. 4223984; Mori H, 2012, MAT SCI ENG C-MATER, V32, P2007, DOI 10.1016/j.msec.2012.05.022; Ohgushi H, 2014, EXPERT OPIN BIOL TH, V14, P197, DOI 10.1517/14712598.2014.866086; RIIKONEN T, 1995, J BIOL CHEM, V270, P376; Siggelkow H, 1998, DIFFERENTIATION, V63, P81, DOI 10.1046/j.1432-0436.1998.6320081.x; Takitoh T, 2010, J BIOSCI BIOENG, V110, P471, DOI 10.1016/j.jbiosc.2010.04.009; Xu L, 2007, BIOMATERIALS, V28, P750, DOI 10.1016/j.biomaterials.2006.09.022; Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1016/S1389-1723(04)70240-6; Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243	33	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					217	225		10.1016/j.jbiosc.2014.07.008		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100017		
J	Tomari, N; Kawasaki, A; Yamamoto, Y; Nishiya, Y				Tomari, Naohiro; Kawasaki, Asako; Yamamoto, Yoshihiro; Nishiya, Yoshiaki			Simple and reliable urea assay based on a signal accumulation type of ion-sensitive field-effect transistor	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Ion-sensitive field-effect transistor; Signal accumulation; Urease; Urea assay; Proton	NITROGEN	A simple urea assay was developed using a signal accumulation type of ion-sensitive field-effect transistor (SA-ISFET). Decreases in proton concentration resulting from urease-catalyzed hydrolysis of urea are detected by SA-ISFET as a change in potential. The method exhibits high sensitivity, linearity, and reproducibility when potential signals are accumulated 10-fold. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Tomari, Naohiro; Yamamoto, Yoshihiro] Kyoto Municipal Inst Ind Technol & Culture, Shimogyo Ku, Kyoto 6008813, Japan; [Kawasaki, Asako; Nishiya, Yoshiaki] Setsunan Univ, Dept Life Sci, Fac Sci & Engn, Neyagawa, Osaka 5728508, Japan	Nishiya, Y (reprint author), Setsunan Univ, Dept Life Sci, Fac Sci & Engn, 17-8 Ikedanaka Machi, Neyagawa, Osaka 5728508, Japan.	nishiya@lif.setsunan.ac.jp			JSPS KAKENHI [13251655]	This work was supported by JSPS KAKENHI Grant Number 13251655.	Hof G, 1997, J DAIRY SCI, V80, P3333; Lee CS, 2009, SENSORS-BASEL, V9, P7111, DOI 10.3390/s90907111; Wang Y, 2008, SENSORS-BASEL, V8, P2043, DOI 10.3390/s8042043; Nousiainen J, 2004, J DAIRY SCI, V87, P386; Risveden K, 2007, BIOSENS BIOELECTRON, V22, P3105, DOI 10.1016/j.bios.2007.01.019; Butler WR, 1996, J ANIM SCI, V74, P858; Duroux L P., 1991, GUT, V32, P240; Nishiya Y., 2011, J ANAL BIOSCI, V34, P247; Nishiya Y., 2009, J ANAL BIOSCI, V32, P240; Nishiya Y., 2011, BIOCLINICA, V26, P62; Sasaki Y., 2012, BIOCATAL AGR BIOTECH, V1, P259; WYBENGA DR, 1971, CLIN CHEM, V17, P891	12	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	2015	119	2					247	250		10.1016/j.jbiosc.2014.07.011		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CC6ZI	WOS:000350517100020		
J	Akimoto, M; Taguchi, H; Takayama, K; Nakagawa, S; Hiroi, K				Akimoto, Masayuki; Taguchi, Hogara; Takayama, Kohei; Nakagawa, Satoko; Hiroi, Kano			Intrascleral fixation technique using catheter needles and 30-gauge ultrathin needles: Lock-and-lead technique	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							CHAMBER INTRAOCULAR-LENS; IMPLANTATION; SUPPORT; EYES; CAPSULES; OUTCOMES	We report a new intrascleral fixation technique for a standard 3-piece posterior intraocular lens (IOL) using catheter needles and 30-gauge ultrathin needles instead of a special forceps and minimal intraocular manipulation in eyes without capsule support. Modified catheter needles are used to deliver the IOL haptic. The IOL haptic is secured extraocularly between the cannula and needle of a catheter needle and then advanced through the sclerotomy site. Scleral tunnels are created using 30-gauge ultrathin needles, which also serve as a guide to introduce the haptics. This technique can be performed even in cases in which miosis and corneal edema prevent anterior chamber observation. The guide needle facilitates haptic insertion into the long and narrow scleral tunnels. The procedure is a good alternative to current techniques.	[Akimoto, Masayuki; Taguchi, Hogara; Takayama, Kohei; Nakagawa, Satoko; Hiroi, Kano] Osaka Red Cross Hosp, Dept Ophthalmol, Osaka, Japan	Akimoto, M (reprint author), 5-30 Fudega Sakicho,Tennojiku, Osaka 5438555, Japan.	masayuki@akimoto3.com					Akimoto M, 2014, J CATARACT REFR SURG, V40, P854, DOI 10.1016/j.jcrs.2014.03.007; Akimoto M, 2014, J CATARACT REFR SURG, V40, P179, DOI 10.1016/j.jcrs.2013.12.009; Agarwal A, 2013, J CATARACT REFR SURG, V39, P317, DOI 10.1016/j.jcrs.2013.01.019; Agarwal A, 2008, J CATARACT REFR SURG, V34, P1433, DOI 10.1016/j.jcrs.2008.04.040; Kumar DA, 2013, J CATARACT REFR SURG, V39, P1211, DOI 10.1016/j.jcrs.2013.03.004; Ohta T, 2014, J CATARACT REFR SURG, V40, P2, DOI 10.1016/j.jcrs.2013.11.003; Kumar DA, 2010, EYE, V24, P1143, DOI 10.1038/eye.2010.10; Gabor SGB, 2007, J CATARACT REFR SURG, V33, P1851, DOI 10.1016/j.jcrs.2007.07.013; Beiko G, 2013, J CATARACT REFR SURG, V39, P323, DOI 10.1016/j.jcrs.2013.01.017; Scharioth GB, 2010, J CATARACT REFR SURG, V36, P254, DOI 10.1016/j.jcrs.2009.09.024; Saleh M, 2013, J CATARACT REFR SURG, V39, P81, DOI 10.1016/j.jcrs.2012.08.063; Por YM, 2005, SURV OPHTHALMOL, V50, P429, DOI 10.1016/j.survophthal.2005.06.010; Yamane S, 2014, OPHTHALMOLOGY, V121, P61, DOI 10.1016/j.ophtha.2013.08.043; Kumar DA, 2012, AM J OPHTHALMOL, V153, P594, DOI 10.1016/j.ajo.2011.09.027; Narang P, 2013, J CATARACT REFR SURG, V39, P4, DOI 10.1016/j.jcrs.2012.11.001; Totan Y, 2012, EYE, V26, P788, DOI 10.1038/eye.2012.19; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karadag R, 2014, J CATARACT REFR SURG, V40, P853, DOI 10.1016/j.jcrs.2014.03.006; López-Guajardo L, 2010, Arch Soc Esp Oftalmol, V85, P278, DOI 10.1016/j.oftal.2010.07.007; Rodriguez-Agirretxe I, 2009, J CATARACT REFR SURG, V35, P2051, DOI 10.1016/j.jcrs.2009.06.044	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	FEB	2015	41	2					257	261		10.1016/j.jcrs.2014.08.030		5	Ophthalmology; Surgery	Ophthalmology; Surgery	CC4NI	WOS:000350329700002		
J	Iijima, K; Kamiya, K; Shimizu, K; Igarashi, A; Komatsu, M				Iijima, Kei; Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Komatsu, Mari			Demographics of patients having cataract surgery after laser in situ keratomileusis	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							LENS POWER CALCULATION; WAVE-FRONT ABERRATIONS; DOUBLE-K METHOD; CORNEAL REFRACTIVE SURGERY; PHOTOREFRACTIVE KERATECTOMY; FEMTOSECOND LASER; EXCIMER-LASER; LASIK; OUTCOMES; TOMOGRAPHY	PURPOSE: To retrospectively assess the demographics of patients having cataract surgery in eyes with previous laser in situ keratomileusis (LASIK). SETTING: Department of Ophthalmology, Kitasato University, Kanagawa, and Sanno Hospital, Tokyo, Japan. DESIGN: Retrospective case series. METHODS: This study evaluated eyes of consecutive patients scheduled for cataract surgery after previous LASIK (Group 1). The control groups comprised eyes with axial lengths (ALs) matched with ALS in Group 1 (Group 2) and all eyes scheduled for cataract surgery (Group 3). Assessed were age, sex, corrected distance visual acuity, manifest refraction, keratometry (K) readings, corneal astigmatism, and corneal higher-order aberrations (HOAs). RESULTS: Group 1 comprised 40 eyes of 40 patients; Group 2, 606 eyes of 606 patients; and Group 3, 3642 eyes of 3642 patients. The mean age at cataract surgery of patients in Group 1 was 54.6 years +/- 8.1 (SD), which was significantly younger than in Group 2 (by approximately 10 years) and Group 3 (by approximately 15 years) (P <.001, Student t test). In Group 1, 70.0% of patients were men, a significantly higher percentage than in Groups 2 and 3 (P<.05, Fisher exact test). The rate of corneal HOAs was significantly higher in Group 1 than in Groups 2 and 3 (P<.05, Student ttest). There were no significant differences in other demographics except in K readings. CONCLUSION: A long AL and an increase in corneal HOAs might contribute to a tendency for cataract surgery to be performed earlier in eyes in which LASIK has been performed. (C) 2015 ASCRS and ESCRS	[Iijima, Kei; Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito] Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Komatsu, Mari] Sanno Hosp, Dept Ophthalmol, Tokyo, Japan	Kamiya, K (reprint author), Kitasato Univ, Dept Ophthalmol, Sch Med, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kamiyak-tky@umin.ac.jp					Ang M, 2013, J CATARACT REFR SURG, V39, P1647, DOI 10.1016/j.jcrs.2013.04.044; Ivarsen A, 2013, J CATARACT REFR SURG, V39, P74, DOI 10.1016/j.jcrs.2012.08.054; Amano S, 2004, AM J OPHTHALMOL, V137, P988, DOI 10.1016/j.ajo.2004.01.005; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Yang RB, 2013, J CATARACT REFR SURG, V39, P1327, DOI 10.1016/j.jcrs.2013.03.032; Randleman JB, 2007, J CATARACT REFR SURG, V33, P1892, DOI 10.1016/j.jcrs.2007.06.045; PALLIKARIS IG, 1990, LASER SURG MED, V10, P463; Oshika T, 1999, AM J OPHTHALMOL, V127, P1, DOI 10.1016/S0002-9394(98)00288-8; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449; Aramberri J, 2003, J CATARACT REFR SURG, V29, P2063, DOI 10.1016/S0886-3350(03)00232-3; Oshika T, 2002, OPHTHALMOLOGY, V109, P1154, DOI 10.1016/S0161-6420(02)01028-X; Saiki M, 2013, J CATARACT REFR SURG, V39, P556, DOI 10.1016/j.jcrs.2012.10.044; Shammas HJ, 2007, J CATARACT REFR SURG, V33, P31, DOI 10.1016/j.jcrs.2006.08.045; Lim R, 1999, INVEST OPHTH VIS SCI, V40, P3021; Tang ML, 2012, J CATARACT REFR SURG, V38, P589, DOI 10.1016/j.jcrs.2011.11.025; Kwitko S, 2012, GRAEF ARCH CLIN EXP, V250, P1029, DOI 10.1007/s00417-012-1974-z; Awwad ST, 2009, OPHTHALMOLOGY, V116, P393, DOI 10.1016/j.ophtha.2008.09.045; Cummings AB, 2013, J CATARACT REFR SURG, V39, P378, DOI 10.1016/j.jcrs.2012.10.041; Hersh PS, 1998, OPHTHALMOLOGY, V105, P1522; Hersh PS, 1998, OPHTHALMOLOGY, V105, P1512, DOI 10.1016/S0161-6420(98)98038-1; Li Yong, 2008, Zhonghua Yan Ke Za Zhi, V44, P899; Nielsen Steven A, 2013, Clin Ophthalmol, V7, P149, DOI 10.2147/OPTH.S38279; Nielsen SA, 2013, CLIN OPHTHALMOL, V7, P725; Rosa N, 2011, OPHTHALMOLOGY, V118, P2309, DOI 10.1016/j.ophtha.2011.08.004; Seider MI, 2013, OPHTHALMOLOGY, V120, P2204, DOI 10.1016/j.ophtha.2013.04.015; Shtein RM, 2012, OPHTHAL SURG LAS IM, V43, P489, DOI 10.3928/15428877-20120920-02; Sy ME, 2013, J REFRACT SURG, V29, P96, DOI 10.3928/1081597X-20130117-03; Tomita M, 2013, J CATARACT REFR SURG, V39, P1543, DOI 10.1016/j.jcrs.2013.03.037	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	FEB	2015	41	2					334	338		10.1016/j.jcrs.2014.05.045		5	Ophthalmology; Surgery	Ophthalmology; Surgery	CC4NI	WOS:000350329700013		
J	Iwata, H; Sawada, R; Mizutani, S; Yamanishi, Y				Iwata, Hiroaki; Sawada, Ryusuke; Mizutani, Sayaka; Yamanishi, Yoshihiro			Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data	JOURNAL OF CHEMICAL INFORMATION AND MODELING			English	Article							BREAST-CANCER; WHIPPLES-DISEASE; PERSONALIZED MEDICINE; VIRAL MYOCARDITIS; INTERFERON-ALPHA; PHASE-II; IN-VITRO; PREDNISONE; EXPRESSION; DISCOVERY	Drug repositioning, or the appslication of known drugs to new indications, is a challenging issue in pharmaceutical science. In this study, we developed a new computational method to predict unknown drug indications for systematic drug repositioning in a framework of supervised network inference. We defined a descriptor for each drug-disease pair based on the phenotypic features of drugs (e.g., medicinal effects and side effects) and various molecular features of diseases (e.g., disease-causing genes, diagnostic markers, disease-related pathways, and environmental factors) and constructed a statistical model to predict new drug-disease associations for a wide range of diseases in the International Classification of Diseases. Our results show that the proposed method outperforms previous methods in terms of accuracy and applicability, and its performance does not depend on drug chemical structure similarity. Finally, we performed a comprehensive prediction of a drug-disease association network consisting of 2349 drugs and 858 diseases and described biologically meaningful examples of newly predicted drug indications for several types of cancers and nonhereditary diseases.	[Iwata, Hiroaki; Sawada, Ryusuke; Yamanishi, Yoshihiro] Kyushu Univ, Med Inst Bioregulat, Multiscale Res Ctr Med Sci, Div Syst Cohort,Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Mizutani, Sayaka] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 6110011, Japan; [Yamanishi, Yoshihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan	Yamanishi, Y (reprint author), Kyushu Univ, Med Inst Bioregulat, Multiscale Res Ctr Med Sci, Div Syst Cohort,Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	yamanishi@bioreg.kyushu-u.ac.jp			Program to Disseminate Tenure Tracking System, MEXT, Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development	This work was supported by the Program to Disseminate Tenure Tracking System, MEXT, Japan, and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development.	Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Boll B, 2011, BLOOD, V118, P6292, DOI 10.1182/blood-2011-07-368167; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Chen B, 2009, J CHEM INF MODEL, V49, P2044, DOI 10.1021/ci9001876; Blagg J, 2006, ANNU REP MED CHEM, V41, P353, DOI 10.1016/S0065-7743(06)41024-1; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Yardley DA, 2010, CLIN BREAST CANCER, V10, P367, DOI 10.3816/CBC.2010.n.048; Kalimuddin S, 2013, J CLIN VIROL, V56, P37, DOI 10.1016/j.jcv.2012.10.005; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Zhao SW, 2012, BIOINFORMATICS, V28, P955, DOI 10.1093/bioinformatics/bts057; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Legros L, 2014, LEUKEMIA RES, V38, P662, DOI 10.1016/j.leukres.2014.01.010; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Chauncey TR, 2010, BRIT J HAEMATOL, V148, P48, DOI 10.1111/j.1365-2141.2009.07919.x; Aziz KU, 2010, CARDIOL YOUNG, V20, P509, DOI 10.1017/S1047951110000594; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim MY, 2014, ONCOLOGY-BASEL, V87, P224, DOI 10.1159/000364880; Kumar AVG, 2004, ANN TROP MED PARASIT, V98, P59, DOI 10.1179/000349804225003037; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee MV, 2001, CANCER RES, V61, P2602; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Wong NS, 2010, J CLIN ONCOL, V28, P723, DOI 10.1200/JCO.2009.24.0143; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Blake SJ, 2012, EXP HEMATOL, V40, P612, DOI 10.1016/j.exphem.2012.04.003; Boulos A, 2004, ANTIMICROB AGENTS CH, V48, P747, DOI 10.1128/AAC.48.3.747-752.2004; Burd J., 2013, GASTROENTEROL RES PR, V2013; Buske C., 2008, LEUKEMIA, V23, P153; Chhetri U., 2012, KATHMANDU U MED J, V9, P45; CHUANG YC, 1989, SCAND J INFECT DIS, V21, P721, DOI 10.3109/00365548909021703; Costa D., 2008, EYE, V23, P708; DeArment MC, 2003, J RHEUMATOL, V30, P1347; Feurle GE, 2013, J INFECTION, V66, P263, DOI 10.1016/j.jinf.2012.12.004; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; HAARSTAD H, 1994, ANN ONCOL, V5, P245; HAWKINS CF, 1976, ANN RHEUM DIS, V35, P502, DOI 10.1136/ard.35.6.502; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hue TF, 2014, JAMA INTERN MED, V174, P1550, DOI 10.1001/jamainternmed.2014.3634; Iwata H., 2013, BMC SYST BIOL, V7, P1; Kanalu-y C.G., 2013, SCI TRANSL MED, V5; KANDA T, 1995, J PHARMACOL EXP THER, V274, P487; Knox C, 2011, NUCLEIC ACIDS RES, V39, P1035, DOI DOI 10.1093/NAR/GKQ1126; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuhn M., 2013, NUCLEIC ACIDS RES, V42, pD401; Lin SF, 2010, ARTIF INTELL MED, V48, P161, DOI 10.1016/j.artmed.2009.11.002; Moore C.M., 2012, CASE REP TRANSPLANT, V2012; Nacher JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030028; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Napolitano F, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-30; Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555; NOZAWA S, 1983, INT J CANCER, V32, P267, DOI 10.1002/ijc.2910320302; Papadakis M.A., 2013, CURRENT MED DIAGNOSI; Penduka D, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0037-1; Roberti I, 2012, PEDIATR TRANSPLANT, V16, pE49, DOI 10.1111/j.1399-3046.2011.01518.x; Schmidt C, 2011, CL LYMPH MYELOM LEUK, V11, P204, DOI [10.1016/j.clml.2011.03.001, 10.1016/j.dml.2011.03.001]; Sirota M., 2011, SCI TRANSL MED, V3; Tabei Y, 2012, BIOINFORMATICS, V28, pi487; Takahira N, 2002, J ORTHOP TRAUMA, V16, P12, DOI 10.1097/00005131-200201000-00003; Takarabe M, 2012, BIOINFORMATICS, V28, pi611; Tanimoto T., 1958, ELEMENTARY MATH THEO; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078518; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Ye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087864; Ye H, 2012, PROTEIN CELL, V3, P132, DOI 10.1007/s13238-012-2011-z	74	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9596	1549-960X		J CHEM INF MODEL	J. Chem Inf. Model.	FEB	2015	55	2					446	459		10.1021/ci500670q		14	Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science, Information Systems; Computer Science, Interdisciplinary Applications	Pharmacology & Pharmacy; Chemistry; Computer Science	CB9HR	WOS:000349943100023		
J	Hoque, MM; Hossian, QD; Deb, K; Das, D; Kobayashi, Y; Kuno, Y				Hoque, Mohammed Moshiul; Hossian, Quazi Delwar; Deb, Kaushik; Das, Dipankar; Kobayashi, Yoshinori; Kuno, Yoshinori			An Empirical Robotic Framework for Initiating Interaction with the Target Human in Multiparty Settings	JOURNAL OF CIRCUITS SYSTEMS AND COMPUTERS			English	Article						Human-robot interaction; initiating interaction; viewing situations; capturing attention; ensuring attention capture	ATTENTION; GAZE; MOTION	Currently work in robotics is expanding from industrial robots to robots that are employed in the living environment. For robots to be accepted into the real world, they must be capable to behave in such a way that humans do with other humans, and initiate interaction in the same way. This paper focuses on designing a robotic framework that is able to perform an important social function such as, initiating interaction with the target human in multiparty setting in a natural and social ways. However, it is not easy task for the robot to initiate an interaction process with a particular human, especially when the robot and the human are not facing each other or the intended target human is intensely engaged his/her work. In order to initiate an interaction process, we propose a framework that consists of two parts: capturing attention and ensuring attention capture. Evaluation experiments reveal the effectiveness of the proposed system in four viewing situations namely, central field of view (CFOV), near peripheral field of view (NPFOV), far peripheral field of view (FPFOV), and out of field of view (OFOV) respectively.	[Hoque, Mohammed Moshiul; Hossian, Quazi Delwar; Deb, Kaushik] Chittagong Univ Engn & Technol, Fac Elect & Comp Engn, Chittagong 4349, Bangladesh; [Das, Dipankar; Kobayashi, Yoshinori; Kuno, Yoshinori] Saitama Univ, Grad Sch Sci & Engn, Saitama, Japan	Hoque, MM (reprint author), Chittagong Univ Engn & Technol, Fac Elect & Comp Engn, Chittagong 4349, Bangladesh.	moshiul_240@cuet.ac.bd; dipankar@cv.ics.saitama-u.ac.ji; yosinori@cv.ics.saitama-u.ac.ji; kuno@cv.ics.saitama-u.ac.ji			JST, CREST, Japan	This work was supported by JST, CREST, Japan.	[Anonymous], 2010, FACEAPI FAC TRACK OE; Yamaoka F, 2010, IEEE T ROBOT, V26, P187, DOI 10.1109/TRO.2009.2035747; Walters ML, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P707, DOI 10.1109/ROMAN.2008.4600750; COOK M, 1975, BRIT J SOC CLIN PSYC, V14, P19; Sisbot EA, 2007, IEEE T ROBOT, V23, P874, DOI 10.1109/TRO.2007.904911; Bergstrom N, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P2623, DOI 10.1109/IROS.2008.4650896; Bennewitz M, 2005, INT J ROBOT RES, V24, P31, DOI 10.1177/0278364904048962; Hoque MM, 2013, ADV ROBOTICS, V27, P813, DOI 10.1080/01691864.2013.791654; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Downing PE, 2004, VIS COGN, V11, P71, DOI 10.1080/13506280344000220; Hoque MM, 2012, IEEE INT C INT ROBOT, P1399, DOI 10.1109/IROS.2012.6385480; Das D, 2013, IEEE INT C INT ROBOT, P2194, DOI 10.1109/IROS.2013.6696663; Bradsky G., 2005, J INTEL TECH, V9, P119; Breazeal C., 2002, DESIGNING SOCIABLE R; Buss M., 2011, P INT C COGN INF, P1; Clark H. H., 1996, USING LANGUAGE; Cranch M. V., 1971, ROLE ORIENTING BEHAV; Dautenhahn K., 2006, P 1 ACM SIGCHI SIGAR, P172, DOI 10.1145/1121241.1121272; Deak G. O., 2001, P INT WORK EP ROB LU; Delaunay F, 2009, P 18 IEEE INT S ROB, P306; Finke M., 2005, P IEEE INT WORKSH RO, P7; Garrell M., 2013, P IEEE INT S ROM GYE, P107; Gockley R., 2006, P IEEE RSJ INT C IRO, P1338; Gockley R., 2007, P ACM IEEE INT C HUM, P17, DOI DOI 10.1145/1228716.1228720; Goffman E., 1963, BEHAV PUBLIC PLACE; Hall E. T., 1966, HIDDEN DIMENSION MAN; Hayashi K, 2007, P ACM IEEE INT C HUM, P137, DOI 10.1145/1228716.1228735; HOQUE MM, 2012, P INT C ICIC HUANG C, V7390, P534; Imai M, 2002, P 11 IEEE INT WORKSH, P411, DOI [10.1109/ROMAN.2002.1045657, DOI 10.1109/ROMAN.2002.1045657]; James W., 1950, PRINCIPLES PSYCHOL; Kanda T., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014810; Kendon A., 1980, FEATURES STRUCTURAL, P29; Kendon A., 1990, SPATIAL ORG SOCIAL E; Kobayashi Y., 2010, P ICIT2010, P1597; Kuzuoka Hideaki, 2010, Proceedings of the 5th ACM/IEEE International Conference on Human-Robot Interaction (HRI 2010), DOI 10.1109/HRI.2010.5453182; Li S., 2006, P 15 IEEE INT S ROB, P129; Mastsui D., 2005, P INT C IROS, P3301; Michalowski M., 2006, P 9 IEEE INT WORKSH, P762, DOI DOI 10.1109/AMC.2006.1631755; Mitsunaga N., 2006, P IEEE RSJ INT C INT, P5066; Miyauchi D, 2005, IEICE T INF SYST, VE88D, P2509, DOI 10.1093/ietisy/e88-d.11.2509; Mutlu B., 2009, P 4 ACM IEEE INT C H, P61, DOI DOI 10.1145/1514095.1514109; Pacchierotti E., 2006, P IEEE RSJ INT C INT, P4965, DOI DOI 10.1109/IROS.2006.282519; Satake S., 2009, P 4 ACM IEEE INT C H, P109, DOI DOI 10.1145/1514095.1514117; Shi C., 2011, P INT C RSS LOS ANG; Shiomi Masahiro, 2010, Proceedings of the 5th ACM/IEEE International Conference on Human-Robot Interaction (HRI 2010), DOI 10.1109/HRI.2010.5453270; Sisbot E. A., 2005, P IEEE RAS INT C HUM, P181; Sisbot E. A., 2006, P ROMAN S, P727; Takashima K., 2008, P GRAPH INT, P169; Ware C., 2004, INFORM VISUALIZATION; Weiss A., 2009, P ACM IEEE INT C HRI, P261, DOI 10.1145/1514095.1514166; Yamamoto M., 2004, P 13 IEEE INT WORKSH, P467; Yamazaki K., 2007, P ECSCW 07, P61; Yoshikawa Y., 2006, P IEEE RSJ INT C INT, P4564	53	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1266	1793-6454		J CIRCUIT SYST COMP	J. Circuits Syst. Comput.	FEB	2015	24	2			SI				1540003	10.1142/S0218126615400034		25	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CD0NK	WOS:000350770800004		
J	Islam, MS; Koguchi, H				Islam, Md. Shahidul; Koguchi, Hideo			Investigation of Order of Singularity in 3D Transversely Isotropic Piezoelectric Bimaterial Joints by FEM	JOURNAL OF CIRCUITS SYSTEMS AND COMPUTERS			English	Article						Piezoelectric bimaterial joints; order of singularity; transversely isotropic material; smart structures; eigen analysis	ANISOTROPIC MATERIALS; GENERAL-SOLUTION; STRESS-FIELDS; MEDIA	The order of singularity near the vertex of bonded joints is one of the main factors responsible for debonding of electronic device under mechanical or electrical loading. The distribution of singularity field near the vertex of bonded joints is very important to maintain the reliability of smart electronic structure. Piezoelectric material, due to its characteristic direct-converse piezoelectric effect, has naturally received considerable attentions. Piezoelectric materials have been extensively used as transducers and sensors due to their piezoelectric effects that take place between electric fields and mechanical deformation. The order of singularity at a vertex and at a point on singularity line in 3D transversely isotropic piezoelectric joints is analyzed. Eigen analysis based on FEM is used for stress singularity field analysis of piezoelectric bimaterial joints. The eigen equation is used for calculating the order of stress singularity and the angular function of elastic displacement, electric potential, stress and electric displacement. The numerical result shows that the angular functions have large value near the interface edge than the inner portion of the joint. Therefore, there is a possibility to debond and delamination occurs at interface edge of the piezoelectric bimaterial joints, due to the higher stress and electric displacement concentration at the free edge.	[Islam, Md. Shahidul] Khulna Univ Engn & Technol, Dept Mech Engn, Khulna 920300, Khulna, Bangladesh; [Koguchi, Hideo] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan	Islam, MS (reprint author), Khulna Univ Engn & Technol, Dept Mech Engn, Khulna 920300, Khulna, Bangladesh.	shahidulbitk@gmail.com; koguchi@me.nagaokaut.ac.jp			MONBUKAGUSHO	I would like to express my deep and sincere gratitude to my supervisor, Prof. Hideo Koguchi, Nagaoka University of Technology. I am deeply grateful to Takahiko Kurahashi, Nagaoka University of Technology, for his detailed and constructive comments, and for his important support throughout this work. I pay my special gratitude to my father, mother, and brother. They have lost a lot due to my research abroad. My special thank to my wife and son for their loving support. The financial support of the MONBUKAGUSHO is gratefully acknowledged.	Aksentian O. K., 1967, PRIKL MAT MEKH, V31, P178; SOSA H, 1991, INT J SOLIDS STRUCT, V28, P491, DOI 10.1016/0020-7683(91)90061-J; Ding HJ, 1997, INT J SOLIDS STRUCT, V34, P3041; Attaporn W, 2009, CMES-COMP MODEL ENG, V39, P237; Bazent Z. P., 1979, INT J SOLIDS STRUCT, V15, P405; HARTRANF.RJ, 1969, J MATH MECH, V19, P123; Islam Md Shahidul, 2010, Journal of Solid Mechanics and Materials Engineering, V4, DOI 10.1299/jmmp.4.1011; Ming H. Z., 2004, ENG ANA BOUNDARY ELE, V28, P753; PAGEAU SS, 1995, INT J NUMER METH ENG, V38, P2225, DOI 10.1002/nme.1620381306; Pageau SS, 1996, INT J SOLIDS STRUCT, V33, P33, DOI 10.1016/0020-7683(95)00023-4; PAGEAU SS, 1995, INT J SOLIDS STRUCT, V32, P571, DOI 10.1016/0020-7683(94)00152-M; Wang Z. K., 1994, ACTA MECH SINICA, V10, P1; WANG ZK, 1995, INT J SOLIDS STRUCT, V32, P105; Williams M. L., 1952, ASME J APPL MECH, V19, P526; Williams M. L., 1957, ASME J APPL MECH, V24, P109; Yamada Y., 1981, P JAP US C TOK, P55; Zak AR, 1963, J APPL MECH, V30, P142	17	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1266	1793-6454		J CIRCUIT SYST COMP	J. Circuits Syst. Comput.	FEB	2015	24	2			SI				1540001	10.1142/S0218126615400010		21	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CD0NK	WOS:000350770800002		
J	Islam, MS; Rahaman, MT; Bhuiyan, AG; Hashimoto, A				Islam, Md. Sherajul; Rahaman, Md. Tawabur; Bhuiyan, Ashraful Ghani; Hashimoto, Akihiro			Numerical Analysis on Phonon Localization of Vacancy Type Disordered Graphene	JOURNAL OF CIRCUITS SYSTEMS AND COMPUTERS			English	Article						Vibrational properties; graphene; vacancy defects; phonon density of states; hydrogen passivation	DISPERSION; GRAPHITE	The phonon properties of hydrogen passivated graphene with vacancy defects are studied using the forced vibrational method. The phonon density of states (PDOSs), typical mode patterns and localization length are calculated over a broad range of vacancies. We find that phonon properties of graphene strongly depend on the system size. We observe a broadening and softening of the PDOS peaks with the increase of vacancy concentrations. We find an increasing C-H stretching mode with the increase of defect density. Our numerical experiments reveal that the typical mode pattern for the K point in-plane TO (iTO) modes phonon show the spatial localized vibrations persuaded by vacancies, which are in conceptually good agreement with the large D band peak of the Raman spectra comes from the imperfections of crystal. For the K point iTO mode phonons, a typical localization length is on the order approximate to 5 nm for vacancy-type defects at high concentrations of 30% is observed. The localization effects manifest themselves in the projected temperature behavior of the constant-volume specific heat capacity of pristine and disordered graphene samples.	[Islam, Md. Sherajul; Hashimoto, Akihiro] Univ Fukui, Dept Elect & Elect Engn, Fukui 9108507, Japan; [Rahaman, Md. Tawabur; Bhuiyan, Ashraful Ghani] Khulna Univ Engn & Technol, Dept Elect & Elect Engn, Khulna 9203, Bangladesh	Hashimoto, A (reprint author), Univ Fukui, Dept Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	sheraj_ruet@yahoo.com; tawabur_eee06@yahoo.com; ashraf90344@yahoo.com; hasimoto@fuee.u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a Grant-in-Aid of Basic Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Tohei T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064304; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Siebentritt S, 1997, PHYS REV B, V55, P7927, DOI 10.1103/PhysRevB.55.7927; OSHIMA C, 1988, SOLID STATE COMMUN, V65, P1601, DOI 10.1016/0038-1098(88)90660-6; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Mohr M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035439; Wirtz L, 2004, SOLID STATE COMMUN, V131, P141, DOI 10.1016/j.ssc.2004.04.042; Benedict LX, 1996, SOLID STATE COMMUN, V100, P177, DOI 10.1016/0038-1098(96)00386-9; Kim K, 2011, NATURE, V479, P338, DOI 10.1038/nature10680; NICKLOW R, 1972, PHYS REV B, V5, P4951, DOI 10.1103/PhysRevB.5.4951; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Gruneis A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085423; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Yan JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125401; Withers F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073403; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Maultzsch J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075501; Gruneis A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165402; JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H; Cheng SH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205435; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; Savic I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.165502; KRAMER B, 1993, REP PROG PHYS, V56, P1469, DOI 10.1088/0034-4885/56/12/001; Piscanec S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185503; LEE C, 1995, PHYS REV B, V51, P8610, DOI 10.1103/PhysRevB.51.8610; Bell R. J., 1970, FARADAY DISCUSS, V50, P55; Born M., 1954, DYNAMICAL THEORY CRY; Dikin A., 2007, NATURE, V448, P457; Jorio A., 2011, RAMAN SPECTROSCOPY G; Maradudin A. A., 1966, THEORETICAL EXPT ASP; Maradudin A.A., 1963, THEORY LATTICE DYNAM; Mayorov S., 2011, NANO LETT, V11, P2396; Nihira T., 2003, PHYS REV B, V68, P13430; Rodriguez-Nieva JF, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245406; Thouless D. J., 1974, PHYS REP           C, V13, P93, DOI DOI 10.1016/0370-1573(74)90029-5; WEGNER F, 1980, Z PHYS B CON MAT, V36, P209, DOI 10.1007/BF01325284; WILLIAMS ML, 1985, PHYS REV B, V31, P4508, DOI 10.1103/PhysRevB.31.4508; Yamamoto T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215503	40	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1266	1793-6454		J CIRCUIT SYST COMP	J. Circuits Syst. Comput.	FEB	2015	24	2			SI				1540002	10.1142/S0218126615400022		16	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CD0NK	WOS:000350770800003		
J	Yamashita, S; Takahashi, S; Osaka, Y; Fujikura, K; Tabata, K; Tanaka, M				Yamashita, Soichiro; Takahashi, Shinji; Osaka, Yoshiko; Fujikura, Kenzo; Tabata, Koya; Tanaka, Makoto			Efficacy of the transillumination method for appropriate tracheal tube placement in small children: a randomized controlled trial	JOURNAL OF CLINICAL ANESTHESIA			English	Article						Child; General anesthesia; Intubation; Transillumination	ENDOBRONCHIAL INTUBATION; DEPTH; AUSCULTATION; MOVEMENT; POSITION; NEONATE; HEAD	Study Objective: To evaluate whether the transillumination method increased the probability of appropriate tracheal tube (TT) placement compared with the main-stem method. Design: Prospective, randomized, controlled study. Setting: Operating room, university hospital. Patients: Eighty children <2 years old scheduled for elective surgery undergoing general anesthesia. Interventions: Trachlight was used for the transillumination method. After intubation, patients were randomly assigned to 1 of 2 groups: (1) deliberate bronchial intubation with subsequent withdrawal of the TT to 2 cm above the carina (main-stem group) or (2) transmitted visual signal from a bright light at the TT tip on the skin at the suprasternal notch after inserting the Trachlight into the TT (transillumination group). Measurements: The TT tip position was assessed by chest radiograph after the procedure. Appropriate TT placement was defined when the TT tip was located between the sternoclavicular junction and 1 cm above the carina. Main Results: Appropriate TT placement was found in 31 (80%) of 39 patients in the transillumination group and 26 (65%) of 40 in the main-stem group. The transillumination method had higher rate of appropriate TT placement than the main-stem method (P = .15; risk ratio, 1.22; 95% confidence interval, 0.93-1.61). Seven patients (18%) had proximal TT placement, and 1 (3%) had distal TT placement in the transillumination group. In the main-stem group, 7 patients (18%) had proximal TT placement, and 7 (18%) had distal TT placement. Conclusions: The transillumination method was reliable for appropriate TT placement in small children <2 years old undergoing general anesthesia, although the transillumination method was not found to be better compared with the main-stem method. (C) 2014 Elsevier Inc. All rights reserved.	[Yamashita, Soichiro; Takahashi, Shinji; Osaka, Yoshiko; Tanaka, Makoto] Univ Tsukuba, Fac Med, Dept Anesthesiol, Tsukuba, Ibaraki 3058575, Japan; [Fujikura, Kenzo; Tabata, Koya] Univ Tsukuba Hosp, Dept Anesthesiol, Tsukuba, Ibaraki, Japan	Yamashita, S (reprint author), Univ Tsukuba, Fac Med, Dept Anesthesiol, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	soichi2003@aol.com					Sugiyama K, 1999, ANESTH ANALG, V88, P1380, DOI 10.1097/00000539-199906000-00033; Mariano ER, 2005, PEDIATR ANESTH, V15, P846, DOI 10.1111/j.1460-9592.2005.01577.x; Verghese ST, 2004, ANESTH ANALG, V99, P56, DOI 10.1213/01.ANE.0000118104.23660.F3; Davis L, 2000, ANESTH ANALG, V90, P745, DOI 10.1097/00000539-200003000-00044; DONN SM, 1980, PEDIATR RADIOL, V9, P37, DOI 10.1007/BF00973968; Goel S, 2003, PAEDIATR ANAESTH, V13, P579, DOI 10.1046/j.1460-9592.2003.01103.x; Hayakawa Y, 2001, Masui, V50, P175; HELLER RM, 1985, PEDIATRICS, V75, P664; KUHNS LR, 1975, PEDIATRICS, V56, P355; Lau N, 2006, PEDIATR ANESTH, V16, P1238, DOI 10.1111/j.1460-9592.2006.01982.x; Locker GJ, 1998, J CLIN ANESTH, V10, P389, DOI 10.1016/S0952-8180(98)00051-8; Roung TJ, 1985, ANESTH ANALG, V64, P1030; SHURTLEF.DB, 1966, ARCH DIS CHILD, V41, P183; SUN KO, 1995, ANAESTH INTENS CARE, V23, P403; ZANARDO V, 1991, Paediatrie und Paedologie, V26, P227	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	FEB	2015	27	1					12	16		10.1016/j.jclinane.2014.09.003		5	Anesthesiology	Anesthesiology	CC7ES	WOS:000350531100003		
J	Matsunami, S; Komasawa, N; Minami, T				Matsunami, Sayuri; Komasawa, Nobuyasu; Minami, Toshiaki			Application of a modified intubating laryngeal mask for pediatric lung biopsies	JOURNAL OF CLINICAL ANESTHESIA			English	Letter							AIRWAY		[Matsunami, Sayuri; Komasawa, Nobuyasu; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Komasawa N, 2012, RESUSCITATION, V83, P365, DOI 10.1016/j.resuscitation.2011.08.025; Jagannathan N, 2012, PEDIATR ANESTH, V22, P161, DOI 10.1111/j.1460-9592.2011.03703.x; Naumann H, 2012, PEDIATR ANESTH, V22, P469, DOI 10.1111/j.1460-9592.2011.03773.x	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	FEB	2015	27	1					82	82		10.1016/j.jclinane.2014.10.005		1	Anesthesiology	Anesthesiology	CC7ES	WOS:000350531100017		
J	Hirabayashi, G; Furukawa, Y; Maeda, R; Takahashi, N; Kaneko, H; Omi, A; Ogihara, Y				Hirabayashi, Go; Furukawa, Yuichi; Maeda, Ryoji; Takahashi, Nanae; Kaneko, Hideto; Omi, Akibumi; Ogihara, Yukihiko			Effects of setting a heat moisture exchanger filter in a vertical position on water accumulation in low-flow anesthesia	JOURNAL OF CLINICAL ANESTHESIA			English	Letter							WET CONDITIONS		[Hirabayashi, Go] Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anesthesiol, Kawasaki, Tokyo 2138507, Japan; [Furukawa, Yuichi; Maeda, Ryoji; Takahashi, Nanae; Kaneko, Hideto; Omi, Akibumi] Tokyo Med Univ, Hachioji Med Ctr, Dept Anesthesiol, Tokyo 1608402, Japan; [Ogihara, Yukihiko] Tokyo Med Univ, Dept Anesthesiol, Tokyo 1608402, Japan	Hirabayashi, G (reprint author), Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anesthesiol,Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Tokyo 2138507, Japan.	hirabayashil967@gmail.com					Hirabayashi G, 2009, EUR J ANAESTH, V26, P469, DOI 10.1097/EJA.0b013e328324b709; Morgan-Hughes NJ, 2001, BRIT J ANAESTH, V87, P289, DOI 10.1093/bja/87.2.289; PRASAD KK, 1990, ANESTHESIOLOGY, V72, P958, DOI 10.1097/00000542-199005000-00040; Turnbull D, 2005, BRIT J ANAESTH, V94, P675, DOI 10.1093/bja/aei091	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	FEB	2015	27	1					84	86		10.1016/j.jclinane.2014.10.003		3	Anesthesiology	Anesthesiology	CC7ES	WOS:000350531100020		
J	Ueshima, H; Tominaga, A; Usuda, Y; Kitamura, A				Ueshima, Hironobu; Tominaga, Asako; Usuda, Yutaka; Kitamura, Akira			The Endotrol tracheal tube using McGrath can be a viable alternative to laryngoscope intubation	JOURNAL OF CLINICAL ANESTHESIA			English	Letter							MACINTOSH LARYNGOSCOPE; VIDEOLARYNGOSCOPE; DIFFICULT; AIRWAY		[Ueshima, Hironobu; Tominaga, Asako; Usuda, Yutaka; Kitamura, Akira] Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Hidaka City, Saitama, Japan	Ueshima, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, 1397-1 Yamane, Hidaka City, Saitama, Japan.	ueshimhi@yahoo.co.jp					Taylor AM, 2013, ANAESTHESIA, V68, P142, DOI 10.1111/anae.12075; Shippey B, 2008, BRIT J ANAESTH, V100, P116, DOI 10.1093/bja/aem303; Ueshima H, 2010, ANAESTHESIA, V65, P684, DOI 10.1111/j.1365-2044.2010.06366.x; COOK RT, 1993, J CLIN ANESTH, V5, P431, DOI 10.1016/0952-8180(93)90110-Z	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	FEB	2015	27	1					86	87		10.1016/j.jclinane.2014.11.001		2	Anesthesiology	Anesthesiology	CC7ES	WOS:000350531100021		
J	Iwasaki, M				Iwasaki, Motoki			Commentary: Factors Associated With Non-participation in Cohort Studies Emphasize the Need to Generalize the Results With Care	JOURNAL OF EPIDEMIOLOGY			English	Editorial Material									[Iwasaki, Motoki] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Div Epidemiol, Tokyo 1040045, Japan	Iwasaki, M (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Div Epidemiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	moiwasak@ncc.go.jp					Hara M, 2010, J EPIDEMIOL, V20, P40, DOI 10.2188/jea.JE20090062; Hara M, 2015, J EPIDEMIOL, V25, P117, DOI 10.2188/jea.JE20140116; Iwasaki M, 2006, EUR J EPIDEMIOL, V21, P253, DOI 10.1007/s10654-006-0004-z; RIMM EB, 1990, AM J EPIDEMIOL, V131, P1068	4	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					89	90		10.2188/jea.JE20140269		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800001		
J	Hilawe, EH; Yatsuya, H; Li, YY; Uemura, M; Wang, CC; Chiang, CF; Toyoshima, H; Tamakoshi, K; Zhang, Y; Kawazoe, N; Aoyama, A				Hilawe, Esayas Haregot; Yatsuya, Hiroshi; Li, Yuanying; Uemura, Mayu; Wang, Chaochen; Chiang, Chifa; Toyoshima, Hideaki; Tamakoshi, Koji; Zhang, Yan; Kawazoe, Nobuo; Aoyama, Atsuko			Smoking and Diabetes: Is the Association Mediated by Adiponectin, Leptin, or C-reactive Protein?	JOURNAL OF EPIDEMIOLOGY			English	Article						adiponectin; C-reactive protein; leptin; mediation analysis; smoking; type 2 diabetes mellitus	HEALTHY JAPANESE MEN; MIDDLE-AGED MEN; CIGARETTE-SMOKING; INFLAMMATORY MARKERS; SERUM ADIPONECTIN; MONICA/KORA AUGSBURG; INVERSE RELATIONSHIP; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK	Background: Although the association between cigarette smoking and risk of type 2 diabetes is well established, its mechanisms are yet to be clarified. This study examined the possible mediating effects of adiponectin, leptin, and C-reactive protein (CRP) concentrations on the smoking-diabetes association. Methods: Between 2002 and 2011, we followed 3338 Japanese workers, aged 35-66 years, who were enrolled in the second Aichi workers' cohort study. We used multivariable-adjusted Cox regression models to determine the hazard ratios and respective 95% confidence intervals (CIs) of the association between smoking status and risk of diabetes. A multiple mediation model with bootstrapping was used to estimate the magnitude and the respective biascorrected (BC) 95% CIs of the indirect effects of smoking on diabetes through the three biomarkers. Results: Relative to never smokers, the risk of diabetes was significantly elevated in current (hazard ratio 1.75, 95% CI 1.25-2.46) and ex-smokers (hazard ratio 1.54, 95% CI 1.07-2.22). The indirect effects of smoking on diabetes through adiponectin levels were statistically significant among light (point estimate 0.033, BC 95% CI 0.005-0.082), moderate (point estimate 0.044, BC 95% CI 0.010-0.094), and heavy smokers (point estimate 0.054, BC 95% CI 0.013-0.113). In contrast, neither the indirect effects of smoking on diabetes through leptin nor CRP levels were significant, as the corresponding BC 95% CIs included zero. Conclusions: In our analysis, adiponectin concentration appeared to partially mediate the effect of smoking on diabetes, while leptin and CRP levels did not.	[Hilawe, Esayas Haregot; Yatsuya, Hiroshi; Uemura, Mayu; Wang, Chaochen; Chiang, Chifa; Zhang, Yan; Kawazoe, Nobuo; Aoyama, Atsuko] Nagoya Univ, Grad Sch Med, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi 4648601, Japan; [Hilawe, Esayas Haregot] Mekelle Univ, Sch Med, Dept Publ Hlth, Mekelle, Ethiopia; [Yatsuya, Hiroshi; Li, Yuanying] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 4701192, Japan; [Toyoshima, Hideaki] Anjo Kosei Hosp, Anjo, Aichi, Japan; [Tamakoshi, Koji] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi 4648601, Japan	Yatsuya, H (reprint author), Fujita Hlth Univ, Sch Med, Toyoake, Aichi 4701192, Japan.	h828@med.nagoya-u.ac.jp			MEXT; JSPS [13470087, 16590499, 17390185, 17790384, 18590594, 22390133, 23590787, 26293153]; Japan Atherosclerosis Prevention Fund	This study was supported by MEXT and JSPS KAKENHI Grant Numbers 13470087, 16590499, 17390185, 17790384, 18590594, 22390133, 23590787, 26293153, and the Japan Atherosclerosis Prevention Fund.	Al-Daghri Nasser M, 2009, Diabetes Res Clin Pract, V83, pe37, DOI 10.1016/j.diabres.2008.11.013; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Welsh P, 2009, DIABETES CARE, V32, P308, DOI 10.2337/dc08-1458; Hotta Y, 2008, DIABETES RES CLIN PR, V81, P358, DOI 10.1016/j.diabres.2008.05.005; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Otsuka F, 2009, J CARDIOL, V53, P219, DOI 10.1016/j.jjcc.2008.11.004; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Matsushita K, 2006, ATHEROSCLEROSIS, V188, P184, DOI 10.1016/j.atherosclerosis.2005.10.031; Doi Y, 2005, DIABETES CARE, V28, P2497, DOI 10.2337/diacare.28.10.2497; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Kawakami N, 1997, AM J EPIDEMIOL, V145, P103; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Wada K, 2009, J CLIN EPIDEMIOL, V62, P306, DOI 10.1016/j.jclinepi.2008.04.006; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Takefuji S, 2007, PREV MED, V45, P471, DOI 10.1016/j.ypmed.2007.07.001; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Nakanishi N, 2000, ANN INTERN MED, V133, P183; Beziaud F, 2004, DIABETES METAB, V30, P161, DOI 10.1016/S1262-3636(07)70102-7; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Efstathiou SP, 2009, ATHEROSCLEROSIS, V205, P632, DOI 10.1016/j.atherosclerosis.2009.01.022; Eliasson B, 1999, EUR J CLIN INVEST, V29, P145, DOI 10.1046/j.1365-2362.1999.00420.x; Fagard Robert H, 2009, Prim Care Diabetes, V3, P205, DOI 10.1016/j.pcd.2009.09.003; Gu W, 2012, BIODRUGS, V26, P1, DOI 10.2165/11594790-000000000-00000; Hastie CE, 2008, NICOTINE TOB RES, V10, P637, DOI 10.1080/14622200801978722; Hayes A. F., 2013, INTRO MEDIATION MODE; Hayes A.F., 2013, BR J MATH STAT PSYCH; Iwashima Y, 2005, HYPERTENSION, V45, P1094, DOI 10.1161/01.HYP.0000169444.05588.4c; Jee Sun Ha, 2013, Diabetes Metab J, V37, P252, DOI 10.4093/dmj.2013.37.4.252; Koc B, 2009, UPSALA J MED SCI, V114, P165, DOI 10.1080/03009730902761631; Lao XQ, 2009, ATHEROSCLEROSIS, V203, P304, DOI 10.1016/j.atherosclerosis.2008.06.028; Li YY, 2012, DIABETES-METAB RES, V28, P349, DOI 10.1002/dmrr.2277; Luo JH, 2013, AM J EPIDEMIOL, V178, P937, DOI 10.1093/aje/kwt071; Marques-Vidal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051768; Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0; Nagayasu S, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-3; O'Loughlin J, 2008, NICOTINE TOB RES, V10, P525, DOI 10.1080/14622200801901997; Ong KL, 2011, DIABETOLOGIA, V54, P2552, DOI 10.1007/s00125-011-2227-0; Perkins Kenneth A, 2002, Nicotine Tob Res, V4, P459, DOI 10.1080/1462220021000018434; Reseland JE, 2005, PROSTAG LEUKOTR ESS, V73, P43, DOI 10.1016/j.plefa.2005.04.006; RIMM EB, 1995, BRIT MED J, V310, P555; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; Schmidt MI, 2006, DIABETOLOGIA, V49, P2086, DOI 10.1007/s00125-006-0351-z; Science and Technology Agency, 2005, STAND TABL FOOD COMP; Stern Naftali, 2007, J Cardiometab Syndr, V2, P174, DOI 10.1111/j.1559-4564.2007.06597.x; Sull JW, 2009, ENDOCR J, V56, P73, DOI 10.1507/endocrj.K08E-231; Thamer C, 2005, ATHEROSCLEROSIS, V179, P421, DOI 10.1016/j.atherosclerosis.2004.12.039; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	72	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					99	109		10.2188/jea.JE20140055		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800003		
J	Fukumoto, K; Taniguchi, T; Usami, N; Kawaguchi, K; Fukui, T; Ishiguro, F; Nakamura, S; Yokoi, K				Fukumoto, Koichi; Taniguchi, Tetsuo; Usami, Noriyasu; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Nakamura, Shota; Yokoi, Kohei			The ABO Blood Group is an Independent Prognostic Factor in Patients With Resected Non-small Cell Lung Cancer	JOURNAL OF EPIDEMIOLOGY			English	Article						non-small cell lung cancer; ABO blood group; surgery; prognostic factor	SERUM CARCINOEMBRYONIC ANTIGEN; EPITHELIAL OVARIAN-CANCER; PANCREATIC-CANCER; GASTRIC-CANCER; NASOPHARYNGEAL CARCINOMA; RISK; METAANALYSIS; ASSOCIATION; POPULATION; SURVIVAL	Background: The ABO blood group is reported to be associated with the incidence and patient survival for several types of malignancies. We conducted a retrospective study to evaluate the prognostic significance of the ABO blood group in patients with resected non-small cell lung cancer (NSCLC). Methods: A total of 333 patients (218 men and 115 women) with resected NSCLC were included in this study. In addition to age, sex, smoking status, preoperative serum carcinoembryonic antigen (CEA) level, operative procedure, histology of tumors, pathological stage (p-stage), and adjuvant therapy, the association between the ABO blood group and survival was explored. Results: The 5-year overall and disease-free survival rates were 83.0% and 71.6% for blood group O, 67.2% and 62.3% for blood group A, 68.8% and 68.8% for blood group B and 69.2% and 65.3% for blood group AB, respectively. A multivariate analysis for overall survival showed the ABO blood group (group A vs. group O: HR 2.47, group AB vs. group O: HR 3.62) to be an independent significant prognostic factor, in addition to age, sex, smoking status, p-stage, and serum CEA level. A multivariate analysis for disease-free survival also showed the ABO blood group to be an independent significant prognostic factor. Conclusions: The ABO blood group is an independent prognostic factor in patients with resected NSCLC. Studies of other larger cohorts are therefore needed to confirm the relationship between the ABO blood group and the prognosis among patients with resected NSCLC.	[Fukumoto, Koichi; Taniguchi, Tetsuo; Usami, Noriyasu; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Nakamura, Shota; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4668550, Japan	Fukumoto, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kfukumoto@med.nagoya-u.ac.jp					Alberg AJ, 2013, CHEST, V143, pe1S, DOI [10.1378/chest.12-23451685278, 10.1378/chest.12-2345]; OuYang PY, 2013, BRIT J CANCER, V109, P2462, DOI 10.1038/bjc.2013.559; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Wang ZW, 2012, INT J MOL SCI, V13, P13308, DOI 10.3390/ijms131013308; Kaffenberger SD, 2012, BJU INT, V110, pE641, DOI 10.1111/j.1464-410X.2012.11366.x; Khalili H, 2011, CANCER EPIDEM BIOMAR, V20, P1017, DOI 10.1158/1055-9965.EPI-10-1250; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Nakao M, 2011, CANCER SCI, V102, P1076, DOI 10.1111/j.1349-7006.2011.01907.x; Joh HK, 2012, CANCER EPIDEMIOL, V36, P528, DOI 10.1016/j.canep.2012.07.001; Franchini M, 2013, BLOOD TRANSFUS-ITALY, V11, P164, DOI 10.2450/2012.0087-12; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Ozeki N, 2014, EUR J CARDIO-THORAC, V45, P687, DOI 10.1093/ejcts/ezt424; Yuzhalin AE, 2012, ASIAN PAC J CANCER P, V13, P5091, DOI 10.7314/APJCP.2012.13.10.5091; Gates MA, 2011, INT J CANCER, V128, P482, DOI 10.1002/ijc.25339; Risch HA, 2013, AM J EPIDEMIOL, V177, P1326, DOI 10.1093/aje/kws458; Matsuguma H, 2008, J THORAC CARDIOV SUR, V135, P44, DOI 10.1016/j.jtcvs.2007.09.032; He MA, 2012, ARTERIOSCL THROM VAS, V32, P2314, DOI 10.1161/ATVBAHA.112.248757; Urun Y, 2013, ASIAN PAC J CANCER P, V14, P2801, DOI 10.7314/APJCP.2013.14.5.2801; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; BANKS RE, 1993, BRIT J CANCER, V68, P122, DOI 10.1038/bjc.1993.298; FUJITA Y, 1978, JPN J HUM GENET, V23, P63, DOI 10.1007/BF02001790; Lim E, 2010, J THORAC CARDIOV SUR, V139, P1441, DOI 10.1016/j.jtcvs.2009.05.048; Liumbruno GM, 2014, J THROMB THROMBOLYS, V38, P160, DOI 10.1007/s11239-013-1027-4; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Miao SY, 2014, ASIA-PAC J CLIN ONCO, V10, P101, DOI 10.1111/ajco.12083; Pare G., 2008, PLOS GENET, V4; Rahbari NN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-319; SZULMAN AE, 1962, J EXP MED, V115, P977, DOI 10.1084/jem.115.5.977; Williams FMK, 2013, ANN NEUROL, V73, P16, DOI 10.1002/ana.23838; Zhou Y, 2013, INT J CANCER, V133, P1867, DOI 10.1002/ijc.28196	35	1	2	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					110	116		10.2188/jea.JE20140102		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800004		
J	Hara, M; Shimanoe, C; Otsuka, Y; Nishida, Y; Nanri, H; Horita, M; Yasukata, J; Miyoshi, N; Yamada, Y; Higaki, Y; Tanaka, K				Hara, Megumi; Shimanoe, Chisato; Otsuka, Yasuko; Nishida, Yuichiro; Nanri, Hinako; Horita, Mikako; Yasukata, Jun; Miyoshi, Nobuyuki; Yamada, Yosuke; Higaki, Yasuki; Tanaka, Keitaro			Factors Associated With Non-participation in a Face-to-Face Second Survey Conducted 5 Years After the Baseline Survey	JOURNAL OF EPIDEMIOLOGY			English	Article						non-participation; second survey; cohort; socioeconomic factors; lifestyle-related factors	FOLLOW-UP; MODERATE DRINKING; ATTRITION; COHORT; HEALTH; PREDICTORS; STRATEGIES; GENDER; CANCER; JAPAN	Background: Non-participation in second surveys is reported to be associated with certain baseline characteristics; however, such data are unavailable for Japanese populations. Although disease incidence during follow-up might influence participation, few reports have addressed this possibility. This study sought to identify factors associated with non-participation in a second survey of a population-based cohort, and to evaluate the influence of self-reported disease incidence on non-participation. Methods: After excluding participants who left the area (n = 423), died (n = 163), and withdrew from the study (n = 9) among 12 078 participants in a baseline survey for the Japan Multi-Institutional Collaborative Cohort Study in the Saga region between 2005 and 2007, 11 483 people were invited by mail to participate in a face-to-face second survey between 2010 and 2012. The 5-year clinical health history of non-participants was assessed by mail or telephone. Baseline characteristics and self-reported clinical outcomes of non-participants were compared with those of participants. Results: Among 11 483 people, 8454 (73.6%) participated in the second survey, and 2608 out of 3029 non-participants answered mail or telephone health surveys. Female sex, youngest and oldest ages, lower education, lower occupational class, current smoking, lower physical activity level, shorter sleep time, obesity, and constipation were associated with non-participation. Light drinking (0.1-22.9 g ethanol/day) was associated with participation. Non-participants reported a significantly higher incidence of cancer and a significantly lower proportion of hypertension compared with participants. Conclusions: Both baseline characteristics and disease incidence during the follow-up period had significant associations with non-participation in the face-to-face second survey.	[Hara, Megumi; Shimanoe, Chisato; Otsuka, Yasuko; Nishida, Yuichiro; Horita, Mikako; Tanaka, Keitaro] Saga Univ, Fac Med, Dept Prevent Med, Saga 8498501, Japan; [Nanri, Hinako] Showa Univ, Dept Publ Hlth, Tokyo, Japan; [Yasukata, Jun; Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Lab Exercise Physiol, Fukuoka 81401, Japan; [Miyoshi, Nobuyuki] Seika Womens Jr Coll, Dept Childhood Care Educ, Fukuoka, Japan; [Yamada, Yosuke] Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan	Hara, M (reprint author), Saga Univ, Fac Med, Dept Prevent Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	harameg@cc.saga-u.ac.jp		Nishida, Yuichiro/0000-0003-2320-7234	Japanese Ministry of Education, Culture, Sports, Science and Technology [25460759, 17015018, 18390182, 18790380, 20249038, 20689014, 221S0001]	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Nos. 25460759, 17015018, 18390182, 18790380, 20249038, 20689014, and 221S0001).	Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Hara M, 2010, J EPIDEMIOL, V20, P40, DOI 10.2188/jea.JE20090062; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P952, DOI 10.1136/jech.2008.086892; Bambs CE, 2013, ANN EPIDEMIOL, V23, P328, DOI 10.1016/j.annepidem.2013.02.007; Alonso A, 2006, EUR J EPIDEMIOL, V21, P351, DOI 10.1007/s10654-006-9008-y; Rao SSC, 2007, J PSYCHOSOM RES, V63, P441, DOI 10.1016/j.jpsychores.2007.05.016; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71; David MC, 2013, J CLIN EPIDEMIOL, V66, P888, DOI 10.1016/j.jclinepi.2013.03.008; El-Guebaly N, 2007, ANN EPIDEMIOL, V17, pS55, DOI 10.1016/j.annepidem.2007.01.013; Garcia M, 2005, ANN EPIDEMIOL, V15, P98, DOI 10.1016/j.anneoidem.2004.06.002; Goldberg M, 2006, J CLIN EPIDEMIOL, V59, P1213, DOI 10.1016/j.jclinepi.2006.02.020; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Heath DB, 2007, ANN EPIDEMIOL, V17, pS71, DOI 10.1016/j.annepidem.2007.01.016; May AM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-148; Pirzada A, 2004, AM J EPIDEMIOL, V159, P94, DOI 10.1093/aje/kwh012; Shimanoe C, 2014, INT J BEHAV MED, V21, P821, DOI 10.1007/s12529-013-9341-y; Yoshihara Chika, 2005, Nihon Arukoru Yakubutsu Igakkai Zasshi, V40, P441	20	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					117	125		10.2188/jea.JE20140116		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800005		
J	Suzuki, H; Hikiji, W; Tanifuji, T; Abe, N; Fukunaga, T				Suzuki, Hideto; Hikiji, Wakako; Tanifuji, Takanobu; Abe, Nobuyuki; Fukunaga, Tatsushige			Characteristics of Sudden Bath-Related Death Investigated by Medical Examiners in Tokyo, Japan	JOURNAL OF EPIDEMIOLOGY			English	Article						bath-related death; sudden death; forensic autopsy; medical examiner	HOT BATH; PRACTITIONERS	Background: Sudden bath-related deaths occur frequently in Japan, particularly among elderly people. However, the precise mechanism of bath-related death remains uncertain, and effective prevention strategies have not been established. Methods: Cases of bath-related deaths (n = 3289) were selected from all cases handled by the Tokyo Medical Examiner's Office from 2009 to 2011 (N = 41 336). The ages and occurrence dates were examined, and major autopsy findings, including toxicological analysis, were evaluated for the autopsied cases (n = 550). Results: Most cases occurred in individuals older than 60 years of age during winter. Analysis of autopsy findings revealed water inhalation signs in many cases (n = 435, 79.1%). Circulatory system diseases constituted more than half of the pathological findings regarding factors that may have contributed significantly to death (n = 300, 54.5%), and cardiac lesions were the most common pathological finding (n = 250, 45.5%). However, approximately one-third of the cases exhibited no remarkable pathological findings (n = 198, 36.0%). A quarter of all cases involved blood ethanol levels that exceeded 0.5 mg/mL (n = 140). Conclusions: The results suggested that drowning plays an important role in the final process of bath-related death. Circulatory system diseases may be the primary underlying pathology; however, there were variations in the medical histories and pathologies of cases of bath-related death. From a preventive perspective, family members should pay attention to elderly people with circulatory system diseases during bathing, particularly in winter. Additionally, the notion that ill or inebriated individuals should not take baths should be reinforced.	[Suzuki, Hideto; Hikiji, Wakako; Tanifuji, Takanobu; Abe, Nobuyuki; Fukunaga, Tatsushige] Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Tokyo 1120012, Japan	Suzuki, H (reprint author), Tokyo Metropolitan Govt, Tokyo Med Examiners Off, 4-21-18 Otsuka, Tokyo 1120012, Japan.	hideto-@qk9.so-net.ne.jp			Health and Labor Sciences Research Grant	This work was supported, in part, by a Health and Labor Sciences Research Grant.	AJIKI W, 1991, FORENSIC SCI INT, V51, P35, DOI 10.1016/0379-0738(91)90204-V; Satoh F, 2013, AM J FOREN MED PATH, V34, P164, DOI 10.1097/PAF.0b013e31828d68c7; Iwase H, 2010, J FORENSIC SCI, V55, P1509, DOI 10.1111/j.1556-4029.2010.01465.x; Sengul C, 2011, CARDIOL J, V18, P682, DOI 10.5603/CJ.2011.0033; Boari B, 2011, REV CARDIOVASC MED, V12, P211, DOI 10.3909/ricm0579; Bureau of General Affairs Tokyo Metropolitan Government, 2014, DAT REG POP TOK METR; Census report Ministry of Health Labour and Welfare, 2014, NUMB DEATH CARD DIS; Chiba T, 2005, FORENSIC SCI INT, V149, P151, DOI 10.1016/j.forsciint.2004.04.085; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Fujimiya Tatsuya, 2009, Leg Med (Tokyo), V11 Suppl 1, pS6, DOI 10.1016/j.legalmed.2009.02.022; Hayashi T, 2010, MED SCI LAW, V50, P11, DOI 10.1258/msl.2009.009002; Hitosugi M, 1999, Leg Med (Tokyo), V1, P80, DOI 10.1016/S1344-6223(99)80017-0; Hori Shingo, 2013, Nihon Rinsho, V71, P1047; Igarashi T, 2003, JJCDP, V38, P16; Kuroki Hisanaga, 2003, Leg Med (Tokyo), V5 Suppl 1, pS307, DOI 10.1016/S1344-6223(02)00157-8; Nagasawa Y, 2001, JPN CIRC J, V65, P587, DOI 10.1253/jcj.65.587; Suzuki H, 2011, LEGAL MED-TOKYO, V13, P273, DOI 10.1016/j.legalmed.2011.09.001; Tokyo Metropolitan Institute of Public health, 2014, AN DEATH ACC JAP; Yoshioka Naofumi, 2003, Leg Med (Tokyo), V5 Suppl 1, pS375, DOI 10.1016/S1344-6223(02)00136-0	19	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					126	132		10.2188/jea.JE20140068		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800006		
J	Nakayama, Y; Mori, M				Nakayama, Yoshimi; Mori, Mitsuru			Association Between Nocturnal Breastfeeding and Snacking Habits and the Risk of Early Childhood Caries in 18-to 23-Month-Old Japanese Children	JOURNAL OF EPIDEMIOLOGY			English	Article						breastfeeding; environmental tobacco smoke; early childhood caries; snacking habits	DENTAL-CARIES; PRESCHOOL-CHILDREN; HUMAN-MILK; ORAL-HEALTH; SMOKING; DETERMINANTS; POPULATION; EXPERIENCE; INFANTS	Background: Early childhood caries (ECC) is one of the most prevalent chronic diseases among children. The aim of this cross-sectional study was to investigate the association between nocturnal breastfeeding, snacking habits, or other risk factors and ECC in 18- to 23-month-old Japanese children. Methods: Study subjects were 1675 children aged 18 to 23 months. A self-administered questionnaire was completed by parents or guardians of the children. The survey contents included such things as number of decayed, missing, and filled teeth per child, smokers in the home, nocturnal breastfeeding habit, snack times, kinds of snacks consumed >= 4 days a week, kinds of drinks consumed >= 4 days a week, parents brushing their child's teeth daily, and the use of fluoride toothpaste. Logistic regression analysis was performed to estimate the odds of ECC. Results: The average number of decayed, missing and filled teeth was 0.10. The prevalence of dental caries was 3.3%. Nocturnal breastfeeding habits were reported in 357 subjects (21.3%). After excluding items of multicollinearity, significant associations were observed between ECC and nocturnal breastfeeding, drinking or eating sweets after dinner every day, and the intake of candy, soda and/or isotonic drinks >= 4 days a week. Conclusions: This study suggests that nocturnal breastfeeding and snacking habits are correlated with ECC.	[Nakayama, Yoshimi] Hokkaido Tomakomai Publ Hlth Ctr, Tomakomai, Hokkaido 0530021, Japan; [Nakayama, Yoshimi; Mori, Mitsuru] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan	Nakayama, Y (reprint author), Hokkaido Tomakomai Publ Hlth Ctr, 2-2-21 Wakakusa, Tomakomai, Hokkaido 0530021, Japan.	nakayama.yoshimi@pref.hokkaido.lg.jp					Abe Y, 1991, JPN J PED DENT, V29, P373; al-Dashti A A, 1995, Community Dent Health, V12, P42; Hallett KB, 2003, AUST DENT J, V48, P27, DOI 10.1111/j.1834-7819.2003.tb00005.x; Hanioka T, 2008, PAEDIATR PERINAT EP, V22, P546, DOI 10.1111/j.1365-3016.2008.00950.x; Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124; Tanaka K, 2009, J PEDIATR-US, V155, P410, DOI 10.1016/j.jpeds.2009.03.032; MATEE M, 1994, COMMUNITY DENT ORAL, V22, P289; Shenkin JD, 2004, J PUBLIC HEALTH DENT, V64, P184, DOI 10.1111/j.1752-7325.2004.tb02750.x; Vazquez-Nava F, 2008, CARIES RES, V42, P141, DOI 10.1159/000121438; Azevedo TDPL, 2005, PEDIATR DENT, V27, P28; Helderman WV, 2006, J DENT RES, V85, P85; Tanaka K, 2012, J EPIDEMIOL, V22, P72, DOI 10.2188/jea.JE20110042; Nunes AMM, 2012, COMMUNITY DENT ORAL, V40, P542, DOI 10.1111/j.1600-0528.2012.00703.x; Johansson I, 2010, CARIES RES, V44, P421, DOI 10.1159/000318569; Tanaka K, 2006, J PUBLIC HEALTH DENT, V66, P279; Feldens CA, 2010, CARIES RES, V44, P445, DOI 10.1159/000319898; Correa-Faria P, 2013, BRAZ ORAL RES, V27, P356, DOI 10.1590/S1806-83242013005000021; Aligne CA, 2003, JAMA-J AM MED ASSOC, V289, P1258, DOI 10.1001/jama.289.10.1258; Bowen WH, 2005, PEDIATRICS, V116, P921, DOI 10.1542/peds.2004-2462; Campus G, 2009, CARIES RES, V43, P155, DOI 10.1159/000211719; Williams SA, 2000, CARIES RES, V34, P117, DOI 10.1159/000016578; Bissar A, 2013, CLIN ORAL INVEST; GREER FR, 1982, J PEDIATR-US, V100, P59, DOI 10.1016/S0022-3476(82)80235-7; Hallett Kerrod B, 2002, Community Dent Health, V19, P237; Ibrahim S, 2009, PEDIAT DENT J, V19, P174; Kin S, 1997, JPN J PED DENT, V35, P447; Kumarihamy Shanika Lm, 2011, BMC Res Notes, V4, P336, DOI 10.1186/1756-0500-4-336; Leroy R, 2008, COMMUNITY DENT ORAL, V36, P249, DOI 10.1111/j.1600-0528.2007.00393.x; Marshall Teresa A, 2003, Dent Clin North Am, V47, P279, DOI 10.1016/S0011-8532(02)00101-5; Maruyama S, 2008, PED DENT J, V18, P156; Mitoh S, 2006, J DENT HLTH, V56, P688; Mizoguchi Kyoko, 2003, Nihon Koshu Eisei Zasshi, V50, P867; Mohebbi SZ, 2008, COMMUNITY DENT ORAL, V36, P363, DOI 10.1111/j.1600-0528.2007.00408.x; Nakayama Y, 2008, J DENT HLTH, V58, P177; Ohsuka K, 2010, J I PSYCHOL PHY SCI, V2, P17; Prakash Prashanth, 2012, Eur J Dent, V6, P141; Roberts G J, 1994, Community Dent Health, V11, P38; Sankeshwari R M, 2013, Eur Arch Paediatr Dent, V14, P147, DOI 10.1007/s40368-013-0035-6; Schluter PJ, 2007, J PUBLIC HEALTH DENT, V67, P69, DOI 10.1111/j.0022-4006.2007.00014.x; Sogabe N, 2011, J CHILD HLTH, V70, P479; Tanaka K, 2013, PEDIATR DENT, V35, P267; Thomson ME, 1996, CARIES RES, V30, P434; Tinanoff Norman, 2005, Dent Clin North Am, V49, P725, DOI 10.1016/j.cden.2005.05.011; Weber-Gasparoni Karin, 2007, J Dent Child (Chic), V74, P52; World Health Organization, 2003, GLOB STRAT INF YOUNG; Yonezu Takuro, 2006, Bull Tokyo Dent Coll, V47, P157, DOI 10.2209/tdcpublication.47.157; Yonezu Takuro, 2006, Bull Tokyo Dent Coll, V47, P161, DOI 10.2209/tdcpublication.47.161; Rosenblatt A, 2004, Int J Paediatr Dent, V14, P439, DOI 10.1111/j.1365-263X.2004.00569.x	48	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					142	147		10.2188/jea.JE20140097		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800008		
J	Tsunematsu, M; Kakehashi, M				Tsunematsu, Miwako; Kakehashi, Masayuki			An Analysis of Mass Screening Strategies Using a Mathematical Model: Comparison of Breast Cancer Screening in Japan and the United States	JOURNAL OF EPIDEMIOLOGY			English	Article						breast cancer; mass screening; mathematical model; benefit; harm	SERVICES TASK-FORCE; COST-EFFECTIVENESS ANALYSIS; MAMMOGRAPHY; OVERDIAGNOSIS; GUIDELINES; MORTALITY; BENEFITS; HARMS; AGE	Background: Although the United States Preventive Services Task Force (USPSTF) downgraded their recommendation for breast cancer screening for women aged 40-49 years in 2009, Japanese women in their 40s have been encouraged to attend breast cancer screenings since 2004. The aim of this study is to examine whether these different mass-screening strategies are justifiable by the different situations of these countries and to provide evidence for suitable judgment. Methods: Performance of screening strategies (annual/biennial intervals; initiating/terminating ages) was evaluated using a mathematical model based on the natural history of breast cancer and the transition between its stages. Benefits (reduced number of deaths and extended average life expectancy) and harm (false-positives) associated with these strategies were calculated. Results: Additional average life expectancy by including women in their 40s as participants were 13 days (26%) and 25 days (22%) in Japan and the United States, respectively, under the biennial screening condition; however, the respective increases in numbers of false-positive cases were 65% and 53% in Japan and the United States. Moreover, the number of screenings needed to detect one diagnosis or to avert one death was smaller when participants were limited to women of age 50 or over than when women in their 40s were included. The validity of including women in their 40s in Japan could not be determined without specifying the weight of harms compared to benefits. Conclusions: Whether screening of women in their 40s in Japan is justifiable must be carefully determined based the quantitative balance of benefits and harms.	[Tsunematsu, Miwako; Kakehashi, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Hlth Informat, Hiroshima, Japan	Tsunematsu, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Hlth Informat, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	tsunematsu@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan;  [23659350]	The present study received Grant-in-Aid for Challenging Exploratory Research (23659350), the Ministry of Education, Culture, Sports, Science and Technology in Japan.	American Cancer Society, BREAST CANC FACTS FI; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Woolf SH, 2010, JAMA-J AM MED ASSOC, V303, P162, DOI 10.1001/jama.2009.1989; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Ohnuki K, 2006, CANCER SCI, V97, P1242, DOI 10.1111/j.1349-7006.2006.00296.x; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; White E, 2004, J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Fletcher SW, 2011, EPIDEMIOL REV, V33, P165, DOI 10.1093/epirev/mxr003; Berlin L, 2010, RADIOLOGY, V255, P311, DOI 10.1148/radiol.10100056; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Stout NK, 2006, J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Mandelblatt JS, 2011, BREAST, V20, pS75, DOI 10.1016/S0960-9776(11)70299-5; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Cronin KA, 2006, J NATL CANC I MONOGR, P112; Elizabeth A, 2011, NATL VITAL STAT REPO, V59, P9; Health Labour and Welfare Statistics Association, 2013, J HLTH WELFARE STAT, V59, P73; Iinuma T, 2004, J JPN ASS BREAST CAN, V3, P47; Jorgensen KJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kasahara Y, 2012, BREAST CANC, V20, P310; Ministry of Health Labor and Welfare of Japan, 2013, THE 19 LIF TABL; Ministry of Health Labor and Welfare of Japan, 2011, REP HLTH CTR ACT HLT; Ministry of Health Labor and Welfare of Japan, 2013, VIT STAT JAP; Ministry of Health Labor and Welfare of Japan, 2007, COMPR SURV LIV COND; Morimoto T, 2011, BREAST CANC INFORM C, P18; National Cancer Institute, CANC STAT REV 1975 2; National Cancer Institute, SURV EP END RES SEER; [National Cancer Institute Breast cancer surveillance consortium], BREAST CANC SURV CON; Ohnuki K, 1997, J JPN ASS BREAST CAN, V6, P145; Ohuchi N, 2008, J JPN ASS BREAST CAN, V17, P15; Research Center for Cancer Prevention and Screening. National Cancer Center, 2013, GUID BREAST CANC SCR; Research Group for the Survey on the justification of cancer screening, 2001, RES GROUP SURV JUST; Salzmann P, 1997, ANN INTERN MED, V127, P955; Sobue T, 2011, JPN J BREAST CANC, V26, P193; Suzuki A, 2008, CANCER SCI, V99, P2264, DOI 10.1111/j.1349-7006.2008.00926.x; The American College of Surgeons, 2013, NAT CANC DAT BAS PUB; The Japan Association of Breast Cancer Screening, 2013, VIEW JAP ASS BREAST; The Japanese Breast Cancer Society, 2013, 2009 NAT BREAST CANC; The Japanese Breast Cancer Society, 2013, EV BAS GUID MAN BREA; Calonge N, 2009, ANN INTERN MED, V151, P716; Vaino H, 2002, IARC HDB CANC PREVEN, P144; World Health Organization, 2013, INC MORT AGE SPEC TA; YAMAGUCHI N, 1991, CANCER CAUSE CONTROL, V2, P147, DOI 10.1007/BF00056207	46	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	FEB	2015	25	2					162	171		10.2188/jea.JE20140047		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4XL	WOS:000350358800011		
J	Joh, M; Matsuda, T; Miyazono, A				Joh, M.; Matsuda, T.; Miyazono, A.			Common otolith microstructure related to key early life-history events in flatfishes identified in the larvae and juveniles of cresthead flounder Pseudopleuronectes schrenki	JOURNAL OF FISH BIOLOGY			English	Article						accessory primordia; check ring; eye migration; lapillus; metamorphosing zone; sagittae	ANCHOVY ENGRAULIS-JAPONICUS; DAILY INCREMENT VALIDATION; RHOMBOSOLEA-TAPIRINA; SOMATIC GROWTH; YOKOHAMAE; TEMPERATURE; PATTERNS; SURVIVAL; SUCCESS; AGE	Otolith microstructure of reared and wild cresthead flounder Pseudopleuronectes schrenki larvae and juveniles was used to investigate the daily periodicity of ring formation, morphological change and unique otolith structure related to important life events. By comparing microstructural features of P. schrenki with those reported for other flatfish species, it was shown that there may be microstructural features that are common to all flatfishes. In the sagittae and lapillus, a check (a distinct ring) was formed in the centre of otoliths at c. 6 days post hatching, and the daily formation of rings observed outside the check was confirmed. During metamorphosis, accessory primordia (AP) of otolith growth were formed on the outer edge of the sagittae, and the shape of the sagittae became more complex. No AP was formed on the lapilli, however, and otolith rings were concentrically formed throughout the larval and juvenile (516 mm standard length, L-S) stages. It is proposed, therefore, that lapilli are more appropriate than sagittae for analysis throughout the larval and juvenile (516 mm L-S) stages. During metamorphosis, unique rings that are relatively wide and show weak contrast are formed on lapilli (metamorphosing zone, MZ). Hence, the duration of metamorphosis, larval duration and the days of juvenile life can be estimated by the number of rings within the MZ, using rings from the check to outermost ring of the MZ, and that of rings formed outside MZ, respectively. The formation of AP on sagittae as well as the absence of AP, bilateral asymmetry and the formation of a unique structure during metamorphosis on lapilli have also been reported for other flatfishes. (C) 2014 The Fisheries Society of the British Isles	[Joh, M.; Miyazono, A.] Hokkaido Res Org, Abashiri Fisheries Res Inst, Abashiri, Hokkaido 0993119, Japan; [Matsuda, T.] Hokkaido Res Org, Mariculture Fisheries Res Inst, Muroran, Hokkaido 0510013, Japan	Joh, M (reprint author), Hokkaido Res Org, Abashiri Fisheries Res Inst, 1-1-1 Masu Ura, Abashiri, Hokkaido 0993119, Japan.	joh-mikimasa@hro.or.jp					ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Joh M, 2013, MAR ECOL PROG SER, V494, P267, DOI 10.3354/meps10509; AMARA R, 1994, NETH J SEA RES, V32, P287, DOI 10.1016/0077-7579(94)90006-X; Narimatsu Y, 2007, FISHERIES SCI, V73, P1257, DOI 10.1111/j.1444-2906.2007.01463.x; Joh M, 2011, FISHERIES SCI, V77, P773, DOI 10.1007/s12562-011-0382-3; Robert D, 2009, MAR ECOL PROG SER, V377, P227, DOI 10.3354/meps07833; Wada T, 2007, J SEA RES, V58, P241, DOI 10.1016/j.seares.2007.03.004; LAROCHE JL, 1982, FISH B-NOAA, V80, P93; MAY HMA, 1992, MAR ECOL PROG SER, V79, P203; CAMPANA SE, 1984, CAN J ZOOL, V62, P1507; Takahashi M, 2005, FISH OCEANOGR, V14, P223, DOI 10.1111/j.1365-2419.2005.00334.x; Campana SE, 1996, MAR ECOL PROG SER, V135, P21, DOI 10.3354/meps135021; Cushing D.H., 1976, Advances mar Biol, V14, P1; JENKINS GP, 1987, MAR BIOL, V95, P157, DOI 10.1007/BF00409001; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Chang CW, 2012, AQUAT BIOL, V15, P251, DOI 10.3354/ab00425; HAYASHI A, 1989, NIPPON SUISAN GAKK, V55, P997; Houde E.D., 1987, AM FISH SOC S, V2, P17; Joh M., 2008, AQUAC SCI, V56, P157; Joh M, 2005, MAR BIOL, V147, P59, DOI 10.1007/s00227-004-1545-x; Kayaba T., 2009, DEV BREEDING HATCHIN, P59; MINAMI T, 1981, B JPN SOC SCI FISH, V47, P1411; Mordin J., 1996, ICES J MAR SCI, V53, P746; SOGARD SM, 1991, CAN J FISH AQUAT SCI, V48, P1862, DOI 10.1139/f91-220; Takasuka A, 2004, MAR ECOL PROG SER, V270, P217, DOI 10.3354/meps270217; TSUJI S, 1984, B JPN SOC SCI FISH, V50, P1105; WARE DM, 1975, J FISH RES BOARD CAN, V32, P2503; Wild A., 1980, INTERAM TROP TUNA CO, V17, P507; Yamada H, 2009, FISHERIES SCI, V75, P1141, DOI 10.1007/s12562-009-0146-5	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	FEB	2015	86	2					448	462		10.1111/jfb.12562		15	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CC6DV	WOS:000350456000003		
J	Ichitsuka, T; Takanohashi, T; Fujita, T; Ichikawa, J				Ichitsuka, Tomohiro; Takanohashi, Tsuyoshi; Fujita, Takeshi; Ichikawa, Junji			A versatile difluorovinylation method: Cross-coupling reactions of the 2,2-difluorovinylzinc-TMEDA complex with alkenyl, alkynyl, allyl, and benzyl halides	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Difluoroalkene; Organozinc; Cross-coupling reaction; Palladium; Copper; Catalyst	GEM-DIFLUOROOLEFINATION; CARBONYL-COMPOUNDS; FACILE SYNTHESIS; EFFICIENT; DIFLUOROMETHYLENATION; HETEROCYCLES; ALDEHYDES; KETONES; 2,2-DIARYL-1,1-DIFLUOROETHENES; ACTIVATION	A thermally stable 2,2-difluorovinylzinc-TMEDA complex was prepared via a deprotonation-transmetallation sequence starting from commercially available 1,1-difluoroethylene. The complex thus formed was successfully applied to transition metal-catalyzed cross-coupling reactions with a wide range of organic halides, which led to the syntheses of 2,2-difluorovinyl compounds. On treatment with the difluorovinylzinc-TMEDA complex in the presence of an appropriate palladium or copper catalyst, alkenyl, alkynyl, allyl, and benzyl halides effectively underwent difluorovinylation to afford 1,1-difluoro-1,3-dienes, 1,1-difluoro-1,3-enynes, 1,1-difluoro-1,4-dienes, and (3,3-difluoroallyl)arenes, respectively. (C) 2014 Elsevier B.V. All rights reserved.	[Ichitsuka, Tomohiro; Takanohashi, Tsuyoshi; Fujita, Takeshi; Ichikawa, Junji] Univ Tsukuba, Div Chem, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Ichikawa, J (reprint author), Univ Tsukuba, Div Chem, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	junji@chem.tsukuba.ac.jp			JSPS KAKENHI [25288016]; Asahi Glass Foundation	This research is partly supported by JSPS KAKENHI (grant number 25288016) and The Asahi Glass Foundation. We acknowledge Central Glass Co., Ltd. for the generous gift of 1,1-difluoroethylene.	Ahrens T., 2015, CHEM REV; Akkerman FA, 2008, CHEM-ASIAN J, V3, P719, DOI 10.1002/asia.200700313; Piettre SR, 1996, TETRAHEDRON LETT, V37, P5881, DOI 10.1016/0040-4039(96)01267-1; Han SY, 2010, ORG LETT, V12, P5518, DOI 10.1021/ol1024037; Ichikawa J, 2007, CHIM OGGI, V25, P54; Qiao YP, 2014, J ORG CHEM, V79, P7122, DOI 10.1021/jo501289v; Li Q, 2014, J FLUORINE CHEM, V163, P38, DOI 10.1016/j.jfluchem.2014.04.011; Wang F, 2014, BEILSTEIN J ORG CHEM, V10, P344, DOI 10.3762/bjoc.10.32; Gogsig TM, 2008, J ORG CHEM, V73, P3404, DOI 10.1021/jo7027097; Magueur G, 2006, J FLUORINE CHEM, V127, P637, DOI 10.1016/j.jfluchem.2005.12.013; Negishi E, 2005, ALDRICHIM ACTA, V38, P71; Zheng J, 2013, CHEM-EUR J, V19, P15261, DOI 10.1002/chem.201303248; Ichikawa J, 2000, J FLUORINE CHEM, V105, P257, DOI 10.1016/S0022-1139(99)00268-7; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Souzy R, 2004, PROG POLYM SCI, V29, P75, DOI 10.1016/j.progpolymsci.2003.09.002; Nowak I, 2005, ORG LETT, V7, P721, DOI 10.1021/ol047416s; Nguyen BV, 1997, J ORG CHEM, V62, P7758, DOI 10.1021/jo971019w; Zheng J, 2013, CHEM COMMUN, V49, P7513, DOI 10.1039/c3cc44271c; MOORE WR, 1992, J AM CHEM SOC, V114, P360, DOI 10.1021/ja00027a056; Zhao YC, 2010, ORG LETT, V12, P1444, DOI 10.1021/ol100090r; Loska R, 2013, ORG LETT, V15, P5706, DOI 10.1021/ol402735m; Raghavanpillai A, 2006, J ORG CHEM, V71, P194, DOI 10.1021/jo051842p; BOBEK M, 1987, J MED CHEM, V30, P1494, DOI 10.1021/jm00391a036; Fujita T, 2011, CHEM LETT, V40, P986, DOI 10.1246/cl.2011.986; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Yokota M, 2007, ORG LETT, V9, P4639, DOI 10.1021/ol702279w; Prakash GKS, 2005, J FLUORINE CHEM, V126, P1361, DOI 10.1016/j.jfluchem.2005.07.011; Choi JH, 2008, TETRAHEDRON LETT, V49, P952, DOI 10.1016/j.tetlet.2007.12.028; Ehm C, 2010, J FLUORINE CHEM, V131, P1173, DOI 10.1016/j.jfluchem.2010.06.017; GILLET JP, 1986, SYNTHESIS-STUTTGART, P538; GILLET JP, 1985, TETRAHEDRON LETT, V26, P3999, DOI 10.1016/S0040-4039(00)98708-2; Ichikawa J, 2010, J SYN ORG CHEM JPN, V68, P1175, DOI 10.5059/yukigoseikyokaishi.68.1175; Ichikawa J, 1996, TETRAHEDRON LETT, V37, P8799, DOI 10.1016/S0040-4039(96)02035-7; JIANG B, 1991, J ORG CHEM, V56, P7336, DOI 10.1021/jo00026a028; Lu L, 2012, J FLUORINE CHEM, V133, P16, DOI 10.1016/j.jfluchem.2011.06.005; Pohmakotr M, 2006, TETRAHEDRON, V62, P5973, DOI 10.1016/j.tet.2006.04.015; Raghavanpillai A, 2004, J ORG CHEM, V69, P7083, DOI 10.1021/jo049179c; Uneyama K., 2006, ORGANOFLUORINE CHEM; Wang X.-P., 2014, EUR J ORG CHEM, P928	39	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	FEB	2015	170						29	37		10.1016/j.jfluchem.2014.12.003		9	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CC7FZ	WOS:000350534400005		
J	Sai-Ut, S; Benjakul, S; Sumpavapol, P; Kishimura, H				Sai-Ut, Samart; Benjakul, Soottawat; Sumpavapol, Punnanee; Kishimura, Hideki			PURIFICATION AND CHARACTERIZATION OF EXTRACELLULAR GELATINOLYTIC PROTEASE FROM BACILLUS AMYLOLIQUEFACIENS H11	JOURNAL OF FOOD BIOCHEMISTRY			English	Article							ALKALINE SERINE-PROTEASE; HYDROGEN-PEROXIDE; SKIN GELATIN; MOJAVENSIS; PROTEINASE; WASTES	Extracellular gelatinolytic enzyme from Bacillus amyloliquefaciensH11 was purified by gel filtration chromatography on Sephacryl S-200 and ion exchange chromatography on diethylaminoethyl-cellulose with 35% yield and 14-fold increase in purity. Based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the molecular weight of the purified enzyme was estimated to be 21kDa. The optimum gelatinolytic activities of purified enzyme toward porcine gelatin were 50C and pH8.0. The inhibitor study revealed that the purified enzyme was a metallo-serine protease and activated by Ca2+ and Mg2+ but resistant to Triton X-100 and methanol at a concentration of 10% (v/v). Among all gelatins, that from unicorn leatherjacket fish skin was the most preferred for hydrolysis by the purified enzyme, in comparison with porcine and tilapia counterparts. Thus, the enzyme from B.amyloliquefaciensH11 could be used as a potential protease for production of gelatin hydrolysate. Practical ApplicationsExtracellular protease from Bacillus amyloliquefaciensH11 plays a specific catalytic role in the hydrolysis of gelatin and can be used for production of gelatin hydrolysate with bioactivities. It can also be a potential alternative for commercial protease in conversion of marine processing by-products to generate high value-added products.	[Sai-Ut, Samart; Benjakul, Soottawat; Sumpavapol, Punnanee] Prince Songkla Univ, Dept Food Technol, Fac Agroind, Hat Yai 90112, Songkhla, Thailand; [Kishimura, Hideki] Hokkaido Univ, Grad Sch Fisheries Sci, Dept Marine Bioresources Chem, Hakodate, Hokkaido, Japan	Benjakul, S (reprint author), Prince Songkla Univ, Dept Food Technol, Fac Agroind, Hat Yai 90112, Songkhla, Thailand.	soottawat.b@psu.ac.th			National Research University Project of Thailand's Office of the Higher Education Commission; TRF Distinguished Research Professor Grant	The authors wish to thank the National Research University Project of Thailand's Office of the Higher Education Commission, the TRF Distinguished Research Professor Grant for funding this project. We also thank Graduate School, Prince of Songkla University for an overseas thesis research study to Mr. Samart Sai-Ut.	Abusham R. A., 2009, RAND MICROB CELL FAC, V8, P1; Adinarayana Kunamneni, 2003, AAPS PharmSciTech, V4, pE56, DOI 10.1208/pt040456; Aleman A, 2011, LWT-FOOD SCI TECHNOL, V44, P407, DOI 10.1016/j.lwt.2010.09.003; Annamalai N, 2014, FOOD BIOPROD PROCESS, V92, P335, DOI 10.1016/j.fbp.2013.08.009; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Tsuruoka N, 2003, APPL ENVIRON MICROB, V69, P162, DOI 10.1128/AEM.69.1.162-169.2003; Haddar A, 2009, BIORESOURCE TECHNOL, V100, P3366, DOI 10.1016/j.biortech.2009.01.061; Rai SK, 2010, BIOCHEM ENG J, V48, P173, DOI 10.1016/j.bej.2009.09.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Wagner GW, 2007, LANGMUIR, V23, P1178, DOI 10.1021/la062708i; Beg QK, 2003, ENZYME MICROB TECH, V32, P294, DOI 10.1016/S0141-0229(02)00293-4; Byun HG, 2001, PROCESS BIOCHEM, V36, P1155, DOI 10.1016/S0032-9592(00)00297-1; Finnegan M, 2010, J ANTIMICROB CHEMOTH, V65, P2108, DOI 10.1093/jac/dkq308; Phanturat P, 2010, LWT-FOOD SCI TECHNOL, V43, P86, DOI 10.1016/j.lwt.2009.06.010; Kim SK, 2010, J FUNCT FOODS, V2, P1, DOI 10.1016/j.jff.2010.01.003; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; Deng AH, 2010, BIORESOURCE TECHNOL, V101, P7100, DOI 10.1016/j.biortech.2010.03.130; Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v; Lin L, 2006, J SCI FOOD AGR, V86, P2290, DOI 10.1002/jsfa.2600; Gimenez B, 2009, FOOD CHEM, V114, P976, DOI 10.1016/j.foodchem.2008.10.050; Jellouli K, 2011, PROCESS BIOCHEM, V46, P1248, DOI 10.1016/j.procbio.2011.02.012; Benjakul S, 1997, J AGR FOOD CHEM, V45, P3423, DOI 10.1021/jf970294g; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Matsushita O, 1999, J BACTERIOL, V181, P923; Joo HS, 2003, J APPL MICROBIOL, V95, P267, DOI 10.1046/j.1365-2672.2003.01982.x; Dipasquale L, 2008, ANN MICROBIOL, V58, P253; Joshi S, 2013, BIORESOURCE TECHNOL, V131, P76, DOI 10.1016/j.biortech.2012.12.124; Asker M. M. S., 2013, J GENET ENG BIOTECHN, V11, P103; BAJORATH J, 1988, EUR J BIOCHEM, V176, P441, DOI 10.1111/j.1432-1033.1988.tb14301.x; Doddapaneni KK, 2009, MICROBIOL RES, V164, P383, DOI 10.1016/j.micres.2007.04.005; Gomez-Guillen MC, 2010, SEA BY PRODUCTS REAL, P89; Haddar A, 2009, PROCESS BIOCHEM, V44, P29, DOI 10.1016/j.procbio.2008.09.003; Holleman A. F., 2001, INORGANIC CHEM; Johnson M, 2013, MAT METHODS, V3, P163; Klomklao S, 2011, FOOD CHEM, V129, P739, DOI 10.1016/j.foodchem.2011.05.014; Maruthiah T., 2013, BIOCATAL AGR BIOTECH, V2, P116, DOI DOI 10.1016/J.BCAB.2013.03.001; Nigam Poonam Singh, 2013, Biomolecules, V3, P597, DOI 10.3390/biom3030597; Sai-Ut S, 2013, FOOD SCI BIOTECHNOL, V22, P1015, DOI 10.1007/s10068-013-0178-6; Sai-Ut S, 2015, J FOOD PROCESS PRES, V39, P394, DOI 10.1111/jfpp.12244; Sareen R, 2008, APPL MICROBIOL BIOT, V79, P399, DOI 10.1007/s00253-008-1429-y; Singh J, 2001, PROCESS BIOCHEM, V36, P781, DOI 10.1016/S0032-9592(00)00275-2; Singh SK, 2012, PROCESS BIOCHEM, V47, P1479, DOI 10.1016/j.procbio.2012.05.021; Sinha R, 2013, BIORESOURCE TECHNOL, V145, P357, DOI 10.1016/j.biortech.2012.11.024; Steel R.G., 1980, PRINCIPLES PROCEDURE; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Zambare V., 2010, ASIATIC J BIOTECHNOL, V3, P83	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8884	1745-4514		J FOOD BIOCHEM	J. Food Biochem.	FEB	2015	39	1					119	128		10.1111/jfbc.12114		10	Biochemistry & Molecular Biology; Food Science & Technology	Biochemistry & Molecular Biology; Food Science & Technology	CC3TZ	WOS:000350274300014		
J	Mataki, H; Enokida, H; Chiyomaru, T; Mizuno, K; Matsushita, R; Goto, Y; Nishikawa, R; Higashimoto, I; Samukawa, T; Nakagawa, M; Inoue, H; Seki, N				Mataki, Hiroko; Enokida, Hideki; Chiyomaru, Takeshi; Mizuno, Keiko; Matsushita, Ryosuke; Goto, Yusuke; Nishikawa, Rika; Higashimoto, Ikkou; Samukawa, Takuya; Nakagawa, Masayuki; Inoue, Hiromasa; Seki, Naohiko			Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C	JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSIVE MICRORNA-133A; MIR-1; CHEMOTHERAPY; GENE; HEAD; DIFFERENTIATION; PROLIFERATION; CONTRIBUTES; MECHANISMS; EXPRESSION	Lung cancer is clearly the primary cause of cancer-related deaths worldwide. Recent molecular-targeted strategy has contributed to improvement of the curative effect of adenocarcinoma of the lung. However, such current treatment has not been developed for squamous cell carcinoma (SCC) of the disease. The new genome-wide RNA analysis of lung-SCC may provide new avenues for research and the development of the disease. Our recent microRNA (miRNA) expression signatures of lung-SCC revealed that clustered miRNAs miR-1/133a were significantly reduced in cancer tissues. Here, we found that restoration of both mature miR-1 and miR-133a significantly inhibited cancer cell proliferation, migration and invasion. Coronin-1C (CORO1C) was a common target gene of the miR-1/133a cluster, as shown by the genome-wide gene expression analysis and the luciferase reporter assay. Silencing of CORO1C gene expression inhibited cancer cell proliferation, migration and invasion. Furthermore, CORO1C-regulated molecular pathways were categorized by using si-CORO1C transfectants. Further analysis of novel cancer signaling pathways modulated by the tumor-suppressive cluster miR-1/133a will provide insights into the molecular mechanisms of lung-SCC oncogenesis and metastasis.	[Mataki, Hiroko; Mizuno, Keiko; Higashimoto, Ikkou; Samukawa, Takuya; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 890, Japan; [Enokida, Hideki; Chiyomaru, Takeshi; Matsushita, Ryosuke; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan; [Goto, Yusuke; Nishikawa, Rika; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan	Seki, N (reprint author), Chiba Univ, Grad Sch Med, Dept Funct Genom, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	naoseki@faculty.chiba-u.jp					Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Hidaka H, 2012, ONCOTARGET, V3, P44; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Kojima S, 2014, J HUM GENET, V59, P78, DOI 10.1038/jhg.2013.121; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Rolfo C, 2014, CURR PHARM BIOTECHNO, V15, P475; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Nohata N, 2011, INT J ONCOL, V39, P1099, DOI 10.3892/ijo.2011.1096; Chan KT, 2011, TRENDS CELL BIOL, V21, P481, DOI 10.1016/j.tcb.2011.04.004; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nohata N, 2012, ONCOTARGET, V3, P9; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Itesako T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084311; Ren G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-67; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Samarin SN, 2010, BIOCHEM BIOPH RES CO, V391, P394, DOI 10.1016/j.bbrc.2009.11.069; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Thal DR, 2008, J PATHOL, V214, P415, DOI 10.1002/path.2308; Wang J, 2014, MOL ONCOL, V8, P1690, DOI 10.1016/j.molonc.2014.07.006; Xavier CP, 2009, J MOL BIOL, V393, P287, DOI 10.1016/j.jmb.2009.07.079; Ziemann A, 2013, NEURO-ONCOLOGY, V15, P548, DOI 10.1093/neuonc/nos388	39	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	FEB	2015	60	2					53	61		10.1038/jhg.2014.111		9	Genetics & Heredity	Genetics & Heredity	CC4WA	WOS:000350354100001		
J	Nakashima, S; Kato, F; Kosho, T; Nagasaki, K; Kikuchi, T; Kagami, M; Fukami, M; Ogata, T				Nakashima, Shinichi; Kato, Fumiko; Kosho, Tomoki; Nagasaki, Keisuke; Kikuchi, Toru; Kagami, Masayo; Fukami, Maki; Ogata, Tsutomu			Silver-Russell syndrome without body asymmetry in three patients with duplications of maternally derived chromosome 11p15 involving CDKN1C	JOURNAL OF HUMAN GENETICS			English	Article							BECKWITH-WIEDEMANN SYNDROME; PCNA-BINDING DOMAIN; GENETIC ALTERATIONS; IMPRINTING CENTER; IMAGE SYNDROME; MUTATIONS; PHENOTYPE; CLONING; REGION; RNA	We report duplications of maternally derived chromosome 11p15 involving CDKN1C encoding a negative regulator for cell proliferation in three Japanese patients (cases 1 and 2 from family A and case 3 from family B) with Silver-Russell syndrome (SRS) phenotype lacking hemihypotrophy. Chromosome analysis showed 46,XX,der(16)t(11;16)(p15.3;q24.3)mat in case 1, 46, XY,der(16)t(11;16)(p15.3;q24.3)mat in case 2 and a de novo 46,XX,der(17)t(11;17)(p15.4;q25.3) in case 3. Genomewide oligonucleotide-based array comparative genomic hybridization, microsatellite analysis, pyrosequencing-based methylation analysis and direct sequence analysis revealed the presence of maternally derived extra copies of the distal chromosome 11p involving the wild-type CDKN1C (a similar to 7.98 Mb region in cases 1 and 2 and a similar to 4.43 Mb region in case 3). The results, in conjunction with the previous findings in patients with similar duplications encompassing CDKN1C and in those with intragenic mutations of CDKN1C, imply that duplications of CDKN1C, as well as relatively mild gain-of-function mutations of CDKN1C lead to SRS subtype that usually lack hemihypotrophy.	[Nakashima, Shinichi; Kato, Fumiko; Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan; [Kosho, Tomoki] Shinshu Univ, Sch Med, Dept Human Genet, Matsumoto, Nagano 390, Japan; [Nagasaki, Keisuke] Niigata Univ, Sch Med, Dept Pediat, Niigata, Japan; [Kikuchi, Toru] Saitama Med Univ, Dept Pediat, Saitama, Japan; [Kagami, Masayo; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan	Ogata, T (reprint author), Hamamatsu Univ Sch Med, Dept Pediat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	tomogata@hama-med.ac.jp			Japan Society for the Promotion of Science [25253023, 23390083]; Ministry of Health, Labor and Welfare (MHLW) [H22-161]; National Center for Child Health and Development [25-10]	This work was supported by Grants-in-Aid for Scientific Research (A) (25253023) and Research (B) (23390083) from the Japan Society for the Promotion of Science, by Grants for Research on Intractable Diseases (H22-161) from the Ministry of Health, Labor and Welfare (MHLW) and by Grant for National Center for Child Health and Development (25-10).	Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Eggermann T, 2010, AM J MED GENET C, V154C, P355, DOI 10.1002/ajmg.c.30274; Chiesa N, 2012, HUM MOL GENET, V21, P10, DOI 10.1093/hmg/ddr419; Brioude F, 2013, J MED GENET, V50, P823, DOI 10.1136/jmedgenet-2013-101691; Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; South ST, 2008, AM J MED GENET A, V146A, P2691, DOI 10.1002/ajmg.a.32516; Bliek J, 2009, EUR J MED GENET, V52, P404, DOI 10.1016/j.ejmg.2009.08.006; Bonaldi A, 2011, AM J MED GENET A, V155A, P2479, DOI 10.1002/ajmg.a.34023; Cardarelli L, 2010, PEDIATR DEVEL PATHOL, V13, P326, DOI 10.2350/09-07-0686-CR.1; Eggermann T, 2010, AM J MED GENET A, V152A, P1484, DOI 10.1002/ajmg.a.33398; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Fisher AM, 2002, HUM GENET, V111, P290, DOI 10.1007/s00439-002-0787-2; Fuke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060105; Kato F, 2014, CLIN ENDOCRINOL, V80, P706, DOI 10.1111/cen.12379; Schonherr N, 2007, J MED GENET, V44, P59, DOI 10.1136/jmg.2006.044370	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	FEB	2015	60	2					91	95		10.1038/jhg.2014.100		5	Genetics & Heredity	Genetics & Heredity	CC4WA	WOS:000350354100006		
J	Kodera, H; Osaka, H; Iai, M; Aida, N; Yamashita, A; Tsurusaki, Y; Nakashima, M; Miyake, N; Saitsu, H; Matsumoto, N				Kodera, Hirofumi; Osaka, Hitoshi; Iai, Mizue; Aida, Noriko; Yamashita, Akio; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi			Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy	JOURNAL OF HUMAN GENETICS			English	Article							SPINAL-CORD INVOLVEMENT; BRAIN-STEM; CAUSE HYPOMYELINATION; HUMAN-DISEASE; LEUKOENCEPHALOPATHY	Aminoacylation is the process of attaching amino acids to their cognate tRNA, and thus is essential for the translation of mRNA into protein. This direct interaction of tRNA with amino acids is catalyzed by aminoacyl-tRNA synthetases. Using whole-exome sequencing, we identified compound heterozygous mutations [c.169T > C (p.Tyr57His) and c.1485dup (p.Lys496*)] in QARS, which encodes glutaminyl-tRNA synthetase, in two siblings with early-onset epileptic encephalopathy (EOEE). Recessive mutations in QARS, including the loss-of-function missense mutation p.Tyr57His, have been reported to cause intractable seizures with progressive microcephaly. The p.Lys496* mutation is novel and causes truncation of the QARS protein, leading to a deletion of part of the catalytic domain and the entire anticodon-binding domain. Transient expression of the p.Lys496* mutant in neuroblastoma 2A cells revealed diminished and aberrantly aggregated expression, indicating the loss-of-function nature of this mutant. Together with the previous report, our data suggest that abnormal aminoacylation is one of the underlying pathologies of EOEE.	[Kodera, Hirofumi; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Osaka, Hitoshi; Iai, Mizue] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Yokohama, Kanagawa, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Radiol, Yokohama, Kanagawa, Japan; [Yamashita, Akio] Yokohama City Univ, Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Akio] Grad Sch Med Sci, Yokohama, Kanagawa, Japan	Saitsu, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26860816, 12024421]; Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science [25293085, 25293235, 13313587, 26670505]; Takeda Science Foundation; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences [11105137]	We thank the patients and their families for their participation in this study. We also thank Nobuko Watanabe for her excellent technical assistance. This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (26860816) and the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research B (25293085, 25293235) and A (13313587), and challenging Exploratory Research (26670505) from the Japan Society for the Promotion of Science; the Takeda Science Foundation; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences (11105137); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12024421).	Abbott Jamie A., 2014, Frontiers in Genetics, V5, DOI 10.3389/fgene.2014.00158; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Sofou Kalliopi, 2015, Mol Genet Genomic Med, V3, P59, DOI 10.1002/mgg3.115	14	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	FEB	2015	60	2					97	101		10.1038/jhg.2014.103		5	Genetics & Heredity	Genetics & Heredity	CC4WA	WOS:000350354100007		
J	Kagawa, S; Nakamura, S; Kondo, Y; Matsubae, K; Nagasaka, T				Kagawa, Shigemi; Nakamura, Shinichiro; Kondo, Yasushi; Matsubae, Kazuyo; Nagasaka, Tetsuya			Forecasting Replacement Demand of Durable Goods and the Induced Secondary Material Flows A Case Study of Automobiles	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						automobile; industrial ecology; product lifetime analysis; replacement demand; shredder scrap; waste input-output analysis	PRODUCT LIFETIME EXTENSION; IRON; STEEL; CYCLE; CONSEQUENCES; CONSUMPTION; DYNAMICS; JAPAN; STOCK	The aim of this article is to propose a method for forecasting future secondary material flows by combining a product lifetime distribution analysis with a waste input-output analysis and present a simple case study of automobiles. The case study demonstrates that the proposed method enables us to estimate replacement demand of new vehicles, number of end-of-life (EOL) vehicles arising from the aging of vehicles, volume of shredder scraps recovered from EOL vehicles, and volume of shredder scraps required to meet final consumption in the future.	[Kagawa, Shigemi] Kyushu Univ, Fac Econ, Fukuoka 8128581, Japan; [Nakamura, Shinichiro; Kondo, Yasushi] Waseda Univ, Grad Sch Econ, Tokyo, Japan; [Matsubae, Kazuyo; Nagasaka, Tetsuya] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Kagawa, S (reprint author), Kyushu Univ, Fac Econ, Higashi Ku, 6-19-1 Hakozaki, Fukuoka 8128581, Japan.	kagawa@econ.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [22360386]; Environment Research and Technology Development Fund from the Japanese Ministry of Environment [K122024]	This research was supported by a Grant-in-Aid for research (No. 22360386) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and partially supported by the Environment Research and Technology Development Fund (K122024) from the Japanese Ministry of Environment. The authors accept full responsibility for the views expressed in this article. The authors thank two anonymous referees for their helpful comments on the manuscript.	Modaresi R, 2012, ENVIRON SCI TECHNOL, V46, P8587, DOI 10.1021/es300648w; Reck BK, 2012, SCIENCE, V337, P690, DOI 10.1126/science.1217501; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P140, DOI 10.1021/es201799k; Nakamura S, 2006, ECOL ECON, V57, P494, DOI 10.1016/j.ecolecon.2005.05.002; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; Geyer R, 2007, RESOUR CONSERV RECY, V51, P101, DOI 10.1016/j.resconrec.2006.08.006; Wang T, 2007, ENVIRON SCI TECHNOL, V41, P5120, DOI 10.1021/es062761t; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Davis J, 2007, RESOUR CONSERV RECY, V51, P118, DOI 10.1016/j.resconrec.2006.08.007; Hashimoto S, 2007, WASTE MANAGE, V27, P1725, DOI 10.1016/j.wasman.2006.10.009; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Kagawa S, 2006, ECOL ECON, V58, P108, DOI 10.1016/j.ecolecon.2005.06.003; van Schaik A, 2004, RESOUR CONSERV RECY, V40, P301, DOI 10.1016/S0921-3449(03)00074-0; Kagawa S, 2009, ENERG ECON, V31, P197, DOI 10.1016/j.eneco.2008.08.011; Kagawa S, 2011, ENVIRON SCI TECHNOL, V45, P1184, DOI 10.1021/es1034552; Kagawa S, 2008, ECON SYST RES, V20, P3, DOI 10.1080/09535310801890615; Leontief W., 1986, INPUT OUTPUT EC; Moriguchi Y., 2003, STUDY SOUND MANAGEME; Nakamura Shinichiro, 2002, Journal of Industrial Ecology, V6, P39, DOI 10.1162/108819802320971632; Nakamura S, 2009, ECO-EFFIC IND SCI, V26, P1; Nakamura S, 2012, ENVIRON SCI TECHNOL, V46, P9266, DOI 10.1021/es3013529	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	FEB	2015	19	1					10	19		10.1111/jiec.12184		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CC3XN	WOS:000350284700004		
J	Hou, WX; Tian, X; Tanikawa, H				Hou, Wanxin; Tian, Xin; Tanikawa, Hiroki			Greening China's Wastewater Treatment Infrastructure in the Face of Rapid Development Analysis Based on Material Stock and Flow through 2050	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						China; CO2 emissions; industrial ecology; material flow analysis (MFA); sustainable development; wastewater treatment infrastructure (WWTI)	RECYCLED AGGREGATE CONCRETE; CO2 EMISSIONS; CONSTRUCTION; DYNAMICS; SYSTEMS; CYCLE; OSLO	Wastewater treatment infrastructure (WWTI) construction in China has entered an accelerated stage of development in recent years as a result of rapid economic growth, urbanization, and the demand for improving water quality. As a result, a large amount of resources and materials will be allocated for the WWTI, and it is particularly important to find ways to reduce resource consumption effectively so that social dematerialization and sustainable development can be achieved. In this study, we employed the dynamic material flow model to estimate the material flows and stocks of WWTIs and the associated carbon dioxide (CO2) emissions through 2050, considering effects of a rise in water consumption, a longer lifetime, and an increased material recycling rate. Our results indicate that material consumption in WWTIs will increase rapidly through 2025 to meet the needs of the increased volume of discharged wastewater as well as to overcome the shortage of existing wastewater treatment plants. In contrast with the moderate effects of rise in water consumption, prolonging the lifetime will greatly reduce material consumption in WWTI construction during the period 2030-2050, and approximately 60% of the total material input will be saved in the medium-lifetime scenario, compared with the short-lifetime scenario. Material output and CO2 emissions associated with WWTIs will be reduced by 87% and 37%, respectively, in the medium-lifetime scenario, compared with the short-lifetime scenario, under high-water-consumption growth. Our results highlight the great importance of pipeline construction and cement consumption in resource consumption associated with WWTI construction in China. Moreover, this study also examined the potential ways to reduce material consumption in WWTI construction in the context of the demand chain, the design, construction, operation and management, and demolition.	[Hou, Wanxin; Tian, Xin; Tanikawa, Hiroki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Tian, X (reprint author), Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan.	tianx05@gmail.com	Tanikawa, Hiroki/G-8033-2012		Environment Research and Technology Development fund of the Ministry of the Environment, Japan [S-6-4]	This research was financially supported by the Environment Research and Technology Development fund (S-6-4) of the Ministry of the Environment, Japan.	Dosho Y, 2007, J ADV CONCR TECHNOL, V5, P27, DOI 10.3151/jact.5.27; Liu G, 2013, NAT CLIM CHANGE, V3, P338, DOI 10.1038/NCLIMATE1698; Lassaux S, 2007, INT J LIFE CYCLE ASS, V12, P118, DOI 10.1065/lca2005.12.243; Xu M, 2012, ENVIRON SCI TECHNOL, V46, P7928, DOI 10.1021/es3025534; Hashimoto S, 2009, WASTE MANAGE, V29, P2859, DOI 10.1016/j.wasman.2009.06.011; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Venkatesh G, 2012, J IND ECOL, V16, P722, DOI 10.1111/j.1530-9290.2011.00426.x; Ke J, 2012, ENERG POLICY, V45, P739, DOI 10.1016/j.enpol.2012.03.036; Fernandez JE, 2007, J IND ECOL, V11, P99, DOI 10.1162/jie.2007.1199; Hu MM, 2010, RESOUR CONSERV RECY, V54, P591, DOI 10.1016/j.resconrec.2009.10.016; Venkatesh G, 2009, J IND ECOL, V13, P532, DOI 10.1111/j.1530-9290.2009.00143.x; Xiao JZ, 2012, CONSTR BUILD MATER, V31, P364, DOI 10.1016/j.conbuildmat.2011.12.074; Shi F, 2012, J IND ECOL, V16, P493, DOI 10.1111/j.1530-9290.2012.00523.x; Butler R, 1996, DESALINATION, V106, P273; CESRG (China Energy Strategy Research Group), 2009, CHIN EN CO2 EM REP 2; [陈东景 Chen Dongjing], 2012, [自然资源学报, Journal of Natural Resources], V27, P332; Hammer S., 2011, OECD REGIONAL DEV WO, V2011/08; Huang T., 2011, THESIS NAGOYA U NAGO; IEA, 2009, CEM TECHN ROADM 2009; IEA, 2008, EN TECHN PERSP 2008; JECES (Japan Education Center of Environmental Sanitation), 2011, SEW TREATM JAP 2010; JSA (Nippon Johkasoh System Association), 2012, SERV LIF SEPT TANKS; van Kempen R, 2001, WATER SCI TECHNOL, V44, P145; Li C. Q., 2006, SCI TECHNOLOGICAL MA, V2006, P64; Long S. M., 2010, J PINGLINGSHAN U, V25, P5; Maria R. C., 2012, J IND ECOL, V16, P901; MCPRC (Ministry of Construction of the People's Republic of China), 2002, UN STAND REL DES BUI; MCPRC (Ministry of Construction of the People's Republic of China), 2001, URB SEW TREATM PROJ; MEPPRC (Ministry of Environmental Protection of the People's Republic of China), 2011, NAT LIST URB SEW TRE; MIC (Ministry of Internal Affairs and Communications), 2009, LIF FIX ASS; Nagaoka K., 2009, ENV SCI, V23, P83; NAHB (National Association of Home Builders/Bank of America Home Equity), 2006, STUD LIF EXP HOM COM; NBSC, 2011, CHIN STAT YB; NBSC (National Bureau of Statistics of China), 2011, CHIN URB CONSTR STAT; NDRC (National Development and Reform Commission), 2005, OUTL CHIN WAT SAV TE; OECD (Organisation for Economic Cooperation and Development), 2006, ENV DAT COMP INL WAT; Piet L., 2001, DECENTRALISED SANITA; Ran R, 2006, SCI TECHNOLOGY REV, V24, P53; Sahely HR, 2005, CAN J CIVIL ENG, V32, P72, DOI 10.1139/L04-072; SCPRC (The State Council of the People's Republic of China), 2011, 12 5 YEAR PLAN CHIN; SCPRC (The State Council of the People's Republic of China), 2006, NAT EC SOC DEV 5 YEA; SCPRC (The State Council of the People's Republic of China), 2008, REG IMPL ENT INC TAX; Wang L., 2009, CHINA CEMENT, V11, P21; Wu WY, 2005, APPL MATH COMPUT, V169, P198, DOI 10.1016/j.amc.2004.10.087; Yang W., 2006, THESIS TIANJIN U TIA; Yang Y., 1999, HDB DESIGN CONCRETE	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	FEB	2015	19	1					129	140		10.1111/jiec.12186		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CC3XN	WOS:000350284700015		
J	Nagasawa, K; Kishida, A; Kajiwara, M; Kanamatsu, T; Takatori, K				Nagasawa, Kokoro; Kishida, Atsushi; Kajiwara, Masahiro; Kanamatsu, Tomoyuki; Takatori, Kazuhiko			A simple convenient synthesis of L-[4-C-13] glutamine	JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS			English	Article						stable labeled synthesis; C-13; glutamine; serine; amino acid; Wittig reaction	VIVO C-13 NMR; ASYMMETRIC-SYNTHESIS; METABOLISM; BRAIN; ACID; GLUCOSE; ALKYLATION; NEURONS; RATS	l-[4-C-13]Glutamine was synthesized from sodium [2-C-13]acetate in 12 steps and 18% overall yield. A Wittig reaction of (R)-benzyl 4-formyl-2,2-dimethyloxazolidine-3-carboxylate and ethyl 2-(triphenylphosphoranylidene)[2-C-13]acetate prepared from d-serine and sodium [2-C-13]acetate, respectively, gave (4S)-4-(2-ethoxycarbonyl[2-C-13]vinyl)-2,2-dimethyloxazolidine-3-carboxylic acid ,-isopropylidene group, oxidation of the resulting hydroxyl group to a carboxyl group and transamidation of the ester moiety gave l-N-Cbz-[4-C-13]glutamine (Cbz=benzyloxycarbonyl). Finally, removal of the Cbz group gave l-[4-C-13]glutamine. l-[4-C-13]Glutamine can be prepared in fewer steps and higher yield by this method compared with previously reported methods.	[Nagasawa, Kokoro; Kishida, Atsushi; Kajiwara, Masahiro; Takatori, Kazuhiko] Meiji Pharmaceut Univ, Dept Synthet Organ Chem, Kiyose, Tokyo 2048588, Japan; [Kanamatsu, Tomoyuki] Soka Univ, Dept Environm Engn Symbiosis, Fac Engn, Hachioji, Tokyo 1928577, Japan	Takatori, K (reprint author), Meiji Pharmaceut Univ, Dept Synthet Organ Chem, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan.	takatori@my-pharm.ac.jp					Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; Patel AB, 2004, J CEREBR BLOOD F MET, V24, P972, DOI 10.1097/01.WCB.0000126234.16188.71; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Bak LK, 2008, NEUROCHEM RES, V33, P273, DOI 10.1007/s11064-007-9471-1; Becmann N., 1991, BIOCHEMISTRY-US, V30, P6362; Bouzier-Sore AK, 2003, BIOCHIMIE, V85, P841, DOI 10.1016/j.biochi.2003.08.003; DELACOTTE JM, 1991, J LABELLED COMPD RAD, V29, P1141, DOI 10.1002/jlcr.2580291006; DELLARIA JF, 1989, J ORG CHEM, V54, P3916, DOI 10.1021/jo00277a032; Kanamatsu T, 1999, BRAIN RES, V841, P11, DOI 10.1016/S0006-8993(99)01772-2; Kanamatsu T, 2006, J VET MED SCI, V68, P259, DOI 10.1292/jvms.68.259; Olstad E, 2007, J CEREBR BLOOD F MET, V27, P811, DOI 10.1038/sj.jcbfm.9600400; Peng L, 2007, J NEUROSCI RES, V85, P3480, DOI 10.1002/jnr.21262; Takatori K, 1998, TETRAHEDRON, V54, P15861, DOI 10.1016/S0040-4020(98)00995-8; Takatori K, 2004, J LABELLED COMPD RAD, V47, P91, DOI 10.1002/jlcr.800; TAKATORI K, 1995, CHEM PHARM BULL, V43, P1797; Takatori K, 2006, J LABELLED COMPD RAD, V49, P445, DOI 10.1002//jlcr.1055; Takatori K, 1999, J LABELLED COMPD RAD, V42, P701, DOI 10.1002/(SICI)1099-1344(199907)42:7<701::AID-JLCR232>3.3.CO;2-A; Takatori K, 2004, J LABELLED COMPD RAD, V47, P787, DOI 10.1002/jlcr.868	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-4803	1099-1344		J LABELLED COMPD RAD	J. Label. Compd. Radiopharm.	FEB	2015	58	2					42	45		10.1002/jlcr.3265		4	Biochemical Research Methods; Chemistry, Medicinal; Chemistry, Analytical	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CC3VN	WOS:000350279000004		
J	Ogawa, Y; Otsuka, K; Hagiwara, A; Inagaki, A; Shimizu, S; Nagai, N; Itani, S; Saito, Y; Suzuki, M				Ogawa, Y.; Otsuka, K.; Hagiwara, A.; Inagaki, A.; Shimizu, S.; Nagai, N.; Itani, S.; Saito, Y.; Suzuki, M.			Clinical study of tympanostomy tube placement for patients with intractable Meniere's disease	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article						Middle Ear Ventilation; Vertigo; Dizziness; Meniere's Syndrome; Endolymphatic Hydrops	VENTILATION TUBES; INSERTION; VERTIGO	Objective: To evaluate the effectiveness of tympanostomy tube placement in controlling symptoms of intractable Meniere's disease. Methods: Fifteen patients with intractable Meniere's disease underwent tympanostomy tube placement in the affected ear. Post-operative changes in vertigo attacks and hearing level were recorded, and were evaluated according to American Academy of Otolaryngology-Head and Neck Surgery criteria. Results: At 12 months after treatment, 3 patients (20 per cent) showed complete control of vertigo, 7 (47 per cent) showed substantial control and 2 (13 per cent) showed limited control; 3 patients (20 per cent) required other treatment. At 24 months after treatment, 7 patients (47 per cent) showed complete control of vertigo, 3 (20 per cent) showed substantial control and 1 (7 per cent) showed limited control; 1 patient required other treatment 15 months after tympanostomy tube placement. Conclusion: There is no definite pathophysiological explanation for the effect of tympanostomy tube placement in reducing vertigo attacks. This treatment is not effective for all patients with intractable Meniere's disease. However, tympanostomy tube placement might be an additional surgical therapeutic option to consider prior to contemplating other, more invasive treatments.	[Ogawa, Y.; Otsuka, K.; Hagiwara, A.; Inagaki, A.; Shimizu, S.; Nagai, N.; Itani, S.; Saito, Y.; Suzuki, M.] Tokyo Med Univ, Dept Otolaryngol, Tokyo 1600023, Japan	Ogawa, Y (reprint author), Tokyo Med Univ, Dept Otolaryngol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	y-ogawa8@tokyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan; Tokyo Medical University	The authors are indebted to the Department of International Medical Communications of Tokyo Medical University for the editorial review of the English manuscript. This study received financial support from a Grant-in-Aid for Scientific Research (category "C') from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Grant-in-Aid for Disease (Vestibular Disorders) from the Ministry of Health, Labor and Welfare, Japan. A follow-up grant for a Tokyo Medical University research project was also received.	[Anonymous], 1995, OTOLARYNGOL HEAD NEC, V113, P181, DOI DOI 10.1016/S0194-5998(95)70102-87675476; CINNAMOND MJ, 1975, J LARYNGOL OTOL, V89, P57, DOI 10.1017/S0022215100080075; Hall M C, 1977, Arch Otolaryngol, V103, P355; Kimura RS, 1997, EUR ARCH OTO-RHINO-L, V254, P213, DOI 10.1007/BF00874091; Lall M, 1969, J Laryngol Otol, V83, P787, DOI 10.1017/S002221510007095X; MONTANDON P, 1988, ORL J OTO-RHINO-LARY, V50, P377; Park JJH, 2009, ACTA OTO-LARYNGOL, V129, P1408, DOI 10.3109/00016480902791678; Perez-Garrigues H, 2008, ARCH OTOLARYNGOL, V134, P1149, DOI 10.1001/archotol.134.11.1149; PICKARD BH, 1967, P ROY SOC MED, V60, P968; Sugawara K, 2003, AURIS NASUS LARYNX, V30, P25, DOI 10.1016/S0385-8146(02)00105-0; Thomsen J, 1998, ACTA OTO-LARYNGOL, V118, P769, DOI 10.1080/00016489850182413; Tumarkin A, 1966, J Laryngol Otol, V80, P1041, DOI 10.1017/S0022215100066366	12	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	FEB	2015	129	2					120	125		10.1017/S0022215115000079		6	Otorhinolaryngology	Otorhinolaryngology	CC3KF	WOS:000350246200003		
J	Chung, Y; Doerr, C; Murphy, E; Shukla, V; Sato, K; Tse, K				Chung, Yun; Doerr, Chris; Murphy, Ed; Shukla, Vishnu; Sato, Ken-ichi; Tse, Kathy			OFC/NFOEC 2014 Special Issue	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Editorial Material									[Chung, Yun] Korea Adv Inst Sci & Technol, Elect Engn, Taejon 305701, South Korea; [Doerr, Chris] Acacia, Maynard, MA 01754 USA; [Murphy, Ed] JDSU, R&D, Bloomfield, CT 06002 USA; [Shukla, Vishnu] Verizon Technol, Waltham, MA 02451 USA; [Sato, Ken-ichi] Nagoya Univ, EECS, Nagoya, Aichi 4648603, Japan; [Tse, Kathy] AT&T, Middletown, NJ 07748 USA	Chung, Y (reprint author), Korea Adv Inst Sci & Technol, Elect Engn, 373-1 Guseong Dong, Taejon 305701, South Korea.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	FEB 1	2015	33	3			SI		545	546		10.1109/JLT.2015.2395051		2	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CC3AL	WOS:000350216400001		
J	Yoshida, Y; Maruta, A; Kitayama, K; Nishihara, M; Tanaka, T; Takahara, T; Rasmussen, JC; Yoshikane, N; Tsuritani, T; Morita, I; Yan, SY; Shu, Y; Yan, Y; Nejabati, R; Zervas, G; Simeonidou, D; Vilalta, R; Munoz, R; Casellas, R; Martinez, R; Aguado, A; Lopez, V; Marhuenda, J				Yoshida, Yuki; Maruta, Akihiro; Kitayama, Ken-ichi; Nishihara, Masato; Tanaka, Toshiki; Takahara, Tomoo; Rasmussen, Jens C.; Yoshikane, Noboru; Tsuritani, Takehiro; Morita, Itsuro; Yan, Shuangyi; Shu, Yi; Yan, Yan; Nejabati, Reza; Zervas, Georgios; Simeonidou, Dimitra; Vilalta, Ricard; Munoz, Rauel; Casellas, Ramon; Martinez, Ricardo; Aguado, Alejandro; Lopez, Victor; Marhuenda, Jaume			SDN-Based Network Orchestration of Variable-Capacity Optical Packet Switching Network Over Programmable Flexi-Grid Elastic Optical Path Network	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Discrete multi-tone; flexi-grid WDM network; optical packet switching; software-defined network	TECHNOLOGIES; ARCHITECTURE	A multidomain and multitechnology optical network orchestration is demonstrated in an international testbed located in Japan, the U.K., and Spain. The application-based network operations architecture is proposed as a carrier software-defined network solution for provisioning end-to-end optical transport services through a multidomain multitechnology network scenario, consisting of a 46-108 Gb/s variable-capacity Open-Flow-capable optical packet switching network and a programmable, flexi-grid elastic optical path network.	[Yoshida, Yuki; Maruta, Akihiro; Kitayama, Ken-ichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Nishihara, Masato; Tanaka, Toshiki; Takahara, Tomoo; Rasmussen, Jens C.] Fujitsu Ltd, Kawasaki, Kanagawa 2118588, Japan; [Yoshikane, Noboru; Tsuritani, Takehiro; Morita, Itsuro] KDDI R&D Labs Inc, Fujimino, Saitama 3568502, Japan; [Yan, Shuangyi; Shu, Yi; Yan, Yan; Nejabati, Reza; Zervas, Georgios; Simeonidou, Dimitra] Univ Bristol, High Performance Networks Grp, Bristol BS8 1TH, Avon, England; [Vilalta, Ricard; Munoz, Rauel; Casellas, Ramon; Martinez, Ricardo] Ctr Tecnol Telecomunicac Catalunya, Barcelona 08860, Spain; [Aguado, Alejandro; Lopez, Victor; Marhuenda, Jaume] Telefon I D, Barcelona 08019, Spain	Yoshida, Y (reprint author), Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan.	yuki@comm.eng.osaka-u.ac.jp; maruta@comm.eng.osaka-u.ac.jp; kitayama@comm.eng.osaka-u.ac.jp; mnishi@jp.fujitsu.com; ttoshiki@jp.fujitsu.com; tomoo.takahara@jp.fujitsu.com; jens.rasmussen@jp.fujitsu.com; yoshikane@kddilabs.jp; tsuri@kddilabs.jp; morita@kddilabs.jp; shuangyi.yan@bristol.ac.uk; Y.Shu@bristol.ac.uk; Yan.Yan@bristol.ac.uk; reza.nejabati@bristol.ac.uk; georgioszervas@gmail.com; Dimitra.Simeonidou@bristol.ac.uk; ricard.vilalta@cttc.es; raul.munoz@cttc.es; ramon.casellas@cttc.es; ricardo.martinez@cttc.es; b.aam@tid.es; victor.lopezalvarez@telefonica.com; b.jmb@tid.es			FP7 EU-Japan Project STRAUSS [GA 608528]; MICINN project [TEC2012-38119 (FARO)]; EPSRC Grant [EP/I01196X]	This work was supported by FP7 EU-Japan Project STRAUSS (GA 608528, 2014-2016), MICINN project TEC2012-38119 (FARO), and EPSRC Grant EP/I01196X: The Photonics Hyperhighway. This paper was presented in part as a post-deadline paper at IEEE/OSA OFC [1].	Aguado A., 2014, IEEE OSA OPT FIB COM; Amaya N, 2013, J OPT COMMUN NETW, V5, P593, DOI 10.1364/JOCN.5.000593; Casellas R, 2013, J OPT COMMUN NETW, V5, pA57, DOI 10.1364/JOCN.5.000A57; Lopez V, 2014, J OPT COMMUN NETW, V6, P476, DOI 10.1364/JOCN.6.000476; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; Channegowda M, 2013, OPT EXPRESS, V21, P5487, DOI 10.1364/OE.21.005487; Channegowda M, 2013, J OPT COMMUN NETW, V5, pA274, DOI 10.1364/JOCN.5.00A274; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Barros DJF, 2010, J LIGHTWAVE TECHNOL, V28, P1811, DOI 10.1109/JLT.2010.2048999; Bergstrom PD, 1999, IEEE T COMMUN, V47, P1593, DOI 10.1109/26.795827; Cao X., 2014, EUR C OPT COMM CANN; Christodoulopoulos K, 2011, J LIGHTWAVE TECHNOL, V29, P1354, DOI 10.1109/JLT.2011.2125777; King D., 2014, INTERNET EN IN PRESS; Kitayama K, 2014, J LIGHTWAVE TECHNOL, V32, P2760, DOI 10.1109/JLT.2014.2324651; Liu X., 2014, IEEE OSA OPT FIB COM; Nishihara M, 2014, PROC SPIE, V9008, DOI 10.1117/12.2036062; Tanaka T., 2014, IEEE OSA OPT FIB COM; Yoshida Y., 2014, IEEE OSA OPT FIB COM	18	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	FEB 1	2015	33	3			SI		609	617		10.1109/JLT.2014.2351852		9	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CC3AL	WOS:000350216400007		
J	Kaneko, S; Yoshida, T; Furusawa, S; Sarashina, M; Tamai, H; Suzuki, A; Mukojima, T; Kimura, S; Yoshimoto, N				Kaneko, Shin; Yoshida, Tomoaki; Furusawa, Satoshi; Sarashina, Masahiro; Tamai, Hideaki; Suzuki, Akiya; Mukojima, Toshiaki; Kimura, Shunji; Yoshimoto, Naoto			Demonstration of Load-Balancing Operation Based on Hitless Dynamic Wavelength Allocation on Symmetric 40-Gbit/s lambda-Tunable WDM/TDM-PON	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Dynamic wavelength allocation (DWA); optical access network; optical access system; passive optical network (PON); wavelength division multiplexing/time division multiplexing-passive optical network (WDM/TDM-PON)		This paper reports the world-first system-level demonstration of dynamic wavelength allocation (DWA) on a wavelength-tunable (lambda-tunable) wavelength division multiplexing/time division multiplexing-passive optical network (WDM/TDM-PON). To achieve DWA, a DWA calculation is necessary that determines new optical network unit assignments to the optical line terminal ports according to the bandwidth demand. In addition, a wavelength-tuning (lambda-tuning) sequence that induces no data-frame loss, i.e., a hitless lambda-tuning sequence, is essential. First, we propose a bidirectional hitless lambda-tuning sequence and investigate its feasibility using media access control boards that we developed for symmetric 40-Gbit/s lambda-tunable WDM/TDM-PONs, which are also the world's first. Then, with a DWA calculation according to the downstream traffic loads, we show automatic dynamic load-balancing operation.	[Kaneko, Shin; Yoshida, Tomoaki] NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan; [Furusawa, Satoshi; Suzuki, Akiya; Mukojima, Toshiaki] Oki Elect Ind Co Ltd, Chiba 2618501, Japan; [Sarashina, Masahiro; Tamai, Hideaki] Oki Elect Ind Co Ltd, Warabi 3358510, Japan; [Kimura, Shunji; Yoshimoto, Naoto] NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan	Kaneko, S (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan.	kaneko.shin@lab.ntt.co.jp; yoshida.tomoaki@lab.ntt.co.jp; furusawa584@oki.com; sarashina238@oki.com; tamai677@oki.com; suzuki444@oki.com; mukoujima380@oki.com; kimura.shunji@lab.ntt.co.jp; n-yoshi@photon.chitose.ac.jp			Ministry of Internal Affairs and Communications of Japan	This work was supported in part by the Ministry of Internal Affairs and Communications of Japan.	Shinohara H, 2007, J OPT NETW, V6, P616, DOI 10.1364/JON.6.000616; [Anonymous], 2013, 40 GIGABIT CAPABLE P; Kani J, 2010, IEEE J SEL TOP QUANT, V16, P1290, DOI 10.1109/JSTQE.2009.2035640; Cheng N., 2014, OPT FIB COMM C OFC S; Effenberger FJ, 2007, J OPT NETW, V6, P808, DOI 10.1364/JON.6.000808; Kaneko S., 2014, OPT FIB COMM C OFC S; Kaneko S., 2014, OPT COMM C OECC MELB; Kimura S., 2010, OPT COMM C OECC SAPP; O'Byrne V., 2014, OPT FIB COMM C OFC S; Senoo Y., 2013, IEICE COMMUN EXP, V2, P501; Taguchi K., 2013, EUR C OPT COMM ECOC; Yoshida T., 2013, EUR C OPT COMM ECOC	12	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	FEB 1	2015	33	3			SI		645	652		10.1109/JLT.2014.2346771		8	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CC3AL	WOS:000350216400012		
J	Richter, T; Schmidt-Langhorst, C; Elschner, R; Kato, T; Tanimura, T; Watanabe, S; Schubert, C				Richter, Thomas; Schmidt-Langhorst, Carsten; Elschner, Robert; Kato, Tomoyuki; Tanimura, Takahito; Watanabe, Shigeki; Schubert, Colja			Coherent Subcarrier Processing Node Based on Optical Frequency Conversion and Free-Running Lasers	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Add-drop multiplexing; coherent detection; fiber nonlinearity; frequency conversion; optical fiber communication; optical frequency-division multiplexing; quadrature amplitude modulation	TRANSMISSION; SUPERCHANNEL; OFDM	We demonstrate the use of frequency conversion in optical fiber to implement a coherent add/drop architecture. Its application is experimentally investigated in an optical frequency-division multiplexing scenario with up to three subcarriers which are modulated by quadrature phase-shift keying. We show sub-carrier drop and replacement in a bus topology. Furthermore, we quantify tolerances with respect to delay and amplitude mismatch by experiments and simulations. Finally, we discuss on the scalability of the scheme.	[Richter, Thomas; Schmidt-Langhorst, Carsten; Elschner, Robert; Schubert, Colja] Heinrich Hertz Inst Nachrichtentech Berlin GmbH, Fraunhofer Inst Telecommun, D-10587 Berlin, Germany; [Kato, Tomoyuki; Tanimura, Takahito; Watanabe, Shigeki] Fujitsu Labs Ltd, Nakahara Ku, Kawasaki, Kanagawa 2118588, Japan	Richter, T (reprint author), Heinrich Hertz Inst Nachrichtentech Berlin GmbH, Fraunhofer Inst Telecommun, D-10587 Berlin, Germany.	thomas.richter@hhi.fraunhofer.de; carsten.schmidt-langhorst@hhi.fraunhofer.de; robert.elschner@hhi.fraunhofer.de; kato.tom@jp.fujitsu.com; tanimura.taka@jp.fujitsu.com; s.watanabe@jp.fujitsu.com; colja.schubert@hhi.fraunhofer.de					Agrawal G. P., 2007, NONLINEAR FIBER OPTI; Chandrasekhar S, 2012, J LIGHTWAVE TECHNOL, V30, P3816, DOI 10.1109/JLT.2012.2210861; Liu X, 2011, OPT EXPRESS, V19, P958, DOI 10.1364/OE.19.00B958; Bosco G, 2010, IEEE PHOTONIC TECH L, V22, P1129, DOI 10.1109/LPT.2010.2050581; Elschner R, 2013, J LIGHTWAVE TECHNOL, V31, P628, DOI 10.1109/JLT.2012.2229259; Igarashi K., 2013, 39 EUR C OPT COMM LO; Kato T., 2013, 18 OPT COMM C OS JAP; Kato T., 2013, 39 EUR C OPT COMM LO; Kato T, 2011, OPT EXPRESS, V19, P295, DOI 10.1364/OE.19.00B295; Nishihara M., 2013, OPT FIB COMM C AN CA; Richter T., 2013, OPT FIB COMM C AN CA; Richter T., 2014, OPT FIB COMM C SAN F; Richter T., 2014, 40 EUR C OPT COMM CA; Sano A., 2012, OPT FIB COMM C LOS A; Tanimura T., 2014, OPT FIB COMM C SAN F; Watanabe S, 2012, IEEE J SEL TOP QUANT, V18, P577, DOI 10.1109/JSTQE.2011.2111358; Winzer PJ, 2013, J LIGHTWAVE TECHNOL, V31, P1775, DOI 10.1109/JLT.2013.2257687; Winzer P. J., 2011, 37 EUR C OPT COMM VI; Yu J., 2011, OPT FIB COMM C LOS A	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	FEB 1	2015	33	3			SI		685	693		10.1109/JLT.2014.2379472		9	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CC3AL	WOS:000350216400018		
J	Kan-on, Y				Kan-on, Yukio			A uniqueness theorem of radially symmetric positive stationary solutions for a competition-diffusion system	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS			English	Article						Competition-diffusion system; Radially symmetric positive solution; Uniqueness theorem	MODEL	In this paper, as a first step to study the global structure of solution, we treat a class of reaction-diffusion systems with competitive interaction, and discuss a uniqueness theorem of radially symmetric solutions for the system. To do this, the comparison principle and the shooting method are employed, and the spatial profile is investigated. (C) 2014 Elsevier Inc. All rights reserved.	Ehime Univ, Dept Math, Fac Educ, Matsuyama, Ehime 7908577, Japan	Kan-on, Y (reprint author), Ehime Univ, Dept Math, Fac Educ, Matsuyama, Ehime 7908577, Japan.						GUI CF, 1994, COMMUN PUR APPL MATH, V47, P1571, DOI 10.1002/cpa.3160471203; HALE J. K., 1988, ASYMPTOTIC BEHAV DIS; Kan-on Y, 2003, JPN J IND APPL MATH, V20, P285; Ni W.-M., 2011, MATH DIFFUSION; Protter M.H., 1984, MAXIMUM PRINCIPLES D; Rabinowitz P.H., 1971, J FUNCT ANAL, V7, P487, DOI DOI 10.1016/0022-1236(71)90030-9	6	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-247X	1096-0813		J MATH ANAL APPL	J. Math. Anal. Appl.	FEB 1	2015	422	1					625	637		10.1016/j.jmaa.2014.08.054		13	Mathematics, Applied; Mathematics	Mathematics	CB9FX	WOS:000349938500035		
J	Vynnycky, M; Kanev, K				Vynnycky, M.; Kanev, K.			Mathematical Analysis of the Multisolution Phenomenon in the P3P Problem	JOURNAL OF MATHEMATICAL IMAGING AND VISION			English	Article						P3P; Quartic polynomial; Multiple solutions	3-POINT POSE PROBLEM; VIEW	The perspective 3-point problem, also known as pose estimation, has its origins in camera calibration and is of importance in many fields: for example, computer animation, automation, image analysis and robotics. One line of activity involves formulating it mathematically in terms of finding the solution to a quartic equation. However, in general, the equation does not have a unique solution, and in some situations there are no solutions at all. Here, we present a new approach to the solution of the problem; this involves closer scrutiny of the coefficients of the polynomial, in order to understand how many solutions there will be for a given set of problem parameters. We find that, if the control points are equally spaced, there are four positive solutions to the problem at 25 % of all available spatial locations for the control-point combinations, and two positive solutions at the remaining 75 %.	[Vynnycky, M.] Univ Limerick, Dept Math & Stat, MACSI, Limerick, Ireland; [Kanev, K.] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Vynnycky, M (reprint author), Royal Inst Technol, Dept Mat Sci & Engn, Div Casting Met, Brinellvagen 23, S-10044 Stockholm, Sweden.	michaelv@kth.se			Mathematics Applications Consortium for Science and Industry - Science Foundation Ireland (SFI) Mathematics Initiative Grant [06/MI/005]; SFI [12/IA/1683]; Research Institute of Electronics, Shizuoka University, Japan	M. Vynnycky acknowledges the support of the Mathematics Applications Consortium for Science and Industry www.macsi.ul.ie, funded by the Science Foundation Ireland (SFI) Mathematics Initiative Grant 06/MI/005 and SFI Grant 12/IA/1683, as well as funding support from Research Institute of Electronics, Shizuoka University, Japan, for visiting and cooperative research. The authors also acknowledge useful discussions with Prof. J. A. Cuminato, and the comments of an anonymous referee.	Quan L, 1999, IEEE T PATTERN ANAL, V21, P774; Gao XS, 2003, IEEE T PATTERN ANAL, V25, P930; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; WOLFE WJ, 1991, IEEE T PATTERN ANAL, V13, P66, DOI 10.1109/34.67632; Finsterwalder S., 1937, SEBASTIAN FINSTERWAL, V75; Grafarend E.W., 1989, DREIDIMENSIONALER RU, P1; Grunert J. A., 1841, GRUNERTS ARCH MATH P, V1, P238; HARALICK RM, 1994, INT J COMPUT VISION, V13, P331; LAZARD D, 1988, J SYMB COMPUT, V5, P261, DOI 10.1016/S0747-7171(88)80015-4; LINNAINMAA S, 1988, IEEE T PATTERN ANAL, V10, P634, DOI 10.1109/34.6772; Merritt E. L., 1949, PHOTOGRAMMETRIC ENG, V15, P649; Rees E. L., 1922, AM MATH MONTHLY, V29, P51, DOI 10.2307/2972804; Rieck MQ, 2012, J MATH IMAGING VIS, V42, P92, DOI 10.1007/s10851-011-0278-y; Rieck MQ, 2014, J MATH IMAGING VIS, V48, P499, DOI 10.1007/s10851-013-0425-8; Rieck Michael Q, 2010, VISAPP 2010. Proceedings of the International Conference on Computer Vision Theory and Applications; Su Cheng, 1998, Chinese Journal of Computers, V21; Su C., 1997, P 5 INT C CAD CG, V1, P211; Yang L., 1998, SIMPLIFIED ALGORITHM; YUAN JSC, 1989, IEEE T ROBOTIC AUTOM, V5, P129, DOI 10.1109/70.88034; Zhang Cai-Xia, 2007, Journal of Software, V18, DOI 10.1360/jos182100; Zhang Cai-Xia, 2006, Acta Automatica Sinica, V32; Zhang CX, 2005, J COMPUT SCI TECHNOL, V20, P836, DOI 10.1007/s11390-005-0836-0	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-9907	1573-7683		J MATH IMAGING VIS	J. Math. Imaging Vis.	FEB	2015	51	2					326	337		10.1007/s10851-014-0525-0		12	Computer Science, Artificial Intelligence; Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CC3IT	WOS:000350241300007		
J	Maeda, Y; Tanaka, T; Nakajima, Y; Miyasaka, T; Izumi, T; Kato, N				Maeda, Yusuke; Tanaka, Toshiaki; Nakajima, Yasuhiro; Miyasaka, Tomoya; Izumi, Takashi; Kato, Norio			Age-related Changes in Dynamic Postural Control Ability in the Presence of Sensory Perturbation	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Elderly population; Sensory disturbance; Standing balance; Translation perturbation	RESPONSES; STRATEGIES; STANCE; SYSTEM; ADULTS	For the development of fall prevention programs, the dynamic postural control of elderly persons under conditions when their senses are perturbed needs to be investigated. The present study investigates the manner in which elderly persons respond to external perturbations when their visual and somatic senses are disturbed. The subjects included 4 healthy older adults and 6 young adults. In the experiment, external perturbation was introduced through a platform that was movable in four directions (forward, backward, right, and left). The effects of sensory disturbance created by wearing translucent goggles and standing on a soft floor were examined. The responses were measured in terms of the center of pressure (COP) on the force plate, the electromyographic (EMG) activity, and the joint angle from video analysis. The COP analysis showed that the older group, especially in the presence of sensory disturbances, required a longer time than that for the younger group to return to an erect standing position after external perturbations (recovery time). The EMG indicated that the older group used the articular muscles of the knee to respond to postural perturbations involving up-and-down movements. The recovery time is a characteristic parameter of the response to external perturbations in the presence of sensory disturbances, and thus a potentially useful indicator in evaluating balance ability. The increases in knee muscle' activities were due to reduced ankle joint torque, which is presumably one of the causes of the prolonged recovery time. These findings could be applied to the development of fall prevention training.	[Maeda, Yusuke; Tanaka, Toshiaki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Nakajima, Yasuhiro] Hokkaido Res Org, Ind Res Inst, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Miyasaka, Tomoya] Hokkaido Inst Technol, Dept Prosthet & Orthot, Fac Clin Engn, Teine Ku, Sapporo, Hokkaido 0068585, Japan; [Izumi, Takashi] Tokai Univ, Sch Int Cultural Relat, Dept Community Dev, Minami Ku, Sapporo, Hokkaido 0058601, Japan; [Kato, Norio] Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido 0600814, Japan	Maeda, Y (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	maeda@human.rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science.	Jeka JJ, 2010, J MOTOR BEHAV, V42, P197, DOI 10.1080/00222895.2010.481693; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339; BOHANNON RW, 1986, PHYS THER, V66, P206; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Maeda Y, 2011, J MED BIOL ENG, V31, P301, DOI 10.5405/jmbe.867; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; FORTIER PA, 1994, J NEUROPHYSIOL, V72, P248; MAKI BE, 1993, GAIT POSTURE, V1, P93, DOI 10.1016/0966-6362(93)90020-2; MAKI BE, 1988, PROG BRAIN RES, V76, P297; MANCHESTER D, 1989, J GERONTOL, V44, pM118; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; Shapiro A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-32	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	FEB	2015	35	1					86	93		10.1007/s40846-015-0009-8		8	Engineering, Biomedical	Engineering	CC5XV	WOS:000350439200010		
J	Suzuki, M; Kirimoto, H; Sugawara, K; Kasahara, Y; Kawaguchi, T; Ishizaka, I; Yamada, S; Matsunaga, A; Fukuda, M; Onishi, H				Suzuki, Makoto; Kirimoto, Hikari; Sugawara, Kazuhiro; Kasahara, Yusuke; Kawaguchi, Takayuki; Ishizaka, Ikuyo; Yamada, Sumio; Matsunaga, Atsuhiko; Fukuda, Michinari; Onishi, Hideaki			Time Course of Change in Movement Structure During Learning of Goal-Directed Movement	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Motor learning; Submovement; Elbow movement; Kinematics; Human	PARKINSONS-DISEASE; ELDERLY ADULTS; RECIPROCAL INHIBITION; OBJECT SHAPE; COACTIVATION; KINEMATICS; PATTERNS; STRENGTH; PLAYERS; DELAYS	Primary and secondary submovements are important in human movements. The purpose of this study was to examine the time course of changes in kinematics and electromyography (EMG) parameters for primary and secondary submovements associated with the learning of a goal-directed aiming movement task. The subjects comprised 9 neurologically normal adults. They were instructed to make horizontal planar movements of elbow flexion that were both fast and accurate. The learning session comprised 20 blocks of 10 movements. Our research found that the kinematics- and EMG-related parameters of the antagonistic triceps brachii muscle gradually changed over the course of the learning period and reached a plateau that fitted an exponential function. However, the EMG parameters of the agonistic biceps brachii muscle did not markedly change. Moreover, the kinematics- and EMG-related parameters for the primary and secondary submovements varied at different rates during the motor learning. Our findings may facilitate the understanding of the learning of a goal-directed aiming movement in sports and rehabilitation settings.	[Suzuki, Makoto; Kawaguchi, Takayuki; Ishizaka, Ikuyo; Matsunaga, Atsuhiko; Fukuda, Michinari] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa 2520373, Japan; [Suzuki, Makoto; Matsunaga, Atsuhiko; Fukuda, Michinari] Kitasato Univ, Grad Sch Med Sci, Sensory & Motor Control Course, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kirimoto, Hikari; Sugawara, Kazuhiro; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata 9503198, Japan; [Kasahara, Yusuke] St Marianna Univ, Yokohama City Seibu Hosp, Dept Rehabil Med, Yokohama, Kanagawa 2410811, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4618673, Japan	Suzuki, M (reprint author), Kitasato Univ, Grad Sch Med Sci, Sensory & Motor Control Course, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	maksuzu@gmail.com			Japan Society for the Promotion of Science (JSPS) [23700633]; Niigata University of Health and Welfare	The authors would like to acknowledge Tomoya Koyama, Yuta Furuta, Aiko Den, Misa Kazama, and Miho Kawahara for their assistance with data collection in this study. This work was supported by a Grant-in-Aid for Young Scientists (B) 23700633 from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Advanced Research from Niigata University of Health and Welfare.	Thomas JR, 2000, J EXP CHILD PSYCHOL, V75, P228, DOI 10.1006/jecp.1999.2535; Aagaard P, 2000, J APPL PHYSIOL, V89, P2249; Paul SS, 2014, CLIN REHABIL, V28, P275, DOI 10.1177/0269215513507462; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Ansuini C, 2007, EXP BRAIN RES, V180, P85, DOI 10.1007/s00221-006-0840-9; Geertsen SS, 2008, J APPL PHYSIOL, V105, P915, DOI 10.1152/japplphysiol.01155.2007; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; McLean SG, 2010, CLIN BIOMECH, V25, P563, DOI 10.1016/j.clinbiomech.2010.02.013; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Santello M, 2002, J NEUROSCI, V22, P1426; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; BARTKO JJ, 1966, PSYCHOL REP, V19, P3; Cools AM, 2014, AM J SPORT MED, V42, P1315, DOI 10.1177/0363546514526692; Dirnberger G, 2010, NEUROPSYCHOLOGIA, V48, P1200, DOI 10.1016/j.neuropsychologia.2009.12.016; Flament D, 1999, EXP BRAIN RES, V129, P441, DOI 10.1007/s002210050911; Fraser SA, 2009, EXP BRAIN RES, V195, P419, DOI 10.1007/s00221-009-1806-5; Gottlieb GL, 1998, J NEUROPHYSIOL, V80, P1860; Iida Y, 2012, EUR J APPL PHYSIOL, V112, P2223, DOI 10.1007/s00421-011-2199-2; Kirsch W, 2010, EXP BRAIN RES, V202, P927, DOI 10.1007/s00221-010-2184-8; Maeo Sumiaki, 2014, BMC Res Notes, V7, P192, DOI 10.1186/1756-0500-7-192; Mandy Anne, 2015, Disabil Rehabil Assist Technol, V10, P108, DOI 10.3109/17483107.2013.845612; Pfann KD, 2001, MOVEMENT DISORD, V16, P1048, DOI 10.1002/mds.1220; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Reyner LA, 2013, PHYSIOL BEHAV, V120, P93, DOI 10.1016/j.physbeh.2013.07.002; Romero DH, 2003, HUM MOVEMENT SCI, V22, P207, DOI 10.1016/S0167-9457(02)00160-4; Romero DH, 2003, EXP BRAIN RES, V151, P249, DOI 10.1007/s00221-003-1452-2; Vegter RJ, 2013, IEEE T NEUR SYS REH, V22, P104; WORRINGHAM CJ, 1990, J NEUROL NEUROSUR PS, V53, P702, DOI 10.1136/jnnp.53.8.702	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	FEB	2015	35	1					113	124		10.1007/s40846-015-0012-0		12	Engineering, Biomedical	Engineering	CC5XV	WOS:000350439200013		
J	Tatsuda, D; Momose, I; Someno, T; Sawa, R; Kubota, Y; Iijima, M; Kunisada, T; Watanabe, T; Shibasaki, M; Nomoto, A				Tatsuda, Daisuke; Momose, Isao; Someno, Tetsuya; Sawa, Ryuichi; Kubota, Yumiko; Iijima, Masatomi; Kunisada, Takao; Watanabe, Takumi; Shibasaki, Masakatsu; Nomoto, Akio			Quinofuracins A-E, Produced by the Fungus Staphylotrichum boninense PF1444, Show p53-Dependent Growth Suppression	JOURNAL OF NATURAL PRODUCTS			English	Article							AFLATOXIN BIOSYNTHESIS; P53; STEREOCHEMISTRY; ANTHRAQUINONES; INHIBITORS; CONVERSION; AVERUFIN; PATHWAY; TUMORS; MDM2	Quinofuracins A-E, novel anthraquinone derivatives containing beta-D-galactofuranose that were isolated from the fungus Staphylotrichum boninense PF1444, induced p53-dependent cell death in human tumor cells. The structures of quinofuracins A-E, including absolute configurations, were elucidated by extensive spectroscopic analysis and chemical transformation studies. Quinofuracins were classified into three groups according to the aglycone moieties. 5'-Oxoaverantin was present in quinofuracins A-C, whereas averantin and versicolorin B were identified in quinofuracins D and E, respectively. These quinofuracins induced p53-dependent growth suppression in human glioblastoma LNZTA3 cells.	[Tatsuda, Daisuke; Momose, Isao; Someno, Tetsuya; Iijima, Masatomi; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Numazu, Shizuoka 4100301, Japan; [Sawa, Ryuichi; Kubota, Yumiko; Watanabe, Takumi; Shibasaki, Masakatsu; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 1410021, Japan; [Kunisada, Takao] Meiji Seika Pharma Ltd, Biosci Labs, Odawara, Kanagawa 2500852, Japan	Momose, I (reprint author), Inst Microbial Chem BIKAKEN, 18-24 Miyamoto, Numazu, Shizuoka 4100301, Japan.	imomose@bikaken.or.jp			JST;  [21790217]	This work was financially supported by JST and Grant-in-Aid for Young Scientists (B) Number 21790217. We thank Mr. S. Ohba for the spectroscopic measurements, Ms. S. Kakuda for technical assistance, and Dr. M. Hatano and Dr. M. Igarashi for helpful advice.	Huang HB, 2012, J NAT PROD, V75, P1346, DOI 10.1021/np3002699; Kojima K, 2010, MOL CANCER THER, V9, P2545, DOI 10.1158/1535-7163.MCT-10-0337; Yabe K, 2011, FOOD HYG SAFE SCI, V52, P135; Richards MR, 2013, CARBOHYD RES, V374, P103, DOI 10.1016/j.carres.2013.03.030; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Yu SH, 2009, J MED CHEM, V52, P7970, DOI 10.1021/jm901400z; YASUZAWA T, 1990, J ANTIBIOT, V43, P336; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Tabernero J, 2011, CLIN CANCER RES, V17, P6313, DOI 10.1158/1078-0432.CCR-11-1101; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Ayer A. W., 1995, TETRAHEDRON LETT, V36, P7953; Birkinshaw J H, 1966, J Chem Soc Perkin 1, V9, P855; CASTONGUAY A, 1977, CAN J CHEM, V55, P1324, DOI 10.1139/v77-183; GORIN PAJ, 1975, CAN J CHEM, V53, P1212, DOI 10.1139/v75-168; GORSTALLMAN CP, 1977, J CHEM SOC PERK T 1, P2181, DOI 10.1039/p19770002181; HAMASAKI T, 1965, AGR BIOL CHEM TOKYO, V29, P166; Kornsakulkarn J, 2012, TETRAHEDRON, V68, P8480, DOI 10.1016/j.tet.2012.07.059; Magome E, 1996, J ANTIBIOT, V49, P599; Nonaka K, 2012, MYCOSCIENCE, V53, P312, DOI 10.1007/s10267-011-0159-7; Padron JI, 1998, J ORG CHEM, V63, P8247, DOI 10.1021/jo981002t; RITCHIE RGS, 1975, CAN J CHEM, V53, P1424, DOI 10.1139/v75-197; Running E. W., 1993, J CHEM INF COMP SCI, V33, P934; Sakuno E, 2003, APPL ENVIRON MICROB, V69, P6418, DOI 10.1128/AEM.69.11.6418-6426.2003; Sakuno E, 2005, APPL ENVIRON MICROB, V71, P2999, DOI 10.1128/AEM.71.6.2999-3006.2005; VAN MEIR EG, 1994, NAT GENET, V8, P171, DOI 10.1038/ng1094-171; YABE K, 1993, APPL ENVIRON MICROB, V59, P2493; YABE K, 1993, APPL ENVIRON MICROB, V59, P2486; Zhao Y., 2013, BIODISCOVERY, V8, P1	30	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	FEB	2015	78	2					188	195		10.1021/np500581m		8	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CC4MX	WOS:000350328600003		
J	Oya, A; Tanaka, N; Kusama, T; Kim, SY; Hayashi, S; Kojoma, M; Hishida, A; Kawahara, N; Sakai, K; Gonoi, T; Kobayashi, J				Oya, Atsushi; Tanaka, Naonobu; Kusama, Taishi; Kim, Sang-Yong; Hayashi, Shigeki; Kojoma, Mareshige; Hishida, Atsuyuki; Kawahara, Nobuo; Sakai, Kanae; Gonoi, Tohru; Kobayashi, Junichi			Prenylated Benzophenones from Triadenum japonicum	JOURNAL OF NATURAL PRODUCTS			English	Article							POLYCYCLIC POLYPRENYLATED ACYLPHLOROGLUCINOLS; HYPERICUM-CHINENSE; CLUSIA-NEMOROSA; A-D; MEROTERPENOIDS; DERIVATIVES; PERFORATUM; CHEMISTRY; GENUS	Six new prenylated benzophenones, (-)-nemorosonol (1) and trijapins A-E (2-6), were isolated from the aerial parts of Triadenum japonicum. (-)-Nemorosonol (1) and trijapins A-C (2-4) have a common tricyclo[4.3.1.0(3,7)]decane skeleton, while 1 is an enantiomer of (+)-nemorosonol previously isolated from Clusia nemorosa. The absolute configuration of (-)-nemorosonol (1) was assigned by ECD spectroscopy. Trijapins A-C (2-4) are analogues of 1 possessing an additional tetrahydrofuran ring. Trijapins D (5) and E (6) are prenylated benzophenones with a 1,2-dioxane moiety and a hydroperoxy group, respectively. (-)-Nemorosonol (1) exhibited antimicrobial activity against Escherichia coli (MIC, 8 mu g/mL), Staphylococcus aureus (MIC, 16 mu g/mL), Bacillus subtilis (MIC, 16 mu g/mL), Micrococcus luteus (MIC, 32 mu g/mL), Aspergillus niger (IC50, 16 mu g/mL), Trichophyton mentagrophytes (IC50, 8 mu g/mL), and Candida albicans (IC50, 32 mu g/mL), while trijapin D (5) showed antimicrobial activity against C. albicans (IC50, 8 mu g/mL).	[Oya, Atsushi; Tanaka, Naonobu; Kusama, Taishi; Kobayashi, Junichi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Tanaka, Naonobu] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Kim, Sang-Yong; Kojoma, Mareshige] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Tobetsu 0610293, Japan; [Hayashi, Shigeki; Hishida, Atsuyuki; Kawahara, Nobuo] Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Hokkaido Div, Nayoro, Hokkaido 0900065, Japan; [Sakai, Kanae; Gonoi, Tohru] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan	Kobayashi, J (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan.	jkobay@pharm.hokudai.ac.jp	Kobayashi, Junjiro/J-8547-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Ms. S. Oka and Ms. A. Tokumitsu, Equipment Management Center, Hokkaido University, for MS measurements. This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Tanaka N, 2010, BIOORG MED CHEM LETT, V20, P4451, DOI 10.1016/j.bmcl.2010.06.047; CERRINI S, 1993, PHYTOCHEMISTRY, V32, P1023, DOI 10.1016/0031-9422(93)85248-P; Tanaka N, 2009, TETRAHEDRON LETT, V50, P4747, DOI 10.1016/j.tetlet.2009.06.021; Singh IP, 2006, NAT PROD REP, V23, P558, DOI 10.1039/b600518g; Ciochina R, 2006, CHEM REV, V106, P3963, DOI 10.1021/cr0500582; Wu SB, 2014, NAT PROD REP, V31, P1158, DOI 10.1039/c4np00027g; Avato P, 2005, STUD NAT PROD CHEM, V30, P603; NAGAI H, 1993, J ANTIBIOT, V46, P520; Abe S, 2012, J NAT PROD, V75, P484, DOI 10.1021/np200741x; Tanaka N, 2012, TETRAHEDRON LETT, V53, P1507, DOI 10.1016/j.tetlet.2012.01.052; Nahrstedt A, 1997, PHARMACOPSYCHIATRY, V30, P129, DOI 10.1055/s-2007-979533; Mamemura T, 2011, TETRAHEDRON LETT, V52, P3575, DOI 10.1016/j.tetlet.2011.04.106; [Anonymous], 2011, SPARTAN 10; Tanaka N, 2011, ORG LETT, V13, P5488, DOI 10.1021/ol2021548; Bringmann G, 2009, EUR J ORG CHEM, P2717, DOI 10.1002/ejoc.200801121; Bruhn T, 2013, SPECDIS VERSION 1 61; Cuesta-Rubio O, 2005, STUD NAT PROD CHEM, V32, P671; DELLEMONACHE F, 1988, PHYTOCHEMISTRY, V27, P2305; Frisch M J, 2010, GAUSSIAN 09 REVISION; Grossman RB, 2000, TETRAHEDRON LETT, V41, P5165, DOI 10.1016/S0040-4039(00)00832-7; Krasovskaya N. P., 1986, CHEM NAT COMPD, V22, P352, DOI 10.1007/BF00598324; Li LY, 2010, BIOCHEM SYST ECOL, V38, P1074, DOI 10.1016/j.bse.2010.09.022; Matsuhisa M, 2002, J NAT PROD, V65, P290, DOI 10.1021/np010310a; Tanaka N, 2015, HETEROCYCLES, V90, P23, DOI 10.3987/REV-14-SR(K)1; Verotta L, 2000, J NAT PROD, V63, P412, DOI 10.1021/np9903752	25	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	FEB	2015	78	2					258	264		10.1021/np500827h		7	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CC4MX	WOS:000350328600012		
J	Arai, MA; Koryudzu, K; Ishibashi, M				Arai, Midori A.; Koryudzu, Kazune; Ishibashi, Masami			Inubosins A, B, and C Are Acridine Alkaloids Isolated from a Culture of Streptomyces sp IFM 11440 with Ngn2 Promoter Activity	JOURNAL OF NATURAL PRODUCTS			English	Article							NEURAL STEM-CELLS; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; SMALL-MOLECULE; PYRIDOACRIDINE ALKALOIDS; SUBVENTRICULAR ZONE; NERVOUS-SYSTEM; RETINOIC ACID; TRANSCRIPTION; NEUROGENESIS	Three new acridine alkaloids, inubosins A (1), B (2), and C (3), were isolated from an extract of a culture of Streptomyces sp. IFM 11440 using bioassay-guided fractionation. Neurogenin2 (Ngn2) is an activator-type basic helix-loop-helix transcription factor that promotes neural stem cell differentiation. Using cell-based Ngn2 promoter activity-guided screening, Streptomyces sp. IFM 11440 was found to induce Ngn2 promoter activity. The structures of 1-3 were established using spectroscopic methods, including 1D- and 2D-NMR measurements. Inubosin B (2) showed potent Ngn2 promoter activity. Moreover, inubosin B (2) increased mRNA expression of genes related to neural stem cell differentiation.	[Arai, Midori A.; Koryudzu, Kazune; Ishibashi, Masami] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Arai, MA (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, I-8-1 Inohana, Chiba 2608675, Japan.	midori_arai@chiba-u.jp	Ishibashi, Masami /E-5328-2015; Arai, Midori/O-4613-2015	Ishibashi, Masami /0000-0002-2839-1045; 	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Asian Core Program (JSPS); Hayashi Memorial Foundation for Female Natural Scientists; Naito Foundation; Tokyo Biochemical Research Foundation	We thank Prof. T. Gonoi (Medical Mycology Research Center, Chiba University) for the identification of Streptomyces sp. IFM11440. We are very grateful to Prof. R. Kageyama and Prof. T. Ohtsuka for the kind provision of plasmids and discussions. This study was supported by a Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), the Asian Core Program (JSPS), Hayashi Memorial Foundation for Female Natural Scientists, the Naito Foundation, and the Tokyo Biochemical Research Foundation.	Bontemps N, 2013, J NAT PROD, V76, P1801, DOI 10.1021/np400284z; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hindley C, 2012, DEVELOPMENT, V139, P1718, DOI 10.1242/dev.077552; Katakura M, 2009, NEUROSCIENCE, V160, P651, DOI 10.1016/j.neuroscience.2009.02.057; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001; Bontemps N, 2010, J NAT PROD, V73, P1044, DOI 10.1021/np900751k; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Warashina M, 2006, ANGEW CHEM INT EDIT, V45, P591, DOI 10.1002/anie.200503089; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.0.CO;2-Q; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Arai MA, 2013, MOL BIOSYST, V9, P2489, DOI 10.1039/c3mb70083f; Jin GH, 2005, NEUROSCI LETT, V386, P105, DOI 10.1016/j.neulet.2005.04.065; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim G.-H., 2014, ANGEW CHEM INT EDIT, V126, P9425; LARSSON R, 1992, INT J CANCER, V50, P177, DOI 10.1002/ijc.2910500204; Liu JW, 2007, J NAT PROD, V70, P1329, DOI 10.1021/np070135j; Roubaud G, 2003, MAGN RESON CHEM, V41, P549, DOI 10.1002/mrc.1170	27	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	FEB	2015	78	2					311	314		10.1021/np5006218		4	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CC4MX	WOS:000350328600020		
J	Toraya, T; Ohya, Y				Toraya, Tetsuo; Ohya, Yukio			Synthesis and Properties of Formylcobalamin and Propionylcobalamin, Novel Acylcobalamins	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						formylcobalamin; acetylcobalamin; propionylcobalamin; acylcobalamin; vitamin B-12	DEM VITAMIN B12-GEBIET; DIOL DEHYDRATASE; COENZYME; GLYCEROL; MECHANISM; INACTIVATION; SUBSTRATE; CHEMISTRY; BOND; B12	Formylcobalamin (formyl-Cbl), a Cl-unit carrying corrinoid, and propionylcobalamin (propionyl-Cbl) were synthesized for the first time, and their properties were compared with those of acetylcobalamin (acetyl-Cbl). Formyl-Cbl, acetyl-Cbl. and propionyl-Cbl were decomposed by a NH2OH treatment, forming formo-, aceto-, and propionohydroxamic acids, respectively, which offers a proof for the presence of "activated" acyl groups and for their structures of Co-acyl-Cbls. These results, together with chromatographic, electrophoretic, and spectroscopic properties, indicate that the acyl-Cbls synthesized are actually formyl-Cbl, acetyl-Cbl, and propionyl-Cbl. Spectroscopic and electrophoretic properties were consistent with the a-donor strength or trans-effect increasing in the order: formyl<acetyl<propionyl. All acyl-Cbls underwent the Co-C bond cleavage upon photo-irradiation with a tungsten light bulb as well as upon treatment with alkali, forming aquacobalamin (aqCbl) and hydroxocobalamin (OH-Cbl), respectively, under air. Formyl-Cbl was thermally unstable and decomposed to aqCbl, and the thermal stability in neutral solution was much lower than in diluted HCl. In contrast, acetyl-Cbl and propionyl-Cbl were heat-stable under these conditions. Formyl-Cbl was essentially unsusceptible to unbufferized KCN solution, although acetyl-Cbl and propionyl-Cbl were rapidly converted to dicyanocobalamin under the same conditions. Such abnormal behaviors of formyl-Cbl suggest that it mainly exists in a hydrated form as formaldehyde.	[Toraya, Tetsuo] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Kita Ku, Okayama 7008530, Japan; [Toraya, Tetsuo; Ohya, Yukio] Kyoto Univ, Fac Engn, Dept Ind Chem, Sakyo Ku, Kyoto 6068501, Japan	Toraya, T (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Kita Ku, Okayama 7008530, Japan.	toraya@cc.okayama-u.ac.jp					Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; BARKER HA, 1960, J BIOL CHEM, V235, P480; LENHERT PG, 1961, NATURE, V192, P937, DOI 10.1038/192937a0; BARKER HA, 1958, P NATL ACAD SCI USA, V44, P1093, DOI 10.1073/pnas.44.11.1093; BACHOVCHIN WW, 1977, BIOCHEMISTRY-US, V16, P1082, DOI 10.1021/bi00625a009; Banerjee R., 1999, CHEM BIOCH B12; BARNETT R, 1966, J BIOL CHEM, V241, P1483; BERNHAUER K, 1964, BIOCHEM Z, V339, P530; Doitomi K, 2012, BIOCHEMISTRY-US, V51, P9202, DOI 10.1021/bi300488u; Dolphin D, 1982, B12, V2; FINK K, 1949, P SOC EXP BIOL MED, V70, P654; FIRTH RA, 1968, J CHEM SOC A, P2419, DOI 10.1039/j19680002419; FIRTH RA, 1968, J CHEM SOC A, P2428, DOI 10.1039/j19680002428; GUEST JR, 1962, NATURE, V195, P340, DOI 10.1038/195340a0; JOHNSON A. W., 1963, Journal of the Chemical Society, P4146, DOI 10.1039/jr9630004146; LINDSTRAND K, 1964, NATURE, V204, P188, DOI 10.1038/204188a0; MULLER O, 1962, BIOCHEM Z, V336, P299; PENLEY MW, 1970, BIOCHEMISTRY-US, V9, P4302; SMITH E. LESTER, 1962, NATURE, V194, P1175, DOI 10.1038/1941175a0; TORAYA T, 1976, BIOCHEM BIOPH RES CO, V69, P475, DOI 10.1016/0006-291X(76)90546-5; YAMADA RH, 1968, J VITAMINOL, V14, P316	21	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					8	13				6	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000002		
J	Teshima, N; Shimo, M; Miyazawa, K; Konegawa, S; Matsumoto, A; Onishi, Y; Sasaki, R; Suzuki, T; Yano, Y; Matsumoto, K; Yamada, T; Gabazza, EC; Takei, Y; Sumida, Y				Teshima, Nobuko; Shimo, Miho; Miyazawa, Kae; Konegawa, Sachi; Matsumoto, Aki; Onishi, Yuki; Sasaki, Ryoma; Suzuki, Toshinari; Yano, Yutaka; Matsumoto, Kazutaka; Yamada, Tomomi; Gabazza, Esteban Cesar; Takei, Yoshiyuki; Sumida, Yasuhiro			Effects of Sugar-Sweetened Beverage Intake on the Development of Type 2 Diabetes Mellitus in Subjects with Impaired Glucose Tolerance: the Mihama Diabetes Prevention Study	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						type 2 diabetes; sugar intake; sweetened beverage; nutritional behavior; cohort study	LIFE-STYLE INTERVENTION; WEIGHT-GAIN; JAPANESE POPULATION; INSULIN-RESISTANCE; RISK; CONSUMPTION; FRUCTOSE; OBESITY; WOMEN; IGT	In Japan, the incidence of type 2 diabetes mellitus (T2DM) is increasing for several reasons, including increased consumption of sugar-sweetened beverages (SSBs). However, whether SSBs cause T2DM by excess of energy production resulting in obesity remains unclear. Therefore, the present study was designed to evaluate the effects of SSB intake on the development of T2DM in subjects with impaired glucose tolerance (IGT). Ninety-three subjects (30 males and 63 females) with IGT aged 40-69 y and residing in the Mihama district (southern Mie Prefecture, Japan) were included in the study. The mean observational period was 3.6 y. All subjects underwent the 75-g oral glucose tolerance test (OGTT) and completed a lifestyle questionnaire survey related to SSB intake. OGTT results and SSB intake were evaluated before and after the observational period. In addition, the correlation between SSB intake and development of T2DM was investigated. Of the 93 subjects, 20 (21.5%) developed T2DM (T2DM group) and demonstrated a significantly high SSB intake compared with the group that did not develop the disease (non-T2DM group). The odds ratio for the incidence of T2DM based on SSB intake was 3.26 (95% confidence interval, 1.17-9.06). The body mass index (BMI; kg/m(2)) and the homeostasis model assessment for insulin resistance (HOMA-R) values was significantly higher in the T2DM group than in the non-T2DM group, while the insulinogenic indices were significantly lower in the former than in the latter group. The sum of insulin secretion levels during OGTT was not significantly different between groups. SSB intake correlated with the predisposition for developing T2DM, possibly by influencing body weight, insulin resistance, and the ability of the pancreatic beta cells to effectively compensate for the insulin resistance.	[Teshima, Nobuko] Mie Univ Hospital, Div Dietary Serv, Tsu, Mie 5148507, Japan; [Shimo, Miho; Miyazawa, Kae; Konegawa, Sachi] Dept Hlth & Welf, Mihama Town, Mie, Japan; [Matsumoto, Aki; Onishi, Yuki; Sasaki, Ryoma; Suzuki, Toshinari; Yano, Yutaka; Matsumoto, Kazutaka] Mie Univ Hosp, Dept Clin Diabet & Endocrinol, Tsu, Mie 5148507, Japan; [Yamada, Tomomi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Osaka 5650871, Japan; [Gabazza, Esteban Cesar] Mie Univ, Grad Sch Med, Dept Immunol, Div Mol & Expt Medicine, Tsu, Mie 5148507, Japan; [Takei, Yoshiyuki] Mie Univ Hosp, Dept Gastroenterol & Hepatol, Tsu, Mie 5148507, Japan; [Sumida, Yasuhiro] Yokkaichi Hazu Med Ctr, Yokaichi, Mie 5100016, Japan	Sumida, Y (reprint author), Yokkaichi Hazu Med Ctr, Yokaichi, Mie 5100016, Japan.	y-sumida@wh.commufa.jp					MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Elliott SS, 2002, AM J CLIN NUTR, V76, P911; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Montonen J, 2007, J NUTR, V137, P1447; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; [Anonymous], 2013, DIABETES ATLAS; Knowler WC, 2002, NEW ENGL J MED, V346, P393; Malik VS, 2006, AM J CLIN NUTR, V84, P274; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003; Kiyohara Y, 2003, J EPIDEMIOL, V13, P251; MCGARRY JD, 1994, J CELL BIOCHEM, V55, P29, DOI 10.1002/jcb.240550005; Nagaya T, 2005, DIABETIC MED, V22, P1107, DOI 10.1111/j.1464-5491.2005.01602.x; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Steil GM, 1998, DIABETES, V47, P714, DOI 10.2337/diabetes.47.5.714; World Health Organization Diabetes Guideline Development Committee, 2006, DEF DIAGN DIAB MELL	26	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					14	19				6	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000003		
J	Yamano, N; Ikeda, Y; Sakama, M; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Miyamoto, L; Tomita, S; Tsuchiya, K; Tamaki, T				Yamano, Noriko; Ikeda, Yasumasa; Sakama, Minoru; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Miyamoto, Licht; Tomita, Shuhei; Tsuchiya, Koichiro; Tamaki, Toshiaki			A Long-Term High-Fat Diet Changes Iron Distribution in the Body, Increasing Iron Accumulation Specifically in the Mouse Spleen	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						iron/spleen/diet; high fat/diabetes mellitus; type 2/DMT1 protein (iron transporter)	OXIDATIVE STRESS; FERRITIN LEVELS; ABSORPTION; STORES; OBESE; RATS; HEMOCHROMATOSIS; SPLENECTOMY; ASSOCIATION; EXPRESSION	Although iron is an essential trace metal, its presence in excess causes oxidative stress in the human body. Recent studies have indicated that iron storage is a risk factor for type 2 diabetes mellitus. Dietary iron restriction or iron chelation ameliorates symptoms of type 2 diabetes in mouse models. However, whether iron content in the body changes with the development of diabetes is unknown. Here, we investigated the dynamics of iron accumulation and changes in iron absorption-related genes in mice that developed obesity and diabetes by consuming a high-fat diet (FIFD-fed mice). HFD-fed mice (18-20 wk) were compared with control mice for hematologic features, serum ferritin levels, and iron contents in the gastrocnemius muscle, heart, epididymal fat, testis, liver, duodenum, and spleen. In addition, the spleen was examined histologically. Iron absorption-related gene expression in the liver and duodenum was also examined. Hemoglobin and serum ferritin levels were increased in HFD-fed mice. The HFD-fed mice showed iron accumulation in the spleen, but not in the heart or liver. Increased percentages of the splenic red pulp and macrophages were observed in HFD-fed mice and iron accumulation in the spleen was found mainly in the splenic red pulp. The HFD-fed mice also showed decreased iron content in the duodenum. The mRNA expression of divalent metal transporter-1 (DMT-1), an iron absorption-related gene, was elevated in the duodenum of HFD-fed mice. These results indicate that iron accumulation (specifically accumulation in the spleen) is enhanced by the development of type 2 diabetes induced by HFD.	[Yamano, Noriko; Ikeda, Yasumasa; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan; [Sakama, Minoru] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Radiol Sci, Tokushima 7708503, Japan; [Ishizawa, Keisuke; Miyamoto, Licht; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 7708503, Japan; [Tomita, Shuhei] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori 6838503, Japan	Yamano, N (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan.	yamanori@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Yoshimi Bando, M.D., Ph.D. for advice on histology. This work was supported by Grants for the Regional Innovation Cluster Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T.T.).	Anderson GJ, 1999, LANCET, V353, P2089, DOI 10.1016/S0140-6736(99)00113-0; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Gulec S, 2014, AM J PHYSIOL-GASTR L, V307, pG397, DOI 10.1152/ajpgi.00348.2013; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P982, DOI 10.1210/jc.2008-1211; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Petroianu A, 2008, J GASTROEN HEPATOL, V23, pE221, DOI 10.1111/j.1440-1746.2007.05263.x; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Kunutsor SK, 2013, DIABETES-METAB RES, V29, P308, DOI 10.1002/dmrr.2394; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Castellani RJ, 2012, BIOFACTORS, V38, P133, DOI 10.1002/biof.1010; Aso Y, 2010, DIABETES RES CLIN PR, V90, P250, DOI 10.1016/j.diabres.2010.09.008; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Inoue M, 2012, HEPATOL RES, V42, P203, DOI 10.1111/j.1872-034X.2011.00914.x; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Mills SE, 2006, HISTOLOGY PATHOLOGIS, P786; Paulo DNS, 2009, MICROSURG, V29, P154, DOI 10.1002/micr.20568; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6	23	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					20	27				8	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000004		
J	Hariya, N; Miyake, K; Kubota, T; Goda, T; Mochizuki, K				Hariya, Natsuyo; Miyake, Kunio; Kubota, Takeo; Goda, Toshinao; Mochizuki, Kazuki			Putative PPAR Target Genes Express Highly in Skeletal Muscle of Insulin-Resistant MetS Model SHR/NDmc-cp Rats	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						insulin resistance; skeletal muscle; fatty acid oxidation; PPAR; SHR/Nllmc-cp rats	PROLIFERATOR-ACTIVATED RECEPTORS; METABOLIC SYNDROME; PEROXISOME; ALPHA; CELLS; GAMMA; TISSUES; OBESITY; LIVER; BETA	It is known that insulin resistance in skeletal muscle induces subsequent metabolic diseases such as metabolic syndrome (MetS). However, which genes are altered in the skeletal muscle by development of insulin resistance in animal models has not been examined. In this study, we performed microarray and subsequent real-time RT-PCR analyses using total RNA extracted from the gastrocnemius muscle of the MetS model, spontaneously hypertensive corpulent congenic (SHR/NDmc-cp) rats, and control Wistar Kyoto (WKY) rats. SHR/NDmc-cp rats displayed overt insulin resistance relative to WKY rats. The expression of many genes related to fatty acid oxidation was higher in SHR/NDmc-cp rats than in WKY rats. Among 18 upregulated genes, putative peroxisome proliferator responsive elements were found in the upstream region of 15 genes. The protein expression of ACOX2, an upregulated gene, and peroxisome proliferator-activated receptor (PPAR) G1, but not of PPARG2, PPARA or PPARD, was higher in the gastrocnemius muscle of SHR/Nllmc-cp rats than that in WKY rats. These results suggest that insulin resistance in the MetS model, SHR/NDmc-cp rats, is positively associated with the expression of fatty acid oxidation-related genes, which are presumably PPARs' targets, in skeletal muscle.	[Hariya, Natsuyo] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Hariya, Natsuyo; Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Epigenet Med, Kofu, Yamanashi 4008510, Japan; [Goda, Toshinao; Mochizuki, Kazuki] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Mochizuki, Kazuki] Univ Yamanashi, Fac Life & Environm Sci, Dept Local Prod & Food Sci, Lab Food & Nutr Sci, Kofu, Yamanashi 4008510, Japan	Mochizuki, K (reprint author), Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	mochizukik@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22680054]; Takeda Science Foundation	This work was supported by a Grant-in-Aid for Young Scientists (22680054) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Takeda Science Foundation.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Kim JH, 2011, J ETHNOPHARMACOL, V133, P244, DOI 10.1016/j.jep.2010.09.029; Ammerschlaeger M, 2004, TOXICOL SCI, V78, P229, DOI 10.1093/toxsci/kfh071; DEFRONZO RA, 1988, DIABETES, V37, P667; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Nangaku M, 2003, J AM SOC NEPHROL, V14, P1212, DOI 10.1097/01.ASN.0000062961.76776.C1; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Hariya N, 2014, J NUTR SCI VITAMINOL, V60, P52; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; Jans A, 2011, OBESITY, V19, P2158, DOI 10.1038/oby.2011.149; Tsukahara T, 2013, BIOCHEM BIOPH RES CO, V433, P281, DOI 10.1016/j.bbrc.2013.02.101; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Wilde J, 2009, J NUTRIGENET NUTRIGE, V2, P280, DOI 10.1159/000308466; Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Harikai N, 2007, METABOLISM, V56, P847, DOI 10.1016/j.metabol.2007.01.016; Inamochi Y, 2014, BBA-GEN SUBJECTS, V1840, P693, DOI [10.1016/j.bbagen.2013.10.026, 10.1016/j.bbagen2013.10.026]; Khoo NKH, 2013, REDOX BIOL, V1, P70, DOI 10.1016/j.redox.2012.12.006; Kruszynska YT, 1998, J CLIN INVEST, V101, P543, DOI 10.1172/JCI1076; Venkatachalam G, 2009, INT J INTEG BIOL, V8, P37; Venkatachalam G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S5; Voss MD., 2005, DIABETOLOGIA, V48, P2677	29	1	1	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					28	36				9	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000005		
J	Sunagawa, Y; Hirano, S; Katanasaka, Y; Miyazaki, Y; Funamoto, M; Okamura, N; Hojo, Y; Suzuki, H; Doi, O; Yokoji, T; Morimoto, E; Takahashi, T; Ozawa, H; Imaizumi, A; Ueno, M; Kakeya, H; Shimatsu, A; Wada, H; Hasegawa, K; Morimoto, T				Sunagawa, Yoichi; Hirano, Sae; Katanasaka, Yasufumi; Miyazaki, Yusuke; Funamoto, Masafumi; Okamura, Nobuko; Hojo, Yuya; Suzuki, Hidetoshi; Doi, Osamu; Yokoji, Tsunehiro; Morimoto, Eriko; Takahashi, Tsukasa; Ozawa, Hitomi; Imaizumi, Atsushi; Ueno, Morio; Kakeya, Hideaki; Shimatsu, Akira; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya			Colloidal Submicron-Particle Curcumin Exhibits High Absorption Efficiency -A Double-Blind, 3-Way Crossover Study-	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						curcumin; colloidal submicron particles; human; plasma levels; drug-delivery system	POSTMENOPAUSAL WOMEN; ORAL BIOAVAILABILITY; RATS; PHARMACOKINETICS; SAFETY; ANTICANCER; METABOLISM; MOLECULE; EFFICACY; KITCHEN	Curcumin is a major constituent of the spice turmeric and has various biological activities, including anticancer, antioxidant, and anti-inflammatory properties. as well as alcohol detoxification. However, because of its poor absorption efficiency, it is difficult for orally administered curcumin to reach blood levels sufficient to exert its bioactivities. To overcome this problem, several curcumin preparations with a drug-delivery system (DDS) have been developed to increase the bioavailability of curcumin after oral administration, and tested as functional foods and potential medical agents in humans. We have also produced capsules containing Theracurmin, curcumin dispersed with colloidal submicron-particles. To evaluate the absorption efficiency of three types of DDS curcumin, we performed a double-blind, 3-way crossover study. We compared plasma curcumin levels after the administration of Theracurmin and 2 other capsule types of curcumin with DDS, BCM-95 (micronized curcumin with turmeric essential oils) and Meriva (curcumin-phospholipid). Nine healthy subjects (male/female = 5/4, age: 24-32 y old) were administered these 3 preparations of DDS curcumin, at commonly used dosages. Six capsules of Theracurmin, 1 capsule of BCM-95, and 2 capsules of Meriva contain 182.4 +/- 1.0, 279.3 +/- 10.7, and 152.5 +/- 20.3 mg of curcumin, respectively. The maximal plasma curcumin concentration (0-24 h) of Theracurmin was 10.7 to 5.6 times higher than those of BCM-95 and Meriva, respectively. Moreover, the area under the blood concentration-time curve at 0-24 h was found to be 11.0- and 4.6-fold higher with Theracurmin than BCM-95 and Meriva, respectively. These data indicate that Theracurmin exhibits a much higher absorption efficiency than other curcumin DDS preparations.	[Sunagawa, Yoichi; Hirano, Sae; Katanasaka, Yasufumi; Miyazaki, Yusuke; Funamoto, Masafumi; Okamura, Nobuko; Hojo, Yuya; Suzuki, Hidetoshi; Morimoto, Tatsuya] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Doi, Osamu; Yokoji, Tsunehiro; Morimoto, Eriko; Morimoto, Tatsuya] Shizuoka Prefectural Gen Hosp, Shizuoka 4208527, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya] Natl Hosp Org, Div Translat Res, Kyoto 6128555, Japan; [Shimatsu, Akira] Natl Hosp Org, Clin Res Inst, Kyoto Med Ctr, Kyoto 6128555, Japan; [Hirano, Sae] Shizuoka Saiseikai Gen Hosp, Shizuoka 4228527, Japan; [Takahashi, Tsukasa; Ozawa, Hitomi; Imaizumi, Atsushi] Theravalues Corp, Tokyo 1020094, Japan; [Ueno, Morio] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6028566, Japan; [Kakeya, Hideaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Chemotherapy & Mol Sci, Div Bioinformat & Chem Genom, Kyoto 6068501, Japan	Morimoto, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan.	morimoto@u-shizuoka-ken.ac.jp			Japan Science and Technology Agency; Japan Society for the Promotion of Sciences; Kowa Life Science Foundation; Theravalues Corporation	This work was supported by a grant from the Japan Science and Technology Agency (T. Morimoto, Y. Sunagawa, Y. Katanasaka), a grant from the Japan Society for the Promotion of Sciences (H. Kakeya). a grant from Kowa Life Science Foundation (T. Morimoto), and joint research funding from the Theravalues Corporation.	Allegri Pia, 2010, Clin Ophthalmol, V4, P1201, DOI 10.2147/OPTH.S13271; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Cuomo J, 2011, J NAT PROD, V74, P664, DOI 10.1021/np1007262; Fang M, 2012, INT J NANOMED, V7, P5395, DOI 10.2147/IJN.S36257; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; HOLDER GM, 1978, XENOBIOTICA, V8, P761; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Akazawa N, 2012, NUTR RES, V32, P795, DOI 10.1016/j.nutres.2012.09.002; Sunagawa Y, 2011, CIRC J, V75, P2151, DOI 10.1253/circj.CJ-10-1072; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Belcaro G, 2010, ALTERN MED REV, V15, P337; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Padhye S, 2010, MINI-REV MED CHEM, V10, P372; Grynkiewicz G, 2012, ACTA BIOCHIM POL, V59, P201; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Chandran B, 2012, PHYTOTHER RES, V26, P1719, DOI 10.1002/ptr.4639; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P65, DOI 10.1007/s00280-011-1673-1; WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86; Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591; Aggarwal BB, 2013, MOL NUTR FOOD RES, V57, P1529, DOI 10.1002/mnfr.201200838; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Benny M., 2006, SPICE INDIA, V19, P11; Deepa Das A., 2012, J HAZARD MATER, V22, P88; Di Pierro F, 2013, J PAIN RES, V6, P201, DOI 10.2147/JPR.S42184; Handran B., 2012, PHYTOTHER RES, V26, P1719; Henrotin Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-56; Ledda A, 2012, Panminerva Med, V54, P17; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; Mazzolani F., 2012, CLIN OPHTHALMOL, V6, P801; Mazzolani Fabio, 2013, Clin Ophthalmol, V7, P939, DOI 10.2147/OPTH.S45820; Morimoto T, 2013, BIOL PHARM BULL, V36, P1708; BHAVANISHANKAR TN, 1980, INDIAN J EXP BIOL, V18, P73; Shimatsu A, 2012, ANTIAGING MED, V9, P75; Steigerwalt R, 2012, Panminerva Med, V54, P11; Sugawara J, 2012, AM J HYPERTENS, V25, P651, DOI 10.1038/ajh.2012.24; Sunagawa V., 2012, BIOL PHARM BULL, V35, P139	45	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					37	44				8	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000006		
J	Kakutani, Y; Kamiya, S; Omi, N				Kakutani, Yuya; Kamiya, Saori; Omi, Naomi			Association between the Frequency of Meals Combining "Shushoku, Shusai, and Hukusai" (Staple Food, Main Dish, and Side Dish) and Intake of Nutrients and Food Groups among Japanese Young Adults Aged 18-24 Years: a Cross-Sectional Study	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Shushoku; Shusai and Hukusai; Japanese diet; brief-type self-administered diet history questionnaire; young adults	DIET HISTORY QUESTIONNAIRES; UNITED-STATES; CANCER; COHORT; WOMEN; VALIDITY; DISEASE; SODIUM; ENERGY; MEN	"Shushoku," "Shusai," and "Hukusai" are staple food, main dish, and side dish, respectively. The recommended meal in Japan is a combination of "Shushoku," "Shusai," and "Hukusai"; however, it remains unclear whether there is an association between the frequency of these meals and intake of nutrients and food groups. This cross-sectional study examined the association between the frequency of meals combining "Shushoku, Shusai, and Hukusai" and intake of nutrients and food groups among 664 Japanese young adults aged 18-24 y. The dietary habits of the subjects during the preceding month were assessed using a validated brief-type self-administered diet history questionnaire. The frequency of meals combining "Shushoku. Shusai, and Hukusai" was self-reported according to four categories: "less than 1 d or 1 d/wk," "2 or 3 d/wk," "4 or 5 d/wk," and "every day" In both women and men, there was an association between the higher frequency of these meals and higher intake of the following food groups: pulses, green and yellow vegetables, other vegetables, mushrooms, seaweeds, fish and shellfish, and eggs. Moreover, there was an association with higher intake of protein, polyunsaturated fat, n-6 and n-3 polyunsaturated fat, total dietary fiber, soluble and insoluble dietary fiber, beta-carotene, alpha-tocopherol, vitamin K, thiamin, riboflavin, folate, pantothenic acid, vitamin C, potassium, calcium, magnesium, iron, and copper, and lower intake of carbohydrate in both women and men. Our findings support the hypothesis that the meals combining "Shushoku, Shusai, and Hukusai" may be associated with intake of many food groups and nutrients among Japanese young adults.	[Kakutani, Yuya; Kamiya, Saori; Omi, Naomi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki 3058574, Japan; [Omi, Naomi] Univ Tsukuba, Fac Hlth & Sport Sci, Ibaraki 3058574, Japan	Omi, N (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki 3058574, Japan.	ominaomi@taiiku.tsukuba.ac.jp					Adachi M, 1984, JPN J HUMAN ECOLOGY, V50, P70; [Anonymous], 2013, GEN SURVEY SCH; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Batres-Marquez SP, 2009, J AM DIET ASSOC, V109, P1719, DOI 10.1016/j.jada.2009.07.010; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154; Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006; Sasaki S, 1998, JPN CIRC J, V62, P431, DOI 10.1253/jcj.62.431; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Cabinet Office Government of Japan, 2012, RES PRES STAT CONSC; Harigai Y., 2007, B FAC ED KOUCHI U, V67, P69; Hirose K, 2003, INT J CANCER, V107, P276, DOI 10.1002/ijc.11373; Iso H, 2007, ASIAN PAC J CANCER P, V8, P35; Ministry of Health Labour and Welfare. Japan, 2012, NAT HLTH NUTR SURV J; Mori M, 2009, MOL NUTR FOOD RES, V53, P191, DOI 10.1002/mnfr.200800285; Ohmura S, 1994, J JPN SOC NUTR FOOD, V47, P349; Okubo H, 2004, PUBLIC HEALTH NUTR, V7, P911, DOI 10.1079/PHN2004635; Otsuka R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-328; Peacock M, 1998, OSTEOPOROSIS INT, V8, pS45; Sasaki S, 2004, RES EVALUATION METHO, V204, P10; Sasaki S, 1998, J Epidemiol, V8, P203; Science and Technology Agency, 2005, STAND TABL FOOD COMP; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P927, DOI 10.1079/PHN2004564; Sonoda T, 2004, CANCER SCI, V95, P238, DOI 10.1111/j.1349-7006.2004.tb02209.x; Tabata I, 2013, J NUTR SCI VITAMINOL, V59, pS26; Turcker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211; Uenishi K, 2013, J NUTR SCI VITAMINOL, V59, pS83; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM; Yamada K, 2013, J NUTR SCI VITAMINOL, V59, pS53	31	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					55	63				9	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000008		
J	Endoh, K; Kuriki, K; Kasezawa, N; Tohyama, K; Goda, T				Endoh, Kaori; Kuriki, Kiyonori; Kasezawa, Nobuhiko; Tohyama, Kazushige; Goda, Toshinao			Interactions between Psychological Stress and Drinking Status in Relation to Diet among Middle-Aged Men and Women: A Large-Scale Cross-Sectional Study in Japan	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						psychological stress; drinking status; diet; cross-sectional study; middle-aged Japanese	DEPRESSIVE SYMPTOMS; FATTY-ACIDS; HISTORY QUESTIONNAIRES; SOCIOECONOMIC-STATUS; FISH CONSUMPTION; JOB STRAIN; ADULTS; FOLATE; N-3; METAANALYSIS	The aim of this study was to investigate the interaction between psychological stress (PS) and drinking status in relation to diet among middle-aged Japanese men and women in a large-scale cross-sectional study. The study population included 5,587 middle-aged Japanese men and 2,718 middle-aged Japanese women who underwent annual health checkups. The subjects were divided into 2 groups (non-drinkers and drinkers) and classified as having low, moderate, or high self-reported PS levels. Energy-adjusted food and nutrient consumption was assessed with a validated food frequency questionnaire. Using a general linear model, food and nutrient consumption was estimated for each self-reported PS level in the 2 groups (non-drinkers and drinkers) and the interactions between self-reported PS levels and drinking status were calculated. In men, pork and beef; squid. octopus, shrimp, and clams; eggs; mushrooms; Japanese-style sweets; ice cream; bread; Chinese noodles; coffee; and soda as foods and protein, animal protein, fat, animal fat, carbohydrate, monounsaturated fatty acid, polyunsaturated fatty acid (PUFA), n-3 PUFA, n-6 PUFA, cholesterol, vitamin D, vitamin B-2, vitamin B-6, vitamin B-12, niacin, pantothenic acid, magnesium, phosphorus, and zinc as nutrients significantly interacted with self-reported PS levels and drinking status (p for interaction <0.05 for all). No specific interactions were found in women. These findings suggest interactions between PS levels and drinking status with consumption of some foods and nutrients, especially macronutrient intake, in men but not in women.	[Endoh, Kaori; Kuriki, Kiyonori] Univ Shizuoka, Publ Hlth Lab, Sch Food & Nutr Sci, Div Nutr Sci,Suruga Ku, Shizuoka, Shizuoka 4228526, Japan; [Goda, Toshinao] Univ Shizuoka, Lab Nutr Physiol, Div Nutr Sci, Sch Food & Nutr Sci,Suruga Ku, Shizuoka, Shizuoka 4228526, Japan; [Kasezawa, Nobuhiko; Tohyama, Kazushige] SBS Shizuoka Hlth Promot Ctr, Suruga Ku, Shizuoka, Shizuoka 4228526, Japan	Kuriki, K (reprint author), Univ Shizuoka, Publ Hlth Lab, Sch Food & Nutr Sci, Div Nutr Sci,Suruga Ku, 52-1 Yada, Shizuoka, Shizuoka 4228526, Japan.	kuriki@u-shizuoka-ken.ac.jp			Global COE Program for the Center of Excellence for Innovation in Human Health Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors declare that they have no conflicts of interest. This study was financially supported by the Global COE Program for the Center of Excellence for Innovation in Human Health Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Lucas M, 2011, AM J CLIN NUTR, V93, P1337, DOI 10.3945/ajcn.111.011817; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Yokoyama A, 2008, ALCOHOL CLIN EXP RES, V32, P1607, DOI 10.1111/j.1530-0277.2008.00739.x; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; GOEDDE HW, 1992, HUM GENET, V88, P344; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; McEwen BS, 1998, NEW ENGL J MED, V338, P171; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lazzarino AI, 2013, JAMA INTERN MED, V173, P22, DOI 10.1001/2013.jamainternmed.951; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Breslow RA, 2013, AM J CLIN NUTR, V97, P1068, DOI 10.3945/ajcn.112.050161; Astorg P, 2008, PROSTAG LEUKOTR ESS, V78, P171, DOI 10.1016/j.plefa.2008.01.003; Fawehinmi TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038607; FRIEDRICH RJ, 1982, AM J POLIT SCI, V26, P797, DOI 10.2307/2110973; GFSIS, 2013, ISSP 2005 WORK OR 3; Heikkila K, 2013, AM J PUBLIC HEALTH, V103, P2090, DOI 10.2105/AJPH.2012.301090; Herbeth B, 2012, J NUTR METAB, V2012; HIGUCHI S, 1994, ALCOHOL CLIN EXP RES, V18, P305, DOI 10.1111/j.1530-0277.1994.tb00018.x; Hozawa A, 2009, AM J CLIN NUTR, V90, P1390, DOI 10.3945/ajcn.2009.28214; Liangpunsakul S, 2010, WORLD J GASTROENTERO, V16, P4055, DOI 10.3748/wjg.v16.i32.4055; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare Japan, 2014, NAT HLTH NUTR SURV J; Miyaki K, 2013, NUTRIENTS, V5, P565, DOI 10.3390/nu5020565; Mochizuki K, 2011, J NUTR SCI VITAMINOL, V57, P65, DOI 10.3177/jnsv.57.65; Nanri A, 2010, EUR J CLIN NUTR, V64, P289, DOI 10.1038/ejcn.2009.143; Office for National Statistics, 2010, DRINK AD BEH KNOWL 2; Prior PL, 2012, ADV NUTR, V3, P257, DOI 10.3945/an.111.001693; WHO, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2012, GLOB BURD MENT DIS N	34	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					64	72				9	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000009		
J	Sakai, T; Taki, T; Nakamoto, A; Tazaki, S; Arakawa, M; Nakamoto, M; Tsutsumi, R; Shuto, E				Sakai, Tohru; Taki, Tomoyo; Nakamoto, Akiko; Tazaki, Shiho; Arakawa, Mai; Nakamoto, Mariko; Tsutsumi, Rie; Shuto, Emi			Dietary Ribonucleic Acid Suppresses Inflammation of Adipose Tissue and Improves Glucose Intolerance That Is Mediated by Immune Cells in C57BL/6 Mice Fed a High-Fat Diet	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						ribonucleic acid; obesity; inflammation; T and B cell; RAG-1 knockout mice	INSULIN-RESISTANCE; T-CELLS; PPAR-GAMMA; OBESITY; NUCLEOTIDES; INCREASE; RESPONSES; PROMOTE; BALANCE; MIXTURE	Recent evidence suggests that immune cells play an important role in differentiation of inflammatory macrophages in adipose tissue, which contributes to systemic chronic inflammation. Dietary ribonucleic acid (RNA) has been shown to modulate immune function. We hypothesized that RNA affects immune cell function in adipose tissue and then improves inflammatory response in adipose tissue. C57/BL6 mice and recombination activating gene-1 (RAG-1) knockout mice on a C57BL/6 mice background were fed a high-fat diet containing 1% RNA for 12 wk. An oral glucose tolerance test was performed. Supplementation of dietary RNA in C57BL/6 mice fed a high-fat diet resulted in a smaller area under the curve (AUC) after oral glucose administration than that for control mice. The mRNA expression levels of inflammation-related cytokines in adipose tissue and serum interleukin-6 levels were reduced by dietary RNA supplementation. Interestingly, reduction of the AUC value by RNA supplementation was abolished in T and B cell-deficient RAG-1 knockout mice. These results indicate that RNA improves inflammation in adipose tissue and reduces the AUC value following oral glucose administration in a T and B cell-dependent manner.	[Sakai, Tohru; Taki, Tomoyo; Nakamoto, Akiko; Tazaki, Shiho; Arakawa, Mai; Nakamoto, Mariko; Tsutsumi, Rie; Shuto, Emi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Publ Hlth & Appl Nutr, Tokushima 7708503, Japan	Sakai, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Publ Hlth & Appl Nutr, Kuramoto Cho 3-18-15, Tokushima 7708503, Japan.	sakai@tokushima-u.ac.jp			Japan Society for the Promotion of Science [25350126]	The authors thank Drs. Koji Yasutomo and Youichi Maekawa for providing RAG-1 KO mice. This work was partly supported by Grant-in-Aid for Scientific Research (25350126) from Japan Society for the Promotion of Science.	ORTEGA MA, 1995, J NUTR, V125, P1413; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; UAUY R, 1990, J PEDIATR GASTR NUTR, V10, P497, DOI 10.1097/00005176-199005000-00014; Hoene M, 2008, OBES REV, V9, P20, DOI 10.1111/j.1467-789X.2007.00410.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Jyonouchi H, 2003, NUTRITION, V19, P41, DOI 10.1016/S0899-9007(02)00931-0; Jyonouchi H, 1996, J NUTR, V126, P1586; KULKARNI AD, 1986, JPEN-PARENTER ENTER, V10, P169, DOI 10.1177/0148607186010002169; Nagafuchi S, 2000, INT ARCH ALLERGY IMM, V122, P33, DOI 10.1159/000024356; Nagafuchi S, 2002, CYTOTECHNOLOGY, V40, P49, DOI 10.1023/A:1023962021081; Nakamoto M, 2011, EUR J NUTR, V50, P421, DOI 10.1007/s00394-010-0153-4; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068596; Sudo N, 2000, CLIN EXP ALLERGY, V30, P979, DOI 10.1046/j.1365-2222.2000.00811.x; SUTER SL, 1992, DIABETES CARE, V15, P193, DOI 10.2337/diacare.15.2.193; Yamauchi K, 1996, J NUTR, V126, P1571	28	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					73	78				6	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000010		
J	Matsushita, M; Yoneshiro, T; Aita, S; Kamiya, T; Kusaba, N; Yamaguchi, K; Takagaki, K; Kameya, T; Sugie, H; Saito, M				Matsushita, Mami; Yoneshiro, Takeshi; Aita, Sayuri; Kamiya, Tomoyasu; Kusaba, Nobutaka; Yamaguchi, Kazuya; Takagaki, Kinya; Kameya, Toshimitsu; Sugie, Hiroki; Saito, Masayuki			Kaempferia parviflora Extract Increases Whole-Body Energy Expenditure in Humans: Roles of Brown Adipose Tissue	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Kaempferia parviflora; brown adipose tissue; energy expenditure; human	HEALTHY HUMANS; COLD; ACTIVATION; CAPSAICIN; FAT; THERMOGENESIS; CAPSINOIDS; CAPSIATE; MEN	Kaempferia parviflom extract (KP) has been reported to have a preventive effect on obesity in mice, probably by increasing energy expenditure (EE). The aims of the current study were to examine the acute effects of KP ingestion on whole-body EE in humans and to analyze its relation to the activity of brown adipose tissue (BAT), a site of non-shivering thermogenesis. After an oral ingestion of an ethanol extract of KP. EE increased significantly, showing a maximal increase of 229 +/- 69 kJ/d at 60 min, while it did not change after placebo ingestion. To evaluate BAT activity, the subjects underwent fluorodeoxyglucose-positron emission tomography, and divided into two groups with high- and low-BAT activities. A similar and greater response of EE to KP ingestion was observed in the high-BAT group (351 +/- 50 kJ/d at 60 min), but not in the low activity group. Placebo ingestion did not cause any significant EE change in either group. These results indicate that a single oral ingestion of the KP extract can potentially increase whole-body EE probably through the activation of BAT in healthy men, and may be useful as an anti-obesity regimen.	[Matsushita, Mami; Saito, Masayuki] Tenshi Coll, Dept Nutr, Sch Nursing & Nutr, Sapporo, Hokkaido 0650013, Japan; [Yoneshiro, Takeshi] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Aita, Sayuri] Hakodate Jr Coll, Dept Food & Nutr, Hakodate, Hokkaido 0420955, Japan; [Kamiya, Tomoyasu; Kusaba, Nobutaka; Yamaguchi, Kazuya; Takagaki, Kinya] Toyo Shinyaku Co Ltd, Div Res & Dev, Tosu, Saga 8410005, Japan; [Kameya, Toshimitsu; Sugie, Hiroki] LSI Sapporo Clin, Higashi Ku, Sapporo, Hokkaido 0650013, Japan	Saito, M (reprint author), Tenshi Coll, Dept Nutr, Sch Nursing & Nutr, Sapporo, Hokkaido 0650013, Japan.	saito@tenshi.ac.jp					Akase T, 2011, J NAT MED-TOKYO, V65, P73, DOI 10.1007/s11418-010-0461-2; Kusirisin W, 2009, MED CHEM, V5, P139; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Okabe Y, 2014, PHYTOMEDICINE, V21, P800, DOI 10.1016/j.phymed.2014.01.014; Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Kurogi M, 2012, CHEM SENSES, V37, P167, DOI 10.1093/chemse/bjr087; Rujjanawate C, 2005, J ETHNOPHARMACOL, V102, P120, DOI 10.1016/j.jep.2005.03.035; Shimada T, 2011, FITOTERAPIA, V82, P1272, DOI 10.1016/j.fitote.2011.08.018; Shintaku K, 2012, BRIT J PHARMACOL, V165, P1476, DOI 10.1111/j.1476-5381.2011.01634.x; Temkitthawon P, 2011, J ETHNOPHARMACOL, V137, P1437, DOI 10.1016/j.jep.2011.08.025; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wattanathorn J, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/732816; Whiting S., 2012, APPETITE, V59, P343; Yenjai C, 2004, FITOTERAPIA, V75, P89, DOI 10.1016/j.fitote.2003.08.017; Yoneshiro T., 2014, ANN MED IN PRESS; Yoshino Susumu, 2014, Food Sci Nutr, V2, P634, DOI 10.1002/fsn3.144	25	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					79	83				5	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000011		
J	Ito, K				Ito, Koji			Anticoagulating Effects of Water-Extractive Components from Heshiko and Narezushi, Japanese Fermented Aquatic Products	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						antithrombotic effect; fermented mackerel; fibrinolysis; plasmin; tPA	SPONTANEOUSLY HYPERTENSIVE-RATS; MACKEREL PRODUCT; CHOLESTEROL-METABOLISM; PROXIMATE COMPOSITION; FIBRINOLYTIC ENZYME; CHEESE NATTO; WISTAR RATS; PLASMA; AGGREGATION; NATTOKINASE	Antithrombotic effects of water-extractive components (extracts) from heshiko and narezushi. traditional fermented aquatic products in Japan. were investigated in terms of blood coagulation and fibrinolysis by means of animal experiments. Blood clot formation was suppressed by administration of heshiko and narezushi extracts to both groups of Wistar rats fed artificial and high-fat experimental diets. Prothrombin time and activated partial thromboplastin time of plasma prepared from the rats, as indices of blood coagulation, were not prolonged by administration of heshiko or narezushi extracts. In contrast, the activities of plasmin and tissue plasminogen activator (tPA), key enzymes in the fibrinolytic system. were significantly increased by administration of heshiko and narezushi extracts. These results suggest that the anticoagulating effects of heshiko and narezushi extracts are associated with the promotion of the fibrinolytic system via enhancement of plasmin and tPA activities.	Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan	Ito, K (reprint author), Fukui Prefectural Univ, Dept Marine Biosci, Gakuencho, Obama, Fukui 9170003, Japan.	kitou@fpu.ac.jp					SUMI H, 1990, ACTA HAEMATOL-BASEL, V84, P139; Itou K, 2010, FISHERIES SCI, V76, P537, DOI 10.1007/s12562-010-0236-4; SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052; Naemura A, 2005, BLOOD COAGUL FIBRIN, V16, P501, DOI 10.1097/01.mbc.0000184737.50594.a8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Fogari R, 2006, AM J HYPERTENS, V19, P1293, DOI 10.1016/j.amjhyper.2006.04.013; HANZAWA A, 1969, Japanese Journal of Geriatrics, V6, P266; Hanzawa A, 1971, JAPANESE J GERIATRIC, V8, P151; Hanzawa A, 1970, JAPANESE J GERIATRIC, V7, P160; Itou K, 2004, FISHERIES SCI, V70, P1121, DOI 10.1111/j.1444-2906.2004.00913.x; Itou K, 2009, FISHERIES SCI, V75, P241, DOI 10.1007/s12562-008-0035-3; Itou K, 2000, NIPPON SUISAN GAKK, V66, P1051; Itou K, 2006, FISHERIES SCI, V72, P1269, DOI 10.1111/j.1444-2906.2006.01285.x; Itou K, 2007, FISHERIES SCI, V73, P1344, DOI 10.1111/j.1444-2906.2007.01477.x; Jorge CE, 1998, DIABETES, V47, P290; Kinugasa C, 2011, BLOOD COAGUL FIBRIN, V22, P526, DOI 10.1097/MBC.0b013e328347b085; Kobayashi Yuko, 2008, Yamagata Medical Journal, V26, P61; Koizumi Y, 2007, J JPN SOC FOOD SCI, V54, P9; MIHARA H, 1991, Journal of the Physiological Society of Japan, V53, P231; Nagai N., 2011, JPN J THROM HEMOSTS, V22, P41, DOI 10.2491/jjsth.22.41; NAKAJIMA N, 1993, BIOSCI BIOTECH BIOCH, V57, P1604; NAMIKI K, 1991, J JPN SOC FOOD SCI, V38, P189; Omura Kazunobu, 2005, J Pharmacol Sci, V99, P247, DOI 10.1254/jphs.FP0050408; Saito M, 1995, JPN J THROMB HAEMOST, V6, P453; Sato K, 1993, J JPN OBSTET GYNECOL, V45, pN231; Skurk T, 2001, HORM METAB RES, V33, P196, DOI 10.1055/s-2001-14948; Sugimoto M, 2011, J JAPANESE COLL ANGI, V51, P275; Sumi H, 2000, NIPPON NOGEIK KAISHI, V74, P1259; Sumi Hiroyuki, 1998, Japanese Journal of Alcohol Studies and Drug Dependence, V33, P263; Sumi H, 1996, J JPN SOC FOOD SCI, V43, P1124; Sumi H, 1996, J JPN SOC FOOD SCI, V43, P318; Urano T, 2011, J JAPANESE COLL ANGI, V51, P293; Wojewodzka-Zelezniakowicz M, 2006, J PHYSIOL PHARMACOL, V57, P231; Yamamoto J, 2008, BLOOD COAGUL FIBRIN, V19, P785, DOI 10.1097/MBC.0b013e3283177b19; Yamamoto J, 2003, BRIT J NUTR, V90, P1031, DOI 10.1079/BJN2003994; Yoshitake S, 2000, JPN THROM HEMOSTS, V11, P95	36	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					84	89				6	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000012		
J	Fushimi, S; Miyazawa, T; Kimura, F; Nakagawa, K; Burdeos, GC; Miyazawa, T				Fushimi, Saki; Miyazawa, Taiki; Kimura, Fumiko; Nakagawa, Kiyotaka; Burdeos, Gregor Carpentero; Miyazawa, Teruo			Young Persimmon Ingestion Suppresses Lipid Oxidation in Rats	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						persimmon; ascorbic acid; tannin; antioxidant; phospholipid hydroperoxide	LOW-DENSITY-LIPOPROTEIN; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; PHOSPHOLIPID HYDROPEROXIDES; DIOSPYROS-KAKI; ANTIOXIDANT; PLASMA; SUPPLEMENTATION; PREVENT; CELLS; ASSAY	Persimmon is widely eaten in Asia and the nutritional components of young and mature persimmons differ. Although raw young persimmon has a strong bitter taste and is difficult to eat, the beneficial health effects of young persimmon powder have attracted attention in recent years. Young persimmon has been suggested to have hypolipidemic activity as well as other biological effects. However, there has been little investigation of the beneficial effects of young persimmon. In the present study, we investigated the antioxidative effects of persimmon in an animal study and compared the effects of young persimmon and mature persimmon. Six-week-old male F344 rats were divided into three groups and fed a standard diet, young persimmon diet, or mature persimmon diet for 4 wk. The young persimmon and mature persimmon groups were fed a diet containing 5% (w/w) freeze-dried young or mature persimmon. We analyzed phosphatidylcholine hydroperoxide (PCOOH) levels in the rats as a biomarker of membrane lipid peroxidation. Our study showed that plasma PCOOH levels were significantly lower in the young persimmon group (36.1 +/- 28.5 pmol/ mL plasma) than in the control group (120 +/- 66 pmol/mL plasma). No significant difference was observed between the mature persimmon group (57.3 +/- 15.6 pmol/mL plasma) and the control group. It is possible that ascorbic acid and soluble tannin contribute to the difference in the antioxidant effects of young and mature persimmons. These results indicated that intake of young persimmon contributes to the reduction of plasma phospholipid hydroperoxide levels in rats.	[Fushimi, Saki; Miyazawa, Taiki; Kimura, Fumiko; Nakagawa, Kiyotaka; Burdeos, Gregor Carpentero; Miyazawa, Teruo] Tohoku Univ, Food & Biodynam Chem Lab, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Fushimi, Saki] Tohoku Univ, Sch Med, Sendai, Miyagi 9808575, Japan; [Miyazawa, Taiki] Tufts Univ, Vasc Biol Lab, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Miyazawa, Teruo] Tohoku Univ, Food & Biotechnol Innovat Project, NICHe, Sendai, Miyagi 9808579, Japan	Miyazawa, T (reprint author), Tohoku Univ, Food & Biodynam Chem Lab, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.	miyazawa@m.tohoku.ac.jp	Miyazawa, Taiki/G-5994-2014		Japanese Society for the Promotion of Science (JSPS, Tokyo,Japan) [20228002]; JSPS	The present study was supported in part by a Grantin-Aid for Scientific Research (Kakenhi Kiban(s) 20228002) from the Japanese Society for the Promotion of Science (JSPS, Tokyo, Japan). Taiki Miyazawa was supported by a JSPS Postdoctoral Fellowship for Research Abroad (http://www.jsps.go.jp/).	Miyazawa T, 2013, J OLEO SCI, V62, P873, DOI 10.5650/jos.62.873; Burdeos GC, 2012, LIPIDS, V47, P471, DOI 10.1007/s11745-012-3659-0; Suzuki T, 2005, FOOD CHEM, V93, P149, DOI 10.1016/j.foodchem.2004.10.017; Sonmez M, 2005, THERIOGENOLOGY, V63, P2063, DOI 10.1016/j.theriogenology.2004.10.003; Knekt P, 1996, BRIT MED J, V312, P478; Mallavadhani UV, 1998, PHYTOCHEMISTRY, V49, P901, DOI 10.1016/S0031-9422(97)01020-0; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Zhao DQ, 2011, PLANT MOL BIOL REP, V29, P646, DOI 10.1007/s11105-010-0272-3; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P512; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Del Bubba M, 2009, J FOOD COMPOS ANAL, V22, P668, DOI 10.1016/j.jfca.2009.02.015; Katsube T, 2004, J AGR FOOD CHEM, V52, P2391, DOI 10.1021/jf035372g; Nakagawa K, 1996, BBA-LIPID LIPID MET, V1299, P110, DOI 10.1016/0005-2760(95)00203-0; Demmig AB, 2002, SCIENCE, V298, P2149; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kato S, 2014, J OLEO SCI, V63, P431, DOI 10.5650/jos.ess13225; Kawakami Y, 2007, BIOSCI BIOTECH BIOCH, V71, P464, DOI 10.1271/bbb.60524; Lin CC, 2001, ANTICANCER RES, V21, P437; Matsumoto K, 2006, BIOL PHARM BULL, V29, P2532, DOI 10.1248/bpb.29.2532; Matsumoto K, 2010, PHYTOTHER RES, V24, P205, DOI 10.1002/ptr.2911; Meydani M., 2000, AM J CLIN NUTR, V62, P873; MIYAZAWA T, 1990, BIOMED CHROMATOGR, V4, P131, DOI 10.1002/bmc.1130040312; MIYAZAWA T, 1992, J LIPID RES, V33, P1051; MIYAZAWA T, 1989, FREE RADICAL BIO MED, V7, P209, DOI 10.1016/0891-5849(89)90017-8; Nagashima T, 2002, DIABETES RES CLIN PR, V56, P19, DOI 10.1016/S0168-8227(01)00353-9; Nakagawa K, 1999, J AGR FOOD CHEM, V47, P3967, DOI 10.1021/jf981195l; Ramin A. A., 2003, Journal of Agricultural Science and Technology, V5, P113; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; U. S. Department of Agriculture Agricultural Research Service USDA National nutrient database for standard reference, 09263 USDA	29	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					90	95				6	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000013		
J	Iuchi, T; Hosaka, T; Shiroishi, M; Ono, H; Inukai, K; Sumita, T; Sakai, G; Katayama, S; Awata, T				Iuchi, Takujiro; Hosaka, Toshio; Shiroishi, Masahiro; Ono, Hiraku; Inukai, Kouichi; Sumita, Takashi; Sakai, Gouta; Katayama, Shigehiro; Awata, Takuya			Influence of Treatment with Extracts of Hypsyzigus marmoreus Mushroom on Body Composition during Obesity Development in KK-A(y) Mice	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						Hypsyzigus marmoreus; fat deposition; pro-inflammatory adipokines	HYPSIZIGUS-MARMOREUS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; INHIBITION; BODIES; CELLS	Hypsyzigus martnoreus (HM), an edible mushroom, has several effects, including antitumor, antioxidant and anti-allergy properties. On the other hand, the possibly useful effect of HM in diabetic mice has not as yet been elucidated. In this study, we showed treatment with a water soluble extract from HM (EHM) to reduce fat deposits without affecting body weight loss in KK-A(y) mice. EHM treatment also abolished the expressions of pro-inflammatory adipokines, such as tumor necrosis factor a and monocyte chemoattractant protein 1, as compared with vehicle treatment. The expressions of uncoupling protein 3 and peroxisome proliferator-activated receptor gamma coactivator 1 a in the soleus muscles of EHM treatment groups were significantly elevated as compared to those in vehicle-treated muscle tissues. These results raise the possibility that EHM can regulate both obesity and insulin resistance.	[Iuchi, Takujiro; Hosaka, Toshio; Ono, Hiraku; Sumita, Takashi; Sakai, Gouta; Katayama, Shigehiro; Awata, Takuya] Saitama Med Univ Hosp, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan; [Hosaka, Toshio; Inukai, Kouichi] Kyorin Univ, Sch Med, Dept Internal Med 3, Mitaka, Tokyo 1818611, Japan; [Shiroishi, Masahiro] Agr Technol Inst Nagano Farmers Federat, Suzaka 3820084, Japan	Hosaka, T (reprint author), Saitama Med Univ Hosp, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan.	toshio.hosaka@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [24500994]; Nagano Prefectural Headquarters, National Federation of Agricultural Cooperative Associations	This work was supported by a Grant-in-Aid for Scientific Research 24500994 (to T. H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a research grant from Nagano Prefectural Headquarters, National Federation of Agricultural Cooperative Associations.	Chang JS, 2004, CANCER LETT, V212, P7, DOI 10.1016/j.canlet.2004.03.013; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Bao H, 2011, BIOSCI BIOTECH BIOCH, V75, P891, DOI 10.1271/bbb.100825; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Antuna-Puente B, 2007, THERAPIE, V62, P285, DOI 10.2515/therapie:2007055; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Després Jean-Pierre, 2008, Can J Cardiol, V24 Suppl D, p7D; FERNANDEZ ML, 1995, J LIPID RES, V36, P2394; Guillausseau PJ, 2003, REV MED INTERNE, V24, P730, DOI 10.1016/S0248-8663(03)00244-3; Kim T, 2014, PHYTOTHER RES, V28, P1539, DOI 10.1002/ptr.5164; Lam SK, 2001, BIOCHEM BIOPH RES CO, V285, P1071, DOI 10.1006/bbrc.2001.5279; MIDKIFF VC, 1984, J ASSOC OFF ANA CHEM, V67, P851; Nozaki H, 2010, BIOL PHARM BULL, V33, P580, DOI 10.1248/bpb.33.580; Stumvoll Michael, 2007, Endocr Res, V32, P19; Xu ML, 2007, ARCH PHARM RES, V30, P28, DOI 10.1007/BF02977775; Yan PS, 2014, BIOTECHNOL PROGR, V30, P872, DOI 10.1002/btpr.1926; Yoshino K, 2008, J FOOD SCI, V73, pT21, DOI 10.1111/j.1750-3841.2008.00664.x	20	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					96	100				5	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000014		
J	Kozuka, M; Murao, S; Yamane, T; Inoue, T; Ohkubo, I; Ariga, H				Kozuka, Miyuki; Murao, Sato; Yamane, Takuya; Inoue, Tsutomu; Ohkubo, Iwao; Ariga, Hiroyoshi			Rapid and Simple Purification of Lysozyme from the Egg Shell Membrane	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						lysozyme; egg shell membrane; rapid and simple purification	STABILITY	Lysozyme (EC 3.2.1.17) is a hydrolytic enzyme that cleaves the beta-(1,4)-gly-cosidic bond between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan, a major bacterial cell wall polymer. In the food industry, lysozyme is used as an additive mainly in the production of wine and beer. Lysozyme was found to be localized in the egg shell membrane. In this study, we found that lysozyme was easily purified from the egg shell membrane and that the enzyme also had antibacterial activity. Furthermore, we found that the antibacterial activity of purified lysozyme from the egg shell membrane was lower than that of purified lysozyme from the egg white at alkaline pH. The method for rapid purification of lysozyme developed in this study should contribute to the food industry.	[Kozuka, Miyuki; Murao, Sato; Yamane, Takuya; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Inoue, Tsutomu] Hokkaido Syst Sci Co Ltd, Div Biosci, Kita Ku, Sapporo, Hokkaido 0010932, Japan; [Ohkubo, Iwao] Tenshi Coll, Dept Nutr, Sch Nursing & Nutr, Higashi Ku, Sapporo, Hokkaido 0650013, Japan	Yamane, T (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	t-yamane@pharm.hokudai.ac.jp			Hokkaido System Science; Hokkaido Wako Junyaku	This work was supported by the Scientific Research Fund from Hokkaido System Science and Hokkaido Wako Junyaku.	Ahlborn G, 2006, J FOOD PROTECT, V69, P729; Ahlborn JG, 2006, PROTEIN J, V125, P71; ALDERTON G, 1946, J BIOL CHEM, V164, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; CHIANG BH, 1993, J FOOD SCI, V58, P303, DOI 10.1111/j.1365-2621.1993.tb04261.x; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Silvetti T, 2010, J I BREWING, V116, P33; Tirelli A, 2007, FOOD CHEM, V105, P1564, DOI 10.1016/j.foodchem.2007.03.017; Mehra T, 2012, EXP DERMATOL, V21, P778, DOI 10.1111/exd.12004; Tankrathok A, 2009, PREP BIOCHEM BIOTECH, V39, P380, DOI 10.1080/10826060903209646; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Ahlborn G, 2005, POULTRY SCI, V84, P1935; Brasca M, 2013, MOLECULES, V18, P6008, DOI 10.3390/molecules18056008; Canfield ER, 1963, J BIOL CHEM, V238, P2698; Hincke TM, 2000, MATRIX BIOL, V19, P443; Ohta K, 1972, KYOTO WOMENS U SHOKU, V27, P1	17	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	FEB	2015	61	1					101	103				3	Nutrition & Dietetics	Nutrition & Dietetics	CC7ID	WOS:000350540000015		
J	Miyazaki, M; Toyoda, M; Yoshiiwa, T; Kawano, M; Kaku, N; Tsumura, H				Miyazaki, Masashi; Toyoda, Masahiro; Yoshiiwa, Toyomi; Kawano, Masanori; Kaku, Nobuhiro; Tsumura, Hiroshi			Enhancement of the Effects of Exfoliated Carbon Nanofibers by Bone Morphogenetic Protein in a Rat Femoral Fracture Model	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						exfoliated carbon nanofiber; bone morphogenetic protein; fracture healing; rat femoral fracture model; scaffold	MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; BIOLOGICAL BEHAVIOR; FUNCTIONAL REPAIR; SPINAL-FUSION; NANOTUBES; TISSUE; SCAFFOLDS; DEFECTS; DELIVERY	Exfoliated carbon nanofibers (ExCNFs) are expected to serve as excellent scaffolds for promoting and guiding bone-tissue regeneration. We aimed to enhance the effects of ExCNFs with bone morphogenetic proteins (BMPs) and examine their feasibility and safety in clinical applications using a rat femoral fracture model. Group I (n = 16) animals were implanted with control MedGEL. Group II (n = 17) animals were implanted with MedGEL containing ExCNFs. Group III (n = 15) animals were implanted with MedGEL containing 1 mu g rhBMP-2. Group IV (n = 15) animals were implanted with MedGEL containing 1 mu g rhBMP-2 and ExCNFs. The rats were euthanized after 6 weeks, and their fractured femurs were explanted and assessed by manual palpation, radiographs, and high-resolution microcomputerized tomography (micro-CT); the femurs were also subjected to biomechanical and histological analysis. The fusion rates in Group IV (73.3%) were considerably higher than those in Groups I (25.0%), II (52.9%), and III (46.7%). The results demonstrated the enhancement of the bone repair effects of ExCNFs by BMP in a rat femoral fracture model. Our results suggest that the enhancement of the effects of ExCNFs by BMP makes the combination a possible attractive therapy for various orthopedic surgeries. (C) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.	[Miyazaki, Masashi; Yoshiiwa, Toyomi; Kawano, Masanori; Kaku, Nobuhiro; Tsumura, Hiroshi] Oita Univ, Dept Orthopaed Surg, Fac Med, Oita 87011, Japan; [Toyoda, Masahiro] Oita Univ, Fac Engn, Dept Appl Chem, Oita 87011, Japan	Miyazaki, M (reprint author), Oita Univ, Dept Orthopaed Surg, Fac Med, Oita 87011, Japan.	masashim@oita-u.ac.jp					Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670; Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673; Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008; Bandaru PR, 2007, J NANOSCI NANOTECHNO, V7, P1239, DOI 10.1166/jnn.2007.307; Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015; Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483; Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020; MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386; Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107; Mikael PE, 2011, J BIOMATER TISS ENG, V1, P76, DOI 10.1166/jbt.2011.1011; Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Aoki N, 2007, DENT MATER J, V26, P178; Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Binkley N, 2002, BONE, V30, P897, DOI 10.1016/S8756-3282(02)00734-2; Doi Y, 2011, BONE, V49, P777, DOI 10.1016/j.bone.2011.07.005; Duan S, 2015, J BIOMED MATER RES A, V103, P1424, DOI 10.1002/jbm.a.35283; Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6; Matsumura K, 2013, J MULTIFUNCT MAT PHO, V4, P27; Mikael PE, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035001; Miyagawa H, 2005, J NANOSCI NANOTECHNO, V5, P1593, DOI 10.1166/jnn.2005.181; Miyazaki M, 2009, SPINE J, V9, P22, DOI 10.1016/j.spinee.2008.08.009; Patel Vikas V, 2006, Spine J, V6, P397, DOI 10.1016/j.spinee.2005.11.006; Toyoda M, 2001, CARBON, V39, P1697, DOI 10.1016/S0008-6223(00)00293-1; Wang W, 2005, DENT MATER J, V24, P478; Wang W, 2007, J BIOMED MATER RES B, V82B, P223, DOI 10.1002/jbm.b.30724; Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	FEB	2015	33	2					185	192		10.1002/jor.22751		8	Orthopedics	Orthopedics	CC6JW	WOS:000350472200004		
J	Matsukura, Y; Muneta, T; Tsuji, K; Miyatake, K; Yamada, J; Abula, K; Koga, H; Tomita, M; Sekiya, I				Matsukura, Yu; Muneta, Takeshi; Tsuji, Kunikazu; Miyatake, Kazumasa; Yamada, Jun; Abula, Kahaer; Koga, Hideyuki; Tomita, Makoto; Sekiya, Ichiro			Mouse Synovial Mesenchymal Stem Cells Increase in Yield with Knee Inflammation	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						mesenchymal stem cells; synovium; mouse; inflammation; infrapatellar fat pad	CARRAGEENAN-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; STROMAL CELLS; BONE-MARROW; ADIPOGENIC DIFFERENTIATION; ADIPOSE-TISSUE; FLUID INCREASE; RAT; CARTILAGE; OSTEOARTHRITIS	Even though mouse studies have various advantages, harvesting an adequate number of synovial mesenchymal stem cells (MSCs) is difficult in mice. We investigated whether the total yield of MSCs increased in synovium with inflammation in mice. Infrapatellar fat pads (IFPs) were harvested from 10 knees of 5 mice 3, 7, and 14 days after intraarticular injection of carrageenan. Ten IFPs were also harvested from untreated knees as a control. Seven days after initial plating, the total yield of cells was compared among the 4 groups (n = 4-6). The harvested cells were analyzed for multipotentiality and surface epitopes. Furthermore, knee synovitis was compared among the 4 groups in histology. The number of cells in the 3 and 7 days treated group was significantly higher than the other groups. The harvested cells had characteristics of MSCs. Synovitis in the 3 and 7 days treated groups was significantly severer than the other groups. There seemed to be a relationship between the synovitis score and the total yield of cells derived from IFPs. In mice, it became possible to increase the yield 50-fold by inducing inflammation. This method makes it possible to analyze the molecular mechanisms of cartilage regeneration of synovial MSCs in mice models. (C) 2014 The Authors. Journal of Orthopaedic Research published by Wiley Periodicals, Inc. on behalf of the Orthopaedic Research Society.	[Matsukura, Yu; Muneta, Takeshi; Miyatake, Kazumasa; Yamada, Jun; Abula, Kahaer; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Surg & Sports Med, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Grad Sch, Dept Cartilage Regenerat, Tokyo, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Clin Res Ctr, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan	Sekiya, I (reprint author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry on Health, Labor and Welfare, Japan	Grant sponsor: Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grant sponsor: Ministry on Health, Labor and Welfare, Japan.	Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Matsukura Y, 2014, CLIN ORTHOP RELAT R, V472, P1357, DOI 10.1007/s11999-013-3418-4; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Hansra P, 2000, INFLAMMATION, V24, P141, DOI 10.1023/A:1007033610430; Ekundi-Valentim E, 2010, BRIT J PHARMACOL, V159, P1463, DOI 10.1111/j.1476-5381.2010.00640.x; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Anton K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035036; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; De Bari C, 2007, CLIN SCI, V113, P339, DOI 10.1042/CS20070126; Dulos J, 2004, ARTHRITIS RHEUM, V50, P3346, DOI 10.1002/art.20509; Futami I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045517; Gong DZ, 2014, PHYTOTHER RES, V28, P1054, DOI 10.1002/ptr.5093; GORDON JL, 1977, BRIT J PHARMACOL, V61, pP140; Kim KS, 2012, RHEUMATOL INT, V32, P3875, DOI 10.1007/s00296-011-2286-z; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; LOWTHER DA, 1976, ARTHRITIS RHEUM, V19, P769, DOI 10.1002/1529-0131(197607/08)19:4<769::AID-ART1780190419>3.0.CO;2-V; Mochizuki T, 2006, ARTHRITIS RHEUM, V54, P843, DOI 10.1002/art.21651; Mohanty ST, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3098; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; SANTER V, 1983, SEMIN ARTHRITIS RHEU, V13, P160, DOI 10.1016/0049-0172(83)90002-1; Silvan AM, 1997, GEN PHARMACOL, V29, P665, DOI 10.1016/S0306-3623(96)00561-7; Waldburger JM, 2011, ARTHRITIS RHEUM-US, V63, P3354, DOI 10.1002/art.30522	38	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	FEB	2015	33	2					246	253		10.1002/jor.22753		8	Orthopedics	Orthopedics	CC6JW	WOS:000350472200012		
J	Yamaguchi, T; Goto, S; Nishigaki, Y; Orias, AAE; Bae, WC; Masuda, K; Inoue, N				Yamaguchi, Tomonori; Goto, Shota; Nishigaki, Yasuhiro; Orias, Alejandro A. Espinoza; Bae, Won C.; Masuda, Koichi; Inoue, Nozomu			Microstructural Analysis of Three-Dimensional Canal Network in the Rabbit Lumbar Vertebral Endplate	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						nutrient canal; vertebral endplate; intervertebral disc; bone morphology; spine	INTERVERTEBRAL DISC DEGENERATION; BACK-PAIN; ADULT; LEVEL	Insufficient nutrient supply through vertebral canal structures to the intervertebral disc (IVD) has been considered as an important contributor for disc degeneration. Despite previous canal structure characterization studies using histology, scanning electron microscopy, and angiography, among others, their three-dimensional (3D) topology inside the vertebral endplate remains poorly understood. This study aims to characterize the 3D canal structure in the rabbit lumbar vertebral endplate using micro computed tomography (mu CT). Vertebral endplates were imaged using high-resolution mCT with 1.4 x 1.4 x 1.8 mu m voxel size. Diameter, length, orientation, and depth starting from the vertebral endplate surface were analyzed for each canal using individual 3D canal models from the vertebral endplate scans. In the layer underneath the vertebral endplate, at a mean depth of 76.2 mu m, longitudinally-oriented relatively short-length (57.6 mu m) and small diameter (45.7 mu m) canals were dominant. Large-scale canals with a mean diameter of 152.1 mu m running parallel to the endplate surface were isolated at the depth of 224.1 mu m. These canals were connected to both IVD and bone marrow spaces through vertically oriented canals. (C) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.	[Yamaguchi, Tomonori; Goto, Shota; Nishigaki, Yasuhiro; Inoue, Nozomu] Doshisha Univ, Dept Biomed Engn, Fac Life & Med Sci, Kyoto 602, Japan; [Orias, Alejandro A. Espinoza; Inoue, Nozomu] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Bae, Won C.] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92103 USA; [Masuda, Koichi] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA	Inoue, N (reprint author), Doshisha Univ, Dept Biomed Engn, Fac Life & Med Sci, Kyoto 602, Japan.	nozomu_inoue@rush.edu			Ministry of Education, Science, Sports and Culture, Japan [22591645]	Grant sponsor: Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research; Grant number: 22591645.	Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; BATTIE MC, 1991, SPINE, V16, P1015, DOI 10.1097/00007632-199109000-00001; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; CROCK HV, 1984, SPINE, V9, P702, DOI 10.1097/00007632-198410000-00009; HUMZAH MD, 1988, ANAT REC, V220, P337, DOI 10.1002/ar.1092200402; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; VIDEMAN T, 1990, SPINE, V15, P728, DOI 10.1097/00007632-199008010-00002; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Moore RJ, 2006, EUR SPINE J, V15, pS333, DOI 10.1007/s00586-006-0170-4; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; Malandrino A, 2014, OSTEOARTHR CARTILAGE, V22, P1053, DOI 10.1016/j.joca.2014.05.005; An HS, 2004, SPINE, V29, P2677, DOI 10.1097/01.brs.0000147573.88916.c6; Battie MC, 2008, SPINE, V33, P2801, DOI 10.1097/BRS.0b013e31818043b7; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; AOKI J, 1987, RADIOLOGY, V164, P411; BROBERG KB, 1983, SPINE, V8, P151, DOI 10.1097/00007632-198303000-00006; CLARK JM, 1990, J ANAT, V171, P105; Crock H V, 1973, J Bone Joint Surg Br, V55, P528; Lotz JC, 2013, SPINE J, V03, P153; Moore RJ, 2000, EUR SPINE J, V9, P92, DOI 10.1007/s005860050217; NACHEMSO.A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1; Vos T, 2010, LANCET, V380, P2163, DOI [10.1016/S0140-6736(12)61729-2, DOI 10.1016/S0140-6736(12)61729-2]	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	FEB	2015	33	2					270	276		10.1002/jor.22759		7	Orthopedics	Orthopedics	CC6JW	WOS:000350472200015		
J	Kato, M; Sasaki, M; Ueyama, Y; Koga, A; Sano, A; Higashi, T; Santa, T				Kato, Masaru; Sasaki, Minoru; Ueyama, Yukari; Koga, Ayaka; Sano, Akira; Higashi, Tatsuya; Santa, Tomofumi			Comparison of the migration behavior of nanoparticles based on polyethylene glycol and silica using micellar electrokinetic chromatography	JOURNAL OF SEPARATION SCIENCE			English	Article						Micellar electrokinetic chromatography; Nanoparticles; Polyethylene glycol; Silica	CAPILLARY-ZONE-ELECTROPHORESIS; SIZE-EXCLUSION CHROMATOGRAPHY; WALLED CARBON NANOTUBES; GOLD NANOPARTICLES; SEPARATION; MOLECULES; DELIVERY; FLUORESCENCE; SIMULATION; PARTICLES	Nanoparticles, spherical particles with diameters less than 100 nm, are promising theranostic devices for noninvasive diagnosis and therapy. In this study, nanoparticles composed of polyethylene glycol and silica were prepared, and their migration behavior was examined using capillary electrophoresis. The effects of the sodium dodecyl sulfate concentration in the electrolyte, the nanoparticle size, and the encapsulated molecule on the migration were examined. The addition of sodium dodecyl sulfate into the electrolyte had a significant effect on the electrophoretic mobility of polyethylene glycol nanoparticles, but a small effect on that of silica nanoparticles. As for the size effect, the mobility became a little faster for smaller nanoparticle sizes for both polyethylene glycol and silica nanoparticles. The encapsulated molecule affected the mobility of the nanoparticles through interactions between the encapsulated molecules and sodium dodecyl sulfate. We propose that the large effect of sodium dodecyl sulfate on the migration of the polyethylene glycol nanoparticles was due to the large spaces within the nanoparticles. These results indicate that nanoparticle migration is mainly determined by the nanoparticle components.	[Kato, Masaru; Sasaki, Minoru; Santa, Tomofumi] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Kato, Masaru; Sasaki, Minoru; Santa, Tomofumi] Univ Tokyo, GPLLI Program, Tokyo 1130033, Japan; [Ueyama, Yukari; Koga, Ayaka; Sano, Akira; Higashi, Tatsuya] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan	Kato, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	masaru-kato@umin.ac.jp			grants (Kakenhi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; JSPS Core-to-Core Program, A. Advanced Research Networks	This work was supported by grants (Kakenhi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and JSPS Core-to-Core Program, A. Advanced Research Networks.	Ishizuka F, 2014, J MATER CHEM B, V2, P4153, DOI 10.1039/c4tb00536h; SCHURE MR, 1993, ANAL CHEM, V65, P3024, DOI 10.1021/ac00069a015; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Murayama S, 2012, CHEM COMMUN, V48, P11461, DOI 10.1039/c2cc35567a; OHSHIMA H, 1983, J CHEM SOC FARAD T 2, V79, P1613, DOI 10.1039/f29837901613; HUANG XH, 1988, ANAL CHEM, V60, P1837, DOI 10.1021/ac00168a040; Oszwaldowski S, 2011, ANAL BIOANAL CHEM, V399, P2831, DOI 10.1007/s00216-011-4650-y; Murayama S, 2013, J MATER CHEM B, V1, P4932, DOI 10.1039/c3tb20828a; Liu FK, 2007, J CHROMATOGR A, V1167, P231, DOI 10.1016/j.chroma.2007.08.058; Pyell U, 2010, ELECTROPHORESIS, V31, P814, DOI 10.1002/elps.200900555; Itoh N, 2014, ANALYST, V139, P4453, DOI 10.1039/c4an00819g; Ibrahim A, 2013, ANAL BIOANAL CHEM, V405, P5369, DOI 10.1007/s00216-013-6972-4; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Liu FK, 2004, CHROMATOGRAPHIA, V59, P115, DOI 10.1365/s10337-003-0135-2; Liu FK, 2004, ANAL CHIM ACTA, V510, P77, DOI 10.1016/j.aca.2003.12.064; Surugau N, 2009, J SEP SCI, V32, P1889, DOI 10.1002/jssc.200900071; Murayama S, 2012, CHEM COMMUN, V48, P8380, DOI 10.1039/c2cc32718j; Amamoto T, 2014, CHEM PHARM BULL, V62, P649; Takagi K, 2014, SOFT MATTER, V10, P3553, DOI 10.1039/c3sm52908h; Watanabe R, 2011, J COLLOID INTERF SCI, V360, P1, DOI 10.1016/j.jcis.2010.09.001; Murayama S, 2014, MACROMOL BIOSCI, V14, P626, DOI 10.1002/mabi.201300393; Ferreira da Silva B., 2011, TRAC TRENDS ANAL CHE, V30, P528; Gao HC, 2002, J COLLOID INTERF SCI, V249, P200, DOI 10.1006/jcis.2002.8258; Grabielle-Madelmont C, 2003, J BIOCHEM BIOPH METH, V56, P189, DOI 10.1016/S0165-022X(03)00059-9; Helle A, 2008, J CHROMATOGR A, V1178, P248, DOI 10.1016/j.chroma.2007.11.041; Kato M, 2007, ANAL CHEM, V79, P4887, DOI 10.1021/ac0701482; Lopez-Lorente AI, 2011, TRAC-TREND ANAL CHEM, V30, P58, DOI 10.1016/j.trac.2010.10.006; MCCORMICK RM, 1991, J LIQ CHROMATOGR, V14, P939, DOI 10.1080/01483919108049296; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385; OBRIEN RW, 1978, J CHEM SOC FARAD T 2, V74, P1607, DOI 10.1039/f29787401607; Petersen SL, 1999, J CHROMATOGR A, V834, P445, DOI 10.1016/S0021-9673(98)00864-4; VanOrman B.B., 1989, J MICROCOLUMN SEP, V1, P289, DOI 10.1002/mcs.1220010607; Yamamoto T, 2009, ANAL CHEM, V81, P7336, DOI 10.1021/ac901197v; Yamamoto T, 2011, J SEP SCI, V34, P2866, DOI 10.1002/jssc.201100247	35	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	FEB	2015	38	3					468	474		10.1002/jssc.201401086		7	Chemistry, Analytical	Chemistry	CC2KZ	WOS:000350175200016		
J	Lee, HS; Park, YJ; Joo, YD; Heo, H; Heo, J; Kim, SH; Park, SS; Hwang, WH; Kang, HS; Kim, KW; Ko, IS; Oh, KM; Noh, SJ; Bak, YH; Matsumoto, H				Lee, Heung-Soo; Park, Young Jung; Joo, Young-Do; Heo, Hoon; Heo, Jinyul; Kim, Sang-Hee; Park, Soung-Soo; Hwang, Woon Ha; Kang, Heung-Sik; Kim, Kwang-woo; Ko, In-Soo; Oh, Kyoung-Min; Noh, Sung-Joo; Bak, Yong Hwan; Matsumoto, Hiroshi			S-band accelerating structures for the PAL-XFEL	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Accelerating structure; PAL-XFEL; Racetrack; Coupler		One hundred seventy-two accelerating structures are required for the Pohang Accelerator Laboratory X-ray free-electron laser's (PAL-XFEL's) 10-GeV main linear accelerator. So far, we have purchased 80 structures from Mitsubishi Heavy Industry (MHI), which have quasi-symmetric couplers in the accelerating structure to reduce the quadruple and the sextuple components of the electric field in the coupling cavity. High-power tests have been conducted for the first structure of the MHI structure, and Research Instruments (RI) has developed a 3-m long accelerating structure that has an operating frequency of 2856 MHz and in/out couplers of quasi-symmetric racetrack shape for the PAL-XFEL linear accelerator. This structure also has been tested by PAL and RI in the Pohang accelerator laboratory (PAL) to check the maximum available electric field gradient. We will describe the test results of these structures and the current status for the fabrication of the other accelerating structures in this paper.	[Lee, Heung-Soo; Park, Young Jung; Joo, Young-Do; Heo, Hoon; Heo, Jinyul; Kim, Sang-Hee; Park, Soung-Soo; Hwang, Woon Ha; Kang, Heung-Sik; Kim, Kwang-woo; Ko, In-Soo] Pohang Accelerator Lab, Pohang 790784, South Korea; [Oh, Kyoung-Min; Noh, Sung-Joo] Vitzrotech Co Ltd, Ansan 425833, South Korea; [Bak, Yong Hwan] Youngdong Univ, Coll Liberal Arts, Youngdong 370701, South Korea; [Matsumoto, Hiroshi] KEK High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan	Lee, HS (reprint author), Pohang Accelerator Lab, Pohang 790784, South Korea.	lhs@postech.ac.kr			ministry of science, ICT and future planning (MSICTFP)	The authors would like to thank G. Y. Mun, S. Y. Bak, J. M. Kim and E. H. Lee for help with programming and installing the communication cable, and gratefully acknowledge the support given by the ministry of science, ICT and future planning (MSICTFP).	Li Z., 2005, P 21 PART ACC C KNOX, P2176; Neal R. B., 1961, 259 SLAC	2	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	FEB	2015	66	3					340	344		10.3938/jkps.66.340		5	Physics, Multidisciplinary	Physics	CC4PN	WOS:000350335400005		
J	Miura, A; Ouchi, N; Oguri, H; Hasegawa, K; Miyao, T; Ikegami, M				Miura, Akihiko; Ouchi, Nobuo; Oguri, Hidetomo; Hasegawa, Kazuo; Miyao, Tomoaki; Ikegami, Masanori			Design and delivery of beam monitors for the energy-upgraded linac in J-PARC	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						J-PARC Linac; Energy upgrade; Beam monitor; Layout; Commissioning		In the J-PARC (Japan Proton Accelerator Research Complex) linac, an energy-upgrade project has started to achieve a design beam power of 1 MW at the exit of the downstream synchrotron. To account for the significant beam parameter upgrades, we will use the newly-fabricated beam monitors for the beam commissioning. This paper discusses the design and assembly of the beam position monitor, phase monitor, current monitor, transverse profile monitor, and beam loss monitor for the energy-upgraded linac. We periodically installed the newly-fabricated monitors for the upgraded beam line, as well as for longitudinal matching, because of the frequency jump between the original RF cavity and the newly-developed cavity. We employed two debunchers to correct for momentum spread and jitter. To account for the new debunchers, we fabricated and installed additional pairs of phase monitors in order to tune the debunchers to the adequate RF set point. Finally, we propose commissioning plans to support the beam monitor check. We will begin to establish the 181-MeV operation to confirm the proper functioning of beam monitors. Herein, we will examine the response to changes of the knobs that control the quadrupole magnets after the energy upgrade. After proper functioning of the beam monitors is confirmed, we will use the new beam monitors to establish the 400-MeV acceleration operation.	[Miura, Akihiko; Ouchi, Nobuo; Oguri, Hidetomo; Hasegawa, Kazuo] Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan; [Miyao, Tomoaki; Ikegami, Masanori] High Energy Accelerator Res Org, J PARC Ctr, Tsukuba, Ibaraki 3050801, Japan	Miura, A (reprint author), Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan.	akihiko.miura@j-parc.jp					Akikawa H., 2006, P LINAC2006 KNOXV US; Feschenko A. V., 2012, P RUPAC2012 SAINT PE; Ikegami M., 2013, P IPAC13 SHANGH CHIN; Maruta T., 2013, P IPAC2013 SHANGH CH; Miura A., 2012, P LINAC2012 TEL AV I; Miura A., 2013, P IPAC13 SHANGH CHIN; Miura A., 2012, P IBIC2012 TSUK JAP; Miyao T., 2011, P DIPAC2011 HAMB GER; Oguri H., 2013, P IPAC2013 SHANGH CH; Sato S., 2004, P LINAC 2004 LUB GER; SHAFER RE, 1994, AIP CONF PROC, P303; Shen G., 2007, P PAC07 ALB NEW MEX; Wei G. H., 2010, P LINAC2010 TSUK JAP; Yamazaki Y., 2003, 200212 JPARC KEK	14	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	FEB	2015	66	3					364	372		10.3938/jkps.66.364		9	Physics, Multidisciplinary	Physics	CC4PN	WOS:000350335400010		
J	Tamura, J; Ao, H; Nemoto, Y; Asano, H; Suzuki, T				Tamura, Jun; Ao, Hiroyuki; Nemoto, Yasuo; Asano, Hiroyuki; Suzuki, Takahiro			High-power test of annular-ring coupled structures for the J-PARC linac energy upgrade	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						J-PARC; High-intensity proton accelerator; Annular-ring coupled structure		Annular-ring coupled structures (ACSs) will increase the beam energy of the Japan proton accelerator research complex (J-PARC) linac from 181 to 400 MeV to achieve a beam power of 1 MW for a materials and life science experimental facility. The mass production of the ACS cavities commenced in March 2009. Before the installation, all cavities require power testing. High-power testing is essential not only for confirming the cavity's design performance but also for preventing delays in cavity conditioning schedule. However, the 2011 Tohoku earthquake damaged J-PARC facilities, including the ACS power-test area, and cavity conditioning was interrupted for two years. After the facility's restoration, two ACS cavities (M01 and M11) were conditioned. They performed 15-20% above the designed accelerating field of 4.2 MV/m. As M01 was initially conditioned six years ago, the most recent conditioning time required for M01 was drastically reduced. From this result, we confirmed that long-term stored ACS cavities purged with nitrogen gas do not produce critical cavity performance issues. During high-power operation of M11, which is a unique cavity equipped with a capacitive iris in a waveguide, no significant increases in the temperature and the discharge rate around the capacitive iris were observed. Even considering beam loss due to residual gas scattering, the vacuum pressure was sufficiently low (4 x 10(-6) Pa). More stable operation can be expected following a month-long conditioning process before the beam is commissioned. M11's conditioning successfully demonstrated an auto-conditioning program, and we established the conditioning scheme using this auto-conditioning program for all ACS cavities in a limited time and with limited manpower.	[Tamura, Jun; Ao, Hiroyuki; Nemoto, Yasuo] Japan Atom Energy Agcy, J PARC Ctr, Ibaraki 3191195, Japan; [Asano, Hiroyuki] Nippon Adv Technol Co Ltd, Ibaraki 3191112, Japan; [Suzuki, Takahiro] Mitsubishi Elect Syst & Serv Co Ltd, Ibaraki 3050045, Japan	Tamura, J (reprint author), Japan Atom Energy Agcy, J PARC Ctr, Ibaraki 3191195, Japan.	jtamura@post.j-parc.jp					Andreev V. G., P 1972 PROT LIN ACC, P114; Ao H., P IPAC2013 SHANGH CH, P3845; Ao H., P LINAC2012 TEL AV I, P888; Ao H, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.011001; Kageyama T., P 1992 LIN ACC C OTT, P456; Yamazaki Y., 2003044 JAERI	6	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	FEB	2015	66	3					399	404		10.3938/jkps.66.399		6	Physics, Multidisciplinary	Physics	CC4PN	WOS:000350335400016		
J	Lee, P; Lee, CS; Moon, JY; Chae, KY; Cha, SM; Yamaguchi, H; Nakao, T; Kahl, DM; Kubono, S; Cherubini, S; Hayakawa, S; Signorini, C				Lee, Pilsoo; Lee, Chun Sik; Moon, Jun Young; Chae, Kyung Yuk; Cha, Soo Mi; Yamaguchi, Hidetoshi; Nakao, Taro; Kahl, David M.; Kubono, Shigeru; Cherubini, Silvio; Hayakawa, Seiya; Signorini, Cosimo			Development and performance test of the analysis software for the CRIB active target	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						GEM-MSTPC; CRIB; MSTPC; Active target	TRACKING PROPORTIONAL CHAMBER; SYSTEM; BEAMS	Software for genuinely event-by-event analysis and event reconstruction of data obtained by using an active target has been developed in the graphical user interface under the CERN ROOT framework. The primary motivation for developing the software was to provide physicists who perform experiments using an active target a more user-friendly environment for the purpose of investigating the performance of detection systems and obtaining ideas about physics from a large amount of experimental data. To test the performance of the software, we analyzed experimental data from a N-16 radioactive ion beam experiment for alpha-decay measurements. As a result of the analysis, we observed the Bragg curve and measured the range of the N-16 RI beam in the detector. Data were calibrated against the calculation after comparing the Bragg curve to the one obtained from an energy loss calculation in P-10 gas. We present a detailed description of the analysis software and its test results.	[Lee, Pilsoo; Lee, Chun Sik] Chung Ang Univ, Dept Phys, Seoul 156756, South Korea; [Moon, Jun Young] Inst for Basic Sci Korea, Taejon 305811, South Korea; [Chae, Kyung Yuk; Cha, Soo Mi] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Yamaguchi, Hidetoshi; Nakao, Taro; Kahl, David M.] Univ Tokyo, Ctr Nucl Study, Saitama 3510198, Japan; [Kubono, Shigeru] Inst Phys & Chem Res RIKEN, Saitama 3510198, Japan; [Kubono, Shigeru] Inst Modern Phys, Lanzhou 730000, Peoples R China; [Cherubini, Silvio; Hayakawa, Seiya] Ist Nazl Fis Nucl, Lab Nazl Sud, I-95129 Catania, Italy; [Signorini, Cosimo] Univ Padua, Dept Phys, I-35131 Padua, Italy; [Signorini, Cosimo] Ist Nazl Fis Nucl, I-35131 Padua, Italy	Lee, P (reprint author), Chung Ang Univ, Dept Phys, Seoul 156756, South Korea.	cslee@cau.ac.kr		Cherubini, Silvio/0000-0002-1974-0389	National Research Foundation - Korea Government [NRF-2009-0093817, NRF-2013R1A1A2063017]; National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2012R1A1A1041763]; Chung-Ang University Excellent Student Scholarship, JSPS KAKENHI [25800125]; Center for Nuclear Study, the University of Tokyo of Japan	This research was supported by the National Research Foundation Grant funded by Korea Government(Grants No. NRF-2009-0093817 and No. NRF-2013R1A1A2063017), by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. NRF-2012R1A1A1041763), by the Chung-Ang University Excellent Student Scholarship, JSPS KAKENHI Grant Number 25800125, and by the Center for Nuclear Study, the University of Tokyo of Japan.	Amdahl G., 1967, AFIPS C P, V30, P483; Baba H, 2010, NUCL INSTRUM METH A, V616, P65, DOI 10.1016/j.nima.2010.02.120; Das SK, 2011, NUCL INSTRUM METH A, V625, P39, DOI 10.1016/j.nima.2010.10.042; Geuzaine C., 2009, INT J NUMER METHODS, P1; Hashimoto T, 2006, NUCL INSTRUM METH A, V556, P339, DOI 10.1016/j.nima.2005.10.018; Knoll G. F., 2000, RAD DETECTION MEASUR; Mizoi Y, 1999, NUCL INSTRUM METH A, V431, P112, DOI 10.1016/S0168-9002(99)00253-3; Reinders J., 2010, INTEL THREADING BUIL; Veenhof R., 1998, NUCL INSTRUM METH A, V419, P2	9	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	FEB	2015	66	3					459	464		10.3938/jkps.66.459		6	Physics, Multidisciplinary	Physics	CC4PN	WOS:000350335400026		
J	Park, J; Kwon, YK; Moon, JY; Komatsubara, T; Jung, II; Kim, YH; Yun, CC; Kim, YK; Kato, S; Moon, CB; Chae, KY; Kubono, S				Park, Junesic; Kwon, Young Kwan; Moon, Jun Young; Komatsubara, Tetsuro; Jung, In-Il; Kim, Yong Hak; Yun, Chong Cheoul; Kim, Yong-Kyun; Kato, Seigo; Moon, Chang-Bum; Chae, Kyung Yuk; Kubono, Shigeru			Design study for the KOBRA (KOrea Broad acceptance Recoil spectrometer and Apparatus) at RAON	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Recoil spectrometer; In-flight separator; Dispersion matching; Ion optics	PROJECT	The KOBRA (KOrea Broad acceptance Recoil spectrometer and Apparatus) is a multi-purpose recoil spectrometer for low-energy nuclear experiments at the RAON accelerator complex. It is divided into two stages based on the operational function: the first stage (F0-F3) is an in-flight separator or beam transport line, and the second stage (F3-F5) is a large acceptance spectrometer. For spectrometers using radioactive ion (RI) beams, high performance, such as high resolution and large acceptance, are especially required due to the limit of quality of RI beams. In this respect, a dispersion-matching technique and a movable magnet system were employed for high resolution and large acceptance, respectively. Reaction spectra at the focal plane for the dispersion matching mode were obtained and analyzed using a Monte Carlo simulation code. In addition, the geometrical angular acceptances with respect to the distance between the reaction target and the first Q-pole doublet of the second stage were calculated, and the expected maximum solid angle of the spectrometer was estimated.	[Park, Junesic; Kwon, Young Kwan; Moon, Jun Young; Komatsubara, Tetsuro; Jung, In-Il; Kim, Yong Hak; Yun, Chong Cheoul; Kim, Yong-Kyun] Inst for Basic Sci Korea, Rare Isotope Sci Project, Taejon 305811, South Korea; [Park, Junesic] Hanyang Univ, Dept Nucl Engn, Seoul 133791, South Korea; [Kato, Seigo] Yamagata Univ, Dept Phys, Yamagata 9908560, Japan; [Moon, Chang-Bum] Hoseo Univ, Dept Display, Cheonan 336795, South Korea; [Chae, Kyung Yuk] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Kubono, Shigeru] RIKEN, Inst Phys & Chem Res, Saitama 3510198, Japan	Park, J (reprint author), Inst for Basic Sci Korea, Rare Isotope Sci Project, Taejon 305811, South Korea.	ykkwon@ibs.re.kr			Rare Isotope Science Project of Institute for Basic Science - Ministry of Science, ICT and Future Planning; National Research Foundation of Korea [2013M7A1A1075765]	This work was supported by the Rare Isotope Science Project of Institute for Basic Science funded by Ministry of Science, ICT and Future Planning and National Research Foundation of Korea (2013M7A1A1075765).	Kwon YK, 2013, FEW-BODY SYST, V54, P961, DOI 10.1007/s00601-013-0605-5; Fujita H, 2002, NUCL INSTRUM METH A, V484, P17, DOI 10.1016/S0168-9002(01)01970-2; Fujita Y, 1997, NUCL INSTRUM METH B, V126, P274, DOI 10.1016/S0168-583X(96)01008-7; Iwasa N, 2011, NUCL INSTRUM METH B, V269, P752, DOI 10.1016/j.nimb.2011.02.007; Kato S, 2009, NUCL INSTRUM METH A, V611, P1, DOI 10.1016/j.nima.2009.08.031; Kato S, 2005, NUCL INSTRUM METH A, V540, P1, DOI 10.1016/j.nima.2004.11.008	6	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	FEB	2015	66	3					509	512		10.3938/jkps.66.509		4	Physics, Multidisciplinary	Physics	CC4PN	WOS:000350335400036		
J	Kimura, N; Itoh, S; Yuri, K; Adachi, K; Matsumoto, H; Yamaguchi, A; Adachi, H				Kimura, Naoyuki; Itoh, Satoshi; Yuri, Koichi; Adachi, Koichi; Matsumoto, Harunobu; Yamaguchi, Atsushi; Adachi, Hideo			Reoperation for enlargement of the distal aorta after initial surgery for acute type A aortic dissection	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							FALSE LUMEN; ENDOVASCULAR REPAIR; STENT-GRAFTS; RISK-FACTORS; OUTCOMES; TEVAR		[Kimura, Naoyuki; Itoh, Satoshi; Yuri, Koichi; Adachi, Koichi; Matsumoto, Harunobu; Yamaguchi, Atsushi; Adachi, Hideo] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Omiya, Saitama 3300834, Japan	Kimura, N (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, 1-847 Amanuma Cho, Omiya, Saitama 3300834, Japan.	kimura-n@omiya.jichi.ac.jp					Kang WC, 2011, J THORAC CARDIOV SUR, V142, P1074, DOI 10.1016/j.jtcvs.2011.03.008; Svensson LG, 2008, ANN THORAC SURG, V85, pS1, DOI 10.1016/j.athoracsur.2007.10.099; Kimura N, 2008, J THORAC CARDIOV SUR, V136, P1160, DOI 10.1016/j.jtcvs.2008.05.052; Zierer A, 2007, ANN THORAC SURG, V84, P479, DOI 10.1016/j.athoracsur.2007.03.084; Trimarchi S, 2013, J THORAC CARDIOV SUR, V145, pS208, DOI 10.1016/j.jtcvs.2012.11.048; Concistre G, 2012, ANN THORAC SURG, V93, P450, DOI 10.1016/j.athoracsur.2011.10.059; Thrumurthy SG, 2011, EUR J VASC ENDOVASC, V42, P632, DOI 10.1016/j.ejvs.2011.08.009; Kimura N, 2014, AM J CARDIOL, V113, P724, DOI 10.1016/j.amjcard.2013.11.017; Sun LZ, 2011, CIRCULATION, V123, P971, DOI 10.1161/CIRCULATIONAHA.110.015081; Trimarchi S, 2010, J THORAC CARDIOV SUR, V140, P784, DOI 10.1016/j.jtcvs.2009.11.014; Fattouch K, 2009, ANN THORAC SURG, V88, P1244, DOI 10.1016/j.athoracsur.2009.06.055; Uchida N, 2011, EUR J CARDIO-THORAC, V40, P1066, DOI 10.1016/j.ejcts.2011.02.074; Yuri K, 2013, EUR J CARDIO-THORAC, V44, P760, DOI 10.1093/ejcts/ezt127; Scali ST, 2013, J VASC SURG, V58, P10, DOI 10.1016/j.jvs.2012.12.071; Conzelmann LO, 2012, EUR J CARDIO-THORAC, V42, P557, DOI 10.1093/ejcts/ezs025; Yokoi Y, 2013, J THORAC CARDIOV SUR, V145, pS103, DOI 10.1016/j.jtcvs.2012.11.058; CRAWFORD ES, 1990, JAMA-J AM MED ASSOC, V264, P2537, DOI 10.1001/jama.264.19.2537; Fattori R, 2000, AM J CARDIOL, V86, P868, DOI 10.1016/S0002-9149(00)01108-5; Gariboldi Vlad, 2007, Interact Cardiovasc Thorac Surg, V6, P47; Grabenwoger M, 2012, EUR J CARDIO-THORAC, V42, P17, DOI 10.1093/ejcts/ezs107; Halstead JC, 2007, J THORAC CARDIOV SUR, V133, P127, DOI 10.1016/j.jctvs.2006.07.043; Ius F, 2011, EUR J CARDIO-THORAC, V40, P1, DOI 10.1016/j.ejcts.2011.01.062; Kimura N, 2008, J THORAC CARDIOVASC, V136, P1166; Kimura N, 2008, J THORAC CARDIOVASC, V136, pe1161; Malvindi PG, 2013, ANN THORAC SURG, V95, P922, DOI 10.1016/j.athoracsur.2012.11.029; Park KH, 2009, ANN THORAC SURG, V87, P103, DOI 10.1016/j.athoracsur.2008.09.032; Shi E, 2013, J THORAC CARDIOVASC; Tsai MT, 2014, J THORAC CARDIOVASC; Wu HB, 2014, J THORAC CARDIOVASC; Yeh CH, 2003, CHEST, V124, P989, DOI 10.1378/chest.124.3.989	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	FEB	2015	149	2		S			S91	U298		10.1016/j.jtcvs.2014.08.008		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7MI	WOS:000350551500021		
J	Okita, Y; Miyata, H; Motomura, N; Takamoto, S				Okita, Yutaka; Miyata, Hiroaki; Motomura, Noboru; Takamoto, Shinichi		Japan Cardiovasc Surg Database Org	A study of brain protection during total arch replacement comparing antegrade cerebral perfusion versus hypothermic circulatory arrest, with or without retrograde cerebral perfusion: Analysis based on the Japan Adult Cardiovascular Surgery Database	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							AORTIC-ARCH; DEEP HYPOTHERMIA; ASCENDING AORTA; THORACIC AORTA; OPERATIONS; RISK; MORTALITY; DETERMINANTS; EXPERIENCE; ANEURYSMS	Objectives: Antegrade cerebral perfusion and hypothermic circulatory arrest, with or without retrograde cerebral perfusion, are 2 major types of brain protection that are used during aortic arch surgery. We conducted a comparative study of these methods in patients undergoing total arch replacement to evaluate the clinical outcomes in Japan, based on the Japan Adult Cardiovascular Surgery Database. Methods: A total of 16,218 patients underwent total arch replacement between 2009 and 2012. Patients with acute aortic dissection or ruptured aneurysm, or who underwent emergency surgery were excluded, leaving 8169 patients for analysis. For the brain protection method, 7038 patients had antegrade cerebral perfusion and 1141 patients had hypothermic circulatory arrest/retrograde cerebral perfusion. A nonmatched comparison was made between the 2 groups, and propensity score analysis was performed among 1141 patients. Results: The matched paired analysis showed that the minimum rectal temperature was lower in the hypothermic circulatory arrest/retrograde cerebral perfusion group (21.2 degrees C +/- 3.7 degrees C vs 24.2 degrees C +/- 3.2 degrees C) and that the duration of cardiopulmonary bypass and cardiac ischemia was longer in the antegrade cerebral perfusion group. There were no significant differences between the antegrade cerebral perfusion and hypothermic circulatory arrest/retrograde cerebral perfusion groups with regard to 30-day mortality (3.2% vs 4.0%), hospital mortality (6.0% vs 7.1%), incidence of stroke (6.7% vs 8.6%), or transient neurologic disorder (4.1% vs 4.4%). There was no difference in a composite outcome of hospital death, bleeding, prolonged ventilation, need for dialysis, stroke, and infection (antegrade cerebral perfusion 28.4% vs hypothermic circulatory arrest 30.1%). However, hypothermic circulatory arrest/retrograde cerebral perfusion resulted in a significantly higher rate of prolonged stay in the intensive care unit (>8 days: 24.2% vs 15.6%). Conclusions: Hypothermic circulatory arrest/retrograde cerebral perfusion and antegrade cerebral perfusion provide comparable clinical outcomes with regard to mortality and stroke rates, but hypothermic circulatory arrest/retrograde cerebral perfusion resulted in a higher incidence of prolonged intensive care unit stay. Antegrade cerebral perfusion might be preferred as the brain protection method for complicated aortic arch procedures.	[Okita, Yutaka] Kobe Univ, Dept Cardiovasc Surg, Kobe, Hyogo 6500017, Japan; [Miyata, Hiroaki] Univ Tokyo, Hlth Care Qual Assessment, Tokyo, Japan; [Motomura, Noboru] Toho Univ, Med Ctr, Sakura Hosp, Dept Cardiovasc Surg, Chiba 2748510, Japan; [Takamoto, Shinichi] Mitsui Mem Hosp, Tokyo 101, Japan	Okita, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg,Chuo ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Amano J, 2014, GEN THORAC CARDIOVAS, V62, P734; GRIEPP RB, 1975, J THORAC CARDIOV SUR, V70, P1051; UEDA Y, 1990, J CARDIOVASC SURG, V31, P553; Motomura N, 2008, CIRCULATION, V118, pS153, DOI 10.1161/CIRCULATIONAHA.107.756684; Okita Y, 2001, ANN THORAC SURG, V72, P72, DOI 10.1016/S0003-4975(01)02671-6; SVENSSON LG, 1993, J THORAC CARDIOV SUR, V106, P19; Okita Y, 2013, J THORAC CARDIOV SUR, V145, pS63, DOI 10.1016/j.jtcvs.2012.11.070; Di Eusanio M, 2002, J THORAC CARDIOV SUR, V124, P1080, DOI 10.1067/mtc.2002.124994; Okita Y, 1998, J THORAC CARDIOV SUR, V115, P129, DOI 10.1016/S0022-5223(98)70451-9; Svensson LG, 2001, ANN THORAC SURG, V71, P1905, DOI 10.1016/S0003-4975(01)02570-X; Hagl C, 2001, J THORAC CARDIOV SUR, V121, P1107, DOI 10.1067/mtc.2001.113179; FRIST WH, 1986, ANN THORAC SURG, V42, P273; Sundt TM, 2008, ANN THORAC SURG, V86, P787, DOI 10.1016/j.athoracsur.2008.05.011; Okada K, 2012, J THORAC CARDIOV SUR, V144, P139, DOI 10.1016/j.jtcvs.2011.08.039; Bachet J, 1999, ANN THORAC SURG, V67, P1874, DOI 10.1016/S0003-4975(99)00411-7; Luehr M, 2014, EUR J CARDIO-THORAC, V45, P27, DOI 10.1093/ejcts/ezt154; Coselli JS, 1997, J CARDIAC SURG, V12, P322; Kamiya H, 2007, J THORAC CARDIOV SUR, V133, P501, DOI 10.1016/j.jtcvs.2006.09.045; GUILMET D, 1986, PRESSE MED, V15, P1096; Ueda Y, 1999, ANN THORAC SURG, V67, P1879, DOI 10.1016/S0003-4975(99)00415-4; BORST HG, 1964, J THORAC CARDIOV SUR, V48, P443; Barnard James, 2004, Interact Cardiovasc Thorac Surg, V3, P621, DOI 10.1016/j.icvts.2004.07.008; Bavaria J E, 1997, Semin Thorac Cardiovasc Surg, V9, P222; DEBAKEY ME, 1962, SURG CLIN N AM, V42, P1543; ERGIN MA, 1994, J THORAC CARDIOV SUR, V107, P788; Hu ZP, 2014, J THORAC CARDIOV SUR, V148, P544, DOI 10.1016/j.jtcvs.2013.10.036; KAZUI T, 1992, ANN THORAC SURG, V53, P109; Morimoto N, 2009, ANN THORAC SURG, V88, P476, DOI 10.1016/j.athoracsur.2009.04.019; Ogino H, 2008, J THORAC CARDIOV SUR, V136, P641, DOI 10.1016/j.jtcvs.2008.02.089; Okada K, 2014, J THORAC CARDIOV SUR, V147, P966, DOI 10.1016/j.jtcvs.2013.02.046; Okada K, 2013, J THORAC CARDIOV SUR, V145, P984, DOI 10.1016/j.jtcvs.2012.03.048; Safi HJ, 2011, J THORAC CARDIOV SUR, V142, P630, DOI 10.1016/j.jtcvs.2010.11.015; Spielvogel D, 2003, ANN THORAC SURG, V75, P1034, DOI 10.1016/S0003-4975(02)04340-0; Tsukui Hiroyuki, 2002, Asian Cardiovasc Thorac Ann, V10, P318; Usui Akihiko, 2012, Gen Thorac Cardiovasc Surg, V60, P132, DOI 10.1007/s11748-011-0857-2; Yan Tristan D, 2013, Ann Cardiothorac Surg, V2, P163, DOI 10.3978/j.issn.2225-319X.2013.03.03	36	5	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	FEB	2015	149	2		S			S65	S73		10.1016/j.jtcvs.2014.08.070		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CC7MI	WOS:000350551500016		
J	Sasaki, E; Kamiya, Y				Sasaki, Eriko; Kamiya, Yasuhiko			Caregivers' Understanding of Pediatric Medication in Central Malawi	JOURNAL OF TROPICAL PEDIATRICS			English	Article						pediatric medication; caregiver understanding; education level	PRESCRIPTION; INSTRUCTIONS; LITERACY; LABELS	Objective: To investigate caregivers' understanding of prescriptions of antibiotics and antimalarials for children in Malawi. Method: A cross-sectional study using interviews with 513 caregivers was undertaken in three different medical settings in two districts in Malawi for their understanding of medication defined as comprehension of dosage, frequency and duration immediately after receiving medicine, and its association with their sociodemographic characteristics. Results: Nearly half (49%) of the caregivers understood medication on the day of prescription. Understanding varied by type of drug. Sixty-five percent understood medication for antimalarials, LA (lumefantrine and artemether), while only 38% understood medication for amoxicillin syrup. Multivariate analysis showed that caregivers with higher education and older children had greater understanding. Conclusions: Caregivers' understanding of pediatric medication was differentially related to kinds and types of medicine as well as their education level. The instruction to caregivers on how to administer medication should be evaluated especially when they are less educated.	[Sasaki, Eriko; Kamiya, Yasuhiko] Nagasaki Univ, Grad Sch Int Hlth Dev, Nagasaki 8528523, Japan	Kamiya, Y (reprint author), Nagasaki Univ, Grad Sch Int Hlth Dev, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	ykami@nagasaki-u.ac.jp			Graduate School of International Health Development at Nagasaki University, Japan	This study was fully supported by Graduate School of International Health Development at Nagasaki University, Japan.	Davis TC, 2006, ANN INTERN MED, V145, P887; Ellis J, 2009, AUST FAM PHYSICIAN, V38, P816; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; Bailey SC, 2009, FAM MED, V41, P715; Kaushal R, 2007, AMBUL PEDIATR, V7, P383, DOI 10.1016/j.ambp.2007.05.005; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; Boonstra E, 2003, QUAL SAF HEALTH CARE, V12, P168, DOI 10.1136/qhc.12.3.168; Davis TC, 2008, J GEN INTERN MED, V24, P57; Fletcher S W, 1979, J Community Health, V4, P183, DOI 10.1007/BF01322963; Parimi N, 2002, PAN AM J PUBLIC HLTH, V12, P11; Parimi Neeta, 2004, BMC Fam Pract, V5, P28, DOI 10.1186/1471-2296-5-28; Sosola AG, 2007, THESIS U MALAWI MALA; WHO, 2011, WORLD MALARIA REPORT 2011, P1	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	FEB	2015	61	1					14	19		10.1093/tropej/fmu057		6	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	CC1MH	WOS:000350104300002		
J	Saito, K; Shirasago, Y; Suzuki, T; Aizaki, H; Hanada, K; Wakita, T; Nishijima, M; Fukasawa, M				Saito, Kyoko; Shirasago, Yoshitaka; Suzuki, Tetsuro; Aizaki, Hideki; Hanada, Kentaro; Wakita, Takaji; Nishijima, Masahiro; Fukasawa, Masayoshi			Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C Virus	JOURNAL OF VIROLOGY			English	Article							RNA REPLICATION COMPLEX; NONSTRUCTURAL PROTEINS; VIRAL REPLICATION; LIPID RAFTS; MEMBRANE ASSOCIATION; NS4B PROTEIN; LIFE-CYCLE; IN-VITRO; INFECTION; EXPRESSION	Hepatitis C virus (HCV) exploits host membrane cholesterol and its metabolism for progeny virus production. Here, we examined the impact of targeting cellular squalene synthase (SQS), the first committed enzyme for cholesterol biosynthesis, on HCV production. By using the HCV JFH-1 strain and human hepatoma Huh-7.5.1-derived cells, we found that the SQS inhibitors YM-53601 and zaragozic acid A decreased viral RNA, protein, and progeny production in HCV-infected cells without affecting cell viability. Similarly, small interfering RNA (siRNA)-mediated knockdown of SQS led to significantly reduced HCV production, confirming the enzyme as an antiviral target. A metabolic labeling study demonstrated that YM-53601 suppressed the biosynthesis of cholesterol and cholesteryl esters at antiviral concentrations. Unlike YM-53601, the cholesterol esterification inhibitor Sandoz 58-035 did not exhibit an antiviral effect, suggesting that biosynthesis of cholesterol is more important than that of cholesteryl esters for HCV production. YM-53601 inhibited transient replication of a JFH-1 subgenomic replicon and entry of JFH-1 pseudoparticles, suggesting that at least suppression of viral RNA replication and entry contributes to the antiviral effect of the drug. Collectively, our findings highlight the importance of the cholesterol biosynthetic pathway in HCV production and implicate SQS as a potential target for antiviral strategies against HCV. IMPORTANCE Hepatitis C virus (HCV) is known to be closely associated with host cholesterol and its metabolism throughout the viral life cycle. However, the impact of targeting cholesterol biosynthetic enzymes on HCV production is not fully understood. We found that squalene synthase, the first committed enzyme for cholesterol biosynthesis, is important for HCV production, and we propose this enzyme as a potential anti-HCV target. We provide evidence that synthesis of free cholesterol is more important than that of esterified cholesterol for HCV production, highlighting a marked free cholesterol dependency of HCV production. Our findings also offer a new insight into a role of the intracellular cholesterol pool that is coupled to its biosynthesis in the HCV life cycle.	[Saito, Kyoko; Shirasago, Yoshitaka; Hanada, Kentaro; Fukasawa, Masayoshi] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Shirasago, Yoshitaka] Tokyo Univ Sci, Grad Sch Biol Sci, Chiba, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Shizuoka, Japan; [Aizaki, Hideki; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Nishijima, Masahiro] Showa Pharmaceut Univ, Tokyo, Japan	Fukasawa, M (reprint author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan.	fuka@nih.go.jp			National Cancer Center Research and Development Fund from the National Cancer Center of Japan; Ministry of Health, Labor and Welfare of Japan; JSPS KAKENHI from the Japan Society for the Promotion of Science [21590085, 23590104]	This study was supported by the National Cancer Center Research and Development Fund (grant no. 7 to M.F.) from the National Cancer Center of Japan, by Health and Labor Sciences research grants for research on hepatitis from the Ministry of Health, Labor and Welfare of Japan, and by Grants-in-Aid for Scientific Research (C) JSPS KAKENHI (grant no. 21590085 to K.S. and 23590104 to M.F.) from the Japan Society for the Promotion of Science.	Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; NIWA H, 1991, GENE, V108, P193; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; HANADA K, 1992, J BIOL CHEM, V267, P23527; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Zheng YH, 2003, P NATL ACAD SCI USA, V100, P8460, DOI 10.1073/pnas.1437453100; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; LANGE Y, 1991, J LIPID RES, V32, P329; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011; WAKITA T, 1994, J BIOL CHEM, V269, P14205; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Voisset C, 2008, CELL MICROBIOL, V10, P606, DOI 10.1111/j.1462-5822.2007.01070.x; GRAKOUI A, 1993, J VIROL, V67, P1385; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Han QX, 2011, J VIROL, V85, P6464, DOI 10.1128/JVI.02298-10; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Ishihara T, 2003, BIOORGAN MED CHEM, V11, P3735, DOI 10.1016/S0968-0896(03)00336-5; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Alexopoulou A, 2012, WORLD J GASTROENTERO, V18, P6060, DOI 10.3748/wjg.v18.i42.6060; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Inoue Y, 2007, JPN J INFECT DIS, V60, P173; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; Mizoguchi T, 2004, J LIPID RES, V45, P396, DOI 10.1194/jlr.D300024-JLR200; Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003; Owens CM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.32; Park EM, 2014, FEBS LETT, V588, P1813, DOI 10.1016/j.febslet.2014.03.043; ROSS AC, 1984, J BIOL CHEM, V259, P815; Shirasago Y, 2014, JPN J INFECT DIS; Ugawa T, 2000, BRIT J PHARMACOL, V131, P63, DOI 10.1038/sj.bjp.0703545; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048	75	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	FEB	2015	89	4					2220	2232		10.1128/JVI.03385-14		13	Virology	Virology	AZ9UT	WOS:000348562800026		
J	Coleman, CB; Wohlford, EM; Smith, NA; King, CA; Ritchie, JA; Baresel, PC; Kimura, H; Rochford, R				Coleman, Carrie B.; Wohlford, Eric M.; Smith, Nicholas A.; King, Christine A.; Ritchie, Julie A.; Baresel, Paul C.; Kimura, Hiroshi; Rochford, Rosemary			Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines	JOURNAL OF VIROLOGY			English	Article							HUMAN LYMPHOCYTES-B; GENE-EXPRESSION; EPITHELIAL-CELLS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; LYMPHOPROLIFERATIVE DISORDERS; NASOPHARYNGEAL CARCINOMA; NUCLEAR ANTIGEN-2; HUMAN THYMOCYTES; RECEPTOR CR-2; EBV	Epstein-Barr virus (EBV) is a well-established B-cell-tropic virus associated with various lymphoproliferative diseases of both B-cell and non-B-cell origin. EBV is associated with a number of T-cell lymphomas; however, in vitro studies utilizing prototypical EBV type 1 (EBV-1) laboratory strains have generally failed to readily infect mature T cells in culture. The difficulties in performing in vitro T-cell experiments have left questions regarding the role of EBV in the pathogenesis of EBV-positive T-cell lymphoproliferative diseases largely unresolved. We report here that the EBV type 2 (EBV-2) strain displays a unique cell tropism for T cells. In remarkable contrast to EBV-1, EBV-2 readily infects primary T cells in vitro, demonstrating a propensity for CD8(+) T cells. EBV-2 infection of purified T cells results in expression of latency genes and ultimately leads to T-cell activation, substantial proliferation, and profound alteration of cytokine expression. The pattern of cytokine production is strikingly skewed toward chemokines with roles in lymphocyte migration, demonstrating that EBV-2 has the ability to modulate normal T-cell processes. Collectively, these novel findings identify a previously unknown cell population potentially utilized by EBV-2 to establish latency and lay the foundation for further studies to elucidate the role of EBV in the pathogenesis of T-cell lymphoproliferative diseases. IMPORTANCE The ability of EBV to infect T cells is made apparent by its association with a variety of T-cell lymphoproliferative disorders. However, studies to elucidate the pathogenic role of EBV in these diseases have been limited by the inability to conduct in vitro T-cell infection experiments. Here, we report that EBV-2 isolates, compromised in the capacity to immortalize B cells, infect CD3(+) T cells ex vivo and propose a working model of EBV-2 persistence where alteration of T-cell functions resulting from EBV-2 infection enhances the establishment of latency in B cells. If indeed EBV-2 utilizes T cells to establish a persistent infection, this could provide one mechanism for the association of EBV with T-cell lymphomas. The novel finding that EBV-2 infects T cells in culture will provide a model to understand the role EBV plays in the development of T-cell lymphomas.	[Coleman, Carrie B.; Wohlford, Eric M.; Smith, Nicholas A.; King, Christine A.; Ritchie, Julie A.; Baresel, Paul C.; Rochford, Rosemary] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Kimura, Hiroshi] Nagoya Univ Grad Sch Med, Dept Virol, Nagoya, Aichi, Japan	Rochford, R (reprint author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	rochforr@upstate.edu	Kimura, Hiroshi/I-2246-2012		National Institutes of Health [NCI CA102667, F30 CA168358]	This work was supported in part by grants from the National Institutes of Health, NCI CA102667 (R.R.) and F30 CA168358 (E.M.W.).	Calattini S, 2010, BLOOD, V116, P4546, DOI 10.1182/blood-2010-05-285452; RICKINSON AB, 1987, J VIROL, V61, P1310; Price AM, 2014, ADV VIRUS RES, V88, P279, DOI 10.1016/B978-0-12-800098-4.00006-4; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; ROWE M, 1989, J VIROL, V63, P1031; Cohen JI, 2011, BLOOD, V117, P5835, DOI 10.1182/blood-2010-11-316745; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; DAMBAUGH T, 1984, P NATL ACAD SCI-BIOL, V81, P7632, DOI 10.1073/pnas.81.23.7632; TOMKINSON B, 1993, J VIROL, V67, P2014; Price AM, 2012, J VIROL, V86, P11096, DOI 10.1128/JVI.01069-12; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Tsai SC, 2013, J VIROL, V87, P9041, DOI 10.1128/JVI.00541-13; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Imai S, 1998, J VIROL, V72, P4371; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; Yoshizaki T, 2001, CLIN CANCER RES, V7, P1946; Ito Y, 2013, PEDIATR BLOOD CANCER, V60, P326, DOI 10.1002/pbc.24319; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; NEMEROW GR, 1985, J VIROL, V55, P347; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Farrell Paul J., 1995, Trends in Microbiology, V3, P105, DOI 10.1016/S0966-842X(00)88891-5; SIXBEY JW, 1989, LANCET, V2, P761; GOLDSCHMIDTS WL, 1992, LEUKEMIA, V6, P875; Iwatsuki K, 2006, ARCH DERMATOL, V142, P587, DOI 10.1001/archderm.142.5.587; MURPHY WJ, 1994, EUR J IMMUNOL, V24, P1823, DOI 10.1002/eji.1830240815; ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; YOUNG LS, 1987, J GEN VIROL, V68, P2853, DOI 10.1099/0022-1317-68-11-2853; Kasahara Y, 2002, CRIT REV ONCOL HEMAT, V44, P283, DOI 10.1016/S1040-8428(02)00119-1; Braun M, 1998, INT IMMUNOL, V10, P1197, DOI 10.1093/intimm/10.8.1197; Buettner M, 2007, INT J CANCER, V121, P2703, DOI 10.1002/ijc.23018; Cancian L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002164; CHEN CL, 1993, J VIROL, V67, P6303; Coen N, 2014, ANTIMICROB AGENTS CH, V58, P7312, DOI 10.1128/AAC.03957-14; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Fujiwara S, 2014, PEDIATR INT, V56, P159, DOI 10.1111/ped.12314; Groux H, 1997, BLOOD, V89, P4521; Hutt-Fletcher L M, 2001, Methods Mol Biol, V174, P119; Kawabe S, 2012, CANCER SCI, V103, P1481, DOI 10.1111/j.1349-7006.2012.02305.x; Kieff E, 2001, FIELDS VIROLOGY, V4th, P2511; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lai HC, 2010, VIROLOGY, V405, P464, DOI 10.1016/j.virol.2010.06.037; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; McColl SR, 1997, J IMMUNOL, V159, P6164; Park S, 2014, J DERMATOL, V41, P29, DOI 10.1111/1346-8138.12322; PATERSON RLK, 1995, J IMMUNOL, V154, P1440; SAMPLE J, 1990, J VIROL, V64, P4084; SCULLEY TB, 1989, VIROLOGY, V171, P401, DOI 10.1016/0042-6822(89)90608-9; SUMMERS WC, 1976, J VIROL, V18, P151; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, TRENDS IMMUNOL, V29, P195, DOI 10.1016/j.it.2008.01.006; Todd SC, 1996, J IMMUNOL, V156, P4217; WANG F, 1990, J VIROL, V64, P3407; Wang Ji Ming, 1996, Methods (Orlando), V10, P135, DOI 10.1006/meth.1996.0087; Yu WW, 2013, J CUTAN PATHOL, V40, P310, DOI 10.1111/cup.12066	55	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	FEB	2015	89	4					2301	2312		10.1128/JVI.03001-14		12	Virology	Virology	AZ9UT	WOS:000348562800032		
J	Taguchi, A; Nagasaka, K; Kawana, K; Hashimoto, K; Kusumoto-Matsuo, R; Plessy, C; Thomas, M; Nakamura, H; Bonetti, A; Oda, K; Kukimoto, I; Carninci, P; Banks, L; Osuga, Y; Fujii, T				Taguchi, Ayumi; Nagasaka, Kazunori; Kawana, Kei; Hashimoto, Kosuke; Kusumoto-Matsuo, Rika; Plessy, Charles; Thomas, Miranda; Nakamura, Hiroe; Bonetti, Alessandro; Oda, Katsutoshi; Kukimoto, Iwao; Carninci, Piero; Banks, Lawrence; Osuga, Yutaka; Fujii, Tomoyuki			Characterization of Novel Transcripts of Human Papillomavirus Type 16 Using Cap Analysis Gene Expression Technology	JOURNAL OF VIROLOGY			English	Article							KERATINOCYTE CELL-LINE; CERVICAL-CANCER; IDENTIFICATION; PROMOTER; RNAS; LANDSCAPE; GENOME	We have performed cap-analysis gene expression (CAGE) sequencing to identify the regulatory networks that orchestrate genome-wide transcription in human papillomavirus type 16 (HPV16)-positive cervical cell lines of different grades: W12E, SiHa, and CaSki. Additionally, a cervical intraepithelial neoplasia grade 1 (CIN1) lesion was assessed for identifying the transcriptome expression profile. Here we have precisely identified a novel antisense noncoding viral transcript in HPV16. In conclusion, CAGE sequencing should pave the way for understanding a diversity of viral transcript expression.	[Taguchi, Ayumi; Nagasaka, Kazunori; Kawana, Kei; Nakamura, Hiroe; Oda, Katsutoshi; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Hashimoto, Kosuke; Plessy, Charles; Bonetti, Alessandro; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Kusumoto-Matsuo, Rika; Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Thomas, Miranda; Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	Nagasaka, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan.	nagasakak-tky@umin.ac.jp; kkawana-tky@umin.org		Plessy, Charles/0000-0001-7410-6295	Ministry of Education, Science and Culture, Japan	This work was supported by a Grant-in-Aid for Scientific Research (K.N., K.K.) from the Ministry of Education, Science and Culture, Japan.	Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Schmitt M, 2011, MOL CELL PROBE, V25, P260, DOI 10.1016/j.mcp.2011.05.003; Schmitt M, 2011, MOL CELL PROBE, V25, P108, DOI 10.1016/j.mcp.2011.03.003; Zheng ZM, 2004, J MOL BIOL, V337, P1091, DOI 10.1016/j.jmb.2004.02.023; YEE C, 1985, AM J PATHOL, V119, P361; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Schwartz S, 2013, VIROLOGY, V445, P187, DOI [10.1016/j.virol.2013.04.034, 10.1016/j.viro1.2013.04.034]; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Lace MJ, 2008, J VIROL, V82, P10841, DOI 10.1128/JVI.01481-08; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/nmeth.1470, 10.1038/NMETH.1470]; Graham SV, 2010, FUTURE MICROBIOL, V5, P1493, DOI [10.2217/fmb.10.107, 10.2217/FMB.10.107]; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Grassmann K, 1996, J VIROL, V70, P2339; Braunstein TH, 1999, J GEN VIROL, V80, P3241; DOORBAR J, 1990, VIROLOGY, V178, P254, DOI 10.1016/0042-6822(90)90401-C; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Lace MJ, 2008, J VIROL, V82, P10724, DOI 10.1128/JVI.00921-08; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; Rosenstierne MW, 2003, J GEN VIROL, V84, P2909, DOI 10.1099/vir.0.19332-0; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Takahashi H, 2014, BIOCH BIOPHYS RES CO; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182	31	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	FEB	2015	89	4					2448	2452		10.1128/JVI.03433-14		5	Virology	Virology	AZ9UT	WOS:000348562800047		
J	Tian, TF; Peng, GR; Li, WH; Ding, J; Nakano, M				Tian, Tongfei; Peng, Gangrou; Li, Weihua; Ding, Jie; Nakano, Masami			Experimental and modelling study of the effect of temperature on shear thickening fluids	KOREA-AUSTRALIA RHEOLOGY JOURNAL			English	Article						shear thickening fluid; temperature effect; viscosity; shear rate	CONCENTRATED DISPERSIONS; SUSPENSIONS; BEHAVIOR; PERFORMANCE; DILATANCY; POINT	This paper is a study of the effect that temperature has on a shear thickening fluid made from ethylene glycol and fumed silica, with 20%-26% weight fractions. Three typical temperatures, ranging from 20 degrees C to 60 degrees C, were selected to study the shear rate dependence of viscosity. The temperature tests showed that a high temperature increased the critical shear rate and lowered the shear thickening ratio. A viscosity function was proposed to represent the three characteristic regions in typical shear thickening fluid and to predict viscosity at different temperatures.	[Tian, Tongfei; Peng, Gangrou; Li, Weihua] Univ Wollongong, Sch Mech Mat & Mechatron, Wollongong, NSW 2522, Australia; [Ding, Jie] Def Sci & Technol Org, Land Div, Port Melbourne, Vic 3207, Australia; [Nakano, Masami] Tohoku Univ, Inst Fluid Sci, Intelligent Fluid Control Syst Lab, Aoba Ku, Sendai, Miyagi 9808577, Japan	Li, WH (reprint author), Univ Wollongong, Sch Mech Mat & Mechatron, Wollongong, NSW 2522, Australia.	weihuali@uow.edu.au; Jie.Ding@dsto.defence.gov.au	Li, Weihua/G-3605-2012	Li, Weihua/0000-0002-6190-8421	Defence Science and Technology Organisation, Australia; "General Collaborative Research Project" scheme, Institute of Fluid Science, Tohoku University	This work is partially supported by the DSTO Fellowship program from the Defence Science and Technology Organisation, Australia, and the "General Collaborative Research Project" scheme, Institute of Fluid Science, Tohoku University.	Brown E, 2010, NAT MATER, V9, P220, DOI [10.1038/nmat2627, 10.1038/NMAT2627]; HOFFMAN RL, 1972, T SOC RHEOL, V16, P155; Jiang JL, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/1/015003; Jiang WQ, 2014, J COLLOID INTERF SCI, V413, P8, DOI 10.1016/j.jcis.2013.09.020; Gong XL, 2014, J COMPOS MATER, V48, P641, DOI 10.1177/0021998313476525; Tian Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011401; BOERSMA WH, 1995, J RHEOL, V39, P841, DOI 10.1122/1.550621; Tian Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3501128; Jiang WF, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795303; Galindo-Rosales FJ, 2011, J NON-NEWTON FLUID, V166, P1421, DOI 10.1016/j.jnnfm.2011.08.008; BARNES HA, 1989, J RHEOL, V33, P329; BOERSMA WH, 1990, AICHE J, V36, P321, DOI 10.1002/aic.690360302; BOERSMA WH, 1991, J RHEOL, V35, P1093, DOI 10.1122/1.550167; Choi HJ, 1999, POLYMER, V40, P2869, DOI 10.1016/S0032-3861(98)00498-4; Ding J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02485; Dratler DI, 1997, J FLUID MECH, V353, P1, DOI 10.1017/S0022112097007167; Jiang B, 2003, J APPL POLYM SCI, V90, P2997, DOI 10.1002/app.12950; Jiang W., 2010, RHEOL ACTA, V49, P1; Lauri H. M., 1992, J RHEOL, V36, P743; Lim ST, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/58003; Galindo-Rosales FJ, 2011, J NON-NEWTON FLUID, V166, P321, DOI 10.1016/j.jnnfm.2011.01.001; To KW, 1998, PHYS REV LETT, V80, P536, DOI 10.1103/PhysRevLett.80.536; Wang B, 2011, J FOOD ENG, V107, P415, DOI 10.1016/j.jfoodeng.2011.06.011; Zhang XZ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015051	24	0	0	KOREAN SOC RHEOLOGY	SEOUL	KOREA SCI TECHNOLOGY CENTER, 635-4 YUKSAM-DONG, STE 806, KANGNAM-GOO, SEOUL 135-703, SOUTH KOREA	1226-119X	2093-7660		KOREA-AUST RHEOL J	Korea-Aust. Rheol. J.	FEB	2015	27	1					17	24		10.1007/s13367-015-0003-2		8	Mechanics; Polymer Science	Mechanics; Polymer Science	CC2SS	WOS:000350195500003		
J	Sugawara, J; Kou, S; Kou, S; Yasumura, K; Satake, T; Maegawa, J				Sugawara, Jun; Kou, Seiko; Kou, Sousei; Yasumura, Kazunori; Satake, Toshihiko; Maegawa, Jiro			Influence of the Frequency of Laser Toning for Melasma on Occurrence of Leukoderma and its Early Detection by Ultraviolet Imaging	LASERS IN SURGERY AND MEDICINE			English	Article						melasma; laser toning; leucoderma; Q-switched 1; 064nm Nd:YAG laser; UV imaging	SWITCHED NDYAG LASER; ALUMINUM-GARNET LASER; ND-YAG LASER; ND/YAG LASER; SKIN; PUNCTATA	Background and ObjectiveLaser toning with a Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser has recently been described to be effective for the treatment of melasma. Leukoderma is a refractory complication of laser toning for melasma, but it can be detected early with ultraviolet (UV) imaging. We assessed the relationship between leukoderma and the frequency or total number of laser toning sessions, as well as the effectiveness of UV imaging for detecting leukoderma. Materials and MethodsThe subjects included 147 patients who received at least five laser toning sessions. Subjects were classified into three groups according to the frequency of treatment (weekly for Group A1, fortnightly for Group A2, and monthly for Group B), and the incidence of leukoderma was compared among the three groups. In patients who developed leukoderma, the interval between clinical diagnosis and leukoderma detection on UV images (obtained with a Visia Evolution during every laser toning session) was determined to evaluate the effectiveness of UV imaging for the early detection of leukoderma. ResultsThe overall incidence of leukoderma was 2% (3/147 patients): 3.8% (1/26 patients) in Group A1, 4% (2/49 patients) in Group A2, and 0% (0/72 patients) in Group B. There were no significant differences in the incidence of leukoderma relative to the frequency of laser toning. In two of the three patients who developed leukoderma, it was diagnosed clinically at the 20th and 21st laser toning session, whereas it was diagnosed by UV imaging at the 12th and 13th session. In the remaining 1 patient, leukoderma was detected clinically and by UV imaging at the 7th session. ConclusionsThere was no significant difference in the incidence of leukoderma related to the frequency of laser toning. This study showed that there are two types of leukoderma associated with laser toning. UV imaging was effective for the early detection of type 1 leukoderma, which seems to be related to the cumulative laser energy delivered, but not for detecting type 2 leukoderma, which may be due to direct phototoxicity. Lasers Surg. Med. 47:161-167, 2015. (c) 2015 Wiley Periodicals, Inc.	[Sugawara, Jun; Yasumura, Kazunori; Satake, Toshihiko] Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Naka Ku, Yokohama, Kanagawa 232, Japan; [Kou, Seiko] KO CLIN Antiaging, Yokohama, Kanagawa, Japan; [Kou, Sousei] Ko Ladies Clin Enoshima, Fujisawa, Kanagawa, Japan; [Maegawa, Jiro] Yokohama City Univ, Yokohama, Kanagawa 232, Japan	Sugawara, J (reprint author), Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Naka Ku, Urafunecho 4-57, Yokohama, Kanagawa 232, Japan.	sugajun19800523@hotmail.com					Friedman PM, 2002, DERMATOL SURG, V28, P199, DOI 10.1046/j.1524-4725.2002.02832.x; Chan NPY, 2010, LASER SURG MED, V42, P712, DOI 10.1002/lsm.20956; Shin JU, 2013, DERMATOL SURG, V39, P435, DOI 10.1111/dsu.12060; Cho SB, 2009, CLIN EXP DERMATOL, V34, pE847, DOI 10.1111/j.1365-2230.2009.03599.x; Choi M, 2010, J DERMATOL TREAT, V21, P224, DOI 10.3109/09546630903401462; Bhawan J, 1998, INT J DERMATOL, V37, P286, DOI 10.1046/j.1365-4362.1998.00433.x; Wattanakrai P, 2010, DERMATOL SURG, V36, P76, DOI 10.1111/j.1524-4725.2009.01383.x; Mun JY, 2011, J ELECTRON MICROSC, V60, P11, DOI 10.1093/jmicro/dfq068; Kim MJ, 2009, J EUR ACAD DERMATOL, V23, P960, DOI 10.1111/j.1468-3083.2008.03070.x; Wu SF, 2012, AESTHET PLAST SURG, V36, P964, DOI 10.1007/s00266-012-9899-9; Niepomniszcze H, 2001, J ENDOCRINOL INVEST, V24, P628; Jeong SY, 2010, DERMATOL SURG, V36, P909, DOI 10.1111/j.1524-4725.2010.01523.x; Bhatnagar A, 2007, J EUR ACAD DERMATOL, V21, P1276, DOI 10.1111/j.1468-3083.2007.02170.x; FALABELLA R, 1988, J AM ACAD DERMATOL, V18, P485, DOI 10.1016/S0190-9622(88)70071-7; Goldberg D J, 2000, J Cutan Laser Ther, V2, P157, DOI 10.1080/14628830050516425; Goldberg DJ, 1997, DERMATOL SURG, V23, P903; Karabudak O, 2008, J DERMATOL TREAT, V19, P300, DOI 10.1080/09546630801961075; Park JH, 2004, INT J DERMATOL, V43, P138, DOI 10.1111/j.1365-4632.2004.01842.x; Polnikorn N, 2008, J COSMET LASER THER, V10, P167, DOI 10.1080/14764170802179687; Prignano F, 2007, DERMATOL CLIN, V25, P337, DOI 10.1016/j.det.2007.04.006; Rigopoulos D, 2007, J Cosmet Dermatol, V6, P195, DOI 10.1111/j.1473-2165.2007.00321.x; Sim JH, 2014, J DERMATOL TREAT, V25, P212, DOI 10.3109/09546634.2012.735639; Sim JH, 2002, INT J DERMATOL, V41, P922; Taylor Anne, 2008, J Cosmet Dermatol, V7, P164, DOI 10.1111/j.1473-2165.2008.00384.x; Yamashita T, 2006, J INVEST DERMATOL, V126, P2281, DOI 10.1038/sj.jid.5700414	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	FEB	2015	47	2			SI		161	167		10.1002/lsm.22325		7	Surgery	Surgery	CC7KQ	WOS:000350546700010		
J	Hattori, Y; Satouchi, M; Shimada, T; Urata, Y; Yoneda, T; Mori, M; Nishimura, T; Sunadome, H; Kumagai, T; Imamura, F; Fujita, S; Kaji, R; Hata, A; Tachihara, M; Morita, S; Negoro, S				Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko; Yoneda, Tsutomu; Mori, Masahide; Nishimura, Takashi; Sunadome, Hironobu; Kumagai, Toru; Imamura, Fumio; Fujita, Shiro; Kaji, Reiko; Hata, Akito; Tachihara, Motoko; Morita, Satoshi; Negoro, Shunichi			A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109)	LUNG CANCER			English	Article						Bevacizumab; Non-small-cell lung cancer; Epidermal growth factor receptor mutation; Second-line; Carboplatin; Paclitaxel	GENE-MUTATIONS; OPEN-LABEL; GEFITINIB; CHEMOTHERAPY; MULTICENTER; ERLOTINIB; TRIAL	Objectives: We have conducted a phase 2 study to evaluate the efficacy and safety of carboplatin, paclitaxel, and bevacizumab in patients with non-squamous non-small-cell lung cancer (NSCLC) who are epidermal growth factor receptor (EGFR) mutation positive and for whom EGFR-tyrosine kinase inhibitor (TKI) 1st-line has failed. Materials and methods: Patients with stage IIIB or IV non-squamous NSCLC harbored activating EGFR mutations that has failed 1st-line EGFR-TKI and an Eastern Cooperative Oncology Group performance status of 0 or I were included in this study. Patients received carboplatin at an area under the concentration-time curve 5 or 6, paclitaxel 200 mg/m(2), and bevacizumab 15 mg/kg on D1. The combination therapy was repeated every 21 days for up to three to six cycles. Bevacizumab was continued until disease progression or unacceptable toxicity for patients without disease progression (PD). The primary endpoint was objective response rate (ORR). Results: Thirty-one patients were enrolled between March 2010 and January 2013, with 30 patients being eligible. ORR was 37% (90% CI; 24-52%) and disease control rate, 83% (95% CI; 66-92%). The median progression free survival (PFS) was 6.6 months (95% CI; 4.8-12.0 months) and median-overall survival, 18.2 months (95% CI; 12.0-23.4 months). The most common grade >= 3 hematologic toxicity was neutropenia (93%), and non-hematologic toxicity, febrile neutropenia (20%). There were no clinically relevant grade >= 3 bleeding events and no treatment-related deaths. Conclusion: The combination therapy of carboplatin, paclitaxel and bevacizumab did not achieve the initial treatment goal. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo 6738558, Japan; [Yoneda, Tsutomu; Mori, Masahide] Toneyama Natl Hosp, Natl Hosp Org, Dept Thorac Oncol, Toyonaka, Osaka, Japan; [Nishimura, Takashi; Sunadome, Hironobu] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Kumagai, Toru; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; [Fujita, Shiro; Kaji, Reiko; Hata, Akito] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan; [Tachihara, Motoko] Kobe Univ, Grad Sch Med, Dept Resp Med, Kobe, Hyogo 657, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Negoro, Shunichi] Hyogo Canc Ctr, Dept Med Oncol, Akashi, Hyogo 6738558, Japan	Satouchi, M (reprint author), Hyogo Canc Ctr, Dept Thorac Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	satouchi@hp.pref.hyogo.jp					Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Dong L, 2014, J INT MED RES, V42, P191, DOI 10.1177/0300060513505808; Mitsudomi T, 2012, J CLIN ONCOL, V30; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Yoshioka H, 2014, P AM SOC CLIN ONCO S, V32	15	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	FEB	2015	87	2					136	140		10.1016/j.lungcan.2014.12.007		5	Oncology; Respiratory System	Oncology; Respiratory System	CC7DS	WOS:000350528500008		
J	Nogami, N; Takigawa, N; Hotta, K; Segawa, Y; Kato, Y; Kozuki, T; Oze, I; Kishino, D; Aoe, K; Ueoka, H; Kuyama, S; Harita, S; Okada, T; Hosokawa, S; Inoue, K; Gemba, K; Shibayama, T; Tabata, M; Takemoto, M; Kanazawa, S; Tanimoto, M; Kiura, K				Nogami, Naoyuki; Takigawa, Nagio; Hotta, Katsuyuki; Segawa, Yoshihiko; Kato, Yuka; Kozuki, Toshiyuki; Oze, Isao; Kishino, Daizo; Aoe, Keisuke; Ueoka, Hiroshi; Kuyama, Shoichi; Harita, Shingo; Okada, Toshiaki; Hosokawa, Shinobu; Inoue, Koji; Gemba, Kenichi; Shibayama, Takuo; Tabata, Masahiro; Takemoto, Mitsuhiro; Kanazawa, Susumu; Tanimoto, Mitsune; Kiura, Katsuyuki			A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501	LUNG CANCER			English	Article						Cisplatin; S-1; Radiation; Chemotherapy; Stage III; Phase II trial	1ST-LINE CHEMOTHERAPY; ELDERLY-PATIENTS; COMBINATION; RADIATION; DOCETAXEL; GENE; MUTATIONS; GEFITINIB; ONCOLOGY	Background: Although cisplatin-based chemotherapy combined with thoracic irradiation (TRT) is a standard treatment for unresectable, locally advanced non-small cell lung cancer (NSCLC), this treatment outcome has remained unsatisfactory. We had previously conducted a phase I trial of cisplatin plus S-1, an oral 5-fluorouracil derivative, and TRT, which were safe and effective. Methods: In this phase II trial, 48 patients with stage III NSCLC received cisplatin (40 mg/m(2) on days 1, 8, 29 and 36) and S-1 (80 mg/m(2) on days 1-14 and 29-42) and TRT (60 Gy). The primary endpoint was the response rate. Results: A partial response was observed in 37 patients (77%; 95% confidence interval: 63-88%). At a median follow up of 54 months, the median progression-free survival and median survival time were 9.3 and 31.3 months, respectively. No difference in efficacy was observed when the patients were stratified by histology. Toxicities were generally mild except for grade 3 or worse febrile neutropenia and pneumonitis of 8% and 4%, respectively. No patient developed severe esophagitis. At the time of this analysis, 35 (73%) of the 48 patients recurred; 15 (31%) showed distant metastasis, 17 (35%) had loco-regional disease, and 2 (4%) showed both loco-regional disease and distant metastasis. Conclusions: This chemoradiotherapy regimen yielded a relatively favorable efficacy with mild toxicities in patients with locally advanced NSCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nogami, Naoyuki; Segawa, Yoshihiko; Kato, Yuka; Kozuki, Toshiyuki; Oze, Isao] NHO Shikoku Canc Ctr, Dept Thorac Oncol, Matsuyama, Ehime, Japan; [Takigawa, Nagio; Hotta, Katsuyuki; Kato, Yuka; Oze, Isao; Tabata, Masahiro; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Thorac Oncol, Okayama 7008558, Japan; [Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan; [Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama 7008558, Japan; [Segawa, Yoshihiko] Saitama Med Univ, Ctr Comprehens Canc, Int Med Ctr, Dept Med Oncol, Hidaka, Japan; [Kishino, Daizo; Aoe, Keisuke; Ueoka, Hiroshi] NHO Yamaguchi Ube Med Ctr, Dept Med Oncol, Ube, Yamaguchi, Japan; [Kuyama, Shoichi; Harita, Shingo; Okada, Toshiaki] Chugoku Cent Hosp, Dept Resp Med, Fukuyama, Hiroshima, Japan; [Hosokawa, Shinobu] Okayama Red Cross Hosp, Dept Resp Med, Okayama, Japan; [Inoue, Koji] Ehime Prefectural Hosp, Dept Resp Med, Matsuyama, Ehime, Japan; [Gemba, Kenichi] Okayama Rosai Hosp, Dept Resp Med, Okayama, Japan; [Shibayama, Takuo] NHO Minami Okayama Med Ctr, Dept Resp Med, Okayama, Japan; [Takemoto, Mitsuhiro; Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Okayama 7008558, Japan; [Kuyama, Shoichi] NHO Iwakuni Med Ctr, Dept Resp Med, Iwakuni, Japan; [Shibayama, Takuo] NHO Okayama Med Ctr, Dept Resp Med, Okayama, Japan	Hotta, K (reprint author), Okayama Univ Hosp, Dept Hematol & Oncol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	khotta@md.okayama-u.ac.jp					Hanna N, 2008, J CLIN ONCOL, V26, P5755, DOI 10.1200/JCO.2008.17.7840; Fukushima M, 2005, EJC SUPPL, V3, P343; Kaira K, 2013, LUNG CANCER, V82, P449, DOI 10.1016/j.lungcan.2013.09.004; Segawa Y, 2010, J CLIN ONCOL, V28, P3299, DOI 10.1200/JCO.2009.24.7577; Yoshioka H, 2013, ANN ONCOL, V24, P1326, DOI 10.1093/annonc/mds629; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Aoe K, 2014, EUR J CANCER, V50, P2783, DOI 10.1016/j.ejca.2014.07.024; Chikamori K, 2009, LUNG CANCER, V65, P74, DOI 10.1016/j.lungcan.2008.10.019; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; Harada K, 2004, ORAL ONCOL, V40, P713, DOI 10.1016/j.oraloncology.2004.01.013; Hisamoto A, 2012, J CLIN ONCOL S, V30; Hotta K, 2007, J THORAC ONCOL, V2, P632, DOI 10.1097/JTO.0b013e318074bc0d; Hotta K, 2007, ONCOL REP, V17, P313; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Kato Y, 2014, CANCER CHEMOTH PHARM, V73, P943, DOI 10.1007/s00280-014-2425-9; Kuyama S, 2008, J THORAC ONCOL, V3, P477, DOI 10.1097/JTO.0b013e31816e2ea3; Ochi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042798; Ohyanagi F, 2009, BRIT J CANCER, V101, P225, DOI 10.1038/sj.bjc.6605152; Katakami N, 2012, J CLIN ONCOL, V30; Segawa Y, 2010, J THORAC ONCOL, V5, P1430, DOI 10.1097/JTO.0b013e3181e3248e; Takigawa N, 2011, LUNG CANCER, V71, P60, DOI 10.1016/j.lungcan.2010.04.012; UMIN, 2014, CLIN TRIAL REG	22	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	FEB	2015	87	2					141	147		10.1016/j.lungcan.2014.11.001		7	Oncology; Respiratory System	Oncology; Respiratory System	CC7DS	WOS:000350528500009		
J	Teramoto, N; Yotsu-Yamashita, M				Teramoto, Noriyoshi; Yotsu-Yamashita, Mari			Selective Blocking Effects of 4,9-Anhydrotetrodotoxin, Purified from a Crude Mixture of Tetrodotoxin Analogues, on Na(V)1.6 Channels and Its Chemical Aspects	MARINE DRUGS			English	Review							GATED SODIUM-CHANNELS; END-PLATE-DISEASE; IONIZATION MASS-SPECTROMETRY; PUFFER FISH; LIQUID-CHROMATOGRAPHY; NERVOUS-SYSTEM; ALPHA-SUBUNITS; FUGU-PARDALIS; NA+ CHANNELS; VAS-DEFERENS	Tetrodotoxin (TTX) is a potent neurotoxin found in a number of marine creatures including the pufferfish, where it is synthesized by bacteria and accumulated through the food chain. It is a potent and selective blocker of some types of voltage-gated Na+ channel (Na-V channel). 4,9-Anhydrotetrodotoxin (4,9-anhydroTTX) was purified from a crude mixture of TTX analogues (such as TTX, 4-epiTTX, 6-epiTTX, 11-oxoTTX and 11-deoxyTTX) by the use of liquid chromatography-fluorescence detection (LC-FLD) techniques. Recently, it has been reported that 4,9-anhydroTTX selectively blocks the activity of Na(V)1.6 channels with a blocking efficacy 40-160 times higher than that for other TTX-sensitive Na(V)1.x channel isoforms. However, little attention has been paid to the molecular properties of the alpha-subunit in Na(V)1.6 channels and the characteristics of binding of 4,9-anhydroTTX. From a functional point of view, it is important to determine the relative expression of Na(V)1.6 channels in a wide variety of tissues. The aim of this review is to discuss briefly current knowledge about the pharmacology of 4,9-anhydroTTX, and provide an analysis of the molecular structure of native Na(V)1.6 channels. In addition, chemical aspects of 4,9-anhydroTTX are briefly covered.	[Teramoto, Noriyoshi] Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan; [Teramoto, Noriyoshi] Tohoku Univ, Grad Sch Biomed Engn, Biomed Engn Lab, Sendai, Miyagi 9808575, Japan; [Yotsu-Yamashita, Mari] Tohoku Univ, Grad Sch Agr Sci, Lab Bioorgan Chem Nat Prod, Sendai, Miyagi 9818555, Japan	Teramoto, N (reprint author), Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan.	noritera@cc.saga-u.ac.jp; myama@biochem.tohoku.ac.jp			KAKENHI from the Japanese Society for the Promotion of Science [26282148, 26292057]; Funding Program for Next Generation World-Leading Researchers from the Japanese Society for the Promotion of Science [LS012, LS096]	This research was supported by a KAKENHI Grant-in-Aid for Scientific Research (B) from the Japanese Society for the Promotion of Science (Noriyoshi Teramoto, Grant Number 26282148) and a KAKENHI Grant-in-Aid for Scientific Research (B) from the Japanese Society for the Promotion of Science (Mari Yotsu-Yamashita, Grant Number 26292057). This research was also supported by a Funding Program for Next Generation World-Leading Researchers (Mari Yotsu-Yamashita, Grant Number LS012; Noriyoshi Teramoto, Grant Number LS096) from the Japanese Society for the Promotion of Science.	ANGAUTPETIT D, 1982, PROC R SOC SER B-BIO, V215, P117, DOI 10.1098/rspb.1982.0031; GOTO T, 1965, TETRAHEDRON, V21, P2059, DOI 10.1016/S0040-4020(01)98344-9; NAKAMURA M, 1985, TOXICON, V23, P271, DOI 10.1016/0041-0101(85)90149-7; Narahashi T, 2008, P JPN ACAD B-PHYS, V84, P147, DOI 10.2183/pjab/84.147; Raman IM, 1997, J NEUROSCI, V17, P4517; Yotsu-Yamashita M, 1999, J PHARMACOL EXP THER, V289, P1688; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Shoji Y, 2001, ANAL BIOCHEM, V290, P10, DOI 10.1006/abio.2000.4953; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Watanabe E, 2000, J NEUROSCI, V20, P7743; YASUMOTO T, 1988, J AM CHEM SOC, V110, P2344, DOI 10.1021/ja00215a078; Yotsu-Yamashita M, 2013, MAR DRUGS, V11, P2799, DOI 10.3390/md11082799; Chahine M, 2005, TRENDS PHARMACOL SCI, V26, P496, DOI 10.1016/j.tips.2005.08.002; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; Jang J, 2006, TOXICON, V48, P980, DOI 10.1016/j.toxicon.2006.07.034; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Brackenbury WJ, 2012, CHANNELS, V6, P352, DOI 10.4161/chan.21910; YASUMOTO T, 1985, AGR BIOL CHEM TOKYO, V49, P3077; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Isom LL, 2001, NEUROSCIENTIST, V7, P42; Yotsu-Yamashita M, 2011, FORENSIC TOXICOL, V29, P61, DOI 10.1007/s11419-010-0106-x; Hiyama TY, 2013, CELL METAB, V17, P507, DOI 10.1016/j.cmet.2013.02.018; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; TSUDA K, 1964, CHEM PHARM BULL, V12, P1357; Yotsu-Yamashita M, 2001, J TOXICOL-TOXIN REV, V20, P51, DOI 10.1081/TXR-100102536; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Nakagawa T, 2006, ANAL BIOCHEM, V352, P142, DOI 10.1016/j.ab.2006.02.010; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; CASADEI JM, 1986, J BIOL CHEM, V261, P4318; DICK DJ, 1985, NEUROPATH APPL NEURO, V11, P141; DUCHEN LW, 1971, J PHYSIOL-LONDON, V212, P535; Fukuoka T, 2010, NEUROSCIENCE, V169, P994, DOI 10.1016/j.neuroscience.2010.05.058; Hille B., 2001, ION CHANNELS EXCITAB, P61; KAO CY, 1985, TOXICON, V23, P725, DOI 10.1016/0041-0101(85)90002-9; Kohrman DC, 1996, J BIOL CHEM, V271, P17576; Kono M, 2008, TOXICON, V52, P714, DOI 10.1016/j.toxicon.2008.08.002; Kudo Y, 2014, ANGEW CHEM INT EDIT, V53, P14546, DOI 10.1002/anie.201408913; Nishikawa T, 2013, CHEM REC, V13, P286, DOI 10.1002/tcr.201200025; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Rosker C, 2007, AM J PHYSIOL-CELL PH, V293, pC783, DOI 10.1152/ajpcell.00070.2007; SCHALLER KL, 1995, J NEUROSCI, V15, P3231; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; Sidman R L, 1979, Ann N Y Acad Sci, V317, P497, DOI 10.1111/j.1749-6632.1979.tb37382.x; Tahara Y., 1909, J PHARM SOC JPN, V29, P587; Teramoto N, 2012, PFLUG ARCH EUR J PHY, V464, P493, DOI 10.1007/s00424-012-1153-4; Tzoumaka E, 2000, J NEUROSCI RES, V60, P37, DOI 10.1002/(SICI)1097-4547(20000401)60:1<37::AID-JNR4>3.0.CO;2-W; Woodward R.B., 1964, PURE APPL CHEM, V9, P49, DOI 10.1351/pac196409010049; Yotsu-Yamashita M, 2005, CHEM RES TOXICOL, V18, P865, DOI 10.1021/tx050015g; Zhu HL, 2010, J CELL PHYSIOL, V223, P234, DOI 10.1002/jcp.22032; Zhu HL, 2008, BIOPHYS J, V94, P3340, DOI 10.1529/biophysj.107.117192	55	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	FEB	2015	13	2					984	995		10.3390/md13020984		12	Chemistry, Medicinal	Pharmacology & Pharmacy	CC3AW	WOS:000350217500018		
J	Mekaru, H				Mekaru, Harutaka			Performance of SU-8 Membrane Suitable for Deep X-Ray Grayscale Lithography	MICROMACHINES			English	Article							HIGH-ASPECT-RATIO; THERMAL-EXPANSION COEFFICIENT; THIN-FILMS; FABRICATION; MASK; PHOTORESIST; SILICON; TECHNOLOGY; BEAM; UV	In combination with tapered-trench-etching of Si and SU-8 photoresist, a grayscale mask for deep X-ray lithography was fabricated and passed a 10-times-exposure test. The performance of the X-ray grayscale mask was evaluated using the TERAS synchrotron radiation facility at the National Institute of Advanced Industrial Science and Technology (AIST). Although the SU-8 before photo-curing has been evaluated as a negative-tone photoresist for ultraviolet (UV) and X-ray lithographies, the characteristic of the SU-8 after photo-curing has not been investigated. A polymethyl methacrylate (PMMA) sheet was irradiated by a synchrotron radiation through an X-ray mask, and relationships between the dose energy and exposure depth, and between the dose energy and dimensional transition, were investigated. Using such a technique, the shape of a 26-mu m-high Si absorber was transformed into the shape of a PMMA microneedle with a height of 76 mu m, and done with a high contrast. Although during the fabrication process of the X-ray mask a 100-mu m-pattern-pitch (by design) was enlarged to 120 mu m. However, with an increase in an integrated dose energy this number decreased to 99 mu m. These results show that the X-ray grayscale mask has many practical applications. In this paper, the author reports on the evaluation results of SU-8 when used as a membrane material for an X-ray mask.	Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn UMEMSME, Tsukuba, Ibaraki 3058564, Japan	Mekaru, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn UMEMSME, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	h-mekaru@aist.go.jp					Lorenz H, 1998, MICROELECTRON ENG, V42, P371; [Anonymous], POL FILM; Tien CL, 2012, APPL OPTICS, V51, P7229, DOI 10.1364/AO.51.007229; Kudryashov V, 2003, MICROELECTRON ENG, V67-8, P306, DOI 10.1016/S0167-9317(03)00083-2; OKADA Y, 1984, J APPL PHYS, V56, P314, DOI 10.1063/1.333965; Bogdanov AL, 2000, MICROELECTRON ENG, V53, P493, DOI 10.1016/S0167-9317(00)00363-4; Malek CK, 2004, MICROELECTRON J, V35, P131, DOI 10.1016/j.mejo.2003.10.003; Tada H, 2000, J APPL PHYS, V87, P4189, DOI 10.1063/1.373050; Awazu K, 2005, J VAC SCI TECHNOL B, V23, P934, DOI 10.1116/1.1924421; Bassous E., 1975, P INT ELECT DEVICES, V21, P17; Becker E. W., 1986, Microelectronic Engineering, V4, DOI 10.1016/0167-9317(86)90004-3; Desta Y., 2009, ADV MICRO NANOSYSTEM, V7, P11; Desta YM, 2000, P SOC PHOTO-OPT INS, V4175, P122, DOI 10.1117/12.395599; DuPont<SUP>&TRADE;</SUP>Kapton<SUP>&REG;</SUP>HN, POL FILM; FLANDERS DC, 1978, J VAC SCI TECHNOL, V15, P995, DOI 10.1116/1.569694; Goldberg Y., 2001, SCITECH BOOK NEWS, V25, P93; del Campo A, 2007, J MICROMECH MICROENG, V17, pR81, DOI 10.1088/0960-1317/17/6/R01; HOFER D, 1979, J VAC SCI TECHNOL, V16, P1968, DOI 10.1116/1.570368; Iba Y, 2000, JPN J APPL PHYS 1, V39, P5329, DOI 10.1143/JJAP.39.5329; Kinoshita H., 2007, EUV LITHOGRAPHY, P1; Lee S, 2004, MICROSYST TECHNOL, V10, P522, DOI 10.1007/s00542-004-0385-4; LUTHJE H, 1989, JPN J APPL PHYS 1, V28, P2342, DOI 10.1143/JJAP.28.2342; Mekaru H, 2008, MICROSYST TECHNOL, V14, P1335, DOI 10.1007/s00542-007-0513-z; Mekaru H, 2009, J MICRO-NANOLITH MEM, V8, DOI 10.1117/1.3158617; Mekaru Harutaka, 2008, Journal of Micro/Nanolithography, MEMS, and MOEMS, V7, DOI 10.1117/1.2894817; Mekaru H, 2007, J VAC SCI TECHNOL B, V25, P2196, DOI 10.1116/1.2794314; Salker V., 2009, LIGA ITS APPL, P1; SCHMIDT CJ, 1975, J APPL PHYS, V46, P4080, DOI 10.1063/1.322117; Spiller E., 1979, SOLID STATE TECHNOL, V19, P62; Toyokawa H., 2004, P 1 ANN M PART ACC S, P203; Utsumi Y, 2005, JPN J APPL PHYS 1, V44, P5500, DOI 10.1143/JJAP.44.5500; Watt F, 1999, NUCL INSTRUM METH B, V158, P165, DOI 10.1016/S0168-583X(99)00513-3; WATTS RK, 1979, SOLID STATE TECHNOL, V22, P68; Wu B, 2007, J VAC SCI TECHNOL B, V25, P1743, DOI DOI 10.1116/1.2794048; Yamada M., 1989, Microelectronic Engineering, V9, DOI 10.1016/0167-9317(89)90031-2	35	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-666X			MICROMACHINES-BASEL	Micromachines	FEB	2015	6	2					252	265		10.3390/mi6020252		14	Nanoscience & Nanotechnology; Instruments & Instrumentation	Science & Technology - Other Topics; Instruments & Instrumentation	CD0EK	WOS:000350743100008		
J	Simoncini, D; Nakata, H; Ogata, K; Nakamura, S; Zhang, KYJ				Simoncini, David; Nakata, Hiroya; Ogata, Koji; Nakamura, Shinichiro; Zhang, Kam Y. J.			Quality Assessment of Predicted Protein Models Using Energies Calculated by the Fragment Molecular Orbital Method	MOLECULAR INFORMATICS			English	Article						Structure prediction; Quality assessment; Model selection; Fragment molecular orbital; Pair interaction energy	SCORING FUNCTION; METHOD FMO; DENSITY; DECOYS; SIMULATION; DISPERSION; CHEMISTRY; ROSETTA; SYSTEM; MD	Protein structure prediction directly from sequences is a very challenging problem in computational biology. One of the most successful approaches employs stochastic conformational sampling to search an empirically derived energy function landscape for the global energy minimum state. Due to the errors in the empirically derived energy function, the lowest energy conformation may not be the best model. We have evaluated the use of energy calculated by the fragment molecular orbital method (FMO energy) to assess the quality of predicted models and its ability to identify the best model among an ensemble of predicted models. The fragment molecular orbital method implemented in GAMESS was used to calculate the FMO energy of predicted models. When tested on eight protein targets, we found that the model ranking based on FMO energies is better than that based on empirically derived energies when there is sufficient diversity among these models. This model diversity can be estimated prior to the FMO energy calculations. Our result demonstrates that the FMO energy calculated by the fragment molecular orbital method is a practical and promising measure for the assessment of protein model quality and the selection of the best protein model among many generated.	[Simoncini, David; Zhang, Kam Y. J.] RIKEN, Struct Bioinformat Team, Div Struct & Synthet Biol, Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Nakata, Hiroya; Ogata, Koji; Nakamura, Shinichiro] RIKEN Res Cluster Innovat, Wako, Saitama 3510198, Japan; [Nakata, Hiroya] Tokyo Inst Technol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakata, Hiroya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	Nakamura, S (reprint author), RIKEN Res Cluster Innovat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	snakamura@riken.jp; kamzhang@riken.jp	Zhang, Kam/B-3552-2012	Zhang, Kam/0000-0002-9282-8045	JSPS by KAKENHI [262235]	We thank RIKEN Integrated Cluster of Clusters (RICC) at RIKEN for the supercomputing resources used for this study. HN thanks JSPS for supporting this work by KAKENHI Grant Number 262235.	Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Scuseria GE, 1999, J PHYS CHEM A, V103, P4782, DOI 10.1021/jp990629s; BOWIE JU, 1994, P NATL ACAD SCI USA, V91, P4436, DOI 10.1073/pnas.91.10.4436; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Avramov PV, 2012, J PHYS CHEM LETT, V3, P2003, DOI 10.1021/jz300625t; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; Nakata H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4800990; Green MC, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790616; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Komeiji Y, 2003, CHEM PHYS LETT, V372, P342, DOI 10.1016/S0009-2614(03)00430-5; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Gao Q, 2014, CHEM PHYS LETT, V593, P165, DOI 10.1016/j.cplett.2014.01.001; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Goedecker S, 1999, REV MOD PHYS, V71, P1085, DOI 10.1103/RevModPhys.71.1085; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Li XS, 2003, J CHEM PHYS, V119, P7651, DOI 10.1063/1.1607961; Fedorov DG, 2006, J COMPUT CHEM, V27, P976, DOI 10.1002/jcc.20406; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; OTTO P, 1975, CHEM PHYS, V8, P192, DOI 10.1016/0301-0104(75)80107-8; Alexeev Y, 2012, CURR TOP MED CHEM, V12, P2013; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Berenger F, 2012, J COMPUT CHEM, V33, P471, DOI 10.1002/jcc.21988; Berenger F, 2011, BIOINFORMATICS, V27, P939, DOI 10.1093/bioinformatics/btr072; Carlson P.J., 2011, J PHYS CHEM B, V116, P503; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Fedorov DG, 2007, J PHYS CHEM A, V111, P2722, DOI 10.1021/jp0671042; Gao JL, 1997, J PHYS CHEM B, V101, P657, DOI 10.1021/jp962833a; Gordon M, 2011, CHEM REV, V112, P632, DOI DOI 10.1021/CR200093J; Grimme S., 2010, J CHEM PHYS, V132; He X, 2009, J PHYS CHEM B, V113, P5290, DOI 10.1021/jp8106952; Komeiji Y, 2009, J COMPUT CHEM, V30, P40, DOI 10.1002/jcc.21025; Li HZ, 2005, J COMPUT CHEM, V26, P1189, DOI 10.1002/jcc.20251; Li JL, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-2; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Nakata H, 2014, THEOR CHEM ACC, V133, DOI 10.1007/s00214-014-1477-6; Reimers JR, 2011, COMPUTATIONAL METHODS FOR LARGE SYSTEMS: ELECTRONIC STRUCTURE APPROACHES FOR BIOTECHNOLOGY AND NANOTECHNOLOGY, pXVII; Sawada T, 2010, J AM CHEM SOC, V132, P16862, DOI 10.1021/ja105051e; Simoncini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038799; Simoncini D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068954; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Skwark MJ, 2013, BIOINFORMATICS, V29, P1817, DOI 10.1093/bioinformatics/btt272; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044480; Watanabe T, 2007, J PHYS CHEM B, V111, P9621, DOI 10.1021/jp071710v; YANG WT, 1991, PHYS REV LETT, V66, P1438, DOI 10.1103/PhysRevLett.66.1438; Zales R. s ny, 2011, LINEAR SCALING TECHN	60	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	FEB	2015	34	2-3					97	104		10.1002/minf.201400108		8	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	CC6LB	WOS:000350475300003		
J	Yoshino, A; Yamauchi, C				Yoshino, Akira; Yamauchi, Chisato			Box/peanut and bar structures in edge-on and face-on nearby galaxies in the Sloan Digital Sky Survey - I. Catalogue	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						Galaxies: classification; fundamental parameters; statistics	PEANUT-SHAPED BULGES; SPIRAL GALAXIES; BOXY BULGES; STELLAR KINEMATICS; DISC GALAXIES; EVOLUTION; DECOMPOSITIONS; Z-SIMILAR-TO-0; PHOTOMETRY; PROFILES	We investigate box/peanut and bar structures in image data of edge-on and face-on nearby galaxies taken from the Sloan Digital Sky Survey (SDSS) to present catalogues containing the surface brightness parameters and the morphology classification. About 1700 edge-on galaxies and 2600 face-on galaxies are selected from SDSS DR7 in the g, r and i-bands. The images of each galaxy are fitted with the model of two-dimensional surface brightness of the Sersic bulge and exponential disk. After removing some irregular data, the box/peanut, bar and other structures are easily distinguished by eye using residual (observed minus model) images. We find 292 box/peanut structures in the 1329 edge-on samples and 630 bar structures in 1890 face-on samples in the i-band, after removing some irregular data. The fraction of box/peanut galaxies is about 22 per cent against the edge-on samples, and that of bar galaxies is about 33 per cent (about 50 per cent if 629 elliptical galaxies are removed) against the face-on samples. Furthermore the strengths of the box/peanuts and bars are evaluated as strong, standard or weak. We find that the strength increases slightly with increasing B/T (bulge-to-total flux ratio), and that the fraction of box/peanuts is generally about a half of that of bars, irrespective of the strength and B/T. Our result supports the idea that a box/peanut is a bar seen edge-on.	[Yoshino, Akira; Yamauchi, Chisato] JAXA Japan Aerosp Explanat Agcy, ISAS, Sagamihara, Kanagawa 2525210, Japan; [Yamauchi, Chisato] Kimino Cho Misato Astron Observ, Wakayama 6401366, Japan; [Yamauchi, Chisato] Wakayama Univ, Inst Educ Space, Wakayama 6408510, Japan	Yoshino, A (reprint author), JAXA Japan Aerosp Explanat Agcy, ISAS, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	yoshino.akira@jaxa.jp; cyamauch@ir.isas.jaxa.jp					COMBES F, 1981, ASTRON ASTROPHYS, V96, P164; Marinova I, 2007, ASTROPHYS J, V659, P1176, DOI 10.1086/512355; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Barazza FD, 2008, ASTROPHYS J, V675, P1194, DOI 10.1086/526510; Melvin T, 2014, MON NOT R ASTRON SOC, V438, P2882, DOI 10.1093/mnras/stt2397; Lutticke R, 2000, ASTRON ASTROPHYS SUP, V145, P405, DOI 10.1051/aas:2000354; WHITMORE BC, 1988, ASTROPHYS J, V324, P741, DOI 10.1086/165933; Bureau M, 1999, ASTRON J, V118, P126, DOI 10.1086/300922; Lackner CN, 2012, MON NOT R ASTRON SOC, V421, P2277, DOI 10.1111/j.1365-2966.2012.20450.x; Paturel G, 2003, ASTRON ASTROPHYS, V412, P45, DOI 10.1051/0004-6361:20031411; Eskridge PB, 2000, ASTRON J, V119, P536, DOI 10.1086/301203; Sellwood JA, 2014, REV MOD PHYS, V86, P1, DOI 10.1103/RevModPhys.86.1; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Athanassoula E, 2002, MON NOT R ASTRON SOC, V330, P35, DOI 10.1046/j.1365-8711.2002.05028.x; BURBIDGE EM, 1959, ASTROPHYS J, V130, P20, DOI 10.1086/146691; Buta R. J., 2007, DE VAUCOULEURS ATLAS; BYUN YI, 1995, ASTROPHYS J, V448, P563, DOI 10.1086/175986; Chung A, 2004, ASTRON J, V127, P3192, DOI 10.1086/420988; de Souza R. E., 2004, APJS, V153, P427; de Vaucouleurs G., 1976, 2 REFERENCE CATALOGU; de Vaucouleurs G., 1991, 3 REFERENCE CATALOGU; DESOUZA RE, 1987, ASTRON ASTROPHYS SUP, V70, P465; Dettmar R.-J., 1988, BAAS, V20, P1085; FREEMAN KC, 1970, ASTROPHYS J, V160, P811, DOI 10.1086/150474; JARVIS BJ, 1986, ASTRON J, V91, P65, DOI 10.1086/113980; Joye W. A., 2003, ASPC, V12, P489; Lutticke R, 2004, ASTRON ASTROPHYS, V417, P527, DOI 10.1051/0004-6361:20031782; Lutticke R, 2000, ASTRON ASTROPHYS, V362, P435; Patsis PA, 2002, MON NOT R ASTRON SOC, V335, P1049, DOI 10.1046/j.1365-8711.2002.05686.x; Patsis PA, 2002, MON NOT R ASTRON SOC, V337, P578, DOI 10.1046/j.1365-8711.2002.05943.x; Pohlen M, 2007, MON NOT R ASTRON SOC, V378, P594, DOI 10.1111/j.1365-2966.2007.11790.x; Press WH, 1988, NUMERICAL RECIPES C; Sersic J. L., 1986, ATLAS GALAXIEAS AUST; SHAW MA, 1987, MON NOT R ASTRON SOC, V229, P691; Simard L, 2011, ASTROPHYS J SUPPL S, V196, DOI 10.1088/0067-0049/196/1/11; Williams MJ, 2011, MON NOT R ASTRON SOC, V414, P2163, DOI 10.1111/j.1365-2966.2011.18535.x; Yoshino A, 2008, PUBL ASTRON SOC JPN, V60, P493	38	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	FEB	2015	446	4					3749	3767		10.1093/mnras/stu2249		19	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3TH	WOS:000350272400040		
J	Brasser, R; Schwamb, ME				Brasser, R.; Schwamb, M. E.			Re-assessing the formation of the inner Oort cloud in an embedded star cluster - II. Probing the inner edge	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						Kuiper belt: general; minor planets, asteroids: general; Oort Cloud	TRANS-NEPTUNIAN OBJECTS; EXTENDED SCATTERED DISK; OUTER SOLAR-SYSTEM; KUIPER-BELT; DYNAMICAL INSTABILITY; STELLAR ENCOUNTERS; CLOSE ENCOUNTERS; COMET SHOWERS; ORIGIN; ORBITS	The detached object Sedna is likely at the inner edge of the Oort cloud, more precisely the inner Oort cloud (IOC). Until recently it was the sole member of this population. The recent discovery of the detached object 2012 VP113 has confirmed that there should be more objects in this region. Three additional IOC candidates with orbits much closer to Neptune have been proposed in the past decade since Sedna's discovery: 2000 CR105, 2004 VN112 and 2010 GB174. Sedna and 2012 VP113 have perhelia near 80 au and semimajor axes over 250 au. The latter three have perihelia between 44 and 50 au and semimajor axes between 200 and 400 au. Here we determine whether the latter three objects belong to the IOC or are from the Kuiper Belt's extended scattered disc (ESD) using numerical simulations. We assume that the IOC was formed when the Sun was in its birth cluster. We analyse the evolution of the IOC and the scattered disc (SD) during an episode of late giant planet migration. We examine the impact of giant planet migration in the context of four and five planets. We report that the detached objects 2004 VN112 and 2010 GB174 are likely members of the IOC that were placed there while the Sun was in its birth cluster or during an episode of solar migration in the Galaxy. The origin of 2000 CR105 is ambiguous but it is likely that it belongs to the ESD. Based on our simulations, we find that the maximum perihelion distance of SD objects is 41 au when the semimajor axis is higher than 250 au. Objects closer in are subject to mean-motion resonances with Neptune that may raise their perihelia. The five-planet model yields the same outcome. We impose a conservative limit and state that all objects with perihelion distance q > 45 au and semimajor axis a > 250 au belong to the IOC.	[Brasser, R.; Schwamb, M. E.] Natl Taiwan Univ, Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Brasser, R.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan	Brasser, R (reprint author), Natl Taiwan Univ, Acad Sinica, Inst Astron & Astrophys, 11F AS NTU,1 Roosevelt Rd, Taipei 10617, Taiwan.	brasser_astro@yahoo.com			Academia Sinica Postdoctoral Fellowship	MES is supported in part by an Academia Sinica Postdoctoral Fellowship. We thank Rodney Gomes, Hal Levison and Alessandro Morbidelli for simulating discussions, and Nathan Kaib for his review. This work was made possible through the use of the ASIAA HTCondor computer clusters at ASIAA. The HTCondor software program was developed by the HTCondor Team at the Computer Sciences Department of the University of Wisconsin-Madison. All rights, title, and interest in HTCondor are owned by the HTCondor Team.	Brasser R, 2013, ICARUS, V225, P40, DOI 10.1016/j.icarus.2013.03.012; HILLS JG, 1981, ASTRON J, V86, P1730, DOI 10.1086/113058; Kaib NA, 2008, ICARUS, V197, P221, DOI 10.1016/j.icarus.2008.03.020; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Gomes RS, 2011, ICARUS, V215, P661, DOI 10.1016/j.icarus.2011.08.002; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Kenyon SJ, 2004, NATURE, V432, P598, DOI 10.1038/nature03136; Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; Gomes RS, 2005, CELEST MECH DYN ASTR, V91, P109, DOI 10.1007/s10569-004-4623-y; Morbidelli A, 2004, ASTRON J, V128, P2564, DOI 10.1086/424617; Trujillo CA, 2014, NATURE, V507, P471, DOI 10.1038/nature13156; Duncan MJ, 1997, SCIENCE, V276, P1670, DOI 10.1126/science.276.5319.1670; Garcia-Sanchez J, 2001, ASTRON ASTROPHYS, V379, P634, DOI 10.1051/0004-6361:20011330; Holmberg J, 2000, MON NOT R ASTRON SOC, V313, P209, DOI 10.1046/j.1365-8711.2000.02905.x; Gomes RS, 2006, ICARUS, V184, P589, DOI 10.1016/j.icarus.2006.05.026; Gladman B, 2002, ICARUS, V157, P269, DOI 10.1006/icar.2002.6860; Schwamb ME, 2010, ASTROPHYS J, V720, P1691, DOI 10.1088/0004-637X/720/2/1691; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Levison HF, 2008, ICARUS, V196, P258, DOI 10.1016/j.icarus.2007.11.035; Brasser R, 2012, ICARUS, V217, P1, DOI 10.1016/j.icarus.2011.10.012; Levison HF, 2001, ASTRON J, V121, P2253, DOI 10.1086/319943; Batygin K, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/1/L3; Batygin K, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/13; Becker AC, 2008, ASTROPHYS J LETT, V682, pL53, DOI 10.1086/590429; Brasser R., 2014, AJ UNPUB; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chen YT, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L8; Gladman B., 2008, SOLAR SYSTEM NEPTUNE, P43; Gladman B, 2006, ASTROPHYS J, V643, pL135, DOI 10.1086/505214; Hernquist L., 1990, APJ, V356, P359; Kaib NA, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/3; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Lykawka PS, 2007, ICARUS, V189, P213, DOI 10.1016/j.icarus.2007.01.001; McMillan PJ, 2010, MON NOT R ASTRON SOC, V402, P934, DOI 10.1111/j.1365-2966.2009.15932.x; Nesvorny D, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/117; Nesvorny D, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L22; Plummer H.C., 1911, Monthly Notices of the Royal Astronomical Society, V71; Ramirez I, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/154; Wisdom J., 1996, FIELDS I COMMUNICATI, V10, P217	41	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	FEB	2015	446	4					3788	3796		10.1093/mnras/stu2374		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3TH	WOS:000350272400044		
J	Chen, CL; Wang, ZC; Kato, T; Shibata, N; Taniguchi, T; Ikuhara, Y				Chen, Chunlin; Wang, Zhongchang; Kato, Takeharu; Shibata, Naoya; Taniguchi, Takashi; Ikuhara, Yuichi			Misfit accommodation mechanism at the heterointerface between diamond and cubic boron nitride	NATURE COMMUNICATIONS			English	Article							CHEMICAL-VAPOR-DEPOSITION; METAL-METAL INTERFACES; HETEROEPITAXIAL GROWTH; DISLOCATIONS; FILM; SEMICONDUCTOR; DISSOCIATION; INSULATOR; EPITAXY; STATE	Diamond and cubic boron nitride (c-BN) are the top two hardest materials on the Earth. Clarifying how the two seemingly incompressible materials can actually join represents one of the most challenging issues in materials science. Here we apply the temperature gradient method to grow the c-BN single crystals on diamond and report a successful epitaxial growth. By transmission electron microscopy, we reveal a novel misfit accommodation mechanism for a {111} diamond/c-BN heterointerface, that is, lattice misfit can be accommodated by continuous stacking fault networks, which are connected by periodically arranged hexagonal dislocation loops. The loops are found to comprise six 60 degrees Shockley partial dislocations. Atomically, the carbon in diamond bonds directly to boron in c-BN at the interface, which electronically induces a two-dimensional electron gas and a quasi-1D electrical conductivity. Our findings point to the existence of a novel misfit accommodation mechanism associated with the superhard materials.	[Chen, Chunlin; Wang, Zhongchang; Ikuhara, Yuichi] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kato, Takeharu; Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostruct Res Lab, Nagoya, Aichi 4568587, Japan; [Shibata, Naoya; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Wang, ZC (reprint author), Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	zcwang@wpi-aimr.tohoku.ac.jp; ikuhara@sigma.t.u-tokyo.ac.jp	Chen, ChunLin/N-4611-2013; Shibata, Naoya/E-5327-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	MEXT of Japan [12024046]; Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan; JSPS; NSFC [11332013]; CAS under Japan-China Scientific Cooperation Program; Murata Science Foundation;  [26820288];  [24686069]	This work was conducted in part at the GRENE (Green Network of Excellence) and Nanotechnology Platform (project No. 12024046) at the University of Tokyo supported by MEXT of Japan, and was supported in part by the Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan and the JSPS Grant-in-Aid for Scientific Research on Innovative Areas 'Nano Informatics'. C.C. acknowledges support from the Grant-in-Aid for Young Scientists (B) (grant no. 26820288). Z.W. thanks the financial support from the Grant-in-Aid for Young Scientists (A) (grant no. 24686069), the NSFC (grant no. 11332013), the JSPS and CAS under Japan-China Scientific Cooperation Program, and the Murata Science Foundation. Calculations were conducted at the ISSP, University of Tokyo.	Ko H, 2010, NATURE, V468, P286, DOI 10.1038/nature09541; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Occelli F, 2003, NAT MATER, V2, P151, DOI 10.1038/nmat831; Pastewka L, 2011, NAT MATER, V10, P34, DOI [10.1038/nmat2902, 10.1038/NMAT2902]; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; WEIDNER DJ, 1994, SCIENCE, V266, P419, DOI 10.1126/science.266.5184.419; WENTORF RH, 1980, SCIENCE, V208, P873, DOI 10.1126/science.208.4446.873; Liu L, 2014, SCIENCE, V343, P163, DOI 10.1126/science.1246137; GRENVILLEWELLS HJ, 1958, NATURE, V181, P758; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Chu MW, 2004, NAT MATER, V3, P87, DOI 10.1038/nmat1057; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Yoon J, 2010, NATURE, V465, P329, DOI 10.1038/nature09054; KNITTLE E, 1989, NATURE, V337, P349, DOI 10.1038/337349a0; BLUNIER S, 1992, PHYS REV LETT, V68, P3599, DOI 10.1103/PhysRevLett.68.3599; Carter C. B., 1991, SI PHIL MAG A, V63, P279; Carter C.B., 1996, TRANSMISSION ELECT M; Cicero G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.156101; EICHHORN K, 1991, ACTA CRYSTALLOGR B, V47, P843, DOI 10.1107/S0108768191006900; ERNST F, 1993, PHILOS MAG A, V68, P1251; Figuera J., 2001, PHYS REV LETT, V86, P3819; FRANK N, 1994, PHYS REV LETT, V73, P2236, DOI 10.1103/PhysRevLett.73.2236; HAMILTON JC, 1995, PHYS REV LETT, V75, P882, DOI 10.1103/PhysRevLett.75.882; Heogen M. H., 1991, PHYS REV LETT, V67, P1130; JACOBSEN J, 1995, PHYS REV LETT, V75, P489, DOI 10.1103/PhysRevLett.75.489; Kirkland E. J., 1998, ADV COMPUTING ELECT; KOIZUMI S, 1990, APPL PHYS LETT, V57, P563, DOI 10.1063/1.103647; Madelung O., 1987, INTRINSIC PROPERTIES; Nabarro F.R.N., 1967, THEORY CRYSTAL DISLO; Nistor LC, 2004, PHYS STATUS SOLIDI A, V201, P2578, DOI 10.1002/pssa.200405192; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; PIROUZ P, 1983, P ROY SOC LOND A MAT, V386, P241, DOI 10.1098/rspa.1983.0034; Taniguchi T., 2014, COMPREHENSIVE HARD M, P587; Taniguchi T, 1997, MATER RES SOC SYMP P, V472, P379; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; YOSHIKAWA M, 1991, APPL PHYS LETT, V58, P1387, DOI 10.1063/1.104316; Zhang WJ, 2004, ADV MATER, V16, P1405, DOI 10.1002/adma.200306658; Zhang XW, 2003, NAT MATER, V2, P312, DOI 10.1038/nmat870; Zhu D, 2013, NAT MATER, V12, P836, DOI [10.1038/nmat3696, 10.1038/NMAT3696]	40	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6327	10.1038/ncomms7327		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZZ	WOS:000350291300003		
J	Kinjyo, I; Qin, J; Tan, SY; Wellard, CJ; Mrass, P; Ritchie, W; Doi, A; Cavanagh, LL; Tomura, M; Sakaue-Sawano, A; Kanagawa, O; Miyawaki, A; Hodgkin, PD; Weninger, W				Kinjyo, Ichiko; Qin, Jim; Tan, Sioh-Yang; Wellard, Cameron J.; Mrass, Paulus; Ritchie, William; Doi, Atsushi; Cavanagh, Lois L.; Tomura, Michio; Sakaue-Sawano, Asako; Kanagawa, Osami; Miyawaki, Atsushi; Hodgkin, Philip D.; Weninger, Wolfgang			Real-time tracking of cell cycle progression during CD8(+) effector and memory T-cell differentiation	NATURE COMMUNICATIONS			English	Article							IN-VIVO; LYMPHOCYTE DIVISION; CLONAL EXPANSION; CUTTING EDGE; L-SELECTIN; NAIVE; FATES; PHENOTYPE; CYTOKINE; PROLIFERATION	The precise pathways of memory T-cell differentiation are incompletely understood. Here we exploit transgenic mice expressing fluorescent cell cycle indicators to longitudinally track the division dynamics of individual CD8(+) T cells. During influenza virus infection in vivo, naive T cells enter a CD62L(intermediate) state of fast proliferation, which continues for at least nine generations. At the peak of the anti-viral immune response, a subpopulation of these cells markedly reduces their cycling speed and acquires a CD62L(hi) central memory cell phenotype. Construction of T-cell family division trees in vitro reveals two patterns of proliferation dynamics. While cells initially divide rapidly with moderate stochastic variations of cycling times after each generation, a slow-cycling subpopulation displaying a CD62L(hi) memory phenotype appears after eight divisions. Phenotype and cell cycle duration are inherited by the progeny of slow cyclers. We propose that memory precursors cell-intrinsically modulate their proliferative activity to diversify differentiation pathways.	[Kinjyo, Ichiko; Qin, Jim; Tan, Sioh-Yang; Mrass, Paulus; Ritchie, William; Cavanagh, Lois L.; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW 2042, Australia; [Wellard, Cameron J.; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; [Wellard, Cameron J.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Doi, Atsushi] Cell Innovator Co Ltd, Fukuoka 8128581, Japan; [Tomura, Michio; Kanagawa, Osami] RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa 2300045, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Saitama 3510198, Japan; [Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Discipline Dermatol, Sydney, NSW 2006, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW 2050, Australia	Weninger, W (reprint author), Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW 2042, Australia.	w.weninger@centenary.org.au		Weninger, Wolfgang/0000-0003-3133-8699	National Health and Medical Research Council [APP1030145]; National Institutes of Health [BAA-NIAID-DAIT-HHSN272201100018C]	We thank members of the Weninger and Hodgkin laboratories for discussions, the Centenary Institute Flow Cytometry/Imaging Facility for cell sorting and microscopy, Animal Facility for mouse housing, Dr S. Turner (University of Melbourne) for providing PR8-OVA influenza virus, Dr D. Day (Swinburne University of Technology) and Microsurfaces Pty. Ltd. for providing the microgrids and the Ramaciotti Center at UNSW for microarray analysis. We acknowledge Ms R. Barugahare, M. Rizk and A. Cooray for maintaining mouse strains. This work was supported by a grant from the National Health and Medical Research Council (APP1030145 to W.W.) and a contract from the National Institutes of Health (BAA-NIAID-DAIT-HHSN272201100018C to W.W.).	Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423; D'Souza WN, 2006, J IMMUNOL, V177, P777; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Oehen S, 1998, J IMMUNOL, V161, P5338; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; BREKELMANS P, 1994, EUR J IMMUNOL, V24, P2896, DOI 10.1002/eji.1830241147; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Tan SY, 2012, IMMUNOL CELL BIOL, V90, P722, DOI 10.1038/icb.2011.104; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Jenkins MR, 2008, J IMMUNOL, V181, P3818; Curtsinger JM, 2003, J IMMUNOL, V171, P5165; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733; Chao CC, 1997, J IMMUNOL, V159, P1686; Dang XT, 2009, BBA-GENE REGUL MECH, V1789, P146, DOI 10.1016/j.bbagrm.2008.10.004; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Gett V. A., 2000, NAT IMMUNOL, V1, P239; Gett V. A., 1998, P NATL ACAD SCI USA, V95, P9488; Harty T. J., 2008, NAT REV IMMUNOL, V8, P107; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Jacob J, 1999, NATURE, V399, P593; Jenkins R. M., 2006, J IMMUNOL, V177, P2917; Kaech M. S., 2002, NAT REV IMMUNOL, V2, P251; Lawrence W. C., 2005, J IMMUNOL, V174, P5332; Lemaitre F, 2013, J IMMUNOL, V191, P1578, DOI 10.4049/jimmunol.1300424; Malek Thomas R, 2008, Annu Rev Immunol, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Muzumdar D. M., 2007, GENESIS, V45, P593; Opferman T. J., 1999, SCIENCE, V283, P1745; Pulmlee C. R., 2013, IMMUNITY, V39, P347; Schlub TE, 2009, EUR J IMMUNOL, V39, P67, DOI 10.1002/eji.200838554; Smyth K. G., 2005, BIOINFORMATICS COMPU, P397; Tanaka K., 2011, J IMMUNOL, V186, P775; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Yo M., 2014, BIOCHEM BIOPH RES CO, V457, P7; Yoon H., 2004, PLOS ONE, V5	57	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6301	10.1038/ncomms7301		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZL	WOS:000350289900003		
J	Kusumoto, S; Nozaki, K				Kusumoto, Shuhei; Nozaki, Kyoko			Direct and selective hydrogenolysis of arenols and aryl methyl ethers	NATURE COMMUNICATIONS			English	Article							C-O BONDS; REDUCTIVE CLEAVAGE; CATALYTIC HYDRODEOXYGENATION; HYDROGENATION; BIOMASS; ACTIVATION; LIGNIN	For valorization of biomass, the conversion of lignin to deoxygenated bulk aromatic compounds is an emerging subject of interest. Because aromatic rings are susceptible to metal-catalysed hydrogenation, the selective hydrogenolysis of carbon-oxygen bonds still remains a great challenge. Herein we report direct and selective hydrogenolysis of sp(2) C-OH bonds in substituted phenols and naphthols catalysed by hydroxycyclopentadienyl iridium complexes. The corresponding arenes were obtained in up to 99% yields, indicating the possible production of arenes from lignin-derived bio-oils. Furthermore, the same catalysts were applied to the unprecedented selective hydrogenolysis of the sp(3) C-O bonds in aryl methyl ethers. Thus, the hydrodeoxygenation of vanillylacetone, a lignin model compound, afforded alkylbenzenes as the major products via triple deoxygenation.	[Kusumoto, Shuhei; Nozaki, Kyoko] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Nozaki, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	nozaki@chembio.t.u-tokyo.ac.jp	Nozaki, Kyoko/E-8779-2010		JSPS	This work was supported by a JSPS Grant-in-Aid for JSPS Fellows. We are grateful to Dr Shingo Ito (The University of Tokyo) for careful proof reading.	Tobisu M, 2011, CHEM COMMUN, V47, P2946, DOI 10.1039/c0cc05169a; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Kusumoto S, 2013, J AM CHEM SOC, V135, P18726, DOI 10.1021/ja409672w; Herrmann JM, 2013, EUR J ORG CHEM, V2013, P7017, DOI 10.1002/ejoc.201300657; Saidi M, 2014, ENERG ENVIRON SCI, V7, P103, DOI 10.1039/c3ee43081b; van der Boom ME, 1998, J AM CHEM SOC, V120, P6531, DOI 10.1021/ja9738889; Laskar DD, 2013, BIOFUEL BIOPROD BIOR, V7, P602, DOI 10.1002/bbb.1422; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Ren YL, 2013, ANGEW CHEM INT EDIT, V52, P12674, DOI 10.1002/anie.201305342; Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Choi J, 2009, J AM CHEM SOC, V131, P15627, DOI 10.1021/ja906930u; BLUM Y, 1985, ORGANOMETALLICS, V4, P1459, DOI 10.1021/om00127a027; Fedorov A, 2013, CHEM SCI, V4, P1640, DOI 10.1039/c3sc22256j; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Cornella J, 2013, J AM CHEM SOC, V135, P1997, DOI 10.1021/ja311940s; Furimsky E, 2000, APPL CATAL A-GEN, V199, P147, DOI 10.1016/S0926-860X(99)00555-4; Mine E, 2006, CHEM LETT, V35, P780, DOI 10.1246/cl.2006.780; NISHIMURA S, 1984, B CHEM SOC JPN, V57, P2557, DOI 10.1246/bcsj.57.2557; Weissermel K., 2003, IND ORGANIC CHEM; Wuts P. G. M., 2006, GREENES PROTECTIVE G, P367; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	21	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6296	10.1038/ncomms7296		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZK	WOS:000350289800004		
J	Matsumoto, M; Tatematsu, M; Nishikawa, F; Azuma, M; Ishii, N; Morii-Sakai, A; Shime, H; Seya, T				Matsumoto, Misako; Tatematsu, Megumi; Nishikawa, Fumiko; Azuma, Masahiro; Ishii, Noriko; Morii-Sakai, Akiko; Shime, Hiroaki; Seya, Tsukasa			Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; POLY-L-LYSINE; INTERFERON-BETA INDUCTION; MYELOID DENDRITIC CELLS; RIG-I; MICROCHIP ELECTROPHORESIS; ANTIVIRAL RESPONSES; ADAPTER MOLECULE; VACCINE ADJUVANT	Ligand stimulation of the Toll-like receptors (TLRs) triggers innate immune response, cytokine production and cellular immune activation in dendritic cells. However, most TLR ligands are microbial constituents, which cause inflammation and toxicity. Toxic response could be reduced for secure immunotherapy through the use of chemically synthesized ligands with defined functions. Here we create an RNA ligand for TLR3 with no ability to activate the RIG-I/MDA5 pathway. This TLR3 ligand is a chimeric molecule consisting of phosphorothioate ODN-guided dsRNA (sODN-dsRNA), which elicits far less cytokine production than poly(I:C) in vitro and in vivo. The activation of TLR3/TICAM-1 pathway by sODN-dsRNA effectively induces natural killer and cytotoxic T cells in tumour-loaded mice, thereby establishing antitumour immunity. Systemic cytokinemia does not occur following subcutaneous or even intraperitoneal administration of sODN-dsRNA, indicating that TICAM-1 signalling with minute local cytokines sufficiently activate dendritic cells to prime tumoricidal effectors in vivo.	[Matsumoto, Misako; Tatematsu, Megumi; Nishikawa, Fumiko; Azuma, Masahiro; Ishii, Noriko; Morii-Sakai, Akiko; Shime, Hiroaki; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Matsumoto, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	matumoto@pop.med.hokudai.ac.jp; seya-tu@pop.med.hokudai.ac.jp					Gauzzi MC, 2010, IMMUNOBIOLOGY, V215, P713, DOI 10.1016/j.imbio.2010.05.008; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Okahira S, 2005, DNA CELL BIOL, V24, P614, DOI 10.1089/dna.2005.24.614; Fernandez NC, 1999, NAT MED, V5, P405; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; LEVINE AS, 1979, CANCER RES, V39, P1645; Intlekofer AM, 2013, J LEUKOCYTE BIOL, V94, P25, DOI 10.1189/jlb.1212621; Shingai M, 2007, J IMMUNOL, V179, P6123; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Gowen BB, 2007, J IMMUNOL, V178, P5200; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; LEVY HB, 1969, P NATL ACAD SCI USA, V62, P357, DOI 10.1073/pnas.62.2.357; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Azuma M, 2012, ONCOIMMUNOLOGY, V1, P581; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; LEVINE AS, 1978, CANCER TREAT REP, V62, P1907; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Sabbatini P, 2012, CLIN CANCER RES, V18, P6497, DOI 10.1158/1078-0432.CCR-12-2189; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Itoh K, 2008, J IMMUNOL, V181, P5522; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; TALMADGE JE, 1985, CANCER RES, V45, P1066; Matsumoto M, 2003, J IMMUNOL, V171, P3154; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Perrot I, 2010, J IMMUNOL, V185, P2080, DOI 10.4049/jimmunol.1000532; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Jasani B, 2009, VACCINE, V27, P3401, DOI 10.1016/j.vaccine.2009.01.071; Jing X. u., 1996, P NATL ACAD SCI USA, V93, P44; LVOVSKY EA, 1985, INT J RADIAT ONCOL, V11, P1721; Nishikawa F, 2006, NUCLEOS NUCLEOT NUCL, V25, P369, DOI 10.1080/15257770600683953; Nishikawa F, 2009, OLIGONUCLEOTIDES, V19, P179, DOI 10.1089/oli.2008.0167; Seya T, 2013, EXPERT OPIN THER TAR, V17, P533, DOI 10.1517/14728222.2013.765407; Seya T, 2003, ANTICANCER RES, V23, P4369; Sugiyama T, 2008, INT IMMUNOL, V20, P1, DOI 10.1093/intimm/dxm112; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001	56	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6280	10.1038/ncomms7280		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZH	WOS:000350289500011		
J	Okamura, T; Sumitomo, S; Morita, K; Iwasaki, Y; Inoue, M; Nakachi, S; Komai, T; Shoda, H; Miyazaki, J; Fujio, K; Yamamoto, K				Okamura, Tomohisa; Sumitomo, Shuji; Morita, Kaoru; Iwasaki, Yukiko; Inoue, Mariko; Nakachi, Shinichiro; Komai, Toshihiko; Shoda, Hirofumi; Miyazaki, Jun-ichi; Fujio, Keishi; Yamamoto, Kazuhiko			TGF-beta 3-expressing CD4(+)CD25(-)LAG3(+) regulatory T cells control humoral immune responses	NATURE COMMUNICATIONS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TGF-BETA; IMMUNOLOGICAL-TOLERANCE; TRANSCRIPTION FACTOR; SELF-TOLERANCE; MRL/LPR MICE; B-CELLS; RECEPTOR; DISEASE; EGR-2	Autoantibodies induce various autoimmune diseases, including systemic lupus erythematosus (SLE). We previously described that CD4(+)CD25(-)LAG3(+) regulatory T cells (LAG3(+) Treg) are regulated by Egr2, a zinc-finger transcription factor required for the induction of T-cell anergy. We herein demonstrate that LAG3(+) Treg produce high amounts of TGF-beta 3 in an Egr2- and Fas-dependent manner. LAG3(+) Treg require TGF-beta 3 to suppress B-cell responses in a murine model of lupus. Moreover, TGF-beta 3- and LAG3(+) Treg-mediated suppression requires PD-1 expression on B cells. We also show that TGF-beta 3-expressing human LAG3(+) Treg suppress antibody production and that SLE patients exhibit decreased frequencies of LAG3(+) Treg. These results clarify the mechanism of B-cell regulation and suggest therapeutic strategies.	[Okamura, Tomohisa; Sumitomo, Shuji; Morita, Kaoru; Iwasaki, Yukiko; Inoue, Mariko; Nakachi, Shinichiro; Komai, Toshihiko; Shoda, Hirofumi; Fujio, Keishi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan; [Okamura, Tomohisa] Univ Tokyo, Max Planck Univ Tokyo, Ctr Integrat Inflammol, Meguro Ku, Tokyo 1538505, Japan; [Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan	Yamamoto, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kfujio-tky@umin.ac.jp	Miyazaki, Jun-ichi/N-1976-2015; 	Miyazaki, Jun-ichi/0000-0003-2475-589X; Sumitomo, Shuji/0000-0003-4980-2664	Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan	We are grateful to K. Watada, K. Sakashita, J. Takezawa and M. Anraku for their excellent technical assistance. We thank Dr Patrick Charnay (INSERM, France) for providing Egr-2-floxed mice. This work was supported by grants from the Japan Society for the Promotion of Science, Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Haas KM, 2011, J IMMUNOL, V187, P5183, DOI 10.4049/jimmunol.1101990; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Liang BT, 2008, J IMMUNOL, V180, P5916; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Borsutzky S, 2004, J IMMUNOL, V173, P3305; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Fuchs A, 2009, EUR J IMMUNOL, V39, P3097, DOI 10.1002/eji.200939392; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Chavele KM, 2011, FEBS LETT, V585, P3603, DOI 10.1016/j.febslet.2011.07.043; Lim HW, 2005, J IMMUNOL, V175, P4180; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; KEHRL JH, 1991, J IMMUNOL, V146, P4016; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; LOMO J, 1995, J IMMUNOL, V154, P1634; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Gillian AL, 2004, J BIOL CHEM, V279, P9056, DOI 10.1074/jbc.M309308200; Hasegawa H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2122; Nitta Y, 1998, HUM GENE THER, V9, P1701, DOI 10.1089/hum.1998.9.12-1701; Okamura T, 2012, ANN RHEUM DIS, V71, P96, DOI 10.1136/annrheumdis-2011-200588; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Suen JL, 2012, J FORMOS MED ASSOC, V111, P465, DOI 10.1016/j.jfma.2012.05.013; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Warren KJ, 2014, J CLIN INVEST, V124, P2204, DOI 10.1172/JCI73683; Wing J. B., 2013, INT IMMUNOL, V26, P61; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041644	52	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6329	10.1038/ncomms7329		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZZ	WOS:000350291300005		
J	Wang, FJ; Kozawa, D; Miyauchi, Y; Hiraoka, K; Mouri, S; Ohno, Y; Matsuda, K				Wang, Feijiu; Kozawa, Daichi; Miyauchi, Yuhei; Hiraoka, Kazushi; Mouri, Shinichiro; Ohno, Yutaka; Matsuda, Kazunari			Considerably improved photovoltaic performance of carbon nanotube-based solar cells using metal oxide layers	NATURE COMMUNICATIONS			English	Article							INTEGRATED-CIRCUITS; EFFICIENCY; RECOMBINATION; ELECTRONICS; ABSORPTION; DEVICES; CHARGE; LIGHT	Carbon nanotube-based solar cells have been extensively studied from the perspective of potential application. Here we demonstrated a significant improvement of the carbon nanotube solar cells by the use of metal oxide layers for efficient carrier transport. The metal oxides also serve as an antireflection layer and an efficient carrier dopant, leading to a reduction in the loss of the incident solar light and an increase in the photocurrent, respectively. As a consequence, the photovoltaic performance of both p-single-walled carbon nanotube (SWNT)/n-Si and n-SWNT/p-Si heterojunction solar cells using MoOx and ZnO layers is improved, resulting in very high photovoltaic conversion efficiencies of 17.0 and 4.0%, respectively. These findings regarding the use of metal oxides as multifunctional layers suggest that metal oxide layers could improve the performance of various electronic devices based on carbon nanotubes.	[Wang, Feijiu; Kozawa, Daichi; Miyauchi, Yuhei; Mouri, Shinichiro; Matsuda, Kazunari] Kyoto Univ, Inst Adv Energy, Uji 6110011, Japan; [Miyauchi, Yuhei] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hiraoka, Kazushi] Hitachi Zosen Corp, Taisho 5510022, Japan; [Ohno, Yutaka] Nagoya Univ, Dept Quantum Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Matsuda, K (reprint author), Kyoto Univ, Inst Adv Energy, Uji 6110011, Japan.	matsuda@iae.kyoto-u.ac.jp	Miyauchi, Yuhei/E-1047-2011; Kozawa, Daichi/C-3917-2012	Kozawa, Daichi/0000-0002-0629-5589	Precursory Research for Embryonic Science and Technology (PRESTO); Japan Society for the Promotion of Science (JSPS) [22740195, 23340085, 24681031, 40311435]; Yazaki Memorial Foundation for Science and Technology; Nippon Sheet Glass Foundation for Materials Science and Engineering; Canon Foundation; Japan Science and Technology (JST)	We are grateful to M. Endo, A. Wakamiya and Y. Murata for their help with the n-SWNT/p-Si fabrication instruments supply. Y.M. was financially supported by the Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology (JST). This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Grant Nos. 22740195, 23340085, 24681031, and 40311435), the Yazaki Memorial Foundation for Science and Technology, the Nippon Sheet Glass Foundation for Materials Science and Engineering, and The Canon Foundation.	Appenzeller J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126801; Dukovic G, 2005, NANO LETT, V5, P2314, DOI [10.1021/nl0518122, 10.1021/nl058122]; Rowell MW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209887; Kempa TJ, 2013, ENERG ENVIRON SCI, V6, P719, DOI 10.1039/c3ee24182c; Li XK, 2014, NANO LETT, V14, P3388, DOI 10.1021/nl500894h; Chen JK, 2009, CARBON, V47, P2704, DOI 10.1016/j.carbon.2009.05.028; Miyauchi Y, 2013, NAT PHOTONICS, V7, P715, DOI [10.1038/nphoton.2013.179, 10.1038/NPHOTON.2013.179]; Kim SK, 2012, NANO LETT, V12, P4971, DOI 10.1021/nl302578z; Miyauchi Y, 2013, J MATER CHEM C, V1, P6499, DOI 10.1039/c3tc00947e; Wang FJ, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.102301; Oh J, 2012, NAT NANOTECHNOL, V7, P743, DOI [10.1038/nnano.2012.166, 10.1038/NNANO.2012.166]; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Chen CW, 2004, NANOTECHNOLOGY, V15, P1837, DOI 10.1088/0957-4484/15/12/025; Kroger M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3231928; Kongkanand A, 2007, NANO LETT, V7, P676, DOI 10.1021/nl0627238; Dimitrov V, 1996, J APPL PHYS, V79, P1736, DOI 10.1063/1.360962; Jung Y, 2013, NANO LETT, V13, P95, DOI 10.1021/nl3035652; Kanungo M, 2009, SCIENCE, V323, P234, DOI 10.1126/science.1166087; TIEDJE T, 1984, IEEE T ELECTRON DEV, V31, P711, DOI 10.1109/T-ED.1984.21594; Chang LY, 2013, NANO LETT, V13, P994, DOI 10.1021/nl3041417; Wang FJ, 2014, ACS PHOTONICS, V1, P360, DOI 10.1021/ph400133k; Agostinelli G, 2006, SOL ENERG MAT SOL C, V90, P3438, DOI 10.1016/j.solmat.2006.04.014; Meyer J, 2012, ADV MATER, V24, P5408, DOI 10.1002/adma.201201630; Brown PR, 2011, NANO LETT, V11, P2955, DOI 10.1021/nl201472u; Moisala A, 2006, CHEM ENG SCI, V61, P4393, DOI 10.1016/j.ces.2006.02.020; Koide N, 2006, J PHOTOCH PHOTOBIO A, V182, P296, DOI 10.1016/j.jphotochem.2006.04.030; Hellstrom SL, 2012, NANO LETT, V12, P3574, DOI 10.1021/nl301207e; Brittman S, 2011, NANO LETT, V11, P5189, DOI 10.1021/nl2023806; Strein E, 2013, ENERG ENVIRON SCI, V6, P769, DOI 10.1039/c2ee24175g; Semonin OE, 2011, SCIENCE, V334, P1530, DOI 10.1126/science.1209845; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]; Liu P, 2008, NANO LETT, V8, P647, DOI 10.1021/nl0730817; Bronstein ND, 2014, ACS NANO, V8, P44, DOI 10.1021/nn404418h; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Kozawa D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.042304; Li YF, 2009, J AM CHEM SOC, V131, P3412, DOI 10.1021/ja810086g; Sun DM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3302; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139	39	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	FEB	2015	6								6305	10.1038/ncomms7305		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CC3ZP	WOS:000350290300003		
J	Sun, PZ; Chen, Q; Li, XD; Liu, H; Wang, KL; Zhong, ML; Wei, JQ; Wu, DH; Ma, RZ; Sasaki, T; Zhu, HW				Sun, Pengzhan; Chen, Qiao; Li, Xinda; Liu, He; Wang, Kunlin; Zhong, Minlin; Wei, Jinquan; Wu, Dehai; Ma, Renzhi; Sasaki, Takayoshi; Zhu, Hongwei			Highly efficient quasi-static water desalination using monolayer graphene oxide/titania hybrid laminates	NPG ASIA MATERIALS			English	Article							OXIDE MEMBRANES; PHOTOCATALYTIC REDUCTION; NANOSHEETS; FILMS; SEPARATION; TRANSPORT; SHEETS	By intercalating monolayer titania (TO) nanosheets into graphene oxide (GO) laminates with mild ultraviolet (UV) reduction, the as-prepared RGO/TO hybrid membranes exhibit excellent water desalination performances. Without external hydrostatic pressures, the ion permeations through the RGO/TO hybrid membranes can be reduced to <5% compared with the GO/TO cases, while the water transmembrane permeations, which are measured using an isotope-labeling technique, can be retained up to similar to 60%. The mechanism for the excellent water desalination performances of the RGO/TO hybrid laminates is discussed, which indicates that the photoreduction of GO by TO is responsible for the effective rejection of ions, while the photoinduced hydrophilic conversion of TO under UV irradiation is responsible for the well-retained water permeabilities. These excellent properties make RGO/TO hybrid membranes favorable for practical water desalination.	[Sun, Pengzhan; Chen, Qiao; Wang, Kunlin; Zhong, Minlin; Wei, Jinquan; Zhu, Hongwei] Tsinghua Univ, Key Lab Mat Proc Technol MOE, State Key Lab New Ceram & Fine Proc, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Chen, Qiao; Zhu, Hongwei] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China; [Li, Xinda; Liu, He; Wu, Dehai] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Ma, Renzhi; Sasaki, Takayoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Ibaraki, Japan	Zhu, HW (reprint author), Tsinghua Univ, Key Lab Mat Proc Technol MOE, State Key Lab New Ceram & Fine Proc, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.	hongweizhu@tsinghua.edu.cn	Zhu, Hongwei/B-5240-2009		Beijing Science and Technology Program [D141100000514001]; National Science Foundation of China [51372133]; National Program on Key Basic Research Project [2014CB932401, 2011CB013000]; Training Program of Innovation and Entrepreneurship for Undergraduates [201410003B046]	This work was supported by the Beijing Science and Technology Program (D141100000514001), the National Science Foundation of China (51372133), the National Program on Key Basic Research Project (2014CB932401, 2011CB013000) and the Training Program of Innovation and Entrepreneurship for Undergraduates (201410003B046).	Akhavan O, 2010, J PHYS CHEM C, V114, P12955, DOI 10.1021/jp103472c; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Mi BX, 2014, SCIENCE, V343, P740, DOI 10.1126/science.1250247; Logan BE, 2012, NATURE, V488, P313, DOI 10.1038/nature11477; Sun PZ, 2013, ACS NANO, V7, P428, DOI 10.1021/nn304471w; Han Y, 2013, ADV FUNCT MATER, V23, P3693, DOI 10.1002/adfm.201202601; Sun PZ, 2014, ACS NANO, V8, P850, DOI 10.1021/nn4055682; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Hu M, 2013, ENVIRON SCI TECHNOL, V47, P3715, DOI 10.1021/es400571g; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Sun PZ, 2015, CHEM COMMUN, V51, P3251, DOI 10.1039/c4cc10103k; Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f; Eda G, 2010, ADV MATER, V22, P2392, DOI 10.1002/adma.200903689; Loh KP, 2010, NAT CHEM, V2, P1015, DOI [10.1038/nchem.907, 10.1038/NCHEM.907]; Sun PZ, 2014, J MATER CHEM A, V2, P7734, DOI 10.1039/c4ta00668b; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Williams G, 2008, ACS NANO, V2, P1487, DOI 10.1021/nn800251f; Huang X, 2011, SMALL, V7, P1876, DOI 10.1002/smll.201002009; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Wang LZ, 2014, CHEM REV, V114, P9455, DOI 10.1021/cr400627u; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722; Sun PZ, 2012, RSC ADV, V2, P10829, DOI 10.1039/c2ra21699j; Tan CL, 2013, MATER TODAY, V16, P29, DOI 10.1016/j.mattod.2013.01.021; Sakai N, 2006, J PHYS CHEM B, V110, P6198, DOI 10.1021/jp0556916; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Boukhvalov DW, 2013, NANO LETT, V13, P3930, DOI 10.1021/nl4020292; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/nnano.2012.162, 10.1038/NNANO.2012.162]; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Sasaki T, 1998, J AM CHEM SOC, V120, P4682, DOI 10.1021/ja974262l; Jin EZ, 2013, ACTA MATER, V61, P6466, DOI 10.1016/j.actamat.2013.07.025; Nair N. N., 2012, SCIENCE, V335, P442; Su Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5843; Sun PZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05528; Sun PZ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/7/075601; Wang Y, 2011, J AM CHEM SOC, V133, P695, DOI 10.1021/ja109314u	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	FEB	2015	7								e162	10.1038/am.2015.7		8	Materials Science, Multidisciplinary	Materials Science	CD0YP	WOS:000350800600003		
J	Vacha, M; Jiang, L				Vacha, Martin; Jiang, Lei			Editorial for 2015	NPG ASIA MATERIALS			English	Editorial Material									[Vacha, Martin] Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 152, Japan; [Jiang, Lei] Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China	Vacha, M (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 152, Japan.	vacha.m.aa@m.titech.ac.jp	Jiang, Lei/B-1066-2011				GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Legge J., 1963, I CHING BOOK CHANGES; Su B., 2014, SMALL, DOI [10.1002/smll.201401307, DOI 10.1002/SMLL.201401307]; Tian Y, 2014, ADV MATER, V26, P6872, DOI 10.1002/adma.201400883; Zhuang Z., BOOK OF HAN, P111	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	FEB	2015	7								e160	10.1038/am.2015.1		3	Materials Science, Multidisciplinary	Materials Science	CD0YP	WOS:000350800600001		
J	Kumai, T; Matsuda, Y; Ohkuri, T; Oikawa, K; Ishibashi, K; Aoki, N; Kimura, S; Harabuchi, Y; Celis, E; Kobayashi, H				Kumai, Takumi; Matsuda, Yoshinari; Ohkuri, Takayuki; Oikawa, Kensuke; Ishibashi, Kei; Aoki, Naoko; Kimura, Shoji; Harabuchi, Yasuaki; Celis, Esteban; Kobayashi, Hiroya			c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma	ONCOIMMUNOLOGY			English	Article						autophagy; CD4(+) helper T lymphocytes; c-Met; head and neck squamous cell carcinoma; immunotherapy; major histocompatibility complex class II; NK/T cell lymphoma; TGF-beta; tumor antigens	EPSTEIN-BARR-VIRUS; BREAST-CANCER; LUNG-CANCER; PHASE-II; TGF-BETA; INHIBITOR; INDUCTION; RESPONSES; PROLIFERATION; CARCINOMA	Background: The expression of c-met and its ligand HGF plays a critical role in cell proliferation and is involved in numerous malignancies. Because c-Met expression and its role in NK/T-cell lymphoma remain unclear, we studied the expression and function of c-Met in NK/T-cell lymphoma cells. In addition, we investigated the possibility that c-Met could function as a tumor-associated antigen for helper T lymphocytes (HTLs). Methods: We evaluated whether HGF and c-Met were expressed in NK/T-cell lymphoma and the capacity of predicted c-Met HTL epitopes to induce antitumor responses in vitro. In addition, c-Met inhibitor was evaluated for the ability to inhibit TGF-beta production in tumor and subsequently increase HTL recognition. Results: c-Met and HGF were expressed in NK/T-cell lymphoma cell lines, nasal NK/T-cell lymphoma specimens and patient serum samples. Moreover, HGF was shown to promote NK/T cell lymphoma (NKTCL) proliferation in an autocrine manner. Furthermore, we have identified three novel c-Met HTL epitopes that were restricted by several HLA-DR molecules. Notably, peptide-induced HTL lines directly recognized and killed c-Met expressing NK/T-cell lymphomas and various epithelial solid tumors. The c-Met specific HTLs could also recognize dendritic cells (DCs) pulsed with c-Met expressing tumor cell lysates. In addition, we observed that c-Met inhibition augmented HTL recognition by decreasing TGF-b production by tumor cells. Lastly, autophagy partly regulated the HTL responses against tumors. Conclusions: We identified novel c-Met HTL epitopes that can elicit effective antitumor responses against tumors expressing c-Met. Our results provide the rationale of combining c-Met targeting therapy and immunotherapy for NKTCLs and epithelial tumors.	[Kumai, Takumi; Matsuda, Yoshinari; Ohkuri, Takayuki; Oikawa, Kensuke; Ishibashi, Kei; Aoki, Naoko; Kimura, Shoji; Kobayashi, Hiroya] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido, Japan; [Kumai, Takumi; Harabuchi, Yasuaki] Asahikawa Med Univ, Dept Otolaryngol Head & Neck Surg, Asahikawa, Hokkaido, Japan; [Kumai, Takumi; Celis, Esteban] Georgia Regents Univ, Ctr Canc, Inflammat & Tolerance Program, Canc Immunol, Augusta, GA 30912 USA	Celis, E (reprint author), Georgia Regents Univ, Ctr Canc, Inflammat & Tolerance Program, Canc Immunol, Augusta, GA 30912 USA.	ecelis@gru.edu; hiroya@asahikawa-med.ac.jp			JSPS KAKENHI [24791735, 25460430]; NIH [R01CA136828, R01CA157303]	This work was supported by JSPS KAKENHI Grant Number 24791735, 25460430, NIH grants R01CA136828 and R01CA157303.	Harabuchi Y, 1996, CANCER, V77, P2137, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.3.CO;2-N; Schag K, 2004, CLIN CANCER RES, V10, P3658, DOI 10.1158/1078-0432.CCR-03-0640; Maulik G, 2002, CLIN CANCER RES, V8, P620; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Miyajima N, 2013, CANCER RES, V73, P7022, DOI 10.1158/0008-5472.CAN-13-1156; Kumai T, 2014, CANCER IMMUNOL IMMUN, V63, P469, DOI 10.1007/s00262-014-1533-z; Kwong YL, 1997, BRIT J HAEMATOL, V97, P821, DOI 10.1046/j.1365-2141.1997.1462962.x; Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; SHIBATA D, 1992, AM J PATHOL, V140, P769; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Southwood S, 1998, J IMMUNOL, V160, P3363; Hayashi S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-191; Peoples GE, 2008, CLIN CANCER RES, V14, P797, DOI 10.1158/1078-0432.CCR-07-1448; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Mortenson ED, 2013, CLIN CANCER RES, V19, P1476, DOI 10.1158/1078-0432.CCR-12-2522; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Filipazzi P, 2012, CLIN CANCER RES, V18, P6485, DOI 10.1158/1078-0432.CCR-12-1516; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Canadas I, 2014, CLIN CANCER RES, V20, P938, DOI 10.1158/1078-0432.CCR-13-1330; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Iwata S, 2012, CANCER SCI, V103, P375, DOI 10.1111/j.1349-7006.2011.02127.x; Kumai T, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0265-3; Murata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063566; Nagata H, 2001, BLOOD, V97, P708, DOI 10.1182/blood.V97.3.708; Tsuge I, 1999, CLIN EXP IMMUNOL, V115, P385	30	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2162-402X			ONCOIMMUNOLOGY	OncoImmunology	FEB	2015	4	2							e976077	10.4161/2162402X.2014.976077		10	Oncology; Immunology	Oncology; Immunology	CC6KE	WOS:000350473000004		
J	Tan, KW; Evrard, M; Tham, M; Hong, M; Huang, C; Kato, M; Prevost-Blondel, A; Donnadieu, E; Ng, LG; Abastado, JP				Tan, Kar Wai; Evrard, Maximilien; Tham, Muly; Hong, Michelle; Huang, Caleb; Kato, Masashi; Prevost-Blondel, Armelle; Donnadieu, Emmanuel; Ng, Lai Guan; Abastado, Jean-Pierre			Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment	ONCOIMMUNOLOGY			English	Article						chemokines; temozolomide; tumor-infiltrating lymphocytes; tumor stroma	HEPARAN-SULFATE PROTEOGLYCAN; INFILTRATING LYMPHOCYTES; CUTANEOUS MELANOMA; DENDRITIC CELLS; IMMUNE CELLS; LYMPH-NODES; CANCER; EXPRESSION; CHEMOTHERAPY; SUPPRESSION	The infiltration of T lymphocytes within tumors is associated with better outcomes in cancer patients, yet current understanding of factors that influence T-lymphocyte infiltration into tumors remains incomplete. In our study, Temozolomide (TMZ), a chemotherapeutic drug used to treat metastatic melanoma, induced T-cell infiltration into transplanted melanoma and into genitourinary (GU) tumors in mice developing spontaneous melanoma. In contrast, TMZ treatment did not increase T-cell infiltration into cutaneous tumors, despite similar increases in the expression of the (C-X-C) chemokines CXCL9 and CXCL10 in all sites after TMZ exposure. Our findings reveal that the matrix architecture of the GU tumor stroma, and its ability to present CXCL9 and CXCL10 after TMZ treatment played a key role in favouring T-cell infiltration. We subsequently demonstrate that modifications of these key elements by combined collagenase and TMZ treatment induced T-cell infiltration into skin tumors. T cells accumulating within GU tumors after TMZ treatment exhibited T helper type-1 effector and cytolytic functional phenotypes, which are important for control of tumor growth. Our findings highlight the importance of the interaction between tumor stroma and chemokines in influencing T-cell migration into tumors, thereby impacting immune control of tumor growth. This knowledge will aid the development of strategies to promote T-cell infiltration into cancerous lesions and has the potential to markedly improve treatment outcomes.	[Tan, Kar Wai; Evrard, Maximilien; Tham, Muly; Ng, Lai Guan; Abastado, Jean-Pierre] ASTAR, BMSI, Singapore Immunol Network, Singapore, Singapore; [Hong, Michelle] Duke NUS Grad Med Sch, EID Program, Singapore, Singapore; [Kato, Masashi] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Environm & Occupat Hlth, Nagoya, Aichi 4648601, Japan; [Prevost-Blondel, Armelle; Donnadieu, Emmanuel] Univ Paris 05, CNRS, INSERM, Inst Cochin,Unit 1016,UMR 8104, Paris, France; [Tan, Kar Wai] Singapore Gen Hosp, Dept Clin Res, Singapore, Singapore	Tan, KW (reprint author), ASTAR, BMSI, Singapore Immunol Network, Singapore, Singapore.	tan.kar.wai@sgh.com.sg	Ng, Lai Guan/E-5673-2011	Ng, Lai Guan/0000-0003-1905-3586	SIgN, A*STAR, Singapore	This research was funded by SIgN, A*STAR, Singapore. The authors declare that no competing financial interests or conflicts exist.	Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Wittke F, 1999, BRIT J CANCER, V79, P1182, DOI 10.1038/sj.bjc.6690189; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Lowes MA, 1997, J INVEST DERMATOL, V108, P914, DOI 10.1111/1523-1747.ep12292705; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Lengagne R, 2008, J IMMUNOL, V180, P130; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; IWAMOTO T, 1991, EMBO J, V10, P3167; Lengagne R, 2004, CANCER RES, V64, P1496, DOI 10.1158/0008-5472.CAN-03-2828; Mishra Mithilesh, 2013, J Oral Maxillofac Pathol, V17, P31, DOI 10.4103/0973-029X.110704; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Roskams T, 1998, J PATHOL, V185, P290, DOI 10.1002/(SICI)1096-9896(199807)185:3<290::AID-PATH91>3.0.CO;2-I; Sabit H, 2001, PATHOL INT, V51, P248, DOI 10.1046/j.1440-1827.2001.01201.x; Schwaab T, 2000, J UROLOGY, V163, P1322, DOI 10.1016/S0022-5347(05)67771-3	39	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2162-402X			ONCOIMMUNOLOGY	OncoImmunology	FEB	2015	4	2							e978709	10.4161/2162402X.2014.978709		16	Oncology; Immunology	Oncology; Immunology	CC6KE	WOS:000350473000006		
J	Arai, Y				Arai, Yasuhiko			Development of in-plane and out-of-plane deformations simultaneous measurement method for the analysis of buckling	OPTICAL ENGINEERING			English	Article						electronic speckle pattern interferometry; buckling analysis; in-plane and out-of-plane deformation measurements; high-resolution deformation measurement; Euler buckling; the phase of difference method	SPECKLE-PATTERN-INTERFEROMETRY; FOURIER-TRANSFORM METHOD; DISPLACEMENT MEASUREMENT; DIGITAL HOLOGRAPHY; PHASE GRADIENTS; INTENSITY; ESPI	In the measurement of deformation of buckling phenomenon, the optical measurement methods have been traditionally employed for performing noncontact measurement. Furthermore, because the in-plane and out-of-plane deformations simultaneously happen in the buckling phenomena, these in-plane and out-of-plane deformations must be separated precisely by analyzing some measured results of dynamic events. In traditional methods, some two-beam interferometers have been combined to measure in-plane and out-of-plane deformations as three-dimensional deformations. An ordinary two-beam interferometer is defined as the optical system that is combined by two independent interferometers. Under this definition, a new interferometer that is set up by two cameras and one laser is constructed by using the idea of a speckle interferometer that uses only two speckle patterns. Then, an analysis method for separation of in-plane and out-of-plane deformations is also proposed. In the experimental results, the high measuring accuracy of the proposed methods is confirmed. Consequently, the independency between in-plane and out-of-plane measurements in this method is confirmed. Furthermore, the new method is applied to the analysis of the buckling phenomenon. As the results, it can be confirmed that the results of the beam of buckling analysis agree very well with the theory of Euler's buckling. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	Kansai Univ, Dept Mech Engn, Fac Engn Sci, Suita, Osaka 5648680, Japan	Arai, Y (reprint author), Kansai Univ, Dept Mech Engn, Fac Engn Sci, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	aria@kansai-u.ac.jp					MOORE AJ, 1990, MEAS SCI TECHNOL, V1, P1024, DOI 10.1088/0957-0233/1/10/006; Schedin S, 1999, APPL OPTICS, V38, P7056, DOI 10.1364/AO.38.007056; Arai Y, 2014, J MOD OPTIC, V61, P297, DOI 10.1080/09500340.2014.884651; Burke J, 1998, OPT COMMUN, V152, P144, DOI 10.1016/S0030-4018(98)00144-8; Arai Y, 2004, OPT ENG, V43, P2168, DOI 10.1117/1.1778731; Martinez A, 2004, APPL OPTICS, V43, P4652, DOI 10.1364/AO.43.004652; Bhaduri B, 2006, OPT EXPRESS, V14, P11598, DOI 10.1364/OE.14.011598; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Flynn EB, 2006, APPL OPTICS, V45, P3218, DOI 10.1364/AO.45.003218; Bhaduri B, 2008, J MOD OPTIC, V55, P861, DOI 10.1080/09500340701504306; Arai Y, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.3.034107; Takatsuji T, 1997, APPL OPTICS, V36, P1438, DOI 10.1364/AO.36.001438; Pavillon N, 2009, APPL OPTICS, V48, pH186, DOI 10.1364/AO.48.00H186; Pedrini G, 1997, APPL OPTICS, V36, P786, DOI 10.1364/AO.36.000786; Arai Y, 2011, MAPAN-J METROL SOC I, V26, P303, DOI 10.1007/s12647-011-0028-z; Bleich F., 1952, BUCKLING STRENGTH ME, P1; Cloud G, 1995, OPTICAL METHODS ENG, P395, DOI 10.1017/CBO9780511575013.018; Jia HK, 2014, OPT LASER ENG, V54, P263, DOI 10.1016/j.optlaseng.2013.08.004; Malacara D, 1992, OPTICAL SHOP TESTING, P501; Miura N., 2012, J SOLID MECH MAT ENG, V6, P545; Sirohi RS, 1997, APPL OPTICS, V36, P5787, DOI 10.1364/AO.36.005787; Sirohi R. S., 1993, SPECKLE METROLOGY, P99; Sirohi RS, 1996, OPT LETT, V21, P1958, DOI 10.1364/OL.21.001958; Thompson B. J., 1996, ELECT SPECKLE PATTER, P1	24	2	2	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	FEB	2015	54	2							024102	10.1117/1.OE.54.2.024102		7	Optics	Optics	CC6NM	WOS:000350481900010		
J	Nagahara, H; Yagi, Y				Nagahara, Hajime; Yagi, Yasushi			Lensless imaging for wide field of view	OPTICAL ENGINEERING			English	Article						wide field of view; lensless imaging; catoptric system		It is desirable to engineer a small camera with a wide field of view (FOV) because of current developments in the field of wearable cameras and computing products, such as action cameras and Google Glass. However, typical approaches for achieving wide FOV, such as attaching a fisheye lens and convex mirrors, require a trade-off between optics size and the FOV. We propose camera optics that achieve a wide FOV, and are at the same time small and lightweight. The proposed optics are a completely lensless and catoptric design. They contain four mirrors, two for wide viewing, and two for focusing the image on the camera sensor. The proposed optics are simple and can be simply miniaturized, since we use only mirrors for the proposed optics and the optics are not susceptible to chromatic aberration. We have implemented the prototype optics of our lensless concept. We have attached the optics to commercial charge-coupled device/complementary metal oxide semiconductor cameras and conducted experiments to evaluate the feasibility of our proposed optics. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Nagahara, Hajime] Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, Fukuoka 8190395, Japan; [Yagi, Yasushi] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Nagahara, H (reprint author), Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nagahara@ait.kyushu-u.ac.jp					Baker S, 1999, INT J COMPUT VISION, V35, P175, DOI 10.1023/A:1008128724364; Nayar SK, 1997, PROC CVPR IEEE, P482, DOI 10.1109/CVPR.1997.609369; [Anonymous], 2013, [No title captured], Patent No. 8503109; Hecht E., 1974, OPTICS; Hong J., 1991, P IEEE INT C ROB AUT, V1, P620; Kingslake Rudolf, 1989, HIST PHOTOGRAPHIC LE, P145; Nayar S. K., 1999, IEEE CVPR, V2, P217; YAGI Y, 1994, IEEE T ROBOTIC AUTOM, V10, P11, DOI 10.1109/70.285581; Yagi Y, 2004, INT J COMPUT VISION, V58, P173, DOI 10.1023/B:VISI.0000019684.35147.fc; Yamazawa K., 1993, P IEEE RSJ INT C ROB	10	1	1	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	FEB	2015	54	2							025114	10.1117/1.OE.54.2.025114		8	Optics	Optics	CC6NM	WOS:000350481900032		
J	Satomi, G				Satomi, Gengi			Guidelines for fetal echocardiography	PEDIATRICS INTERNATIONAL			English	Article							CONGENITAL HEART-DISEASE; COMPLETE ATRIOVENTRICULAR-BLOCK; PRENATAL-DIAGNOSIS; SUPRAVENTRICULAR TACHYCARDIA; CARDIAC-MALFORMATIONS; CLINICAL-SIGNIFICANCE; ATRIAL-FLUTTER; GREAT-ARTERIES; 4-CHAMBER VIEW; IN-UTERO		[Satomi, Gengi] Nagano Childrens Hosp, Dept Pediat Cardiol, Azumino, Nagano, Japan	Satomi, G (reprint author), Nagano Childrens Hosp, Dept Pediat Cardiol, Azumino, Nagano, Japan.	g3_satomi8688@bc4.so-net.ne.jp					Allan LD, 1990, FETAL NEONATAL CARDI, P180, DOI WB Saunders; Allan LD, 2000, SEMIN PERINATOL, V24, P324, DOI 10.1053/sper.2000.16551; Duke C, 2001, AM J CARDIOL, V88, P1379, DOI 10.1016/S0002-9149(01)02117-8; Nield LE, 2002, CIRCULATION, V105, P843, DOI 10.1161/hc0702.104182; Kirk JS, 1997, OBSTET GYNECOL, V89, P227, DOI 10.1016/S0029-7844(96)00510-8; SMITH RS, 1995, OBSTET GYNECOL, V85, P187, DOI 10.1016/0029-7844(94)00350-M; Buskens E, 1996, CIRCULATION, V94, P67; ACHIRON R, 1992, BRIT MED J, V304, P671; ANDERSON N, 1995, AM J ROENTGENOL, V165, P943; Strasburger JF, 2004, CIRCULATION, V109, P375, DOI 10.1161/01.CIR.0000109494.05317.58; KIRK JS, 1994, OBSTET GYNECOL, V84, P427; Cuneo BF, 2000, OBSTET GYNECOL, V96, P575, DOI 10.1016/S0029-7844(00)00996-0; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; COPEL JA, 1987, AM J OBSTET GYNECOL, V157, P648; DEVORE GR, 1993, J ULTRAS MED, V12, P659; Oudijk MA, 2000, CIRCULATION, V101, P2721; Naheed ZJ, 1996, J AM COLL CARDIOL, V27, P1736, DOI 10.1016/0735-1097(96)00054-X; Bonnet D, 1999, CIRCULATION, V99, P916; Moak JP, 2001, J AM COLL CARDIOL, V37, P238, DOI 10.1016/S0735-1097(00)01048-2; Shinohara K, 1999, OBSTET GYNECOL, V93, P952, DOI 10.1016/S0029-7844(99)00006-X; ten Cate FEAU, 2001, J AM COLL CARDIOL, V37, P1129; SHIPP TD, 1995, OBSTET GYNECOL, V85, P97, DOI 10.1016/0029-7844(94)00328-B; Montana E, 1996, J AM COLL CARDIOL, V28, P1805; Kirk JS, 1999, OBSTET GYNECOL, V93, P189, DOI 10.1016/S0029-7844(98)00391-3; Buyon JP, 1998, J AM COLL CARDIOL, V31, P1658, DOI 10.1016/S0735-1097(98)00161-2; Tworetzky W, 2001, CIRCULATION, V103, P1269; Simpson JM, 1998, HEART, V79, P576; Simpson JM, 1997, PEDIATR CARDIOL, V18, P78, DOI 10.1007/s002469900118; Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67; Maeno YV, 1999, CIRCULATION, V99, P1209; SILVERMAN NH, 1985, CIRCULATION, V72, P825; Jaeggi ET, 2002, J AM COLL CARDIOL, V39, P130, DOI 10.1016/S0735-1097(01)01697-7; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; BLANCH G, 1994, LANCET, V344, P1646, DOI 10.1016/S0140-6736(94)90445-6; Buskens E, 1996, OBSTET GYNECOL, V87, P423, DOI 10.1016/0029-7844(95)00439-4; CARPENTER RJ, 1986, J AM COLL CARDIOL, V8, P1434; Chaoui R, 2003, ULTRASOUND OBST GYN, V21, P81, DOI 10.1002/uog.5; Comstock CH, 2000, SEMIN PERINATOL, V24, P331, DOI 10.1053/sper.2000.16724; Comstock CH, 1998, OBSTET GYNECOL, V91, P495, DOI 10.1016/S0029-7844(98)00018-0; COPEL JA, 1995, AM J OBSTET GYNECOL, V173, P1384, DOI 10.1016/0002-9378(95)90621-5; DEVORE GR, 1992, J ULTRAS MED, V11, P345; DEWOLF D, 1988, ACTA PAEDIATR SCAND, V77, P616; Ebenroth ES, 2001, PEDIATR CARDIOL, V22, P483, DOI 10.1007/s002460010279; Feigenbaum H, 1994, ECHOCARDIOGR-J CARD, P431; Fouron JC, 2003, HEART, V89, P1211, DOI 10.1136/heart.89.10.1211; FROHNMULDER IM, 1994, J AM COLL CARDIOL, V23, P1677; GEMBRUCH U, 1993, AM HEART J, V125, P1290, DOI 10.1016/0002-8703(93)90997-N; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Groves AMM, 1996, HEART, V75, P190, DOI 10.1136/hrt.75.2.190; GROVES AMM, 1995, CIRCULATION, V92, P3394; HORGER EO, 1989, OBSTET GYNECOL, V74, P617; HORNBERGER LK, 1995, CIRCULATION, V92, P1531; HUHTA JC, 1986, J AM COLL CARDIOL, V8, P451; Jaeggi E, 1998, HEART, V79, P582; Jaeggi E, 1998, J PEDIATR-US, V132, P335, DOI 10.1016/S0022-3476(98)70455-X; Kasanuki H, 2001, JPN CIR J S5, V65, P1127; Krapp M, 1997, ULTRASOUND OBST GYN, V10, P32, DOI 10.1046/j.1469-0705.1997.10010032.x; Lisowski LA, 2000, J AM COLL CARDIOL, V35, P771, DOI 10.1016/S0735-1097(99)00589-6; Maeno Y., 2002, ANN REV CARDIOLOGY 2, P176; Maeno Y, 1993, PEDIAT ECHOCARDIOGRA, P54; Maeno Y, 2003, ULTRASOUND OBST GYN, V21, P234, DOI 10.1002/uog.71; Pepas LP, 2003, CARDIOL YOUNG, V13, P240; Rein AJJT, 2002, CIRCULATION, V106, P1827, DOI 10.1161/01.CIR.0000031571.92807.CC; Respondek M, 1997, PEDIATR CARDIOL, V18, P361, DOI 10.1007/s002469900201; Rosenthal D, 1998, OBSTET GYNECOL, V92, P689, DOI 10.1016/S0029-7844(98)00149-5; Rosenthal R., 2000, TXB FETAL CARDIOLOGY, P438; Satomi G, 1998, P 2 WORLD C PED CARD, P618; Satomi G, 2000, SHONIKA, V41, P634; Satomi G, 1999, ATLAS ECHOCARDIOGRAP, P218; Satomi G, 1999, PEDIATR INT, V41, P728, DOI 10.1046/j.1442-200x.1999.01154.x; Satomi G, 2001, CLIN DEV CARDIOLOGY, P65; SCHMIDT KG, 1991, J AM COLL CARDIOL, V17, P1360; SHARLAND GK, 1992, BRIT J OBSTET GYNAEC, V99, P220, DOI 10.1111/j.1471-0528.1992.tb14503.x; Simpson J, 2000, TXB FETAL CARDIOLOGY, P423; SMYTHE JF, 1992, AM J CARDIOL, V69, P1471, DOI 10.1016/0002-9149(92)90903-C; TULZER G, 1994, EUR J PEDIATR, V153, P151, DOI 10.1007/BF01958973; vansEngelen AD, 1994, J AM COLL CARDIOL, V24, P1371; Wakai RT, 2003, CIRCULATION, V107, P307, DOI 10.1161/01.CIR.0000043801.92580.79	78	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					1	21		10.1111/ped.12467		21	Pediatrics	Pediatrics	CC4TN	WOS:000350346800007		
J	Ohtsuka, Y				Ohtsuka, Yoshikazu			Food intolerance and mucosal inflammation	PEDIATRICS INTERNATIONAL			English	Review						C-X-C motif chemokine ligand 13; food protein-induced proctocolitis; high-affinity IgE receptor type I; IgA; mucosal damage; neonatal transient enterocolitis	INTESTINAL EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; EOSINOPHIL CATIONIC PROTEIN; HIGH-AFFINITY RECEPTOR; COWS MILK ALLERGY; T-CELLS; MOUSE INTESTINE; GROWTH-FACTOR; MAST-CELL; HYPERSENSITIVITY REACTIONS	Most infants are immunologically active and are able to develop a tolerance to oligoclonal antigens by producing IgA, along with activation of regulatory T cells, in early infancy. Cytokines and their signaling molecules are important mediators in the intestine, regulating both oral tolerance and mucosal inflammation. This system works efficiently in most individuals, but for an as yet undefined reason, some people react to food and other proteins as though they were pathogens, with induction of chronic inflammation in the mucosa. The adverse reaction caused by ingested foods is defined as food intolerance. The clinical features of food intolerance include vomiting, diarrhea, bloody stool, eczema, failure to thrive, and a protean range of other symptoms. Intolerance can be divided into two categories depending on whether or not they are immunologically mediated. Food intolerance and mucosal inflammation are deeply related because tolerance cannot be established when there is an inflammation in the intestinal mucosa. Mast cells, eosinophils, mucosal lymphocytes, and epithelial cells are deeply involved and related to each other in the development of mucosal inflammation. Meanwhile, rectal bleeding in infancy is related to lymphoid hyperplasia with eosinophil infiltration into the colonic mucosa facilitated by C-C motif ligand 11 (CCL11, known as eotaxin-1) and C-X-C motif chemokine ligand 13 (CXCL13). Rectal bleeding in infancy may not be simply caused by allergic reactions against specific antigens, but may be due to migrated lymphocytes developing immunological tolerance; including IgA synthesizing, in the intestinal mucosa.	[Ohtsuka, Yoshikazu] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo 1138421, Japan	Ohtsuka, Y (reprint author), Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescence Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yohtsuka@med.juntendo.ac.jp					AMENT ME, 1972, GASTROENTEROLOGY, V62, P227; Ohno Y, 1997, P NATL ACAD SCI USA, V94, P10279, DOI 10.1073/pnas.94.19.10279; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Ohtsuka Y, 2012, J ALLERGY CLIN IMMUN, V129, P1676, DOI 10.1016/j.jaci.2012.01.042; Ohtsuka Y, 2012, PEDIATR RES, V71, P46, DOI 10.1038/pr.2011.11; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; Grulee CG, 1936, J PEDIATR-US, V9, P223, DOI 10.1016/S0022-3476(36)80058-4; WALKERSMITH JA, 1984, ANN ALLERGY, V53, P629; PRESTA LG, 1993, J IMMUNOL, V151, P2623; Majamaa H, 1996, CLIN EXP ALLERGY, V26, P181, DOI 10.1111/j.1365-2222.1996.tb00078.x; ISHIZAKA K, 1966, J IMMUNOL, V97, P75; Fusunyan RD, 1998, PEDIATR RES, V43, P84, DOI 10.1203/00006450-199801000-00013; Ohtsuka Y, 2011, J PEDIATR SURG, V46, P489, DOI 10.1016/j.jpedsurg.2010.07.032; HEYMAN M, 1994, GASTROENTEROLOGY, V106, P1514; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Arslanoglu S, 2008, J NUTR, V138, P1091; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Nonaka Y, 2008, INT ARCH ALLERGY IMM, V145, P249, DOI 10.1159/000109294; Ohtsuka Y, 2003, PEDIATR RES, V53, P143, DOI 10.1203/01.PDR.0000041519.16507.06; Caffarelli C, 1998, PEDIATR RES, V44, P485, DOI 10.1203/00006450-199810000-00004; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Kim JY, 2010, PEDIAT ALLERG IMM-UK, V21, pE386, DOI 10.1111/j.1399-3038.2009.00958.x; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; BajajElliott M, 1997, AM J PATHOL, V151, P1469; Bengtsson U, 1997, J ALLERGY CLIN IMMUN, V100, P216, DOI 10.1016/S0091-6749(97)70227-6; CAPRON M, 1981, J IMMUNOL, V126, P2087; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; CROWE SE, 1995, GASTROENTEROLOGY, V108, P65, DOI 10.1016/0016-5085(95)90009-8; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Furuta GT, 1997, GASTROENTEROLOGY, V113, P1560, DOI 10.1053/gast.1997.v113.pm9352858; GOLDMAN AS, 1963, PEDIATRICS, V32, P425; Grulee CG, 1934, J AMER MED ASSOC, V103, P0735; Iacono G, 1998, NEW ENGL J MED, V339, P1100, DOI 10.1056/NEJM199810153391602; JALONEN T, 1991, J ALLERGY CLIN IMMUN, V88, P737, DOI 10.1016/0091-6749(91)90180-V; KAPLAN B, 1984, J PEDIATR GASTR NUTR, V3, P704, DOI 10.1097/00005176-198411000-00012; KOSNAI I, 1984, J PEDIATR GASTR NUTR, V3, P368, DOI 10.1097/00005176-198406000-00011; MACDONALD TT, 1977, CELL TISSUE KINET, V10, P301, DOI 10.1111/j.1365-2184.1977.tb00298.x; MACDONALD TT, 1976, GUT, V17, P81, DOI 10.1136/gut.17.2.81; Marth T, 1999, J IMMUNOL, V162, P7233; Marth T, 1997, EUR J IMMUNOL, V27, P1213, DOI 10.1002/eji.1830270524; McCormick BA, 1998, J IMMUNOL, V160, P455; Mori M, 2014, PEDIATR INT, V56, P884, DOI 10.1111/ped.12366; NOLTE H, 1989, ALLERGY, V44, P554, DOI 10.1111/j.1398-9995.1989.tb04200.x; OFARRELLY C, 1991, J ORAL PATHOL MED, V20, P476, DOI 10.1111/j.1600-0714.1991.tb00407.x; Ohtsuka Y, 1999, PEDIATR RES, V45, P300, DOI 10.1203/00006450-199903000-00002; Ohtsuka Y, 2001, PROBLEMS PRACTICAL P, P247; Ohtsuka Y, 1998, PEDIATR RES, V44, P791, DOI 10.1203/00006450-199811000-00025; Ohtsuka Y, 2007, J PEDIATR GASTR NUTR, V44, P501, DOI 10.1097/01.mpg.0000252194.06955.18; Pender SLF, 1997, J IMMUNOL, V158, P1582; PHILLIPS AD, 1979, GUT, V20, P509, DOI 10.1136/gut.20.6.509; RA C, 1993, INT IMMUNOL, V5, P47, DOI 10.1093/intimm/5.1.47; Rognum TO, 1992, INT ARCH ALLER A IMM, V89, P256; SANDERSON IR, 1993, GASTROENTEROLOGY, V104, P622; Shima T, 2008, FEMS IMMUNOL MED MIC, V52, P69, DOI 10.1111/j.1574-695X.2007.00344.x; Skripak JM, 2008, CURR OPIN IMMUNOL, V20, P690, DOI 10.1016/j.coi.2008.09.002; STEINIGER B, 1989, IMMUNOLOGY, V68, P507; VENGE P, 1987, INT ARCH ALLER A IMM, V82, P333; Weinstein DL, 1997, INFECT IMMUN, V65, P395; Wershil BK, 1996, GASTROENTEROLOGY, V110, P1482, DOI 10.1053/gast.1996.v110.pm8613053; Woodbury RM, 1922, M J HYG, V2, P668; Wright R, 1987, FOOD ALLERGY INTOLER, P248	63	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					22	29		10.1111/ped.12546		8	Pediatrics	Pediatrics	CC4TN	WOS:000350346800008		
J	Haga, N; Kubota, M; Miwa, Z				Haga, Nobuhiko; Kubota, Masaya; Miwa, Zenzo		Japanese Res Grp Congenital	Hereditary sensory and autonomic neuropathy types IV and V in Japan	PEDIATRICS INTERNATIONAL			English	Review						anhidrosis; Charcot's joint; complications; congenital insensitivity to pain; hereditary sensory and autonomic neuropathies	NERVE GROWTH-FACTOR; TRKA/NGF RECEPTOR GENE; CONGENITAL INSENSITIVITY; FAMILIAL INSENSITIVITY; PAIN; ANHIDROSIS; MUTATION; MANIFESTATIONS; LESSONS	Hereditary sensory and autonomic neuropathy (HSAN) is a group of genetic disorders involving varying sensory and autonomic dysfunction. HSAN types IV and V are characterized by congenital generalized loss of pain and thermal sensation. HSAN type IV is additionally accompanied by decreased sweating and intellectual disability. From 2010 to 2013, we (members of the Japanese Research Group on Congenital Insensitivity to Pain) carried out research on HSAN types IV and V. Research by this group included epidemiological data, examination of clinical findings, solutions of disease etiology, investigation of complications and development of their management. Complications were categorized into musculoskeletal complications, oral/dental complications, dermal complications, ocular complications, complications resulting from impaired thermal control, anesthetic considerations, other complications possibly related to autonomic dysfunction, and abnormal mental development and behavior. Treatment and care for patients with HSAN types IV and V require a wide range of knowledge and experience, and a multidisciplinary team approach. Therefore, we produced the Guideline of Total Management and Care for Congenital Insensitivity to Pain (Ver.1) in 2012, to provide information for medical specialists based on our knowledge and experience. This guideline includes medical issues, as well as descriptions of social participation and welfare. This review outlines the situation of HSAN types IV and V in Japan, and the recommendations of treatment and care for patients, mostly based on research conducted by the Japanese Research Group.	[Haga, Nobuhiko] Univ Tokyo, Dept Rehabil Med, Tokyo 1138655, Japan; [Kubota, Masaya] Natl Ctr Child Hlth & Dev, Div Neurol, Tokyo, Japan; [Miwa, Zenzo] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat Dent, Tokyo, Japan	Haga, N (reprint author), Univ Tokyo, Dept Rehabil Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hagan-reh@h.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare; JSPS KAKENHI [26120008]	We appreciate the contribution of co-researchers in the Japanese Research Group on Congenital Insensitivity to Pain, including Shiro Amano, Yasuhiro Indo, Chizuko Tanaka, Toshiya Tomioka, Naoko Baba, Kenji Nihei, Kikuko Ikeda, Tomoko Uehara, Tetsuji Sato, Kumiko Sugimoto, Masakazu Ikeda, Tomoko Kubodera, Kimiko Shirakawa, Fumiko Hamabe, Noritaka Kawashima, Makoto Nozaki, Hiroshi Tanaka, Masahiro Iijima, Arito Yozu, and Yasu Zhang. We also express our sincere appreciation to all of the participants of this study, especially the nationwide Patients' and Supporters' Society for Congenital Insensitivity to Pain with Anhidrosis "Tomorrow". We dedicate this article to Yutaka Awaya, a pediatric neurologist, and Nobuyuki Tanaka, a pediatric orthopedic surgeon, both of whom passed away during the research period, in appreciation of their continued great contribution to the support of patients and our research. This work was partly supported by Health and Labour Sciences Research Grants for Research on Intractable Diseases, the Ministry of Health, Labour and Welfare, and by JSPS KAKENHI, a Grant-in-Aid for ScientificResearch on Innovative Areas (Grant Number 26120008). The authors have no conflicts of interest to declare.	Amano A, 1998, ORAL SURG ORAL MED O, V86, P425, DOI 10.1016/S1079-2104(98)90368-7; Amano S, 2006, AM J OPHTHALMOL, V141, P472, DOI 10.1016/j.ajo.2005.10.016; SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Sayyahfar S, 2013, PEDIATR DERMATOL, V30, P754, DOI 10.1111/j.1525-1470.2012.01833.x; Tomioka T, 2002, ANESTH ANALG, V94, P271, DOI 10.1097/00000539-200202000-00008; Shatzky S, 2000, AM J MED GENET, V92, P353, DOI 10.1002/1096-8628(20000619)92:5<353::AID-AJMG12>3.0.CO;2-C; Zhang YR, 2013, SOLID STATE SCI, V16, P16, DOI 10.1016/j.solidstatesciences.2012.11.012; Rotthier A, 2012, NAT REV NEUROL, V8, P73, DOI 10.1038/nrneurol.2011.227; ROSEMBERG S, 1994, PEDIATR NEUROL, V11, P50, DOI 10.1016/0887-8994(94)90091-4; Rozentsveig V, 2004, PEDIATR ANESTH, V14, P344, DOI 10.1046/j.1460-9592.2003.01235.x; DYCK PJ, 1983, BRAIN, V106, P373, DOI 10.1093/brain/106.2.373; Miyamoto H, 2012, J NEUROSCI, V32, P14794, DOI 10.1523/JNEUROSCI.0793-12.2012; Nolano M, 2000, CLIN NEUROPHYSIOL, V111, P1596, DOI 10.1016/S1388-2457(00)00351-5; Kawashima N, 2012, EXP BRAIN RES, V218, P579, DOI 10.1007/s00221-012-3050-7; Yuan JH, 2013, NEUROLOGY, V80, P1641, DOI 10.1212/WNL.0b013e3182904fdd; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; Bar-On E, 2002, J BONE JOINT SURG BR, V84B, P252, DOI 10.1302/0301-620X.84B2.11939; Erez DL, 2010, DEV MED CHILD NEUROL, V52, P559, DOI 10.1111/j.1469-8749.2009.03567.x; Feldman DS, 2009, J PEDIATR ORTHOPED, V29, P91, DOI 10.1097/BPO.0b013e31818f9cc4; Haga N, 2013, AM J MED GENET A, V161A, P871, DOI 10.1002/ajmg.a.35803; Iijima M, 2010, CHILD NERV SYST, V26, P1085, DOI 10.1007/s00381-009-1057-6; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Indo Y, 2010, EXPERT REV NEUROTHER, V10, P1707, DOI [10.1586/ern.10.154, 10.1586/ERN.10.154]; Indo Y, 2012, CLIN GENET, V82, P341, DOI 10.1111/j.1399-0004.2012.01943.x; Kubota M., 2000, RECENT ADV CHILD DEV, P164; Mimura T, 2008, CURR EYE RES, V33, P940, DOI 10.1080/02713680802450992; Minde J, 2004, MUSCLE NERVE, V30, P752, DOI 10.1002/mus.20172; Minde J, 2006, ACTA ORTHOP, V77, P198, DOI 10.1080/17453670610045911; Segawa M, 2006, SLEEP BIOL RHYTHMS, V4, P4, DOI 10.1111/j.1479-8425.2006.00205.x; Segawa M, 2005, BRAIN DEV-JPN, V27, pS54, DOI 10.1016/j.braindev.2004.11.010; Szoke G, 1996, INT ORTHOP, V20, P107, DOI 10.1007/s002640050041; Tomioka Toshiya, 2002, J Anesth, V16, P84, DOI 10.1007/s540-002-8100-y; Yagev R, 1999, AM J OPHTHALMOL, V127, P322, DOI 10.1016/S0002-9394(98)00370-5; Yotsumoto S, 1999, J INVEST DERMATOL, V112, P810, DOI 10.1046/j.1523-1747.1999.00569.x; Zhang Y, 2014, J ORTHOP SCI, V19, P827, DOI 10.1007/s00776-014-0595-2	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					30	36		10.1111/ped.12538		7	Pediatrics	Pediatrics	CC4TN	WOS:000350346800009		
J	Nakamura, K; Matsumoto, S; Mitsubuchi, H; Endo, F				Nakamura, Kimitoshi; Matsumoto, Shirou; Mitsubuchi, Hiroshi; Endo, Fumio			Diagnosis and treatment of hereditary tyrosinemia in Japan	PEDIATRICS INTERNATIONAL			English	Review						liver cancer; liver transplantation; nitisinone; succinylacetone; tyrosine	4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; MICE; FUMARYLACETOACETATE; RESCUE; TYPE-1	Hereditary tyrosinemia is an autosomal recessive inherited disease that manifests as three types (types I-III). We conducted a nationwide survey of this disease in Japan, and here review the results in relation to prevalence, clinical characteristics, and treatment and diagnosis. A definitive diagnosis of tyrosinemia type I is difficult to obtain based only on blood tyrosine level. Detection of succinylacetone using dried blood spots or urinary organic acid analysis, however, is useful for diagnosis. In tyrosinemia type I, dietary therapy and nitisinone (Orfandin (R)) are effective. Prognosis is greatly affected by the complications of liver cancer and hypophosphatemic rickets; even patients that are treated early with nitisinone may develop liver cancer. Long-term survival can be expected in type I if nitisinone therapy is effective. Prognosis in types II and III is relatively good.	[Nakamura, Kimitoshi; Matsumoto, Shirou; Endo, Fumio] Kumamoto Univ Hosp, Dept Pediat, Kumamoto 8608556, Japan; [Mitsubuchi, Hiroshi] Kumamoto Univ Hosp, Dept Neonatol, Kumamoto 8608556, Japan	Nakamura, K (reprint author), Kumamoto Univ Hosp, Dept Pediat, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	nakamura@kumamoto-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan	The work was supported by a Grant-in-Aid from the Ministry of Health, Labor, and Welfare of Japan. We thank Dr Torayuki Okuyama and Dr Mureo Kawahara of the National Center for Child Health and Development, Dr Michinori Ito of Kagawa National Children's Hospital, and Dr Go Tajima of Hiroshima University for useful discussions and information. The authors declare no conflicts of interest.	Kubo S, 1998, P NATL ACAD SCI USA, V95, P9552, DOI 10.1073/pnas.95.16.9552; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; Scott CR, 2006, AM J MED GENET C, V142C, P121, DOI 10.1002/ajmg.c.30092; Endo F, 1997, J BIOL CHEM, V272, P24426, DOI 10.1074/jbc.272.39.24426; FOIS A, 1986, J INHERIT METAB DIS, V9, P262, DOI 10.1007/BF01799723; KELSEY G, 1993, GENE DEV, V7, P2285, DOI 10.1101/gad.7.12a.2285; Mayorandan S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0107-7; Meissner T, 2008, PEDIATR DERMATOL, V25, P378, DOI 10.1111/j.1525-1470.2008.00687.x; Mitchell GA, 2001, METABOLIC MOL BASES, V2, P1777; Nakamura K., 2007, J NUTR, V137, p1573S; RICE DN, 1989, J INHERIT METAB DIS, V12, P13, DOI 10.1007/BF01805526	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					37	40		10.1111/ped.12550		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800010		
J	Hori, T; Yamaguchi, S; Shinkaku, H; Horikawa, R; Shigematsu, Y; Takayanagi, M; Fukao, T				Hori, Tomohiro; Yamaguchi, Seiji; Shinkaku, Haruo; Horikawa, Reiko; Shigematsu, Yosuke; Takayanagi, Masaki; Fukao, Toshiyuki			Inborn errors of ketone body utilization	PEDIATRICS INTERNATIONAL			English	Review						inborn errors of ketone body utilization; ketone body; ketone body metabolism; mitochondrial acetoacetyl-CoA thiolase (beta-ketothiolase; T2) deficiency; succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency	2-METHYL-3-HYDROXYBUTYRYL-COA DEHYDROGENASE-DEFICIENCY; SUCCINYL-COA-3-KETOACID COA-TRANSFERASE; SINGLE-BASE SUBSTITUTION; THIOLASE T2 DEFICIENCY; BETA-KETOTHIOLASE DEFICIENCY; URINARY ORGANIC-ACID; SPLICE DONOR SITE; SUCCINYL-COA; ISOLEUCINE METABOLISM; SCOT DEFICIENCY	Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency and mitochondrial acetoacetyl-CoA thiolase (beta-ketothiolase or T2) deficiency are classified as autosomal recessive disorders of ketone body utilization characterized by intermittent ketoacidosis. Patients with mutations retaining no residual activity on analysis of expression of mutant cDNA are designated as severe genotype, and patients with at least one mutation retaining significant residual activity, as mild genotype. Permanent ketosis is a pathognomonic characteristic of SCOT-deficient patients with severe genotype. Patients with mild genotype, however, may not have permanent ketosis, although they may develop severe ketoacidotic episodes similar to patients with severe genotype. Permanent ketosis has not been reported in T2 deficiency. In T2-deficient patients with severe genotype, biochemical diagnosis is done on urinary organic acid analysis and blood acylcarnitine analysis to observe characteristic findings during both ketoacidosis and non-episodic conditions. In Japan, however, it was found that T2-deficient patients with mild genotype are common, and typical profiles were not identified on these analyses. Based on a clinical study of ketone body utilization disorders both in Japan and worldwide, we have developed guidelines for disease diagnosis and treatment. These diseases are treatable by avoiding fasting and by providing early infusion of glucose, which enable the patients to grow without sequelae.	[Hori, Tomohiro; Fukao, Toshiyuki] Gifu Univ, Dept Pediat, Grad Sch Med, Gifu 5011194, Japan; [Yamaguchi, Seiji] Shimane Univ, Fac Med, Dept Pediat, Izumo, Shimane, Japan; [Shinkaku, Haruo] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan; [Horikawa, Reiko] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo, Japan; [Shigematsu, Yosuke] Univ Fukui, Fac Med Sci, Dept Hlth Sci, Fukui 910, Japan; [Takayanagi, Masaki] Chiba Childrens Hosp, Div Emergency & Gen Med, Chiba, Japan	Fukao, T (reprint author), Gifu Univ, Dept Pediat, Grad Sch Med, Yanagido 1-1, Gifu 5011194, Japan.	toshi-gif@umin.net					Fukao T, 2002, MOL GENET METAB, V75, P235, DOI 10.1006/mgme.2001.3288; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; Zschocke J, 2012, J INHERIT METAB DIS, V35, P81, DOI 10.1007/s10545-011-9415-4; Baric I, 2001, J INHERIT METAB DIS, V24, P81, DOI 10.1023/A:1005671109585; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; Buhas D, 2013, MOVEMENT DISORD, V28, P1054, DOI 10.1002/mds.25538; Catanzano F, 2010, J INHERIT METAB DIS, V33, pS91, DOI 10.1007/s10545-009-9028-3; Cazorla MR, 2007, PEDIATR NEUROL, V36, P264, DOI 10.1016/j.pediatrneurol.2006.11.014; CORNBLAT.M, 1971, J PEDIATR-US, V79, P413, DOI 10.1016/S0022-3476(71)80149-X; DAUM RS, 1971, LANCET, V2, P1289; Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169; Fukao T, 2000, GENOMICS, V68, P144, DOI 10.1006/geno.2000.6282; Fukao T, 2010, MOL GENET METAB, V100, P339, DOI 10.1016/j.ymgme.2010.03.012; Fukao T, 2010, MOL GENET METAB, V100, P37, DOI 10.1016/j.ymgme.2010.01.007; Fukao T, 2014, J HUM GENET, V59, P609, DOI 10.1038/jhg.2014.79; Fukao T, 2008, MOL GENET METAB, V94, P417, DOI 10.1016/j.ymgme.2008.04.014; Fukao T, 2012, JIMD REP, V3, P107, DOI 10.1007/8904_2011_72; Fukao T, 2003, J INHERIT METAB DIS, V26, P423, DOI 10.1023/A:1025117226051; Fukao T, 2003, HUM MUTAT, V21, P587, DOI 10.1002/humu.10209; Fukao T, 2011, BBA-MOL BASIS DIS, V1812, P619, DOI 10.1016/j.bbadis.2011.01.015; Fukao T, 2010, J INHERIT METAB DIS, V33, P307, DOI DOI 10.1007/S10545-010-9168-5; Fukao T, 1996, PRENATAL DIAG, V16, P471, DOI 10.1002/(SICI)1097-0223(199605)16:5<471::AID-PD898>3.3.CO;2-5; Fukao T, 2006, MOL GENET METAB, V89, P280, DOI 10.1016/j.ymgme.2006.04.014; Fukao T, 1998, HUM MUTAT, V12, P245, DOI 10.1002/(SICI)1098-1004(1998)12:4<245::AID-HUMU5>3.0.CO;2-E; Fukao T, 2004, PEDIATR RES, V56, P858, DOI 10.1203/01.PDR.0000145297.90577.67; Fukao T, 2001, MOL GENET METAB, V72, P109, DOI 10.1006/mgme.2000.3113; Fukao T, 2007, MOL GENET METAB, V92, P216, DOI 10.1016/j.ymgme.2007.07.005; Garcia-Villoria J, 2010, EUR J HUM GENET, V18, P1353, DOI 10.1038/ejhg.2010.118; Garcia-Villoria J, 2009, CLIN BIOCHEM, V42, P27, DOI 10.1016/j.clinbiochem.2008.10.006; Hori T, 2013, HUM MUTAT, V34, P473, DOI 10.1002/humu.22258; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Longo N, 2004, J INHERIT METAB DIS, V27, P691, DOI 10.1023/B:BOLI.0000043023.57321.18; Merron S, 2009, INT J OBSTET ANESTH, V18, P280, DOI 10.1016/j.ijoa.2009.02.001; Mitchell GA, 2001, METABOLIC MOL BASES, P2327; Mrazova L, 2005, J INHERIT METAB DIS, V28, P235, DOI 10.1007/s10545-005-7497-6; Nakamura K, 2001, MOL GENET METAB, V72, P115, DOI 10.1006/mgme.2000.3125; NiezenKoning KE, 1997, EUR J PEDIATR, V156, P870, DOI 10.1007/s004310050733; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Olpin SE, 2002, J INHERIT METAB DIS, V25, P477, DOI 10.1023/A:1021251202287; Perez-Cerda Celia, 2005, Pediatr Res, V58, P488, DOI 10.1203/01.pdr.0000176916.94328.cd; PEREZCERDA C, 1992, J INHERIT METAB DIS, V15, P371, DOI 10.1007/BF02435979; Poll-The BT, 2004, MOL GENET METAB, V81, P295, DOI 10.1016/j.ymgme.2003.11.013; Pretorius CJ, 1996, J INHERIT METAB DIS, V19, P296, DOI 10.1007/BF01799257; Rolland MO, 1998, J INHERIT METAB DIS, V21, P687, DOI 10.1023/A:1005453105414; SAKAZAKI H, 1995, J INHERIT METAB DIS, V18, P323, DOI 10.1007/BF00710423; Sakurai S, 2007, MOL GENET METAB, V90, P370, DOI 10.1016/j.ymgme.2006.12.002; Sarafoglou K, 2011, PEDIATRICS, V128, P246; Sass JO, 2004, BRAIN DEV-JPN, V26, P12, DOI 10.1016/S0387-7604(03)00071-8; Seaver LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027348; Snyderman SE, 1998, PEDIATRICS, V101, P709, DOI 10.1542/peds.101.4.709; Song XQ, 1998, HUM MUTAT, V12, P83, DOI 10.1002/(SICI)1098-1004(1998)12:2<83::AID-HUMU2>3.0.CO;2-P; Sutton VR, 2003, J INHERIT METAB DIS, V26, P69, DOI 10.1023/A:1024083715568; Thummler S, 2010, TOHOKU J EXP MED, V220, P27, DOI 10.1620/tjem.220.27; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; Yamada K, 2007, MOL GENET METAB, V90, P291, DOI 10.1016/j.ymgme.2006.10.010; YAMAGUCHI S, 1988, J CLIN INVEST, V81, P813, DOI 10.1172/JCI113388; Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106; Zhang GX, 2006, MOL GENET METAB, V89, P222, DOI 10.1016/j.ymgme.2006.06.010; Zhang GX, 2004, PEDIATR RES, V56, P60, DOI 10.1203/01.PDR.0000129657.48122.52; Zschocke J, 2000, PEDIATR RES, V48, P852, DOI 10.1203/00006450-200012000-00025	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					41	48		10.1111/ped.12585		8	Pediatrics	Pediatrics	CC4TN	WOS:000350346800011		
J	Toriyama, M; Ishiguro, A; Motojima, Y; Yamana, K; Sobajima, H; Tamura, M				Toriyama, Mihiro; Ishiguro, Akio; Motojima, Yukiko; Yamana, Keiji; Sobajima, Hisanori; Tamura, Masanori			Oxygen requirement and surfactant therapy in preterm infants after delivery	PEDIATRICS INTERNATIONAL			English	Article						International Liaison Committee on Resuscitation; oxygen; preterm infant; resuscitation; surfactant	RESPIRATORY-DISTRESS-SYNDROME; STABLE MICROBUBBLE TEST; LESS OXIDATIVE STRESS; CHRONIC LUNG-DISEASE; 30 WEEKS GESTATION; 100-PERCENT OXYGEN; RANDOMIZED-TRIAL; NEWBORN-INFANTS; AMNIOTIC-FLUID; RESUSCITATION	BackgroundSeveral reports have shown the beneficial effects of early or prophylactic surfactant therapy for preterm infants, who often develop respiratory distress syndrome. No report, however, has addressed which infants should receive surfactant therapy in the delivery room. Therefore, the aim of this study was to assess the validity of identifying infants who need surfactant therapy based on fraction of inspiratory oxygen (FiO(2)) requirement in the delivery room. MethodsIn this observational, retrospective study, FiO(2) given in the delivery room, use of surfactant therapy, stable microbubble test (SMT) results, and changes in FiO(2) both before and after surfactant therapy were reviewed in infants born at <33 weeks' gestation. ResultsOverall, 170 infants were included. Forty infants were given oxygen with FiO(2) 0.6, and all received surfactant therapy. Of these 40 infants, FiO(2) could be reduced in 36 (90%) by an average of 0.46 after surfactant therapy. SMT was done in 22 of 40 infants, and surfactant insufficiency was suspected in 20 (91%). In contrast, 81 of 102 infants (79%) with FiO(2) <0.4 did not need surfactant therapy within 48h after birth. ConclusionsPreterm infants who need FiO(2) 0.6 in the delivery room appear to be at high risk of surfactant insufficiency and would benefit from surfactant. Surfactant therapy would provide a more effective resuscitation method for preterm infants, and thus a larger prospective study is needed to confirm these results.	[Toriyama, Mihiro; Ishiguro, Akio; Motojima, Yukiko; Yamana, Keiji; Sobajima, Hisanori; Tamura, Masanori] Saitama Med Univ, Saitama Med Ctr, Ctr Maternal Fetal & Neonatal Med, Dept Pediat,Div Neonatal Med, Kawagoe, Saitama 3508550, Japan; [Toriyama, Mihiro] Ehime Prefectural Ctr Hosp, Dept Neonatal Med, Ctr Maternal Fetal & Neonatal Med, Matsuyama, Ehime, Japan	Ishiguro, A (reprint author), Saitama Med Univ, Saitama Med Ctr, Ctr Maternal Fetal & Neonatal Med, Dept Pediat,Div Neonatal Med, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	akio-i@k4.dion.ne.jp					Amizuka T, 2003, EUR J PEDIATR, V162, P697, DOI 10.1007/s00431-003-1276-x; KENDIG JW, 1991, NEW ENGL J MED, V324, P865, DOI 10.1056/NEJM199103283241301; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; DUNN MS, 1991, PEDIATRICS, V87, P377; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; CHIDA S, 1993, EUR J PEDIATR, V152, P152, DOI 10.1007/BF02072494; Egberts J, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e4; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Ezaki S, 2009, J CLIN BIOCHEM NUTR, V44, P111, DOI 10.3164/jcbn.08-221; Fiori HH, 2006, J PERINAT MED, V34, P66, DOI 10.1515/JPM.2006.008; Gitto E, 2009, EUR RESPIR J, V34, P1461, DOI 10.1183/09031936.00032809; Jobe A H, 2012, Early Hum Dev, V88 Suppl 2, pS42, DOI 10.1016/S0378-3782(12)70013-0; Neonatal Research Network Database in Japan, RDS GEST AG; PATTLE RE, 1979, BRIT J OBSTET GYNAEC, V86, P615, DOI 10.1111/j.1471-0528.1979.tb10823.x; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; Stevens TP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003063.pub3; Verder H, 2003, ACTA PAEDIATR, V92, P728, DOI 10.1080/08035250310002597; Yost CC, 2000, COCHRANE DB SYST REV	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					55	59		10.1111/ped.12435		5	Pediatrics	Pediatrics	CC4TN	WOS:000350346800013		
J	Yamamoto, Y; Ibara, S; Tokuhisa, T; Hirakawa, E; Yoneda, S; Kobayashi, K; Kato, E; Maruyama, Y; Maede, Y; Kuwabara, T				Yamamoto, Yutaka; Ibara, Satoshi; Tokuhisa, Takuya; Hirakawa, Eiji; Yoneda, Satoshi; Kobayashi, Kosuke; Kato, Eiji; Maruyama, Yuko; Maede, Yoshinobu; Kuwabara, Takako			Calcium concentration in hypoxic-ischemic encephalopathy during hypothermia	PEDIATRICS INTERNATIONAL			English	Article						asphyxia; calcium; hypothermia; hypoxia-ischemia; newborn	IONIZED CALCIUM; TERM INFANTS; NEONATAL ENCEPHALOPATHY; BB ISOENZYME; BRAIN; BLOOD; SERUM; ASPHYXIA; DAMAGE; DEATH	BackgroundThe aim of this study was to investigate the relationship between prognosis and the changes in serum-ionized calcium concentration in neonates with hypoxic-ischemic encephalopathy (HIE) before and during brain hypothermia (BHT). MethodsSerum samples were obtained from 16 HIE neonates who underwent BHT. All patients underwent developmental testing at 18 months of age. ResultsMean serum-ionized calcium concentration in the poor outcome group (developmental quotient [DQ], <80; nine infants) was significantly lower than in the good outcome group (DQ >80; seven infants), both immediately before and after 6h of BHT. Mean serum-ionized calcium concentration significantly decreased in both groups for 6h, and the lowest adjusted serum-ionized calcium during 6h of BHT was <1.05mmol/L, known as the cut-off value for poor outcome, in 57.1% of the good outcome group. ConclusionThe influx of calcium into cells continues regardless of neurological prognosis during the early phase of BHT, but BHT might protect some high-risk patients against neurological damage at low adjusted serum-ionized calcium concentration.	[Yamamoto, Yutaka] Gifu Prefectural Gen Med Ctr, Dept Neonatol, Gifu 5008717, Japan; [Yamamoto, Yutaka] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Yamamoto, Yutaka; Ibara, Satoshi; Tokuhisa, Takuya; Hirakawa, Eiji; Yoneda, Satoshi; Kobayashi, Kosuke; Kato, Eiji; Maruyama, Yuko; Maede, Yoshinobu; Kuwabara, Takako] Kagoshima City Hosp, Perinatal Med Ctr, Kagoshima, Japan; [Maruyama, Yuko] Imakiire Gen Hosp, Perinatal Ctr, Kagoshima, Japan; [Tokuhisa, Takuya] Fukuda Hosp, Dept Neonatol, Kumamoto, Japan; [Yoneda, Satoshi] Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan; [Kobayashi, Kosuke] Asahi Cent Hosp, Dept Obstet & Gynecol, Chiba, Japan; [Kato, Eiji] Funabashi Cent Hosp, Dept Neonatol, Chiba, Japan	Yamamoto, Y (reprint author), Gifu Prefectural Gen Med Ctr, Dept Neonatol, Noisshiki 4-6-1, Gifu 5008717, Japan.	yama-gon@nifty.com					Karlsson M, 2008, PEDIATR RES, V64, P74, DOI 10.1203/PDR.0b013e318174efdd; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; FERNANDEZ F, 1987, ACTA PAEDIATR SCAND, V76, P914, DOI 10.1111/j.1651-2227.1987.tb17263.x; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; GARCIAALIX A, 1994, PEDIATRICS, V93, P234; Kristian T, 1998, STROKE, V29, P705; WALSH P, 1982, J PEDIATR-US, V101, P988, DOI 10.1016/S0022-3476(82)80027-9; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Perlman JM, 1997, PEDIATRICS, V99, P851, DOI 10.1542/peds.99.6.851; Sweet DG, 1999, J PERINAT MED, V27, P478, DOI 10.1515/JPM.1999.064; Avery GB, 2005, CALCIUM MAGNESIUM HO, P847; BICKLER PE, 1994, BRAIN RES, V665, P269, DOI 10.1016/0006-8993(94)91347-1; Gomella TL, 2009, NEONATOLOGY MANAGEME, V6th; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Kobayashi K, 2005, J PERINAT MED, V33, P360, DOI 10.1515/JPM.2005.064; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696; THODE J, 1990, CLIN CHEM, V36, P541; THODE J, 1985, SCAND J CLIN LAB INV, V45, P131, DOI 10.3109/00365518509160985; Yoneda S, 2005, J OBSTET GYNAECOL RE, V31, P57, DOI 10.1111/j.1447-0756.2005.00241.x	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					64	67		10.1111/ped.12438		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800015		
J	Hosono, S; Hine, K; Nagano, N; Taguchi, Y; Yoshikawa, K; Okada, T; Mugishima, H; Takahashi, S; Takahashi, S				Hosono, Shigeharu; Hine, Kotaro; Nagano, Nobuhiko; Taguchi, Yosuke; Yoshikawa, Kayo; Okada, Tomoo; Mugishima, Hideo; Takahashi, Shigeru; Takahashi, Shori			Residual blood volume in the umbilical cord of extremely premature infants	PEDIATRICS INTERNATIONAL			English	Article						delayed cord clamping; delivery room resuscitation; neonate; placental transfusion; umbilical cord milking	RANDOMIZED-CONTROLLED-TRIAL; PLACENTAL TRANSFUSION; NEONATAL ADAPTATION; PRETERM INFANTS; BIRTH-WEIGHT; MILKING; GESTATION; BORN	BackgroundThe aim of this study was to investigate residual blood volume in the umbilical cord of extremely premature infants. MethodsTwenty extremely premature infants were held at or below the placenta while the umbilical cord was clamped and cut at approximately 2-3cm from the umbilicus within 30s after birth. The umbilical cord was then clamped near the placenta to obtain a length of approximately 30cm and cut. The residual blood volume in the segment of cord was drained and measured in milliliters. ResultsMean birthweight was 846 172g (range, 587-1180g). The average length of the clamped segment of umbilical cord was 29.8 +/- 1.5cm (range, 27-32cm). Total residual blood volume and residual blood volume per cm were 15.5 +/- 6.7mL (range, 6-25mL) and 0.5 +/- 0.2mL/cm (range, 0.2-0.8mL/cm), respectively. The residual cord blood volume per kilogram of infant weight per 30cm was 17.7 +/- 5.5mL/kg/30cm (range, 8.9-29.0mL/kg/30cm). ConclusionInfants could receive approximately 18mL/kg of whole blood by one-time milking of 30cm umbilical cord. With an average hematocrit of 40%, this volume is equivalent to approximately 13mL of packed red blood cells (hematocrit 55%).	[Hosono, Shigeharu; Hine, Kotaro; Nagano, Nobuhiko; Taguchi, Yosuke; Yoshikawa, Kayo; Okada, Tomoo; Mugishima, Hideo; Takahashi, Shigeru; Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo 1738610, Japan	Hosono, S (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, 30-1 Oyaguchi, Tokyo 1738610, Japan.	hosono.shigeharu@nihon-u.ac.jp			MEXT KAKENHI [22591209]	This work was supported by MEXT KAKENHI (Grant-in-Aid for Scientific Research (C) Grant Number 22591209. The authors declare no conflict of interest.	McDonnell M, 1997, J PAEDIATR CHILD H, V33, P308, DOI 10.1111/j.1440-1754.1997.tb01606.x; YAO AC, 1969, LANCET, V2, P871; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Rabe H, 2011, OBSTET GYNECOL, V117, P205, DOI 10.1097/AOG.0b013e3181fe46ff; Strauss RG, 2003, TRANSFUSION, V43, P1168, DOI 10.1046/j.1537-2995.2003.00454.x; March MI, 2013, J PERINATOL, V33, P763, DOI 10.1038/jp.2013.70; Aladangady N, 2006, PEDIATRICS, V117, P93, DOI 10.1542/peds.2004-1773; Kaempf JW, 2012, OBSTET GYNECOL, V120, P325, DOI 10.1097/AOG.0b013e31825f269f; FORESTIER F, 1991, BLOOD, V77, P2360; Hosono S, 2008, PEDIATR INT, V50, P306, DOI 10.1111/j.1442-200X.2008.02586.x; Itabashi K, 2010, J JPN PEDIAT SOC, V114, P1271; Jelin AC, 2013, J MATERN-FETAL NEO M, V27, P1457; Proctor LK, 2013, PLACENTA, V34, P62, DOI 10.1016/j.placenta.2012.10.015; Rabe H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003248.pub3; Takami T, 2012, J PEDIATR-US, V161, P742, DOI 10.1016/j.jpeds.2012.03.053; Upadhyay A, 2013, AM J OBSTET GYNECOL, V208; Yao AC, 1982, PLACENTAL TRANSFUSIO, P5	17	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					68	71		10.1111/ped.12464		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800016		
J	Nakamura, A				Nakamura, Akio			Genotypes of the renin-angiotensin system and glucocorticoid complications	PEDIATRICS INTERNATIONAL			English	Article						angiotensin-converting enzyme; angiotensinogen; body mass index; nephrotic syndrome; polymorphism	I-CONVERTING-ENZYME; ACE I/D POLYMORPHISM; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; ALDOSTERONE SYSTEM; CUSHINGS-SYNDROME; OBESE-PATIENTS; GENE; JAPANESE; ASSOCIATION	BackgroundAngiotensinogen (AGT) and angiotensin-converting enzyme (ACE) are recognized as important regulators of body mass index (BMI) and systemic blood pressure (BP). An association between these single nucleotide polymorphisms (SNP) of AGT and ACE genes and obesity or hypertension has been established. This study examined relationships between the molecular variants of the AGT and ACE genes and bodyweight or BP in children treated with glucocorticoids for nephrotic syndrome. MethodsTwenty Japanese children (male, n = 14; female, n = 6; age, 2-13years) were genotyped for AGT polymorphisms (M235T and A-6G) and the ACE polymorphisms (insertion/deletion: I/D and rs4341). All of the children studied were treated with daily prednisolone 2mg/kg for 4weeks and thereafter alternate-day prednisolone for 8weeks. BMI, BMI z-scores, blood lipids, renal function and BP in each group were evaluated during the study period. ResultsBMI and BMI z-scores during the glucocorticoid therapy were significantly higher in the TT genotype of the AGT M235T polymorphisms and the AA genotype of the AGT A-6G polymorphisms compared to other genotypes (P < 0.05). In contrast, the molecular variant of ACE I/D and rs4341 genotypes did not change bodyweight during the glucocorticoid exposure. It was evident, however, that the BP and blood lipids and renal function were not significantly influenced by the AGT and ACE polymorphisms. ConclusionsThe TT genotype of the AGT M235T and the AA genotype of the A-6G polymorphisms may predispose children to bodyweight gain when initially treated with glucocorticoids for nephrotic syndrome.	[Nakamura, Akio] Teikyo Univ, Sch Med, Dept Paediat, Tokyo 1738605, Japan; [Nakamura, Akio] Social Insurance Omiya Gen Hosp, Dept Paediat, Saitama, Japan	Nakamura, A (reprint author), Teikyo Univ, Sch Med, Dept Pediat, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	akio@med.teikyo-u.ac.jp			Kawano Masanori Memorial Foundation for Promotion of Pediatrics	I am very grateful for support from Kawano Masanori Memorial Foundation for Promotion of Pediatrics. I thank Dr Kouhei Uemura, Department of Epidemiology and Biostatistics, University of Tokyo, Tokyo, Japan, for assistance with statistical analysis, and Dr Ryo Niimi, Dr Katsutoshi Kobori, and Mrs Kumiko Kurosaki for technical support. I also thank Professor E. J. Johns, Department of Physiology, University of Cork, Ireland, for critical review of the manuscript and suggestions, and Emeritus Professor Yukishige Yanagawa, Department of Pediatrics, Teikyo University School of Medicine, for general support. There are no conflicts of interest to declare.	Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Lovati E, 2001, KIDNEY INT, V60, P46, DOI 10.1046/j.1523-1755.2001.00769.x; Strazzullo P, 2003, ANN INTERN MED, V138, P17; Inokuchi M, 2007, ACTA PAEDIATR, V96, P1674, DOI 10.1111/j.1651-2227.2007.00490.x; Lagou V, 2007, INT J OBESITY, V31, P1052, DOI 10.1038/sj.ijo.0803605; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; TIRET L, 1992, AM J HUM GENET, V51, P197; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Cicala MV, 2010, NEUROENDOCRINOLOGY, V92, P44, DOI 10.1159/000314315; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Moran CN, 2005, OBES RES, V13, P1499, DOI 10.1038/oby.2005.181; Kunz R, 1997, HYPERTENSION, V30, P1331; Petrovic D, 2002, FOLIA BIOL-KRAKOW, V50, P53; Aubert J, 1997, BIOCHEM J, V328, P701; Faloia E, 2000, J ENDOCRINOL INVEST, V23, P54; Glenn KL, 2009, MOL BIOL REP, V36, P1305, DOI 10.1007/s11033-008-9313-5; KAMITANI A, 1994, J HUM HYPERTENS, V8, P521; Kato N, 1999, J HYPERTENS, V17, P757, DOI 10.1097/00004872-199917060-00006; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; Kotchen TA, 1998, HYPERTENSION, V32, P402; Liu KP, 2004, PEDIATR NEPHROL, V19, P594, DOI 10.1007/s00467-003-1379-7; Prat-Larquemin L, 2004, OBES RES, V12, P556, DOI 10.1038/oby.2004.63; Rodriguez-Perez JC, 2000, J HUM HYPERTENS, V14, P789, DOI 10.1038/sj.jhh.1001110; Takakura Y, 2006, METABOLISM, V55, P819, DOI 10.1016/j.metabol.2006.02.008; Teranishi J, 2014, J RENIN ANGIOTENSIN; Tiago AD, 2002, CIRCULATION, V106, P1483, DOI 10.1161/01.CIR.0000029093.93362.FC; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Vasku A, 1998, KIDNEY INT, V53, P1479, DOI 10.1046/j.1523-1755.1998.00924.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					72	78		10.1111/ped.12434		7	Pediatrics	Pediatrics	CC4TN	WOS:000350346800017		
J	Hibi, Y; Uemura, O; Nagai, T; Yamakawa, S; Yamasaki, Y; Yamamoto, M; Nakano, M; Kasahara, K				Hibi, Yoshiko; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Yamasaki, Yasuhito; Yamamoto, Masaki; Nakano, Masaru; Kasahara, Katsuaki			The ratios of urinary beta 2-microglobulin and NAG to creatinine vary with age in children	PEDIATRICS INTERNATIONAL			English	Article						children; creatinine ratio; spot urine; urinary N-acetyl--d-glucosaminidase; urinary-2-microglobulin	BETA-D-GLUCOSAMINIDASE; MOLECULAR-WEIGHT PROTEINS; RETINOL-BINDING PROTEIN; NEPHROTIC CHILDREN; RENAL-DISEASE; NORMAL VALUES; EXCRETION; BETA(2)-MICROGLOBULIN; SAMPLES; PRETERM	BackgroundAlthough urinary biochemical markers can be assessed by their ratio to urinary creatinine (U-Cr) concentration, reference values in adults may not be applicable to children because the amount of Cr excreted varies by body size. We therefore measured the relationship between age and the ratios of urinary -2-microglobulin (U-2MG), N-acetyl--d-glucosaminidase (U-NAG), calcium (U-Ca) and protein (U-Pr) concentration to those of U-Cr in children. MethodsFifty-seven patients aged >1 year with benign familial hematuria (median age, 6.3 years) were divided into three age groups: 1-4, 5-9, and 10 years. Urinary biomarkers were assayed using actual values; ratios to actual U-Cr values; and our standardized metric, namely 100-fold the ratio of serum Cr to U-Cr concentration; and the relationship of each of these to age was determined. ResultsThe ratios of U-2MG, U-NAG and U-Ca to Cr varied significantly by age, being higher in younger than in older children, but the actual and standardized values of each did not vary by age, nor did any measurement of U-Pr. ConclusionsThe ratios of urinary markers of tubular function, including U-2MG, U-NAG and U-Ca, to Cr vary by age, being higher in younger children. In contrast, the ratios of urinary markers of glomerular filtration (such as U-Pr)to Cr do not vary by age, making them suitable for corrections relative to Cr.	[Hibi, Yoshiko; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Yamasaki, Yasuhito; Yamamoto, Masaki; Nakano, Masaru; Kasahara, Katsuaki] Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, Obu, Aichi 4748710, Japan	Hibi, Y (reprint author), Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, 1-2 Osakada Morioka Cho, Obu, Aichi 4748710, Japan.	vida5055@yahoo.co.jp					ABITBOL C, 1990, J PEDIATR-US, V116, P243, DOI 10.1016/S0022-3476(05)82881-1; DAVEY PG, 1982, CLIN CHEM, V28, P1330; BERGGARD I, 1968, J BIOL CHEM, V243, P4095; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Hogg RJ, 2000, PEDIATRICS, V105, P1242, DOI 10.1542/peds.105.6.1242; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Assadi FK, 1996, PEDIATR NEPHROL, V10, P642; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; SARGENT JD, 1993, J PEDIATR-US, V123, P393, DOI 10.1016/S0022-3476(05)81738-X; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; BERNARD AM, 1982, CLIN CHIM ACTA, V126, P1, DOI 10.1016/0009-8981(82)90356-4; Caliskan S, 1996, NEPHRON, V74, P401; DANCE N, 1970, CLIN CHIM ACTA, V27, P87, DOI 10.1016/0009-8981(70)90378-5; Davies HEF., 1976, J PHYSL, V263, P254; ELISES JS, 1988, CLIN NEPHROL, V30, P225; EVRIN PE, 1972, SCAND J CLIN LAB INV, V29, P69, DOI 10.3109/00365517209081057; Giebisch G, 2009, MED PHYSL, P747; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; GINEVRI F, 1993, PEDIATR NEPHROL, V7, P240; Guinard JP, 2004, PEDIAT NEPHROLOGY, P399; HOUSER M, 1984, J PEDIATR-US, V104, P845, DOI 10.1016/S0022-3476(84)80478-3; HOUSER MT, 1986, INT J PED NEPHROL, V7, P197; IYER R S, 1991, Indian Pediatrics, V28, P463; LANGHENDRIES JP, 1987, ARCH DIS CHILD, V62, P483; Nishida M, 1998, ACTA PAEDIATR JAPON, V40, P424; Skinner AM, 1996, EUR J PEDIATR, V155, P596, DOI 10.1007/BF01957912; SUTPHEN JL, 1982, PEDIATRICS, V69, P719; TOMLINSON PA, 1992, PEDIATR NEPHROL, V6, P565; TOMLINSON PA, 1990, CLIN CHIM ACTA, V192, P99, DOI 10.1016/0009-8981(90)90073-2; Uemura O, 2012, EUR J PEDIATR, V171, P1401, DOI 10.1007/s00431-012-1772-y; YOSHIMOTO M, 1990, PEDIATR NEPHROL, V4, P136	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					79	84		10.1111/ped.12470		6	Pediatrics	Pediatrics	CC4TN	WOS:000350346800018		
J	Hibino, S; Uemura, O; Nagai, T; Yamakawa, S; Iwata, N; Ito, H; Nakano, M; Tanaka, K				Hibino, Satoshi; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Iwata, Naoyuki; Ito, Hidekazu; Nakano, Masaru; Tanaka, Kazuki			Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol	PEDIATRICS INTERNATIONAL			English	Article						childhood; cyclosporine A; mycophenolate mofetil; steroid-dependent nephrotic syndrome; steroid-resistant nephrotic syndrome	MYCOPHENOLATE-MOFETIL; CYCLOSPORINE; CHILDREN; TRIAL	Background: This retrospective study was performed to assess the 3year outcome of a unified protocol for childhood idiopathic nephrotic syndrome. Methods: Cyclosporine A (CsA) or CsA plus mycophenolate mofetil (MMF) were used in patients without remission on high-dose steroid therapy. CsA was maintained at an area under the whole blood concentration-time curve up to 4h after dose (AUC(0-4)) of 1500 and 2000ngh/mL in steroid-dependent nephrotic syndrome (SDNS) and steroid-resistant nephrotic syndrome (SRNS), respectively. Ninety-one children were enrolled in the study (SDNS, n = 64; SRNS, n = 18). Patients were divided into minimal change (MC) and focal segmental glomerulosclerosis (FSGS) groups. Threeyear outcome was evaluated using clinical severity defined as degree of dependence on immunosuppressive therapy for maintenance of remission. Results: In the SDNS group, the numbers of MC and no biopsy were 51 and 13, respectively. No patient had FSGS. Twelve SRNS patients had FSGS and six had MC. In SDNS, 15/64 patients (23%) received no medication. CsA was effective as steroid-sparing agent in 31/38 patients (82%). MMF was effective in all eight patients for whom CsA was unsuccessful. Remission rate in the SRNS group was 14/18 (78%; eight with CsA, and six with a combination of CsA + MMF). Five of the 14 SRNS remission patients received methylprednisolone pulse therapy. Four were resistant to therapy, and had impaired renal function. The clinical severity of MC and FSGS overlapped. Conclusions: Treatment with CsA and combination of CsA plus MMF was useful for SDNS and for remission induction in SRNS.	[Hibino, Satoshi; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Iwata, Naoyuki; Ito, Hidekazu; Nakano, Masaru; Tanaka, Kazuki] Aichi Childrens Hlth & Med Ctr, Pediat Nephrol, Nagoya, Aichi, Japan	Hibino, S (reprint author), 1-2 Osakada,Morioka Cho, Obu, Aichi 4748710, Japan.	satohibino@yahoo.co.jp					Afzal K, 2007, PEDIATR NEPHROL, V22, P2059, DOI 10.1007/s00467-007-0617-9; Ishikura K, 2012, CLIN J AM SOC NEPHRO, V7, P1576, DOI 10.2215/CJN.00110112; Hamasaki Y, 2009, PEDIATR NEPHROL, V24, P2177, DOI 10.1007/s00467-009-1264-0; Banerjee S, 2013, PEDIATR NEPHROL, V28, P93, DOI 10.1007/s00467-012-2278-6; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; desMello V R, 2010, PEDIATR NEPHROL, V25, P453; EI-Husseini A, 2005, NEPHROL DIAL TRANSPL, V20, P2433; Ishikura K, 2008, KIDNEY INT, V73, P1167, DOI 10.1038/ki.2008.24; Kengne-Wafo S, 2009, CLIN J AM SOC NEPHRO, V4, P1409, DOI 10.2215/CJN.01520209; Li ZH, 2010, PEDIATR NEPHROL, V25, P883, DOI 10.1007/s00467-009-1375-7; Liberman KV, 1996, J AM SOC NEPHROL, V7, P56; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; PONTICELLI C, 1993, KIDNEY INT, V43, P1377, DOI 10.1038/ki.1993.194; Ushijima K, 2012, EUR J PEDIATR, V171, P663, DOI 10.1007/s00431-011-1633-0	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					85	91		10.1111/ped.12498		7	Pediatrics	Pediatrics	CC4TN	WOS:000350346800019		
J	Suzuki, M; Saito, N; Naritaka, N; Nakano, S; Minowa, K; Honda, Y; Ohtsuka, Y; Yamataka, A; Shimizu, T				Suzuki, Mitsuyoshi; Saito, Nobutomo; Naritaka, Nakayuki; Nakano, Satoshi; Minowa, Kei; Honda, Yuka; Ohtsuka, Yoshikazu; Yamataka, Atsuyuki; Shimizu, Toshiaki			Scoring system for the prediction of severe acute pancreatitis in children	PEDIATRICS INTERNATIONAL			English	Article						guideline; Ministry of Health; Labour and Welfare of Japan (JPN) scoring system; pediatrics; severe acute pancreatitis; severity assessment	REGIONAL ARTERIAL INFUSION; INFLAMMATORY RESPONSE; PROGNOSTIC FACTORS; MANAGEMENT; JAPAN	BackgroundThe lack of an accurate scoring system for pediatric acute pancreatitis could cause delays in appropriate clinical management and increase the risk of progressive life-threatening complications. We investigated a modified Ministry of Health, Labour and Welfare of Japan (JPN) scoring system that uses pediatric systemic inflammatory response syndrome (SIRS) score, age, and weight to establish a more useful scoring system for children. MethodsA retrospective chart review was conducted of pediatric patients with acute pancreatitis who were admitted to Juntendo University Hospital between 1985 and 2011. The sensitivity, specificity, and positive and negative predictive values of the pediatric JPN scoring system were calculated and then compared with those of previously developed scoring systems. ResultsThe patient group consisted of 145 patients (88 girls, 57 boys). The pediatric JPN score had greater sensitivity (80%) than the Ranson (60%), modified Glasgow (50%), and DeBanto (60%) scores. The specificity was 96% for the pediatric JPN score, 94% for the Ranson score, 99% for the modified Glasgow score, and 86% for the DeBanto score. ConclusionThe pediatric JPN score can be used to predict severe acute pancreatitis during the initial medical assessment.	[Suzuki, Mitsuyoshi; Saito, Nobutomo; Naritaka, Nakayuki; Nakano, Satoshi; Minowa, Kei; Honda, Yuka; Ohtsuka, Yoshikazu; Shimizu, Toshiaki] Juntendo Univ, Sch Med, Dept Pediat, Tokyo 1138421, Japan; [Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Tokyo 1138421, Japan	Suzuki, M (reprint author), Juntendo Univ, Sch Med, Dept Pediat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	msuzuki@juntendo.ac.jp			Pancreatic Research Foundation of Japan [555]	This work was supported by grant no. 555 from the Pancreatic Research Foundation of Japan. The authors declare that they have no conflicts of interest.	Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Toouli J, 2002, J GASTROEN HEPATOL, V17, pS15, DOI 10.1046/j.1440-1746.17.s1.2.x; BLAMEY SL, 1984, GUT, V25, P1340, DOI 10.1136/gut.25.12.1340; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Dervenis C, 1999, INT J PANCREATOL, V25, P195; Yasuda T, 2007, J GASTROENTEROL, V42, P681, DOI 10.1007/s00535-007-2081-5; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; DeBanto JR, 2002, AM J GASTROENTEROL, V97, P1726; McColl KEL, 2005, GUT, V54, P1, DOI 10.1136/gut.2004.047126; Banks PA, 2002, GASTROINTEST ENDOSC, V56, pS226, DOI 10.1067/mge.2002.129022; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Carvalho Paulo R A, 2005, J Pediatr (Rio J), V81, P143, DOI 10.1590/S0021-75572005000300010; Fukushima H, 2013, PEDIATR INT, V55, pE11, DOI 10.1111/j.1442-200X.2012.03702.x; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6; Lautz TB, 2012, J PEDIATR SURG, V47, P1185, DOI 10.1016/j.jpedsurg.2012.03.023; Lautz TB, 2011, J PEDIATR SURG, V46, P1144, DOI 10.1016/j.jpedsurg.2011.03.044; Nydegger A, 2006, J GASTROEN HEPATOL, V21, P499, DOI 10.1111/j.1440-1746.2006.04246.x; Ogawa M, 2002, PANCREAS, V25, P325, DOI 10.1097/00006676-200211000-00001; PEZZILLI R, 1995, DIGEST DIS SCI, V40, P2341, DOI 10.1007/BF02063235; Piascik M, 2010, PANCREAS, V39, P863, DOI 10.1097/MPA.0b013e3181d37239; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; RANSON JHC, 1982, AM J GASTROENTEROL, V77, P633; Shibata Keizo, 2004, Nihon Rinsho, V62, P2184; Suzuki M, 2008, PANCREAS, V37, P222, DOI 10.1097/MPA.0b013e31816618e1; TOMOMASA T, 1994, J PEDIATR GASTR NUTR, V19, P109, DOI 10.1097/00005176-199407000-00018; VIEDMA JA, 1994, GUT, V35, P822, DOI 10.1136/gut.35.6.822; Werlin SL, 2003, J PEDIATR GASTR NUTR, V37, P591, DOI 10.1097/00005176-200311000-00017	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					113	118		10.1111/ped.12449		6	Pediatrics	Pediatrics	CC4TN	WOS:000350346800023		
J	Ser, PH; Banu, B; Jebunnesa, F; Fatema, K; Rosy, N; Yasmin, R; Furusawa, H; Ali, L; Ahmad, SA; Watanabe, C				Ser, Ping Han; Banu, Bilkis; Jebunnesa, Fatema; Fatema, Kaneez; Rosy, Nasrin; Yasmin, Rabeya; Furusawa, Hana; Ali, Liaquat; Ahmad, Sk Akhtar; Watanabe, Chiho			Arsenic exposure increases maternal but not cord serum IgG in Bangladesh	PEDIATRICS INTERNATIONAL			English	Article						arsenic; immune system; immunoglobulin; infant; maternal exposure	PLACENTAL-TRANSFER; DRINKING-WATER; PREGNANCY OUTCOMES; IMMUNE-RESPONSE; IMMUNOGLOBULINS; ANTIBODIES; ASSOCIATION; POPULATION; SUBCLASSES; APOPTOSIS	BackgroundThousands of pregnant women are exposed to arsenic (As), which has been shown to lead to a higher risk of maternal and infant morbidity. We hypothesized that As-induced modifications to the humoral immune system may be partly responsible, and examined the relationship between As and immunoglobulin G (IgG). MethodsPregnant women were recruited in As-contaminated rural areas in Bangladesh. Blood and urine samples, and questionnaire data were collected. We analyzed data from 202 pregnant women and a subset of 121 mother-infant pairs. Urinary As was measured on inductively coupled plasma-mass spectrometry and adjusted with specific gravity (U-As-SG). Maternal (IgG(mat)) and cord (IgG(cord)) serum total IgG were measured using immunoturbidity assay. ResultsThe geometric mean U-As-SG (n = 202) was 69g/L (range, 3.1-1356g/L). Urinary-As-SG was significantly associated with IgG(mat) (n = 202; (r = 0.24; 95% confidence interval [CI]: 0.10-0.36; P < 0.001) and remained so after the inclusion of maternal-associated variables in a multiple-regression model ( = 1.26; 95%CI: 0.47-2.05; P < 0.01). U-As-SG, however, was not significantly associated with IgG(cord) (n = 121), while IgG(mat) and IgG(cord) were also not associated with each other. ConclusionsMaternal As exposure was positively associated with IgG(mat) but not IgG(cord). Elevated IgG(mat) may have implications as regards maternal morbidity and the placental transfer of specific IgGs. Further studies are required to better understand how As may affect maternal and child health by modifying the humoral immune system.	[Ser, Ping Han; Furusawa, Hana; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Banu, Bilkis] Bangladesh Univ Hlth Sci, Dept Hlth Promot & Hlth Educ, Dhaka, Bangladesh; [Jebunnesa, Fatema; Ali, Liaquat] Bangladesh Univ Hlth Sci, Dept Biochem & Cell Biol, Dhaka, Bangladesh; [Yasmin, Rabeya; Ahmad, Sk Akhtar] Bangladesh Univ Hlth Sci, Dept Occupat & Environm Hlth, Dhaka, Bangladesh; [Fatema, Kaneez] Faridpur Med Coll Hosp, Dept Gynecol & Obstet, Faridpur, Bangladesh; [Rosy, Nasrin] Madaripur Sadar Hosp, Dept Gynecol & Obstet, Madaripur, Bangladesh	Ser, PH (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo To Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	pinghan.ser@gmail.com					Akao Y, 1998, BRIT J HAEMATOL, V102, P1055, DOI 10.1046/j.1365-2141.1998.00869.x; AMINO N, 1978, OBSTET GYNECOL, V52, P415; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Yu HS, 2002, J INVEST DERMATOL, V119, P812, DOI 10.1046/j.1523-1747.2002.00475.x; SIKORSKI EE, 1989, FUND APPL TOXICOL, V13, P843, DOI 10.1016/0272-0590(89)90338-2; Andrew AS, 2008, ENVIRON HEALTH PERSP, V116, P524, DOI 10.1289/ehp.10861; Milton AH, 2005, EPIDEMIOLOGY, V16, P82, DOI 10.1097/01.ede.0000147105.94041.e6; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Wang L, 2012, ARCH TOXICOL, V86, P879, DOI 10.1007/s00204-012-0845-z; Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Saha A, 2013, VACCINE, V31, P647, DOI 10.1016/j.vaccine.2012.11.049; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; BRAMBELL FW, 1966, LANCET, V2, P1087; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI [10.1289/ehp.1002086, 10.1289/ehp.1102086]; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; PITCHERWILMOTT RW, 1980, CLIN EXP IMMUNOL, V41, P303; Germolec DR, 1996, TOXICOL APPL PHARM, V141, P308; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; BEST JM, 1969, LANCET, V2, P65; Blackburn ST, 2013, MATERNAL FETAL NEONA; BLAKLEY BR, 1980, TOXICOL APPL PHARM, V52, P245, DOI 10.1016/0041-008X(80)90111-8; FALKOFF R, 1987, CLIN REV ALLERG, V5, P287; GENDREL D, 1990, J TROP PEDIATRICS, V36, P279; Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; Islam LN, 2007, J ENVIRON SCI HEAL A, V42, P1807, DOI 10.1080/10934520701566777; Islam LN, 2012, J TOXICOL, V2012, DOI DOI 10.1155/2012/302817; Lessa ALS, 2011, FEMS IMMUNOL MED MIC, V62, P236, DOI 10.1111/j.1574-695X.2011.00807.x; National Arsenic Mitigation Information Centre, 2004, UP WIS SUMM RES BANG; Orczyk-Pawilowicz M, 2012, PRENATAL DIAG, V32, P432, DOI 10.1002/pd.3832; Palmeira P, 2012, CLIN DEV IMMUNOL, V2012, DOI [DOI 10.1155/2012/985646, 10.1155/2012/985646]; R Core Team, 2012, R COMP PROGR VERS 2; STUDD JWW, 1971, J OBSTET GYN BR COMM, V78, P786; vonsEhrenstein OS, 2006, AM J EPIDEMIOL, V163, P662; WHO, 2011, GUID DRINK WAT QUAL; WHO, 2001, ENV HLTH CRIT	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					119	125		10.1111/ped.12396		7	Pediatrics	Pediatrics	CC4TN	WOS:000350346800024		
J	Minematsu, K; Kawabuchi, R; Okazaki, H; Tomita, H; Tobina, T; Tanigawa, T; Tsunawake, N				Minematsu, Kazuo; Kawabuchi, Ryosuke; Okazaki, Hiromi; Tomita, Hiroyuki; Tobina, Takuro; Tanigawa, Takeshi; Tsunawake, Noriaki			Physical activity cut-offs and risk factors for preventing child obesity in Japan	PEDIATRICS INTERNATIONAL			English	Article						child obesity; Japan; metabolic equivalent; school-aged children; step	ENERGY COSTS; ADOLESCENTS; STUDENTS; HEALTH; YOUTH	BackgroundThere is no official recommendations for physical activity level or steps for preventing and improving child obesity in Japan. MethodsThree hundred and two Japanese children aged 9-12 years were recruited wore 3-D speed sensors. Subjects were divided into two groups using the criteria for child obesity in Japan. Body composition was measured on bioelectrical impedance analysis. Physical fitness test was done to evaluate physical strength. Twenty-four hour total steps, energy expenditure, and metabolic equivalents (MET) from Monday to Sunday were consecutively measured. The cut-offs for steps and physical activity level for preventing child obesity were evaluated on receiver operating characteristic curves. Daily life-related risk factors for child obesity were assessed on logistic regression analysis. ResultsIn both sexes, body volume; bodyweight, body mass index, fat mass, and percentage body fat in the obese group was significantly higher than in the normal group, but age and height were not different (P < 0.001). Aerobic power, running speed, and explosive strength in the obese group were inferior to those in the normal group (P < 0.001). More than 40min of 4MET exercise, defined as moderate-vigorous exercise, and 11000 steps per day are essential to prevent child obesity. Additionally, >2h TV viewing per day is a significant risk factor for child obesity (OR, 3.43; 95%CI: 1.27-9.31). ConclusionCut-offs for physical activity and potential risk factors for child obesity have been identified. Recommendations for changes to daily lifestyle for school-aged Japanese children are given.	[Minematsu, Kazuo; Tanigawa, Takeshi] Juntendo Univ, Sch Med, Dept Publ Hlth, Tokyo 1138421, Japan; [Kawabuchi, Ryosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Okazaki, Hiromi] Nagasaki Univ, Nonprofit Org Nagasaki Wellness Sport Res Ctr, Nagasaki 852, Japan; [Tobina, Takuro; Tsunawake, Noriaki] Nagasaki Univ, Grad Sch Human Hlth Sci, Nagasaki 852, Japan; [Tomita, Hiroyuki] Juntendo Univ, Sch Hlth & Sports Sci, Chiba, Japan	Minematsu, K (reprint author), Juntendo Univ, Sch Med, Dept Publ Hlth, Tokyo 1138421, Japan.	kminema@juntendo.ac.jp					American Academy of Pediatrics Committee on Public Education, 2002, PEDIATR S, V107, P423; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; [Anonymous], 1999, J HLTH NUTR INFORM, V6; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Gunter K, 2008, J BONE MINER RES, V23, P986, DOI 10.1359/JBMR.071201; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; Adachi M, 2007, JPN J PHYS FIT SPORT, V56, P347; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Tudor-Locke C, 2004, PREV MED, V38, P857, DOI 10.1016/j.ypmed.2003.12.018; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Ridley K, 2008, MED SCI SPORT EXER, V40, P1439, DOI 10.1249/MSS.0b013e31817279ef; Asayama K, 2002, OBES RES, V8, P96; Baranowski T, 1997, MMWR RECOMM REP, V7, P1; Canadian Paediatric Society Healthy Active Living Committee, 2002, PAEDIAT CHILD HLTH, V7, P347; [Centers for Disease Control and Prevention Prevention CfDCa], 2003, MMWR-MORBID MORTAL W, P785; Council on Sports Medicine and Fitness and Council on School Health, 2006, PEDIATRICS, V117, P1834; Hatano Y, 1979, J HLTH PHYS ED RECRE, V29, P28; Japan Sports Association, 2010, ACT CHILD 60 MIN GUI; McMurray Robert G, 2008, Dyn Med, V7, P5, DOI 10.1186/1476-5918-7-5; Minematsu K, 2012, MED SCI SPORT EXER, V44, P1382, DOI 10.1249/MSS.0b013e318245d92c; Ministry of Education Culture Sports Science and Technology Japan, 2012, GUID EX CHILDH JAP; Ministry of Education Culture Sports Science and Technology Japan, 2013, NAT SCH HLTH SURV 20; Ministry of Education Sports Science and Technology Japan, 2010, NAT SURV PHYS STRENG; Ministry of Health Labour and Welfare Japan, 1998, PHYS STRENGTH TEST 6; Ministry of Health Labour and Welfare Japan, 1969, REC DIET ALL JAP; National Association for Sports and Physical Education, 2004, PHYS ACT CHILDR STAT; National Association for Sports and Physical Education, 2009, ACT START STAT PHYS; Okada T, 2009, CHILD OBESITY; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Vincent SD, 2002, PEDIATR EXERC SCI, V14, P432; Y atano, 1993, INT COUNCIL HLTH PHY, V29, P4	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					131	136		10.1111/ped.12446		6	Pediatrics	Pediatrics	CC4TN	WOS:000350346800026		
J	Suzumura, S				Suzumura, Shunsuke			Quality of life in mothers of preschoolers with high-functioning pervasive developmental disorders	PEDIATRICS INTERNATIONAL			English	Article						autism spectrum disorder; child psychiatry; outpatient; parenting; quality of life	MENTAL-HEALTH STATUS; SCHOOL-AGE-CHILDREN; FRAGILE-X-SYNDROME; PARENTING STRESS; INTELLECTUAL DISABILITY; BEHAVIOR PROBLEMS; DIFFICULTIES QUESTIONNAIRE; SYNDROME SPECIFICITY; SPECTRUM DISORDERS; ASPERGER-SYNDROME	BackgroundParents of children with pervasive developmental disorders (PDD) are likely to experience serious distress. The aims of this study were to (i) assess distress among mothers of preschoolers with high-functioning PDD (HFPDD); and (ii) examine its relation to the child's behavioral characteristics. MethodsParticipants were 30 mothers of preschoolers with HFPDD, and 30 mothers of a matched control group. Short Form 36 Health Survey Questionnaire (version 2), and the Strengths and Difficulties Questionnaire were used for assessment. The children's autistic traits were assessed using the total number of items for the DSM-IV-TR autistic disorder diagnosis. ResultsMothers in the HFPDD group were more distressed mentally than physically. Neither physical nor mental distress in the group was related to the child's autistic traits, while their mental distress was significantly related to the child's behavior problems. ConclusionsMothers in the HFPDD group were at increased risk of impaired mental wellbeing. Maternal mental distress in the group was significantly related to general behavior problems, but not to autistic traits in the child.	[Suzumura, Shunsuke] Tokyo Metropolitan Otsuka Hosp, Dept Child Psychiat, Tokyo 1708476, Japan	Suzumura, S (reprint author), Tokyo Metropolitan Otsuka Hosp, Dept Child Psychiat, Toshima Ku, 2-8-1 Minami Ohtsuka, Tokyo 1708476, Japan.	s.suzumura@mac.com					Allik H, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Schieve LA, 2007, PEDIATRICS, V119, pS114, DOI 10.1542/peds.2006-2089Q; WOLF LC, 1989, J AUTISM DEV DISORD, V19, P157, DOI 10.1007/BF02212727; Hastings RP, 2005, J AUTISM DEV DISORD, V35, P635, DOI 10.1007/s10803-005-0007-8; Kheir N, 2012, AUTISM, V16, P293, DOI 10.1177/1362361311433648; Kasari C, 1997, J AUTISM DEV DISORD, V27, P39, DOI 10.1023/A:1025869105208; Epstein T, 2008, CHILD CARE HLTH DEV, V34, P503, DOI 10.1111/j.1365-2214.2008.00834.x; GUYATT GH, 1993, ANN INTERN MED, V118, P622; Fombonne E, 2001, J AM ACAD CHILD PSY, V40, P820, DOI 10.1097/00004583-200107000-00017; Herring S, 2006, J INTELL DISABIL RES, V50, P874, DOI 10.1111/j.1365-2788.2006.00904.x; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Eisenhower AS, 2005, J INTELL DISABIL RES, V49, P657, DOI 10.1111/j.1365-2788.2005.00699.x; Blacher J, 2006, J INTELL DISABIL RES, V50, P184, DOI 10.1111/j.1365-2788.2005.00768.x; Emerson E, 2003, J INTELL DISABIL RES, V47, P385, DOI 10.1046/j.1365-2788.2003.00498.x; Montes G, 2007, PEDIATRICS, V119, pE1040, DOI 10.1542/peds.2006-2819; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Bromley J, 2004, AUTISM, V8, P409, DOI 10.1177/1362361304047224; Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Mori K, 2009, PEDIATR INT, V51, P364, DOI 10.1111/j.1442-200X.2008.02728.x; Johnston C, 2003, J DEV BEHAV PEDIATR, V24, P267; Estes A, 2009, AUTISM, V13, P375, DOI 10.1177/1362361309105658; Dabrowska A, 2010, J INTELL DISABIL RES, V54, P266, DOI 10.1111/j.1365-2788.2010.01258.x; Hastings RP, 2003, J INTELL DISABIL RES, V47, P231, DOI 10.1046/j.1365-2788.2003.00485.x; Lee GK, 2009, FOCUS AUTISM DEV DIS, V24, P227, DOI 10.1177/1088357609347371; Khanna R, 2011, J AUTISM DEV DISORD, V41, P1214, DOI 10.1007/s10803-010-1140-6; Yamada A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-119; Baker BL, 2002, AM J MENT RETARD, V107, P433, DOI 10.1352/0895-8017(2002)107<0433:BPAPSI>2.0.CO;2; Yamazaki S, 2005, QUAL LIFE RES, V14, P1079, DOI 10.1007/s11136-004-3288-z; Lee LC, 2008, J AUTISM DEV DISORD, V38, P1147, DOI 10.1007/s10803-007-0491-0; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Hedov G, 2000, QUAL LIFE RES, V9, P415, DOI 10.1023/A:1008910527481; Brehaut Jamie C, 2004, Pediatrics, V114, pe182, DOI 10.1542/peds.114.2.e182; Dyson LL, 1997, AM J MENT RETARD, V102, P267, DOI 10.1352/0895-8017(1997)102<0267:FAMOSC>2.0.CO;2; Fombonne Eric, 2009, Mcgill J Med, V12, P73; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; Griffith GM, 2009, J AUTISM DEV DISORD, V40, P610; HOLROYD J, 1976, AM J MENT DEF, V80, P431; Mugno D, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-22; KUYKEN W, 1995, SOC SCI MED, V41, P1403; Yamada A, 2007, PSYCHIAT CLIN NEUROS, V61, P651, DOI 10.1111/j.1440-1819.2007.01736.x	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					149	154		10.1111/ped.12560		6	Pediatrics	Pediatrics	CC4TN	WOS:000350346800029		
J	Yokoyama, T; Sugimoto, N; Kato, E; Ohta, K; Ishikawa, S; Ueno, K; Shimizu, M; Yachie, A				Yokoyama, Tadafumi; Sugimoto, Naotoshi; Kato, Eiji; Ohta, Kazuhide; Ishikawa, Sayaka; Ueno, Kazuyuki; Shimizu, Masaki; Yachie, Akihiro			Rotavirus gastroenteritis-associated urinary ammonium acid urate crystals	PEDIATRICS INTERNATIONAL			English	Article						ammonium acid urate crystal; excretion of sodium; rotavirus gastroenteritis; urinary sediment	STONES; JAPAN	Although ammonium acid urate (AAU) calculi are extremely rare renal stone components, it was recently found that many urinary tract calculi that cause post-renal renal failure in rotavirus (RV) gastroenteritis are AAU calculi. The mechanism of AAU calculi development in RV gastroenteritis has not been fully elucidated. We analyzed data from eight RV gastroenteritis patients who transiently had AAU crystals in their urinary sediment. In these patients, formation of AAU crystals occurred earlier than the formation of AAU calculi. No difference was observed in serum and urine uric acid levels between RV gastroenteritis patients with or without AAU crystals. Interestingly, fractional excretion of sodium was extremely low among patients with AAU crystals. These results suggest that the formation of AAU crystals might not be due to excretion of uric acid, but excretion of sodium.	[Yokoyama, Tadafumi; Kato, Eiji] Fukuiken Saiseikai Hosp, Dept Pediat, Fukui, Fukui 9188503, Japan; [Sugimoto, Naotoshi] Kanazawa Univ, Dept Physiol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ishikawa, Sayaka; Ueno, Kazuyuki; Shimizu, Masaki; Yachie, Akihiro] Kanazawa Univ, Dept Pediat, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ohta, Kazuhide] Natl Hlth Org, Kanazawa Med Ctr, Dept Pediat, Kanazawa, Ishikawa, Japan	Yokoyama, T (reprint author), Fukuiken Saiseikai Hosp, Dept Pediat, Wadanaka Machi,7-1 Funahashi, Fukui, Fukui 9188503, Japan.	yokoyamaped@yahoo.co.jp					Ashida A, 2012, CLIN NEPHROL, V77, P49, DOI 10.5414/CN107098; Fujinaga S, 2005, PEDIATR NEPHROL, V20, P239, DOI 10.1007/s00467-004-1675-x; Kaneko K, 2010, PEDIATR NEPHROL, V25, P2187, DOI 10.1007/s00467-010-1490-5; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; Fujita T, 2009, PEDIATR NEPHROL, V24, P2467, DOI 10.1007/s00467-009-1222-x; Soble JJ, 1999, J UROLOGY, V161, P869, DOI 10.1016/S0022-5347(01)61794-4; BORDEN TA, 1979, UROLOGY, V14, P9, DOI 10.1016/0090-4295(79)90202-4; Dick WH, 1990, J UROLOGY, V143, P224; Gray J, 2008, J PEDIATR GASTR NUTR, V46, pS24, DOI 10.1097/MPG.0b013e31816f78ee; Kuruma H, 2006, INT J UROL, V13, P498, DOI 10.1111/j.1442-2042.2006.01348.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					158	160		10.1111/ped.12405		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800031		
J	Hirata, K; Kawahara, H; Shiono, N; Nishihara, M; Kubota, A; Nakayama, M; Kitajima, H				Hirata, Katsuya; Kawahara, Hisayoshi; Shiono, Nobuko; Nishihara, Masahiro; Kubota, Akio; Nakayama, Masahiro; Kitajima, Hiroyuki			Mesenteric hernia causing bowel obstruction in very low-birthweight infants	PEDIATRICS INTERNATIONAL			English	Article						internal hernia; meconium obstruction; mesenteric hernia; premature infant; very low-birthweight infant	INTESTINAL-OBSTRUCTION; EMPHASIS; CHILDREN	Internal hernia through a mesenteric defect, called mesenteric hernia, is an uncommon cause of acute intestinal obstruction in newborns. Strangulated mesenteric hernia results in intestinal necrosis or perforation and progressive deterioration with fatal outcome, especially when it occurs in low-birthweight infants. We report two very low-birthweight (VLBW) infants, who presented with acute intestinal obstruction related to mesenteric defect. The initial diagnosis was meconium obstruction in those cases, which is a common cause of bowel obstruction occurring in VLBW infants. Correct diagnosis of mesenteric hernia was difficult in these cases because of rapid deterioration and non-specific radiological findings. Awareness of the possibility of rare mesenteric hernia causing acute intestinal obstruction and surgical intervention in an appropriate timeframe are important for rescuing VLBW infants with such organic abnormalities.	[Hirata, Katsuya; Shiono, Nobuko; Nishihara, Masahiro; Kitajima, Hiroyuki] Osaka Med Ctr, Dept Neonatal Med, Izumi, Osaka 5941101, Japan; [Kawahara, Hisayoshi; Kubota, Akio] Osaka Med Ctr, Dept Pediat Surg, Izumi, Osaka 5941101, Japan; [Nakayama, Masahiro] Osaka Med Ctr, Dept Clin Lab Med & Anat Pathol, Izumi, Osaka 5941101, Japan; [Hirata, Katsuya] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan	Hirata, K (reprint author), Osaka Med Ctr, Dept Neonatal Med, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	khirata0513@gmail.com					Oretti C, 2010, J PEDIATR SURG, V45, pE25, DOI 10.1016/j.jpedsurg.2010.05.029; Fujita A, 2003, EUR J PEDIATR, V162, P147, DOI 10.1007/s00431-002-1086-6; Page MP, 2008, J PEDIATR SURG, V43, P755, DOI 10.1016/j.jpedsurg.2007.11.044; Blachar A, 2001, RADIOLOGY, V218, P68; Garignon C, 2002, J PEDIATR SURG, V37, P1493, DOI 10.1053/jpsu.2002.35429; Garza-Cox S, 2004, PEDIATRICS, V114, P285, DOI 10.1542/peds.114.1.285; Malit Michele, 2012, Int J Surg Case Rep, V3, P121, DOI 10.1016/j.ijscr.2011.12.006; Ming YC, 2007, EUR J PEDIATR, V166, P1045, DOI 10.1007/s00431-006-0377-8; Shaffner Lde S, 1971, SURG CLIN N AM, V51, P1355; Tang V, 2011, PEDIATR RADIOL, V41, P1559, DOI 10.1007/s00247-011-2158-4	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					161	163		10.1111/ped.12409		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800032		
J	Umeda, K; Shibata, H; Saida, S; Hiramatsu, H; Arakawa, Y; Mizowaki, T; Nishiuchi, R; Adachi, S; Heike, T; Watanabe, KI				Umeda, Katsutsugu; Shibata, Hirofumi; Saida, Satoshi; Hiramatsu, Hidefumi; Arakawa, Yoshiki; Mizowaki, Takashi; Nishiuchi, Ritsuo; Adachi, Souichi; Heike, Toshio; Watanabe, Ken-Ichiro			Long-term efficacy of bevacizumab and irinotecan in recurrent pediatric glioblastoma	PEDIATRICS INTERNATIONAL			English	Article						bevacizumab; glioblastoma; irinotecan; posterior reversible encephalopathy syndrome	GLIOMA; TEMOZOLOMIDE; RESECTION; CHILDREN	A 5-year-old boy with glioblastoma relapsed soon after postoperative irradiation in combination with temozolomide. Second-line chemotherapy was also ineffective; therefore, the bevacizumab and irinotecan were given after a third gross-total resection of the tumor. Treatment was interrupted for 1 month due to development of posterior reversible encephalopathy syndrome, but was re-initiated at a lower dose of bevacizumab with prolonged intervals between treatments. The patient was alive and disease free 2 years after initial diagnosis. Bevacizumab and irinotecan are a promising regimen for pediatric cases of recurrent glioblastoma after gross-total resection, although the optimal treatment schedule must be determined on a patient-by-patient basis.	[Umeda, Katsutsugu; Shibata, Hirofumi; Saida, Satoshi; Hiramatsu, Hidefumi; Heike, Toshio; Watanabe, Ken-Ichiro] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Arakawa, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Mizowaki, Takashi] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan; [Nishiuchi, Ritsuo] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Japan	Umeda, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	umeume@kuhp.kyoto-u.ac.jp					Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Gururangan S, 2010, J CLIN ONCOL, V28, P3069, DOI 10.1200/JCO.2009.26.8789; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Wolff JEA, 2010, CANCER-AM CANCER SOC, V116, P705, DOI 10.1002/cncr.24730; Friedman GK, 2013, J PEDIAT HEMATOL ONC, V35, pE123, DOI 10.1097/MPH.0b013e318282cd7f; Levy CF, 2009, PEDIATR BLOOD CANCER, V52, P669, DOI 10.1002/pbc.21866; Stefanik DF, 2001, J NEURO-ONCOL, V55, P91, DOI 10.1023/A:1013329832067; Tlemsani C, 2011, TARGET ONCOL, V6, P253, DOI 10.1007/s11523-011-0201-x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					169	171		10.1111/ped.12414		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800035		
J	Kohama, H; Komasawa, N; Ueki, R; Kaminoh, Y; Nishi, S				Kohama, Hanako; Komasawa, Nobuyasu; Ueki, Ryusuke; Kaminoh, Yoshiroh; Nishi, Shin-ichi			Simulation analysis of three intubating supraglottic devices during infant chest compression	PEDIATRICS INTERNATIONAL			English	Article						chest compression; infant; intubating supraglottic device; manikin	LARYNGEAL MASK AIRWAY; CARDIOPULMONARY-RESUSCITATION; MANAGEMENT; MANNEQUIN	Current guidelines for pediatric cardiopulmonary resuscitation suggest that supraglottic devices are alternatives for tracheal intubation with minimal interruption of chest compression. We examined the utility of three intubating supraglottic devices, air-Q (R) (air-Q), Ambu (R) aura-i (aura-i), and i-gel (R) (i-gel), utilizing manikin simulation. Twenty-two novice physicians performed securing of airway on an infant manikin with the three devices. We measured the rate of success on ventilation and the insertion time with or without chest compression. Successful ventilation rate did not significantly decrease with chest compression in the three devices (without chest compression: air-Q, 21/22; aura-i, 20/22; i-gel, 20/22, during chest compression: air-Q, 20/22; aura-i, 20/22; i-gel, 18/22). The insertion time with air-Q and aura-i did not extend significantly for chest compression. In contrast, the insertion time with i-gel was significantly extended in chest compression (P < 0.05). Air-Q and aura-i are more useful for airway management during chest compression than i-gel.	[Kohama, Hanako; Nishi, Shin-ichi] Hyogo Coll Med, Div Intens Care Unit, Nishinomiya, Hyogo, Japan; [Ueki, Ryusuke] Hyogo Coll Med, Dept Anesthesiol, Nishinomiya, Hyogo, Japan; [Komasawa, Nobuyasu] Osaka Med Coll, Dept Anesthesiol, Osaka 5698686, Japan; [Kaminoh, Yoshiroh] Social Insurance Kinan Hosp, Dept Anesthesiol, Tanabe, Hyogo, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Hein C, 2010, SIMUL HEALTHC, V5, P33, DOI 10.1097/SIH.0b013e3181b5c3fb; Gatward JJ, 2008, BRIT J ANAESTH, V100, P351, DOI 10.1093/bja/aem364; Diggs LA, 2014, RESUSCITATION, V85, P885, DOI 10.1016/j.resuscitation.2014.02.032; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Komasawa N, 2012, RESUSCITATION, V83, P365, DOI 10.1016/j.resuscitation.2011.08.025; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Yeung J, 2014, RESUSCITATION, V85, P898, DOI 10.1016/j.resuscitation.2014.02.018; Komasawa N, 2010, J ANESTH, V24, P582, DOI 10.1007/s00540-010-0950-1; Komasawa N, 2014, J ANESTH, V28, P676, DOI 10.1007/s00540-014-1802-1; Mort TC, 2006, ANESTH ANALG, V103, P1264, DOI 10.1213/01.ane.0000242521.58073.85	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					180	182		10.1111/ped.12541		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800039		
J	Hirano, D; Kakegawa, D; Yamada, A; Ito, A; Miwa, S; Ida, H				Hirano, Daishi; Kakegawa, Daisuke; Yamada, Akifumi; Ito, Akira; Miwa, Saori; Ida, Hiroyuki			Tolvaptan in a pediatric patient with diuretic-resistant heart and kidney failure	PEDIATRICS INTERNATIONAL			English	Article						children; chronic kidney disease; congestive heart failure; furosemide; tolvaptan	ANTAGONIST; FUROSEMIDE; THERAPY	Despite conventional diuretic therapy, volume overload persists in many patients with decompensated heart failure. Adverse effects of diuretics are common, including worsening kidney function and electrolyte disturbance. Furthermore, decreased kidney function also affects the response to diuretics and is associated with an increased risk of mortality. A 10-year-old boy with congestive heart failure (CHF) complicated by advanced chronic kidney disease (CKD) presented with oliguria and generalized edema. He was being treated with furosemide and spironolactone, and these doses were increased to 3mg/kg/day after admission. Although edema decreased temporarily, the symptoms worsened and furosemide resistance developed 2 months later. Tolvaptan (0.1mg/kg/day) was started, resulting in a gradual increase in the plasma sodium level and adequate decongestion of the volume overload state. Cardiac function also improved. The use of tolvaptan should be considered in pediatric cases of conventional diuretic-resistant CHF, even when complicated by advanced CKD.	[Hirano, Daishi; Kakegawa, Daisuke; Yamada, Akifumi; Ito, Akira; Miwa, Saori; Ida, Hiroyuki] Jikei Univ, Dept Pediat, Sch Med, Tokyo 1050003, Japan	Hirano, D (reprint author), Jikei Univ, Dept Pediat, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1050003, Japan.	bqx1976@hotmail.com					Shoaf SE, 2014, KIDNEY INT, V85, P953, DOI 10.1038/ki.2013.350; Domanski M, 2003, J AM COLL CARDIOL, V42, P705, DOI 10.1016/S0735-1097(03)00765-4; Otsuka T, 2013, CLIN EXP NEPHROL, V17, P834, DOI 10.1007/s10157-013-0788-6; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Ellison DH, 2001, CARDIOLOGY, V96, P132, DOI 10.1159/000047397; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; KAISSLING B, 1985, AM J PHYSIOL, V248, pF374; LOON NR, 1989, KIDNEY INT, V36, P682, DOI 10.1038/ki.1989.246; Nishizaki Y, 2013, J CARDIOL CASES, V8, P151; Shin DD, 2007, AM J CARDIOL, V99, p4A, DOI 10.1016/j.amjcard.2006.11.025	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					183	185		10.1111/ped.12590		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800040		
J	Mizumoto, H; Iki, Y; Yamashita, S; Hata, D				Mizumoto, Hiroshi; Iki, Yoichi; Yamashita, Sumie; Hata, Daisuke			Expiratory CO2 as the first sign of successful ventilation during neonatal resuscitation	PEDIATRICS INTERNATIONAL			English	Article						electrocardiogram; expiratory carbon dioxide; neonatal resuscitation; positive pressure ventilation	MASK VENTILATION; CARBON-DIOXIDE; AIRWAY	Three-lead electrocardiography and expired CO2 monitoring were used during positive pressure ventilation of seven non-intubated newborns (gestational age, 31-37 weeks; birthweight, 1503-2885g). In all cases, adequate CO2 (>15mmHg) was detected prior to the achievement of stable heart rate (>100 beats/min). The delay between detection of adequate CO2 and improvement of bradycardia ranged from 8 to 73s (median, 15s). Inadequate expired CO2 during positive pressure ventilation indicates airway obstruction or poor aeration of the newborn lungs. Thus, positive expiratory CO2 can be the first recognizable sign of successful ventilation during neonatal resuscitation.	[Mizumoto, Hiroshi; Iki, Yoichi; Yamashita, Sumie; Hata, Daisuke] Kitano Hosp, Med Res Inst, Dept Pediat, Tazuke Kofukai, Osaka, Japan	Mizumoto, H (reprint author), 2-4-20 Ohgimachi,Kita Ku, Osaka 5308480, Japan.	h-mizumoto@kitano-hp.or.jp					Finer NN, 2009, PEDIATRICS, V123, P865, DOI 10.1542/peds.2008-0560; Leone TA, 2006, PEDIATRICS, V118, pE202, DOI 10.1542/peds.2005-2493; Mizumoto H, 2012, PEDIATR INT, V54, P205, DOI 10.1111/j.1442-200X.2011.03506.x; Hooper SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070895; Nicoll J, 2013, RESUSCITATION, V84, P1439, DOI 10.1016/j.resuscitation.2013.05.004; Perlman JM, 2010, PEDIATRICS, V126, pE1319, DOI 10.1542/peds.2010-2972B; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					186	188		10.1111/ped.12553		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800041		
J	Ogawa, R; Mori, R; Sako, M; Kageyama, M; Tamura, M; Namba, F				Ogawa, Ryo; Mori, Rintaro; Sako, Mayumi; Kageyama, Misao; Tamura, Masanori; Namba, Fumihiko			Drug treatment for bronchopulmonary dysplasia in Japan: Questionnaire survey	PEDIATRICS INTERNATIONAL			English	Article						bronchopulmonary dysplasia; caffeine; drug; questionnaire; steroid	THERAPY	Bronchopulmonary dysplasia (BPD) is one of the most common complications in premature infants. Although several different drugs have been developed for BPD, there is a wide variation in the choice of drug used among facilities. The aim of this study was to carry out a survey of the current drugs used to treat BPD in Japan. Questionnaires regarding the current use of drugs for BPD were sent to tertiary neonatal units. The response rate was 80% (77/96). Most units used antenatal steroids and oral diuretics for the prevention and treatment of BPD, respectively. Only 4% used caffeine for prevention, whereas 88% used systemic corticosteroids for treatment. Few units used inhaled anticholinergics and i.v. vitamins for the prevention and treatment of BPD, respectively. It was found that the drugs used to treat BPD vary greatly among institutions. Further research is required to develop evidence-based clinical guidelines for BPD in premature infants.	[Ogawa, Ryo; Tamura, Masanori; Namba, Fumihiko] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama 3508550, Japan; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Sako, Mayumi] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Div Clin Trials, Tokyo, Japan; [Kageyama, Misao] Okayama Med Ctr, Dept Neonatol, Okayama, Japan	Namba, F (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Pediat, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	nambaf@saitama-med.ac.jp			Young Investigator Grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Saitama Medical University Internal Research Grant from Saitama Medical University; Health Labour Sciences Research Grant, "Studies to elucidate the pathogenesis and long-term outcomes of low birthweight infants" from the Ministry of Health Labour and Welfare	Dr Namba is supported by Young Investigator Grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics, Saitama Medical University Internal Research Grant from Saitama Medical University, and Health Labour Sciences Research Grant, "Studies to elucidate the pathogenesis and long-term outcomes of low birthweight infants" from the Ministry of Health Labour and Welfare.	NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Crowley P, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000065.PUB2; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Henderson-Smart DJ, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000140; WHO, 2013, WHO MOD LIST ESS MED	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					189	192		10.1111/ped.12584		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800042		
J	Fujisawa, D; Mitsubuchi, H; Matsumoto, S; Iwai, M; Nakamura, K; Hoshide, R; Harada, N; Yoshino, M; Endo, F				Fujisawa, Daisuke; Mitsubuchi, Hiroshi; Matsumoto, Shirou; Iwai, Masanori; Nakamura, Kimitoshi; Hoshide, Ryuji; Harada, Nawomi; Yoshino, Makoto; Endo, Fumio			Early intervention for late-onset ornithine transcarbamylase deficiency	PEDIATRICS INTERNATIONAL			English	Article						arginine supplementation; blood amino acid analysis; genetic analysis; genetic counseling; late-onset ornithine transcarbamylase deficiency		We report the case of a family with late-onset ornithine transcarbamylase deficiency (OTCD). Several family members had died from OTCD, and the c.221G>A, p.Lys221Lys mutation was detected at the 3 end of exon 6 of OTC in the X-chromosome of some members. We provided genetic counseling on pregnancy, delivery, and neonate management to a 4th-generation female carrier and decided on metabolic management of her child from birth. Two male patients were diagnosed with late-onset OTCD on the basis of blood amino acid and genetic analysis, and they received arginine supplementation from the asymptomatic, early neonatal period. These children grew and developed normally, without decompensation. Patients with late-onset OTCD can and should be diagnosed and treated in the early neonatal period, especially those from families already diagnosed with late-onset OTCD, and family members must be provided with genetic counseling.	[Fujisawa, Daisuke; Mitsubuchi, Hiroshi; Matsumoto, Shirou; Iwai, Masanori; Nakamura, Kimitoshi; Hoshide, Ryuji; Endo, Fumio] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto 8608556, Japan; [Harada, Nawomi] Kurume Univ Med, Dept Pediat & Child Hlth, Kurume, Fukuoka, Japan; [Yoshino, Makoto] Kurume Univ, Cognit & Mol Res Inst Brain Dis, Div Gene Therapy & Regenerat Med, Kurume, Fukuoka 830, Japan	Mitsubuchi, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, 1-1-1 Honjo, Kumamoto 8608556, Japan.	mitsubuchi@fc.kuh.kumamoto-u.ac.jp					McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Kido J, 2012, J INHERIT METAB DIS, V35, P777, DOI 10.1007/s10545-011-9427-0; Ausems MGEM, 1997, AM J MED GENET, V68, P236, DOI 10.1002/(SICI)1096-8628(19970120)68:2<236::AID-AJMG23>3.0.CO;2-U; Balasubramaniam S, 2010, MOL GENET METAB, V99, P34, DOI 10.1016/j.ymgme.2009.08.007; Berry GT, 2001, J PEDIATR-US, V138, pS56, DOI 10.1067/mpd.2001.111837; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; Nagasaka H, 2006, EUR J PEDIATR, V165, P618, DOI 10.1007/s00431-006-0143-y; Shimadzu M, 1998, HUM MUTAT, pS5	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E1	E3		10.1111/ped.12457		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800001		
J	Fuwa, K; Hosono, S; Nagano, N; Munakata, S; Fukamachi, R; Okada, T; Takahashi, S; Takahashi, S; Sato, N; Nakayama, T				Fuwa, Kazumasa; Hosono, Shigeharu; Nagano, Nobuhiko; Munakata, Shun; Fukamachi, Ritsuko; Okada, Tomoo; Takahashi, Shigeru; Takahashi, Shori; Sato, Naoyuki; Nakayama, Tomohiro			Japanese neonate with congenital chloride diarrhea caused by SLC26A3 mutation	PEDIATRICS INTERNATIONAL			English	Article						butyrate; congenital chloride diarrhea; proton pump inhibitor; SLC26A3 mutation		Congenital chloride diarrhea (CCD) beginning in utero is a rare autosomal recessive inherited disorder characterized by impairment of Cl-/HCO3- exchange in an otherwise normal distal ileum and colon. Life-long secretory diarrhea is caused by mutations in solute carrier family 26, member 3, (SLC26A3), which disrupt epithelial Cl-/HCO3- transport in the ileum and colon. Although 55 mutations in SLC26A3 have been identified throughout the world, few Japanese cases have been confirmed on genetic analysis. We report the successful treatment of a Japanese neonate with CCD caused by SLC26A3 mutation.	[Fuwa, Kazumasa; Hosono, Shigeharu; Nagano, Nobuhiko; Munakata, Shun; Fukamachi, Ritsuko; Okada, Tomoo; Takahashi, Shigeru; Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo 1738610, Japan; [Sato, Naoyuki; Nakayama, Tomohiro] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med, Tokyo 1738610, Japan	Hosono, S (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, 30-1 Oyaguchi Itabashi, Tokyo 1738610, Japan.	hosono.shigeharu@nihon-u.ac.jp					Aichbichler BW, 1997, NEW ENGL J MED, V336, P106, DOI 10.1056/NEJM199701093360205; Canani RB, 2004, GASTROENTEROLOGY, V127, P630, DOI 10.1053/j.gastro.2004.03.071; DARROW DC, 1945, J PEDIATR-US, V26, P519, DOI 10.1016/S0022-3476(45)80079-3; GAMBLE JL, 1945, J PEDIATR-US, V26, P509, DOI 10.1016/S0022-3476(45)80078-1; Hong J, 2013, EUR J PEDIATR, V172, P545, DOI 10.1007/s00431-012-1905-3; Lee ES, 2012, ANN LAB MED, V32, P312, DOI 10.3343/alm.2012.32.4.312; Pieroni KP, 2011, DIGEST DIS SCI, V56, P673, DOI 10.1007/s10620-010-1491-z; Sato N, 2009, BIOCHEM BIOPH RES CO, V380, P548, DOI 10.1016/j.bbrc.2009.01.117; Satu W, 2011, HUM MUTAT, V32, P715; Siru M, 2002, HUM MUTAT, V29, P425	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E11	E13		10.1111/ped.12501		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800004		
J	Jimbo, K; Aoyagi, Y; Tanaka, M; Ohbayashi, N; Fujii, T; Kudo, T; Ohtsuka, Y; Shimizu, T				Jimbo, Keisuke; Aoyagi, Yo; Tanaka, Masanori; Ohbayashi, Naho; Fujii, Tohru; Kudo, Takahiro; Ohtsuka, Yoshikazu; Shimizu, Toshiaki			Collagenous sprue in a 3-month-old infant	PEDIATRICS INTERNATIONAL			English	Article						children; collagenous sprue; IgG4; intractable diarrhea; matrix metalloproteinase-1		Collagenous sprue (CS) is a severe malabsorption disorder, the etiology of which has not been well defined. Herein, we report the case of a 3-month-old infant with CS who responded to steroid and immunomodulator treatment and presented a thick subepithelial collagen band. A 3-month-old Japanese girl presented with severe watery diarrhea that lasted for 2 weeks. She was admitted to the referring hospital, but symptomatic improvement was not achieved with fasting and rehydration. Gastroduodenal endoscopy showed an edematous duodenal mucosal surface. Duodenal biopsy indicated severe villous atrophy with infiltration of mostly CD8-positive T cells; and deposition of subepithelial collagen was confirmed. The subepithelial collagen deposits, however, had disappeared after treatment. Historically, child-onset CS is extremely rare and this case is likely to be the youngest case of infantile CS. The present case suggests that CS should be considered as a differential diagnosis for intractable diarrhea, even in infants.	[Jimbo, Keisuke; Aoyagi, Yo; Ohbayashi, Naho; Fujii, Tohru; Kudo, Takahiro; Ohtsuka, Yoshikazu; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo 1138421, Japan; [Tanaka, Masanori] Hirosaki Municipal Hosp, Dept Pathol & Lab Med, Hirosaki, Aomori, Japan	Jimbo, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kjinbo@juntendo.ac.jp					Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Billiemaz K, 2009, ENDOSCOPY, V41, pE233, DOI 10.1055/s-2008-1077440; Daum S, 2006, CLIN GASTROENTEROL H, V4, P1232, DOI 10.1016/j.cgh.2006.07.003; Freeman HJ, 2005, GASTROENTEROLOGY, V129, P338, DOI 10.1053/j.gastro.2005.05.020; Robert ME, 2000, AM J SURG PATHOL, V24, P676, DOI 10.1097/00000478-200005000-00006; Schoolmeester JK, 2013, HUM PATHOL, V44, P1624, DOI 10.1016/j.humpath.2013.01.013; Xiao Zuoliang, 2009, Gastroenterol Hepatol (N Y), V5, P418; Zhao XR, 2011, ARCH PATHOL LAB MED, V135, P803, DOI 10.1043/2010-0028-RS.1	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E18	E22		10.1111/ped.12506		5	Pediatrics	Pediatrics	CC4TN	WOS:000350346800006		
J	Ochi, F; Tauchi, H; Moritani, K; Miyamoto, H; Ohkusu, K; Ishii, E				Ochi, Fumihiro; Tauchi, Hisamichi; Moritani, Kyoko; Miyamoto, Hitoshi; Ohkusu, Kiyofumi; Ishii, Eiichi			Tsukamurella inchonensis infection in a child with Hodgkin's lymphoma	PEDIATRICS INTERNATIONAL			English	Article						bacteremia; catheter-related bloodstream infection; central venous catheters; Hodgkin's lymphoma; Tsukamurella inchonensis	SP NOV.; BACTEREMIA	Tsukamurella spp. infection is a rare but important cause of bacteremia in immunocompromised patients. The organism is an aerobic, Gram-positive, weakly acid-fast bacillus that is difficult to differentiate from other aerobic Actinomycetales by standard laboratory methods. Here, we report on the case of a 14-year-old patient with Hodgkin's lymphoma who, after intensive chemotherapy, developed Tsukamurella inchonensis bacteremia, which was identified on the peripherally inserted central venous catheter (PICC) using 16S rRNA sequencing analysis. The bacteremia was successfully controlled with antimicrobial therapy and subsequent removal of the PICC. This is the first report of bacteremia by Tsukamurella inchonensis in immunocompromised children. Careful observation and prompt analysis of opportunistic infection, including Tsukamurella spp., is very important in immunocompromised children.	[Ochi, Fumihiro; Tauchi, Hisamichi; Moritani, Kyoko; Ishii, Eiichi] Ehime Univ, Grad Sch Med, Dept Pediat, Toon, Ehime 7910295, Japan; [Miyamoto, Hitoshi] Ehime Univ Hosp, Div Clin Lab, Toon, Ehime, Japan; [Ohkusu, Kiyofumi] Gifu Univ, Sch Med, Dept Microbiol Regenerat & Adv Med Sci, Gifu 500, Japan	Ochi, F (reprint author), Ehime Univ, Grad Sch Med, Dept Pediat, Toon, Ehime 7910295, Japan.	fmochi2000@yahoo.co.jp					YASSIN AF, 1995, INT J SYST BACTERIOL, V45, P522; Bouza E, 2009, EUR J CLIN MICROBIOL, V28, P203, DOI 10.1007/s10096-008-0607-2; Schwartz MA, 2002, CLIN INFECT DIS, V35, pE72, DOI 10.1086/342561; Chong Y, 1997, CLIN INFECT DIS, V24, P1267; Kattar MM, 2001, J CLIN MICROBIOL, V39, P1467, DOI 10.1128/JCM.39.4.1467-1476.2001; Liu CY, 2011, INT J ANTIMICROB AG, V38, P534, DOI 10.1016/j.ijantimicag.2011.07.018; Sheridan EAS, 2003, CLIN INFECT DIS, V36, pE69, DOI 10.1086/367654; Wang T, 2011, PATHOLOGY, V43, P58, DOI 10.1097/PAT.0b013e328340e431; Weon HY, 2010, INT J SYST EVOL MICR, V60, P1667, DOI 10.1099/ijs.0.014852-0	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E7	E10		10.1111/ped.12472		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800003		
J	Ohkawa, T; Miyamoto, S; Sugie, M; Tomizawa, D; Imai, K; Nagasawa, M; Morio, T; Mizutani, S; Takagi, M				Ohkawa, Teppei; Miyamoto, Satoshi; Sugie, Manabu; Tomizawa, Daisuke; Imai, Kohsuke; Nagasawa, Masayuki; Morio, Tomohiro; Mizutani, Shuki; Takagi, Masatoshi			Transient abnormal myelopoiesis in non-Down syndrome neonate	PEDIATRICS INTERNATIONAL			English	Article						acute megakaryoblastic leukemia; Down syndrome; GATA1; neonate; transient abnormal myelopoiesis	ACUTE MEGAKARYOBLASTIC LEUKEMIA; MUTATIONS; GATA1	We encountered a case of neonatal acute megakaryoblastic leukemia not associated with Down syndrome (DS). Molecular cytogenetic analysis of leukemic blast cells indicated that increased blast cell status was caused by transient abnormal myelopoiesis with trisomy 21 and GATA1 mutation. Based on these molecular cytogenetic data, intensive chemotherapy was avoided, and the patient was successfully cured with low-dose cytarabine. Morphologically, leukemic blast cells of acute megakaryoblastic leukemia in a non-DS neonate are indistinguishable from a blast cell of transient abnormal myelopoiesis. The possibility of transient abnormal myelopoiesis should be carefully considered before intensive chemotherapy is adopted.	[Ohkawa, Teppei; Miyamoto, Satoshi; Sugie, Manabu; Tomizawa, Daisuke; Imai, Kohsuke; Nagasawa, Masayuki; Morio, Tomohiro; Mizutani, Shuki; Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med, Tokyo 1138519, Japan	Takagi, M (reprint author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, 1-5-45 Bunkyo Ku, Tokyo 1138519, Japan.	m.takagi.ped@tmd.ac.jp		Tomizawa, Daisuke/0000-0003-1520-7007			Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Isaacs H, 2003, J PEDIAT HEMATOL ONC, V25, P348; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Malinge S, 2012, J CLIN INVEST, V122, P948, DOI 10.1172/JCI60455; de Rooij JDE, 2013, LEUKEMIA, V27, P2280, DOI 10.1038/leu.2013.87; BADER JL, 1979, AM J DIS CHILD, V133, P157; Devlin L, 2004, Ulster Med J, V73, P4; Kudo K, 2010, INT J HEMATOL, V91, P630, DOI 10.1007/s12185-010-0549-1; Polski JM, 2002, J PEDIAT HEMATOL ONC, V24, P50, DOI 10.1097/00043426-200201000-00014; Richards M, 1998, ARCH DIS CHILD, V79, pF215; Sandoval C, 2005, PEDIATR BLOOD CANCER, V44, P85, DOI 10.1002/pbc.20161; Yanase K, 2010, INT J HEMATOL, V92, P527, DOI 10.1007/s12185-010-0646-1	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E14	E17		10.1111/ped.12500		4	Pediatrics	Pediatrics	CC4TN	WOS:000350346800005		
J	Okura, Y; Kawamura, N; Okano, M; Toita, N; Takezaki, S; Yamada, M; Kobayashi, I; Ariga, T				Okura, Yuka; Kawamura, Nobuaki; Okano, Motohiko; Toita, Nariaki; Takezaki, Shunichiro; Yamada, Masafumi; Kobayashi, Ichiro; Ariga, Tadashi			Fusarium falciforme infection in a patient with chronic granulomatous disease: Unique long-term course of epidural abscess	PEDIATRICS INTERNATIONAL			English	Article						chronic granulomatous disease; epidural abscess; Fusarium; meningitis; myelitis	FUNGAL-INFECTION; MANAGEMENT	Chronic granulomatous disease (CGD) is a primary immunodeficiency disease characterized by recurrent life-threatening bacterial and fungal infections with granuloma formation. Species of the genus Fusarium are opportunistic environmental microorganisms that are rarely pathogenic in humans. We report here the first case of X-linked CGD complicated with epidural abscess caused by Fusarium falciforme infection. The abscesses extended along the dura mater for >7 years and finally resulted in fatal meningitis and cervical myelitis. Early intervention with hematopoietic stem cell transplantation should be considered, especially in patients with severe CGD, before the development of serious infectious complication.	[Okura, Yuka; Kawamura, Nobuaki; Okano, Motohiko; Toita, Nariaki; Takezaki, Shunichiro; Yamada, Masafumi; Kobayashi, Ichiro; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; [Kawamura, Nobuaki] Sapporo City Gen Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Okano, Motohiko] Hokkaido Inst Publ Hlth, Ctr Infect Dis Control, Sapporo, Hokkaido 0600819, Japan; [Toita, Nariaki] Sapporo Kosei Gen Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Okura, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	okura@med.hokudai.ac.jp			Japanese Ministry of Health, Labor and Welfare	The authors thank the staff of Hokkaido University Hospital who participated in the care of the patient. This work was supported in part by a grant for Research on Intractable Diseases from the Japanese Ministry of Health, Labor and Welfare. The authors declare no competing financial interests.	Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Falcone EL, 2012, CURR OPIN INFECT DIS, V25, P658, DOI 10.1097/QCO.0b013e328358b0a4; Tortorano AM, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12465; Mansoory D, 2003, CLIN INFECT DIS, V37, pE107, DOI 10.1086/377608; ARIGA T, 1995, HUM GENET, V96, P6, DOI 10.1007/BF00214178; Bassiri-Jahromi S, 2012, J MYCOL MED, V22, P52, DOI 10.1016/j.mycmed.2011.12.079; COHEN MS, 1981, AM J MED, V71, P59, DOI 10.1016/0002-9343(81)90259-X; Okano M, 1999, RESPIRATION, V66, P551, DOI 10.1159/000029435; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	FEB	2015	57	1					E4	E6		10.1111/ped.12458		3	Pediatrics	Pediatrics	CC4TN	WOS:000350346800002		
J	Adzlan, A; Tsutsumi, S; Gotoda, H				Adzlan, Ahmad; Tsutsumi, Shunsuke; Gotoda, Hiroshi			Near-field behavior of variable property jet with swirling flow generated by a change in gravitational orientation	PHYSICS OF FLUIDS			English	Article							DIRECT NUMERICAL SIMULATIONS; DENSITY GAS JETS; VORTEX BREAKDOWN; INSTABILITY; HELIUM; PLUMES; AIR	This paper presents the near-field behavior of a variable property jet with swirling flow generated by a change in gravitational orientation, focusing on the onset of vortex formation at the jet interface and the subsequent vortex breakdown (VB). Two types of gases are used to create a significant difference in the physical properties between the inner and outer fluids: CO2 with high-density and low-viscosity, and helium with low-density and high-viscosity. We propose a nondimensional instability parameter M* as a useful index for predicting the onset of vortex formation at a swirling jet interface. Inverted gravity (+1g) enlarges the region of unstable VB of the CO2 jet compared with that in normal gravity (-1g), which clearly shows that the buoyancy force has a significant impact on unstable VB. The trends of the changes in the jet half-angle and stagnation point height are investigated in detail for the preceding stable VB. Our physical model derived by considering the momentum balance in a swirling flow is adopted to understand the mechanism of the notable change in the stagnation point height in +1g with increasing swirl number of the inner jet and Reynolds number of the outer jet. (C) 2015 AIP Publishing LLC.	[Adzlan, Ahmad] Univ Malaysia Sarawak, Dept Mech & Mfg Engn, Kota Samarahan 94300, Sarawak, Malaysia; [Adzlan, Ahmad; Tsutsumi, Shunsuke; Gotoda, Hiroshi] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan	Gotoda, H (reprint author), Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan.	gotoda@se.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); JGC-S Scholarship Foundation; Research Acculturation Grant Scheme by the Ministry of Education Malaysia [RAGS/C(5)/938/2012(39)]	H.G. was partially supported by a Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and JGC-S Scholarship Foundation. A. A. was supported by Research Acculturation Grant Scheme by the Ministry of Education Malaysia (Grant No. RAGS/C(5)/938/2012(39)). The authors are grateful to Professor Toshihisa Ueda of Keio University for his collaboration in deriving an early version of our model<SUP>20</SUP> to explain the change in the stagnation point height of stable VB.	Abid M, 2008, J FLUID MECH, V605, P19, DOI 10.1017/S0022112008001377; Abid M, 1998, PHYS FLUIDS, V10, P469, DOI 10.1063/1.869534; Adzlan A, 2012, CHEM ENG SCI, V80, P174, DOI 10.1016/j.ces.2012.05.027; CHIGIER NA, 1967, J APPL MECH, V34, P443; Cetegen BM, 2000, EXP FLUIDS, V28, P546, DOI 10.1007/s003480050415; HALL MG, 1972, ANNU REV FLUID MECH, V4, P195, DOI 10.1146/annurev.fl.04.010172.001211; Liang HZ, 2005, J FLUID MECH, V525, P115, DOI 10.1017/S0022112004002629; Billant P, 1998, J FLUID MECH, V376, P183, DOI 10.1017/S0022112098002870; Oberleithner K, 2012, AIAA J, V50, P1437, DOI [10.2514/1.1050642, 10.2514/1.J050642]; PANCHAPAKESAN NR, 1993, J FLUID MECH, V246, P225, DOI 10.1017/S0022112093000102; Gotoda H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026211; RICHARDS CD, 1993, J FLUID MECH, V254, P417, DOI 10.1017/S0022112093002204; Birkhoff G., 1957, APPL MATH MECH, V2; Cetegen BM, 1996, PHYS FLUIDS, V8, P2974, DOI 10.1063/1.869075; DAI Z, 1994, J HEAT TRANS-T ASME, V116, P409, DOI 10.1115/1.2911413; Dehmani L, 1996, INT J HEAT FLUID FL, V17, P452, DOI 10.1016/0142-727X(96)00050-1; Delbende I, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1868412; Delery JM, 1994, PROGR AEROSPACE SCI, V30, P1, DOI 10.1016/0376-0421(94)90002-7; Escudier M., 1988, Progress in Aerospace Sciences, V25, DOI 10.1016/0376-0421(88)90007-3; Escuider M. P., 1983, AGARD C P AERODYNAMI, V342, P25; FALER JH, 1977, PHYS FLUIDS, V20, P1385, DOI 10.1063/1.862033; Liang H., 2003, THESIS U SO CALIFORN; Liang HZ, 2008, EXP FLUIDS, V45, P283, DOI 10.1007/s00348-008-0478-4; Mastorakos E, 1996, EXP FLUIDS, V20, P279, DOI 10.1007/BF00192673; Matsubara S, 2011, EXP FLUIDS, V51, P881, DOI 10.1007/s00348-011-1097-z; MONKEWITZ PA, 1990, J FLUID MECH, V213, P611, DOI 10.1017/S0022112090002476; Mourtazin D, 2007, J FLUID MECH, V571, P177, DOI 10.1017/S0022112006002862; Rajaratnam N., 1976, TURBULENT JETS, V5; Ravier S, 2006, J FLUID MECH, V546, P153, DOI 10.1017/S0022112005006993; Santhosh R, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4817665; Satti RP, 2006, INT J HEAT FLUID FL, V27, P336, DOI 10.1016/j.ijheatfluidflow.2005.10.012; SPALL RE, 1987, PHYS FLUIDS, V30, P3434, DOI 10.1063/1.866475; Taub GN, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3658732; Wardana ING, 2009, EXP FLUIDS, V47, P239, DOI 10.1007/s00348-009-0651-4; Yep TW, 2003, AIAA J, V41, P1973, DOI 10.2514/2.1887	35	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	FEB	2015	27	2							024105	10.1063/1.4906372		19	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CC7MG	WOS:000350551300022		
J	Lee, D; Kawai, S; Nonomura, T; Anyoji, M; Aono, H; Oyama, A; Asai, K; Fujii, K				Lee, Donghwi; Kawai, Soshi; Nonomura, Taku; Anyoji, Masayuki; Aono, Hikaru; Oyama, Akira; Asai, Keisuke; Fujii, Kozo			Mechanisms of surface pressure distribution within a laminar separation bubble at different Reynolds numbers	PHYSICS OF FLUIDS			English	Article							DIRECT NUMERICAL-SIMULATION; LARGE-EDDY SIMULATION; BOUNDARY-LAYER; TURBULENT REATTACHMENT; LEADING-EDGE; AIRFOIL; FLOW; TRANSITION; PERFORMANCE; EQUATIONS	Mechanisms behind the pressure distribution and skin friction within a laminar separation bubble (LSB) are investigated by large-eddy simulations around a 5% thickness blunt flat plate at the chord length based Reynolds number 5.0 x 10(3), 6.1 x 10(3), 1.1 x 10(4), and 2.0 x 10(4). The characteristics inside the LSB change with the Reynolds number; a steady laminar separation bubble (LSB_S) at the Reynolds number 5.0 x 10(3) and 6.1 x 10(3), and a steady-fluctuating laminar separation bubble (LSB_SF) at the Reynolds number 1.1 x 10(4), and 2.0 x 10(4). Different characteristics of pressure and skin friction distributions are observed by increasing the Reynolds number, such that a gradual monotonous pressure recovery in the LSB_S and a plateau pressure distribution followed by a rapid pressure recovery region in the LSB_SF. The reasons behind the different characteristics of pressure distributions at different Reynolds numbers are discussed by deriving the Reynolds averaged pressure gradient equation. It is confirmed that the viscous stress distributions near the surface play an important role in determining the formation of different pressure distributions. Depending on the Reynolds numbers, the viscous stress distributions near the surface are affected by the development of a separated laminar shear layer or the Reynolds shear stress. In addition, we show that the same analyses can be applied to the flows around a NACA0012 airfoil. (C) 2015 AIP Publishing LLC.	[Lee, Donghwi] Univ Tokyo, Dept Aeronaut & Astronaut, Sagamihara, Kanawawa 2525210, Japan; [Kawai, Soshi; Nonomura, Taku; Anyoji, Masayuki; Aono, Hikaru; Oyama, Akira; Fujii, Kozo] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanawawa 2525210, Japan; [Asai, Keisuke] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan	Lee, D (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, 3-1-1 Yoshinodai, Sagamihara, Kanawawa 2525210, Japan.	lee@flab.isas.jaxa.jp			Asahi Glass Scholarship foundation; graduate school of engineering, the university of Tokyo doctoral student special incentives program; Mars Exploration Airplane Working Group of Institute of Space and Astronautical Science, JAXA;  [24246136]	This work was supported by the Asahi Glass Scholarship foundation and the graduate school of engineering, the university of Tokyo doctoral student special incentives program. Computer resources were provided by the V-system of JAXA Supercomputer system at Japan Aerospace Exploration Agency (JAXA). This work was also partially supported by the Mars Exploration Airplane Working Group of Institute of Space and Astronautical Science, JAXA, and by a Grant-in-Aid for Scientific Research (A), No. 24246136.	Abe Y., 2013, J COMPUT PHYS, V260, P163; AIAA Standard, 1999, S017A1999 AIAA; ALVING AE, 1995, PHYS FLUIDS, V7, P1956, DOI 10.1063/1.868772; LISSAMAN PBS, 1983, ANNU REV FLUID MECH, V15, P223, DOI 10.1146/annurev.fl.15.010183.001255; Kawai S, 2010, J COMPUT PHYS, V229, P1739, DOI 10.1016/j.jcp.2009.11.005; Watmuff JH, 1999, J FLUID MECH, V397, P119, DOI 10.1017/S0022112099006138; Nishida H, 2009, J COMPUT PHYS, V228, P3182, DOI 10.1016/j.jcp.2009.01.032; Kawai S, 2008, AIAA J, V46, P690, DOI 10.2514/1.32239; PAULEY LL, 1990, J FLUID MECH, V220, P397, DOI 10.1017/S0022112090003317; Counsil JNN, 2013, J AIRCRAFT, V50, P204, DOI 10.2514/1.C031856; Jones LE, 2008, J FLUID MECH, V602, P175, DOI 10.1017/S0022112008000864; Lin JCM, 1996, AIAA J, V34, P1570, DOI 10.2514/3.13273; OMEARA MM, 1987, AIAA J, V25, P1033, DOI 10.2514/3.9739; CHOI H, 1994, J COMPUT PHYS, V113, P1, DOI 10.1006/jcph.1994.1112; Spalart PR, 2000, J FLUID MECH, V403, P329, DOI 10.1017/S0022112099007077; Hain R, 2009, J FLUID MECH, V630, P129, DOI 10.1017/S0022112009006661; Gaitonde DV, 2000, AIAA J, V38, P2103, DOI 10.2514/2.872; Diwan SS, 2007, SADHANA-ACAD P ENG S, V32, P103, DOI 10.1007/s12046-007-0009-7; DENGEL P, 1990, J FLUID MECH, V212, P615, DOI 10.1017/S0022112090002117; MUELLER TJ, 1982, AIAA J, V20, P457, DOI 10.2514/3.51095; RIPLEY MD, 1993, PHYS FLUIDS A-FLUID, V5, P3099, DOI 10.1063/1.858719; Alam M, 2000, J FLUID MECH, V403, P223, DOI 10.1017/S0022112099007119; LELE SK, 1992, J COMPUT PHYS, V103, P16, DOI 10.1016/0021-9991(92)90324-R; ROBERTS WB, 1980, AIAA J, V18, P25, DOI 10.2514/3.50726; Marxen O, 2011, J FLUID MECH, V671, P1, DOI 10.1017/S0022112010004957; Hu H, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2907416; ARENA AV, 1980, AIAA J, V18, P747, DOI 10.2514/3.50815; Shan H, 2005, COMPUT FLUIDS, V34, P1096, DOI 10.1016/j.compfluid.2004.09.003; Anyoji M., 2011, 20110852 AIAA; Anyoji M, 2014, J AIRCRAFT, V51, P1864, DOI 10.2514/1.C032553; Carmichael B., 1982, NASACR165803; Chakravarthy S.R., 1984, 19840165 AIAA; Gaster M., 1966, AGARD CP, V4, P813; Horton H. P., 1968, THESIS U LONDON; Iizuka N, 2006, THESIS U TOKYO; Karasu I., 2013, J APPL MECH ENG, V2, P131; Kojima R, 2013, J AIRCRAFT, V50, P187, DOI 10.2514/1.C031849; Lee D, 2015, J AIRCRAFT, V52, P296, DOI 10.2514/1.C032721; Obayashi S., 1988, TM100042 NASA; SASAKI K, 1991, J FLUID ENG-T ASME, V113, P405, DOI 10.1115/1.2909510; Shyy W, 2008, CAMB AERO SER, P1; Suluksna K, 2008, INT J HEAT FLUID FL, V29, P48, DOI 10.1016/j.ijheatfluidflow.2007.08.003; Tani I., 1964, PROGRESS AERONAUTICA, V5, P70, DOI DOI 10.1016/0376-0421(64)90004-1; Tani I., 1961, 361 AER RES I; Yarusevych S, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2187069; Zhou Y., 2011, 20110736 AIAA	46	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	FEB	2015	27	2							023602	10.1063/1.4913500		22	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CC7MG	WOS:000350551300016		
J	Yano, T; Nishino, K; Kawamura, H; Ueno, I; Matsumoto, S				Yano, T.; Nishino, K.; Kawamura, H.; Ueno, I.; Matsumoto, S.			Instability and associated roll structure of Marangoni convection in high Prandtl number liquid bridge with large aspect ratio	PHYSICS OF FLUIDS			English	Article							OSCILLATORY THERMOCAPILLARY FLOW; HYDROTHERMAL WAVE; RAYLEIGH-LIMIT; MICROGRAVITY; SURFACE; COLUMNS; LAYERS; FLUID	This paper reports the experimental results on the instability and associated roll structures (RSs) of Marangoni convection in liquid bridges formed under the microgravity environment on the International Space Station. The geometry of interest is high aspect ratio (AR = height/diameter >= 1.0) liquid bridges of high Prandtl number fluids (Pr = 67 and 207) suspended between coaxial disks heated differentially. The unsteady flow field and associated RSs were revealed with the three-dimensional particle tracking velocimetry. It is found that the flow field after the onset of instability exhibits oscillations with azimuthal mode number m = 1 and associated RSs traveling in the axial direction. The RSs travel in the same direction as the surface flow (co-flow direction) for 1.00 <= AR <= 1.25 while they travel in the opposite direction (counter-flow direction) for AR >= 1.50, thus showing the change of traveling directions with AR. This traveling direction for AR >= 1.50 is reversed to the co-flow direction when the temperature difference between the disks is increased to the condition far beyond the critical one. This change of traveling directions is accompanied by the increase of the oscillation frequency. The characteristics of the RSs for AR >= 1.50, such as the azimuthal mode of oscillation, the dimensionless oscillation frequency, and the traveling direction, are in reasonable agreement with those of the previous sounding rocket experiment for AR = 2.50 and those of the linear stability analysis of an infinite liquid bridge. (C) 2015 AIP Publishing LLC.	[Yano, T.; Nishino, K.] Yokohama Natl Univ, Dept Mech Engn, Yokohama, Kanagawa 2408501, Japan; [Kawamura, H.] Tokyo Univ Sci, Suwa, Chino 3918502, Japan; [Ueno, I.] Tokyo Univ Sci, Fac Sci & Technol, Dept Mech Engn, Noda, Chiba 2788510, Japan; [Matsumoto, S.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Tsukuba, Ibaraki 3058505, Japan	Yano, T (reprint author), Japan Soc Promot Sci, Tokyo, Japan.	nish@ynu.ac.jp		Yano, Taishi/0000-0002-7443-3410	Japan Society for the Promotion of Science (JSPS) KAK-ENHI [21360101, 24360078, 13J02728]	The authors greatly appreciate Dr. M. Ohnishi and Dr. M. Sakurai from JAXA for their support for the present space experiment. The authors also would like to thank the all members of MEIS. This study was financially supported by Japan Society for the Promotion of Science (JSPS) KAK-ENHI (Grant-in-Aid for Scientific Research (B), Nos. 21360101 and 24360078, Grant-in-Aid for JSPS Fellows, No. 13J02728).	VILLERS D, 1992, J FLUID MECH, V234, P487, DOI 10.1017/S0022112092000880; SMITH MK, 1983, J FLUID MECH, V132, P119, DOI 10.1017/S0022112083001512; Ryzhkov II, 2012, INT J HEAT MASS TRAN, V55, P1236, DOI 10.1016/j.ijheatmasstransfer.2011.09.030; XU JJ, 1984, PHYS FLUIDS, V27, P1102, DOI 10.1063/1.864756; Chernatinsky VI, 2002, ADV SPACE RES, V29, P619, DOI 10.1016/S0273-1177(01)00652-4; Gaponenko Y, 2012, MICROGRAVITY SCI TEC, V24, P297, DOI 10.1007/s12217-012-9316-7; Hadid H. B., 1990, Journal of Fluid Mechanics, V221, DOI 10.1017/S0022112090003494; Kamotani Y, 2003, INT J HEAT MASS TRAN, V46, P3211, DOI 10.1016/S0017-9310(03)00098-X; Kawaji M, 1998, NUCL ENG DES, V184, P379, DOI 10.1016/S0029-5493(98)00210-6; Kawamura H, 2010, PROCEEDINGS OF THE ASME INTERNATIONAL HEAT TRANSFER CONFERENCE - 2010, VOL 8, P343; Kawamura H, 2007, INT J HEAT MASS TRAN, V50, P1263, DOI 10.1016/j.ijheatmasstransfer.2006.09.035; Kawamura H, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005145; KUHLMANN HC, 1993, PHYS FLUIDS A-FLUID, V5, P2117, DOI 10.1063/1.858551; Leypoldt J, 2000, J FLUID MECH, V414, P285, DOI 10.1017/S0022112000008570; Nishino K., 1989, J FLUIDS ENG, V111, P384; PREISSER F, 1983, J FLUID MECH, V126, P545, DOI 10.1017/S0022112083000324; Ryzhkov II, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3627150; Sato F, 2013, MICROGRAVITY SCI TEC, V25, P43, DOI 10.1007/s12217-012-9332-7; SCHWABE D, 1992, PHYS FLUIDS A-FLUID, V4, P2368, DOI 10.1063/1.858478; Schwabe D, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2135805; Schwabe D, 2005, ADV SPACE RES, V36, P36, DOI 10.1016/j.asr.2005.02.085; Schwabe D., 1998, J JPN SOC MICROGR S2, V15, P425; Shevtsova V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.134503; Shevtsova V., 2014, FLUID DYN MAT PROC, V10, P197; Shevtsova V, 2013, J FLUID MECH, V714, P644, DOI 10.1017/jfm.2012.519; Shevtsova VM, 1999, ACTA ASTRONAUT, V44, P625, DOI 10.1016/S0094-5765(99)00071-5; Shevtsova VM, 1998, PHYS FLUIDS, V10, P1621, DOI 10.1063/1.869681; Shin-Etsu Chemical Co. Ltd, 2004, SIL FLUID KF 96 PERF; Tiwari S, 2007, J CRYST GROWTH, V300, P486, DOI 10.1016/j.jcrysgro.2006.12.049; VELTEN R, 1991, PHYS FLUIDS A-FLUID, V3, P267, DOI 10.1063/1.858135; Wang A, 2007, INT J HEAT MASS TRAN, V50, P4195, DOI 10.1016/j.ijheatmasstransfer.2007.02.035; Yano T, 2012, EXP FLUIDS, V53, P9, DOI 10.1007/s00348-011-1136-9; Yano T, 2011, J PHYS CONF SER, V327, DOI 10.1088/1742-6596/327/1/012029	33	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	FEB	2015	27	2							024108	10.1063/1.4908042		13	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CC7MG	WOS:000350551300025		
J	Fujiwara, Y; Ito, M				Fujiwara, Yumi; Ito, Michiho			Synergistic Effect of Fragrant Herbs in Japanese Scent Sachets	PLANTA MEDICA			English	Article						sedative effect; inhalation; fragrant herbs; synergistic effect	OIL; INHALATION; SANTALOL; EXTRACT; L.	The sedative activity of eight aromatic natural medicines that are traditionally used in Japanese scent sachets was examined using an open field test with mice. Galangal (Kaempferia galanga), patchouli (Pogostemon cablin), sandalwood (Santalum album), spikenard (Nardostachys chinensis), cinnamon (Cinnamomum cassia), clove (Syzygium aromaticum), star anise (Illicium verum), and borneol (Dryobalanops aromatica) distilled oils were used. These natural medicines have various pharmacological effects. For example, galangal has insecticidal activity and clove extracts possess strong total antioxidant activity. Aromatherapy, a well-known complementary medicine system that uses inhalation, has recently attracted much attention. The sedative activity of inhaled aromatic compounds or essential oils has been examined by measuring the spontaneous motor activity of mice in an open field test. The galangal, patchouli, sandalwood, spikenard, and borneol oils showed significant sedative effects. The effect was stronger for a mixture of the five oils than for any of the single oils. This suggests that the oil mixture may have synergistic activity. Sedative activity was not observed when inactive oils (cinnamon, clove, and star anise) were added to the mixture of the five active oils.	[Fujiwara, Yumi; Ito, Michiho] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Kyoto 6068501, Japan	Fujiwara, Y (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Sakyo Ku, 46-29 Yoshida Shimo Adachicho, Kyoto 6068501, Japan.	shoyaku.shigen@gmail.com					Takemoto H, 2008, J NAT MED, V62, P41, DOI 10.1007/s11418-007-0177-0; Kagawa D, 2003, PLANTA MED, V69, P637, DOI 10.1055/s-2003-41114; Ito K, 2011, J NAT MED-TOKYO, V65, P336, DOI 10.1007/s11418-010-0502-x; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; JONES DL, 1981, NEUROPHARMACOLOGY, V20, P29, DOI 10.1016/0028-3908(81)90038-1; BUCHBAUER G, 1993, J PHARM SCI-US, V82, P660, DOI 10.1002/jps.2600820623; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; PANDJI C, 1993, PHYTOCHEMISTRY, V34, P415, DOI 10.1016/0031-9422(93)80020-S; Gulcin I, 2004, FOOD CHEM, V87, P393, DOI 10.1016/j.foodchem.2003.12.008; Ebihara T, 2006, J AM GERIATR SOC, V54, P1401, DOI 10.1111/j.1532-5415.2006.00840.x; Huang LF, 2008, J ETHNOPHARMACOL, V120, P123, DOI 10.1016/j.jep.2008.07.045; Burden R L, 2010, NUMERICAL ANAL, P193; HONDA G, 1986, CHEM PHARM BULL, V34, P1672; Ito N, 2011, EVID-BASED COMPL ALT, V2011; Iwasaki Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2608, DOI 10.1271/bbb.80289; Misra B B, 2013, PEER J PREPRINTS, V1, pe96v1; Misra BB, 2013, PHYTOMEDICINE, V20, P409, DOI 10.1016/j.phymed.2012.12.017; Ohmori Asae, 2007, Japanese Journal of Neuropsychopharmacology, V27, P167; Takemoto H, 2009, J NAT MED, V63, P380, DOI 10.1007/s11418-009-0340-x; Tianpeng Y, 2007, ZHONGGUO KANGFU YIXU, V22, P487	20	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	FEB	2015	81	3					193	199		10.1055/s-0034-1396138		7	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CC3CY	WOS:000350223500003		
J	Calvopina, M; Cevallos, W; Atherton, R; Saunders, M; Small, A; Kumazawa, H; Sugiyama, H				Calvopina, Manuel; Cevallos, William; Atherton, Richard; Saunders, Matthew; Small, Alexander; Kumazawa, Hideo; Sugiyama, Hiromu			High Prevalence of the Liver Fluke Amphimerus sp in Domestic Cats and Dogs in an Area for Human Amphimeriasis in Ecuador	PLOS NEGLECTED TROPICAL DISEASES			English	Article							OPISTHORCHIS-VIVERRINI INFECTION; CLONORCHIASIS; THAILAND; CHINA	Background Amphimerus sp. is a liver fluke which recently has been shown to have a high prevalence of infection among an indigenous group, Chachi, who reside in a tropical rainforest in the northwestern region of Ecuador. Since it is unknown which animals can act as a reservoir and/or definitive hosts for Amphimerus sp. in this endemic area, a study was done to determine the prevalence of infection in domestic cats and dogs. This information is important to understand the epidemiology, life cycle and control of this parasite. Methodology/Findings In July 2012, three Chachi communities located on Rio Cayapas, province of Esmeraldas, were surveyed. A total of 89 of the 109 registered households participated in the study. Of the 27 cats and 43 dogs found residing in the communities, stool samples were collected from 14 cats and 31 dogs (total of 45 animals) and examined microscopically for the presence of Amphimerus eggs. The prevalence of infection was 71.4% in cats and 38.7% in dogs, with similar rates of infection in all three communities. Significantly more cats were infected than dogs (p = 0.042). Conclusions/Significance The data show a high rate of Amphimerus sp. infection in domestic cats and dogs residing in Chachi communities. It can be concluded that these animals act as definitive and reservoir hosts for this liver fluke and that amphimeriasis is a zoonotic disease. These findings provide important epidemiological data which will aid in the development and implementation of control strategies against the transmission of Amphimerus.	[Calvopina, Manuel; Cevallos, William; Atherton, Richard] Univ Cent, Ctr Biomed, Carrera Med, Quito, Ecuador; [Saunders, Matthew] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Small, Alexander] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Kumazawa, Hideo] Kochi Med Sch, Dept Parasitol, Kochi, Japan; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan	Calvopina, M (reprint author), Univ Cent, Ctr Biomed, Carrera Med, Quito, Ecuador.	manuelcalvopina@gmail.com			Universidad Central del Ecuador [CUP 91750000.0000.374072]; Japan Society for the Promotion of Science, JSPS (KAKENHI) [25305011]; Ministry of Health, Labor and Welfare of Japan [H23-Shinko-ippan-014, H26-Shinkoippan-009]	This study was funded by the grants from the Universidad Central del Ecuador (CUP 91750000.0000.374072) and in part by the Japan Society for the Promotion of Science, JSPS (KAKENHI: Grant No. 25305011) and by grants for Research on Emerging and Re-emerging Infectious Diseases (H23-Shinko-ippan-014 and H26-Shinkoippan-009) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Eisenberg JNS, 2006, P NATL ACAD SCI USA, V103, P19460, DOI 10.1073/pnas.0609431104; Blair D, 1997, PARASITOLOGY, V115, P411, DOI 10.1017/S0031182097001534; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; BOWLES J, 1995, MOL PHYLOGENET EVOL, V4, P103, DOI 10.1006/mpev.1995.1011; Artigas PT, 1962, MEM I BUTANTAN, V30, P157; Aunpromma S, 2012, PARASITOL INT, V61, P60, DOI 10.1016/j.parint.2011.08.004; Bowman DD, 2002, FELINE CLIN PARASITO, V1st, P151; Calvopina M, 2011, EMERG INFECT DIS, V17, P2331, DOI 10.3201/eid1712.110373; EOM K-S, 1984, Korean Journal of Parasitology, V22, P215; INEC Instituto Nacional Ecuatoriano de Censos, 2001, 6 CENS POBL VIV; KIFUNE T, 1981, Medical Bulletin of Fukuoka University, V8, P393; Lin RQ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-180; Miyazaki I, 1978, REPORTS FUKUOKA U SC, P1; Neto AHAD, 1998, MEM I OSWALDO CRUZ, V93, P181; Rodriguez JD, 1949, REV ECUAT HIG MED TR, V6, P11; Sierra R, 1999, ENVIRON CONSERV, V26, P136, DOI 10.1017/S0376892999000181; THATCHER VE, 1970, P HELM SOC WASH, V37, P207; Thomasson Crompton DW David William, 2010, WHO TECH REP SER; Trostle JA, 2008, EPIDEMIOLOGY, V19, P384, DOI 10.1097/EDE.0b013e31816a9db0; Wongratanacheewin S, 2003, ACTA TROP, V88, P195, DOI 10.1016/j.actatropica.2003.02.002; Yamaguti S., 1971, SYNOPSIS DIGENETIC T, V2, P1074	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2015	9	2							UNSP e0003526	10.1371/journal.pntd.0003526		9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CD3PW	WOS:000350992500051		
J	Yoon, S; Watanabe, E; Ueno, H; Kishi, MJ				Yoon, Seokjin; Watanabe, Eiji; Ueno, Hiromichi; Kishi, Michio J.			Potential habitat for chum salmon (Oncorhynchus keta) in the Western Arctic based on a bioenergetics model coupled with a three-dimensional lower trophic ecosystem model	PROGRESS IN OCEANOGRAPHY			English	Review							NORTH PACIFIC-OCEAN; BERING-SEA; SOCKEYE-SALMON; GRAZING IMPACT; CLIMATE-CHANGE; JUVENILE PINK; MIGRATION; FISH; CONSUMPTION; EDDIES	Chum salmon (Oncorhynchus keta) are predominantly located in the Bering Sea during summer and fall. However, several studies have recently reported a different tendency as follows. Observed densities of chum salmon were higher in the vicinity of the Bering Strait and the Chukchi Sea than the eastern Bering Sea in September 2007, and Japanese chum salmon migrated to northern areas in the Bering Sea during summer 2009. The sea surface temperature (SST) in the Arctic marginal seas has increased since the mid1960s, and especially since 2000. We speculated that the SST increase directly promoted salmon northing from the Bering Sea to the Western Arctic. In this study, we estimated the potential habitat for chum salmon in the Western Arctic using a bioenergetics model coupled with a three-dimensional lower trophic ecosystem model (3-D NEMURO). "Potential habitat" was defined as "an area where chum salmon could grow (i.e., the growth rate was positive)". In the bioenergetics model, the growth rate of an individual chum salmon was calculated as a function of water temperature, salinity, and prey density, which were obtained from the 3-D NEMURO model results. To evaluate the habitat responses under a global warming scenario, we used the modeled monthly change of water temperature between 2005 (averaged from 2001 to 2010) and 2095 (averaged from 2091 to 2100) under the IPCC SRES-A1 B scenario. Our calculations, following the global warming scenario, suggested that the potential habitat for chum salmon would expand to the north due to the increase in water temperature and prey density. In contrast, south of 71 degrees N during summer, the potential habitat would shrink regionally because the water temperature exceeded the optimal condition. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Yoon, Seokjin; Ueno, Hiromichi; Kishi, Michio J.] Hokkaido Univ, Fac Fisheries Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Watanabe, Eiji] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Ueno, Hiromichi; Kishi, Michio J.] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Yoon, S (reprint author), Kyoto Univ, Field Sci Educ & Res Ctr, Fisheries & Environm Oceanog, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	seokjin.yoon@gmail.com	Yoon, Seokjin/O-4002-2014; WATANABE, EIJI/C-2797-2009		Ministry of Agriculture, Forestry and Fisheries, Japan; Japan Society for the Promotion of Science [22221003]	This work was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan through a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries". E. Watanabe and M.J. Kishi were funded by the Grants-in-Aid for Scientific Research (S) of Japan Society for the Promotion of Science JFY2010-2014, No. 22221003, "Catastrophic reduction of sea ice in the Arctic Ocean: its impact on the marine ecosystems in the polar region". The 3-D NEMURO experiments were executed using Earth Simulator version 2 of Japan Agency for Marine-Science and Technology (JAMSTEC).	Ishida Y, 2001, FISHERIES SCI, V67, P1030; Watanabe E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006259; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; THORNTON KW, 1978, T AM FISH SOC, V107, P284, DOI 10.1577/1548-8659(1978)107<284:ATAFMB>2.0.CO;2; Campbell RG, 2009, DEEP-SEA RES PT II, V56, P1274, DOI 10.1016/j.dsr2.2008.10.027; Aita MN, 2007, ECOL MODEL, V202, P81, DOI 10.1016/j.ecolmodel.2006.07.045; TYLER JA, 1994, REV FISH BIOL FISHER, V4, P91, DOI 10.1007/BF00043262; Watanabe E, 2009, J PHYS OCEANOGR, V39, P2194, DOI 10.1175/2009JPO4010.1; Azumaya T, 2005, FISH OCEANOGR, V14, P81, DOI 10.1111/j.1365-2419.2004.00323.x; Watanabe E, 2012, J OCEANOGR, V68, P703, DOI 10.1007/s10872-012-0128-6; Walker RV, 2000, FISH OCEANOGR, V9, P171, DOI 10.1046/j.1365-2419.2000.00131.x; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; BEAUCHAMP DA, 1989, T AM FISH SOC, V118, P597, DOI 10.1577/1548-8659(1989)118<0597:COABMF>2.3.CO;2; Sherr EB, 2009, DEEP-SEA RES PT II, V56, P1264, DOI 10.1016/j.dsr2.2008.10.036; Azumaya T, 2004, FISH OCEANOGR, V13, P10, DOI 10.1046/j.1365-2419.2003.00271.x; Cook M.E.A., 2013, 9 N PAC AN FISH COMM, V9, P118; Echave K., 2012, NMFSAFSC236 NOAA US, P131; Hanson P.C., 1997, FISH BIOENERGETICS 3; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Hasumi H., 2006, CCSR OCEAN COMPONENT; Hopcroft R.R., 2010, DEEP SEA RES 2, V57, P27, DOI DOI 10.1016/J.DSR2.2009.08.003; Ito S, 2004, FISH OCEANOGR, V13, P111, DOI 10.1111/j.1365-2419.2004.00307.x; Kaeriyama M, 2012, ENVIRON BIOL FISH, V94, P165, DOI 10.1007/s10641-011-9930-z; Kaeriyama Masahide, 2008, P371; Kamezawa M., 2007, B JAPANESE SOC FISHE, V71, P87; Kawamiya M., 2005, J EARTH SIMULATOR, V4, P18; Kishi J.M., 2007, ECOL MODEL, V202, P12; Kishi MJ, 2010, DEEP-SEA RES PT II, V57, P1257, DOI 10.1016/j.dsr2.2009.12.013; Locarnini R. A., 2006, NOAA ATLAS NESDIS 61, V1, P182; Megrey B.A., 2002, 20 PICES, V20, P4; Morita K., 2009, 1191 N PAC AN FISH C; Moss Jamal H., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P191; Nagasawa Toru, 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P1; Neave F., 1976, INT N PAC FISH COMM, V35, P1; Orsi JA, 2004, REV FISH BIOL FISHER, V14, P335, DOI 10.1007/s11160-004-3813-8; Perry RI, 1996, FISH OCEANOGR, V5, P73, DOI 10.1111/j.1365-2419.1996.tb00107.x; Rudstam L.G., 1988, KIELER MEERESFORSCH, V6, P312; Sato Shunpei, 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P99; Sato S., 2012, 8 N PAC AN FISH COMM, V8, P50; Sato Shunpei, 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P29; Tadokoro K, 1996, FISH OCEANOGR, V5, P89, DOI 10.1111/j.1365-2419.1996.tb00108.x; Trudel M, 2004, T AM FISH SOC, V133, P326, DOI 10.1577/02-116; Urawa Shigehiko, 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P131; Urawa S., 2000, NATL SALMON RESOURCE, V5, P3; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220; Watanabe E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4950; Yoon S, 2013, PROG OCEANOGR, V119, P48, DOI 10.1016/j.pocean.2013.06.005	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0079-6611			PROG OCEANOGR	Prog. Oceanogr.	FEB	2015	131						146	158		10.1016/j.pocean.2014.12.009		13	Oceanography	Oceanography	CC7IH	WOS:000350540400011		
J	Asano, T; Baba, H; Kawano, R; Takei, H; Maeshima, H; Takahashi, Y; Suzuki, T; Arai, H				Asano, Tadashi; Baba, Hajime; Kawano, Rumiko; Takei, Hiroto; Maeshima, Hitoshi; Takahashi, Yukina; Suzuki, Toshihito; Arai, Heii			Temperament and character as predictors of recurrence in remitted patients with major depression: A 4-year prospective follow-up study	PSYCHIATRY RESEARCH			English	Article						Depression; TCI; Personality; Follow-up; Recurrence	AGE-OF-ONSET; AFFECTIVE-DISORDER; JAPANESE VERSION; CASE REGISTER; INVENTORY; EPISODES; MOOD; DIMENSIONS; VALIDITY; TRAITS	The aim of the present study was to examine whether the specific personality traits, Harm-Avoidance (HA) and Self-Directedness (SD) as measured by the Temperament and Character Inventory (TCI), were predictive for subsequent depressive episodes in remitted patients with major depressive disorders (MDDs) over a 4-year follow-up. A total of 109 inpatients with MDD participated in this study. The subjects completed the TCI when they were assessed to be in remission. They were divided into high or low HA groups and high or low SD groups, as discriminated by the quartile value. A total of 69 patients were followed-up over a 4-year period or until recurrence. Both Kaplan-Meier analysis and Cox's proportional hazards regression analysis indicated that patients with a low SD score had a significantly shorter time to recurrence from remission than patients with a high SD score even when some prognostic predictors were controlled for. In contrast, HA was not found to be a predictor of recurrence for future depressive episodes. A part of MDD patients with low scores in Self-Directedness are likely to develop depression over a subsequent period of time. Interventions that improve SD may help to delay recurrence of depression in MDD patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Asano, Tadashi] Bunkyo Univ, Grad Sch Human Sci, Dept Human Sci, Saitama, Japan; [Baba, Hajime; Kawano, Rumiko; Takei, Hiroto; Maeshima, Hitoshi; Takahashi, Yukina; Suzuki, Toshihito] Juntendo Univ, Koshigaya Hosp, Dept Psychiat, Juntendo Univ Mood Disorder Project JUMP, Saitama, Japan; [Baba, Hajime; Kawano, Rumiko; Maeshima, Hitoshi; Suzuki, Toshihito; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo 113, Japan	Baba, H (reprint author), Juntendo Koshigaya Hosp, Dept Psychiat, Juntendo Univ Mood Disorder Project JUMP, Fukuroyama 560, Koshigaya, Saitama 3430032, Japan.	hbaba@juntendo.ac.jp					Anderson CB, 2002, COMPR PSYCHIAT, V43, P182, DOI 10.1053/comp.2002.32359; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; Cloninger CR, 2012, J AFFECT DISORDERS, V136, P758, DOI 10.1016/j.jad.2011.09.046; Smith DJ, 2005, J AFFECT DISORDERS, V87, P83, DOI 10.1016/j.jad.2005.03.014; Farmer RF, 2009, DEPRESS ANXIETY, V26, P371, DOI 10.1002/da.20459; Klein DN, 1999, J AFFECT DISORDERS, V55, P149, DOI 10.1016/S0165-0327(99)00020-8; Klein DN, 2006, AM J PSYCHIAT, V163, P872, DOI 10.1176/appi.ajp.163.5.872; Grilo CM, 2010, J CLIN PSYCHIAT, V71, P1629, DOI 10.4088/JCP.08m04200gre; Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x; Sato T, 2001, COMPR PSYCHIAT, V42, P337, DOI 10.1053/comp.2001.24587; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; Kessing LV, 1998, J AFFECT DISORDERS, V49, P101, DOI 10.1016/S0165-0327(97)00163-8; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; COX DR, 1972, J R STAT SOC B, V34, P187; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; Kessing LV, 1999, J AFFECT DISORDERS, V53, P225, DOI 10.1016/S0165-0327(98)00125-6; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Mortberg E, 2007, PSYCHIAT RES, V152, P81, DOI 10.1016/j.psychres.2006.10.003; Nery FG, 2009, DEPRESS ANXIETY, V26, P382, DOI 10.1002/da.20478; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Marijnissen G, 2002, J AFFECT DISORDERS, V70, P219, DOI 10.1016/S0165-0327(01)00364-0; DOOGAN DP, 1992, BRIT J PSYCHIAT, V160, P217, DOI 10.1192/bjp.160.2.217; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kijimas N, 1996, ARCH PSYCHIAT DIAGN, V7, P379; Naito M, 2000, J CLIN PSYCHOL, V56, P1579, DOI 10.1002/1097-4679(200012)56:12<1579::AID-8>3.0.CO;2-K; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Rosenstrom T, 2014, J AFFECT DISORDERS, V158, P139, DOI 10.1016/j.jad.2014.01.017; Rothschild L, 2002, J PERS DISORD, V16, P189, DOI 10.1521/pedi.16.2.189.22551; Takeuchi M, 2011, COMPR PSYCHIAT, V52, P109, DOI 10.1016/j.comppsych.2010.04.002	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	FEB	2015	225	3					322	325		10.1016/j.psychres.2014.12.017		4	Psychiatry	Psychiatry	CC2NI	WOS:000350181500014		
J	Chen, N; Tanaka, K; Matsuyoshi, D; Watanabe, K				Chen, Na; Tanaka, Kanji; Matsuyoshi, Daisuke; Watanabe, Katsumi			Associations Between Color and Shape in Japanese Observers	PSYCHOLOGY OF AESTHETICS CREATIVITY AND THE ARTS			English	Article						color; geometric shape; color-shape association; semantic information	SYNESTHETIC COLORS; INDIVIDUAL-DIFFERENCES; SYNAESTHESIA; AESTHETICS; SOUND; CORRESPONDENCES; RECTANGLES; PREFERENCE; GRAPHEMES; PITCH	Albertazzi et al. (2013) showed naturally biased associations between geometric shapes and colors in Italian participants, suggesting that the "warmth" and "lightness" of color might account for the color-shape associations. In the present study, we replicated the previous study in Japanese participants to examine whether color-shape associations were unlikely influenced by differences between languages and cultures. Results showed that Japanese participants associated shapes with specific colors, and these color-shape associations, by and large, were consistent with those in the previous literature. In addition, correspondence analysis indicated that most of the color-shape associations could be interpreted by congruent "warmth" perception for colors and shapes. Therefore, semantic associations between visual features of color and shape might lead to the color-shape associations.	[Chen, Na; Tanaka, Kanji; Matsuyoshi, Daisuke; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan	Chen, N (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	nanachen@fennel.rcast.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24300279]; Japan Science and Technology Agency (CREST)	This study was supported by Grants-in-Aid for Scientific Research (24300279) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Science and Technology Agency (CREST) to KW.	Akaike Hirotogu, 1998, INFORM THEORY EXTENS, V1998, P199, DOI DOI 10.1007/978-1-4612-1694-0_; Hubbard TL, 1996, AM J PSYCHOL, V109, P219, DOI 10.2307/1423274; Palmer SE, 2013, PSYCHON B REV, V20, P453, DOI 10.3758/s13423-012-0355-2; Larson CL, 2012, MOTIV EMOTION, V36, P404, DOI 10.1007/s11031-011-9249-2; MCMANUS IC, 1981, PERCEPTION, V10, P651, DOI 10.1068/p100651; Spector F, 2008, PERCEPTION, V37, P841, DOI 10.1068/p5830; Simner J, 2005, COGN NEUROPSYCHOL, V22, P1069, DOI 10.1080/02643290500200122; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Ou LC, 2004, COLOR RES APPL, V29, P232, DOI 10.1002/col.20010; Asano M, 2012, CONSCIOUS COGN, V21, P983, DOI 10.1016/j.concog.2012.02.005; Walker P, 2010, PSYCHOL SCI, V21, P21, DOI 10.1177/0956797609354734; Spector F, 2011, J EXP PSYCHOL HUMAN, V37, P484, DOI 10.1037/a0021437; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Woods AT, 2013, I-PERCEPTION, V4, P365, DOI 10.1068/i0586; Stone NJ, 1998, J ENVIRON PSYCHOL, V18, P175, DOI 10.1006/jevp.1998.0084; Albertazzi L, 2013, J EXP PSYCHOL HUMAN, V39, P37, DOI 10.1037/a0028816; Brang D, 2011, NEUROPSYCHOLOGIA, V49, P1355, DOI 10.1016/j.neuropsychologia.2011.01.002; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Asano M, 2011, CONSCIOUS COGN, V20, P1816, DOI 10.1016/j.concog.2011.05.012; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Jurgens UM, 2012, TRANSL NEUROSCI, V3, P22, DOI 10.2478/s13380-012-0010-4; MARKS LE, 1974, AM J PSYCHOL, V87, P173, DOI 10.2307/1422011; Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P903, DOI 10.2466/PMS.95.7.903-913; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Ballast D. K., 2010, INTERIOR DESIGN REFE; Christensen R., 1997, LOG LINEAR MODELS LO; D'Andrade R., 1974, AM ETHNOL, V1, P49, DOI 10.1525/ae.1974.1.1.02a00030; Dumitrescu A, 2003, POLITEHNICA U SCI B, V65, P77; Dumitrescu A, 2011, P 22 INT DAAAM S, V22, P1041; Greenacre M., 2007, CORRES ANAL PRACTICE, DOI [10.1201/9781420011234, DOI 10.1201/9781420011234]; Hsu J., 1996, MULTIPLE COMPARISONS, DOI [10.1007/978-1-4899-7180-7, DOI 10.1007/978-1-4899-7180-7]; Jacobsen T., 2007, DES J, V10, P16, DOI DOI 10.2752/146069207789271902; Jurgens U. T., 2010, GRAPHEMECOLOR SYNEST; Kandinsky W., 2012, KANDINSKY COMPLETE W, P114; Kandinsky W., 1947, POINT LINE PLANE; Kharkhurin AV, 2012, EMPIR STUD ARTS, V30, P167, DOI 10.2190/EM.30.2.d; Kohler W, 1947, GESTALT PSYCHOL; Lau C., 2011, 11 ANN M VIS SCI SOC; Liu C. H., 1997, METAPHOR SYMBOL, V12, P135, DOI [10.1207/s15327868ms1202_3, DOI 10.1207/S15327868MS1202_3]; Liu C. H., 1993, PSYKE LOGOS, V14, P441; Lupton E., 1993, DREIECK QUADRAT KRIE; Lupton E., 1991, ABCS DESIGN BAUHAUS; MCMANUS IC, 1980, BRIT J PSYCHOL, V71, P505; McManus IC, 2013, PSYCHOL AESTHET CREA, V7, P130, DOI 10.1037/a0030469; McManus IC, 2010, PSYCHOL AESTHET CREA, V4, P113, DOI 10.1037/a0017316; NAKANO M, 1972, JPN J PSYCHOL, V43, P22; Oyama T., 2003, EMPIRICAL STUDIES AR, V21, P137, DOI [10.2190/EYFT-B5UE-APPW-10B6, DOI 10.2190/EYFT-B5UE-APPW-10B6]; Oyama T., 1963, PSYCHOL, V6, P131; SIMPSON R H, 1956, J Genet Psychol, V89, P95; Sommer R., 2004, J INTERIOR DES, V30, P41, DOI [10.1111/j.1939-1668.2004.tb00574.x, DOI 10.1111/J.1939-1668.2004.TB00574.X]; WHITFIELD TWA, 1990, GENET SOC GEN PSYCH, V116, P385	53	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1931-3896	1931-390X		PSYCHOL AESTHET CREA	Psychol. Aesthet. Creat. Arts.	FEB	2015	9	1					101	110		10.1037/a0038056		10	Humanities, Multidisciplinary; Psychology, Experimental	Arts & Humanities - Other Topics; Psychology	CC4VD	WOS:000350351300013		
J	Matsushima, S; Inui, N; Yasui, H; Kono, M; Nakamura, Y; Toyoshima, M; Shirai, T; Suda, T				Matsushima, Sayomi; Inui, Naoki; Yasui, Hideki; Kono, Masato; Nakamura, Yutaro; Toyoshima, Mikio; Shirai, Toshihiro; Suda, Takafumi			Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Chronic obstructive pulmonary disease; Combination therapy; Forced oscillation technique; Indacaterol; Tiotropium	FORCED OSCILLATION TECHNIQUE; LONG-ACTING BRONCHODILATORS; ONCE-DAILY INDACATEROL; COPD ASSESSMENT TEST; RESPIRATORY MECHANICS; RESISTANCE; REACTANCE; ASTHMA; FORMOTEROL; MANAGEMENT	Background: Combination therapy with a long-acting antimuscarinic agent and a long-acting beta(2)-agonist are recommended in chronic obstructive pulmonary disease (COPD) if control is not adequate with one long-acting bronchodilator alone. We evaluated the effects of indacaterol and tiotropium combination therapy, including the effects of adding indacaterol to tiotropium (indacaterol add-on group) and adding tiotropium to indacaterol (tiotropium add-on group). Methods: We recruited 79 patients with COPD already treated with tiotropium or indacaterol. We undertook pulmonary function tests, the COPD assessment test (CAT), and the multi-frequency forced oscillation technique (to measure respiratory resistance and reactance) before and after 8 weeks of indacaterol and tiotropium combination therapy. Results: The median age was 72.1 years and the mean forced expiratory volume in 1 s (FEV1) as a proportion of predicted was 57.2 +/- 18.3%. After 8 weeks of combination therapy, FEV1 and %predicted FEV1 had increased significantly. There was no change in CAT score. For respiratory impedance, combination therapy improved resistance at 5 Hz (R5) and resistance at 20 Hz (R20) in the whole-breath, inspiratory and expiratory phases, and resonant frequency (Fres) in the inspiratory phase. The indacaterol add-on group (43 patients) and tiotropium add-on group (36 patients) showed improvements in FEV1 and % predicted FEV1 over monotherapy, although the CAT score fell significantly in the indacaterol add-on group (p = 0.005). Conclusions: Indacaterol and tiotropium combination therapy improved airflow limitation and respiratory resistances. Adding indacaterol to tiotropium, or tiotropium to indacaterol, had similar effects on airflow limitation. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsushima, Sayomi; Inui, Naoki; Yasui, Hideki; Kono, Masato; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan; [Toyoshima, Mikio] Hamamatsu Rosai Hosp, Dept Resp Med, Hamamatsu, Shizuoka 4308525, Japan; [Shirai, Toshihiro] Shizuoka Prefectural Gen Hosp, Dept Resp Med, Shizuoka 4200881, Japan	Inui, N (reprint author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	inui@hama-med.ac.jp					Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Donohue JF, 2010, AM J RESP CRIT CARE, V182, P155, DOI 10.1164/rccm.200910-1500OC; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Williamson PA, 2011, LUNG, V189, P121, DOI 10.1007/s00408-010-9275-y; Dahl R, 2010, THORAX, V65, P473, DOI 10.1136/thx.2009.125435; van Noord JA, 2000, THORAX, V55, P289, DOI 10.1136/thorax.55.4.289; Kornmann O, 2011, EUR RESPIR J, V37, P273, DOI 10.1183/09031936.00045810; Mori K, 2011, COPD, V8, P456, DOI 10.3109/15412555.2011.626818; Mori K, 2013, RESP PHYSIOL NEUROBI, V185, P235, DOI 10.1016/j.resp.2012.10.009; Borrill ZL, 2005, BRIT J CLIN PHARMACO, V59, P379, DOI 10.1111/j.1365-2125.2004.02261.x; Rodrigo GJ, 2012, PULM PHARMACOL THER, V25, P40, DOI 10.1016/j.pupt.2011.10.006; Buhl R, 2011, EUR RESPIR J, V38, P797, DOI 10.1183/09031936.00191810; Borrill ZL, 2008, BRIT J CLIN PHARMACO, V65, P244, DOI 10.1111/j.1365-2125.2007.03013.x; Cazzola M, 2005, RESP MED, V99, P524, DOI 10.1016/j.rmed.2004.10.004; Mahler DA, 2012, THORAX, V67, P781, DOI 10.1136/thoraxjnl-2011-201140; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Paredi P, 2010, THORAX, V65, P263, DOI 10.1136/thx.2009.120790; Abe T, 2011, PULM PHARMACOL THER, V24, P617, DOI 10.1016/j.pupt.2011.06.002; Cope S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-100; Global initiative For Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; GROSS NJ, 1984, NEW ENGL J MED, V311, P421, DOI 10.1056/NEJM198408163110701; Japanese Respiratory Society, 2004, GUID RESP FUNCT TEST; Karner C, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD008989.PUB2; Rodrigo GJ, 2012, CHEST, V142, P1104, DOI 10.1378/chest.11-2252; Shirai T, 2013, CLIN EXP ALLERGY, V43, P521, DOI 10.1111/cea.12083; Tashkin DP, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-49; Timmins SC, 2014, RESP MED, V108, P344, DOI 10.1016/j.rmed.2013.10.004; Vogelmeier C, 2010, RESP RES, V11, P135	30	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	FEB	2015	30						11	15		10.1016/j.pupt.2014.10.003		5	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	CC1BI	WOS:000350075800002		
J	Yokoba, M; Ichikawa, T; Takakura, A; Ishii, N; Kurosaki, Y; Yamada, Y; Tsukushi, T; Masuda, N; Easton, PA; Katagiri, M				Yokoba, Masanori; Ichikawa, Tsuyoshi; Takakura, Akira; Ishii, Naohito; Kurosaki, Yoshifumi; Yamada, Yuya; Tsukushi, Tomoaki; Masuda, Noriyuki; Easton, Paul A.; Katagiri, Masato			Aminophylline increases respiratory muscle activity during hypercapnia in humans	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Aminophylline; Hypercapnia; Electromyogram; Parasternal intercostal muscle; Transversus abdominis muscle	OBSTRUCTIVE PULMONARY-DISEASE; HISTONE DEACETYLASE ACTIVITY; PARASTERNAL INTERCOSTAL; ISOLATED HEMIDIAPHRAGM; VENTILATORY RESPONSES; CRURAL DIAPHRAGM; AWAKE CANINES; IN-VITRO; THEOPHYLLINE; RAT	Background: Theophylline is an old drug traditionally used as a bronchodilator, although it was recently shown to possess anti-inflammatory properties, enhance the actions of corticosteroid actions, and stimulate the respiratory neuronal network. Theophylline has been recognized as an important drug for not only asthma but also corticosteroid-insensitive chronic obstructive pulmonary disease (COPD). To clarify the role of theophylline in hypercapnic ventilatory responses in humans, we analyzed the effects of aminophylline administered at the usual clinical therapeutic doses on ventilation and augmentation of respiratory muscle contractility in room air and under 3 conditions of hypercapnia. Study design: We performed electromyography (EMG) of the parasternal intercostal muscle (PARA) and transversus abdominis muscle (TA) in 7 healthy subjects and recorded both ventilatory parameters and EMG data in room air and under 3 conditions of hypercapnia before (control) and during aminophylline administration. Results: Before aminophylline administration (control), hypercapnic stimulation elicited ventilatory augmentation in a hypercapnia intensity-dependent manner. Ventilatory parameters (tidal volume, frequency of respiration, and minute ventilation) showed significant increases from lower PaCO2 levels during aminophylline administration when compared with the corresponding values before aminophylline administration. EMG activity of both PARA and TA increased significantly at each level of hypercapnia, and those augmentations were shown from lower PaCO2 levels during aminophylline administration. Conclusion: Aminophylline administered at the usual clinical therapeutic dose increases ventilation and EMG activity of both inspiratory and expiratory muscles during hypercapnia in healthy humans. (C) 2014 Elsevier Ltd. All rights reserved.	[Yokoba, Masanori; Ishii, Naohito; Kurosaki, Yoshifumi; Katagiri, Masato] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Yokoba, Masanori; Takakura, Akira; Masuda, Noriyuki; Katagiri, Masato] Kitasato Univ Hosp, Div Resp Med, Sagamihara, Kanagawa, Japan; [Ichikawa, Tsuyoshi; Yamada, Yuya] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 2520373, Japan; [Ichikawa, Tsuyoshi] Tokai Univ, Oiso Hosp, Hiratsuka, Kanagawa, Japan; [Tsukushi, Tomoaki] Kitasato Univ Hosp, Dept Clin Labs, Sagamihara, Kanagawa, Japan; [Easton, Paul A.] Univ Calgary, Calgary, AB, Canada	Yokoba, M (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520373, Japan.	myoko@kitasato-u.ac.jp					Abe T, 1999, J APPL PHYSIOL, V86, P1994; Jagers JV, 2009, RESP PHYSIOL NEUROBI, V167, P273, DOI 10.1016/j.resp.2009.05.008; Iizuka M, 2007, RESP PHYSIOL NEUROBI, V157, P196, DOI 10.1016/j.resp.2007.01.004; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Abe T, 1996, J APPL PHYSIOL, V80, P1379; Barnes PJ, 2003, AM J RESP CRIT CARE, V167, P813, DOI 10.1164/rccm.200210-1142PP; AUBIER M, 1986, J ALLERGY CLIN IMMUN, V78, P787, DOI 10.1016/0091-6749(86)90062-X; Gandevia SC, 2006, J PHYSIOL-LONDON, V573, P263, DOI 10.1113/jphysiol.2005.101915; Yokoba M, 2003, RESP PHYSIOL NEUROBI, V137, P51, DOI 10.1016/S1569-9048(03)00092-2; KAWAI A, 1995, RESP PHYSIOL, V100, P25, DOI 10.1016/0034-5687(94)00124-I; Gandevia SC, 1996, AM J RESP CRIT CARE, V153, P622; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; AUBIER M, 1987, CHEST, V92, pS27, DOI 10.1378/chest.92.1_Supplement.27S; Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR; Barnes PJ, 2005, P AM THORAC SOC, V2, P40; CATTAROSSI L, 1993, ARCH DIS CHILD, V69, P52; DALY JW, 1981, LIFE SCI, V28, P2083, DOI 10.1016/0024-3205(81)90614-7; DECRAMER M, 1991, AM REV RESPIR DIS, V144, P797; De Troyer A, 1998, J APPL PHYSIOL, V84, P562; EASTON PA, 1993, J APPL PHYSIOL, V74, P1406; EASTON PA, 1995, J APPL PHYSIOL, V78, P1985; Easton PA, 1999, J APPL PHYSIOL, V87, P1097; ELDRIDGE FL, 1983, RESP PHYSIOL, V53, P239, DOI 10.1016/0034-5687(83)90070-1; ESAU SA, 1991, AM REV RESPIR DIS, V143, P954; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233; Fredholm B B, 1980, Eur J Respir Dis Suppl, V109, P29; FREDHOLM BB, 1982, EUR J PHARMACOL, V81, P673, DOI 10.1016/0014-2999(82)90359-4; Gandevia SC, 1999, AM J RESP CRIT CARE, V160, P1598; GORINI M, 1994, AM J RESP CRIT CARE, V149, P1227; Griffiths TL, 1997, EUR RESPIR J, V10, P156, DOI 10.1183/09031936.97.10010156; Hawes HG, 2000, AM J RESP CRIT CARE, V161, pA690; Katagiri M, 2003, RESP MED, V97, P1027, DOI 10.1016/S0954-6111(03)00133-1; KENTERA D, 1975, BRIT J PHARMACOL, V54, P375; Losavio AS, 1996, LIFE SCI, V58, P1031, DOI 10.1016/0024-3205(96)00056-2; MAXWELL DL, 1986, J APPL PHYSIOL, V61, P1762; MOSS IR, 1986, FASEB J, V45, P2133; Nishii Y, 2008, RESP PHYSIOL NEUROBI, V161, P69, DOI 10.1016/j.resp.2007.12.004; PROSTRAN M, 1993, GEN PHARMACOL, V24, P225, DOI 10.1016/0306-3623(93)90039-Z; Ram FS, 2006, CURR OPIN PULM MED, V12, P132, DOI 10.1097/01.mcp.0000208453.95972.e2; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; Self TH, 2002, J ASTHMA, V39, P677, DOI 10.1081/JAS-120015790; SIGRIST S, 1982, AM REV RESPIR DIS, V126, P46; Somerville LL, 2001, ALLERGY ASTHMA PROC, V22, P347; Xu XL, 2006, PHARMACOL RES, V53, P171, DOI 10.1016/j.phrs.2005.10.008	46	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	FEB	2015	30						96	101		10.1016/j.pupt.2014.03.006		6	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	CC1BI	WOS:000350075800013		
J	Hoshino, M; Ohtawa, J; Akitsu, K				Hoshino, Makoto; Ohtawa, Junichi; Akitsu, Kenta			Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair (R) in chronic obstructive pulmonary disease	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Airway geometry; Quantitative computed tomography; Pulmonary function; Long-acting beta(2)-adrenergic receptor agonist; Long-acting muscarinic receptor antagonist; Pulmonary hyperinflation	COMPUTED-TOMOGRAPHY ASSESSMENT; FLUTICASONE PROPIONATE; FLOW LIMITATION; ANTICHOLINERGIC THERAPY; LUNG-FUNCTION; COPD PATIENTS; DOUBLE-BLIND; SALMETEROL; COMBINATION; HYPERINFLATION	Background: Current guidelines recommend combining long-acting bronchodilators with different modes of action in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). We evaluated the effects of airway dimensions and pulmonary function with tiotropium plus indacaterol versus Advair (R). Methods: Subjects (n = 46) were randomized to receive tiotropium (18 mu g once daily) plus indacaterol (150 mu g once daily) or Advair (R) (50/250 mu g twice daily) for 16 weeks. Airway geometry was determined by quantitative computed tomography (luminal area, Ai; total area of the airway, Ao; wall area, WA; and percentage wall area, WA/Ao and wall thickness, T). Spirometry (forced expiratory volume in 1 s, FEVi; forced vital capacity, FVC and inspiratory capacity, IC) and St. George's Respiratory Questionnaire (SGRQ) were evaluated. Results: Tiotropium plus indacaterol significantly increased CT-indices including Ai corrected for body surface area (Ai/BSA), and decreased WA/BSA, WA/Ao and T/root BSA compared with Advair (R) (p < 0.05, respectively). In physiological parameters, mean difference in IC was significantly higher under treatment with tiotropium plus indacaterol than Advair (R) (p < 0.05). The changes in Ai/BSA, WA/BSA, WA/Ao and T/root BSA were significantly correlated with changes in IC (r = 0.535, p = 0.011; r = -0.688, p<0.001; r = -0.555, p = 0.002 and r = -0.542, p = 0.007; respectively). There were more significant improvements in SGRQ scores after treatment with tiotropium plus indacaterol than Advair (R). Conclusions: These findings suggest that dual bronchodilation with tiotropium plus indacaterol is superior in airway geometry and lung function compared with Advair in COPD. (C) 2014 Elsevier Ltd. All rights reserved.	[Hoshino, Makoto] Int Univ Hlth & Welf, Atami Hosp, Dept Resp Med, Atami, Shizuoka 4130012, Japan; [Ohtawa, Junichi; Akitsu, Kenta] Int Univ Hlth & Welf, Atami Hosp, Dept Radiol, Atami, Shizuoka 4130012, Japan	Hoshino, M (reprint author), Int Univ Hlth & Welf, Atami Hosp, Dept Resp Med, 13-1 Higashikaigan Cho, Atami, Shizuoka 4130012, Japan.	hoshino@iuhw.ac.jp					Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Aaron SD, 2007, ANN INTERN MED, V146, P545; O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004; Kistemaker LEM, 2012, LIFE SCI, V91, P1126, DOI 10.1016/j.lfs.2012.02.021; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Vogelmeier CF, 2013, LANCET RESP MED, V1, P51, DOI 10.1016/S2213-2600(12)70052-8; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; van Noord JA, 2010, RESP MED, V104, P995, DOI 10.1016/j.rmed.2010.02.017; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Celli B, 2003, CHEST, V124, P1743, DOI 10.1378/chest.124.5.1743; Racke K, 2004, PULM PHARMACOL THER, V17, P181, DOI 10.1016/j.pupt.2004.03.001; Hoshino M, 2013, RESPIRATION, V86, P280, DOI 10.1159/000351116; THURLBECK WM, 1994, AM J ROENTGENOL, V163, P1017; Okazawa M, 1996, AM J RESP CRIT CARE, V154, P1557; Vogelmeier C, 2008, RESP MED, V102, P1511, DOI 10.1016/j.rmed.2008.07.020; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321; O'Donnell DE, 2004, EUR RESPIR J, V24, P86, DOI 10.1183/09031936.04.00072703; Beier J, 2009, PULM PHARMACOL THER, V22, P492, DOI 10.1016/j.pupt.2009.05.001; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Newton MF, 2002, CHEST, V121, P1042, DOI 10.1378/chest.121.4.1042; Tashkin DP, 2009, COPD, V6, P17, DOI 10.1080/15412550902724073; Mahler DA, 2012, THORAX, V67, P781, DOI 10.1136/thoraxjnl-2011-201140; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Rabe KF, 2008, CHEST, V134, P255, DOI 10.1378/chest.07-2138; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P345, DOI 10.1513/pats.200409-045MS; BERGIN C, 1986, AM REV RESPIR DIS, V133, P541; Calverley Peter, 2006, Int J Chron Obstruct Pulmon Dis, V1, P209, DOI 10.2147/copd.2006.1.3.209; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Committee of Pulmonary Physiology the Japanese Respiratory Society, 2004, GUID PULM FUNCT TEST; Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), 2010, GLOB STRAT DIAGN MAN; Hasegawa M, 2009, THORAX, V64, P32; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoshino M, 2014, RESPIROLOGY, V19, P403, DOI 10.1111/resp.12256; Jenkins CR, 2009, RESP RES, V30, P59; O'Donnell DE, 1999, AM J RESP CRIT CARE, V160, P542; Tanabe N, 2012, COPD, V9, P401, DOI 10.3109/15412555.2012.674986	40	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	FEB	2015	30						128	133		10.1016/j.pupt.2014.08.002		6	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	CC1BI	WOS:000350075800017		
J	Zhang, CY; Zhang, Y; Zhang, HX; Hu, YM; Zhang, XQ; Masuda, T				Zhang, Chunyu; Zhang, Yu; Zhang, Hexin; Hu, Yanming; Zhang, Xuequan; Masuda, Toshio			Synthesis and ion responsiveness of optically active polyacetylenes containing salicylidene Schiff-base moieties	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Conjugated polymer; Polyacetylene; Helix; Stimuli-responsive; Polymerization	FLUORESCENT SENSOR; HELICAL POLYMERS; FUNCTIONAL POLYACETYLENES; CHIROPTICAL PROPERTIES; CARBON NANOTUBES; COMPLEXES; POLYMERIZATION; DERIVATIVES; CATALYSTS; POLY(PHENYLACETYLENE)S	Acetylenic monomers containing salicylidene Schiff-base groups (1a and 1b) as well as Schiff-base and hydroxy groups (1c) were synthesized and polymerized with [(nbd)RhCl](2)/Et3N catalyst to afford the corresponding polymers 2a-c with high molecular weights (M-n = 2.6-7.2 x 10(5)) in high yields (75-97%). Polarimetric, circular dichroism (CD), and UV-vis spectroscopic analyses indicated that the polymers formed helical structures with a predominantly one-handed screw sense. The addition of metal ions to salicylidene Schiff-base-containing polymers 2a and 2b produced insoluble polymer/metal complexes through ionic cross-linking as a result of salicylaldimine-metal ion complexation. Polymers 2b and 2c underwent a helix-coil transition upon the addition of HSO4-, whereas these polymers did not exhibit responsiveness to other anions, such as F-, Cl-, and Br-. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Chunyu; Zhang, Hexin; Hu, Yanming; Zhang, Xuequan] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China; [Zhang, Yu] Dalian Univ Technol, Sch Chem Engn, Dept Polymer Sci & Engn, Dalian 116024, Peoples R China; [Masuda, Toshio] Muroran Inst Technol, Res Ctr Environm Friendly Mat Engn, Muroran, Hokkaido 0508585, Japan	Hu, YM (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.	ymhu@ciac.ac.cn					TABATA M, 1990, POLYM J, V22, P1105, DOI 10.1295/polymj.22.1105; Aoki T, 2006, POLYMER, V47, P4867, DOI 10.1016/j.polymer.2006.04.047; Aoki T, 2003, J AM CHEM SOC, V125, P6346, DOI 10.1021/ja021233o; Katsuki T, 2004, CHEM SOC REV, V33, P437, DOI 10.1039/b304133f; Filarowski A, 2005, J PHYS ORG CHEM, V18, P686, DOI 10.1002/poc.940; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Schwartz E, 2011, POLYM CHEM-UK, V2, P33, DOI 10.1039/c0py00246a; Zhang CH, 2012, REACT FUNCT POLYM, V72, P832, DOI 10.1016/j.reactfunctpolym.2012.08.008; Plaquet A, 2008, J PHYS CHEM C, V112, P5638, DOI 10.1021/jp711511t; Jochum FD, 2009, MACROMOLECULES, V42, P5941, DOI 10.1021/ma900945s; Li L, 2011, REACT FUNCT POLYM, V71, P972, DOI 10.1016/j.reactfunctpolym.2011.06.006; Kishimoto Y, 1999, J AM CHEM SOC, V121, P12035, DOI 10.1021/ja991903z; Yashima E, 2004, CHEM-EUR J, V10, P42, DOI 10.1002/chem.200305295; Cozzi PG, 2004, CHEM SOC REV, V33, P410, DOI 10.1039/b307853c; Iglesias AL, 2004, POLYHEDRON, V23, P3051, DOI 10.1016/j.poly.2004.09.007; Baleizao C, 2006, CHEM REV, V106, P3987, DOI 10.1021/cr050973n; Dong Y, 2011, POLYMER, V52, P5811, DOI 10.1016/j.polymer.2011.10.034; Li WF, 2014, POLYM CHEM-UK, V5, P1107, DOI 10.1039/c3py01031g; Cheuk KKL, 2003, MACROMOLECULES, V36, P9752, DOI 10.1021/ma035340u; Megens RP, 2011, CHEM-EUR J, V17, P8514, DOI 10.1002/chem.201100672; Xu ZC, 2010, CHEM SOC REV, V39, P1996, DOI 10.1039/b916287a; Zhang JF, 2010, ORG LETT, V12, P3852, DOI 10.1021/ol101535s; Trindade AF, 2009, CHEM REV, V109, P418, DOI 10.1021/cr800200t; Gupta KC, 2008, COORDIN CHEM REV, V252, P1420, DOI 10.1016/j.ccr.2007.09.005; Ma C, 2004, ORG LETT, V6, P3841, DOI 10.1021/ol0483549; Linseis M, 2012, J AM CHEM SOC, V134, P16671, DOI 10.1021/ja3059606; Zhao LY, 2006, J PHYS CHEM B, V110, P24299, DOI 10.1021/jp062476w; Sun JZ, 2013, POLYM CHEM-UK, V4, P211, DOI 10.1039/c2py20469j; Song FY, 2011, POLYMER, V52, P6029, DOI 10.1016/j.polymer.2011.11.017; Lam JWY, 2005, ACCOUNTS CHEM RES, V38, P745, DOI 10.1021/ar040012f; Chen D, 2012, J POLYM SCI POL CHEM, V50, P4191, DOI 10.1002/pola.26230; CIARDELL.F, 1974, MACROMOLECULES, V7, P174, DOI 10.1021/ma60038a005; Gao HA, 2010, MACROMOLECULES, V43, P6156, DOI 10.1021/ma100761a; He Q, 2014, POLYM CHEM, V4, P48963; Kennemur JG, 2011, POLYMER, V52, P1693, DOI 10.1016/j.polymer.2011.02.040; Lam JWY, 2000, MACROMOLECULES, V33, P5027, DOI 10.1021/ma992097j; Li S, 2014, MACROMOLECULES, V47, P3288, DOI 10.1021/ma5003529; Liu D, 2011, REACT FUNCT POLYM, V71, P1040, DOI 10.1016/j.reactfunctpolym.2011.07.009; Liu J., 2009, CHEM REV, V100, P1645; Mastai Y, 2009, CHEM SOC REV, V38, P772, DOI 10.1039/b812587m; Nikishkin NI, 2013, POLYMER, V54, P3175, DOI 10.1016/j.polymer.2013.04.028; Nomura R, 2000, J AM CHEM SOC, V122, P8830, DOI 10.1021/ja000877y; Onimura K, 2011, CHIRALITY, V23, pE43, DOI 10.1002/chir.20959; Rudick JG, 2008, MACROMOL CHEM PHYS, V209, P1759, DOI 10.1002/macp.200800271; Sakai R, 2011, MACROMOLECULES, V44, P4249, DOI 10.1021/ma200710r; Sanda F, 2007, J POLYM SCI POL CHEM, V45, P4450, DOI 10.1002/pola.22203; Sanda F., 2012, POLYM SCI COMPREHENS, V3, P875; Selvi C, 2012, SPECTROCHIM ACTA A, V95, P165, DOI 10.1016/j.saa.2012.04.079; Shirakawa Y., 2010, MACROMOLECULES, V43, P55755; Yuan WZ, 2009, MACROMOLECULES, V42, P52, DOI 10.1021/ma801978x; Zhang Y, 2013, J POLYM SCI POL CHEM, V51, P5248, DOI 10.1002/pola.26955	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	FEB	2015	87						46	52		10.1016/j.reactfunctpolym.2015.01.003		7	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	CC9SF	WOS:000350710800007		
J	Yang, LL; Fujimoto, M; Murota, H; Serada, S; Fujimoto, M; Honda, H; Yamada, K; Suzuki, K; Nishikawa, A; Hosono, Y; Yoneda, Y; Takehara, K; Imura, Y; Mimori, T; Takeuchi, T; Katayama, I; Naka, T				Yang, Lingli; Fujimoto, Minoru; Murota, Hiroyuki; Serada, Satoshi; Fujimoto, Manabu; Honda, Hiromi; Yamada, Kohji; Suzuki, Katsuya; Nishikawa, Ayumi; Hosono, Yuji; Yoneda, Yoshihiro; Takehara, Kazuhiko; Imura, Yoshitaka; Mimori, Tsuneyo; Takeuchi, Tsutomu; Katayama, Ichiro; Naka, Tetsuji			Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon	RHEUMATOLOGY			English	Article						proteomics; Raynaud's phenomenon; autoantibody; heterogeneous nuclear RNP-K	SYSTEMIC-LUPUS-ERYTHEMATOSUS; ADHESION MOLECULE EXPRESSION; CONNECTIVE-TISSUE DISEASE; CELLS IN-VITRO; REVISED CRITERIA; HNRNP K; ANTIBODIES; AUTOANTIBODIES; KERATINOCYTES; PATHOGENESIS	Objective. The aim of this study was to identify cold-associated autoantibodies in patients with RP secondary to CTDs. Methods. Indirect immunofluorescence staining was performed on non-permeabilized cold-stimulated normal human dermal microvascular endothelial cells (dHMVECs), using patients' sera. Cold-induced alterations in cell surface proteomes were analysed by isobaric tag for relative and absolute quantitation (iTRAQ) analysis. Serological proteome analysis (SERPA) was applied to screen cold-associated autoantigens. The prevalence of the candidate autoantibody was determined by ELISA in 290 patients with RP secondary to CTDs (SSc, SLE or MCTD), 10 patients with primary RP and 27 healthy controls. Results. Enhanced cell surface immunoreactivity was detected in cold-stimulated dHMVECs when incubated with sera from patients with secondary RP. By iTRAQ analysis, many proteins, including heterogeneous nuclear ribonucleoprotein K (hnRNP-K), were found to be increased on the cell surface of dHMVECs after cold stimulation. By the SERPA approach, hnRNP-K was identified as a candidate autoantigen in patients with secondary RP. Cold-induced translocation of hnRNP-K to the cell surface was confirmed by immunoblotting and flow cytometry. By ELISA analysis, patients with secondary RP show a significantly higher prevalence of anti-hnRNP-K autoantibody (30.0%, 61/203) than patients without RP (9.2%, 8/87, P = 0.0001), patients with primary RP (0%, 0/10, P = 0.0314) or healthy controls (0%, 0/27, P = 0.0001). Conclusion. By comprehensive proteomics, we identified hnRNP-K as a novel cold-associated autoantigen in patients with secondary RP. Anti-hnRNP-K autoantibody may potentially serve as a biomarker for RP secondary to various CTDs.	[Yang, Lingli; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Dept Dermatol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Yang, Lingli; Fujimoto, Minoru; Serada, Satoshi; Honda, Hiromi; Yamada, Kohji; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Kanazawa, Ishikawa, Japan; [Fujimoto, Manabu; Takehara, Kazuhiko] Kanazawa Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan; [Yamada, Kohji] Osaka Univ, Biomol Dynam Grp, Grad Sch Frontier Biosci, Osaka, Japan; [Suzuki, Katsuya; Nishikawa, Ayumi; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Hosono, Yuji; Imura, Yoshitaka; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Yoneda, Yoshihiro] Natl Inst Biomed Innovat, Osaka 5670085, Japan	Naka, T (reprint author), Natl Inst Biomed Innovat, Lab Immune Signal, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	tnaka@nibio.go.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare of Japan [H20-0005]	Funding: This study was supported by a grant-in-aid for the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and a Grant-in-Aid for Research on Biological Markers for New Drug Development (H20-0005) from the Ministry of Health, Labour and Welfare of Japan.	Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Herrick AL, 2012, NAT REV RHEUMATOL, V8, P469, DOI 10.1038/nrrheum.2012.96; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; BRENNAN P, 1993, BRIT J RHEUMATOL, V32, P357; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Lin CF, 2005, J IMMUNOL, V174, P395; Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377; Yokoyama T, 2013, INT J CANCER, V132, P472, DOI 10.1002/ijc.27679; Van den Bergh K, 2009, CLIN CHEM, V55, P946, DOI 10.1373/clinchem.2008.115626; MARICQ HR, 1983, CLIN EXP RHEUMATOL, V1, P195; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Furtado RNV, 2002, LUPUS, V11, P35, DOI 10.1191/0961203302lu144oa; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Bakst R, 2008, J AM ACAD DERMATOL, V59, P633, DOI 10.1016/j.jaad.2008.06.004; BUCHANAN RRC, 1989, BRIT J RHEUMATOL, V28, P221; DelPapa N, 1996, ARTHRITIS RHEUM, V39, P758, DOI 10.1002/art.1780390507; DIMANT J, 1979, ARTHRITIS RHEUM, V22, P815, DOI 10.1002/art.1780220802; D.S.G, 1964, SCIENCE, V143, P227; FURUKAWA F, 1990, J INVEST DERMATOL, V94, P77, DOI 10.1111/1523-1747.ep12873930; GOLAN TD, 1992, J CLIN INVEST, V90, P1067, DOI 10.1172/JCI115922; Grader-Beck T, 2005, RHEUM DIS CLIN N AM, V31, P465, DOI 10.1016/j.rdc.2005.04.006; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; Kasukawa R, 1987, MIXED CONNECTIVE TIS, P41; MASI A T, 1980, Arthritis and Rheumatism, V23, P581, DOI 10.1002/art.1780230510; Op de Beeck K, 2012, ARTHRITIS RHEUM-US, V64, P213, DOI 10.1002/art.33327; Qi ZR, 2010, ANN HEMATOL, V89, P1255, DOI 10.1007/s00277-010-1020-3; Serada S, 2007, PROTEOM CLIN APPL, V1, P185, DOI 10.1002/prca.200600497; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Umegaki-Arao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076416; Wang BX, 1999, CHINESE MED J-PEKING, V112, P512; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	FEB	2015	54	2					349	358		10.1093/rheumatology/keu325		10	Rheumatology	Rheumatology	CC2ZK	WOS:000350213500023		
J	Ong, SY; Wong, KS; Qi, XJ; Tanaka, KS				Ong, SimYing; Wong, KokSheik; Qi, Xiaojun; Tanaka, Kiyoshi			Beyond format-compliant encryption for JPEG image	SIGNAL PROCESSING-IMAGE COMMUNICATION			English	Article						Beyond format-compliant encryption; Virtual queue decomposition; Format-compliant encryption; Scalable capacity; JPEG	COMPRESSED IMAGES; VIDEO; ALGORITHMS	In this work, a format-compliant encryption method with the data embedding feature for JPEG compressed image is proposed. First, DC coefficients are encoded based on the regions induced by the textural information carried by AC coefficients. Second, AC coefficients are scanned in eight different orders and the order that results in the smallest bitstream size is selected. Next, AC coefficients from each block are extracted in the form of Run/Size and Value, and manipulated to significantly increase the scope of permutation. Then the virtual queue decomposition is proposed to embed external information. All the processes are completely reversible where the embedded information can be extracted and the original content can be perfectly reconstructed from its processed counterpart. The performance of the proposed method is verified through experiments using various standard test images and the UCID dataset. The proposed method is also compared against the conventional format-compliant encryption methods, where its superiority in terms of robustness against sketch attacks, suppression of bitstream size increment, and data embedding are highlighted. In the best case scenario, the proposed method is able to generate an encrypted image of the same size as the original image (e.g., 512 x 512) with more than 5800 bits of additionally embedded information while achieving a compression gain of 1%. (C) 2014 Elsevier B.V. All rights reserved.	[Ong, SimYing; Wong, KokSheik] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Qi, Xiaojun] Utah State Univ, Dept Comp Sci, Logan, UT USA; [Tanaka, Kiyoshi] Shinshu Univ, Fac Engn, Matsumoto, Nagano, Japan	Wong, KS (reprint author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	simying@siswa.um.edu.my; koksheik.um@gmail.com; xiaojun.qi@usu.edu; ktanaka@shinshu-u.ac.jp	Wong, KokSheik/B-9796-2011		University of Malaya Research Grant (UMRG) [RP001G-13ICT]	This work was supported by the University of Malaya Research Grant (UMRG) under Grant RP001G-13ICT (Project title: Real Time Scalable Software Video Encoding and its Applications through Hi-Performance Computing).	Cheng H, 2000, IEEE T SIGNAL PROCES, V48, P2439, DOI 10.1109/78.852023; Li SJ, 2007, IEEE T CIRC SYST VID, V17, P214, DOI 10.1109/TCSVT.2006.888840; Xu DW, 2014, IEEE T INF FOREN SEC, V9, P596, DOI 10.1109/TIFS.2014.2302899; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Cancellaro M, 2011, SIGNAL PROCESS-IMAGE, V26, P1, DOI 10.1016/j.image.2010.11.001; Schaefer G, 2004, P SOC PHOTO-OPT INS, V5307, P472; Bhargava B, 2004, MULTIMED TOOLS APPL, V24, P57, DOI 10.1023/B:MTAP.0000033983.62130.00; Kundur D, 2004, P IEEE, V92, P918, DOI 10.1109/JPROC.2004.827356; Pazarci M, 2002, IEEE T CONSUM ELECTR, V48, P345, DOI 10.1109/TCE.2002.1010141; Tian J, 2003, IEEE T CIRC SYST VID, V13, P890, DOI 10.1109/TCSVT.2003.815962; Zeng WJ, 2003, IEEE T MULTIMEDIA, V5, P118, DOI 10.1109/TMM.2003.808817; AYOUB F, 1984, IEE PROC-F, V131, P684; Coltuc D, 2011, IEEE T INF FOREN SEC, V6, P873, DOI 10.1109/TIFS.2011.2145372; Haralick R.M., 1992, COMPUTER ROBOT VISIO; Itoh Y, 2003, IEICE T INF SYST, VE86D, P1087; Kailasanathan C., 2002, IEEE INT DIG SIGN PR, V2, p1329 ; Kawaguchi E., 1998, P SPIE MULTIMEDIA SY, V3528, P464; Li WH, 2007, INT J COMPUT MATH, V84, P1367, DOI 10.1080/00207160701294376; Lin CC, 2009, INFORM SCIENCES, V179, P140, DOI 10.1016/j.ins.2008.09.001; Minemura K, 2012, IEEE IMAGE PROC, P261, DOI 10.1109/ICIP.2012.6466845; Niu XA, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P308, DOI 10.1109/IIH-MSP.2008.207; Ong S, 2013, IEEE IMAGE PROC, P4574; Pan F, 2002, PATTERN RECOGN LETT, V23, P1837, DOI 10.1016/S0167-8655(02)00156-3; Pennebaker W. B., 1992, JPEG STILL IMAGE DAT; Qian Z., 2014, IEEE T MULTIMED, VPP, P1; Shi C., 1998, ACM INT C MULT BRIST, P81; Takayama M., 2006, IEEE INT C MULT EXP, P1349; TAKAYAMA M, 2008, INT S COMM CONTR SIG, P1035; Wang YS, 2013, IEEE T CIRC SYST VID, V23, P1476, DOI 10.1109/TCSVT.2013.2248588; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wong K., 2010, 2010 4 INT S COMM CO, P1, DOI 10.1109/ISCCSP.2010.5463307	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-5965	1879-2677		SIGNAL PROCESS-IMAGE	Signal Process.-Image Commun.	FEB	2015	31						47	60		10.1016/j.image.2014.11.008		14	Engineering, Electrical & Electronic	Engineering	CC1CM	WOS:000350078800005		
J	Kurotani, K; Kochi, T; Nanri, A; Eguchi, M; Kuwahara, K; Tsuruoka, H; Akter, S; Ito, R; Pham, NM; Kabe, I; Mizoue, T				Kurotani, Kayo; Kochi, Takeshi; Nanri, Akiko; Eguchi, Masafumi; Kuwahara, Keisuke; Tsuruoka, Hiroko; Akter, Shamima; Ito, Rie; Ngoc Minh Pham; Kabe, Isamu; Mizoue, Tetsuya			Dietary patterns and sleep symptoms in Japanese workers: the Furukawa Nutrition and Health Study	SLEEP MEDICINE			English	Article						Insomnia; Dietary pattern; Difficulty initiating sleep; Difficulty maintaining sleep; Poor quality of sleep; Short sleep duration	DEPRESSIVE SYMPTOMS; QUALITY INDEX; INSOMNIA; MEN; WOMEN; DURATION; HUMANS; ADULTS; ASSOCIATION; PERSPECTIVE	Objective: Experimental studies have shown that some nutrients are involved in initiating and maintaining sleep, but epidemiological evidence on overall dietary patterns and insomnia is scarce. We investigated the relationship between dietary patterns and sleep symptoms in a Japanese working population. Methods: The participants were 2025 workers, aged 18-70 years, who participated in a health survey during a periodic checkup in 2012 and 2013. Dietary intake was assessed with a self-administered diet history questionnaire. Dietary patterns were extracted by principal component analysis on the basis of the energy-adjusted intake of 52 food and beverage items. Sleep duration, difficulty initiating and maintaining sleep, and poor quality of sleep were self-reported. Logistic regression was used to estimate the odds ratios of each sleep symptom according to quartile categories of each dietary pattern with adjustment for potential confounding variables. Results: We identified three major dietary patterns. A healthy pattern, characterized by a high intake of vegetables, mushrooms, potatoes, seaweeds, soy products, and eggs, was associated with a decreased prevalence of difficulty initiating sleep once or more a week (P for trend = 0.03); the multivariate adjusted odds ratio in the highest quartile of this score compared with the lowest was 0.75 (95% CI: 0.570.99). This association persisted after the exclusion of individuals with severe depressive symptoms. However, there was no significant association with difficulty initiating sleep at least three times a week. Conclusions: Our findings suggest that a healthy dietary pattern may be associated with difficulty initiating sleep at least once a week. (C) 2014 Elsevier B.V. All rights reserved.	[Kurotani, Kayo; Nanri, Akiko; Kuwahara, Keisuke; Akter, Shamima; Kabe, Isamu; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo 1628655, Japan; [Kochi, Takeshi; Eguchi, Masafumi; Tsuruoka, Hiroko; Ito, Rie; Kabe, Isamu] Furukawa Elect Corp, Dept Hlth Adm, Tokyo, Japan; [Ngoc Minh Pham] Thai Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Thai Nguyen City, Thai Nguyen Pro, Vietnam	Kurotani, K (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kkurotani@ri.ncgm.go.jp			Industrial Health Foundation; Japan Society for the Promotion of Science [25293146, 25702006]	This study was supported by grants from the Industrial Health Foundation, Grant-in-Aid for Scientific Research (B) (25293146) (Dr Mizoue) and Grant-in-Aid for Young Scientists (A) (25702006) (Dr Nanri) from the Japan Society for the Promotion of Science. The funding bodies had no role in the analysis and interpretation of the data, in writing the report or in the decision to submit the paper for publication.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Vgontzas AN, 2012, SLEEP, V35, P61, DOI 10.5665/sleep.1586; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; Cappuccio FP, 2008, SLEEP, V31, P619; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Jacques PF, 2001, AM J CLIN NUTR, V73, P1; Allen GFG, 2009, MOL GENET METAB, V97, P6, DOI 10.1016/j.ymgme.2009.01.010; Grandner MA, 2014, J SLEEP RES, V23, P22, DOI 10.1111/jsr.12084; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17; Grandner MA, 2010, SLEEP MED, V11, P180, DOI 10.1016/j.sleep.2009.07.014; Espana RA, 2011, SLEEP, V34, P845, DOI 10.5665/SLEEP.1112; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Yokoyama E, 2010, SLEEP, V33, P1693; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Shi Z, 2008, INT J OBESITY, V32, P1835, DOI 10.1038/ijo.2008.191; Council for Science and Technology; Ministry of Education C Sports Science and Technology Japan, 2005, STAND TABL FOOD COMP; DAWSON D, 1993, J PINEAL RES, V15, P1, DOI 10.1111/j.1600-079X.1993.tb00503.x; Doi Y, 2000, J Epidemiol, V10, P79; Furihata R, 2012, SLEEP MED, V13, P831, DOI 10.1016/j.sleep.2012.03.011; Hakkarainen R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-14; Hashimoto S, 1996, NEUROSCI LETT, V220, P129, DOI 10.1016/S0304-3940(96)13247-X; Imaki Masahide, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P115, DOI 10.2114/jpa.21.115; Kang Jeong-Mi, 2013, Korean J Fam Med, V34, P107, DOI 10.4082/kjfm.2013.34.2.107; Khamseh ME, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-61; Kurotani K, 2010, BRIT J NUTR, V104, P1703, DOI 10.1017/S0007114510002606; Liang B, 2013, EUR REV MED PHARMACO, V17, P2517; Meolie Amy Lynn, 2005, J Clin Sleep Med, V1, P173; Mizoue T, 2005, AM J EPIDEMIOL, V161, P338, DOI 10.1093/aje/kwi049; Monk TH, 2013, J SLEEP RES, V22, P201, DOI 10.1111/jsr.12003; Nanri A, 2008, DIABETES CARE, V31, P1568, DOI 10.2337/dc08-0297; Nanri A, 2012, PSYCHIAT RES, V200, P349, DOI 10.1016/j.psychres.2012.04.040; Nanri A, 2013, EUR J CLIN NUTR, V67, P18, DOI 10.1038/ejcn.2012.171; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINSON CR, 1977, BIOL PSYCHIAT, V12, P139; Tanaka E, 2013, J EPIDEMIOL, V23, P132, DOI 10.2188/jea.JE20120101; Willett W., 1998, NUTR EPIDEMIOLOGY; Yamadera W, 2007, SLEEP BIOL RHYTHMS, V5, P126, DOI 10.1111/j.1479-8425.2007.00262.x; Zadeh SS, 2011, NUTR RES PRACT, V5, P230, DOI 10.4162/nrp.2011.5.3.230	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	FEB	2015	16	2					298	304		10.1016/j.sleep.2014.09.017		7	Clinical Neurology	Neurosciences & Neurology	CC3CP	WOS:000350222500014		
J	Komeda, H; Kosaka, H; Saito, DN; Mano, Y; Jung, MY; Fujii, T; Yanaka, HT; Munesue, T; Ishitobi, M; Sato, M; Okazawa, H				Komeda, Hidetsugu; Kosaka, Hirotaka; Saito, Daisuke N.; Mano, Yoko; Jung, Minyoung; Fujii, Takeshi; Yanaka, Hisakazu T.; Munesue, Toshio; Ishitobi, Makoto; Sato, Makoto; Okazawa, Hidehiko			Autistic empathy toward autistic others	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						autism spectrum disorder; empathy; self; similarity; ventromedial prefrontal cortex	FUNCTIONAL CONNECTIVITY MRI; MEDIAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; SPECTRUM DISORDERS; NARRATIVE COMPREHENSION; COMMUNICATION DISORDERS; SENTENCE COMPREHENSION; HEMODYNAMIC-RESPONSES; DIAGNOSTIC INTERVIEW; SOCIAL COGNITION	Individuals with autism spectrum disorder (ASD) are thought to lack self-awareness and to experience difficulty empathizing with others. Although these deficits have been demonstrated in previous studies, most of the target stimuli were constructed for typically developing (TD) individuals. We employed judgment tasks capable of indexing self-relevant processing in individuals with and without ASD. Fourteen Japanese men and 1 Japanese women with high-functioning ASD (17-41 years of age) and 13 Japanese men and 2 TD Japanese women (22-40 years of age), all of whom were matched for age and full and verbal intelligence quotient scores with the ASD participants, were enrolled in this study. The results demonstrated that the ventromedial prefrontal cortex was significantly activated in individuals with ASD in response to autistic characters and in TD individuals in response to non-autistic characters. Although the frontal-posterior network between the ventromedial prefrontal cortex and superior temporal gyrus participated in the processing of non-autistic characters in TD individuals, an alternative network was involved when individuals with ASD processed autistic characters. This suggests an atypical form of empathy in individuals with ASD toward others with ASD.	[Komeda, Hidetsugu] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Kosaka, Hirotaka; Saito, Daisuke N.; Fujii, Takeshi; Sato, Makoto; Okazawa, Hidehiko] Univ Fukui, Res Ctr Child Mental Dev, Fukui 9101193, Japan; [Kosaka, Hirotaka; Ishitobi, Makoto] Univ Fukui, Dept Neuropsychiat, Fac Med Sci, Fukui 9101193, Japan; [Kosaka, Hirotaka; Saito, Daisuke N.; Jung, Minyoung] Chiba Univ, Div Dev Higher Brain Funct, United Grad Sch Child Dev, Dept Child Dev,Osaka Univ,Kanazawa Univ,Hamamatsu, Fukui 9101193, Japan; [Kosaka, Hirotaka; Saito, Daisuke N.; Jung, Minyoung; Sato, Makoto] Univ Fukui, Fukui 9101193, Japan; [Saito, Daisuke N.; Fujii, Takeshi; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan; [Mano, Yoko] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Fujii, Takeshi] Natl Ctr Neurol, Dept Psychiat, Kodaira, Tokyo 1878551, Japan; [Fujii, Takeshi] Hosp Psychiat, Kodaira, Tokyo 1878551, Japan; [Yanaka, Hisakazu T.] Tottori Univ, Fac Reg Sci, Tottori 6808551, Japan; [Munesue, Toshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan; [Sato, Makoto] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Sato, Makoto] Chiba Univ, United Grad Sch Child Dev, Hamamatsu Univ Sch Med, Div Dev Neurosci,Osaka Univ,Kanazawa Univ, Suita, Osaka 22, Japan; [Sato, Makoto] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan	Komeda, H (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Yoshida Ushinomiya Cho, Kyoto 6068501, Japan.	komeda.hidetsugu.5w@kyoto-u.ac.jp			Japan Society for the Promotion of Science [26118505, 25293248, 21791120, 26590145]; Takeda Science Foundation; JSPS Postdoctoral Fellowship for Research Abroad	We express our sincere appreciation to the participants and their families, who generously contributed their time and had the courage to participate in this research. We are also grateful to Taisuke Shimada for data collection. This research was funded, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26118505, 25293248, 21791120, 26590145) and by the Takeda Science Foundation. Part of this research is the result of 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research Program for Brain Sciences by the MEXT of Japan. H.K.'s contribution was supported by a JSPS Postdoctoral Fellowship for Research Abroad.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Shamay-Tsoory Simone G, 2011, Neuroscientist, V17, P18, DOI 10.1177/1073858410379268; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Krienen FM, 2010, J NEUROSCI, V30, P13906, DOI 10.1523/JNEUROSCI.2180-10.2010; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Pfeifer JH, 2013, J AUTISM DEV DISORD, V43, P272, DOI 10.1007/s10803-012-1563-3; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Greimel E, 2010, NEUROIMAGE, V49, P1055, DOI 10.1016/j.neuroimage.2009.07.057; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Nygren G, 2009, J AUTISM DEV DISORD, V39, P730, DOI 10.1007/s10803-008-0678-z; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; Mizuno A, 2011, BRAIN, V134, P2422, DOI 10.1093/brain/awr151; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Asberg J, 2010, SCAND J PSYCHOL, V51, P534, DOI 10.1111/j.1467-9450.2010.00822.x; Asberg J., 2010, J RES SPECIAL ED NEE, V10, P91, DOI [10.1111/j.1471-3802.2020.01147.x, DOI 10.1111/J.1471-3802.2010.01147.X, 10.1111/j.1471-3802.2010.01147.x]; Bruck M, 2007, DEV PSYCHOPATHOL, V19, P73, DOI 10.1017/S0954579407070058; Chen AC, 2010, NEUROIMAGE, V51, P930, DOI 10.1016/j.neuroimage.2010.02.044; Constantino J. N., 2012, SOCIAL RESPONSIVENES; Dern S., 2008, AUTISTIC INTELLIGENC; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith U., 2003, AUTISM EXPLAINING EN; Kamio Y, 2009, SEISHIN IGAKU, V51, P1101; Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034; Komeda H, 2013, ACTA PSYCHOL, V142, P349, DOI 10.1016/j.actpsy.2013.01.002; Komeda H, 2009, COGNITION EMOTION, V23, P135, DOI 10.1080/02699930801949116; Komeda H, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-20; Lind SE, 2010, AUTISM, V14, P430, DOI 10.1177/1362361309358700; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Meltzer JA, 2008, HUM BRAIN MAPP, V29, P385, DOI 10.1002/hbm.20391; Millward C, 2000, J AUTISM DEV DISORD, V30, P15, DOI 10.1023/A:1005455926727; Mitchell JP, 2006, SOC COGN AFFECT NEUR, V1, P49, DOI 10.1093/scan/nsl007; Morita T., 2012, SOCIAL NEUROSCIENCE, V7, P37; Schulte-Ruther M, 2011, SOC NEUROSCI-UK, V6, P1, DOI 10.1080/17470911003708032; Shorvon S. D., 1994, MAGNETIC RESONANCE S; Toichi M, 2002, AM J PSYCHIAT, V159, P1422, DOI 10.1176/appi.ajp.159.8.1422; Wechsler D, 1997, WECHSLER ADULT INTEL; Whitfield-Gabrieli Susan, 2012, Brain Connect, V2, P125, DOI 10.1089/brain.2012.0073; Williams D, 2010, AUTISM, V14, P285, DOI 10.1177/1362361309344849; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	72	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	FEB	2015	10	2					145	152		10.1093/scan/nsu126		8	Neurosciences; Psychology; Psychology, Experimental	Neurosciences & Neurology; Psychology	CC1NV	WOS:000350108800001		
J	Kikuchi, M; Yoshimura, Y; Hiraishi, H; Munesue, T; Hashimoto, T; Tsubokawa, T; Takahashi, T; Suzuki, M; Higashida, H; Minabe, Y				Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Hashimoto, Takanori; Tsubokawa, Tsunehisa; Takahashi, Tsutomu; Suzuki, Michio; Higashida, Haruhiro; Minabe, Yoshio			Reduced long-range functional connectivity in young children with autism spectrum disorder	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						autism spectrum disorder (ASD); coherence; long-range connectivity; magnetoencephalography (MEG); theta oscillation; young children	WORKING-MEMORY TASK; CORPUS-CALLOSUM; BRAIN CONNECTIVITY; FRONTAL-CORTEX; SENTENCE COMPREHENSION; WHITE-MATTER; SYNCHRONIZATION; EEG; UNDERCONNECTIVITY; NEUROANATOMY	Autism spectrum disorder (ASD) is often described as a disorder of aberrant neural connectivity. Although it is important to study the pathophysiology of ASD in the developing cortex, the functional connectivity in the brains of young children with ASD has not been well studied. In this study, brain activity was measured non-invasively during consciousness in 50 young human children with ASD and 50 age- and gender-matched typically developing human (TD) children. We employed a custom child-sized magnetoencephalography (MEG) system in which sensors were located as close to the brain as possible for optimal recording in young children. We focused on theta band oscillations because they are thought to be involved in long-range networks associated with higher cognitive processes. The ASD group showed significantly reduced connectivity between the left-anterior and the right-posterior areas, exhibiting a decrease in the coherence of theta band (6 Hz) oscillations compared with the TD group. This reduction in coherence was significantly correlated with clinical severity in right-handed children with ASD. This is the first study to demonstrate reduced long-range functional connectivity in conscious young children with ASD using a novel MEG approach.	[Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Munesue, Toshio; Higashida, Haruhiro; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208641, Japan; [Kikuchi, Mitsuru; Munesue, Toshio; Hashimoto, Takanori; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9208641, Japan; [Tsubokawa, Tsunehisa] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol, Kanazawa, Ishikawa 9208641, Japan; [Takahashi, Tsutomu; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 9300152, Japan	Kikuchi, M (reprint author), Kanazawa Univ, Res Ctr Child Mental Dev, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mitsuru@zc4.so-net.ne.jp			Strategic Research Program for Brain Sciences from MEXT; SENSHIN Medical Research Foundation, Japan;  [24000012]	This study was supported by a Grant-in-Aid for Specially Promoted Research (Number 24000012), the Strategic Research Program for Brain Sciences from MEXT and SENSHIN Medical Research Foundation, Japan.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Meltzer JA, 2008, CEREB CORTEX, V18, P1843, DOI 10.1093/cercor/bhm213; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Brito AR, 2009, J NEUROIMAGING, V19, P337, DOI 10.1111/j.1552-6569.2009.00366.x; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Honaga E, 2010, NEUROSCI LETT, V478, P141, DOI 10.1016/j.neulet.2010.05.004; Hardan AY, 2000, NEUROLOGY, V55, P1033; Orekhova E, 2006, CLIN NEUROPHYSIOL, V117, P1047, DOI 10.1016/j.clinph.2005.12.027; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Babiloni C, 2008, NEUROIMAGE, V39, P1314, DOI 10.1016/j.neuroimage.2007.09.043; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Raghavachari S, 2001, J NEUROSCI, V21, P3175; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Manes F, 1999, J NEUROPSYCH CLIN N, V11, P470; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Hu SQ, 2010, IEEE T SYST MAN CY B, V40, P1294, DOI 10.1109/TSMCB.2009.2037237; Kaufman A. S., 1983, KAUFMAN ASSESSMENT B; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lord C., 1999, AUTISM DIAGNOSTIC OB; Sekihara K, 2011, IEEE T BIO-MED ENG, V58, P3121, DOI 10.1109/TBME.2011.2162514	48	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	FEB	2015	10	2					248	254		10.1093/scan/nsu049		7	Neurosciences; Psychology; Psychology, Experimental	Neurosciences & Neurology; Psychology	CC1NV	WOS:000350108800012		
J	Makabe, C; Yamazaki, S; Miyazaki, T; Fujikawa, M				Makabe, Chobin; Yamazaki, Shinya; Miyazaki, Tatsujiro; Fujikawa, Masaki			FATIGUE LIFE AND CRACK GROWTH BEHAVIOR IN ANNEALED AND NORMALIZED 0.83% CARBON STEEL	SURFACE REVIEW AND LETTERS			English	Article						Fatigue limit; fatigue life; crack initiation; crack growth behavior; heat treatment; variation of microstructure		The variations of fatigue limit and fatigue life of a plain specimen of annealed and normalized 0.83% carbon steel were investigated. This material is used for cutting tools and the original microstructure includes a spherical microstructure. After heat treatment under some conditions, the microstructure changed to a lamellar microstructure. However, the fatigue lives of the plain specimens of this material showed almost the same tendency even after heat treatment under some conditions. In those cases, the initial crack length in the fatigue process is related to the size of the crystal structure and related to the distribution of ferrite. In the present study, the relationship between the distribution of hardness and the fatigue limit was investigated. Also, it was discussed that the fatigue limit of heat-treated 0.83% carbon steel could be evaluated by a relationship in which the parameters are the hardness and initial crack length. Finally, the tendencies of fatigue life of heat-treated 0.83% carbon steel were discussed based on the observations of crack growth behavior.	[Makabe, Chobin; Miyazaki, Tatsujiro; Fujikawa, Masaki] Univ Ryukyus, Mech Syst Engn Dept, Nishihara, Okinawa 9030213, Japan; [Yamazaki, Shinya] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan	Makabe, C (reprint author), Univ Ryukyus, Mech Syst Engn Dept, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	makabe@tec.u-ryukyu.ac.jp; yumeginga2013@yahoo.co.jp; t-miya@tec.u-ryukyu.ac.jp; fujikawa@tec.uryukyu.ac.jp					BAO H, 1995, METALL MATER TRANS A, V26, P1725, DOI 10.1007/BF02670759; Goto M, 2013, ENG FRACT MECH, V110, P218, DOI 10.1016/j.engfracmech.2013.07.018; Hamada S., 2011, J SOC MATER SCI JPN, V60, P790; Makabe C, 2013, MATER SCI FORUM, V750, P112, DOI 10.4028/www.scientific.net/MSF.750.112; Makabe C, 2011, KEY ENG MAT, V452-453, P597, DOI 10.4028/www.scientific.net/KEM.452-453.597; McEvily A. J., 2001, METAL FAILURES MECH; Murakami Y, 1986, BEHAV SHORT FATIGUE, V1, P275; Nisitani H., 1984, T JAPANESE SOC MEC A, V50, P23; Yamazaki S., 2013, MAT TESTING RES ASS, V58, P43	9	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-625X	1793-6667		SURF REV LETT	Surf. Rev. Lett.	FEB	2015	22	1							1550001	10.1142/S0218625X15500018		10	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CC1PP	WOS:000350113900001		
J	Takahashi, S				Takahashi, Satomi			The effects of learner profiles on pragmalinguistic awareness and learning	SYSTEM			English	Article						Learner profile; Individual differences; Motivation; Listening proficiency; Pragmalinguistic awareness; Pragmatic intervention; Requests	PRAGMATIC PROFICIENCY; RESEARCH AGENDA; MOTIVATION; ATTENTION; INTERLANGUAGE; INSTRUCTION; FEEDBACK; MEMORY; TASKS	By focusing on motivation and proficiency, this study examined the effects of Japanese English as a foreign language (EFL) learners' "learner profiles" on their awareness of biclausal request forms and their learning of these forms in the context of implicit intervention. The study involved 154 Japanese EFL learners. The concept of awareness was operationalized as the summation of learners' "interest" in the target forms and their "detection capacity" of these forms; data relevant to the awareness session were obtained through video dictation tasks. Learners' pragmalinguistic development was assessed through oral discourse completion tasks in the pre- and post-test sessions. Cluster analysis was performed on the two motivation subscales and listening proficiency, yielding three learner groups constituting the independent variable. The results of a one-way repeated measures analysis of variance revealed that the learner profiles constrained awareness of target bi-clausal request forms, although these profiles did not affect their learning of biclausal forms. Qualitative data obtained from learners' awareness journals and follow-up data on their post-test performance supported the findings from the quantitative analysis. The study suggests that pragmalinguistic learning requires learners' deep processing of instructional input, which may be greatly constrained by listening proficiency and grammatical knowledge. (C) 2014 Elsevier Ltd. All rights reserved.	Rikkyo Univ, Coll Intercultural Commun, Toshima Ku, Tokyo 1718501, Japan	Takahashi, S (reprint author), Rikkyo Univ, Coll Intercultural Commun, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	satomit@rikkyo.ac.jp			Japan Society for the Promotion of Science [19520518]	This study was funded by a grant from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 19520518 (2007-2009)).	Alcon Eva, 2012, INTERCULT PRAGMAT, V9, P511; Rosa EM, 2004, APPL PSYCHOLINGUIST, V25, P269; Bardovi-Harlig K, 1999, LANG LEARN, V49, P677, DOI 10.1111/0023-8333.00105; Hama M, 2010, STUD SECOND LANG ACQ, V32, P465, DOI 10.1017/S0272263110000045; Mackey A, 2006, APPL LINGUIST, V27, P405, DOI 10.1093/applin/ami051; Csizer K, 2005, LANG LEARN, V55, P613, DOI 10.1111/j.0023-8333.2005.00319.x; Takahashi S, 2005, APPL LINGUIST, V26, P90, DOI 10.1093/applin/amh040; Takimoto M, 2006, LANG TEACH RES, V10, P393, DOI 10.1191/1362168806Ir198oa; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Williams J, 1999, LANG LEARN, V49, P583, DOI 10.1111/0023-8333.00103; CROOKES G, 1991, LANG LEARN, V41, P469, DOI 10.1111/j.1467-1770.1991.tb00690.x; Gass S, 2003, LANG LEARN, V53, P497, DOI 10.1111/1467-9922.00233; Bialystok E., 1994, STUDIES 2 LANGUAGE A, V16, P157, DOI DOI 10.1017/S0272263100012857; Bialystok Ellen, 1993, INTERLANGUAGE PRAGMA, P43; Cheng YC, 2009, BRIT J EDUC TECHNOL, V40, P597, DOI 10.1111/j.1467-8535.2008.00857.x; DeKeyser R, 2003, HDB 2 LANGUAGE ACQUI, P313; DeKeyser R., 2006, PRACTICING 2 LANGUAG; Doughty Catherine, 2003, HDB 2 LANGUAGE ACQUI, P256, DOI 10.1002/9780470756492.ch10; Ellis Nick, 2007, THEORIES 2 LANGUAGE, P77; Eslami ZR, 2008, SECOND LANG ACQUIS, V30, P178; Fukuya YJ, 2008, FOREIGN LANG ANN, V41, P478; Gonzalez-Lloret M, 2008, SECOND LANG ACQUIS, V30, P114; Hassall T., 1997, THESIS AUSTR NATL U; Hassall T, 2008, SECOND LANG ACQUIS, V30, P72; Jeon EH, 2006, LANG LEARN LANG TEAC, V13, P165; Kasper G., 2002, PRAGMATIC DEV 2 LANG; Kasper Gabriele, 1996, STUDIES 2 LANGUAGE A, V18, P149, DOI 10.1017/S0272263100014868; Kasper Gabriele, 1993, INTERLANGUAGE PRAGMA, P21; Keller J. M., 1983, INSTRUCTIONAL DESIGN, P386; Keller J. M., 1994, INT ENCY ED, V7, P3943; Kuriscak L. M., 2006, THESIS INDIANA U US; Kuriscak LM, 2010, LANG LEARN LANG TEAC, V26, P23; Leow R. P., 2000, STUDIES 2 LANGUAGE A, V22, P557, DOI DOI 10.1017/S0272263100004046; Liddicoat A. J., 2001, PRAGMATICS LANGUAGE, P125; lzumi S., 2002, STUDIES 2 LANGUAGE A, V24, P541; Mackey A., 2002, INDIVIDUAL DIFFERENC, P181; Maehr M. L., 1987, CURRENT TOPICS EARLY, P85; MartinezFlor A, 2010, LANG LEARN LANG TEAC, V26, P1; Martinez-Flor A., 2010, PRAGMATICS LANGUAGES, V7, P423; Martinez-Flor A., 2005, SYSTEM, V33, P463, DOI DOI 10.1016/J.SYSTEM.2005.06.007; Martinez-Flor A., 2012, INTERLANGUAGE REQUES, P243; Martinez-Flor A., 2006, PRAGMATICS LANGUAGE, V11, P199; Nguyen T. T. M., 2013, PRAGMATICS LANGUAGE, V13, P213; Nikula T, 2008, SECOND LANG ACQUIS, V30, P94; Philp J, 2003, STUDIES SECOND LANGU, V25, P99, DOI DOI 10.1017/S0272263103000044; Pintrich P. R., 1989, ADV MOTIVATION ACHIE, P117; Pintrich P. R., 2014, MOTIVATION ED THEORY; ROBINSON P, 1995, LANG LEARN, V45, P283, DOI 10.1111/j.1467-1770.1995.tb00441.x; Robinson P., 2003, HDB 2 LANGUAGE ACQUI, P631, DOI 10.1002/9780470756492.ch19; Safont-Jorda M. P., 2012, INTERLANGUAGE REQUES, P275; Schmidt R., 1994, AILA REV, V11, P11; Schmidt R., 2001, TECHNICAL REPORT, P313; Schmidt R., 1996, TECHNICAL REPORT, P9; Schmidt R., 2001, COGNITION 2 LANGUAGE, P3, DOI DOI 10.1017/CB09781139524780.003; Schmidt R., 1995, TECHNICAL REPORT, P1; SCHMIDT RW, 1990, APPL LINGUIST, V11, P129, DOI 10.1093/applin/11.2.129; Simard D., 2001, STUDIES 2 LANGUAGE A, V23, P103, DOI DOI 10.1017/S0272263101001048; Taguchi N., 2012, CONTEXT INDIVIDUAL D; Takahashi S, 2010, LANG LEARN LANG TEAC, V26, P127; Takahashi S., 2012, LANGUAGE CULTURE COM, V4, P103; Takahashi S., 2013, LANGUAGE CULTURE COM, V5, P53; Takahashi S., 2005, SYSTEM, V33, P437, DOI 10.1016/j.system.2005.06.006; Takahashi S., 2001, PRAGMATICS LANGUAGE, P171; Takahashi S., 2010, HDB PRAGMATICS, VVII, P391; Takahashi S., 1995, THESIS U HAWAII MANO; Takahashi S., 1998, STUDIES LANGUAGES CU, V9, P135; Takimoto M., 2006, SYSTEM, V34, P601, DOI 10.1016/j.system.2006.09.003; Takimoto M, 2009, APPL LINGUIST, V30, P1, DOI 10.1093/applin/amm049; Tomlin R. S., 1994, STUDIES 2ND LANGUAGE, V16, P183, DOI DOI 10.1017/S0272263100012870	69	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0346-251X	1879-3282		SYSTEM	System	FEB	2015	48				SI		48	61		10.1016/j.system.2014.09.004		14	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CC6YV	WOS:000350515800005		
J	Ogata, K; Sumida, K; Miyata, K; Kushida, M; Kuwamura, M; Yamate, J				Ogata, Keiko; Sumida, Kayo; Miyata, Kaori; Kushida, Masahiko; Kuwamura, Mitsuru; Yamate, Jyoji			Circulating miR-9*and miR-384-5p as Potential Indicators for Trimethyltin-induced Neurotoxicity	TOXICOLOGIC PATHOLOGY			English	Article						microRNAs; biomarker; serum; neurotoxicity; trimethyltin; hippocampus	CHROMATIN-REMODELING COMPLEXES; HIPPOCAMPAL DENTATE GYRUS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT MICE; MICRORNAS; RAT; EXPRESSION; CELLS; APOPTOSIS	Circulating microRNAs (miRNAs) show promise as biomarkers due to their tissue-specific expression and high stability. This study was conducted to investigate whether nervous system-enriched miR-9* and hippocampus-enriched miR-384-5p could be indicators of neurotoxicity in serum. Rats were given a single administration of trimethyltin (TMT) chloride at 6, 9, or 12 mg/kg by gavage, and brain and serum were collected 1, 4, and 7 days after administration. MiR-9* and miR-384-5p levels in serum and hippocampus were analyzed by reverse transcriptase polymerase chain reaction (RT-PCR), and their neurotoxicity detection sensitivities were compared with nervous symptoms, auditory response, and histopathology. TMT caused tremor, hypersensitivity, and decreased auditory response at 12 mg/kg on day 1 and at 9 mg/kg on day 4. Histopathologically, neural cell death and glial reaction were observed in brain (mainly hippocampus) at 12 mg/kg on day 1, 4, and 7 and at 6 and 9 mg/kg on day 4 and 7. MiR-9* and miR-384-5p levels were elevated in serum at 9 and 12 mg/kg on days 4 and 7 (at 9 mg/kg on day 7, miR-9* only) but were not changed in hippocampus. These miRNAs were considered to be elevated with the evolution of neural cell death and were thus considered possible novel indicators of neurotoxicity.	[Ogata, Keiko; Sumida, Kayo; Miyata, Kaori; Kushida, Masahiko] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Ogata, Keiko; Kuwamura, Mitsuru; Yamate, Jyoji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Lab Vet Pathol, Osaka, Japan	Ogata, K (reprint author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugadenaka 3 Chome, Osaka 5548558, Japan.	ogatak2@sc.sumitomo-chem.co.jp					Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Corvino V, 2005, BRAIN RES BULL, V65, P471, DOI 10.1016/j.brainresbull.2005.02.031; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Zhang ZP, 2010, INT J BIOCHEM CELL B, V42, P367, DOI 10.1016/j.biocel.2009.11.023; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Tokarz P, 2012, ACTA BIOCHIM POL, V59, P467; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; He XJ, 2007, ACTA BIOCH BIOPH SIN, V39, P708, DOI 10.1111/j.1745-7270.2007.00324.x; Wang XX, 2010, J ENVIRON SCI HEAL B, V45, P648, DOI 10.1080/03601234.2010.502435; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Corvino V, 2013, NEUROCHEM RES, V38, P240, DOI 10.1007/s11064-012-0932-9; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao YY, 2013, APOPTOSIS, V18, P260, DOI 10.1007/s10495-013-0802-1; BOULDIN TW, 1981, AM J PATHOL, V104, P237; BROWN AW, 1979, AM J PATHOL, V97, P59; BUSHNELL PJ, 1985, TOXICOL APPL PHARM, V79, P134, DOI 10.1016/0041-008X(85)90375-8; CROFTON KM, 1990, TOXICOL APPL PHARM, V105, P123, DOI 10.1016/0041-008X(90)90364-Z; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; DYER RS, 1982, NEUROBEH TOXICOL TER, V4, P127; EASTMAN CL, 1987, NEUROTOXICOL TERATOL, V9, P329, DOI 10.1016/0892-0362(87)90026-2; FECHTER LD, 1986, HEARING RES, V23, P275, DOI 10.1016/0378-5955(86)90116-4; Fiedorowicz A, 2001, BRAIN RES, V912, P116, DOI 10.1016/S0006-8993(01)02675-0; Figiel I, 2002, NEUROTOXICOLOGY, V23, P77, DOI 10.1016/S0161-813X(02)00006-2; Jenkins SM, 2004, TOXICOL LETT, V147, P63, DOI 10.1016/j.toxlet.2003.10.023; Kaur P, 2012, J TOXICOLOGY, V2012, P1, DOI [10.2353/ajpath.2010.091202, DOI 10.2353/AJPATH.2010.091202]; Little AR, 2012, NEUROTOXICOL TERATOL, V34, P72, DOI 10.1016/j.ntt.2011.09.012; Liu Y, 1996, TOXICOL IN VITRO, V10, P567, DOI 10.1016/S0887-2333(96)00036-7; Morita M, 2008, NEUROSCIENCE, V153, P1135, DOI 10.1016/j.neuroscience.2008.01.078; Ogita Kiyokazu, 2012, Japanese Journal of Neuropsychopharmacology, V32, P281; Omar F. L., 2009, CLIN CHEM, V55, P1977; Perretta G, 1993, Ann Ist Super Sanita, V29, P167; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; RUPPERT PH, 1984, TOXICOL LETT, V22, P33, DOI 10.1016/0378-4274(84)90042-0; Shintani N, 2007, YAKUGAKU ZASSHI, V127, P451, DOI 10.1248/yakushi.127.451; Su YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037395; Wang ES, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-165; Wei XW, 2013, NEUROCHEM RES, V38, P1605, DOI 10.1007/s11064-013-1062-8; Yokota Takanori, 2009, Brain and Nerve (Tokyo), V61, P167; YOUNG JS, 1986, TOXICOL APPL PHARM, V82, P87, DOI 10.1016/0041-008X(86)90441-2; Zhao JJ, 2006, CHILD NERV SYST, V22, P1419, DOI 10.1007/s00381-006-0173-9	65	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	FEB	2015	43	2					198	208		10.1177/0192623314530533		11	Pathology; Toxicology	Pathology; Toxicology	CC4RO	WOS:000350341100004		
J	Klaunig, JE; Shinohara, M; Iwai, H; Chengelis, CP; Kirkpatrick, JB; Wang, ZM; Bruner, RH				Klaunig, James E.; Shinohara, Motoki; Iwai, Hiroyuki; Chengelis, Christopher P.; Kirkpatrick, Jeannie B.; Wang, Zemin; Bruner, Richard H.			Evaluation of the Chronic Toxicity and Carcinogenicity of Perfluorohexanoic Acid (PFHxA) in Sprague-Dawley Rats	TOXICOLOGIC PATHOLOGY			English	Article						rat chronic exposure; perfluorohexanoic acid (PFHxA); fluorocompounds	FUNCTIONAL OBSERVATIONAL BATTERY; CARBON-CHAIN LENGTH; PERFLUORINATED FATTY-ACIDS; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; PERFLUOROOCTANOIC ACID; HUMAN EXPOSURE; WATER; CANCER; ELIMINATION	Perfluorohexanoic acid (PFHxA), a 6-carbon perfluoroalkyl (C6; CAS # 307-24-4), has been proposed as a replacement for the commonly used 8-carbon perfluoroalkyls: perfluorooctanoic acid and perfluorooctane sulfonate. PFHxA is not currently a commercial product but rather the ultimate degradation product of C6 fluorotelomer used to make C6 fluorotelomer acrylate polymers. It can be expected that, to a greater or lesser extent, the environmental loading of PFHxA will increase, as C6 fluorotelomer acrylate treatments are used and waste is generated. This article reports on a chronic study (duration 104 weeks) that was performed to evaluate the possible toxicologic and carcinogenic effects of PFHxA in gavage (daily gavage, 7 days per week) treated male and female Sprague-Dawley (SD) rats. In the current study, dosage levels of 0, 2.5, 15, and 100 mg/kg/day of PFHxA (males) and 5, 30, and 200 mg/kg/day of PFHxA (females) were selected based on a previous subchronic investigation. No effects on body weights, food consumption, a functional observational battery, or motor activity were observed after exposure to PFHxA. While no difference in survival rates in males was seen, a dose-dependent decrease in survival in PFHxA-treated female rats was observed. Hematology and serum chemistry were unaffected by PFHxA. PFHxA-related histologic changes were noted in the kidneys of the 200-mg/kg/day group females. Finally, there was no evidence that PFHxA was tumorigenic in male or female SD rats at any of the dosage levels examined.	[Klaunig, James E.; Wang, Zemin] Indiana Univ, Dept Environm Hlth, Bloomington, IN 47408 USA; [Shinohara, Motoki] Asahi Glass Com Ltd, AGC Chem, Ichihara, Chiba, Japan; [Iwai, Hiroyuki] Daikin Ind Ltd, Div Chem, EHS Dept, Osaka, Japan; [Chengelis, Christopher P.; Kirkpatrick, Jeannie B.] WIL Res, Ashland, OH USA; [Bruner, Richard H.] Res Pathol Associates LLC, Clemson, SC USA	Klaunig, JE (reprint author), Indiana Univ, Dept Environm Hlth, 2719 East Tenth St, Bloomington, IN 47408 USA.	jklauni@indiana.edu		Wang, Zemin/0000-0003-4189-578X	AGC Chemicals, Asahi Glass Com., Ltd. Goikaigan, Ichihara-shi, Chiba, Japan; Daikin Industries, Ltd. Chemicals Division EHS Department, Hitotsuya-Nishi, Settsu, Osaka, Japan	This work was performed at WIL Research in Ashland, Ohio, and was supported jointly by AGC Chemicals, Asahi Glass Com., Ltd. 10 Goikaigan, Ichihara-shi, Chiba 290-8566, Japan, and Daikin Industries, Ltd. Chemicals Division EHS Department, 1-1 Hitotsuya-Nishi, Settsu, Osaka 565-8585, Japan.	Mulkiewicz E, 2007, ENVIRON TOXICOL PHAR, V23, P279, DOI 10.1016/j.etap.2006.11.002; MCCONNELL EE, 1986, J NATL CANCER I, V76, P283; Eriksen KT, 2009, J NATL CANCER I, V101, P605, DOI 10.1093/jnci/djp041; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196; Domingo JL, 2012, ENVIRON INT, V40, P187, DOI 10.1016/j.envint.2011.08.001; Pico Y, 2011, CRIT REV FOOD SCI, V51, P605, DOI 10.1080/10408391003721727; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Ohmori K, 2003, TOXICOLOGY, V184, P135, DOI 10.1016/S0300-483X(02)00573-5; Tao L, 2008, ENVIRON SCI TECHNOL, V42, P3096, DOI 10.1021/es702789k; MOSER VC, 1991, TOXICOL APPL PHARM, V108, P267, DOI 10.1016/0041-008X(91)90117-W; MOSER VC, 1988, FUND APPL TOXICOL, V11, P189, DOI 10.1016/0272-0590(88)90144-3; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Mak YL, 2009, ENVIRON SCI TECHNOL, V43, P4824, DOI 10.1021/es900637a; Shankar A, 2011, AM J EPIDEMIOL, V174, P893, DOI 10.1093/aje/kwr171; Key BD, 1997, ENVIRON SCI TECHNOL, V31, P2445, DOI 10.1021/es961007c; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P189, DOI 10.1897/1551-5028(2003)022<0189:DAOPAI>2.0.CO;2; Nakata H, 2006, ENVIRON SCI TECHNOL, V40, P4916, DOI 10.1021/es0603195; DeWitt JC, 2012, TOXICOL PATHOL, V40, P300, DOI 10.1177/0192623311428473; Chengelis CP, 2009, REPROD TOXICOL, V27, P342, DOI 10.1016/j.reprotox.2009.01.006; Biegel LB, 2001, TOXICOL SCI, V60, P44, DOI 10.1093/toxsci/60.1.44; D'Hollander W, 2010, REV ENVIRON CONTAM T, V208, P179, DOI 10.1007/978-1-4419-6880-7_4; Naile JE, 2010, ENVIRON POLLUT, V158, P1237, DOI 10.1016/j.envpol.2010.01.023; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Kudo N, 2001, CHEM-BIOL INTERACT, V134, P203, DOI 10.1016/S0009-2797(01)00155-7; Alexander BH, 2007, ANN EPIDEMIOL, V17, P471, DOI 10.1016/j.annepidem.2007.01.036; Russell MH, 2013, CHEMOSPHERE, V93, P2419, DOI 10.1016/j.chemosphere.2013.08.060; Kudo N, 2006, BIOL PHARM BULL, V29, P1952, DOI 10.1248/bpb.29.1952; Tilton SC, 2008, ENVIRON HEALTH PERSP, V116, P1047, DOI 10.1289/ehp.11190; Melzer D, 2010, ENVIRON HEALTH PERSP, V118, P686, DOI 10.1289/ehp.0901584; Alexander BH, 2003, OCCUP ENVIRON MED, V60, P722, DOI 10.1136/oem.60.10.722; Vestergren R, 2009, ENVIRON SCI TECHNOL, V43, P5565, DOI 10.1021/es900228k; Olsen GW, 2012, ENVIRON SCI TECHNOL, V46, P6330, DOI 10.1021/es300604p; GAD SC, 1982, J TOXICOL ENV HEALTH, V9, P691; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Sinclair E, 2006, ARCH ENVIRON CON TOX, V50, P398, DOI 10.1007/s00244-005-1188-z; Benninghoff AD, 2012, TOXICOL SCI, V125, P69, DOI 10.1093/toxsci/kfr267; Bonefeld-Jorgensen EC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-88; Fiette L, 2011, METHODS MOL BIOL, V691, P39, DOI 10.1007/978-1-60761-849-2_3; GILLILAND FD, 1993, J OCCUP ENVIRON MED, V35, P950, DOI 10.1097/00043764-199309000-00020; HAGGERTY GC, 1989, J AM COLL TOXICOL, V8, P53; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; ODONOGHUE JL, 1989, J AM COLL TOXICOL, V8, P97; Peto R., 1980, IARC MONOGRAPHS EV S, P311; Snedecor G.W., 1980, STATISTICAL METHODS, P215; STEEL R. G. D., 1997, PRINCIPLES PROCEDURE; USEPA (U.S. Environmental Protection Agency), 2013, PERFL AC PFOA FLUOR; Zhang T, 2011, J AGR FOOD CHEM, V59, P11168, DOI 10.1021/jf2007216	48	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	FEB	2015	43	2					209	220		10.1177/0192623314530532		12	Pathology; Toxicology	Pathology; Toxicology	CC4RO	WOS:000350341100005		
J	Tateno, C; Yamamoto, T; Utoh, R; Yamasaki, C; Ishida, Y; Myoken, Y; Oofusa, K; Okada, M; Tsutsui, N; Yoshizato, K				Tateno, Chise; Yamamoto, Toshinobu; Utoh, Rie; Yamasaki, Chihiro; Ishida, Yuji; Myoken, Yuka; Oofusa, Ken; Okada, Miyoko; Tsutsui, Naohisa; Yoshizato, Katsutoshi			Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator-activated Receptor-alpha	TOXICOLOGIC PATHOLOGY			English	Article						PPAR; humanized mice; human hepatocytes; fenofibrate	PPAR-ALPHA; SPECIES-DIFFERENCES; ANIMAL-MODEL; EXPRESSION; MOUSE; FENOFIBRATE; ENZYMES; HEPATOCARCINOGENESIS; TRANSPORTERS; TROGLITAZONE	Peroxisome proliferator (PP)-activated receptor- (PPAR) agonists exhibit species-specific effects on livers of the rodent and human (h), which has been considered to reside in the difference of PPAR gene structures. However, the contribution of h-hepatocytes (heps) to the species-specificity remains to be clarified. In this study, the effects of fenofibrate were investigated using a hepatocyte-humanized chimeric mouse (m) model whose livers were replaced with h-heps at >70%. Fenofibrate induced hepatocellular hypertrophy, cell proliferation, and peroxisome proliferation in livers of severe combined immunodeficiency (SCID) mice, but not in the h-hep of chimeric mouse livers. Fenofibrate increased the expression of the enzymes of - and -hydroxylation and deoxygenation of lipids at both gene and protein levels in SCID mouse livers, but not in the h-heps of chimeric mouse livers, supporting the studies with h-PPAR-transgenic mice, a hitherto reliable model for studying the regulation of h-PPAR in the h-liver in most respects, except the induction of the peroxisome proliferation. This study indicates the importance of not only h-PPAR gene but also h-heps themselves to correctly predict effects of fibrates on h-livers, and, therefore, suggests that the chimeric mouse is a currently available, consistent, and reliable model to obtain pharmaceutical data concerning the effects of fibrates on h-livers.	[Tateno, Chise; Utoh, Rie; Yamasaki, Chihiro; Yoshizato, Katsutoshi] Hiroshima Prefectural Inst Ind Sci & Technol, Yoshizato Project, Cooperat Link Unique Sci & Technol Econ Revitaliz, Higashihiroshima, Japan; [Tateno, Chise; Ishida, Yuji; Yoshizato, Katsutoshi] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Tateno, Chise; Yamasaki, Chihiro; Ishida, Yuji; Yoshizato, Katsutoshi] PhoenixBio Co Ltd, Higashihiroshima, Japan; [Yamamoto, Toshinobu; Okada, Miyoko; Tsutsui, Naohisa] Mitsubishi Tanabe Pharma Corp, Safety Res Lab, Kisarazu, Japan; [Utoh, Rie] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Myoken, Yuka; Oofusa, Ken] Prophoenix Co Ltd, Dev Biol Lab, Higashihiroshima, Japan; [Oofusa, Ken] Idea Consultants, Prophoenix Div, Osaka, Japan; [Yoshizato, Katsutoshi] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 21st Century COE Program Adv Radiat Casualty Med, Higashihiroshima 724, Japan	Tateno, C (reprint author), PhoenixBio Co Ltd, 3-4-1 Kagamiyama, Hiroshima 7390046, Japan.	chise.mukaidani@phoenixbio.co.jp; katsutoshi.yoshizato@phoenixbio.co.jp			Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER), Promotion of Science and Technology in Regional Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER), Promotion of Science and Technology in Regional Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan.	Tachibana K, 2008, PPAR RES, DOI 10.1155/2008/102737; Ammerschlaeger M, 2004, TOXICOL SCI, V78, P229, DOI 10.1093/toxsci/kfh071; Fidaleo M, 2009, EXP TOXICOL PATHOL, V61, P215, DOI 10.1016/j.etp.2008.09.002; Yoshizato K, 2013, EXPERT OPIN DRUG MET, V9, P1419, DOI 10.1517/17425255.2013.826649; Palmer CNA, 1998, MOL PHARMACOL, V53, P14; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Shoda J, 2007, HEPATOL RES, V37, P548, DOI 10.1111/j.1872-034X.2007.00069.x; Katoh M, 2004, DRUG METAB DISPOS, V32, P1402, DOI 10.1124/dmd.104.001347; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Peters JM, 1998, CARCINOGENESIS, V19, P1989, DOI 10.1093/carcin/19.11.1989; Morimura K, 2006, CARCINOGENESIS, V27, P1074, DOI 10.1093/carcin/bgi329; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Mates JM, 2000, TOXICOLOGY, V153, P83; BENTLEY P, 1993, FOOD CHEM TOXICOL, V31, P857, DOI 10.1016/0278-6915(93)90225-N; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206; Parzefall W, 2001, CARCINOGENESIS, V22, P519, DOI 10.1093/carcin/22.3.519; Cattley RC, 1998, REGUL TOXICOL PHARM, V27, P47, DOI 10.1006/rtph.1997.1163; Katoh M, 2005, DRUG METAB DISPOS, V33, P1333, DOI 10.1124/dmd.105.005157; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; Cheung C, 2004, CANCER RES, V64, P3849, DOI 10.1158/0008-5472.CAN-04-0322; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; BLUMCKE S, 1983, ATHEROSCLEROSIS, V46, P105, DOI 10.1016/0021-9150(83)90169-7; Chang EY, 2005, FREE RADICAL BIO MED, V39, P1666, DOI 10.1016/j.freeradbiomed.2005.08.008; Foster JR, 2012, TOXICOL PATHOL, V40, P1106, DOI 10.1177/0192623312447542; GARIOT P, 1983, ARCH TOXICOL, V53, P151; Guyton KZ, 2009, ENVIRON HEALTH PERSP, V117, P1664, DOI 10.1289/ehp.0900758; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Kakuni M, 2012, TOXICOL LETT, V214, P9, DOI 10.1016/j.toxlet.2012.08.001; Kristensen DB, 2000, ELECTROPHORESIS, V21, P430, DOI 10.1002/(SICI)1522-2683(20000101)21:2<430::AID-ELPS430>3.3.CO;2-S; Maxwell A. G., 2009, J BIOL CHEM, V284, P9321; Nishimura J, 2007, TOXICOL SCI, V97, P44, DOI 10.1093/toxsci/kfm011; Nishimura M, 2005, XENOBIOTICA, V35, P877, DOI 10.1080/00498250500307251; NOVIKOFF AB, 1969, J HISTOCHEM CYTOCHEM, V17, P675; Pyper S. R., 2012, NUCL RECEPT SIGNAL, V8, pe002; Rakhshandehroo Maryam, 2007, PPAR Res, V2007, P26839, DOI 10.1155/2007/26839; Rininger J. A., 1997, CARCINOGENESIS, V18, P935; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Walgren JE, 2000, RES COMMUN MOL PATH, V108, P116; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yoshizato K, 2009, PPAR RES, DOI 10.1155/2009/476217	45	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	FEB	2015	43	2					233	248		10.1177/0192623314544378		16	Pathology; Toxicology	Pathology; Toxicology	CC4RO	WOS:000350341100007		
J	Hsieh, KY; Tsai, WP; Chen, MJ				Hsieh, Kai-Yu; Tsai, Wenpin; Chen, Ming-Jer			IF THEY CAN DO IT, WHY NOT US? COMPETITORS AS REFERENCE POINTS FOR JUSTIFYING ESCALATION OF COMMITMENT	ACADEMY OF MANAGEMENT JOURNAL			English	Article							ENTRY MODE CHOICE; INSTITUTIONAL INFLUENCES; INTERNATIONAL EXPANSION; AIRLINE INDUSTRY; REAL OPTIONS; MARKET ENTRY; BIG MUDDY; DYNAMICS; FIRMS; BEHAVIOR	This study highlights competitive market conditions as an important structural determinant of escalation of commitment. Bridging escalation behavior literature and competitive dynamics research, we argue that reference to certain rivals may enable or disable decision makers to justify continuing investment in an underperforming initiative, thereby influencing a firm's tendency toward escalating commitment. We test our ideas using data on a set of leading companies in the information technology industry and their investment activities in China. Empirical analysis reveals strong evidence that a firm's escalating tendency is increased by larger competitors' high action volume and smaller competitors' positive performance. In contrast to prior research focus on decision makers' persistence irrespective of external cues, we also find that a firm's escalation behavior is decreased by larger rivals' negative performance.	[Hsieh, Kai-Yu] Waseda Univ, Grad Sch Commerce, Tokyo, Japan; [Tsai, Wenpin] Penn State Univ, University Pk, PA 16802 USA; [Chen, Ming-Jer] Univ Virginia, Darden Grad Sch Business, Charlottesville, VA 22903 USA	Hsieh, KY (reprint author), Waseda Univ, Grad Sch Commerce, Tokyo, Japan.	khsieh@live.jp; wtsai@psu.edu; chenm@darden.virginia.edu	Hsieh, Kai-Yu/B-2438-2009	Hsieh, Kai-Yu/0000-0003-2544-134X	Singapore Ministry of Education Academic Research Fund; Tokutei Kadai Research Program at Waseda University; Smeal Research Grant Program at Pennsylvania State University; Darden Foundation at University of Virginia	This paper benefited from the insights of associate editor Gerry McNamara and three anonymous reviewers. The authors would like to thank Sea-Jin Chang, Weiru Chen, You-Ta Chuang, Andrew Delios, Suresh Kotha, Jane Lu, Pasha Mahmood, Ivan Png, Metin Sengul, Ken Smith, and Tieying Yu for their valuable comments on early drafts. Financial support from the Singapore Ministry of Education Academic Research Fund, the Tokutei Kadai Research Program at Waseda University, the Smeal Research Grant Program at Pennsylvania State University, and the Darden Foundation at University of Virginia is gratefully acknowledged.	AMBURGEY TL, 1992, STRATEGIC MANAGE J, V13, P335, DOI 10.1002/smj.4250130503; Anand J, 2009, ACAD MANAGE J, V52, P802; MILLER D, 1994, ADMIN SCI QUART, V39, P1, DOI 10.2307/2393492; Adner R, 2004, ACAD MANAGE REV, V29, P74; PORAC JF, 1995, ADMIN SCI QUART, V40, P203, DOI 10.2307/2393636; Ferrier WJ, 1999, ACAD MANAGE J, V42, P372, DOI 10.2307/257009; Haunschild PR, 1997, ADMIN SCI QUART, V42, P472, DOI 10.2307/2393735; Livengood RS, 2010, ACAD MANAGE REV, V35, P48; Guler I, 2007, ADMIN SCI QUART, V52, P248; Markman GD, 2009, ACAD MANAGE REV, V34, P423; Johanson J, 2009, J INT BUS STUD, V40, P1411, DOI 10.1057/jibs.2009.24; Barkema HG, 1998, ACAD MANAGE J, V41, P7, DOI 10.2307/256894; Terlaak A, 2007, STRATEG MANAGE J, V28, P1167, DOI 10.1002/smj.636; Tsai WP, 2011, ACAD MANAGE J, V54, P761; Zardkoohi A, 2004, ACAD MANAGE REV, V29, P111; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Chan CM, 2006, J INT BUS STUD, V37, P642, DOI 10.1057/palgrave.jibs.8400216; Young G, 1996, ORGAN SCI, V7, P243, DOI 10.1287/orsc.7.3.243; STAW BM, 1981, ADMIN SCI QUART, V26, P501, DOI 10.2307/2392337; Ferrier WJ, 2001, ACAD MANAGE J, V44, P858, DOI 10.2307/3069419; Baum JAC, 2000, ADMIN SCI QUART, V45, P766, DOI 10.2307/2667019; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Puck JF, 2009, J INT BUS STUD, V40, P388, DOI 10.1057/jibs.2008.56; Tsai WP, 2002, ORGAN SCI, V13, P179, DOI 10.1287/orsc.13.2.179.536; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151; CHEN MJ, 1995, ACAD MANAGE J, V38, P453, DOI 10.2307/256688; STAW BM, 1976, ORGAN BEHAV HUM PERF, V16, P27, DOI 10.1016/0030-5073(76)90005-2; DAVENI RA, 1990, ADMIN SCI QUART, V35, P634, DOI 10.2307/2393512; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.1093/biomet/62.2.269; Sleesman DJ, 2012, ACAD MANAGE J, V55, P541, DOI 10.5465/amj.2010.0696; Chen MJ, 2012, ACAD MANAG ANN, V6, P135, DOI 10.1080/19416520.2012.660762; Upson JW, 2012, ACAD MANAGE J, V55, P93, DOI 10.5465/amj.2008.0330; Lieberman MB, 2006, ACAD MANAGE REV, V31, P366; McGrath RG, 1998, ACAD MANAGE REV, V23, P724, DOI 10.2307/259059; Kim KH, 2012, STRATEGIC MANAGE J, V33, P115, DOI 10.1002/smj.945; Miller D, 1996, SOC FORCES, V74, P1209, DOI 10.2307/2580349; Guler I, 2002, ADMIN SCI QUART, V47, P207, DOI 10.2307/3094804; Briscoe F, 2011, ADMIN SCI QUART, V56, P408, DOI 10.1177/0001839211432540; Chen MJ, 1996, ACAD MANAGE REV, V21, P100; Fiegenbaum A, 1996, STRATEGIC MANAGE J, V17, P219, DOI 10.1002/(SICI)1097-0266(199603)17:3<219::AID-SMJ806>3.0.CO;2-N; Ndofor HA, 2011, STRATEGIC MANAGE J, V32, P640, DOI 10.1002/smj.901; Yin XL, 2012, ORGAN SCI, V23, P1682, DOI 10.1287/orsc.1110.0711; Ketchen DJ, 2004, J MANAGE, V30, P779, DOI 10.1016/j.jm.2004.06.002; Haleblian J, 2012, STRATEGIC MANAGE J, V33, P1037, DOI 10.1002/smj.1961; GRESOV C, 1993, ORGAN SCI, V4, P181, DOI 10.1287/orsc.4.2.181; Chen MJ, 2007, ACAD MANAGE J, V50, P101; Derfus PJ, 2008, ACAD MANAGE J, V51, P61; Gimeno J, 2005, ACAD MANAGE J, V48, P297; ARKES HR, 1985, ORGAN BEHAV HUM DEC, V35, P124, DOI 10.1016/0749-5978(85)90049-4; Boyd JL, 2008, STRATEGIC MANAGE J, V29, P1077, DOI 10.1002/smj.710; BROCKNER J, 1992, ACAD MANAGE REV, V17, P39, DOI 10.2307/258647; Caves RE, 2007, CAMB SURV ECON LIT, P1, DOI 10.1017/CBO9780511619113; CHEN MJ, 1992, MANAGE SCI, V38, P439, DOI 10.1287/mnsc.38.3.439; Chen MJ, 2010, STRATEGIC MANAGE J, V31, P1410, DOI 10.1002/smj.891; Clark BH, 1999, J MARKETING, V63, P67, DOI 10.2307/1251776; Cleves M., 2010, INTRO SURVIVAL ANAL; Creswell J. W., 2008, RES DESIGN QUALITATI; Cyert R., 1963, BEHAV THEORY FIRM; D'Aveni R. A., 1994, HYPERCOMPETITION MAN; Dedrick J., 1998, ASIAS COMPUTER CHALL; Fhionnlaoich CM, 2002, MANAGERIAL DECISION, V23, P301, DOI 10.1002/mde.1067; Gimeno J, 2001, ADV STRAT M, V18, P357; HAMBRICK DC, 1993, STRATEGIC MANAGE J, V14, P401, DOI 10.1002/smj.4250140602; Hsieh KY, 2014, ORGAN SCI, V25, P299, DOI 10.1287/orsc.2013.0832; Hymer Stephen H., 1976, INT OPERATIONS NATL; Institute for Information Industry, 2011, INF IND YB; Knickerbocker F. T., 1973, OLIGOPOLISTIC REACTI; Kumar P, 2004, ORGAN BEHAV HUM DEC, V95, P175, DOI 10.1016/j.obhdp.2004.06.004; Lieberman MB, 1998, STRATEGIC MANAGE J, V19, P1111, DOI 10.1002/(SICI)1097-0266(1998120)19:12<1111::AID-SMJ21>3.0.CO;2-W; Lu JW, 2002, J INT BUS STUD, V33, P19, DOI 10.1057/palgrave.jibs.8491003; Marcel JJ, 2011, STRATEGIC MANAGE J, V32, P115, DOI 10.1002/smj.870; Martinko M. J., 1995, ATTRIBUTION THEORY O, P7; McNamara G, 2002, ACAD MANAGE J, V45, P443, DOI 10.2307/3069358; Nisbett R.E., 1982, JUDGMENT UNCERTAINTY, P101; Ocasio W, 1997, STRATEGIC MANAGE J, V18, P187, DOI 10.1002/(SICI)1097-0266(199707)18:1+<187::AID-SMJ936>3.3.CO;2-B; Pindyck R. S., 1994, INVESTMENT UNCERTAIN; Rindova V, 2010, STRATEGIC MANAGE J, V31, P1474, DOI 10.1002/smj.892; Rogers E., 2003, DIFFUSION INNOVATION; Rose EL, 2008, J INT BUS STUD, V39, P864, DOI 10.1057/palgrave.jibs.8400391; Scherer F.M., 1990, IND MARKET STRUCTURE; Schwab A, 2007, ORGAN SCI, V18, P233, DOI 10.1287/orsc.1060.0238; Shapira Z., 1997, ORG DECISION MAKING, P191; Smith K.G., 2001, HDB STRATEGIC MANAGE, P315; SMITH KG, 1991, ACAD MANAGE J, V34, P60, DOI 10.2307/256302; Yu TY, 2009, ACAD MANAGE J, V52, P127; Yu TY, 2007, ACAD MANAGE J, V50, P665; Zaheer S, 1997, STRATEGIC MANAGE J, V18, P439, DOI 10.1002/(SICI)1097-0266(199706)18:6<439::AID-SMJ884>3.0.CO;2-Y; Zhang Y, 2010, ACAD MANAGE J, V53, P743	88	0	0	ACAD MANAGEMENT	BRIARCLIFF MANOR	PACE UNIV, PO BOX 3020, 235 ELM RD, BRIARCLIFF MANOR, NY 10510-8020 USA	0001-4273	1948-0989		ACAD MANAGE J	Acad. Manage. J.	FEB	2015	58	1					38	58		10.5465/amj.2011.0869		21	Business; Management	Business & Economics	CB8LX	WOS:000349882200003		
J	Zhu, C; Saito, K; Yamanaka, M; Akiyama, T				Zhu, Chen; Saito, Kodai; Yamanaka, Masahiro; Akiyama, Takahiko			Benzothiazoline: Versatile Hydrogen Donor for Organocatalytic Transfer Hydrogenation	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							ASYMMETRIC TRANSFER HYDROGENATION; CATALYZED TRANSFER HYDROGENATION; ALPHA-IMINO ESTERS; CHIRAL BRONSTED ACID; ENANTIOSELECTIVE TRANSFER HYDROGENATION; PHOSPHORIC-ACID; REDUCTIVE AMINATION; HANTZSCH ESTERS; CONJUGATE REDUCTION; REDUCING AGENT	The asymmetric reduction of ketimines is an important method for the preparation of amines in optically pure form. Inspired by the biological system using NAD(P)H, Hantzsch ester has been extensively employed as a hydrogen donor in combination with chiral phosphoric acid for the transfer hydrogenation of ketimines to furnish amines with high to excellent enantioselectivities. We focused on 2-substituted benzothiazoline as a hydrogen donor in the phosphoric acid catalyzed transfer hydrogenation reaction of ketimines for the following reasons: (1) benzothiazoline is readily prepared just by mixing 2-aminobenzenethiol and aldehyde, (2) both reactivity (hydrogen donating ability) and enantioselectivity would be controlled by tuning the 2-substituent of benzothiazoline, and (3) benzothiazoline can be stored in a refrigerator under inert atmosphere without conceivable decomposition. Both the 2-position of benzothiazoline and the 3,3'-position of phosphoric acid are tunable in order to achieve excellent enantioselectivity. Benzothiazoline proved to be useful hydrogen donor in combination with chiral phosphoric acid for the transfer hydrogenation reaction of ketimine derivatives to afford the corresponding amines with high to excellent enantioselectivities by tuning the 2-substituent of benzothiazoline. Ketimines derived from acetophenone, propiophenone, a-keto ester, trifluoromethyl ketone, and difluoromethyl ketone derivatives proved to be suitable substrates. Benzothiazoline could be generated in situ starting from 2-aminobenzenethiol and aromatic aldehyde in the presence of ketimine and chiral phosphoric acid and successfully worked in the sequential transfer hydrogenation reaction. The reductive amination of dialkyl ketones also proceeded with high enantioselectivities. Use of 2-deuterated benzothiazoline led to the formation of a-deuterated amines with excellent enantioselectivities. The kinetic isotope effect (k(H)/k(C) = 3.8) was observed in the competitive reaction between H- and D-benzothiazoline, which explicitly implies that the cleavage of the CH (CD) bond is the rate-determining step in the transfer hydrogenation reaction. Benzothiazoline yielded products with higher enantioselectivity in the transfer hydrogenation reaction of ketimines, particularly ketimines derived from propiophenone derivatives, than Hantzsch ester. DFT study elucidated the mechanism, as well as the difference in selectivity, between benzothiazoline and Hantzsch ester. The chiral phosphoric acid activates ketimines and benzothiazoline by means of the Bronsted acidic site (proton) and the Bronsted basic site (phosphoryl oxygen), respectively, to accelerate the hydride transfer reaction.	[Zhu, Chen] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Key Lab Organ Synth Jiangsu Prov, Suzhou 215123, Jiangsu, Peoples R China; [Zhu, Chen; Saito, Kodai; Akiyama, Takahiko] Gakushuin Univ, Dept Chem, Toshima Ku, Tokyo 1718588, Japan; [Yamanaka, Masahiro] Rikkyo Univ, Fac Sci, Dept Chem, Toshima Ku, Tokyo 1718501, Japan; [Yamanaka, Masahiro] Rikkyo Univ, Fac Sci, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan	Akiyama, T (reprint author), Gakushuin Univ, Dept Chem, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	takahiko.akiyama@gakushuin.ac.jp		Akiyama, Takahiko/0000-0003-4709-4107	MEXT, Japan; JSPS; Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	T.A. acknowledges financial support in the form of a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Transformation by Organocatalysis" from MEXT, Japan, and a Grant-in-Aid for Scientific Research from JSPS. C.Z. acknowledges the support from Soochow University and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Wang ZB, 2015, J AM CHEM SOC, V137, P383, DOI 10.1021/ja510980d; Xie JH, 2011, CHEM REV, V111, P1713, DOI 10.1021/cr100218m; Zhu C, 2010, ADV SYNTH CATAL, V352, P1846, DOI 10.1002/adsc.201000328; Henseler A, 2011, ANGEW CHEM INT EDIT, V50, P8180, DOI 10.1002/anie.201103240; Wang DS, 2012, CHEM REV, V112, P2557, DOI 10.1021/cr200328h; Zheng C, 2012, CHEM SOC REV, V41, P2498, DOI 10.1039/c1cs15268h; Shibata Y, 2013, J ORG CHEM, V78, P3731, DOI 10.1021/jo4002195; Li GL, 2007, J AM CHEM SOC, V129, P5830, DOI 10.1021/ja070519w; Enders D, 2010, CHEM-EUR J, V16, P9763, DOI 10.1002/chem.201001623; Fleury-Bregeot N, 2010, CHEMCATCHEM, V2, P1346, DOI 10.1002/cctc.201000078; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Zhu C, 2009, ORG LETT, V11, P4180, DOI 10.1021/ol901762g; Saito K, 2013, J AM CHEM SOC, V135, P11740, DOI 10.1021/ja406004q; Lu LQ, 2013, ANGEW CHEM INT EDIT, V52, P8382, DOI 10.1002/anie.201301972; Kang Q, 2008, ORG LETT, V10, P2031, DOI 10.1021/ol800494r; Simon L, 2008, J AM CHEM SOC, V130, P8741, DOI 10.1021/ja800793t; Rueping M, 2005, ORG LETT, V7, P3781, DOI 10.1021/ol0515964; Zhu C, 2011, CHEMCATCHEM, V3, P1850, DOI 10.1002/cctc.201100241; Blaser HU, 2003, ADV SYNTH CATAL, V345, P103, DOI 10.1002/adsc.200390000; Gladiali S, 2006, CHEM SOC REV, V35, P226, DOI 10.1039/b513396c; Marcelli T, 2009, ADV SYNTH CATAL, V351, P525, DOI 10.1002/adsc.200800613; Saito K, 2014, CHEM-EUR J, V20, P7616, DOI 10.1002/chem.201402763; de Vries JG, 2011, CATAL SCI TECHNOL, V1, P727, DOI 10.1039/c1cy00050k; Ouellet SG, 2005, J AM CHEM SOC, V127, P32, DOI 10.1021/ja043834g; Storer RI, 2006, J AM CHEM SOC, V128, P84, DOI 10.1021/ja057222n; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Zhu C, 2012, TETRAHEDRON LETT, V53, P416, DOI 10.1016/j.tetlet.2011.11.061; Rueping M, 2011, CHEM SOC REV, V40, P4539, DOI 10.1039/c1cs15087a; Abe H, 2001, ORG LETT, V3, P313, DOI 10.1021/ol0002471; Sakamoto T, 2012, ORG LETT, V14, P3312, DOI 10.1021/ol3012869; Zhou JQ, 2013, TETRAHEDRON LETT, V54, P3082, DOI 10.1016/j.tetlet.2013.03.138; Rueping M, 2011, GREEN CHEM, V13, P1084, DOI 10.1039/c1gc15027h; Akiyama T, 2006, ADV SYNTH CATAL, V348, P999, DOI 10.1002/adsc.200606074; Yu J, 2011, ACCOUNTS CHEM RES, V44, P1156, DOI 10.1021/ar2000343; Saito K, 2014, ORG LETT, V16, P5312, DOI 10.1021/ol502486f; Connon SJ, 2007, ORG BIOMOL CHEM, V5, P3407, DOI 10.1039/b711499k; You SL, 2007, CHEM-ASIAN J, V2, P820, DOI 10.1002/asia.200700081; Chen QA, 2012, J AM CHEM SOC, V134, P2442, DOI 10.1021/ja211684v; Kang Q, 2007, ADV SYNTH CATAL, V349, P1657, DOI 10.1002/adsc.200700235; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Marcelli T, 2008, CHEM-EUR J, V14, P8562, DOI 10.1002/chem.200800890; Saito K, 2012, CHEM COMMUN, V48, P4573, DOI 10.1039/c2cc31486j; Chen MW, 2010, ORG LETT, V12, P5075, DOI 10.1021/ol1020256; Chikashita H., 1987, J CHEM SOC PERK T, P699; CHIKASHITA H, 1984, SYNTHESIS-STUTTGART, P308; Hoffmann S, 2005, ANGEW CHEM INT EDIT, V44, P7424, DOI 10.1002/anie.200503062; Miyazaki D, 2003, ORG LETT, V5, P3555, DOI 10.1021/ol0349920; Nugent TC, 2010, ADV SYNTH CATAL, V352, P753, DOI 10.1002/adsc.200900719; Ouellet SG, 2007, ACCOUNTS CHEM RES, V40, P1327, DOI 10.1021/ar7001864; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Rueping M, 2010, SYNLETT, P852, DOI 10.1055/s-0029-1219528; Sakamoto T., 2013, J ORG CHEM, V2, P943; Tang WJ, 2003, CHEM REV, V103, P3029, DOI 10.1021/cr020049i; Tararov VI, 2005, SYNLETT, P203, DOI 10.1055/s-2004-837225; Terada M, 2010, SYNTHESIS-STUTTGART, P1929, DOI 10.1055/s-0029-1218801; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Wakchaure VN, 2010, SYNLETT, P2708, DOI 10.1055/s-0030-1259003; Wang SG, 2013, ORG LETT, V15, P1488, DOI 10.1021/ol4002416; Wang SG, 2014, ANGEW CHEM INT EDIT, V53, P2194, DOI 10.1002/anie.201309876; Yang JW, 2004, ANGEW CHEM INT EDIT, V43, P6660, DOI 10.1002/anie.200461816; Zhu C, 2011, SYNLETT, P1251, DOI 10.1055/s-0030-1260539; Zhu C.J., UNPUB	62	10	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	FEB	2015	48	2					388	398		10.1021/ar500414x		11	Chemistry, Multidisciplinary	Chemistry	CB7KS	WOS:000349806300025		
J	Yuan, SC; Li, Z; Kang, J; Hong, YL; Kamimura, A; Otsubo, A; Miyoshi, T				Yuan, Shichen; Li, Zhen; Kang, Jia; Hong, You-lee; Kamimura, Akihiro; Otsubo, Akihiro; Miyoshi, Toshikazu			Determination of Local Packing Structure of Mesomorphic Form of Isotactic Polypropylene by Solid-State NMR	ACS MACRO LETTERS			English	Article							CHAIN-FOLDING STRUCTURE; SEMICRYSTALLINE POLYMER; EXCHANGE NMR; DYNAMICS; CRYSTALLIZATION; CRYSTALS; PHASE; ELUCIDATION; DISORDERS	Understanding the local packing structures of a disordered mesomorphic phase is a challenging issue in polymer characterization. In this work, C-13-C-13 through-space interactions, as well as a molecular dynamics analysis based on the reorientation of chemical shift anisotropy (CSA), were proposed for the evaluation of the local packing structure of the mesomorphic form of isotactic polypropylene (iPP). C-13-C-13 double quantum (DQ) buildup curves of C-13 1596 CH3 selectively labeled iPP and spin-dynamics simulations demonstrated that the local packing structures in the mesomorphic form were very similar to the packing in the beta phase. Moreover, centerband only detection of exchange (CODEX) NMR proved that the correlation time <tau(c)> of the overall stem dynamics in the mesomorphic form followed the same Arrhenius line observed for the beta phase, but it deviated from that for the a phase. Based on both structural and dynamic results, it was concluded that the local packing structure in the mesomorphic form was exceedingly dose or the same as that of the beta phase.	[Yuan, Shichen; Li, Zhen; Kang, Jia; Hong, You-lee; Miyoshi, Toshikazu] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; [Kamimura, Akihiro; Otsubo, Akihiro] SunAllomer Ltd, Kawasaki Ku, Kawasaki, Kanagawa 2100863, Japan	Miyoshi, T (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.	miyoshi@uakron.edu			National Science Foundation [DMR-1105829, 1408855]; UA	This work was financially supported by the National Science Foundation (Grant DMR-1105829 and 1408855) and startup funds from the UA. We are thankful to Dr. Yamamoto for kindly providing the atomic coordinates of the calculated mesophase of iPP.	Dorset DL, 1998, POLYMER, V39, P6331, DOI 10.1016/S0032-3861(97)10160-4; CORRADINI P, 1986, MACROMOLECULES, V19, P2699, DOI 10.1021/ma00165a006; GOMEZ MA, 1987, POLYMER, V28, P2227, DOI 10.1016/0032-3861(87)90378-8; deAzevedo ER, 1999, J AM CHEM SOC, V121, P8411, DOI 10.1021/ja992022v; Schmidt-Rohr K, 1998, SCIENCE, V280, P714, DOI 10.1126/science.280.5364.714; Hong YL, 2014, ACS MACRO LETT, V3, P556, DOI 10.1021/mz500196s; Li Z, 2013, MACROMOLECULES, V46, P6507, DOI 10.1021/ma401032z; MENCIK Z, 1972, J MACROMOL SCI PHYS, VB  6, P101, DOI 10.1080/00222347208224792; Coccorullo I, 2003, POLYMER, V44, P307, DOI 10.1016/S0032-3861(02)00762-0; Allegra G, 2005, ADV POLYM SCI, V191, P87, DOI 10.1007/12_009; Miyoshi T, 1999, MACROMOLECULES, V32, P8914, DOI 10.1021/ma991012b; Hong YL, 2013, ACS MACRO LETT, V2, P501, DOI 10.1021/mz300630j; Fortier-McGill B, 2012, MACROMOLECULES, V45, P6015, DOI 10.1021/ma300534t; Asakura T, 1996, POLYMER, V37, P1965, DOI 10.1016/0032-3861(96)87315-0; CALDAS V, 1994, POLYMER, V35, P899, DOI 10.1016/0032-3861(94)90931-8; CORRADINI P, 1989, POLYM COMMUN, V30, P281; Gailey J. A., 1964, POLYM ENG SCI, V4, P29, DOI 10.1002/pen.760040108; Miyoshi T, 2004, MACROMOLECULES, V37, P6460, DOI 10.1021/ma049487c; Miyoshi T, 2007, MACROMOLECULES, V40, P6789, DOI 10.1021/ma070518o; Miyoshi T, 2010, MACROMOLECULES, V43, P3986, DOI 10.1021/ma901927m; Natta G., 1960, NUOVO CIMENTO SUPPL, V15, P40, DOI DOI 10.1007/BF02731859; Singh M, 2011, J AM CHEM SOC, V133, P2626, DOI 10.1021/ja109104f; Spiess H.W., 1994, MULTIDIMENSIONAL SOL; Wunderlich B., 1988, ADV POLYM SCI, V87; Yamamoto T, 2014, MACROMOLECULES, V47, P3192, DOI 10.1021/ma500307h	25	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	FEB	2015	4	2					143	146		10.1021/mz5007969		4	Polymer Science	Polymer Science	CB7NM	WOS:000349814100001		
J	Suzuki, M; Yokota, K; Tsuchida, H; Yamoto, K; Nagata, M; Matsuoka, S; Takagi, K; Johmoto, K; Uekusa, H				Suzuki, Masato; Yokota, Kohei; Tsuchida, Hiroe; Yamoto, Kazuhisa; Nagata, Masayuki; Matsuoka, Shin-ichi; Takagi, Koji; Johmoto, Kohei; Uekusa, Hidehiro			Solid-State Polycondensation via Ionic-to-Covalent Bond Transformation to Control Polymer Structure: Preparation of Porphyrin-Based Ladder Polymer	ACS MACRO LETTERS			English	Article							INTERCALATION; CRYSTALS	The controlled formation and the regular arrangement of polymer chains have been performed by novel solid-state polycondensation including the ionic-to-covalent bond transformation in the ionic molecular crystals. The combination of the tetra-anion and -cation of tetraphenylporphyrin derivatives, tetrakis(benzylpyridinium carboxylate), was found to form layered crystal structures and underwent thermal solid-state polycondensation, thus, releasing the pyridine and forming the benzyl ester linkages. Powder X-ray diffraction, when compared to the monomer crystal structure data, suggested that the ladder polymer was produced with a layered structure.	[Suzuki, Masato; Yokota, Kohei; Tsuchida, Hiroe; Yamoto, Kazuhisa; Nagata, Masayuki; Matsuoka, Shin-ichi; Takagi, Koji] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Johmoto, Kohei; Uekusa, Hidehiro] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Suzuki, M (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	suzuki.masahito@nitech.ac.jp	Takagi, Koji/O-1035-2015	Takagi, Koji/0000-0002-6107-0761	JSPS KAKENHI [21550117]	This work was supported by JSPS KAKENHI Grant Number 21550117.	Dou LT, 2014, SCIENCE, V343, P272, DOI 10.1126/science.1245875; Wen LQ, 1997, J AM CHEM SOC, V119, P7726, DOI 10.1021/ja970612s; Bhola R, 2013, J AM CHEM SOC, V135, P14134, DOI 10.1021/ja404351p; Lepeltier M, 2009, J MATER CHEM, V19, P5167, DOI 10.1039/b822997j; Meng H, 2003, J AM CHEM SOC, V125, P15151, DOI 10.1021/ja037115y; KISSEL P, 2012, J NAT CHEM, V4, P287; Matsumoto A, 2001, MACROMOL RAPID COMM, V22, P1195, DOI 10.1002/1521-3927(20011001)22:15<1195::AID-MARC1195>3.0.CO;2-K; NIEDERCORN F, 1988, NEW J CHEM, V12, P897; Shimogaki T, 2011, MACROMOLECULES, V44, P3323, DOI 10.1021/ma200226a; Tezuka Y, 2013, TOPOLOGICAL POLYMER CHEMISTRY: PROGRESS OF CYCLIC POLYMERS IN SYNTHESES, PROPERTIES AND FUNCTIONS, P1, DOI 10.1142/8443	10	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	FEB	2015	4	2					247	250		10.1021/acsmacrolett_5b00013		4	Polymer Science	Polymer Science	CB7NM	WOS:000349814100021		
J	Masuda, Y; Yamamoto, T; Akutsu, H; Shiigai, M; Masumoto, T; Ishikawa, E; Matsuda, M; Matsumura, A				Masuda, Y.; Yamamoto, T.; Akutsu, H.; Shiigai, M.; Masumoto, T.; Ishikawa, E.; Matsuda, M.; Matsumura, A.			Usefulness of Subtraction of 3D T2WI-DRIVE from Contrast-Enhanced 3D T1WI: Preoperative Evaluations of the Neurovascular Anatomy of Patients with Neurovascular Compression Syndrome	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; PRIMARY TRIGEMINAL NEURALGIA; MICROVASCULAR DECOMPRESSION; HEMIFACIAL SPASM; CONSTRUCTIVE INTERFERENCE; CONSECUTIVE PATIENTS; SURGICAL FINDINGS; SEQUENCE; NERVES; SERIES	BACKGROUND AND PURPOSE: High-resolution 3D MR cisternography techniques such as 3D T2WI-driven equilibrium radiofrequency reset pulse (DRIVE) are used preoperatively to assess neurovascular anatomy in patients with neurovascular compression syndrome, but contrast between vessels and cranial nerves at the point of neurovascular contact is limited. The postprocessing technique subtraction of 3D T2WI-driven equilibrium radiofrequency reset pulse from contrast-enhanced 3D T1WI (sDRICE) provides both high spatial resolution and excellent contrast in depicting the neurovascular contact. We evaluated the usefulness of sDRICE compared with 3D T2WI-DRIVE. MATERIALS AND METHODS: Twelve patients who underwent microvascular decompression for hemifacial spasm or trigeminal neuralgia were examined preoperatively With 3D T2WI-DRIVE and sDRICE. Two neuroradiologists retrospectively analyzed and scored lesion conspicuity, defined as the ease of discrimination between offending vessels and compressed nerves or the brain stem at the neurovascular contact. They also quantitatively analyzed the contrast and contrast-to-noise ratio at the neurovascular contact. RESULTS: The lesion conspicuity scores of sDRICE images were significantly higher than those of 3D T2WI-DRIVE for all 12 patients (P = .006) and the 6 cases of hemifacial spasm (P = .023) but were not significantly higher in the 6 trigeminal neuralgia cases alone (P = .102). For all 12 patients, the contrast-to-noise ratio between the offending vessels and the brain stem and between the vessels and nerves on sDRICE images was significantly higher than that on 3D T2WI-DRIVE (P = .003 and P = .007, respectively). Among these structures, the contrast values were also significantly higher on the sDRICE than on the 3D T2WI-DRIVE (P < .001) images. CONCLUSIONS: The postprocessing technique sDRICE is useful to evaluate neurovascular anatomy and to improve contrast and the contrast-to-noise ratio in patients with neurovascular compression syndrome.	[Masuda, Y.; Yamamoto, T.; Akutsu, H.; Ishikawa, E.; Matsuda, M.; Matsumura, A.] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Shiigai, M.; Masumoto, T.] Univ Tsukuba, Fac Med, Dept Radiol, Tsukuba, Ibaraki, Japan	Akutsu, H (reprint author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	akutsuh@md.tsukuba.ac.jp					Leal PRL, 2011, NEUROSURGERY, V69, P15, DOI 10.1227/NEU.0b013e318212bafa; Samii M, 2002, NEUROSURGERY, V50, P712, DOI 10.1097/00006123-200204000-00005; Zhang H, 2013, WORLD NEUROSURG, V79, P756, DOI 10.1016/j.wneu.2012.01.040; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; Morioka T, 2009, CHILD NERV SYST, V25, P309, DOI 10.1007/s00381-008-0721-6; JANNETTA PJ, 1977, J NEUROSURG, V47, P321, DOI 10.3171/jns.1977.47.3.0321; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leal PRL, 2010, ACTA NEUROCHIR, V152, P817, DOI 10.1007/s00701-009-0588-7; Satoh T, 2007, J NEUROSURG, V106, P82, DOI 10.3171/jns.2007.106.1.82; Naraghi R, 2007, J NEUROSURG, V107, P1154, DOI 10.3171/JNS-07/12/1154; BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; Sindou M, 2007, J NEUROSURG, V107, P1144, DOI 10.3171/JNS-07/12/1144; Oishi M, 2012, J NEUROSURG, V117, P555, DOI 10.3171/2012.5.JNS112334; Benes L, 2005, NEUROSURG REV, V28, P131, DOI 10.1007/s10143-004-0372-3; Chang JW, 2000, STEREOT FUNCT NEUROS, V74, P167, DOI 10.1159/000056476; Ciftci E, 2004, EUR J RADIOL, V51, P234, DOI 10.1016/j.erjad.2004.10.019; Girard N, 1997, NEURORADIOLOGY, V39, P46; Holley P, 1996, J NEURORADIOLOGY, V23, P149; Kondo A, 2012, ACTA NEUROCHIR, V154, P773, DOI 10.1007/s00701-012-1277-5; Raslan AM, 2009, J NEUROSURG, V111, P733, DOI 10.3171/2009.3.JNS08393; Sanchez JJG, 2010, ACTA NEUROCHIR, V152, P355, DOI 10.1007/s00701-009-0569-x; Satoh T, 2009, AM J NEURORADIOL, V30, P603, DOI 10.3174/ajnr.A1409; Tarnaris A, 2007, BRIT J NEUROSURG, V21, P375, DOI 10.1080/02688690701474564; Yamakami I, 2000, NEUROL MED-CHIR, V40, P545, DOI 10.2176/nmc.40.545; Yamakami I, 2000, NEUROL MED CHIR TOKY, V40, P555; Zhou Q, 2012, MAGN RESON IMAGING, V30, P666, DOI 10.1016/j.mri.2011.12.022	27	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2015	36	2					317	322		10.3174/ajnr.A4130		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB5GR	WOS:000349656000015		
J	Futami, K; Sano, H; Kitabayashi, T; Misaki, K; Nakada, M; Uchiyama, N; Ueda, F				Futami, K.; Sano, H.; Kitabayashi, T.; Misaki, K.; Nakada, M.; Uchiyama, N.; Ueda, F.			Parent Artery Curvature Influences Inflow Zone Location of Unruptured Sidewall Internal Carotid Artery Aneurysms	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							COMPUTATIONAL FLUID-DYNAMICS; WALL SHEAR-STRESS; INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; SACCULAR ANEURYSMS; COIL EMBOLIZATION; FLOW DYNAMICS; RUPTURE RISK; BLOOD-FLOW; IN-VIVO	BACKGROUND AND PURPOSE: Future aneurysmal behaviors or treatment outcomes of cerebral aneurysms may be related to the hemodynamics around the inflow zone. Here we investigated the influence of parent artery curvature on the inflow zone location of unruptured sidewall internal carotid artery aneurysms. MATERIALS AND METHODS: In 32 aneurysms, the inflow zone location was decided by 4D flow MR imaging, and the radius of the parent artery curvature was measured in 2D on an en face image of the section plane corresponding to the aneurysm orifice. RESULTS: The inflow zone was on the distal neck in 10 (group 1, 31.3%), on the lateral side in 19 (group 2, 59.4%), and on the proximal neck in 3 (group 3, 9.4%) aneurysms. The radius in group 1 was significantly larger than that in group 2 (8.3 mm [4.5 mm] versus 4.5 mm [1.9 mm]; median [interquartile range]; P < .0001). All 7 aneurysms with a radius of >8.0 mm were in group 1. All 18 aneurysms with a radius of <6.0 mm were in group 2 or 3. In two group 3 aneurysms, the inflow zone was located in a part of the neck extending beyond the central axis of the parent artery. CONCLUSIONS: The inflow zone locations of sidewall aneurysms can be influenced by the parent artery curvature evaluated in 2D on an en face image of the section plane corresponding to the aneurysm orifice.	[Futami, K.] Mattoh Ishikawa Cent Hosp, Dept Neurosurg, Haku San, Ishikawa 9208588, Japan; [Sano, H.; Kitabayashi, T.; Misaki, K.; Nakada, M.; Uchiyama, N.] Kanazawa Univ, Sch Med, Dept Neurosurg, Kanazawa, Ishikawa 9201192, Japan; [Ueda, F.] Kanazawa Univ, Sch Med, Dept Radiol, Kanazawa, Ishikawa 9201192, Japan	Futami, K (reprint author), Mattoh Ishikawa Cent Hosp, Dept Neurosurg, 3-8 Kuramitsu, Haku San, Ishikawa 9208588, Japan.	kfutami@mattohp.com					Isoda H, 2010, NEURORADIOLOGY, V52, P913, DOI 10.1007/s00234-009-0634-4; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Liou TM, 1997, EXP FLUIDS, V23, P317, DOI 10.1007/s003480050116; Sforza DM, 2009, ANNU REV FLUID MECH, V41, P91, DOI 10.1146/annurev.fluid.40.111406.102126; Meng H, 2006, AM J NEURORADIOL, V27, P1861; Naito T, 2012, ACTA NEUROCHIR, V154, P993, DOI 10.1007/s00701-012-1305-5; STROTHER CM, 1992, AM J NEURORADIOL, V13, P1089; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Imai Y, 2008, ANN BIOMED ENG, V36, P1489, DOI 10.1007/s10439-008-9522-z; Boussel L, 2009, MAGN RESON MED, V61, P409, DOI 10.1002/mrm.21861; Meckel S, 2008, NEURORADIOLOGY, V50, P473, DOI 10.1007/s00234-008-0367-9; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; Castro MA, 2006, AM J NEURORADIOL, V27, P1703; Szikora I, 2008, NEURORADIOLOGY, V50, P411, DOI 10.1007/s00234-007-0350-x; Cebral JR, 2010, AM J NEURORADIOL, V31, P304, DOI 10.3174/ajnr.A1819; Schnell S, 2014, J MAGN RESON IMAGING, V39, P120, DOI 10.1002/jmri.24110; Byun HS, 2004, MED ENG PHYS, V26, P755, DOI 10.1016/j.medengphy.2004.06.008; Schirmer CM, 2010, NEUROSURGERY, V67, P1692, DOI 10.1227/NEU.0b013e3181f9a93b; BURLESON AC, 1995, NEUROSURGERY, V37, P774; Burleson AC, 1995, NEUROSURGERY, V37, P782; Dhar S, 2008, NEUROSURGERY, V63, P196; Futami K, 2014, AM J NEURORADIOL, V35, P1363, DOI 10.3174/ajnr.A3877; GONZALEZ CF, 1992, AM J NEURORADIOL, V13, P181; GRAVES VB, 1992, AM J NEURORADIOL, V13, P189; Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561; Hoh BL, 2001, J NEUROSURG, V95, P24, DOI 10.3171/jns.2001.95.1.0024; Liou Tong-Miin, 1999, Proceedings of the National Science Council Republic of China Part B Life Sciences, V23, P133; Lorensen W. E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI DOI 10.1145/37402.37422; Oshima M, 2001, COMPUT METHOD APPL M, V191, P661, DOI 10.1016/S0045-7825(01)00307-3; Russell JH, 2013, NEUROSURGERY, V73, P1061, DOI 10.1227/NEU.0000000000000137; Sato K, 2008, MED ENG PHYS, V30, P774, DOI 10.1016/j.medengphy.2007.09.006; Shimai Hiroyuki, 2005, Proceedings of the SPIE, V6051, DOI 10.1117/12.648945; STEIGER H J, 1988, Heart and Vessels, V4, P162, DOI 10.1007/BF02058429; STEIGER HJ, 1987, ACTA NEUROCHIR, V86, P98, DOI 10.1007/BF01402292; Tateshima S, 2003, STROKE, V34, P187, DOI 10.1161/01.STR.0000046456.26587.8B; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007	38	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2015	36	2					342	348				7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB5GR	WOS:000349656000019		
J	Tzakis, AG; Nunnelley, MJ; Tekin, A; Buccini, LD; Garcia, J; Uchida, K; Neville, HL; Nares, MA; Ruiz, P; Bodamer, O				Tzakis, A. G.; Nunnelley, M. J.; Tekin, A.; Buccini, L. D.; Garcia, J.; Uchida, K.; Neville, H. L.; Nares, M. A.; Ruiz, P.; Bodamer, O.			Liver, Pancreas and Kidney Transplantation for the Treatment of Wolcott-Rallison Syndrome	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							EIF2AK3; MUTATION	We present the case of a child who underwent a combined liver, pancreas and double kidney transplant following complications of Wolcott-Rallison syndrome (WRS) a rare genetic disorder that causes infantile insulin-dependent diabetes mellitus (IDDM) and often death in childhood from fulminant liver and concomitant kidney failure. WRS is characterized clinically through infantile IDDM, propensity for liver failure following viral infections, bone dysplasia and growth failure and developmental delay. Fewer than 60 cases with WRS are reported in the literature, mostly from consanguineous parents. Future episodes of liver failure, the main contributor to the increased mortality in WRS, may be prevented through timely liver transplantation. To the best of our knowledge, transplantation has not been utilized to manage complications of WRS prior to this report.	[Tzakis, A. G.] Cleveland Clin Florida, Transplant Ctr, Weston, FL 33331 USA; [Nunnelley, M. J.; Bodamer, O.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Tekin, A.; Garcia, J.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Miami Transplant Inst, Miami, FL 33136 USA; [Buccini, L. D.] Cleveland Clin, Transplant Ctr, Digest Dis Inst, Cleveland, OH 44106 USA; [Uchida, K.] Asahikawa Med Coll, Dept Surg, Asahikawa, Hokkaido 078, Japan; [Neville, H. L.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Nares, M. A.] Univ Miami, Miller Sch Med, Holtz Childrens Hosp, Miami, FL 33136 USA; [Ruiz, P.] Univ Miami, Dept Surg, Miami, FL USA	Tzakis, AG (reprint author), Cleveland Clin Florida, Transplant Ctr, Weston, FL 33331 USA.	TZAKISA@ccf.org					Brickwood S, 2003, J MED GENET, V40, P685, DOI 10.1136/jmg.40.9.685; Delepine M, 2000, NAT GENET, V25, P406; Durocher F, 2006, CLIN GENET, V70, P34, DOI 10.1111/j.1399-0004.2006.00632.x; Julier C, 2010, ORPHANET J RARE DIS, V4, P29; Stewart FJ, 1996, CLIN GENET, V49, P152; Tzakis TG, 2005, ANN SURG, V2424, P480	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	FEB	2015	15	2					565	567		10.1111/ajt.13005		3	Surgery; Transplantation	Surgery; Transplantation	CB9UQ	WOS:000349979100038		
J	Matsuyama, S; Orihara, Y; Kinugasa, S; Ohtani, H				Matsuyama, Shigetomo; Orihara, Yukari; Kinugasa, Shinichi; Ohtani, Hajime			Effects of Densities of Brominated Flame Retardants on the Detection Response for HPLC Analysis with a Corona-charged Aerosol Detector	ANALYTICAL SCIENCES			English	Article						Corona-charged aerosol detector; HPLC; density; concentration; response; brominated flame retardants	SUPERCRITICAL-FLUID CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; UNIVERSAL DETECTORS; LIGHT-SCATTERING; PHARMACEUTICAL ANALYSIS; SUGARS	Dependence of the response of a corona-charged aerosol detector (corona CAD) on the concentration and densities of brominated flame retardants and some related substrates was studied. The calibration curves of the substrates did not show linearity and the substrate with a lower density exhibited the stronger response. Regardless of the solvents (chloroform or toluene), and the injected volume of the substrate solution, the signal intensity of the substrate observed by a corona CAD was substantially proportional to 2/3 power law of concentration and proportional to (-2/3) power law of the density of the substrates. These results suggest that the responses should be proportional to the surface area of the particles generated through the drying process in corona CAD. Contrary to the former reports that the detector response of a corona CAD was independent of chemical species, it was proved that the response varies with the density of a substrate.	[Matsuyama, Shigetomo; Orihara, Yukari; Kinugasa, Shinichi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058565, Japan; [Matsuyama, Shigetomo; Ohtani, Hajime] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan	Matsuyama, S (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Higashi 1-1-1, Tsukuba, Ibaraki 3058565, Japan.	s.matsuyama@aist.go.jp					CHARLESWORTH JM, 1978, ANAL CHEM, V50, P1414, DOI 10.1021/ac50033a011; Gorecki T, 2006, ANAL CHEM, V78, P3186, DOI 10.1021/ac060078j; Hutchinson JP, 2012, ANAL CHIM ACTA, V750, P199, DOI 10.1016/j.aca.2012.04.002; Almeling S, 2012, J PHARMACEUT BIOMED, V69, P50, DOI 10.1016/j.jpba.2012.03.019; Brunelli C, 2007, ANAL CHEM, V79, P2472, DOI 10.1021/ac061854q; Hutchinson JP, 2011, J CHROMATOGR A, V1218, P1646, DOI 10.1016/j.chroma.2011.01.062; Megoulas NC, 2005, CRIT REV ANAL CHEM, V35, P301, DOI 10.1080/10408340500431306; ALLEN LB, 1993, ANAL CHEM, V65, P841, DOI 10.1021/ac00054a033; Moreau RA, 2006, LIPIDS, V41, P727, DOI 10.1007/s11745-006-5024-7; Asa D, 2006, AM LAB, V38, P16; Dixson R. W., 2002, ANAL CHEM, V74, P2930; Fukushima K., 2011, CHROMATOGRAPHY, V32, P161; Holtzgrabe U., 2010, J SEP SCI, V33, P2402; Hutchinson JP, 2010, J CHROMATOGR A, V1217, P7418, DOI 10.1016/j.chroma.2010.09.056; Khandagale MM, 2013, J CHROMATOGR A, V1308, P96, DOI 10.1016/j.chroma.2013.07.111; Kow D., 2009, J CHROMATOGR A, V1216, P5424; Marquez-Sillero I, 2013, MICROCHEM J, V110, P629, DOI 10.1016/j.microc.2013.07.008; Matsuyama S, 2014, BUNSEKI KAGAKU, V63, P817; Merle C, 2010, J LIQ CHROMATOGR R T, V33, P629, DOI 10.1080/10826071003608520; Poole C.F., 2003, ESSENCE CHROMATOGRAP; Psitorino M., 2008, ANAL BIOANAL CHEM, V390, P1189; Schrader D., 1999, POLYM HDB, VV, P91; Senda M., 2006, CHROMATOGRAPHY, V27, P119; Shaodong J, 2010, J PHARMACEUT BIOMED, V51, P973, DOI 10.1016/j.jpba.2009.10.019; Sun P, 2008, J CHROMATOGR A, V1177, P87, DOI 10.1016/j.chroma.2007.11.035; Takahashi K, 2008, J CHROMATOGR A, V1193, P151, DOI 10.1016/j.chroma.2008.04.012; Wunderlich W., 1999, POLYM HDB, VV, P87	27	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					61	65				5	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900001		
J	Tanaka, Y; Shimizu, Y				Tanaka, Yo; Shimizu, Yoshihiro			Integration of a Reconstituted Cell-free Protein-synthesis System on a Glass Microchip	ANALYTICAL SCIENCES			English	Article						Cell-free protein synthesis system; PURE system; continuous flow; microchip	SURFACE MODIFICATION; POLY(ETHYLENE GLYCOL); MICROFLUIDIC CHANNELS; TRANSLATION SYSTEMS; POLY(DIMETHYLSILOXANE); MICROCHANNELS	Recently, a cell-free protein synthesis system reconstituted solely from essential elements of the Escherichia coli translation system, termed protein synthesis using recombinant elements (PURE), has been widely used in synthetic biology to analyze fundamental life systems. Here, the system was integrated on a glass microchip system to construct a simple protein synthesis system. GFP template DNAs were immobilized on Sepharose microbeads by streptavidin-biotin binding. The beads were introduced into a Y-shaped microchannel in a glass microchip with a 10-mu m height dam structure, and a PURE system reaction mixture was flowed through the microchannel. The recovered solutions had a higher fluorescent intensity than that of the reaction mixture before its introduction into the microchannel, thus verifying that GFP synthesis had been achieved. The microchip with DNA immobilized microbeads is reusable. This is advantageous over a conventional in vitro protein synthesis protocol requiring the preparation and addition of template DNA or mRNA into the reaction mixtures in aspect of simpleness and rapidness.	[Tanaka, Yo] RIKEN, Quantitat Biol Ctr QBiC, Lab Integrated Biodevice, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shimizu, Yoshihiro] RIKEN, Quantitat Biol Ctr QBiC, Lab Cell Free Prot Synth, Kobe, Hyogo 6500047, Japan	Tanaka, Y (reprint author), RIKEN, Quantitat Biol Ctr QBiC, Lab Integrated Biodevice, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yo.tanaka@riken.jp; yshimizu@riken.jp			JSPS; Leading-edge Research Infrastructure Program, Japan;  [21681019];  [25709081];  [26710014];  [23651133];  [26640134]	This study was supported by the JSPS bilateral program (to Y. T.), Grants-in-Aid for Young Scientist (A) (21681019 and 25709081, to Y. T., and 26710014, to Y. S.), Challenging Exploratory Research (23651133, to Y. T. and 26640134, to Y. S.), and Leading-edge Research Infrastructure Program, Japan (to Y. T.). The authors thank Dr. H. R. Ueda of RIKEN, Japan for useful discussions.	Abate AR, 2008, LAB CHIP, V8, P516, DOI 10.1039/b800001h; Lee S, 2005, LANGMUIR, V21, P11957, DOI 10.1021/la051932p; Stogbauer T, 2012, INTEGR BIOL-UK, V4, P494, DOI 10.1039/c2ib00102k; Xiong AS, 2008, FEMS MICROBIOL REV, V32, P522, DOI 10.1111/j.1574-6976.2008.00109.x; Shimizu Y, 2006, FEBS J, V273, P4133, DOI 10.1111/j.1742-4658.2006.05431.x; Sato K, 2010, LAB CHIP, V10, P1262, DOI 10.1039/b927460j; Tanaka Y, 2011, ANAL CHEM, V83, P3352, DOI 10.1021/ac103185j; Osaki T, 2011, ANAL CHEM, V83, P3186, DOI 10.1021/ac2000048; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Hibara A, 2005, ANAL CHEM, V77, P943, DOI 10.1021/ac0490088; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Okano T, 2012, LAB CHIP, V12, P2704, DOI [10.1039/c2lc40098g, 10.1039/c21c40098g]; Rosenblum G, 2014, FEBS LETT, V588, P261, DOI 10.1016/j.febslet.2013.10.016; Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Wu TZ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4746754; Kovarik ML, 2013, ANAL CHEM, V85, P451, DOI 10.1021/ac3031543; Hu SW, 2004, ANAL CHEM, V76, P1865, DOI 10.1021/ac049937z; Kitamori T, 2004, ANAL CHEM, V76, p52A, DOI 10.1021/ac041508d; Popat KC, 2004, BIOSENS BIOELECTRON, V19, P1037, DOI 10.1016/j.bios.2003.10.007; Shimizu Y, 2014, METHODS MOL BIOL, V1118, P275, DOI 10.1007/978-1-62703-782-2_19; Shimizu Y, 2010, METHODS MOL BIOL, V607, P11, DOI 10.1007/978-1-60327-331-2_2; Tanaka Y, 2007, ANAL SCI, V23, P261, DOI 10.2116/analsci.23.261; Tanaka Y, 2013, RSC ADV, V3, P10213, DOI 10.1039/c3ra41218k; Tanaka Y, 2014, MICROMACHINES-BASEL, V5, P289, DOI 10.3390/mi5020289; Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f	27	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					67	71				5	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900002		
J	Baidurah, S; Kubo, Y; Kuno, M; Kodera, K; Ishida, Y; Yamane, T; Ohtani, H				Baidurah, Siti; Kubo, Yasuko; Kuno, Mitsuhiro; Kodera, Kazuho; Ishida, Yasuyuki; Yamane, Tsuneo; Ohtani, Hajime			Rapid and Direct Compositional Analysis of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in Whole Bacterial Cells by Thermally Assisted Hydrolysis and Methylation-Gas Chromatography	ANALYTICAL SCIENCES			English	Article						Poly(3-hydroxybutyrate-co-3-hydroxyvalerate); thermally assisted hydrolysis and methylation-GC; tetramethylammonium hydroxide; copolymer composition	BETA-HYDROXYBUTYRIC ACID; BIODEGRADABLE PLASTICS; ORGANIC ALKALI; COPOLYMER; POLYESTERS	Thermally assisted hydrolysis and methylation-gas chromatography (THM-GC) in the presence of an organic alkali was applied to the direct analysis of copolymer composition for poly(3-hydroxybutyrate-co-3-hydroxyvalerate) [P(3HB-co-3HV)] accumulated in whole bacterial cells. Cupriavidus necator was grown on a liquid medium with different molar ratios of valeric acid (V) to glucose (G) in order to control the compositions of P(3HB-co-3HV) produced in the cells. Trace amounts (0.03 mg) of dried Cupriavidus necator cells were directly subjected to THM-GC in the presence of tetramethylammonium hydroxide (TMAH) at 400 degrees C. The obtained chromatograms clearly showed nine characteristic peaks, attributed to the THM products from 3HB and 3HV units in the polymer chains, without any appreciable interference by the bacterial matrix components. Based on these peak intensities, the copolymer compositions were determined rapidly without using any cumbersome sample pretreatment. Moreover, the compositions thus obtained were in good agreement with those obtained by the conventional technique.	[Baidurah, Siti; Kubo, Yasuko; Kuno, Mitsuhiro; Kodera, Kazuho; Ishida, Yasuyuki] Chubu Univ, Dept Biol Chem, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan; [Yamane, Tsuneo] Chubu Univ, Dept Environm Biol, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan; [Ohtani, Hajime] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Ishida, Y (reprint author), Chubu Univ, Dept Biol Chem, Coll Biosci & Biotechnol, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	yishida@isc.chubu.ac.jp	Yusoff, Siti Baidurah/L-7759-2015		Japan Health Foundation, Chubu University; JSPS KAKENHI [26410164]	The authors are grateful to Dr. Yasuo Takagi (National Industrial Research Institute of Nagoya) for his helpful advice and discussion concerning culture of bacteria. This work was supported in part by Japan Health Foundation, Chubu University Grant (A), and JSPS KAKENHI Grant No. 26410164.	ABDELHAD H.M., 2009, J APPL SCI RES, V5, P343; Ishigaki T, 2004, CHEMOSPHERE, V54, P225, DOI 10.1016/S0045-6535(03)00750-1; JORGENSEN AD, 1990, ANAL CHEM, V62, P683, DOI 10.1021/ac00206a007; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Kulkarni SO, 2010, BIORESOURCE TECHNOL, V101, P9765, DOI 10.1016/j.biortech.2010.07.089; Betancourt A, 2007, J CHROMATOGR A, V1154, P473, DOI 10.1016/j.chroma.2007.04.022; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Baidurah S, 2012, INT J POLYM ANAL CH, V17, P29, DOI 10.1080/1023666X.2012.638439; Baidurah S., 2012, J ANAL APPL PYROL, V103, P73; Chanprateep S, 2008, J IND MICROBIOL BIOT, V35, P1205, DOI 10.1007/s10295-008-0427-5; Demirbas A, 2007, ENERG SOURCE PART A, V29, P419, DOI 10.1080/009083190965820; Fabra MJ, 2014, LWT-FOOD SCI TECHNOL, V59, P760, DOI 10.1016/j.lwt.2014.07.021; Hakkarainen M, 2002, ADV POLYM SCI, V157, P113; Ishida Y, 1997, J ANAL APPL PYROL, V40-1, P321, DOI 10.1016/S0165-2370(97)00005-3; Proirier Y., 1995, BIOL TECHNOLOGY, V13, P142; Sato H, 2005, J ANAL APPL PYROL, V74, P193, DOI 10.1016/j.jaap.2004.12.011; Sato H, 2003, J ANAL APPL PYROL, V68-9, P37, DOI 10.1016/S0165-2370(03)00078-0; SUZUKI T, 1986, APPL MICROBIOL BIOT, V23, P322; Wang YP, 2013, BIORESOURCE TECHNOL, V148, P61, DOI 10.1016/j.biortech.2013.08.102	20	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					79	83				5	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900004		
J	Katano, H; Okamoto, N; Takakuwa, M; Taira, S; Kambe, T; Takahashi, M				Katano, Hajime; Okamoto, Nobuhiro; Takakuwa, Masahiro; Taira, Shu; Kambe, Taiho; Takahashi, Masakazu			Simple and Rapid Separation of Soyasaponin Bb from a Soy Extract	ANALYTICAL SCIENCES			English	Article						Separation; purification; soyasaponin Bb; soy extract; organic-water mixed solvent	POLY-L-LYSINE; BORONIC ACID FLUOROPHORE; QUILLAJA SAPONIN; LIQUID-CHROMATOGRAPHY; MICELLAR PROPERTIES; PURIFICATION; PRECIPITATION; CHOLESTEROL	A simple method to separate soyasaponin Bb from a soy extract is presented. This method is based on the difference in the solubility of soyasaponin Bb and Ba and other components into 3:7 and 1:1 (v/v) acetone-water mixed solvents. The crude soyasaponin consisting of soyasaponins Aa, Ab, Ba, and Bb at the 10 wt% level and other components was examined as the soy extract. A 10 mg quantity of the crude soyasaponin was mixed with 1 mL of the 3:7 acetone-water containing 0.1 mol/L HCl, and the supernatant was removed to obtain a precipitate, which was found to contain mainly soyasaponins Bb and Ba. The precipitate was mixed with 0.4 mL of the 1:1 acetone-water containing 0.1 mol/L HCl; the supernatant was transferred, and was mixed with 0.6 mL of water to obtain a precipitate, which was found to contain mainly soyasaponin Bb. The yield was ca. 30%, which may be much higher than that by the conventional preparative chromatographic approach. The separation method is rapid and easy to carry out, and is useful for the preparation of a soyasaponin Bb sample.	[Katano, Hajime; Okamoto, Nobuhiro; Takakuwa, Masahiro; Taira, Shu; Takahashi, Masakazu] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Katano, H (reprint author), Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan.	hajime@fpu.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [26410226]	The authors are thankful to Prof. Hajime Ohigashi for fruitful discussions. This work was supported by Grant-in-Aids from Ministry of Education, Science, Sports and Culture of Japan (No. 26410226).	Guclu-Ustundag O, 2007, CRIT REV FOOD SCI, V47, P231, DOI 10.1080/10408390600698197; Kang J, 2010, J AGR FOOD CHEM, V58, P8119, DOI 10.1021/jf100901b; Hu J, 2002, J AGR FOOD CHEM, V50, P2587, DOI 10.1021/jf0114740; Mitra S, 2001, J AGR FOOD CHEM, V49, P384, DOI 10.1021/jf000568r; Katano H, 2012, ANAL SCI, V28, P1153; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Hamano Y, 2014, APPL ENVIRON MICROB, V80, P4993, DOI 10.1128/AEM.01201-14; Gurfinkel DM, 2005, INT J FOOD SCI NUTR, V56, P501, DOI 10.1080/09637480500460601; Kamo S, 2014, NUTRITION, V30, P596, DOI 10.1016/j.nut.2013.10.017; Mitra S, 2000, COLLOID SURFACE B, V17, P117, DOI 10.1016/S0927-7765(99)00088-0; Zhang W, 2009, MOLECULES, V14, P2959, DOI 10.3390/molecules14082959; Mitra S, 1997, J AGR FOOD CHEM, V45, P1587, DOI 10.1021/jf960349z; Katano H, 2014, ANAL SCI, V30, P17; Decroos K, 2007, FOOD CHEM, V101, P324, DOI 10.1016/j.foodchem.2006.01.041; Gu LW, 2002, J AGR FOOD CHEM, V50, P6951, DOI 10.1021/jf0257300; Guang CE, 2014, J AGR FOOD CHEM, V62, P8247, DOI 10.1021/jf503047a; Kano H, 2014, ANAL SCI, V30, P643; Katano H., 2014, J CHITIN CHITOSAN SC, V2, P75; Kumai M, 2012, ANAL SCI, V28, P121; Oda K, 2003, VACCINE, V21, P2145, DOI 10.1016/S0264-410X(02)00739-9; Philbrick DJ, 2003, KIDNEY INT, V63, P1230, DOI 10.1046/j.1523-1755.2003.00869.x; Stevenson KJ, 1997, LANGMUIR, V13, P6824, DOI 10.1021/la970811p	22	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					85	89				5	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900005		
J	Sakamaki, H; Uchida, T; Lim, LW; Takeuchi, T				Sakamaki, Hiroshi; Uchida, Takeharu; Lim, Lee Wah; Takeuchi, Toyohide			Evaluation of Column Carryover of Phosphorylated Peptides and Fumonisins by Duplicated Solvent Gradient Method in Liquid Chromatography/Tandem Mass Spectrometry	ANALYTICAL SCIENCES			English	Article						Carryover; column hardware; liquid chromatography/tandem mass spectrometry; metal free; duplicated solvent gradient method	AUTOSAMPLER CARRYOVER; MS/MS METHOD; HUMAN PLASMA; LC-MS/MS; METABOLITES; DRUGS; MONO	Columns made of three different materials were evaluated with regard to the carryover of phosphorylated peptides and fumonisins in liquid chromatography/tandem mass spectrometry (LC/MS/MS). In order to eliminate carryover caused by the injection operation in the autosampler, the column carryover was calculated using the duplicated solvent gradient method. A column made of a glass-lined stainless-steel tube and polyethylene frits (GL-PE column) yielded the most significant improvements in the peak shape and the carryover as compared to the other columns. The carryover of fumonisin B-1 (FB1) and HLADLSpK (T19p) in the GL-PE column could be reduced; the lower limit of quantitation of T19p, and the range of the calibration curve were also improved. Since carryover peaks with the GL-PE column were symmetrical peaks of the samples, carryover in the column did not occur. The carryover calculated by the duplicated solvent gradient method corresponded to those in the flow path from the injection port to the inlet frit of the column. The carryover value of FB1 in the column with a stainless-steel tube and stainless-steel frits (S-S column) was 1.70%, and that of the flow path was 0.23%. We found that the majority of the carryover in our system occurred in the S-S column.	[Sakamaki, Hiroshi; Uchida, Takeharu] Chem Evaluat & Res Inst, Kitakatsushika, Saitama 3450043, Japan; [Sakamaki, Hiroshi; Lim, Lee Wah; Takeuchi, Toyohide] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Sakamaki, H (reprint author), Chem Evaluat & Res Inst, 1600 Shimotakano, Kitakatsushika, Saitama 3450043, Japan.	sakamaki-hiroshi@ceri.jp					Gazzotti T, 2011, FOOD CHEM, V125, P1379, DOI 10.1016/j.foodchem.2010.10.009; Dolman S, 2013, J CHROMATOGR B, V912, P56, DOI 10.1016/j.jchromb.2012.11.016; Zeng W, 2006, RAPID COMMUN MASS SP, V20, P635, DOI 10.1002/rcm.2353; Liu S, 2005, RAPID COMMUN MASS SP, V19, P2747, DOI 10.1002/rcm.2105; Vallano PT, 2005, J PHARMACEUT BIOMED, V36, P1073, DOI 10.1016/j.jpba.2004.09.010; Tamura M, 2011, ANAL SCI, V27, P629; Vu DH, 2013, J CHROMATOGR B, V917, P1, DOI 10.1016/j.jchromb.2012.12.023; [Anonymous], SHIM TECHN REP, V17; Wakamatsu A, 2005, J SEP SCI, V28, P1823, DOI 10.1002/jssc.200400027; Asakawa Y, 2007, J PHARMACEUT BIOMED, V43, P683, DOI 10.1016/j.jpba.2006.08.007; Chassaing C, 2001, CHROMATOGRAPHIA, V53, P122; De Vijlder T, 2011, INT J MASS SPECTROM, V304, P83, DOI 10.1016/j.ijms.2010.05.022; Dolan JW, 2001, LC GC N AM, V19, P164; Dolan JW, 2001, LC GC N AM, V19, P478; Dunn-Meynell KW, 2005, RAPID COMMUN MASS SP, V19, P2905, DOI 10.1002/rcm.2147; EMA, 2011, EMACHMPEWP1922172009; Grant RP, 2002, RAPID COMMUN MASS SP, V16, P1785, DOI 10.1002/rcm.784; Hughes N. C., 2007, AAPS J, V9, P353; Sakamaki H., 2015, J CHROMATOG IN PRESS; Schellen A, 2003, J CHROMATOGR B, V788, P251, DOI 10.1016/S1570-0232(02)01013-9; SHIOI Y, 1987, ANAL BIOCHEM, V162, P493, DOI 10.1016/0003-2697(87)90425-8; Tamura M., 2014, J SEP SCI, P1; ter Heine R, 2007, RAPID COMMUN MASS SP, V21, P2505, DOI 10.1002/rcm.3119; US Food and Drug Administration, 2013, GUID IND BI IN PRESS	24	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					91	97				7	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900006		
J	Ueta, I; Mochizuki, S; Kawakubo, S; Kuwabara, T; Saito, Y				Ueta, Ikuo; Mochizuki, Suguru; Kawakubo, Susumu; Kuwabara, Tetsuo; Saito, Yoshihiro			Determination of Formaldehyde in Aqueous Samples with a Miniaturized Extraction Capillary Coupled to High-Performance Liquid Chromatography	ANALYTICAL SCIENCES			English	Article						Formaldehyde; derivatization; sample preparation; purge and trap; HPLC	VOLATILE ORGANIC-COMPOUNDS; FIBER-PACKED NEEDLE; GAS-CHROMATOGRAPHY; PREPARATION DEVICE; MASS SPECTROMETRY; AIR SAMPLES; TAP WATER; ALDEHYDES	A novel analytical method for determining formaldehyde (FA) in aqueous samples was developed with a miniaturized extraction capillary in high-performance liquid chromatography (HPLC). The extraction capillary was prepared by packing silica gel particles in a stainless steel capillary of 0.8 mm i.d. and 1.6 mm o.d. A derivatization reagent of 2,4-dinitrophenylhydrazine (DNPH) was impregnated on the silica gel particles by pumping a solution of DNPH to the capillary. Two extraction methods; dynamic extraction and purge-and-trap (PT) methods, were investigated for derivatizing and extracting FA from water samples onto the silica gel in the extraction capillary. The extraction capillary was directly connected to a six-port valve, and then desorption of the derivative from the capillary and injection to conventional HPLC system were simultaneously achieved with a flow of acetonitrile through the capillary. In the dynamic extraction, FA was determined with a simple sample preparation procedure, and the limit of detection (LOD) was 18 mu g L-1 at a sample volume of 20 mL, while several limitations were found in the method, such as bleeding of the derivatization reagent and the corresponding derivatized FA from the capillary during the sample load/extraction process. The sensitivity was significantly improved by introducing a PT technique, where the LOD was 6.9 mu g L-1 at a sample volume of 20 mL with a sampling time of approximately 20 min. With the PT method, successful recoveries of FA were confirmed for spiked tap water, river water and fruit juice samples.	[Ueta, Ikuo; Mochizuki, Suguru; Kawakubo, Susumu; Kuwabara, Tetsuo] Univ Yamanashi, Dept Appl Chem, Kofu, Yamanashi 4008511, Japan; [Saito, Yoshihiro] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Ueta, I (reprint author), Univ Yamanashi, Dept Appl Chem, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	iueta@yamanashi.ac.jp	Ueta, Ikuo/F-7879-2010; Saito, Yoshihiro/F-4112-2010		JSPS KAKENHI [4612002]	This work was supported by JSPS KAKENHI Grant No. 4612002.	Saito Y, 2007, J PHARMACEUT BIOMED, V44, P1, DOI 10.1016/j.jpba.2007.02.011; Saito Y, 2006, ANAL BIOANAL CHEM, V386, P725, DOI 10.1007/s00216-006-0509-z; COTSARIS E, 1993, ANALYST, V118, P265, DOI 10.1039/an9931800265; Saito Y, 2009, ANAL BIOANAL CHEM, V393, P861, DOI 10.1007/s00216-008-2400-6; Ogawa M, 2007, ANAL BIOANAL CHEM, V388, P619, DOI 10.1007/s00216-007-1255-6; Ueta I, 2015, ANAL BIOANAL CHEM, V407, P899, DOI 10.1007/s00216-014-8144-6; Ueta I, 2012, ANAL CHIM ACTA, V746, P77, DOI 10.1016/j.aca.2012.08.014; Liu JF, 2005, TALANTA, V65, P705, DOI 10.1016/j.talanta.2004.07.037; Ueta I, 2014, ANAL SCI, V30, P105; Ueta I, 2013, J CHROMATOGR A, V1317, P211, DOI 10.1016/j.chroma.2013.07.011; IARC, 2006, IARC MON EV CARC RIS, V88, P1; LEHOTAY J, 1994, J LIQ CHROMATOGR, V17, P579, DOI 10.1080/10826079408013161; Ueta I, 2014, ANAL SCI, V30, P979; Ueta I, 2014, CLIN CHIM ACTA, V430, P156, DOI 10.1016/j.cca.2014.01.009; Ueta I, 2014, J PHARMACEUT BIOMED, V88, P423, DOI 10.1016/j.jpba.2013.09.028; U.S. EPA, 1998, DET CARB COMP DRINK; WHO (World Health Organization), 1993, GUID DRINK WAT QUAL	17	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					99	103				5	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900007		
J	Ohata, M; Kurosawa, S; Shinoduka, I; Takaku, Y; Kishi, Y				Ohata, Masaki; Kurosawa, Satoru; Shinoduka, Ism; Takaku, Yuichi; Kishi, Yoko			Spectroscopic Characteristics of Spiral Flow ICP for Axially Viewing ICP Optical Emission Spectrometry	ANALYTICAL SCIENCES			English	Article						Spiral flow ICP; axially viewing ICPOES; low gas flow ICP	INDUCTIVELY-COUPLED PLASMA; WATER-COOLED TORCH; GAS CONSUMPTION; ARGON; TEMPERATURES; FIBER	Spectroscopic characteristics of a spiral flow inductively coupled plasma (ICP), which could be sustained stably at 9 L min(-1) of Ar plasma gas flow rate with 1.5 kW RF forward power, were studied for axially viewing ICPOES. The emission intensity profile, excitation temperature and plasma robustness were evaluated, and were similar to those of the standard ICP. The background and emission intensities of elements as well as the excitation behavior for both atom and ion lines were also examined and compared to those of the standard ICP. Since the spectroscopic characteristics of the spiral flow ICP were similar to those of the standard ICP, it could be used as a new low gas flow ICP in axially viewing ICPOES.	[Ohata, Masaki] Natl Inst Adv Ind Sci & Technol, NMIJ, Tsukuba, Ibaraki 3058563, Japan; [Kurosawa, Satoru; Shinoduka, Ism] NTT Adv Technol Corp, Atsugi, Kanagawa 2430124, Japan; [Takaku, Yuichi] Inst Environm Sci, Kamikita, Aomori 0393212, Japan; [Kishi, Yoko] IAS Inc, Kunitachi, Tokyo 1860003, Japan	Ohata, M (reprint author), Natl Inst Adv Ind Sci & Technol, NMIJ, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	m-oohata@aist.go.jp					ALLEMAND CD, 1977, APPL SPECTROSC, V31, P434, DOI 10.1366/000370277774463346; RIPSON PAM, 1984, ANAL CHEM, V56, P2329, DOI 10.1021/ac00277a015; VANDERPLAS PSC, 1985, SPECTROCHIM ACTA B, V40, P1457, DOI 10.1016/0584-8547(85)80169-5; Klostermeier A, 2005, J ANAL ATOM SPECTROM, V20, P308, DOI 10.1039/b416632a; Engelhard C, 2007, SPECTROCHIM ACTA B, V62, P1161, DOI 10.1016/j.sab.2007.07.010; Dennaud J, 2001, SPECTROCHIM ACTA B, V56, P101, DOI 10.1016/S0584-8547(00)00299-8; Ohata M, 1997, J ANAL ATOM SPECTROM, V12, P341, DOI 10.1039/a605930i; Engelhard C, 2008, SPECTROCHIM ACTA B, V63, P619, DOI 10.1016/j.sab.2008.03.015; KORNBLUM GR, 1979, ANAL CHEM, V51, P2378, DOI 10.1021/ac50050a020; Corliss H., 1962, NATL BUREAU STANDARD, V53; Engelhard C, 2008, J ANAL ATOM SPECTROM, V23, P407, DOI 10.1039/b712382e; GENNA JL, 1977, ANAL CHEM, V49, P1450, DOI 10.1021/ac50017a040; Grotrian D. W., 1928, GRAPHISCHE DARSTELLU; HORII K, 1990, T JPN SOC AERONAUT S, V32, P165; HORII K, 1990, T JPN SOC AERONAUT S, V32, P176; HORII K, 1991, T JPN SOC AERONAUT S, V33, P141; HORII K, 1990, T JPN SOC AERONAUT S, V32, P155; KAWAGUCHI H, 1983, SPECTROCHIM ACTA B, V38, P1319, DOI 10.1016/0584-8547(83)80076-7; KAWAGUCHI H, 1980, ANAL CHEM, V52, P2440, DOI 10.1021/ac50064a051; Kurosawa S., 1996, U. S. Patent, Patent No. [5818581(A), 5818581]; Kurosawa S., 1996, European Patent, Patent No. [EP 079209(A1), 079209]; Kurosawa S., 1996, European Patent, Patent No. [EP079209(B1, 079209B1]; Miyahara H, 2014, ANAL SCI, V30, P231; Montaser A., 1998, INDUCTIVELY COUPLED; Montaser A., 1992, INDUCTIVELY COUPLED; Moore C. E., 1971, 35 NSRDSNBS, VI - III; Nelms S. M., 2005, ICP MASS SPECTROMETR; Nowak S, 2014, TALANTA, V129, P575, DOI 10.1016/j.talanta.2014.06.045; Ohata M, 2013, CHEM LETT, V42, P347, DOI 10.1246/cl.121257; RIPSON PAM, 1982, SPECTROCHIM ACTA B, V37, P733, DOI 10.1016/0584-8547(82)80086-4; SAVAGE RN, 1980, ANAL CHEM, V52, P1267, DOI 10.1021/ac50058a026; SAVAGE RN, 1979, ANAL CHEM, V51, P408, DOI 10.1021/ac50039a020; SAVAGE RN, 1981, ANAL CHIM ACTA, V123, P319, DOI 10.1016/S0003-2670(01)83187-1; WEISS AD, 1981, ANAL CHIM ACTA, V124, P245, DOI 10.1016/S0003-2670(01)93571-8	34	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	FEB	2015	31	2					105	111				7	Chemistry, Analytical	Chemistry	CB9GV	WOS:000349940900008		
J	Yoshizaki, A; Sato, S				Yoshizaki, Ayumi; Sato, Shinichi			Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis	ANNALS OF DERMATOLOGY			English	Review						Autoimmunity; B lymphocyte; Bleomycin-induced systemic sclerosis model mouse; CD19; Systemic sclerosis; Tight-skin mouse	TIGHT-SKIN MOUSE; BLEOMYCIN-INDUCED SCLERODERMA; RECEPTOR SIGNAL-TRANSDUCTION; AUTOIMMUNE-DISEASE; T-CELL; CLINICAL-SIGNIFICANCE; CD22-DEFICIENT MICE; PULMONARY-FIBROSIS; FIBRILLIN-1 GENE; SERUM HYALURONAN	Systemic sclerosis (SSc) is characterized by tissue fibrosis and autoimmunity. Although the pathogenic relationship between autoimmunity and clinical manifestations of SSc remains unknown, SSc patients display abnormal immune responses including the production of disease-specific autoantibodies. Previous studies have demonstrated that B cells play a critical role in systemic autoimmunity and disease expression through various functions such as induction of the activation of other immune cells in addition to autoantibody production. CD19 is a crucial regulator of B cell activation. Recent studies demonstrated that B cells from SSc patients showed an up-regulated CD19 signaling pathway that induced SSc-specific autoantibody production in SSc mouse models. CD19 transgenic mice lost tolerance for autoantigen and generated autoantibodies spontaneously. B cells from SSc patients exhibited an overexpression of CD19 that induced SSc-specific autoantibody production in transgenic mice. Moreover, SSc patients displayed intrinsic B cell abnormalities characterized by chronic hyper-reactivity of memory B cells, which was possibly due to CD19 overexpression. Similarly, B cells from a tight-skin mouse, a genetic model of SSc, showed augmented CD19 signaling. In bleomycin-induced SSc mouse models, endogenous ligands for toll-like receptor 4 induced by bleomycin stimulated B cells to produce various fibrogenic cytokines and autoantibodies. Remarkably, the loss of CD19 resulted in the inhibition of B cell hyper-reactivity and autoantibody production, which are associated with improvements in fibrosis and a parallel decrease in fibrogenic cytokine production by B cells. Taken together, the findings suggest that altered B cell function may result in tissue fibrosis as well as autoimmunity in SSc.	[Yoshizaki, Ayumi; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Yoshizaki, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ayuyoshi@me.com					OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Yoshizaki A, 2008, J RHEUMATOL, V35, P1825; Yoshizaki A, 2009, J CLIN IMMUNOL, V29, P180, DOI 10.1007/s10875-008-9252-x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Arnett FC, 2001, ARTHRITIS RHEUM, V44, P1359, DOI 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S; Yoshizaki A, 2011, ANN RHEUM DIS, V70, P194, DOI 10.1136/ard.2009.121053; Sato S, 1996, J IMMUNOL, V157, P4371; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Sato S, 2000, J IMMUNOL, V165, P6635; Sato S, 1997, J IMMUNOL, V158, P4662; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; FLEISCHMAJER R, 1977, ARTHRITIS RHEUM, V20, P975, DOI 10.1002/art.1780200410; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Furst DE, 1997, J RHEUMATOL, V24, P53; WALLACE VA, 1994, EUR J IMMUNOL, V24, P1463, DOI 10.1002/eji.1830240634; Inghilleri S, 2006, HISTOCHEM CELL BIOL, V125, P661, DOI 10.1007/s00418-005-0116-7; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Ogawa F, 2006, RHEUMATOLOGY, V45, P815, DOI 10.1093/rheumatology/ke1012; Matsushita T, 2007, J INVEST DERMATOL, V127, P2772, DOI 10.1038/sj.jid.5700919; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Hasegawa M, 2005, J DERMATOL SCI, V39, P1, DOI 10.1016/j.jdermsci.2005.03.013; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Hasegawa M, 2006, AM J PATHOL, V169, P954, DOI 10.2353/ajpath.2006.060205; Asano N, 2004, AM J PATHOL, V165, P641, DOI 10.1016/S0002-9440(10)63328-7; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Tedder TF, 1998, SEMIN IMMUNOL, V10, P259, DOI 10.1006/smim.1998.0118; Yoshizaki A, 2011, ARTHRITIS RHEUM-US, V63, P3575, DOI 10.1002/art.30539; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Saito E, 2002, J CLIN INVEST, V109, P1453, DOI 10.1172/JCI200215078; Tedder Thomas E., 2005, V8, P55; Sato S, 2004, MOL IMMUNOL, V41, P1123, DOI 10.1016/j.molimm.2004.06.025; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Fujimoto M, 2000, IMMUNOL RES, V22, P281, DOI 10.1385/IR:22:2-3:281; Sato S, 2004, ARTHRITIS RHEUM, V50, P1918, DOI 10.1002/art.20274; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Yamamoto T, 2006, ARCH DERMATOL RES, V297, P333, DOI 10.1007/s00403-005-0635-z; FAMULARO G, 1989, J CLIN LAB IMMUNOL, V29, P59; Freitas JP, 1996, DERMATOLOGY, V192, P46; Fujimoto M, 2005, CURR OPIN RHEUMATOL, V17, P746, DOI 10.1097/01.bor.0000179945.73518.28; Hayakawa I, 2004, CLIN RHEUMATOL, V23, P345, DOI 10.1007/s10067-004-0876-9; Kodera T, 2002, P NATL ACAD SCI USA, V99, P3800, DOI 10.1073/pnas.052709999; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mendoza G, 2007, CARBOHYD RES, V342, P96, DOI 10.1016/j.carres.2006.10.027; Neudecker BA, 2004, BRIT J DERMATOL, V150, P469, DOI 10.1046/j.1365-2133.2004.05805.x; Okano Y, 1996, RHEUM DIS CLIN N AM, V22, P709, DOI 10.1016/S0889-857X(05)70297-0; PAINTER CJ, 1988, J EXP MED, V167, P1137, DOI 10.1084/jem.167.3.1137; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Saito S, 2000, MOL MED, V6, P825; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Sirrionini G, 2000, TOXICOLOGY, V155, P1; Wang J, 1999, Int Rev Immunol, V18, P367, DOI 10.3109/08830189909088489; Yamamoto T, 2004, J INVEST DERMATOL, V122, P44, DOI 10.1046/j.0022-202X.2003.22121.x; Yoshizaki A, 2011, ARTHRITIS RHEUM-US, V63, P3086, DOI 10.1002/art.30470; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884; Zhu H, 2004, AUTOIMMUNITY, V37, P51, DOI 10.1080/08916930310001633782	65	1	1	KOREAN DERMATOLOGICAL ASSOC	SEOUL	305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL, 137-858, SOUTH KOREA	1013-9087			ANN DERMATOL	Ann. Dermatol.	FEB	2015	27	1					1	9		10.5021/ad.2015.27.1.1		9	Dermatology	Dermatology	CC1CC	WOS:000350077800001		
J	Kikushima, S; Hanawa, N; Kotake, F				Kikushima, Shoichi; Hanawa, Noboru; Kotake, Fumio			Diagnostic performance of bone scintigraphy analyzed by three artificial neural network systems	ANNALS OF NUCLEAR MEDICINE			English	Article						Bone scan; Bone metastases; Artificial neural network; Receiver operating characteristic	METASTATIC PROSTATE-CANCER; SCAN INDEX; BREAST-CANCER; DISEASE; SEGMENTATION; DIFFERENCE; BIOMARKER; EXTENT	The accuracy of bone scintigraphy analyzed by computer-assisted diagnosis (CAD) software involving multiple artificial neural network (ANN) systems has not been well established. We conducted a retrospective study to examine the accuracy of bone scintigraphy analyzed by CAD software, BONENAVI(A (R)) version 2 (BN2; FUJIFILM RI Pharma Co., Ltd.), in patients with suspected bone metastases. In 399 patients, bone metastases were analyzed by means of the BN2 focused on balance of sensitivity and specificity ANN system (BN2-B), focused on specificity-ANN system (BN2-Sp), and focused on sensitivity-ANN system (BN2-Sen). The ANN presented an output between 0 and 1 for each patient. A cutoff value of 0.5 was chosen to provide BN2 with the binary classification of "bone metastasis" or "no bone metastasis". The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. A total of 18 % of male patients (36/196) and 12 % of female patients (24/203) had bone metastases. BN2-Sp and BN2-Sen were similar to BN2-B in the ability to identify patients who had bone metastases; the AUC values were 0.87 [95 % confidence interval (CI) 0.79-0.95], 0.92 (95 % CI 0.85-0.97), and 0.90 (95 % CI 0.83-0.97), respectively, in male patients. In female patients, the AUC values were 0.81 (95 % CI 0.71-0.91), 0.85 (95 % CI 0.78-0.93), and 0.81 (95 % CI 0.71-0.92), respectively. A total of 65.4 % of patients were classified as concordance of "bone metastases" (17.8 %) or "no bone metastases" (47.6 %), and 34.6 % were classified as mismatch. In the concordance group, BN2-B revealed an AUC of 0.94 (95 % CI 0.88-0.99), with a sensitivity of 94 % (95 % CI 79-98 %) and a specificity of 88 % (95 % CI 79-93 %) in 120 male patients and an AUC of 0.89 (95 % CI 0.78-1.00), with a sensitivity of 86 % (95 % CI 60-96 %) and a specificity of 85 % (95 % CI 78-90 %) in 141 female patients. Bone scintigraphy analyzed by BN2-B accurately identifies the presence of bone metastases in patients with concordance using three ANN systems, comprising 65 % of the patients we studied.	[Kikushima, Shoichi; Hanawa, Noboru; Kotake, Fumio] Tokyo Med Univ Ibaraki, Med Ctr, Dept Radiol, Inashiki, Ibaraki 3000395, Japan	Kikushima, S (reprint author), Tokyo Med Univ Ibaraki, Med Ctr, Dept Radiol, 3-20-1 Chuo Ami Machi, Inashiki, Ibaraki 3000395, Japan.	shoichi.kikushima@tokyo-med-img.co.jp					Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; Hamaoka T, 2004, J CLIN ONCOL, V22, P2942, DOI 10.1200/jco.2004.08.181; Wakabayashi H, 2013, ANN NUCL MED, V27, P802, DOI 10.1007/s12149-013-0749-x; Erdi YE, 1997, J NUCL MED, V38, P1401; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Kikuchi A, 2012, NUCL MED COMMUN, V33, P947, DOI 10.1097/MNM.0b013e3283567407; Takahashi Y, 2012, ANN NUCL MED, V26, P586, DOI 10.1007/s12149-012-0617-0; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; Sabbatini P, 1999, J CLIN ONCOL, V17, P948; Horikoshi H, 2012, ANN NUCL MED, V26, P622, DOI 10.1007/s12149-012-0620-5; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; Mitsui Y, 2012, BJU INT, V110, pE628, DOI 10.1111/j.1464-410X.2012.11355.x; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Dahnert W, 2011, RADIOLOGY REV MANUAL; Koizumi M, 2003, ANN ONCOL, V14, P1234, DOI 10.1093/annonc/mdg348; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83; VALENSTEIN PN, 1990, AM J CLIN PATHOL, V93, P252; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yang L, 2010, ANN ONCOL, V21, P389, DOI 10.1093/annonc/mdp303	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	FEB	2015	29	2					125	131		10.1007/s12149-014-0919-5		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB8UO	WOS:000349907000003		
J	Koizumi, M; Wagatsuma, K; Miyaji, N; Murata, T; Miwa, K; Takiguchi, T; Makino, T; Koyama, M				Koizumi, Mitsuru; Wagatsuma, Kei; Miyaji, Noriaki; Murata, Taisuke; Miwa, Kenta; Takiguchi, Tomohiro; Makino, Tomoko; Koyama, Masamichi			Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting	ANNALS OF NUCLEAR MEDICINE			English	Article						Bone scan; Skeletal metastasis; Computer-aided diagnosis; BONENAVI version 2	METASTATIC PROSTATE-CANCER; SCAN FLARE PHENOMENON; INDEX	To evaluate a computer-assisted diagnosis system, BONEVAVI version 2 for bone scintigraphy, this study examined the performance of the software in patients with and without skeletal metastasis. Bone scans of various patients were analyzed by BONENAVI version 2. Patients with skeletal metastasis from prostate cancer, lung cancer, breast cancer, and other cancers were included in the study as true positive cases. Patients with normal bone scans, consecutive patients with several days of no skeletal metastasis (regardless of hot spots), and patients with abnormal bone scans but no skeletal metastasis were included as negative cases. Patient artificial neural network (ANN) values equal to or above 0.5 were regarded as positive, and those below 0.5 as negative. This study also analyzed cases according to primary cancer factors, osseous metastasis type, and bone tumor burden. The sensitivity of patient ANN values was 121/142 (85 %) for all cancers, 25/29 (86 %) for prostate cancer, 35/40 (88 %) for lung cancer, 37/45 (82 %) for breast cancer, and 24/28 (86 %) for other cancers. The specificity of ANN values was 40/49 (82 %) for normal bone scans, 99/122 (81 %) for consecutive patients with several days of no skeletal metastasis, and 44/81 (54 %) for patients with abnormal bone scans but no skeletal metastasis. Patients showing false negatives included: 10 patients with small lesions (6 of whom showed positive lesion ANN values), 4 patients with osteolytic lesions, 5 patients with intertrabecular osseous metastasis, and 1 patient with a metastatic lesion adjacent to the urinary bladder. The correlation between manually counted lesion numbers and Bone Scan Index was excellent for prostate cancer, and was good for lung cancer, breast cancer, and other cancers. BONENAVI version 2 is an effective computer-assisted diagnosis system for bone scanning, but the drawbacks of bone scanning remain unresolved.	[Koizumi, Mitsuru; Wagatsuma, Kei; Miyaji, Noriaki; Murata, Taisuke; Miwa, Kenta; Takiguchi, Tomohiro; Makino, Tomoko; Koyama, Masamichi] Canc Inst Hosp, Dept Nucl Med, Koto Ku, Tokyo 1358550, Japan	Koizumi, M (reprint author), Canc Inst Hosp, Dept Nucl Med, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	mitsuru@jfcr.or.jp					Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; POLLEN JJ, 1984, AM J ROENTGENOL, V142, P773; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; Horikoshi H, 2012, ANN NUCL MED, V26, P622, DOI 10.1007/s12149-012-0620-5; Tokuda O, 2014, ANN NUCL MED, V28, P329, DOI 10.1007/s12149-014-0819-8; Evangelista L, 2012, BIOMED PHARMACOTHER, V66, P448, DOI 10.1016/j.biopha.2012.06.004; Sadik M, 2006, NUCL MED COMMUN, V27, P417, DOI 10.1097/00006231-200605000-00002; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; Meirelles GSP, 2010, CLIN CANCER RES, V16, P6093, DOI 10.1158/1078-0432.CCR-10-1357; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Koizumi M, 1999, CLIN NUCL MED, V24, P15, DOI 10.1097/00003072-199901000-00004; Lemieux J, 2002, CLIN NUCL MED, V27, P486, DOI 10.1097/01.RLU.0000016387.49863.1D; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83; Yamaguchi T, 1996, CANCER, V78, P1384	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	FEB	2015	29	2					138	148		10.1007/s12149-014-0921-y		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB8UO	WOS:000349907000005		
J	Shiiba, T; Nishii, R; Sasaki, M; Kihara, Y; Tsuruta, K; Maeda, M; Morishita, J				Shiiba, Takuro; Nishii, Ryuichi; Sasaki, Masayuki; Kihara, Yasushi; Tsuruta, Kazuhito; Maeda, Masaji; Morishita, Junji			Assessment of the efficacy of early phase parameters by I-123-MIBG dynamic imaging for distinguishing Lewy body-related diseases from Parkinson's syndrome	ANNALS OF NUCLEAR MEDICINE			English	Article						Lewy body-related disease; Dynamic imaging; I-123-MIBG myocardial scintigraphy; Washout rate; Time-activity curve	CHRONIC HEART-FAILURE; MYOCARDIAL SCINTIGRAPHY; CARDIAC SCINTIGRAPHY; DIAGNOSIS; METAANALYSIS; DEMENTIA; BODIES; DISORDERS; MARKER; SPECT	The aim of this study was to assess the efficacy of early phase washout rate (early WR) and area under the time-activity curve (AUTAC) by I-123-metaiodobenzylguanidine (MIBG) dynamic chest imaging for distinguishing Lewy body-related diseases (LBRD) from Parkinson's syndrome (PS) and reducing examination time. Sixty-two patients with suspected LBRD who underwent I-123-MIBG dynamic imaging in early phase were retrospectively selected. The early WR and AUTAC were calculated from I-123-MIBG dynamic data of the heart. We evaluated the relationships between proposed and conventional parameters by using Spearman's rank correlation coefficient. Differences in parameters between LBRD and PS groups were tested for statistical significance using the Mann-Whitney U test. The diagnostic performance of all parameters for distinguishing LBRD from PS was assessed in terms of receiver operating characteristic (ROC) analysis. Additionally, combination diagnostic performance and concordance rate between early phase parameters and late H/M ratio by kappa statistics were also assessed. The early WR and AUTAC showed a positive and negative correlation with conventional parameters. Both the early WR and AUTAC of LBRD group were significantly distinguishable from those of the PS group (p < 0.001). Area under the ROC curve of the early WR (0.98) was greater than that of AUTAC (0.91). The diagnostic performance of combination of the early phase parameters was 93 % sensitivity and 100 % specificity. Moreover, the early phase parameters showed excellent agreement with late H/M ratio (k = 0.93). The early WR and AUTAC showed high performance for distinguishing LBRD from PS, and the combination diagnosis with early H/M ratio and early WR contribute to improve the diagnostic performance. Thus, these parameters would be useful for reducing the examination time of myocardial I-123-MIBG scintigraphy to diagnose LBRD.	[Shiiba, Takuro; Maeda, Masaji] Koga Gen Hosp, Dept Radiol Technol, Ikeuchi, Miyazaki 8800041, Japan; [Shiiba, Takuro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Nishii, Ryuichi] Miyazaki Univ, Dept Radiol, Kiyotake, Miyazaki 8891692, Japan; [Sasaki, Masayuki; Morishita, Junji] Kyushu Univ, Dept Hlth Sci, Fac Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kihara, Yasushi] Koga Gen Hosp, Dept Radiol, Ikeuchi, Miyazaki 8800041, Japan; [Tsuruta, Kazuhito] Junwakai Mem Hosp, Dept Neurol, Miyazaki 8802112, Japan	Shiiba, T (reprint author), Koga Gen Hosp, Dept Radiol Technol, 1749-1 Sudaki, Ikeuchi, Miyazaki 8800041, Japan.	tshiiba@kgh.or.jp					American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; McKeith IG, 1996, NEUROLOGY, V47, P1113; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HOEHN MM, 1967, NEUROLOGY, V17, P427; Agostini D, 2009, EUR J NUCL MED MOL I, V36, P555, DOI 10.1007/s00259-008-0976-x; Suzuki M, 2006, J NEUROL SCI, V240, P15, DOI 10.1016/j.jns.2005.08.011; Veltman CE, 2012, EUR J NUCL MED MOL I, V39, P1599, DOI 10.1007/s00259-012-2180-2; Treglia G, 2012, CLIN AUTON RES, V22, P43, DOI 10.1007/s10286-011-0135-5; Kashihara K, 2010, PARKINSONISM RELAT D, V16, P252, DOI 10.1016/j.parkreldis.2009.12.010; King AE, 2011, MOVEMENT DISORD, V26, P1218, DOI 10.1002/mds.23659; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Orimo S, 2012, PARKINSONISM RELAT D, V18, P494, DOI 10.1016/j.parkreldis.2012.01.009; Flotats A, 2010, EUR J NUCL MED MOL I, V37, P1802, DOI 10.1007/s00259-010-1491-4; Taki J, 2004, ANN NUCL MED, V18, P453, DOI 10.1007/BF02984560; ARBAB AS, 1995, J NUCL MED, V36, P962; Arimoto T, 2004, ANN NUCL MED, V18, P145, DOI 10.1007/BF02985105; Calne DB, 1992, ANN NEUROL S, V32, P125, DOI 10.1002/ana.410320721; Fujishiro H, 2012, J NEUROL SCI, V315, P115, DOI 10.1016/j.jns.2011.11.012; Miyamoto T, 2009, SLEEP MED, V10, P577, DOI 10.1016/j.sleep.2008.04.013; Muxi A, 2011, EUR J NUCL MED MOL I, V38, P1139, DOI 10.1007/s00259-011-1754-8; Okuda K, 2011, J NUCL CARDIOL, V18, P82, DOI 10.1007/s12350-010-9313-4; Orimo Satoshi, 2008, Rinsho Shinkeigaku, V48, P11; Uchiyama Y, 2011, ANN NUCL MED, V25, P478, DOI 10.1007/s12149-011-0490-2; Yamashina S, 2007, EUR J NUCL MED MOL I, V34, P939, DOI 10.1007/s00259-006-0359-0	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	FEB	2015	29	2					149	156		10.1007/s12149-014-0923-9		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB8UO	WOS:000349907000006		
J	Hosokawa, C; Ishii, K; Hyodo, T; Sakaguchi, K; Usami, K; Shimamoto, K; Yamazoe, Y; Hosono, M; Hanada, K; Ueda, M; Saigo, K; Murakami, T				Hosokawa, Chisa; Ishii, Kazunari; Hyodo, Tomoko; Sakaguchi, Kenta; Usami, Kimio; Shimamoto, Kenji; Yamazoe, Yuzuru; Hosono, Makoto; Hanada, Kazushi; Ueda, Masami; Saigo, Kazuma; Murakami, Takamichi			Investigation of C-11-PiB equivocal PET findings	ANNALS OF NUCLEAR MEDICINE			English	Article						PiB; PET; Equivocal; Dementia	PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; LEWY BODIES; DEMENTIA; DIAGNOSIS	We have encountered occasional equivocal findings when assessing cerebral cortical amyloid retention with C-11-Pittsburgh compound B (PiB) PET. We investigated the diagnostic significance of equivocal PiB PET findings. This retrospective study included 101 consecutive patients complaining of cognitive disorders (30 Alzheimer's disease, 25 mild cognitive impairment, 8 Lewy body disease, 7 frontotemporal lobar degeneration, 31 others) who underwent both C-11-PiB PET and F-18-fluorodeoxy-d-glucose (FDG) PET. We visually classified PiB-positive, PiB-equivocal or PiB-negative ratings according to cortical uptake. For quantitative assessments of PiB PET, standard uptake values referred to cerebellar cortex (SUVR) were calculated in regional template volume of interests (frontal, temporoparietal, precuneus/posterior cingulate cortex, cerebral white matter and cerebellar cortex). The results of visual assessment were compared with the regional and mean cortical SUVRs and cortical-to-white matter ratio of PiB uptake, as well as clinical and FDG PET findings. Among the 101 scans, 41 were PiB negative, 11 were PiB equivocal, and 49 were rated PiB positive in the visual assessments. The mean cortical SUVR and cortical-to-white matter ratio were 0.97 +/- A 0.07 and 0.57 +/- A 0.21 in PiB-negative, 1.51 +/- A 0.17 and 0.75 +/- A 0.06 in PiB equivocal and 2.10 +/- A 0.33 and 0.97 +/- A 0.11 in PiB-positive group, respectively. Nine of 11 subjects with PiB-equivocal findings had cognitive impairments and FDG distribution compatible with Alzheimer's disease or dementia with Lewy bodies. We considered equivocal visual findings on PiB PET equivalent to PiB-positive with slight cortical uptake. In addition, slight cortical amyloid deposits were considered to cause cerebral metabolic abnormality and cognitive impairment. Although mean cortical SUVR was more sensitive than visual assessment because of low cortical-to-white matter contrast due to non-specific accumulation in white matter, it is important not to overlook small amounts of cortical uptake of PiB in visual inspection for exact diagnosis.	[Hosokawa, Chisa; Ishii, Kazunari; Hyodo, Tomoko; Hosono, Makoto; Murakami, Takamichi] Kinki Univ, Fac Med, Dept Radiol, Osakasayama, Japan; [Hosokawa, Chisa; Sakaguchi, Kenta; Usami, Kimio; Shimamoto, Kenji; Yamazoe, Yuzuru; Hosono, Makoto; Murakami, Takamichi] Kinki Univ, Fac Med, Inst Adv Clin Med, Osakasayama, Japan; [Ishii, Kazunari; Hanada, Kazushi; Ueda, Masami; Saigo, Kazuma] Kinki Univ Hosp, Neurocognit Disorders Ctr, Osaka 5898511, Japan	Hosokawa, C (reprint author), Kinki Univ, Fac Med, Dept Radiol, Osakasayama, Japan.	ch4111@gmail.com			JSPS KAKENHI [50534103]; 21st Century Research and Development Incentive Wages at Kinki University	We thank Mr. Yoshiyuki Nakayama for his support for brain FDG PET and PIB-PET at Kinki University Hospital. This study was supported in part by JSPS KAKENHI Grant Number 50534103 and the 21st Century Research and Development Incentive Wages at Kinki University.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Neary D, 1998, NEUROLOGY, V51, P1546; Yaqub M, 2008, NEUROIMAGE, V42, P76, DOI 10.1016/j.neuroimage.2008.04.251; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; van Berckel BNM, 2013, J NUCL MED, V54, P1570, DOI 10.2967/jnumed.112.113654; Minoshima S, 2002, J GERIATR PSYCH NEUR, V15, P200; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mormino EC, 2012, NEUROIMAGE, V59, P1152, DOI 10.1016/j.neuroimage.2011.07.098; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Cohen AD, 2013, NEUROIMAGE, V71, P207, DOI 10.1016/j.neuroimage.2013.01.015; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Federo-Tavoletti MT, 2009, J NUCL MED, V50, P198; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; MCKHANN G, 1984, NEUROLOGY, V34, P939; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Suotunen T, 2010, EUR J NUCL MED MOL I, V37, P1141, DOI 10.1007/s00259-010-1382-8; Villemagne VL, 2012, EUR J NUCL MED MOL I, V39, P209, DOI 10.1007/s00259-011-2045-0	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	FEB	2015	29	2					164	169		10.1007/s12149-014-0924-8		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB8UO	WOS:000349907000008		
J	Sakurai, K; Imabayashi, E; Ito, K; Tokumaru, AM; Ozawa, Y; Muto, M; Nakagawa, M; Okita, K; Matsukawa, N; Shibamoto, Y				Sakurai, Keita; Imabayashi, Etsuko; Ito, Kimiteru; Tokumaru, Aya M.; Ozawa, Yoshiyuki; Muto, Masahiro; Nakagawa, Motoo; Okita, Kenji; Matsukawa, Noriyuki; Shibamoto, Yuta			The utility of cerebral perfusion SPECT analysis using SPM8, eZIS and vbSEE for the diagnosis of multiple system atrophy-parkinsonism	ANNALS OF NUCLEAR MEDICINE			English	Article						Multiple system atrophy (MSA); Single photon emission computed tomography (SPECT); Statistical parametric mapping (SPM); Easy Z-score imaging system (eZIS); Voxel-based stereotactic extraction estimation (vbSEE)	ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; CONSENSUS STATEMENT; CLINICAL-DIAGNOSIS; ACCURACY; DEMENTIA; FEATURES; CORTEX; IMAGE; PET	Although a correct diagnosis is important for appropriate management, accurately differentiating between multiple system atrophy with predominant parkinsonism (MSA-P) and Parkinson's disease (PD) is often difficult because of similarities in the early-stage symptoms. The aim of this study was to evaluate the diagnostic value of cerebral perfusion single photon emission computed tomography (SPECT) and voxel-based analysis for diagnosing MSA-P patients. Thirty-eight subjects (9 with early-stage MSA-P, 11 with PD, and 18 controls) were included in this study. Z-scores suggestive of hypoperfusion were calculated between patients and controls using statistical parametric mapping (SPM) 8 and easy Z-score imaging system (eZIS) programs. A voxel-based stereotactic extraction estimation (vbSEE) program was performed to determine the target volumes of interest (VOIs) in the putamen, pons, and cerebellum, and quantify Z-scores as "extent" (the rate of voxels with a Z-score > 2.0 in these VOIs) and "severity" (average Z-scores in these VOIs). These parameters were used as the determinant in receiver operating characteristic (ROC) analyses. The extent and severity of the cerebellar VOIs were higher in MSA-P patients than in PD patients. In ROC analyses, the extent and severity of the cerebellar VOI exhibited the highest areas under the curves of 0.86 and 0.84, and accuracies of 90 and 90 %, respectively. The diagnostic value of significant cerebellar hypoperfusion was the highest for differentiating MSA-P from PD. This voxel-based analysis of cerebral perfusion SPECT using the SPM8, eZIS, and vbSEE programs is useful for clinically diagnosing MSA-P.	[Sakurai, Keita; Ozawa, Yoshiyuki; Muto, Masahiro; Nakagawa, Motoo; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Imabayashi, Etsuko] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Ito, Kimiteru; Tokumaru, Aya M.] Tokyo Metropolitan Med Ctr Gerontol, Dept Diagnost Radiol, Tokyo, Japan; [Okita, Kenji; Matsukawa, Noriyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi, Japan	Sakurai, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ksak666@yahoo.co.jp		Sakurai, Keita/0000-0002-8849-7335	 [24591785]	This study was supported in part by a Grant-in-Aid for Scientific Research (Kakenhi C) (24591785; KS).	HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Kawai Y, 2008, NEUROLOGY, V70, P1390, DOI 10.1212/01.wnl.0000310413.04462.6a; Imabayashi E, 2004, J NUCL MED, V45, P1450; Waragai M, 2007, J NEUROL SCI, V260, P57, DOI 10.1016/j.jns.2007.03.027; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Bosman T, 2003, EUR J NUCL MED MOL I, V30, P16, DOI 10.1007/s00259-002-1009-9; Cilia R, 2005, J NEURAL TRANSM, V112, P1635, DOI 10.1007/s00702-005-0382-5; Dubey R, 2014, NEUROIMAGE, V87, P220, DOI 10.1016/j.neuroimage.2013.10.005; Fahn S., 1987, RECENT DEV PARKINSON, P153; Feigin A, 2002, MOVEMENT DISORD, V17, P1265, DOI 10.1002/mds.10270; Imabayashi E, 2014, NEUROSCI BULL, V30, P755, DOI 10.1007/s12264-014-1464-x; Imon Y, 1999, J NUCL MED, V40, P1583; Inui Y, 2014, ANN NUCL MED, V28, P796, DOI 10.1007/s12149-014-0873-2; Juh R, 2004, EUR J RADIOL, V51, P223, DOI 10.1016/S0720-048X(03)00214-6; Kamei Hiroshi, 2002, No To Shinkei, V54, P667; Kikuchi A, 2001, J NEUROL SCI, V193, P29, DOI 10.1016/S0022-510X(01)00641-4; Kimura N, 2010, MOVEMENT DISORD, V26, P2530; Litvan I, 1997, ARCH NEUROL-CHICAGO, V54, P937; Matsui H, 2005, PARKINSONISM RELAT D, V11, P227, DOI 10.1016/j.parkreldis.2005.01.001; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Munoz E, 2011, J NEUROL, V258, P2248, DOI 10.1007/s00415-011-6108-8; Sakurai K, 2010, NEURORADIOLOGY, V52, P809, DOI 10.1007/s00234-009-0621-9; Sakurai K, 2011, EUR NEUROL, V66, P42, DOI 10.1159/000328674; Taniwaki T, 2002, J NEUROL SCI, V200, P79, DOI 10.1016/S0022-510X(02)00151-X; Van Laere K, 2006, J NUCL MED, V47, P384; Van Laere K, 2004, J NUCL MED, V45, P933; Yamamoto Y, 2014, ANN NUCL MED, V28, P263, DOI 10.1007/s12149-014-0807-z	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	FEB	2015	29	2					206	213		10.1007/s12149-014-0928-4		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB8UO	WOS:000349907000014		
J	Carney, N				Carney, Nathaniel			SOCIOCULTURAL THEORY AND THE PEDAGOGICAL IMPERATIVE IN L2 EDUCATION: VYGOTSKIAN PRAXIS AND THE RESEARCH/PRACTICE DIVIDE	APPLIED LINGUISTICS			English	Book Review									[Carney, Nathaniel] Kobe Coll, Kobe, Hyogo, Japan	Carney, N (reprint author), Kobe Coll, Kobe, Hyogo, Japan.	nathaniel@mail.kobe-c.ac.jp					Han ZH, 2007, TESOL QUART, V41, P387; Ellis R, 2010, LANG TEACHING, V43, P182, DOI 10.1017/S0261444809990139; Ellis R., 2012, STUDY 2 LANGUAGE ACQ; Fulcher G., 2010, PRACTICAL LANGUAGE T; Hatch E., 1979, STUDIES 2 LANGUAGE A, V2, P123; Lantolf JP, 2014, ESL APPL LINGUIST, P1	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6001	1477-450X		APPL LINGUIST	Appl. Lingusit	FEB	2015	36	1					143	146		10.1093/applin/amu073		5	Linguistics	Linguistics	CC0VR	WOS:000350056600012		
J	Singh, RP; Kumari, P; Reddy, CRK				Singh, Ravindra Pal; Kumari, Puja; Reddy, C. R. K.			Antimicrobial compounds from seaweeds-associated bacteria and fungi	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Biotechnological application; Seaweed; Antibacterial; Antifungal; Antifouling; Bioactive compounds; Metagenomics	NA+-TRANSLOCATING NADH; PENICILLIUM-CHRYSOGENUM QEN-24S; RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-PRODUCING BACTERIUM; MARINE VIBRIO-ALGINOLYTICUS; ASPERGILLUS-NIGER EN-13; PSEUDOALTEROMONAS-TUNICATA; QUINONE REDUCTASE; SECONDARY METABOLITES; NATURAL-PRODUCTS	In recent decade, seaweeds-associatedmicrobial communities have been significantly evaluated for functional and chemical analyses. Such analyses let to conclude that seaweeds-associated microbial communities are highly diverse and rich sources of bioactive compounds of exceptional molecular structure. Extracting bioactive compounds from seaweed-associated microbial communities have been recently increased due to their broad-spectrum antimicrobial activities including antibacterial, antifungal, antiviral, anti-settlement, antiprotozoan, antiparasitic, and antitumor. These allelochemicals not only provide protection to host from other surrounding pelagic microorganisms, but also ensure their association with the host. Antimicrobial compounds from marine sources are promising and priority targets of biotechnological and pharmaceutical applications. This review describes the bioactive metabolites reported from seaweed-associated bacterial and fungal communities and illustrates their bioactivities. Biotechnological application of metagenomic approach for identifying novel bioactive metabolites is also dealt, in view of their future development as a strong tool to discover novel drug targets from seaweed-associated microbial communities.	[Singh, Ravindra Pal; Kumari, Puja; Reddy, C. R. K.] Cent Salt & Marine Chem Res Inst, Discipline Marine Biotechnol & Ecol, CSIR, Bhavnagar 364002, Gujarat, India; [Singh, Ravindra Pal] Kyushu Univ, Dept Biosci & Biotechnol, Lab Microbial Technol, Fac Agr, Fukuoka 8128581, Japan; [Kumari, Puja] Agr Res Org, Inst Plant Sci, Volcani Ctr, IL-50250 Bet Dagan, Israel; [Reddy, C. R. K.] Acad Sci & Innovat Res AcSIR, New Delhi, India	Singh, RP (reprint author), Cent Salt & Marine Chem Res Inst, Discipline Marine Biotechnol & Ecol, CSIR, Bhavnagar 364002, Gujarat, India.	ravindrapal.1441@gmail.com; crk@csmcri.org	Chennur, Radhakrishna/G-2014-2012	Chennur, Radhakrishna/0000-0002-9869-5597	CSIR	CSIR is gratefully acknowledged for awarding the Senior Research Fellowship (SRF) to R.P. Singh and P. Kumari. CSIR-CSMCRI also thanked for facilities and encouragement provided while preparing this manuscript.	Zuccaro A, 2008, APPL ENVIRON MICROB, V74, P931, DOI 10.1128/AEM.01158-07; Suryanarayanan TS, 2012, FUNGAL DIVERS, V54, P19, DOI 10.1007/s13225-012-0168-7; GOTO T, 1965, TETRAHEDRON, V21, P2059, DOI 10.1016/S0040-4020(01)98344-9; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Gerard J, 1997, J NAT PROD, V60, P223, DOI 10.1021/np9606456; Osterhage C, 2002, J NAT PROD, V65, P306, DOI 10.1021/np010092l; Burgess JG, 2003, BIOFOULING, V19, P197, DOI 10.1080/0892701031000061778; Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4; Osterhage C, 2000, J ORG CHEM, V65, P6412, DOI 10.1021/jo000307g; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Burgess JG, 1999, J BIOTECHNOL, V70, P27, DOI 10.1016/S0168-1656(99)00054-1; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Reverchon S, 2002, J BACTERIOL, V184, P654; Lee CH, 2008, CHANNELS, V2, P407; Myobatake Y, 2012, J NAT PROD, V75, P135, DOI 10.1021/np200523b; FENICAL W, 1993, CHEM REV, V93, P1673, DOI 10.1021/cr00021a001; Tran H, 2007, NEW PHYTOL, V175, P731, DOI 10.1111/j.1469-8137.2007.02138.x; Lee YM, 2013, MAR BIOTECHNOL, V15, P499, DOI 10.1007/s10126-013-9506-3; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Loque CP, 2010, POLAR BIOL, V33, P641, DOI 10.1007/s00300-009-0740-0; Lu XL, 2008, NAT PROD RES, V22, P342, DOI 10.1080/14786410701768162; Penesyan A, 2010, MAR DRUGS, V8, P438, DOI 10.3390/md8030438; Ekkers DM, 2012, APPL MICROBIOL BIOT, V93, P1005, DOI 10.1007/s00253-011-3804-3; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Egan S, 2008, CURR OPIN MICROBIOL, V11, P219, DOI 10.1016/j.mib.2008.04.001; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Schulz B, 2008, BOT MAR, V51, P219, DOI 10.1515/BOT.2008.029; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Abdel-Lateff A, 2003, PLANTA MED, V69, P831, DOI 10.1055/s-2003-43209; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Krohn-Molt I, 2013, APPL ENVIRON MICROB, V79, P6196, DOI 10.1128/AEM.01641-13; Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002; Wang S, 2006, J NAT PROD, V69, P1622, DOI 10.1021/np060248n; Wang GYS, 2000, ORG LETT, V2, P2401, DOI 10.1021/ol005860z; Miao FP, 2012, MAR DRUGS, V10, P131, DOI 10.3390/md10010131; Franks A, 2005, MOLECULES, V10, P1286, DOI 10.3390/10101286; Goecke F, 2013, PHYCOLOGIA, V52, P14, DOI 10.2216/12-24.1; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Godinho VM, 2013, ISME J, V7, P1434, DOI 10.1038/ismej.2013.77; Nagao T, 2001, J ANTIBIOT, V54, P333; Prieto ML, 2012, MAR DRUGS, V10, P2280, DOI 10.3390/md10102280; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Brady SF, 2000, J AM CHEM SOC, V122, P12903, DOI 10.1021/ja002990u; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Gao SS, 2011, MAR DRUGS, V9, P59, DOI 10.3390/md9010059; Mondol MAM, 2011, BIOORG MED CHEM LETT, V21, P3832, DOI 10.1016/j.bmcl.2010.12.050; Holmstrom C, 2002, FEMS MICROBIOL ECOL, V41, P47, DOI 10.1111/j.1574-6941.2002.tb00965.x; Waters AL, 2010, CURR OPIN BIOTECH, V21, P780, DOI 10.1016/j.copbio.2010.09.013; Pontius A, 2008, J NAT PROD, V71, P272, DOI 10.1021/np0704710; Kanoh K, 1997, BIOORG MED CHEM LETT, V7, P2847, DOI 10.1016/S0960-894X(97)10104-4; TSUDA K, 1964, CHEM PHARM BULL, V12, P1357; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Singh RP, 2011, FEMS MICROBIOL ECOL, V76, P381, DOI 10.1111/j.1574-6941.2011.01057.x; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Qiao MF, 2010, BIOORG MED CHEM LETT, V20, P5677, DOI 10.1016/j.bmcl.2010.08.024; Tait K, 2009, ENVIRON MICROBIOL, V11, P1792, DOI 10.1111/j.1462-2920.2009.01904.x; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Rastogi G, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P29, DOI 10.1007/978-1-4419-7931-5_2; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; Yung PY, 2011, APPL ENVIRON MICROB, V77, P1512, DOI 10.1128/AEM.02038-10; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; YASUMOTO T, 1986, AGR BIOL CHEM TOKYO, V50, P793; Kanoh K, 1999, BIOSCI BIOTECH BIOCH, V63, P1130, DOI 10.1271/bbb.63.1130; Pontius A, 2008, CHEM-EUR J, V14, P9860, DOI 10.1002/chem.200801574; Burke C, 2007, ENVIRON MICROBIOL, V9, P814, DOI 10.1111/j.1462-2920.2006.01177.x; Zhang Y, 2007, J ANTIBIOT, V60, P204; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Furbino LE, 2014, MICROB ECOL, V67, P775, DOI 10.1007/s00248-014-0374-9; Suryanarayanan TS, 2010, BOT MAR, V53, P457, DOI 10.1515/BOT.2010.045; Armstrong E, 2001, HYDROBIOLOGIA, V461, P37, DOI 10.1023/A:1012756913566; Cui CM, 2009, HELV CHIM ACTA, V92, P1366; Subramaniam S, 2014, PHARM BIOL, V52, P86, DOI 10.3109/13880209.2013.815634; BEATTIE P, 1994, FEBS LETT, V356, P333, DOI 10.1016/0014-5793(94)01275-X; Bondoso J, 2013, FEMS MICROBIOL ECOL, V88, P445; Brana AF, 2014, MICROB ECOL, DOI [10.1007/s00248-014-0508-0, DOI 10.1007/S00248-014-0508-0]; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Butzin NC, 2010, PROTEIN EXPRES PURIF, V70, P88, DOI 10.1016/j.pep.2009.10.014; Chakraborty K, 2014, J AGR FOOD CHEM, V62, P12194, DOI 10.1021/jf504845m; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1849, DOI 10.1271/bbb.120221; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Cui CM, 2010, J NAT PROD, V73, P1780, DOI 10.1021/np100386q; Dai J, 2011, EUR J ORG CHEM, V36, P6928; Debnath M, 2007, CURR PHARM BIOTECHNO, V8, P253, DOI 10.2174/138920107782109976; Dobretsov SV, 2002, BIOFOULING, V18, P217, DOI 10.1080/08927010290013026; Egan S, 2001, FEMS MICROBIOL ECOL, V35, P67, DOI 10.1016/S0168-6496(00)00112-4; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Elsebai MF, 2010, ORG BIOMOL CHEM, V9, P802; Fenical W, 1991, MARINE BIOTECHNOLOGY; Ferreira CV, 2004, BLOOD, V104, P1459, DOI 10.1182/blood-2004-02-0594; Foerstner KU, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003515; Franks A, 2006, APPL ENVIRON MICROB, V72, P6079, DOI 10.1128/AEM.0059-06; Fudou R, 2001, J ANTIBIOT, V54, P149; Gamal-Eldeen AM, 2009, ENVIRON TOXICOL PHAR, V28, P317, DOI 10.1016/j.etap.2009.05.010; Gandhi NM, 1973, J ANTIBIOT, V26, P799; Gao SS, 2011, BIOORG MED CHEM LETT, V21, P2894, DOI 10.1016/j.bmcl.2011.03.076; Gao SS, 2011, CHEM BIODIVERS, V8, P1748, DOI 10.1002/cbdv.201000378; GAUTHIER MJ, 1976, INT J SYST BACTERIOL, V26, P459; GAUTHIER MJ, 1979, INT J SYST BACTERIOL, V29, P366; GAUTHIER MJ, 1976, CAN J MICROBIOL, V22, P138; Ravisankar A, 2013, APPL BIOCHEM BIOTECH, V171, P1968, DOI 10.1007/s12010-013-0473-y; Harder T, 2009, MARINE IND BIOFOULIN, P219; HAYASHI M, 1994, FEBS LETT, V356, P330, DOI 10.1016/0014-5793(94)01274-1; HAYASHI M, 1995, FEBS LETT, V363, P75, DOI 10.1016/0014-5793(95)00283-F; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Imamura N, 1997, J ANTIBIOT, V50, P8; Ismail-Ben Ali A., 2012, Journal of Applied Phycology, V24, P525, DOI 10.1007/s10811-011-9758-0; Isnansetyo A, 2001, J ANTIMICROB CHEMOTH, V47, P719; Izumikawa M, 2010, J ANTIBIOT, V63, P389, DOI 10.1038/ja.2010.57; Jamal MT, 2006, MAR BIOTECHNOL, V8, P587, DOI 10.1007/s10126-005-6160-4; JanakiDevi V, 2013, INT J CUR MICOBIOL A, V2, P140; Jaruchoktaweechai C, 2000, J NAT PROD, V63, P984, DOI 10.1021/np990605c; Jiang Z, 2001, NAT PROD LETT, V14, P435; Kamei Y, 2003, INT J ANTIMICROB AG, V21, P71, DOI 10.1016/S0924-8579(02)00251-0; Kanagasabhapathy M, 2006, ANN MICROBIOL, V56, P167; Kanagasabhapathy M, 2008, WORLD J MICROB BIOT, V24, P2315, DOI 10.1007/s11274-008-9746-y; Kanagasabhapathy M, 2009, LETT APPL MICROBIOL, V49, P573, DOI 10.1111/j.1472-765X.2009.02712.x; Kim HH, 1997, J MICROBIOL BIOTECHN, V7, P429; Kumar V, 2011, WORLD J MICROB BIOT, V27, P1543, DOI 10.1007/s11274-010-0606-1; Lafi FF, 2005, MICROB ECOL, V50, P213, DOI 10.1007/s00248-004-0202-8; Lane A. L., 2008, P229, DOI 10.1007/978-3-540-74181-7_11; LEMOS ML, 1985, MICROBIAL ECOL, V11, P149, DOI 10.1007/BF02010487; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332; Li Yong, 2005, Natural Product Sciences, V11, P136; Ma Yuexin, 2009, Acta Ecologica Sinica, V29, P222; Mathan S, 2013, INT J RES PHARM SCI, V4, P45; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; Naganuma M, 2008, BIOORGAN MED CHEM, V16, P2939, DOI 10.1016/j.bmc.2007.12.044; Nakanishi K, 1999, MAR BIOTECHNOL, V1, P107, DOI 10.1007/PL00011744; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Ogawa A, 2004, BIOORG MED CHEM LETT, V14, P3539, DOI 10.1016/j.bmcl.2004.04.050; Oliveira A., 2012, BRAZIL J PHARMACOGN, V22, P906; Penesyan A, 2013, INT J SYST EVOL MICR, V63, P1589, DOI 10.1099/ijs.0.042838-0; Penesyan A, 2013, MAR DRUGS, V11, P40, DOI 10.3390/md11010040; Pontius A, 2008, J NAT PROD, V71, P1793, DOI 10.1021/np800392w; Rungprorn W, 2008, TETRAHEDRON, V64, P3147, DOI 10.1016/j.tet.2008.01.089; Schallmey M, 2011, FEMS MICROBIOL LETT, V321, P150, DOI 10.1111/j.1574-6968.2011.02324.x; Silva-Aciares Fernando, 2008, Electron. J. Biotechnol., V11, P60; Simu K, 2004, APPL ENVIRON MICROB, V70, P2445, DOI 10.1128/AEM.70.4.2445-2451.2004; Singh RP, 2014, FEMS MICROBIOL ECOL, V88, P213, DOI 10.1111/1574-6941.12297; Singh RP, 2011, AQUAT BIOL, V12, P13, DOI 10.3354/ab00312; Streit WR, 2004, CURR OPIN BIOTECH, V15, P285, DOI 10.1016/j.copbio.2004.05.006; Suja M., 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P661; Suresh M., 2014, BIOCATAL AGR BIOTECH, V3, P161, DOI [DOI 10.1016/J.BCAB.2014.08.005, 10.1016/j.bcab.2014.08.005]; Suryanarayanan TS, 2012, BIOL MARINE FUNGI, P53; Suvega T, 2014, BRIT MICROBIOL RES J, V4, P2014; Takahashi H, 2007, J BIOL CHEM, V282, P9073, DOI 10.1074/jbc.M611319200; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Tebben J, 2014, MAR DRUGS, V12, P2802, DOI 10.3390/md12052802; Thirunavukkarasu N, 2011, MYCOSPHERE, V2, P147; UNEMOTO T, 1977, J BIOCHEM-TOKYO, V82, P1389; Villarreal-Gomez LJ, 2010, REV BIOL MAR OCEANOG, V45, P267, DOI 10.4067/S0718-19572010000200008; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; Woodward RB, 1964, PURE APPL CHEM, V9, P49; Yokoo A, 1950, NIPPON KAGAKU ZASSHI, V71, P590; Yoshikawa K, 2003, J ANTIBIOT, V56, P866; Yoshikawa K, 1999, J ANTIBIOT, V52, P182; Yoshikawa K, 1997, J ANTIBIOT, V50, P949; Zhang Y, 2010, NAT PROD RES, V24, P1036, DOI 10.1080/14786410902940875; Zhu TJ, 2009, CHINESE CHEM LETT, V20, P917, DOI 10.1016/j.cclet.2009.03.009; Zuccaro A, 2003, MYCOL RES, V107, P1451, DOI 10.1017/S095376203008657; Zuccaro A, 2005, FUNGAL COMMUNITY, P533	170	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					1571	1586		10.1007/s00253-014-6334-y		16	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600003		
J	Kobayashi, D; Fujita, K; Nakamura, N; Ohno, H				Kobayashi, Daigo; Fujita, Kyoko; Nakamura, Nobuhumi; Ohno, Hiroyuki			A simple recovery process for biodegradable plastics accumulated in cyanobacteria treated with ionic liquids	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Ionic liquid; Cyanobacteria; Poly(3-hydroxybutyrate) (PHB); Polarity; Recovery process	SYNECHOCYSTIS SP PCC-6803; UNICELLULAR CYANOBACTERIUM; GREEN-ALGAE; PCC 6803; POLAR; PURIFICATION; DISSOLUTION; SEPARATION; EXTRACTION; ANIONS	Here, we proposed a simple recovery process for poly(3-hydroxybutyrate) (PHB) accumulated in cyanobacteria by using ionic liquids (ILs), which dissolve cyanobacteria but not PHB. First, we investigated the effects of IL polarity on hydrogen-bonding receipt ability (beta value) and hydrogen-bonding donating ability (alpha value) and evaluated the subsequent dissolution of cyanobacteria. We found that ILs having alpha values higher than approximately 0.4 and beta values of approximately 0.9 were suitable for dissolution of cyanobacteria. In particular, 1-ethyl-3-methylimidazolium methylphosphonate ([C(2)mim][MeO(H)PO2]) was found to dissolve cyanobacteria components, but not PHB. Thus, we verified that PHB produced in cyanobacteria could be separated and recovered by simple filtering after dissolution of cyanobacteria in [C(2)mim][MeO(H)PO2]. Using this technique, more than 98 % of PHB was obtained on the filter as residues separated from cyanobacteria. Furthermore, [C(2)mim][MeO(H)PO2] maintained the ability to dissolve cyanobacteria after a simple recycling procedure.	[Kobayashi, Daigo; Fujita, Kyoko; Nakamura, Nobuhumi; Ohno, Hiroyuki] Tokyo Univ Agr, Dept Biotechnol, Koganei, Tokyo 1848588, Japan; [Kobayashi, Daigo; Fujita, Kyoko; Nakamura, Nobuhumi; Ohno, Hiroyuki] FILL, Koganei, Tokyo 1848588, Japan; [Fujita, Kyoko; Nakamura, Nobuhumi; Ohno, Hiroyuki] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Fujita, K (reprint author), Tokyo Univ Agr, Dept Biotechnol, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	kyokof@cc.tuat.ac.jp	Ohno, Hiroyuki/F-6459-2012; Nakamura, Nobuhumi/C-1972-2013; FUJITA, Kyoko/J-5365-2014	Ohno, Hiroyuki/0000-0001-9716-3495; Nakamura, Nobuhumi/0000-0002-5373-2972; FUJITA, Kyoko/0000-0002-5153-1819	JST through the CREST program; Japan Society for the Promotion of Science [21225007, 26810066]; Women's Future Development Organization of Tokyo University of Agriculture and Technology	This research was supported JST through the CREST program. It was also supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21225007 and 26810066). K.F. is grateful to the funds from the Women's Future Development Organization of Tokyo University of Agriculture and Technology. We would like to dedicate this article to celebrate the 20th anniversary of the Department of Biotechnology and Life Science at Tokyo University of Agriculture and Technology.	Kaneko T, 2003, DNA RES, V10, P221, DOI 10.1093/dnares/10.5.221; Fukaya Y, 2013, PHYS CHEM CHEM PHYS, V15, P4066, DOI 10.1039/c3cp44214d; Kim YH, 2012, BIORESOURCE TECHNOL, V109, P312, DOI 10.1016/j.biortech.2011.04.064; Ando T, 2013, CHEM COMMUN, V49, P10248, DOI 10.1039/c3cc45671d; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.010498; Ohno H, 2009, CHEM LETT, V38, P2, DOI 10.1246/cl.2009.2; Fukaya Y, 2008, GREEN CHEM, V10, P44, DOI 10.1039/b713289a; Osanai T, 2014, PLANT PHYSIOL, V164, P1831, DOI 10.1104/pp.113.232025; Panda B, 2007, LETT APPL MICROBIOL, V44, P194, DOI 10.1111/j.1472-765X.2006.02048.x; Muramatsu M, 2009, MICROBIOL-SGM, V155, P989, DOI 10.1099/mic.0.024018-0; Abed RMM, 2009, J APPL MICROBIOL, V106, P1, DOI 10.1111/j.1365-2672.2008.03918.x; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Fujita K, 2013, ENZYME MICROB TECH, V52, P199, DOI 10.1016/j.enzmictec.2012.12.004; STANIER RY, 1971, BACTERIOL REV, V35, P171; Tang B, 2012, J CHROMATOGR B, V904, P1, DOI 10.1016/j.jchromb.2012.07.020; Jacquel N, 2008, BIOCHEM ENG J, V39, P15, DOI 10.1016/j.bej.2007.11.029; Kagimoto J, 2008, CHEM LETT, V37, P1026, DOI 10.1246/cl.2008.1026; Capon JR, 1983, PHOTOCHEMISTRY, V22, P1181; Karr BD, 1983, APPL ENVIRON MICROB, V46, P1339; Mata M. T., 2010, RENEW SUST ENERG REV, V14, P217; Zou YJ, 2009, BIOTECHNOL BIOENG, V104, P939, DOI 10.1002/bit.22466; Rogers DR, 2003, SCIENCE, V302, P792; SCHENK MP, 2008, BIOENERG RES, V1, P20; Swatloski P., 2002, J AM CHEM SOC, V124, P4974; Teixeira ER, 2012, GREEN CHEM, V14, P419; Wilkes SJ, 2002, GREEN CHEM, V4, P73	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					1647	1653		10.1007/s00253-014-6234-1		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600009		
J	Inokuma, K; Yoshida, T; Ishii, J; Hasunuma, T; Kondo, A				Inokuma, Kentaro; Yoshida, Takanobu; Ishii, Jun; Hasunuma, Tomohisa; Kondo, Akihiko			Efficient co-displaying and artificial ratio control of alpha-amylase and glucoamylase on the yeast cell surface by using combinations of different anchoring domains	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Saccharomyces cerevisiae; Cell-surface display; alpha-Amylase; Glucoamylase; Ratio control	DIRECT ETHANOL-PRODUCTION; SACCHAROMYCES-CEREVISIAE; CELLULOLYTIC ENZYME; DELTA-INTEGRATION; STATIONARY-PHASE; ARMING YEAST; RAW STARCH; STRAIN; FERMENTATION; EXPRESSION	Recombinant yeast strains that display heterologous amylolytic enzymes on their cell surface via the glycosylphosphatidylinositol (GPI)-anchoring system are considered as promising biocatalysts for direct ethanol production from starchy materials. For the effective hydrolysis of these materials, the ratio optimization of multienzyme activity displayed on the cell surface is important. In this study, we have presented a ratio control system of multienzymes displayed on the yeast cell surface by using different GPI-anchoring domains. The novel gene cassettes for the cell-surface display of Streptococcus bovis alpha-amylase and Rhizopus oryzae glucoamylase were constructed using the Saccharomyces cerevisiae SED1 promoter and two different GPI-anchoring regions derived from Saccharomyces cerevisiae SED1 or SAG1. These gene cassettes were integrated into the Saccharomyces cerevisiae genome in different combinations. Then, the cell-surface alpha-amylase and glucoamylase activities and ethanol productivity of these recombinant strains were evaluated. The combinations of the gene cassettes of these enzymes affected the ratio of cell-surface alpha-amylase and glucoamylase activities and ethanol productivity of the recombinant strains. The highest ethanol productivity from raw starch was achieved by the strain harboring one alpha-amylase gene cassette carrying the SED1-anchoring region and two glucoamylase gene cassettes carrying the SED1-anchoring region (BY-AASS/GASS/GASS). This strain yielded 22.5 +/- 0.6 g/L of ethanol from 100 g/L of raw starch in 120 h of fermentation.	[Inokuma, Kentaro; Ishii, Jun; Hasunuma, Tomohisa] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Yoshida, Takanobu] Kobe Univ, Integrated Res Ctr, Technol Res Assoc Highly Efficient Gene Design, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kondo, Akihiko] RIKEN, Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kondo, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015	Hasunuma, Tomohisa/0000-0002-8382-2362	commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by the commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan. This work was also supported in part by a Special Coordination Fund for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Kotaka A, 2008, J BIOSCI BIOENG, V105, P622, DOI 10.1263/jbb.105.622; Matano Y, 2012, BIORESOURCE TECHNOL, V108, P128, DOI 10.1016/j.biortech.2011.12.144; Fujita Y, 2004, APPL ENVIRON MICROB, V70, P1207, DOI 10.1128/AEM.70.2.1207-1212.2004; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]; OHTA K, 1991, APPL ENVIRON MICROB, V57, P2810; Fukuda H, 2009, BIOCHEM ENG J, V44, P2, DOI 10.1016/j.bej.2008.11.016; Yanase S, 2010, BIOTECHNOL J, V5, P449, DOI 10.1002/biot.200900291; Ueda M, 2000, J BIOSCI BIOENG, V90, P125, DOI 10.1016/S1389-1723(00)80099-7; VanderVaart JM, 1997, APPL ENVIRON MICROB, V63, P615; Hasunuma T, 2011, APPL MICROBIOL BIOT, V90, P997, DOI 10.1007/s00253-011-3085-x; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Shimoi H, 1998, J BACTERIOL, V180, P3381; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Yamakawa S, 2012, ENZYME MICROB TECH, V50, P343, DOI 10.1016/j.enzmictec.2012.03.005; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Bao YL, 2011, BIORESOURCE TECHNOL, V102, P8077, DOI 10.1016/j.biortech.2011.05.078; Inokuma K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-8; Lau MW, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-11; Murai T, 1999, APPL MICROBIOL BIOT, V51, P65, DOI 10.1007/s002530051364; OLSSON L, 1993, PROCESS BIOCHEM, V28, P249, DOI 10.1016/0032-9592(93)80041-E; Yamada R, 2010, APPL MICROBIOL BIOT, V85, P1491, DOI 10.1007/s00253-009-2198-y; Yamada R, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-8; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					1655	1663		10.1007/s00253-014-6250-1		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600010		
J	Oka, T; Komachi, Y; Ohshima, K; Kawano, Y; Fukuda, K; Nagahama, K; Ekino, K; Nomura, Y				Oka, Takuji; Komachi, Yuji; Ohshima, Kazufumi; Kawano, Yoichi; Fukuda, Kohsai; Nagahama, Kazuhiro; Ekino, Keisuke; Nomura, Yoshiyuki			Isolation, sequencing, and heterologous expression of the Paecilomyces variotii gene encoding S-hydroxymethylglutathione dehydrogenase (fldA)	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Paecilomyces variotii; Formaldehyde degradation; S-hydroxymethylglutathione dehydrogenase; fldA; Heterologous expression	DEPENDENT FORMALDEHYDE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; WATER-STRESS; DETOXIFICATION; PROTEINS; DNA; OVEREXPRESSION; METABOLISM	The filamentous fungus Paecilomyces variotii NBRC 109023 (teleomorph: Byssochlamys spectabilis NBRC 109023) degrades formaldehyde at concentrations as high as 2.4 % (w/v). In many prokaryotes and in all known eukaryotes, formaldehyde degradation is catalyzed by S-hydroxymethylglutathione (S-HMGSH) dehydrogenase. We report here the isolation and characterization of the gene encoding S-HMGSH dehydrogenase activity in P. variotii. The 1.6-kb fldA gene contained 5 introns and 6 exons, and the corresponding cDNA was 1143 bp, encoding a 40-kDa protein composed of 380 amino acids. FldA was predicted to have 74.3, 73.7, 68.5, and 67.4% amino acid identity to the S-HMGSH dehydrogenases of Hansenula polymorpha, Candida boidinii, Saccharomyces cerevisiae, and Kluyveromyces lactis, respectively. The predicted protein also showed high amino acid similarity (84 similar to 86 %) to the products of putative fldA genes from other filamentous fungi, including Aspergillus sp. and Penicillium sp. Notably, the P. variotii fldA gene was able to functionally complement a Saccharomyces cerevisiae strain (BY4741 Delta sfa1) lacking the gene for S-HMGSH dehydrogenase. The heterologous expression construct rendered BY4741 Delta sfa1 tolerant to exogenous formaldehyde. Although BY4741 (parental wild-type strain) was unable to degrade even low concentrations of formaldehyde, BY4741 Delta sfa1 harboring Paecilomyces fldA was able to degrade 4 mM formaldehyde within 30 h. The findings from this study confirm the essential role of S-HMGSH dehydrogenase in detoxifying formaldehyde.	[Oka, Takuji; Komachi, Yuji; Ohshima, Kazufumi; Kawano, Yoichi; Fukuda, Kohsai; Nagahama, Kazuhiro; Ekino, Keisuke; Nomura, Yoshiyuki] Sojo Univ, Dept Appl Microbial Technol, Fac Biotechnol & Life Sci, Kumamoto 8600082, Japan	Nomura, Y (reprint author), Sojo Univ, Dept Appl Microbial Technol, Fac Biotechnol & Life Sci, Ikeda 4-22-1, Kumamoto 8600082, Japan.	nomura@bio.sojo-u.ac.jp			Sojo University	We are grateful to Prof. Izumi Yamaura (Sojo University) for his useful advice on HPLC operation. We are grateful to Mr. Makoto Muguruma (Sojo University) for his technical assistance. This work was supported by a grant-in-aid for scientific research from Sojo University.	Ando M, 1998, FORMALDEHYDE SHIGEN, V34, P53; Lee B, 2002, MICROBIOL-SGM, V148, P2697; BARRATT RW, 1965, GENETICS, V52, P233; Cray JA, 2013, MICROB BIOTECHNOL, V6, P453, DOI 10.1111/1751-7915.12027; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Gutheil WG, 1997, BIOCHEM BIOPH RES CO, V238, P693, DOI 10.1016/S0006-291X(00)90000-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Neculai AM, 2005, J BIOL CHEM, V280, P2826, DOI 10.1074/jbc.C400517200; Achkor H, 2003, PLANT PHYSIOL, V132, P2248, DOI 10.1104/pp.103.022277; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; Baerends RJS, 2008, APPL ENVIRON MICROB, V74, P3182, DOI 10.1128/AEM.02858-07; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; Wilson SM, 2008, MICROBIOL-SGM, V154, P296, DOI 10.1099/mic.0.2007/011346-0; Bhaganna P, 2010, MICROB BIOTECHNOL, V3, P701, DOI 10.1111/j.1751-7915.2010.00203.x; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; MASON RP, 1986, BIOCHEMISTRY-US, V25, P4504, DOI 10.1021/bi00364a008; Hallsworth JE, 2003, ENVIRON MICROBIOL, V5, P1270, DOI 10.1046/j.1462-2920.2003.00478.x; Cray JA, 2013, ENVIRON MICROBIOL, V15, P287, DOI 10.1111/1462-2920.12018; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Fliegmann J, 1997, PLANT MOL BIOL, V34, P843, DOI 10.1023/A:1005872222490; Fukuda R, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-32; GRAFSTROM RC, 1983, SCIENCE, V220, P216, DOI 10.1126/science.6828890; Iwahara Masayoshi, 2002, Biocontrol Science, V7, P107; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Nian HJ, 2013, APPL BIOCHEM BIOTECH, V169, P170, DOI 10.1007/s12010-012-9957-4; Oka T, 2014, GENOME ANNOUNC, V2; Pais TM, 2013, PLOS GENET, V9; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; SAITO I, 1986, P NATL ACAD SCI USA, V83, P8664, DOI 10.1073/pnas.83.22.8664; SCHECHTER DS, 1995, OZONE-SCI ENG, V17, P53, DOI 10.1080/01919519508547577; UOTILA L, 1974, J BIOL CHEM, V249, P7664; WEHNER EP, 1993, MOL GEN GENET, V237, P351; Zahn JA, 2001, J BACTERIOL, V183, P6832, DOI 10.1128/JB.183.23.6832-6840.2001	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					1755	1763		10.1007/s00253-014-6203-8		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600019		
J	Suzuki, K; Tanaka, M; Konno, Y; Ichikawa, T; Ichinose, S; Hasegawa-Shiro, S; Shintani, T; Gomi, K				Suzuki, Kuta; Tanaka, Mizuki; Konno, Yui; Ichikawa, Takanori; Ichinose, Sakurako; Hasegawa-Shiro, Sachiko; Shintani, Takahiro; Gomi, Katsuya			Distinct mechanism of activation of two transcription factors, AmyR and MalR, involved in amylolytic enzyme production in Aspergillus oryzae	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Aspergillus oryzae; Transcription factor; Gene expression regulation; Amylase gene; Nuclear localization; Inducing sugar	GENE-EXPRESSION; NIDULANS; DOMAIN; PHOSPHORYLATION; TRANSFORMATION; MARKER	The production of amylolytic enzymes in Aspergillus oryzae is induced in the presence of starch or maltose, and two Zn(2)Cys(6)-type transcription factors, AmyR and MalR, are involved in this regulation. AmyR directly regulates the expression of amylase genes, and MalR controls the expression of maltose-utilizing (MAL) cluster genes. Deletion of malR gene resulted in poor growth on starch medium and reduction in alpha-amylase production level. To elucidate the activation mechanisms of these two transcription factors in amylase production, the expression profiles of amylases and MAL cluster genes under carbon catabolite derepression condition and subcellular localization of these transcription factors fused with a green fluorescent protein (GFP) were examined. Glucose, maltose, and isomaltose induced the expression of amylase genes, and GFP-AmyR was translocated from the cytoplasm to nucleus after the addition of these sugars. Rapid induction of amylase gene expression and nuclear localization of GFP-AmyR by isomaltose suggested that this sugar was the strongest inducer for AmyR activation. In contrast, GFP-MalR was constitutively localized in the nucleus and the expression of MAL cluster genes was induced by maltose, but not by glucose or isomaltose. In the presence of maltose, the expression of amylase genes was preceded by MAL cluster gene expression. Furthermore, deletion of the malR gene resulted in a significant decrease in the alpha-amylase activity induced by maltose, but had apparently no effect on the expression of alpha-amylase genes in the presence of isomaltose. These results suggested that activation of AmyR and MalR is regulated in a different manner, and the preceding activation of MalR is essential for the utilization of maltose as an inducer for AmyR activation.	[Suzuki, Kuta; Tanaka, Mizuki; Konno, Yui; Ichikawa, Takanori; Ichinose, Sakurako; Hasegawa-Shiro, Sachiko; Shintani, Takahiro; Gomi, Katsuya] Tohoku Univ, Dept Bioind Informat & Genom, Grad Sch Agr Sci, Lab Bioind Genom,Aoba Ku, Sendai, Miyagi 9818555, Japan	Gomi, K (reprint author), Tohoku Univ, Dept Bioind Informat & Genom, Grad Sch Agr Sci, Lab Bioind Genom,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	gomi@biochem.tohoku.ac.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JSPS KAKENHI [22248007, 25292044]	We thank Tetsuo Kobayashi for providing the plasmids pAGAR-F and pAR-Zn3 and for technical advice about subcellular localization analysis. We also thank Yasuji Koyama and Osamu Mizutani for providing Delta malR::pyrG and Delta ligD::loxP pyrG<SUP>-</SUP> strains, respectively. This study was supported by Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and JSPS KAKENHI (Grant No. 22248007, 25292044).	Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367; Murakoshi Y, 2012, APPL MICROBIOL BIOT, V94, P1629, DOI 10.1007/s00253-012-3874-x; Kato N, 2002, APPL ENVIRON MICROB, V68, P1250, DOI 10.1128/AEM.68.3.1250-1256.2002; Gomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P816, DOI 10.1271/bbb.64.816; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Noguchi Y, 2011, BIOSCI BIOTECH BIOCH, V75, P953, DOI 10.1271/bbb.100923; Mizutani O, 2012, APPL ENVIRON MICROB, V78, P4126, DOI 10.1128/AEM.00080-12; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Ichinose S, 2014, APPL MICROBIOL BIOT, V98, P335, DOI 10.1007/s00253-013-5353-4; Kato N, 2002, CURR GENET, V42, P43, DOI 10.1007/s00294-002-0325-8; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Tanaka M, 2012, APPL MICROBIOL BIOT, V96, P1275, DOI 10.1007/s00253-012-4169-y; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Hasegawa S, 2010, FUNGAL GENET BIOL, V47, P1, DOI 10.1016/j.fgb.2009.10.005; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Sato H, 2011, APPL MICROBIOL BIOT, V92, P961, DOI 10.1007/s00253-011-3422-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Bali M, 2003, J BIOL CHEM, V278, P47441, DOI 10.1074/jbc.M309536200; Danzi SE, 2003, CURR GENET, V44, P173, DOI 10.1007/s00294-003-0429-9; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Makita T, 2009, BIOSCI BIOTECH BIOCH, V73, P391, DOI 10.1271/bbb.80654; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Ran F, 2008, GENETICS, V179, P331, DOI 10.1534/genetics.107.084921; Ran FL, 2010, J BIOL CHEM, V285, P13850, DOI 10.1074/jbc.M109.040600; Tamalampudi S, 2007, APPL MICROBIOL BIOT, V75, P387, DOI 10.1007/s00253-006-0814-7; Tonomura K, 1961, AGR BIOL CHEM TOKYO, V25, P1; Tsuboi H, 2005, BIOSCI BIOTECH BIOCH, V69, P206, DOI 10.1271/bbb.69.206	30	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					1805	1815		10.1007/s00253-014-6264-8		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600023		
J	Urano, N; Fujii, M; Kaino, H; Matsubara, M; Kataoka, M				Urano, Nobuyuki; Fujii, Misaki; Kaino, Hiroshi; Matsubara, Mitsuru; Kataoka, Michihiko			Fermentative production of 1-propanol from sugars using wild-type and recombinant Shimwellia blattae	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Shimwellia blattae; 1-Propanol production; 1,2-Propanediol production; Glycerol dehydratase	ENGINEERED ESCHERICHIA-COLI; L-RHAMNOSE; PROPANEDIOL OXIDOREDUCTASE; B-12-DEPENDENT GLYCEROL; ALDEHYDE REDUCTASE; METABOLISM; FUCOSE; 1,2-PROPANEDIOL; METHYLGLYOXAL; SYNTHASE	Shimwellia blattae is an enteric bacterium and produces endogenous enzymes that convert 1,2-propanediol (1,2-PD) to 1-propanol, which is expected to be used as a fuel substitute and a precursor of polypropylene. Therefore, if S. blattae could be induced to generate its own 1,2-PD from sugars, itmight be possible to produce 1-propanol from sugars with this microorganism. Here, two 1,2-PD production pathways were constructed in S. blattae, resulting in two methods for 1-propanol production with the bacterium. One method employed the L-rhamnose utilization pathway, in which L-rhamnose is split into dihydroxyacetone phosphate and 1,2-PD. When wild-type S. blattae was cultured with L-rhamnose, an accumulation of 1,2-PD was observed. The other method for producing 1,2-PD was to introduce an engineered 1,2-PD production pathway from glucose into S. blattae. In both cases, the produced 1,2-PD was then converted to 1-propanol by 1,2-PD converting enzymes, whose production was induced by the addition of glycerol.	[Urano, Nobuyuki; Fujii, Misaki; Kaino, Hiroshi; Matsubara, Mitsuru; Kataoka, Michihiko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Kataoka, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Naka Ku, 1-1 Gakuencho, Sakai, Osaka 5998531, Japan.	kataoka@biochem.osakafu-u.ac.jp	Kataoka, Michihiko/E-5847-2011		Japan Society for the Promotion of Science (JSPS) [23380051]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)	This work was supported in part by a Grant-in-Aid for Scientific Research, no. 23380051 (to MK), from the Japan Society for the Promotion of Science (JSPS), and by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST).	Altaras NE, 2000, BIOTECHNOL PROGR, V16, P940, DOI 10.1021/bp000076z; Heinrich D, 2013, APPL ENVIRON MICROB, V79, P3582, DOI 10.1128/AEM.00161-13; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; BALDOMA L, 1988, J BACTERIOL, V170, P416; Altaras NE, 1999, APPL ENVIRON MICROB, V65, P1180; Andres S, 2004, J MOL MICROB BIOTECH, V8, P150, DOI 10.1159/000085788; Cameron DC, 1998, BIOTECHNOL PROGR, V14, P116, DOI 10.1021/bp9701325; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Atsumi S, 2008, APPL ENVIRON MICROB, V74, P7802, DOI 10.1128/AEM.02046-08; BORONAT A, 1979, J BACTERIOL, V140, P320; BADIA J, 1985, J BACTERIOL, V161, P435; Bennett GN, 2001, APPL MICROBIOL BIOT, V55, P1, DOI 10.1007/s002530000476; Berrios-Rivera SJ, 2003, J IND MICROBIOL BIOT, V30, P34, DOI 10.1007/s10295-002-0006-0; BORONAT A, 1981, BIOCHIM BIOPHYS ACTA, V672, P98, DOI 10.1016/0304-4165(81)90283-X; Brzuszkiewicz E, 2012, J BACTERIOL, V194, P4436, DOI 10.1128/JB.00829-12; Daniel R, 1998, FEMS MICROBIOL REV, V22, P553, DOI 10.1111/j.1574-6976.1998.tb00387.x; HACKING AJ, 1976, J BACTERIOL, V126, P1166; HOPPER DJ, 1972, BIOCHEM J, V128, P321; Jain R, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-97; Kataoka M, 2009, Jpn Patent Appl, Patent No. [2009-118806, 2009118806]; Kita K, 1999, APPL ENVIRON MICROB, V65, P5207; Ko J, 2005, J BACTERIOL, V187, P5782, DOI 10.1128/JB.187.5782-5789.2005; Misra K, 1996, MOL CELL BIOCHEM, V156, P117, DOI 10.1007/BF00426333; MORALEJO P, 1993, J BACTERIOL, V175, P5585; MURATA K, 1985, BIOCHEM BIOPH RES CO, V131, P190; Sambrook J, 2001, MOL CLONING LAB MANU; SAWADA H, 1964, BIOCHIM BIOPHYS ACTA, V92, P26, DOI 10.1016/0926-6569(64)90265-2; TAKAGI Y, 1964, BIOCHIM BIOPHYS ACTA, V92, P18, DOI 10.1016/0926-6569(64)90264-0; TAKAGI Y, 1964, BIOCHIM BIOPHYS ACTA, V92, P10, DOI 10.1016/0926-6569(64)90263-9	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	4					2001	2008		10.1007/s00253-014-6330-2		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC0MA	WOS:000350028600039		
J	Abramowski, A; Aharonian, F; Benkhali, FA; Akhperjanian, AG; Anguner, E; Anton, G; Backes, M; Balenderan, S; Balzer, A; Barnacka, A; Becherini, Y; Tjus, JB; Bernlohr, K; Birsin, E; Bissaldi, E; Biteau, J; Bottcher, M; Boisson, C; Bolmont, J; Bordas, P; Brucker, J; Brun, F; Brun, P; Bulik, T; Carrigan, S; Casanova, S; Chadwick, PM; Chalme-Calvet, R; Chaves, RCG; Cheesebrough, A; Chreetien, M; Colafrancesco, S; Cologna, G; Conrad, J; Couturier, C; Cui, Y; Dalton, M; Daniel, MK; Davids, ID; Degrange, B; Deil, C; deWilt, P; Dickinson, HJ; Djannati-Atai, A; Domainko, W; Drury, LOC; Dubus, G; Dutson, K; Dyks, J; Dyrda, M; Edwards, T; Egberts, K; Eger, P; Espigat, P; Farnier, C; Fegan, S; Feinstein, F; Fernandes, MV; Fernandez, D; Fiasson, A; Fontaine, G; Forster, A; Fussling, M; Gajdus, M; Gallant, YA; Garrigoux, T; Giavitto, G; Giebels, B; Glicenstein, JF; Grondin, MH; Grudzinska, M; Haffner, S; Hahn, J; Harris, J; Heinzelmann, G; Henri, G; Hermann, G; Hervet, O; Hillert, A; Hinton, JA; Hofmann, W; Hofverberg, P; Holler, M; Horns, D; Jacholkowska, A; Jahn, C; Jamrozy, M; Janiak, M; Jankowsky, F; Jung, I; Kastendieck, MA; Katarzynski, K; Katz, U; Kaufmann, S; Khelifi, B; Kieffer, M; Klepser, S; Klochkov, D; Kluzniak, W; Kneiske, T; Kolitzus, D; Komin, N; Kosack, K; Krakau, S; Krayzel, F; Kruger, PP; Laffon, H; Lamanna, G; Lefaucheur, J; Lemiere, A; Lemoine-Goumard, M; Lenain, JP; Lohse, T; Lopatin, A; Lu, CC; Marandon, V; Marcowith, A; Marx, R; Maurin, G; Maxted, N; Mayer, M; McComb, TJL; Mehault, J; Meintjes, PJ; Menzler, U; Meyer, M; Moderski, R; Mohamed, M; Moulin, E; Murach, T; Naumann, CL; de Naurois, M; Niemiec, J; Nolan, SJ; Oakes, L; Odaka, H; Ohm, S; Wilhelmi, ED; Opitz, B; Ostrowski, M; Oya, I; Panter, M; Parsons, RD; Arribas, MP; Pekeur, NW; Pelletier, G; Perez, J; Petrucci, PO; Peyaud, B; Pita, S; Poon, H; Puhlhofer, G; Punch, M; Quirrenbach, A; Raab, S; Raue, M; Reichardt, I; Reimer, A; Reimer, O; Renaud, M; Reyes, RD; Rieger, F; Rob, L; Romoli, C; Rosier-Lees, S; Rowell, G; Rudak, B; Rulten, CB; Sahakian, V; Sanchez, DA; Santangelo, A; Schlickeiser, R; Schussler, F; Schulz, A; Schwanke, U; Schwarzburg, S; Schwemmer, S; Sol, H; Spengler, G; Spies, F; Stawarz, L; Steenkamp, R; Stegmann, C; Stinzing, F; Stycz, K; Sushch, I; Tavernet, JP; Tavernier, T; Taylor, AM; Terrier, R; Tluczykont, M; Trichard, C; Valerius, K; van Eldik, C; van Soelen, B; Vasileiadis, G; Venter, C; Viana, A; Vincent, P; Volk, HJ; Volpe, F; Vorster, M; Vuillaume, T; Wagner, SJ; Wagner, P; Wagner, RM; Ward, M; Weidinger, M; Weitzel, Q; White, R; Wierzcholska, A; Willmann, P; Wornlein, A; Wouters, D; Yang, R; Zabalza, V; Zacharias, M; Zdziarski, AA; Zech, A; Zechlin, HS; Acero, F; Casandjian, JM; Cohen-Tanugi, J; Giordano, F; Guillemot, L; Lande, J; Pletsch, H; Uchiyama, Y				Abramowski, A.; Aharonian, F.; Benkhali, F. Ait; Akhperjanian, A. G.; Anguener, E.; Anton, G.; Backes, M.; Balenderan, S.; Balzer, A.; Barnacka, A.; Becherini, Y.; Tjus, J. Becker; Bernloehr, K.; Birsin, E.; Bissaldi, E.; Biteau, J.; Boettcher, M.; Boisson, C.; Bolmont, J.; Bordas, P.; Brucker, J.; Brun, F.; Brun, P.; Bulik, T.; Carrigan, S.; Casanova, S.; Chadwick, P. M.; Chalme-Calvet, R.; Chaves, R. C. G.; Cheesebrough, A.; Chretien, M.; Colafrancesco, S.; Cologna, G.; Conrad, J.; Couturier, C.; Cui, Y.; Dalton, M.; Daniel, M. K.; Davids, I. D.; Degrange, B.; Deil, C.; deWilt, P.; Dickinson, H. J.; Djannati-Atai, A.; Domainko, W.; Drury, L. O'C.; Dubus, G.; Dutson, K.; Dyks, J.; Dyrda, M.; Edwards, T.; Egberts, K.; Eger, P.; Espigat, P.; Farnier, C.; Fegan, S.; Feinstein, F.; Fernandes, M. V.; Fernandez, D.; Fiasson, A.; Fontaine, G.; Foerster, A.; Fuessling, M.; Gajdus, M.; Gallant, Y. A.; Garrigoux, T.; Giavitto, G.; Giebels, B.; Glicenstein, J. F.; Grondin, M. -H.; Grudzinska, M.; Haeffner, S.; Hahn, J.; Harris, J.; Heinzelmann, G.; Henri, G.; Hermann, G.; Hervet, O.; Hillert, A.; Hinton, J. A.; Hofmann, W.; Hofverberg, P.; Holler, M.; Horns, D.; Jacholkowska, A.; Jahn, C.; Jamrozy, M.; Janiak, M.; Jankowsky, F.; Jung, I.; Kastendieck, M. A.; Katarzynski, K.; Katz, U.; Kaufmann, S.; Khelifi, B.; Kieffer, M.; Klepser, S.; Klochkov, D.; Kluzniak, W.; Kneiske, T.; Kolitzus, D.; Komin, Nu.; Kosack, K.; Krakau, S.; Krayzel, F.; Krueger, P. P.; Laffon, H.; Lamanna, G.; Lefaucheur, J.; Lemiere, A.; Lemoine-Goumard, M.; Lenain, J. -P.; Lohse, T.; Lopatin, A.; Lu, C. -C.; Marandon, V.; Marcowith, A.; Marx, R.; Maurin, G.; Maxted, N.; Mayer, M.; McComb, T. J. L.; Mehault, J.; Meintjes, P. J.; Menzler, U.; Meyer, M.; Moderski, R.; Mohamed, M.; Moulin, E.; Murach, T.; Naumann, C. L.; de Naurois, M.; Niemiec, J.; Nolan, S. J.; Oakes, L.; Odaka, H.; Ohm, S.; Wilhelmi, E. de Ona; Opitz, B.; Ostrowski, M.; Oya, I.; Panter, M.; Parsons, R. D.; Arribas, M. Paz; Pekeur, N. W.; Pelletier, G.; Perez, J.; Petrucci, P. -O.; Peyaud, B.; Pita, S.; Poon, H.; Puehlhofer, G.; Punch, M.; Quirrenbach, A.; Raab, S.; Raue, M.; Reichardt, I.; Reimer, A.; Reimer, O.; Renaud, M.; Reyes, R. de los; Rieger, F.; Rob, L.; Romoli, C.; Rosier-Lees, S.; Rowell, G.; Rudak, B.; Rulten, C. B.; Sahakian, V.; Sanchez, D. A.; Santangelo, A.; Schlickeiser, R.; Schuessler, F.; Schulz, A.; Schwanke, U.; Schwarzburg, S.; Schwemmer, S.; Sol, H.; Spengler, G.; Spies, F.; Stawarz, L.; Steenkamp, R.; Stegmann, C.; Stinzing, F.; Stycz, K.; Sushch, I.; Tavernet, J. -P.; Tavernier, T.; Taylor, A. M.; Terrier, R.; Tluczykont, M.; Trichard, C.; Valerius, K.; van Eldik, C.; van Soelen, B.; Vasileiadis, G.; Venter, C.; Viana, A.; Vincent, P.; Voelk, H. J.; Volpe, F.; Vorster, M.; Vuillaume, T.; Wagner, S. J.; Wagner, P.; Wagner, R. M.; Ward, M.; Weidinger, M.; Weitzel, Q.; White, R.; Wierzcholska, A.; Willmann, P.; Woernlein, A.; Wouters, D.; Yang, R.; Zabalza, V.; Zacharias, M.; Zdziarski, A. A.; Zech, A.; Zechlin, H. -S.; Acero, F.; Casandjian, J. M.; Cohen-Tanugi, J.; Giordano, F.; Guillemot, L.; Lande, J.; Pletsch, H.; Uchiyama, Y.		HESS Collaboration; Fermi-LAT Collaboration	Probing the gamma-ray emission from HESS J1834-087 using HESS and Fermi LAT observations	ASTRONOMY & ASTROPHYSICS			English	Article						acceleration of particles; ISM: supernova remnants; ISM: clouds; cosmic rays	LARGE-AREA TELESCOPE; PULSAR WIND NEBULAE; SUPERNOVA REMNANT; SPACE-TELESCOPE; GALACTIC PLANE; PARTICLE-ACCELERATION; SOURCE CATALOG; DISCOVERY; EVOLUTION; CLOUDS	Aims. Previous observations with the High Energy Stereoscopic System (H.E.S.S.) have revealed an extended very-high-energy (VHE; E > 100 GeV) gamma-ray source, HESS J1834-087, coincident with the supernova remnant (SNR) W41. The origin of the gamma-ray emission was investigated in more detail with the H.E.S.S. array and the Large Area Telescope (LAT) onboard the Fermi Gamma-ray Space Telescope. Methods. The gamma-ray data provided by 61 h of observations with H.E.S.S., and four years with the Fermi LAT were analyzed, covering over five decades in energy from 1.8 GeV up to 30 TeV. The morphology and spectrum of the TeV and GeV sources were studied and multiwavelength data were used to investigate the origin of the gamma-ray emission toward W41. Results. The TeV source can be modeled with a sum of two components: one point-like and one significantly extended (sigma(TeV) = 0.17 degrees +/- 0.01 degrees), both centered on SNR W41 and exhibiting spectra described by a power law with index Gamma(TeV) similar or equal to 2.6. The GeV source detected with Fermi LAT is extended (sigma(GeV) = 0.15 degrees +/- 0.03 degrees) and morphologically matches the VHE emission. Its spectrum can be described by a power-law model with an index Gamma(GeV) = 2.15 +/- 0.12 and smoothly joins the spectrum of the whole TeV source. A break appears in the gamma-ray spectra around 100 GeV. No pulsations were found in the GeV range. Conclusions. Two main scenarios are proposed to explain the observed emission: a pulsar wind nebula (PWN) or the interaction of SNR W41 with an associated molecular cloud. X-ray observations suggest the presence of a point-like source (a pulsar candidate) near the center of the remnant and nonthermal X-ray diffuse emission that could arise from the possibly associated PWN. The PWN scenario is supported by the compatible positions of the TeV and GeV sources with the putative pulsar. However, the spectral energy distribution from radio to gamma-rays is reproduced by a one-zone leptonic model only if an excess of low-energy electrons is injected following a Maxwellian distribution by a pulsar with a high spin-down power (> 10(37) erg s(-1)). This additional low-energy component is not needed if we consider that the point-like TeV source is unrelated to the extended GeV and TeV sources. The interacting SNR scenario is supported by the spatial coincidence between the gamma-ray sources, the detection of OH (1720 MHz) maser lines, and the hadronic modeling.	[Abramowski, A.; Fernandes, M. V.; Heinzelmann, G.; Horns, D.; Kastendieck, M. A.; Kneiske, T.; Opitz, B.; Raue, M.; Spies, F.; Tluczykont, M.; Zechlin, H. -S.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Aharonian, F.; Benkhali, F. Ait; Bernloehr, K.; Brun, F.; Carrigan, S.; Casanova, S.; Deil, C.; Domainko, W.; Edwards, T.; Eger, P.; Foerster, A.; Grondin, M. -H.; Hahn, J.; Hermann, G.; Hillert, A.; Hofmann, W.; Hofverberg, P.; Krueger, P. P.; Lu, C. -C.; Marandon, V.; Marx, R.; Odaka, H.; Wilhelmi, E. de Ona; Panter, M.; Parsons, R. D.; Poon, H.; Reyes, R. de los; Rieger, F.; Viana, A.; Voelk, H. J.; Volpe, F.; Weitzel, Q.; Yang, R.; Zabalza, V.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Aharonian, F.; Drury, L. O'C.; Romoli, C.; Taylor, A. M.] Dublin Inst Adv Studies, Dublin 2, Ireland; [Aharonian, F.; Akhperjanian, A. G.; Sahakian, V.] Natl Acad Sci Republ Armenia, Yerevan 375014, Armenia; [Akhperjanian, A. G.; Sahakian, V.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Anguener, E.; Bernloehr, K.; Birsin, E.; Gajdus, M.; Lohse, T.; Murach, T.; Oakes, L.; Oya, I.; Arribas, M. Paz; Schwanke, U.; Spengler, G.; Sushch, I.; Wagner, P.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Anton, G.; Brucker, J.; Haeffner, S.; Jahn, C.; Jung, I.; Katz, U.; Lopatin, A.; Raab, S.; Stinzing, F.; Valerius, K.; van Eldik, C.; Willmann, P.; Woernlein, A.] Univ Erlangen Nurnberg, Inst Phys, D-91058 Erlangen, Germany; [Backes, M.; Davids, I. D.; Steenkamp, R.] Univ Namibia, Dept Phys, Windhoek, Namibia; [Balenderan, S.; Chadwick, P. M.; Cheesebrough, A.; Daniel, M. K.; Harris, J.; McComb, T. J. L.; Nolan, S. J.; Ward, M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Balzer, A.; Giavitto, G.; Klepser, S.; Schulz, A.; Stegmann, C.; Stycz, K.] DESY, D-15738 Zeuthen, Germany; [Balzer, A.; Fuessling, M.; Holler, M.; Mayer, M.; Stegmann, C.] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Barnacka, A.; Dyks, J.; Janiak, M.; Kluzniak, W.; Moderski, R.; Rudak, B.; Zdziarski, A. A.] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Becherini, Y.] Linnaeus Univ, Dept Phys & Elect Engn, S-35195 Vaxjo, Sweden; [Tjus, J. Becker; Krakau, S.; Menzler, U.; Schlickeiser, R.; Weidinger, M.; Zacharias, M.] Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; [Bissaldi, E.; Egberts, K.; Kolitzus, D.; Perez, J.; Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Biteau, J.; Degrange, B.; Fegan, S.; Fontaine, G.; Giebels, B.; de Naurois, M.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Boettcher, M.; Casanova, S.; Davids, I. D.; Krueger, P. P.; Pekeur, N. W.; Sushch, I.; Venter, C.; Vorster, M.] North West Univ, Ctr Space Res, ZA-2520 Potchefstroom, South Africa; [Boisson, C.; Hervet, O.; Rulten, C. B.; Sol, H.; Zech, A.] Univ Paris Diderot, CNRS, LUTH, Observ Paris, F-92190 Meudon, France; [Bolmont, J.; Chalme-Calvet, R.; Chretien, M.; Couturier, C.; Garrigoux, T.; Jacholkowska, A.; Kieffer, M.; Lenain, J. -P.; Naumann, C. L.; Tavernet, J. -P.; Vincent, P.] Univ Paris 07, Univ Paris 06, CNRS, IN2P3,LPNHE, F-75252 Paris 5, France; [Bordas, P.; Cui, Y.; Klochkov, D.; Puehlhofer, G.; Santangelo, A.; Schwarzburg, S.] Univ Tubingen, Inst Astron & Astrophys, D-72076 Tubingen, Germany; [Brun, P.; Chaves, R. C. G.; Glicenstein, J. F.; Kosack, K.; Moulin, E.; Peyaud, B.; Schuessler, F.; Wouters, D.] CEA Saclay, DSM Irfu, F-91191 Gif Sur Yvette, France; [Bulik, T.; Grudzinska, M.] Univ Warsaw, Astron Observ, PL-00478 Warsaw, Poland; [Colafrancesco, S.] Univ Witwatersrand, Sch Phys, ZA-2050 Johannesburg, South Africa; [Cologna, G.; Grondin, M. -H.; Jankowsky, F.; Kaufmann, S.; Mohamed, M.; Quirrenbach, A.; Schwemmer, S.; Wagner, S. J.] Heidelberg Univ, Landessternwarte, D-69117 Heidelberg, Germany; [Conrad, J.; Dickinson, H. J.; Farnier, C.; Meyer, M.; Wagner, R. M.] Stockholm Univ, Dept Phys, Oskar Klein Ctr, Albanova Univ Ctr, S-10691 Stockholm, Sweden; [Dalton, M.; Laffon, H.; Lemoine-Goumard, M.; Mehault, J.] Univ Bordeaux 1, CNRS, IN2P3, CEN Bordeaux Gradignan, F-33175 Gradignan, France; [deWilt, P.; Maxted, N.; Rowell, G.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Djannati-Atai, A.; Espigat, P.; Khelifi, B.; Lefaucheur, J.; Lemiere, A.; Pita, S.; Punch, M.; Reichardt, I.; Tavernier, T.; Terrier, R.] Sorbonne Paris Cite, Univ Paris Diderot, CNRS, IN2P3,CEA Irfu,Observ Paris,AstroParticule & Cosm, F-75205 Paris 13, France; [Dubus, G.; Henri, G.; Pelletier, G.; Petrucci, P. -O.; Vuillaume, T.] UJF Grenoble 1, CNRS INSU, Inst Planetol & Astrophys Grenoble, UMR 5274, F-38041 Grenoble, France; [Dutson, K.; Hinton, J. A.; Ohm, S.; White, R.; Zabalza, V.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Dyrda, M.; Niemiec, J.] Inst Fizyki Jadrowej PAN, PL-31342 Krakow, Poland; [Feinstein, F.; Fernandez, D.; Gallant, Y. A.; Marcowith, A.; Renaud, M.; Vasileiadis, G.; Cohen-Tanugi, J.] Univ Montpellier 2, CNRS, IN2P3, Lab Univ & Particules Montpellier, F-34095 Montpellier 5, France; [Fiasson, A.; Komin, Nu.; Krayzel, F.; Lamanna, G.; Maurin, G.; Rosier-Lees, S.; Sanchez, D. A.; Trichard, C.] Univ Savoie, CNRS, IN2P3, Lab Annecy Le Vieux Phys Particules, F-74941 Annecy Le Vieux, France; [Jamrozy, M.; Ostrowski, M.; Stawarz, L.; Wierzcholska, A.] Jagiellonian Univ, Obserwatorium Astron, PL-30244 Krakow, Poland; [Katarzynski, K.] Nicholas Copernicus Univ, Torun Ctr Astron, PL-87100 Torun, Poland; [Meintjes, P. J.; van Soelen, B.] Univ Free State, Dept Phys, ZA-9300 Bloemfontein, South Africa; [Rob, L.] Charles Univ Prague, Fac Math & Phys, Inst Nucl & Particle Phys, CR-18000 Prague 8, Czech Republic; [Zechlin, H. -S.; Acero, F.; Casandjian, J. M.] Univ Paris Diderot, CEA Saclay, CNRS, Serv Astrophys,CEA IRFU,Lab AIM, F-91191 Gif Sur Yvette, France; [Giordano, F.] M Merlin Univ & Politecn Bari, Dipartimento Fis, I-70126 Bari, Italy; [Giordano, F.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Guillemot, L.] CNRS, Lab Phys & Chim Environm, UMR 6115, F-54071 Orleans 02, France; [Guillemot, L.] Observ Paris, CNRS INSU, Stn Radioastron Nancay, F-18330 Nancay, France; [Lande, J.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Lande, J.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Pletsch, H.] Max Planck Inst Gravitat Phys, Albert Einstein Inst, D-30167 Hannover, Germany; [Pletsch, H.] Leibniz Univ Hannover, D-30167 Hannover, Germany; [Uchiyama, Y.] Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan	Mehault, J (reprint author), Univ Bordeaux 1, CNRS, IN2P3, CEN Bordeaux Gradignan, F-33175 Gradignan, France.	grondin@cenbg.in2p3.fr; mehault@cenbg.in2p3.fr	de Ona Wilhelmi, Emma/I-2696-2015; Komin, Nukri/J-6781-2015; Schussler, Fabian/G-5313-2013; Katarzynski, Krzysztof/G-4528-2014; Jamrozy, Marek/F-4507-2015; Katz, Uli/E-1925-2013; Casanova, Sabrina/J-8935-2013; Anton, Gisela/C-4840-2013; Reimer, Olaf/A-3117-2013; van Eldik, Christopher/C-3901-2013	Chadwick, Paula/0000-0002-1468-2685; Meyer, Manuel/0000-0002-0738-7581; de Ona Wilhelmi, Emma/0000-0002-5401-0744; Komin, Nukri/0000-0003-3280-0582; Kneiske, Tanja M./0000-0002-3210-6200; Drury, Luke/0000-0002-9257-2270; Punch, Michael/0000-0002-4710-2165; mohamed, mahmoud/0000-0002-4625-6242; Schussler, Fabian/0000-0003-1500-6571; Katz, Uli/0000-0002-7063-4418; Casanova, Sabrina/0000-0002-6144-9122; Anton, Gisela/0000-0003-2039-4724; van Eldik, Christopher/0000-0001-9669-645X	German Ministry for Education and Research (BMBF); Max Planck Society; French Ministry for Research; CNRS-IN2P3; Astroparticle Interdisciplinary Programme of the CNRS; UK Science and Technology Facilities Council (STFC); IPNP of the Charles University; Polish Ministry of Science and Higher Education; South African Department of Science and Technology; National Research Foundation; University of Namibia; Istituto Nazionale di Astrofisica in Italy; Centre National d'Etudes Spatiales in France	The support of the Namibian authorities and of the University of Namibia in facilitating the construction and operation of H.E.S.S. is gratefully acknowledged, as is the support by the German Ministry for Education and Research (BMBF), the Max Planck Society, the French Ministry for Research, the CNRS-IN2P3 and the Astroparticle Interdisciplinary Programme of the CNRS, the UK Science and Technology Facilities Council (STFC), the IPNP of the Charles University, the Polish Ministry of Science and Higher Education, the South African Department of Science and Technology and National Research Foundation, and by the University of Namibia. We appreciate the excellent work of the technical support staff in Berlin, Durham, Hamburg, Heidelberg, Palaiseau, Paris, Saclay, and in Namibia in the construction and operation of the equipment. The Fermi LAT Collaboration acknowledges generous ongoing support from a number of agencies and institutes that have supported both the development and the operation of the LAT as well as scientific data analysis. These include the National Aeronautics and Space Administration and the Department of Energy in the United States, the Commissariat A l'Energie Atomique and the Centre National de la Recherche Scientifique/Institut National de Physique Nucleaire et de Physique des Particules in France, the Agenzia Spaziale Italiana and the Istituto Nazionale di Fisica Nucleare in Italy, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), High Energy Accelerator Research Organization (KEK) and Japan Aerospace Exploration Agency (JAXA) in Japan, and the K. A. Wallenberg Foundation, the Swedish Research Council and the Swedish National Space Board in Sweden. Additional support for science analysis during the operations phase is gratefully acknowledged from the Istituto Nazionale di Astrofisica in Italy and the Centre National d'Etudes Spatiales in France.	Abdo AA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/17; Abramowski A, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117445; Acero F, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/77; Ackermann M, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/4; Aguirre JE, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/4; Aharonian F, 2005, SCIENCE, V309, P746, DOI 10.1126/science.1113764; AKUJOR CE, 1987, ASTROPHYS SPACE SCI, V135, P187, DOI 10.1007/BF00644473; Albert J, 2006, ASTROPHYS J, V643, pL53, DOI 10.1086/504917; Aleksic J., 2012, ASTRON ASTROPHYS, V541, P13; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; de Naurois M, 2009, ASTROPART PHYS, V32, P231, DOI 10.1016/j.astropartphys.2009.09.001; Leahy DA, 2008, ASTRON J, V135, P167, DOI 10.1088/0004-6256/135/1/167; Abdo AA, 2010, SCIENCE, V327, P1103, DOI 10.1126/science.1182787; Rieke GH, 2004, ASTROPHYS J SUPPL S, V154, P25, DOI 10.1086/422717; Abdo AA, 2009, ASTROPHYS J LETT, V706, pL1, DOI 10.1088/0004-637X/706/1/L1; Aharonian F, 2006, ASTRON ASTROPHYS, V457, P899, DOI 10.1051/0004-6361:20065351; Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Aharonian F, 2006, ASTRON ASTROPHYS, V460, P743, DOI 10.1051/0004-6361:20065940; KENNEL CF, 1984, ASTROPHYS J, V283, P694, DOI 10.1086/162356; Helfand DJ, 2006, ASTRON J, V131, P2525, DOI 10.1086/503253; Slane P, 2010, ASTROPHYS J, V720, P266, DOI 10.1088/0004-637X/720/1/266; Aharonian FA, 1996, ASTRON ASTROPHYS, V309, P917; Jackson JM, 2006, ASTROPHYS J SUPPL S, V163, P145, DOI 10.1086/500091; Abdo AA, 2010, ASTROPHYS J, V712, P459, DOI 10.1088/0004-637X/712/1/459; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; Aharonian F, 2006, ASTROPHYS J, V636, P777, DOI 10.1086/498013; Li H, 2012, MON NOT R ASTRON SOC, V421, P935, DOI 10.1111/j.1365-2966.2012.20270.x; de Jager OC, 2009, ASTROPHYS SPACE SC L, V357, P451; Abdo AA, 2010, ASTROPHYS J, V722, P1303, DOI 10.1088/0004-637X/722/2/1303; Aharonian F, 2006, ASTRON ASTROPHYS, V448, pL43, DOI 10.1051/0004-6361:200600014; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Aharonian F, 2005, SCIENCE, V307, P1938, DOI 10.1126/science.1108643; White RL, 2005, ASTRON J, V130, P586, DOI 10.1086/431249; Berge D, 2007, ASTRON ASTROPHYS, V466, P1219, DOI 10.1051/0004-6361:20066674; Abdo AA, 2010, ASTROPHYS J SUPPL S, V188, P405, DOI 10.1088/0067-0049/188/2/405; Abdo AA, 2010, ASTROPHYS J, V718, P348, DOI 10.1088/0004-637X/718/1/348; Uchiyama Y, 2010, ASTROPHYS J LETT, V723, pL122, DOI 10.1088/2041-8205/723/1/L122; Smith DA, 2008, ASTRON ASTROPHYS, V492, P923, DOI 10.1051/0004-6361:200810285; Spitkovsky A, 2008, ASTROPHYS J LETT, V682, pL5, DOI 10.1086/590248; Carrigan S., 2013, ICRC IN PRESS; Castro D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/36; COX DP, 1972, ASTROPHYS J, V178, P159, DOI 10.1086/151775; Feinstein F, 2009, AIP Conference Proceedings, V1112, DOI 10.1063/1.3125791; Frail DA, 2013, ASTROPHYS J LETT, V773, DOI 10.1088/2041-8205/773/2/L19; GAENSLER BM, 1995, MON NOT R ASTRON SOC, V275, pL73; Gallant Y. A., 2008, AIP C SER, V983, P195; Grondin MH, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/42; Kargaltsev O., 2008, MAGNETARS MORE, V983, P171, DOI DOI 10.1063/1.2900138; Lande J, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/5; Lockett P, 1999, ASTROPHYS J, V511, P235, DOI 10.1086/306667; Loparco F, 2011, NUCL INSTRUM METH A, V646, P167, DOI 10.1016/j.nima.2011.05.023; Mattana F, 2009, ASTROPHYS J, V694, P12, DOI 10.1088/0004-637X/694/1/12; Mattox JR, 1996, ASTROPHYS J, V461, P396, DOI 10.1086/177068; Mehault J., 2011, ICRC, V7, P180; Misanovic Z, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/33; Mukherjee R, 2009, ASTROPHYS J, V691, P1707, DOI 10.1088/0004-637X/691/2/1707; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Pletsch HJ, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/105; Porter T. A., 2005, INT COSM RAY C, V4, P77; REYNOLDS SP, 1984, ASTROPHYS J, V278, P630, DOI 10.1086/161831; Thompson DJ, 2012, ASTROPART PHYS, V39-40, P22, DOI 10.1016/j.astropartphys.2011.10.009; Tian WW, 2007, ASTROPHYS J, V657, pL25, DOI 10.1086/512544	62	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A27	10.1051/0004-6361/201322694		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000027		
J	Baldi, RD; Giroletti, M; Capetti, A; Giovannini, G; Casasola, V; Perez-Torres, MA; Kuno, N				Baldi, Ranieri D.; Giroletti, Marcello; Capetti, Alessandro; Giovannini, Gabriele; Casasola, Viviana; Perez-Torres, Miguel A.; Kuno, Nario			Molecular gas and nuclear activity in early-type galaxies: any link with radio loudness?	ASTRONOMY & ASTROPHYSICS			English	Article						galaxies: active; galaxies: elliptical and lenticular, cD; galaxies: nuclei; galaxies: ISM; ISM: molecules	HOST GALAXY/AGN CONNECTION; NEARBY SPIRAL GALAXIES; ELLIPTIC GALAXIES; ATLAS(3D) PROJECT; ASTRONOMICAL DATA; STAR-FORMATION; BRIGHTNESS PROFILES; STATISTICAL-METHODS; INTERSTELLAR-MEDIUM; PHYSICAL CONDITIONS	Aims. We want to study the amount of molecular gas in a sample of nearby early-type galaxies (ETGs) that host low-luminosity active galactic nuclei (AGN). We look for possible differences between the radio-loud (RL) and radio-quiet (RQ) AGN. Methods. We observed the CO(1-0) and CO(2-1) spectral lines with the IRAM 30 m and NRO 45 m telescopes for eight galaxies. They belong to a large sample of 37 local ETGs that host both RQ and RL AGN. We gather data from the literature for the entire sample. Results. We report the new detection of CO(1-0) emission in four galaxies (UGC 0968, UGC 5617, UGC 6946, and UGC 8355) and CO(2-1) emission in two of them (UGC 0968 and UGC 5617). The CO(2-1)/CO(1-0) ratio in these sources is similar to 0.7 +/- 0.2. Considering both the new observations and the literature, the detection rate of CO in our sample is 55 +/- 9%, with no statistically significant difference between the hosts of RL and RQ AGNs. For all the detected galaxies we converted the CO luminosities into the molecular masses, M-H2, which range from 10(6.5) to 10(8.5) M-circle dot, without any statistically significant differences between RL and RQ galaxies. This suggests that the amount of molecular gas does not likely set the radio loudness of the AGN. Furthermore, despite the low statistical significance, the presence of a weak trend between the H-2 mass with various tracers of nuclear activity (mainly [O III] emission line nuclear power) cannot be excluded.	[Baldi, Ranieri D.] SISSA ISAS, I-34136 Trieste, Italy; [Baldi, Ranieri D.] Technion, Dept Phys, IL-32000 Haifa, Israel; [Baldi, Ranieri D.] Univ Haifa, Dept Phys, Fac Nat Sci, IL-32000 Haifa, Israel; [Giroletti, Marcello; Giovannini, Gabriele; Casasola, Viviana] INAF Ist Radio Astron, I-40129 Bologna, Italy; [Capetti, Alessandro] INAF Osservatorio Astron Torino, I-10025 Pino Torinese, Italy; [Giovannini, Gabriele] Univ Bologna, Dipartimento Fis & Astron, I-40127 Bologna, Italy; [Perez-Torres, Miguel A.] Inst Astrofis Andalucia CSIC, Granada 18008, Spain; [Kuno, Nario] Univ Tsukuba, Fac Pure & Appl Sci, Div Phys, Tsukuba, Ibaraki 305, Japan	Baldi, RD (reprint author), SISSA ISAS, Via Bonomea 265, I-34136 Trieste, Italy.	baldi@ph.technion.ac.il		Giovannini, Gabriele/0000-0003-4916-6362; capetti, alessandro/0000-0003-3684-4275	European Community [R113CT 2003 5058187]; Lady Davis Foundation	This work has benefited from research funding from the European Community's sixth Framework Program under RadioNet R113CT 2003 5058187. R.D.B. was supported at the Technion by a fellowship from the Lady Davis Foundation. We thank the referee for the constructive comments that have helped us to improve the paper.	BRAINE J, 1993, ASTRON ASTROPHYS SUP, V97, P887; Balmaverde B, 2008, ASTRON ASTROPHYS, V486, P119, DOI 10.1051/0004-6361:200809810; FEIGELSON ED, 1985, ASTROPHYS J, V293, P192, DOI 10.1086/163225; Werner N, 2014, MON NOT R ASTRON SOC, V439, P2291, DOI 10.1093/mnras/stu006; Bolatto AD, 2008, ASTROPHYS J, V686, P948, DOI 10.1086/591513; Sage LJ, 2007, ASTROPHYS J, V657, P232, DOI 10.1086/510577; LAVALLEY M, 1992, ASTR SOC P, V25, P245; Alatalo K, 2013, MON NOT R ASTRON SOC, V432, P1796, DOI 10.1093/mnras/sts299; Capetti A, 2005, ASTRON ASTROPHYS, V440, P73, DOI 10.1051/0004-6361:20053113; WILSON AS, 1995, ASTROPHYS J, V438, P62, DOI 10.1086/175054; Komugi S, 2008, ASTROPHYS J SUPPL S, V178, P225, DOI 10.1086/590469; Crocker AF, 2011, MON NOT R ASTRON SOC, V410, P1197, DOI 10.1111/j.1365-2966.2010.17537.x; Balmaverde B, 2006, ASTRON ASTROPHYS, V451, P35, DOI 10.1051/0004-6361:20053799; Chiaberge M, 1999, ASTRON ASTROPHYS, V349, P77; LEES JF, 1991, ASTROPHYS J, V379, P177, DOI 10.1086/170494; Faber SM, 1997, ASTRON J, V114, P1771, DOI 10.1086/118606; PHILLIPS MM, 1986, ASTRON J, V91, P1062, DOI 10.1086/114083; Davis TA, 2013, MON NOT R ASTRON SOC, V429, P534, DOI 10.1093/mnras/sts353; Allen SW, 2006, MON NOT R ASTRON SOC, V372, P21, DOI 10.1111/j.1365-2966.2006.10778.x; Glover SCO, 2011, MON NOT R ASTRON SOC, V412, P337, DOI 10.1111/j.1365-2966.2010.17907.x; ISOBE T, 1986, ASTROPHYS J, V306, P490, DOI 10.1086/164359; Burstein D, 1997, ASTRON J, V114, P1365, DOI 10.1086/118570; Vollmer B, 2005, ASTRON ASTROPHYS, V441, P473, DOI [10.1051/0004-6361:20041389, 10.1051/0004-6361:20041289]; Baldi RD, 2009, ASTRON ASTROPHYS, V508, P603, DOI 10.1051/0004-6361/200913021; Ogle P, 2010, ASTROPHYS J, V724, P1193, DOI 10.1088/0004-637X/724/2/1193; ISOBE T, 1990, ASTROPHYS J, V364, P104, DOI 10.1086/169390; Boselli A, 2002, ASTRON ASTROPHYS, V384, P33, DOI [10.1051/0004-6361:20011747, 10.1051/0004-6361:2001174]; Arimoto N, 1996, PUBL ASTRON SOC JPN, V48, P275; Balmaverde B, 2006, ASTRON ASTROPHYS, V447, P97, DOI [10.1051/0004-6361:20054031, 10.1051/004-6361:20054031]; Beuing J, 1999, MON NOT R ASTRON SOC, V302, P209, DOI 10.1046/j.1365-8711.1999.02108.x; Boker T, 2003, ASTRON ASTROPHYS, V406, P87, DOI 10.1051/0004-6361:20030755; Bettoni D, 2003, ASTRON ASTROPHYS, V405, P5, DOI 10.1051/0004-6361:20030557; BRAINE J, 1992, ASTRON ASTROPHYS, V264, P433; Capetti A, 2007, ASTRON ASTROPHYS, V469, P75, DOI 10.1051/0004-6361:20066684; Capetti A, 2006, ASTRON ASTROPHYS, V453, P27, DOI 10.1051/0004-6361:20054490; Casasola V, 2007, ASTRON ASTROPHYS, V473, P771, DOI 10.1051/0004-6361:20077883; Combes F, 2007, MON NOT R ASTRON SOC, V377, P1795, DOI 10.1111/j.1365-2966.2007.11759.x; FABBIANO G, 1989, ANNU REV ASTRON ASTR, V27, P87; Fanaroff B. L., 1974, MNRAS, V167, p3II; HUCHTMEIER WK, 1994, ASTRON ASTROPHYS, V281, P327; Israel FP, 1997, ASTRON ASTROPHYS, V328, P471; Kaplan E. L., 1958, J AM STAT ASSOC, V457, P53; KENDALL M., 1983, BIOMETRIKA, V30, P81; Kharb P, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/4/78; KNAPP GR, 1985, ASTRON J, V90, P454, DOI 10.1086/113751; KNAPP GR, 1989, ASTROPHYS J SUPPL S, V70, P329, DOI 10.1086/191342; Lisenfeld U, 2008, ASTROPHYS J, V685, P181, DOI 10.1086/590420; Magrini L, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201116872; Maiolino R, 1997, ASTROPHYS J, V485, P552, DOI 10.1086/304438; MALONEY P, 1990, ASTROPHYS SPACE SC L, V161, P493; Nemmen R. S., 2014, MNRAS UNPUB; Nesvadba NPH, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200913333; O'Sullivan E, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424835; Flaquer BO, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/200913392; Papadopoulos PP, 1998, ASTROPHYS J, V492, P521, DOI 10.1086/305052; Sage L. J., 1989, APJ, P204; Sage L. J., 1989, IAU S, V344, P204; Sage L. J., 1989, APJ, P344; SCHMITT JHMM, 1985, ASTROPHYS J, V293, P178, DOI 10.1086/163224; SOFUE Y, 1993, PUBL ASTRON SOC JPN, V45, P529; Solomon P. M., 1991, IAU S, V146, P235; TANIGUCHI Y, 1994, ASTRON J, V108, P468, DOI 10.1086/117084; Welch GA, 2003, ASTROPHYS J, V584, P260, DOI 10.1086/345537; WIKLIND T, 1995, ASTRON ASTROPHYS, V297, P643; WROBEL JM, 1991, ASTRON J, V101, P148, DOI 10.1086/115674; Young LM, 2005, ASTROPHYS J, V634, P258, DOI 10.1086/491728; Young LM, 2011, MON NOT R ASTRON SOC, V414, P940, DOI 10.1111/j.1365-2966.2011.18561.x; Young LM, 2002, ASTRON J, V124, P788, DOI 10.1086/341648	68	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A65	10.1051/0004-6361/201425131		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000065		
J	Diehl, R; Siegert, T; Hillebrandt, W; Krause, M; Greiner, J; Maeda, K; Ropke, FK; Sim, SA; Wang, W; Zhang, XL				Diehl, Roland; Siegert, Thomas; Hillebrandt, Wolfgang; Krause, Martin; Greiner, Jochen; Maeda, Keiichi; Roepke, Friedrich K.; Sim, Stuart A.; Wang, Wei; Zhang, Xiaoling			SN2014J gamma rays from the Ni-56 decay chain	ASTRONOMY & ASTROPHYSICS			English	Article						supernovae: general; supernovae: individual: SN2014J; stars: abundances; binaries: close; gamma rays: general; gamma rays: stars	IA SUPERNOVA 2014J; SN 2014J; EXPLOSION MECHANISM; M82; EMISSION; CONSTRAINTS; SPECTRA; MODELS	Context. The detection and measurement of gamma-ray lines from the decay chain of Ni-56 provides unique information about the explosion in supernovae. SN2014J at 3.3 Mpc is a sufficiently-nearby supernova of type Ia so that such measurements have been feasible with the gamma-ray spectrometer SPI on ESA's INTEGRAL gamma-ray observatory. Aims. The Ni-56 freshly produced in the supernova is understood to power the optical light curve, because it emits gamma rays upon its radioactive decay first to Co-56 and then to Fe-56. Gamma-ray lines from Co-56 decay are expected to become directly visible through the white dwarf material several weeks after the explosion, as they progressively penetrate the overlying material of the supernova envelope, which is diluted as it expands. The lines are expected to be Doppler-shifted or broadened from the kinematics of the Ni-56 ejecta. We aim to exploit high-resolution gamma-ray spectroscopy with the SPI spectrometer on INTEGRAL toward constraining the Ni-56 distribution and kinematics in this supernova. Methods. We use the observations with the SPI spectrometer on INTEGRAL, together with an improved instrumental background method. Results. We detect the two main lines from Co-56 decay at 847 and 1238 keV, which are significantly Doppler-broadened, and at intensities (3.65 +/- 1.21) x 10(-4) and (2.27 +/- 0.69) x 10(-4) ph cm(-2) s(-1), respectively, at their brightness maximum. We measure their rise toward a maximum after about 60-100 days and a decline thereafter. The intensity ratio of the two lines is found to be consistent with expectations from Co-56 decay (0.62 +/- 0.28 at brightness maximum, the expected ratio is 0.68). We find that the broad lines seen in the late, gamma-ray transparent phase are not representative of the early gamma-ray emission, and notice instead that the emission spectrum is complex and irregular until the supernova is fully transparent to gamma rays, with progressive uncovering of the bulk of Ni-56. We infer that the explosion morphology is not spherically symmetric, both in the distribution of Ni-56 and in the unburnt material which occults the Co-56 emission. After we compare light curves from different plausible models, the resulting Ni-56 mass is determined to be 0.49 +/- 0.09 M-circle dot.	[Diehl, Roland; Siegert, Thomas; Krause, Martin; Greiner, Jochen; Wang, Wei; Zhang, Xiaoling] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Diehl, Roland; Hillebrandt, Wolfgang; Krause, Martin; Greiner, Jochen; Wang, Wei] Excellence Cluster Universe, D-85748 Garching, Germany; [Hillebrandt, Wolfgang] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Maeda, Keiichi] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Roepke, Friedrich K.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany; [Sim, Stuart A.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Wang, Wei] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China	Diehl, R (reprint author), Max Planck Inst Extraterr Phys, D-85741 Garching, Germany.	rod@mpe.mpg.de			German DEG; DEG Transregio [33]; DEG [RO3676/1-1]; ARCHES prize of the German Ministry for Education and Research (BMBF); JSPS [23740141, 26800100]; WPI initiative, MEXT, Japan; Chinese Academy of Sciences; Max Planck Gesellschaft	This research was supported by the German DEG cluster of excellence "Origin and Structure of the Universe", and from DEG Transregio Project No 33 "Dark Universe", F.K.R. was supported by the DEG (Emmy Noether Programm RO3676/1-1) and the ARCHES prize of the German Ministry for Education and Research (BMBF). The work by K.M. is partly supported by JSPS Grant-in-Aid for Scientific Research (23740141, 26800100) and by WPI initiative, MEXT, Japan. W.W. is supported by the Chinese Academy of Sciences and the Max Planck Gesellschaft, and by the German DEG cluster of excellence "Origin and Structure of the Universe". We are grateful to E. Kuulkers for handling the observations for the INTEGRAL SN2014J campaign. The INTEGRAL/SPI project has been completed under the responsibility and leadership of CNES; we are grateful to ASI, CEA, CNES, DER, ESA, INTA, NASA and OSTC for support of this ESA space science mission. INTEGRAL's data archive (http://www.isdc.unige.ch/integral/archive#Datadelease) is at the ISDC in Versoix, CH, and includes the SN2014J data used in this paper.	Foley RJ, 2014, MON NOT R ASTRON SOC, V443, P2887, DOI 10.1093/mnras/stu1378; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Hillebrandt W, 2013, FRONT PHYS-BEIJING, V8, P116, DOI 10.1007/s11467-013-0303-2; Diehl R, 2014, SCIENCE, V345, P1162, DOI 10.1126/science.1254738; Dessart L, 2014, MON NOT R ASTRON SOC, V441, P3249, DOI 10.1093/mnras/stu789; Milne PA, 2004, ASTROPHYS J, V613, P1101, DOI 10.1086/423235; WOOSLEY SE, 1994, ASTROPHYS J, V423, P371, DOI 10.1086/173813; Maeda K, 2010, ASTROPHYS J, V708, P1703, DOI 10.1088/0004-637X/708/2/1703; Churazov E, 2014, NATURE, V512, P406, DOI 10.1038/nature13672; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; LIVNE E, 1995, ASTROPHYS J, V452, P62, DOI 10.1086/176279; Maeda K, 2010, NATURE, V466, P82, DOI 10.1038/nature09122; Cao Y., 2014, ATEL, V5786, P1; Dessart L, 2014, MON NOT R ASTRON SOC, V441, P532, DOI 10.1093/mnras/stu598; Fossey J., 2014, CBET, V3792, P1; Goobar A, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L12; Hoeflich P., 1998, APJ, V492, P228; Isern J., 1997, TRANSPARENT UNIVERSE, V382, P89; Isern J, 2011, LECT NOTES PHYS, V812, P233, DOI 10.1007/978-3-642-12698-7_5; Isern J, 2008, NEW ASTRON REV, V52, P377, DOI 10.1016/j.newar.2008.06.021; Khokhlov AM, 2001, SPACE TEL S, V13, P239; Kuulkers E., 2014, ATEL, V5835, P1; Nomoto K., 1997, Nuclear Physics A, VA621, DOI 10.1016/S0375-9474(97)00291-1; Stritzinger M, 2006, ASTRON ASTROPHYS, V450, P241, DOI 10.1051/0004-6361:20053652; The LS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/141; Vedrenne G, 2003, ASTRON ASTROPHYS, V411, pL63, DOI 10.1051/0004-6361:20031482; Zheng WK, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L24	28	5	5	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A72	10.1051/0004-6361/201424991		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000072		
J	Frau, P; Girart, JM; Alves, FO; Franco, GAP; Onishi, T; Roman-Zuniga, CG				Frau, P.; Girart, J. M.; Alves, F. O.; Franco, G. A. P.; Onishi, T.; Roman-Zuniga, C. G.			Formation of dense structures induced by filament collisions Correlation of density, kinematics, and magnetic field in the Pipe nebula	ASTRONOMY & ASTROPHYSICS			English	Article						ISM: clouds; ISM: magnetic fields; ISM: individual objects: Pipe nebula; dust, extinction; evolution; ISM: kinematics and dynamics	STAR-FORMATION ACTIVITY; NEAR-INFRARED SURVEY; CORE POPULATION; EXTINCTION MAPS; DARK CLOUD; DUST; SHOCKS	Context. The Pipe nebula is a molecular cloud that lacks star formation feedback and has a relatively simple morphology and velocity structure. This makes it an ideal target for testing cloud evolution through collisions. Aims. We aim at drawing a comprehensive picture of this relatively simple cloud to better understand the formation and evolution of molecular clouds on large scales. Methods. We use archival data to compare the optical polarization properties, the visual extinction, and the (CO)-C-13 velocities and linewidths of the entire cloud in order to identify trends among the observables. Results. The Pipe nebula can be roughly divided into two filaments with different orientations and gas velocity ranges: E-W at 2-4 km s(-1) and N-S at 6-7 km s(-1). The two filaments overlap at the bowl, where the gas shows a velocity gradient spanning from 2 to 7 km s(-1). Compared to the rest of the Pipe nebula, the bowl gas appears to be denser and exhibits larger linewidths. In addition, the polarization data at the bowl shows lower angular dispersion and higher polarization degree. Cores in the bowl tend to cluster in space and to follow the (CO)-C-13 velocity gradient. In the stem, cores tend to cluster in regions with properties similar to those of the bowl. Conclusions. The velocity pattern points to a collision between the filaments in the bowl region. The magnetic field seems to be compressed and strengthened in the shocked region. The proportional increase in density and magnetic field strength by a factor similar to the Alfvenic Mach number suggests a continuous shock at low Alfvenic Mach number under the flux-freezing condition. Shocked regions seem to enhance the formation and clustering of dense cores.	[Frau, P.] Inst Ciencia Mat Madrid CSIC, Madrid 28049, Spain; [Frau, P.] Observ Astron Nacl, Madrid 28014, Spain; [Girart, J. M.] Inst Ciencies Espai CSIC IEEC, Fac Ciencies, Bellaterra 08193, Catalonia, Spain; [Alves, F. O.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Franco, G. A. P.] Univ Fed Minas Gerais, ICEx, Dept Fis, BR-30123970 Belo Horizonte, MG, Brazil; [Onishi, T.] Osaka Prefecture Univ, Dept Phys Sci, Sakai, Osaka 5998531, Japan; [Roman-Zuniga, C. G.] Univ Nacl Autonoma Mexico, Inst Astron, Unidad Acad Ensenada, Mexico City 22860, DF, Mexico	Frau, P (reprint author), Inst Ciencia Mat Madrid CSIC, Sor Juana Ines de la Cruz 3, Madrid 28049, Spain.	pfrau@icmm.csic.es	Franco, Gabriel/A-8009-2011		CONSOLIDER, Spain [CSD2009-00038]; MINECO project, Spain [AYA2011-30228-C03-02]; CNPq agency, Brazil; program CONACYT, Mexico [CB-2010 152160]	We thank Daniele Galli and Andy Pon for useful comments and suggestions that are greatly appreciated. P.F is supported by the CONSOLIDER project CSD2009-00038, Spain. P.F. and J.M.G. are supported by the MINECO project AYA2011-30228-C03-02, Spain. G.A.P.F. is supported by the CNPq agency, Brazil. CRZ is supported by program CONACYT CB-2010 152160, Mexico.	Alves FO, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424678; Alves FO, 2008, ASTRON ASTROPHYS, V486, pL13, DOI 10.1051/0004-6361:200810091; Lada CJ, 2008, ASTROPHYS J, V672, P410, DOI 10.1086/523837; Rathborne JM, 2008, ASTROPHYS J SUPPL S, V174, P396, DOI 10.1086/522889; Henshaw JD, 2013, MON NOT R ASTRON SOC, V428, P3425, DOI 10.1093/mnras/sts282; Bergin EA, 2007, ANNU REV ASTRON ASTR, V45, P339, DOI 10.1146/annurev.astro.45.071206.100404; Forbrich J, 2009, ASTROPHYS J, V704, P292, DOI 10.1088/0004-637X/704/1/292; Frau P, 2010, ASTROPHYS J, V723, P1665, DOI 10.1088/0004-637X/723/2/1665; Lombardi M, 2006, ASTRON ASTROPHYS, V454, P781, DOI 10.1051/0004-6361:20042474; Lombardi M, 2001, ASTRON ASTROPHYS, V377, P1023, DOI 10.1051/0004-6361:20011099; Duarte-Cabral A, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015477; Franco GAP, 2010, ASTROPHYS J, V723, P146, DOI 10.1088/0004-637X/723/1/146; Frau P, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/3; Frau P, 2012, THESIS; Hacar A, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220090; Lesaffre P, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201219928; Muench AA, 2007, ASTROPHYS J, V671, P1820, DOI 10.1086/523265; Nakamura F, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L23; Onishi T, 1999, PUBL ASTRON SOC JPN, V51, P871; Peretto N, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118663; Pon A, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/25; Roman-Zuniga CG, 2010, ASTROPHYS J, V725, P2232, DOI 10.1088/0004-637X/725/2/2232; Roman-Zuniga CG, 2009, ASTROPHYS J, V704, P183, DOI 10.1088/0004-637X/704/1/183; Whittet D. C. B., 2003, DUST GALACTIC ENV	24	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								L6	10.1051/0004-6361/201425234		4	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000154		
J	Kolotkov, DY; Nakariakov, VM; Kupriyanova, EG; Ratcliffe, H; Shibasaki, K				Kolotkov, D. Y.; Nakariakov, V. M.; Kupriyanova, E. G.; Ratcliffe, H.; Shibasaki, K.			Multi-mode quasi-periodic pulsations in a solar flare	ASTRONOMY & ASTROPHYSICS			English	Article						Sun: flares; Sun: oscillations; waves; Sun: corona; magnetohydrodynamics (MHD)	EMPIRICAL MODE DECOMPOSITION; X-RAY PULSATIONS; MICROWAVE EMISSION; CORONAL LOOPS; RADIO PULSATIONS; MAGNETIC-FIELD; OSCILLATIONS; WAVES; RECONNECTION; PLASMA	Context. Quasi-periodic pulsations (QPP) of the electromagnetic radiation emitted in solar and stellar flares are often detected in microwave, white light, X-ray, and gamma-ray bands. Mechanisms for QPP are intensively debated in the literature. Previous studies revealed that QPP may manifest non-linear, non-stationary and, perhaps, multi-modal processes operating in flares. Aims. We study QPP of the microwave emission generated in an X3.2-class solar flare on 14 May, 2013, observed with the Nobeyama Radioheliograph (NoRH), aiming to reveal signatures of the non-linear, non-stationary, and multi-modal processes in the signal. Methods. The NoRH correlation signal obtained at the 17 GHz intensity has a clear QPP pattern. The signal was analysed with the Hilbert-Huang transform (HHT) that allows one to determine its instant amplitude and frequency, and their time variation. Results. It was established that the QPP consists of at least three well-defined intrinsic modes, with the mean periods of 15, 45, and 100 s. All the modes have quasi-harmonic behaviour with different modulation patterns. The 100 s intrinsic mode is a decaying oscillation, with the decay time of 250 s. The 15 s intrinsic mode shows a similar behaviour, with the decay time of 90 s. The 45 s mode has a wave-train behaviour. Conclusions. Dynamical properties of detected intrinsic modes indicate that the 100 s and 15 s modes are likely to be associated with fundamental kink and sausage modes of the flaring loop, respectively. The 100 s oscillation could also be caused by the fundamental longitudinal mode, while this interpretation requires the plasma temperature of about 30 million K and hence is not likely. The 45 s mode could be the second standing harmonics of the kink mode.	[Kolotkov, D. Y.; Nakariakov, V. M.; Ratcliffe, H.] Univ Warwick, Dept Phys, Ctr Fus Space & Astrophys, Coventry CV4 7AL, W Midlands, England; [Nakariakov, V. M.] Kyung Hee Univ, Sch Space Res, Yongin 446701, Gyeonggi, South Korea; [Nakariakov, V. M.; Kupriyanova, E. G.] Russian Acad Sci, Cent Astron Observ Pulkovo, St Petersburg 196140, Russia; [Shibasaki, K.] Natl Inst Nat Sci, Natl Astron Observ Japan, Nobeyama Solar Radio Observ, Minamimaki, Nagano 3841305, Japan	Kolotkov, DY (reprint author), Univ Warwick, Dept Phys, Ctr Fus Space & Astrophys, Coventry CV4 7AL, W Midlands, England.	V.Nakariakov@warwick.ac.uk	Nakariakov, Valery/E-2375-2013	Nakariakov, Valery/0000-0001-6423-8286	Marie Curie RadioSun project [PIRSES-GA-2011-295272]; Royal Society - Daiwa Anglo Japanese Foundation International Exchanges Scheme; European Research Council [321141]; STFC consolidated grant [ST/L000733/1]; BK21 plus program through the National Research Foundation - Ministry of Education of Korea; Russian Foundation for Basic Research [12-02-00616, 14-02-00924, 13-02-00044]	This work is supported by the Marie Curie PIRSES-GA-2011-295272 RadioSun project (D.Y.K., V.M.N., E.G.K.), the Royal Society - Daiwa Anglo Japanese Foundation International Exchanges Scheme (D.Y.K., V.M.N., K.S.); the European Research Council research project 321141 SeismoSun (V.M.N., H.R.), STFC consolidated grant ST/L000733/1, BK21 plus program through the National Research Foundation funded by the Ministry of Education of Korea (V.M.N.); and the Russian Foundation for Basic Research projects 12-02-00616 and 14-02-00924 (E.G.K.), and 13-02-00044 (E.G.K., V.M.N.).	Anfinogentov S, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/156; Kliem B, 2000, ASTRON ASTROPHYS, V360, P715; Zolotova NV, 2007, SOL PHYS, V243, P193, DOI 10.1007/s11207-007-0405-5; De Moortel I, 2012, PHILOS T R SOC A, V370, P3193, DOI 10.1098/rsta.2011.0640; Mathioudakis M, 2003, ASTRON ASTROPHYS, V403, P1101, DOI 10.1051/0004-6361:20030394; Jakimiec J, 2010, SOL PHYS, V261, P233, DOI 10.1007/s11207-009-9489-4; Nakariakov VM, 2003, ASTRON ASTROPHYS, V412, pL7, DOI 10.1051/0004-6361:20031660; Ofman L, 2006, ASTROPHYS J, V644, pL149, DOI 10.1086/505622; Sych R, 2009, ASTRON ASTROPHYS, V505, P791, DOI 10.1051/0004-6361/200912132; Nakariakov VM, 2009, SPACE SCI REV, V149, P119, DOI 10.1007/s11214-009-9536-3; Nagovitsyn YA, 1997, ASTRON LETT+, V23, P742; ZAITSEV VV, 1982, SOV ASTRON LETT+, V8, P132; Kislyakov AG, 2006, SOL PHYS, V233, P89, DOI 10.1007/s11207-006-2850-y; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903; Andries J, 2009, SPACE SCI REV, V149, P3, DOI 10.1007/s11214-009-9561-2; Kupriyanova EG, 2013, SOL PHYS, V284, P559, DOI 10.1007/s11207-012-0141-3; Ofman L, 2002, ASTROPHYS J, V580, pL85, DOI 10.1086/345548; Nakariakov VM, 2006, ASTRON ASTROPHYS, V452, P343, DOI [10.1051/0004-6361:20054608, 10.1051/0004-6361:200546908]; Chen PF, 2006, SOL PHYS, V238, P313, DOI 10.1007/s11207-006-0215-1; Inglis AR, 2009, ASTRON ASTROPHYS, V493, P259, DOI 10.1051/0004-6361:200810473; NAKAJIMA H, 1985, PUBL ASTRON SOC JPN, V37, P163; ASCHWANDEN MJ, 1987, SOL PHYS, V111, P113, DOI 10.1007/BF00145445; Murray MJ, 2009, ASTRON ASTROPHYS, V494, P329, DOI 10.1051/0004-6361:200810406; Kupriyanova EG, 2010, SOL PHYS, V267, P329, DOI 10.1007/s11207-010-9642-0; De Moortel I, 2003, ASTRON ASTROPHYS, V408, P755, DOI 10.1051/0004-6361:20030984; Terradas J, 2004, ASTROPHYS J, V614, P435, DOI 10.1086/423332; Zaitsev VV, 2008, PHYS-USP+, V51, P1123, DOI 10.1070/PU2008v051n11ABEH006657; Mitra-Kraev U, 2005, ASTRON ASTROPHYS, V436, P1041, DOI 10.1051/0004-6361:20052834; Komm RW, 2001, ASTROPHYS J, V558, P428, DOI 10.1086/322464; Nakariakov VM, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124009; Chorley N, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913683; Dubinov AE, 2012, TECH PHYS+, V57, P585, DOI 10.1134/S1063784212050088; Dubinov AE, 2012, PLASMA PHYS REP+, V38, P833, DOI 10.1134/S1063780X12090036; Fleishman GD, 2008, ASTROPHYS J, V684, P1433, DOI 10.1086/589821; NAKAJIMA H, 1994, P IEEE, V82, P705, DOI 10.1109/5.284737; Khodachenko ML, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014860; Kim S, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/2/L36; Kupriyanova EG, 2014, ASTRON REP+, V58, P573, DOI 10.1134/S1063772914080022; Li KJ, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/135; Li KJ, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/49; Li Q., 2007, CHINESE ASTRONOMY AS, V31, P261, DOI 10.1016/j.chinastron.2007.06.002; Nakariakov VM, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/134; Nakariakov VM, 2010, ASTROPHYS J LETT, V708, pL47, DOI 10.1088/2041-8205/708/1/L47; Nakariakov VM, 2007, ADV SPACE RES, V39, P1804, DOI 10.1016/j.asr.2007.01.044; Ning ZJ, 2014, SOL PHYS, V289, P1239, DOI 10.1007/s11207-013-0405-6; Van Doorsselaere T, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/90; Vecchio A, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/27; Wang TJ, 2011, SPACE SCI REV, V158, P397, DOI 10.1007/s11214-010-9716-1; Wu Z, 2009, ADV ADAPTIVE DATA AN, V1, P1, DOI DOI 10.1142/S1793536909000047	49	2	2	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A53	10.1051/0004-6361/201424988		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000053		
J	Leloudas, G; Hsiao, EY; Johansson, J; Maeda, K; Moriya, TJ; Nordin, J; Petrushevska, T; Silverman, JM; Sollerman, J; Stritzinger, MD; Taddia, F; Xu, D				Leloudas, G.; Hsiao, E. Y.; Johansson, J.; Maeda, K.; Moriya, T. J.; Nordin, J.; Petrushevska, T.; Silverman, J. M.; Sollerman, J.; Stritzinger, M. D.; Taddia, F.; Xu, D.			Supernova spectra below strong circumstellar interaction	ASTRONOMY & ASTROPHYSICS			English	Article						supernovae: general	CORE-COLLAPSE SUPERNOVAE; ABSOLUTE MAGNITUDE DISTRIBUTIONS; GAMMA-RAY BURST; IA SUPERNOVAE; LIGHT-CURVES; IIN SUPERNOVAE; SN 2009IP; STRIPPED-ENVELOPE; MASSIVE STAR; LOW-LUMINOSITY	We construct spectra of supernovae (SNe) interacting strongly with a circumstellar medium (CSM) by adding SN templates, a black-body continuum, and an emission-line spectrum. In a Monte Carlo simulation we vary a large number of parameters, such as the SN type, brightness and phase, the strength of the CSM interaction, the extinction, and the signal to noise ratio (S/N) of the observed spectrum. We generate more than 800 spectra, distribute them to ten different human classifiers, and study how the different simulation parameters affect the appearance of the spectra and their classification. The SNe IIn showing some structure over the continuum were characterized as "SNe IInS" to allow for a better quantification. We demonstrate that the flux ratio of the underlying SN to the continuum f(v) is the single most important parameter determining whether a spectrum can be classified correctly. Other parameters, such as extinction, S/N, and the width and strength of the emission lines, do not play a significant role. Thermonuclear SNe get progressively classified as Ia-CSM, IInS, and IIn as f(v) decreases. The transition between Ia-CSM and IInS occurs at f(v) similar to 0.2-0.3. It is therefore possible to determine that SNe Ia-CSM are found at the (un-extincted) magnitude range -19.5 > M > -21.6, in very good agreement with observations, and that the faintest SN IIn that can hide a SN Ia has M = -20.1. The literature sample of SNe Ia-CSM shows an association with 91T-like SNe Ia. Our experiment does not support that this association can be attributed to a luminosity bias (91T-like being brighter than normal events). We therefore conclude that this association has real physical origins and we propose that 91T-like explosions result from single degenerate progenitors that are responsible for the CSM. Despite the spectroscopic similarities between SNe Ibc and SNe Ia, the number of misclassifications between these types was very small in our simulation and mostly at low S/N. Combined with the SN luminosity function needed to reproduce the observed SN Ia-CSM luminosities, it is unlikely that SNe Ibc constitute an important contaminant within this sample. We show how Type II spectra transition to IIn and how the H alpha profiles vary with f(v). SNe IIn fainter than M = -17.2 are unable to mask SNe IIP brighter than M = -15. A more advanced simulation, including radiative transfer, shows that our simplified model is a good first order approximation. The spectra obtained are in good agreement with real data.	[Leloudas, G.; Johansson, J.; Petrushevska, T.] Stockholm Univ, Dept Phys, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Leloudas, G.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Leloudas, G.; Xu, D.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; [Hsiao, E. Y.] Las Campanas Observ, Carnegie Observ, Colina El Pino, Chile; [Hsiao, E. Y.; Stritzinger, M. D.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Maeda, K.] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Maeda, K.] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Moriya, T. J.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Nordin, J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Nordin, J.] EO Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Silverman, J. M.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Sollerman, J.; Taddia, F.] Stockholm Univ, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden	Leloudas, G (reprint author), Stockholm Univ, Dept Phys, Oskar Klein Ctr, S-10691 Stockholm, Sweden.	giorgos@dark-cosmology.dk			Swedish Research Council [623-2011-7117]; Danish Agency for Science and Technology and Innovation realized through a Sapere Aude Level 2 grant; JSPS [23740141, 26800100]; Japan Society for the Promotion of Science Postdoctoral Fellowships Astrophysics Postdoctoral fellowship [AST-1302771]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Swedish Research Council; Danish National Research Foundation	We thank Joe Anderson for sharing with us the results on the absolute magnitude distribution of Type II SNe prior to publication. We also thank Ariel Goobar and Rahman Amanullah for discussions, and Jens Hjorth for comments on th manuscipt. G.L. was supported by the Swedish Research Council through grant No. 623-2011-7117 during the time this work was carried out. E.Y.H. and M.D.S. gratefully acknowledge generous support provided by the Danish Agency for Science and Technology and Innovation realized through a Sapere Aude Level 2 grant. The work by K.M. is supported by JSPS Grant-in-Aid for Scientific Research (23740141, 26800100). T.J.M. is supported by Japan Society for the Promotion of Science Postdoctoral Fellowships Astrophysics Postdoctoral fellowship under award AST-1302771. This research is supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. The Oskar Klein Centre is funded by the Swedish Research Council. The Dark Cosmology Centre is funded by the Danish National Research Foundation.	Amanullah R, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/20; Anderson JP, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/67; Anderson JP, 2012, MON NOT R ASTRON SOC, V424, P1372, DOI 10.1111/j.1365-2966.2012.21324.x; Andrews JE, 2010, ASTROPHYS J, V715, P541, DOI 10.1088/0004-637X/715/1/541; Inserra C, 2012, MON NOT R ASTRON SOC, V422, P1122, DOI 10.1111/j.1365-2966.2012.20685.x; Mauerhan JC, 2013, MON NOT R ASTRON SOC, V430, P1801, DOI 10.1093/mnras/stt009; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Patat F, 2007, SCIENCE, V317, P924, DOI 10.1126/science.1143005; Harutyunyan AH, 2008, ASTRON ASTROPHYS, V488, P383, DOI 10.1051/0004-6361:20078859; Taubenberger S, 2006, MON NOT R ASTRON SOC, V371, P1459, DOI 10.1111/j.1365-2966.2006.10776.x; Smith N, 2007, ASTRON J, V134, P846, DOI 10.1086/518563; Valenti S, 2008, ASTROPHYS J LETT, V673, pL155, DOI 10.1086/527672; TURATTO M, 1993, MON NOT R ASTRON SOC, V262, P128; Aldering G, 2006, ASTROPHYS J, V650, P510, DOI 10.1086/507020; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; Garavini G, 2004, ASTRON J, V128, P387, DOI 10.1086/421747; Puls J, 2008, ASTRON ASTROPHYS REV, V16, P209, DOI 10.1007/s00159-008-0015-8; Li WD, 2011, MON NOT R ASTRON SOC, V412, P1441, DOI 10.1111/j.1365-2966.2011.18160.x; CHUGAI NN, 1994, MON NOT R ASTRON SOC, V268, P173; Howell DA, 2005, ASTROPHYS J, V634, P1190, DOI 10.1086/497119; Sullivan M, 2006, ASTROPHYS J, V648, P868, DOI 10.1086/506137; Sternberg A, 2011, SCIENCE, V333, P856, DOI 10.1126/science.1203836; Hamuy M, 2003, NATURE, V424, P651, DOI 10.1038/nature01854; Smith N, 2008, ASTROPHYS J, V686, P467, DOI 10.1086/591021; Benetti S, 2005, ASTROPHYS J, V623, P1011, DOI 10.1086/428608; Mazzali PA, 2002, ASTROPHYS J, V572, pL61, DOI 10.1086/341504; Kankare E, 2012, MON NOT R ASTRON SOC, V424, P855, DOI 10.1111/j.1365-2966.2012.21224.x; Blondin S, 2007, ASTROPHYS J, V666, P1024, DOI 10.1086/520494; Smith N, 2009, ASTROPHYS J, V695, P1334, DOI 10.1088/0004-637X/695/2/1334; Folatelli G, 2010, ASTRON J, V139, P120, DOI 10.1088/0004-6256/139/1/120; Maguire K, 2013, MON NOT R ASTRON SOC, V436, P222, DOI 10.1093/mnras/stt1586; Thompson TA, 2009, ASTROPHYS J, V705, P1364, DOI 10.1088/0004-637X/705/2/1364; Wang XF, 2013, SCIENCE, V340, P170, DOI 10.1126/science.1231502; Kasen D, 2006, ASTROPHYS J, V651, P366, DOI 10.1086/506190; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Van Dyk SD, 2000, PUBL ASTRON SOC PAC, V112, P1532, DOI 10.1086/317727; Nugent P, 2002, PUBL ASTRON SOC PAC, V114, P803, DOI 10.1086/341707; Ganeshalingam M, 2010, ASTROPHYS J SUPPL S, V190, P418, DOI 10.1088/0067-0049/190/2/418; Dilday B, 2012, SCIENCE, V337, P942, DOI 10.1126/science.1219164; Kulkarni SR, 2007, NATURE, V447, P458, DOI 10.1038/nature05822; Mannucci F, 2005, ASTRON ASTROPHYS, V433, P807, DOI 10.1051/0004-6361:20041411; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Maoz D, 2012, MON NOT R ASTRON SOC, V426, P3282, DOI 10.1111/j.1365-2966.2012.21871.x; Valenti S, 2009, NATURE, V459, P674, DOI 10.1038/nature08023; FILIPPENKO AV, 1992, ASTROPHYS J, V384, pL15, DOI 10.1086/186252; Richardson D, 2002, ASTRON J, V123, P745, DOI 10.1086/338318; Pastorello A, 2004, MON NOT R ASTRON SOC, V347, P74, DOI 10.1111/j.1365-2966.2004.07173.x; Fransson C, 2002, ASTROPHYS J, V572, P350, DOI 10.1086/340295; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Li WD, 2001, ASTROPHYS J, V546, P734, DOI 10.1086/318299; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Moriya TJ, 2014, MON NOT R ASTRON SOC, V439, P2917, DOI 10.1093/mnras/stu163; Smith N, 2011, MON NOT R ASTRON SOC, V412, P1522, DOI 10.1111/j.1365-2966.2011.17229.x; Pastorello A, 2007, NATURE, V447, P829, DOI 10.1038/nature05825; Fryer CL, 2007, PUBL ASTRON SOC PAC, V119, P1211, DOI 10.1086/523768; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395; Benetti S, 2006, ASTROPHYS J, V653, pL129, DOI 10.1086/510667; Botticella MT, 2009, MON NOT R ASTRON SOC, V398, P1041, DOI 10.1111/j.1365-2966.2009.15082.x; CHEVALIER RA, 1982, ASTROPHYS J, V258, P790, DOI 10.1086/160126; CHEVALIER RA, 1994, ASTROPHYS J, V420, P268, DOI 10.1086/173557; Chugai NN, 2001, MON NOT R ASTRON SOC, V326, P1448, DOI 10.1111/j.1365-2966.2001.04717.x; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; Dwarkadas VV, 2011, MON NOT R ASTRON SOC, V412, P1639, DOI 10.1111/j.1365-2966.2010.18001.x; Fassia A, 2001, MON NOT R ASTRON SOC, V325, P907, DOI 10.1046/j.1365-8711.2001.04282.x; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Firster F., 2013, APJ, V772, P19; Foley RJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/101; Fox OD, 2015, MON NOT R ASTRON SOC, V447, P772, DOI 10.1093/mnras/stu2435; Fraser M, 2013, MON NOT R ASTRON SOC, V433, P1312, DOI 10.1093/mnras/stt813; Gal-Yam A, 2007, ASTROPHYS J, V656, P372, DOI 10.1086/510523; Goobar A, 2008, ASTROPHYS J LETT, V686, pL103, DOI 10.1086/593060; Hamuy M, 2000, ASTRON J, V120, P1479, DOI 10.1086/301527; Inserra C, 2014, MON NOT R ASTRON SOC, V437, pL51, DOI 10.1093/mnrasl/slt138; Inserra C, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201220496; Kiewe M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/10; Leloudas G, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116692; Levesque EM, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/23; Li WD, 2001, ASTROPHYS J, V546, P719, DOI 10.1086/318298; Margutti R, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/21; Maund JR, 2006, MON NOT R ASTRON SOC, V369, P390, DOI 10.1111/j.1365-2966.2006.10308.x; Moore K, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/182; Ofek EO, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/42; Osterbrock D. E., 1989, ASTROPHYSICS GASEOUS; Pastorello A, 2008, MON NOT R ASTRON SOC, V389, P113, DOI 10.1111/j.1365-2966.2008.13602.x; Pastorello A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/1; Pastorello A, 2007, NATURE, V449, pE1, DOI 10.1038/nature06282; PHILLIPS MM, 1993, ASTROPHYS J, V413, pL105, DOI 10.1086/186970; Prieto J. L., 2007, ARXIV07064088; Prieto JL, 2008, ASTROPHYS J LETT, V681, pL9, DOI 10.1086/589922; Richardson D, 2006, ASTRON J, V131, P2233, DOI 10.1086/500578; Scalzo RA, 2014, MON NOT R ASTRON SOC, V445, P30, DOI 10.1093/mnras/stu1723; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Silverman JM, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/1/3; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737; Smith N, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/63; Smith N, 2010, ASTROPHYS J, V709, P856, DOI 10.1088/0004-637X/709/2/856; Stritzinger M, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/173; Taddia F, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201220105; Taddia F, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201423915; Taddia F, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321180; Taubenberger S, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/2/L43	101	5	5	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A61	10.1051/0004-6361/201322035		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000061		
J	Muller, C; Krauss, F; Dauser, T; Kreikenbohm, A; Beuchert, T; Kadler, M; Ojha, R; Wilms, J; Bock, M; Carpenter, B; Dutka, M; Markowitz, A; McConville, W; Pottschmidt, K; Stawarz, L; Taylor, GB				Mueller, C.; Krauss, F.; Dauser, T.; Kreikenbohm, A.; Beuchert, T.; Kadler, M.; Ojha, R.; Wilms, J.; Boeck, M.; Carpenter, B.; Dutka, M.; Markowitz, A.; McConville, W.; Pottschmidt, K.; Stawarz, L.; Taylor, G. B.			Redshifted Fe K alpha line from the unusual gamma-ray source PMN J1603-4904	ASTRONOMY & ASTROPHYSICS			English	Article						galaxies: active; galaxies: jets; galaxies: individual: PMN J1603-4904; X-rays: galaxies; gamma rays: galaxies	ACTIVE GALACTIC NUCLEI; COMPACT STEEP-SPECTRUM; LARGE-AREA TELESCOPE; EXTRAGALACTIC RADIO-SOURCES; PHOTON IMAGING CAMERA; XMM-NEWTON; SYMMETRIC OBJECTS; TIMING-EXPLORER; FERMI-LAT; EMISSION	Context. Multiwavel ngth observations have revealed the highly unusual properties of the gamma-ray source PIYIN J1603-4904, which are difficult to reconcile with any other well established gamma-ray source class. The object either a very atypical blazar or a compact jet source seen at a larger angle to the line of sight. Aims. To determine the physical origin of the high-energy emission processes in PMNJ1603-4904, we study the X-ray spectrum in detail, Methods. We performed quasi simultaneous X-ray observations with XMM -Newton and Suzaku in 2013 September. This resulted in the first high signal-to-noise X-ray spectrum of this source. Results. The 2-10 keV X-ray spectrum can be well described by an absorbed power law with an emission line at 5.44 +/- 0.05 key (observed frame). We interpret this feature as a Ka line from neutral iron and accordingly determine the redshift of PMNJ1603-4904 to be z = 0.18 +/- 0.01, which corresponds to a luminosity distance of 872 +/- 54 Mpc. Conclusions. The detection of a redshiftecl X-ray emission line further challenges the original BL Lac classification of PMN J1603-4904. This result suggests that the source is observed at a larger angle to the line of sight than expected for blazars. and thus the source would add to the elusive class of gamma-ray loud misaligned jet objects, possibly a gamma-ray bright young radio galaxy.	[Mueller, C.; Krauss, F.; Kreikenbohm, A.; Beuchert, T.; Kadler, M.; Boeck, M.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany; [Mueller, C.; Krauss, F.; Dauser, T.; Kreikenbohm, A.; Beuchert, T.; Wilms, J.; Boeck, M.; Markowitz, A.] Univ Erlangen Nurnberg, Dr Remeis Sternwarte, D-96049 Bamberg, Germany; [Mueller, C.; Krauss, F.; Dauser, T.; Kreikenbohm, A.; Beuchert, T.; Wilms, J.; Boeck, M.; Markowitz, A.] Univ Erlangen Nurnberg, ECAP, D-96049 Bamberg, Germany; [Ojha, R.; Pottschmidt, K.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Ojha, R.; Carpenter, B.; Dutka, M.; McConville, W.; Pottschmidt, K.] CRESST, Greenbelt, MD 20771 USA; [Ojha, R.; Carpenter, B.; Dutka, M.; McConville, W.; Pottschmidt, K.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Carpenter, B.] Catholic Univ Amer, Washington, DC 20064 USA; [Boeck, M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Markowitz, A.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Stawarz, L.] Inst Space & Astronaut Sci JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Stawarz, L.] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Taylor, G. B.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	Muller, C (reprint author), Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany.	cornelia.mueller@astro.uni-wuerzburg.de	Wilms, Joern/C-8116-2013; XRAY, SUZAKU/A-1808-2009	Wilms, Joern/0000-0003-2065-5410; 	Bundesministerium fur Wirtschaft und Technologie (BMWi) through Deutsches Zentrum fur Luftund Raumfahrt (DLR) [50 OR 1404]; Studienstiftung des Deutschen Volkes; National Aeronautics and Space Administration (NASA) through Fermi Guest Investigator [NNH09ZDA001N, NNH10ZDA001N, NNH12ZDA001N]; BMWi through DLR [50 OR 1311]; Deutsche Forschungsgemeinschaft [WI1860/10-1]	We thank the referee for the helpful comments, and R. Schulz and PG. Edwards for the useful discussions that improved the manuscript. C.M. acknowledges the support of the Bundesministerium fur Wirtschaft und Technologie (BMWi) through Deutsches Zentrum fur Luftund Raumfahrt (DLR) grant 50 OR 1404 and of the Studienstiftung des Deutschen Volkes. This research was funded in part by the National Aeronautics and Space Administration (NASA) through Fermi Guest Investigator grants NNH09ZDA001N, NNH10ZDA001N, and NNH12ZDA001N, by BMWi through DLR grant 50 OR 1311, by Deutsche Forschungsgemeinschaft grant WI1860/10-1, and by an appointment to the NASA Postdoctoral Program at the Goddard Space Flight Center, administered by Oak Ridge Associated Universities through a contract with NASA. We thank J. E. Davis for the development of the slxfig module that has been used to prepare figure in this work. This research has made use of ISIS functions provided by ECAP/Dr. Karl Remeis-Observatoty (Bamberg, Germany) and MIT (http://www.sternwarte.uni-erlangen.de/isis/)	Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Ackermann M, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/2/34; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; ODea CP, 1997, ASTRON J, V113, P148, DOI 10.1086/118241; Eracleous M, 2000, ASTROPHYS J, V537, P654, DOI 10.1086/309076; Bianchi S, 2004, ASTRON ASTROPHYS, V422, P65, DOI 10.1051/0004-6361:20047128; Risaliti G, 2013, NATURE, V494, P449, DOI 10.1038/nature11938; Fossati G, 1998, MON NOT R ASTRON SOC, V299, P433, DOI 10.1046/j.1365-8711.1998.01828.x; Soldi S, 2008, ASTRON ASTROPHYS, V486, P411, DOI 10.1051/0004-6361:200809947; Markowitz A, 2007, ASTROPHYS J, V665, P209, DOI 10.1086/519271; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Tengstrand O, 2009, ASTRON ASTROPHYS, V501, P89, DOI 10.1051/0004-6361/200811284; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Grandi P, 2004, SCIENCE, V306, P998, DOI 10.1126/science.1101787; Houck JC, 2000, ASTR SOC P, V216, P591; Siemiginowska A, 2008, ASTROPHYS J, V684, P811, DOI 10.1086/589437; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Migliori G, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/165; Grandi P, 2006, ASTROPHYS J, V642, P113, DOI 10.1086/500100; Sambruna RM, 1999, ASTROPHYS J, V526, P60, DOI 10.1086/307981; FANTI C, 1995, ASTRON ASTROPHYS, V302, P317; Stawarz L, 2008, ASTROPHYS J, V680, P911, DOI 10.1086/587781; Hardcastle MJ, 2006, MON NOT R ASTRON SOC, V370, P1893, DOI 10.1111/j.1365-2966.2006.10615.x; Donato D, 2001, ASTRON ASTROPHYS, V375, P739, DOI 10.1051/0004-6361:20010675; Readhead ACS, 1996, ASTROPHYS J, V460, P612, DOI 10.1086/176996; Katsuta J, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220270; Abdo AA, 2010, ASTROPHYS J, V720, P912, DOI 10.1088/0004-637X/720/1/912; Shu XW, 2010, ASTROPHYS J SUPPL S, V187, P581, DOI 10.1088/0067-0049/187/2/581; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Ushio M, 2010, ASTROPHYS J, V724, P1509, DOI 10.1088/0004-637X/724/2/1509; Ojha R, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200912724; Marinucci A, 2014, MON NOT R ASTRON SOC, V440, P2347, DOI 10.1093/mnras/stu404; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Chang C.-S., 2010, THESIS MAXPLANCK I G; Perez ID, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/200913798; Evans DA, 2006, ASTROPHYS J, V642, P96, DOI 10.1086/500658; Fukazawa Y, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/74; Guainazzi M, 2006, ASTRON ASTROPHYS, V446, P87, DOI 10.1051/0004-6361:20053374; Jansen F., 2001, Astronomy & Astrophysics, V365, DOI 10.1051/0004-6361:20000036; Kino M, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/134; Koyama K., 2007, PASJ, V59, P23; Kubo H, 1998, ASTROPHYS J, V504, P693, DOI 10.1086/306125; Kunert-Bajraszewska M, 2014, MON NOT R ASTRON SOC, V437, P3063, DOI 10.1093/mnras/stt1978; Marinucci A, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/83; McConville W, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/148; Muller C, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322827; Nandra K, 2006, MON NOT R ASTRON SOC, V368, pL62, DOI 10.1111/j.1745-3933.2006.00158.x; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; O'Dea CP, 1998, PUBL ASTRON SOC PAC, V110, P493, DOI 10.1086/316162; Ostorero L, 2010, ASTROPHYS J, V715, P1071, DOI 10.1088/0004-637X/715/2/1071; READHEAD ACS, 1995, P NATL ACAD SCI USA, V92, P11447, DOI 10.1073/pnas.92.25.11447; Readhead ACS, 1996, ASTROPHYS J, V460, P634, DOI 10.1086/176997; Ricci C, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201322701; Rivers E, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/114; Shaw MS, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/135; Siemiginowska A, 2009, ASTRON NACHR, V330, P264, DOI 10.1002/asna.200811172; Vink J, 2006, MON NOT R ASTRON SOC, V367, P928, DOI 10.1111/j.1365-2966.2006.10036.x	60	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2015	574								A117	10.1051/0004-636/201425442		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CB2OJ	WOS:000349467000117		
J	Grady, C; Fukagawa, M; Maruta, Y; Ohta, Y; Wisniewski, J; Hashimoto, J; Okamoto, Y; Momose, M; Currie, T; McElwain, M; Muto, T; Kotani, T; Kusakabe, N; Feldt, M; Sitko, M; Follette, K; Bonnefoy, M; Henning, T; Takami, M; Karr, J; Kwon, J; Kudo, T; Abe, L; Brandner, W; Brandt, T; Carson, J; Egner, S; Goto, M; Guyon, O; Hayano, Y; Hayashi, M; Hayashi, S; Hodapp, K; Ishii, M; Iye, M; Janson, M; Kandori, R; Knapp, G; Kuzuhara, M; Matsuo, T; Miyama, S; Morino, JI; Moro-Martin, A; Nishimura, T; Pyo, TS; Serabyn, E; Suenaga, T; Suto, H; Suzuki, R; Takahashi, YH; Takato, N; Terada, H; Thalmann, C; Tomono, D; Turner, EL; Watanabe, M; Yamada, T; Takami, H; Usuda, T; Tamura, M				Grady, C.; Fukagawa, M.; Maruta, Y.; Ohta, Y.; Wisniewski, J.; Hashimoto, J.; Okamoto, Y.; Momose, M.; Currie, T.; McElwain, M.; Muto, T.; Kotani, T.; Kusakabe, N.; Feldt, M.; Sitko, M.; Follette, K.; Bonnefoy, M.; Henning, T.; Takami, M.; Karr, J.; Kwon, J.; Kudo, T.; Abe, L.; Brandner, W.; Brandt, T.; Carson, J.; Egner, S.; Goto, M.; Guyon, O.; Hayano, Y.; Hayashi, M.; Hayashi, S.; Hodapp, K.; Ishii, M.; Iye, M.; Janson, M.; Kandori, R.; Knapp, G.; Kuzuhara, M.; Matsuo, T.; Miyama, S.; Morino, J. -I.; Moro-Martin, A.; Nishimura, T.; Pyo, T. -S.; Serabyn, E.; Suenaga, T.; Suto, H.; Suzuki, R.; Takahashi, Y. H.; Takato, N.; Terada, H.; Thalmann, C.; Tomono, D.; Turner, E. L.; Watanabe, M.; Yamada, T.; Takami, H.; Usuda, T.; Tamura, M.			The outer disks of Herbig stars from the UV to NIR	ASTROPHYSICS AND SPACE SCIENCE			English	Review						Stars: pre-main sequence; Stars: Herbig Ae/Be; Protoplanetary disks; Planet-disk interactions	INTERMEDIATE-MASS STARS; SPECTRAL ENERGY-DISTRIBUTIONS; YOUNG STELLAR OBJECTS; AE/BE STARS; PROTOPLANETARY DISKS; X-RAY; HIGH-RESOLUTION; CIRCUMSTELLAR DISK; SCATTERED-LIGHT; AE SYSTEMS	Spatially-resolved imaging of Herbig stars and related objects began with HST, but intensified with commissioning of high-contrast imagers on 8-m class telescopes. The bulk of the data taken from the ground have been polarized intensity imagery at H-band, with the majority of the sources observed as part of the Strategic Exploration of Exoplanets and Disks with Subaru (SEEDS) survey. Sufficiently many systems have been imaged that we discuss disk properties in scattered, polarized light in terms of groups defined by the IR spectral energy distribution. We find novel phenomena in many of the disks, including spiral density waves, and discuss the disks in terms of clearing mechanisms. Some of the disks have sufficient data to map the dust and gas components, including water ice dissociation products.	[Grady, C.] Eureka Sci & Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Fukagawa, M.; Maruta, Y.; Ohta, Y.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 560004, Japan; [Wisniewski, J.; Hashimoto, J.] Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA; [Okamoto, Y.; Momose, M.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Currie, T.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON, Canada; [McElwain, M.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Muto, T.] Kogakuin Univ, Div Liberal Arts, Shinjuku Ku, Tokyo 1638677, Japan; [Kotani, T.; Kusakabe, N.; Kudo, T.; Hayashi, M.; Ishii, M.; Iye, M.; Morino, J. -I.; Suenaga, T.; Suto, H.; Suzuki, R.; Takahashi, Y. H.; Takami, H.; Usuda, T.; Tamura, M.] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Follette, K.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Feldt, M.; Bonnefoy, M.; Henning, T.; Brandner, W.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Sitko, M.] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA; [Takami, M.; Karr, J.] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Knapp, G.; Turner, E. L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Currie, T.; Egner, S.; Guyon, O.; Hayano, Y.; Hayashi, S.; Kandori, R.; Nishimura, T.; Pyo, T. -S.; Takato, N.; Terada, H.; Tomono, D.] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Kwon, J.; Takahashi, Y. H.; Tamura, M.] Univ Tokyo, Dept Astron, Tokyo 1130033, Japan; [Abe, L.] Univ Nice, Lab Lagrange, CNRS, Observ Cote Azur,UMR 7293, F-06108 Nice 2, France; [Brandt, T.] Inst Adv Study, Dept Astrophys, Princeton, NJ 08540 USA; [Carson, J.] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Goto, M.] Univ Munich, D-81679 Munich, Germany; [Hodapp, K.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [Kuzuhara, M.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Matsuo, T.] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Miyama, S.] Hiroshima Univ, Higashihiroshima, Hiroshima 7398511, Japan; [Moro-Martin, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Serabyn, E.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Suenaga, T.] Grad Univ Adv Studies, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Thalmann, C.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Watanabe, M.] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, T.] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Janson, M.] Stockholm Univ, Dept Astron, AlbaNova Univ Ctr, S-10691 Stockholm, Sweden	Grady, C (reprint author), Eureka Sci & Goddard Space Flight Ctr, Code 667, Greenbelt, MD 20771 USA.	Carol.A.Grady@nasa.gov	MIYAMA, Shoken/A-3598-2015		World Premier International Research Center Initiative, MEXT, Japan; NSF AST [1008440]; NASA Origins of Solar Systems program [NNG13PB64P]; NASA RTOP through the NASA Origins of Solar Systems program [12-OSS12-0045]; NSF-AST [1009314]; NASA Origins of Solar System program [NNX13AK17G]; NASA ADP [SOF-0026, NNX09AC73G]	We wish to thank the referee, Glenn Schneider, for helpful comments which improved the quality of this chapter. This research is based in part on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. This research has been supported in part by the World Premier International Research Center Initiative, MEXT, Japan. This research has made use of the SIMBAD database and Vizier service, operated at CDS, Strasbourg, France. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. CAG has been supported by NSF AST 1008440 and through the NASA Origins of Solar Systems program on NNG13PB64P, as well as by SOF-0026. MWMcE is supported under NASA RTOP 12-OSS12-0045 through the NASA Origins of Solar Systems program. JPW is supported under NSF-AST 1009314 and the NASA Origins of Solar System program under NNX13AK17G. MLS was supported under NASA ADP grant NNX09AC73G and SOF-0026.	Andrews S.M., 2011, ASTROPHYS J, V732, p42A; Chambers JE, 2014, ICARUS, V233, P83, DOI 10.1016/j.icarus.2014.01.036; Hamaguchi K, 2005, ASTROPHYS J, V618, P360, DOI 10.1086/423192; Castillo-Rogez J, 2009, ICARUS, V204, P658, DOI 10.1016/j.icarus.2009.07.025; vandenAncker ME, 1997, ASTRON ASTROPHYS, V324, pL33; Collins KA, 2009, ASTROPHYS J, V697, P557, DOI 10.1088/0004-637X/697/1/557; Casassus S, 2013, NATURE, V493, P191, DOI 10.1038/nature11769; Pietu V, 2007, ASTRON ASTROPHYS, V467, P163, DOI 10.1051/0004-6361:20066537; van der Marel N, 2013, SCIENCE, V340, P1199, DOI 10.1126/science.1236770; Alexander RD, 2006, MON NOT R ASTRON SOC, V369, P229, DOI 10.1111/j.1365-2966.2006.10294.x; Stelzer B, 2006, ASTRON ASTROPHYS, V457, P223, DOI 10.1051/0004-6361:20065006; Owen JE, 2011, MON NOT R ASTRON SOC, V412, P13, DOI 10.1111/j.1365-2966.2010.17818.x; Isella A, 2010, ASTROPHYS J, V725, P1735, DOI 10.1088/0004-637X/725/2/1735; Owen JE, 2012, MON NOT R ASTRON SOC, V422, P1880, DOI 10.1111/j.1365-2966.2011.20337.x; van den Ancker ME, 1998, ASTRON ASTROPHYS, V330, P145; Mannings V, 1997, ASTROPHYS J, V490, P792, DOI 10.1086/304897; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rice WKM, 2006, MON NOT R ASTRON SOC, V373, P1619, DOI 10.1111/j.1365-2966.2006.11113.x; Grady CA, 1997, ASTROPHYS J, V483, P449, DOI 10.1086/304230; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476; Dent WRF, 2005, MON NOT R ASTRON SOC, V359, P663, DOI 10.1111/j.1365-2966.2005.08938.x; Folsom CP, 2012, MON NOT R ASTRON SOC, V422, P2072, DOI 10.1111/j.1365-2966.2012.20718.x; Alexander RD, 2006, MON NOT R ASTRON SOC, V369, P216, DOI 10.1111/j.1365-2966.2006.10293.x; Hinkley S, 2009, ASTROPHYS J, V701, P804, DOI 10.1088/0004-637X/701/1/804; OUDMAIJER RD, 1992, ASTRON ASTROPHYS SUP, V96, P625; Dullemond CP, 2004, ASTRON ASTROPHYS, V417, P159, DOI 10.1051/0004-6361:20031768; Dullemond CP, 2004, ASTRON ASTROPHYS, V421, P1075, DOI 10.1051/0004-6361:20040284; Chiang EI, 1999, ASTROPHYS J, V519, P279, DOI 10.1086/307351; HILLENBRAND LA, 1992, ASTROPHYS J, V397, P613, DOI 10.1086/171819; Wisniewski JP, 2008, ASTROPHYS J, V682, P548, DOI 10.1086/589629; Pinte C, 2009, ASTRON ASTROPHYS, V498, P967, DOI 10.1051/0004-6361/200811555; Pontoppidan KM, 2008, ASTROPHYS J, V684, P1323, DOI 10.1086/590400; Biller B., 2014, ASTROPHYS J LETT, V792L, p22B; Biller B., 2012, ASTROPHYS J LETT, V753L, p38B; Biller BA, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/160; Birnstiel T., 2012, ASTRON ASTROPHYS, V544A, p79B; Boccaletti A., 2013, ASTRON ASTROPHYS, V560A, p20B; Bonnefoy M, 2014, COMMUNICATION; Boss A.P, 2011, ASTROPHYS J, V731, p74B; Brandt T, 2014, ASTROPHYS J, V786, p1B; Brittain S.D., 2014, ASTROPHYS J, V791, p136B; Brittain S.D., 2013, ASTROPHYS J, V767, p159B; Brown A, 2010, HEAD 11 1709B; Brown J.M., 2012, ASTROPHYS J, V744, p116B; Bruderer S, 2014, ASTRON ASTROPHYS, V562A, p26B; Carmona A, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201322534; Casassus S., 2012, ASTROPHYS J LETT, V754L, p31C; Christiaens V., 2014, ASTROPHYS J, V785, p12C; Close L.M., 2014, SPIE J E, V9148E, p1MC; Close L.M., 2014, ASTROPHYS J LETT, V781L, p30C; Currie T., 2014, ASTROPHYS J LETT, V796; de Juan Ovelar M., 2013, ASTRON ASTROPHYS, V560A, p111D; Debes J.H., 2013, ASTROPHYS J, V771, p45D; Espaillat C., 2010, ASTROPHYS J, V717, p414E; Feigelson ED, 2003, ASTROPHYS J, V599, P1207, DOI 10.1086/379365; Follette K.B., 2014, ASTROPHYS J IN PRESS; Follette K.B., 2013, ASTROPHYS J, V767, p10F; Fukagawa M., 2006, ASTROPHYS J LETT, V636L, p153F; Fukagawa M., 2014, COMMUNICATION; Fukagawa M., 2003, ASTROPHYS J LETT, V590L, p49F; Garufi A., 2013, ASTRON ASTROPHYS, V560A, p105G; Garufi A., 2014, ASTRON ASTROPHYS, V568A, p40G; Grady C., 2013, ASTROPHYS J, V762, p48G; Grady C., 1999, ASTROPHYS J LETT, V523L, p151G; Grady CA, 2010, ASTROPHYS J, V719, P1565, DOI 10.1088/0004-637X/719/2/1565; Grady CA, 2009, ASTROPHYS J, V699, P1822, DOI 10.1088/0004-637X/699/2/1822; Grady CA, 2001, ASTRON J, V122, P3396, DOI 10.1086/324447; Grady CA, 2007, ASTROPHYS J, V665, P1391, DOI 10.1086/519757; Grady CA, 2000, ASTROPHYS J, V544, P895, DOI 10.1086/317222; Hashimoto J., 2011, ASTROPHYS J LETT, V729L, p17H; Hashimoto J., 2014, UNPUB; Hashimoto J., 2012, ASTROPHYS J LETT, V758L, p19H; Honda M., 2012, ASTROPHYS J, V752, p143H; Honda M., 2009, ASTROPHYS J LETT, V690L, p110H; Isella A., 2013, ASTROPHYS J, V775, p30I; Koepferl CM, 2013, MON NOT R ASTRON SOC, V428, P3327, DOI 10.1093/mnras/sts276; Kraus S., 2013, ASTROPHYS J, V768, p80K; Kuhn J.R., 2001, ASTROPHYS J LETT, V533L, p189K; Kusakabe Nb., 2012, ASTROPHYS J, V753, p153K; Liskowsky J.P., 2012, ASTROPHYS J, V760, p153L; Lubow SH, 2006, ASTROPHYS J, V641, P526, DOI 10.1086/500356; Maaskant K.M., 2013, ASTRON ASTROPHYS, V555A, p64M; Mannings V, 1997, NATURE, V388, P555, DOI 10.1038/41505; Mannings V, 2000, ASTROPHYS J, V529, P391, DOI 10.1086/308253; Marinas N., 2011, ASTROPHYS J, V737, p57M; Maruta Y., 2015, PUBL ASTRON SO UNPUB; Meeus G., 2013, ASTRON ASTROPHYS, V559A, p84M; Meeus G., 2012, ASTRON ASTROPHYS, V544A, p78M; Menard F., 2014, COMMUNICATION; Moeckel N, 2008, ASTROPHYS J, V688, P1361, DOI 10.1086/592286; Momose M., 2013, ASTRON SOC PAC C SER, V476, p389M; Morzinski K.M., 2014, SPIE J E, V9148E; Muto T, 2012, ASTROPHYS J LETT, V748L, p22M; Natta A, 2000, ASTRON ASTROPHYS, V364, P633; Ohta Y, 2015, PUBL ASTRON SO UNPUB; Osorio M, 2014, ASTROPHYS J LETT, V791L, p360O; Perez L. M., 2014, ASTROPHYS J LETT, V783, P13; Perrin M.D., 2009, ASTROPHYS J LETT, V707L, P132; Perrin M.D., 2009, B AM ASTRON SOC, V41, P208; Pineda J. E., 2014, APJ, V788, P34; Pinilla P, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424679; Quanz S.P., 2013, ASTROPHYS J LETT, V766L, p2Q; Quanz S.P., 2011, ASTROPHYS J, V738, p23Q; Quanz S.P., 2012, ASTRON ASTROPHYS, V538A, p92Q; Quanz S.P., 2013, ASTROPHYS J LETT, V766L, p1Q; Rameau J., 2012, ASTRON ASTROPHYS, V546A, p24R; RAY TP, 1994, ASTROPHYS SPACE SCI, V216, P71, DOI 10.1007/BF00982471; Reggiani M., 2014, ASTROPHYS J LETT, V792L, p23R; Rodigas T.J., 2014, ASTROPHYS J LETT, V791L, p37R; Schindhelm E., 2012, ASTROPHYS J LETT, V756L, p23S; Semenov D., 2010, PROTOPLANETARY DUST, P113; Sitko ML, 2008, ASTROPHYS J, V678, P1070, DOI 10.1086/529003; Stelzer B, 2009, ASTRON ASTROPHYS, V493, P1109, DOI 10.1051/0004-6361:200810540; Sturm B., 2013, ASTRON ASTROPHYS, V553A, p5S; Suzuki R., 2010, SPIE J E, V7735E, p30S; Tamura M, 2009, AIP CONF PROC, V1158, P11, DOI 10.1063/1.3215811; Tang Y.-W., 2012, ASTRON ASTROPHYS, V547A, p84T; Telleschi A, 2007, ASTRON ASTROPHYS, V468, P541, DOI 10.1051/0004-6361:20065422; Thalmann C., 2010, ASTROPHYS J LETT, V718L, p87T; Verhoeff A.P., 2011, ASTRON ASTROPHYS, V528A, p91V; Walsh C., 2014, ASTROPHYS J LETT, V791L, p6W; Whitney BA, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/30; Zhu Z., 2012, ASTROPHYS J, V755, p6Z; Zhu Z., 2011, ASTROPHYS J, V729, p47Z	124	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0004-640X	1572-946X		ASTROPHYS SPACE SCI	Astrophys. Space Sci.	FEB	2015	355	2					253	266		10.1007/s10509-014-2214-2		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CC2WV	WOS:000350206600007		
J	Kasai, T; Takeya, R; Tanaka, S				Kasai, Tetsuko; Takeya, Ryuji; Tanaka, Sho			Emergence of visual objects involves multiple stages of spatial selection	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Spatial attention; Object; Grouping; Individuation; Perceptual load; Event-related potential	EVENT-RELATED POTENTIALS; BILATERAL STIMULUS ARRAYS; FIGURE-GROUND SEGREGATION; INDEX FOCUSED ATTENTION; ILLUSORY OBJECTS; BRAIN POTENTIALS; PERCEPTUAL LOAD; TIME-COURSE; CORTEX; SEARCH	Attention may select objects or perceptual groups as fundamental units. Previous studies with event-related potentials (ERPs) have found that obligatory attention-spreading over spatial regions within stable objects is associated with intermediate feedforward visual processing, as reflected by the posterior N1 component of the ERP at a latency of 140-180 ms. The present study examined object-based spatial attention effects in response to individual objects, by recording lateralized ERP attention effects over the posterior scalp (i.e., contralateral versus ipsilateral to the attended visual fields). The stumuli were bilateral unfilled line objects with minimal figural enhancement, and their connectedness and the difficulty of the perceptual task were manipulated. The effects of spatial attention on successive ERP components (N1, P2, and N2) provided information on the timing of the different stages of processing that underlie the formation of perceptual objects.	[Kasai, Tetsuko; Tanaka, Sho] Hokkaido Univ, Fac Educ, Sapporo, Hokkaido 0600811, Japan; [Takeya, Ryuji] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido 0600811, Japan	Kasai, T (reprint author), Hokkaido Univ, Fac Educ, Sapporo, Hokkaido 0600811, Japan.	tetsu@edu.hokudai.ac.jp			JSPS KAKENHI [23500320]	The authors are grateful to Zaifeng Gao and Steve Hillyard for clarifying comments on the original manuscript. We would especially like to thank the latter for his help in improving our writing. This research was supported by JSPS KAKENHI Grant Numbers 23500320.	HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; Schoenfeld MA, 2014, NAT NEUROSCI, V17, P619, DOI 10.1038/nn.3656; Kasai T, 2010, J COGNITIVE NEUROSCI, V22, P12, DOI 10.1162/jocn.2008.21158; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4&lt;273::AID-HBM12&gt;3.0.CO;2-F; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; He X, 2004, J COGNITIVE NEUROSCI, V16, P1085, DOI 10.1162/0898929041502689; Watson SE, 1999, PERCEPT PSYCHOPHYS, V61, P31, DOI 10.3758/BF03211947; Woodman GF, 1999, NATURE, V400, P867; Poort J, 2012, NEURON, V75, P143, DOI 10.1016/j.neuron.2012.04.032; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Khoe W, 2005, VISION RES, V45, P3004, DOI 10.1016/j.visres.2005.04.021; Martinez A, 2007, J NEUROSCI, V27, P7963, DOI 10.1523/JNEUROSCI.0031-07.2007; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Avrahami J, 1999, PERCEPT PSYCHOPHYS, V61, P1604, DOI 10.3758/BF03213121; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cosman JD, 2012, J EXP PSYCHOL HUMAN, V38, P576, DOI 10.1037/a0027406; Driver J, 1998, ATTENTIVE BRAIN, P299; Flevaris A. V., 2013, J VISION, V13, P1; GROSSBERG S, 1994, PSYCHOL REV, V101, P470, DOI 10.1037/0033-295X.101.3.470; Ho MC, 2009, J EXP PSYCHOL HUMAN, V35, P1661, DOI 10.1037/a0016893; Kasai T., 2014, JAPANESE J PSYCHOL, V85, P276; Kasai T, 2012, NEUROPSYCHOLOGIA, V50, P2281, DOI 10.1016/j.neuropsychologia.2012.05.032; Kasai T, 2011, BRAIN RES, V1399, P49, DOI 10.1016/j.brainres.2011.05.016; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Martinez A, 2007, BRAIN RES, V1139, P143, DOI 10.1016/j.brainres.2006.12.056; Palmer SE, 2003, PERCEPTUAL ORGANIZATION IN VISION: BEHAVIORAL AND NEURAL PERSPECTIVES, P3; Pitts MA, 2011, J COGNITIVE NEUROSCI, V23, P880, DOI 10.1162/jocn.2010.21438; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; Woldorff MG, 2002, COGNITIVE BRAIN RES, V15, P1, DOI 10.1016/S0926-6410(02)00212-4; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	FEB	2015	77	2					441	449		10.3758/s13414-014-0799-8		9	Psychology; Psychology, Experimental	Psychology	CC1LS	WOS:000350102800006		
J	Li, Q; Saiki, J				Li, Qi; Saiki, Jun			Different effects of color-based and location-based selection on visual working memory	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Visual working memory; Feature-based attention; Location-based attention; Retro-cue	SHORT-TERM-MEMORY; ORIENTING ATTENTION; INTERNAL ATTENTION; CHANGE BLINDNESS; FEATURES; STORAGE; OBJECTS; REPRESENTATIONS; CONJUNCTIONS; INFORMATION	In the present study, we investigated how feature- and location-based selection influences visual working memory (VWM) encoding and maintenance. In Experiment 1, cue type (color, location) and cue timing (precue, retro-cue) were manipulated in a change detection task. The stimuli were color-location conjunction objects, and binding memory was tested. We found a significantly greater effect for color precues than for either color retro-cues or location precues, but no difference between location pre- and retro-cues, consistent with previous studies (e.g., Griffin & Nobre in Journal of Cognitive Neuroscience, 15, 1176-1194, 2003). We also found no difference between location and color retro-cues. Experiment 2 replicated the color precue advantage with more complex color-shape-location conjunction objects. Only one retro-cue effect was different from that in Experiment 1: Color retro-cues were significantly less effective than location retro-cues in Experiment 2, which may relate to a structural property of multidimensional VWM representations. In Experiment 3, a visual search task was used, and the result of a greater location than color precue effect suggests that the color precue advantage in a memory task is related to the modulation of VWM encoding rather than of sensation and perception. Experiment 4, using a task that required only memory for individual features but not for feature bindings, further confirmed that the color precue advantage is specific to binding memory. Together, these findings reveal new aspects of the interaction between attention and VWM and provide potentially important implications for the structural properties of VWM representations.	[Li, Qi] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Saiki, Jun] Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Saiki, J (reprint author), Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsucho, Kyoto 6068501, Japan.	saiki@cv.jinkan.kyoto-u.ac.jp					Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037//0096-3445.109.2.160; Ling S, 2009, VISION RES, V49, P1194, DOI 10.1016/j.visres.2008.05.025; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Woodman GF, 2003, PSYCHON B REV, V10, P80, DOI 10.3758/BF03196470; Munneke J, 2010, BRAIN COGNITION, V72, P368, DOI 10.1016/j.bandc.2009.11.001; Scholl BJ, 2000, VIS COGN, V7, P377, DOI 10.1080/135062800394856; Becker MW, 2000, PERCEPTION, V29, P273; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Makovski T, 2008, J EXP PSYCHOL LEARN, V34, P369, DOI 10.1037/0278-7393.34.2.369; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Theeuwes J, 2007, J EXP PSYCHOL HUMAN, V33, P1335, DOI 10.1037/0096-1523.33.6.1335; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; AVERBACH E, 1961, AT&T TECH J, V40, P309; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Berryhill ME, 2012, Q J EXP PSYCHOL, V65, P426, DOI 10.1080/17470218.2011.604786; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Baddeley A. D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Fougnie D, 2011, J VISION, V11, DOI 10.1167/11.12.3; Green DM, 1966, SIGNAL DETECTION THE; Katus T, 2014, CEREB CORTEX, V24, P707, DOI 10.1093/cercor/bhs350; Kondo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050962; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1; Tanoue RT, 2012, ATTEN PERCEPT PSYCHO, V74, P1199, DOI 10.3758/s13414-012-0305-0; THEEUWES J, 1989, ACTA PSYCHOL, V72, P177, DOI 10.1016/0001-6918(89)90043-7; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201; Zhuang XH, 2011, J VISION, V11, DOI 10.1167/11.7.6	37	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	FEB	2015	77	2					450	463		10.3758/s13414-014-0775-3		14	Psychology; Psychology, Experimental	Psychology	CC1LS	WOS:000350102800007		
J	Higashiyama, A; Murakami, T				Higashiyama, Atsuki; Murakami, Takashi			The effects of luminance, size, and duration of a visual line on apparent vertical while the head is being inclined in roll	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Spatial Vision; Multisensory Processing; Kinesthesis	TONIC FIELD-THEORY; BODY TILT; ORIENTATION CONSTANCY; PERCEPTION; POSITION; UPRIGHT; STIMULI; TORSION; SENSE; ROD	We determined orientation of a line that is seen to be vertical (i.e., apparent vertical) while the head is inclined with the trunk upright. In this condition, it has been documented that apparent vertical is independent of head orientation (i.e., orientation constancy) or is in a direction opposite to the head inclination (i.e., the Muller effect). In this study, we have focused not only on the effect of head inclination but also on visual parameters of the line that was used to indicate apparent vertical. As the visual parameters, size (5.5A degrees and 22A degrees in visual angle), duration (0.1 s, 3 s, and no time limit), and luminance (0.026, 0.003, and 0.001 cd/m(2) against total darkness) were varied with the head being inclined within +/- 30A degrees. The main findings were: 1) the Muller effect was at best 2A degrees, but the head inclination was judged to be much larger than it was; 2) the correlation between apparent vertical and the judgmental error of head inclination was significant but was not very high (r = -0.20); 3) the line of short duration or of low luminance facilitated the Muller effect; and 4) the magnitude of the Muller effect was large when the head was inclined to the right rather than to the left. These findings were compared with the predictions from the theory of allowing for apparent head position, the theory of ocular countertorsion, and the sensory-tonic field theory. Many aspects of the results were consistent with the predictions from the sensory-tonic field theory.	[Higashiyama, Atsuki; Murakami, Takashi] Ritsumeikan Univ, Kyoto, Japan	Higashiyama, A (reprint author), Ritsumeikan Univ, Kyoto, Japan.	achan@lt.ritsumei.ac.jp			JSPS KAKENHI by the Japan Society for the Promotion of Science [20530672]	The authors thank Nicolas J. Wade who let us read his own papers regarding apparent vertical. We also appreciate Jack Loomis who gave a helpful comment about our earlier draft. This research was partially supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (C) 20530672) provided by the Japan Society for the Promotion of Science.	Goonetilleke SC, 2008, VISION RES, V48, P1488, DOI 10.1016/j.visres.2008.03.012; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0; EPSTEIN W, 1973, PERCEPTION, V2, P267, DOI 10.1068/p020267; Kaptein RG, 2004, J NEUROPHYSIOL, V91, P2205, DOI 10.1152/jn.00804.2003; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Van Beuzekom AD, 2001, VISION RES, V41, P3229, DOI 10.1016/S0042-6989(01)00144-4; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; Mast FW, 2000, JPN PSYCHOL RES, V42, P194, DOI 10.1111/1468-5884.00146; Tarnutzer AA, 2010, J NEUROPHYSIOL, V103, P934, DOI 10.1152/jn.00407.2009; Ash S. E., 1948, J EXP PSYCHOL, V38, P455; Aubert H, 1861, VIRCHOWS ARCH, V20, P381; BAUERMEISTER M, 1964, J EXP PSYCHOL, V67, P142, DOI 10.1037/h0046424; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; DAY RH, 1969, PSYCHOL BULL, V71, P33, DOI 10.1037/h0026872; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; Ebenholtz S. M., 2001, OCULOMOTOR SYSTEMS P; Gibson JJ, 1937, PSYCHOL REV, V44, P222, DOI 10.1037/h0061358; Higashiyama A, 2009, PERCEPTION, V38, P281, DOI 10.1068/p6139; Higashiyama A, 1998, PERCEPT PSYCHOPHYS, V60, P331, DOI 10.3758/BF03206041; Howard I. P., 1982, HUMAN VISUAL ORIENTA, DOI Wiley; HOWARD IP, 1986, HDB PERCEPTION HUMAN, V1, P1; Li WX, 2005, PERCEPTION, V34, P699, DOI 10.1068/p5411; Muller G. E., 1916, Z SINNESPHYSIOL, V49, P109; Poljac E, 2005, VISION RES, V45, P485, DOI 10.1016/j.visres.2004.09.009; Rosenthal R., 1985, CONTRAST ANAL FOCUSE; Trousselard M, 2003, PERCEPT PSYCHOPHYS, V65, P1179, DOI 10.3758/BF03194843; Udo De Haes HA, 1970, PERCEPT PSYCHOPHYS, V8, P137, DOI [10.3758/BF03210192, DOI 10.3758/BF03210192]; WADE NJ, 1970, Q J EXP PSYCHOL, V22, P420, DOI 10.1080/14640747008401915; WADE NJ, 1972, PSYCHOL FORSCH, V35, P131, DOI 10.1007/BF00416488; WADE NJ, 1969, AUST J PSYCHOL, V21, P177, DOI 10.1080/00049536908257782; WADE NJ, 1970, PSYCHON SCI, V19, P201; WAPNER S, 1951, J EXP PSYCHOL, V42, P351, DOI 10.1037/h0058847; WAPNER S, 1951, J EXP PSYCHOL, V42, P341, DOI 10.1037/h0053846; Wapner S., 1957, PERCEPTUAL DEV INVES; WERNER H, 1952, J EXP PSYCHOL, V43, P68, DOI 10.1037/h0060658; WERNER H, 1951, J EXP PSYCHOL, V42, P346, DOI 10.1037/h0062186; WERNER H, 1952, PSYCHOL REV, V59, P324, DOI 10.1037/h0059673; Yardley Y., 1990, PERCEPT PSYCHOPHYS, V48, P131	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	FEB	2015	77	2					681	691		10.3758/s13414-014-0774-4		11	Psychology; Psychology, Experimental	Psychology	CC1LS	WOS:000350102800023		
J	Payapvipapong, K; Tanaka, M				Payapvipapong, Kittisak; Tanaka, Masaru			Dermoscopic classification of Bowen's disease	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Article									[Payapvipapong, Kittisak] Phramongkutklao Hosp, Div Dermatol, Dept Med, Bangkok, Thailand; [Tanaka, Masaru] Tokyo Womens Med Univ, Med Ctr East, Dept Dermatol, Tokyo 1168567, Japan	Tanaka, M (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Dermatol, Arakawa Ku, 2-1-10 Nishi Ogu, Tokyo 1168567, Japan.	tanaka.twmu@gmail.com					Zalaudek I, 2004, BRIT J DERMATOL, V150, P1112, DOI 10.1111/j.1365-2133.2004.05924.x; Cameron A, 2010, J AM ACAD DERMATOL, V62, P597, DOI 10.1016/j.jaad.2009.06.008; Bugatti L, 2004, J EUR ACAD DERMATOL, V18, P572, DOI 10.1111/j.1468-3083.2004.01008.x; Inoue T, 2010, DERMATOL RES PRACT, DOI [10.1155/2010/543091, DOI 10.1155/2010/543091]; Mun JH, 2010, J EUR ACAD DERMATOL, V24, P805, DOI 10.1111/j.1468-3083.2009.03529.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	FEB	2015	56	1					32	35		10.1111/ajd.12200		4	Dermatology	Dermatology	CB8QM	WOS:000349895800015		
J	Hayama, K; Takano, Y; Tamura, J; Tagami, H; Terui, T				Hayama, Koremasa; Takano, Yusaku; Tamura, Jin; Tagami, Hachiro; Terui, Tadashi			Effectiveness of a heparinoid-containing moisturiser to treat senile xerosis	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Article						activities of daily life; administration; heparinoid; moisturiser; senile xerosis; topical	STRATUM-CORNEUM; DRY SKIN; HYDRATION; CAPACITANCE	Background and ObjectivesWith the increasing elderly population in Japan, skin problems have become a greater concern. A heparinoid-containing moisturiser is frequently used in Japan, but there is a lack of evidence for its efficacy in treating senile xerosis. To determine whether there is a correlation between age and the hydration state of the stratum corneum (SC) assessed by skin capacitance, and to evaluate the efficiency of a heparinoid-containing moisturiser and a bed bath to treat senile xerosis. MethodsWe recruited 73 individuals to assess the hydration state of the SC on their flexor forearm by measuring their skin capacitance. To evaluate the efficacy of a heparinoid-containing moisturiser on senile xerosis, we recruited seven inpatients with an inactive daily life (IDL) who had senile xerosis. They were treated with the moisturiser in addition to a bed bath in two different protocols, and we measured the skin capacitance on their flexor forearms on days 0, 7 and 14. ResultsThere was a weak negative correlation (-0.3854, P<0.01) between skin capacitance and age. Following the moisturiser treatments, the seven inpatients had increased hydration of both arms on days 7 and 14. The skin capacitance of the right forearm slightly decreased on day 14, even though it was significantly different from day 0 (P<0.05). ConclusionsThese findings indicate that treatment with a heparinoid-containing moisturiser together with a bed bath is an effective method for treating patients who have senile xerosis and IDL.	[Hayama, Koremasa; Terui, Tadashi] Nihon Univ, Sch Med, Dept Dermatol, Div Cutaneous Sci, Tokyo 1738610, Japan; [Hayama, Koremasa; Takano, Yusaku] Tokiwadaira Cent Hosp, Dept Dermatol, Matsudo, Chiba, Japan; [Tamura, Jin] Tokiwadaira Cent Hosp, Dept Gen Med, Matsudo, Chiba, Japan; [Tagami, Hachiro] Tohoku Univ, Sch Med, Dept Dermatol, Sendai, Miyagi 980, Japan	Hayama, K (reprint author), Nihon Univ, Sch Med, Dept Dermatol, Div Cutaneous Sci,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	hayama@med.nihon-u.ac.jp					Andre OB, 2006, HDB NONINVASIVE MEHO, P337; O'Goshi KI, 2000, SKIN PHARMACOL APPL, V13, P120, DOI 10.1159/000029916; Clarys P, 2012, SKIN RES TECHNOL, V18, P316, DOI 10.1111/j.1600-0846.2011.00573.x; Chiang C, 2009, PEDIATR DERMATOL, V26, P273, DOI 10.1111/j.1525-1470.2009.00911.x; White-Chu EF, 2011, CLIN DERMATOL, V29, P37, DOI 10.1016/j.clindermatol.2010.07.005; Matsumoto T, 2007, J DERMATOL, V34, P447, DOI 10.1111/j.1346-8138.2007.00308.x; Aoyama H, 1999, DERMATOLOGY, V199, P135, DOI 10.1159/000018220; Doi T, 2007, NISHINIHON HIFUKA, V68, P44; Hara M, 1993, J GERIATR DERMATOL, V1, P111; Kumokawa T, 2011, ARZNEIMITTEL-FORSCH, V61, P85, DOI 10.1055/s-0031-1296172; Proksch E, 2008, SKIN PHARMACOL PHYS, V21, P75, DOI 10.1159/000112957; Tabata N, 2000, DERMATOLOGY, V200, P308, DOI 10.1159/000018393; Tagami H, 2006, HDB NONINVASIVE METH, P329; TAKENOUCHI M, 1986, J INVEST DERMATOL, V87, P574, DOI 10.1111/1523-1747.ep12455817; Vecchio C, 2008, CLIN DRUG INVEST, V28, P603, DOI 10.2165/00044011-200828100-00001	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	FEB	2015	56	1					36	39		10.1111/ajd.12179		4	Dermatology	Dermatology	CB8QM	WOS:000349895800016		
J	Sato, S; Morita, K; Nakamura, H				Sato, Shinichi; Morita, Kohei; Nakamura, Hiroyuki			Regulation of Target Protein Knockdown and Labeling Using Ligand-Directed Ru(bpy)(3) Photocatalyst	BIOCONJUGATE CHEMISTRY			English	Article							ASSISTED LASER INACTIVATION; SINGLET OXYGEN; BIOLOGICAL EVALUATION; SUPEROXIDE ION; CROSS-LINKING; DEGRADATION; COMPLEXES; INHIBITION; PHOTODEGRADATION; UBIQUITINATION	Ligand-directed Ru(bpy)(3) photocatalysts induce chromophore-assisted light inactivation (CALI) of target proteins under visible light irradiation in vitro and within cells. Here, histidine, methionine, and tryptophan residues were oxidized by the singlet oxygen (O-1(2)) generated by Ru(bpy)(3) with light. The addition of a tyrosyl radical trapper (TRT), such as N'-acyl-N,N-dimethyl phenylenediamine, inhibited peptide/protein oxidation and induced labeling on the tyrosine residue. This mechanistic study suggests that TRT scavenges O-1(2), concomitant with the coupling reaction to the tyrosyl radical generated by Ru(bpy)(3). Both CALI and labeling can be regulated by the Ru(bpy)(3) photocatalysts in the absence or presence of TRT. Ligand-conjugated Ru(bpy)(3) photocatalysts (local environmental single-electron transfer catalysts: LSCs) were used not only for target-selective protein labeling, but also for protein knockdown by CALI.	[Sato, Shinichi; Nakamura, Hiroyuki] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Morita, Kohei] Gakushuin Univ, Dept Chem, Fac Sci, Tokyo 1718588, Japan	Nakamura, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan.	hiro@res.titech.ac.jp	Nakamura, Hiroyuki/E-8627-2014; Sato, Shinichi/E-7536-2014	Nakamura, Hiroyuki/0000-0002-4511-2984; 	Ministry of Education, Culture, Sports, Science and Technology, Japan [26102721, 25810104]	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products (26102721 to H.N.)" and "Young Scientist (B) (25810104 to S.S.)" from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abdel-Shafi AA, 2004, DALTON T, P30, DOI 10.1039/b310238f; Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Tsumura K, 2011, ORG BIOMOL CHEM, V9, P6357, DOI 10.1039/c1ob05629h; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Lee JY, 2010, NAT CHEM BIOL, V6, P258, DOI [10.1038/nchembio.333, 10.1038/NCHEMBIO.333]; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Horstkotte E, 2005, PHOTOCHEM PHOTOBIOL, V81, P358, DOI 10.1562/2004-07-22-RA-240.1; [Anonymous], 2004, J CELL SCI; Sato S, 2013, ANGEW CHEM INT EDIT, V52, P8681, DOI 10.1002/anie.201303831; [Anonymous], 2008, BIOCHEMISTRY-US; WINTERLE JS, 1976, J AM CHEM SOC, V98, P3719, DOI 10.1021/ja00428a062; Cai X, 2010, J MED CHEM, V53, P2000, DOI 10.1021/jm901453q; Okuhira K, 2011, FEBS LETT, V585, P1147, DOI 10.1016/j.febslet.2011.03.019; Biswas S, 2013, BIOORGAN MED CHEM, V21, P2314, DOI 10.1016/j.bmc.2013.02.022; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; [Anonymous], 2003, NAT REV MOL CELL BIO; Tanimoto S, 2012, CHEM-ASIAN J, V7, P911, DOI 10.1002/asia.201101043; SAITO I, 1981, J AM CHEM SOC, V103, P188, DOI 10.1021/ja00391a035; Itoh Y, 2011, BIOORGAN MED CHEM, V19, P3229, DOI 10.1016/j.bmc.2011.03.057; Itoh Y, 2011, BIOORGAN MED CHEM, V19, P6768, DOI 10.1016/j.bmc.2011.09.041; [Anonymous], 2010, J AM CHEM SOC; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Lee JY, 2008, MOL BIOSYST, V4, P59, DOI 10.1039/b712307h; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; MILLER SS, 1985, INORG CHEM, V24, P3978, DOI 10.1021/ic00218a003; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; [Anonymous], 2002, BRIEF FUNCT GENOMICS; Kim S, 2013, J PHYS CHEM B, V117, P13985, DOI 10.1021/jp406638g; Puckett CA, 2007, J AM CHEM SOC, V129, P46, DOI 10.1021/ja0677564; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Itoh Y, 2012, BIOORG MED CHEM LETT, V22, P4453, DOI 10.1016/j.bmcl.2012.04.134; [Anonymous], 1994, J PHYS CHEM-US; Ban HS, 2010, BIOORGAN MED CHEM, V18, P870, DOI 10.1016/j.bmc.2009.11.035; Min D. B., 2002, Comprehensive Reviews in Food Science and Food Safety, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x; Demas J. N., 1977, J AM CHEM SOC, V99, P3547; Hirabayashi A, 2014, CHEM COMMUN, V50, P9543, DOI 10.1039/c4cc03791j; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; Liu XD, 2012, CHEMBIOCHEM, V13, P2082, DOI 10.1002/cbic.201200445; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Schneekloth AR, 2008, BIOORG MED CHEM LETT, V18, P5904, DOI 10.1016/j.bmcl.2008.07.114	43	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	FEB	2015	26	2					250	256		10.1021/bc500518t		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CB7KZ	WOS:000349807200011		
J	Ng, KK; Takada, M; Jin, CCS; Zheng, G				Ng, Kenneth K.; Takada, Misa; Jin, Cheng C. S.; Zheng, Gang			Self-Sensing Porphysomes for Fluorescence-Guided Photothermal Therapy	BIOCONJUGATE CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; QUANTUM-DOT; IN-VIVO; NANOPARTICLES; MEMBRANE; CHOLESTEROL; STABILITY; DRIVEN; TUMORS	Porphysomes are highly quenched unilamellar porphyrin-lipid nanovesicles with structurally dependent photothermal properties. The high packing density of porphyrin molecules in the lipid bilayer enables their application in photothermal therapy, whereas the partial disruption of the porphysome structure over time restores the porphyrin fluorescence and enables the fluorescence-guided photothermal ablation. This conversion is a time-dependent process and cannot be easily followed using existing analytical techniques. Here we present the design of a novel self-sensing porphysome (FRETysomes) capable of fluorescently broadcasting its structural state through Forster resonance energy transfer. By doping in a near-infrared emitting fluorophore, it is possible to divert a small fraction of the absorbed energy toward fluorescence emission which provides information on whether the vesicle is intact or disrupted. Addition of bacteriopheophorbide-lipid into the vesicle bilayer as a fluorescence acceptor (0.5-7.5 mol %) yields a large separation of 100 nm between the absorption and fluorescence bands of the nanoparticle. Furthermore, a progressive increase in FRET efficiency (14.6-72.7%) is observed. Photothermal heating and serum stability in FRETysomes is comparable with the undoped porphysomes. The fluorescence arising from the energy transfer between the donor and acceptor dyes can be clearly visualized in vivo through hyperspectral imaging. By calculating the ratio between the acceptor and donor fluorescence, it is possible to determine the structural fate of the nanovesicles. We observe using this technique that tumor accumulation of structurally intact porphyrin-lipid nanovesicles persists at 24 and 48 h postinjection. The development of FRETysomes offers a unique and critical imaging tool for planning porphysome-enabled fluorescence-guided photothermal treatment, which maximizes light-induced thermal toxicity.	[Ng, Kenneth K.; Jin, Cheng C. S.; Zheng, Gang] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1L7, Canada; [Takada, Misa; Zheng, Gang] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Jin, Cheng C. S.; Zheng, Gang] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5G 1L7, Canada; [Ng, Kenneth K.; Takada, Misa; Jin, Cheng C. S.; Zheng, Gang] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Ng, Kenneth K.; Takada, Misa; Jin, Cheng C. S.; Zheng, Gang] Univ Hlth Network, Techna Inst, Toronto, ON M5G 1L7, Canada; [Takada, Misa] Osaka Univ, Dept Chem, Osaka 5600043, Japan	Zheng, G (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1L7, Canada.	gang.zheng@uhnres.utoronto.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; Ontario Institute for Cancer Research; Prostate Cancer Canada; Canadian Foundation of Innovation; Princess Margaret Cancer Foundation; Terry Fox New Frontiers Program Project Grant; Joey and Toby Tanenbaum/Brazilian Ball Chair in Prostate Cancer Research	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes for Health Research, with additional support from the Ontario Institute for Cancer Research, Prostate Cancer Canada, the Canadian Foundation of Innovation, Princess Margaret Cancer Foundation, Terry Fox New Frontiers Program Project Grant, the Joey and Toby Tanenbaum/Brazilian Ball Chair in Prostate Cancer Research. We thank W. Chan, C. Yip, and J. Chen for insightful discussion.	[Anonymous], 2011, MACROMOLECULES; [Anonymous], 2006, REV FLUORESCENCE; Lovell JF, 2011, J AM CHEM SOC, V133, P18580, DOI 10.1021/ja2083569; Liu TW, 2012, ANGEW CHEM INT EDIT, V51, P13128, DOI 10.1002/anie.201206939; Jin CS, 2014, ADV HEALTHC MATER, V3, P1240, DOI 10.1002/adhm.201300651; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Wagh A, 2012, BIOCONJUGATE CHEM, V23, P981, DOI 10.1021/bc200637h; [Anonymous], 2014, J CONTROL RELEASE; Taira MC, 2004, DRUG DELIV, V11, P123, DOI 10.1080/10717540490280769; MacDonald TD, 2014, ANGEW CHEM INT EDIT, V53, P6956, DOI 10.1002/anie.201400133; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Silvius JR, 2003, BIOPHYS J, V85, P1034, DOI 10.1016/S0006-3495(03)74542-1; Lovell JF, 2011, NAT MATER, V10, P324, DOI [10.1038/nmat2986, 10.1038/NMAT2986]; PORTIS A, 1979, BIOCHEMISTRY-US, V18, P780, DOI 10.1021/bi00572a007; Liu TW, 2013, ACS NANO, V7, P4221, DOI 10.1021/nn400669r; Skajaa T, 2010, NANO LETT, V10, P5131, DOI 10.1021/nl1037903; Jin CS, 2013, ACS NANO, V7, P2541, DOI 10.1021/nn3058642; Feigenson GW, 2001, BIOPHYS J, V80, P2775; Drummond D. C., 1999, PHARMACOL REV, V51, P691; Lakowicz J., 2006, ENERGY TRANSFER PRIN, P443; Lee SY, 2013, MOL PHARMACEUT, V10, P3497, DOI 10.1021/mp4003333; SENIOR J, 1982, LIFE SCI, V30, P2123, DOI 10.1016/0024-3205(82)90455-6; Zhao YM, 2014, SMALL, V10, P1163, DOI 10.1002/smll.201301962	24	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	FEB	2015	26	2					345	351		10.1021/bc500595d		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CB7KZ	WOS:000349807200022		
J	Yamazaki, Y; Fujii, S				Yamazaki, Yoshihiko; Fujii, Satoshi			Extracellular ATP modulates synaptic plasticity induced by activation of metabotropic glutamate receptors in the hippocampus	BIOMEDICAL RESEARCH-TOKYO			English	Review							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; PROTEIN-KINASE-C; CA1 NEURONS; RAT HIPPOCAMPUS; PERFORANT PATH; GUINEA-PIG; ADENOSINE-TRIPHOSPHATE; NMDA RECEPTORS; DENTATE GYRUS	Synaptic plasticity is believed to be a cellular mechanism for memory formation in the brain. It has been known that the metabotropic glutamate receptor (mGluR) is required for persistent forms of memory and induction of synaptic plasticity. Application of mGluR agonists induces synaptic plasticity in the absence of electrical conditioning stimulation, such as high or low frequency stimulation. The direction of the mGluR-induced synaptic plasticity, i.e., either long-term potentiation (LTP) or long-term-depression (LTD), is dependent on whether N-methyl-D-aspartate receptors (NMDARs) are co-activated with mGluRs. ATP has modulatory effects on neuronal functions and, in particular, there is increasing evidence that it plays a crucial role in synaptic plasticity. LTP can be induced by application of ATP, and this effect is inhibited by NMDAR antagonist. Although cooperative effects of NMDARs and mGluRs and of NMDARs and extracellular ATP in synaptic plasticity have been revealed, the effect of extracellular ATP on mGluR-induced synaptic plasticity is unknown. In this article, we summarize published data on mGluR- and ATP-induced synaptic plasticity, and present new data showing that extracellular ATP facilitates both the LTP and LTD induced by mGluR activation.	[Yamazaki, Yoshihiko; Fujii, Satoshi] Yamagata Univ, Sch Med, Dept Physiol, Yamagata 9909585, Japan	Yamazaki, Y (reprint author), Yamagata Univ, Sch Med, Dept Physiol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	yyamazak@med.id.yamagata-u.ac.jp			JSPS KAKENHI grant [24500434, 25117005, 25350986]	This work was supported by JSPS KAKENHI grant numbers 24500434, 25117005, and 25350986.	ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; Huber KM, 2001, J NEUROPHYSIOL, V86, P321; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; BEHNISCH T, 1993, NEUROSCIENCE, V54, P37, DOI 10.1016/0306-4522(93)90381-O; Fujii S, 2002, NEUROSCIENCE, V113, P617, DOI 10.1016/S0306-4522(02)00190-2; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Grunze HCR, 1996, J NEUROSCI, V16, P2034; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Wang Y, 2004, NEUROREPORT, V15, P633, DOI 10.1097/01.wnr.0000116970.73984.6a; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Lee HU, 2013, GLIA, V61, P210, DOI 10.1002/glia.22427; Gerges NZ, 2003, NEUROSCIENCE, V120, P535, DOI 10.1016/S0306-4522(03)00297-5; EHRLICH YH, 1986, NATURE, V320, P67, DOI 10.1038/320067a0; Yamazaki Y, 2012, NEUROSCIENCE, V207, P1, DOI 10.1016/j.neuroscience.2012.01.045; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Yang SN, 2000, NEUROSCIENCE, V96, P253, DOI 10.1016/S0306-4522(99)00582-5; Mukherjee S, 2013, NEUROPHARMACOLOGY, V66, P65, DOI 10.1016/j.neuropharm.2012.06.005; Li JM, 2013, BIOMED RES-TOKYO, V34, P75; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; Duster R, 2014, CURR NEUROPHARMACOL, V12, P37, DOI 10.2174/1570159X113119990045; EHRLICH YH, 1988, J NEUROCHEM, V50, P295, DOI 10.1111/j.1471-4159.1988.tb13263.x; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Fujii S, 2003, NEUROSCI RES, V46, P509, DOI 10.1016/S0168-0102(03)00162-7; FUJII S, 1995, NEUROSCI LETT, V187, P130, DOI 10.1016/0304-3940(95)11347-9; Fujii S, 2004, BRAIN RES, V999, P20, DOI 10.1016/j.brainres.2003.11.058; Fujiwara H, 2012, BIOMED RES-TOKYO, V33, P265; Ievglevskyi O, 2012, PURINERG SIGNAL, V8, P705, DOI 10.1007/s11302-012-9296-5; Keslo SR, 1992, J PHYSL, V449, P705; LYNCH GS, 1981, EXP NEUROL, V71, P527, DOI 10.1016/0014-4886(81)90030-3; ManahanVaughan D, 1996, NEUROSCIENCE, V74, P723, DOI 10.1016/0306-4522(96)00162-5; Nett W, 2002, TRIPARTITE SYNAPSE G, P127; O'Kane EM, 2000, EUR J PHARMACOL, V409, P159, DOI 10.1016/S0014-2999(00)00785-8; Oliet HR, 1997, NEURON, V18, P969; OMARA SM, 1995, NEUROPHARMACOLOGY, V34, P983, DOI 10.1016/0028-3908(95)00062-B; Riedel G, 1996, ACTA PHYSIOL SCAND, V157, P1, DOI 10.1046/j.1365-201X.1996.484231000.x; WALKER MC, 1995, J NEUROCHEM, V65, P725; Watabe MA, 2001, J NEUROPHYSIOL, V87, P1395; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; WIERASZKO A, 1989, BRAIN RES, V491, P356, DOI 10.1016/0006-8993(89)90070-X; Yamazaki Y, 2003, HIPPOCAMPUS, V13, P81, DOI 10.1002/hipo17999; Yamazaki Y, 2005, NEUROSCIENCE, V134, P791, DOI 10.1016/j.neuroscience.2005.04.024; Yamazaki Y, 2002, NEUROSCI LETT, V324, P65, DOI 10.1016/S0304-3940(02)00175-1; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	52	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					1	9				9	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900001		
J	Otsuki, Y; Nakamura, Y; Harada, S; Yamamoto, Y; Ogino, K; Morikawa, K; Ninomiya, H; Miyagawa, S; Sawa, Y; Hisatome, I; Nishimura, M				Otsuki, Yuki; Nakamura, Yoshinobu; Harada, Shingo; Yamamoto, Yasutaka; Ogino, Kazuhide; Morikawa, Kumi; Ninomiya, Haruaki; Miyagawa, Shigeru; Sawa, Yoshiki; Hisatome, Ichiro; Nishimura, Motonobu			Adipose stem cell sheets improved cardiac function in the rat myocardial infarction, but did not alter cardiac contractile responses to beta-adrenergic stimulation	BIOMEDICAL RESEARCH-TOKYO			English	Article							AUTOLOGOUS CELL; MYOBLAST SHEETS; STROMAL CELLS; MURINE MODEL; TISSUE; TRANSPLANTATION; REPAIR; ANGIOGENESIS; ISCHEMIA; HEART	Adipose stem cells (ASCs) are a source of regenerative cells available for autologous transplantation to hearts. We compared protective actions of ASC sheets on rat myocardial infarction (MI) in comparison with those of skeletal myoblast cell sheets. Their effects on infarcted hearts were evaluated by biological, histochemical as well as physiological analyses. ASC sheets secreted higher concentrations of angiogenic factors (HGF, VEGF, and bFGF; P < 0.05) under normoxic and hypoxic conditions than those of myoblast cell sheets, associated with reduction of cell apoptosis (P < 0.05). Like myoblast cell sheets, ASC sheets improved cardiac function (P < 0.05) and decreased the plasma level of ANP (P < 0.05) in MI hearts. ASC sheets restored cardiac remodeling characterized by fibrosis, cardiac hypertrophy and impaired angiogenesis (P < 0.05), which was associated with increases in angiogenic factors (P < 0.05). In isolated perfused rat hearts, ASC sheets improved both systolic and diastolic functions, which was comparable to cardiac functions of myoblast cell sheets, while both cell sheets failed to restore cardiac contractile response to either isoproterenol, pimobendan or dibutyryl cAMP. These results indicated that ASC sheets improved cardiac function and remodeling of MI hearts mediated by their paracrine action and this improvement was comparable to those by myoblast cell sheets.	[Otsuki, Yuki; Nakamura, Yoshinobu; Harada, Shingo; Nishimura, Motonobu] Tottori Univ, Fac Med, Div Organ Regenerat Surg, Yonago, Tottori 6838503, Japan; [Yamamoto, Yasutaka; Hisatome, Ichiro] Tottori Univ, Grad Sch Med Sci, Dept Genet Med & Regenerat Therapeut, Div Regenerat Med & Therapeut, Yonago, Tottori 6838503, Japan; [Ogino, Kazuhide] Tottori Univ Hosp, Ctr Clin Residency Program, Yonago, Tottori, Japan; [Morikawa, Kumi] Tottori Univ Hosp, Ctr Promoting Next Generat Highly Adv Med, Yonago, Tottori, Japan; [Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan	Hisatome, I (reprint author), Tottori Univ, Grad Sch Med Sci, Dept Genet Med & Regenerat Therapeut, Div Regenerat Med & Therapeut, 36-1 Nishichou, Yonago, Tottori 6838503, Japan.	hisatome@med.tottori-u.ac.jp					Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Harada Y, 2013, BIOMED RES-TOKYO, V34, P23; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; OGINO K, 1995, ENDOCRINOLOGY, V136, P3024, DOI 10.1210/en.136.7.3024; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Sun Y, 2001, J MOL CELL CARDIOL, V33, P995, DOI 10.1006/jmcc.2001.1365; Shudo Y, 2014, TISSUE ENG PT A, V20, P728, DOI 10.1089/ten.TEA.2012.0534; Sekiya N, 2009, J THORAC CARDIOV SUR, V138, P985, DOI 10.1016/j.jtcvs.2009.02.004; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Leosco D, 2008, CARDIOVASC RES, V78, P385, DOI 10.1093/cvr/cvm109; Hamdi H, 2011, CARDIOVASC RES, V91, P483, DOI 10.1093/cvr/cvr099; Kawamura M, 2012, CIRCULATION S1, V126, P29; Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a; Nakamura Y, 2006, AM J PHYSIOL-HEART C, V291, pH939, DOI 10.1152/ajpheart.00155.2006; Yamamoto Y, 2009, AM J PHYSIOL-HEART C, V297, pH1329, DOI 10.1152/ajpheart.00321.2009	21	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					11	19				9	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900002		
J	Okuma, T; Hirata, M; Yano, F; Mori, D; Kawaguchi, H; Chung, UI; Tanaka, S; Saito, T				Okuma, Tomotake; Hirata, Makoto; Yano, Fumiko; Mori, Daisuke; Kawaguchi, Hiroshi; Chung, Ung-il; Tanaka, Sakae; Saito, Taku			Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins	BIOMEDICAL RESEARCH-TOKYO			English	Article							C/EBP-BETA; TRANSCRIPTION FACTORS; DEFICIENT MICE; OSTEOARTHRITIS DEVELOPMENT; ENDOCHONDRAL OSSIFICATION; GENE-TRANSCRIPTION; EXPRESSION; DELTA; REPRESSION; CARTILAGE	CCAAT/enhancer-binding protein (C/EBP) beta regulates chondrocyte differentiaion and proliferation during endochondral ossification. However, expression and function of other C/EBP family members in chondrocytes have not been fully understood. To understand the comprehensive regulation of chondrocyte differentiation by C/EBPs, we initially examined their expression levels. Among four members (C/EBP alpha, C/EBP beta, C/EBP delta and C/EBP epsilon) with transactivation domain, expression of Cebpb and Cebpd was abundant compared to Cebpa, while Cebpe was hardly expressed in mouse isolated chondrocytes. Doxycycline (DOX)-inducible overexpression of each of the three C/EBPs (C/EBP alpha, C/EBP beta and C/EBP delta) in ATDC5 cells suppressed expressions of early differentiation markers including Col2a1, aggrecan and Sox9, enhanced those of late differentiation markers including Mmp13, Vegfa and Col10a1, and decelerated cell proliferation, indicating their overlapped functions in chondrocytes. In contrast, DOX-inducible overexpression of A-CEBP, which exerts a dominant-negative effect against all C/EBPs, increased expressions of early differentiation markers and decreased those of late differentiation markers. Finally, microarray and gene ontology analyses showed that A-CEBP altered many genes related with various events or tissues such as skeletal development, cartilage, cell cycle, inflammation and apoptosis. In conclusion, C/EBP alpha, C/EBP beta and C/EBP delta regulate proliferation and differentiation of chondrocytes and possibly is involved with apoptosis and inflammation. C/EBPs may play a variety of roles in the homeostasis of joint cartilage under physiological and pathological conditions.	[Okuma, Tomotake; Hirata, Makoto; Yano, Fumiko; Mori, Daisuke; Kawaguchi, Hiroshi; Tanaka, Sakae; Saito, Taku] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yano, Fumiko; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth care Org, Tokyo Shinjulcu Med Ctr, Spine Ctr, Shinjuku Ku, Tokyo 1628543, Japan	Saito, T (reprint author), Univ Tokyo, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	tasaitou-tky@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 21591930, 23689065]	We thank D. Mori, J. Sugita, R. Yamaguchi and H. Kawahara for technical assistance. This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#19109007, #21591930, #23689065).	Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; SCREPANTI I, 1995, EMBO J, V14, P1932; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Ushijima T, 2014, J BIOL CHEM, V289, P2852, DOI 10.1074/jbc.M113.492843; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Ramji DP, 2002, BIOCHEM J, V365, P561; de Rooy DPC, 2014, ANN RHEUM DIS, V73, P1163, DOI 10.1136/annrheumdis-2013-203375; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Duitman J, 2014, LAB INVEST, V94, P89, DOI 10.1038/labinvest.2013.127; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Imamura T, 2008, ARTHRITIS RHEUM, V58, P1366, DOI 10.1002/art.23438; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kan A, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-4; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Liu YQ, 2014, ARCH IMMUNOL THER EX, V62, P363, DOI 10.1007/s00005-014-0285-y; Meszaros Evan, 2012, Ther Adv Chronic Dis, V3, P219, DOI 10.1177/2040622312454157; O'Neill KE, 2014, CELL REPROGRAM, V16, P314, DOI 10.1089/cell.2014.0032; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Thomas B, 2000, EUR J BIOCHEM, V267, P6798, DOI 10.1046/j.1432-1033.2000.01778.x; Wilm B, 1998, P NATL ACAD SCI USA, V95, P8692, DOI 10.1073/pnas.95.15.8692; Yano F, 2013, ARTHRITIS RHEUM-US, V65, P429, DOI 10.1002/art.37779	44	1	1	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					21	29				9	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900003		
J	Toriumi, T; Takayama, N; Murakami, M; Sato, M; Yuguchi, M; Yamazaki, Y; Eto, K; Otsu, M; Nakauchi, H; Shirakawa, T; Isokawa, K; Honda, MJ				Toriumi, Taku; Takayama, Naoya; Murakami, Miyako; Sato, Momoko; Yuguchi, Maki; Yamazaki, Yosuke; Eto, Koji; Otsu, Makoto; Nakauchi, Hiromitsu; Shirakawa, Tetsuo; Isokawa, Keitaro; Honda, Masaki J.			Characterization of mesenchymal progenitor cells in the crown and root pulp of primary teeth	BIOMEDICAL RESEARCH-TOKYO			English	Article							PLURIPOTENT STEM-CELLS; RETINOBLASTOMA GENE-PRODUCT; DENTAL-PULP; TOOTH DEVELOPMENT; HUMAN FIBROBLASTS; DECIDUOUS TEETH; CYCLIN-A; GENERATION; PHOSPHORYLATION; DIFFERENTIATION	The existence of progenitor/mesenchymal stem cells (MSCs) was demonstrated previously in human primary/deciduous teeth. In this study, we examined dental pulp cells from root portion (root cells) of primary teeth without discernible root resorption and compared them with pulp cells from the crown portion (crown cells). Root cells and crown cells were characterized and compared to each other based on progenitor/MSC characteristics and on their generation efficiency of induced pluripotent stem (iPS) cells. Root cells and crown cells included cells manifesting typical progenitor/MSC properties such as osteogenic and adipogenic differentiation potential and clonogenicity. Interestingly, root cells showed a higher expression level of embryonic stem cell marker, KLF4, than crown cells. Moreover, the number of colony-forming unit-fibroblast and cell proliferation rate were higher for root cells than crown cells, and the efficiency of generating iPS cells from root cells was approximately four times higher than that from crown cells. Taken together, these results suggest that root cells from primary teeth show the MSC-like properties and thus could be a potent alternative source for iPS cell generation and the subsequent transplantation therapy.	[Toriumi, Taku] Nihon Univ, Grad Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Takayama, Naoya; Murakami, Miyako; Eto, Koji; Otsu, Makoto; Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Takayama, Naoya; Eto, Koji] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Sato, Momoko; Shirakawa, Tetsuo] Nihon Univ, Sch Dent, Dept Pediat Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Yuguchi, Maki; Yamazaki, Yosuke; Isokawa, Keitaro; Honda, Masaki J.] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, Tokyo 1018310, Japan; [Yuguchi, Maki; Yamazaki, Yosuke; Shirakawa, Tetsuo; Isokawa, Keitaro; Honda, Masaki J.] Nihon Univ, Sch Dent, Dent Res Ctr, Chiyoda Ku, Tokyo 1018310, Japan	Honda, MJ (reprint author), Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	honda.masaki@nihon-u.ac.jp			Nihon University Multidisciplinary Research Grant; Sato Fund from Nihon University School of Dentistry; Dental Research Center at Nihon University School of Dentistry; Nihon University Graduate School of Dentistry Research Fund;  [24390447]	This work was supported in part by Nihon University Multidisciplinary Research Grant for 2012 and 2013 (MEI), Grant-in-Aid for Scientific Research (B) (24390447 to MH), Sato Fund from Nihon University School of Dentistry for 2012 (TT), Grant from Dental Research Center at Nihon University School of Dentistry for 2013 (TT), and Nihon University Graduate School of Dentistry Research Fund for 2010 and 2011 (TT).	Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ishkitiev N, 2010, J ENDODONT, V36, P469, DOI 10.1016/j.joen.2009.12.022; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; Kerkis I, 2012, TISSUE ENG PART B-RE, V18, P129, DOI [10.1089/ten.TEB.2011.0327, 10.1089/ten.teb.2011.0327]; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Sumita Y, 2009, EUR J ORAL SCI, V117, P113, DOI 10.1111/j.1600-0722.2008.00603.x; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Mikami Y, 2011, STEM CELLS DEV, V20, P901, DOI 10.1089/scd.2010.0299; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Govindasamy V, 2010, J ENDODONT, V36, P1504, DOI 10.1016/j.joen.2010.05.006; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Honda MJ, 2013, INT J ORAL MAX IMPL, V28, pE451, DOI 10.11607/jomi.te25; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Sato M, 2015, ORAL DIS, V21, pE86, DOI 10.1111/odi.12234; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406	36	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					31	45				15	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900004		
J	Katsuyama, S; Otowa, A; Kamio, S; Sato, K; Yagi, T; Kishikawa, Y; Komatsu, T; Bagetta, G; Sakurada, T; Nakamura, H				Katsuyama, Soh; Otowa, Akira; KAmio, Satomi; Sato, Kazuma; Yagi, Tomomi; Kishikawa, Yukinaga; Komatsu, Takaaki; Bagetta, Giacinto; Sakurada, Tsukasa; Nakamura, Hitoshi			Effect of plantar subcutaneous administration of bergamot essential oil and linalool on formalin-induced nociceptive behavior in mice	BIOMEDICAL RESEARCH-TOKYO			English	Article							INTRAPLANTAR INJECTION; ANTINOCICEPTIVE ACTIVITY; IN-VITRO; (-)-LINALOOL; PAIN; RECEPTORS; INVOLVEMENT; MODELS; KERATINOCYTES	This study investigated the effect of bergamot essential oil (BEO) or linalool, a major volatile component of BEO, on the nociceptive response to formalin. Plantar subcutaneous injection of BEO or linalool into the ipsilateral hindpaw reduced both the first and late phases of the formalin-induced licking and biting responses in mice. Plantar subcutaneous injection of BEO or linalool into the contralateral hindpaw did not yield an antinociceptive effect, suggesting that the antinociceptive effect of BEO or linalool in the formalin test occurred peripherally. Intraperitoneal and plantar subcutaneous injection pretreatment with naloxone hydrochloride, an opioid receptor antagonist, significantly attenuated both BEO- and linalool-induced antinociception. Pretreatment with naloxone methiodide, a peripherally acting opioid receptor antagonists, also significantly antagonized the antinociceptive effects of BEO and linalool. Our results provide evidence for the involvement of peripheral opioids in antinociception induced by BEO and linalool. These results suggest that activation of peripheral opioid receptors may play an important role in reducing formalin-induced nociception.	[Katsuyama, Soh; Otowa, Akira; KAmio, Satomi; Sato, Kazuma; Yagi, Tomomi; Kishikawa, Yukinaga; Nakamura, Hitoshi] Tohoku Pharmaceut Univ, Dept Clin Pharmaceut, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Komatsu, Takaaki; Sakurada, Tsukasa] Daiichi Coll Pharmaceut Sci, Dept Pharmacol, Minami Ku, Fukuoka 8158511, Japan; [Bagetta, Giacinto] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; [Bagetta, Giacinto] Univ Calabria, Univ Consortium Adapt Disorders & Headache, Sect Neuropharmacol Normal & Pathol Neuronal Plas, I-87036 Arcavacata Di Rende, Italy	Nakamura, H (reprint author), Tohoku Pharmaceut Univ, Dept Clin Pharmaceut, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	nakamura@tohoku-pharm.ac.jp	Bagetta, Giacinto/E-8402-2012	Bagetta, Giacinto/0000-0001-8540-6218	NISHINOMIYA Basic Research Fund (Japan)	This study was supported by a NISHINOMIYA Basic Research Fund (Japan).	Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Dugo P, 2000, J PHARMACEUT BIOMED, V24, P147, DOI 10.1016/S0731-7085(00)00400-3; Lewanowitsch T, 2002, EUR J PHARMACOL, V445, P61, DOI 10.1016/S0014-2999(02)01715-6; Batista PA, 2010, J PAIN, V11, P1222, DOI 10.1016/j.jpain.2010.02.022; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Peana AT, 2006, LIFE SCI, V78, P719, DOI 10.1016/j.lfs.2005.05.065; Peana AT, 2002, PHYTOMEDICINE, V9, P721, DOI 10.1078/094471102321621322; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Berliocchi L, 2009, INT REV NEUROBIOL, V85, P221, DOI 10.1016/S0074-7742(09)85017-4; Sakurada T, 2009, INT REV NEUROBIOL, V85, P237, DOI 10.1016/S0074-7742(09)85018-6; Morrone LA, 2007, PHARMACOL RES, V55, P255, DOI 10.1016/j.phrs.2006.11.010; Bagetta G, 2010, FITOTERAPIA, V81, P453, DOI 10.1016/j.fitote.2010.01.013; SAKURADA T, 1995, PAIN, V60, P175, DOI 10.1016/0304-3959(94)00107-P; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Batista PA, 2008, NEUROSCI LETT, V440, P299, DOI 10.1016/j.neulet.2008.05.092; Elisabetsky E, 1999, PHYTOMEDICINE, V6, P107; Hosseinzadeh H, 2012, PHYTOTHER RES, V26, P1399, DOI 10.1002/ptr.3736; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Katsuyama S, 2012, BIOMED RES-TOKYO, V33, P175, DOI 10.2220/biomedres.33.175; Mondello L, 1993, FLAVOUR FRAG J, V8, P17, DOI 10.1002/ffj.2730080105; Peana AT, 2006, LIFE SCI, V78, P2471, DOI 10.1016/j.lfs.2005.10.025; Peana AT, 2003, EUR J PHARMACOL, V460, P37, DOI 10.1016/S0014-2999(02)02856-X; Peana AT, 2004, EUR J PHARMACOL, V485, P165, DOI 10.1016/j.ejphar.2003.11.066; Sakurada T, 2011, PHARMACOL BIOCHEM BE, V97, P436, DOI 10.1016/j.pbb.2010.09.020; Sato T, 1999, EUR J PHARMACOL, V369, P183, DOI 10.1016/S0014-2999(99)00065-5; Zanello SB, 1999, ANN NY ACAD SCI, V885, P85; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	29	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					47	54				8	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900005		
J	Ishijima, M; Soltanzadeh, P; Hirota, M; Tsukimura, N; Ishigami, T; Ogawa, T				Ishijima, Manabu; Soltanzadeh, Pooya; Hirota, Makoto; Tsukimura, Naoki; Ishigami, Tomohiko; Ogawa, Takahiro			Enhancing osteoblast-affinity of titanium scaffolds for bone engineering by use of ultraviolet light treatment	BIOMEDICAL RESEARCH-TOKYO			English	Article							PHOTOFUNCTIONALIZED DENTAL IMPLANTS; IN-VITRO; EXTRACELLULAR-MATRIX; FIBER MESH; SURFACES; WEB; OSSEOINTEGRATION; INTEGRATION; STABILITY; MECHANISM	Ultraviolet (UV) treatment immediately prior to use is attracting attention as an effective surface conditioning method for titanium to improve osteoblast-affinity. The affinity of titanium to osteoblasts in two-dimensional plate culture has been well studied, but that in three-dimensional cultures remains unclear. Here, we examined the effect of UV treatment on titanium scaffolds, comprising micro-thin titanium fibers, used in bone engineering. Titanium scaffolds, with and without UV treatment, were seeded with rat bone marrow derived osteoblasts, and the number of cells attached to scaffolds and osteoblastic phenotype in the cultures were examined. UV treatment improved the weftability of scaffolds and significantly reduced the percentage of surface carbon. Along with these physicochemical changes in the scaffolds, cell attachment increased by a factor of 1.3 as compared to that of the untreated control. In addition, alkaline phosphatase activity and calcium deposition significantly increased by a factor of 2.3 and 2.0, respectively. Robust formation of mineralized structures consisting of clear peaks of calcium and phosphorus was observed in the UV-treated scaffolds. The observed increase in osteoblast affinity and capability of mineralized matrix formation indicates the potential use of UV-treated titanium scaffolds for bone engineering.	[Ishijima, Manabu] Nihon Univ, Grad Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Ishijima, Manabu; Soltanzadeh, Pooya; Hirota, Makoto; Ogawa, Takahiro] Univ Calif Los Angeles, Sch Dent, Div Adv Prosthodont Biomat & Hosp Dent, Weintraub Ctr Reconstruct Biotechnol,Lab Bone & I, Los Angeles, CA 90024 USA; [Ishijima, Manabu; Tsukimura, Naoki; Ishigami, Tomohiko] Nihon Univ, Sch Dent, Dept Partial Denture Prosthodont, Tokyo 1018310, Japan	Ishijima, M (reprint author), Nihon Univ, Grad Sch Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	dema11003@g.nihon-u.ac.jp					Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Funato A, 2013, INT J ORAL MAX IMPL, V28, P1589, DOI 10.11607/jomi.3232; Hirota M, 2012, INT J ORAL MAX SURG, V41, P1304, DOI 10.1016/j.ijom.2011.12.035; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Hirota M, 2011, INT J ORAL MAX IMPL, V26, P245; Hirota M, 2010, INT J ORAL MAX IMPL, V25, P888; Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200; Hayashi R, 2014, J DENT RES, V93, P698, DOI 10.1177/0022034514536578; Lee JH, 2012, IMPLANT DENT, V21, P415, DOI 10.1097/ID.0b013e31826a51f4; Suzuki S, 2013, IMPLANT DENT, V22, P481, DOI 10.1097/ID.0b013e31829deb62; Att W, 2012, INT J ORAL MAX IMPL, V27, P753; Att Wael, 2009, Biomaterials, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040; Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024; Funato A, 2013, INT J ORAL MAX IMPL, V28, P1261, DOI 10.11607/jomi.3263; Guo ZK, 2013, ARTIF ORGANS, V37, P623, DOI 10.1111/aor.12058; Kuboki Y, 2014, BIO-MED MATER ENG, V24, P1539, DOI 10.3233/BME-140958; NANCOLLAS GH, 1989, ANAT REC, V224, P234, DOI 10.1002/ar.1092240213; Ogawa T, 2014, INT J ORAL MAX IMPL, V29, pE95, DOI 10.11607/jomi.te47; Ogawa Takahiro, 2002, J Prosthodont, V11, P241, DOI 10.1053/jpro.2002.129772; Tian YS, 2009, BIOCHEM BIOPH RES CO, V386, P499, DOI 10.1016/j.bbrc.2009.06.087; van den Dolder J, 2002, J BIOMED MATER RES, V62, P350, DOI 10.1002/jbm.10189; Yoshinari M, 2003, BIOMED RES-TOKYO, V24, P195; Yunoki S, 2008, BIOMACROMOLECULES, V9, P879, DOI 10.1021/bm7012058	28	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					55	62				8	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900006		
J	Le, TKC; Hosaka, T; Nguyen, TT; Kassu, A; Dang, TO; Tran, HB; Pham, TP; Tran, QB; Le, THH; Da Pham, X				Thi Kim Chung Le; Hosaka, Toshio; Thanh Trung Nguyen; Kassu, Afework; Thi Oanh Dang; Hong Ba Tran; Tran Phuong Pham; Quang Binh Tran; Thi Hong Hao Le; Xuan Da Pham			Bifidobacterium species lower serum glucose, increase expressions of insulin signaling proteins, and improve adipokine profile in diabetic mice	BIOMEDICAL RESEARCH-TOKYO			English	Article							KAPPA-B ACTIVATION; 3T3-L1 ADIPOCYTES; RECEPTOR GENE; IKK-BETA; RESISTANCE; INTERLEUKIN-6; ALPHA; CELLS; INFLAMMATION; PREVENTION	This study, using C57BL/6J mice with streptozotocin (STZ)-induced diabetes, aimed to determine whether Bifidobacterium species (spp.) both induces the expressions of proteins in the insulin signaling pathway and enhances the expressions of certain adipocytokines. The protein expressions of I kappa B kinase alpha (IKK alpha), I kappa B kinase beta (IKK beta), nuclear factor-kappaB inhibitor alpha (I kappa B alpha), and the mitogen-activated protein kinase (MAPK) pathway were also investigated. Oral administration of Bifidobacterium spp. reduced blood glucose levels significantly and increased the protein expressions of insulin receptor beta, insulin receptor substrate 1, protein kinase B (Akt/PKB), IKK alpha, and I kappa B alpha. Extracellular-signal-regulated kinase 2 (ERK2) showed increased expression. Bifidobacterium spp. also induced the adiponectin expression and decreased both macrophage chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) expression. In addition, IKK beta, c-Jun NH2-terminal kinase (JNK) and p38 MAP kinase expressions showed no significant changes in both groups. In conclusion, Bifidobacterium spp. may be the promising bacteria for treating diabetes.	[Thi Kim Chung Le; Thanh Trung Nguyen; Thi Oanh Dang; Hong Ba Tran; Thi Hong Hao Le; Xuan Da Pham] Natl Inst Food Control, Dept Food Microbiol, Hanoi, Vietnam; [Hosaka, Toshio] Kyorin Univ, Sch Med, Dept Internal Med 3, Div Endocrinol Diabet & Metab, Mitaka, Tokyo 181, Japan; [Tran Phuong Pham; Quang Binh Tran] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Kassu, Afework] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia	Le, TKC (reprint author), Natl Inst Food Control, Dept Food Microbiol, 13 Phan Huy Chu, Hanoi, Vietnam.	lethikimchung27@yahoo.com			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.05-2011.58]	This research was funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.05-2011.58.	Joshi RL, 1996, EMBO J, V15, P1542; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Passoja A, 2011, J CLIN PERIODONTOL, V38, P687, DOI 10.1111/j.1600-051X.2011.01731.x; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Asemi Z, 2013, ANN NUTR METAB, V63, P1, DOI 10.1159/000349922; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Lin PP, 2013, INT J MOL MED, V32, P1319, DOI 10.3892/ijmm.2013.1524; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Ha U, 2007, J IMMUNOL, V178, P1736; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Niu JL, 2014, EXP MOL PATHOL, V96, P71, DOI 10.1016/j.yexmp.2013.11.001; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Antuna-Puente B, 2007, THERAPIE, V62, P285, DOI 10.2515/therapie:2007055; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Huang WC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-3; Kim N, 2007, CLIN IMMUNOL, V123, P30, DOI 10.1016/j.clim.2006.11.005; Kyiak Iu H, 2012, Fiziol Zh, V58, P65; Rosenberg L, 2004, ANN SURG, V240, P875, DOI 10.1097/01.sla.0000143270.99191.10; Solomon J Ritchie Sharon, 2013, Pediatr Endocrinol Rev, V11, P34; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062081; Tomosada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059259; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yoon SS, 2011, GASTROENT RES PRACT, P971	37	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	FEB	2015	36	1					63	70				8	Medicine, Research & Experimental	Research & Experimental Medicine	CC0EZ	WOS:000350009900007		
J	Konishi, Y; Koosaka, Y; Maruyama, R; Imanishi, K; Kasahara, K; Matsuda, A; Akiduki, S; Hishida, Y; Kurata, Y; Shibamoto, T; Satomi, J; Tanida, M				Konishi, Yuuki; Koosaka, Yasutaka; Maruyama, Ryuutaro; Imanishi, Kazuki; Kasahara, Kazuaki; Matsuda, Ai; Akiduki, Saori; Hishida, Yukihiro; Kurata, Yasutaka; Shibamoto, Toshishige; Satomi, Jun; Tanida, Mamoru			L-Ornithine intake affects sympathetic nerve outflows and reduces body weight and food intake in rats	BRAIN RESEARCH BULLETIN			English	Article						Autonomic nervous system; Appetite; Adipose tissue; Hypothalamus; Electrophysiology; Afferent vagal nerve	METABOLISM; TISSUE; GAIN	Ingesting the amino acid L-ornithine effectively improves lipid metabolism in humans, although it is unknown whether it affects the activities of autonomic nerves that supply the peripheral organs related to lipid metabolism, such as adipose tissues. Thus, we investigated the effects of L-ornithine ingestion on autonomic nerves that innervate adipose tissues and the feeding behaviors of rats. Intragastric injection of L-ornithine (2.5%) in urethane-anesthetized rats activated sympathetic nerve activity to white adipose tissue (WAT-SNA), and stimulated sympathetic nerve activity to brown adipose tissue (BAT-SNA). In addition, WAT-SNA responses to L-ornithine were abolished in rats with ablated abdominal vagal nerves. L-ornithine ingestion for 9 weeks also significantly reduced rats' body weight, food intake, and abdominal fat weight. Proopiomelanocortin (POMC) levels in the hypothalamus and uncoupling protein 1 (UCP1) levels in brown adipose tissue were significantly increased in rats that ingested 2.5% L-ornithine for 9 weeks. These results suggested that ingested L-ornithine was taken up in the gastrointestinal organs and stimulated afferent vagal nerves and activated the central nervous system. Subsequently, increased hypothalamic POMC activated sympathetic neurotransmission to adipose tissues and accelerated energy expenditure. (C) 2014 Elsevier Inc. All rights reserved.	[Konishi, Yuuki; Koosaka, Yasutaka; Maruyama, Ryuutaro; Imanishi, Kazuki; Kasahara, Kazuaki; Matsuda, Ai; Satomi, Jun; Tanida, Mamoru] Ritsumeikan Univ, Dept Biomed Sci, Coll Life Sci, Shiga 5258577, Japan; [Akiduki, Saori; Hishida, Yukihiro] Kyowa Hakko Bio Co Ltd, Healthcare Prod Dev Ctr, Tsukuba, Ibaraki 3050841, Japan; [Kurata, Yasutaka; Shibamoto, Toshishige; Tanida, Mamoru] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan	Tanida, M (reprint author), Kanazawa Med Univ, Dept Physiol 2, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	mtanida@kanazawa-med.ac.jp			Kyowa Hakko Bio., Ltd, Japan	This research was supported by grants from the seeds contest 2010 in Kyowa Hakko Bio., Ltd, Japan.	Bahri S, 2013, NUTRITION, V29, P479, DOI 10.1016/j.nut.2012.07.002; Tanida M, 2008, OBES RES CLIN PRACT, V2, P159, DOI 10.1016/j.orcp.2008.04.003; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Tujioka K, 2012, J NUTR SCI VITAMINOL, V58, P346, DOI 10.3177/jnsv.58.346; Yasuda T, 2004, EXP BIOL MED, V229, P235; Sugino T, 2008, NUTR RES, V28, P738, DOI 10.1016/j.nutres.2008.08.008; Kondoh T, 2008, PHYSIOL BEHAV, V95, P135, DOI 10.1016/j.physbeh.2008.05.010; BRIGGS S, 1976, BIOCHEM J, V160, P205; Sobrino Crespo C., 2014, FRONT ENDOCRINOL LAU, V24, P1; Tanida M, 2009, BIOSCI BIOTECH BIOCH, V73, P2374, DOI 10.1271/bbb.90196; Tanida M, 2014, J DIABETES INVEST, V5, P153, DOI 10.1111/jdi.12141; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004; Tanida M, 2011, NEUROSCI LETT, V491, P211, DOI 10.1016/j.neulet.2011.01.040	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	FEB	2015	111						48	52		10.1016/j.brainresbull.2014.11.004		5	Neurosciences	Neurosciences & Neurology	CC1CR	WOS:000350079300006		
J	Tsuji, K; Tsujimura, T; Magara, J; Sakai, S; Nakamura, Y; Inoue, M				Tsuji, Kojun; Tsujimura, Takanori; Magara, Jin; Sakai, Shogo; Nakamura, Yuki; Inoue, Makoto			Changes in the frequency of swallowing during electrical stimulation of superior laryngeal nerve in rats	BRAIN RESEARCH BULLETIN			English	Article						Swallowing; Superior laryngeal nerve; Rat; Central pattern generator; Nucleus tractus solitarii	JAW-OPENING REFLEX; SOLITARY NUCLEUS; CORTEX; AFFERENT; PROJECTIONS; RESPONSES; BEHAVIOR; HUMANS; REGION; SHEEP	The aim of the present study was to investigate the adaptation of the swallowing reflex in terms of reduced swallowing reflex initiation following continuous superior laryngeal nerve stimulation. Forty-four male Sprague Dawley rats were anesthetized with urethane. To identify swallowing, electromyographic activity of the left mylohyoid and thyrohyoid muscles was recorded. To evoke the swallowing response, the superior laryngeal nerve (SLN), recurrent laryngeal nerve, or cortical swallowing area was electrically stimulated. Repetitive swallowing evoked by continuous SLN stimulation was gradually reduced, and this reduction was dependent on the resting time duration between stimulations. Prior SLN stimulation also suppressed subsequent swallowing initiation. The reduction in evoked swallows induced by recurrent laryngeal nerve or cortical swallowing area stimulation was less than that following superior laryngeal nerve stimulation. Decerebration had no effect on the reduction in evoked swallows. Prior subthreshold stimulation reduced subsequent initiation of swallowing, suggesting that there was no relationship between swallowing movement evoked by prior stimulation and the subsequent reduction in swallowing initiation. Overall, these data suggest that reduced sensory afferent nerve firing and/or trans-synaptic responses, as well as part of the brainstem central pattern generator, are involved in adaptation of the swallowing reflex following continuous stimulation of swallow-inducing peripheral nerves and cortical areas. (C) 2014 Elsevier Inc. All rights reserved.	[Tsuji, Kojun; Tsujimura, Takanori; Magara, Jin; Sakai, Shogo; Nakamura, Yuki; Inoue, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Chuo Ku, Niigata 9518514, Japan	Inoue, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	k-tsuji@dent.niigata-u.ac.jp; tsujimura@dent.niigata-u.ac.jp; jin-m@dent.niigata-u.ac.jp; s-sakai@dent.niigata-u.ac.jp; nakayuki@dent.niigata-u.ac.jp; inoue@dent.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24390431]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Japan Society for the Promotion of Science; Promotion of Niigata University Research Projects [25C024]	This study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24390431 to M.I.), by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (S2504) from the Japan Society for the Promotion of Science and by a grant for Promotion of Niigata University Research Projects (#25C024 to T.T.).	Tsujimura T, 2013, J PHYSIOL-LONDON, V591, P4667, DOI 10.1113/jphysiol.2013.256024; Lamkadem M, 1999, BRAIN RES, V832, P97, DOI 10.1016/S0006-8993(99)01483-3; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; Kecskes S, 2013, BRAIN RES BULL, V99, P109, DOI 10.1016/j.brainresbull.2013.09.006; TERREBERRY RR, 1983, BRAIN RES, V278, P245, DOI 10.1016/0006-8993(83)90246-9; MILLER AJ, 1982, PHYSIOL REV, V62, P129; Hiraoka K, 2004, DYSPHAGIA, V19, P155, DOI 10.1007/s00455-004-0002-9; Takatsuji H, 2012, DYSPHAGIA, V27, P473, DOI 10.1007/s00455-012-9393-1; Nakamura Y, 2013, EXP BRAIN RES, V230, P197, DOI 10.1007/s00221-013-3641-y; Jean A, 2001, PHYSIOL REV, V81, P929; Tsujimura T, 2012, NEUROSCI LETT, V528, P159, DOI 10.1016/j.neulet.2012.09.005; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; BARTLETT D, 1992, J PHYSIOL-LONDON, V457, P187; BOUSHEY HA, 1974, J PHYSIOL-LONDON, V240, P153; BRADLEY RM, 1983, BRAIN RES, V276, P81, DOI 10.1016/0006-8993(83)90550-4; Doty R.W., 1968, HDB PHYSL ALIMENTA 6, P1861; Fukuhara T, 2011, BRAIN RES, V1391, P44, DOI 10.1016/j.brainres.2011.03.065; Furusawa K, 1996, J COMP NEUROL, V375, P147, DOI 10.1002/(SICI)1096-9861(19961104)375:1<147::AID-CNE9>3.0.CO;2-3; HISA Y, 1985, NEUROSCI LETT, V55, P185, DOI 10.1016/0304-3940(85)90017-5; Kajii Y, 2002, PHYSIOL BEHAV, V77, P321, DOI 10.1016/S0031-9384(02)00854-5; Martin Ruth E., 1993, Dysphagia, V8, P195, DOI 10.1007/BF01354538; Pascual-Font A, 2011, J ANAT, V219, P217, DOI 10.1111/j.1469-7580.2011.01390.x; PATRICKSON JW, 1991, BRAIN RES, V539, P169, DOI 10.1016/0006-8993(91)90702-W; Rosen Andrew M, 2010, Front Neurosci, V4, P175, DOI 10.3389/fnins.2010.00175; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Shiozawa M, 2012, J TEXTURE STUD, V44, P45; SINCLAIR WJ, 1971, AM J PHYSIOL, V221, P1260; Tsujimura T., 2012, J ORAL BIOSCI, V54, P112; VANDERKOOY D, 1982, NEUROSCI LETT, V33, P123, DOI 10.1016/0304-3940(82)90238-5; Yamada A, 2013, NEUROSCI LETT, V535, P73, DOI 10.1016/j.neulet.2012.12.047; ZHANG WB, 1991, BRAIN RES, V558, P87, DOI 10.1016/0006-8993(91)90717-A	31	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	FEB	2015	111						53	61		10.1016/j.brainresbull.2014.12.008		9	Neurosciences	Neurosciences & Neurology	CC1CR	WOS:000350079300007		
J	Kato, M				Kato, Masaru			Function Analysis of Intracellular Protein Using Nanoparticles Containing Protein	BUNSEKI KAGAKU			Japanese	Review						stimuli-responsive nanoparticle; protein; intracellular reaction; cell	HIGH-THROUGHPUT ANALYSIS; DELIVERY-SYSTEM; MOLECULES; POLYMER; CELLS; HYDROGEL; RELEASE; GENE; STABILIZATION; NANOMATERIALS	Much attention has been paid concerning the local function of proteins within a cell. Stimuli-responsive nanoparticles containing protein have begun to be used for its analysis. A nanoparticle-encapsulated protein was internalized to a cell, was stored within the cell stably until it received a stimulus, and was released while showing activity within the cell after noninvasive external stimulus. Because these stimuli-responsive nanoparticles allowed us to activate various proteins spatiotemporally, these nanoparticles are promising tools to study the local functions of intracellular proteins. In this review, the latest developments regarding protein-containing nanoparticles have been introduced. Their application to the study of protein function within a cell is also discussed.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kato, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	masaru-kato@umin.ac.jp					Sneh-Edri H, 2011, BIOCHEM BIOPH RES CO, V405, P228, DOI 10.1016/j.bbrc.2011.01.015; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Morimoto N, 2013, BIOMACROMOLECULES, V14, P56, DOI 10.1021/bm301286h; Murayama S, 2010, ANAL CHEM, V82, P2186, DOI 10.1021/ac1003757; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/nmat2614, 10.1038/NMAT2614]; Ishizuka F, 2014, J MATER CHEM B, V2, P4153, DOI 10.1039/c4tb00536h; Takahashi H, 2013, BIOMATER SCI-UK, V1, P842, DOI 10.1039/c3bm00178d; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Biswas A, 2011, ACS NANO, V5, P1385, DOI 10.1021/nn1031005; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Huang JG, 2011, NANO TODAY, V6, P478, DOI 10.1016/j.nantod.2011.08.002; Sakai-Kato K, 2005, ANAL CHEM, V77, P7080, DOI 10.1021/ac050714y; Panyam J, 2003, PHARMACEUT RES, V20, P212, DOI 10.1023/A:1022219003551; Murayama S, 2012, CHEM COMMUN, V48, P11461, DOI 10.1039/c2cc35567a; Ge J, 2012, ACS NANO, V6, P227, DOI 10.1021/nn203430m; Murayama S, 2013, J MATER CHEM B, V1, P4932, DOI 10.1039/c3tb20828a; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Zhao MX, 2011, BIOMATERIALS, V32, P5223, DOI 10.1016/j.biomaterials.2011.03.060; Gu Z, 2009, NANO LETT, V9, P4533, DOI 10.1021/nl902935b; Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116; Kato M, 2005, ANAL CHEM, V77, P1813, DOI 10.1021/ac048388u; Clavero C, 2014, NAT PHOTONICS, V8, P95, DOI [10.1038/nphoton.2013.238, 10.1038/NPHOTON.2013.238]; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Murayama S, 2012, CHEM COMMUN, V48, P8380, DOI 10.1039/c2cc32718j; Amamoto T, 2014, CHEM PHARM BULL, V62, P649; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Takagi K, 2014, SOFT MATTER, V10, P3553, DOI 10.1039/c3sm52908h; Murayama S, 2012, ANAL CHEM, V84, P1374, DOI 10.1021/ac2023603; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Murayama S, 2014, MACROMOL BIOSCI, V14, P626, DOI 10.1002/mabi.201300393; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Hirakura T, 2004, BIOMACROMOLECULES, V5, P1804, DOI 10.1021/bm049860o; Hoffman S. A., 2004, MACROMOL S, V207, P139; Ishihama Y., 2014, CHROMATOGRAPHY, V35, P73; Johnson BJ, 2014, NANO TODAY, V9, P102, DOI 10.1016/j.nantod.2014.02.005; Kato M, 2004, ANAL CHEM, V76, P1896, DOI 10.1021/ac035107u; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385	48	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					77	87				11	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000001		
J	Yukawa, H; Baba, Y				Yukawa, Hiroshi; Baba, Yoshinobu			In vivo Imaging of Transplanted Stem Cells Using Quantum Dots	BUNSEKI KAGAKU			Japanese	Article						quantum dots; adipose tissue-derived stem cells; poly-cationic liposome; octa-arginine; in vivo imaging	HEPARIN; NANOPARTICLES; DELIVERY; LIVER; MICE	Quantum dots (QDs) have excellent fluorescence properties compared to traditional fluorescence probes. Thus, the optical application of QDs is in a rapid expansion to each field of analytical chemistry. In this paper, we described about the application of QDs to regenerative medicine, especially stem cell transplantation therapy. Specifically, labeling technologies of stem cells by QDs composed of semiconductor materials in combination with poly-cationic liposome (Lipofectamine) or cell-penetrating peptide (octa-arginine) were reviewed. Moreover, in vivo imaging technology of transplanted stem cells in mice by QDs emitting fluorescence in near-infrared region, which could be detected by fluorescence in vivo imaging machines, such as an IVIS imaging system, was reviewed.	[Yukawa, Hiroshi; Baba, Yoshinobu] Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Yukawa, H (reprint author), Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	hiroshiy@med.nagoya-u.ac.jp					Kaji N, 2014, ANAL SCI, V30, P859; Yukawa H, 2012, BIOMATERIALS, V33, P2177, DOI 10.1016/j.biomaterials.2011.12.009; Takasaki Y, 2011, ANAL CHEM, V83, P8252, DOI 10.1021/ac202053y; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Burns AA, 2009, NANO LETT, V9, P442, DOI 10.1021/nl803405h; Bakalova R, 2004, NAT BIOTECHNOL, V22, P1360, DOI 10.1038/nbt1104-1360; Yukawa H, 2009, CELL TRANSPLANT, V18, P591; Biju V, 2010, CHEM SOC REV, V39, P3031, DOI 10.1039/b926512k; Taha MF, 2010, TISSUE CELL, V42, P211, DOI 10.1016/j.tice.2010.04.003; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Park YS, 2010, ACS NANO, V4, P121, DOI 10.1021/nn901570m; Bourzac K, 2013, NATURE, V493, P283, DOI 10.1038/493283a; Bakalova R., 2007, NANOTECHNOLOGIES LIF; Gaponenko S. V., 1998, OPTICAL PROPERTIES S; Jose R, 2006, J AM CHEM SOC, V128, P629, DOI 10.1021/ja0565018; Yukawa H., 2013, CELL MED, V6, P83; Yukawa H, 2009, CELL TRANSPLANT, V18, P611	24	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					89	97				9	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000002		
J	Yasukawa, T; Kiba, Y; Mizutani, F				Yasukawa, Tomoyuki; Kiba, Yuya; Mizutani, Fumio			Electrochemical Assay System with a Membrane Fluidic Device	BUNSEKI KAGAKU			Japanese	Article						nitrocellulose membrane; lateral flow; electrochemical quantitation; glucose oxidase; enzyme reaction	PROSTATE-SPECIFIC ANTIGEN; FLOW TEST STRIP; IMMUNOCHROMATOGRAPHIC ASSAY; NEGATIVE-DIELECTROPHORESIS; SENSITIVE DETECTION; FLUORESCENCE IMMUNOASSAY; HORSERADISH-PEROXIDASE; NANOPARTICLE PROBES; SURFACE-ANTIGENS; LIVING CELLS	We fabricated an electrochemical detection system involving redox species flowing in a nitrocellulose membrane incorporated into two plates with both poles and electrodes. We prepared an upper substrate with poles inserted a Pt microelectrode and a Ag/AgC1 electrode as well as a bottom substrate with a small pole array and poles that were used as supports of nitrocellulose membranes. The presence of poles allowed a uniform flow of a solution in the membrane and a steady-state oxidation current of hydrogen peroxide. A solution containing different concentrations of glucose was introduced into the device with membranes to be immobilized by glucose oxidase (GOx). Hydrogen peroxide produced through the enzyme reaction in the presence of glucose flowed downstream to give an electrochemical response with the electrode arranged 6 mm away from the GOx immobilization area. Oxidation currents of hydrogen peroxide increased with increasing the concentration of glucose. Thus, an electrochemical detection system of redox species flowing in the membrane indicated the possibility for developing an enzymatic and immunological assay format with electrochemical quantitation.	[Yasukawa, Tomoyuki; Kiba, Yuya; Mizutani, Fumio] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan	Yasukawa, T (reprint author), Univ Hyogo, Grad Sch Mat Sci, 3-2-1 Kouto, Kamigori, Hyogo 6781297, Japan.	yasu@sci.u-hyogo.ac.jp					Wang LM, 2011, BIOSENS BIOELECTRON, V26, P2835, DOI 10.1016/j.bios.2010.11.008; Li ZH, 2010, ANAL CHEM, V82, P7008, DOI 10.1021/ac101405a; Lu F, 2005, ANALYST, V130, P1513, DOI 10.1039/b507682j; Choi S, 2004, CLIN CHIM ACTA, V339, P147, DOI 10.1016/j.cccn.2003.10.002; Shyu RH, 2002, TOXICON, V40, P255, DOI 10.1016/S0041-0101(01)00193-3; Mao X, 2008, ELECTROCHEM COMMUN, V10, P1636, DOI 10.1016/j.elecom.2008.08.032; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Lin YY, 2008, BIOSENS BIOELECTRON, V23, P1659, DOI 10.1016/j.bios.2008.01.037; Tsagkogeorgas F, 2006, ANAL CHIM ACTA, V573, P133, DOI 10.1016/j.aca.2006.03.006; Lei CH, 1996, ANAL CHEM, V68, P3344, DOI 10.1021/ac960291n; Tanaka R, 2006, ANAL BIOANAL CHEM, V385, P1414, DOI 10.1007/s00216-006-0549-4; Nian HC, 2012, ANAL CHIM ACTA, V713, P50, DOI 10.1016/j.aca.2011.11.028; Lai GS, 2009, ANAL CHEM, V81, P9730, DOI 10.1021/ac901996a; Munge B, 2005, ANAL CHEM, V77, P4662, DOI 10.1021/ac050132g; Inoue K, 2007, TALANTA, V73, P886, DOI 10.1016/j.talanta.2007.05.008; Yasukawa T, 2012, ANAL CHEM, V84, P8830, DOI 10.1021/ac302239k; Du D, 2012, ANAL CHEM, V84, P1380, DOI 10.1021/ac202391w; Tang DP, 2008, ANAL CHEM, V80, P8064, DOI 10.1021/ac801091j; Zou ZX, 2010, ANAL CHEM, V82, P5125, DOI 10.1021/ac100260m; Wang J, 2004, J AM CHEM SOC, V126, P3010, DOI 10.1021/ja031723w; Chu X, 2005, BIOSENS BIOELECTRON, V20, P1805, DOI 10.1016/j.bios.2004.07.012; Kiba Y, 2012, ELECTROCHIM ACTA, V81, P14, DOI 10.1016/j.electacta.2012.07.074; Liu GD, 2007, ANAL CHEM, V79, P7644, DOI 10.1021/ac070691i; Oh SW, 2009, CLIN CHIM ACTA, V406, P18, DOI 10.1016/j.cca.2009.04.013; ZUK RF, 1985, CLIN CHEM, V31, P1144; Yu X, 2006, J AM CHEM SOC, V128, P11199, DOI 10.1021/ja062117e; Chen ZP, 2007, TALANTA, V71, P2029, DOI [10.1016/j.talanta.2006.09.011, 10.1016/j.tatanta.2006.09.01]; Chu X, 2005, J IMMUNOL METHODS, V301, P77, DOI 10.1016/j.jim.2005.03.005; Dong XY, 2011, TALANTA, V84, P531, DOI 10.1016/j.talanta.2011.01.060; Hatanaka H, 2011, ANAL CHEM, V83, P7207, DOI 10.1021/ac201789m; Lee H, 2008, BIOSENS BIOELECTRON, V24, P1000, DOI 10.1016/j.bios.2008.08.002; Lee HJ, 2010, TALANTA, V81, P657, DOI 10.1016/j.talanta.2009.12.058; Ramon-Azcon J, 2011, ANAL CHEM, V83, P1053, DOI 10.1021/ac102854z; Ramon-Azcon J, 2010, BIOSENS BIOELECTRON, V25, P1928, DOI 10.1016/j.bios.2010.01.006; Lee KS, 1999, ANAL CHIM ACTA, V380, P17, DOI 10.1016/S0003-2670(98)00711-9; Yasukawa T, 2014, ANAL CHEM, V86, P304, DOI 10.1021/ac402962f; Yasukawa T, 2010, CHEM LETT, V39, P88, DOI 10.1246/cl.2010.88; Yasukawa T, 2012, BIOSENS BIOELECTRON, V37, P19, DOI 10.1016/j.bios.2012.04.039; Zoua Z.-X., 2012, TALANTA, V94, P58	39	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					99	104				6	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000003		
J	Takayanagi, T				Takayanagi, Toshio			Equilibrium Analyses in Aqueous Solution under Accompanying Side Reactions by Capillary Zone Electrophoresis	BUNSEKI KAGAKU			Japanese	Article						equilibrium analysis; capillary zone electrophoresis; affinity capillary electrophoresis; side reaction	TETRABROMOPHENOLPHTHALEIN ETHYL-ESTER; DISSOCIATION-CONSTANTS; PHENOLPHTHALEIN; MIXTURES; KINETICS; BINDING; REACTOR; ANION; ION	Analysis methods of equilibrium in an aqueous solution have been developed by capillary zone electrophoresis (CZE) utilizing its separation principle. The equilibrium of interest has been analyzed by affinity capillary electrophoresis (ACE) through the change in the electrophoretic mobility. Coexisting substances including degraded compounds are resolved from the equilibrium species by CZE, and an acid dissociation constant of photo-degradable haloperidol was determined in the presence of the degraded substances. In addition to the classical CZE separation, it has been noticed that gradually generated substances during CZE are resolved from the equilibrium species, and that the generated substances are observed as a leading/tailing signal to the equilibrium species. Slowly generated species from phenolphthalein by the addition of OH- in an alkaline pH solution was resolved from the equilibrium species, and the side reaction to the objective acid-base equilibria was excluded. Thus, two steps of the acid dissociation constants of phenolphthalein were determined by ACE. The acid-base equilibrium of tetrabromophenolphthalein ethyl ester (TBPE) was also analyzed by CZE under the degrading conditions, although the hydrolysis of the ester moiety accompanies with TBPE in acidic pH conditions. The precipitation reaction as a side reaction can also be excluded in the CZE analysis. The low concentration of analyte below its solubility is detected as a usual CZE signal, and the equilibrium of interest can be analyzed. The ion-association constants of dipicrylaminate ion with pairing cations were determined by ACE. Even under precipitating conditions, the precipitate is resolved from the equilibrium species by CZE, and it is dissolved again in the separation buffer. Acid dissociation constants of tetrabromophenolphthalein are determined by ACE under precipitable conditions. It was demonstrated in this study that the utilization of the CZE separation is advantageous on equilibrium analysis by ACE to such reactions as to be degradable and precipitable ones, compared to the ordinary analysis in homogeneous solutions, including potentiometric and photometric titrations.	Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Takayanagi, T (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minamijousanjima Cho, Tokushima 7708506, Japan.	takayana@chem.tokushima-u.ac.jp					ISHIHAMA Y, 1994, J PHARM SCI, V83, P1500, DOI 10.1002/jps.2600831025; Busch MHA, 1997, J CHROMATOGR A, V777, P311, DOI 10.1016/S0021-9673(97)00369-5; Iki N, 2000, ANAL CHEM, V72, P4812, DOI 10.1021/ac000312k; Avdeef A, 2006, EUR J PHARM SCI, V28, P43, DOI 10.1016/j.ejps.2005.12.008; Ornskov E, 2003, J PHARMACEUT BIOMED, V33, P379, DOI 10.1016/S0731-7085(03)00238-3; Berezovski M, 2002, J AM CHEM SOC, V124, P13674, DOI 10.1021/ja028212e; Krylov SN, 2007, ELECTROPHORESIS, V28, P69, DOI 10.1002/elps.200600577; Busch MHA, 1997, J CHROMATOGR A, V777, P329, DOI 10.1016/S0021-9673(97)00368-3; Driouich R, 2001, CHROMATOGRAPHIA, V53, P629, DOI 10.1007/BF02493010; Eringathodi S, 2005, EUR J INORG CHEM, P2198, DOI 10.1002/ejic.200401033; FRIEDL W, 1995, J CHROMATOGR A, V709, P163, DOI 10.1016/0021-9673(95)00159-K; HIROKAWA T, 1992, ANAL SCI, V8, P737, DOI 10.2116/analsci.8.737; Iki N, 2009, ANAL CHEM, V81, P7849, DOI 10.1021/ac901296j; Janos P, 2004, J CHROMATOGR A, V1037, P15, DOI 10.1016/j.chroma.2003.11.101; Jensen H., 2013, DRUG DELIV SCI TEC, V23, P333; Krylov SN, 2003, ANALYST, V128, P571, DOI 10.1039/b212913b; MOTOMIZU S, 1992, ANALYST, V117, P1775, DOI 10.1039/an9921701775; MOTOMIZU S, 1994, ANAL SCI, V10, P187, DOI 10.2116/analsci.10.187; Ohtsuka K, 2013, ANAL SCI, V29, P553; Poole SK, 2004, J CHROMATOGR A, V1037, P445, DOI 10.1016/j.chroma.2004.02.087; Sakai T., 1986, ANAL SCI, V2, P275, DOI 10.2116/analsci.2.275; Takayanagi T, 2013, ANAL SCI, V29, P1067; Takayanagi T, 2014, ANAL SCI, V30, P919; Takayanagi T, 2004, ANAL SCI, V20, P255, DOI 10.2116/analsci.20.255; Takayanagi T, 2013, ANAL SCI, V29, P547; Takayanagi T., 2001, CHEM LETT, V14; Tamura Z, 1996, ANAL SCI, V12, P927, DOI 10.2116/analsci.12.927; Tamura Z, 1999, ANAL SCI, V15, P339, DOI 10.2116/analsci.15.339	28	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					105	116				12	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000004		
J	Itagaki, T; Ashino, T; Takada, K; Wagatsuma, N				Itagaki, Toshiko; Ashino, Tetsuya; Takada, Kunio; Wagatsuma, Nazuaki			A Simultaneous Internal Standard Method for Improving the Analytical Precision of Flame Atomic Absorption Spectrometry Using High-resolution Continuum-light-source Apparatus	BUNSEKI KAGAKU			Japanese	Article						high-resolution continuum light source flame atomic absorption spectrometry; simultaneous internal standard method; nickel; steel	HIGH-PURITY IRON; REDUCTIVE COPRECIPITATION; TRACE AMOUNTS; ACTIVATED CARBON; COMPLEXATION; PALLADIUM; SORPTION; BISMUTH; STEELS; ACID	In order to conduct more precise measurements on a flame atomic absorption spectrometer (FAAS) with a continuum light source, the authors investigated a simultaneous internal standard method. For this purpose, an FAAS instrument, equipped with a xenon short-arc lamp as the radiation source and a high-resolution echelle monochromator, was employed. Synthetic mixed solutions of mixed nickel (10 mu g mL(-1)) and iron (500 and 1000 mu g mL(-1)) were prepared so that the determination of nickel in steel samples could be carried out. Neighboring spectrum lines of nickel (Ni I 232.003 nm) and iron (Fe I 232.036 nm) were selected, and their atomic absorbances were simultaneously measured for each test solution and sample solution. The matrix iron was employed as an internal standard element for nickel analysis by FAAS. In the proposed method, any variance of the analytical results in the measurement using a test solution could be reduced; in addition, the physical interference in the FAAS measurement by sulfuric acid coexisting in the sample solution could be removed. The amounts of nickel in steel CRMs were determined by a calibration curve method and the proposed method. Analytical values obtained by the both methods agreed with the certified reference values in the CRMs. However, in six or ten replicate measurements by these methods, the relative standard deviation of the analytical values obtained by the proposed method was lower than that by the calibration curve method. Therefore, the simultaneous internal standard method is very useful for improving the analytical precision in measurements with FAAS. Furthermore, it was effective for correcting any long-term drift of the sensitivity in the experimental system.	[Itagaki, Toshiko; Ashino, Tetsuya; Takada, Kunio; Wagatsuma, Nazuaki] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Itagaki, T (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	itagaki@imr.tohoku.ac.jp					Raposo JL, 2012, TALANTA, V92, P53, DOI 10.1016/j.talanta.2012.01.035; Oliveira SR, 2010, SPECTROCHIM ACTA B, V65, P316, DOI 10.1016/j.sab.2010.02.003; Bechlin MA, 2014, ANAL CHIM ACTA, V831, P24, DOI 10.1016/j.aca.2014.05.002; Ashino T, 1996, J ANAL ATOM SPECTROM, V11, P577, DOI 10.1039/ja9961100577; ASHINO T, 1994, ANAL CHIM ACTA, V297, P443, DOI 10.1016/0003-2670(94)00226-6; Fernandes KG, 2002, ANALYST, V127, P157, DOI 10.1039/b105309b; Giacomelli MBO, 1998, TALANTA, V47, P877, DOI 10.1016/S0039-9140(98)00176-3; Giacomelli MBO, 1999, MIKROCHIM ACTA, V132, P25; Itagaki T, 2000, FRESEN J ANAL CHEM, V368, P344, DOI 10.1007/s002160000455; Miranda K, 2010, MICROCHEM J, V96, P99, DOI 10.1016/j.microc.2010.02.011; Oliveira S. R., 2009, SPECTROCHIM ACTA B, V64, P593; Raposo JL, 2008, SPECTROCHIM ACTA B, V63, P992, DOI 10.1016/j.sab.2008.05.003	12	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					117	124				8	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000005		
J	Kato, N				Kato, Norio			Reduction of Chromium(VI) Elution from Coal Ash by Two-stage Combustion Method for Pulverized Coal Firing	BUNSEKI KAGAKU			Japanese	Article						hexavalent chromium; leaching test; coal fly-ash; Cr(VI) reduction; two-stage combustion method	OXY-FUEL COMBUSTION; FLY-ASH; SPECIATION; SPECTROSCOPY; CR(VI); NICKEL; XANES; CR	This study investigated the combustion conditions for Cr(VI) formation during pulverized coal combustion using three types of furnaces. Cr(VI) compounds can be highly soluble in water, whereas Cr(III) compounds are less soluble. The amount of Cr(VI) in coal ash was measured using the amount of Cr(VI) leached in a leaching solution, with ICP-AES after the separation of Cr(III) by Fe(OH)(3) co-precipitation. The results from laboratory drop tube furnace experiments indicated that the amount of Cr(VI) leached from coal ash depended on the temperature of the furnace, the air ratio (amount of air used in combustion to the theoretical air demand), and the O-2 concentration in the carrier gas. Since these dependences were similar to those for NOx emission, a two-stage combustion method used as a NOx reducing method was examined by using an experimental furnace with a burner for pulverized coal firing and a coal-fired power plant. The results showed that the amount of leached Cr(VI) decreased along with NOx as the two-stage combustion ratio increased. Low-NOx combustion conditions likely reduced the Cr(VI) formation in the combustion zone.	Ehime Prefectural Univ Hlth Sci, Fac Hlth Sci, Tobe, Ehime 7912101, Japan	Kato, N (reprint author), Ehime Prefectural Univ Hlth Sci, Fac Hlth Sci, 543 Takooda, Tobe, Ehime 7912101, Japan.	n-katoh@epu.ac.jp					Chen J, 2012, ENVIRON SCI TECHNOL, V46, P3567, DOI 10.1021/es204255h; Narukawa T, 2007, TALANTA, V73, P178, DOI 10.1016/j.talanta.2007.03.003; Goodarzi F, 2002, FUEL, V81, P1199, DOI 10.1016/S0016-2361(02)00023-6; Jiao F, 2011, ENVIRON SCI TECHNOL, V45, P6640, DOI 10.1021/es200545e; Goodarzi F, 2001, J ENVIRON MONITOR, V3, P1, DOI 10.1039/b006733o; Apte AD, 2006, J HAZARD MATER, V128, P164, DOI 10.1016/j.jhazmat.2005.07.057; Wang KS, 2001, WASTE MANAGE, V21, P85, DOI 10.1016/S0956-053X(00)00041-6; Shah P, 2008, FUEL, V87, P1859, DOI 10.1016/j.fuel.2007.12.001; Huggins FE, 1999, FUEL, V78, P233, DOI 10.1016/S0016-2361(98)00142-2; Chen J, 2013, J HAZARD MATER, V261, P260, DOI 10.1016/j.jhazmat.2013.07.023; Galbreath KC, 2004, FUEL PROCESS TECHNOL, V85, P701, DOI 10.1016/j.fuproc.2003.11.015; HUFFMAN GP, 1994, FUEL PROCESS TECHNOL, V39, P47, DOI 10.1016/0378-3820(94)90171-6; Shah P, 2012, FUEL, V102, P1, DOI 10.1016/j.fuel.2008.11.019	13	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					125	130				6	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000006		
J	Nakao, T; Suematsu, T; Utsumi, H; Furukawa, T; Kubota, H				Nakao, Tomoki; Suematsu, Takako; Utsumi, Hiroaki; Furukawa, Toshihiro; Kubota, Hajime			Effect of the Magnetic Inhomogeneity in NMR Signal Intensity Estimation Based on High-order Estimation Selective Evaluation (HOESE) Method and a Precision Improvement	BUNSEKI KAGAKU			Japanese	Article						NMR; quantitative NMR; magnetic inhomogeneity; peak separation method; reference deconvolution method	SPECTROSCOPY	For intensity estimations of the NMR signal, we have proposed the High-Order Estimation Selective Evaluation (HOESE) method. This Method estimates the poles (half-widths, frequencies) and the amplitudes of each signal element included in the NMR signal, and calculates intensity as the sum of these amplitudes. However, the HOESE may obtain a biased estimation value with respect to the parameter under the inhomogeneity of the magnetic distribution. In order to overcome the drawback above, we would like to propose a method in which the Reference Deconvolution Method (RDM) is firstly performed to the observed NMR signal, and the HOESE secondly is applied to the pre-processed NMR signal. Theoretical analysis indicate that the proposed method can obtain approximately an unbiased estimation value of the parameter already mentioned. Computer simulations and experiments show the effectiveness of the proposed method.	[Nakao, Tomoki; Furukawa, Toshihiro] Tokyo Univ Sci, Dept Ind Engn, Shinzyuku Ku, Tokyo 1628601, Japan; [Suematsu, Takako; Utsumi, Hiroaki] JEOL RESONANCE Inc, Tokyo 1968558, Japan; [Kubota, Hajime] Chiba Inst Tech, Fac Engn, Chiba 2750016, Japan	Nakao, T (reprint author), Tokyo Univ Sci, Dept Ind Engn, Shinzyuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	nakao_t@ms.kagu.tus.ac.jp					Koehl P, 1999, PROG NUCL MAG RES SP, V34, P257, DOI 10.1016/S0079-6565(99)00002-3; Bradley SA, 2010, J AM CHEM SOC, V132, P9531, DOI 10.1021/ja101962c; Monakhova YB, 2014, J PHARMACEUT BIOMED, V100, P381, DOI 10.1016/j.jpba.2014.08.024; Pauli GF, 2007, J NAT PROD, V70, P589, DOI 10.1021/np060535r; Malz F, 2005, J PHARMACEUT BIOMED, V38, P813, DOI 10.1016/j.jpba.2005.01.043; Bharti SK, 2012, TRAC-TREND ANAL CHEM, V35, P5, DOI 10.1016/j.trac.2012.02.007; Fukushima M, 1997, ANAL SCI, V13, P841, DOI 10.2116/analsci.13.841; Holzgrabe U., 2008, NMR SPECTROSCOPY PHA, P53; Metz KR, 2000, CONCEPT MAGNETIC RES, V12, P21; Shaw AK, 2001, IEEE T ANTENN PROPAG, V49, P327, DOI 10.1109/8.918605	10	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					131	146				16	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000007		
J	Sugimura, N; Furuya, A; Yatsu, T; Shibue, T				Sugimura, Natsuhiko; Furuya, Asami; Yatsu, Takahiro; Shibue, Toshimichi			Application of Density Functional Theory (DFT) and Empirical Scaling to Practical Prediction of C-13-NMR of (-)-Napyradiomycin A1	BUNSEKI KAGAKU			Japanese	Article						density functional theory; napyradiomycin A1; C-13-NMR; gauge-including atom orbital	ANTIBIOTICS NAPYRADIOMYCINS; STEREOCHEMISTRY; APPROXIMATION; EXCHANGE; DIASTEREOISOMERS; MODELS	We tested a practical method for reducing any error in computed C-13-NMR chemical shifts of the halogenated natural product (-)-Napyradiomycin A1. Linear-regression parameters were employed as empirical scaling factors. The DFT (density functional theory) method B3LYP/6 - 311 + (2d,p) with an empirical scaling factor reduced the error of two chlorine attached carbon, from 14.4 to 1.1 ppm, and from 10.8 to 2.4 ppm. This method provide a 1.95 ppm root mean square error and a 0.999 correlation coefficient.	[Sugimura, Natsuhiko; Furuya, Asami; Yatsu, Takahiro; Shibue, Toshimichi] Waseda Univ, Mat Characterizat Cent Lab, Shinjuku Ku, Tokyo 1698555, Japan	Sugimura, N (reprint author), Waseda Univ, Mat Characterizat Cent Lab, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	shib@waseda.jp					Smith SG, 2009, J ORG CHEM, V74, P4597, DOI 10.1021/jo900408d; Smith SG, 2010, J AM CHEM SOC, V132, P12946, DOI 10.1021/ja105035r; Snyder SA, 2009, J AM CHEM SOC, V131, P5744, DOI 10.1021/ja9014716; Neese F, 1998, INORG CHEM, V37, P6568, DOI 10.1021/ic980948i; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Lodewyk MW, 2012, CHEM REV, V112, P1839, DOI 10.1021/cr200106v; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; [Anonymous], 2009, GAUSS 09 REVISIOND 0; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Adamo C, 1998, J CHEM PHYS, V108, P664, DOI 10.1063/1.475428; Bifulco G, 2007, CHEM REV, V107, P3744, DOI 10.1021/cr030733c; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; d'Antuono P., 2006, J CHEM PHYS, V125, P144; Fukui H, 2002, J CHEM PHYS, V117, P7836, DOI 10.1063/1.1510118; SHIOMI K, 1987, J ANTIBIOT, V40, P1213; SHIOMI K, 1986, J ANTIBIOT, V39, P487; SHIOMI K, 1986, J ANTIBIOT, V39, P494; Tatsuta K, 2002, CHEM LETT, P14, DOI 10.1246/cl.2002.14	20	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2015	64	2					147	150				4	Chemistry, Analytical	Chemistry	CB9GW	WOS:000349941000008		
J	Suzuki, K; Mitsutake, N; Saenko, V; Yamashita, S				Suzuki, Keiji; Mitsutake, Norisato; Saenko, Vladimir; Yamashita, Shunichi			Radiation signatures in childhood thyroid cancers after the Chernobyl accident: Possible roles of radiation in carcinogenesis	CANCER SCIENCE			English	Review						Chernobyl; chromosome rearrangement; radiation; signature; thyroid cancer	COMPARATIVE GENOMIC HYBRIDIZATION; NUCLEAR-POWER-PLANT; GENE-EXPRESSION PROFILES; ATOMIC-BOMB SURVIVORS; POST-CHERNOBYL; IONIZING-RADIATION; CHROMOSOMAL REARRANGEMENT; ONCOGENIC REARRANGEMENTS; MOLECULAR-GENETICS; RET PROTOONCOGENE	After the Tokyo Electric Power Company Fukushima Daiichi nuclear power plant accident, cancer risk from low-dose radiation exposure has been deeply concerning. The linear no-threshold model is applied for the purpose of radiation protection, but it is a model based on the concept that ionizing radiation induces stochastic oncogenic alterations in the target cells. As the elucidation of the mechanism of radiation-induced carcinogenesis is indispensable to justify the concept, studies aimed at the determination of molecular changes associated with thyroid cancers among children who suffered effects from the Chernobyl nuclear accident will be overviewed. We intend to discuss whether any radiation signatures are associated with radiation-induced childhood thyroid cancers.	[Suzuki, Keiji; Mitsutake, Norisato; Saenko, Vladimir; Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan	Suzuki, K (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	kzsuzuki@nagasaki-u.ac.jp		Mitsutake, Norisato/0000-0002-2744-8046	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan.	Agate L, 2008, J CLIN ENDOCR METAB, V93, P2729, DOI 10.1210/jc.2008-0060; Tuttle RM, 2011, CLIN ONCOL-UK, V23, P268, DOI 10.1016/j.clon.2011.01.178; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Guarino V, 2010, MOL CELL ENDOCRINOL, V321, P94, DOI 10.1016/j.mce.2009.10.003; Rodrigues R, 2007, ONCOL REP, V18, P917; Ivanov VK, 2012, RADIAT PROT DOSIM, V151, P489, DOI 10.1093/rpd/ncs019; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Tronko MD, 2006, J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Likhtarov I, 2006, RADIAT RES, V166, P375, DOI 10.1667/RR3593.1; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Saenko V, 2011, CLIN ONCOL-UK, V23, P234, DOI 10.1016/j.clon.2011.01.502; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Kodama Y, 2005, CANCER SCI, V96, P143, DOI 10.1111/j.1349-7006.2005.00023.x; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Muzza M, 2010, CLIN ENDOCRINOL, V72, P702, DOI 10.1111/j.1365-2265.2009.03699.x; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Ricarte JC, 2013, J CLIN INVEST, V123, P4935, DOI 10.1172/JCI69766; Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Cardis E, 2005, J NATL CANCER I, V97, P724; Yamashita S, 2014, HEALTH PHYS, V106, P166, DOI 10.1097/HP.0000000000000007; Leeman-Neill RJ, 2013, CANCER-AM CANCER SOC, V119, P1792, DOI 10.1002/cncr.27893; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Fenton CL, 2000, J CLIN ENDOCR METAB, V85, P1170, DOI 10.1210/jc.85.3.1170; Pacini F, 1998, LANCET, V352, P763, DOI 10.1016/S0140-6736(97)11397-6; Yamashita S, 2007, NAT CLIN PRACT ENDOC, V3, P422, DOI 10.1038/ncpendmet0499; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Hess J, 2011, P NATL ACAD SCI USA, V108, P9595, DOI 10.1073/pnas.1017137108; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Dom G, 2012, BRIT J CANCER, V107, P994, DOI 10.1038/bjc.2012.302; Eszlinger M, 2006, J CLIN ENDOCR METAB, V91, P1934, DOI 10.1210/jc.2005-1620; Klugbauer S, 1995, ONCOGENE, V11, P2459; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Akiba S, 2012, J RADIOL PROT, V32, P1, DOI 10.1088/0952-4746/32/1/1; Ron E, 2007, HEALTH PHYS, V93, P502; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Demidchik YE, 2007, ARQ BRAS ENDOCRINOL, V51, P748, DOI 10.1590/S0004-27302007000500012; Bennett B, 2006, WHO REPORT UN CHERNO; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Finn S, 2007, ARCH PATHOL LAB MED, V131, P65; Gembicki M, 1997, ENVIRON HEALTH PERSP, V105, P1487, DOI 10.2307/3433657; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; Hemmer S, 1999, AM J PATHOL, V154, P1539, DOI 10.1016/S0002-9440(10)65407-7; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; Kimmel RR, 2006, RADIAT RES, V166, P519, DOI 10.1667/RR0547.1; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; Maenhaut C, 2011, CLIN ONCOL-UK, V23, P282, DOI 10.1016/j.clon.2011.01.509; Menicali E, 2012, FRONT ENDOCRINOL, V3, P1; Mizuno T, 2000, ONCOGENE, V19, P438, DOI 10.1038/sj.onc.1203343; Niwa O, 2010, RADIAT RES, V174, P833, DOI 10.1667/RR1970.1; OKAYASU I, 1995, J CANCER RES CLIN, V121, P746, DOI 10.1007/BF01213321; Ostroumova E, 2009, ENVIRON HEALTH PERSP, V117, P745, DOI 10.1289/ehp.0800184; Podtcheko A, 2005, THYROID, V15, P306, DOI 10.1089/thy.2005.15.306; Port M, 2007, RADIAT RES, V168, P639, DOI 10.1667/RR0968.1; Richter H, 2004, THYROID, V14, P1061, DOI 10.1089/thy.2004.14.1061; Romei Cristina, 2012, Front Endocrinol (Lausanne), V3, P54, DOI 10.3389/fendo.2012.00054; Santoro M, 2013, COLD SPRING HARB PER, V5, P1; Santoro M, 2013, J CLIN INVEST, V123, P4566, DOI 10.1172/JCI72725; Suzuki K, 2014, ADV WOUND CARE, V3, P16; Tronko M., 2010, Experimental Oncology, V32, P200; United Nations, 2011, SOURC EFF ION RAD; United Nations, 2014, SOURC EFF RISKS ION; Wang XQ, 2013, BBA-PROTEINS PROTEOM, V1834, P2205, DOI 10.1016/j.bbapap.2012.10.008; WHO, 2013, HLTH RISK ASS NUCL A; Williams D, 2009, ONCOGENE, V27, pS9, DOI DOI 10.1038/ONC.2009.349; Zitzelsberger H, 2010, CLIN CHIM ACTA, V411, P301, DOI 10.1016/j.cca.2009.11.028; Zitzelsberger H, 1999, CANCER RES, V59, P135; Zitzelsberger H, 2011, CLIN ONCOL-UK, V23, P289, DOI 10.1016/j.clon.2011.01.154	79	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					127	133		10.1111/cas.12583		7	Oncology	Oncology	CC2JJ	WOS:000350171000001		
J	Ohshio, Y; Teramoto, K; Hanaoka, J; Tezuka, N; Itoh, Y; Asai, T; Daigo, Y; Ogasawara, K				Ohshio, Yasuhiko; Teramoto, Koji; Hanaoka, Jun; Tezuka, Noriaki; Itoh, Yasushi; Asai, Tohru; Daigo, Yataro; Ogasawara, Kazumasa			Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine	CANCER SCIENCE			English	Article						Cancer-associated fibroblasts; dendritic cell-based vaccine immunotherapy; suppressor immune cells; tranilast; tumor microenvironment	REGULATORY T-CELLS; TUMOR-ASSOCIATED FIBROBLASTS; ACTIVATION PROTEIN; STROMAL FIBROBLASTS; COLLAGEN-SYNTHESIS; SUPPRESSOR-CELLS; LYMPH-NODE; TRANILAST; GROWTH; PROLIFERATION	Given the close interaction between tumor cells and stromal cells in the tumor microenvironment (TME), TME-targeted strategies would be promising for developing integrated cancer immunotherapy. Cancer-associated fibroblasts (CAFs) are the dominant stromal component, playing critical roles in generation of the pro-tumorigenic TME. We focused on the immunosuppressive trait of CAFs, and systematically explored the alteration of tumor-associated immune responses by CAF-targeted therapy. C57BL/6 mice s.c. bearing syngeneic E.G7 lymphoma, LLC1 Lewis lung cancer, or B16F1 melanoma were treated with an anti-fibrotic agent, tranilast, to inhibit CAF function. The infiltration of immune suppressor cell types, including regulatory T cells and myeloid-derived suppressor cells, in the TME was effectively decreased through reduction of stromal cell-derived factor-1, prostaglandin E-2, and transforming growth factor-. In tumor-draining lymph nodes, these immune suppressor cell types were significantly decreased, leading to activation of tumor-associated antigen-specific CD8(+) T cells. In addition, CAF-targeted therapy synergistically enhanced multiple types of systemic antitumor immune responses such as the cytotoxic CD8(+) T cell response, natural killer activity, and antitumor humoral immunity in combination with dendritic cell-based vaccines; however, the suppressive effect on tumor growth was not observed in tumor-bearing SCID mice. These data indicate that systemic antitumor immune responses by various immunologic cell types are required to bring out the efficacy of CAF-targeted therapy, and these effects are enhanced when combined with effector-stimulatory immunotherapy such as dendritic cell-based vaccines. Our mouse model provides a novel rationale with TME-targeted strategy for the development of cell-based cancer immunotherapy.	[Ohshio, Yasuhiko; Hanaoka, Jun; Tezuka, Noriaki; Asai, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan; [Teramoto, Koji; Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 5202192, Japan; [Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 5202192, Japan	Teramoto, K (reprint author), Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 5202192, Japan.	teramoto@belle.shiga-med.ac.jp			Ministry of Education, Science, and Culture of Japan [20591666]; Shiga University of Medical Science [1515503I];  [1515503ZC]	Ministry of Education, Science, and Culture of Japan (20591666). Shiga University of Medical Science (1515503I). (1515503ZC).	Rogosnitzky M, 2012, ANTICANCER RES, V32, P2471; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Wen YA, 2010, CANCER SCI, V101, P2325, DOI 10.1111/j.1349-7006.2010.01695.x; Munn DH, 2006, IMMUNOL REV, V213, P146, DOI 10.1111/j.1600-065X.2006.00444.x; Balsamo M, 2009, P NATL ACAD SCI USA, V106, P20847, DOI 10.1073/pnas.0906481106; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI [10.1053/j.gastro.2008.03.020, 10.1053/i.gastro.2008.03.020]; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Ito M, 2006, J IMMUNOL, V176, P5637; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mandelboim O, 1997, J IMMUNOL, V159, P6030; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Durr C, 2010, CANCER RES, V70, P10170, DOI 10.1158/0008-5472.CAN-10-1943; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fujita T, 2009, CANCER RES, V69, P5142, DOI 10.1158/0008-5472.CAN-08-2499; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Kinoshita T, 2013, CANCER SCI, V104, P409, DOI 10.1111/cas.12099; Ding Zhen-Yu, 2012, Cancer Microenviron, V5, P333, DOI 10.1007/s12307-012-0107-x; Hattori T, 2004, EUR J PHARMACOL, V498, P79, DOI 10.1016/j.ejphar.2004.07.061; Isaji M, 2000, CORNEA, V19, P364, DOI 10.1097/00003226-200005000-00021; Karagoz B, 2010, MED ONCOL, V27, P29, DOI 10.1007/s12032-008-9165-9; Kontani K, 2003, INT J MOL MED, V12, P767; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Murata T, 2011, CANCER RES, V71, P6633, DOI 10.1158/0008-5472.CAN-11-0034; Ohshio Y, 2014, SCAND J IMMUNOL, V80, P406; Oshima T, 2000, CURR EYE RES, V20, P283, DOI 10.1076/0271-3683(200004)20:4;1-5;FT283; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; SUZAWA H, 1992, JPN J PHARMACOL, V60, P91, DOI 10.1254/jjp.60.91; TANAKA K, 1994, ATHEROSCLEROSIS, V107, P179, DOI 10.1016/0021-9150(94)90019-1; Teramoto K, 2003, CANCER RES, V63, P7920; Teramoto K, 2007, CANCER IMMUNOL IMMUN, V56, P331, DOI 10.1007/s00262-006-0192-0; Yasukawa T, 2002, OPHTHALMIC RES, V34, P206, DOI 10.1159/000063884	40	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					134	142		10.1111/cas.12584		9	Oncology	Oncology	CC2JJ	WOS:000350171000002		
J	Inoue, K; Saegusa, N; Omiya, M; Ashizawa, T; Miyata, H; Komiyama, M; Iizuka, A; Kume, A; Sugino, T; Yamaguchi, K; Kiyohara, Y; Nakagawa, M; Akiyama, Y				Inoue, Keita; Saegusa, Noriko; Omiya, Maho; Ashizawa, Tadashi; Miyata, Haruo; Komiyama, Masaru; Iizuka, Akira; Kume, Akiko; Sugino, Takashi; Yamaguchi, Ken; Kiyohara, Yoshio; Nakagawa, Masahiro; Akiyama, Yasuto			Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model	CANCER SCIENCE			English	Article						Dendritic cell; head and neck cancer; immuno-flap; local recurrence; rat model	REGULATORY T-CELLS; RECURRENT HEAD; PHASE-I; IMMUNOTHERAPY; CARCINOMA; TUMOR; RECONSTRUCTION	Local recurrence is a major clinical issue following surgical resection in head and neck cancer, and the dissemination and lymph node metastasis of minimal residual disease is relatively difficult to treat due to the lack of suitable therapeutic approaches. In the present study, we developed and evaluated a novel immunotherapy using a skin flap transfer treated with sensitized dendritic cells (DC), termed the immuno-flap, in a rat tumor model. After the local round area of skin was resected, SCC-158 cells (a rat head and neck cancer cell line) were inoculated into the muscle surface; lastly, the groin skin flap injected with mature DC was overlaid. Two weeks after the second DC injection, systemic immunological reactions and tumor size were measured. The DC-treated group showed a significant reduction in tumor size compared with the control. Although the induction of CTL activity in spleen cells was marginal, Th1 cytokines such as interleukin-2 and interferon- were elevated in the DC-treated group. These results suggest that a novel immunotherapy based on the immuno-flap method has the potential for clinical application to prevent the local recurrence of head and neck cancer patients.	[Inoue, Keita; Saegusa, Noriko; Nakagawa, Masahiro] Shizuoka Canc Ctr Hosp, Div Plast & Reconstruct Surg, Nagaizumi, Shizuoka, Japan; [Omiya, Maho; Ashizawa, Tadashi; Miyata, Haruo; Komiyama, Masaru; Iizuka, Akira; Kume, Akiko; Akiyama, Yasuto] Shizuoka Canc Ctr Res Inst, Div Immunotherapy, Nagaizumi, Shizuoka 4118777, Japan; [Sugino, Takashi] Shizuoka Canc Ctr Hosp, Div Pathol, Nagaizumi, Shizuoka, Japan; [Yamaguchi, Ken] Shizuoka Canc Ctr Hosp, Off President, Nagaizumi, Shizuoka, Japan; [Kiyohara, Yoshio] Shizuoka Canc Ctr Hosp, Div Dermatol, Nagaizumi, Shizuoka, Japan	Akiyama, Y (reprint author), Shizuoka Canc Ctr Res Inst, Div Immunotherapy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	y.akiyama@scchr.jp			JSPS KAKENHI [20337306]; Public Trust Fund for Clinical Cancer Research; Foundation for Promotion of Cancer Research in Japan; Graduate School of Medicine, Keio University	This work was supported by a grant to K. I., Y. A., M. N. and Y. K. from JSPS KAKENHI (Grant Number 20337306) and grants to K. I. from the Public Trust Fund for Clinical Cancer Research and the Foundation for Promotion of Cancer Research in Japan. N. S. is supported by a scholarship from the Graduate School of Medicine, Keio University.	Akiyama Y, 2004, ANTICANCER RES, V24, P571; Akiyama Y, 2008, INT J ONCOL, V33, P433, DOI 10.3892/ijo_00000025; Uchida T, 2008, CANCER IMMUNOL IMMUN, V57, P337, DOI 10.1007/s00262-007-0373-5; Aarntzen EHJG, 2013, CLIN CANCER RES, V19, P1525, DOI 10.1158/1078-0432.CCR-12-1879; Badoual C, 2013, CANCER RES, V73, P128, DOI 10.1158/0008-5472.CAN-12-2606; Wong CH, 2010, HEAD NECK-J SCI SPEC, V32, P1236, DOI 10.1002/hed.21284; Winquist E, 2007, HEAD NECK-J SCI SPEC, V29, P38, DOI 10.1002/hed.20465; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Jie HB, 2013, BRIT J CANCER, V109, P2629, DOI 10.1038/bjc.2013.645; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Turksma AW, 2013, IMMUNOTHERAPY-UK, V5, P49, DOI [10.2217/imt.12.135, 10.2217/IMT.12.135]; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Ramos CA, 2013, J IMMUNOTHER, V36, P66, DOI 10.1097/CJI.0b013e318279652e; Christian NA, 2009, MOL IMAGING BIOL, V11, P167, DOI 10.1007/s11307-008-0184-x; Bourdeaux C, 2014, P NATL ACAD SCI USA, V111, P3502, DOI 10.1073/pnas.1401115111; Crittenden MR, 2005, IMMUNOLOGY, V114, P11, DOI 10.1111/j.1365-2567.2004.02001.x; DELLON A L, 1985, Journal of Reconstructive Microsurgery, V2, P7, DOI 10.1055/s-2007-1007040; Dempsey MP, 2008, PLAST RECONSTR SURG, V121, P1541, DOI 10.1097/PRS.0b013e31816ff6aa; desVries IJ, 2005, NAT BIOTECHNOL, V23, P1407; Erfani N, 2013, IMMUNOL INVEST, V42, P81, DOI 10.3109/08820139.2012.708376; Herbst RS, 2005, J CLIN ONCOL, V23, P5577; Herold-Mende C, 2005, ADV OTO-RHINO-LARYNG, V62, P173; Kornfehl J, 1997, J ORAL PATHOL MED, V26, P29, DOI 10.1111/j.1600-0714.1997.tb00006.x; Kurosaki M, 2010, CANCER IMMUNOL IMMUN, V60, P207; Manzo T, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25996; Murphy Barbara A, 2013, J Support Oncol, V11, P149; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; PARSA FD, 1978, PLAST RECONSTR SURG, V62, P271, DOI 10.1097/00006534-197808000-00019; Routray S, 2014, MOL BIOL INT, V2014; Strojan P, 2015, HEAD NECK-J SCI SPEC, V37, P134, DOI 10.1002/hed.23542; van Schalkwyk MCI, 2013, HUM GENE THER CL DEV, V24, P134, DOI 10.1089/humc.2013.144; Yamasaki K, 2010, CLIN IMMUNOL, V138, P255, DOI DOI 10.1016/J.CLIM.2010.11.014	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					143	150		10.1111/cas.12586		8	Oncology	Oncology	CC2JJ	WOS:000350171000003		
J	Isoyama, S; Kajiwara, G; Tamaki, N; Okamura, M; Yoshimi, H; Nakamura, N; Kawamura, K; Nishimura, Y; Namatame, N; Yamori, T; Dan, S				Isoyama, Sho; Kajiwara, Gensei; Tamaki, Naomi; Okamura, Mutsumi; Yoshimi, Hisashi; Nakamura, Naoki; Kawamura, Kento; Nishimura, Yumiko; Namatame, Nachi; Yamori, Takao; Dan, Shingo			Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474	CANCER SCIENCE			English	Article						Drug resistance; insulin-like growth factor 1 receptor; insulin-like growth factor 1 receptor tyrosine kinase inhibitors; phosphatidylinositol 3-kinase; phosphatidylinositol 3-kinase inhibitors	PHOSPHOINOSITIDE 3-KINASE; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; PI3K INHIBITORS; FACTOR SYSTEM; LUNG-CANCER; IN-VITRO; PATHWAY; PHOSPHORYLATION; THERAPY	Drug resistance often critically limits the efficacy of molecular targeted drugs. Although pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) is an attractive therapeutic strategy for cancer therapy, molecular determinants for efficacy of PI3K inhibitors (PI3Kis) remain unclear. We previously identified that overexpression of insulin-like growth factor 1 receptor (IGF1R) contributed to the development of drug resistance after long-term exposure to PI3Kis. In this study, we examined the involvement of basal IGF1R expression in intrinsic resistance of drug-naive cancer cells to PI3Kis and whether inhibition of IGF1R overcomes the resistance. We found that cancer cells highly expressing IGF1R showed resistance to dephosphorylation of Akt and subsequent antitumor effect by ZSTK474 treatment. Knockdown of IGF1R by siRNAs facilitated the dephosphorylation and enhanced the drug efficacy. These cells expressed tyrosine-phosphorylated insulin receptor substrate 1 at high levels, which was dependent on basal IGF1R expression. In these cells, the efficacy of ZSTK474 in vitro and in vivo was improved by its combination with the IGF1R inhibitor OSI-906. Finally, we found a significant correlation between the basal expression level of IGF1R and the inefficacy of ZSTK474 in an in vivo human cancer panel, as well as in vitro. These results suggest that basal IGF1R expression affects intrinsic resistance of cancer cells to ZSTK474, and IGF1R is a promising target to improve the therapeutic efficacy. The current results provide evidence of combination therapy of PI3Kis with IGF1R inhibitors for treating IGF1R-positive human cancers.	[Isoyama, Sho; Kajiwara, Gensei; Tamaki, Naomi; Okamura, Mutsumi; Yoshimi, Hisashi; Nakamura, Naoki; Kawamura, Kento; Nishimura, Yumiko; Namatame, Nachi; Yamori, Takao; Dan, Shingo] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Isoyama, Sho; Yoshimi, Hisashi; Namatame, Nachi] Zenyaku Kogyo Co Ltd, Res Lab, Tokyo, Japan	Dan, S (reprint author), Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	sdan@jfcr.or.jp			National Cancer Center Research Development Fund [23-A-15, 26-A-5]	National Cancer Center Research Development Fund (23-A-15). (26-A-5).	STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Yaguchi SI, 2006, J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Shepherd PR, 1998, BIOCHEM J, V333, P471; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Yamori T, 1999, CANCER RES, V59, P4042; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Gridelli C, 2010, EXPERT OPIN INV DRUG, V19, P631, DOI 10.1517/13543781003767434; Mothe I, 1996, J BIOL CHEM, V271, P11222; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Sachdev D, 2010, CURR DRUG TARGETS, V11, P1121; Isoyama S, 2012, CANCER SCI, V103, P1955, DOI 10.1111/cas.12004; Isoyama S, 2012, BIOL PHARM BULL, V35, P1607; LasThangue NB, 2011, NAT REV CLIN ONCOL, V8, P587; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Philip R, 2011, BIOANALYSIS, V3, P383, DOI [10.4155/bio.11.1, 10.4155/BIO.11.1]; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1; Zick Y., 2005, SCI STKE, V268, ppe4	38	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					171	178		10.1111/cas.12582		8	Oncology	Oncology	CC2JJ	WOS:000350171000006		
J	Takamatsu, H; Honda, S; Miyamoto, T; Yokoyama, K; Hagiwara, S; Ito, T; Tomita, N; Iida, S; Iwasaki, T; Sakamaki, H; Suzuki, R; Sunami, K				Takamatsu, Hiroyuki; Honda, Sumihisa; Miyamoto, Toshihiro; Yokoyama, Kenji; Hagiwara, Shotaro; Ito, Toshiro; Tomita, Naoto; Iida, Shinsuke; Iwasaki, Toshihiro; Sakamaki, Hisashi; Suzuki, Ritsuro; Sunami, Kazutaka			Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era	CANCER SCIENCE			English	Article						Autologous stem cell transplantation; immunomodulator drugs; International Staging System; multiple myeloma; proteasome inhibitors	INTERNATIONAL STAGING SYSTEM; IMPROVED SURVIVAL; THERAPY; IMPACT; RISK	We evaluated the clinical significance of prognostic factors including the International Staging System (ISS) and modified European Group for Blood and Marrow Transplantation response criteria in 1650 Japanese patients with multiple myeloma (MM) who underwent upfront single autologous stem cell transplantation (ASCT). We categorized patients into two treatment cohorts: pre-novel agent era (1995-2006) and novel agent era (2008-2011). The combined percentage of pre-ASCT complete response and very good partial response cases (463 of 988, 47%) significantly increased during the novel agent era compared with the pre-novel agent era (164 of 527, 31%; P<0.0001). The 2-year overall survival (OS) rate of 87% during the novel agent era was a significant improvement relative to that of 82% during the pre-novel agent era (P=0.019). Although significant differences in OS were found among ISS stages during the pre-novel agent era, no significant difference was observed between ISS I and II (P=0.107) during the novel agent era. The factors independently associated with a superior OS were female gender (P=0.002), a good performance status (P=0.024), lower ISS (P<0.001), pre-ASCT response at least partial response (P<0.001) and ASCT during the novel agent era (P=0.017). These results indicate that the response rate and OS were significantly improved, and the ISS could not clearly stratify the prognoses of Japanese patients with MM who underwent upfront single ASCT during the novel agent era.	[Takamatsu, Hiroyuki] Kanazawa Univ, Cellular Transplantat Biol Hematol Respirol, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Honda, Sumihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki 852, Japan; [Miyamoto, Toshihiro] Kyushu Univ Hosp, Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Yokoyama, Kenji] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Hagiwara, Shotaro] Natl Ctr Global Hlth & Med, Div Hematol, Internal Med, Tokyo, Japan; [Ito, Toshiro] Shinshu Univ, Sch Med, Dept Internal Med 2, Div Hematol, Matsumoto, Nagano 390, Japan; [Tomita, Naoto] Yokohama City Univ, Dept Internal Med & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Iida, Shinsuke] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Iwasaki, Toshihiro] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi, Japan; [Sakamaki, Hisashi] Komagome Hosp, Div Hematol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Suzuki, Ritsuro] Nagoya Univ, Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 466, Japan; [Sunami, Kazutaka] Natl Hosp Org, Okayama Med Ctr, Dept Hematol, Okayama, Japan	Takamatsu, H (reprint author), Kanazawa Univ, Cellular Transplantat Biol Hematol Respirol, Inst Med Pharmaceut & Hlth Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	takamaz@staff.kanazawa-u.ac.jp			International Myeloma Foundation Japan	This study was supported by the International Myeloma Foundation Japan.	Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Costa LJ, 2013, BIOL BLOOD MARROW TR, V19, P1615, DOI 10.1016/j.bbmt.2013.08.002; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Wang LH, 2001, J BIOL CHEM, V276, P31839, DOI 10.1074/jbc.M105185200; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Hari PN, 2009, LEUKEMIA, V23, P1528, DOI 10.1038/leu.2009.61; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Iriuchishima H, 2015, EUR J HAEMATOL, V94, P145, DOI 10.1111/ejh.12407; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim H, 2006, BIOL BLOOD MARROW TR, V12, P837, DOI 10.1016/j.bbmt.2006.04.006; Landgren O, 2006, CANCER EPIDEM BIOMAR, V15, P2342, DOI 10.1158/1055-9965.EPI-06-0097; Nagura E, 2012, TAHATSUSEIKOTSUZUISH; Tan D, 2012, EUR J HAEMATOL, V89, P136, DOI 10.1111/j.1600-0609.2012.01797.x; Tanaka H, 2013, BLOOD, V122; Venner CP, 2011, LEUKEMIA LYMPHOMA, V52, P34, DOI 10.3109/10428194.2010.531409	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					179	185		10.1111/cas.12594		7	Oncology	Oncology	CC2JJ	WOS:000350171000007		
J	Tateishi, U; Tatsumi, M; Terauchi, T; Ando, K; Niitsu, N; Kim, WS; Suh, C; Ogura, M; Tobinai, K				Tateishi, Ukihide; Tatsumi, Mitsuaki; Terauchi, Takashi; Ando, Kiyoshi; Niitsu, Nozomi; Kim, Won Seog; Suh, Cheolwon; Ogura, Michinori; Tobinai, Kensei			Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma	CANCER SCIENCE			English	Article						[F-18] fluorodeoxyglucose; diffuse large B-cell lymphoma; lymphoma; metabolic tumor burden; positron emission tomography; computed tomography	NON-HODGKINS-LYMPHOMA; INTRATUMORAL HETEROGENEITY; RESPONSE ASSESSMENT; AMERICAN-COLLEGE; NUCLEAR-MEDICINE; F-18-FDG PET; INTERIM; VOLUME; RECOMMENDATIONS; RADIOLOGY	The aim of the present study was to investigate the feasibility of measuring metabolic tumor burden using [F-18] fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) treated with bendamustine-rituximab. Because the standardized uptake value is a critical parameter of tumor characterization, we carried out a phantom study of F-18-FDG PET/CT to ensure quality control for 28 machines in the 24 institutions (Japan, 17 institutions; Korea, 7 institutions) participating in our clinical study. Fifty-five patients with relapsed or refractory DLBCL were enrolled. The F-18-FDG PET/CT was acquired before treatment, after two cycles, and after the last treatment cycle. Treatment response was assessed after two cycles and after the last cycle using the Lugano classification. Using this classification, remission was complete in 15 patients (27%) and incomplete in 40 patients (73%) after two cycles of therapy, and remission was complete in 32 patients (58%) and incomplete in 23 patients (42%) after the last treatment cycle. The percentage change in all PET/CT parameters except for the area under the curve of the cumulative standardized uptake value-volume histogram was significantly greater in complete response patients than in non-complete response patients after two cycles and the last cycle. The Cox proportional hazard model and best subset selection method revealed that the percentage change of the sum of total lesion glycolysis after the last cycle (relative risk, 5.24; P=0.003) was an independent predictor of progression-free survival. The percent change of sum of total lesion glycolysis, calculated from PET/CT, can be used to quantify the response to treatment and can predict progression-free survival after the last treatment cycle in patients with relapsed or refractory DLBCL treated with bendamustine-rituximab.	[Tateishi, Ukihide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Tokyo 1138519, Japan; [Tatsumi, Mitsuaki] Osaka Univ, Grad Sch Med, Dept Radiol, Osaka, Japan; [Terauchi, Takashi] Natl Canc Ctr, Div Diagnost Radiol, Tokyo, Japan; [Ando, Kiyoshi] Tokai Univ Hosp, Dept Hematol & Oncol, Isehara, Kanagawa, Japan; [Niitsu, Nozomi] Saitama Med Univ, Dept Hematol, Int Med Ctr, Saitama, Japan; [Kim, Won Seog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Hematol Oncol, Seoul, South Korea; [Suh, Cheolwon] Asan Med Ctr, Hematol Oncol, Seoul, South Korea; [Ogura, Michinori] Nagoya Daini Red Cross Ctr Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Tobinai, Kensei] Natl Canc Ctr, Dept Hematol, Tokyo, Japan	Tateishi, U (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ttisdrnm@tmd.ac.jp			Scientific Research Expenses for Health Program; Scientific Research Expenses for Welfare Program; Ministry of Health, Tokyo, Japan, Labor and Welfare of Japan, Tokyo, Japan; Symbio Pharmaceuticals; Eisai Company	Scientific Research Expenses for Health and Welfare Programs; Ministry of Health, Tokyo, Japan, Labor and Welfare of Japan, Tokyo, Japan; Symbio Pharmaceuticals; Eisai Company.	Ohmachi K, 2013, J CLIN ONCOL, V31, P2103, DOI 10.1200/JCO.2012.46.5203; Itti E, 2013, EUR J NUCL MED MOL I, V40, P1312, DOI 10.1007/s00259-013-2435-6; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Terasawa T, 2009, J CLIN ONCOL, V27, P1906, DOI 10.1200/JCO.2008.16.0861; Song MK, 2012, CANCER SCI, V103, P477, DOI 10.1111/j.1349-7006.2011.02164.x; Huang BS, 2012, AM J ROENTGENOL, V199, P169, DOI 10.2214/AJR.11.7336; Casasnovas RO, 2011, BLOOD, V118, P37, DOI 10.1182/blood-2010-12-327767; Horning SJ, 2010, BLOOD, V115, P775, DOI 10.1182/blood-2009-08-234351; Scheuermann JS, 2009, J NUCL MED, V50, P1187, DOI 10.2967/jnumed.108.057455; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Shankar LK, 2006, J NUCL MED, V47, P1059; Itti E, 2009, J NUCL MED, V50, P527, DOI 10.2967/jnumed.108.057703; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Song MK, 2012, ANN HEMATOL, V91, P697, DOI 10.1007/s00277-011-1357-2; Watabe T, 2012, ANN NUCL MED, V26, P222, DOI 10.1007/s12149-011-0562-3; Yang DH, 2011, EUR J CANCER, V47, P1312, DOI 10.1016/j.ejca.2010.12.027; Biggi A, 2013, J NUCL MED, V54, P683, DOI 10.2967/jnumed.112.110890; Berkowitz A, 2009, NUCL MED COMMUN, V29, P521; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Coleman RE, 2005, J NUCL MED, V46, P1225; Esfahani Shadi A, 2013, Am J Nucl Med Mol Imaging, V3, P272; Fukukita H, 2010, ANN NUCL MED, V24, P325, DOI 10.1007/s12149-010-0377-7; Hanaoka K, 2011, NUCL MED COMMUN, V32, P678, DOI 10.1097/MNM.0b013e328346b32a; Kim TM, 2012, CANCER, V119, P1195; Larson SM, 1999, CLIN POSITRON IMAGIN, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Ogura M, 2011, CANCER SCI, V102, P1687, DOI 10.1111/j.1349-7006.2011.01994.x; Rossi M, 2011, ACTA RADIOL, V52, P995, DOI 10.1258/ar.2011.110099; Tseng D, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-5; vansVelden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636; Vriens D, 2012, INT J RADIAT ONCOL, V82, pE725, DOI 10.1016/j.ijrobp.2011.11.039; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI DOI 10.2967/JNUMED.108.057307; Zinzani PL, 2011, CANCER-AM CANCER SOC, V117, P1010, DOI 10.1002/cncr.25579	32	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					186	193		10.1111/cas.12588		8	Oncology	Oncology	CC2JJ	WOS:000350171000008		
J	Ishima, Y; Inoue, A; Fang, J; Kinoshita, R; Ikeda, M; Watanabe, H; Maeda, H; Otagiri, M; Maruyama, T				Ishima, Yu; Inoue, Aki; Fang, Jun; Kinoshita, Ryo; Ikeda, Mayumi; Watanabe, Hiroshi; Maeda, Hiroshi; Otagiri, Masaki; Maruyama, Toru			Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide	CANCER SCIENCE			English	Article						Autophagy; bevacizumab; drug resistance; nitric oxide; SNO-HSA	HUMAN SERUM-ALBUMIN; PHASE-II TRIAL; IN-VIVO; CANCER; THERAPY; TUMORS; DRUG; MECHANISM; THERAPEUTICS; ANGIOGENESIS	Autophagy is one of the major causes of drug resistance. For example, the angiogenesis inhibitor bevacizumab shows only transient and short-term therapeutic effects, whereas long-term therapeutic benefits are rarely observed, probably due to hypoxia-induced autophagy. Nitric oxide (NO) is an important molecule with multiple functions, and it has recently been reported to function as a regulator of autophagy. Therefore, a reasonable therapeutic strategy for overcoming drug resistance by NO would involve it being directly delivered to the tumor. Here, we investigated the inhibitory effect of NO on autophagy by using a macromolecular NO donor S-nitrosated human serum albumin (SNO-HSA) with a high degree of NO loading and tumor targeting potential. In colon 26 (C26) cells, SNO-HSA significantly suppressed hypoxia-induced autophagy by inhibiting the phosphorylation of JNK1 and the expression of its downstream molecule Beclin1. The effect of SNO-HSA was also confirmed in vivo by combining it with Bev. In C26-bearing mice, significant suppression of tumor growth as well as lung metastasis was achieved in the combination group compared to the SNO-HSA or bevacizumab alone group. Similar to the in vitro experiments, the immunostaining of tumor tissues clearly showed that SNO-HSA inhibited the autophagy of tumor cells induced by bevacizumab treatment. In addition to other known antitumor effects of SNO-HSA, that is, the induction of apoptosis and the inhibition of multidrug efflux pumps, these data may open alternate strategies for cancer chemotherapy by taking advantage of the ability of SNO-HSA to suppress autophagy-mediated drug resistance and enhance the efficacy of chemotherapy.	[Ishima, Yu; Inoue, Aki; Kinoshita, Ryo; Ikeda, Mayumi; Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Ishima, Yu; Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Fang, Jun; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Maeda, Hiroshi; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan	Maruyama, T (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan [Kakenhi 25860118, 23390142, 21390177]; Uehara Memorial Foundation; Yasuda Medical Foundation	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (Kakenhi 25860118, 23390142, and 21390177), Japan. The work was also supported in part by grants from the Uehara Memorial Foundation and the Yasuda Medical Foundation.	Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; Katayama N, 2008, J PHARMACOL EXP THER, V325, P69, DOI 10.1124/jpet.107.132100; Ishima Y, 2012, BIOCONJUGATE CHEM, V23, P264, DOI 10.1021/bc2005363; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Seki T, 2009, CANCER SCI, V100, P2426, DOI 10.1111/j.1349-7006.2009.01323.x; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Ishima Y, 2012, J CONTROL RELEASE, V164, P1, DOI 10.1016/j.jconrel.2012.10.003; CULOTTA E, 1992, SCIENCE, V258, P1862, DOI 10.1126/science.1361684; Shojaei F, 2007, CANCER J, V13, P345, DOI 10.1097/PPO.0b013e31815a7b69; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Wu J, 1998, CANCER RES, V58, P159; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Augustine M. K., 2013, NEW ENGL J MED, V368, P651; Choudhari SK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-118; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Katayama N, 2010, NITRIC OXIDE-BIOL CH, V22, P259, DOI 10.1016/j.niox.2009.09.003; Ling V, 1997, CANC CHEMOTHER PHA S, V40, P3; Takeda T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00494; Wu Y, 2010, CLIN DEV IMMUNOL, V2010; Yoshizawa Y, 2012, MOL PHARMACEUT, V9, P3486, DOI 10.1021/mp300318q	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					194	200		10.1111/cas.12577		7	Oncology	Oncology	CC2JJ	WOS:000350171000009		
J	Nakazawa, Y; Kawano, S; Matsui, J; Funahashi, Y; Tohyama, O; Muto, H; Nakagawa, T; Matsushima, T				Nakazawa, Youya; Kawano, Satoshi; Matsui, Junji; Funahashi, Yasuhiro; Tohyama, Osamu; Muto, Hiroki; Nakagawa, Takayuki; Matsushima, Tomohiro			Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model	CANCER SCIENCE			English	Article						Ang2; angiogenesis; golvatinib; lenvatinib; microenvironment	TYROSINE KINASE INHIBITOR; TIE2-EXPRESSING MONOCYTES; ANGIOPOIETIN-2 FUNCTIONS; VASCULAR MORPHOGENESIS; VESSEL MATURATION; GROWTH; VEGF; MECHANISMS; EXPRESSION; CELLS	Almost all cancers show intrinsic and/or evasive resistance to vascular endothelial growth factor (VEGF) inhibitors by multiple mechanisms. Serum angiopoietin-2 (Ang2) level has been proposed as a potential biomarker of VEGF inhibitor response in several cancers. From these clinical observations, the Ang2 and Tie2 (its receptor) axis has been focused on as a promising target. Here, we show a novel strategy to circumvent the resistance by combining multi-tyrosine kinase inhibitors lenvatinib (VEGF receptor, fibroblast growth factor receptor, and RET inhibitor) and golvatinib (E7050; c-Met, Tie2, and EphB4 inhibitor). Tie2 identifies a highly pro-angiogenic macrophage subset, Tie2-expressing macrophages (TEM). Angi-Tie2 and EphB4-EphrinB2 signaling plays critical roles in pericyte-mediated vessel stabilization. In vitro analyses suggested that golvatinib combined with lenvatinib inhibited pericyte-mediated vessel stabilization and TEM differentiation. In thyroid and endometrial cancer models, golvatinib and lenvatinib inhibited pericyte network development and TEM infiltration, resulting in severe perfusion disorder and massive apoptosis. Body weight loss was tolerable, and no macroscopic change was observed. These preclinical studies suggest that modulation of the tumor microenvironment by a strategic and well-tolerated combination of multi-targeting tyrosine kinase inhibitors may sensitize cancer to VEGF inhibitors.	[Nakazawa, Youya; Kawano, Satoshi; Matsui, Junji; Tohyama, Osamu; Muto, Hiroki; Nakagawa, Takayuki; Matsushima, Tomohiro] Eisai & Co Ltd, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; [Funahashi, Yasuhiro] Eisai Inc, Andover, MA USA	Nakazawa, Y (reprint author), Eisai & Co Ltd, Tsukuba Res Lab, Tokodai 5-1-3, Tsukuba, Ibaraki 3002635, Japan.	y2-nakazawa@hhc.eisai.co.jp			Eisai Co., Ltd.	Eisai Co., Ltd.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Boss DS, 2012, BRIT J CANCER, V106, P1598, DOI 10.1038/bjc.2012.154; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Miyahara K, 2011, J GASTROEN HEPATOL, V26, P1604, DOI 10.1111/j.1440-1746.2011.06887.x; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Wang W, 2012, CLIN CANCER RES, V18, P1663, DOI 10.1158/1078-0432.CCR-11-1171; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; Murdoch C, 2007, J IMMUNOL, V178, P7405; Goede V, 2010, BRIT J CANCER, V103, P1407, DOI 10.1038/sj.bjc.6605925; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Nakagawa T, 2014, CANCER SCI, V105, P723, DOI 10.1111/cas.12409; Tesarova P, 2013, FOLIA BIOL-PRAGUE, V59, P15; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; O'Neil BH, 2013, J CLIN ONCOL, V31; van der Veldt AAM, 2012, INT J CANCER, V131, pE484, DOI 10.1002/ijc.26456	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					201	207		10.1111/cas.12581		7	Oncology	Oncology	CC2JJ	WOS:000350171000010		
J	Saijo, K; Imamura, J; Narita, K; Oda, A; Shimodaira, H; Katoh, T; Ishioka, C				Saijo, Ken; Imamura, Jin; Narita, Koichi; Oda, Akifumi; Shimodaira, Hideki; Katoh, Tadashi; Ishioka, Chikashi			Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors	CANCER SCIENCE			English	Article						Drug development; dual inhibitor; HDAC; PI3K; romidepsin	HISTONE DEACETYLASE INHIBITOR; HDAC INHIBITORS; CANCER; PI3K; PATHWAY; BIM; DEPSIPEPTIDE; COMBINATION; ACTIVATION; RESISTANCE	Romidepsin (FK228, depsipeptide) is a potent histone deacetylase (HDAC) inhibitor that has FDA approval for the treatment of cutaneous and peripheral T-cell lymphomas. We have previously reported that FK228 and its analogs have an additional activity as phosphatidylinositol 3-kinase (PI3K) inhibitors, and are defined as HDAC/PI3K dual inhibitors. Because a combination of an HDAC inhibitor and a PI3K inhibitor induces apoptosis in human cancer cells in a synergistic manner, development of an HDAC/PI3K dual inhibitor will provide an attractive novel drug for cancer therapy. Using structure-based optimization of the analogs, FK-A11 was identified as the most potent analog. FK-A11 inhibited phosphorylation of AKT and accelerated histone acetylation at lower concentrations, resulting in stronger cytotoxic effects than FK228 and the other analogs in human cancer cells. In this study, we have characterized the biochemical, biological and structural properties of FK228 analogs as PI3K inhibitors. First, FK-A11 is an ATP competitive PI3K inhibitor. Second, FK-A11 is a pan-p110 isoform inhibitor. Third, FK-A11 selectively inhibits PI3K among 22 common cellular kinases. Fourth, conformational changes of FK228 analogs by reduction of an internal disulfide bond have no effect on PI3K inhibitory activity, unlike HDAC inhibitory activity. Finally, molecular modeling of PI3K-FK228 analogs and analyses of the binding affinities identified the structure that defines potency for PI3K inhibitory activity. These results prove our concept that a series of FK228 analogs are HDAC/PI3K dual inhibitors. These findings should help in the development of FK228 analogs as novel HDAC/PI3K dual inhibitors.	[Saijo, Ken; Imamura, Jin; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Sendai, Miyagi 9808575, Japan; [Narita, Koichi; Katoh, Tadashi] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Lab Synthet & Med Chem, Sendai, Miyagi, Japan; [Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Ishioka, C (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Sendai, Miyagi 9808575, Japan.	chikashi@idac.tohoku.ac.jp	ODA, Akifumi/D-8405-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [24300339, 25830110, 26460034]; Gonryo Medical Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (24300339). (25830110). (26460034). Gonryo Medical Foundation	Akinleye A, 2013, J HEMATOL ONCOL, V6, P88; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Yaguchi SI, 2006, J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Qian CG, 2012, CLIN CANCER RES, V18, P4104, DOI 10.1158/1078-0432.CCR-12-0055; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Furumai R, 2002, CANCER RES, V62, P4916; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Mummaneni P, 2014, PHARMACOTHERAPY, V34, P495, DOI 10.1002/phar.1408; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Chakraborty AR, 2013, BLOOD, V121, P4115, DOI 10.1182/blood-2012-08-449140; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Martini Miriam, 2013, Front Oncol, V3, P108, DOI 10.3389/fonc.2013.00108; Narita K, 2009, CHEM-EUR J, V15, P11174, DOI 10.1002/chem.200901552; Oda A, 2014, J MOL GRAPH MODEL, V54, P46, DOI 10.1016/j.jmgm.2014.08.007; Saijo K, 2012, CANCER SCI, V103, P1994, DOI 10.1111/cas.12002; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Yoshioka T, 2013, GYNECOL ONCOL, V129, P425, DOI 10.1016/j.ygyno.2013.02.008	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	FEB	2015	106	2					208	215		10.1111/cas.12585		8	Oncology	Oncology	CC2JJ	WOS:000350171000011		
J	Takeshima, H; Wakabayashi, M; Hattori, N; Yamashita, S; Ushijima, T				Takeshima, Hideyuki; Wakabayashi, Mika; Hattori, Naoko; Yamashita, Satoshi; Ushijima, Toshikazu			Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy	CARCINOGENESIS			English	Article							SMALL-MOLECULE INHIBITOR; CPG ISLAND METHYLATION; SELECTIVE-INHIBITION; GASTRIC-CANCER; TUMOR-CELLS; E-CADHERIN; CHROMATIN; GENES; PROMOTER; HYPERMETHYLATION	Alterations of epigenetic modifications are promising targets for cancer therapy, and several epigenetic drugs are now being clinically utilized. At the same time, individual epigenetic modifications have physiological functions in normal cells, and cancer cell specificity is considered difficult to achieve using a drug against a single epigenetic modification. To overcome this limitation, a combination of epigenetic modifications specifically or preferentially present in cancer cells is a candidate target. In this study, we aimed to demonstrate (i) the presence of a cancer cell-specific combination of epigenetic modifications by focusing on DNA methylation and trimethylation of histone H3 lysine 27 (H3K27me3) and (ii) the therapeutic efficacy of a combination of DNA demethylation and EZH2 inhibition. Analyses of DNA methylation and H3K27me3 in human colon, breast and prostate cancer cell lines revealed that 24.7 +/- 4.1% of DNA methylated genes had both DNA methylation and H3K27me3 (dual modification) in cancer cells, while it was 11.8 +/- 7.1% in normal cells. Combined treatment with a DNA demethylating agent, 5-aza-2'-deoxycytidine (5-aza-dC) and an EZH2 inhibitor, GSK126, induced marked re-expression of genes with the dual modification, including known tumor-suppressor genes such as IGFBP7 and SFRP1, and showed an additive inhibitory effect on growth of cancer cells in vitro. Finally, an in vivo combined treatment with 5-aza-dC and GSK126 inhibited growth of xenograft tumors more efficiently than a single treatment with 5-aza-dC. These results showed that the dual modification exists specifically in cancer cells and is a promising target for cancer cell-specific epigenetic therapy.	[Takeshima, Hideyuki; Wakabayashi, Mika; Hattori, Naoko; Yamashita, Satoshi; Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Chuo Ku, Tokyo 1040045, Japan	Ushijima, T (reprint author), Natl Canc Ctr, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp			Ministry of Health, Labour and Welfare, Japan [H22002, H26-106]; Foundation for Promotion of Cancer Research in Japan; National Cancer Center Research and Development Fund [26-A-15]	Third-Term Comprehensive Cancer Control Strategy (H22002) and Applied Research for Innovative Treatment of Cancer (H26-106) from the Ministry of Health, Labour and Welfare, Japan; Foundation for Promotion of Cancer Research in Japan; The National Cancer Center Research and Development Fund (26-A-15).	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Dammann R, 2000, NAT GENET, V25, P315; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Kantarjian H, 2006, CANCER, V106, P1794, DOI 10.1002/cncr.21792; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Gao F, 2014, GENOMICS, V103, P204, DOI 10.1016/j.ygeno.2013.12.006; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; Mund C, 2010, BIOESSAYS, V32, P949, DOI 10.1002/bies.201000061; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Dennis Jr G, 2003, GENOME BIOL, V4, pP3, DOI DOI 10.1186/GB-2003-4-5-P3; DeWoskin VA, 2013, NAT REV DRUG DISCOV, V12, P661, DOI 10.1038/nrd4091; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274	50	7	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	FEB	2015	36	2					192	201		10.1093/carcin/bgu238		10	Oncology	Oncology	CC2ZX	WOS:000350214900003		
J	Hidaka, A; Sasazuki, S; Matsuo, K; Ito, H; Sawada, N; Shimazu, T; Yamaji, T; Iwasaki, M; Inoue, M; Tsugane, S				Hidaka, Akihisa; Sasazuki, Shizuka; Matsuo, Keitaro; Ito, Hidemi; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro		JPHC Study Grp	Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective study	CARCINOGENESIS			English	Article							ALDEHYDE DEHYDROGENASE-2 GENOTYPES; POPULATION-BASED COHORT; STOMACH-CANCER; LINE SURVEY; DRINKING; ACETALDEHYDE; METABOLISM; ESOPHAGEAL; SMOKING; JPHC	The association between alcohol consumption, alcohol (ADH), aldehyde dehydrogenase (ALDH) polymorphisms and gastric cancer remains elusive. To find the relation between alcohol consumption and gastric cancer, it is important to consider both alcohol consumption level and ADH1C, ALDH2 polymorphisms.The association between alcohol consumption, genetic polymorphisms of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) and gastric cancer risk is not completely understood. We investigated the association between ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms, alcohol consumption and the risk of gastric cancer among Japanese subjects in a population-based, nested, case-control study (1990-2004). Among 36 745 subjects who answered the baseline questionnaire and provided blood samples, 457 new gastric cancer cases matched to 457 controls were used in the analysis. The odds ratios (OR) and corresponding 95% confidence intervals (CI) were calculated using logistic regression models. No association was observed between alcohol consumption, ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms and gastric cancer risk. However, considering gene-environmental interaction, ADH1C G allele carriers who drink a parts per thousand yen150g/week of ethanol had a 2.5-fold increased risk of gastric cancer (OR = 2.54, 95% CI = 1.05-6.17) relative to AA genotype carriers who drink 0 to < 150g/week (P for interaction = 0.02). ALDH2 A allele carriers who drink a parts per thousand yen150g/week also had an increased risk (OR = 2.08, 95% CI = 1.05-4.12) relative to GG genotype carriers who drink 0 to < 150g/week (P for interaction = 0.08). To find the relation between alcohol consumption and gastric cancer risk, it is important to consider both alcohol consumption level and ADH1C and ALDH2 polymorphisms.	[Hidaka, Akihisa; Sasazuki, Shizuka; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 1040045, Japan; [Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Fukuoka 8128582, Japan; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan	Sasazuki, S (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 1040045, Japan.	ssasazuk@ncc.go.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830	National Cancer Center Research and Development Fund [23-A31[toku], 26-A-2]; Ministry of Health, Labor and Welfare of Japan [H24-3jigan-ippan-002]	National Cancer Center Research and Development Fund (23-A31[toku] and 26-A-2; since 2011), a grant-in-aid for Cancer Research (1989 to 2010), and a grant-in-aid for the Third-Term Comprehensive Ten-Year Strategy for Cancer Control (H24-3jigan-ippan-002) from the Ministry of Health, Labor and Welfare of Japan.	Duell EJ, 2012, CARCINOGENESIS, V33, P361, DOI 10.1093/carcin/bgr285; Shin CM, 2011, INT J EPIDEMIOL, V40, P1047, DOI 10.1093/ije/dyr067; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4457, DOI 10.1021/bi9521102; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; EHRIG T, 1990, ALCOHOL ALCOHOLISM, V25, P105; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Otani T, 2003, CANCER EPIDEM BIOMAR, V12, P1492; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Terry MB, 2007, CANCER CAUSE CONTROL, V18, P1039, DOI 10.1007/s10552-007-9046-0; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; Balbo S, 2012, MUTAGENESIS, V27, P485, DOI 10.1093/mutage/ges008; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Cao HX, 2010, ASIAN PAC J CANCER P, V11, P1073; ENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141, DOI 10.1111/j.1530-0277.1991.tb00532.x; Hidaka A., 2014, INT J CANC; International Agency For Research On Cancer (IARC), 2012, IARC MON EV CARC R E, V100E; Iwasaki M, 2003, J EPIDEMIOL, V13, P216; Sasazuki S, 2002, INT J CANCER, V101, P560, DOI 10.1002/ijc.10649; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2001, J Epidemiol, V11, pS24; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; WHO, 2000, INT CLASSIFICATION D	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	FEB	2015	36	2					223	231		10.1093/carcin/bgu244		9	Oncology	Oncology	CC2ZX	WOS:000350214900006		
J	Lin, QH; Yang, GH; Chen, QJ; Fan, RG; Yoneyama, Y; Wan, HL; Tsubaki, N				Lin, Qihang; Yang, Guohui; Chen, Qingjun; Fan, Ronggang; Yoneyama, Yoshiharu; Wan, Huilin; Tsubaki, Noritatsu			Design of a Hierarchical Meso/Macroporous Zeolite-Supported Cobalt Catalyst for the Enhanced Direct Synthesis of Isoparaffins from Syngas	CHEMCATCHEM			English	Article						cobalt; cracking; mesoporous materials; supported catalysts; zeolites	FISCHER-TROPSCH SYNTHESIS; DRY-GEL CONVERSION; BIMODAL PORE CATALYSTS; DUAL-BED REACTOR; H-ZSM-5-SUPPORTED COBALT; RUTHENIUM NANOPARTICLES; C-5-C-11 ISOPARAFFINS; HYBRID CATALYST; BETA; TEMPLATE	A hierarchical meso/macroporous zeolite-supported Co catalyst (Co/ASB) was designed and employed for the direct synthesis of isoparaffins. The hierarchical porous zeolite (ASB) was developed by a steam-assisted crystallization method using alumina-modified meso/macroporous silica as the precursor. Structural characterization indicated that the as-synthesized ASB exhibited nanosized -zeolite crystallites and a hierarchical meso/macroporous structure. The activity of the Co/ASB catalyst was much higher than that of conventional Co catalysts supported on SiO2 (Co/SiO2) and H--zeolite (Co/B). A high isoparaffins selectivity of 30.5% was obtained from Co/ASB because of the hydrocracking/isomerization of long-chain hydrocarbons at the strong acidic sites of the -zeolite. Furthermore, as a result of the fast diffusion of syngas in the unique hierarchical pores, the methane selectivity of Co/ASB was lower than that of Co/B.	[Lin, Qihang; Yang, Guohui; Chen, Qingjun; Yoneyama, Yoshiharu; Tsubaki, Noritatsu] Toyama Univ, Dept Appl Chem, Sch Engn, Toyama 9308555, Japan; [Lin, Qihang; Wan, Huilin] Xiamen Univ, Natl Engn Lab Green Chem Prod Alcohols Ethers & E, State Key Lab Phys Chem Solid Surfaces, Coll Chem & Chem Engn,Dept Chem, Xiamen 361005, Peoples R China; [Fan, Ronggang] Shinka Co Ltd, Toyama 9300875, Japan	Yang, GH (reprint author), Toyama Univ, Dept Appl Chem, Sch Engn, Gofuku 3190, Toyama 9308555, Japan.	thomas@eng.u-toyama.ac.jp; chenqingjunsh@gmail.com; hlwan@xmu.edu.cn; tsubaki@eng.u-toyama.ac.jp			JST-CREST; NEDO, Japan; JX (Nippon Oil) Co. Ltd; China Scholarship Council (CSC)	This work was supported financially by JST-CREST and NEDO, Japan. Financial aid from JX (Nippon Oil) Co. Ltd is also acknowledged. Q.L. thanks the China Scholarship Council (CSC) for financial support.	Zhang QH, 2010, CHEMCATCHEM, V2, P1030, DOI 10.1002/cctc.201000071; Sartipi S, 2014, CHEMCATCHEM, V6, P142, DOI 10.1002/cctc.201300635; Cheng K, 2012, ACS CATAL, V2, P441, DOI 10.1021/cs200670j; Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v; Dong AG, 2002, ADV MATER, V14, P926, DOI 10.1002/1521-4095(20020618)14:12<926::AID-ADMA926>3.0.CO;2-1; Matsukata M, 2002, MICROPOR MESOPOR MAT, V56, P1, DOI 10.1016/S1387-1811(02)00412-2; Sartipi S, 2013, CHEMSUSCHEM, V6, P1646, DOI 10.1002/cssc.201300339; Qin Z, 2013, CHEM MATER, V25, P2759, DOI 10.1021/cm400719z; Perez-Ramirez J, 2009, ADV FUNCT MATER, V19, P3972, DOI 10.1002/adfm.200901394; Kang JC, 2011, ANGEW CHEM INT EDIT, V50, P5200, DOI 10.1002/anie.201101095; Sun J, 2014, ACS CATAL, V4, P1, DOI 10.1021/cs4008842; Zhang Y, 2005, APPL CATAL A-GEN, V292, P252, DOI 10.1016/j.apcata.2005.06.004; Wang HT, 2001, CHEM COMMUN, P1364, DOI 10.1039/b104275k; Fierro G, 2000, TOP CATAL, V10, P39, DOI 10.1023/A:1019151731177; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; Iglesia E, 1997, APPL CATAL A-GEN, V161, P59, DOI 10.1016/S0926-860X(97)00186-5; Jacobs G, 2002, APPL CATAL A-GEN, V233, P263, DOI 10.1016/S0926-860X(02)00195-3; Yoneyama Y, 2005, CATAL TODAY, V104, P37, DOI 10.1016/j.cattod.2005.03.031; Yang ZX, 2004, ADV MATER, V16, P727, DOI 10.1002/adma.200306295; Corma A, 2002, NATURE, V418, P514, DOI 10.1038/nature00924; Zhao TS, 2005, IND ENG CHEM RES, V44, P769, DOI 10.1021/ie040097o; Steynberg AP, 2004, STUD SURF SCI CATAL, V152, P1; Sartipi S, 2013, J CATAL, V305, P179, DOI 10.1016/j.jcat.2013.05.012; Verboekend D, 2011, CATAL SCI TECHNOL, V1, P879, DOI 10.1039/c1cy00150g; Yang GH, 2008, ENERG FUEL, V22, P1463, DOI 10.1021/ef700682y; Tong YC, 2006, CHEM MATER, V18, P4218, DOI 10.1021/cm060035j; Huang X, 2011, APPL CATAL A-GEN, V408, P38, DOI 10.1016/j.apcata.2011.09.004; Rao PRHP, 1998, APPL CATAL A-GEN, V166, P97; Rao PRHP, 1996, CHEM COMMUN, P1441, DOI 10.1039/cc9960001441; Inaba M, 1996, CATAL LETT, V39, P269, DOI 10.1007/BF00805594; Jablonski JM, 2003, J CATAL, V220, P146, DOI 10.1016/S0021-9517(03)00287-2; Jacobsen J. H., 2000, J AM CHEM SOC, V122, P7116; Lin QH, 2013, CHEMCATCHEM, V5, P3101, DOI 10.1002/cctc.201300336; Moller K, 2011, J AM CHEM SOC, V133, P5284, DOI 10.1021/ja108698s; Rao PRHP, 1998, MICROPOR MESOPOR MAT, V21, P305; Richter M, 1999, CATAL TODAY, V54, P531, DOI 10.1016/S0920-5861(99)00215-1; Sakthivel A, 2004, CHEM MATER, V16, P3168, DOI 10.1021/cm035293k; Shinoda M, 2004, FUEL PROCESS TECHNOL, V86, P73, DOI 10.1016/j.fuproc.2003.12.004; Srivastava R, 2006, CHEM COMMUN, P4489, DOI 10.1039/b612116k; Tavasoli A, 2006, FUEL PROCESS TECHNOL, V87, P641, DOI 10.1016/j.fuproc.2006.01.010; Tavasoli A, 2007, IRAN J CHEM CHEM ENG, V26, P109; Tsubaki N., 2001, CATAL COMMUN, V2, P311, DOI 10.1016/S1566-7367(01)00055-3; Zhang Y, 2009, J NANOSCI NANOTECHNO, V9, P3866, DOI 10.1166/jnn.2009.NS81; Yang G., 2011, APPL CATAL A-GEN, V394, P195; Zhang Y, 2005, CATAL LETT, V99, P193, DOI 10.1007/s10562-005-2118-4; Zhang Y, 2003, TOP CATAL, V26, P129, DOI 10.1023/B:TOCA.0000012993.82766.5f; Zhu J, 2014, J AM CHEM SOC, V136, P2503, DOI 10.1021/ja411117y; Zhu J, 2009, CHEM COMMUN, P3282, DOI 10.1039/b902661d	48	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	FEB	2015	7	4					682	689		10.1002/cctc.201402929		8	Chemistry, Physical	Chemistry	CB8YI	WOS:000349917900020		
J	Yu, L; Zhang, GL; Terashima, S; Tanihata, I; Le, XY				Yu Lei; Zhang Gao-Long; Terashima, S.; Tanihata, I.; Le Xiao-Yun			Simulation of 200-400 MeV/u C-12+C-12 elastic scattering on SHARAQ spectrometer	CHINESE PHYSICS C			English	Article						elastic scattering; three-body force; SHARAQ; Monte Carlo method		In order to further obtain the information of three-body force (TBF) from 200-400 MeV/u C-12+C-12 elastic scattering, we plan to perform this experiment on a SHARAQ spectrometer. Based on the experimental condition of the Radioactive Ion Beam Factory (RIBF)-SHARAQ facility, a simulation is given to find a compromise between the better energy and angular resolutions, and higher yield by optimizing the target thickness, beam transport mode, beam intensity and angular step. From the simulation, we found that the beam quality mainly limits the improvements of energy and angular resolutions. A beam tracking system as well as a lateral and angular dispersion-matching technique are adopted to reduce the influence of beam quality. According to the two angular settings of SHARAQ as well as the expected cross sections on the basis of the theoretical model, the energy and angular resolutions, and statistical accuracy are estimated.	[Yu Lei; Zhang Gao-Long; Terashima, S.; Tanihata, I.; Le Xiao-Yun] Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China; [Tanihata, I.] Osaka Univ, Nucl Phys Res Ctr, Osaka 5670047, Japan	Zhang, GL (reprint author), Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China.	zgl@buaa.edu.cn	Le, Xiaoyun/G-1132-2011		National Nature Science Foundation of China [11035007, 11235002, 11175011]	Supported by National Nature Science Foundation of China (11035007, 11235002, 11175011)	Furumoto T, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014618; HIGHLAND VL, 1975, NUCL INSTRUM METHODS, V129, P497, DOI 10.1016/0029-554X(75)90743-0; Furumoto T, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.044612; HIGHLAND VL, 1979, NUCL INSTRUM METHODS, V161, P171; Guo CL, 2012, CHINESE PHYS C, V36, P205, DOI 10.1088/1674-1137/36/3/003; Lynch G R, 2012, PROGR THEORETICAL PH, V196, P150; Uesaka T, 2008, NUCL INSTRUM METH B, V266, P4218, DOI 10.1016/j.nimb.2008.05.095; VANSEN N, 1987, NUCL PHYS A, V464, P717, DOI 10.1016/0375-9474(87)90372-1; Yoshiko S, 2013, NUCL STRUCT PROBL P	9	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	FEB	2015	39	2					61	65	026201	10.1088/1674-1137/39/2/026201		5	Physics, Nuclear; Physics, Particles & Fields	Physics	CB6MF	WOS:000349740400010		
J	Adachi, T; Yoshida, K; Takeyasu, N; Masuda, K; Sekiguchi, Y; Sato, A; Tada, H; Nogami, A; Aonuma, K				Adachi, Toru; Yoshida, Kentaro; Takeyasu, Noriyuki; Masuda, Keita; Sekiguchi, Yukio; Sato, Akira; Tada, Hiroshi; Nogami, Akihiko; Aonuma, Kazutaka			Left Septal Atrial Tachycardia After Open-Heart Surgery Relevance to Surgical Approach, Anatomical and Electrophysiological Characteristics Associated With Catheter Ablation, and Procedural Outcomes	CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY			English	Article						atrial flutter; atrial septum; catheter ablation; heart surgery	MITRAL-VALVE SURGERY; FIBRILLATION; CONDUCTION; FLUTTER; REPAIR	Background-Septal atrial tachycardia (AT) can occur in patients without structural heart disease and in patients with previous catheter ablation of atrial fibrillation. We aimed to assess septal AT that occurs after open-heart surgery. Methods and Results-This study comprised 20 consecutive patients undergoing catheter ablation of macroreentrant AT after open-heart surgery. Relevance to surgical approach, mechanisms, anatomic and electrophysiological characteristics, and outcomes were assessed. Septal AT was identified in 7 patients who had all undergone mitral valve surgery. All septal ATs were localized in the left atrial septum, whereas 10 of 13 nonseptal ATs originated from the right atrium. Patients with left septal AT had a thicker fossa ovalis (median, 4.0; 25th-75th percentile, 3.6-4.2 versus 2.3; 1.6-2.6 mm; P = 0.006) and broader area of low voltage (<0.3 mV) in the septum than patients with nonseptal AT (82; 76-89 versus 31; 28%-36%; P= 0.02). Repeated gradual prolongations of the tachycardia cycle length without change of the septal circuit were observed in all patients with septal AT (70; 63-100 versus 15; 10-40 ms; P = 0.0008). Although ablation terminated all ATs, recurrence of targeted ATs was more frequent in patients with left septal AT during 30-month follow-up (71 versus 0%; P= 0.001). Conclusions-Left septal AT after open-heart surgery was characterized by a thicker septum, more scar burden in the septum, and repeated prolongations of the tachycardia cycle length during ablation. Such an arrhythmogenic substrate may interfere with transmural lesion formation by ablation and may account for higher likelihood of recurrence of left septal AT.	[Adachi, Toru; Yoshida, Kentaro; Takeyasu, Noriyuki; Masuda, Keita; Sekiguchi, Yukio; Sato, Akira; Nogami, Akihiko; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Cardiovasc Div, Tsukuba, Ibaraki 3058575, Japan; [Tada, Hiroshi] Univ Fukui, Div Cardiovasc Med, Fukui, Japan	Yoshida, K (reprint author), Univ Tsukuba, Fac Med, Cardiovasc Div, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kentaroyo@nifty.com					Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; Marrouche NF, 2004, CIRCULATION, V109, P2440, DOI 10.1161/01.CIR.0000129439.03836.96; Fukamizu S, 2013, J CARDIOVASC ELECTR, V24, P404, DOI 10.1111/jce.12059; Chae S, 2007, J AM COLL CARDIOL, V50, P1781, DOI 10.1016/j.jacc.2007.07.044; Shanewise JS, 1999, ANESTH ANALG, V89, P870, DOI 10.1097/00000539-199910000-00010; Nakagawa H, 2001, CIRCULATION, V103, P699; Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; Hall B, 2006, J INTERV CARD ELECTR, V17, P127, DOI 10.1007/s10840-006-9052-2; Igawa O, 2004, J CARDIOVASC ELECTR, V15, P829, DOI 10.1046/j.1540-8167.2004.03447.x; Lukac P, 2006, PACE, V29, P719, DOI 10.1111/j.1540-8159.2006.00425.x; Lukac P, 2006, ANN THORAC SURG, V81, P509, DOI 10.1016/j.athoracsur.2005.07.083; Magnin-Poll I, 2005, J CARDIOVASC ELECTR, V16, P681, DOI 10.1111/j.1540-8167.2005.30605.x; Markowitz SM, 2002, J AM COLL CARDIOL, V39, P1973, DOI 10.1016/S0735-1097(02)01905-8; Roberts-Thomson KC, 2007, HEART RHYTHM, V4, P32, DOI 10.1016/j.hrthm.2006.09.032; WALDO AL, 1973, CIRCULATION, V48, P19; Wessels A, 2000, ANAT REC, V259, P288, DOI 10.1002/1097-0185(20000701)259:3<288::AID-AR60>3.0.CO;2-D	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	FEB	2015	8	1					59	67		10.1161/CIRCEP.114.001680		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB8IU	WOS:000349873000011		
J	Hosomi, M				Hosomi, Masaaki			Are there cities at risk of disappearing-an inconvenient truth?	CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY			English	Editorial Material									Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan	Hosomi, M (reprint author), Tokyo Univ Agr & Technol, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	hosomi@cc.tuat.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-954X	1618-9558		CLEAN TECHNOL ENVIR	Clean Technol. Environ. Policy	FEB	2015	17	2					295	296		10.1007/s10098-015-0917-x		2	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB8BO	WOS:000349853500001		
J	Sikdar, SK; Matsunaga, T				Sikdar, Subhas K.; Matsunaga, Tadashi			An E-Conversation with Prof. Tadashi Matsunaga, President of Tokyo University of Agriculture and Technology	CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY			English	Editorial Material									[Matsunaga, Tadashi] Tokyo Univ Agr & Technol, Fuchu, Tokyo 183, Japan		sikdar.subhas@epa.gov	Matsunaga, Tadashi/A-6293-2015	Matsunaga, Tadashi/0000-0002-6216-3687				0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-954X	1618-9558		CLEAN TECHNOL ENVIR	Clean Technol. Environ. Policy	FEB	2015	17	2					297	299		10.1007/s10098-014-0882-9		3	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB8BO	WOS:000349853500002		
J	Yasmin, L; Takano, J; Nagai, Y; Otsuki, J; Sankai, T				Yasmin, Lubna; Takano, Jun-ichiro; Nagai, Yasushi; Otsuki, Junko; Sankai, Tadashi			Detection and Quantification of Male-Specific Fetal DNA in the Serum of Pregnant Cynomolgus Monkeys (Macaca fascicularis)	COMPARATIVE MEDICINE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; SEX DETERMINATION; MATERNAL PLASMA; QUANTITATIVE-ANALYSIS; GENDER DETERMINATION; CIRCULATION; MULATTA; DISORDERS; EMBRYO; BLOOD	Because of their developmental similarities to humans, nonhuman primates are often used as a model to study fetal development for potential clinical applications in humans. The detection of fetal DNA in maternal plasma or serum offers a source of fetal genetic material for prenatal diagnosis. However, no such data have been reported for cynomolgus monkeys (Macaca fascicularis), an important model in biomedical research. We have developed a specific, highly sensitive PCR system for detecting and quantifying male-specific fetal DNA in pregnant cynomolgus monkeys. We used multiplex quantitative real-time PCR to analyze cell-free DNA in maternal blood serum obtained from 46 pregnant monkeys at gestational weeks 5, 12, and 22. The presence of SRY gene and DYS14 Y chromosomal sequences was determined in 28 monkeys with male-bearing pregnancies. According to confirmation of fetal sex at birth, the probe and primers for detecting the Y chromosomal regions at each time point revealed 100% specificity of the PCR test and no false-positive or false-negative results. Increased levels of the SRY-specific sequences (mean, 4706 copies/mL serum DNA; range, 1731 to 12,625) and DYS14-specific sequences (mean, 54,814 copies/mL serum DNA; range, 4175-131,250 copies) were detected at week 22. The SRY- and DYS14-specific probes appear to be an effective combination of markers in a multiplex PCR system. To our knowledge, this report is the first to describe the detection of cell-free DNA in cynomolgus monkeys.	[Yasmin, Lubna; Takano, Jun-ichiro; Otsuki, Junko; Sankai, Tadashi] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Nagai, Yasushi; Otsuki, Junko] Nagai Clin, Dept Obstet & Gynecol, Saitama, Japan; [Otsuki, Junko] Hanabusa Womens Clin, Kobe, Hyogo, Japan	Sankai, T (reprint author), Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan.	t-sankai@nibio.go.jp					Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Miura K, 2011, J HUM GENET, V56, P296, DOI 10.1038/jhg.2011.7; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Hill M, 2012, BEST PRACT RES CL OB, V26, P639, DOI 10.1016/j.bpobgyn.2012.03.004; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Jimenez DF, 2003, J MED PRIMATOL, V32, P315, DOI 10.1046/j.1600-0684.2003.00041.x; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Honda H, 2002, HUM GENET, V110, P75, DOI 10.1007/s00439-001-0649-3; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Davoudi A, 2011, EURASIA J BIOSCI, V5, P119; Hromadnikova I, 2009, DNA CELL BIOL, V28, P351, DOI 10.1089/dna.2009.0855; Jimenez DF, 2003, PEDIATR RES, V53, P18, DOI 10.1203/01.PDR.0000039837.34834.65; Jimenez DF, 2005, TRANSPLANTATION, V79, P142, DOI 10.1097/01.TP.0000144468.71962.AA; Kadivar A, 2013, THERIOGENOLOGY, V79, P995, DOI 10.1016/j.theriogenology.2013.01.027; Ostrer H, 2006, CLIN GENET, V70, P98, DOI 10.1111/j.1399-0004.2006.00640.x; Tachdjian G, 2002, HUM REPROD, V17, P2183, DOI 10.1093/humrep/17.8.2183; Treff NR, 2011, MOL HUM REPROD, V17, P434, DOI 10.1093/molehr/gar016; Xue YL, 2011, GENES-BASEL, V2, P36, DOI 10.3390/genes2010036	23	0	0	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1532-0820			COMPARATIVE MED	Comparative Med.	FEB	2015	65	1					70	76				7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CC0FD	WOS:000350010300009		
J	Romero-Jimenez, M; Santodomingo-Rubido, J; Gonzalez-Meijome, JM; Flores-Rodriguez, P; Villa-Collar, C				Romero-Jimenez, Miguel; Santodomingo-Rubido, Jacinto; Gonzalez-Meijome, Jose-Manuel; Flores-Rodriguez, Patricia; Villa-Collar, Cesar			Which soft lens power is better for piggyback in keratoconus? Part II	CONTACT LENS & ANTERIOR EYE			English	Article						Piggyback; Contact lens; Cornea; Keratoconus; Keratometry	HIGHER-ORDER ABERRATIONS; CONTACT-LENS; SCLERAL LENSES; MANAGEMENT	Purpose: To evaluate how soft lens power affects rigid gas-permeable (RGP) lens power and visual acuity (VA) in piggyback fittings for keratoconus. Methods: Sixteen keratoconus subjects (30 eyes) were included in the study. Piggyback contact lens fittings combining Senofilcon-A soft lenses of -6.00, -3.00, +3.00 and +6.00 D with Rose K2 RGP contact lenses were performed. Corneal topography was taken on the naked eye and over each soft contact lens before fitting RGP lenses. Mean central keratometry, over-refraction, RGP back optic zone radius (BOZR) and estimated final power as well as VA were recorded and analyzed. Results: In comparison to the naked eye, the mean central keratometry flattened with both negative lens powers (p < 0.05 in all cases), did not change with the +3.00 soft lens power (p = 1.0); and steepened with the +6.00 soft lens power (p = 0.02). Rigid gas-permeable over-refraction did not change significantly between different soft lens powers (all p > 0.05). RGP's BOZR decreased significantly with both positive in comparison with both negative soft lens powers (all p < 0.001), but no significant differences were found among negative- or positive-powers separately (both p > 0.05). Estimated RGP's final power increased significantly with positive in comparison with negative lens powers (all p < 0.001), but no significant differences were found among negative or positive lens powers separately (both p > 0.05). Visual acuity did not change significantly between the different soft lens powers assessed (all p > 0.05). Conclusion: The use of negative-powered soft lenses in piggyback fitting reduces RGP lens power without impacting VA in keratoconus subjects. (C) 2014 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.	[Romero-Jimenez, Miguel] MRG Doctores SC, Madrid, Spain; [Santodomingo-Rubido, Jacinto] Menicon Co Ltd, Menicon R & DIC, Nagoya, Aichi, Japan; [Gonzalez-Meijome, Jose-Manuel] Univ Minho, Ctr Phys, Clin & Expt Optometry Res Lab, Braga, Portugal; [Flores-Rodriguez, Patricia] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile; [Villa-Collar, Cesar] European Univ Madrid, Madrid, Spain	Romero-Jimenez, M (reprint author), Vallehermoso 32,Bajo A, Madrid, Spain.	mrjlentes@gmail.com		GONZALEZ-MEIJOME, JOSE M./0000-0001-9050-4170			Caporossi A, 2010, AM J OPHTHALMOL, V149, P585, DOI 10.1016/j.ajo.2009.10.021; Zadnik K, 2002, CORNEA, V21, P671, DOI 10.1097/00003226-200210000-00008; Negishi K, 2007, AM J OPHTHALMOL, V144, P924, DOI 10.1016/j.ajo.2007.08.004; Zadnik K, 1998, INVEST OPHTH VIS SCI, V39, P2537; McMahon TT, 2006, CORNEA, V25, P794, DOI 10.1097/01.ico.0000226359.26678.d1; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Awwad ST, 2008, EYE CONTACT LENS, V34, P2, DOI 10.1097/ICL.0b013e31804f8113; BALDONE J A, 1970, Contact Lens Medical Bulletin, V3, P25; BALDONE J A, 1985, CLAO Journal, V11, P130; Baldone JA., 1973, CONTACT LENS MED B, V6, P15; Carballo-Alvarez J, 2014, CONTACT LENS ANTERIO, V37, P377, DOI 10.1016/j.clae.2014.06.001; Carracedo G, 2013, EYE CONT LENS, V40, P2; Chopra Ira, 2005, Clin Exp Optom, V88, P146; Colin J, 2007, J CATARACT REFR SURG, V33, P69, DOI 10.1016/j.jcrs.2006.08.057; Collins M J, 2001, Cont Lens Anterior Eye, V24, P59, DOI 10.1016/S1367-0484(01)80014-X; Edrington TB, 1996, OPTOMETRY VISION SCI, V73, P369, DOI 10.1097/00006324-199606000-00003; Gonzalez-Meijome JM, 2013, INT J KERAT ECT COR, V2, P56; Lopez-Alemany A, 2006, CORNEA, V25, P214; Michaud L, 2013, CONTACT LENS ANTERIO, V36, P318, DOI 10.1016/j.clae.2013.02.005; O'Donnell Clare, 2004, Eye Contact Lens, V30, P44, DOI 10.1097/01.ICL.0000104596.50832.7F; Ortenberg I, 2013, EYE CONTACT LENS, V39, P381, DOI 10.1097/ICL.0b013e31829e8faa; Romero-Jimenez M, 2013, EYE CONTACT LENS, V39, P269, DOI 10.1097/ICL.0b013e318295b4f4; Romero-Jimenez M, 2013, CONTACT LENS ANTERIO, V36, P45, DOI 10.1016/j.clae.2012.10.070; Romero-Jimenez M, 2013, CONTACT LENS ANTERIO, V36, P146, DOI 10.1016/j.clae.2012.12.006; Schornack MM, 2010, EYE CONTACT LENS, V36, P39, DOI 10.1097/ICL.0b013e3181c786a6; Sengor Tomris, 2011, Clin Ophthalmol, V5, P331, DOI 10.2147/OPTH.S16727; Tse JS, 2011, CONTACT LENS ANTE S1, V34, P39; Visser Esther-Simone, 2007, Eye Contact Lens, V33, P13, DOI 10.1097/01.icl.0000233217.68379.d5; Weissman Barry A, 2006, Cont Lens Anterior Eye, V29, P231, DOI 10.1016/j.clae.2006.09.001; Woo GC, 1984, INT CONTACT LENS DIN, V11, P748	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1367-0484	1476-5411		CONTACT LENS ANTERIO	Contact Lens Anterior Eye	FEB	2015	38	1					48	53		10.1016/j.clae.2014.09.012		6	Ophthalmology	Ophthalmology	CC1GZ	WOS:000350090500009		
J	Lu, ZP; Shoji, T; Takeda, Y				Lu, Z. P.; Shoji, T.; Takeda, Y.			Effects of water chemistry on stress corrosion cracking of 316NG weld metals in high temperature water	CORROSION ENGINEERING SCIENCE AND TECHNOLOGY			English	Article						Stress corrosion cracking; High temperature water; 316NG weld metal; Crack growth rate; Boiling water reactors; Ferrite content; Dissolved oxygen concentration	OXYGENATED PURE WATER; STAINLESS-STEEL; GROWTH-RATES; REACTOR ENVIRONMENTS; LOADING MODE; 304-STAINLESS-STEEL; KINETICS; BEHAVIOR	Effects of dissolved oxygen concentration from 0.2 to 11 ppm on stress corrosion cracking growth rates of 316NG weld metals in pure water at 288 degrees C were investigated. Crack growth rates in the weld metal with a ferrite content of about 6.5 wt-% are higher than those in the weld metal with a ferrite content of about 8.5 wt-% under the same test environments, which increased with increasing dissolved oxygen concentration from 0.2 to 2 ppm. The dependence of crack growth rates on dissolved oxygen concentration in the range from 2 to 11 ppm was affected by the ferrite content in the weld metals.	[Lu, Z. P.; Shoji, T.; Takeda, Y.] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan; [Lu, Z. P.] Shanghai Univ, Inst Mat Sci, Sch Mat Sci & Engn, Shanghai 200072, Peoples R China	Shoji, T (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan.	tshoji@fri.niche.tohoku.ac.jp			Japan Society for the Promotion of Science [23560078]; Shanghai Pujiang Program [12PJ1403600]	This work has been performed as a part of the PEACE-E program jointly supported by EDF, EPRI, SSM (Swedish Radiation Safety Authority), TEPCO, KEPCO, TohokuEPCO, ChubuEPCO, JAPCO, HITACHI Ltd, MHI, TOSHIBA Co. and IHI. This work has been also performed under the support of Grant-in-Aid for Scientific Research (C) 23560078, Japan Society for the Promotion of Science. Z. P. Lu acknowledges the support of Shanghai Pujiang Program No. 12PJ1403600. The help from Mr Koji Negishi for the experiments is gratefully appreciated.	Abe H, 2008, METALL MATER TRANS A, V39A, P1392, DOI 10.1007/s11661-008-9511-8; Ando M., 2007, P 13 INT C ENV DEGR; Andresen PL, 2007, J PRESS VESS-T ASME, V129, P488, DOI 10.1115/1.2748830; ANDRESEN PL, 1988, MAT SCI ENG A-STRUCT, V103, P167, DOI 10.1016/0025-5416(88)90564-2; Angeliu TM, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P311; Macdonald DD, 1996, CORROSION, V52, P768; Lu ZP, 2011, CORROS SCI, V53, P247, DOI 10.1016/j.corsci.2010.09.018; Andresen PL, 2008, J NUCL MATER, V383, P97, DOI 10.1016/j.jnucmat.2008.08.005; Lu ZP, 2011, CORROS SCI, V53, P1916, DOI 10.1016/j.corsci.2011.02.009; Lu ZP, 2012, J NUCL MATER, V423, P28, DOI 10.1016/j.jnucmat.2011.12.030; MACDONALD DD, 1991, CORROS SCI, V32, P51, DOI 10.1016/0010-938X(91)90063-U; Lu ZP, 2008, CORROS SCI, V50, P625, DOI 10.1016/j.corsci.2007.08.021; Lee CH, 2014, APPL THERM ENG, V63, P140, DOI 10.1016/j.applthermaleng.2013.11.001; Lu ZP, 2010, CORROS SCI, V52, P2547, DOI 10.1016/j.corsci.2010.03.027; Arai T., 2008, P 55 MAT CORR S JSCE, P35; Ehrnsten U., 2001, P 10 INT C ENV DEGR; Engelhardt GR, 1999, CORROS SCI, V41, P2267, DOI 10.1016/S0010-938X(99)00058-X; Itow M., 2008, P 55 MAT CORR S NAG, P31; Itow M., 2004, P 2004 ASME PRESS VE, P167; Kim JH, 2008, CORROSION, V64, P645; KIM YJ, 1992, JOM-J MIN MET MAT S, V44, P14; Kim YJ, 2003, CORROSION, V59, P511; Lu Z, 2007, CORROSION, V63, P1021, DOI 10.5006/1.3278317; Lu ZP, 2008, CORROS SCI, V50, P698, DOI 10.1016/j.corsci.2007.08.022; Lu ZP, 2008, CORROS SCI, V50, P561, DOI 10.1016/j.corsci.2007.08.005; Lu Z.P., 2009, P 14 INT C ENV DEGR, P636; Negishi K., 2008, P 2008 C JAP SOC MEC, V43, P99; Platts N., 2009, P 14 INT C ENV DEGR, P87; Platts N, 2011, 15TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P561; Shoji T., 2003, P 11 INT S ENV DEGR, P588; Suzuki S., 2004, MAINTENOLOGY, V3, P65; Suzuki S., 2009, E J ADV MAINT, V1, P1; Turnbull A, 1997, CORROS SCI, V39, P789, DOI 10.1016/S0010-938X(97)89342-0	33	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1478-422X	1743-2782		CORROS ENG SCI TECHN	Corros. Eng. Sci. Technol.	FEB	2015	50	1					41	48		10.1179/1743278214Y.0000000186		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA2CC	WOS:000348715600006		
J	Nakagawa, N; Matsubara, M; Shimooka, Y; Nishikawa, M				Nakagawa, Naofumi; Matsubara, Miki; Shimooka, Yukiko; Nishikawa, Mari			Embracing in a Wild Group of Yakushima Macaques (Macaca fuscata yakui) as an Example of Social Customs	CURRENT ANTHROPOLOGY			English	Article							GROOMING HAND-CLASP; SELF-DIRECTED BEHAVIOR; WHITE-FACED CAPUCHINS; LONG-TAILED MACAQUES; JAPANESE MACAQUES; PAN-TROGLODYTES; TOOL-USE; NEOTROPICAL PRIMATE; NONHUMAN-PRIMATES; ANIMAL CULTURES	Recently, some primatologists have begun studying social customs, which had been neglected in research despite their importance to human culture. We observed embracing behaviors 64 times during 543.8 hours of focal animal sampling, targeting adult females in a wild group of Japanese macaques in Yakushima, Japan, and compared the results with those in macaques in Kinkazan. Embracing occurred immediately after the spontaneous pause of allogrooming, aggressions, and approach between dyads frequently exchanging antagonistic interactions, all of which are considered to be stressful conditions. Embracing in Yakushima may, therefore, serve to reduce stress; this may also be the case in Kinkazan. Despite this functional similarity, the forms of embracing in Yakushima are slightly different from those in Kinkazan. First, not only ventro-ventral embraces, but also ventro-lateral and ventro-dorsal embraces were found in Yakushima. Second, kneading another's fur by rhythmically opening and closing the palm occurred in Yakushima, instead of a rhythmic, body-rocking movement in Kinkazan. Because we cannot devise genetic or ecological explanations for the subtle local differences in embraces, this type of behavior may be identified as the first evidence for social customs in wild Japanese macaques.	[Nakagawa, Naofumi; Nishikawa, Mari] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Matsubara, Miki] Chukyo Univ, Nagoya, Aichi 4668666, Japan; [Shimooka, Yukiko] Teikyo Univ Sci, Fac Life & Environm Sci, Uenohara, Yamanashi 4090193, Japan	Nakagawa, N (reprint author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	nakagawa@jinrui.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports and Technology (MEXT), Japan; MEXT, Japan [19107007, 23370099]	We are grateful to Drs. Shigeru Suzuki, Hideki Sugiura, Sachiko Hayakawa, and Shiho Fujita for their cooperation in field research, and to Drs. Michio Nakamura and Masaki Shimada for their invaluable suggestions. We also express our thanks to three anonymous reviewers for providing comments and encouragements. This research was funded by a grant, "The 21st Century COE," from the Ministry of Education, Culture, Sports and Technology (MEXT), Japan, and by a grant from MEXT, Japan (no. 19107007 to Juichi Yamagiwa and no. 23370099 to Naofumi Nakagawa).	Agetsuma N, 1998, PRIMATES, V39, P275, DOI 10.1007/BF02573077; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495; Leca JB, 2010, ANIM BEHAV, V79, P117, DOI 10.1016/j.anbehav.2009.09.035; Majolo B, 2005, INT J PRIMATOL, V26, P321, DOI 10.1007/s10764-005-2927-8; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Lycett SJ, 2009, J HUM EVOL, V57, P337, DOI 10.1016/j.jhevol.2009.05.015; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Nakagawa N, 1998, PRIMATES, V39, P375, DOI 10.1007/BF02573085; Maestripieri D, 1997, PRIMATES, V38, P127, DOI 10.1007/BF02382003; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Kutsukake N, 2003, BEHAVIOUR, V140, P1153, DOI 10.1163/156853903322589687; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Nakagawa N, 2008, AM J PRIMATOL, V70, P238, DOI 10.1002/ajp.20481; Watson CFI, 2009, INT J PRIMATOL, V30, P143, DOI 10.1007/s10764-009-9334-5; Hamada Y, 2010, JAPANESE MACAQUES, P27, DOI 10.1007/978-4-431-53886-8_2; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Manson JH, 2000, ETHOLOGY, V106, P301, DOI 10.1046/j.1439-0310.2000.00527.x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; Vasey PL, 2010, ARCH SEX BEHAV, V39, P1439, DOI 10.1007/s10508-009-9518-2; SCHINO G, 1990, BEHAVIOUR, V113, P264, DOI 10.1163/156853990X00518; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Takahashi H, 1998, PRIMATES, V39, P365, DOI 10.1007/BF02573084; Nishikawa M, 2014, AM J PRIMATOL, V76, P694, DOI 10.1002/ajp.22263; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; AUNGER R, 1995, CURR ANTHROPOL, V36, P97, DOI 10.1086/204345; Bateson Patrick, 1990, MEASURING BEHAV; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Brockett RC, 2005, FOLIA PRIMATOL, V76, P227, DOI 10.1159/000086024; Caldwell Christine A., 2007, P652; Cronin Katherine A., 2014, ANIMAL COGNITION, DOI [10.1007/s10071-014-0766-8, DOI 10.1007/S10071-014-0766-8.]; de Waal Frans, 2001, APE SUSHI MASTER; de Waal Frans B. M., 1997, AM J PRIMATOL, V43, P399; Falotico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079535; Fragaszy DM, 2003, BIOL TRADITIONS MODE; Green S., 1975, Primate Behav, V4, P1; GREEN S, 1975, Zeitschrift fuer Tierpsychologie, V38, P304; GREWAL B S, 1981, Primates, V22, P277, DOI 10.1007/BF02382617; Gruber T, 2012, J COMP PSYCHOL, V126, P446, DOI 10.1037/a0028702; Hanya G, 2004, ECOL RES, V19, P179, DOI 10.1111/j.1440-1703.2003.00622.x; HAYASAKA K, 1988, MOL BIOL EVOL, V5, P270; Heine S., 2011, CULTURAL PSYCHOL; Hesler Nana, 2007, P159; Hill K., 2009, QUESTION ANIMAL CULT, P269; HUFFMAN MA, 1984, J HUM EVOL, V13, P725, DOI 10.1016/S0047-2484(84)80022-6; Huffman MA, 2010, JAPANESE MACAQUES, P191, DOI 10.1007/978-4-431-53886-8_9; Imanishi Kinji, 1952, MAN, P36; Ingold T, 2001, BEHAV BRAIN SCI, V24, P337; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Isaji Mina, 2010, JAPANESE MONKEYS MIY, V26, P25; Itani Junichiro, 1973, PRECULTURAL PRIMATE, P26; Itani Junnichiro, 1963, PRIMATES, V4, P11, DOI 10.1007/BF01659149; Izawa Kosei, 2009, STUDIES WILD JAPANES; Izawa Kosei, 2010, JAPANESE MONKEYS JAP, V26, P32; Izawa Kosei, 1988, B MIYAGI U ED, V23, P1; Kawai M, 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Kawamura Shunzo, 1956, SHIZEN, V11, P28; Kawamura Shunzo, 1965, MONKEYS APES SOCIOLO, P237; Krutzen Michael, 2006, TRENDS ECOL EVOL, V22, P6; Laidre ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014610; Laidre ME, 2008, ANIM COGN, V11, P179, DOI 10.1007/s10071-007-0121-4; Laland K., 2002, INT ENCY SOCIAL BEHA, P3164; Laland KN, 2009, QUESTION ANIMAL CULT; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Leca JB, 2008, AM J PRIMATOL, V70, P803, DOI 10.1002/ajp.20551; Leca JB, 2007, BEHAVIOUR, V144, P251, DOI 10.1163/156853907780425712; Leca JB, 2011, J COMP PSYCHOL, V125, P61, DOI 10.1037/a0020868; Leca J.-B., 2014, ANIMAL BEHAV COGNITI, V1, P387; Lumsden C. J., 1981, GENES MIND CULTURE C; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Maestripieri D., 2007, GESTURAL COMMUNICATI, P51; Marmi J, 2004, MOL PHYLOGENET EVOL, V30, P676, DOI 10.1016/S1055-7903(03)00247-1; Maruhashi T, 1998, PRIMATES, V39, P291, DOI 10.1007/BF02573078; Matsusaka T, 2006, PRIMATES, V47, P113, DOI 10.1007/s10329-005-0158-4; McDougall P, 2011, INT J PRIMATOL, V32, P335, DOI 10.1007/s10764-010-9471-x; MCGREW W C, 1975, Zeitschrift fuer Tierpsychologie, V37, P145; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew WC, 2004, CULTURED CHIMPANZEE; McGrew WC, 1992, CHIMPANZEE MAT CULTU; McGrew William C., 1978, MAN, V13, P243; Mead M., 1928, COMING AGE SAMOA; MORI A, 1975, Primates, V16, P107, DOI 10.1007/BF02381412; Moura Antonio Christian de, 2005, FOLIA PRIMATOL, V78, P36; Nakagawa N, 2010, JAPANESE MACAQUES, P271, DOI 10.1007/978-4-431-53886-8_12; Nakagawa N, 2009, PRIMATES, V50, P131, DOI 10.1007/s10329-009-0129-2; Nakagawa Naofumi, 2011, Primate Research, V27, P111; NAKAGAWA N, 1989, PRIMATES, V30, P1, DOI 10.1007/BF02381206; Nakagawa N., 2013, MONKEYS APES HUMANS, P1; Nakamura M, 2004, CURR ANTHROPOL, V45, P108, DOI 10.1086/381007; Nakamura M, 2013, AM J PRIMATOL, V75, P186, DOI 10.1002/ajp.22098; Nakamura M, 2006, PRIMATES, V47, P35, DOI 10.1007/s10329-005-0142-z; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; Nishida T., 1987, P462; NISHIDA T, 1980, J HUM EVOL, V9, P117, DOI 10.1016/0047-2484(80)90068-8; Nishida T, 2004, FOLIA PRIMATOL, V75, P31, DOI 10.1159/000073429; NOZAWA K, 1977, JPN J GENET, V52, P15, DOI 10.1266/jjg.52.15; PAVANI S, 1991, FOLIA PRIMATOL, V57, P34, DOI 10.1159/000156561; Perry S, 2003, EVOL ANTHROPOL, V12, P71, DOI 10.1002/evan.10105; Pusey A.E., 1987, P250; Richerson P. J., 2005, NOT GENES ALONE CULT; Saito C, 1998, PRIMATES, V39, P303, DOI 10.1007/BF02573079; SAKURA O, 1989, ANIM BEHAV, V38, P900, DOI 10.1016/S0003-3472(89)80123-X; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024400; Sapolsky RM, 2006, CURR ANTHROPOL, V47, P641, DOI 10.1086/504162; Shimooka Yukiko, 2014, PRIMATES, V52, P327; Stephenson Gordon R., 1973, PRECULTURAL PRIMATE, P51; Takahashi Hiroyuki, 1994, TECHNIQUES CULTURES, V23, P91; Thierry B., 2000, Primate Research, V16, P203; Thierry B, 2000, J CONSCIOUSNESS STUD, V7, P60; Thierry Bernard, 1983, BEHAVIOUR, V89, P1; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Weinberg Susan M., 1981, MACACA FUSCATA AM J, V1, P465; Wolfe Linda, 1979, PRIMATES, V20, P525; Yamagiwa J, 1998, PRIMATES, V39, P255, DOI 10.1007/BF02573075	119	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0011-3204	1537-5382		CURR ANTHROPOL	Curr. Anthropol.	FEB	2015	56	1					104	120		10.1086/679448		17	Anthropology	Anthropology	CB6UA	WOS:000349761000005		
J	Yamazaki, A; Hayashi, M				Yamazaki, Akihiro; Hayashi, Makoto			Building the interaction interfaces: host responses upon infection with microorganisms	CURRENT OPINION IN PLANT BIOLOGY			English	Review							PSEUDOMONAS-SYRINGAE EFFECTOR; CHITIN-TRIGGERED IMMUNITY; RESISTANCE PROTEIN RPW8.2; POWDERY MILDEW FUNGUS; LOTUS-JAPONICUS; MYCORRHIZAL FUNGI; MAGNAPORTHE-GRISEA; PLANT DEVELOPMENT; THREAD FORMATION; EPIDERMAL-CELLS	Research fields of plant symbiosis and plant immunity were relatively ignorant with each other until a little while ago. Recently, however, increasing intercommunications between those two fields have begun to provide novel aspects and knowledge for understanding relationships between plants and microorganisms. Here, we review recent reports on plant-microbe interactions, focusing on the infection processes, in order to elucidate plant cellular responses that are triggered by both symbionts and pathogens. Highlighting the core elements of host responses over biotic interactions will provide insights into general mechanisms of plant-microbe interactions.	[Yamazaki, Akihiro; Hayashi, Makoto] RIKEN Ctr Sustainable Resource Sci Tsurumi, Plant Symbiosis Res Team, Yokohama, Kanagawa 2300045, Japan	Hayashi, M (reprint author), RIKEN Ctr Sustainable Resource Sci Tsurumi, Plant Symbiosis Res Team, Yokohama, Kanagawa 2300045, Japan.	makoto.hayashi@riken.jp	Hayashi, Makoto/N-5379-2015	Hayashi, Makoto/0000-0001-6389-4265	Japan Society for the Promotion of Science [GS029]	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (GS029).	Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Genre A, 2005, PLANT CELL, V17, P3489, DOI 10.1105/tpc.105.035410; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Leborgne-Castel N, 2010, PROTOPLASMA, V247, P177, DOI 10.1007/s00709-010-0195-8; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Cardenas L, 1998, PLANT PHYSIOL, V116, P871, DOI 10.1104/pp.116.3.871; Qin Y, 2011, SEMIN CELL DEV BIOL, V22, P816, DOI 10.1016/j.semcdb.2011.06.004; Chandran D, 2010, P NATL ACAD SCI USA, V107, P460, DOI 10.1073/pnas.0912492107; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Schenk ST, 2014, PLANT CELL, V26, P2708, DOI 10.1105/tpc.114.126763; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Govindarajulu M, 2009, PLANT PHYSIOL, V149, P994, DOI 10.1104/pp.108.128728; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wang WM, 2013, PLANT CELL, V25, P4242, DOI 10.1105/tpc.113.117226; Heindl JE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00176; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Wildermuth MC, 2010, CURR OPIN PLANT BIOL, V13, P449, DOI 10.1016/j.pbi.2010.05.005; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Ivanov S, 2012, P NATL ACAD SCI USA, V109, P8316, DOI 10.1073/pnas.1200407109; Bauer WD, 2004, CURR OPIN PLANT BIOL, V7, P429, DOI 10.1016/j.pbi.2004.05.008; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Lu YJ, 2012, CELL MICROBIOL, V14, P682, DOI 10.1111/j.1462-5822.2012.01751.x; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Perrine-Walker FM, 2014, PROTOPLASMA, V251, P1099, DOI 10.1007/s00709-014-0618-z; An QL, 2006, CELL MICROBIOL, V8, P1009, DOI 10.1111/j.1462-5822.2006.00683.x; Roberts NJ, 2013, PLANT PHYSIOL, V161, P556, DOI 10.1104/pp.112.206110; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; Liang Y, 2013, SCIENCE, V341, P1384, DOI 10.1126/science.1242736; Etzler ME, 1999, P NATL ACAD SCI USA, V96, P5856, DOI 10.1073/pnas.96.10.5856; Bainard LD, 2011, PLANT CELL ENVIRON, V34, P1577, DOI 10.1111/j.1365-3040.2011.02354.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Cannon SB, 2003, MOL GENET GENOMICS, V270, P347, DOI 10.1007/s00438-003-0928-x; Day RB, 2000, MOL PLANT MICROBE IN, V13, P1053, DOI 10.1094/MPMI.2000.13.10.1053; Dormann P, 2015, NEW PHYTOL, V204, P815; Fusconi A, 2005, MYCORRHIZA, V15, P313, DOI 10.1007/s00572-004-0338-x; Gan Pamela H P, 2010, Plant Signal Behav, V5, P1272, DOI 10.4161/psb.5.10.13013; Genre A, 2012, PLANT CELL PHYSIOL, V53, P244, DOI 10.1093/pcp/pcr170; Gilbert RD, 1996, PHYSIOL MOL PLANT P, V48, P335, DOI 10.1006/pmpp.1996.0027; Gobbato E., 2013, Plant Signaling and Behavior, V8, pe26049, DOI 10.4161/psb.26049; Göhre Vera, 2008, Curr Biol, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Hermanns M, 2008, PHYSIOL MOL PLANT P, V72, P96, DOI 10.1016/j.pmpp.2008.06.002; Hoefle C, 2011, PLANT CELL, V23, P2422, DOI 10.1105/tpc.110.082131; Kim H, 2014, PLANT J, V79, P835, DOI 10.1111/tpj.12591; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; Lanver D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004272; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Palmer AG, 2015, ACS CHEM BIOL, V9, P1834; Perez-Gimenez J., 2009, INT J MICROBIOL, V2009; Perrine-Walker FM, 2014, PROTOPLASMA, V251, P817, DOI 10.1007/s00709-013-0584-x; Plett JM, 2014, P NATL ACAD SCI USA, V111, P8229; Suzaki T, 2014, DEVELOPMENT, V141, P2441, DOI 10.1242/dev.107946; Tahiri-Alaoui A, 2002, CAN J BOT, V80, P607, DOI [10.1039/B02-041, 10.1139/b02-041]; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Tanaka Kiwamu, 2011, Plant Signal Behav, V6, P1034; van Workum WAT, 1998, MOL PLANT MICROBE IN, V11, P1233, DOI 10.1094/MPMI.1998.11.12.1233; Wang P, 2008, ARCH MICROBIOL, V189, P525, DOI 10.1007/s00203-007-0345-3; Yoon HJ, 2014, PLANT J, V78, P811, DOI 10.1111/tpj.12520	75	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	FEB	2015	23						132	139		10.1016/j.pbi.2014.12.003		8	Plant Sciences	Plant Sciences	CB8LK	WOS:000349880900019		
J	Yamada, I; Matsuo, J; Toyoda, N; Aoki, T; Seki, T				Yamada, I.; Matsuo, J.; Toyoda, N.; Aoki, T.; Seki, T.			Progress and applications of cluster ion beam technology	CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE			English	Review						Cluster ion beam; Gas cluster ion beam (GCIB); MD simulation; Low energy implantation; Lateral sputtering; Surface modification; Surface smoothing; Bio-materials; Analytical instrumentation	MOLECULAR-DYNAMICS SIMULATIONS; KEV C-60; BOMBARDMENT	Cluster ion beam processing has been extensively developed during the 25 years since the concept originated. Low energy surface interaction effects, lateral sputtering phenomena and high-rate chemical reaction effects have been explored experimentally and have been explained by means of molecular dynamics (MD) modeling. Practical production equipment for a wide range of applications has also been successfully developed. The technology is now advancing rapidly in the fields of sub-nanoscale processing of metals, semiconductors and insulating materials. This paper reviews important events which have taken place during the development with emphasis placed on emerging new advances which have occurred during several recent years. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamada, I.; Toyoda, N.] Univ Hyogo, Grad Sch Engn, Kobe, Hyogo 6500044, Japan; [Matsuo, J.] Kyoto Univ, Quantum Sci & Engn Ctr, Kyoto 6068501, Japan; [Aoki, T.] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan; [Seki, T.] Kyoto Univ, Dept Nucl Engn, Kyoto 6068501, Japan	Yamada, I (reprint author), Univ Hyogo, Grad Sch Engn, Kobe, Hyogo 6500044, Japan.	i-yamada@kuee.kyoto-u.ac.jp					Ninomiya S, 2007, NUCL INSTRUM METH B, V256, P493, DOI 10.1016/j.nimb.2006.12.047; Aoki T, 2009, NUCL INSTRUM METH B, V267, P2999, DOI 10.1016/j.nimb.2009.06.019; Aoki T, 2014, J COMPUT ELECTRON, V13, P108, DOI 10.1007/s10825-013-0504-5; Yamada I, 2001, MAT SCI ENG R, V34, P231, DOI 10.1016/S0927-796X(01)00034-1; Yamada I, 2014, APPL SURF SCI, V310, P77, DOI 10.1016/j.apsusc.2014.03.147; Aoki T, 2007, NUCL INSTRUM METH B, V257, P645, DOI 10.1016/j.nimb.2007.01.048; Aoki T, 2010, VACUUM, V84, P994, DOI 10.1016/j.vacuum.2009.11.018; Aoki T, 2011, NUCL INSTRUM METH B, V269, P1582, DOI 10.1016/j.nimb.2010.12.013; Aoki T, 2003, AIP CONF PROC, V680, P741; Aoki T, 2012, NUCL INSTRUM METH B, V282, P29, DOI 10.1016/j.nimb.2011.08.061; Aoki T, 2000, THESIS KYOTO U; Aoki T, 2010, INT WORK JUNCTION TE; Czerwinski B, 2013, NUCL INSTRUM METH B, V303, P23, DOI 10.1016/j.nimb.2012.11.030; Eggs C, 2006, 7 WORKSH CLUST ION B, P46; Fenner DB, 2001, J VAC SCI TECHNOL A, V19, P1207, DOI 10.1116/1.1349193; Fujii M, 2014, RAPID COMMUN MASS SP, V28, P917, DOI 10.1002/rcm.6867; Garrison B.J., 2013, TOF SIMS SURFACE ANA, Vsecond, P151; Goto K, 1997, IEDM, V1997; Goto K, 1996, IEDM - INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST 1996, P435, DOI 10.1109/IEDM.1996.553620; Hautala J., 2004, 12th IEEE International Conference on Advanced Thermal Processing of Semiconductors (IEEE Cat. No.03EX847), DOI 10.1109/RTP.2004.1441709; Horsky TN, 2009, US Patent, No, Patent No. [7491953 B2, 7491953]; Horsky TN, 2000, US Patent, No, Patent No. 6107634; Ichiki K, 2013, SURF INTERFACE ANAL, V45, P522, DOI 10.1002/sia.5092; Kawasaki Y, 2012, THESIS HIROSHIMA U; Kennedy PE, 2013, SURF INTERFACE ANAL, V45, P42, DOI 10.1002/sia.5022; Khoury J, 2013, NUCL INSTRUM METH B, V307, P630, DOI 10.1016/j.nimb.2012.11.087; Khoury J, 2010, FASEB J; Kirkpatrick A, 2013, NUCL INSTRUM METH B, V307, P281, DOI 10.1016/j.nimb.2012.11.084; Kirkpatrick A., 2000, WORKSH CLUST ION BEA, P17; Koike K, 2010, APPL PHYS EXP, V3; Kunibe T, 2009, 9 WORKSH CLUST ION B, P57; MacCrimmon R, 2006, NUCL INSTRUM METH B, V242, P427, DOI 10.1016/j.nimb.2005.08.074; Matsuo J, 2014, APPL PHYS EXPRESS, V7; Matsuo J, 1999, THESIS KYOTO U; Ministry of Economy, 2004, CLUST ION BEAM PROC; New Energy and Industrial Technology Development Organization (NEDO), 2007, ADV NAN PROC TECHN U; Ninomiya S, 2010, 10 WORKSH CLUST ION, P43; Ninomiya S, 2007, 8 WORKSH CLUST ION B, P41; Postawa Z, 2014, SURF INTERFACE ANAL, V46, P3, DOI 10.1002/sia.5550; Renau A, 2010, 2010 INT WORKSH JUNC, P1, DOI 10.1109/IWJT.2010.5475003; Samela J., 2008, REPORT SERIES PHYS, V150; Seki T, 2000, THESIS KYOTO U; Seki T, 2010, AIP CONF PROC, V1321, P317; Suda T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HA02; SUDA T, 2010, 18 INT C ION IMPL TE, V1321, P290; Toyoda N, 1999, THESIS KYOTO U; Toyoda N, 2009, J APPL PHYS, V105; Toyoda N, 2001, MAT RES SOC P, V647; Toyoda N, 2004, MATER RES SOC S P, V792; Yamada I, 2011, MATER RES SOC S P, V1354, P21; Yamada I, 2010, AIP CONF PROC, V1321, P1; Yamada I, 2007, NUCL INSTRUM METH B, V257, P632, DOI 10.1016/j.nimb.2007.01.124	52	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-0286	1879-0348		CURR OPIN SOLID ST M	Curr. Opin. Solid State Mat. Sci.	FEB	2015	19	1					12	18		10.1016/j.cossms.2014.11.002		7	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CC1FC	WOS:000350085600002		
J	Hiraishi, N; Tochio, N; Kigawa, T; Otsuki, M; Tagami, J				Hiraishi, Noriko; Tochio, Naoya; Kigawa, Takanori; Otsuki, Masayuki; Tagami, Junji			Molecular level evaluation on HEMA interaction with a collagen model	DENTAL MATERIALS			English	Article						Dentin; Nuclear magnetic resonance; Atelocollagen; 2-ydroxyethylmethacrylate; Dental adhesives	TRANSFER DIFFERENCE NMR; DEMINERALIZED DENTIN; DIMENSIONAL CHANGES; WATER; SPECTROSCOPY; MATRIX; TENDON; GIBBERELLIN; ADHESIVES; DYNAMICS	Objective. 2-Hydroxyethylmethacrylate (HEMA) diffuses in wet dentin and promotes adhesion during dentin priming and bonding. We have investigated the molecular level interaction between HEMA and a collagen model by using saturation transfer difference(STD) NMR. Methods. The binding of HEMA to collagen was preliminarily investigated by suspending demineralized human dentin powders in a 4 mM HEMA solution for 1 h and measuring the decrease in the HEMA concentration on a spectrophotometer. The molecular level interaction of HEMA with atelocollagen, which was used as a collagen model, was investigated bySTD-NMR spectroscopy. Results. The HEMA concentration in the suspension did not change, indicating that HEMA did not bind to dentin collagen. This was confirmed by STD- NMR; when the atelocollagen resonance was saturated, no saturation was propagated to HEMA and no STD signals were detected. Significance. The HEMA protons were not near the atelocollagen surface, indicating HEMA did not interact with atelocollagen. The collagen fibrils may be surrounded by water molecules in dentin/ bond interfaces, which prevent the direct HEMA binding interaction. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Hiraishi, Noriko; Otsuki, Masayuki; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch, Dept Oral Hlth Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Tochio, Naoya] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398511, Japan; [Kigawa, Takanori] RIKEN, Syst & Struct Biol Ctr, NMR Pipeline Methodol Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tagami, Junji] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo 1138549, Japan	Hiraishi, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral Hlth Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	hiraope@tmd.ac.jp	Hiraishi, Noriko/H-8751-2015		Japanese Ministry of Education, Culture, Sports, Science and Technology under the Global Center of Excellence (GCOE) program " International Research Center for Molecular Science in Tooth and Bone Diseases"; JSPS [22592114]	This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology under the Global Center of Excellence (GCOE) program " International Research Center for Molecular Science in Tooth and Bone Diseases" and by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS No. 22592114).	NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M; Pashley EL, 1998, DENT MATER, V14, P6, DOI 10.1016/S0109-5641(98)00003-7; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Ku CS, 2007, CHEMOSPHERE, V67, P1618, DOI 10.1016/j.chemosphere.2006.11.037; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Nakaoki Y, 2000, DENT MATER, V16, P441, DOI 10.1016/S0109-5641(00)00042-7; Bertassoni LE, 2012, ACTA BIOMATER, V8, P2419, DOI 10.1016/j.actbio.2012.02.022; Murata T, 2003, BIOCHEM BIOPH RES CO, V307, P498, DOI 10.1016/S0006-291X(03)01219-1; PETO S, 1990, BIOPHYS J, V57, P71; Pashley DH, 2002, AM J DENT, V15, P97; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Mallamace F, 2011, J PHYS CHEM B, V115, P14280, DOI 10.1021/jp205285t; Van Landuyt KL, 2005, J DENT RES, V84, P183; Nezu T, 2005, BIOMATERIALS, V26, P3801, DOI 10.1016/j.biomaterials.2004.10.010; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919; Sadek FT, 2010, J DENT RES, V89, P1499, DOI 10.1177/0022034510385240; CUSACK S, 1984, BIOPOLYMERS, V23, P337, DOI 10.1002/bip.360230212; Hiraishi N, 2013, J DENT RES, V92, P284, DOI 10.1177/0022034512474310; HOEVE CAJ, 1974, BIOPOLYMERS, V13, P1661, DOI 10.1002/bip.1974.360130812; Luensmann Doerte, 2008, Cont Lens Anterior Eye, V31, P179, DOI 10.1016/j.clae.2008.05.004; Lynn AK, 2004, J BIOMED MATER RES B, V71, P343; Mayer M, 2000, J MED CHEM, V43, P2093, DOI 10.1021/jm990194x; Murata T, 2005, FEBS J, V272, P4938, DOI 10.1111/j.1742-4658.2005.04902.x; Nishiyama N, 2002, J DENT RES, V81, P469; Nishiyama N, 2003, J DENT RES, V82, P257; Pashley DH, 2000, DENT MATER, V16, P7; Pashley DH, 2001, J BIOMED MATER RES, V56, P273, DOI 10.1002/1097-4636(200108)56:2<273::AID-JBM1095>3.0.CO;2-A; WANG T, 1991, J DENT RES, V70, P59, DOI 10.1177/00220345910700011001	31	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	FEB	2015	31	2					88	92		10.1016/j.dental.2014.11.005		5	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CB6TK	WOS:000349759400008		
J	Inokoshi, M; Vanmeensel, K; Zhang, F; De Munck, J; Eliades, G; Minakuchi, S; Naert, I; Van Meerbeek, B; Vleugels, J				Inokoshi, Masanao; Vanmeensel, Kim; Zhang, Fei; De Munck, Jan; Eliades, George; Minakuchi, Shunsuke; Naert, Ignace; Van Meerbeek, Bart; Vleugels, Jozef			Aging resistance of surface-treated dental zirconia	DENTAL MATERIALS			English	Article						Zirconia; Alumina sandblasting; Tribochemical silica sandblasting; Aging; Rough polishing; Low-temperature degradation	LOW-TEMPERATURE DEGRADATION; BIAXIAL FLEXURE STRENGTH; Y-TZP CERAMICS; AIR-PARTICLE ABRASION; PHASE-TRANSFORMATION; MECHANICAL-PROPERTIES; TETRAGONAL ZIRCONIA; HEAT-TREATMENT; HYDROTHERMAL STABILITY; SPECTROSCOPIC ANALYSIS	The influence of surface treatment on the low-temperature degradation (LTD) of tetragonal zirconia polycrystalline (TZP) is still unclear. Objectives. The effect of surface treatments on the LTD behavior of zirconia was investigated. Methods. Fully-sintered specimens of seven commercial dental zirconia (Aadva, GC; In CeramYZ, VITA; IPS e.max ZirCAD, Ivoclar Vivadent; LAVA Frame and LAVA Plus, 3M ESPE; NANOZR, Panasonic; ZirTough, Kuraray Noritake) were provided by the manufacturers with specimen dimensions of approximately 10 mm x 5 mm x 3 mm. For each zirconia grade, samples were kept 'as sintered' (untreated) or were subjected to one of the three surface treatments: rough polished, sandblasted with Al2O3, tribochemical silica sandblasted (n = 3/group). The tetragonal to monoclinic transformation was evaluated by X-ray diffraction at several intervals during LTD testing up to 40 h in steam in an autoclave (134 degrees C, 2 bar). Results. The five yttria-stabilized TZP (Y-TZP: Aadva, In-CeramYZ, IPS e.max ZirCAD, LAVA Frame, LAVA Plus) zirconia showed a similar trend in LTD behavior. The Al2O3 sand-blasted zirconia showed the highest monoclinic volume fraction. The as sintered (untreated) zirconia degraded faster than the surface-treated zirconia. Although the surface-treated ceria-stabilized TZP/alumina (Ce-TZP/Al2O3: NANOZR) zirconia had a higher initial monoclinic volume fraction compared to the Y-TZP zirconia, it showed a stronger aging resistance. The as sintered (untreated) Y-TZP/alumina (Y-TZP/Al2O3: ZirTough) zirconia showed a strong aging resistance, whereas the surface-treated Y-TZP/Al2O3 zirconia degraded slightly. Significance. Surface treatment improved the aging resistance of Y-TZP zirconia. Surface treatment did not affect the LTD behavior of Ce-TZP/Al2O3 zirconia, while surface treatment decreased the aging resistance of Y-TZP/Al2O3 zirconia. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Inokoshi, Masanao; De Munck, Jan; Naert, Ignace; Van Meerbeek, Bart] Univ Louvain, KU Leuven, KU Leuven BIOMAT, Dept Oral Hlth Sci, B-3000 Louvain, Belgium; [Inokoshi, Masanao; De Munck, Jan; Naert, Ignace; Van Meerbeek, Bart] Univ Hosp Leuven, B-3000 Louvain, Belgium; [Vanmeensel, Kim; Zhang, Fei; Vleugels, Jozef] Univ Louvain, KU Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium; [Eliades, George] Univ Athens, Dept Biomat, Athens 11527, Greece; [Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138549, Japan	Van Meerbeek, B (reprint author), Univ Louvain, KU Leuven, KU Leuven BIOMAT, Dept Oral Hlth Sci, Kapucijnenvoer 7,Blok Bus 7001, B-3000 Louvain, Belgium.	bart.vanmeerbeek@med.kuleuven.be			Flemish scholarship for Japanese students; Research Fund of KU Leuven [OT/10.052]; Research Foundation Flanders (FWO-Flanders) [G.0431.10]	M.I. acknowledges the Flemish scholarship for Japanese students. This work was performed within the framework of the Research Fund of KU Leuven under project 'OT/10.052' and the Research Foundation Flanders (FWO-Flanders) under project G.0431.10'. K.V. acknowledges the Research Foundation Flanders (FWO-Flanders) for his postdoctoral fellowship.	Alghazzawi TF, 2012, J PROSTHODONT, V21, P363, DOI 10.1111/j.1532-849X.2011.00838.x; Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006; Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73; Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547; Matsui K, 2009, J AM CERAM SOC, V92, P467, DOI 10.1111/j.1551-2916.2008.02861.x; Hallmann L, 2012, J BIOMED MATER RES B, V100B, P447, DOI 10.1002/jbm.b.31969; WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x; Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020; Chevalier J, 1999, J AM CERAM SOC, V82, P2150; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Turp V, 2013, AUST DENT J, V58, P183, DOI 10.1111/adj.12065; Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016; Luthardt RG, 2002, J DENT RES, V81, P487; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022; Kim JW, 2010, J DENT RES, V89, P91, DOI 10.1177/0022034509354193; TORAYA H, 1984, J AM CERAM SOC, V67, pC119; Kosmac T, 2012, J EUR CERAM SOC, V32, P2613, DOI 10.1016/j.jeurceramsoc.2012.02.024; Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250; Boyle MH, 2001, J CHILD PSYCHOL PSYC, V42, P141, DOI 10.1017/S0021963001006606; Kristjansson SD, 2007, PSYCHOPHYSIOLOGY, V44, P728, DOI 10.1111/j.1469-8986.2007.00544.x; Souza ROA, 2013, J MECH BEHAV BIOMED, V26, P155, DOI 10.1016/j.jmbbm.2013.04.018; Hallmann L, 2012, SURF COAT TECH, V206, P4293, DOI 10.1016/j.surfcoat.2012.04.043; Ozcan M, 2013, J MECH BEHAV BIOMED, V20, P19, DOI 10.1016/j.jmbbm.2013.01.005; LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S; Chevalier J, 2011, ACTA BIOMATER, V7, P2986, DOI 10.1016/j.actbio.2011.03.006; Nakahara I, 2010, J ARTHROPLASTY, V25, P1182, DOI 10.1016/j.arth.2009.09.006; Hallmann L, 2012, J EUR CERAM SOC, V32, P4091, DOI 10.1016/j.jeurceramsoc.2012.07.032; Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1; Bhargava S, 2012, BIO-MED MATER ENG, V22, P383, DOI 10.3233/BME-2012-0727; Karakoca S, 2009, J BIOMED MATER RES B, V91B, P930, DOI 10.1002/jbm.b.31477; Kosmac T, 2008, J EUR CERAM SOC, V28, P1085, DOI 10.1016/j.jeurceramsoc.2007.09.013; Sato H, 2008, DENT MATER J, V27, P408; Ban S, 2007, KEY ENG MAT, V330-332, P353; Ban S, 2008, J BIOMED MATER RES B, V87B, P492, DOI 10.1002/jbm.b.31131; Ban S, 2008, KEY ENG MAT, V361-363, P779; Ban SJ, 2013, KEY ENG MATER, V529-530, P501, DOI 10.4028/www.scientific.net/KEM.529-530.501; Ban S, 2006, KEY ENG MAT, V309-311, P1219; Cattani Lorente Maria, 2010, Dent Mater, V26, P1035, DOI 10.1016/j.dental.2010.06.005; CHAN CJ, 1991, J AM CERAM SOC, V74, P807, DOI 10.1111/j.1151-2916.1991.tb06929.x; Iijima T, 2013, DENT MATER J, V32, P274; Kosmac T, 2007, INT J APPL CERAM TEC, V4, P164, DOI 10.1111/j.1744-7402.2007.02124.x; Kosmac T, 2009, KEY ENG MAT, V409, P161; Lee TH, 2012, J BIOMED MATER RES B, V100B, P1334, DOI 10.1002/jbm.b.32700; Munoz-Tabares JA, 2012, J EUR CERAM SOC, V32, P325, DOI 10.1016/j.jeurceramsoc.2011.08.029; Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679; Pezzotti G, 2005, ANAL BIOANAL CHEM, V381, P577, DOI 10.1007/s00216-004-2780-1; Sato H, 2008, J CERAM SOC JPN, V116, P28, DOI 10.2109/jcersj2.116.28; SRINIVASAN GV, 1989, J AM CERAM SOC, V72, P2098, DOI 10.1111/j.1151-2916.1989.tb06038.x; VIRKAR AV, 1986, J AM CERAM SOC, V69, pC224; Virkar A. V., 1998, Key Engineering Materials, V153-154; Zinelis S, 2010, DENT MATER, V26, P295	52	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	FEB	2015	31	2					182	194		10.1016/j.dental.2014.11.018		13	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CB6TK	WOS:000349759400018		
J	Tezvergil-Mutluay, A; Agee, KA; Mazzoni, A; Carvalho, RM; Carrilho, M; Tersariol, IL; Nascimento, FD; Imazato, S; Tjaderhane, L; Breschi, L; Tay, FR; Pashley, DH				Tezvergil-Mutluay, Arzu; Agee, Kelli A.; Mazzoni, Annalisa; Carvalho, Ricardo M.; Carrilho, Marcela; Tersariol, Ivarne L.; Nascimento, Fabio D.; Imazato, Satoshi; Tjaderhane, Leo; Breschi, Lorenzo; Tay, Franklin R.; Pashley, David H.			Can quaternary ammonium methacrylates inhibit matrix MMPs and cathepsins?	DENTAL MATERIALS			English	Article						Degradation of collagen; CTX; ICTP; Quaternary ammonium compounds; MMPs; Cathepsins	COLLAGEN DEGRADATION; DENTIN MATRIX; I COLLAGEN; CHLORHEXIDINE; METALLOPROTEINASES	Objective. Dentin matrices release ICTP and CTX fragments during collagen degradation. ICTP fragments are known to be produced by MMPs. CTX fragments are thought to come from cathepsin K activity. The purpose of this study was to determine if quaternary methacrylates (QAMs) can inhibit matrix MMPs and cathepsins. Methods. Dentin beams were demineralizated, and dried to constant weight. Beams were incubated with rh-cathepsin B, K, L or S for 24 h at pH 7.4 to identify which cathepsins release CTX at neutral pH. Beams were dipped in ATA, an antimicrobial QAM to determine if it can inhibit dentin matrix proteases. Other beams were dipped in another QAM (MDPB) to determine if it produced similar inhibition of dentin proteases. Results. Only beams incubated with cathepsin K lost more dry mass than the controls and released CTX. Dentin beams dipped in ATA and incubated for 1 week at pH 7.4, showed a concentration-dependent reduction in weight-loss. There was no change in ICTP release from control values, meaning that ATA did not inhibit MMPs. Media concentrations of CTX fell significantly at 15 wt% ATA indicating that ATA inhibits capthesins. Beams dipped in increasing concentrations of MDPB lost progressively less mass, showing that MDPB is a protease-inhibitor. ICTP released from controls or beams exposed to low concentrations were the same, while 5 or 10% MDPB significantly lowered ICTP production. CTX levels were strongly inhibited by 2.5-10% MDPB, indicating that MDPB is a potent inhibitor of both MMPs and cathepsin K. Significance. CTX seems to be released from dentin matrix only by cathepsin K. MMPs and cathepsin K and B may all contribute to matrix degradation. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Tezvergil-Mutluay, Arzu] Univ Turku, Inst Dent, Adhes Dent Res Grp, Turku, Finland; [Agee, Kelli A.; Tay, Franklin R.; Pashley, David H.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA; [Mazzoni, Annalisa; Breschi, Lorenzo] Univ Bologna, Dept SAU& FAL, Bologna, Italy; [Carvalho, Ricardo M.] Univ British Columbia, Sch Dent, Dept Oral Sci, Vancouver, BC V5Z 1M9, Canada; [Carrilho, Marcela; Nascimento, Fabio D.; Breschi, Lorenzo] UNIBAN Univ Bandeirante Anhanguera, Biomat Res Grp, Sao Paulo, Brazil; [Tersariol, Ivarne L.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil; [Tersariol, Ivarne L.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil; [Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan; [Tjaderhane, Leo] Univ Oulu, Oulu Univ Hosp, Inst Dent, Oulu, Finland; [Tjaderhane, Leo] Univ Turku, Inst Dent, Turku, Finland	Pashley, DH (reprint author), Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA.	dpashley@gru.edu	Tersariol, Ivarne/G-4042-2012; Tjaderhane, Leo/J-5017-2015; 	Tjaderhane, Leo/0000-0002-5018-478X; Breschi, Lorenzo/0000-0001-7621-226X	NIDCR [R01 DE015306]; Academy of Finland; Finnish Dental Society Apollonia	This work was supported, in part, by grant R01 DE015306 from the NIDCR to DHP (PI) and by grants from the Academy of Finland and the Finnish Dental Society Apollonia to AT-M and LT (PIs). Dr. Pashley is a visiting scholar at the King Abdulaziz University, School of Dentistry, Jeddah, Saudi Arabia. The authors are grateful to Mrs. Michelle Barnes for her secretarial support.	Pashley DH, 2004, J DENT RES, V83, P216; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Pashley DH, 2007, AM J DENT, V20, P7; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; KIRSCHKE H, 1982, BIOCHEM J, V201, P367; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Osorio R, 2011, EUR J ORAL SCI, V119, P79, DOI 10.1111/j.1600-0722.2010.00789.x; Simecek JW, 2009, J AM DENT ASSOC, V140, P200; Scaffa PMC, 2012, J DENT RES, V91, P420, DOI 10.1177/0022034511435329; BURLEIGH MC, 1974, BIOCHEM J, V137, P387; Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1; Mazzoni A, 2007, J DENT RES, V86, P436; Gendron R, 1999, CLIN DIAGN LAB IMMUN, V6, P437; Malla N, 2008, J BIOL CHEM, V283, P13652, DOI 10.1074/jbc.M709140200; Novinec M, 2013, BIOL CHEM, V394, P1163, DOI 10.1515/hsz-2013-0134; Sulkala M, 2007, ARCH ORAL BIOL, V52, P121, DOI 10.1016/j.archoralbio.2006.08.009; Wood JD, 2008, DENT MATER, V24, P859, DOI 10.1016/j.dental.2007.10.005; Tezvergil-Mutluay A, 2011, J DENT RES, V90, P535, DOI 10.1177/0022034510389472; Karsdal MA, 2011, ARTHRITIS RES THER, V13, P215; Kometoni M, 2010, CURR TOP MED CHEM, V10, P734; Mazzoni A, 2012, ENDODONTIC TOPICS, V21, P19, DOI DOI 10.1111/J.1601-1546.2012.00268.X; MELLOR GW, 1993, BIOCHEM J, V290, P289; NAKABAYASHI N., 1998, HYBRIDIZATION DENT H; Nascimento FD, 2011, J ENDODONT, V40, P506; Sassi ML, 2000, BONE, V26, P367, DOI 10.1016/S8756-3282(00)00235-0; Tersariol M, 2010, J ENDODONT, V36, P475; Tezvergil-Mutluay A, 2013, J DENT RES, V92, P87, DOI 10.1177/0022034512466264; Tjaderhane L, 2012, ENDODONTIC TOPICS, V20, P3; Vital CMP, 2014, J DENT RES, V93, P269	31	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	FEB	2015	31	2					E25	E32		10.1016/j.dental.2014.10.006		8	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CB6TK	WOS:000349759400003		
J	Weng, JP; Soegondo, S; Schnell, O; Sheu, WHH; Grzeszczak, W; Watada, H; Yamamoto, N; Kalra, S				Weng, Jianping; Soegondo, Sidartawan; Schnell, Oliver; Sheu, Wayne H-H.; Grzeszczak, Wladyslaw; Watada, Hirotaka; Yamamoto, Noriyuki; Kalra, Sanjay			Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database	DIABETES-METABOLISM RESEARCH AND REVIEWS			English	Article						acarbose; Asian; European Caucasian; diabetes mellitus; ethnicity; non-interventional study	TYPE-2 DIABETIC-PATIENTS; ALPHA-GLUCOSIDASE INHIBITORS; POSTPRANDIAL PLASMA-GLUCOSE; FIXED-DOSE COMBINATION; INTIMA-MEDIA THICKNESS; GLYCEMIC CONTROL; DOUBLE-BLIND; LONG-TERM; POSTMARKETING SURVEILLANCE; CARDIOVASCULAR-DISEASE	BackgroundAlpha-glucosidase inhibitors are recommended in some international guidelines as first-line, second-line and third-line treatment options but are not used worldwide due to perceived greater effectiveness in Asians than Caucasians. MethodsData from ten post-marketing non-interventional studies using acarbose, the most widely used alpha-glucosidase inhibitor, from 21 countries, provinces and country groups were pooled. Effects on glycated hemoglobin (HbA(1c)) were analysed for four major ethnicity/region groups (European Caucasians and Asians from East, Southeast and South Asia) to identify differences in the response to acarbose. ResultsThe safety and efficacy populations included 67682 and 62905 patients, respectively. Mean HbA(1c) in the total population decreased by 1.121.31% at the 3-month visit from 8.4% at baseline (p<0.0001). Reductions in HbA(1c), fasting plasma glucose and post-prandial plasma glucose were greater in patients with higher baseline values. Acarbose was well tolerated, with few episodes of hypoglycemia (0.03%) and gastrointestinal adverse events (2.76%). Data from 30730 Caucasians from Europe and Asians from three major regions of Asia with non-missing gender/age information and baseline/3-month HbA(1c) data were analysed by multivariable analyses of covariance. After adjustment for relevant baseline confounding factors, Southeast and East Asians had slightly better responses to acarbose than South Asians and European Caucasians; however, the differences were small. ConclusionsAcarbose was effective in both European Caucasians and Asians; however, after adjustment for baseline confounding factors, significant small differences in response favoured Southeast and East Asians. (c) 2014 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons, Ltd.	[Weng, Jianping] Guangdong Prov Key Lab Diabetol, Guangzhou, Guangdong, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab Dis, Guangzhou 510275, Guangdong, Peoples R China; [Soegondo, Sidartawan] Univ Indonesia, Fac Med, Jakarta, Indonesia; [Schnell, Oliver] Helmholtz Ctr Munich, Forschergrp Diabet eV, Munich, Germany; [Sheu, Wayne H-H.] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Grzeszczak, Wladyslaw] Silesian Univ Med, Dept & Clin Internal Med Diabetol & Nephrol, Katowice, Poland; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Tokyo, Japan; [Yamamoto, Noriyuki] Bayer Healthcare, Beijing, Peoples R China; [Kalra, Sanjay] Bharti Res Inst Diabet & Endocrinol, Karnal, Haryana, India	Weng, JP (reprint author), Guangdong Prov Key Lab Diabetol, Guangzhou, Guangdong, Peoples R China.	wjianp@mail.sysu.edu.cn			Bayer Healthcare Company Ltd.	We thank Kathrin Stauch from Global Non-Interventional Studies, Bayer Healthcare, for data structure and analyses advice, Raluca Ilinca Schmitt from Global Integrated Analysis, Bayer Healthcare, for statistical analysis advice, and Institut Dr. Schauerte (Germany) for database construction and statistical analysis. Jemma Lough, Rapiergroup, provided writing and editorial support. Database construction/analysis (coded as GBPOOL) and medical writing were funded by Bayer Healthcare Company Ltd.	Derosa G, 2012, ARCH MED SCI, V8, P899, DOI 10.5114/aoms.2012.31621; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Segal P, 2005, CLIN DRUG INVEST, V25, P589, DOI 10.2165/00044011-200525090-00004; Sheu WHH, 2011, DIABETES RES CLIN PR, V92, P312, DOI 10.1016/j.diabres.2011.04.019; Rosenstock J, 1998, DIABETES CARE, V21, P2050, DOI 10.2337/diacare.21.12.2050; Holman RR, 1999, DIABETES CARE, V22, P960, DOI 10.2337/diacare.22.6.960; Hara T, 1996, DIABETES CARE, V19, P642, DOI 10.2337/diacare.19.6.642; Davidson JA, 2010, ENDOCR PRACT, V16, P818, DOI 10.4158/EP09285.OR; Standl E, 2012, DIABETES VASC DIS RE, V9, P163, DOI 10.1177/1479164112441524; CHIASSON JL, 1994, ANN INTERN MED, V121, P928; Wang JS, 2011, DIABETES-METAB RES, V27, P79, DOI 10.1002/dmrr.1149; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Garber AJ, 2013, ENDOCR PRACT, V19, P327, DOI 10.4158/EP12437.GL; Dickinson S, 2002, J NUTR, V132, P2574; Kalra S, 2010, DIABETES RES CLIN PR, V88, P282, DOI 10.1016/j.diabres.2010.03.004; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; [Anonymous], 2013, DIABETES ATLAS; Wang JS, 2013, DIABETES RES CLIN PR, V102, P16, DOI 10.1016/j.diabres.2013.08.001; Zhang WW, 2013, CLIN DRUG INVEST, V33, P263, DOI 10.1007/s40261-013-0063-3; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; BISCHOFF H, 1995, CLIN INVEST MED, V18, P303; Hanefeld M, 2004, EUR HEART J, V25, P10, DOI 10.1016/S0195-668X(03)00468-8; Bachmann W, 2003, CLIN DRUG INVEST, V23, P679, DOI 10.2165/00044011-200323100-00007; Bayer, 2012, ACARBOSE SUMMARY PRO; Braun D, 1996, ENDOCRINOL METAB, V3, P275; Burdens ML, 1994, PRACT DIABETES INT, V11, P208, DOI 10.1002/pdi.1960110508; Cais X, 2013, PLOS ONE, V8; Chan JCN, 1998, DIABETES CARE, V21, P1058, DOI 10.2337/diacare.21.7.1058; CONIFF RF, 1995, AM J MED, V98, P443, DOI 10.1016/S0002-9343(99)80343-X; Costa B, 1997, DIABETES RES CLIN PR, V38, P33, DOI 10.1016/S0168-8227(97)00083-1; Esposito K, 2008, J CLIN ENDOCR METAB, V93, P1345, DOI 10.1210/jc.2007-2000; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Halimi S, 2000, DIABETES RES CLIN PR, V50, P49, DOI 10.1016/S0168-8227(00)00163-7; HANEFELD M, 1991, DIABETES CARE, V14, P732, DOI 10.2337/diacare.14.8.732; Hasche H, 1999, DIABETES NUTR METAB, V12, P277; Henry CJK, 2008, BRIT J NUTR, V99, P840, DOI 10.1017/S0007114507831801; HOTTA N, 1993, DIABETIC MED, V10, P134; Hung YJ, 2006, CLIN DRUG INVEST, V26, P559, DOI 10.2165/00044011-200626100-00002; Hus EA, 2012, BMJ-BRIT MED J, V344, pe1454; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, DIABETES ATLAS; International Diabetes Federation, 2011, 2011 GUID MAN POSTM; Jayaram S, 2010, J ASSOC PHYSICIAN I, V58, P687; Jayaram S, 2010, J Assoc Physicians India, V58, P679; John M, 2011, MED HYPOTHESES, V77, P460, DOI 10.1016/j.mehy.2011.06.010; Kalra S, 2013, J Assoc Physicians India, V61, P9; Lams KS, 1998, DIABETES CARE, V21, P1154; Lins BJ, 2003, J DIABETES COMPLICAT, V17, P179; Lis C, 2011, DIABETES RES CLIN PR, V92, P57; Mays C, 1995, DIABETOL STOFFWECHS, V4, P3; Pans CY, 2007, CLIN DRUG INVEST, V27, P397; Patnaik R, 2009, J BIOSCIENCES, V34, P729, DOI 10.1007/s12038-009-0056-9; Phillips P, 2003, DIABETES CARE, V26, P269, DOI 10.2337/diacare.26.2.269; Razs I, 2013, DIABETES CARE, V36, P1779; Rosak Christoph, 2012, Diabetes Metab Syndr Obes, V5, P357, DOI 10.2147/DMSO.S28340; Spengler M, 2005, CLIN DRUG INVEST, V25, P651, DOI 10.2165/00044011-200525100-00004; Sumuals AR, 2003, J ASEAN FED ENDOCRIN, V21, P24; Van de Laars FA, 2005, COCHRANE DB SYST REV, V2; van des Laars FA, 2005, DIABETES CARE, V28, P154; Wang JS, 2011, CLIN THER, V33, P1932, DOI 10.1016/j.clinthera.2011.10.014; Willms B, 1999, DIABETIC MED, V16, P755, DOI 10.1046/j.1464-5491.1999.00149.x; World Health Organization, 2013, DIABETES; Zhus Q, 2013, CLIN THER, V35, P880	68	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-7560			DIABETES-METAB RES	Diabetes-Metab. Res. Rev.	FEB	2015	31	2					155	167		10.1002/dmrr.2576		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CB9RJ	WOS:000349969600005		
J	Morikawa, M; Yamada, T; Akaishi, R; Kojima, T; Nishida, R; Koyama, T; Cho, K; Minakami, H				Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Kojima, Takashi; Nishida, Ryutaro; Koyama, Takahiro; Cho, Kazutoshi; Minakami, Hisanori			Prevalence of hyperglycaemia in singleton versus twin pregnancy	DIABETES-METABOLISM RESEARCH AND REVIEWS			English	Article						glucose metabolism; maternal body mass index; twin pregnancy	GESTATIONAL DIABETES-MELLITUS; GUIDELINES; JAPAN; RISK	BackgroundThere is conflicting information regarding the risk of gestational diabetes mellitus in twin pregnancies. This study was conducted to determine whether the risk of gestational diabetes mellitus is higher in pregnant Japanese women with twin versus singleton pregnancy. MethodsThe prevalence of gestational diabetes mellitus was studied in two different populations: 144589 women registered with the Japan Society of Obstetrics and Gynecology (JSOG cohort) over 3years between 2007 and 2009 in which patient selection bias was unavoidable; and 430 Japanese women who gave birth at a single centre over 5years between 2008 and 2012 (single-centre cohort), consisting of 86 women with twins and 344 women with singletons matched for maternal age and prepregnancy body mass index. The gestational diabetes mellitus was diagnosed on the basis of the previous criteria in the JSOG cohort. The gestational diabetes mellitus was screened in a stepwise method and diagnosed on the basis of the new criteria in the single-centre cohort. ResultsIn the single-centre cohort, neither frequency of random glucose level 105mg/dL in the first trimester [9.0% (31/344) vs 5.8% (5/86)], positive result (140mg/dL) on 50g glucose challenge test in the second trimester [26.5% (90/339) vs 26.7% (23/86)], nor women diagnosed with GDM [8.4% (29/344) vs 9.3% (8/86)] differed between the two groups. The prevalence of hyperglycaemia was higher in singleton than in twin pregnancies in the JSOG cohort (2.6% vs 1.8%, p<0.001). ConclusionsThe risk of gestational diabetes mellitus may be similar between Japanese women with singleton and twin pregnancies. Difference in the risk of hyperglycaemia in the JSOG cohort may have been due to selection bias. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Kojima, Takashi; Nishida, Ryutaro; Koyama, Takahiro; Cho, Kazutoshi; Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Morikawa, M (reprint author), Hokkaido Univ Hosp, Dept Obstet, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	mmamoru@med.hokudai.ac.jp					American College of Obstetricians and Gynecologists, 2004, OBSTET GYNECOL, V56, P869; Sivan E, 2002, OBSTET GYNECOL, V99, P91, DOI 10.1016/S0029-7844(01)01661-1; Minakami H, 1996, JAMA-J AM MED ASSOC, V275, P1432, DOI 10.1001/jama.275.18.1432; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Schwartz DB, 1999, AM J OBSTET GYNECOL, V181, P912, DOI 10.1016/S0002-9378(99)70324-8; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Morikawa M, 2010, DIABETES RES CLIN PR, V90, P339, DOI 10.1016/j.diabres.2010.08.023; Buhling Kai J., 2003, Archives of Gynecology and Obstetrics, V269, P33, DOI 10.1007/s00404-003-0483-z; Morikawa M, 2012, INT J GYNECOL OBSTET, V118, P198, DOI 10.1016/j.ijgo.2012.04.019; Rauh-Hain JA, 2009, J MATERN-FETAL NEO M, V22, P293, DOI 10.1080/14767050802663194; Roach VJ, 1998, AUST NZ J OBSTET GYN, V38, P56, DOI 10.1111/j.1479-828X.1998.tb02958.x; Sapienza AD, 2010, DIABETES RES CLIN PR, V88, P81, DOI 10.1016/j.diabres.2009.12.023; SEOUD MAF, 1992, FERTIL STERIL, V57, P825; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-7560			DIABETES-METAB RES	Diabetes-Metab. Res. Rev.	FEB	2015	31	2					198	203		10.1002/dmrr.2586		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CB9RJ	WOS:000349969600010		
J	Baba, K				Baba, Kurando			Local orbit types of the isotropy representations for semisimple pseudo-Riemannian symmetric spaces	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						Pseudo-Riemannian symmetric space; s-Representation; Local orbit type; Restricted root system; Satake diagram		We list up all the possible local orbit types of hyperbolic or elliptic orbits for the isotropy representations of semisimple pseudo-Riemannian symmetric spaces. Our method to determine the local orbit types is based on the theory of restricted root systems and Satake diagrams associated with the spaces. (C) 2015 Elsevier B.V. All rights reserved.	Fukushima Natl Coll Technol, Dept Gen Educ, Iwaki, Fukushima 9708034, Japan	Baba, K (reprint author), Fukushima Natl Coll Technol, Dept Gen Educ, 30 Nagao, Iwaki, Fukushima 9708034, Japan.	baba@fukushima-nct.ac.jp					OSHIMA T, 1980, INVENT MATH, V57, P1, DOI 10.1007/BF01389818; Tamaru H, 1999, DIFFER GEOM APPL, V11, P29, DOI 10.1016/S0926-2245(99)00023-6; Baba K., 2009, TOKYO J MATH, V32, P127; Baba K., 2008, SUT J MATH, V44, P307; Berger M., 1957, ANN SCI ECOLE NORM S, V74, P85; Boumuki N, 2007, J MATH SOC JPN, V59, P1135, DOI 10.2969/jmsj/05941135; HEINTZE E, 1992, INDIANA U MATH J, V41, P869, DOI 10.1512/iumj.1992.41.41047; Helgason S., 2001, GRADUATE STUDIES MAT; Knapp A., 2002, PROG MATH; Loos O., 1969, SYMMETRIC SPACES 1 G; Oshima T., 1984, ADV STUDIES PURE MAT, V4, P433; ROSSMANN W, 1979, CAN J MATH, V31, P157, DOI 10.4153/CJM-1979-017-6	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	FEB	2015	38						124	150		10.1016/j.difgeo.2014.12.002		27	Mathematics, Applied; Mathematics	Mathematics	CC1HL	WOS:000350091700009		
J	Kondo, H; Naitoh, I; Nakazawa, T; Ohara, H				Kondo, Hiromu; Naitoh, Itaru; Nakazawa, Takahiro; Ohara, Hirotaka			Authors' reply to Comment on "Efficacy of pancreatic stenting prior to extracorporeal shock wave lithotripsy for pancreatic stones" by Hiromu Kondo et al. [Digestive and Liver Disease 2014;46:639-44]	DIGESTIVE AND LIVER DISEASE			English	Letter									[Kondo, Hiromu; Naitoh, Itaru; Nakazawa, Takahiro] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan	Naitoh, I (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan.	inaito@med.nagoya-cu.ac.jp					Inui K, 2005, PANCREAS, V30, P26; Kondo H, 2014, DIGEST LIVER DIS, V46, P639, DOI 10.1016/j.dld.2014.02.017; Li BR, 2014, ENDOSCOPY; Ohara H, 1996, AM J GASTROENTEROL, V91, P1388; Wang D, 2015, DIGEST LIVER DIS, V47, P177, DOI 10.1016/j.dld.2014.10.012; Wang D, 2014, DIGEST LIVER DIS, V46, P639; Ye B, 2013, J INTERVENTIONAL GAS, V3, P141	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	FEB	2015	47	2					178	179		10.1016/j.dld.2014.10.020		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB9RY	WOS:000349971300019		
J	Murase, M; Morisawa, T; Ishida, A				Murase, Masanori; Morisawa, Takeshi; Ishida, Akihito			Serial assessment of right ventricular function using tissue Doppler imaging in preterm infants within 7 days of life	EARLY HUMAN DEVELOPMENT			English	Article						Tissue Doppler imaging; Echocardiography; Right ventricle; Preterm infants	FILLING PRESSURES; GESTATIONAL-AGE; HEART-FAILURE; CHILDREN; OUTPUT; MOTION	Background: We aimed to evaluate right ventricular (RV) function longitudinally using tissue Doppler imaging (TDI) echocardiography in preterm infants. Methods: We selected 101 very-low-birth-weight (VLBW) infants for the study. Echocardiographic examinations including TDI were performed serially within 7 days of life. Pulsed-Doppler TIN waveforms were recorded at the tricuspid valve annulus, and peak systolic velocities (Sa), early diastolic velocities (Ea), and late diastolic velocities (Aa) were measured. Results: Sa, Ea and Aa were all reduced significantly from 3 h to 12 h, and then increased gradually thereafter. These three velocities also increased with gestational age in the early neonatal period. The ratio of Ea to Aa (Ea/Aa) did not change significantly within the first week of life. The ratio of E to Ea (E/Ea) in VLBW infants also seemed to remain stable from birth to day 7. The values of Sa appeared to be associated with cardiac output in the early neonatal period. Both Sa and Aa in intubated infants were significantly higher than in non-intubated infants. Conclusion: RV TDI velocities of preterm infants in the early neonatal period are influenced by gestational age, postnatal age, and respiratory status, although the RV E/Ea ratio appears to be almost stable throughout the neonatal period. Our findings may provide some basis for assessment of RV function in critically ill preterm infants. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Murase, Masanori] Int Univ Hlth & Welf Hosp, Dept Pediat, Nasushiobara, Tochigi 3292763, Japan; [Morisawa, Takeshi] Kakogawa Municipal Hosp, Dept Pediat, Kakogawa, Hyogo, Japan; [Ishida, Akihito] Kobe Childrens First Aid Ctr, Kobe, Hyogo, Japan	Murase, M (reprint author), Int Univ Hlth & Welf Hosp, Dept Pediat, 537-3 Iguchi, Nasushiobara, Tochigi 3292763, Japan.	m-m-mura@ya2.so-net.ne.jp					Altin H, 2012, EARLY HUM DEV, V88, P757, DOI 10.1016/j.earlhumdev.2012.04.003; ALVERSON DC, 1982, J PEDIATR-US, V101, P46, DOI 10.1016/S0022-3476(82)80178-9; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Sundereswaran L, 1998, AM J CARDIOL, V82, P352, DOI 10.1016/S0002-9149(98)00346-4; Yates AR, 2008, J PEDIATR, V152, P766, DOI 10.1016/j.jpeds.2007.11.039; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Meluzin J, 2005, J AM SOC ECHOCARDIOG, V18, P435, DOI 10.1016/j.echo.2005.02.004; Nageh MF, 1999, AM J CARDIOL, V84, P1448, DOI 10.1016/S0002-9149(99)00595-0; Ciccone MM, 2011, EARLY HUM DEV, V87, P555, DOI 10.1016/j.earlhumdev.2011.04.012; Cicala S, 2002, Eur J Echocardiogr, V3, P135, DOI 10.1053/euje.2001.0124; Dokainish H, 2004, CURR OPIN CARDIOL, V19, P437, DOI 10.1097/01.hco.0000131538.55528.8f; Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P213; Figenbaum H, 2005, RIGHT VENTRICLE FEIG, P202; Frommelt PC, 2002, AM J CARDIOL, V89, P610, DOI 10.1016/S0002-9149(01)02308-6; Iwashima S, 2013, EARLY HUM DEV, V89, P687, DOI 10.1016/j.earlhumdev.2013.04.017; Matter M, 2010, PEDIATR CARDIOL, V31, P634, DOI 10.1007/s00246-010-9661-5; Meluzín J, 2003, Eur J Echocardiogr, V4, P262, DOI 10.1016/S1525-2167(02)00171-3; Murase M, 2009, PEDIATR CARDIOL, V30, P928, DOI 10.1007/s00246-009-9464-8; Murase M, 2013, PEDIATR CARDIOL, V34, P1491, DOI 10.1007/s00246-013-0675-7; Murase M, 2002, PEDIATR CARDIOL, V23, P442, DOI 10.1007/s00246-002-1457-9; Negrine RJS, 2012, ARCH DIS CHILD-FETAL, V97, pF304, DOI 10.1136/adc.2009.175109; Pascotto M, 2004, AM J CARDIOL, V94, P1202, DOI 10.1016/j.amjcard.2004.07.098; Patel N, 2008, NEONATOLOGY, V96, P193; Roberson DA, 2007, J AM SOC ECHOCARDIOG, V20, P1276, DOI 10.1016/j.echo.2007.02.023; Rychik J, 2012, FETAL CARDIOVASCULAR, P1; Sekii K, 2012, EARLY HUM DEV, V88, P517, DOI 10.1016/j.earlhumdev.2011.12.014; Wei Y, 2009, PEDIATR CARDIOL, V30, P741, DOI 10.1007/s00246-009-9421-6	28	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	FEB	2015	91	2					125	130		10.1016/j.earlhumdev.2014.12.013		6	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CC1GQ	WOS:000350089600006		
J	Chiba, S; Batten, SD; Yoshiki, T; Sasaki, Y; Sasaoka, K; Sugisaki, H; Ichikawa, T				Chiba, Sanae; Batten, Sonia D.; Yoshiki, Tomoko; Sasaki, Yuka; Sasaoka, Kosei; Sugisaki, Hiroya; Ichikawa, Tadafumi			Temperature and zooplankton size structure: climate control and basin-scale comparison in the North Pacific	ECOLOGY AND EVOLUTION			English	Article						Climate control; continuous plankton recorder; copepod; functional diversity; North Pacific; Pacific decadal oscillation; thermal niche; zooplankton size	SUB-ARCTIC PACIFIC; COPEPOD BIODIVERSITY; WARMER OCEAN; PLANKTON; ECOSYSTEMS; MESOZOOPLANKTON; OSCILLATION; POPULATIONS; BIOMASS; TRAITS	The global distribution of zooplankton community structure is known to follow latitudinal temperature gradients: larger species in cooler, higher latitudinal regions. However, interspecific relationships between temperature and size in zooplankton communities have not been fully examined in terms of temporal variation. To re-examine the relationship on a temporal scale and the effects of climate control thereon, we investigated the variation in copepod size structure in the eastern and western subarctic North Pacific in 2000-2011. This report presents the first basin-scale comparison of zooplankton community changes in the North Pacific based on a fully standardized data set obtained from the Continuous Plankton Recorder (CPR) survey. We found an increase in copepod community size (CCS) after 2006-2007 in the both regions because of the increased dominance of large cold-water species. Sea surface temperature varied in an east-west dipole manner, showing the typical Pacific Decadal Oscillation pattern: cooling in the east and warming in the west after 2006-2007. The observed positive correlation between CCS and sea surface temperature in the western North Pacific was inconsistent with the conventional interspecific temperature-size relationship. We explained this discrepancy by the geographical shift of the upper boundary of the thermal niche, the 9 degrees C isotherm, of large cold-water species. In the eastern North Pacific, the boundary stretched northeast, to cover a large part of the sampling area after 2006-2007. In contrast, in the western North Pacific, the isotherm location hardly changed and the sampling area remained within its thermal niche throughout the study period, despite the warming that occurred. Our study suggests that while a climate-induced basin-scale cool-warm cycle can alter copepod community size and might subsequently impact the functions of the marine ecosystem in the North Pacific, the interspecific temperature-size relationship is not invariant and that understanding region-specific processes linking climate and ecosystem is indispensable.	[Chiba, Sanae; Yoshiki, Tomoko; Sasaoka, Kosei] JAMSTEC, Res & Dev Ctr Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Batten, Sonia D.] Sir Alister Hardy Fdn Ocean Sci, Nanaimo, BC V9V 1N8, Canada; [Sasaki, Yuka] Suidosha Co Ltd, Tama Ku, Kawasaki, Kanagawa 2140038, Japan; [Sugisaki, Hiroya] Fisheries Res Agcy, Nishi Ku, Yokohama, Kanagawa 2206115, Japan; [Ichikawa, Tadafumi] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Chiba, S (reprint author), JAMSTEC, Res & Dev Ctr Global Change, Kanazawa Ku, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	chibas@jamstec.go.jp			consortium for the North Pacific CPR survey; North Pacific Research Board (NPRB); Exxon Valdex Oil Spill Trustee Council; Canadian Department of Fisheries and Oceans; Sir Alister Hardy Foundation for Ocean Science (SAHFOS); JSPS [21241012, 24121007]; JST CREST	This study was supported by a consortium for the North Pacific CPR survey that is coordinated by the North Pacific Marine Science Organization (PICES), and funded by the North Pacific Research Board (NPRB), Exxon Valdex Oil Spill Trustee Council, Canadian Department of Fisheries and Oceans, the Sir Alister Hardy Foundation for Ocean Science (SAHFOS), Grants-in-Aid for Scientific Research (No. 21241012 and 24121007) from JSPS, and JST CREST.	HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Bi HS, 2011, FISH OCEANOGR, V20, P125, DOI 10.1111/j.1365-2419.2011.00573.x; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Hirst AG, 2002, MAR ECOL PROG SER, V230, P195, DOI 10.3354/meps230195; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.poccan.2003.08.004; Chiba S, 2006, GLOBAL CHANGE BIOL, V12, P907, DOI 10.1111/j.1365-2483.2006.01136.x; Chiba S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052912; Greene CH, 2003, PROG OCEANOGR, V58, P301, DOI 10.1016/j.pocean.2003.08.009; Beaugrand G, 2010, P NATL ACAD SCI USA, V107, P10120, DOI 10.1073/pnas.0913855107; Kobari T, 2003, PROG OCEANOGR, V57, P279, DOI 10.1016/S0079-6611(03)00102-2; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Edwards M, 2010, TRENDS ECOL EVOL, V25, P602, DOI 10.1016/j.tree.2010.07.007; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Chiba S, 2008, PROG OCEANOGR, V77, P112, DOI 10.1016/j.pocean.2008.03.004; Alcaraz M, 2014, J PLANKTON RES, V36, P3, DOI 10.1093/plankt/fbt111; Racault MF, 2014, J PLANKTON RES, V36, P621, DOI 10.1093/plankt/fbu016; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Mackas DL, 2007, PROG OCEANOGR, V75, P223, DOI 10.1016/j.pocean.2007.08.010; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Barton AD, 2013, ECOL LETT, V16, P522, DOI 10.1111/ele.12063; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Batten SD, 2006, DEEP-SEA RES PT II, V53, P270, DOI 10.1016/j.dsr2.2006.01.004; Batten SD, 2007, FISH OCEANOGR, V16, P536, DOI 10.1111/j.1365-2419.2007.00448.x; Beaugrand G., 2000, GLOBAL CHANGE BIOL, V16, P1268; Chiba S., 2012, NPAFC TECH REP, V8, P19; Chihara M., 1997, ILLUSTRATED GUIDE MA; DisLorenzo E., 2014, OCEANOGRAPHY, V26, P68; DisLorenzo E, 2008, GEOPHYS RES LETT, V35, DOI DOI 10.1029/2007GL032838; Harrison PJ, 2004, J OCEANOGR, V60, P93, DOI 10.1023/B:JOCE.0000038321.57391.2a; IPCC, 2013, CLIM CHANG 2013 PHYS; Miller AJ, 1994, OCEANOGRAPHY, V7, P21, DOI DOI 10.5670/0CEAN0G.1994.11; Miller JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099814; Robinson K. V., 2014, CONTINUOUS PLANKTON; San Martin E, 2006, DEEP SEA RES 2, V53, P1560, DOI [10.1016/j.dsr.2.2006.05.006, DOI 10.1016/J.DSR2.2006.05.006]; Sasaoka K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048299; Tadokoro K, 2005, FISH OCEANOGR, V14, P210, DOI 10.1111/j.1365-2419.2005.00333.x	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	FEB	2015	5	4					968	978		10.1002/ece3.1408		11	Ecology	Environmental Sciences & Ecology	CB8RJ	WOS:000349898100013		
J	Okumura, Y				Okumura, Yasunori			Existence of free entry equilibrium in aggregative games with asymmetric agents	ECONOMICS LETTERS			English	Article						Entry; Aggregative games; Cournot; Constructive proof	COMPARATIVE STATICS; COURNOT EQUILIBRIUM	In this paper, we examine a free entry aggregative game where agents can be asymmetric. We show the existence of a pure strategy subgame perfect equilibrium of this game. The proof is a constructive one and therefore we provide a method to derive a subgame perfect equilibrium within a reasonable time. (C) 2014 Elsevier B.V. All rights reserved.	Hannan Univ, Fac Econ, Matsubara, Osaka 5808502, Japan	Okumura, Y (reprint author), Hannan Univ, Fac Econ, 5-4-33 Amami Higashi, Matsubara, Osaka 5808502, Japan.	okuyasu@gs.econ.keio.ac.jp					Acemoglu D, 2013, GAME ECON BEHAV, V81, P27, DOI 10.1016/j.geb.2013.03.009; Jensen MK, 2010, ECON THEOR, V43, P45, DOI 10.1007/s00199-008-0419-8; SUZUMURA K, 1987, REV ECON STUD, V54, P157, DOI 10.2307/2297451; CORCHON LC, 1994, MATH SOC SCI, V28, P151, DOI 10.1016/0165-4896(94)90001-9; Corchon LC, 2002, MATH SOC SCI, V44, P155; Cornes R, 2012, ECON LETT, V116, P631, DOI 10.1016/j.econlet.2012.06.024; LAFFONT JJ, 1983, ECONOMETRICA, V51, P455, DOI 10.2307/1912000; Lopez-Cunat J., 1999, INVEST ECON-SPAIN, V23, P115; MANKIW NG, 1986, RAND J ECON, V17, P48, DOI 10.2307/2555627; NOVSHEK W, 1980, REV ECON STUD, V47, P473, DOI 10.2307/2297299; Vives X, 2001, OLIGOPOLY PRICING OL	11	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	FEB	2015	127						14	16		10.1016/j.econlet.2014.12.018		3	Economics	Business & Economics	CC1IM	WOS:000350094400004		
J	Mino, K				Mino, Kazuo			A simple model of endogenous growth with financial frictions and firm heterogeneity	ECONOMICS LETTERS			English	Article						Financial frictions; Firm heterogeneity; Endogenous growth; Wealth distribution	PRODUCTIVITY	This paper constructs a simple model of endogenous growth with financial frictions and firm heterogeneity. In the presence of financial constraints and heterogeneity in production efficiency of firms, the firms whose efficiency exceeds the cutoff level produce and the entrepreneurs who own those firms become borrowers. We show that even if production technology of each firm has an Ak property, the aggregate economy has transition dynamics and that the balanced growth rate depends on the aggregate distribution of wealth between rentiers and entrepreneurs. (C) 2015 Published by Elsevier B.V.	Kyoto Univ, Inst Econ Res, Sakyo Ku, Kyoto 6068501, Japan	Mino, K (reprint author), Kyoto Univ, Inst Econ Res, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	mino@kier.kyoto-u.ac.jp			JSPS Kakenhi Project [23530220]; JSPS [230001]	This paper is based on a part of our research financially supported by JSPS Kakenhi Project (No. 23530220), as well by JSPS Grand-in-Aid Specially Promoted Research Project (No. 230001).	Liu Z, 2014, AM ECON J-MACROECON, V6, P32, DOI 10.1257/mac.6.1.32; Miao JJ, 2012, AM ECON REV, V102, P82, DOI 10.1257/aer.102.3.82; Chen B. -L., 2014, EQUILIBRIUM DY UNPUB; Itskhoki O., 2014, OPTIMAL DEV PO UNPUB; Jaimovich N., 2012, 18473 NBER; Moll B, 2014, AM ECON REV, V104, P3186, DOI 10.1257/aer.104.10.3186; Quadrini Vincenzo, 2011, EC Q, V97, P209	7	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	FEB	2015	127						20	23		10.1016/j.econlet.2014.12.022		4	Economics	Business & Economics	CC1IM	WOS:000350094400006		
J	Nakamura, T				Nakamura, Tomoya			One-leader and multiple-follower Stackelberg games with private information	ECONOMICS LETTERS			English	Article						Stackelberg competition; Cournot competition; First and second mover advantages; Public and private information	MOVER DISADVANTAGES; SOCIAL VALUE	This study analyzes one-leader and multiple-follower Stackelberg games with demand uncertainty. We demonstrate that the weight on public information regarding a follower's estimation of demand uncertainty determines the strategic relationship between the leader and each follower. When the relationship is strategic complement, the leader can exit from a market. The threshold is determined by the intensity of Cournot competition among the followers. (C) 2014 Elsevier B.V. All rights reserved.	Osaka Univ, ISER, Osaka 5670047, Japan	Nakamura, T (reprint author), Osaka Univ, ISER, 6-1 Mihogaoka, Osaka 5670047, Japan.	nakamura@iser.osaka-u.ac.jp					Angeletos GM, 2007, ECONOMETRICA, V75, P1103, DOI 10.1111/j.1468-0262.2007.00783.x; Morris S, 2002, AM ECON REV, V92, P1521, DOI 10.1257/000282802762024610; Shinkai T, 2000, J ECON THEORY, V90, P293, DOI 10.1006/jeth.1999.2608; Cumbul E., 2014, WORKING PAPER; GALOR E, 1987, REV ECON STUD, V54, P279, DOI 10.2307/2297517; Ui T., 2013, WORKING PAPER	6	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	FEB	2015	127						27	30		10.1016/j.econlet.2014.12.010		4	Economics	Business & Economics	CC1IM	WOS:000350094400008		
J	Greene, W; McKenzie, C				Greene, William; McKenzie, Colin			An LM test based on generalized residuals for random effects in a nonlinear model	ECONOMICS LETTERS			English	Article						LM test; Panel data; Probit; Random effects	SPECIFICATION	We obtain an LM test for the random effects probit model. In the natural parameterization of the model the necessary derivatives are identically zero under the null hypothesis. After a reparameterization, the feasible LM test is based on generalized residuals. (C) 2014 Elsevier B.V. All rights reserved.	[Greene, William] NYU, New York, NY 10012 USA; [McKenzie, Colin] Keio Univ, Tokyo 108, Japan	Greene, W (reprint author), NYU, Stern Sch Business, 44 West 4 St, New York, NY 10012 USA.	wgreene@stern.nyu.edu			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors thank Debopam Bhattacharya for helpful comments on an earlier version of this paper. The second author acknowledges the financial support of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities entitled 'Globalization and the Building of a High Quality Economic System.'	Andrews DWK, 2001, ECONOMETRICA, V69, P683, DOI 10.1111/1468-0262.00210; BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111; BUTLER JS, 1982, ECONOMETRICA, V50, P761, DOI 10.2307/1912613; GOURIEROUX C, 1987, J ECONOMETRICS, V34, P5, DOI 10.1016/0304-4076(87)90065-0; Arulampalam W, 1999, OXFORD B ECON STAT, V61, P597, DOI 10.1111/1468-0084.00146; CHESHER A, 1987, J ECONOMETRICS, V34, P33, DOI 10.1016/0304-4076(87)90066-2; CHESHER A, 1984, ECONOMETRICA, V52, P865, DOI 10.2307/1911188; Hinkley D.V., 1974, THEORETICAL STAT; Kiefer N. M., 1982, 278 CORN U DEP EC; LEE LF, 1986, J ECONOMETRICS, V31, P121, DOI 10.1016/0304-4076(86)90045-X; Riphahn RT, 2003, J APPL ECONOM, V18, P387, DOI 10.1002/jae.680	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	FEB	2015	127						47	50		10.1016/j.econlet.2014.12.031		4	Economics	Business & Economics	CC1IM	WOS:000350094400013		
J	Hiraguchi, R; Kobayashi, K				Hiraguchi, Ryoji; Kobayashi, Keiichiro			Multiplicity of monetary steady states	ECONOMICS LETTERS			English	Article						Multiple equilibria; Search; Bargaining	MONEY	We investigate a monetary model in which the centralized market opens once, but the decentralized markets open twice in each period. We show that there may be multiple stationary equilibria. (C) 2015 Elsevier B.V. All rights reserved.	[Hiraguchi, Ryoji] Chiba Univ, Fac Law & Econ, Inage Ku, Chiba, Japan; [Kobayashi, Keiichiro] Keio Univ, Fac Econ, Minato Ku, Tokyo, Japan	Hiraguchi, R (reprint author), Chiba Univ, Fac Law & Econ, Inage Ku, 1-33 Yayoi Cho, Chiba, Japan.	ryojih@chiba-u.jp; kobayasi@econ.keio.ac.jp					Berentsen A, 2005, INT ECON REV, V46, P465, DOI 10.1111/j.1468-2354.2005.00329.x; Ennis HM, 2009, INT ECON REV, V50, P607, DOI 10.1111/j.1468-2354.2009.00542.x; Lagos R, 2005, J POLIT ECON, V113, P463, DOI 10.1086/429804; Lagos R, 2003, J ECON THEORY, V109, P156, DOI 10.1016/S0022-0531(03)00021-8; Wright R, 2010, J ECON THEORY, V145, P382, DOI 10.1016/j.jet.2009.11.004	5	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	FEB	2015	127						93	96		10.1016/j.econlet.2014.12.036		4	Economics	Business & Economics	CC1IM	WOS:000350094400025		
J	Elnozahy, A; Rahman, AKA; Ali, AHH; Abdel-Salam, M; Ookawara, S				Elnozahy, Ahmed; Rahman, Ali K. Abdel; Ali, Ahmed Hamza H.; Abdel-Salam, Mazen; Ookawara, S.			Performance of a PV module integrated with standalone building in hot arid areas as enhanced by surface cooling and cleaning	ENERGY AND BUILDINGS			English	Article						Automatic cooling and cleaning system; Control circuit; PV module; Film of water; Bernoulli equation	SOLAR COLLECTORS; PHOTOVOLTAIC PANELS; SYSTEM; DESIGN; WATER; FLOW; EFFICIENCY; FRONT; CELLS	This study investigated experimentally the performance due to automatic cooling and surface cleaning of Photovoltaic (PV) module installed on the roof of a building in hot arid area as compared with that of a module without cooling and cleaning. The module cooling is controlled automatically according to the rear side temperature via rejection of none-converted solar-energy to the ambient to keep the PV module surface temperature always close to the ambient temperature. In addition, this system controls the cleaning period of the module front surface. The results showed a decrease of about 45.5% and 39% in module temperature at front and rear faces, respectively. Consequently, the cooled and surface cleaned module has an efficiency of 11.7% against 9% for the module without cooling and cleaning. Moreover, the maximum output power produced by cooled and cleaned module is 89.4W against 68.4W for non-cooled and non-cleaned module. (C) 2014 Elsevier B.V. All rights reserved.	[Elnozahy, Ahmed; Rahman, Ali K. Abdel] Egypt Japan Univ Sci & Technol E JUST, Dept Energy Recourses Engn, Alexandria 21934, Egypt; [Ali, Ahmed Hamza H.] Egypt Japan Univ Sci & Technol E JUST, Ctr Res Excellence Energy Resources & Management, Alexandria 21934, Egypt; [Abdel-Salam, Mazen] Assiut Univ, Dept Elect Engn, Assiut, Egypt; [Ookawara, S.] Tokyo Inst Technol, Tokyo 152, Japan	Elnozahy, A (reprint author), Egypt Japan Univ Sci & Technol E JUST, Dept Energy Recourses Engn, POB 179, Alexandria 21934, Egypt.	ahmed.elnozahy@ejust.edu.eg; ali.kamel@ejust.edu.eg; drahmedhamza@yahoo.com; Mazen2000as@yahoo.com; sokawara@chemeng.titech.ac.jp		Ali, Prof. Dr. Ahmed Hamza H./0000-0002-8734-6762	Mission department of the Ministry of Higher Education (MoHE) of Egypt	The first two authors would like to acknowledge the Mission department of the Ministry of Higher Education (MoHE) of Egypt for providing a scholarship to conduct this study as well as the Egypt - Japan University of Science and Technology (E-JUST) for offering the facility, tools and equipment needed to conduct this research work.	Amori KE, 2012, APPL ENERG, V98, P384, DOI 10.1016/j.apenergy.2012.03.061; Ibrahim A, 2011, RENEW SUST ENERG REV, V15, P352, DOI 10.1016/j.rser.2010.09.024; Abdolzadeh M, 2009, RENEW ENERG, V34, P91, DOI 10.1016/j.renene.2008.03.024; Alami AH, 2014, ENERG CONVERS MANAGE, V77, P668, DOI 10.1016/j.enconman.2013.10.019; Touafek K, 2014, ENERG CONVERS MANAGE, V80, P71, DOI 10.1016/j.enconman.2014.01.021; Teo HG, 2012, APPL ENERG, V90, P309, DOI 10.1016/j.apenergy.2011.01.017; Tonui JK, 2008, SOL ENERGY, V82, P1, DOI 10.1016/j.solener.2007.06.004; Chandrasekar M, 2013, ENERG CONVERS MANAGE, V71, P43, DOI 10.1016/j.enconman.2013.03.012; Tagliafico LA, 2014, RENEW SUST ENERG REV, V30, P526, DOI 10.1016/j.rser.2013.10.023; Herrando M, 2014, APPL ENERG, V122, P288, DOI 10.1016/j.apenergy.2014.01.061; Valeh-e-Sheyda P, 2013, ENERG CONVERS MANAGE, V69, P122, DOI 10.1016/j.enconman.2013.01.029; Shan F, 2014, RENEW SUST ENERG REV, V33, P467, DOI 10.1016/j.rser.2014.02.018; Bahaidarah H, 2013, ENERGY, V59, P445, DOI 10.1016/j.energy.2013.07.050; Yin HM, 2013, SOL ENERGY, V87, P184, DOI 10.1016/j.solener.2012.10.022; Zhang XX, 2013, SOL ENERGY, V97, P551, DOI 10.1016/j.solener.2013.09.022; Verma LK, 2011, RENEW ENERG, V36, P2489, DOI 10.1016/j.renene.2011.02.017; Chandrasekar M, 2015, ENERG BUILDINGS, V86, P692, DOI 10.1016/j.enbuild.2014.10.071; Gang P., 2012, ENERG CONVERS MANAGE, V56, P8; Garcia-Heller V, 2014, RENEW SUST ENERG REV, V34, P8, DOI 10.1016/j.rser.2014.02.037; Hussain F, 2013, RENEW SUST ENERG REV, V25, P431, DOI 10.1016/j.rser.2013.04.014; Kordzadeh A, 2010, RENEW ENERG, V35, P1098, DOI 10.1016/j.renene.2009.10.024; Krauter S, 2004, SOL ENERG MAT SOL C, V82, P131, DOI 10.1016/j.solmat.2004.01.011; Mei L, 2006, RENEW ENERG, V31, P1265, DOI 10.1016/j.renene.2005.06.013; Munson B. R., 2009, FUNDAMENTALS FLUID M; Rossi C, 2013, ENERG CONVERS MANAGE, V76, P634, DOI 10.1016/j.enconman.2013.07.088; Serageldin A., 2013, INT C REN EN RES APP, P674	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0378-7788	1872-6178		ENERG BUILDINGS	Energy Build.	FEB 1	2015	88						100	109		10.1016/j.enbuild.2014.12.012		10	Construction & Building Technology; Energy & Fuels; Engineering, Civil	Construction & Building Technology; Energy & Fuels; Engineering	CB6JA	WOS:000349732100010		
J	Ihara, T; Grynning, S; Gao, T; Gustavsen, A; Jelle, BP				Ihara, Takeshi; Grynning, Steinar; Gao, Tao; Gustavsen, Arild; Jelle, Bjorn Petter			Impact of convection on thermal performance of aerogel granulate glazing systems	ENERGY AND BUILDINGS			English	Article						Window; Aerogel glazing; Aerogel granular cavity; Convection; U-value; Hot box	SILICA AEROGEL; WINDOWS	Among currently available window systems, aerogel granulate glazing systems are considered promising for achieving good thermal and visual comfort in buildings. In aerogel granulate glazing systems, it is important to evaluate how convection in the granular-filled cavity affects their thermal performance because double glazing systems, which have a similar structure, show variable thermal properties related to the convection effect. In this study, it is shown that the granular-filled cavity hardly influences the air permeance, and therefore, convection can occur in such cavities. Nevertheless, a mock-up of commercially available aerogel granulate window shows practically identical window U-values in hot box measurement with various tilt angles. In other words, convection in the granular cavity does not affect the thermal performance of aerogel granulate glazing systems. The center-of-glass U-values are 0.28 and 0.69 W/(m(2) K) for aerogel thickness of 60 and 30 mm, respectively. The total window U-values (using a wood frame) are 0.69 and 0.84 W/(m(2) K) for aerogel thickness of 60 and 30 mm, respectively. Furthermore, the granular aerogel in the cavity subsided by similar to 3% of its total volume after the hot box measurement. The risks posed by this subsidence under actual conditions should be assessed in later research. (C) 2014 Elsevier B.V. All rights reserved.	[Ihara, Takeshi; Grynning, Steinar; Gao, Tao; Gustavsen, Arild] Norwegian Univ Sci & Technol NTNU, Dept Architectural Design Hist & Technol, NO-7491 Trondheim, Norway; [Ihara, Takeshi] Takenaka Res & Dev Inst, Chiba 2701395, Japan; [Jelle, Bjorn Petter] Norwegian Univ Sci & Technol NTNU, Dept Civil & Transport Engn, NO-7491 Trondheim, Norway; [Grynning, Steinar; Jelle, Bjorn Petter] SINTEF Bldg & Infrastruct, Dept Mat & Struct, NO-7465 Trondheim, Norway	Ihara, T (reprint author), Norwegian Univ Sci & Technol NTNU, Dept Architectural Design Hist & Technol, NO-7491 Trondheim, Norway.	ihara.takeshi@takenaka.co.jp			Takenaka Corporation of Japan; Research Council of Norway; Lian Trevarefabrikk; Lawrence Berkeley National Laboratory (LBNL) through the NTNU; Lawrence Berkeley National Laboratory (LBNL) through SINTEF research project "Improved Window Technologies for Energy Efficient Buildings" (EffWin)	This work has been funded by the Takenaka Corporation of Japan. In addition, this work has been supported by the Research Council of Norway, Lian Trevarefabrikk, and Lawrence Berkeley National Laboratory (LBNL) through the NTNU and SINTEF research project "Improved Window Technologies for Energy Efficient Buildings" (EffWin).	Alnaief M, 2010, J NON-CRYST SOLIDS, V356, P1644, DOI 10.1016/j.jnoncrysol.2010.06.027; Reim M, 2002, SOL ENERGY, V72, P21, DOI 10.1016/S0038-092X(01)00086-X; [Anonymous], 2013, 125712013E ISO; Duer K, 1998, SOL ENERGY, V63, P259, DOI 10.1016/S0038-092X(98)00063-2; [Anonymous], 2000, 121142000 EN; [Anonymous], 2010, 1256712010E ISO; Stahl T, 2012, ENERG BUILDINGS, V44, P114, DOI 10.1016/j.enbuild.2011.09.041; Cuce E, 2014, RENEW SUST ENERG REV, V34, P273, DOI 10.1016/j.rser.2014.03.017; [Anonymous], WUFI PRO 5; Jelle BP, 2012, SOL ENERG MAT SOL C, V96, P1, DOI 10.1016/j.solmat.2011.08.010; Jensen KI, 2004, J NON-CRYST SOLIDS, V350, P351, DOI 10.1016/j.jnoncrysol.2004.06.047; [Anonymous], 2007, 104562007E ISO; Bhagat SD, 2008, SOLID STATE SCI, V10, P1113, DOI 10.1016/j.solidstatesciences.2007.11.016; [Anonymous], 1995, 92371995E ISO; [Anonymous], 2003, 150992003E ISO; Gustavsen A, 2011, ENERG BUILDINGS, V43, P2583, DOI 10.1016/j.enbuild.2011.05.010; [Anonymous], E96E96M13 ASTM; Baetens R, 2011, ENERG BUILDINGS, V43, P761, DOI 10.1016/j.enbuild.2010.12.012; [Anonymous], WINDOW VERS 7 1 32 0; Gao T, 2014, APPL ENERG, V128, P27, DOI 10.1016/j.apenergy.2014.04.037; WITTWER V, 1992, J NON-CRYST SOLIDS, V145, P233, DOI 10.1016/S0022-3093(05)80462-4; Gao T, 2013, ACS APPL MATER INTER, V5, P761, DOI 10.1021/am302303b; Barnyakov AY, 2009, NUCL INSTRUM METH A, V598, P166, DOI 10.1016/j.nima.2008.08.089; BATTY WJ, 1984, APPL ENERG, V18, P143, DOI 10.1016/0306-2619(84)90051-5; Brendeng E., 1980, INT J REFRIG, V3, P317, DOI 10.1016/0140-7007(80)90121-8; Buratti C., 2014, APPL ENERG, V97, P430; International Organization for Standardization, 1994, 89901994E ISO; Jelle B. P., 2014, INT J STRUCT ANAL DE, V1, P43; JENNINGS SG, 1988, J AEROSOL SCI, V19, P159, DOI 10.1016/0021-8502(88)90219-4; Mukhopadhyaya P., 2011, J ASTM INT, V8; Sandberg LIC, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/483651	31	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0378-7788	1872-6178		ENERG BUILDINGS	Energy Build.	FEB 1	2015	88						165	173		10.1016/j.enbuild.2014.12.001		9	Construction & Building Technology; Energy & Fuels; Engineering, Civil	Construction & Building Technology; Energy & Fuels; Engineering	CB6JA	WOS:000349732100016		
J	Kato, H				Kato, Hayato			The importance of government commitment in attracting firms: A dynamic analysis of tax competition in an agglomeration economy	EUROPEAN ECONOMIC REVIEW			English	Article						Economic geography; Tax competition; Differential games; Commitment; Forward-looking behavior	CORE-PERIPHERY MODEL; EXPECTATIONS; GEOGRAPHY; INTEGRATION; CAPACITY; HISTORY; STATES; TRADE	Agglomeration tendencies of industrial firms significantly affect the nature of tax competition. This paper analyzes tax competition between two countries over an infinite time horizon in an economy with trade costs and internationally mobile industrial firms. Most of the previous studies on tax competition in the 'new economic geography' framework employ static models. In this study, two governments dynamically compete with each other to attract firms through their choices of taxes and subsidies. It is shown that the commitment of the governments to their policies is crucial in determining the distribution of firms in the long run. Specifically, if governments find each others' tax policies credible, then one country will attract all the firms when trade costs are low enough to make agglomeration forces dominant. If policies are not credible, both countries may attract an equal share of firms even when trade costs are low, as the lack of commitment by governments acts as a dispersion force. (C) 2014 Elsevier B.V. All rights reserved.	Hitotsubashi Univ, Grad Sch Econ, Kunitachi, Tokyo 1868601, Japan	Kato, H (reprint author), Hitotsubashi Univ, Grad Sch Econ, Naka 2-1, Kunitachi, Tokyo 1868601, Japan.	hayato.kato2@gmail.com			 [13J03694]	I am grateful to the editor, Theo S. Eicher, and two anonymous referees for their careful and helpful comments. I deeply acknowledge Jota Ishikawa and Taiji Furusawa for their invaluable advice and continuous encouragement. I am also indebted to Daisuke Oyama whose suggestions greatly improved the analysis. Thanks are also due to Naohito Abe, Richard Baldwin, Shota Fujishima, John Gilbert, Hideshi ltoh, Gang Li, Jim Markusen, Kiminori Matsuyama, Toshihiro Okubo, Tetsuya Saito, Etsuro Shioji, E. Young Song, Yoichi Sugita, and seminar and meeting participants at Hitotsubashi University, Otaru University of Commerce, University of Toyama, Sogang University and Toyo University for their helpful comments. Advice on academic writing from Philip MacLellan was extremely useful. All remaining errors are mine. Financial support from Grant-in-Aid for JSPS Fellows (Grant No. 13J03694) is gratefully acknowledged.	Andersson F., 2003, J PUBLIC ECON THEORY, V5, P279, DOI 10.1111/1467-9779.00133; Haufler A, 2010, J INT ECON, V80, P239, DOI 10.1016/j.jinteco.2009.10.002; Janeba E, 2000, AM ECON REV, V90, P1508, DOI 10.1257/aer.90.5.1508; Ottaviano G, 2002, INT ECON REV, V43, P409; Forslid R, 2003, J ECON GEOGR, V3, P229, DOI 10.1093/jeg/3.3.229; Baldwin RE, 2004, EUR ECON REV, V48, P1, DOI 10.1016/S0014-2921(02)00318-5; HARTL RF, 1995, SIAM REV, V37, P181, DOI 10.1137/1037043; Baldwin R., 2003, EC GEOGRAPHY PUBLIC; Baldwin RE, 2001, REG SCI URBAN ECON, V31, P21, DOI 10.1016/S0166-0462(00)00068-5; Baldwin RE, 2014, SPAT ECON ANAL, V9, P309, DOI 10.1080/17421772.2014.930164; Borck R, 2006, EUR ECON REV, V50, P647, DOI 10.1016/j.euroecorev.2005.01.006; Brulhart M, 2012, ECON J, V122, P1069, DOI 10.1111/j.1468-0297.2012.02511.x; Charlot S, 2007, J ECON GEOGR, V7, P247, DOI 10.1093/jeg/lbm016; Coulibaly S., 2008, EMPIRICAL ASSESSMENT; Department of Finance of Ireland, 2013, IR INT TAX STRAT; Dockner E. J., 2000, DIFFERENTIAL GAMES E; Fujita M, 2013, EC AGGLOMERATION CIT; Han YT, 2014, J PUBLIC ECON, V119, P71, DOI 10.1016/j.jpubeco.2014.07.008; Keen M., 2012, THEORY INT TAX COMPE; Kenny LW, 2006, INT TAX PUBLIC FINAN, V13, P181, DOI 10.1007/s10797-006-3564-7; Kind H.J., 2000, J PUB EC, V78, P253; KRUGMAN P, 1991, Q J ECON, V106, P651, DOI 10.2307/2937950; Ludema RD, 2000, J INT ECON, V52, P331, DOI 10.1016/S0022-1996(99)00050-1; Markusen J. R., 2002, REV INT ECON, V10, P694, DOI 10.1111/1467-9396.00359; MATSUYAMA K, 1991, Q J ECON, V106, P617, DOI 10.2307/2937949; Mitchell D.J., 2009, EC TAX COMPETITION H; Ottaviano GIP, 2001, REG SCI URBAN ECON, V31, P51, DOI 10.1016/S0166-0462(00)00072-7; Ottaviano GIP, 2005, J INT ECON, V67, P25, DOI 10.1016/j.jinteco.2004.08.010; Oyama D, 2009, J ECON DYN CONTROL, V33, P394, DOI 10.1016/j.jedc.2008.06.007; Oyama D, 2009, REG SCI URBAN ECON, V39, P696, DOI 10.1016/j.regsciurbeco.2009.07.001; REYNOLDS SS, 1987, INT ECON REV, V28, P69, DOI 10.2307/2526860; ROTEMBERG JJ, 1982, J POLIT ECON, V90, P1187, DOI 10.1086/261117; Stewart J., 2011, 375 TRIN COLL DUBL I; Summers Lawrence H., 1981, BROOKINGS PAPERS EC, V12, P67; Thisse JF, 2010, J REGIONAL SCI, V50, P281, DOI 10.1111/j.1467-9787.2009.00651.x	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2921	1873-572X		EUR ECON REV	Eur. Econ. Rev.	FEB	2015	74						57	78		10.1016/j.euroecorev.2014.11.008		22	Economics	Business & Economics	CC1GJ	WOS:000350088900004		
J	Vogl, C; Tanifuji, S; Danis, B; Daniels, V; Foerch, P; Wolff, C; Whalley, BJ; Mochida, S; Stephens, GJ				Vogl, Christian; Tanifuji, Shota; Danis, Benedicte; Daniels, Veronique; Foerch, Patrik; Wolff, Christian; Whalley, Benjamin J.; Mochida, Sumiko; Stephens, Gary J.			Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						Cav2.2; cholinergic; rat; synaptic transmission	NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; PRESYNAPTIC CALCIUM; SECRETORY VESICLES; GANGLION NEURONS; SYNPRINT SITE; CA2+ CHANNELS; BINDING-SITE; PROTEINS SV2; SYNAPTOTAGMIN	Synaptic vesicle glycoprotein (SV)2A is a transmembrane protein found in secretory vesicles and is critical for Ca2+-dependent exocytosis in central neurons, although its mechanism of action remains uncertain. Previous studies have proposed, variously, a role of SV2 in the maintenance and formation of the readily releasable pool (RRP) or in the regulation of Ca2+ responsiveness of primed vesicles. Such previous studies have typically used genetic approaches to ablate SV2 levels; here, we used a strategy involving small interference RNA (siRNA) injection to knockdown solely presynaptic SV2A levels in rat superior cervical ganglion (SCG) neuron synapses. Moreover, we investigated the effects of SV2A knockdown on voltage-dependent Ca2+ channel (VDCC) function in SCG neurons. Thus, we extended the studies of SV2A mechanisms by investigating the effects on vesicular transmitter release and VDCC function in peripheral sympathetic neurons. We first demonstrated an siRNA-mediated SV2A knockdown. We showed that this SV2A knockdown markedly affected presynaptic function, causing an attenuated RRP size, increased paired-pulse depression and delayed RRP recovery after stimulus-dependent depletion. We further demonstrated that the SV2A-siRNA-mediated effects on vesicular release were accompanied by a reduction in VDCC current density in isolated SCG neurons. Together, our data showed that SV2A is required for correct transmitter release at sympathetic neurons. Mechanistically, we demonstrated that presynaptic SV2A: (i) acted to direct normal synaptic transmission by maintaining RRP size, (ii) had a facilitatory role in recovery from synaptic depression, and that (iii) SV2A deficits were associated with aberrant Ca2+ current density, which may contribute to the secretory phenotype in sympathetic peripheral neurons.	[Vogl, Christian; Whalley, Benjamin J.; Stephens, Gary J.] Univ Reading, Sch Pharm, Reading, Berks, England; [Tanifuji, Shota; Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Danis, Benedicte; Daniels, Veronique; Foerch, Patrik; Wolff, Christian] UCB Pharma SA, UCB Ctr CNS Innovat, Braine Lalleud, Belgium	Stephens, GJ (reprint author), Univ Reading, Sch Pharm, Reading, Berks, England.	g.j.stephens@reading.ac.uk	Whalley, Ben/C-4808-2009		Japan Society for Promotion of Science	The authors would like to thank Dr James Foster, Dr Giovanna Bucci, Camille Soubrane and Michinori Mori for excellent technical support. Part of this work was supported by a Japan Society for Promotion of Science award to C.V.	Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Vogl C, 2012, MOL PHARMACOL, V82, P199, DOI 10.1124/mol.111.076687; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; FEANY MB, 1993, J CELL BIOL, V123, P575, DOI 10.1083/jcb.123.3.575; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Gillard M, 2006, EUR J PHARMACOL, V536, P102, DOI 10.1016/j.ejphar.2006.02.022; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Tanifuji S, 2013, J BIOL CHEM, V288, P19050, DOI 10.1074/jbc.M112.445874; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Bucci G, 2011, J PHYSIOL-LONDON, V589, P3085, DOI 10.1113/jphysiol.2010.204735; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Schivell AE, 1996, J BIOL CHEM, V271, P27770; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Crevecoeur J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-87; Daniels V, 2013, BRIT J PHARMACOL, V169, P1091, DOI 10.1111/bph.12192; desKok J. B., 2000, CLIN CHEM, V46, P313; DesSmedt T., 2007, CNS DRUG REV, V13, P43; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; IACOVITTI L, 1981, J NEUROSCI, V1, P685; Iezzi Mariella, 2005, J Cell Sci, V118, P5647, DOI 10.1242/jcs.02658; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Ma H, 2009, J NEUROSCI, V29, P13019, DOI 10.1523/JNEUROSCI.2517-09.2009; Mendoza-Torreblanca JG, 2013, EUR J NEUROSCI, V38, P3529, DOI 10.1111/ejn.12360; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mori M, 2014, MOL PHARMACOL, V86, P297, DOI 10.1124/mol.114.094029; Nowack A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029560; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Stephens GJ, 2005, J PHYSIOL-LONDON, V563, P765, DOI 10.1103/jphysiol.2004.080192; Venkatesan K, 2012, J NEUROSCI RES, V90, P2317, DOI 10.1002/jnr.23111; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	52	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2015	41	4					398	409		10.1111/ejn.12799		12	Neurosciences	Neurosciences & Neurology	CC0UW	WOS:000350054000001		
J	Ishikawa, J; Nishimura, R; Ishikawa, A				Ishikawa, Junko; Nishimura, Ryoichi; Ishikawa, Akinori			Early-life stress induces anxiety-like behaviors and activity imbalances in the medial prefrontal cortex and amygdala in adult rats	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						development; emotion; limbic; trauma	DEPRESSIVE-LIKE BEHAVIOR; C-FOS EXPRESSION; BORDERLINE PERSONALITY-DISORDER; VOLUNTARY RUNNING EXERCISE; DORSAL RAPHE NUCLEUS; SOCIAL-ISOLATION; CHILDHOOD TRAUMA; NEUROCIRCUITRY MODELS; INTERCALATED NEURONS; BASOLATERAL AMYGDALA	Early-life stress increases the prevalence of psychiatric diseases associated with emotional dysregulation. Emotional regulation requires the inhibitory influence of the medial prefrontal cortex (mPFC) on amygdalar activity, and dysfunction of this system is believed to induce anxiety. Because mPFC and amygdala have dense reciprocal connections and projections between them continue to develop until adolescence, early-life stress may impair the function of this circuit and cause emotional dysregulation. We examined the effects of stress during circuit development on anxiety-like behaviors, neural activities in the mPFC and amygdala, and impulse transmission in the mPFC-amygdala circuit in adult rats. Early-life stress, unpredictable stress twice a day for 12days following early weaning, increased anxiety-like behaviors in the open-field and elevated plus-maze tests. In the open-field test, stress altered Fos expression in the mPFC and amygdala. Compared to non-stressed rats, which were exposed to neither unpredictable stress nor early weaning, stressed rats exhibited decreased Fos expression in the right superficial layers of the infralimbic cortex and increased Fos expression in the right basolateral amygdala and both sides of the central amygdala. Electrophysiological analysis revealed that excitatory latencies of mPFC neurons to amygdalar stimulation in stressed rats were significantly longer than control rats in the right, but not left, hemisphere. Stress had no effect on excitatory latencies of amygdalar neurons to mPFC stimulation in the mPFC-amygdala circuits in the both hemisphere. These data suggest that early-life stress impairs the mPFC-amygdala circuit development, resulting in imbalanced mPFC and amygdala activities and anxiety-like behaviors.	[Ishikawa, Junko; Nishimura, Ryoichi; Ishikawa, Akinori] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Ube, Yamaguchi 7558505, Japan	Ishikawa, J (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Neurosci, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	junko-lc@yamaguchi-u.ac.jp			Kakenhi [22700415]; Yamaguchi University Foundation	This work was supported by Kakenhi (22700415) and the Yamaguchi University Foundation.	Andersen SL, 1999, NEUROREPORT, V10, P3497, DOI 10.1097/00001756-199911260-00006; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Cressman VL, 2010, J COMP NEUROL, V518, P2693, DOI 10.1002/cne.22359; Sullivan RM, 1999, J NEUROSCI, V19, P2834; Quirk GJ, 2003, J NEUROSCI, V23, P8800; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Sullivan RM, 2002, BRAIN RES, V927, P69, DOI 10.1016/S0006-8993(01)03328-5; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Draijer N, 1999, AM J PSYCHIAT, V156, P379; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Mauchnik J, 2010, CURR PSYCHIAT REP, V12, P46, DOI 10.1007/s11920-009-0089-7; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Naqvi F, 2012, PHARMACOL REP, V64, P64; Wang YC, 2012, BRAIN STRUCT FUNCT, V217, P337, DOI 10.1007/s00429-011-0355-4; Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Baker KB, 2004, BEHAV NEUROSCI, V118, P15, DOI 10.1037/0735-7044.118.1.15; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Wall VL, 2012, PHYSIOL BEHAV, V107, P440, DOI 10.1016/j.physbeh.2012.09.002; Ito A, 2006, BEHAV BRAIN RES, V171, P87, DOI 10.1016/j.bbr.2006.03.023; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Mc Fie S, 2012, BRAIN RES, V1467, P91, DOI 10.1016/j.brainres.2012.05.047; Perez-Cruz C, 2009, EUR J NEUROSCI, V29, P738, DOI 10.1111/j.1460-9568.2009.06622.x; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; MCDONALD AJ, 1987, J COMP NEUROL, V262, P46, DOI 10.1002/cne.902620105; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb,2007.11.004; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Vicentic A, 2006, NEUROSCIENCE, V140, P355, DOI 10.1016/j.neuroscience.2006.02.008; Avital A, 2006, BRAIN RES BULL, V68, P419, DOI 10.1016/j.brainresbull.2005.09.015; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Kumar V, 2013, J PHARMACOL TOX MET, V68, P175, DOI 10.1016/j.vascn.2013.05.003; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Sun JD, 2012, NEUROPSYCHOPHARMACOL, V37, P1305, DOI 10.1038/npp.2011.319; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Luo XM, 2014, PHYSIOL BEHAV, V135, P7, DOI 10.1016/j.physbeh.2014.05.035; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Cooke BM, 2000, BEHAV BRAIN RES, V117, P107, DOI 10.1016/S0166-4328(00)00301-6; Bouwmeester H, 2002, J COMP NEUROL, V450, P241, DOI 10.1002/cne.10321; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Corral-Frias NS, 2013, NEUROPSYCHOPHARMACOL, V38, P350, DOI 10.1038/npp.2012.189; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Tsoory M, 2008, NEUROPSYCHOPHARMACOL, V33, P378, DOI 10.1038/sj.npp.1301397; Patki G, 2014, PHYSIOL BEHAV, V130, P47, DOI 10.1016/j.physbeh.2014.03.016; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Bienkowski MS, 2013, BRAIN STRUCT FUNCT, V218, P187, DOI 10.1007/s00429-012-0393-6; Cai L, 2010, EUR NEUROPSYCHOPHARM, V20, P839, DOI 10.1016/j.euroneuro.2010.06.019; Fraga MC, 2014, PHYSIOL BEHAV, V124, P100, DOI 10.1016/j.physbeh.2013.11.001; Gaszner B, 2012, NEUROSCIENCE, V202, P283, DOI 10.1016/j.neuroscience.2011.11.046; Gomes VD, 2013, BEHAV BRAIN RES, V257, P39, DOI 10.1016/j.bbr.2013.09.028; Hale MW, 2008, NEUROSCIENCE, V157, P733, DOI 10.1016/j.neuroscience.2008.09.050; Hu H, 2010, NEUROSCIENCE, V169, P171, DOI 10.1016/j.neuroscience.2010.04.057; Hubert G. W., 2013, BRAIN STRUCT FUNCT, V219, P1169; Ishikawa A, 2005, EUR J NEUROSCI, V22, P1713, DOI 10.1111/j.1460-9568.2005.04332.x; Ishikawa J, 2014, BEHAV BRAIN RES, V264, P197, DOI 10.1016/j.bbr.2014.02.007; Ishikawa J, 2013, NEUROSCIENCE, V230, P31, DOI 10.1016/j.neuroscience.2012.11.020; Kikusui T, 2009, PSYCHONEUROENDOCRINO, V34, P762, DOI 10.1016/j.psyneuen.2008.12.009; Li YN, 2013, J MOL NEUROSCI, V51, P127, DOI [10.1007/s12031-013-9965-z, 10.1007/s1203-013-9965-z]; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; Lkhagvasuren B, 2014, NEUROSCIENCE, V272, P34, DOI 10.1016/j.neuroscience.2014.04.047; Matsuzaki H, 2009, EUR J PHARMACOL, V615, P76, DOI 10.1016/j.ejphar.2009.05.012; Nakamura K, 2008, BEHAV BRAIN RES, V187, P442, DOI 10.1016/j.bbr.2007.10.002; NAKAMURA S, 1991, PROG BRAIN RES, V88, P587; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Pechlivanova D, 2010, BEHAV BRAIN RES, V209, P205, DOI 10.1016/j.bbr.2010.01.037; Perez-Cruz Claudia, 2007, Neural Plast, V2007, P46276, DOI 10.1155/2007/46276; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Schmahl C, 2006, J PSYCHIAT RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008	78	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2015	41	4					442	453		10.1111/ejn.12825		12	Neurosciences	Neurosciences & Neurology	CC0UW	WOS:000350054000005		
J	Nakauchi, Y; Yamazaki, S; Napier, SC; Usui, J; Ota, Y; Takahashi, S; Watanabe, N; Nakauchi, H				Nakauchi, Yusuke; Yamazaki, Satoshi; Napier, Stephanie C.; Usui, Jo-ichi; Ota, Yasunori; Takahashi, Satoshi; Watanabe, Nobukazu; Nakauchi, Hiromitsu			Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model	EXPERIMENTAL HEMATOLOGY			English	Article							STEM-CELL TRANSPLANTATION; ACUTE GVHD; CANCER; BLOOD; MICE; ALEMTUZUMAB; RECIPIENTS; DEPLETION; LEUKEMIA; FAILURE	Graft-versus-host disease (GYM)), mediated by donor-derived alloreactive T cells, is a major cause of nonrelapse mortality in allogeneic hematopoietic stem cell transplantation. Its therapy is not well-defined. We established allele-specific anti-human leukocyte antigen (HLA) monoclonal antibodies (ASHmAbs) that specifically target HLA molecules, with steady death of target-expressing cells. One such ASHmAb, against HLA-A*02:01 (A2-kASHmAb), was examined in a xenogeneic GVHD mouse model. To induce fatal GVHD, non-irradiated NOD/Shi-scid/IL-2R gamma(null) mice were injected with healthy donor human peripheral blood mononuclear cells, some expressing HLA-A*02:01, some not. Administration of A2-kASHmAb promoted the survival of mice injected with HLA-A*02:01-expressing peripheral blood mononuclear cells (p < 0.0001) and, in humanized NOD/Shi-scid/IL-2 gamma(null) mice, immediately cleared HLA-A*02:01-expressing human blood cells from mouse peripheral blood. Human peripheral blood mononuclear cells were again detectable in mouse blood 2 to 4 weeks after A2-kASHmAb administration, suggesting that kASHmAb may be safely administered to GVHD patients without permanently ablating the graft. This approach, different from those in existing GVHD pharmacotherapy, may open a new door for treatment of GVHD in HLA-mismatched allogeneic hematopoietic stem cell transplantation. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nakauchi, Yusuke; Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Napier, Stephanie C.; Watanabe, Nobukazu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Div Stem Cell Therapy,Lab Diagnost Med, Tokyo, Japan; [Usui, Jo-ichi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Nephrol, Ibaraki, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pathol, Tokyo, Japan; [Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan; [Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Yamazaki, S (reprint author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	y-sato4@ims.u-tokyo.ac.jp					Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Gerber HP, 2013, NAT PROD REP, V30, P625, DOI 10.1039/c3np20113a; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Nishimori H, 2012, BLOOD, V119, P285, DOI 10.1182/blood-2011-01-332478; del Campo AB, 2012, TISSUE ANTIGENS, V79, P147, DOI 10.1111/j.1399-0039.2011.01831.x; Martinez C, 2009, BIOL BLOOD MARROW TR, V15, P639, DOI 10.1016/j.bbmt.2009.01.014; Kanda Y, 2013, AM J HEMATOL, V88, P294, DOI 10.1002/ajh.23392; Takanashi M, 2010, BLOOD, V116, P2839, DOI 10.1182/blood-2009-10-249219; Hod E, 2008, BRIT J HAEMATOL, V142, P348, DOI 10.1111/j.1365-2141.2008.07189.x; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; Loupy A, 2012, NAT REV NEPHROL, V8, P348, DOI 10.1038/nrneph.2012.81; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Ho VT, 2001, BLOOD, V98, P3192, DOI 10.1182/blood.V98.12.3192; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Storb R, 2013, J CLIN ONCOL, V31, P1530, DOI 10.1200/JCO.2012.45.0247; Warren EH, 2013, TISSUE ANTIGENS, V81, P183, DOI 10.1111/tan.12090; CHATENOUD L, 1984, IMMUNOL TODAY, V5, P20, DOI 10.1016/0167-5699(84)90061-6; Ikuya Tsuge SK, 1995, CURR THER RES, V56, P671; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Jorgensen KA, 2003, SCAND J IMMUNOL, V57, P93, DOI 10.1046/j.1365-3083.2003.01221.x; KARAKI S, 1993, IMMUNOGENETICS, V37, P139; Knop S, 2007, LEUKEMIA, V21, P1830, DOI 10.1038/sj.leu.2404731; Mueller TF, 2007, TRANSPLANTATION, V84, pS5, DOI 10.1097/01.tp.0000295420.49063.b1; Sabir HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054366; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Storb R, 2012, NATURE, V491, P334, DOI 10.1038/491334a; Taniguchi K, 2012, BONE MARROW TRANSPL, V47, P1338, DOI 10.1038/bmt.2012.28; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Watanabe N, 2008, BIOL BLOOD MARROW TR, V14, P693, DOI 10.1016/j.bbmt.2008.04.001; Yamazaki S, 2009, J IMMUNOL METHODS, V343, P56, DOI 10.1016/j.jim.2009.01.007; Zachary AA, 2010, IMMUNOL RES, V47, P232, DOI 10.1007/s12026-009-8154-1	37	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	FEB	2015	43	2					79	88		10.1016/j.exphem.2014.10.008		10	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CC0FB	WOS:000350010100002		
J	Miyoshi, H; Morita, M; Ohshima, N; Sato, C				Miyoshi, Hirotoshi; Morita, Misa; Ohshima, Norio; Sato, Chiaki			Expansion of mouse hematopoietic progenitor cells in three-dimensional cocultures on frozen-thawed stromal cell layers formed within porous scaffolds	EXPERIMENTAL HEMATOLOGY			English	Article							LONG-TERM CULTURE; FETAL LIVER-CELLS; BONE-MARROW; EX-VIVO; STEM-CELLS; STEM/PROGENITOR CELLS; MESONEPHROS REGION; POTENT SUPPORTERS; MATRIX SUPPORT; MITOMYCIN-C	To establish a highly efficient method of ex vivo expansion of hematopoietic cells (HCs), three-dimensional (3D) cocultures of HCs and stromal cell lines were performed using porous polymer scaffolds. Hematopoietic cells derived from mouse fetal livers were expanded by two successive cultures without the use of exogenous cytokines, namely, 3D cultures of stromal cells (DAS 104-8 cell line) to form stromal layers within the scaffolds, and, subsequently, by cocultures of the HCs on the stromal cell layers for 2 weeks. To expand the HCs more conveniently, in some experiments the stromal layers formed within the scaffolds were frozen (3D freezing) before the cocultures, then stored and applied to the cocultures after thawing. When the HCs were cocultured on the stromal layers of the DAS 104-8 cells, primitive HCs (c-kit and CD34(+) cells) were expanded several fold during the cocultures. In contrast, the expansion of these primitive HCs was remarkably enhanced in the cocultures using the 3D frozen-thawed DAS 104-8 stromal layers (c-kit cells > fifteenfold and CD34(+) cells > thirtyfold), and these expansions were significantly higher than those without the 3D freezing. The expansions enhanced by cocultures on the 3D frozen-thawed stromal layers were also observed in the cocultures with another stromal cell line (DAS 104-4). Because 3D frozen-thawed stromal cell lines are easy to handle, 3D coculture of HCs on frozen-thawed stromal cell lines may be an effective and convenient method for expanding primitive HCs. Copyright (C) 2015 ISEH International Society for Experimental Hematology. Published by Elsevier Inc.	[Miyoshi, Hirotoshi; Morita, Misa; Ohshima, Norio; Sato, Chiaki] Univ Tsukuba, Fac Med, Dept Biomed Engn, Tsukuba, Ibaraki 3058575, Japan	Miyoshi, H (reprint author), Univ Tsukuba, Fac Med, Dept Biomed Engn, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hmiyoshi@md.tsukuba.ac.jp			Japan Society for the Promotion of Science [24500526]	We thank Prof. Osamu Ohneda (Faculty of Medicine, University of Tsukuba) for providing DAS 104-8 and DAS 104-4 stromal cell lines. We thank Ms. Flaminia Miyamasu (Medical English Communications Center, University of Tsukuba) for her editorial assistance. This work was supported by a Grant-in-Aid for Scientific Research (no. 24500526) from the Japan Society for the Promotion of Science.	Miyoshi H, 2000, ASAIO J, V46, P397, DOI 10.1097/00002480-200007000-00005; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Yang TH, 2001, J BIOMED MATER RES, V55, P379, DOI 10.1002/1097-4636(20010605)55:3<379::AID-JBM1026>3.0.CO;2-Z; Weisel KC, 2006, EXP HEMATOL, V34, P1505, DOI 10.1016/j.exphem.2006.06.013; Roy A, 2001, J HEMATOTH STEM CELL, V10, P873, DOI 10.1089/152581601317210962; Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002; Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829; Taichman RS, 1996, BLOOD, V87, P518; Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029; WANG TY, 1995, EXP HEMATOL, V23, P26; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; da Silva CL, 2005, EXP HEMATOL, V33, P828, DOI 10.1016/j.exphem.2005.03.017; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI 10.1089/ten.TEB.2009.0270; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Ponchio L, 2000, CYTOTHERAPY, V2, P281, DOI 10.1080/146532400539215; Miyoshi H, 2011, J TISSUE ENG REGEN M, V5, P112, DOI 10.1002/term.295; Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8; Ehashi T, 2005, J CELL PHYSIOL, V202, P698, DOI 10.1002/jcp.20167; KOLLER MR, 1992, BLOOD, V80, P403; MIYOSHI H, 1994, BIOTECHNOL BIOENG, V43, P635, DOI 10.1002/bit.260430713; Miyoshi H, 2013, J TISSUE ENG REGEN M, V7, P32, DOI 10.1002/term.493; Miyoshi H, 2010, ARTIF ORGANS, V34, P609, DOI 10.1111/j.1525-1594.2009.00933.x; Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohneda O, 1998, BLOOD, V92, P908; Panoskaltsis N, 2005, J BIOSCI BIOENG, V100, P28, DOI 10.1263/jbb.100.28; Rosenzweig M, 1997, GENE THER, V4, P928, DOI 10.1038/sj.gt.3300480; Tiwari A, 2013, J TISSUE ENG REGEN M, V7, P871, DOI 10.1002/term.1479; Tun T, 2002, ARTIF ORGANS, V26, P333, DOI 10.1046/j.1525-1594.2002.06842.x; Tun T, 2000, ASAIO J, V46, P522, DOI 10.1097/00002480-200009000-00002; VERFAILLIE CM, 1993, BLOOD, V82, P2045	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	FEB	2015	43	2					115	124		10.1016/j.exphem.2014.08.008		10	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CC0FB	WOS:000350010100006		
J	Tanizaki, Y; Ishida-Iwata, T; Obuchi-Shimoji, M; Kato, T				Tanizaki, Yuta; Ishida-Iwata, Takako; Obuchi-Shimoji, Miyako; Kato, Takashi			Cellular characterization of thrombocytes in Xenopus laevis with specific monoclonal antibodies	EXPERIMENTAL HEMATOLOGY			English	Article							CONNECTED CANALICULAR SYSTEM; CHICKEN THROMBOCYTES; PLATELET-RELEASE; LOW-TEMPERATURE; RAINBOW-TROUT; CFU-MK; C-MPL; THROMBOPOIETIN; MEGAKARYOCYTES; RECEPTOR	Platelets are produced from megakaryocytes (MKs) in the bone marrow. In contrast, most nonmammalian vertebrates have nucleated and spindle-shaped thrombocytes instead of platelets in their circulatory systems, and the presence of MKs as thrombocyte progenitors has not been verified. In developing a new animal model in adult African clawed frog (Xenopus laevis), we needed to distinguish nucleated thrombocytes and their progenitors from other blood cells, because the cellular morphology of activated thrombocytes resembles lymphocytes and other cells. We initially generated two monoclonal antibodies, T5 and T12, to X. laevis thrombocytes. Whereas T5 recognized both thrombocytes and leukocytes, T12 specifically reacted to spindle-shaped thrombocytes. The T12(+) thrombocytes displayed much higher DNA ploidy than nucleated erythrocytes, and they expressed CD41 and Fli-1. In the presence of CaCl2, adenosine diphosphate, thrombin, or various collagens, T12(+) thrombocytes exhibited aggregation. These thrombocytes were located predominantly in the hepatic sinusoids and the splenic red pulp, suggesting that both organs are the sites of thrombopoiesis. Notably, circulating thrombocytes exhibited lower DNA ploidy than hepatic thrombocytes. Intraperitoneal administration of T12 produced immune thrombocytopenia in frogs, which reached a nadir 4 days postinjection, followed by recovery, suggesting that humoral regulation maintained the number of circulating thrombocytes. Although differences between MKs and thrombocytes in X. laevis remain to be defined, our results provide further insight into MK development and thrombopoiesis in vertebrates. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Tanizaki, Yuta; Kato, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1628480, Japan; [Tanizaki, Yuta] Japan Soc Promot Sci, Tokyo, Japan; [Ishida-Iwata, Takako; Obuchi-Shimoji, Miyako; Kato, Takashi] Waseda Univ, Dept Biol Educ & Integrated Arts & Sci, Tokyo 1628480, Japan	Kato, T (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan.	tkato@waseda.jp			Japan Society for the Promotion of Science [244479]; KAKENHI [20570063, 26440171]; Waseda University [2005B-077, 2007B-061, 2011B-047, 2012B-045, 2013B-056]; Japanese Ministry of Education, Culture, Sports, Science, and Technology [07H016]; MEXT	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 244479), KAKENHI Grants-in-Aid for Scientific Research (No. 20570063 and 26440171), and from Waseda University grants for special research projects (No. 2005B-077, 2007B-061, 2011B-047, 2012B-045 and 2013B-056). Part of this study was performed as a component of a Private University High-Tech Research Center project supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (07H016). Part of this study was performed as a MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; Oda A, 1996, BLOOD, V87, P4664; Okui T, 2013, CELL TISSUE RES, V353, P153, DOI 10.1007/s00441-013-1624-8; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Rombout JHWM, 1996, J FISH BIOL, V49, P521; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Tahara T, 1996, BRIT J HAEMATOL, V93, P783, DOI 10.1046/j.1365-2141.1996.d01-1741.x; Nogawa-Kosaka N, 2011, J EXP BIOL, V214, P921, DOI 10.1242/jeb.050286; Bartunek P, 2008, EXP HEMATOL, V36, P495, DOI 10.1016/j.exphem.2007.12.001; Schwertz H, 2010, BLOOD, V115, P3801, DOI 10.1182/blood-2009-08-239558; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Nogawa-Kosaka N, 2010, EXP HEMATOL, V38, P363, DOI 10.1016/j.exphem.2010.02.009; KAUFMAN RM, 1965, BLOOD-J HEMATOL, V26, P720; Brass LF, 2005, J CLIN INVEST, V115, P3329, DOI 10.1172/JCI27111; WOODWARD JJ, 1981, COMP BIOCHEM PHYS A, V68, P457, DOI 10.1016/0300-9629(81)90076-1; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; Work TM, 1998, AM J VET RES, V59, P1252; Aizawa Y, 2005, J BIOCHEM, V138, P167, DOI 10.1093/jb/mvi113; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kato T, 1998, STEM CELLS, V16, P322; Horiuchi H, 2004, J VET MED SCI, V66, P243, DOI 10.1292/jvms.66.243; KATO T, 1995, J BIOCHEM-TOKYO, V118, P229; Maekawa S, 2012, J EXP BIOL, V215, P3087, DOI 10.1242/jeb.072488; LACOSTEELEAUME AS, 1994, EXP CELL RES, V213, P198, DOI 10.1006/excr.1994.1191; JACKSON CW, 1973, BLOOD, V42, P413; HADJIAZIMI I, 1987, DEV COMP IMMUNOL, V11, P807, DOI 10.1016/0145-305X(87)90068-1; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; Boyle JJ, 2012, AM J PATHOL, V181, P347, DOI 10.1016/j.ajpath.2012.03.040; DAIMON T, 1978, J ANAT, V125, P11; DAIMON T, 1979, CELL TISSUE RES, V203, P355; DAIMON T, 1979, CELL TISSUE RES, V201, P431; Fischer U, 2001, CELL DEATH DIFFER, V8, P1143; Hone K, 1997, EXP HEMATOL, V25, P169; Horb M, 2014, 2014 XENOPUS COMMUNI; INOUE H, 1993, BRIT J HAEMATOL, V85, P260, DOI 10.1111/j.1365-2141.1993.tb03165.x; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Kakeda M, 2002, DEV GROWTH DIFFER, V44, P63; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219; MIYAZAKI H, 1995, EXP HEMATOL, V23, P1224; MIYAZAKI H, 1992, EXP HEMATOL, V20, P855; Moroi M, 1997, THROMB HAEMOSTASIS, V78, P439; Nagasawa K, 2013, BIOL OPEN, V2, P1057, DOI 10.1242/bio.20136106; Passer BJ, 1997, EXP CELL RES, V234, P347, DOI 10.1006/excr.1997.3611; Robinson MSC, 1998, BRIT J HAEMATOL, V100, P351; SLIERENDRECHT WJ, 1995, VET IMMUNOL IMMUNOP, V46, P349, DOI 10.1016/0165-2427(94)05362-V; SPORNITZ UM, 1975, ANAT EMBRYOL, V146, P245, DOI 10.1007/BF00302173; Thattaliyath B, 2005, BLOOD, V106, P118, DOI 10.1182/blood-2004-10-4118; TRANUMJENSEN J, 1981, EUR J CELL BIOL, V24, P275; ZAJICEK J, 1954, J HISTOCHEM CYTOCHEM, V2, P115; Zucker-Franklin D, 1996, Stem Cells, V14 Suppl 1, P1; ZuckerFranklin D, 1996, BLOOD, V88, P1632	54	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	FEB	2015	43	2					125	136		10.1016/j.exphem.2014.10.005		12	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CC0FB	WOS:000350010100007		
J	Kagomiya, I; Kaneko, S; Kakimoto, K; Park, K; Cho, KH				Kagomiya, I.; Kaneko, S.; Kakimoto, K.; Park, K.; Cho, K. H.			Fabrication and Power Densities of Anode-Supported Solid Oxide Fuel Cells with Different Ni-YSZ Anode Functional Layer Thicknesses	FUEL CELLS			English	Article						Activation Polarization Resistance; Anode Functional Layer; Anode-Supported Solid Oxide Fuel Cells; Concentration Polarization Resistance; Power Density; Warpage	ELECTROLYTE; SOFC; TEMPERATURE; INTERLAYER; CATHODE	We investigated an appropriate preparation condition for anode-supported SOFCs: (La,Sr)MnO3/cathode functional layer/YSZ/Ni-YSZ were fabricated with and without a Ni-YSZ anode functional layer (AFL) via the tape-casting method, where the AFL thicknesses were controlled from approximately 20 to 80 mm. The warpage depended on the co-sintering temperature of the electrolyte/AFL/anode-support half-cells, indicating that similar shrinkage of the electrolyte/AFL/anode support is significant for lower warpages. The electrical properties of SOFCs with AFLs were compared to those of SOFCs without AFLs. In this regard, the use of an AFL decreased the ohmic and activation polarization resistances due to both the decrease in contact resistance between the electrolyte and the AFL and the increase in three-phase boundaries. However, the polarization diffusion increased when an AFL was employed, because AFL layers are denser than the anode support. The maximum power densities of samples with AFL were higher than those of SOFCs without AFLs, indicating that the decrease in both ohmic and activation-polarization resistances is more significant for improving the power densities, as compared to the concentration polarization resistance.	[Kagomiya, I.; Kaneko, S.; Kakimoto, K.] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan; [Park, K.] Sejong Univ, Fac Nanotechnol & Adv Mat Engn, Seoul 143747, South Korea; [Cho, K. H.] Samchun Pure Chem Co, R&D Ctr, Pyeongtaek Si 4403, Gyeonggi Do, South Korea	Kagomiya, I (reprint author), Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kagomiya@nitech.ac.jp			Korea Association of Industry, Academy and Research Institute (KAIARI)	We thank the staff members of the Instrument and Research Technology Center of the Nagoya Institute of Technology for the EPMA characterization. This study was partially supported by the Korea Association of Industry, Academy and Research Institute (KAIARI).	Wagner N, 1998, ELECTROCHIM ACTA, V43, P3785, DOI 10.1016/S0013-4686(98)00138-8; Leng YJ, 2004, SOLID STATE IONICS, V170, P9, DOI 10.1016/j.ssi.2004.02.026; Mai A, 2005, SOLID STATE IONICS, V176, P1341, DOI 10.1016/j.ssi.2005.03.009; Perednis D, 2004, SOLID STATE IONICS, V166, P229, DOI 10.1016/j.ssi.2003.11.011; Jin C, 2010, J MEMBRANE SCI, V363, P250, DOI 10.1016/j.memsci.2010.07.044; [Anonymous], R2203 JIS; Leng YJ, 2003, J POWER SOURCES, V117, P26, DOI 10.1016/S0378-7753(03)00350-1; Nguyen TL, 2004, SOLID STATE IONICS, V174, P163, DOI 10.1016/j.ssi.2004.06.017; Koide H, 2000, SOLID STATE IONICS, V132, P253, DOI 10.1016/S0167-2738(00)00652-4; Hassan AAE, 2002, ADV ENG MATER, V4, P125, DOI 10.1002/1527-2648(200203)4:3<125::AID-ADEM125>3.3.CO;2-4; Kim SD, 2007, J POWER SOURCES, V169, P265, DOI 10.1016/j.jpowsour.2007.03.046; Menzler NH, 2014, FUEL CELLS, V14, P96, DOI 10.1002/fuce.201300153; Muccillo R, 2006, J POWER SOURCES, V156, P455, DOI 10.1016/j.jpowsour.2005.06.021; Wang ZR, 2007, J ALLOY COMPD, V437, P264, DOI 10.1016/j.jallcom.2006.07.110; Wu W, 2014, FUEL CELLS, V14, P171, DOI 10.1002/fuce.201300158; Yang SQ, 2013, INT J ELECTROCHEM SC, V8, P2330	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	FEB	2015	15	1					90	97		10.1002/fuce.201400138		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CB9RS	WOS:000349970700009		
J	Wu, S; Yamada, M; Tamaribuchi, K; Beck, JL				Wu, S.; Yamada, M.; Tamaribuchi, K.; Beck, J. L.			Multi-events earthquake early warning algorithm using a Bayesian approach	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Earthquake interaction, forecasting, and prediction; Seismic attenuation; Early warning	SYSTEM; IDENTIFICATION	Current earthquake early warning (EEW) systems lack the ability to appropriately handle multiple concurrent earthquakes, which led to many false alarms during the 2011 Tohoku earthquake sequence in Japan. This paper uses a Bayesian probabilistic approach to handle multiple concurrent events for EEW. We implement the theory using a two-step algorithm. First, an efficient approximate Bayesian model class selection scheme is used to estimate the number of concurrent events. Then, the Rao-Blackwellized Importance Sampling method with a sequential proposal probability density function is used to estimate the earthquake parameters, that is hypocentre location, origin time, magnitude and local seismic intensity. A real data example based on 2 months data (2011 March 9-April 30) around the time of the 2011 M9 Tohoku earthquake is studied to verify the proposed algorithm. Our algorithm results in over 90 per cent reduction in the number of incorrect warnings compared to the existing EEW system operating in Japan.	[Wu, S.; Beck, J. L.] CALTECH, Pasadena, CA 91125 USA; [Yamada, M.] Kyoto Univ, Disaster Prevent Res Inst, Uji 611, Japan; [Tamaribuchi, K.] Japan Meteorol Agcy, Tokyo, Japan	Wu, S (reprint author), CALTECH, Pasadena, CA 91125 USA.	stewu@caltech.edu			funding program for Next Generation World-Leading Researchers in Japan	We would like to thank the Japan Meteorological Agency and NIED for providing the seismic waveform data during the period of 2011 M9 Tohoku earthquake. This research was supported by the funding program for Next Generation World-Leading Researchers in Japan.	Horiuchi S, 2005, B SEISMOL SOC AM, V95, P708, DOI 10.1785/0120030133; Beck JL, 2010, STRUCT CONTROL HLTH, V17, P825, DOI 10.1002/stc.424; Satriano C, 2008, B SEISMOL SOC AM, V98, P1482, DOI 10.1785/0120060159; ALLEN RV, 1978, B SEISMOL SOC AM, V68, P1521; Zollo A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036689; Hoshiba M, 2011, EARTH PLANETS SPACE, V63, P547, DOI 10.5047/eps.2011.05.031; Kamigaichi O, 2009, SEISMOL RES LETT, V80, P717, DOI 10.1785/gssrl.80.5.717; Satriano C, 2011, SOIL DYN EARTHQ ENG, V31, P137, DOI 10.1016/j.soildyn.2010.06.008; Earthquake Early Warning (EEW), 2014, EARTHQ EARL WARN HIS; Hoshiba M, 2008, EOS T AGU, V89, P73, DOI DOI 10.1029/2008E0080001; Japan Meteorological Agency (JMA), 2013, 4 EARTHQ EARL WARN M; Japan Meteorological Agency (JMA), 2012, 4 EARTHQ EARL WARN M; Japan Meteorological Agency (JMA), 2005, EARTHQ EARL WARN ACC; Japan Meteorological Agency (JMA), 2013, EARTHQ EARL WARN REP; Japan Meteorological Agency (JMA), 2010, 2 EARTHQ EARL WARN M; Kamigaichi O, 2004, J JAPAN ASS EARTHQUA, V4, P134; Katsumata A., 2008, Q J SEISMOL, V71, P89; Liu A, 2014, B SEISMOL SOC AM, V104, P1111, DOI 10.1785/0120130208; Liu J. S., 2002, MONTE CARLO STRATEGI; National Research Institute for Earth Science and Disaster Prevention (NIED), 2014, JMA EARTHQ CAT; NEWTON NJ, 1994, SIAM J APPL MATH, V54, P1780, DOI 10.1137/S0036139992236220; Shiomi K., 2005, ZISIN 2, V57, P451; Si H., 2000, P 12 WORLD C EARTHQ; Tamaribuchi K., 2014, ZISIN2, V67, P41; Ueno H., 2002, Q J SEISMOL, V65, P123; Yamada M., 2012, P JPGU ANN M SAN FRA; Yamada M., 2014, J JPN ASS EARTHQ ENG, V14, P21	27	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	FEB	2015	200	2					789	806		10.1093/gji/ggu437		18	Geochemistry & Geophysics	Geochemistry & Geophysics	CC0RC	WOS:000350042400007		
J	Tanaka, S; Kawakatsu, H; Obayashi, M; Chen, YJ; Ning, JY; Grand, SP; Niu, FL; Ni, J				Tanaka, Satoru; Kawakatsu, Hitoshi; Obayashi, Masayuki; Chen, Y. John; Ning, Jieyuan; Grand, Stephen P.; Niu, Fenglin; Ni, James			Rapid lateral variation of P-wave velocity at the base of the mantle near the edge of the Large-Low Shear Velocity Province beneath the western Pacific	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Composition of the mantle; Body waves; Pacific Ocean	DOUBLE-ARRAY STACKING; LOWERMOST MANTLE; DEEP MANTLE; EARTHS MANTLE; SOUTHWESTERN PACIFIC; SEISMOLOGICAL CONSTRAINTS; SEISMIC TOMOGRAPHY; PARTIAL MELT; TRAVEL-TIME; D''-LAYER	We examine P-wave velocity structure at the base of the mantle beneath the western Pacific, near the western edge of the Pacific Large-Low Shear Velocity Province (LLSVP), using high-quality seismograms provided by a large-scale mobile broad-band seismic observation in northeastern China (the NECESSArray project). Forward modelling using the reflectivity method is conducted to explain the variation of P-wave traveltimes as a function of epicentral distance near the core shadow zone. Additionally, PcP-P traveltimes are examined to enlarge the survey area. As a result, a rapid variation of P-wave velocity is detected at the base of the mantle. Regions of thin (20-50 km thick) and low velocity (-2 to -5 per cent) layers at the base of the mantle are intersected by an 80-km-thick region with a high velocity (+2 per cent). A slightly fast region exists at the northwest of the region with the thin low-velocity layer. These layers are typically separated by several hundred kilometres and would be difficult to explain by thermal effects alone. These observations suggest that very complicated thermochemical reactions occur near the edge of the Pacific LLSVP.	[Tanaka, Satoru; Obayashi, Masayuki] Japan Agcy Marine Earth Sci & Technol, Dept Deep Earth Struct & Dynam Res, Yokosuka, Kanagawa 2370061, Japan; [Kawakatsu, Hitoshi] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Chen, Y. John; Ning, Jieyuan] Peking Univ, Sch Earth & Space Sci, Inst Theoret & Appl Geophys, Beijing 100871, Peoples R China; [Grand, Stephen P.] Univ Texas Austin, Dept Geol Sci, Austin, TX USA; [Niu, Fenglin] Rice Univ, Dept Earth Sci, Houston, TX USA; [Ni, James] New Mexico State Univ, Dept Phys, Las Cruces, NM 88003 USA	Tanaka, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Deep Earth Struct & Dynam Res, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	stan@jamstec.go.jp	Grand, Stephen/B-4238-2011		NSFC from China [40821062]; NSF from United States [EAR-0635666, EAR-0635855, EAR-0634903];  [1910411];  [22000003]	We thank all the people in the NECESSArray project for installing and servicing the seismic array, especially Koji Miyakawa, Koki Idehara, Takashi Tonegawa, Ryohei Iritani, Yucai Tang, Xienguan Wang and the technicians, postdoctoral researchers, graduate students of Peking University and IRIS-PASSCAL staffs for their cooperation during the observations. We are grateful for valuable comments by Sebastian Rost, Dan Shim, and an anonymous reviewer. This project is supported by Grants-in-Aid for Scientific Research (S) (No. 1910411) and partly Grants-in-Aid for Specially Promoted Research (No. 22000003) from Japan, the NSFC grant #40821062 from China, the NSF grant EAR-0635666, EAR-0635855, EAR-0634903 from United States.	Aki K., 2002, QUANTITATIVE SEISMOL; Hutko AR, 2009, PHYS EARTH PLANET IN, V173, P60, DOI 10.1016/j.pepi.2008.11.003; Tsuchiya T, 2011, PHYS EARTH PLANET IN, V188, P142, DOI 10.1016/j.pepi.2011.06.018; Wicks JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043689; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Obayashi M, 2013, GEOPHYS RES LETT, V40, P5652, DOI 10.1002/2013GL057401; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; Boschi L, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001733; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Tang YC, 2014, NAT GEOSCI, V7, P470, DOI 10.1038/NGEO2166; Rawlinson N, 2004, GEOPHYS J INT, V157, P332, DOI 10.1111/j.1365-246X.2004.02188.x; VIDALE JE, 1992, NATURE, V359, P627, DOI 10.1038/359627a0; DZIEWONSKI AM, 1984, J GEOPHYS RES, V89, P5929, DOI 10.1029/JB089iB07p05929; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Burke K, 2008, EARTH PLANET SC LETT, V265, P49, DOI 10.1016/j.epsl.2007.09.042; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Rost S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006420; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Kennett BLN, 1996, GEOPHYS J INT, V127, P40, DOI 10.1111/j.1365-246X.1996.tb01533.x; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Young MK, 2013, J GEOPHYS RES-SOL EA, V118, P5467, DOI 10.1002/jgrb.50391; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Houser C, 2008, GEOPHYS J INT, V174, P195, DOI 10.1111/J.1365-246X.2008.03763.X; Sun DY, 2013, EARTH PLANET SC LETT, V361, P333, DOI 10.1016/j.epsl.2012.10.027; Cottaar S, 2012, EARTH PLANET SC LETT, V355, P213, DOI 10.1016/j.epsl.2012.09.005; Dobson DP, 2005, NATURE, V434, P371, DOI [10.1038/nature03430, 10.1038/nature03385]; [Anonymous], 2002, GEOCHEM GEOPHY GEOSY, DOI DOI 10.1029/2001GC000168; Stacey FD, 2004, PHYS EARTH PLANET IN, V142, P137, DOI 10.1016/j.pepi.2004.02.003; Tao K, 2014, EARTH PLANET SC LETT, V398, P48, DOI 10.1016/j.epsl.2014.04.043; Thorne MS, 2013, EARTH PLANET SC LETT, V364, P59, DOI 10.1016/j.epsl.2012.12.034; INOUE H, 1990, PHYS EARTH PLANET IN, V59, P294, DOI 10.1016/0031-9201(90)90236-Q; Schimmel M, 1997, GEOPHYS J INT, V130, P497, DOI 10.1111/j.1365-246X.1997.tb05664.x; Tan E, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003665; Idehara K, 2011, PHYS EARTH PLANET IN, V184, P80, DOI 10.1016/j.pepi.2010.10.014; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; Steinberger B, 2006, GEOPHYS J INT, V167, P1461, DOI 10.1111/j.1365-246X.2006.03131.x; Revenaugh J, 1997, SCIENCE, V277, P670, DOI 10.1126/science.277.5326.670; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Takeuchi N, 2014, J GEOPHYS RES-SOL EA, V119, P7667, DOI 10.1002/2014JB011161; Ranasinghe NR, 2015, GEOPHYS J INT, V200, P67, DOI 10.1093/gji/ggu375; Zhao DP, 2004, PHYS EARTH PLANET IN, V146, P3, DOI 10.1016/j.pepi.2003.07.032; Nomura R, 2011, NATURE, V473, P199, DOI 10.1038/nature09940; Idehara K, 2007, PHYS EARTH PLANET IN, V165, P25, DOI 10.1016/j.pepi.2007.07.005; Soldati G, 2012, GEOPHYS J INT, V189, P730, DOI 10.1111/j.1365-246X.2012.05413.x; Rost S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006981; WEN LX, 1995, EARTH PLANET SC LETT, V133, P185, DOI 10.1016/0012-821X(95)00064-J; MORI J, 1995, J GEOPHYS RES-SOL EA, V100, P20359, DOI 10.1029/95JB02243; Hernlund JW, 2010, EARTH PLANET SC LETT, V296, P1, DOI 10.1016/j.epsl.2010.04.027; Antolik M., 2001, P 22 ANN DOD DOE SEI, VII; Boschi L, 2008, PHYS EARTH PLANET IN, V167, P230, DOI 10.1016/j.pepi.2008.03.009; Bower D.J., 2011, EARTH PLANET SC LETT, V303, P192; Castle JC, 2000, EARTH PLANET SC LETT, V176, P311, DOI 10.1016/S0012-821X(00)00027-3; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Efron B., 1993, INTRO BOOTSTRAP; Frost DA, 2014, EARTH PLANET SC LETT, V403, P380, DOI 10.1016/j.epsl.2014.06.046; Havens E, 2001, J GEOPHYS RES-SOL EA, V106, P30809, DOI 10.1029/2000JB000072; He YM, 2006, EARTH PLANET SC LETT, V244, P302, DOI 10.1016/j.epsl.2006.02.007; He YM, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005814; Idehara K, 2013, GEOPHYS J INT, V192, P1, DOI 10.1093/gji/ggs002; Karason H, 2001, J GEOPHYS RES-SOL EA, V106, P6569, DOI 10.1029/2000JB900380; Kennett B.L.N, 1988, SEISMOLOGICAL ALGORI, P237; Kito T, 2001, GEOPHYS RES LETT, V28, P2545, DOI 10.1029/2000GL012801; Kito T, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002677; KNITTLE E, 1989, GEOPHYS RES LETT, V16, P609, DOI 10.1029/GL016i007p00609; Mao WL, 2005, P NATL ACAD SCI USA, V102, P9751, DOI 10.1073/pnas.0503737102; MULLER G, 1985, J GEOPHYS-Z GEOPHYS, V58, P153; Obayashi M, 2011, P AGU FALL M SAN FRA; Persh SE, 2001, GEOPHYS RES LETT, V28, P387, DOI 10.1029/2000GL011607; Russell SA, 2001, GEOPHYS RES LETT, V28, P2281, DOI 10.1029/2000GL012553; SHIBUTANI T, 1993, J GEOMAGN GEOELECTR, V45, P1275; Simmons NA, 2006, EARTH PLANET SC LETT, V246, P109, DOI 10.1016/j.epsl.2006.04.003; Steinberger B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005080; Sun D, 2007, P NATL ACAD SCI USA, V104, P9151, DOI 10.1073/pnas.0608160104; Takeuchi N, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033197; Trampert J, 2001, PHYS EARTH PLANET IN, V124, P255, DOI 10.1016/S0031-9201(01)00201-1; WEBER M, 1992, PHYS EARTH PLANET IN, V73, P1, DOI 10.1016/0031-9201(92)90104-4; Wysession ME, 1998, GEODYNAMICS, V28, P273; WYSESSION ME, 1992, J GEOPHYS RES-SOL EA, V97, P8749, DOI 10.1029/92JB00511; Xu Y, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039387; Yamada A, 1996, GEOPHYS RES LETT, V23, P1553, DOI 10.1029/96GL01564; Yamada A, 1998, GEOPHYS RES LETT, V25, P4545, DOI 10.1029/1998GL900188; Yao JY, 2014, PHYS EARTH PLANET IN, V233, P103, DOI 10.1016/j.pepi.2014.05.009; Yoshida M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002008; Yoshida M, 2012, PHYS EARTH PLANET IN, V210, P63, DOI 10.1016/j.pepi.2012.08.006	85	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	FEB	2015	200	2					1050	1063		10.1093/gji/ggu455		14	Geochemistry & Geophysics	Geochemistry & Geophysics	CC0RC	WOS:000350042400026		
J	Kameyama, M; Miyagoshi, T; Ogawa, M				Kameyama, Masanori; Miyagoshi, Takehiro; Ogawa, Masaki			Linear analysis on the onset of thermal convection of highly compressible fluids: implications for the mantle convection of super-Earths	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Equations of state; Dynamics: convection currents, and mantle plumes; Planetary interiors	INFINITE-PRANDTL-NUMBER; TEMPERATURE-DEPENDENT VISCOSITY; PLATE-TECTONICS; STABILITY ANALYSIS; SOLID EXOPLANETS; STRUCTURE MODELS; SPHERICAL-SHELL; PLANETS; RADIUS; EVOLUTION	A series of linear analysis was performed on the onset of thermal convection of highly compressible fluids, in order to deepen the fundamental insights into the mantle convection of massive super-Earths in the presence of strong adiabatic compression. We consider the temporal evolution (growth or decay) of an infinitesimal perturbation superimposed to a highly compressible fluid which is in a hydrostatic (motionless) and conductive state in a basally heated horizontal layer. As a model of pressure-dependence in material properties, we employed an exponential decrease in thermal expansivity alpha and exponential increase in (reference) density rho with depth. The linearized equations for conservation of mass, momentum and internal (thermal) energy are numerically solved for the critical Rayleigh number as well as the vertical profiles of eigenfunctions for infinitesimal perturbations. The above calculations are repeatedly carried out by systematically varying (i) the dissipation number (Di), (ii) the temperature at the top surface and (iii) the magnitude of pressure-dependence in alpha and rho. Our analysis demonstrated that the onset of thermal convection is strongly affected by the adiabatic compression, in response to the changes in the static stability of thermal stratification in the fluid layer. For sufficiently large Di where a thick sublayer of stable stratification develops in the layer, for example, the critical Rayleigh number explosively increases with Di, together with drastic decreases in the length scales of perturbations both in vertical and horizontal directions. In particular, for very large Di, a thick 'stratosphere' occurs in the fluid layer where the vertical motion is significantly suppressed, resulting in a shrink of the incipient convection in a thin sublayer of unstable thermal stratification. In addition, when Di exceeds a threshold value above which a thermal stratification becomes stable in the entire layer, no perturbation is allowed to grow with time regardless of the Rayleigh number and/or the horizontal wavelength. We also found that the effect of adiabatic compression becomes prominent for higher temperature at the top surface of the fluid layer. These findings may imply the crucial importance of adiabatic compression in understanding the dynamics and evolution of the mantles of massive super-Earths, particularly for those orbiting their parent stars very closely.	[Kameyama, Masanori] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime, Japan; [Miyagoshi, Takehiro] Japan Agcy Marine Earth Sci & Technol, Dept Deep Earth Struct & Dynam Res, Yokohama, Kanagawa, Japan; [Ogawa, Masaki] Univ Tokyo Komaba, Dept Earth Sci & Astron, Tokyo, Japan	Kameyama, M (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime, Japan.	kameyama@sci.ehime-u.ac.jp	Masaki, Ogawa/H-7044-2012		Japan Society for the Promotion of Science [22340127, 26400457]	We thank Takatoshi Yanagisawa, Hiroki Ichikawa and Hiroki Senshu for fruitful discussion. We thank Stephane Labrosse and two anonymous reviewers for their helpful comments which improved the paper. MK acknowledges financial support from Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (B; #22340127 and C; #26400457), and travel support from Japan Agency for Marine-Earth Science and Technology (JAMSTEC) on conducting this study in part as a visiting senior scientist of the Department of Mathematical Science and Advanced Technology (MAT).	JARVIS GT, 1980, J FLUID MECH, V96, P515, DOI 10.1017/S002211208000225X; Tackley PJ, 2013, ICARUS, V225, P50, DOI 10.1016/j.icarus.2013.03.013; Kameyama M, 2013, GEOPHYS J INT, V195, P1443, DOI 10.1093/gji/ggt321; Valencia D, 2007, ASTROPHYS J, V656, P545, DOI 10.1086/509800; Tachinami C, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/70; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; van Heck HJ, 2011, EARTH PLANET SC LETT, V310, P252, DOI 10.1016/j.epsl.2011.07.029; Gaidos E, 2010, ASTROPHYS J, V718, P596, DOI 10.1088/0004-637X/718/2/596; Sotin C, 2007, ICARUS, V191, P337, DOI 10.1016/j.icarus.2007.04.006; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Foley BJ, 2012, EARTH PLANET SC LETT, V331, P281, DOI 10.1016/j.epsl.2012.03.028; Stamenkovic V, 2011, ICARUS, V216, P572, DOI 10.1016/j.icarus.2011.09.030; Leng W, 2008, GEOPHYS J INT, V173, P693, DOI 10.1111/j.1365-246X.2008.03745.x; Tsuchiya T, 2011, P NATL ACAD SCI USA, V108, P1252, DOI 10.1073/pnas.1013594108; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; BERCOVICI D, 1992, J FLUID MECH, V239, P683, DOI 10.1017/S0022112092004580; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; Dumusque X, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/154; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Kameyama M, 2013, THEOR COMP FLUID DYN, V27, P21, DOI 10.1007/s00162-011-0250-x; King SD, 2010, GEOPHYS J INT, V180, P73, DOI 10.1111/j.1365-246X.2009.04413.x; Kite ES, 2009, ASTROPHYS J, V700, P1732, DOI 10.1088/0004-637X/700/2/1732; Korenaga J, 2010, ASTROPHYS J LETT, V725, pL43, DOI 10.1088/2041-8205/725/1/L43; Madhusudhan N, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L40; Liu X, 2013, GEOPHYS J INT, V194, P125, DOI 10.1093/gji/ggt117; Miyagoshi T, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L8; Miyauchi A, 2014, J EARTH SCI-CHINA, V25, P126, DOI 10.1007/s12583-014-0405-y; Miyauchi A, 2013, PHYS EARTH PLANET IN, V223, P86, DOI 10.1016/j.pepi.2013.08.001; O'Neill C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030598; Papuc AM, 2008, ICARUS, V195, P447, DOI 10.1016/j.icarus.2007.12.016; Rivera EJ, 2005, ASTROPHYS J, V634, P625, DOI 10.1086/491669; SCHUBERT G., 2001, MANTLE CONVECTION EA; Stamenkovic V, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/41; Stein C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049341; Stein C, 2013, EARTH PLANET SC LETT, V361, P448, DOI 10.1016/j.epsl.2012.11.011; Tachinami C, 2014, ICARUS, V231, P377, DOI 10.1016/j.icarus.2013.12.022; Valencia D, 2009, EARTH PLANET SC LETT, V286, P492, DOI 10.1016/j.epsl.2009.07.015; Valencia D, 2007, ASTROPHYS J, V670, pL45, DOI 10.1086/524012; Valencia D, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200912839; van den Berg AP, 2010, PHYS EARTH PLANET IN, V178, P136, DOI 10.1016/j.pepi.2009.11.001; Wagner FW, 2011, ICARUS, V214, P366, DOI 10.1016/j.icarus.2011.05.027	41	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	FEB	2015	200	2					1064	1075		10.1093/gji/ggu457		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CC0RC	WOS:000350042400027		
J	Hirano, S; Yamashita, T				Hirano, Shiro; Yamashita, Teruo			Dynamic antiplane rupture propagation crossing a material interface: modelling with BIEM	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Numerical solutions; Numerical approximations and analysis; Earthquake dynamics; Dynamics and mechanics of faulting	BIMATERIAL INTERFACE; WEAKENING FRICTION; DEPENDENT FRICTION; EARTHQUAKE; FAULTS; AFTERSHOCKS; PLASTICITY; VELOCITY; ROCKS; CRACK	Because the Earth's crust is quite heterogeneous and consists of various types of rocks, many faults are located near material interfaces. Recent observational studies have revealed that some faults cross the interfaces, but theoretical treatment of their dynamic behaviour is still undeveloped. In this paper, we develop a boundary integral equation method (BIEM) to analyse the dynamic behaviour of antiplane rupture propagation crossing a material interface. First, we obtain an exact solution of the stress response due to a rectangular slip rate function on one discretized crack element embedded in one of the elastic half-spaces welded along a planar interface. This solution is helpful not only in BIEM simulations of rupture propagation but also in benchmark testing or extension of other numerical schemes. Next, we simulate the dynamic propagation of an antiplane rupture crossing the material interface by using the exact solution for a stress response in a BIEM framework. We find that a shear wave reflected from the material interface generates a significant change in the slip rate on the crack depending on the angle between the interface and the crack, contrast in the elastic properties, and rupture velocity. Moreover, we infer from our numerical results and previous related works that a backward propagating healing front emerges under rate-weakening friction owing to interaction between the reflected wave and friction.	[Hirano, Shiro] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan; [Yamashita, Teruo] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Hirano, S (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan.	hirano@kz.tsukuba.ac.jp			MegaQuake project, University of Tsukuba	We thank Satoshi Ide, Nobuki Kame, Tetsuya Kusakabe and two anonymous reviewers for useful discussions. The XBIEM solution plotted in Fig. 3 was provided by Tetsuya Kusakabe. We acknowledge partial financial support by the MegaQuake project, University of Tsukuba.	Aki K., 2002, QUANTITATIVE SEISMOL; Ampuero JP, 2005, B SEISMOL SOC AM, V95, P390, DOI 10.1785/0120040103; Ampuero JP, 2008, GEOPHYS J INT, V173, P674, DOI 10.1111/J.1365-246X.2008.03736.X; Gabriel AA, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009468; Naoi M, 2011, B SEISMOL SOC AM, V101, P2399, DOI 10.1785/0120100346; Williams DP, 2000, J ENG MATH, V37, P253, DOI 10.1023/A:1004750715261; Dunham EM, 2011, B SEISMOL SOC AM, V101, P2308, DOI 10.1785/0120100076; RICE JR, 1983, J APPL MECH-T ASME, V50, P343; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Yabe Y, 2009, EARTH PLANETS SPACE, V61, pE49; BIRCH F, 1961, J GEOPHYS RES, V66, P2199, DOI 10.1029/JZ066i007p02199; Bonafede M, 2002, GEOPHYS J INT, V149, P698, DOI 10.1046/j.1365-246X.2002.01670.x; Carlson B. C., 1995, Numerical Algorithms, V10, DOI 10.1007/BF02198293; COCHARD A, 1994, PURE APPL GEOPHYS, V142, P419, DOI 10.1007/BF00876049; DIETERIC.JH, 1972, J GEOPHYS RES, V77, P3690, DOI 10.1029/JB077i020p03690; Ferrari C, 2012, GEOPHYS J INT, V190, P151, DOI 10.1111/j.1365-246X.2012.05517.x; Goto H, 2010, GEOPHYS J INT, V183, P975, DOI 10.1111/j.1365-246X.2010.04772.x; Hirano S, 2011, GEOPHYS J INT, V187, P1460, DOI 10.1111/j.1365-246X.2011.05202.x; Kame N, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005899; Kato A, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004016; Kusakabe T., 2013, THESIS U TOKYO; Nielsen S, 2003, B SEISMOL SOC AM, V93, P2375, DOI 10.1785/0120020090; Noda H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006143; Okada T, 2010, EARTH PLANETS SPACE, V62, P347, DOI 10.5047/eps.2009.11.005; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Roche V, 2012, TERRA NOVA, V24, P499, DOI 10.1111/j.1365-3121.2012.01088.x; Rybicki KR, 2008, ACTA GEOPHYS, V56, P286, DOI 10.2478/s11600-008-0005-2; Tada T, 1997, GEOPHYS J INT, V130, P269, DOI 10.1111/j.1365-246X.1997.tb05647.x; Tada T, 2001, INT J NUMER METH ENG, V50, P227, DOI 10.1002/1097-0207(20010110)50:1<227::AID-NME166>3.0.CO;2-5; Tada T, 2009, INT GEOPHYS SER, V94, P217; Tamura S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008283; Wada K, 2012, B SEISMOL SOC AM, V102, P1712, DOI 10.1785/0120110212; Wang KL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002888	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	FEB	2015	200	2					1220	1233		10.1093/gji/ggu471		14	Geochemistry & Geophysics	Geochemistry & Geophysics	CC0RC	WOS:000350042400037		
J	Nishimoto, K; Tanaka, K; Murakami, T; Nakashita, H; Sakamoto, H; Oguri, S				Nishimoto, Keisuke; Tanaka, Kaori; Murakami, Takahiro; Nakashita, Hideo; Sakamoto, Hikaru; Oguri, Suguru			Datura stramonium agglutinin: Cloning, molecular characterization and recombinant production in Arabidopsis thaliana	GLYCOBIOLOGY			English	Article						chitin-binding; Datura stramonium; DSA; recombinant lectin; Solanaceae	WHEAT-GERM-AGGLUTININ; URTICA-DIOICA AGGLUTININ; CARBOHYDRATE BINDING-PROPERTIES; POTATO LECTIN; MEMBRANE-GLYCOPROTEINS; SEQUENCE SIMILARITIES; TOMATO LECTIN; N-GLYCANS; PROTEIN; SEEDS	Datura stramonium seeds contain at least three chitin-binding isolectins [termed Datura stramonium agglutinin (DSA)] as homo- or heterodimers of A and B subunits. We isolated a cDNA encoding isolectin B (DSA-B) from an immature fruit cDNA library; this contained an open reading frame encoding 279 deduced amino acids, which was confirmed by partial sequencing of the native DSA-B peptide. The sequence consisted of: (i) a cysteine (Cys)-rich carbohydrate-binding domain composed of four conserved chitin-binding domains and (ii) an extensin-like domain of 37 residues containing four SerPro4-6 motifs that was inserted between the second and third chitin-binding domains (CBDs). Although each chitin-binding domain contained eight conserved Cys residues, only the second chitin-binding domain contained an extra Cys residue, which may participate in dimerization through inter-disulfide bridge formation. Using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry, the molecular mass of homodimeric lectin composed of two B-subunits was determined as 68,821 Da. The molecular mass of the S-pyridilethylated B-subunit were found to be 37,748 Da and that of the de-glycosylated form was 26,491 Da, which correlated with the molecular weight estimated from the deduced sequence. Transgenic Arabidopsis plants overexpressing the dsa-b demonstrated hemagglutinating activity. Recombinant DSA-B was produced as a homodimeric glycoprotein with a similar molecular mass to that of the native form. Moreover, the N-terminus of the purified recombinant DSA-B protein was identical to that of the native DSA-B, confirming that the cloned cDNA encoded DSA-B.	[Nishimoto, Keisuke; Tanaka, Kaori; Murakami, Takahiro; Sakamoto, Hikaru; Oguri, Suguru] Tokyo Univ Agr, Fac Bioind, Dept Bioprod, Abashiri, Hokkaido 0992493, Japan; [Nakashita, Hideo] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo 1568502, Japan	Oguri, S (reprint author), Tokyo Univ Agr, Fac Bioind, Dept Bioprod, Abashiri, Hokkaido 0992493, Japan.	s-oguri@bioindustry.nodai.ac.jp			Science and Technology Incubation Program in Advanced Regions, Japan Science and Technology Agency	This work was partially supported by the Science and Technology Incubation Program in Advanced Regions, Japan Science and Technology Agency.	Allen AK, 1996, INT J BIOCHEM CELL B, V28, P1285, DOI 10.1016/S1357-2725(96)00043-X; SAITOH O, 1992, J BIOL CHEM, V267, P5700; De Jaeger G, 2002, NAT BIOTECHNOL, V20, P1265, DOI 10.1038/nbt755; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; HIRAIZUMI S, 1992, JPN J CANCER RES, V83, P1063; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.arplant.44.1.591; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ciopraga J, 1999, BBA-GEN SUBJECTS, V1428, P424, DOI 10.1016/S0304-4165(99)00085-9; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; Hirabayashi J, 2013, CHEM SOC REV, V42, P4443, DOI 10.1039/c3cs35419a; ASHFORD D, 1982, BIOCHEM J, V201, P199; BROEKAERT WF, 1986, LECTINS BIOL BIOCH C, V5, P57; BROEKAERT WF, 1988, PLANT PHYSIOL, V86, P569, DOI 10.1104/pp.86.2.569; BROEKAERT WF, 1987, FEBS LETT, V220, P116, DOI 10.1016/0014-5793(87)80887-6; Brownleader MD, 1996, BIOCHEM J, V320, P577; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; CROWLEY JF, 1981, FEBS LETT, V130, P149, DOI 10.1016/0014-5793(81)80685-0; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; DESAI NN, 1981, BIOCHEM J, V197, P345; Does MP, 1999, PLANT MOL BIOL, V39, P335, DOI 10.1023/A:1006134932290; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; GOLDSTEIN IJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P53, DOI 10.1016/0005-2795(75)90313-X; Harata K, 2000, J MOL BIOL, V297, P673, DOI 10.1006/jmbi.2000.3594; HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1; JIMBO A, 1984, J BIOCHEM-TOKYO, V95, P267; KAWASHIMA H, 1990, GLYCOCONJUGATE J, V7, P323, DOI 10.1007/BF01073376; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KILPATRICK DC, 1978, BIOCHEM J, V175, P1151; Kinoshita M, 2014, J PROTEOME RES, V13, P1021, DOI 10.1021/pr401015b; LERNER DR, 1992, J BIOL CHEM, V267, P11085; MATSUMOTO I, 1983, J BIOL CHEM, V258, P2886; Muraki M, 2002, BBA-GEN SUBJECTS, V1569, P10, DOI 10.1016/S0304-4165(01)00231-8; Muraki M, 2000, PROTEIN ENG, V13, P385, DOI 10.1093/protein/13.6.385; NACHBAR MS, 1980, J BIOL CHEM, V255, P2056; Naito Y, 2001, BIOSCI BIOTECH BIOCH, V65, P86, DOI 10.1271/bbb.65.86; Oguri S, 2008, BIOSCI BIOTECH BIOCH, V72, P2640, DOI 10.1271/bbb.80310; Oguri S, 2005, GLYCOCONJUGATE J, V22, P453, DOI 10.1007/s10719-005-5329-4; Oliveira C, 2013, CRIT REV BIOTECHNOL, V33, P66, DOI 10.3109/07388551.2012.670614; Sasaki T, 2002, BRIT J CANCER, V87, P918, DOI 10.1038/sj.bjc.6600550; Sharon N., 2007, LECTINS; SHIBUYA N, 1986, ARCH BIOCHEM BIOPHYS, V249, P215, DOI 10.1016/0003-9861(86)90577-1; SMITH JJ, 1989, PLANT MOL BIOL, V13, P601, DOI 10.1007/BF00027321; Sun QL, 2009, ARCH BIOCHEM BIOPHYS, V484, P24, DOI 10.1016/j.abb.2009.01.009; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; WRIGHT CS, 1987, J MOL BIOL, V194, P501, DOI 10.1016/0022-2836(87)90678-4; Wright CS, 1996, PROTEIN SCI, V5, P1466; Yamaguchi K, 1996, BIOSCI BIOTECH BIOCH, V60, P1380	52	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	FEB	2015	25	2					157	169		10.1093/glycob/cwu098		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC0RX	WOS:000350045000004		
J	Rahman, AMA; Ryczko, M; Nakano, M; Pawling, J; Rodrigues, T; Johswich, A; Taniguchi, N; Dennis, JW				Rahman, Anas M. Abdel; Ryczko, Michael; Nakano, Miyako; Pawling, Judy; Rodrigues, Tania; Johswich, Anita; Taniguchi, Naoyuki; Dennis, James W.			Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism	GLYCOBIOLOGY			English	Article						Golgi N-glycan branching; hexosamine biosynthetic pathway; metabolism; N-acetylglucosaminyltransferase enzymes; nutrient uptake	GLUCOSE-METABOLISM; CELL-GROWTH; UDP-GLCNAC; BETA-1,6-BRANCHED OLIGOSACCHARIDES; TRANSCRIPTIONAL REGULATION; COLORECTAL-CARCINOMA; TUMOR PROGRESSION; GLYCOSYLATION; PATHWAY; EXPRESSION	Nutrient transporters are critical gate-keepers of extracellular metabolite entry into the cell. As integral membrane proteins, most transporters are N-glycosylated, and the N-glycans are remodeled in the Golgi apparatus. The Golgi branching enzymes N-acetylglucosaminyltransferases I, II, IV, V and avian VI (encoded by Mgat1, Mgat2, Mgat4a/b/c Mgat5 and Mgat6), each catalyze the addition of N-acetylglucosamine (GlcNAc) in N-glycans. Here, we asked whether N-glycan branching promotes nutrient transport and metabolism in immortal human HeLa carcinoma and non-malignant HEK293 embryonic kidney cells. Mgat6 is absent in mammals, but ectopic expression can be expected to add an additional beta 1,4-linked branch to N-glycans, and may provide evidence for functional redundancy of the N-glycan branches. Tetracycline (tet)-induced overexpression of Mgat1, Mgat5 and Mgat6 resulted in increased enzyme activity and increased N-glycan branching concordant with the known specificities of these enzymes. Tet-induced Mgat1, Mgat5 and Mgat6 combined with stimulation of hexosamine biosynthesis pathway (HBP) to UDP-GlcNAc, increased cellular metabolite levels, lactate and oxidative metabolism in an additive manner. We then tested the hypothesis that N-glycan branching alone might promote nutrient uptake when glucose (Glc) and glutamine are limiting. In low glutamine and Glc medium, tet-induced Mgat5 alone increased amino acids uptake, intracellular levels of glycolytic and TCA intermediates, as well as HEK293 cell growth. More specifically, tet-induced Mgat5 and HBP elevated the import rate of glutamine, although transport of other metabolites may be regulated in parallel. Our results suggest that N-glycan branching cooperates with HBP to regulate metabolite import in a cell autonomous manner, and can enhance cell growth in low-nutrient environments.	[Rahman, Anas M. Abdel; Ryczko, Michael; Pawling, Judy; Rodrigues, Tania; Johswich, Anita; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Ryczko, Michael; Rodrigues, Tania; Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Dennis, James W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; [Nakano, Miyako; Taniguchi, Naoyuki] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Dept Biol Chem, Dis Glyc Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima 7398530, Japan	Dennis, JW (reprint author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave,Room 988, Toronto, ON M5G 1X5, Canada.	dennis@lunenfeld.ca			Canadian Cancer Society [2010-7000444]; MRI-ORF GL2; CIHR [MOP-62975]; Sydney C. Cooper Program for the Prevention of Cancer Progression; MITACS-Accelerate; Frank Fletcher Memorial Fund; Mary Gertrude I'Anson Scholarship; Paul Starita Graduate Student Fellowship	Research described in this manuscript was supported by grants from Canadian Cancer Society (2010-7000444), MRI-ORF GL2, CIHR (MOP-62975) and The Sydney C. Cooper Program for the Prevention of Cancer Progression to J.W.D. A.A.R. was supported by MITACS-Accelerate, and M.R. was supported by the Frank Fletcher Memorial Fund, Mary Gertrude I'Anson Scholarship and Paul Starita Graduate Student Fellowship. Metabolomics data have been deposited at ftp://PASS00385:PU9246h@ftp.peptideatlas.org/.	Abdel Rahman Anas M, 2013, ACS Chem Biol, V8, P2053, DOI 10.1021/cb4004173; Abdel Rahman Anas M, 2014, Anal Chim Acta, V845, P53, DOI 10.1016/j.aca.2014.06.012; Seelentag WKF, 1998, CANCER RES, V58, P5559; KITAGAWA T, 1995, J CELL SCI, V108, P3735; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Granovsky M, 2000, NAT MED, V6, P306; FERNANDES B, 1991, CANCER RES, V51, P718; D'Arrigo A, 2005, INT J CANCER, V115, P256, DOI 10.1002/ijc.20883; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Cheung P, 2007, GLYCOBIOLOGY, V17, P767, DOI 10.1093/glycob/cwm037; Johswich A, 2014, J BIOL CHEM, V289, P15927, DOI 10.1074/jbc.M114.563734; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; DENNIS JW, 1989, ONCOGENE, V4, P853; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Kang R, 1996, J BIOL CHEM, V271, P26706; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Lau KS, 2008, PROTEOMICS, V8, P3294, DOI 10.1002/pmic.200800208; Nakano M, 2011, MOL CELL PROTEOMICS, V10; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163; Shirato K, 2011, J CLIN BIOCHEM NUTR, V48, P20, DOI 10.3164/jcbn.11-015FR; Soliman MA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004785; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Taguchi T, 2000, J BIOL CHEM, V275, P32598, DOI 10.1074/jbc.M004673200; Takamatsu S, 1999, CANCER RES, V59, P3949; Varki A., 2009, ESSENTIALS GLYCOBIOL; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Watanabe T, 2006, GLYCOBIOLOGY, V16, P431, DOI 10.1093/glycob/cwj079; Yoshimura M, 1995, P NATL ACAD SCI USA, V92, P8753	49	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	FEB	2015	25	2					225	240		10.1093/glycob/cwu105		16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC0RX	WOS:000350045000009		
J	Kuramoto, G; Takagi, S; Ishitani, K; Shimizu, T; Okano, T; Matsui, H				Kuramoto, Goro; Takagi, Soichi; Ishitani, Ken; Shimizu, Tatsuya; Okano, Teruo; Matsui, Hideo			Preventive effect of oral mucosal epithelial cell sheets on intrauterine adhesions	HUMAN REPRODUCTION			English	Article						tissue engineering; regenerative medicine; cell sheet; Asherman's syndrome; intrauterine adhesions	MODEL; SURGERY; DEVICE; ACID	STUDY QUESTION: Can regenerative-medicine techniques using oral mucosal epithelial cell sheets (OMECS) provide a new treatment method for intrauterine adhesions (IUA) which cause female infertility? SUMMARY ANSWER: Transplantation of OMECS was confirmed to be effective in preventing IUA after endometrial damage in rats. WHAT IS KNOWN ALREADY: Uterine disorders such as IUA, commonly known as Asherman's syndrome, are one factor that can result in infertility. Clinical therapy for this kind of disease is targeted at the prevention of re-adhesion by surgical synechiotomy, administration of hormones after the operation, and the use of intrauterine devices. Recently, a new approach called 'cell-sheet engineering', which harvests confluent culture cells as a contiguous cell sheet having intact cell-cell junctions and an extracellular matrix, without having to use enzymatic treatment, has been developed for tissue regeneration. STUDY DESIGN, SIZE, DURATION: OMECS were prepared from rat oral mucosal tissues. An IUA model was made in rat uteri, and OMECS were transplanted into the model. Uteri transplanted with OMECS were compared with the non-transplanted control uteri by histological analysis at 1, 2 and 8 days after surgery (n = 3). PARTICIPANTS/MATERIALS, SETTING, METHODS: Oral mucosal tissues were resected from neonatal rats, and oral mucosal epithelial cells were collected with enzymatic treatment. An isolated cell suspension was seeded on a temperature-responsive cell culture-insert and incubated. After being detached from the insert, a cell sheet was transplanted onto the endometrium defect. At 1, 2 and 8 days after surgery, uteri were resected and examined. MAIN RESULTS AND THE ROLE OF CHANCE: Histological examination of the non-treated specimens at 1, 2 and 8 days after surgery did not show any uterine cavities typically caused by IUA. In contrast, the histology of uteri transplanted with OMECS immediately after endometrial damage showed the presence of uterine cavities, and furthermore, stratified squamous epithelial cells on the luminal surface (n = 3). LIMITATIONS, REASONS FOR CAUTION: The results of this study are difficult to apply directly to humans, because the structure and function of rat uteri are different from those of human. WIDER IMPLICATIONS OF THE FINDINGS: Transplantation of OMECS offers a reliable method not only to protect the woman's fertility from intrauterine re-adhesion after synechiotomy for IUA or uterine lumen adhesion but also to prevent adhesion after any intrauterine surgery in clinical cases. study funding/competing interest(s): This study was supported by Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems 'Cell Sheet Tissue Engineering Center (CSTEC)' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Teruo Okano is a director on the board of CellSeed Inc. Tatsuya Shimizu had been a scientific consultant for CellSeed Inc. until December 2013. These two authors are stakeholders of the company and are inventors of cell sheet-related patents. Tokyo Women's Medical University is receiving research funds from CellSeed Inc. The other authors have no conflicting interests to declare.	[Kuramoto, Goro; Ishitani, Ken; Matsui, Hideo] Tokyo Womens Med Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1628666, Japan; [Kuramoto, Goro; Takagi, Soichi; Shimizu, Tatsuya; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan	Shimizu, T (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shimizu.tatsuya@twmu.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems 'Cell Sheet Tissue Engineering Center (CSTEC)' from the Ministry of Education	This study was supported by Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems 'Cell Sheet Tissue Engineering Center (CSTEC)' from the Ministry of Education	ADONI A, 1982, INT J FERTIL, V27, P117; Taskin O, 2000, J AM ASSOC GYN LAP, V7, P351, DOI 10.1016/S1074-3804(05)60478-1; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; FRIEDLER S, 1993, HUM REPROD, V8, P442; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ASHERMAN JG, 1948, J OBSTET GYN BRIT EM, V55, P23; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; March CM, 2011, REPROD BIOMED ONLINE, V23, P63, DOI 10.1016/j.rbmo.2010.11.018; Cocuzza MA, 2011, FERTIL STERIL, V95, P2418, DOI 10.1016/j.fertnstert.2011.03.064; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; BERGMAN P, 1961, Acta Obstet Gynecol Scand Suppl, V40(Suppl 4), P1; ERIKSEN J, 1960, Dan Med Bull, V7, P50; Fehr MK, 1996, AM J OBSTET GYNECOL, V175, P115, DOI 10.1016/S0002-9378(96)70260-0; Iwata T, 2013, J TISSUE ENG REGEN M, DOI [10.1002/term. 1785., DOI 10.1002/TERM.1785.]; Krzemien AA, 1999, LASER SURG MED, V25, P315, DOI 10.1002/(SICI)1096-9101(1999)25:4<315::AID-LSM6>3.0.CO;2-N; MASSOURA.HG, 1973, AM J OBSTET GYNECOL, V116, P576; Ohki T, 2012, GASTROENTEROLOGY, V143; PENNES DR, 1987, J CLIN ULTRASOUND, V15, P165, DOI 10.1002/jcu.1870150303; POLISHUK WZ, 1969, FERTIL STERIL, V20, P241; Preutthipan Sangchai, 2000, Journal of the Medical Association of Thailand, V83, P42; SCHENKER JG, 1982, FERTIL STERIL, V37, P593; Szymański R, 2000, Ginekol Pol, V71, P1031; Taskin O, 1996, J AM ASSOC GYN LAP, V3, P555, DOI 10.1016/S1074-3804(05)80167-7; Vacanti JP, 2008, SURGERY, V143, P181, DOI 10.1016/j.surg.2007.11.003	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1161	1460-2350		HUM REPROD	Hum. Reprod.	FEB	2015	30	2					406	416		10.1093/humrep/deu326		11	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CC2AK	WOS:000350146600018		
J	Mazzanti, G; Chen, G; Fothergill, JC; Hozumi, N; Li, J; Marzinotto, M; Mauseth, F; Morshuis, P; Reed, C; Tzimas, A; Wu, K				Mazzanti, G.; Chen, G.; Fothergill, J. C.; Hozumi, N.; Li, J.; Marzinotto, M.; Mauseth, F.; Morshuis, P.; Reed, C.; Tzimas, A.; Wu, Kai			A Protocol for Space Charge Measurements in Full-size HVDC Extruded Cables	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						HVDC insulation; power cables; power cable testing; space charge	XLPE-INSULATED CABLE; THERMAL STEP METHOD; TEMPERATURE-GRADIENT; ELECTRIC-FIELD; HIGH-VOLTAGE; DC; ACCUMULATION; TRANSMISSION; DESIGN; DIELECTRICS	This position paper, prepared by the IEEE DEIS HVDC Cable Systems Technical Committee, illustrates a protocol recommended for the measurement of space charges in full-size HVDC extruded cables during load cycle qualification tests (either prequalification load cycles or type test load cycles). The protocol accounts for the experimental practices of space charge measurements in the thick insulation of coaxial cables in terms of poling time, depolarization time, heating and cooling of specimens, as well as for the experience gained very recently from such kind of measurements performed in the framework of qualification tests relevant to ongoing HVDC cable system projects. The goal of the protocol is not checking the compliance with any maximum acceptable limit of either space charge or electric field. Rather, this protocol aims at assessing the variation of the electric field profile in the cable insulation wall during poling time at the beginning and at the end of load cycle qualification tests for full-size HVDC extruded cables. Indeed, in the design stage the electric field distributions are determined by the cable geometry and by temperature gradient in the insulation. Thus, the design is based on macroscopic parameters conductivity and permittivity and how they depend upon temperature. Any disturbance of the electric field due to space charge accumulation will only be revealed during space charge measurements either in as-manufactured state or in the aged state after load cycle qualification tests.	[Mazzanti, G.] Univ Bologna, Dept El Energy Engin Informat, I-40136 Bologna, Italy; [Chen, G.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Fothergill, J. C.] City Univ London, London EC1V 0HB, England; [Hozumi, N.] Toyohashi Univ Technol, Dept El & Elect Inform Engin, Toyohashi, Aichi 4418580, Japan; [Li, J.] Chongqing Univ, Coll Elect Eng, Dept High Voltage & Insulat Eng, Chongqing 400044, Peoples R China; [Marzinotto, M.] TERNA, Dept Engn, I-00156 Rome, Italy; [Mauseth, F.] Norw Univ Sci & Technol, Dept Elect Power Engn, N-7491 Trondheim, Norway; [Morshuis, P.] Delft Univ Technol, NL-2628 CD Delft, Netherlands; [Reed, C.] USA Consultant, Scotia, NY 12302 USA; [Tzimas, A.] ALSTOM Grid, Res & Technol Ctr, Stafford ST17 4LX, England; [Wu, Kai] Xi An Jiao Tong Univ, State Key Lab Elect Insul Power Equip, Xian 710049, Peoples R China	Mazzanti, G (reprint author), Univ Bologna, Dept El Energy Engin Informat, Viale Risorgimento 2, I-40136 Bologna, Italy.						Ahmed NH, 1997, IEEE T DIELECT EL IN, V4, P644, DOI 10.1109/94.625650; Fabiani D, 2007, IEEE ELECTR INSUL M, V23, P11, DOI 10.1109/MEI.2007.4389975; Lundberg P, 2012, IEEE POWER ENERGY M, V10, P30, DOI 10.1109/MPE.2012.2212651; [Anonymous], 2012, B132 CIGRE WG; Ohki Y, 2013, IEEE ELECTR INSUL M, V29, P65; [Anonymous], 2006, SPACE CHARGE MEASURE; TAKADA T, 1987, IEEE T ELECTR INSUL, V22, P497, DOI 10.1109/TEI.1987.298914; Delpino S, 2008, IEEE ELECTR INSUL M, V24, P14, DOI 10.1109/MEI.2008.4455499; Fu M, 2008, IEEE T DIELECT EL IN, V15, P851, DOI 10.1109/TDEI.2008.4543123; Choo W, 2011, IEEE T DIELECT EL IN, V18, P596, DOI 10.1109/TDEI.2011.5739466; Mazzanti G, 2005, IEEE T DIELECT EL IN, V12, P876, DOI 10.1109/TDEI.2005.1522183; Hampton RN, 2008, IEEE ELECTR INSUL M, V24, P5, DOI 10.1109/MEI.2008.4455498; Liu RS, 2013, IEEE ELECTR INSUL M, V29, P37; Ohki Y, 2013, IEEE ELECTR INSUL M, V29, P85; Bodega R, 2005, Proceedings of the 2005 International Symposium on Electrical Insulating Materials, Vols, 1-3, P107, DOI 10.1109/ISEIM.2005.193340; Castellon J, 2009, IEEE ELECTR INSUL M, V25, P30, DOI 10.1109/MEI.2009.4977240; CHERIFI A, 1992, IEEE T ELECTR INSUL, V27, P1152, DOI 10.1109/14.204866; Fabiani D, 2008, IEEE ELECTR INSUL M, V24, P5, DOI 10.1109/MEI.2008.4473049; Fukunaga K., 1990, T IEE JAPAN A, V110, P647; Hanley T.L., 2003, IEEE ELECTR INSUL M, V19, P14; HOZUMI N, 1994, IEEE T DIELECT EL IN, V1, P1068, DOI 10.1109/94.368656; Ildstad E., CIGRE SESS 2004; Jacobson B., 2006, B4105 CIGRE, P1; Morshuis P, 1997, IEEE ELECTR INSUL M, V13, P26, DOI 10.1109/57.591529; Jeroense M., 2008, B1304 CIGRE, P1; Lim F.N., 1998, INT S EL INS MAT TOY, P199; Lim F.N., 1998, IEEE 3 INT C EL CHAR, P329; Lim FN, 1999, IEEE T DIELECT EL IN, V6, P273, DOI 10.1109/94.775611; Maruyama S, 2004, FURUKAWA REV, V25, P47; Marzinotto M., 2011, P 2011 IEEE C EL INS, P804; Marzinotto M., 2012, CIGRE SESS 2012 PAR, P1; Mazzanti G., 2013, POWER ENG SERIES; Mori H., 2013, JIC HVDC 13 PERP FRA; Notingher P, 2001, IEEE T DIELECT EL IN, V8, P985, DOI 10.1109/94.971455; Olsson C. O., 2011, 8 INT C INS POW CABL; Rendina R., 2012, B1101 CIGRE, P1; Takada T, 1999, IEEE T DIELECT EL IN, V6, P519, DOI 10.1109/94.798112; Takeda T, 1998, IEEE T POWER DELIVER, V13, P28, DOI 10.1109/61.660842; Terashima K, 1998, IEEE T POWER DELIVER, V13, P7, DOI 10.1109/61.660837; Yamanaka T., 2003, IEEE 7 INT C PROP AP, V2, P689	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					21	34		10.1109/TDEI.2014.004557		14	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900005		
J	Somekawa, T; Fujita, M; Izawa, Y; Kasaoka, M; Nagano, Y				Somekawa, Toshihiro; Fujita, Masayuki; Izawa, Yasukazu; Kasaoka, Makoto; Nagano, Yoshitomo			Furfural Analysis in Transformer Oils Using Laser Raman Spectroscopy	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Power transformers; insulation testing; Raman scattering; lasers applications	DEGRADATION	The concentration of furfural in transformer oils is a well known indicator for decomposition of insulating paper. Using laser Raman spectroscopy, we performed detection experiments of furfural dissolved in insulating oils without complex and time consuming preprocessing procedures. Furfural was characterized by Raman signal at 1707 cm(-1), where no spectral interferences caused by oil-derived Raman signals occur. The results show that laser Raman spectroscopy is a useful alternative method for transformer health diagnosis.	[Somekawa, Toshihiro; Fujita, Masayuki; Izawa, Yasukazu] Inst Laser Technol, Suita, Osaka 5650871, Japan; [Kasaoka, Makoto; Nagano, Yoshitomo] Kanden Engn Corp, Minato Ku, Osaka 5520013, Japan	Somekawa, T (reprint author), Inst Laser Technol, 2-6 Yamadaoka, Suita, Osaka 5650871, Japan.						ALLEN G, 1955, CAN J CHEM, V33, P1055, DOI 10.1139/v55-121; Okabe S, 2013, IEEE T DIELECT EL IN, V20, P346, DOI 10.1109/TDEI.2013.6451376; Kim T, 2011, J RAMAN SPECTROSC, V42, P2069, DOI 10.1002/jrs.2951; Duval M., 1989, IEEE Electrical Insulation Magazine, V5, DOI 10.1109/57.44605; Morais RM, 1999, IEEE T DIELECT EL IN, V6, P159, DOI 10.1109/94.765905; Somekawa T, 2013, OPT LETT, V38, P1086, DOI 10.1364/OL.38.001086	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					229	231		10.1109/TDEI.2014.004800		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900028		
J	Okabe, S; Tsuboi, T; Ueta, G				Okabe, Shigemitsu; Tsuboi, Toshihiro; Ueta, Genyo			Uncertainty in K-factor Measurement for Lightning Impulse Voltage Test	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Lightning impulse voltage test; k-factor; uncertainty; measuring system; IEC 60060-1; IEC 60060-2	TIME-RELATED CHARACTERISTICS; TEST WAVE-FORM; INSULATION BREAKDOWN CHARACTERISTICS; OVERSHOOT	The IEC-60060-1 "High-voltage test technique" was revised in 2010 and an evaluation method using the k-factor function (test voltage function) was introduced for the lightning impulse voltage test, which involved the overshoot waveform being converted into the test voltage waveform. Test standards for UHV-class equipment are also presently being studied. To date, authors have measured k-factor values with the largest possible model, assuming actual UHV-class power equipment and proposed a new k-factor function for large-scale equipment. The present paper reports on the evaluation results of expanded uncertainty when measuring a k-factor value on the basis of the ISO/IEC Guide 98-3. As a result, it was clarified that significant uncertainty in measuring a k-factor value is brought about by the definition of the k-factor itself because small differences in the 50% breakdown voltage between the smooth lightning impulse and overshoot waveforms with respective uncertainties at a certain level were calculated. The expanded uncertainty when measuring the k-factor value in the present study for an overshoot rate of 10%, which is particularly important for practical use, was a large value of +/-0.23 to +/-0.36, or 0.46 to 0.72 in top-to-bottom width compared to k-factor values themselves ranging from 0.2 to 1.0. However, this is actually considered a minimum level of uncertainty, which is inevitable in principle, and the best achievable measurement result rather than something caused by any problem in measurement itself.	[Okabe, Shigemitsu; Tsuboi, Toshihiro; Ueta, Genyo] Tokyo Elect Power Co Ltd, High Voltage & Insulat Grp, R&D Ctr, Tsurumi Ku, Yokohama, Kanagawa 2308510, Japan	Okabe, S (reprint author), Tokyo Elect Power Co Ltd, High Voltage & Insulat Grp, R&D Ctr, Tsurumi Ku, 4-1 Egasaki Cho, Yokohama, Kanagawa 2308510, Japan.						[Anonymous], 2010, 600601 IEC; Simon P, 2006, IEEE T POWER DELIVER, V21, P560, DOI 10.1109/TPWRD.2005.858807; Ueta G, 2011, IEEE T DIELECT EL IN, V18, P783, DOI 10.1109/TDEI.2011.5931066; [Anonymous], 1993, UNC MEAS 3; [Anonymous], 2010, IEC600602; [Anonymous], 2013, IEC610832; Hinow M, 2010, IEEE T DIELECT EL IN, V17, P1628, DOI 10.1109/TDEI.2010.5595567; [Anonymous], 2001, IEC610831; Berlijn S., 1999, DIGITAL MEASUREMENT; Garnacho F., 2002, 204 EL, P30; Hallstrom J., 2005, 14 INT S HIGH VOLT I; Okabe S., 2012, CIGRE PAR SESS 2012; Riechert U., 2011, CIGRE SC A2 D1 JOINT; Riechert U., 2013, CIGRE SC B3 D1 JOINT; Tsuboi T, 2011, IEEE T DIELECT EL IN, V18, P1734, DOI 10.1109/TDEI.2011.6032845; Tsuboi T, 2011, IEEE T DIELECT EL IN, V18, P2049, DOI 10.1109/TDEI.2011.6118643; Ueta G, 2012, IEEE T DIELECT EL IN, V19, P1383, DOI 10.1109/TDEI.2012.6260015; Ueta G, 2012, IEEE T DIELECT EL IN, V19, P877, DOI 10.1109/TDEI.2012.6215090	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					266	277		10.1109/TDEI.204.004692		12	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900033		
J	Hirose, H; Sakumura, T				Hirose, Hideo; Sakumura, Takenori			Foundation of Mathematical Deterioration Models for the Thermal Stress	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Thermal deterioration; Arrhenius law; generalized Pareto distribution; generalized logistic distribution; log-normal distribution; ordinary differential equation; growth curve; maximum likelihood estimation method; method of least squares	LIFE TEST DATA; ELECTRICAL INSULATION; DEGRADATION	We construct mathematical models to represent the relationship between the thermal stress and the deterioration rate for electrical insulation. The Arrhenius-log-normal model has been used generally for such a deterioration model due to the thermal stress. The Arrhenius law is based on the chemical reaction theory between the absolute temperature and the activity of materials. On the other hand, as for the log-normal distribution, we have been only followed the traditional statistical treatment such that the deterioration could be represented by the normal distribution when logarithmic time is used. The Arrhenius-log-normal model is a combination of these two models. However, in the International Electrotechnical Commission 60216-1, deterioration due to the thermal stress is represented by the mechanical strength, and the time showing 50% mechanical strength to the initial strength is defined as the failure time. We assume here the generalized Pareto distribution model, the generalized logistic distribution model, or the normal distribution model for such a model. Thus, in this paper, we construct new mathematical models combined by the Arrhenius law with the generalized Pareto distribution model, the generalized logistic distribution model, or the normal distribution model.	[Hirose, Hideo; Sakumura, Takenori] Kyushu Inst Technol, Fukuoka, Japan	Hirose, H (reprint author), Kyushu Inst Technol, Fukuoka, Japan.						60216 IEC, 2001, 60216 IEC; NELDER JA, 1965, COMPUT J, V7, P308; Montanari GC, 2002, IEEE T DIELECT EL IN, V9, P730, DOI 10.1109/TDEI.2002.1038660; CYGAN P, 1990, IEEE T ELECTR INSUL, V25, P923, DOI 10.1109/14.59867; Dakin T.W., 1960, Electro-Technology, V66; Dakin Thomas W., 1948, AIEE T, V67, P113; Devaux A., 1968, RELIABILITY DEV HI 1, P21; Glasstone S., 1941, THEORY RATE PROCESSE; HIROSE H, 1987, IEEE T ELECTR INSUL, V22, P745, DOI 10.1109/TEI.1987.298936; Hirose H., 1986, T IEE JAPAN A, V106-A, P185; MONTANARI GC, 1990, IEEE T ELECTR INSUL, V25, P1037, DOI 10.1109/14.64488; MONTANARI GC, 1990, IEEE T ELECTR INSUL, V25, P309, DOI 10.1109/14.52377; MONTANARI GC, 1993, IEEE T ELECTR INSUL, V28, P755, DOI 10.1109/14.237740; Montsinger V. M., 1944, AIEE T, V67, P113; NELSON W, 1972, IEEE T ELECTR INSUL, VEI 7, P36; NELSON W, 1981, IEEE T RELIAB, V30, P149; Nelson W., 2003, APPL LIFE DATA ANAL; NELSON W, 1971, IEEE T ELECTR INSUL, VEI 6, P165, DOI 10.1109/TEI.1971.299172; Nelson W. B., 1970, 71C011 TIS; OCCHINI E, 1971, IEEE T POWER AP SYST, VPA90, P2671, DOI 10.1109/TPAS.1971.292920; SIMONI L, 1981, IEEE T ELECTR INSUL, V16, P277, DOI 10.1109/TEI.1981.298361; Skiadas CH, 2010, METHODOL COMPUT APPL, V12, P261, DOI 10.1007/s11009-009-9145-3	22	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					482	487		10.1109/TDEI.2014.004450		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900056		
J	Hirose, H; Sakumura, T; Tabuchi, N				Hirose, Hideo; Sakumura, Takenori; Tabuchi, Naoki			Optimum and Semi-optimum Life Test Plans of Electrical Insulation for Thermal Stress	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Optimum test plan; semi-optimum test plan; thermal deterioration; Arrhenius law; normal distribution; generalized Pareto distribution; generalized logistic distribution; method of least squares; maximum likelihood estimation method	DISTRIBUTIONS	Assuming that the Arrhenius law holds between the thermal stress and the lifetime, and that the logarithmic lifetime follows some consistent probability distributions at a constant stress. Under such life models, it is crucial to show the optimum test design from an efficiency viewpoint. It would also be useful to know the semi-optimum test plan in which the efficiency is close to that in the optimum one and the test condition is simple. The optimization target is to find the optimum number of test specimens at each test stress level, and we consider the case that the number of stress level is three. The criterion for optimality is measured by the root mean squared error for the lifetime in use condition. To take into account the reality, we used the parameter values in a real experimental case. Comparing the optimum results with those using the conventional test method where test specimens are equally allocated to each test stress level, we have found that there is only a small difference between the optimum test result and the conventional test result if linearity of the Arrhenius plot is required. We may regard the conventional test plan as one of the semi-optimum test plans. We have checked the consistency between the theoretical results and the simulation results.	[Hirose, Hideo; Sakumura, Takenori; Tabuchi, Naoki] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Iizuka, Fukuoka 8208502, Japan	Hirose, H (reprint author), Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Kawazu 680-4, Iizuka, Fukuoka 8208502, Japan.						MEEKER WQ, 1984, TECHNOMETRICS, V26, P157, DOI 10.2307/1268110; Zhang Y, 2006, TECHNOMETRICS, V48, P49, DOI 10.1198/004017005000000373; NELDER JA, 1965, COMPUT J, V7, P308; Montanari GC, 2002, IEEE T DIELECT EL IN, V9, P730, DOI 10.1109/TDEI.2002.1038660; NELSON W, 1976, TECHNOMETRICS, V18, P105, DOI 10.2307/1267923; CYGAN P, 1990, IEEE T ELECTR INSUL, V25, P923, DOI 10.1109/14.59867; Dakin Thomas W., 1948, AIEE T, V67, P113; Hirose H, 2015, IEEE T DIELECT EL IN, V22, P482, DOI 10.1109/TDEI.2014.004450; Kielpinski T.J., 1975, IEEE T RELIAB, V24, pI310; MEETER CA, 1994, TECHNOMETRICS, V36, P71, DOI 10.2307/1269200; MONTANARI GC, 1990, IEEE T ELECTR INSUL, V25, P1037, DOI 10.1109/14.64488; MONTANARI GC, 1993, IEEE T ELECTR INSUL, V28, P755, DOI 10.1109/14.237740; Montsinger V. M., 1944, AIEE T, V67, P113; NELSON W, 1972, IEEE T ELECTR INSUL, VEI 7, P36; Nelson W., 1972, 72CRD215 TIS GEN EL; NELSON W, 1971, IEEE T ELECTR INSUL, VEI 6, P165, DOI 10.1109/TEI.1971.299172; SIMONI L, 1981, IEEE T ELECTR INSUL, V16, P277, DOI 10.1109/TEI.1981.298361	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					488	494		10.1109/TDEI.2014.004506		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900057		
J	Okabe, S; Ueta, G; Nojima, K				Okabe, Shigemitsu; Ueta, Genyo; Nojima, Kenichi			Insulation Characteristics of GIS Epoxy Insulators with Non-uniform Surface Resistance under DC Voltage	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Gas insulated switchgear (GIS); epoxy insulator; dc voltage; surface resistance; SF6 gas; insulation characteristic; transient electric field analysis; lightning impulse voltage test	SF6 GAS; SPACERS; MECHANISM	Now that gas-insulated switchgear (GIS) for ac systems are becoming increasingly compact as specifications are rationalized, more consideration of their insulation characteristics for residual dc voltage is required. Furthermore, with dc power transmission technology drawing more and more global attention, clarifying the insulation characteristics of GIS for dc voltage is increasingly important. For GIS insulating epoxy spacer, the present paper experimentally and analytically studied the influence of spacer surface condition on dc withstand voltage performance. In specific terms, initially, an insulating spacer model with an area of non-uniform resistivity present in the surface layer was created and the dc voltage breakdown characteristics were obtained. As a result, it was clarified that the time delay to breakdown increased with lowering the applied voltage, or in other words, even if a low voltage was applied, breakdown may occur after an extended period. Subsequently, using the same non-uniform resistivity model, the change in the electric field distribution over time under dc voltage was investigated through transient electric field analysis. Consequently, it was found that the electric field distribution varied from a capacitive to a resistive field and the maximum electric field was generated in the boundary between the high-and low-resistivity areas. It was further clarified, based on these breakdown characteristics and electric field analytical results, that the presence of an area of non-uniform resistivity on the insulating spacer creepage surface caused electric field concentration over time and breakdown occurred if the electric field in the creepage surface direction exceeded 40 kV/mm or so. Moreover, the breakdown characteristics were investigated where a lightning impulse voltage was superimposed over a dc voltage. Consequently, the creepage breakdown electric field where a dc voltage was applied alone was almost identical to that where the superimposed voltage was applied. It means that the application of the superimposed voltage may potentially allow the insulating spacer withstand voltage performance to be evaluated by a shorter time test for a dc voltage alone or the dc voltage with a superimposed VFTO.	[Okabe, Shigemitsu; Ueta, Genyo] Tokyo Elect Power Co Ltd, Tsurumi Ku, Yokohama, Kanagawa 2308510, Japan; [Nojima, Kenichi] Toshiba Co Ltd, Kawasaki Ku, Kawasaki, Kanagawa 2100862, Japan	Okabe, S (reprint author), Tokyo Elect Power Co Ltd, Tsurumi Ku, 4-1 Egasaki Cho, Yokohama, Kanagawa 2308510, Japan.						FUJINAMI H, 1989, IEEE T POWER DELIVER, V4, P1765, DOI 10.1109/61.32671; [Anonymous], 2012, WGD103 CIGRE; [Anonymous], 2008, WGC4302 CIGRE; [Anonymous], 2000, IEEJ T B, V120- B, P581; De Lorenzi A, 2009, IEEE T DIELECT EL IN, V16, P77, DOI 10.1109/TDEI.2009.4784554; NAKANISHI K, 1983, IEEE T POWER AP SYST, V102, P3919, DOI 10.1109/TPAS.1983.317931; [Anonymous], 2011, 62271203 IEC; Houghton T., 2012, C1117 CIGRE; Nayak R. N., 2009, IEC CIGRE 2 UHV S; Okabe S, 2014, IEEE T DIELECT EL IN, V21, P1260, DOI [10.1109/TDEI.2014.6832273, 10.1109/TDEI.2014.004428]; Okabe S, 2007, IEEE T DIELECT EL IN, V14, P46, DOI 10.1109/TDEI.2007.302871; Qi B., 2013, CIGRE SC B3 D1 JOINT; Schichler U., 2013, CIGRE SC B3 D1 JOINT	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					516	525		10.1109/TDEI.2014.004513		10	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900061		
J	Naruse, H; Saito, H; Sakaki, M; Yamamoto, O				Naruse, Hiroki; Saito, Hitoshi; Sakaki, Masayuki; Yamamoto, Osamu			Flashover Mechanisms of Bridged Vacuum Gaps Based on Cathode Electric Field Measurement	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Flashover; vacuum; SEEA charge; electric field; insulator; roughness; Al2O3	SURFACE; VOLTAGE	In bridged vacuum gaps, it is believed that the secondary electron emission avalanche (SEEA) and the resultant insulator charging play a crucial role in the progress of discharge leading to the surface flashover. This paper deals with the electric field just before the flashover that includes the accumulated SEEA charge component (E-sF) and applied geometrical field component (E-gF) on a cathode and their relation to the flashover voltage. The test gap consists of parallel disc electrodes bridged by an insulating solid cylinder made of Al2O3. The test insulator changes its length from 5 to 50 mm. As it has been clarified in our previous works that surface roughness of the insulator affects SEEA charge accumulation, we have examined the roughness ranging from 0.2 to 6 mu m. Aluminum electrodes are mainly examined, and copper and stainless electrodes are used for comparison. A ring type electrostatic probe embedded near the triple junction on the cathode is employed to measure the electric field. As a result, the total field strength (E-gF + E-sF) for various insulator conditions with aluminum electrodes is 6.7 kVmm(-1) as an average. However, the rate (gamma) of SEEA charge component that accounts for the total electric field varies according to the insulator length and the roughness. When. exceeds ca. 15%, the flashover voltage V-b depends on the square root of the insulator length. On the other hand, V-b is a linear function of the insulator length when the SEEA charging is depressed and thus gamma is smaller than 15%. On the condition that gamma<15%, the material of electrode makes an impact on the flashover voltage.	[Naruse, Hiroki] Kyoto Univ, Dept Elect Engn, Kyoto 6158510, Japan; [Saito, Hitoshi; Sakaki, Masayuki] Meidensha Co, Numazu 4108588, Japan; [Yamamoto, Osamu] Res Inst Appl Sci, Kyoto 6068202, Japan	Naruse, H (reprint author), Kyoto Univ, Dept Elect Engn, Kyoto 6158510, Japan.				JSPS KAKENHI [22560272]	This work was partly supported by JSPS KAKENHI Grant Number 22560272.	Inguimbert V, 2013, IEEE T PLASMA SCI, V41, P3370, DOI 10.1109/TPS.2013.2259150; Boersch H., 1963, Zeitschrift fur Angewandte Physik, V15; DETOURRE.CH, 1973, IEEE T ELECTR INSUL, VEI 8, P17, DOI 10.1109/TEI.1973.299238; Hawley R., 1967, PROG DIELECTR, V7, P115; Nakano Y., 2014, IEEE T DIELECT EL IN, V21, P503; Pillai S., 1982, J APPL PHYS, V53, P2983; Yamamoto O, 2003, IEEE T DIELECT EL IN, V10, P550, DOI 10.1109/TDEI.2003.1219636; Yamamoto O, 1998, IEEE T DIELECT EL IN, V5, P961, DOI 10.1109/94.740783; Zheng A. N., 2011, IEEE T DIELECT EL IN, V18, P1011	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	FEB	2015	22	1					597	603		10.1109/TDEI.2014.004566		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CB6ZZ	WOS:000349776900071		
J	Galli, L; Baracchini, E; Bettarini, S; Bosi, F; Cavallaro, E; Dussoni, S; Minuti, M; Morsani, F; Nicolo, D; Signorelli, G; Tenchini, F; Venturini, M; Walsh, J				Galli, L.; Baracchini, E.; Bettarini, S.; Bosi, F.; Cavallaro, E.; Dussoni, S.; Minuti, M.; Morsani, F.; Nicolo, D.; Signorelli, G.; Tenchini, F.; Venturini, M.; Walsh, J.			A Silicon-Based Cosmic Ray Telescope as an External Tracker to Measure Detector Performance	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Instrumentation and measurement; ionizing radiation sensors; nuclear measurement; particle tracking sensors; radiation detectors; semiconductor radiation detectors	VERTEX TRACKER	High-energy physics experiments at the high-intensity frontier place ever-greater demands on detectors, and in particular on tracking devices. In order to compare the performance of many possible small-size tracking prototypes, a high-resolution cosmic ray tracker may be used as an external track reference. We have constructed a telescope by assembling four spare ladders of the external layers of the Silicon Vertex Tracker of the BaBar experiment. This test facility, operating at INFN Sezione di Pisa, provides the detector under test with an external track with an intrinsic resolution of 15-30 mu m. The DAQ originally used in the BaBar experiment was replaced by custom-designed boards coupled with an acquisition front-end personal computer through commercial field-programmable gate array evaluation boards. We show that the facility is operative, and we present the performance in terms of tracking resolution and efficiency. A first device has been characterized, and some plots from the analysis demonstrating the telescope performance are shown.	[Galli, L.; Bettarini, S.; Bosi, F.; Cavallaro, E.; Dussoni, S.; Minuti, M.; Morsani, F.; Nicolo, D.; Signorelli, G.; Tenchini, F.; Venturini, M.; Walsh, J.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Baracchini, E.] Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; [Bettarini, S.; Cavallaro, E.; Nicolo, D.] Univ Pisa, I-56126 Pisa, Italy; [Venturini, M.] Scuola Normale Super Pisa, I-56126 Pisa, Italy	Galli, L (reprint author), Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy.	luca.galli@pi.infn.it					Bozzi C, 2000, NUCL INSTRUM METH A, V453, P78, DOI 10.1016/S0168-9002(00)00609-4; Aubert B, 2002, NUCL INSTRUM METH A, V479, P1, DOI 10.1016/S0168-9002(01)02012-5; Baldini A. M., 2013, MEG UPGRADE PR UNPUB; Galli L, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/01/P01008; Galli L, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/04/P04022; Papoulis A., 1991, PROBABILITY RANDOM V; Re V, 1998, NUCL INSTRUM METH A, V409, P354, DOI 10.1016/S0168-9002(97)01298-9	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	FEB	2015	62	1	2				395	402		10.1109/TNS.2014.2387881		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CB5MZ	WOS:000349672900027		
J	Xie, M; Hu, JK; Guo, S				Xie, Miao; Hu, Jiankun; Guo, Song			Segment-Based Anomaly Detection with Approximated Sample Covariance Matrix in Wireless Sensor Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Wireless sensor network; anomaly detection; distributed computing; spatial analysis; Spearman's rank correlation coefficient; differential compression		In wireless sensor networks (WSNs), it has been observed that most abnormal events persist over a considerable period of time instead of being transient. As existing anomaly detection techniques usually operate in a point-based manner that handles each observation individually, they are unable to reliably and efficiently report such long-term anomalies appeared in an individual sensor node. Therefore, in this paper, we focus on a new technique for handling data in a segment-based manner. Considering a collection of neighbouring data segments as random variables, we determine those behaving abnormally by exploiting their spatial predictabilities and, motivated by spatial analysis, specifically investigate how to implement a prediction variance detector in a WSN. As the communication cost incurred in aggregating a covariance matrix is finally optimised using the Spearman's rank correlation coefficient and differential compression, the proposed scheme is able to efficiently detect a wide range of long-term anomalies. In theory, comparing to the regular centralised approach, it can reduce the communication cost by approximately 80 percent. Moreover, its effectiveness is demonstrated by the numerical experiments, with a real world data set collected by the Intel Berkeley Research Lab (IBRL).	[Xie, Miao; Hu, Jiankun] Univ New S Wales, Australian Def Force Acad, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Performance Evaluat Lab, Aizu Wakamatsu, Fukushima 9658580, Japan	Xie, M (reprint author), Univ New S Wales, Australian Def Force Acad, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia.	clifford1984621@gmail.com; j.hu@adfa.edu.au; sguo@u-aizu.ac.jp					Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Sharma AB, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1754414.1754419; Vuran MC, 2006, IEEE ACM T NETWORK, V14, P316, DOI 10.1109/TNET.2006.872544; Rajasegarar S, 2010, IEEE T INF FOREN SEC, V5, P518, DOI 10.1109/TIFS.2010.2051543; Wiesel A, 2009, IEEE T SIGNAL PROCES, V57, P4369, DOI 10.1109/TSP.2009.2025806; Raymond DR, 2008, IEEE PERVAS COMPUT, V7, P74, DOI 10.1109/MPRV.2008.6; Xie M, 2013, IEEE T PARALL DISTR, V24, P1661, DOI 10.1109/TPDS.2012.261; Baronti P, 2007, COMPUT COMMUN, V30, P1655, DOI 10.1016/j.comcom.2006.12.020; Xie M, 2011, J NETW COMPUT APPL, V34, P1302, DOI 10.1016/j.jnca.2011.03.004; Guo S, 2009, SENSYS 09: PROCEEDINGS OF THE 7TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS, P253; Vuran MC, 2004, COMPUT NETW, V45, P245, DOI 10.1016/j.comnet.2004.03.007; Wiesel A, 2012, IEEE T SIGNAL PROCES, V60, P211, DOI 10.1109/TSP.2011.2172430; Delouille V, 2006, IEEE T SIGNAL PROCES, V54, P2998, DOI 10.1109/TSP.2006.874839; Ding M, 2005, IEEE INFOCOM SER, P902; Carman D.W., 010 SEC RES DIV NETW; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Chen Jiaqian, 2006, Proceedings of the 2006 IEEE International Conference on Information Acquisition, DOI 10.1109/ICIA.2006.305813; Cormen T. H., 2001, INTRO ALGORITHMS; Gay D., 2009, TECHNICAL REPORT; Jindal A., 2006, ACM T SENSOR NETWORK, V2, P466, DOI 10.1145/1218556.1218558; Kahan W., 1965, J SOC IND APPL MAT B, V2, P205, DOI DOI 10.1137/0702016; Knight K., 1999, MATH STAT; Liu F., 2007, P 26 IEEE INT C COMP, P1937; Moshtaghi M., 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), DOI 10.1109/ICDM.2011.80; Myers JL, 2003, RES DESIGN STAT ANAL; Nijim YW, 1996, IEEE T GEOSCI REMOTE, V34, P52, DOI 10.1109/36.481892; Rajamani S. K., 2006, Proceedings. 21st IEEE International Conference on Automated Software Engineering; Subramaniam S., 2006, P 32 INT C VER LARG, P187; Webster R., 2007, GEOSTATISTICS ENV SC; Wen S., 2010, P 12 IEEE INT C HIGH, P695; Xie M., 2012, P IEEE 11 INT C TRUS, P751	31	2	2	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	FEB	2015	26	2					574	583		10.1109/TPDS.2014.2308198		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CB6XE	WOS:000349769300023		
J	Man, CS; Nakamura, G; Tanuma, K; Wang, SZ				Man, Chi-Sing; Nakamura, Gen; Tanuma, Kazumi; Wang, Shengzhang			Dispersion of Rayleigh waves in vertically-inhomogeneous prestressed elastic media	IMA JOURNAL OF APPLIED MATHEMATICS			English	Article						Rayleigh waves; vertical inhomogeneity; dispersion; surface impedance matrix; prestressed anisotropic media	OSCILLATING-DECAYING SOLUTIONS; RESIDUAL-STRESS; ULTRASONIC MEASUREMENT; IMPEDANCE METHOD; STROH FORMALISM; SURFACE-WAVES; HALF-SPACES; SYSTEMS; ALLOY	Herein we consider Rayleigh waves propagating in a given direction along the traction-free boundary of an anisotropic and prestressed elastic half-space, the effective incremental elasticity tensor and mass density of which are smooth functions of depth from the traction-free surface. We derive a high-frequency asymptotic formula which, for a large wave number, expresses the phase velocity of the Rayleigh waves in question in terms of the values of the effective incremental elasticity tensor, the mass density, and their first and higher-order normal derivatives at the traction-free boundary. We develop a procedure which, through an asymptotic expansion of the surface impedance matrix, can deliver an expression for each term of the asymptotic expansion of the Rayleigh-wave velocity. Our asymptotic formula thus gives a characterization of the frequency dependence of Rayleigh waves as caused by the vertical inhomogeneity of the medium, thereby providing a mathematical foundation for work on non-destructive evaluation of the depth dependence of near-surface stress and/or material parameters through their effect on the dispersion of Rayleigh waves.	[Man, Chi-Sing] Univ Kentucky, Dept Math, Lexington, KY 40506 USA; [Nakamura, Gen] Hokkaido Univ, Grad Sch Sci, Dept Math, Sapporo, Hokkaido 0600810, Japan; [Tanuma, Kazumi] Gunma Univ, Fac Sci & Technol, Dept Math, Kiryu, Gumma 3768515, Japan; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Tanuma, K (reprint author), Gunma Univ, Fac Sci & Technol, Dept Math, Kiryu, Gumma 3768515, Japan.	tanuma@gunma-u.ac.jp	Man, Chi-Sing/E-4794-2011	Man, Chi-Sing/0000-0001-9166-2832	National Science Foundation of the United States [DMS-0807543]; Society for the Promotion of Science, Japan [22340023, 22540111]	This work was supported by the National Science Foundation of the United States (DMS-0807543 to C.-S. M.); Grant-in-Aid for Scientific Research (B), Society for the Promotion of Science, Japan (22340023 to G. N.); and Grant-in-Aid for Scientific Research (C), Society for the Promotion of Science, Japan (22540111 to K. T.).	LOTHE J, 1976, J APPL PHYS, V47, P428, DOI 10.1063/1.322665; Nakamura G, 2006, CONTEMP MATH, V408, P219; Fu YB, 2002, P ROY SOC A-MATH PHY, V458, P2523, DOI 10.1098/rspa.2002.1000; BARNETT DM, 1985, P ROY SOC LOND A MAT, V402, P135, DOI 10.1098/rspa.1985.0111; Bellman R, 1997, INTRO MATRIX ANAL, V2nd; Biryukov S.V., 1995, SURFACE ACOUSTIC WAV; BIRYUKOV SV, 1985, SOV PHYS ACOUST+, V31, P350; CHADWICK P, 1977, ADV APPL MECH, V17, P303, DOI 10.1016/S0065-2156(08)70223-0; Destrade M, 2007, P R SOC A, V463, P495, DOI 10.1098/rspa.2006.1774; Duvaut G, 1976, INEQUALITIES MECH PH; Evans L.C., 2002, PARTIAL DIFFERENTIAL; Gantmacher F. R., 1960, THEORY MATRICES; HOGER A, 1986, J ELASTICITY, V16, P303, DOI 10.1007/BF00040818; Horgan C, 1996, ANISOTROPIC ELASTICI; Lavrentyev AI, 2001, REV PROG Q, V557, P1472; Lions J.-L., 1972, NONHOMOGENEOUS BOUND; Man CS, 2000, AIP CONF PROC, V509, P1613; MAN CS, 1987, J ELASTICITY, V17, P159, DOI 10.1007/BF00043022; MAN CS, 1994, ARCH RATION MECH AN, V128, P223, DOI 10.1007/BF00386246; Man CS, 2002, AIP CONF PROC, V615, P1651; Mielke A, 2004, MATH MECH SOLIDS, V9, P5, DOI 10.1177/1081286503035196; Mizohata S., 1973, THEORY PARTIAL DIFFE; Moreau A, 2006, AIP CONF PROC, V820, P1434; Moreau A., 2005, P MS T 2005 C PITTS, P97; Nakamura G, 2003, CHINESE J MECH-SER A, V19, P119; NAKAMURA G, 1991, SIAM PROC S, P215; Pham C. V., 2009, WAVE MOTION, V46, P427; RODMAN L., 1982, MATRIX POLYNOMIALS; Tanuma K, 2007, J ELASTICITY, V89, P5, DOI 10.1007/s10659-007-9117-1; Taylor M. E., 1979, P C PDE GEOM NEW YOR, P273; Ting TCT, 2011, WAVE MOTION, V48, P335, DOI 10.1016/j.wavemoti.2010.12.001; Ting TCT, 2011, J ELASTICITY, V105, P331, DOI 10.1007/s10659-011-9314-9; Wloka J., 1987, PARTIAL DIFFERENTIAL	33	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0272-4960	1464-3634		IMA J APPL MATH	IMA J. Appl. Math.	FEB	2015	80	1					47	84		10.1093/imamat/hxt025		38	Mathematics, Applied	Mathematics	CC2WA	WOS:000350204300003		
J	Singh, TS; Hiromu, S; Devi, KR; Singh, WA				Singh, T. S.; Hiromu, S.; Devi, K. R.; Singh, W. A.			First case of Paragonimus westermani infection in a female patient in India	INDIAN JOURNAL OF MEDICAL MICROBIOLOGY			English	Article						India; northeast India; Paragonimus westermani; pulmonary paragonimiasis	NORTHEASTERN INDIA; HETEROTREMUS; DIAGNOSIS; FEATURES; MANIPUR; FOCUS	Paragonimiasis is a foodborne parasitic zoonosis caused by lung fluke species of the genus Paragonimus. The Paragonimus westermani is the most common human pathogen in Asian countries. In northeast India, Paragonimus heterotremus has been documented as the only human pathogen in the earlier literature. In India, P. westermani infection in humans remained undetermined. Herein, we report a case of pulmonary paragonimiasis due to P. westermani in an adult female in Manipur. The diagnosis was made by morphological and molecular characterisation of the eggs in the sputum. This is the first confirmed case of paragonimiasis due to P. westermani in India.	[Singh, T. S.] Sikkim Manipal Inst Med Sci, Dept Microbiol, Gangtok, Sikkim, India; [Hiromu, S.] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Devi, K. R.] Reg Inst Med Sci, Dept Microbiol, Imphal, Manipur, India; [Singh, W. A.] Reg Inst Med Sci, Dept TB & Chest Med, Imphal, Manipur, India	Singh, TS (reprint author), Sikkim Manipal Inst Med Sci, Dept Microbiol, Gangtok, Sikkim, India.	shantikumar_singh@rediffmail.com			Japan Society for the Promotion of Science, JSPS (KAKENHI) [25305011]; Ministry of Health, Labor and Welfare of Japan [H23-Shinko-ippan-014, H26-Shinko-ippan-009]	This study was supported in part by the Japan Society for the Promotion of Science, JSPS (KAKENHI: Grant No. 25305011) and by grants for Research on Emerging and Re-emerging Infectious Diseases (H23-Shinko-ippan-014 and H26-Shinko-ippan-009) from the Ministry of Health, Labor and Welfare of Japan.	Singh TS, 2012, INDIAN J MED RES, V136, P192; Devi KR, 2010, ACTA TROP, V116, P31, DOI 10.1016/j.actatropica.2010.05.003; Devi KR, 2007, T ROY SOC TROP MED H, V101, P786, DOI 10.1016/j.trstmh.2007.02.028; Miyazaki I., 1974, S EP PAR DIS INT MED, P101; Narain KL, 2003, CURR SCI INDIA, V84, P985; Singh T. S., 2007, SE ASIAN J TROP M S1, V38, P82; Singh TS, 2009, INDIAN J MED MICROBI, V27, P123, DOI 10.4103/0255-0857.49424; SINGH TS, 1993, INDIAN J MED RES-A, V97, P247; SINGH TS, 1986, T ROY SOC TROP MED H, V80, P967, DOI 10.1016/0035-9203(86)90275-0; Sugiyama H, 2002, MOL CELL PROBE, V16, P231, DOI 10.1006/mcpr.2002.0417; Sugiyama H, 2013, MOL DETECTION HUMAN, P421	11	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0255-0857	1998-3646		INDIAN J MED MICROBI	Indian J. Med. Microbiol.	FEB	2015	33			1			S156	S159		10.4103/0255-0857.150950		4	Immunology	Immunology	CB7YE	WOS:000349843900035		
J	Motoyama, H; Chen, FS; Hijiya, K; Kondo, T; Ohata, K; Takahashi, M; Yamada, T; Sato, M; Aoyama, A; Date, H				Motoyama, Hideki; Chen, Fengshi; Hijiya, Kyoko; Kondo, Takeshi; Ohata, Keiji; Takahashi, Mamoru; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Date, Hiroshi			Novel thermographic detection of regional malperfusion caused by a thrombosis during ex vivo lung perfusion	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung transplantation; Marginal donor; Ex vivo lung perfusion; Thrombosis	HEART-BEATING DONORS; FEASIBLE METHOD; BREAST-CANCER; TRANSPLANTATION	OBJECTIVES: Although ex vivo lung perfusion (EVLP) has been clinically applied as a novel rig to evaluate marginal donor lungs, no parameters have been reported to objectively detect regional lung damage during EVLP. The aim of this study was to investigate whether regional donor lung malperfusion-related damage caused by a thrombus could be detected by thermography during EVLP. METHODS: Lewis rats were divided into two groups: the Thrombosis group and the Control group (n = 6 in each group). All rats were heparinized and the lungs were flushed with 20 ml of Steen solution. In the Thrombosis group, a 30-mg artificial thrombus was inserted into the left main pulmonary artery. All the lungs were perfused and ventilated using the EVLP system. Perfusion flow was increased every 2 min up to 10 ml/min. The lungs were evaluated by collecting thermographical and physiological data during EVLP. RESULTS: Pulmonary artery pressure was higher and lung compliance was lower in the Thrombosis group compared with those in the Control group (P = 0.0005 and <0.0001, respectively). Macroscopically, no differences were seen between the perfused area and the malperfused area, whereas significant differences were detected between them by thermography. The surface temperature of both lungs in the Control group and the right lungs in the Thrombosis group rose with increasing perfusion flow, whereas the surface temperature of the left lungs in the Thrombosis group did not rise (P < 0.0001). CONCLUSIONS: Although physiological data could possibly imply the existence of thrombi in the Thrombosis group, it could not reveal which area was obstructed by thrombi; however, thermography could detect a malperfused region. Thermographical evaluation may become a promising strategy to detect regional damage in donor lungs.	[Motoyama, Hideki; Chen, Fengshi; Hijiya, Kyoko; Kondo, Takeshi; Ohata, Keiji; Takahashi, Mamoru; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto 6068507, Japan	Date, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp					FEIG SA, 1977, AM J ROENTGENOL, V128, P403; de Antonio DG, 2007, J HEART LUNG TRANSPL, V26, P529, DOI 10.1016/j.healun.2007.01.028; Kontos M, 2011, CLIN RADIOL, V66, P536, DOI 10.1016/j.crad.2011.01.009; Inci I, 2008, J HEART LUNG TRANSPL, V27, P1229, DOI 10.1016/j.healun.2008.07.027; Warnecke G, 2012, LANCET, V380, P1851, DOI 10.1016/S0140-6736(12)61344-0; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Brkljacic B, 2013, COLLEGIUM ANTROPOL, V37, P589; Christensen J, 2014, J ORAL MAXIL SURG, V72, P463, DOI 10.1016/j.joms.2013.09.035; Egan TM, 2004, J HEART LUNG TRANSPL, V23, P3, DOI 10.1016/S1053-2498(02)00658-7; Isogai N, 1997, HEAD NECK-J SCI SPEC, V19, P143, DOI 10.1002/(SICI)1097-0347(199703)19:2<143::AID-HED10>3.0.CO;2-E; Kolaric D, 2013, COLLEGIUM ANTROPOL, V37, P583; Motoyama H, 2013, J HEART LUNG TRANSPL, V32, P505, DOI 10.1016/j.healun.2013.02.007; Nakajima D, 2012, J HEART LUNG TRANSPL, V31, P187, DOI 10.1016/j.healun.2011.11.007; Oto T, 2005, J THORAC CARDIOV SUR, V130, P1446, DOI 10.1016/j.jtcvs.2005.07.025; Sato Masaaki, 2014, Gen Thorac Cardiovasc Surg, V62, P594, DOI 10.1007/s11748-014-0418-6; Ware LB, 2005, J HEART LUNG TRANSPL, V24, P1650, DOI 10.1016/j.healun.2004.11.011; Yeung JC, 2012, J HEART LUNG TRANSPL, V31, P1120, DOI 10.1016/j.healun.2012.08.016; Yeung JC, 2011, MULTIMED MAN CARDIOT, V1	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	FEB	2015	20	2					242	247		10.1093/icvts/ivu386		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CC2UG	WOS:000350199500017		
J	Ohira, S; Watanabe, T; Yaku, H				Ohira, Suguru; Watanabe, Taiji; Yaku, Hitoshi			Layered wrapping technique combined with oxidized cellulose and vascular prosthesis for effective haemostasis in aortic surgery	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Aortic operation; Bleeding control; Surgical techniques	CIRCULATORY ARREST	Bleeding from anastomotic sites is one of the major complications of aortic surgery. We describe a novel double-layer wrapping technique using a combination of oxidized cellulose and a vascular prosthesis to effectively achieve haemostasis. The anastomotic site is surrounded by a prosthetic graft inlaid with a strip of Nu-Knit. These are fixed by horizontal mattress and over-and-over sutures. Nu-Knit acts as an ideal cushion to achieve haemostasis, because it has a haemostatic effect and fills the space between the anastomotic site and wrapping graft. This technique is simple, and facilitates adequate haemostasis without complications.	[Ohira, Suguru; Watanabe, Taiji; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto 6028566, Japan	Ohira, S (reprint author), Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	s-ohira@koto.kpu-m.ac.jp					Kamiya H, 2007, J THORAC CARDIOV SUR, V133, P501, DOI 10.1016/j.jtcvs.2006.09.045; BACHMANN F, 1975, J THORAC CARDIOV SUR, V70, P76; ISHII K, 1989, CHEST, V95, P1353, DOI 10.1378/chest.95.6.1353; LEBENDIGER A, 1960, Surg Forum, V10, P440; Lee SH, 2014, TRANSFUSION, V54, P1379, DOI 10.1111/trf.12479; Lisy M, 2013, J CARDIAC SURG, V28, P736, DOI 10.1111/jocs.12208; Matsushita T, 2013, ANN THORAC SURG, V96, P1099, DOI 10.1016/j.athoracsur.2013.04.088; Sakakibara Y, 2010, ANN THORAC SURG, V89, P992, DOI 10.1016/j.athoracsur.2009.05.066; Sasaki Kenichi, 2014, Gen Thorac Cardiovasc Surg, V62, P171, DOI 10.1007/s11748-013-0234-4; Uchida N, 2013, ANN VASC SURG, V27	10	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	FEB	2015	20	2					276	277		10.1093/icvts/ivu396		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CC2UG	WOS:000350199500025		
J	Kojima, R; Kawachi, M; Ito, M				Kojima, Ryoji; Kawachi, Masanao; Ito, Mikio			Butein suppresses ICAM-1 expression through the inhibition of I kappa B alpha and c-Jun phosphorylation in TNF-alpha- and PMA-treated HUVECs	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						ICAM-1; Butein; I kappa B; c-Jun; PMA	INTERCELLULAR-ADHESION MOLECULE-1; HUMAN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; RESPIRATORY-DISTRESS-SYNDROME; HEME OXYGENASE-1 INDUCTION; NITRIC-OXIDE PRODUCTION; ACTIVATOR PROTEIN-1; GENE-EXPRESSION; LEUKOCYTE RECRUITMENT; EPITHELIAL-CELLS	Butein (3,4,2',4'-tetrahydroxychalcone), a flavonoid derivative, has been reported to show several biological actions, including anti-inflammatory and anti-cancer. However, the possible molecular mechanisms involved are poorly understood. Treatment of human umbilical vein endothelial cells (HUVECs) with butein significantly inhibited cell surface intercellular adhesion molecule-1 (ICAM-1) expression, ICAM-1 protein synthesis, and mRNA expression induced by tumor necrotic factor-alpha (TNF-alpha) and/or phorbol 12-myristate 13-acetate (PMA). Electrophoretic mobility shift assay revealed that butein blocked activation of transcription factors, nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1), induced by TNF-a and PMA. Moreover, butein abolished TNF-alpha- and PMA-induced I kappa B alpha phosphorylation, which participates in NF-kappa B activation, and PMA-induced phosphorylation of c-Jun, a subunit composed of AP-1. In vitro, butein inhibited the phosphorylation of c-Jun, binding to GST beads, mediated by JNK isolated from PMA-treated cells. The inhibitory action of butein on the JNK-mediated in vitro c-Jun phosphorylation was abrogated in the presence of ATP. These results indicate that in HUVECs, butein suppresses the expression of ICAM-1 mRNA and protein through the inhibition of the activation of NF-kappa B and AP-1 induced by TNF-alpha and PMA, that the inhibitory action of butein on NF-kappa B activation results from the inhibition of I kappa B alpha phosphorylation by I kappa B kinase (IKK), and that the inactivation of PMA-activated AP-1 by butein is due to the blocking of JNK-mediated c-Jun phosphorylation through the inhibition of ATP binding. (C) 2014 Elsevier B.V. All rights reserved.	[Kojima, Ryoji; Kawachi, Masanao; Ito, Mikio] Meijo Univ, Lab Analyt Pharmacol, Fac Pharm, Nagoya, Aichi 4688503, Japan	Kojima, R (reprint author), Meijo Univ, Dept Analyt Pharmacol, Fac Pharm, Nagoya, Aichi 4688503, Japan.	kojima@meijo-u.ac.jp			Meijo University Research Institute	This work was supported by grants from the Meijo University Research Institute (Grant-in-Aid for Specially Promoted Research).	Yang EB, 1998, BIOCHEM BIOPH RES CO, V245, P435, DOI 10.1006/bbrc.1998.8452; Choi JS, 2004, J NUTR, V134, P1013; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Chen CC, 2004, MOL PHARMACOL, V66, P683; Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Kumar S, 2007, BIOCHEM PHARMACOL, V73, P1602, DOI 10.1016/j.bcp.2007.01.015; Kontogiorgis C, 2008, MINI-REV MED CHEM, V8, P1224, DOI 10.2174/138955708786141034; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.C700890200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; COLLINS T, 1995, FASEB J, V9, P899; Rinna A, 2008, AM J RESP CELL MOL, V39, P97, DOI 10.1165/rcmb.2007-0371OC; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Manach C, 2004, AM J CLIN NUTR, V79, P727; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Kobuchi H, 1999, AM J PHYSIOL-CELL PH, V277, pC403; Lee SH, 2004, BIOCHEM BIOPH RES CO, V323, P125, DOI 10.1016/j.bbrc.2004.08.063; Jang JH, 2012, INT J MOL MED, V30, P1357, DOI 10.3892/ijmm.2012.1158; Chang YL, 2001, MOL PHARMACOL, V60, P507; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; Hayashi K, 1996, EUR J PHARMACOL, V316, P297, DOI 10.1016/S0014-2999(96)00689-9; Hayashi K, 1996, JPN J PHARMACOL, V70, P157, DOI 10.1254/jjp.70.157; Ikezumi Y, 2003, KIDNEY INT, V63, P83, DOI 10.1046/j.1523-1755.2003.00717.x; Kojima R, 2004, BIOCHEM J, V380, P783, DOI 10.1042/BJ20040313; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee SH, 2007, BIOCHEM PHARMACOL, V74, P870, DOI 10.1016/j.bcp.2007.06.034; Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje; Madan B, 2000, MOL PHARMACOL, V58, P526; Min JK, 2005, J IMMUNOL, V175, P531; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Park PH, 2009, EUR J PHARMACOL, V606, P215, DOI 10.1016/j.ejphar.2008.12.034; Park PH, 2009, ARCH PHARM RES, V32, P79, DOI 10.1007/s12272-009-1121-5; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Yang EB, 2001, BBA-PROTEIN STRUCT M, V1550, P144, DOI 10.1016/S0167-4838(01)00276-X	43	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	FEB	2015	24	2					267	275		10.1016/j.intimp.2014.12.016		9	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CC2OD	WOS:000350183600018		
J	Yamada, T; Chen, CC; Murata, C; Hirai, H; Ojima, T; Kondo, K; Harris, JR				Yamada, Tetsuji; Chen, Chia-Ching; Murata, Chiyoe; Hirai, Hiroshi; Ojima, Toshiyuki; Kondo, Katsunori; Harris, Joseph R., III			Access Disparity and Health Inequality of the Elderly: Unmet Needs and Delayed Healthcare	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							SOCIOECONOMIC INEQUALITIES; MEDICAL-CARE; OLDER-ADULTS; INSURANCE; SATISFACTION; EXPENDITURES; ASSESSMENTS; EQUALITY; PATIENT; EQUITY	The purpose of this study is to investigate healthcare access disparity that will cause delayed and unmet healthcare needs for the elderly, and to examine health inequality and healthcare cost burden for the elderly. To produce clear policy applications, this study adapts a modified PRECEDE-PROCEED model for framing theoretical and experimental approaches. Data were collected from a large collection of the Community Tracking Study Household Survey 2003-2004 of the USA. Reliability and construct validity are examined for internal consistency and estimation of disparity and inequality are analyzed by using probit/ols regressions. The results show that predisposing factors (e.g., attitude, beliefs, and perception by socio-demographic differences) are negatively associated with delayed healthcare. A 10% increase in enabling factors (e.g., availability of health insurance coverage, and usual sources of healthcare providers) are significantly associated with a 1% increase in healthcare financing factors. In addition, information through a socio-economic network and support system has a 5% impact on an access disparity. Income, health status, and health inequality are exogenously determined. Designing and implementing easy healthcare accessibility (healthcare system) and healthcare financing methods, and developing a socio-economic support network (including public health information) are essential in reducing delayed healthcare and health inequality.	[Yamada, Tetsuji] Rutgers State Univ, Dept Econ, Ctr Children & Childhood Studies, Camden, NJ 08102 USA; [Chen, Chia-Ching] New York Med Coll, Dept Epidemiol & Community Hlth, Sch Hlth Sci & Practice, Valhalla, NY 10595 USA; [Murata, Chiyoe] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Social Sci, Obu, Aichi 4748511, Japan; [Hirai, Hiroshi] Iwate Univ, Dept Civil Environm Engn, Morioka, Iwate 0208551, Japan; [Ojima, Toshiyuki] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chuou Ku, Chiba 2608670, Japan; [Harris, Joseph R., III] Rutgers State Univ, Dept Publ Policy & Adm, Camden, NJ 08102 USA	Yamada, T (reprint author), Rutgers State Univ, Dept Econ, Ctr Children & Childhood Studies, 311 North 5th St, Camden, NJ 08102 USA.	tyamada@crab.rutgers.edu; ChiaChing_Chen@nymc.edu; cmurata@ncgg.go.jp; hirai181kan@gmail.com; ojima@hama-med.ac.jp; kkondo@chiba-u.jp; hajoseph@scarletmail.rutgers.edu			Research Council of Rutgers University, the State University of New Jersey, U.S.A. [2-02180, 2-02243]; Ministry of Education and Science of Japan	We are grateful to Michael Grossman and Philip DeCicca and would like to thank Oby Okoye, Sean P. Kilpatrick, Clayton T. Cook, and Matthew Miller for their research assistance at Rutgers University, the State University of New Jersey, U.S.A. Any credits, analyses, interpretations, conclusions and the views expressed in this paper are those of authors, and do not necessarily reflect those of the institutions. We greatly acknowledge the research support provided by the Research Council of Rutgers University, the State University of New Jersey, U.S.A. (#2-02180 and 2-02243). This paper was presented at International Conference for Healthcare and Long Term Care Costs funded by the Special Grant to Hitotsubashi University for Intergenerational Equity Problem from the Ministry of Education and Science of Japan.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; DeVoe J, 2007, MED CARE, V45, P88, DOI 10.1097/01.mlr.0000241048.85215.8b; Lima-Costa MF, 2012, AM J PUBLIC HEALTH, V102, P1535, DOI 10.2105/AJPH.2012.300765; Valdez A, 2002, J COMMUN HEALTH, V27, P33, DOI 10.1023/A:1013880210074; Kenney G, 2007, HEALTH SERV RES, V42, P1520, DOI 10.1111/j.1475-6773.2007.00707.x; Shim M, 2006, J HEALTH COMMUN, V11, P157, DOI 10.1080/10810730600637475; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Murata C, 2008, HEALTH PLACE, V14, P406, DOI 10.1016/j.healthplace.2007.08.007; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; van Doorslaer E, 2003, J HEALTH ECON, V22, P61; Kroneman MW, 2006, HEALTH POLICY, V76, P72, DOI 10.1016/j.healthpol.2005.05.003; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; Berger MC, 2002, APPL ECON, V34, P2105, DOI 10.1080/00036840210135665; Capretta J. C., 2009, HLTH AGEING, V20, P11; CULYER AJ, 1993, J HEALTH ECON, V12, P431, DOI 10.1016/0167-6296(93)90004-X; Cunningham Peter J, 2009, Issue Brief (Commonw Fund), V63, P1; Cunningham PJ, 2007, MED CARE, V45, P842, DOI 10.1097/MLR.0b013e318053678f; Cunningham PJ, 2008, TRACK REP, V21, P1; Draper D. A., 2007, ISSUE BRIEF CENT STU, V114, P1; Gerdtham UG, 1997, HEALTH ECON, V6, P303, DOI 10.1002/(SICI)1099-1050(199705)6:3<303::AID-HEC270>3.0.CO;2-P; Green LW, 2005, HLTH PROGRAM PLANNIN; Green WH, 2012, ECONOMETRIC ANAL; Grossman M., 1972, DEMAND HLTH THEORETI; Grossman M., 2003, HDB HLTH EC, P347; Gujarati D., 2009, BASIC ECONOMETRICS; Herrera-Espineira C, 2009, HEALTH POLICY, V89, P37, DOI 10.1016/j.healthpol.2008.04.012; Joyce GF, 2000, AM J MANAG CARE, V6, P1189; Kennedy P., 2008, GUIDE ECONOMETRICS; Kirby JB, 2006, MED CARE, V44, P64; Kreuter M. W., 1992, J HLTH ED, V23, P140; Mollborn S, 2005, HEALTH SERV RES, V40, P1898, DOI 10.1111/j.1475-6773.2005.00457.x; Murray E, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e17; Oliveira MD, 2004, APPL ECON, V36, P2237, DOI 10.1080/0003684042000280553; Oliver A., 2007, HARV HLTH POLICY REV, V8, P100; Reschovsky JD, 2000, HEALTH SERV RES, V35, P219; Chen Z, 2009, J HEALTH ECON, V28, P169, DOI 10.1016/j.jhealeco.2008.09.004; Shi Leiyu, 2009, J Ambul Care Manage, V32, P342, DOI 10.1097/JAC.0b013e3181ba6fd8; Sohler NL, 2003, J URBAN HEALTH, V80, P650, DOI 10.1093/jurban/jtg071; Strunk B. C., 2004, TRACK REP, V10, P1; Tu H, 2003, ISSUE BRIEF CTR STUD, V61, P1; Tu HT, 2002, NEW ENGL J MED, V346, P1288, DOI 10.1056/NEJMsa011250; U. S. Department of Health and Human Services, 2010, HHS ACT PLAN RED RAC; Voigt K, 2012, HEALTH ECON POLICY L, V7, P263, DOI 10.1017/S1744133110000277; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1297, DOI 10.1001/jama.289.10.1297; WOLINSKY FD, 1994, GERONTOLOGIST, V34, P470; Yamada T, 2005, ADV HEALTH, V16, P431; Zuckerman S, 2004, AM J PUBLIC HEALTH, V94, P53, DOI 10.2105/AJPH.94.1.53	50	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2015	12	2					1745	1772		10.3390/ijerph120201745		28	Environmental Sciences	Environmental Sciences & Ecology	CC2XZ	WOS:000350209800038		
J	Lee, J; Park, BJ; Ohira, T; Kagawa, T; Miyazaki, Y				Lee, Juyoung; Park, Bum-Jin; Ohira, Tatsuro; Kagawa, Takahide; Miyazaki, Yoshifumi			Acute Effects of Exposure to a Traditional Rural Environment on Urban Dwellers: A Crossover Field Study in Terraced Farmland	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							NATURAL-ENVIRONMENT; SALIVARY CORTISOL; FOREST LANDSCAPES; SHINRIN-YOKU; HEALTH; URBANIZATION; STRESS; RECOVERY; BENEFITS; WINDOW	Despite an increasing attention and public preference for rural amenities, little evidence is available on the health benefits of a rural environment. In this study, we identified physiological and psychological benefits of exposure to a rural environment using multiparametric methods. Twelve young male adults participated in a 3-day field experiment (mean +/- standard deviation age, 22.3 +/- 1.3 years). Sleeping environment, diet program, physical activities, and other factors possibly affecting physiological responses were controlled during experiment period. For all participants, salivary cortisol concentration, heart rate variability, and blood pressure were measured at rural and urban field sites. Self-evaluation questionnaires were administered to analyze the psychological states in two different environments. Volatile compounds in the air were also analyzed to investigate air quality. The data were compared between rural and urban environments. The data showed that exposure to a rural environment reduced stress hormone secretion and sympathetic nervous activity and increased parasympathetic nervous activity. Short-term exposure to a rural environment also improved mood states. Our findings indicate that exposure to a rural environment effectively reduced physiological stress and enhanced psychological well-being.	[Lee, Juyoung] Korea Forest Serv, Taejon 302701, South Korea; [Park, Bum-Jin] Chungnam Natl Univ, Coll Agr & Life Sci, Taejon 305764, South Korea; [Ohira, Tatsuro; Kagawa, Takahide] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, 6-2-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	lohawi@gmail.com; bjpark@cnu.ac.jp; otatsu@ffpri.affrc.go.jp; kagawa@ffpri.affrc.go.jp; ymiyazaki@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16107007]	This project was supported by Grants-in-Aid for Scientific Research (S; 16107007) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Adediran Olufemi Sola, 2013, BMC Res Notes, V6, P123, DOI 10.1186/1756-0500-6-123; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; MACKAY C, 1978, BRIT J SOC CLIN PSYC, V17, P283; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; [Anonymous], 1999, EV HLTH PROM EFF SHA; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Stilgoe JR, 2001, AM J PREV MED, V20, P243, DOI 10.1016/S0749-3797(00)00319-6; Galea S, 2011, EPIGENETICS-US, V6, P400, DOI 10.4161/epi.6.4.14944; Wagner KH, 2012, PREV MED, V54, pS38, DOI 10.1016/j.ypmed.2011.11.012; Tsunetsugu Yuko, 2007, Journal of Physiological Anthropology, V26, P135, DOI 10.2114/jpa2.26.135; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee J, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/834360; Sung J, 2012, CLIN EXP HYPERTENS, V34, P1, DOI 10.3109/10641963.2011.618195; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Kim TH, 2010, SCI TOTAL ENVIRON, V408, P2600, DOI 10.1016/j.scitotenv.2010.02.025; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Lopez R, 2004, AM J PUBLIC HEALTH, V94, P1574, DOI 10.2105/AJPH.94.9.1574; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Takayama N, 2014, INT J ENV RES PUB HE, V11, P7207, DOI 10.3390/ijerph110707207; Herzog TR, 1997, J ENVIRON PSYCHOL, V17, P165, DOI 10.1006/jevp.1997.0051; Brown DK, 2013, ENVIRON SCI TECHNOL, V47, P5562, DOI 10.1021/es305019p; Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Mage D, 1996, ATMOS ENVIRON, V30, P681, DOI 10.1016/1352-2310(95)00219-7; Antrop M, 2004, LANDSCAPE URBAN PLAN, V67, P9, DOI 10.1016/S0169-2046(03)00026-4; Sayadi S, 2009, LAND USE POLICY, V26, P334, DOI 10.1016/j.landusepol.2008.04.003; McGranahan DA, 2008, LANDSCAPE URBAN PLAN, V85, P228, DOI 10.1016/j.landurbplan.2007.12.001; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Roe J, 2011, HEALTH PLACE, V17, P103, DOI 10.1016/j.healthplace.2010.09.003; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Delisle H, 2012, BRIT J NUTR, V107, P1534, DOI 10.1017/S0007114511004661; Fleischer A., 2008, J AGR ECON, V60, p[132, 153], DOI 10.1111/j.1477-9552.2008.00179.x; Frumkin Howard, 2001, American Journal of Preventive Medicine, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Ginter Emil, 2012, Adv Exp Med Biol, V771, P42; Goodkin K., 2000, PSYCHONEUROIMMUNOLOG; Goodwin RD, 2014, PSYCHIAT CLIN NEUROS, V68, P395, DOI 10.1111/pcn.12144; Harvey T., 2002, LOCAL ENV, V7, P381, DOI DOI 10.1080/1354983022000027509; Igarashi M, 2014, COGN PROCESS, V15, P551, DOI 10.1007/s10339-014-0627-z; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Kalnay E, 2003, NATURE, V425, P102, DOI 10.1038/nature01952; Kaplan R., 1989, EXPERIENCE NATURE PS; Lee J., 2012, PUBLIC HLTH SOCIAL B, P325; Li Q, 2007, Int J Immunopathol Pharmacol, V20, P3; Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22; Osgood C.E., 1957, MEASUREMENT MEANING; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Rogge E, 2007, LANDSCAPE URBAN PLAN, V82, P159, DOI 10.1016/j.landurbplan.2007.02.006; SCAPAGNINI U, 1992, PSYCHONEUROENDOCRINO, V17, P411, DOI 10.1016/0306-4530(92)90046-A; Shin WS, 2007, SCAND J FOREST RES, V22, P248, DOI 10.1080/02827580701262733; Camm AJ, 1996, CIRCULATION, V93, P1043; Taylor F. A., 2001, ENVIRON BEHAV, V33, p[77, 54], DOI [10.1177/00139160121972864, DOI 10.1177/00139160121972864]; Tsunetsugu Y., 2012, FOREST MED, p[169, 181]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; VERDERBER S, 1986, ENVIRON BEHAV, V18, P450, DOI 10.1177/0013916586184002; Wilson E., 1984, BIOPHILIA HUMAN BOND; World Health Organization, 2010, B WORLD HEALTH ORGAN, V88, P245, DOI DOI 10.2471/BLT.10.010410; Korpela KM, 2007, HEALTH PLACE, V13, P138, DOI 10.1016/j.healthplace.2005.11.002; Yokoyama K., 1990, JAPANESE J PUBLIC HL, V37, P913	66	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2015	12	2					1874	1893		10.3390/ijerph120201874		20	Environmental Sciences	Environmental Sciences & Ecology	CC2XZ	WOS:000350209800046		
J	Nagano, Y; Hattori, H				Nagano, Yasutaka; Hattori, Hirofumi			Improvement of an LRN two-equation turbulence model reflecting multi-time scales	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Two-equation model; k-epsilon model; Turbulence; Time-scale; Complex flow field	K-EPSILON MODEL; PREDICTING FLUID-FLOW; HEAT-TRANSFER MODEL; FIELD CALCULATIONS; DIRECT SIMULATIONS; REATTACHING FLOWS; SHEAR FLOWS; WALL; COMPUTATION	It is well known that turbulence energy is overpredicted by the linear k-epsilon model at the stagnation point. This problem causes inadequate predictions of the flow field. In this paper, to evaluate the performance of a low-Reynolds-number (LRN) type turbulence model for flows on a complex wall shape, we carried out simulations of flows around various wall shapes. Based on this evaluation, we improved the model by introducing a time scale based on the velocity gradient parameter. The proposed model is evaluated in four complex turbulent flows, i.e., forward-facing step, two-dimensional block, two-dimensional hill and three-dimensional block flows. The results, together with the proposed model, are in good agreement with the experimental data. (C) 2014 Elsevier Inc. All rights reserved.	[Nagano, Yasutaka] Nagoya Ind Sci Res Inst, Dept Res, Chikusa Ku, Nagoya, Aichi 4640819, Japan; [Nagano, Yasutaka; Hattori, Hirofumi] Nagoya Inst Technol, Dept Mech Engn, Informat & Anal Technol Div, Showa Ku, Nagoya, Aichi 4668555, Japan	Hattori, H (reprint author), Nagoya Inst Technol, Dept Mech Engn, Informat & Anal Technol Div, Showa Ku, Nagoya, Aichi 4668555, Japan.	hattori@nitech.ac.jp					ABE K, 1995, INT J HEAT MASS TRAN, V38, P1467, DOI 10.1016/0017-9310(94)00252-Q; Abe K, 1997, INT J HEAT FLUID FL, V18, P266, DOI 10.1016/S0142-727X(97)00008-8; JONES WP, 1972, INT J HEAT MASS TRAN, V15, P301, DOI 10.1016/0017-9310(72)90076-2; Moser RD, 1999, PHYS FLUIDS, V11, P943, DOI 10.1063/1.869966; Popovac M, 2007, FLOW TURBUL COMBUST, V78, P177, DOI 10.1007/s10494-006-9067-x; ABE K, 1994, INT J HEAT MASS TRAN, V37, P139, DOI 10.1016/0017-9310(94)90168-6; ALMEIDA GP, 1993, EXP THERM FLUID SCI, V7, P87, DOI 10.1016/0894-1777(93)90083-U; MYONG HK, 1990, JSME INT J II-FLUID, V33, P63; MURAKAMI S, 1990, J WIND ENG IND AEROD, V35, P87, DOI 10.1016/0167-6105(90)90211-T; NAGANO Y, 1990, J FLUID ENG-T ASME, V112, P33, DOI 10.1115/1.2909365; Craft T.J., 1996, INT J HEAT FLUID FL, V17, P3; Craft TJ, 2000, FLOW TURBUL COMBUST, V63, P59, DOI 10.1023/A:1009973923473; Durbin PA, 1996, INT J HEAT FLUID FL, V17, P89, DOI 10.1016/0142-727X(95)00073-Y; Hattori H, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/1/012402; Hattori H, 1998, NUMER HEAT TR B-FUND, V33, P153, DOI 10.1080/10407799808915028; Hattori H., 1997, P 5 ASME USME THERM, P227; Hattori H, 1995, JSME INT J B-FLUID T, V38, P518; Irikado T., 2000, P 4 JSME KSME THERM, P2473; Kato M., 1993, P 9 S TURB SHEAR FLO, V1; Moss W. D., 1980, Aeronautical Quarterly; Nagano Y, 1996, PHYS FLUIDS, V8, P3379, DOI 10.1063/1.869124; Nagano Y., 2002, J TURBUL, V3, P1; Rober T, 2006, NOTE N FL MECH MUL D, V92, P446, DOI 10.1007/978-3-540-33287-9_55; Sato H., 2005, P INT C JETS WAK SEP, P117; Smimov P.E., 2009, J TURBOMACH, V131, P8	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	FEB	2015	51						221	228		10.1016/j.ijheatfluidflow.2014.10.020		8	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CB6KQ	WOS:000349736300017		
J	Kuwata, Y; Suga, K				Kuwata, Y.; Suga, K.			Progress in the extension of a second-moment closure for turbulent environmental flows	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Turbulence modelling; Second-moment closure; Porous media; Vegetated flow	POROUS-MEDIA; STRESS DISSIPATION; HEAT-TRANSFER; TRANSPORT; MODEL; AERODYNAMICS; VEGETATION; CANOPIES; EQUATION; CHANNELS	An advanced second-moment closure for the double-averaged turbulence equations of porous medium and vegetation flows is proposed. It treats three kinds of second moments which appear in the double-averaged momentum equation. They are the dispersive covariance, the volume averaged (total) Reynolds stress and the micro-scale Reynolds stress. The two-component-limit pressure-strain correlation model is applied to model the total Reynolds stress equation whilst a novel scale-similarity non-linear k-epsilon two-equation eddy viscosity model is employed for the micro-scale turbulence. For the dispersive covariance, an algebraic relation is applied. Model validation in several fully developed homogeneous porous medium flows, porous channel flows and aquatic vegetation canopy flows is performed with satisfactory agreement with the data. (C) 2014 Elsevier Inc. All rights reserved.	[Kuwata, Y.; Suga, K.] Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan	Suga, K (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan.	suga@me.osakafu-u.ac.jp			JSPS Japan [24360073]	The authors express their respect to Professors Brian E. Launder and Kemal Hanjalic for their half-century dedication to turbulence modelling. The financial support by the research Grant (No. 24360073) of the JSPS Japan covered a part of this study.	Nezu I, 2008, J HYDRO-ENVIRON RES, V2, P62, DOI 10.1016/j.jher.2008.05.003; RAUPACH MR, 1982, BOUND-LAY METEOROL, V22, P79, DOI 10.1007/BF00128057; HANJALIC K, 1976, J FLUID MECH, V74, P593, DOI 10.1017/S0022112076001961; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Al-Sharif SF, 2010, INT J HEAT FLUID FL, V31, P401, DOI 10.1016/j.ijheatfluidflow.2010.02.024; Kuwata Y, 2013, INT J HEAT FLUID FL, V43, P35, DOI 10.1016/j.ijheatfluidflow.2013.03.001; DALY BJ, 1970, PHYS FLUIDS, V13, P2634, DOI 10.1063/1.1692845; HANJALIC K, 1972, J FLUID MECH, V52, P609, DOI 10.1017/S002211207200268X; LIEN FS, 1994, COMPUT METHOD APPL M, V114, P123, DOI 10.1016/0045-7825(94)90165-1; LAUNDER BE, 1989, AIAA J, V27, P1319, DOI 10.2514/3.10267; GIBSON MM, 1978, J FLUID MECH, V86, P491, DOI 10.1017/S0022112078001251; Nepf H, 2008, ACTA GEOPHYS, V56, P753, DOI 10.2478/s11600-008-0017-y; Breugem WP, 2006, J FLUID MECH, V562, P35, DOI 10.1017/S0022112006000887; ROTTA J, 1951, Z PHYS, V129, P547, DOI 10.1007/BF01330059; Iacovides H, 1999, INT J HEAT FLUID FL, V20, P320, DOI 10.1016/S0142-727X(99)00018-1; Pedras MHJ, 2001, INT J HEAT MASS TRAN, V44, P1081, DOI 10.1016/S0017-9310(00)00202-7; Hanjalic K, 1998, COMPUT FLUIDS, V27, P137, DOI 10.1016/S0045-7930(97)00036-4; LAUNDER BE, 1975, J FLUID MECH, V68, P537, DOI 10.1017/S0022112075001814; Suga K, 2010, INT J HEAT FLUID FL, V31, P974, DOI 10.1016/j.ijheatfluidflow.2010.02.023; Nakayama A, 1999, J FLUID ENG-T ASME, V121, P427, DOI 10.1115/1.2822227; [Anonymous], 1978, ADV APPL MECH, DOI DOI 10.1016/S0065-2156(08)70266-7; Hanjalic K, 2005, J FLUID ENG-T ASME, V127, P831, DOI 10.1115/1.2037084; Suga K, 2009, PROG COMPUT FLUID DY, V9, P201, DOI 10.1504/PCFD.2009.024820; RHIE CM, 1983, AIAA J, V21, P1525, DOI 10.2514/3.8284; Foudhil H, 2005, ENVIRON FLUID MECH, V5, P247, DOI 10.1007/s10652-004-2124-x; Ayotte KW, 1999, BOUND-LAY METEOROL, V90, P189, DOI 10.1023/A:1001722609229; Batten P, 1999, AIAA J, V37, P785, DOI 10.2514/2.801; CHOU PY, 1945, Q APPL MATH, V3, P38; Craft T, 2014, FLOW TURBUL COMBUST, V92, P413, DOI 10.1007/s10494-013-9486-4; CRAFT TJ, 1996, INT J HEAT FLUID FL, V17, P246; Craft TJ, 1998, INT J HEAT FLUID FL, V19, P541, DOI 10.1016/S0142-727X(98)10020-6; de Lemos M.J.S., 2006, TURBULENCE POROUS ME; Dunn C., 1996, 51 UIUC DEP CIV ENG; Fu S., 1988, THESIS UMIST MANCHES; Ghisalberti M, 2009, TRANSPORT POROUS MED, V78, P385, DOI 10.1007/s11242-009-9434-x; Hanjalic K., 2011, MODELLING TURBULENCE; HANJALIC K, 1993, APPL SCI RES, V51, P513, DOI 10.1007/BF01082584; Heynes OR, 2013, FLOW TURBUL COMBUST, V91, P931, DOI 10.1007/s10494-013-9504-6; Jakirlic S, 2002, J FLUID MECH, V459, P139, DOI 10.1017/S0022112002007905; Jakirlic S, 2013, FLUID DYN RES, V45, DOI 10.1088/0169-5983/45/5/055509; JOHANSSON AV, 1994, J FLUID MECH, V269, P143, DOI 10.1017/S0022112094001515; Keramaris E, 2009, J POROUS MEDIA, V12, P155; Kuwata Y, 2014, INT J HEAT FLUID FL, V49, P135, DOI 10.1016/j.ijheatfluidflow.2014.02.007; Kuwata Y., 2014, P ETMM10 MARB SPAIN; Kuwata Y., 2013, T JAPAN SOC MECH E B, V79, P1752; Launder B. E., 1974, Letters in Heat and Mass Transfer, V1, DOI 10.1016/0094-4548(74)90150-7; LIEN FS, 1994, INT J NUMER METH FL, V19, P527, DOI 10.1002/fld.1650190606; Nakayama A., 2008, J FLUIDS ENG, V130; Patankar S. V., 1980, NUMERICAL HEAT TRANS; Pedras MHJ, 2000, INT COMMUN HEAT MASS, V27, P211, DOI 10.1016/S0735-1933(00)00102-0; Pinson F, 2006, INT J HEAT FLUID FL, V27, P955, DOI 10.1016/j.ijheatfluidflow.2006.03.018; SOULIOTIS D, 2011, J HYDRAUL ENG, V137, P315; SPEZIALE C, 1991, J FLUID MECH, V227, P254, DOI DOI 10.1017/S0022112091000101JFLSA70022-1120; Suga K, 2011, INT J HEAT FLUID FL, V32, P586, DOI 10.1016/j.ijheatfluidflow.2011.02.016; Suga K, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/1/012401; Suga K, 2004, J FLUID ENG-T ASME, V126, P634, DOI 10.1115/1.1779660; Suga K., 2013, P 1 INT C MECH HSINC; Suga K., 2009, OPEN TRANSP PHENOM J, V1, P35; Suga K, 2003, INT J HEAT MASS TRAN, V46, P161, DOI 10.1016/S0017-9310(02)00249-1; Whitaker S, 1996, TRANSPORT POROUS MED, V25, P27, DOI 10.1007/BF00141261; WHITAKER S, 1986, TRANSPORT POROUS MED, V1, P3, DOI 10.1007/BF01036523	61	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	FEB	2015	51						268	284		10.1016/j.ijheatfluidflow.2014.10.011		17	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CB6KQ	WOS:000349736300020		
J	Tsuzuki, T				Tsuzuki, Toyonori			Intraductal carcinoma of the prostate: A comprehensive and updated review	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						diagnostic criteria; intraductal carcinoma of the prostate; prognosis	IN-SITU HYBRIDIZATION; INTRAEPITHELIAL NEOPLASIA; CHROMOSOMAL-ANOMALIES; CANCER PROGRESSION; ADENOCARCINOMA; LESIONS; PATTERNS; AMPLIFICATION; HYPERPLASIA; METASTASES	Intraductal carcinoma of the prostate is characterized by prostatic carcinoma cells growing within ducts and/or acini. These tumors are usually associated with a high-grade Gleason score, large tumor volume and advanced stage. Intraductal carcinoma of the prostate is also a well-known adverse independent prognostic factor regardless of treatment. Recent studies have shown that intraductal carcinoma of the prostate is a distinctive disease entity that is different from invasive prostate carcinoma, which is generally invasive. Although the Gleason score does not consider intraductal carcinoma of the prostate, some cribriform prostate carcinomas graded as pattern4 could be considered as intraductal carcinomas. The definition of intraductal carcinoma of the prostate is not unified, because it can occur with or without invasive prostate carcinoma. Furthermore, diagnosis of intraductal carcinoma of the prostate without invasive prostate carcinoma by needle biopsy is crucial, but is a rare event. Differential diagnosis of intraductal carcinoma of the prostate includes several pathologies. This is especially true for high-grade prostatic intraepithelial neoplasia, although its distinction is not always straightforward. The present review discusses the concept of intraductal carcinoma of the prostate, and also describes its morphological characteristics, molecular features and clinical outcome. Given the current state of knowledge, the presence of intraductal carcinoma of the prostate should be evaluated and documented correctly in both radical prostatectomy and needle biopsy, and the clinical implications should be taken into consideration during treatment and follow up.	[Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi 4668650, Japan	Tsuzuki, T (reprint author), Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Showa Ku, 2-9 Myoken Cho, Nagoya, Aichi 4668650, Japan.	tsuzuki@nagoya2.jrc.or.jp					Qian JQ, 1997, MODERN PATHOL, V10, P1113; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; KOVI J, 1985, CANCER, V56, P1566, DOI 10.1002/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Kryvenko ON, 2013, ARCH PATHOL LAB MED, V137, P610, DOI 10.5858/arpa.2012-0128-OA; Van der Kwast T, 2012, EUR J CANCER, V48, P1318, DOI 10.1016/j.ejca.2012.02.003; Kimura K, 2014, PROSTATE, V74, P680, DOI 10.1002/pros.22786; Lotan TL, 2013, MODERN PATHOL, V26, P587, DOI 10.1038/modpathol.2012.201; Shah RB, 2010, AM J SURG PATHOL, V34, P470, DOI 10.1097/PAS.0b013e3181cfc44b; Jenkins RB, 1997, CANCER RES, V57, P524; CATALONA WJ, 1978, J UROLOGY, V120, P259; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Watts K, 2013, HISTOPATHOLOGY, V63, P574, DOI 10.1111/his.12198; McNeal JE, 1996, AM J SURG PATHOL, V20, P802, DOI 10.1097/00000478-199607000-00003; Cohen RJ, 2007, ARCH PATHOL LAB MED, V131, P1103; Rubin MA, 1998, AM J SURG PATHOL, V22, P840, DOI 10.1097/00000478-199807000-00006; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Miyai K, 2014, INT J CLIN EXP PATHO, V7, P2518; Robinson BD, 2010, J UROLOGY, V184, P1328, DOI 10.1016/j.juro.2010.06.017; Dawkins HJS, 2000, PROSTATE, V44, P265; Bettendorf O, 2008, GENE CHROMOSOME CANC, V47, P565, DOI 10.1002/gcc.20560; AYALA AG, 1986, AM J SURG PATHOL, V10, P665, DOI 10.1097/00000478-198610000-00001; Bonkhoff H, 2013, PROSTATE, V73, P442, DOI 10.1002/pros.22579; BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I; Cohen RJ, 2000, PROSTATE, V43, P11, DOI 10.1002/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B; Efstathiou E, 2010, EUR UROL, V57, P1030, DOI 10.1016/j.eururo.2009.10.020; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Guos CC, 2006, MODERN PATHOL, V19, P1528; Hans B, 2010, AM J SURG PATHOL, V34, P478; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; MCNEAL JE, 1986, CANCER, V58, P1714, DOI 10.1002/1097-0142(19861015)58:8<1714::AID-CNCR2820580823>3.0.CO;2-M; Miyai K, 2014, HUM PATHOL, V45, P1572, DOI 10.1016/j.humpath.2014.03.011; O'Brien BA, 2011, BJU INT, V107, P389, DOI 10.1111/j.1464-410X.2010.09539.x; O'Brien C, 2010, AM J CLIN PATHOL, V133, P654, DOI 10.1309/AJCP8EL5FTZSOBIH; Pickup M, 2007, J CLIN PATHOL, V60, P856, DOI 10.1136/jcp.2006.043224; RHAMY RK, 1973, J UROLOGY, V109, P457; Rioux-Leclercq NC, 2002, AM J SURG PATHOL, V26, P237, DOI 10.1097/00000478-200202000-00011; Wilcox G, 1998, HUM PATHOL, V29, P1119, DOI 10.1016/S0046-8177(98)90423-3	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					140	145		10.1111/iju.12657		6	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800001		
J	Mitsuzuka, K				Mitsuzuka, Koji			Editorial Comment to Transperineal template-guided mapping biopsy of the prostate	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 980, Japan	Mitsuzuka, K (reprint author), Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 980, Japan.	mitsuzuka@uro.med.tohoku.ac.jp					Ukimura O, 2013, EUR UROL, V63, P214, DOI 10.1016/j.eururo.2012.09.033; Shen PF, 2012, ASIAN J ANDROL, V14, P310, DOI 10.1038/aja.2011.130; Chang DTS, 2013, NAT REV UROL, V10, P690, DOI 10.1038/nrurol.2013.195; Cepek J, 2013, MED PHYS, V40, DOI 10.1118/1.4773043; Pelzer AE, 2013, EUR J RADIOL, V82, P814, DOI 10.1016/j.ejrad.2012.11.035; Sivaraman A, 2015, INT J UROL, V22, P146, DOI 10.1111/iju.12660	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					152	152		10.1111/iju.12677		1	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800003		
J	Tsuzuki, T				Tsuzuki, Toyonori			Editorial Comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: A population-based study	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							RADICAL CYSTECTOMY		Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi, Japan	Tsuzuki, T (reprint author), Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi, Japan.	tsuzuki@nagoya2.jrc.or.jp					Amins MB, 2013, PROTOCOL EXAMINATION; Mazzucchelli R, 2012, ANAL QUANT CYTOL, V34, P173; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Berman DM, 2015, INT J UROL, V22, P163, DOI 10.1111/iju.12611; Kunju LP, 2008, J UROLOGY, V180, P1932; Kunju LP, 2008, J UROLOGY, V180, P1928, DOI 10.1016/j.juro.2008.07.056	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					170	171		10.1111/iju.12627		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800007		
J	Gondo, T				Gondo, Tatsuo			Editorial Comment from Dr Gondo to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: A population-based study	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							NEGATIVE LYMPH-NODES; RADICAL CYSTECTOMY; RECURRENCE; SURVIVAL		Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan	Gondo, T (reprint author), Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan.	eswl3500@yahoo.co.jp					Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Tilki D, 2013, BJU INT, V111, P1215, DOI 10.1111/j.1464-410X.2012.11455.x; Berman DM, 2015, INT J UROL, V22, P163, DOI 10.1111/iju.12611; Sonpavde G, 2011, BJU INT, V108, P687, DOI 10.1111/j.1464-410X.2010.09902.x	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					171	171		10.1111/iju.12628		1	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800008		
J	Shoji, S; Hiraiwa, S; Endo, J; Hashida, K; Tomonaga, T; Nakano, M; Sugiyama, T; Tajiri, T; Terachi, T; Uchida, T				Shoji, Sunao; Hiraiwa, Shinichiro; Endo, Jun; Hashida, Kazunobu; Tomonaga, Tetsuro; Nakano, Mayura; Sugiyama, Tomoko; Tajiri, Takuma; Terachi, Toshiro; Uchida, Toyoaki			Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						fusion image; magnetic resonance imaging; prostate cancer; targeted biopsy; transrectal ultrasound	CANCER; MRI; GUIDANCE	ObjectivesTo report our early experience with manually controlled targeted biopsy with real-time multiparametric magnetic resonance imaging and transrectal ultrasound fusion images for the diagnosis of prostate cancer. MethodsA total of 20 consecutive patients suspicious of prostate cancer at the multiparametric magnetic resonance imaging scan were recruited prospectively. Targeted biopsies were carried out for each cancer-suspicious lesion, and 12 systematic biopsies using the BioJet system. Pathological findings of targeted and systematic biopsies were analyzed. ResultsThe median age of the patients was 70years (range 52-83years). The median preoperative prostate-specific antigen value was 7.4ng/mL (range 3.54-19.9ng/mL). Median preoperative prostate volume was 38mL (range 24-68mL). The number of cancer-detected cases was 14 (70%). The median Gleason score was 6.5 (range 6-8). Cancer-detected rates of the systematic and targeted biopsy cores were 6.7 and 31.8%, respectively (P<0.0001). In six patients who underwent radical prostatectomy, the geographic locations and pathological grades of clinically significant cancers and index lesions corresponded to the pathological results of the targeted biopsies. ConclusionProstate cancers detected by targeted biopsies with manually controlled targeted biopsy using real-time multiparametric magnetic resonance imaging and transrectal ultrasound fusion imaging have significantly higher grades and longer length compared with those detected by systematic biopsies. Further studies and comparison with the pathological findings of whole-gland specimens have the potential to determine the role of this biopsy methodology in patients selected for focal therapy and those under active surveillance.	[Shoji, Sunao; Tomonaga, Tetsuro; Nakano, Mayura; Uchida, Toyoaki] Tokai Univ, Hachioji Hosp, Dept Urol, Hachioji, Tokyo 1920032, Japan; [Hiraiwa, Shinichiro; Sugiyama, Tomoko; Tajiri, Takuma] Tokai Univ, Hachioji Hosp, Dept Pathol, Hachioji, Tokyo 1920032, Japan; [Endo, Jun; Hashida, Kazunobu] Tokai Univ, Hachioji Hosp, Dept Radiol, Hachioji, Tokyo 1920032, Japan; [Terachi, Toshiro] Tokai Univ, Sch Med, Dept Urol, Hiratsuka, Kanagawa 25912, Japan	Shoji, S (reprint author), Tokai Univ, Hachioji Hosp, Dept Urol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	sunashoj@mail.goo.ne.jp					Sonn GA, 2014, UROL ONCOL-SEMIN ORI, V32, P903, DOI 10.1016/j.urolonc.2013.08.006; Haffner J, 2011, BJU INT, V108, pE171, DOI 10.1111/j.1464-410X.2011.10112.x; Lawrentschuk N, 2009, J UROLOGY, V182, P2659, DOI 10.1016/j.juro.2009.08.036; Sciarra A, 2010, CLIN CANCER RES, V16, P1875, DOI 10.1158/1078-0432.CCR-09-2195; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Turkbey B, 2011, RADIOLOGY, V258, P488, DOI 10.1148/radiol.10100667; Kasivisvanathan V, 2013, J UROLOGY, V189, P860, DOI 10.1016/j.juro.2012.10.009; Hambrock T, 2010, J UROLOGY, V183, P520, DOI 10.1016/j.juro.2009.10.022; Sciarra A, 2011, EUR UROL, V59, P962, DOI 10.1016/j.eururo.2011.02.034; Zelhof B, 2009, BJU INT, V103, P883, DOI 10.1111/j.1464-410X.2008.08130.x; Moore CM, 2013, EUR UROL, V63, P125, DOI 10.1016/j.eururo.2012.06.004; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Marks L, 2013, CURR OPIN UROL, V23, P43, DOI 10.1097/MOU.0b013e32835ad3ee; Harnden P, 2008, CANCER, V112, P971, DOI 10.1002/cncr.23277; Fiard G, 2013, UROLOGY, V81, P1372, DOI 10.1016/j.urology.2013.02.022; Park BK, 2011, AM J ROENTGENOL, V197, pW876, DOI 10.2214/AJR.11.6829; Mouraviev V, 2013, J ENDOUROL, V27, P820, DOI 10.1089/end.2012.0215; Natarajan S, 2011, UROL ONCOL-SEMIN ORI, V29, P334, DOI 10.1016/j.urolonc.2011.02.014; Baumanns M, 2009, COMPUT COMPUT ASSIST, V12, P67; Collins DJ, 2004, IEEE ENG MED BIOL, V23, P65, DOI 10.1109/MEMB.2004.1360410; Gibbss P, 2009, TESLA INVEST RADIOL, V44, P572; Guos Y, 2009, J ULTRAS MED, V28, P1561; Hara N, 2005, PROSTATE, V62, P140, DOI 10.1002/pros.20124; Labanaris AP, 2010, PROSTATE CANCER P D, V13, P65, DOI 10.1038/pcan.2009.41; Moore CM, 2013, EUR UROL, V64, P544, DOI 10.1016/j.eururo.2013.03.030; Mozers P, 2014, BJU INT; Otos A, 2010, RADIOLOGY, V257, P715; Rosenkrantz Andrew B, 2013, Radiology, V269, P482, DOI 10.1148/radiol.13122233; Tois A, 2007, J UROLOGY, V177, P516; Wysocks JS, 2013, EUR UROL	30	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					173	178		10.1111/iju.12643		6	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800010		
J	Shoji, S				Shoji, Sunao			Response to Editorial Comment to Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Tokai Univ, Hachioji Hosp, Dept Urol, Tokyo 151, Japan	Shoji, S (reprint author), Tokai Univ, Hachioji Hosp, Dept Urol, Tokyo 151, Japan.	sunashoj@mail.goo.ne.jp					Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Marks L, 2013, CURR OPIN UROL, V23, P43, DOI 10.1097/MOU.0b013e32835ad3ee; Mouraviev V, 2013, J ENDOUROL, V27, P820, DOI 10.1089/end.2012.0215; Rosenkrantz Andrew B, 2013, Radiology, V269, P482, DOI 10.1148/radiol.13122233; Telonis D, 2015, INT J UROL, V22, P178, DOI 10.1111/iju.12675	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					179	180		10.1111/iju.12694		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800012		
J	Togo, Y				Togo, Yoshikazu			Editorial Comment from Dr Togo to Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							CARE		Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo 6638501, Japan	Togo, Y (reprint author), Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo 6638501, Japan.	ytogo@hyo-med.ac.jp					Anastasiadis E, 2015, INT J UROL, V22, P181, DOI 10.1111/iju.12634; Ukimura O, 2013, EUR UROL, V63, P214, DOI 10.1016/j.eururo.2012.09.033; Taylor AK, 2012, J UROLOGY, V187, P1275, DOI 10.1016/j.juro.2011.11.115; Kakehis Y, 2008, INT J UROL, V15, P318; Togo Y, 2014, J INFECT CHEMOTHER, V20, P232, DOI 10.1016/j.jiac.2013.10.003	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					187	187		10.1111/iju.12647		1	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800015		
J	Hashimoto, T; Yoshioka, K; Nagao, G; Nakagami, Y; Ohno, Y; Horiguchi, Y; Namiki, K; Nakashima, J; Tachibana, M				Hashimoto, Takeshi; Yoshioka, Kunihiko; Nagao, Go; Nakagami, Yoshihiro; Ohno, Yoshio; Horiguchi, Yutaka; Namiki, Kazunori; Nakashima, Jun; Tachibana, Masaaki			Prediction of biochemical recurrence after robot-assisted radical prostatectomy: Analysis of 784 Japanese patients	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						biochemical recurrence; pathological Gleason score; pathological Tstage; positive surgical margin; prostate-specific antigen density	MINIMUM FOLLOW-UP; CANCER; OUTCOMES; ANTIGEN; COHORT; RATES; RISK; MEN; CARCINOMA; PATHOLOGY	ObjectivesTo examine biochemical recurrence after robot-assisted radical prostatectomy in Japanese patients, and to develop a risk stratification model for biochemical recurrence. MethodsThe study cohort consisted of 784 patients with localized prostate cancer who underwent robot-assisted radical prostatectomy without neoadjuvant or adjuvant endocrine therapy. The relationships of biochemical recurrence with perioperative findings were evaluated. The prognostic factors for biochemical recurrence-free survival were evaluated using Cox proportional hazard model analyses. ResultsDuring the follow-up period, 80 patients showed biochemical recurrence. The biochemical recurrence-free survival rates at 1, 3, and 5 years were 92.2%, 85.2% and 80.1%, respectively. In univariate analysis, the prostate-specific antigen level, prostate-specific antigen density, biopsy Gleason score, percent positive core, pathological Tstage, pathological Gleason score, lymphovascular invasion, perineural invasion and positive surgical margin were significantly associated with biochemical recurrence. In multivariate analysis, prostate-specific antigen density 0.4 (P=0.0011), pathological Tstage 3a (P=0.002), pathological Gleason score 8 (P=0.007) and positive surgical margin (P<0.0001) were independent predictors of biochemical recurrence. The patients were stratified into three risk groups according to these factors. The 5-year biochemical recurrence-free survival rate was 89.4% in the low-risk group, 65.6% in the intermediate-risk group and 30.3% in the high-risk group. ConclusionsThe prostate-specific antigen density, pathological Tstage, pathological Gleason score and positive surgical margin were independent prognostic factors for biochemical recurrence. The risk stratification model developed using these four factors could help clinicians identify patients with a poor prognosis who might be good candidates for clinical trials of alternative management strategies.	[Hashimoto, Takeshi; Yoshioka, Kunihiko; Nagao, Go; Nakagami, Yoshihiro; Ohno, Yoshio; Horiguchi, Yutaka; Namiki, Kazunori; Nakashima, Jun; Tachibana, Masaaki] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan	Yoshioka, K (reprint author), Tokyo Med Univ Hosp, Dept Urol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	kunihiko@tokyo-med.ac.jp					Kikuchi E, 2005, J UROLOGY, V174, P2120, DOI 10.1097/01.ju.0000181801.22474.8b; Liss MA, 2012, J UROLOGY, V188, P2205, DOI 10.1016/j.juro.2012.08.009; Radwan MH, 2007, UROLOGY, V69, P1121, DOI 10.1016/j.urology.2007.01.087; Sundi D, 2013, J CLIN ONCOL, V31, P2991, DOI 10.1200/JCO.2012.47.0302; Murphy DG, 2009, EUR UROL, V55, P1358, DOI 10.1016/j.eururo.2008.12.035; Sooriakumaran P, 2012, EUR UROL, V62, P768, DOI 10.1016/j.eururo.2012.05.024; Suardi N, 2012, UROLOGY, V79, P133, DOI 10.1016/j.urology.2011.08.045; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Atzpodien J, 2003, BRIT J CANCER, V88, P348, DOI 10.1038/sj.bjc.6600768; Jones TD, 2006, BJU INT, V97, P480, DOI 10.1111/j.1464-410X.2006.06022.x; Novara G, 2012, EUR UROL, V62, P382, DOI 10.1016/j.eururo.2012.05.047; Menon M, 2010, EUR UROL, V58, P838, DOI 10.1016/j.eururo.2010.09.010; Zlotta AR, 2013, JNCI-J NATL CANCER I, V105, P1050, DOI 10.1093/jnci/djt151; Carpenter WR, 2009, CANCER, V115, P5048, DOI 10.1002/cncr.24539; Patel VR, 2011, BJU INT, V108, P1007, DOI 10.1111/j.1464-410X.2011.10521.x; Tanaka N, 2011, INT J CLIN ONCOL, V16, P553, DOI 10.1007/s10147-011-0226-2; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1097/01.ju.0000045749.90353.c7; Blute ML, 2001, J UROLOGY, V165, P119, DOI 10.1097/00005392-200101000-00030; Coughlin G, 2009, J ROBOT SURG, V1, P13; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hashimoto T, 2014, INT J CLIN ONCOL, V19, P702, DOI 10.1007/s10147-013-0611-0; Hashine K, 2012, INT J UROL, V19, P855, DOI 10.1111/j.1442-2042.2012.03041.x; Kim KH, 2013, ASIAN J ANDROL, V15, P404, DOI 10.1038/aja.2013.5; Naito S, 2008, J UROLOGY, V180, P904, DOI 10.1016/j.juro.2008.05.047; Okubo H, 2014, INT J UROL, V21, P479, DOI 10.1111/iju.12327; Samadi DB, 2010, J ENDOUROL, V24, P1105, DOI 10.1089/end.2010.0136; Sejima Takehiro, 2013, Cent European J Urol, V66, P126, DOI 10.5173/ceju.2013.02.art3; The Japanese Urological Association The Japanese Society of Pathology Japan Radiological Society, 2010, GEN RUL CLIN PATH ST	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					188	193		10.1111/iju.12624		6	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800016		
J	Shimbo, M				Shimbo, Masaki			Editorial Comment to Prediction of biochemical recurrence after robot-assisted radical prostatectomy: Analysis of 784 Japanese patients	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							LEARNING-CURVE		St Lukes Int Hosp, Dept Urol, Tokyo, Japan	Shimbo, M (reprint author), St Lukes Int Hosp, Dept Urol, Tokyo, Japan.	urolshin@yahoo.co.jp					Patel VR, 2005, J UROLOGY, V174, P269, DOI 10.1097/01.ju.0000162082.12962.40; Thompson JE, 2014, EUR UROL, V65, P521, DOI 10.1016/j.eururo.2013.10.030; Mirheydar HS, 2013, WORLD J UROL, V31, P455, DOI 10.1007/s00345-012-1015-x; Hashimoto T, 2015, INT J UROL, V22, P188, DOI 10.1111/iju.12624	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					193	194		10.1111/iju.12671		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800017		
J	Kitta, T; Mitsui, T; Kanno, Y; Chiba, H; Moriya, K; Nonomura, K				Kitta, Takeya; Mitsui, Takahiko; Kanno, Yukiko; Chiba, Hiroki; Moriya, Kimihiko; Nonomura, Katsuya			Postoperative detrusor contractility temporarily decreases in patients undergoing pelvic organ prolapse surgery	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						clean intermittent catheterization; pelvic organ prolapse; pressure flow study; tension-free vaginal mesh	BLADDER OUTLET OBSTRUCTION; VAGINAL MESH PROCEDURE; URINARY RETENTION; SHORT-TERM; INCONTINENCE SURGERY; STRESS-INCONTINENCE; GENITAL PROLAPSE; VOIDING FUNCTION; WALL PROLAPSE; PRESSURE-FLOW	ObjectivesTo assess the postoperative lower urinary tract function in patients undergoing pelvic organ prolapse surgery. MethodsA total of 24 women with advanced anterior vaginal wall prolapse underwent transvaginal repair using a polypropylene mesh. The preoperative, 1-week and 3-month postoperative evaluations were carried out by urodynamics. Maximal flow rate detrusor pressure at maximal flow rate, voided volume and bladder contractility index were measured. A value of P<0.05 was considered to be statistically significant. ResultsThe mean age of patients was 73.5 years (range 49-84 years). The mean postoperative maximal flow rate, voiding efficiency and bladder contractility index decreased significantly after the operation compared with the preoperative values (P<0.05). No significant differences were observed between preoperative and 3-month postoperative parameters. Of the patients, 33.3%, 11.1% and 50% were classified as having normal/strong contractility preoperative, 1 week and 3 months, respectively. The proportion of normal/strong contractility decreased significantly after the operation, and it recovered 3 months postoperatively. The grade of obstruction did not change significantly. ConclusionsPatients undergoing pelvic organ prolapse surgery present temporary impaired detrusor contractility, which improves significantly during the midterm postoperative period.	[Kitta, Takeya; Mitsui, Takahiko; Kanno, Yukiko; Chiba, Hiroki; Moriya, Kimihiko; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0608638, Japan	Kitta, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	kitta@fb3.so-net.ne.jp					Alonzo-Sosa J E, 1997, Ginecol Obstet Mex, V65, P455; Altman D, 2008, INT UROGYNECOL J, V19, P787, DOI 10.1007/s00192-007-0526-2; Miller EA, 2003, J UROLOGY, V169, P2234, DOI 10.1097/01.ju.0000063590.13100.4d; Roovers JPWR, 2007, INT UROGYNECOL J, V18, P455, DOI 10.1007/s00192-006-0260-1; Abrams P, 1999, BJU INT, V84, P14; Klutke JJ, 2000, AM J OBSTET GYNECOL, V182, P1378, DOI 10.1067/mob.2000.106176; Chaikin DC, 2000, J UROLOGY, V163, P531, DOI 10.1016/S0022-5347(05)67918-9; Takahashi S, 2010, INT J UROL, V17, P353, DOI 10.1111/j.1442-2042.2010.02469.x; Nauth MA, 2008, EUR J OBSTET GYN R B, V136, P249, DOI 10.1016/j.ejogrb.2007.06.012; Hakvoort RA, 2004, BJOG-INT J OBSTET GY, V111, P828, DOI 10.1111/j.1471-0528.2004.00181.x; Sokol AI, 2005, AM J OBSTET GYNECOL, V192, P1537, DOI 10.1016/j.ajog.2004.10.623; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Bodker B, 2003, INT UROGYNECOL J PEL, V14, P94, DOI 10.1007/s00192-003-1038-3; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Blaivas JG, 2000, NEUROUROL URODYNAM, V19, P553, DOI 10.1002/1520-6777(2000)19:5<553::AID-NAU2>3.0.CO;2-B; Romanzi LJ, 1999, J UROLOGY, V161, P581, DOI 10.1016/S0022-5347(01)61957-8; Araki I, 2009, INT UROGYNECOL J, V20, P1301, DOI 10.1007/s00192-009-0954-2; Cormier L, 2002, J UROLOGY, V167, P2083, DOI 10.1016/S0022-5347(05)65090-2; Debodinance P, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P577; FitzGerald MP, 2000, AM J OBSTET GYNECOL, V183, P1361, DOI 10.1067/mob.2000.110956; Foon R, 2008, INT UROGYNECOL J, V19, P1697, DOI 10.1007/s00192-008-0668-x; Hakvoort RA, 2009, NEUROUROL URODYNAM, V28, P225, DOI 10.1002/nau.20636; Kato K, 2009, INT J UROL, V16, P314, DOI 10.1111/j.1442-2042.2008.02249.x; Kims SO, 2011, INT UROGYNECOL J, V22, P1287; Komesu YM, 2007, J REPROD MED, V52, P611; Kuribayashi M, 2011, INT UROGYNECOL J, V22, P1299, DOI 10.1007/s00192-011-1433-0; Maher C, 2006, INT UROGYNECOL J, V17, P195, DOI 10.1007/s00192-005-1296-3; Mueller ER, 2007, J UROLOGY, V177, P600, DOI 10.1016/j.juro.2006.09.060; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					201	205		10.1111/iju.12656		5	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800020		
J	Taniguchi, H; Iwamoto, T; Ichikawa, T; Nagai, A; Okada, H; Fujisawa, M; Tsujimura, A; Shiraishi, K; Hibi, H; Nagao, K; Iwasaki, A; Kamba, T; Tomomasa, H; Takada, S; Matsuda, T				Taniguchi, Hisanori; Iwamoto, Teruaki; Ichikawa, Tomohiko; Nagai, Atsushi; Okada, Hiroshi; Fujisawa, Masato; Tsujimura, Akira; Shiraishi, Koji; Hibi, Hatsuki; Nagao, Koichi; Iwasaki, Akira; Kamba, Tomomi; Tomomasa, Hiroshi; Takada, Shingo; Matsuda, Tadashi		Male Infertility Surgical Forum	Contemporary outcomes of seminal tract re-anastomoses for obstructive azoospermia: A nationwide Japanese survey	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						male infertility; obstructive azoospermia; seminal tract re-anastomosis; vasoepididymostomy; vasovasostomy		ObjectivesTo evaluate current outcomes of seminal tract re-anastomoses in Japan, and to compare them with historical data. MethodsA total of 213 patients with obstructive azoospermia who underwent seminal tract re-anastomosis from April 2008 to March 2012 at 25 institutions were enrolled in the present study. The outcomes of the procedure were compared with those reported in a previous multi-institutional study carried out in 2000. ResultsThe percentage of partners aged over 35 years was 37%. A microsurgical double-layer anastomosis was carried out 83.0% of the time. Sperm were observed in ejaculate postoperatively in 68.9% and 41.5% of patients who underwent a vasovasostomy or a vasoepididymostomy, respectively. Natural conception occurred in 27.5% of patients after a vasectomy and 32.3% of patients with an epididymal obstruction. Except for the ratio of natural conception in patients with vasal obstruction after herniorrhaphies, there were no significant differences in final ratios of sperm appearance and natural conception between the previously reported study and the present study. ConclusionsCompared with historical data, contemporary seminal tract re-anastomosis in Japan seems to provide equivalent or better outcomes, depending on the cause of obstruction. Seminal tract re-anastomosis is a valid treatment option for patients with obstructive azoospermia.	[Taniguchi, Hisanori; Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka 5731010, Japan; [Iwamoto, Teruaki] Int Univ Hlth & Welf Hosp Reprod Ctr, Nasushiobara, Tochigi, Japan; [Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; [Nagai, Atsushi] Kawasaki Med Univ, Dept Urol, Okayama, Japan; [Okada, Hiroshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Urol, Saitama, Japan; [Fujisawa, Masato] Kobe Univ, Grad Sch Med, Fac Med, Div Urol,Dept Surg Related, Kobe, Hyogo 657, Japan; [Tsujimura, Akira] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Shiraishi, Koji] Yamaguchi Univ, Sch Med, Dept Urol, Yamaguchi, Japan; [Hibi, Hatsuki] Kyoritsu Gen Hosp, Dept Urol, Toyohashi, Aichi, Japan; [Nagao, Koichi] Toho Univ, Omori Reprod Ctr, Tokyo, Japan; [Iwasaki, Akira] Yokohama City Minato Red Cross Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kamba, Tomomi] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Tomomasa, Hiroshi] Itabashi Chuo Med Ctr, Dept Urol, Tokyo, Japan; [Takada, Shingo] Osaka Police Hosp, Dept Urol, Osaka, Japan	Matsuda, T (reprint author), Kansai Med Univ, Dept Urol & Androl, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	matsudat@hirakata.kmu.ac.jp					Matsuda T, 1998, J UROLOGY, V159, P837, DOI 10.1016/S0022-5347(01)63747-9; ART Registry of Japan, 2012, ACTA OBSTET GYNAECOL, V64, P2110; BELKER AM, 1991, J UROLOGY, V145, P505; Chan PT, 2013, ASIAN J ANDROL, V15, P49, DOI 10.1038/aja.2012.80; Matsuda Tadashi, 2000, Japanese Journal of Fertility and Sterility, V45, P143; Practice Committee of American Society for Reproductive Medicine, 2008, FERTIL STERIL, V90, pS78; World Health Organization, 2010, WHO LAB MAN EX PROC	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					213	218		10.1111/iju.12631		6	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800022		
J	Yamamoto, T; Kinoshita, H; Ikeda, J; Sugi, M; Matsuda, T				Yamamoto, Teppei; Kinoshita, Hidefumi; Ikeda, Junichi; Sugi, Motohiko; Matsuda, Tadashi			Refractory urinary fistula with infundibular stenosis after partial nephrectomy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						embolization; infundibular stenosis; partial nephrectomy; renal cell carcinoma; urinary fistula	SINGLE INSTITUTION EXPERIENCE; NEPHRON SPARING SURGERY; MANAGEMENT; COMPLICATIONS	A 71-year-old male patient who was diagnosed with renal cell carcinoma (cT1aN0M0) underwent a laparoscopic left partial nephrectomy. Because the bleeding could not be controlled, conversion to laparotomy was instigated. A ureteral stent was placed on confirmation of postoperative urine leakage from the drain, but the volume of drainage did not decrease. The findings of retrograde pyelography and computed tomography showed a urinary fistula resulting from isolated calyces caused by infundibular stenosis, for which transurethral dilatation for the stenosis was carried out. However, owing to the severity of stenosis, the guidewire was unable to achieve passage, and endoscopic dilatation was abandoned. Selective embolization of the left renal artery was then carried out. No drainage fluid was observed after embolization, and residual renal function of the left kidney was confirmed.	[Yamamoto, Teppei; Kinoshita, Hidefumi; Ikeda, Junichi; Sugi, Motohiko; Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka 5731010, Japan	Yamamoto, T (reprint author), Kansai Med Univ, Dept Urol & Androl, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	t_yama9@yahoo.co.jp					Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Thompson RH, 2005, J UROLOGY, V174, P855, DOI 10.1097/01.ju.0000169453.29706.42; Meeks JJ, 2008, J UROLOGY, V180, P2375, DOI 10.1016/j.juro.2008.08.018; Bruner B, 2009, J ENDOUROL, V23, P37, DOI 10.1089/end.2008.0291; Mues AC, 2010, J ENDOUROL, V24, P1241, DOI 10.1089/end.2009.0663; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					219	221		10.1111/iju.12629		3	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800023		
J	Shigehara, K; Namiki, M				Shigehara, Kazuyoshi; Namiki, Mikio			Editorial Comment to Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									[Shigehara, Kazuyoshi] Ishikawa Prefectural Cent Hosp, Dept Urol, Kanazawa, Ishikawa, Japan; [Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan	Shigehara, K (reprint author), Ishikawa Prefectural Cent Hosp, Dept Urol, Kanazawa, Ishikawa, Japan.	kshigehara0415@yahoo.co.jp					Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Kawaguchi S, 2012, J CLIN MICROBIOL, V50, P401, DOI 10.1128/JCM.05219-11; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; Ginori A, 2015, INT J UROL, V22, P222, DOI 10.1111/iju.12633; Lis N, 2011, J INFECT DIS, V204, P217; Shigehara K, 2013, APMIS, V121, P1169, DOI 10.1111/apm.12070	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					225	226		10.1111/iju.12661		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800025		
J	Kato, T; Sugimoto, M; Matsuoka, Y; Sakura, Y; Hayashida, Y; Hirama, H; Tsunemori, H; Ueda, N; Uemura, N; Miyawaki, Y; Shirakami, G; Kakehi, Y				Kato, Takuma; Sugimoto, Mikio; Matsuoka, Yuki; Sakura, Yuma; Hayashida, Yushi; Hirama, Hiromi; Tsunemori, Hiroyuki; Ueda, Nobufumi; Uemura, Naoya; Miyawaki, Yuki; Shirakami, Gotaro; Kakehi, Yoshiyuki			Case of vascular air embolism during holmium laser enucleation of the prostate	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						holmium laser enucleation of the prostate; transurethral surgery; vascular air embolism	TRANSURETHRAL RESECTION; GAS EMBOLISM	Vascular air embolism is a rare complication during transurethral surgery. A case of air embolism during holmium laser enucleation of the prostate in a 76-year-old man is presented. During the step of morcellation, the patient's blood pressure suddenly oscillated up and down, and end-tidal CO2 and arterial saturation decreased. Transesophageal and transthoracic echocardiography showed air collection in the right atrium. It was also discovered that incorrect assembly of the tube from the morcellator caused rapid entrainment of air into the vein. Computed tomography and abdominal X-ray showed niveau formation in the femoral vein and air collection in the pelvic retroperitoneal space. The patient recovered with careful observation and was discharged 7 days after the operation with no sequelae. This report is presented to remind urologists of this unusual complication that can occur during holmium laser enucleation of the prostate procedures.	[Kato, Takuma; Sugimoto, Mikio; Matsuoka, Yuki; Sakura, Yuma; Hayashida, Yushi; Hirama, Hiromi; Tsunemori, Hiroyuki; Ueda, Nobufumi; Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 760, Japan; [Uemura, Naoya; Miyawaki, Yuki; Shirakami, Gotaro] Kagawa Univ, Fac Med, Dept Anesthesiol, Takamatsu, Kagawa 760, Japan	Kato, T (reprint author), Kurashiki Cent Hosp, Dept Urol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	takuma_k@med.kagawa-u.ac.jp					Frasco PE, 2004, ANESTH ANALG, V99, P1864, DOI 10.1213/01.ANE.0000136847.41264.60; Fukanos N, 2007, JPN J ANESTHESIOL, V56, P178; HOFSESS DW, 1984, J UROLOGY, V131, P355; Inokuchis G, 2010, JPN J LEGAL MED, V64, P70; Matsuno Daisuke, 2007, Hinyokika Kiyo, V53, P409; Shaikh Nissar, 2009, J Emerg Trauma Shock, V2, P180, DOI 10.4103/0974-2700.55330; Tsou MY, 2003, ANESTH ANALG, V97, P1833, DOI 10.1213/01.ANE.0000087065.1255.68; VACANTI CA, 1991, ANESTHESIOLOGY, V74, P186, DOI 10.1097/00000542-199101000-00028; VOURCH G, 1982, INTENS CARE MED, V8, P239, DOI 10.1007/BF01694528; Yamamotos M, 2000, JPN J ANESTHESIOL, V49, P696	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					227	229		10.1111/iju.12651		3	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800026		
J	Yamada, Y; Sakamoto, S; Furuya, M; Nihei, N; Nakatani, Y; Ichikawa, T				Yamada, Yasutaka; Sakamoto, Shinichi; Furuya, Mitsuko; Nihei, Naoki; Nakatani, Yukio; Ichikawa, Tomohiko			Case of bilateral and multifocal renal cell carcinoma associated with Birt-Hogg-Dube syndrome	INTERNATIONAL JOURNAL OF UROLOGY			English	Article							FAMILIES		[Yamada, Yasutaka; Sakamoto, Shinichi; Nihei, Naoki; Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan; [Furuya, Mitsuko] Yokohama City Univ, Grad Sch Med, Dept Mol Pathol, Yokohama, Kanagawa, Japan	Yamada, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan.	rbatbat1@yahoo.co.jp					Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Kluger N, 2010, BRIT J DERMATOL, V162, P527, DOI 10.1111/j.1365-2133.2009.09517.x; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Nakamura Mami, 2013, Hinyokika Kiyo, V59, P503; Palvovichs CP, 2005, J UROLOGY, V173, P1482	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					230	231		10.1111/iju.12649		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800027		
J	Kuroda, N				Kuroda, Naoto			Editorial Comment to Case of bilateral and multifocal renal cell carcinoma associated with Birt-Hogg-Dube syndrome	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan	Kuroda, N (reprint author), Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan.	kurochankochi@yahoo.co.jp					Coleman JA, 2009, CURR OPIN UROL, V19, P478, DOI 10.1097/MOU.0b013e32832f0d40; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Kuroda N, 2014, POL J PATHOL, V65, P93, DOI 10.5114/PJP.2014.43958; Gupta GN, 2010, J UROLOGY, V184, P59, DOI 10.1016/j.juro.2010.03.035; Pfagffenroths EC, 2008, EXPERT OPIN BIOL TH, V8, P779; Yamada Y, 2015, INT J UROL, V22, P230, DOI 10.1111/iju.12649	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					231	232		10.1111/iju.12659		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800028		
J	Akita, H; Okamura, T; Nakane, A; Kobayashi, T; Yamada, K; Tanaka, Y				Akita, Hidetoshi; Okamura, Takehiko; Nakane, Akihiro; Kobayashi, Takahiro; Yamada, Kenji; Tanaka, Yutaro			Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article							INTRAVESICAL BCG THERAPY; MYCOTIC-ANEURYSM; CANCER; COMPLICATIONS		[Akita, Hidetoshi; Okamura, Takehiko; Nakane, Akihiro; Kobayashi, Takahiro; Yamada, Kenji; Tanaka, Yutaro] JA Aichi Anjo Kosei Hosp, Dept Urol, Anjo, Aichi, Japan	Akita, H (reprint author), JA Aichi Anjo Kosei Hosp, Dept Urol, Anjo, Aichi, Japan.	hiko2546@sf.commufa.jp					Samadian S, 2013, AGE AGEING, V42, P129, DOI 10.1093/ageing/afs164; Koya MP, 2006, J UROLOGY, V175, P2004, DOI 10.1016/S0022-5347(06)00264-3; LAMM DL, 1992, J UROLOGY, V147, P596; Damm O, 1998, J UROLOGY, V159, P984, DOI 10.1016/S0022-5347(01)63796-0; IZES JK, 1993, J UROLOGY, V150, P1498; Oriis K, 2012, JPN J VASC SURG, V21, P803; Witjes JA, 2003, UROL INT, V71, P430, DOI 10.1159/000074100	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					234	235		10.1111/iju.12635		2	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800030		
J	Takao, T; Tsujimura, A; Kiuchi, H; Takezawa, K; Nonomura, N; Miyagawa, Y				Takao, Tetsuya; Tsujimura, Akira; Kiuchi, Hiroshi; Takezawa, Kentaro; Nonomura, Norio; Miyagawa, Yasushi			Improvement of nocturia and sleep disturbance by silodosin in male patients with lower urinary tract symptoms	INTERNATIONAL JOURNAL OF UROLOGY			English	Article							OVERACTIVE BLADDER; QUALITY; TRIAL		[Takao, Tetsuya; Tsujimura, Akira; Kiuchi, Hiroshi; Takezawa, Kentaro; Nonomura, Norio; Miyagawa, Yasushi] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan	Takao, T (reprint author), Osaka Gen Med Ctr, Dept Urol, Osaka, Japan.	akitsuji@uro.med.osaka-u.ac.jp					ABRAMS P, 1995, BRIT J UROL, V76, P325, DOI 10.1111/j.1464-410X.1995.tb07709.x; Johnson TM, 2003, J UROLOGY, V170, P145, DOI 10.1097/01.ju.0000069827.09120.79; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1046/j.1464-410X.2003.04527.x; Takao T, 2011, UROLOGY, V78, P648, DOI 10.1016/j.urology.2011.04.020	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	FEB	2015	22	2					236	238		10.1111/iju.12638		3	Urology & Nephrology	Urology & Nephrology	CB9TU	WOS:000349976800032		
J	Toiyama, Y; Inoue, Y; Kawamura, M; Kawamoto, A; Okugawa, Y; Hiro, J; Saigusa, S; Tanaka, K; Mohri, Y; Kusunoki, M				Toiyama, Yuji; Inoue, Yasuhiro; Kawamura, Mikio; Kawamoto, Aya; Okugawa, Yoshinaga; Hiro, Jyunichiro; Saigusa, Susumu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato			Elevated Platelet Count as Predictor of Recurrence in Rectal Cancer Patients Undergoing Preoperative Chemoradiotherapy Followed by Surgery	INTERNATIONAL SURGERY			English	Article						Platelet; Neutrophil/lymphocyte ratio; Platelet/lymphocyte ratio; Rectal cancer; Prognosis; Chemoradiotherapy	SYSTEMIC INFLAMMATORY RESPONSE; DISEASE-FREE SURVIVAL; COLORECTAL-CANCER; PROGNOSTIC SCORE; CURATIVE RESECTION; LYMPHOCYTE RATIO; NEOADJUVANT CHEMORADIOTHERAPY; TUMOR-REGRESSION; RANDOMIZED-TRIAL; THROMBOCYTOSIS	The impact of systemic inflammatory response (SIR) on prognostic and predictive outcome in rectal cancer after neoadjuvant chemoradiotherapy (CRT) has not been fully investigated. This retrospective study enrolled 89 patients with locally advanced rectal cancer who underwent neoadjuvant CRT and for whom platelet (PLT) counts and SIR status [neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR)] were available. Both clinical values of PLT and SIR status in rectal cancer patients were investigated. Elevated PLT, NLR, PLR, and pathologic TNM stage III [ypN(+)] were associated with significantly poor overall survival (OS). Elevated PLT, NLR, and ypN(+) were shown to independently predict OS. Elevated PLT and ypN(+) significantly predicted poor disease-free survival (DFS). Elevated PLT was identified as the only independent predictor of DFS. PLT counts are a promising pre-CRT biomarker for predicting recurrence and poor prognosis in rectal cancer.	[Toiyama, Yuji; Inoue, Yasuhiro; Kawamura, Mikio; Kawamoto, Aya; Okugawa, Yoshinaga; Hiro, Jyunichiro; Saigusa, Susumu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan	Toiyama, Y (reprint author), Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan.	ytoi0725@clin.medic.mie-u.ac.jp					Chiang SF, 2012, INT J COLORECTAL DIS, V27, P1347, DOI 10.1007/s00384-012-1459-x; CEDERMARK B, 1995, CANCER, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Bujko K, 2007, INT J RADIAT ONCOL, V67, P369, DOI 10.1016/j.ijrobp.2006.08.065; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; Park JW, 2009, INT J RADIAT ONCOL, V74, P810, DOI 10.1016/j.ijrobp.2008.08.057; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Mawdsley S, 2005, INT J RADIAT ONCOL, V63, P745, DOI 10.1016/j.ijrobp.2005.03.003; Perez RO, 2009, DIS COLON RECTUM, V52, P1137, DOI 10.1007/DCR.0b013e31819ef76b; Garcia VM, 2009, INT J COLORECTAL DIS, V24, P741, DOI 10.1007/s00384-009-0682-6; Kawai K, 2013, INT J COLORECTAL DIS, V28, P527, DOI 10.1007/s00384-012-1594-4; Lu K, 2011, HEPATO-GASTROENTEROL, V58, P1507, DOI 10.5754/hge11133; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Kim TH, 2010, INT J RADIAT ONCOL, V77, P1158, DOI 10.1016/j.ijrobp.2009.06.019; Beresford M, 2005, CLIN ONCOL-UK, V17, P448, DOI 10.1016/j.clon.2005.05.007; LEVIN J, 1964, ARCH INTERN MED, V114, P497; Nissan A, 2006, J CLIN ONCOL, V24, P4078, DOI 10.1200/JCO.2006.06.2968; Carruthers R, 2012, COLORECTAL DIS, V14, pE701, DOI 10.1111/j.1463-1318.2012.03147.x; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Kawai K, 2011, INT J COLORECTAL DIS, V26, P45, DOI 10.1007/s00384-010-1054-y; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Yoshikawa R, 2001, CANCER RES, V61, P1029; Malik HZ, 2007, ANN SURG, V246, P806, DOI 10.1097/SLA.0b013e318142d964; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Cravioto-Villanueva A, 2012, ARCH MED RES, V43, P305, DOI 10.1016/j.arcmed.2012.06.008; Dutcher J P, 1987, Hematol Oncol Clin North Am, V1, P281; Huh JW, 2011, SURGERY, V150, P980, DOI 10.1016/j.surg.2011.06.018; Ishizuka M, 2012, J SURG ONCOL, V106, P887, DOI 10.1002/jso.23163; Japanese Research Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Lindebjerg J, 2009, COLORECTAL DIS, V11, P264, DOI 10.1111/j.1463-1318.2008.01599.x; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Naschitz JE, 1996, CANCER, V77, P1759; Ruscetti F W, 1994, Curr Opin Hematol, V1, P210; Yasuda Koji, 2012, J Gastrointest Cancer, V43, P236, DOI 10.1007/s12029-011-9268-y	40	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					199	207		10.9738/INTSURG-D-13-00178.1		9	Surgery	Surgery	CB9MY	WOS:000349957000003		
J	Kawamoto, A; Inoue, Y; Okigami, M; Yasuda, H; Okugawa, Y; Hiro, J; Toiyama, Y; Tanaka, K; Uchida, K; Mohri, Y; Kusunoki, M				Kawamoto, Aya; Inoue, Yasuhiro; Okigami, Masato; Yasuda, Hiromi; Okugawa, Yoshinaga; Hiro, Junichiro; Toiyama, Yuji; Tanaka, Koji; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato			Preoperative Assessment of Vascular Anatomy by Multidetector Computed Tomography Before Laparoscopic Colectomy for Transverse Colon Cancer: Report of a Case	INTERNATIONAL SURGERY			English	Article						Multidetector computed tomography; Transverse colon cancer; Laparoscopic surgery	RANDOMIZED CONTROLLED-TRIAL; SPIRAL CT ANGIOGRAPHY; SHORT-TERM OUTCOMES; ASSISTED GASTRECTOMY; ARTERIOGRAPHY; RESECTION; DONORS	Although the safety of laparoscopic surgery for colon cancer has been reported in many randomized controlled trials, concerns about the difficulty of surgery for transverse colon cancer has not been fully resolved, mainly because of the variation in the vascular anatomy of mesenteric vessels, which leads to difficulty in determining the optimal operative procedure and the extent of lymph node dissection. We present the case of a patient with transverse colon cancer who underwent laparoscopic surgery after preoperative assessment using a combination of endoscopic clipping and three-dimensional computed tomography angiography (3DCTA). A 68-year-old man was diagnosed with transverse colon cancer, and laparoscopic surgery has been planned. 3DCTA showed right-middle and left-middle colic arteries arising independently from the superior mesenteric artery. The relationship between the clip and vessels showed that the right-middle colic artery was the feeding artery of the tumor. Operative findings were consistent with 3DCTA findings, and transverse colectomy with lymph node dissection was successfully performed.	[Kawamoto, Aya; Inoue, Yasuhiro; Okigami, Masato; Yasuda, Hiromi; Okugawa, Yoshinaga; Hiro, Junichiro; Toiyama, Yuji; Tanaka, Koji; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan	Kawamoto, A (reprint author), Mie Univ, Grad Sch Med, Inst Life Sci, Dept Gastrointestinal & Pediat Surg,Div Reparat M, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ayayaka@clin.medic.mie-u.ac.jp					Yamamoto M, 2012, SURG ENDOSC, V26, P1566, DOI 10.1007/s00464-011-2071-9; Akiyoshi T, 2010, J GASTROINTEST SURG, V14, P818, DOI 10.1007/s11605-010-1182-2; Mari FS, 2013, SURG ENDOSC, V27, P2058, DOI 10.1007/s00464-012-2710-9; Schlachta CM, 2007, SURG ENDOSC, V21, P396, DOI 10.1007/s00464-006-9042-6; Foley WD, 2000, AM J ROENTGENOL, V175, P679; Makino T, 2012, ANN SURG, V255, P228, DOI 10.1097/SLA.0b013e31823dcbf7; Miyaki A, 2012, LANGENBECK ARCH SURG, V397, P945, DOI 10.1007/s00423-012-0956-2; RUBIN GD, 1993, RADIOLOGY, V186, P147; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hewett PJ, 2008, ANN SURG, V248, P728, DOI 10.1097/SLA.0b013e31818b7595; Natsume T, 2011, SURG ENDOSC, V25, P1420, DOI 10.1007/s00464-010-1407-1; GALANSKI M, 1993, RADIOLOGY, V189, P185; Holden A, 2005, RADIOLOGY, V237, P973, DOI 10.1148/radiol.2373041303; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kawamoto S, 2003, AM J ROENTGENOL, V180, P1633; Kim HS, 2001, ABDOM IMAGING, V26, P123; Matsuki M, 2004, AM J ROENTGENOL, V183, P145; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Sakorafas GH, 2006, SURG ONCOL, V15, P243, DOI 10.1016/j.suronc.2007.03.002; Spasojevic M, 2011, DIS COLON RECTUM, V54, P1503, DOI 10.1097/DCR.0b013e318232116b; WINTER TC, 1995, RADIOLOGY, V195, P363; Yamamoto M, 2013, AM SURGEON, V79, P366	22	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					208	212		10.9738/INTSURG-D-13-00232.1		5	Surgery	Surgery	CB9MY	WOS:000349957000004		
J	Tanaka, K; Hashimoto, H; Ohki, T				Tanaka, Keiichiro; Hashimoto, Hisashi; Ohki, Takao			Lactate Levels in Bowel Strangulation With Experimental Animal Model	INTERNATIONAL SURGERY			English	Article						Bowel strangulation; Lactate; Blood gas analyzer; Animal model	INTESTINAL ISCHEMIA; OBSTRUCTION; PREDICT	Bowel strangulation is a common disease and often requires an urgent operation. Our previous report showed that lactate concentration in the blood is a good predictive marker for emergency. However, the alteration in lactate levels during the course of bowel strangulation remains unclear. We have investigated the progressive increase of lactate after induction of bowel strangulation with animal experiments. Thirty-six mice were randomly divided into 6 groups: 0, 8, 16, 24, 48, and 72 hours after operation. Under anesthesia, laparotomy was performed and a 5-cm segment of terminal ileum with the mesenteric artery and veins was ligated to create a strangulation obstruction. After operation, the arterial blood was collected and lactate concentration and pH were measured using a blood gas analyzer. Lactate concentration in the 8-hour group was markedly increased, while pH decreased significantly (P < 0.05). Lactate concentrations were kept at a high level from 8 to 72 hours after operation. The time lag between strangulation and an increase of lactate is 8 hours. Our study is the first report of a bowel strangulation mouse model. Therefore, it would be possible to find a more specific marker of bowel strangulation using our experimental model.	[Tanaka, Keiichiro; Ohki, Takao] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan; [Hashimoto, Hisashi] Jikei Univ, Sch Med, Dept Anat, Minato Ku, Tokyo 1058461, Japan	Tanaka, K (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	keiichiro@jikei.ac.jp					Abramson D, 1993, J TRAUMA, V35, P588; SARR MG, 1983, AM J SURG, V145, P176, DOI 10.1016/0002-9610(83)90186-1; MURRAY MJ, 1994, AM J SURG, V167, P575, DOI 10.1016/0002-9610(94)90101-5; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; DELAURIER GA, 1989, AM J SURG, V158, P32, DOI 10.1016/0002-9610(89)90311-5; Firoozmand E, 2001, AM SURGEON, V67, P1145; Kobayashi S, 2007, J GASTROINTEST SURG, V11, P240, DOI 10.1007/s11605-007-0092-4; LIAO XP, 1995, J PEDIATR SURG, V30, P1412, DOI 10.1016/0022-3468(95)90394-1; Margenthaler JA, 2006, ANN SURG, V243, P456, DOI 10.1097/01.sla.0000205668.58519.76; Schein Moshe, 2010, World J Surg, V34, P920, DOI 10.1007/s00268-010-0460-1; SHATILA AH, 1976, AM J SURG, V132, P299, DOI 10.1016/0002-9610(76)90379-2; Tanaka K, 2012, AM SURGEON, V78, P86; Yamamoto T, 2005, DIS COLON RECTUM, V48, P1451, DOI 10.1007/s10350-005-0019-7	15	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					240	243		10.9738/INTSURG-D-13-00211.1		4	Surgery	Surgery	CB9MY	WOS:000349957000009		
J	Chinburen, J; Gillet, M; Yamamoto, M; Enkh-Amgalan, T; Taivanbaatar, E; Enkhbold, C; Natsagnyam, P				Chinburen, Jigjidsuren; Gillet, Michele; Yamamoto, Masakazu; Enkh-Amgalan, Tsiiregzen; Taivanbaatar, Erdenebileg; Enkhbold, Chinbold; Natsagnyam, Puntsagdulam			Impact of Glissonean Pedicle Approach for Centrally Located Hepatocellular Carcinoma in Mongolia	INTERNATIONAL SURGERY			English	Article						Centrally located HCC; Glissonean approach; Glissonean pedicle transection; Central hepatectomy	CENTRAL LIVER-TUMORS; CENTRAL HEPATECTOMY; HEPATIC RESECTION; CIRRHOTIC-PATIENTS; MESOHEPATECTOMY	Approaches to surgical resection of centrally located HCC remain controversial. Traditionally, hemi- or extended hepatectomy is suggested. However, it carries a high risk of postoperative complications in patients with cirrhosis. An alternative approach is Glissonean pedicle transection method. This study was conducted to assess the surgical and survival outcomes associated with central liver resection using the Glissonean pedicle transection. Sixty-nine patients with centrally located HCC were studied retrospectively. They were divided into conventional approach group with hemi- or extended hepatectomy, and Glissonean approach group with multisegmental central liver resection using the Glissonean pedicle transection. Glissonean pedicle transection method has comparable or superior surgical and survival outcomes to conventional hemi- or extended hepatectomy with regard to intraoperative bleeding, complications, hospital stay, and postoperative mortality and survival outcomes in patients with centrally located HCC. The 1-, 3-, and 5-year overall survival rates of the conventional approach group were 74%, 64%, and 55% respectively. For the Glissonean approach group, the 1 and 3-year overall survival rates were 86% and 61%, respectively. Glissonean pedicle transection method is a safe and effective surgical procedure in patients with centrally located HCC.	[Chinburen, Jigjidsuren; Enkh-Amgalan, Tsiiregzen; Taivanbaatar, Erdenebileg; Enkhbold, Chinbold] Natl Canc Ctr, HPB Surg Dept, Ulaanbaatar 210648, Mongol Peo Rep; [Gillet, Michele] Natl Canc Ctr, Ulaanbaatar, Mongol Peo Rep; [Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Natsagnyam, Puntsagdulam] Hlth Sci Univ Mongolia, Ulaanbaatar, Mongol Peo Rep	Chinburen, J (reprint author), Natl Canc Ctr, HPB Surg Dept, Nam Yan Ju St, Ulaanbaatar 210648, Mongol Peo Rep.	chburen@hotmail.com					Machado MA, 2011, SURG ENDOSC, V25, P2020, DOI 10.1007/s00464-010-1483-2; Dahiya D, 2010, SURGERY, V147, P676, DOI 10.1016/j.surg.2009.10.043; Poon RTP, 2002, ANN SURG, V236, P602, DOI 10.1097/01.SLA.0000033038.38956.5E; Stratopoulos C, 2007, SURG ONCOL, V16, P99, DOI 10.1016/j.suronc.2007.05.002; Chouillard E, 2003, ANN SURG, V238, P29, DOI 10.1097/01.sla.0000075058.37052.49; Scudamore CH, 2000, AM J SURG, V179, P356, DOI 10.1016/S0002-9610(00)00374-3; Agrawal S, 2011, ANN SURG, V253, P656, DOI 10.1097/SLA.0b013e3181fc08ca; Wu CC, 1999, J AM COLL SURGEONS, V188, P508, DOI 10.1016/S1072-7515(99)00026-5; Yamamoto M, 2012, J HEPATO-BIL-PAN SCI, V19, P3, DOI 10.1007/s00534-011-0443-0; Jazag A, 2012, KOREAN J INTERN MED, V27, P121, DOI 10.3904/kjim.2012.27.2.121; Liu CL, 2006, ANN SURG, V244, P194, DOI 10.1097/01.sla.0000225095.18754.45; Hu R, 2003, SURGERY, V133, P251, DOI 10.1067/msy.2003.102; Chen XP, 2008, INT J COLORECTAL DIS, V23, P543, DOI 10.1007/s00384-007-0411-y; Arkadopoulos N, 2012, LANGENBECK ARCH SURG, V397, P1283, DOI 10.1007/s00423-012-0984-y; Baatarkhuu O, 2011, ONCOLOGY-BASEL, V81, P148, DOI 10.1159/000333278; Cheng Chih-Hsien, 2012, Chang Gung Med J, V35, P178; Chiappa A, 2000, EUR J SURG ONCOL, V26, P387, DOI 10.1053/ejso.1999.0904; Guerin F, 2010, J PEDIATR SURG, V45, P555, DOI 10.1016/j.jpedsurg.2009.09.025; Hasegawa K, 2009, SURG TODAY, V39, P833, DOI 10.1007/s00595-008-4024-z; Hu JX, 2009, SURGERY, V146, P854, DOI 10.1016/j.surg.2009.06.008; Ji B, 2012, INT J MED SCI, V9, P843, DOI 10.7150/ijms.4870; Kassahun Woubet T, 2006, Exp Clin Transplant, V4, P549; Katagiri S, 2012, J HEPATO-BIL-PAN SCI, V19, P25, DOI 10.1007/s00534-011-0445-y; Lee JG, 2008, BRIT J SURG, V95, P990, DOI 10.1002/bjs.6130; Llovet JM, 2008, J HEPATOL S1, V48, P20; Machado MAC, 2006, AM J SURG, V192, P388, DOI 10.1016/j.amjsurg.2006.01.017; MCBRIDE CM, 1972, ARCH SURG-CHICAGO, V105, P289; Mehrabi A, 2008, J AM COLL SURGEONS, V207, P499, DOI 10.1016/j.jamcollsurg.2008.05.024; Takasaki K, 1998, J Hepatobiliary Pancreat Surg, V5, P286, DOI 10.1007/s005340050047; Yanaga K, 2012, J HEPATO-BIL-PAN SCI, V19, P44, DOI 10.1007/s00534-011-0449-7; Yoon YS, 2009, J LAPAROENDOSC ADV S, V19, P653, DOI 10.1089/lap.2009.0012	31	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					268	274		10.9738/INTSURG-D-14-00006.1		7	Surgery	Surgery	CB9MY	WOS:000349957000014		
J	Kitaguchi, K; Kato, Y; Kojima, M; Okubo, S; Takahashi, D; Okada, R; Nakayama, Y; Nishida, Y; Gotohda, N; Takahashi, S; Konishi, M				Kitaguchi, Kazuhiko; Kato, Yuichiro; Kojima, Motohiro; Okubo, Satoshi; Takahashi, Daigoro; Okada, Rei; Nakayama, Yusuke; Nishida, Yasunori; Gotohda, Naoto; Takahashi, Shinichiro; Konishi, Masaru			A Resected Case of Intraductal Tubulopapillary Neoplasm of the Pancreas: Report of a Case	INTERNATIONAL SURGERY			English	Article						Intraductal tubulopapillary neoplasm (ITPN); Intraductal neoplasms of the pancreas; Pancreaticoduodenectomy	CARCINOMA; GROWTH; ACTIVATION; TUMOR	The patient was a 61-year-old male who was referred to our hospital after dilatation of the main pancreatic duct was detected by screening ultrasonography. Computed tomography revealed a protruding lesion measuring 15 mm in diameter within the main pancreatic duct in the head of the pancreas, and magnetic resonance cholangiopancreatography revealed interruption of the duct at the tumor site. We performed pancreaticoduodenectomy under a suspected diagnosis of invasive ductal carcinoma. Gross examination of the resected specimen showed that the tumor invaginated into the main pancreatic duct, and no mucin was found. Histological examination revealed proliferation of high-grade dysplastic cells in a tubulopapillary growth pattern. Immunohistochemically, cytokeratin 7 expression was detected, but not trypsin expression. Based on these morphological features, we diagnosed the tumor as intraductal tubulopapillary neoplasm (ITPN). We report the case with bibliographic consideration, together with a review of intraductal neoplasms of the pancreas encountered at our institution.	[Kitaguchi, Kazuhiko; Kato, Yuichiro; Okubo, Satoshi; Takahashi, Daigoro; Okada, Rei; Nakayama, Yusuke; Nishida, Yasunori; Gotohda, Naoto; Takahashi, Shinichiro; Konishi, Masaru] Natl Canc Ctr Hosp East, Div Hepatobiliary & Pancreat Surg, Kashiwa, Chiba 2778577, Japan; [Kojima, Motohiro] Natl Canc Ctr Hosp East, Pathol Fields, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan	Kato, Y (reprint author), Natl Canc Ctr Hosp East, Div Hepatobiliary & Pancreat Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	yuikato@east.ncc.go.jp					Ahls MG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-11; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Yamaguchi H, 2011, AM J SURG PATHOL, V35, P1812, DOI 10.1097/PAS.0b013e31822769a0; Kasugai H, 2013, J NIPPON MED SCH, V80, P224; Jokoji R, 2012, PATHOL INT, V62, P339, DOI 10.1111/j.1440-1827.2012.02791.x; Bhuva N, 2011, BMJ CASE REP, V2011; Furuhata A, 2014, DIAGN CYTOPATHOL, V42, P314, DOI 10.1002/dc.23083; Hioki M, 2010, ANTICANCER RES, V30, P4435; Imamura M, 2009, SURG TODAY, V39, P1006, DOI 10.1007/s00595-009-3968-y; Matsuyama M, 2012, J HEPATO-BIL-PAN SCI, V19, P242, DOI 10.1007/s00534-011-0401-x; Motosugi U, 2012, J COMPUT ASSIST TOMO, V36, P710, DOI 10.1097/RCT.0b013e31826d1fc8; Recavarren C, 2011, HUM PATHOL, V42, P18, DOI 10.1016/j.humpath.2010.05.022; Sanada Y, 2008, ONCOL REP, V19, P1435; Tajiri T, 2005, PANCREAS, V30, P115, DOI 10.1097/01.mpa.0000148513.69873.4b; Yamaguchi H, 2008, AM J SURG PATHOL, V33, P1164; YANAGISAWA A, 1993, CANCER RES, V53, P953; Yazawa N, 2011, SURG TODAY, V41, P737, DOI 10.1007/s00595-009-4321-1	17	1	1	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					281	286		10.9738/INTSURG-D-14-00172.1		6	Surgery	Surgery	CB9MY	WOS:000349957000016		
J	Fujiwara, Y; Shiba, H; Uwagawa, T; Futagawa, Y; Misawa, T; Yanaga, K				Fujiwara, Yuki; Shiba, Hiroaki; Uwagawa, Tadashi; Futagawa, Yasuro; Misawa, Takeyuki; Yanaga, Katsuhiko			Radical Resection of a Primarily Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy Using Gemcitabine, TS-1, and Nafamostat Mesilate; Report of a Case	INTERNATIONAL SURGERY			English	Article						Nafamostat mesilate; Neoadjuvant chemotherapy; Unresectable pancreatic cancer; Down-staging	NF-KAPPA-B; REGIONAL ARTERIAL INFUSION; COMBINATION TREATMENT; CELL-DEATH; PHASE-II; INHIBITION; THERAPY; ADENOCARCINOMA; ACTIVATION; MICE	A 58-year-old male visited his primary physician for epigastric and back pain. Abdominal-enhanced computed tomography (CT) revealed a hypovascular pancreatic tumor measuring 17x11 mm in the uncinate process of the pancreas extending into the superior mesenteric plexus for greater than 180 degrees. With a diagnosis of unresectable pancreatic cancer, the patient received gemcitabine and TS-1 with arterial infusion of nafamostat mesilate. After 3 courses of chemotherapy, enhanced CT revealed a decrease in size of the pancreatic tumor with no lymph node and distant metastasis and improved invasion of the superior mesenteric plexus down to 120 degrees. The patient underwent R0 pancreaticoduodenectomy. The patient made a satisfactory recovery without complications and was discharged on postoperative day 10. We herein report the first curative resected case of a primarily unresectable pancreatic cancer after neoadjuvant chemotherapy using gemcitabine, TS-1, and nafamostat mesilate.	[Fujiwara, Yuki; Shiba, Hiroaki; Uwagawa, Tadashi; Futagawa, Yasuro; Misawa, Takeyuki; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Fujiwara, Y (reprint author), Jikei Univ, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	sheetan@jikei.ac.jp					Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Furukawa K, 2010, ONCOL REP, V24, P843, DOI 10.3892/or_00000928; Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Fujiwara Y, 2011, J HEPATO-BIL-PAN SCI, V18, P731, DOI 10.1007/s00534-011-0390-9; Uwagawa T, 2013, AM J CLIN ONCOL-CANC, V36, P44, DOI 10.1097/COC.0b013e31823a53b2; Uwagawa T, 2009, ANTICANCER RES, V29, P3173; Tempero MA, 2012, J NATL COMPR CANC NE, V10, P703; IWAKI M, 1986, JPN J PHARMACOL, V41, P155, DOI 10.1254/jjp.41.155; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Uwagawa T, 2009, ANN ONCOL, V20, P239, DOI 10.1093/annonc/mdn640; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Evans DB, 2001, CANC PRINCIPLES PRAC, P1126; Fujiwara Y, 2011, PANCREAS, V40, P600, DOI 10.1097/MPA.0b013e31820b9257; Fujiwara Y, 2013, J AM COLL SURGEONS, V216, P320, DOI 10.1016/j.jamcollsurg.2012.09.016; Furukawa K, 2011, CANCER LETT, V306, P92, DOI 10.1016/j.canlet.2011.02.036; Uwagawa T, 2007, CANCER, V109, P2142, DOI 10.1002/cncr.22658	18	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					287	291		10.9738/INTSURG-D-13-00193.1		5	Surgery	Surgery	CB9MY	WOS:000349957000017		
J	Osawa, H; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Yamamoto, H; Doki, Y; Mori, M				Osawa, Hideki; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki			Surgical Management of Perforated Gastrointestinal Posttransplantation Lymphoproliferative Disorder After Heart Transplantation	INTERNATIONAL SURGERY			English	Article						Lymphoma; Intestinal perforation; Posttransplantation; Lymphoproliferative disorder; Transplantation	SOLID-ORGAN TRANSPLANTATION; PRIMARY ANASTOMOSIS; HARTMANNS PROCEDURE; MODERN-ERA; RECIPIENTS; DISEASE; LYMPHOMA; THERAPY; PTLD; PERITONITIS	Posttransplantation lymphoproliferative disorder (PTLD) is a relatively rare and life-threatening complication after organ transplantation. From 1999 to 2012, 45 adult patients underwent heart transplantation at our hospital. Two of the patients developed PTLD after transplantation and required emergency surgery due to intestinal perforation. These cases were informative regarding the adequate surgical management of such cases. Both cases revealed Epstein-Barr virus-related PTLD. The optimal treatment of PTLD remains controversial, and PTLD with gastrointestinal perforation could be critical because the patients are already debilitated and immunocompromised after transplantation. Therefore, the nonspecific abdominal symptoms can be diagnostic for PTLD, and proper surgical intervention should be performed immediately. We present these two suggestive and rare cases in regard to the management of perforation with PTLD and a review of literature.	[Osawa, Hideki; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Uemura, M (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, E2-2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	muemura@gesurg.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423			Kremers WK, 2006, AM J TRANSPLANT, V6, P1017, DOI 10.1111/j.1600-6143.2006.01294.x; Knight JS, 2009, J CLIN ONCOL, V27, P3354, DOI 10.1200/JCO.2008.20.0857; McDonald RA, 2008, AM J TRANSPLANT, V8, P984, DOI 10.1111/j.1600-6143.2008.02167.x; Jagadeesh D, 2012, CURR TREAT OPTION ON, V13, P122, DOI 10.1007/s11864-011-0177-x; Salem L, 2004, DIS COLON RECTUM, V47, P1953, DOI 10.1007/s10350-004-0701-1; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P155, DOI 10.1016/j.critrevonc.2005.03.015; Kremer BE, 2012, J HEART LUNG TRANSPL, V31, P296, DOI 10.1016/j.healun.2011.10.013; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Kaffarnik MF, 2012, TECHNOL HEALTH CARE, V20, P37, DOI 10.3233/THC-2011-0654; Paya CV, 1999, TRANSPLANTATION, V68, P1517, DOI 10.1097/00007890-199911270-00015; Evens AM, 2010, J CLIN ONCOL, V28, P1038, DOI 10.1200/JCO.2009.25.4961; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Trenti L, 2011, INT J COLORECTAL DIS, V26, P377, DOI 10.1007/s00384-010-1071-x; OPELZ G, 1993, LANCET, V342, P1514, DOI 10.1016/S0140-6736(05)80084-4; Evens AM, 2010, CURR ONCOL REP, V12, P383, DOI 10.1007/s11912-010-0132-1; Evens AM, 2013, AM J TRANSPLANT, V13, P1512, DOI 10.1111/ajt.12211; Burns DM, 2004, BLOOD REV, V18, P193, DOI 10.1016/j.bire.2003.12.002; Cornejo A, 2009, CANCER CHEMOTH PHARM, V64, P857, DOI 10.1007/s00280-009-1062-1; Cruz RJ, 2012, TRANSPLANTATION, V94, P417, DOI 10.1097/TP.0b013e3182584854; Cruz RJ, 2010, J GASTROINTEST SURG, V14, P1709, DOI 10.1007/s11605-010-1317-5; Fuertes MJ, 2012, WORLD J SURG, V36, P1148, DOI 10.1007/s00268-012-1513-4; Kollmar O, 2002, TRANSPLANTATION, V73, P669, DOI 10.1097/00007890-200202270-00038; Moran B J, 2010, Acta Chir Iugosl, V57, P47; Muzaffar M, 2010, AM J THER, V17, pE230, DOI 10.1097/MJT.0b013e3181c08042; Roithmaier S, 2007, J HEART LUNG TRANSPL, V26, P845, DOI 10.1016/j.healun.2007.05.019; Swerdlow SH, 2007, AM J CLIN PATHOL, V127, P887, DOI 10.1309/LYXN3RGF7D7KPYG0; Yilmaz M, 2012, EXP CLIN TRANSPLANT	28	1	1	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					358	364		10.9738/INTSURG-D-13-00270.1		7	Surgery	Surgery	CB9MY	WOS:000349957000027		
J	Yanoma, T; Fukuchi, M; Sakurai, S; Shoji, H; Naitoh, H; Kuwano, H				Yanoma, Toru; Fukuchi, Minoru; Sakurai, Shinji; Shoji, Hisanori; Naitoh, Hiroshi; Kuwano, Hiroyuki			Granular Cell Tumor of the Esophagus With Elevated Preoperative Serum Carbohydrate Antigen 19-9: A Case Report	INTERNATIONAL SURGERY			English	Article						Granular cell tumor; Esophagus; Tumor-associated carbohydrate antigens	OF-THE-LITERATURE; CA-19-9 ELEVATION	A 59-year-old Japanese man was admitted to our hospital for treatment of a submucosal tumor of the esophagus detected by upper gastrointestinal endoscopy and computed tomography (CT). Endoscopic examination revealed a submucosal tumor in the esophagus 35 cm from the incisor teeth. Biopsy of the lesions identified granular cell tumor. CT indicated a projecting and slightly enhanced homogenous mass measuring 2.0 x 1.5 cm in the esophagus below the tracheal bifurcation. Serum tumor marker studies revealed elevated carbohydrate antigen (CA) 19-9. Therefore, the tumor was considered to have malignant potential, and surgical resection was performed. The final pathologic diagnosis was a benign granular cell tumor, positive for S-100 protein. The patient was doing well with normal CA 19-9 levels and no recurrence more than 5 years after surgery. To the best of our knowledge, this is the first report of a granular cell tumor with elevated serum CA 19-9.	[Yanoma, Toru; Fukuchi, Minoru; Shoji, Hisanori; Naitoh, Hiroshi] Social Insurance Gunma Chuo Gen Hosp, Dept Surg, Maebashi, Gunma 3710025, Japan; [Sakurai, Shinji] Social Insurance Gunma Chuo Gen Hosp, Dept Diagnost Pathol, Maebashi, Gunma 3710025, Japan; [Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma, Japan	Yanoma, T (reprint author), Social Insurance Gunma Chuo Gen Hosp, Dept Surg, 1-7-13 Kouun Cho, Maebashi, Gunma 3710025, Japan.	tyanoma@sea.plala.or.jp					Abrikossoff AI, 1926, VIRCHOWS ARCH PATHOL, V260, P214; Fanburg-Smith JC, 1998, AM J SURG PATHOL, V22, P779, DOI 10.1097/00000478-199807000-00001; LACK EE, 1980, J SURG ONCOL, V13, P301, DOI 10.1002/jso.2930130405; COUTINHO DSD, 1985, AM J GASTROENTEROL, V80, P758; David O, 1999, ARCH PATHOL LAB MED, V123, P967; DZUBOW LM, 1985, J DERMATOL SURG ONC, V11, P392; Fukuchi M, 2011, SURG TODAY, V42, P788; GAMBOA LG, 1955, ARCH PATHOL, V60, P663; Garcia-Donas J, 2007, J CLIN ONCOL, V25, P4012, DOI 10.1200/JCO.2007.12.4214; Inokuma T, 2010, CASE REP GASTROENTER, V4, P191; Johnston MJ, 1981, DIGEST DIS SCI, V26, P807, DOI 10.1007/BF01309613; Kitada Masahiro, 2010, Gen Thorac Cardiovasc Surg, V58, P298, DOI 10.1007/s11748-009-0523-0; KLIMA M, 1987, ARCH PATHOL LAB MED, V111, P1070; Nakajima M, ESOPHAGUS, V8, P203; OHMORI T, 1987, ACTA PATHOL JAPON, V37, P775; Pinto V, 2010, J MINIM INVAS GYN, V17, P252, DOI 10.1016/j.jmig.2009.11.013; STEFANSSON K, 1982, CANCER, V49, P1834, DOI 10.1002/1097-0142(19820501)49:9<1834::AID-CNCR2820490916>3.0.CO;2-G; Tekin O, 2002, MAYO CLIN PROC, V77, P398; Ventrucci M, 2009, DIGEST LIVER DIS, V41, P357, DOI 10.1016/j.dld.2008.04.002; Voskuil JH, 2001, DIGEST DIS SCI, V46, P1610, DOI 10.1023/A:1010676715046	20	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	FEB	2015	100	2					365	369		10.9738/INTSURG-D-13-00195.1		5	Surgery	Surgery	CB9MY	WOS:000349957000028		
J	Kojima, S; Inoue, T; Nakashima, KI; Fukushima, A; Tanihara, H				Kojima, Sachi; Inoue, Toshihiro; Nakashima, Kei-Ichi; Fukushima, Ayako; Tanihara, Hidenobu			Filtering Blebs Using 3-Dimensional Anterior-Segment Optical Coherence Tomography A Prospective Investigation	JAMA OPHTHALMOLOGY			English	Article							MITOMYCIN-C; AQUEOUS-HUMOR; RISK-FACTORS; TRABECULECTOMY; APPEARANCE; SURGERY	IMPORTANCE Posttrabeculectomy changes in bleb parameters measured using 3-dimensional (3-D) anterior-segment optical coherence tomography (OCT) remain uncharacterized and might be related to postsurgical intraocular-pressure (IOP) control. OBJECTIVE To evaluate time-dependent posttrabeculectomy changes in filtering bleb parameters using 3-D anterior-segment OCT. DESIGN, SETTING, AND PARTICIPANTS This prospective observational study was conducted at Kumamoto University Hospital, Kumamoto, Japan. Patients with open-angle glaucoma who underwent uncombined fornix-based trabeculectomy at Kumamoto University Hospital between January 1, 2012, and October 31, 2012, were included. Twenty-nine eyes were enrolled, 23 of which were followed up for 1 year without additional glaucoma surgical procedures; 3 required additional glaucoma surgery. INTERVENTIONS Imaging filtering blebs using 3-D anterior-segment OCT. MAIN OUTCOMES AND MEASURES The primary end points were changes in bleb parameters including the position and width of the filtration openings on the scleral flap, the total bleb height, fluid-filled cavity height, bleb wall thickness, and bleb wall intensity, which were measured using 3-D anterior-segment OCT. The secondary end points were postsurgical IOP measured 0.5, 3, 6, and 12 months after trabeculectomy, and the effects of aqueous cytokine levels on the bleb parameters. RESULTS We observed increased total bleb height (0.82 to 1.25 mm; difference: 95% CI, 0.10 to 0.75; P =.01), bleb wall thickness (0.46 to 0.61 mm; difference: 95% CI, 0.02 to 0.28; P =.03), and distance from the top of the scleral flap to the filtration opening (1.69 to 2.16 mm; difference: 95% CI, 0.28 to 0.70; P < .001), as well as decreased width of the filtration opening (2.08 to 1.12 mm; difference: 95% CI, -1.75 to -0.49; P = .002) between 0.5 and 12 months posttrabeculectomy. The filtration openings tended to close from the fornix side of the scleral flap during the wound healing process. Moreover, the width of the filtration opening at 0.5 months posttrabeculectomy correlated with the IOP at 12 months (P = .02). The aqueous humor level of monocyte chemoattractant protein-1 was correlated with the width of the filtration opening at 3 and 6 months posttrabeculectomy. CONCLUSIONS AND RELEVANCE The width of the filtration opening at 0.5 months posttrabeculectomy correlated with the IOP at 12 months. The width of the filtration opening at the early stage may be a prognostic factor for long-term IOP control. Large-scale studies with longer follow-up periods are required.	[Kojima, Sachi; Inoue, Toshihiro; Nakashima, Kei-Ichi; Fukushima, Ayako; Tanihara, Hidenobu] Kumamoto Univ, Dept Ophthalmol, Kumamoto 8608556, Japan	Inoue, T (reprint author), Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	noel@da2.so-net.ne.jp			JSPS KAKENHI [23390403, 23659814, 23791994]	This work was supported in part by JSPS KAKENHI grants 23390403, 23659814, and 23791994.	Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Kawana K, 2009, OPHTHALMOLOGY, V116, P848, DOI 10.1016/j.ophtha.2008.11.019; Singh M, 2007, OPHTHALMOLOGY, V114, P47, DOI 10.1016/j.ophtha.2006.05.078; Ramulu PY, 2007, OPHTHALMOLOGY, V114, P2265, DOI 10.1016/j.ophtha.2007.02.005; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, INVEST OPHTH VIS SCI, V53, P8288, DOI 10.1167/iovs.12-10941; Cantor LB, 2003, J GLAUCOMA, V12, P266, DOI 10.1097/00061198-200306000-00015; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Miura M, 2008, J GLAUCOMA, V17, P193, DOI 10.1097/IJG.0b013e31815a34cd; Hamanaka T, 2013, INVEST OPHTH VIS SCI, V54, P6536, DOI 10.1167/iovs.13-12439; Kojima Sachi, 2014, Clin Ophthalmol, V8, P767, DOI 10.2147/OPTH.S59778; Kojima S, 2014, J GLAUCOMA, V23, P312, DOI 10.1097/IJG.0b013e3182741ee6; Kojima S, 2014, J GLAUCOMA, V23, P307, DOI 10.1097/IJG.0b013e3182741c85; Leung CKS, 2007, BRIT J OPHTHALMOL, V91, P340, DOI 10.1136/bjo.2006.100321; Nakano N, 2010, GRAEF ARCH CLIN EXP, V248, P1173, DOI 10.1007/s00417-010-1311-3; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Sacu S, 2003, J GLAUCOMA, V12, P430, DOI 10.1097/00061198-200310000-00006; SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wells AP, 2006, OPHTHALMOLOGY, V113, P77, DOI 10.1016/j.ophtha.2005.06.037; Yamamoto T, 1995, OPHTHALMOLOGY, V102, P1770	21	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	FEB	2015	133	2					148	156		10.1001/jamaophthalmol.2014.4489		9	Ophthalmology	Ophthalmology	CB5NB	WOS:000349673100005		
J	Kamei, M; Nishida, K				Kamei, Motohiro; Nishida, Kohji			Reperfusion of Areas of Ischemia in Central Retinal Vein Occlusion Reply	JAMA OPHTHALMOLOGY			English	Letter							BEVACIZUMAB; NONPERFUSION		[Kamei, Motohiro; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan	Kamei, M (reprint author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, 2-2 Yamadaoka,Room E7, Suita, Osaka 5650871, Japan.	mkamei@ophthal.med.osaka-u.ac.jp					Ameri H, 2007, INVEST OPHTH VIS SCI, V48, P5708, DOI 10.1167/iovs.07-0731; Campochiaro PA, 2013, OPHTHALMOLOGY, V120, P795, DOI 10.1016/j.ophtha.2012.09.032; Terui T, 2011, RETINA-J RET VIT DIS, V31, P1068, DOI 10.1097/IAE.0b013e31820c83c2; Kamei M, 2014, JAMA OPHTHALMOL, V132, P361, DOI 10.1001/jamaophthalmol.2013.6334; Kim KS, 2008, ACTA OPHTHALMOL, V86, DOI 10.1111/j.1755-3768.2008.01175.x; Sabet-Peyman EJ, 2009, OPHTHAL SURG LAS IM, V40, P316, DOI 10.9999/15428877-20090430-17	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	FEB	2015	133	2					228	229		10.1001/jamaophthalmol.2014.4249		2	Ophthalmology	Ophthalmology	CB5NB	WOS:000349673100027		
J	Kim, JK; Miyake, H; Yonezu, H				Kim, Jong Kyu; Miyake, Hideto; Yonezu, Hiroo			Recent Advances in White LEDs and Solid-State Lighting FOREWORD	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Editorial Material									[Kim, Jong Kyu] POSTECH, Pohang, South Korea; [Miyake, Hideto] Mie Univ, Tsu, Mie, Japan; [Yonezu, Hiroo] Toyohashi Univ Technol, Toyohashi, Aichi, Japan	Kim, JK (reprint author), POSTECH, Pohang, South Korea.							0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	FEB	2015	54	2			SI				02B001	10.7567/JJAP.54.02B001		1	Physics, Applied	Physics	CC1HG	WOS:000350091200001		
J	Miyamoto, N; Yabusaki, S; Sakamoto, K; Kikuchi, Y; Mimura, R; Kato, F; Oyama-Manabe, N; Takahashi, B; Soyama, T; Abo, D; Sakuhara, Y; Kudo, K; Shirato, H; Nakamura, T; Tsuchikawa, T; Okamura, K; Hirano, S				Miyamoto, Noriyuki; Yabusaki, Satoshi; Sakamoto, Keita; Kikuchi, Yasuka; Mimura, Rie; Kato, Fumi; Oyama-Manabe, Noriko; Takahashi, Bunya; Soyama, Takeshi; Abo, Daisuke; Sakuhara, Yusuke; Kudo, Kohsuke; Shirato, Hiroki; Nakamura, Toru; Tsuchikawa, Takahiro; Okamura, Keisuke; Hirano, Satoshi			Prediction of pancreatic anastomotic failure after pancreatic head resection using preoperative diffusion-weighted MR imaging	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Pancreas; Post-operative anastomotic failure; MRI; Diffusion-weighted imaging; Apparent diffusion coefficient	LIVER FIBROSIS; CHRONIC HEPATITIS; RISK-FACTORS; FISTULA; PANCREATICODUODENECTOMY; LEAKAGE; COMPLICATIONS; ENHANCEMENT; MANAGEMENT; OUTCOMES	To determine whether the preoperative pancreatic apparent diffusion coefficient (ADC) can be used to predict the development of postoperative pancreatic anastomotic failure (PAF). We retrospectively examined the cases of 79 patients who underwent pancreatic head resection between January 2010 and October 2013. The patients underwent 1.5-T MR imaging including diffusion-weighted imaging before surgery. The main pancreatic duct diameter (MPD), the pancreatic parenchymal thickness (PT), and the ADC of the pancreatic remnant parenchyma were measured. Two radiologists blinded to the patients' outcomes performed the measurements. The imaging parameters were compared between the patients who developed PAF and those who did not. The cut-off ADC for the development of PAF was calculated with a receiver operating characteristic analysis. The imaging parameters were highly correlated between the two observers. The MPD and PT did not differ significantly among the patients. The mean pancreatic ADCs were significantly higher in the patients with PAF than in those without PAF. An ADC higher than 1.50 x 10(-3) mm(2)/s (Az = 0.719, observer-1) or 1.35 x 10(-3) mm(2)/s (Az = 0.752, observer-2) was optimal for predicting the development of postoperative PAF. Measuring the preoperative non-tumorous pancreatic ADC may be useful for the prediction of a postoperative PAF.	[Miyamoto, Noriyuki; Yabusaki, Satoshi; Sakamoto, Keita; Kikuchi, Yasuka; Mimura, Rie; Kato, Fumi; Oyama-Manabe, Noriko; Takahashi, Bunya; Soyama, Takeshi; Abo, Daisuke; Sakuhara, Yusuke; Kudo, Kohsuke] Hokkaido Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido 0608638, Japan; [Nakamura, Toru; Tsuchikawa, Takahiro; Okamura, Keisuke; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0608638, Japan	Miyamoto, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	nm-00@fg7.so-net.ne.jp	Sakuhara, Yusuke/A-5989-2012				Miyamoto N, 2003, ABDOM IMAGING, V28, P347, DOI 10.1007/s00261-002-0041-3; Tamada T, 2009, J MAGN RESON IMAGING, V29, P636, DOI 10.1002/jmri.21689; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Kim A, 2012, EUR J RADIOL, V81, P3998, DOI 10.1016/j.ejrad.2012.03.032; Adsay NV, 2012, SEMIN DIAGN PATHOL, V29, P127, DOI 10.1053/j.semdp.2012.08.010; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Akisik MF, 2009, RADIOLOGY, V250, P103, DOI 10.1148/radiol.2493080160; Wellner UF, 2010, HPB, V12, P696, DOI 10.1111/j.1477-2574.2010.00239.x; Ronot M, 2010, RADIOLOGY, V256, P135, DOI 10.1148/radiol.10091295; Balci C, 2011, DIAGN INTERV RADIOL, V17, P249, DOI 10.4261/1305-3825.DIR.3889-10.0; de Castro SMM, 2005, BRIT J SURG, V92, P1117, DOI 10.1002/bjs.5047; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Hashimoto Y, 2010, SURGERY, V147, P503, DOI 10.1016/j.surg.2009.10.034; Hashimoto Y, 2011, J GASTROINTEST SURG, V15, P2193, DOI 10.1007/s11605-011-1687-3; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Roberts KJ, 2014, HPB, V16, P620, DOI 10.1111/hpb.12186; Braithwaite AC, 2009, RADIOLOGY, V250, P459, DOI 10.1148/radiol.2502080849; Dinter DJ, 2009, J GASTROINTEST SURG, V13, P735, DOI 10.1007/s11605-008-0765-7; Morita S, 2010, JPN J RADIOL, V28, P117, DOI 10.1007/s11604-009-0395-3; Zink SI, 2009, ABDOM IMAGING, V34, P767, DOI 10.1007/s00261-008-9455-x; Balci NC, 2008, ACAD RADIOL, V15, P1264, DOI 10.1016/j.acra.2008.05.002; Cece H, 2013, EUR J RADIOL, V82, pE307, DOI 10.1016/j.ejrad.2013.02.022; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Farnell MB, 2005, SURGERY, V138, P28; Lee SE, 2010, ANN SURG, V251, P932, DOI 10.1097/SLA.0b013e3181d65483; Schafer M, 2011, HPB, V13, P132, DOI 10.1111/j.1477-2574.2010.00260.x; Sugimoto M, 2013, J GASTROINTEST SURG, V17, P1744, DOI 10.1007/s11605-013-2320-4; Tajima Y, 2006, J AM COLL SURGEONS, V202, P723, DOI 10.1016/j.jamcollsurg.2006.01.008; Watanabe H, 2014, RADIOLOGY, V270, P791, DOI 10.1148/radiol.13131194; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	FEB	2015	33	2					59	66		10.1007/s11604-014-0377-y		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9PJ	WOS:000349963700002		
J	Kobayashi, T; Tanaka, N; Matsumoto, T; Ueda, K; Hoshii, Y; Kunihiro, Y; Tanaka, T; Hayashi, M; Matsunaga, N				Kobayashi, Taiga; Tanaka, Nobuyuki; Matsumoto, Tsuneo; Ueda, Kazuhiro; Hoshii, Yoshinobu; Kunihiro, Yoshie; Tanaka, Toshiki; Hayashi, Masataro; Matsunaga, Naofumi			HRCT findings of small cell lung cancer measuring 30 mm or less located in the peripheral lung	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Solitary pulmonary nodule; Small cell lung cancer; Tomography; X-ray computed; Diagnosis; Differentia	SOLITARY PULMONARY NODULES; HIGH-RESOLUTION CT; COMPUTED-TOMOGRAPHY; CARCINOMA; BENIGN; CLASSIFICATION; LESIONS	To evaluate the high-resolution CT (HRCT) features of peripherally located small cell lung cancer (SCLC). We retrospectively reviewed the HRCT findings of 33 patients with peripherally located SCLC measuring 30 mm or less. The shape and marginal and internal characteristics of the nodules were evaluated. We also assessed the differences in these HRCT findings associated with the differences in the stages of disease. In 10 surgically treated cases, the HRCT-pathological correlations were evaluated. The findings of a well-defined margin (97.0 %), lobulation (78.8 %), thickening of the bronchovascular bundle (BVB) (57.6 %) and inhomogeneous enhancement (64.0 %) were common. A vermiform/branching and polygonal shape were observed in 33.3 and 21.2 % of cases, respectively. Air bronchograms (15.2 %) and marginal ground-glass opacity (GGO) (3.0 %) were less common findings. The vermiform/branching shape and thickening of the BVB were more frequently observed in non-stage I than in stage I tumors. The pathologic findings showed expansive tumor growth along the lymphatics and minimal necrosis between the tumor nests. A non-round shape and thickening of the BVB were common, while marginal GGO and air bronchogram were less common in small-sized, peripherally located SCLC. Furthermore, the vermiform/branching shape and thickening of the BVB suggested relatively advanced disease.	[Kobayashi, Taiga; Tanaka, Nobuyuki; Kunihiro, Yoshie; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Matsumoto, Tsuneo] Yamaguchi Ube Med Ctr, Natl Hosp Org, Dept Lab Med, Ube, Yamaguchi 7550241, Japan; [Ueda, Kazuhiro; Hayashi, Masataro] Yamaguchi Univ, Grad Sch Med, Dept Surg, Ube, Yamaguchi 7558505, Japan; [Hoshii, Yoshinobu] Yamaguchi Univ, Div Pathol, Ube, Yamaguchi 7558505, Japan; [Tanaka, Toshiki] Yamaguchi Ube Med Ctr, Natl Hosp Org, Dept Thorac Surg, Ube, Yamaguchi 7550241, Japan	Tanaka, N (reprint author), Saiseikai Yamaguchi Gen Hosp, Dept Radiol, 2-11 Midorimachi, Yamaguchi, Yamaguchi 7538517, Japan.	taiga.k@yamaguchi-u.ac.jp; ntanaka@yamaguchi.saiseikai.or.jp					[Anonymous], 2006, J COMPUT ASSIST TOMO, V30, P653; Swensen SJ, 2000, RADIOLOGY, V214, P73; Akata S, 2008, CLIN IMAG, V32, P259, DOI 10.1016/j.clinimag.2007.10.002; Furuya K, 1999, ACTA RADIOL, V40, P496; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/01.PAS.0000022995.91977.CD; Sone S, 2007, LUNG CANCER, V56, P207, DOI 10.1016/j.lungcan.2006.12.014; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43; Brandman S, 2011, J THORAC IMAG, V26, P90, DOI 10.1097/RTI.0b013e31821639a9; KURIYAMA K, 1991, AM J ROENTGENOL, V156, P921; Stupp R, 2004, LUNG CANCER-J IASLC, V45, P105, DOI 10.1016/j.lungcan.2003.12.006; Takashima S, 2003, AM J ROENTGENOL, V180, P955; Aoki T, 2000, AM J ROENTGENOL, V174, P763; Groskin SA, 1993, HEITZMANS LUNG RADIO, P360; Hashimoto M, 2009, TOHOKU J EXP MED, V217, P217; Hashimoto M, 1999, Radiat Med, V17, P417; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; JOHKOH T, 1992, AM J ROENTGENOL, V158, P1217; Wang CW, 2013, CLIN IMAG, V37, P487, DOI 10.1016/j.clinimag.2012.09.010; Yabuuchi H, 1999, J THORAC IMAG, V14, P105, DOI 10.1097/00005382-199904000-00007	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	FEB	2015	33	2					67	75		10.1007/s11604-014-0381-2		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9PJ	WOS:000349963700003		
J	Iwasawa, T; Matsumoto, S; Aoki, T; Okada, F; Nishimura, Y; Yamagata, H; Ohno, Y				Iwasawa, Tae; Matsumoto, Sumiaki; Aoki, Takatoshi; Okada, Fumito; Nishimura, Yoshihiro; Yamagata, Hitoshi; Ohno, Yoshiharu			A comparison of axial versus coronal image viewing in computer-aided detection of lung nodules on CT	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Lung; Neoplasm; CT; Computer-aided detection	RADIOLOGISTS DETECTION; PULMONARY NODULES; MULTIDETECTOR CT; 2ND READER; ROW CT; DIAGNOSIS; OBSERVER; PERFORMANCE; CAD; MPR	To compare primarily viewing axial images (Axial mode) versus coronal reconstruction images (Coronal mode) in computer-aided detection (CAD) of lung nodules on multidetector computed tomography (CT) in terms of detection performance and reading time. Sixty CT data sets from two institutions were collected prospectively. Ten observers (6 radiologists, 4 pulmonologists) with varying degrees of experience interpreted the data sets using CAD as a second reader (performing nodule detection first without then with aid). The data sets were interpreted twice, once each for Axial and Coronal modes, in two sessions held 4 weeks apart. Jackknife free-response receiver-operating characteristic analysis was used to compare detection performances in the two modes. Mean figure-of-merit values with and without aid were 0.717 and 0.684 in Axial mode and 0.702 and 0.671 in Coronal mode; use of CAD significantly increased the performance of observers in both modes (P < 0.01). Mean reading times for radiologists did not significantly differ between Axial (156 +/- A 74 s) and Coronal mode (164 +/- A 69 s; P = 0.08). Mean reading times for pulmonologists were significantly lower in Coronal (112 +/- A 53 s) than in Axial mode (130 +/- A 80 s; P < 0.01). There was no statistically significant difference between Axial and Coronal modes for lung nodule detection with CAD.	[Iwasawa, Tae] Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360051, Japan; [Matsumoto, Sumiaki; Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo 657, Japan; [Matsumoto, Sumiaki; Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Div Diagnost & Funct Imaging Res, Kobe, Hyogo 657, Japan; [Aoki, Takatoshi] Univ Occupat & Environm Hlth, Dept Radiol, Kitakyushu, Fukuoka 807, Japan; [Okada, Fumito] Oita Univ, Fac Med, Dept Radiol, Oita 87011, Japan; [Nishimura, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo 657, Japan; [Yamagata, Hitoshi] Toshiba Med Syst Corp, Otawara, Japan	Iwasawa, T (reprint author), Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Kanazawa Ku, 6-16-1 Tomiokahigashi, Yokohama, Kanagawa 2360051, Japan.	tae_i_md@wb3.so-net.ne.jp			Toshiba Medical Systems Corp.	Two of the authors (S. Matsumoto and Y. Ohno) have received research grants from Toshiba Medical Systems Corp., and one of the authors (H. Yamagata) is an employee of Toshiba Medical Systems Corp. The other authors declare that have no conflict of interest.	Matsumoto S, 2013, EUR J RADIOL, V82, P1332, DOI 10.1016/j.ejrad.2013.02.005; Godoy MCB, 2013, AM J ROENTGENOL, V200, P74, DOI 10.2214/AJR.11.7532; Choi EJ, 2008, BRIT J RADIOL, V81, P463, DOI 10.1259/bjr/63217190; Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049; Zhao YR, 2012, EUR RADIOL, V22, P2076, DOI 10.1007/s00330-012-2437-y; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Aoki T, 2014, RADIOLOGY, V271, P255, DOI 10.1148/radiol.13130460; Arakawa H, 2004, J THORAC IMAG, V19, P24, DOI 10.1097/00005382-200401000-00004; Brown MS, 2005, ACAD RADIOL, V12, P681, DOI 10.1016/j.acra.2005.02.041; Camarlinghi N, 2012, INT J COMPUT ASS RAD, V7, P455, DOI 10.1007/s11548-011-0637-6; Matsumoto S, 2012, EUR J RADIOL, V81, P366, DOI 10.1016/j.ejrad.2010.12.020; Nishino M, 2006, EUR J RADIOL, V59, P33, DOI 10.1016/j.ejrad.2005.12.035; Peldschus K, 2005, CHEST, V128, P1517, DOI 10.1378/chest.128.3.1517; Peloschek P, 2007, RADIOLOGY, V243, P561, DOI 10.1148/radiol.2432052052; Sahiner B, 2009, ACAD RADIOL, V16, P1518, DOI 10.1016/j.acra.2009.08.006; The Japanese Society of CT screening, 2013, GUID MAN PULM NOD DE; White CS, 2008, ACAD RADIOL, V15, P326, DOI 10.1016/j.acra.2007.09.027	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	FEB	2015	33	2					76	83		10.1007/s11604-014-0383-0		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9PJ	WOS:000349963700004		
J	Machida, H; Lin, XZ; Fukui, R; Shen, Y; Suzuki, S; Tanaka, I; Ishikawa, T; Tate, E; Ueno, E				Machida, Haruhiko; Lin, Xiao-Zhu; Fukui, Rika; Shen, Yun; Suzuki, Shigeru; Tanaka, Isao; Ishikawa, Takuya; Tate, Etsuko; Ueno, Eiko			Influence of the motion correction algorithm on the quality and interpretability of images of single-source 64-detector coronary CT angiography among patients grouped by heart rate	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Coronary CT angiography; Heart rate; Image quality; Motion artifact; Motion correction algorithm	COMPUTED-TOMOGRAPHY ANGIOGRAPHY; RADIATION-DOSE REDUCTION; DIAGNOSTIC-ACCURACY; RATE-VARIABILITY; CARDIAC CT; ROW CT; RECONSTRUCTION; FEASIBILITY; STENOSIS; SCAN	We retrospectively investigated the effect of the motion correction algorithm (MCA) on image quality and interpretability by heart rate (HR) in coronary CT angiography (CCTA). For 105 patients (6 HR groups) undergoing CCTA, 2 readers independently graded the image quality of the 4 major coronary arteries reconstructed with and without MCA at diastole with HR a parts per thousand currency sign64 bpm and at systole and diastole a parts per thousand yen65 bpm using a 5-point scale. For each HR group and cardiac phase, we compared per-vessel and per-segment image quality using Wilcoxon signed rank test and percentages of interpretable image quality (scores 3-5) among without MCA at diastole with HR a parts per thousand currency sign64 bpm, as a reference, with MCA at diastole a parts per thousand currency sign69 bpm and at systole 70-79 bpm using the chi-square test. The motion correction algorithm reconstruction provided similar or better image quality and interpretability in all groups, with 96-100 % per-vessel (P = 0.008 for the right coronary artery; otherwise, P > 0.05) and 99 % per-segment interpretable image quality (P = 0.0002) at diastole with HR a parts per thousand currency sign69 bpm and at systole 70-79 bpm compared to the reference (88-100 and 97 %, respectively). MCA reconstruction preserved image quality and interpretability of CCTA with HR a parts per thousand currency sign79 bpm.	[Machida, Haruhiko; Fukui, Rika; Shen, Yun; Tanaka, Isao; Ishikawa, Takuya; Tate, Etsuko; Ueno, Eiko] Tokyo Womens Med Univ, Med Ctr East, Dept Radiol, Arakawa Ku, Tokyo 1168567, Japan; [Lin, Xiao-Zhu] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, Shanghai 200025, Peoples R China; [Suzuki, Shigeru] Saitama Red Cross Hosp, Dept Diagnost Radiol, Chuo Ku, Saitama 3380001, Japan	Machida, H (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Radiol, Arakawa Ku, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	machira@dnh.twmu.ac.jp					Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; Achenbach S, 2000, RADIOLOGY, V216, P457; Shapiro MD, 2008, EUR J RADIOL, V66, P37, DOI 10.1016/j.ejrad.2007.05.006; Dewey M, 2010, AM J ROENTGENOL, V194, P93, DOI 10.2214/AJR.09.2833; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Husmann L, 2007, RADIOLOGY, V245, P567, DOI 10.1148/radiol.2451061791; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Herzog C, 2006, RADIOLOGY, V238, P75, DOI 10.1148/radiol.2381041595; Leipsic J, 2012, J CARDIOVASC COMPUT, V6, P164, DOI 10.1016/j.jcct.2012.04.004; Pontone G, 2009, J AM COLL CARDIOL, V54, P346, DOI 10.1016/j.jacc.2009.04.027; Muenzel D, 2011, EUR RADIOL, V21, P2277, DOI 10.1007/s00330-011-2185-4; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; LaBounty TM, 2010, AM J ROENTGENOL, V194, P933, DOI 10.2214/AJR.09.3371; Hoffmann MHK, 2005, RADIOLOGY, V234, P86, DOI 10.1148/radiol.2341031408; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Wintersperger BJ, 2006, INVEST RADIOL, V41, P436, DOI 10.1097/01.rli.0000202639.99949.c6; Buechel RR, 2011, J AM COLL CARDIOL, V57, P332, DOI 10.1016/j.jacc.2010.08.634; Leipsic J, 2010, AM J ROENTGENOL, V195, P655, DOI 10.2214/AJR.10.4288; Shim SS, 2005, AM J ROENTGENOL, V184, P649; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; Austen W G, 1975, Circulation, V51, P5; Baumuller S, 2009, RADIOLOGY, V253, P56, DOI 10.1148/radiol.2531090065; Earls James P, 2009, J Cardiovasc Comput Tomogr, V3, P45, DOI 10.1016/j.jcct.2008.10.013; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Leshka S, 2006, RADIOLOGY, V241, P378; Li QW, 2014, EUR J RADIOL, V83, P2024, DOI 10.1016/j.ejrad.2014.08.002; Okerlund D, 2011, SNAPSHOT FREEZE MOTI; Pannu HK, 2006, AM J ROENTGENOL, V186, pS341, DOI 10.2214/AJR.04.1944; Wang YT, 2009, KOREAN J RADIOL, V10, P227, DOI 10.3348/kjr.2009.10.3.227	32	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	FEB	2015	33	2					84	93		10.1007/s11604-014-0382-1		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9PJ	WOS:000349963700005		
J	Nasu, H; Miura, K; Baba, M; Nagata, M; Yoshida, M; Ogura, H; Takehara, Y; Sakahara, H				Nasu, Hatsuko; Miura, Katsutoshi; Baba, Megumi; Nagata, Masao; Yoshida, Masayuki; Ogura, Hiroyuki; Takehara, Yasuo; Sakahara, Harumi			Breast cancer metastatic to the kidney with renal vein involvement	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Breast; Cancer; Metastasis; Kidney; Renal vein thrombus	PATHOLOGICAL CORRELATION; CELL CARCINOMA; MRI	The common sites of breast cancer metastases include bones, lung, brain, and liver. Renal metastasis from the breast is rare. We report a case of breast cancer metastatic to the kidney with extension into the renal vein. A 40-year-old woman had undergone left mastectomy for breast cancer at the age of 38. A gastric tumor, which was later proved to be metastasis from breast cancer, was detected by endoscopy. Computed tomography performed for further examination of the gastric tumor revealed a large left renal tumor with extension into the left renal vein. It mimicked a primary renal tumor. Percutaneous biopsy of the renal tumor confirmed metastasis from breast cancer. Surgical intervention of the stomach and the kidney was avoided, and she was treated with systemic chemotherapy. Breast cancer metastatic to the kidney may present a solitary renal mass with extension into the renal vein, which mimics a primary renal tumor.	[Nasu, Hatsuko; Takehara, Yasuo; Sakahara, Harumi] Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Miura, Katsutoshi] Hamamatsu Univ Sch Med, Dept Hlth Sci Pathol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Baba, Megumi] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Masao] Hamamatsu Univ Sch Med, Dept Urol, Hamamatsu, Shizuoka 4313192, Japan; [Yoshida, Masayuki] Seirei Hamamatsu Gen Hosp, Dept Breast Surg, Hamamatsu, Shizuoka, Japan; [Ogura, Hiroyuki] Hamamatsu Univ Sch Med, Dept Breast Surg, Hamamatsu, Shizuoka 4313192, Japan	Nasu, H (reprint author), Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	hatsuko8@hama-med.ac.jp					Akin O, 2011, ABDOM IMAGING, V36, P62; Akin Y, 2012, SAUDI MED J, V33, P1346; Allen BC, 2014, ABDOM IMAGING, V39, P358, DOI 10.1007/s00261-014-0074-4; Pickhardt PJ, 2000, RADIOGRAPHICS, V20, P215; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109; Shinmoto H, 1998, JMRI-J MAGN RESON IM, V8, P690, DOI 10.1002/jmri.1880080327; CASKEY CI, 1991, CLIN IMAG, V15, P166, DOI 10.1016/0899-7071(91)90071-3; Ellis MC, 2009, AM J SURG, V197, P633, DOI [10.1016/j.amjsurg.2008.12.015, 10.1016/j.amjsurg.2009.12.015]; HERZBERG AJ, 1991, CANCER, V68, P1015, DOI 10.1002/1097-0142(19910901)68:5<1015::AID-CNCR2820680518>3.0.CO;2-Z; Klatte T, 2007, UROLOGY, V69; Takehara K, 1999, ANTICANCER RES, V19, P5571; Takeuchi M, 2013, CLIN IMAG, V37, P908, DOI 10.1016/j.clinimag.2013.04.010; WEINER SN, 1982, J UROLOGY, V128, P372; Williams TR, 2008, UROLOGY, V71, DOI 10.1016/j.urology.2007.10.035	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	FEB	2015	33	2					107	111		10.1007/s11604-014-0386-x		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9PJ	WOS:000349963700008		
J	Sato, S				Sato, Shigeru			Subacute ruminal acidosis (SARA) challenge, ruminal condition and cellular immunity in cattle	JAPANESE JOURNAL OF VETERINARY RESEARCH			English	Review						cattle; cellular immunity; cytokine mRNA; SARA; ruminal pH	MESSENGER-RNA EXPRESSION; PH-MEASUREMENT SYSTEM; DIRECT-FED MICROBIALS; DAIRY-COWS; INFLAMMATORY RESPONSE; HOLSTEIN CALVES; FEEDLOT CATTLE; CALF STARTER; RUMEN PH; BACTERIA	Subacute ruminal acidosis (SARA) is characterized by repeated bouts of low ruminal pH. Cows with SARA often develop complications or other diseases, and associate physiologically with immunosuppression and inflammation. Ruminal free lipopolysaccharide (LPS) increases during SARA and translocates into the blood circulation activating an inflammatory response. Ruminal fermentation and cellular immunity are encouraged by supplementing hay with calf starter during weaning. SARA calves given a 5-day repeated administration of a bacteria-based probiotic had stable ruminal pH levels (6.6-6.8). The repeated administration of probiotics enhance cellular immune function and encourage recovery from diarrhea in pre-weaning calves. Furthermore, the ruminal fermentation could guard against acute and short-term feeding changes, and changes in the rumen microbial composition of SARA cattle might occur following changes in ruminal pH. The repeated bouts of low ruminal pH in SARA cattle might be associated with depression of cellular immunity.	Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate 0208550, Japan	Sato, S (reprint author), Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate 0208550, Japan.	sshigeru@iwate-u.ac.jp					Gozho GN, 2007, J DAIRY SCI, V90, P856; Timmerman HM, 2005, J DAIRY SCI, V88, P2154; Laarman AH, 2012, J DAIRY SCI, V95, P4478, DOI 10.3168/jds.2011-4822; Laarman AH, 2011, J DAIRY SCI, V94, P5661, DOI 10.3168/jds.2011-4273; Beauchemin KA, 2003, J ANIM SCI, V81, P1628; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Sun P, 2010, J DAIRY SCI, V93, P5851, DOI 10.3168/jds.2010-3263; Plaizier JC, 2008, VET J, V176, P21, DOI [10.1016/j.tvjl.2007.12.016, 10.1016/j.tvj1.2007.12.016]; Aschenbach JR, 2011, J ANIM SCI, V89, P1092, DOI 10.2527/jas.2010-3301; Emmanuel DGV, 2007, J ANIM SCI, V85, P233, DOI 10.2527/jas.2006-216; QUIGLEY JD, 1992, J DAIRY SCI, V75, P228; Enemark JMD, 2008, VET J, V176, P32, DOI [10.1016/j.tvjl.2007.12.021, 10.1016/j.tvj1.2007.12.021]; Enemark JMD, 2004, VET RES COMMUN, V28, P687, DOI 10.1023/B:VERC.0000045949.31499.20; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Malmuthuge N, 2012, VET IMMUNOL IMMUNOP, V146, P18, DOI 10.1016/j.vetimm.2012.01.010; Callaway ES, 1997, J DAIRY SCI, V80, P2035; Khafipour E, 2009, J DAIRY SCI, V92, P1712, DOI 10.3168/jds.2008-1656; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Lesmeister KE, 2004, J DAIRY SCI, V87, P3439; Chiquette J, 2012, J DAIRY SCI, V95, P5985, DOI 10.3168/jds.2012-5511; Ghorbani GR, 2002, J ANIM SCI, V80, P1977; Indart M., 2012, Open Journal of Veterinary Medicine, V2, P225, DOI 10.4236/ojvm.2012.24035; Kawakami S. I., 2010, Research Journal of Biological Sciences, V5, P13; Kimura A, 2012, J VET MED SCI, V74, P1023, DOI 10.1292/jvms.12-0084; Kohiruimaki M, 2008, J VET MED SCI, V70, P321, DOI 10.1292/jvms.70.321; Novak KN, 2012, RES VET SCI, V92, P427, DOI 10.1016/j.rvsc.2011.04.008; Qadis AQ, 2014, J VET MED SCI, V76, P877, DOI 10.1292/jvms.14-0028; Qadis AQ, 2014, J VET MED SCI, V76, P189, DOI 10.1292/jvms.13-0370; Qadis AQ, 2014, J VET MED SCI, V76, P677, DOI 10.1292/jvms.13-0534; Sato S, 2012, PREV VET MED, V103, P274, DOI 10.1016/j.prevetmed.2011.09.004; Sato S, 2012, VET RES COMMUN, V36, P85, DOI 10.1007/s11259-012-9518-x; Signorini ML, 2012, RES VET SCI, V93, P250, DOI 10.1016/j.rvsc.2011.05.001; Weinberg ZG, 2004, APPL BIOCHEM BIOTECH, V118, P1, DOI 10.1385/ABAB:118:1-3:001; West CE, 2012, CLIN EXP ALLERGY, V42, P540, DOI 10.1111/j.1365-2222.2011.03941.x	36	0	0	HOKKAIDO UNIV	SAPPORO	ED COMMITTEE JAPANESE JOURNAL VETERINARY RES, GRAD SCH VET MED, KITA 18 NISHI 9 KITAKU, SAPPORO, 060-0818, JAPAN	0047-1917			JPN J VET RES	Jpn. J. Vet. Res.	FEB	2015	63			1			S25	S36				12	Veterinary Sciences	Veterinary Sciences	CC3TC	WOS:000350271800003		
J	Shinoda, K; Sun, X; Oyamada, A; Yamada, H; Muta, H; Podack, ER; Kira, JI; Yoshikai, Y				Shinoda, Koji; Sun, Xun; Oyamada, Akiko; Yamada, Hisakata; Muta, Hiromi; Podack, Eckhard R.; Kira, Jun-Ichi; Yoshikai, Yasunobu			CD30 ligand is a new therapeutic target for central nervous system autoimmunity	JOURNAL OF AUTOIMMUNITY			English	Article						EAE; CD30 ligand; CD30; CD30-Ig	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TUMOR-NECROSIS-FACTOR; T-CELL RESPONSES; KAPPA-B; RECEPTOR; MICE; EXPRESSION; TNF; ACTIVATION; CD30L/CD30	The CD30 ligand (CD30L)/CD30 axis plays a critical role in Th1 and Th17 cell differentiation. However, the role in the pathogenesis of central nervous system autoimmunity remains unknown. Here we show the resistance for experimental autoimmune encephalomyelitis (EAE) with markedly reduced induction of antigen-specific Th1 and Th17 cells in CD30L knockout mice. Bone marrow chimera experiments indicated that CD30L on bone marrow-derived cells were critical for the development of EAE and that CD30L reverse signaling in CD4 T cells was dispensable for the pathogenic Th17 cell differentiation at the induction phase. Adoptive transfer experiment revealed an additional role for CD30L in the environment at the effector phase. In vivo neutralization of CD30L by soluble murine CD30-Immunoglobulin fusion protein before disease onset or even after disease onset significantly ameliorated the clinical symptoms. These results indicate that CD30L/CD30 signaling is critically involved in antigen-specific CD4 T cell responses at both the induction and effector phase, thus could be a new target molecule for the treatment of central nervous system autoimmunity. (C) 2014 Elsevier Ltd. All rights reserved.	[Shinoda, Koji; Oyamada, Akiko; Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Div Host Def, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Shinoda, Koji; Kira, Jun-Ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 8128582, Japan; [Sun, Xun] China Med Univ, Dept Immunol, Shenyang 110001, Peoples R China; [Muta, Hiromi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Podack, Eckhard R.] Univ Miami, Dept Microbiol & Immunol, Miami, FL 33124 USA	Yoshikai, Y (reprint author), Kyushu Univ, Div Host Def, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoshikai@bioreg.kyushu-u.acjp			Japan Society for the Promotion of Science; Japanese Ministry of Education, Science and Culture [25670213, 26293098]; Yakult Bioscience Foundation; Takeda Science Foundation	This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science, and grants from the Japanese Ministry of Education, Science and Culture (Grant number 25670213, 26293098) (Y.Y.), Yakult Bioscience Foundation (Y.Y.) and Takeda Science Foundation (Y.Y.). We thank Kanako Motomura in the Laboratory for Technical Support, Medical Institute of Bioregulation, and Sachiko Koyama in the Department of Neuropathology, Neurological Institute, Kyushu University for their technical support for the histopathological analysis. We also thank Akiko Yano, Miki Kijima and Mihoko Ohkubo for their technical assistance.	Komiyama Y, 2006, J IMMUNOL, V177, P566; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; O'Connor RA, 2008, J IMMUNOL, V181, P3750; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Blazar BR, 2004, J IMMUNOL, V173, P2933; Tompkins SM, 2002, J IMMUNOL, V168, P4173; vanOosten BW, 1996, NEUROLOGY, V47, P1531; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sun X, 2010, J IMMUNOL, V185, P7671, DOI 10.4049/jimmunol.1002229; Sun X, 2008, GASTROENTEROLOGY, V134, P447, DOI [10.1053/j.gastro.2007.11.004, 10.1053/j.gastro.2007.1.1.004]; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Zhang ZX, 2000, NAT MED, V6, P782; Tang C, 2008, J IMMUNOL, V181, P6316; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Bowen MA, 1996, J IMMUNOL, V156, P442; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sun X, 2010, J IMMUNOL, V185, P2222, DOI 10.4049/jimmunol.1000024; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Duckett CS, 1997, MOL CELL BIOL, V17, P1535; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Bengtsson A, 2001, ALLERGY, V56, P593, DOI 10.1034/j.1398-9995.2001.00137.x; Fuchiwaki T, 2011, EUR J IMMUNOL, V41, P2947, DOI 10.1002/eji.201141423; Gilfillan MC, 1998, J IMMUNOL, V160, P2180; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; Nishimura H, 2005, J IMMUNOL, V175, P4627; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; ROMAGNANI S, 1995, J LEUKOCYTE BIOL, V57, P726; SHANEBECK KD, 1995, EUR J IMMUNOL, V25, P2147, DOI 10.1002/eji.1830250805; Shimozato O, 1999, BIOCHEM BIOPH RES CO, V256, P519, DOI 10.1006/bbrc.1999.0336; Sun X, 2013, MUCOSAL IMMUNOL, V6, P1191, DOI 10.1038/mi.2013.18; Arnason BGW, 1999, NEUROLOGY, V53, P457; Wiley SR, 1996, J IMMUNOL, V157, P3635; Williams SM, 2014, OXFORD GER STUD, V43, P1, DOI 10.1179/0078719114Z.00000000051	44	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0896-8411	1095-9157		J AUTOIMMUN	J. Autoimmun.	FEB	2015	57						14	23		10.1016/j.jaut.2014.11.005		10	Immunology	Immunology	CB8LB	WOS:000349880000002		
J	Horikoshi, R				Horikoshi, Ryo			Illustrating Catalysis with Interlocking Building Blocks: A BINAP-Ruthenium Complex Catalyzed Asymmetric Hydrogenation	JOURNAL OF CHEMICAL EDUCATION			English	Article						High School/Introductory Chemistry; First-Year Undergraduate/General; Inorganic Chemistry; Hands-On Learning/Manipulatives; Catalysis		A unique method has been developed using an interlocking building-block model equipped with magnets to illustrate the catalytic asymmetric hydrogenation of beta-keto esters by a BINAP-ruthenium complex to enhance students' understanding of this process. A BINAP-ruthenium block model, mimicking the coordination environment around the metal center in the real complex, can be used to convert the beta-keto ester model into a beta-hydroxy ester model. This model was used to provide a greater understanding of the essence of the catalytic reaction and to assist students in their understanding of its mechanism.	Osaka Sangyo Univ, Coll Gen Educ, Dept Chem, Daito, Osaka 5748530, Japan	Horikoshi, R (reprint author), Osaka Sangyo Univ, Coll Gen Educ, Dept Chem, Daito, Osaka 5748530, Japan.	ryo.horikoshi@las.osaka-sandai.ac.jp			Hayao Nakayama Foundation for Science & Technology and Culture	This work was supported by the Hayao Nakayama Foundation for Science & Technology and Culture. The author wishes to express his thanks to T. Mochida (Kobe University), Y. Kobayashi, and H. Kageyama (Kyoto University) for their helpful discussions. Finally, the author would like to acknowledge the contributions of the following: H. Kishimoto, and M. Mitani, and their students at Kyotoyawata High School, and our students at Osaka Sangyo University.	Noyori R, 2005, PHILOS T ROY SOC A, V363, P901, DOI 10.1098/rsta.2004.1536; Campbell DJ, 2011, J CHEM EDUC, V88, P602, DOI 10.1021/ed100673k; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Ault A, 2002, J CHEM EDUC, V79, P572; Campbell D. J., 2001, CHEM ED, V6, P321, DOI 10.1007/s00897010517a; Cloonan CA, 2011, J CHEM EDUC, V88, P1400, DOI 10.1021/ed1010773; Horikoshi R, 2014, J CHEM EDUC, V91, P255, DOI 10.1021/ed400413k; Horikoshi R, 2013, J CHEM EDUC, V90, P620, DOI 10.1021/ed200871c; Noyori R., 2004, P NATL ACAD SCI USA, V101, P5336; Peeters CM, 2009, J CHEM EDUC, V86, P87	10	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9584	1938-1328		J CHEM EDUC	J. Chem. Educ.	FEB	2015	92	2					332	335		10.1021/ed500484u		4	Chemistry, Multidisciplinary; Education, Scientific Disciplines	Chemistry; Education & Educational Research	CB8ML	WOS:000349883600020		
J	Chen, TC; Tsay, JD; Matsumoto, J; Alpert, J				Chen, Tsing-Chang; Tsay, Jenq-Dar; Matsumoto, Jun; Alpert, Jordan			Development and Formation Mechanism of the Southeast Asian Winter Heavy Rainfall Events around the South China Sea. Part I: Formation and Propagation of Cold Surge Vortex	JOURNAL OF CLIMATE			English	Article							GLOBAL FORECAST SYSTEM; CENTRAL VIETNAM; INTERANNUAL VARIATION; MONSOON; PRECIPITATION; CONVECTION; MALAYSIA; PACIFIC; CLIMATE; DATASET	Examination of the development of cold season heavy rainfall/flood (HRF) events around the South China Sea (SCS) from their parent cold surge vortices (CSVs) shows three new development processes. First, the formation mechanism of the parent CSV of an HRF event [CSV(HRF)] has a preference as to geographic location, flow type of the cold surge inside the SCS, and time of day. The surface trough east of the Philippines, Taiwan, and southern Japan island chain in late fall and the near-equator trough across Borneo in winter facilitate the CSV(HRF) formation in two regions-the vicinity of the Philippines and Borneo. The formation of the Philippine (Borneo) CSV(HRF) occurs at 0600 UTC (0000 UTC) with involvement from the Philippine Sea (PHS)type (SCS type) of cold surge flow. Second, the flow type of the cold surge determines the CSV(HRF) propagation across the South China Sea. The PHS-type (SCS type) facilitates (hinders) the CSV(HRF) westward propagation. This occurs because the easterly (northerly) flow is greater than (less than) the northerly (easterly) flow at the maximum isotach location of the cold surge flow associated with CSV(HRF) and is centered east of the demarcation line for propagation. This flow-type contrast is substantiated by the vorticity budget analysis for CSV(HRF). The positive 925-hPa vorticity tendency is located west of (coincident with) the 925-hPa vorticity center for the PHS-type (SCS type) of cold surge. Third, the CSV(HRF) development into a HRF event is achieved through multiple interactions of former vortices with sequential cold surges across the South China Sea. The first two CSV(HRF) development processes are reported herein; the last process is presented in Part II.	[Chen, Tsing-Chang; Tsay, Jenq-Dar] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA 50011 USA; [Matsumoto, Jun] Tokyo Metropolitan Univ, Dept Geog, Tokyo 158, Japan; [Matsumoto, Jun] JAMSTEC, Res Inst Global Change, Yokosuka, Kanagawa, Japan; [Alpert, Jordan] NOAA, Environm Modeling Ctr, Natl Ctr Environm Predict, Ctr Weather & Climate Predict, College Pk, MD USA	Chen, TC (reprint author), Iowa State Univ, Dept Geol & Atmospher Sci, Atmospher Sci Program, 3010 Agronomy Hall, Ames, IA 50011 USA.	tmchen@iastate.edu			Cheney Research Fund; NSF [ATM-0836220]; Japan Society for the Promotion of Science [26220202]	The Cheney Research Fund and NSF Grant ATM-0836220 sponsored this study. Jun Matsumoto's contribution to this study is supported by the Grant-in-Aid for Scientific Research (26220202) from the Japan Society for the Promotion of Science. Comments and suggestions offered by two anonymous reviewers were very helpful in improving the presentation of this study.	Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; HOUZE RA, 1981, MON WEATHER REV, V109, P1595, DOI 10.1175/1520-0493(1981)109<1595:WMCITV>2.0.CO;2; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Wu PM, 2008, J METEOROL SOC JPN, V86A, P187; Chen TC, 2002, J CLIMATE, V15, P2359, DOI 10.1175/1520-0442(2002)015<2359:ANPSWT>2.0.CO;2; Compo GP, 1999, Q J ROY METEOR SOC, V125, P29, DOI 10.1256/smsqj.55302; Simpson J, 1996, METEOROL ATMOS PHYS, V60, P19, DOI 10.1007/BF01029783; NITTA T, 1994, J METEOROL SOC JPN, V72, P627; SANDERS F, 1980, MON WEATHER REV, V108, P1589, DOI 10.1175/1520-0493(1980)108<1589:SDCOT>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Yokoi S, 2008, MON WEATHER REV, V136, P3275, DOI 10.1175/2008MWR2456.1; Blersch D. J., 1991, J PRACT APPL SPACE, V2, P1; CHEANG BK, 1977, PURE APPL GEOPHYS, V115, P1303, DOI 10.1007/BF00874411; Chen TC, 2012, J CLIMATE, V25, P392, DOI 10.1175/JCLI-D-11-00068.1; Chen TC, 2012, WEATHER FORECAST, V27, P1155, DOI 10.1175/WAF-D-11-00104.1; Chen TC, 2012, MON WEATHER REV, V140, P1219, DOI 10.1175/MWR-D-11-00111.1; Chen TC, 2005, J ATMOS SCI, V62, P3637, DOI 10.1175/JAS3566.1; Chen TC, 2013, J CLIMATE, V26, P936, DOI 10.1175/JCLI-D-12-00174.1; Chen TC, 2013, J CLIMATE, V26, P4630, DOI 10.1175/JCLI-D-12-00367.1; Chen TC, 2015, J CLIMATE, V28, P1444, DOI 10.1175/JCLI-D-14-00171.1; DFO, 2013, GLOB ACT ARCH LARG F; EM-DAT, 2013, INT DIS DAT; Gianotti RL, 2012, J CLIMATE, V25, P638, DOI 10.1175/JCLI-D-11-00025.1; Huffman G. J., 2013, VERSION 1 2 GPCP ONE; KANAMITSU M, 1991, WEATHER FORECAST, V6, P425, DOI 10.1175/1520-0434(1991)006<0425:RCIITG>2.0.CO;2; Kincaid D. R., 2002, NUMERICAL ANAL MATH; Lindzen R. S., 1971, MESOSPHERIC MODELS R, P122; Meteorological Services Centre Japan, 1997, GMS 5 US GUID; Rienecker M. M., 2008, NASA GSFC TECHNICAL, V27; Spencer R. W., 1993, CLIMATE, V6, P1301, DOI [10.1175/ 1520- 0442( 1993) 006,1301: GOPFTM. 2.0. CO; 2, DOI 10.1175/1520-0442(1993)006]; Susskind J, 1997, B AM METEOROL SOC, V78, P1449, DOI 10.1175/1520-0477(1997)078<1449:COTTPP>2.0.CO;2; Yang FL, 2006, MON WEATHER REV, V134, P3668, DOI 10.1175/MWR3264.1	32	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	FEB	2015	28	4					1417	1443		10.1175/JCLI-D-14-00170.1		27	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB5LX	WOS:000349670000005		
J	Chen, TC; Tsay, JD; Matsumoto, J				Chen, Tsing-Chang; Tsay, Jenq-Dar; Matsumoto, Jun			Development and Formation Mechanism of the Southeast Asian Winter Heavy Rainfall Events around the South China Sea. Part II: Multiple Interactions	JOURNAL OF CLIMATE			English	Article							INTERANNUAL VARIATION; CENTRAL VIETNAM; COLD SURGE; MALAYSIA; MONSOON	About 44% of the cold-season heavy rainfall/flood (HRF) events around the South China Sea require six days or longer to develop from the formation time of their parent cold surge vortices (CSVs). Formations for both the parent CSV and HRF event are involved with interactions of the concerned vortices with two different cold surge flows. The occurrence frequency of the East Asian cold surge flow varies from 4.5 to 6 days. The longevous CSVs enable their developments to interact with the second cold surge flows between formations of these CSVs and HRF events. Two requirements for the formation of HRF events are 1) synchronized occurrence of the HRF event and the northwestern Pacific explosive cyclone and 2) simultaneous occurrence of the maximum speeds among westerlies of the northwestern Pacific explosive cyclone and easterlies of the tropical trade winds and the HRF event. These requirements cannot be met by the CSV at its second maximum peak intensity, but the CSV at this stage plays an indispensible role for the formation of the HRF event to make its intensity and rainfall amount larger than those HRF events without this relay intensification. The development of an HRF event through multiple interactions of CSVs with sequential cold surge flows may pose difficulties to numerically simulate/predict the occurrence of these HRF events over the cold-season rainfall centers around the South China Sea.	[Chen, Tsing-Chang; Tsay, Jenq-Dar] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA 50011 USA; [Matsumoto, Jun] Tokyo Metropolitan Univ, Dept Geog, Tokyo 158, Japan; [Matsumoto, Jun] JAMSTEC, Res Inst Global Change, Yokosuka, Kanagawa, Japan	Chen, TC (reprint author), Iowa State Univ, Dept Geol & Atmospher Sci, Atmospher Sci Program, 3010 Agronomy Hall, Ames, IA 50011 USA.	tmchen@iastate.edu			Cheney Research Fund; NSF [ATM-0836220]; Japan Society for the Promotion of Science [26220202]	The Cheney Research Fund and NSF Grant ATM-0836220 sponsored this study. Jun Matsumoto's contribution to this study is supported by the Grant-in-Aid for Scientific Research (26220202) from the Japan Society for the Promotion of Science. Comments and suggestions offered by two anonymous reviewers are very helpful in improving the presentation of this study.	Chen TC, 2004, J CLIMATE, V17, P401, DOI 10.1175/1520-0442(2004)017<0401:IVOTEA>2.0.CO;2; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; SANDERS F, 1980, MON WEATHER REV, V108, P1589, DOI 10.1175/1520-0493(1980)108<1589:SDCOT>2.0.CO;2; Yokoi S, 2008, MON WEATHER REV, V136, P3275, DOI 10.1175/2008MWR2456.1; CHEANG BK, 1977, PURE APPL GEOPHYS, V115, P1303, DOI 10.1007/BF00874411; CHEN TC, 1991, J GEOPHYS RES-ATMOS, V96, P13163, DOI 10.1029/91JD01356; CHEN TC, 1985, MON WEATHER REV, V113, P1801, DOI 10.1175/1520-0493(1985)113<1801:GWVFAM>2.0.CO;2; Chen TC, 2012, WEATHER FORECAST, V27, P1155, DOI 10.1175/WAF-D-11-00104.1; Chen TC, 2012, MON WEATHER REV, V140, P1219, DOI 10.1175/MWR-D-11-00111.1; Chen TC, 2013, J CLIMATE, V26, P936, DOI 10.1175/JCLI-D-12-00174.1; Chen TC, 2013, J CLIMATE, V26, P4630, DOI 10.1175/JCLI-D-12-00367.1; CHEN TC, 1991, TELLUS A, V43, P213, DOI 10.1034/j.1600-0870.1991.t01-2-00004.x; Chen TC, 2015, J CLIMATE, V28, P1417, DOI 10.1175/JCLI-D-14-00170.1; DFO, 2013, GLOB ACT ARCH LARG F; GREENFIELD RS, 1979, B AM METEOROL SOC, V60, P439; Johnson R. H, 2005, MESOSCALE PROCESSES, P331; Johnson R.H, 1987, PRECIPITATING CLOUD, P298; Zwiers F. W., 2002, STAT ANAL CLIMATE RE	18	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	FEB	2015	28	4					1444	1464		10.1175/JCLI-D-14-00171.1		21	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB5LX	WOS:000349670000006		
J	Takahashi, HG; Fujinami, H; Yasunari, T; Matsumoto, J; Baimoung, S				Takahashi, Hiroshi G.; Fujinami, Hatsuki; Yasunari, Tetsuzo; Matsumoto, Jun; Baimoung, Somchai			Role of Tropical Cyclones along the Monsoon Trough in the 2011 Thai Flood and Interannual Variability	JOURNAL OF CLIMATE			English	Article							WESTERN NORTH PACIFIC; ASIAN SUMMER MONSOON; INDO-CHINA PENINSULA; GLOBAL PRECIPITATION; RAINFALL; CIRCULATION; RESOLUTION	The atmospheric circulation patterns that were responsible for the heavy flooding that occurred in Thailand in 2011 are examined. This paper also investigates the interannual variation in precipitation over Indochina over a 33-yr period from 1979-2011, focusing on the role of westward-propagating tropical cyclones (TCs) over the Asian monsoon region. Cyclonic anomalies and more westward-propagating TCs than expected from the climatology of the area were observed in 2011 along the monsoon trough from the northern Indian subcontinent, the Bay of Bengal, Indochina, and the western North Pacific, which contributed significantly to the 2011 Thai flood. The strength of monsoon westerlies was normal, which implies that the monsoon westerly was not responsible for the seasonal heavy rainfall in 2011. Similar results were also obtained from the 33-yr statistical analysis. The 5-month total precipitation over Indochina covaried interannually with that along the monsoon trough. In addition, above-normal precipitation over Indochina was observed when enhanced cyclonic circulation with more westward-propagating TCs along the monsoon trough was observed. Notably, the above-normal precipitation was not due to the enhanced monsoon westerly over Indochina. Therefore, the 2011 Thai flood was caused by the typical atmospheric circulation pattern for an above-normal precipitation year. It is noteworthy that the effect of sea surface temperature (SST) forcing over the western North Pacific and the Nino-3.4 region on total precipitation during the summer rainy season over Indochina was unclear over the 33-yr period.	[Takahashi, Hiroshi G.; Matsumoto, Jun] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan; [Takahashi, Hiroshi G.; Matsumoto, Jun] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Fujinami, Hatsuki] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan; [Yasunari, Tetsuzo] Res Inst Humanity & Nat, Kyoto, Japan; [Baimoung, Somchai] Minist Informat & Commun Technol, Bangkok, Thailand	Takahashi, HG (reprint author), Tokyo Metropolitan Univ, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	hiroshi3@tmu.ac.jp	Takahashi, Hiroshi G./F-1380-2010	Takahashi, Hiroshi G./0000-0002-1991-422X	Green Network of Excellence (GRENE) program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; 7th Japan Aerospace Exploration Agency (JAXA) Precipitation Measuring Mission (PMM) Project [306]; KAMANHI from the Japan Society for the Promotion of Science [26220202]	We thank the two anonymous reviewers of this manuscript for their helpful suggestions and comments. This work was partly supported by the Green Network of Excellence (GRENE) program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, the 7th Japan Aerospace Exploration Agency (JAXA) Precipitation Measuring Mission (PMM) Project 306, and KAMANHI (26220202) from the Japan Society for the Promotion of Science.	Takahashi HG, 2008, J METEOROL SOC JPN, V86, P429, DOI 10.2151/jmsj.86.429; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Zhang YS, 2002, J CLIMATE, V15, P3206, DOI 10.1175/1520-0442(2002)015<3206:OOTSMO>2.0.CO;2; Wang B, 1999, B AM METEOROL SOC, V80, P629, DOI 10.1175/1520-0477(1999)080<0629:COSASM>2.0.CO;2; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Goswami BN, 2001, J CLIMATE, V14, P1180, DOI 10.1175/1520-0442(2001)014<1180:IOAIVO>2.0.CO;2; Yokoi S, 2013, J CLIMATE, V26, P4096, DOI 10.1175/JCLI-D-12-00218.1; KRIPALANI RH, 1995, INT J CLIMATOL, V15, P657, DOI 10.1002/joc.3370150606; Takahashi HG, 2006, J CLIMATE, V19, P1545, DOI 10.1175/JCLI3724.1; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Chen TC, 2000, J CLIMATE, V13, P1979, DOI 10.1175/1520-0442(2000)013<1979:IVIISM>2.0.CO;2; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Fukutomi Y, 1999, J METEOROL SOC JPN, V77, P753; Goswami BN, 1999, Q J ROY METEOR SOC, V125, P611, DOI 10.1256/smsqj.55411; Yokoi S, 2007, J CLIMATE, V20, P5301, DOI 10.1175/2007JCLI1357.1; CHEN TC, 1993, MON WEATHER REV, V121, P2465, DOI 10.1175/1520-0493(1993)121<2465:TDMOTI>2.0.CO;2; Fujinami H, 2011, INT J CLIMATOL, V31, P1192, DOI 10.1002/joc.2146; Komori D., 2012, HYDROL RES LETT, V6, P41, DOI DOI 10.3178/HRL.6.41; Matsumoto J, 1997, ADV ATMOS SCI, V14, P231, DOI 10.1007/s00376-997-0022-0; Takahashi HG, 2009, ATMOS SCI LETT, V10, P14, DOI 10.1002/asl.203; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Yoki S, 2005, MON WEATHER REV, V133, P2091, DOI 10.1175/MWR2967.1	24	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	FEB	2015	28	4					1465	1476		10.1175/JCLI-D-14-00147.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB5LX	WOS:000349670000007		
J	Qiu, B; Chen, SM; Wu, LX; Kida, S				Qiu, Bo; Chen, Shuiming; Wu, Lixin; Kida, Shinichiro			Wind- versus Eddy-Forced Regional Sea Level Trends and Variability in the North Pacific Ocean	JOURNAL OF CLIMATE			English	Article							KUROSHIO EXTENSION; SUBTROPICAL COUNTERCURRENT; DECADAL VARIABILITY; RECIRCULATION GYRE; TROPICAL PACIFIC; CIRCULATION; JET; TOPEX/POSEIDON; OSCILLATION; SYSTEM	Regional sea level trend and variability in the Pacific Ocean have often been considered to be induced by low-frequency surface wind changes. This study demonstrates that significant sea level trend and variability can also be generated by eddy momentum flux forcing due to time-varying instability of the background oceanic circulation. Compared to the broad gyre-scale wind-forced variability, the eddy-forced sea level changes tend to have subgyre scales and, in the North Pacific Ocean, they are largely confined to the Kuroshio Extension region (30 degrees-40 degrees N, 140 degrees-175 degrees E) and the Subtropical Countercurrent (STCC) region (18 degrees-28 degrees N, 130 degrees-175 degrees E). Using a two-layer primitive equation model driven by the ECMWF wind stress data and the eddy momentum fluxes specified by the AVISO sea surface height anomaly data, the relative importance of the wind-and eddy-forced regional sea level trends in the past two decades is quantified. It is found that the increasing (decreasing) trend south (north) of the Kuroshio Extension is due to strengthening of the regional eddy forcing over the past two decades. On the other hand, the decreasing (increasing) sea level trend south (north) of the STCC is caused by the decadal weakening of the regional eddy momentum flux forcing. These decadal eddy momentum flux changes are caused by the background Kuroshio Extension and STCC changes in connection with the Pacific decadal oscillation (PDO) wind pattern shifting from a positive to a negative phase over the past two decades.	[Qiu, Bo; Chen, Shuiming] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Wu, Lixin] Ocean Univ China, Phys Oceanog Lab, Qingdao, Peoples R China; [Kida, Shinichiro] JAMSTEC, Applicat Lab, Yokohama, Kanagawa, Japan	Qiu, B (reprint author), Univ Hawaii Manoa, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.	bo@soest.hawaii.edu	Kida, Shinichiro/E-9137-2014	Kida, Shinichiro/0000-0002-9471-4316	NSF [OCE-0926594]; National Global Change Major Research Project of China [2013CB956201]; MEXT through KAKENHI [22106002]	Detailed and constructive comments made by the three reviewers helped improve an early version of the manuscript. The ERA-Interim reanalysis surface wind stress data are provided by the European Centre for Medium-Range Weather Forecast, and the merged satellite altimeter data by the CLS Space Oceanography Division as part of the Environment and Climate EU ENACT project. BQ and SC acknowledge the support of NSF OCE-0926594. LW is supported through the National Global Change Major Research Project of China 2013CB956201. SK is supported by MEXT through KAKENHI 22106002.	Bromirski PD, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006759; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Stammer D, 2013, ANNU REV MAR SCI, V5, P21, DOI 10.1146/annurev-marine-121211-172406; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Qiu B, 2011, J PHYS OCEANOGR, V41, P503, DOI 10.1175/2010JPO4575.1; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Cazenave A, 2010, ANNU REV MAR SCI, V2, P145, DOI 10.1146/annurev-marine-120308-081105; Penduff T, 2011, J CLIMATE, V24, P5652, DOI 10.1175/JCLI-D-11-00077.1; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Bindoff NL, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Kohl A, 2008, J CLIMATE, V21, P1876, DOI 10.1175/2007JCLI2081.1; Qiu B, 2013, J PHYS OCEANOGR, V43, P344, DOI 10.1175/JPO-D-12-0133.1; Timmermann A, 2010, J CLIMATE, V23, P4429, DOI 10.1175/2010JCLI3519.1; Waterman S, 2011, J PHYS OCEANOGR, V41, P1182, DOI 10.1175/2010JPO4564.1; RHINES PB, 1979, DYNAM ATMOS OCEANS, V3, P289, DOI 10.1016/0377-0265(79)90015-0; Ceballos LI, 2009, J CLIMATE, V22, P5163, DOI 10.1175/2009JCLI2848.1; Hurlburt HE, 1996, J GEOPHYS RES-OCEANS, V101, P941, DOI 10.1029/95JC01674; Hallberg R, 1997, J COMPUT PHYS, V135, P54, DOI 10.1006/jcph.1997.5734; Feng M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042796; Qiu B, 2012, J PHYS OCEANOGR, V42, P193, DOI 10.1175/JPO-D-11-061.1; Qiu B, 2004, J PHYS OCEANOGR, V34, P2148, DOI 10.1175/1520-0485(2004)034<2148:SAFFIT>2.0.CO;2; Taguchi B, 2007, J CLIMATE, V20, P2357, DOI 10.1175/JCLI4142.1; Rio MH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006505; Yoshida S, 2011, J GEOPHYS RES-OCEANS, V116, DOI [10.1029/2011J0007286, 10.1029/2011JC007286]; Qiu B, 2008, J PHYS OCEANOGR, V38, P1764, DOI 10.1175/2008JPO3921.1; Qiu B, 2002, J PHYS OCEANOGR, V32, P353, DOI 10.1175/1520-0485(2002)032<0353:LSVITM>2.0.CO;2; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Jayne SR, 2009, DEEP-SEA RES PT I, V56, P2088, DOI 10.1016/j.dsr.2009.08.006; Church J. A., 2013, CLIMATE CHANGE 2013, V13, P1137, DOI DOI 10.1017/CBO9781107415324.026; Cummins PF, 2004, DEEP-SEA RES PT I, V51, P2105, DOI 10.1016/j.dsr.2004.08.004; Greatbatch RJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045473; Greatbatch RJ, 2010, OCEAN DYNAM, V60, P617, DOI 10.1007/s10236-010-0282-6; Jayne SR, 1996, J PHYS OCEANOGR, V26, P492, DOI 10.1175/1520-0485(1996)026<0492:RGFBAB>2.0.CO;2; KESSLER WS, 1990, J GEOPHYS RES-OCEANS, V95, P5183, DOI 10.1029/JC095iC04p05183; Merrifield MA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049576; Nakano H, 2010, DEEP-SEA RES PT II, V57, P1111, DOI 10.1016/j.dsr2.2009.12.002; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; Pierini S, 2014, J CLIMATE, V27, P448, DOI 10.1175/JCLI-D-13-00306.1; Qiu B, 2003, J PHYS OCEANOGR, V33, P2465, DOI 10.1175/2459.1; Qiu B, 2010, DEEP-SEA RES PT II, V57, P1098, DOI 10.1016/j.dsr2.2008.11.036; Sasaki YN, 2014, J GEOPHYS RES-OCEANS, V119, P266, DOI 10.1002/2013JC009327; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Taguchi B, 2010, OCEAN DYNAM, V60, P673, DOI 10.1007/s10236-010-0295-1; Waterman S, 2011, J PHYS OCEANOGR, V41, P682, DOI 10.1175/2010JPO4477.1; Yasuda T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024920	49	3	3	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	FEB	2015	28	4					1561	1577		10.1175/JCLI-D-14-00479.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB5LX	WOS:000349670000013		
J	Pang, J; Sullivan, DR; Harada-Shiba, M; Ding, PYA; Selvey, S; Ali, S; Watts, GF				Pang, Jing; Sullivan, David R.; Harada-Shiba, Mariko; Ding, Phillip Y. A.; Selvey, Sheryl; Ali, Shariq; Watts, Gerald F.			Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Familial hypercholesterolemia; Awareness; Knowledge; Practices; Perception; Asia; Physicians; Models of care	CORONARY-HEART-DISEASE; GENERAL-POPULATION; CARE; GUIDANCE; PREVALENCE; MANAGEMENT; MEDICINE; MODEL	BACKGROUND: Familial hypercholesterolemia (FH) is a dominantly inherited disorder characterized by high plasma cholesterol levels and a very high risk of early heart disease. The prevalence of FH is estimated to be at least 1:500, with at least 3.6 million individuals in the Asia-Pacific region. OBJECTIVE: To assess awareness, knowledge, and perception of FH among practicing physicians in Japan, South Korea, and Taiwan. METHODS: Physicians from 3 economically developed Asian countries were requested to anonymously complete a structured Internet-based survey regarding FH. This survey sought responses on the clinical description, inheritance, prevalence, cardiovascular disease risk, practices, and opinions on screening. RESULTS: Of 230 physicians surveyed, 47% were aware of the heritability, 27% of the prevalence, and 13% of the risk of cardiovascular disease relating to FH. The majority (70%) perceived themselves to have an above-moderate familiarity with FH. Primary care physicians (59%) and lipid specialists (41%) were perceived as the best providers for caring for FH, including cascade screening services, with a lesser role perceived for cardiologists, endocrinologists, and no significant role for nursing staff. Only 35% of physicians were aware of specialist clinical services for lipid disorders in their geographic area. CONCLUSION: Extensive education and training programs are required to complement the implementation of region-specific models of care for FH in Asia. Further enhancement of existing lipid services and facilities are also warranted to optimise service models. (C) 2015 National Lipid Association. All rights reserved.	[Pang, Jing; Watts, Gerald F.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Sullivan, David R.] Univ Sydney, Royal Prince Alfred Hosp, Dept Biochem, Sydney, NSW 2006, Australia; [Harada-Shiba, Mariko] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Innovat Lipidol, Osaka, Japan; [Ding, Phillip Y. A.] Fu Jen Catholic Univ, Yonghe Cardinal Tien Hosp, Dept Cardiovasc Med, New Taipei City, Taiwan; [Selvey, Sheryl; Ali, Shariq] Genzyme, Cambridge, MA USA; [Watts, Gerald F.] Royal Perth Hosp, Dept Internal Med, Cardiometab Serv, Lipid Disorders Clin, Perth, WA, Australia	Watts, GF (reprint author), GPO Box X2213, Perth, WA 6847, Australia.	gerald.watts@uwa.edu.au			Genzyme; Genzyme, A Sanofi Company	The funding for this survey was provided by Genzyme, A Sanofi Company. We acknowledge the contribution of Jennifer Chien (Genzyme) in formulating the survey questions. The survey was conducted by Reason Research (www.reasonresearch.com), a health care market research consulting firm with headquarters in Philadelphia, PA.	Watts GF, 2014, INT J CARDIOL, V171, P309, DOI 10.1016/j.ijcard.2013.11.025; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Hu M, 2013, INT J CARDIOL, V167, P762, DOI 10.1016/j.ijcard.2012.03.048; Bell DA, 2014, HEART LUNG CIRC, V23, P309, DOI 10.1016/j.hlc.2013.08.005; Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Hadfield SG, 2009, ANN CLIN BIOCHEM, V46, P24, DOI 10.1258/acb.2008.008094; Watts GF, 2012, HEART LUNG CIRC, V21, P543, DOI 10.1016/j.hlc.2012.04.010; Ock SM, 2009, J KOREAN MED SCI, V24, P1, DOI 10.3346/jkms.2009.24.1.1; Watts GF, 2011, ATHEROSCLEROSIS SUPP, V12, P221, DOI 10.1016/j.atherosclerosissup.2011.06.001; Harada-Shiba M, 2012, J ATHEROSCLER THROMB, V19, P1043; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Foody JM, 2013, CLIN CARDIOL, V37, P119; GOLDSTEI.JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Hamilton-Craig Ian, 2004, Semin Vasc Med, V4, P87; Jervise L, 2013, AUST PHARM, P73; Jiang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071673; Mabuchi H, 2011, ATHEROSCLEROSIS, V214, P404, DOI 10.1016/j.atherosclerosis.2010.11.005; Nomura H, 2005, BRIT MED J, V331, P648, DOI 10.1136/bmj.331.7518.648; Tai ES, 2001, ATHEROSCLEROSIS, V154, P252, DOI 10.1016/S0021-9150(00)00649-3; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Versmissen J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2423	26	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	FEB	2015	9	1					42	48		10.1016/j.jacl.2014.09.011		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1IB	WOS:000350093300007		
J	Mori, N; Ikeda, N				Mori, Naoya; Ikeda, Naoshi			Majority support of shareholders, monitoring incentive, and dividend policy	JOURNAL OF CORPORATE FINANCE			English	Article						Ownership structure; Corporate governance; Tax preferences	PAYOUT POLICY; CORPORATE GOVERNANCE; OWNERSHIP; INVESTMENT; CLIENTELES; CHOICES	As an alternative version of the side-payment model, this paper presents a demonstration of how the necessity of winning majority support of shareholders influences the relation between a blockholder's monitoring incentive and a firm's dividend policy. When dividend-averse individuals collectively hold a majority stake in a dispersed ownership structure, a dividend-seeking blockholder might be compelled to propose lower dividends than the tax-optimum to dominate the zero-dividend proposal. Under such circumstances, the blockholder has an incentive to provide unprofitable monitoring activity as long as the private benefits of tax-saving are greater than the pecuniary loss from the monitoring activity. (C) 2014 Elsevier B.V. All rights reserved.	[Mori, Naoya] Nihon Univ, Coll Commerce, Setagaya Ku, Tokyo 1578570, Japan; [Ikeda, Naoshi] Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, Tokyo 1528552, Japan	Mori, N (reprint author), Nihon Univ, Coll Commerce, Setagaya Ku, 5-2-1 429 Kinuta, Tokyo 1578570, Japan.	mori.naoya@nihon-u.ac.jp; ikeda.n.ab@m.titech.ac.jp			Nihon University [803265-2012]	Authors wish to thank the editor (Jeffry Netter) and an anonymous referee. For helpful comments and suggestions, we also thank Toshiki Honda, Nobuyuld Isagawa, Katsumasa,Nishide, Kazuhiko Ohashi, Wataru Ohta, Takashi Shibata, Masahiko Sugie and seminar participants at Doshisha University, Hitotsubashi University, Osaka University, Tokyo Metropolitan University, and Yokohama National University. Financial support from Nihon University (803265-2012) and language help from Brad Fast are gratefully acknowledged.	Allen F, 2003, HANDB ECON, V21, P337; Maug E, 1998, J FINANC, V53, P65, DOI 10.1111/0022-1082.35053; JENSEN GR, 1992, J FINANC QUANT ANAL, V27, P247, DOI 10.2307/2331370; Allen F, 2000, J FINANC, V55, P2499, DOI 10.1111/0022-1082.00298; Short H, 2002, J CORP FINANC, V8, P105, DOI 10.1016/S0929-1199(01)00030-X; Grinstein Y, 2005, J FINANC, V60, P1389, DOI 10.1111/j.1540-6261.2005.00765.x; Shleifer A, 1997, J FINANC, V52, P737, DOI 10.1111/j.1540-6261.1997.tb04820.x; ADMATI AR, 1994, J POLIT ECON, V102, P1097, DOI 10.1086/261965; Chen X, 2007, J FINANC ECON, V86, P279, DOI 10.1016/j.jfineco.2006.09.005; Ang JS, 2000, J FINANC, V55, P81, DOI 10.1111/0022-1082.00201; SHLEIFER A, 1986, J POLIT ECON, V94, P461, DOI 10.1086/261385; Bates TW, 2009, J FINANC, V64, P1985, DOI 10.1111/j.1540-6261.2009.01492.x; Black D, 1948, J POLIT ECON, V56, P23, DOI 10.1086/256633; GROSSMAN SJ, 1980, BELL J ECON, V11, P42, DOI 10.2307/3003400; Brav A, 2005, J FINANC ECON, V77, P483, DOI 10.1016/j.jfineco.2004.07.004; Bah R, 2001, J BUSINESS FINANCE A, V28, P671, DOI 10.1111/1468-5957.00389; Barclay MJ, 2009, REV FINANC STUD, V22, P2423, DOI 10.1093/rfs/hhn060; Bray A., 1998, WORKING PAPER; Chetty R, 2005, Q J ECON, V120, P791, DOI 10.1093/qje/120.3.791; Desai MA, 2011, J FINANC ECON, V100, P68, DOI 10.1016/j.jfineco.2010.10.013; DOWNS A, 1957, J POLIT ECON, V65, P135, DOI 10.1086/257897; Drug M., 2005, J CORP FINANC, V12, P121; Eckbo B. Espen, 1994, J CORP FINANC, V1, P33; Gaspar JM, 2013, REV FINANC, V17, P261, DOI 10.1093/rof/rfr040; Gugler K, 2003, J BANK FINANC, V27, P1297, DOI 10.1016/S0378-4266(02)00258-3; Hirshleifer J., 2005, PRICE THEORY APPL DE; Korkeamaki T, 2010, J CORP FINANC, V16, P572, DOI 10.1016/j.jcorpfin.2009.12.003; Mori N, 2010, J BANK FINANC, V34, P1089, DOI 10.1016/j.jbankfin.2009.11.009; Perry Larry G., 1995, FINANCIAL REV, V30, P367, DOI 10.1111/j.1540-6288.1995.tb00837.x; RICHARDSON G, 1986, J FINANC ECON, V17, P313, DOI 10.1016/0304-405X(86)90068-1	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-1199	1872-6313		J CORP FINANC	J. Corp. Financ.	FEB	2015	30						1	10		10.1016/j.jcorpfin.2014.10.015		10	Business, Finance	Business & Economics	CC1BP	WOS:000350076500001		
J	Date, M; Takada, H; Honda, Y; Ozawa, S; Mieda, S; Kojima, A				Date, Munekazu; Takada, Hideaki; Honda, Yuma; Ozawa, Shiro; Mieda, Satoshi; Kojima, Akira			Highly Realistic 3D Display System for Space Composition Telecommunication	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Communication systems; three-dimensional (3D) displays; image generation; telecommunications; visual effects	STEREOSCOPIC DISPLAY; DIFFERENT DEPTHS; 3-D DISPLAY; IMAGES; TECHNOLOGY	In this paper, we describe a highly realistic 3D display system that generates composites of current and remote places for telecommunication purposes. It uses a 3D projector and head tracking to display a person in a remote place as a life-size stereoscopic image against background scenery. Since it generates displayed images that correspond to the observer's viewing position, it reproduces well the fidelity of existence and the feel of materials. We also describe a simple, fast, and high quality background scenery generation method, the development of which was inspired by the visual effects of depth-fused 3D (DFD) displays, and applied to a single direction conceptual demonstration system. Our system is a promising means for achieving real-time communication between two different places in cases where a sense of reality is required.	[Date, Munekazu; Takada, Hideaki; Ozawa, Shiro; Mieda, Satoshi; Kojima, Akira] NTT Corp, NTT Media Intelligence Labs, Yokosuka, Kanagawa, Japan; [Honda, Yuma] Nagoya Univ, Dept Informat Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Date, M (reprint author), NTT Corp, NTT Media Intelligence Labs, Yokosuka, Kanagawa, Japan.	date.munekazu@lab.ntt.co.jp; takada.hideaki@lab.ntt.co.jp; honda.yuma@f.mbox.nagoya-u.ac.jp; ozawa.shiro@lab.ntt.co.jp; mieda.satoshi@lab.ntt.co.jp; kojima.akira@lab.ntt.co.jp					Takaki Y, 2006, P IEEE, V94, P654, DOI 10.1109/JPROC.2006.870684; Kajiki Y, 1997, P SOC PHOTO-OPT INS, V3012, P154, DOI 10.1117/12.274452; Ishii R, 2011, LECT NOTES COMPUT SC, V6772, P131, DOI 10.1007/978-3-642-21669-5_16; Iso K, 2012, J DISP TECHNOL, V8, P511, DOI 10.1109/JDT.2012.2193662; Suyama S, 2002, IEICE T ELECTRON, VE85C, P1911; Suyama S, 2004, VISION RES, V44, P785, DOI [10.1016/j.visres.2003.10.023, 10.1016/j.visres.2003.10.23]; Kajiki Y, 2000, IEEE T CIRC SYST VID, V10, P254, DOI 10.1109/76.825725; Kuribayashi H, 2006, J SOC INF DISPLAY, V14, P493, DOI 10.1889/1.2206115; Date M., 2007, P SOC PHOTO-OPT INS, V6778; Date M, 2005, APPL OPTICS, V44, P898, DOI 10.1364/AO.44.000898; Date M, 2005, IEEE T ELECTRON DEV, V52, P190, DOI 10.1109/TED.2004.842548; Date M, 2010, J SOC INF DISPLAY, V18, P470, DOI 10.1889/JSID18.7.470; Date M, 2005, IDW/AD '05: PROCEEDINGS OF THE 12TH INTERNATIONAL DISPLAY WORKSHOPS IN CONJUNCTION WITH ASIA DISPLAY 2005, VOLS 1 AND 2, P1793; Date M., 2007, TAIW JAP JOINT C COM, P75; Date M., 2003, P 10 INT DISPL WORKS, P1409; Honda T., 2000, SPIE CRIT REV, VCR76, P218; Inoue N., 2010, FINENESS MOTION PARA, V109, P3; Kanade T, 1999, MIXED REALITY, P41; Koyama S, 2013, IEEE T AUDIO SPEECH, V21, P685, DOI 10.1109/TASL.2012.2229985; Seitz S. M., 1996, P SIGGRAPH 96, P21, DOI 10.1145/237170.237196; Suyama S., 2001, SID 01, P1300; Suyama S., 2000, SID 00, P1208; Takada H., 2003, SID 03, P1526; Tsuboi M., 2006, NTT DOCOMO TECH J, V8, P45	24	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	FEB	2015	11	2			SI		121	128		10.1109/JDT.2014.2338858		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB8PN	WOS:000349893100001		
J	Aoshima, K; Machida, K; Kato, D; Mishina, T; Wada, K; Cai, YF; Kinjo, H; Kuga, K; Kikuchi, H; Ishibashi, T; Shimidzu, N				Aoshima, Kenichi; Machida, Kenji; Kato, Daisuke; Mishina, Tomoyuki; Wada, Kakeru; Cai, Yong-fu; Kinjo, Hidekazu; Kuga, Kiyoshi; Kikuchi, Hiroshi; Ishibashi, Takayuki; Shimidzu, Naoki			A Magneto-Optical Spatial Light Modulator Driven by Spin Transfer Switching for 3D Holography Applications	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Magneto-optical Kerr effect; spatial light modulator; 3D holography	SIDE-BAND HOLOGRAPHY; ENLARGEMENT; DISPLAYS	We have successfully fabricated a basic magneto-optical spatial light modulator (MO-SLM) device driven by spin-transfer-switching (STS), which we call Spin-SLM technology. The SLM device is comprised of a one dimensional ten-pixel light modulation array (1 x 10 pixels) with a fine pitch of 1 m. The light modulation pixels were composed of Gd-Fe based giant magneto resistance (GMR) devices, with a free layer of Gd-Fe, an Ag spacer and a Co-Fe/Tb-Fe-Co pinned layer. The GMR devices were sandwiched by a Cu bottom and Indium zinc oxide top electrodes in order to inject current perpendicular to the film plane for switching. Incident light penetrating the transparent top electrode can be modulated due to its magneto-optic Kerr effect with the Gd-Fe free layer. The fabricated device cell size is 220 x 300 nm(2). We confirmed successful switching of the individual free layers, which was controlled by STS. We have also fabricated magnetic hologram patterns with the same magnetic materials used in the light modulation layer of the Spin-SLM device in order to determine its feasibility in display applications. The pixel pitch of the pattern was one micron and a reconstructed image by laser light was successfully observed with a wide viewing zone angle as 38 deg, which is nearly the same value expected from calculations. Although these patterns do not have an electrode to switch the magnetization direction, we confirmed the potential of Spin-SLM technology as a display device for 3D holography applications.	[Aoshima, Kenichi; Machida, Kenji; Kato, Daisuke; Mishina, Tomoyuki; Kinjo, Hidekazu; Kuga, Kiyoshi; Kikuchi, Hiroshi; Shimidzu, Naoki] Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Tokyo 1578510, Japan; [Wada, Kakeru; Cai, Yong-fu; Ishibashi, Takayuki] Nagaoka Univ Technol, Dept Mat Sci & Technol, Niigata 9402188, Japan	Aoshima, K (reprint author), Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Tokyo 1578510, Japan.	aoshima.k-ia@nhk.or.jp			National Institute of Information and Communications Technology in Japan	This work was supported by the National Institute of Information and Communications Technology in Japan, (program period: 2009-2014).	Andricacos C., 1998, IBM J RES DEV, V42, P567; Mishina T, 2002, APPL OPTICS, V41, P1489, DOI 10.1364/AO.41.001489; Aoshima KI, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767770; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; LEITH EN, 1962, J OPT SOC AM, V52, P1123, DOI 10.1364/JOSA.52.001123; Takaki Y, 2009, APPL OPTICS, V48, pH64, DOI 10.1364/AO.48.000H64; Aoshima K, 2010, J DISP TECHNOL, V6, P374, DOI 10.1109/JDT.2010.2058998; Mishina T, 1999, APPL OPTICS, V38, P3703, DOI 10.1364/AO.38.003703; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; MOK F, 1986, OPT LETT, V11, P748, DOI 10.1364/OL.11.000748; Senoh T, 2011, J DISP TECHNOL, V7, P382, DOI 10.1109/JDT.2011.2114327; Aoshima K, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676237; Aoshima KI, 2008, IEEE T MAGN, V44, P2491, DOI 10.1109/TMAG.2008.2002615; HASHIMOTO N, 1991, P SOC PHOTO-OPT INS, V1461, P291, DOI 10.1117/12.44740; Hilaire P. S., 1990, P SOC PHOTO-OPT INS, V1212, P174; Hilaire P. S., 1993, P SOC PHOTO-OPT INS, V1914, P188; Machida K, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838473; Mayer E. B., 1999, SCIENCE, V285, P867; PSALTIS D, 1984, OPT ENG, V23, P698, DOI 10.1117/12.7973366; Sonehara T., 1992, P 12 INT DISPL RES C, P315	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	FEB	2015	11	2			SI		129	135		10.1109/JDT.2014.2341243		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB8PN	WOS:000349893100002		
J	Unno, H; Isaka, S; Takashima, Y; Uehira, K				Unno, Hiroshi; Isaka, Sae; Takashima, Youichi; Uehira, Kazutake			New Technique for Embedding Depth Information in Captured Images Using Light Beam Containing Invisible High-Frequency Patterns-Design and Preparation of New Experimental Setup With Some Comments	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Depth map; information hiding; 3D image	MAP	This paper proposes the method and system to invisibly embed the depth data of a target object into the image captured with a camera at the same timing as taking its shot. The proposed system consists of a projector to throw the illumination light wherein the invisible periodical pattern has been contained, and a camera to take a shot of target object. The projector and camera were aligned so that these devices could be positioned in different depths along the z-coordinate. This kind of alignment enables us to set the spatial frequency of the invisible periodical pattern super-imposed onto the image of target object taken with the camera, changeable depending on the depth of the target object. This kind of spatial frequency determined depending on the depth of the object allow us to estimate the depth of target object taken with the camera, based on the spatial frequency of the periodical pattern being taken with the camera at the same time. Based on the fundamental study described above, since this paper allows us to estimate the spatial frequency of the periodical pattern contained in the image being taken with the camera, we are enabled to simultaneously generate the depth map of the 2D image being captured. A 3D image could thus be constituted with the captured 2D image combined with the depth map generated. The proposed new techniques, employing a traditional -D image format without any modification, are advantageous in easiness of transferring and storing the 3D images over the conventional 3D image generations.	[Unno, Hiroshi; Isaka, Sae; Uehira, Kazutake] Kanagawa Inst Technol, Atsugi, Kanagawa, Japan; [Takashima, Youichi] NTT Corp, NTT Serv Evolut Labs, Yokosuka, Kanagawa, Japan	Unno, H (reprint author), Kanagawa Inst Technol, Atsugi, Kanagawa, Japan.	unno@nw.kanagawa-it.ac.jp; takashima.youichi@lab.ntt.co.jp					Vetro A, 2011, P IEEE, V99, P626, DOI 10.1109/JPROC.2010.2098830; CARRIHILL B, 1985, COMPUT VISION GRAPH, V32, P337, DOI 10.1016/0734-189X(85)90056-8; Fehn C., 2004, P SPIE STER DISPL VI, V5291; Isaka S., 2012, P SOC PHOTO-OPT INS, V8290; Khanna Amit, 2009, 2009 Conference on Lasers & Electro-Optics Europe & 11th European Quantum Electronics Conference (CLEO/EQEC), DOI 10.1109/CLEOE-EQEC.2009.5191969; Khan A, 2012, INFORM SCIENCES, V216, P155, DOI 10.1016/j.ins.2012.06.014; Shimizu S, 2007, IEEE T CIRC SYST VID, V17, P1485, DOI 10.1109/TCSVT.2007.903773; Vuylsteke P., 1986, P 1 IFAC WORKSH DIG, P47; Wang W., 2011, P 3 INT C INT MULT C, P82	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	FEB	2015	11	2			SI		136	145		10.1109/JDT.2014.2386256		10	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB8PN	WOS:000349893100003		
J	Hou, JG; Zhang, Q; Fujino, M; Cai, S; Ito, H; Takahashi, K; Abe, F; Nakajima, M; Tanaka, T; Xu, JH; Zou, HJ; Ding, Q; Li, XK				Hou, Jiangang; Zhang, Qi; Fujino, Masayuki; Cai, Songjie; Ito, Hidenori; Takahashi, Kiwamu; Abe, Fuminori; Nakajima, Motowo; Tanaka, Tohru; Xu, Jinhua; Zou, Hejian; Ding, Qiang; Li, Xiao-Kang			5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article						allograft; 5-ALA; cardiac transplantation; foxp3; regulatory T cell; tolerance	TOLEROGENIC DENDRITIC CELLS; HEME OXYGENASE-1; T-CELLS; HEART-TRANSPLANTATION; CHRONIC REJECTION; TOLERANCE; SURVIVAL; BILIVERDIN; GENERATION; BILIRUBIN	BACKGROUND: 5-Aminolevulinic acid (5-ALA), a precursor of heme biosynthesis, plays a fundamentally important role in aerobic energy metabolism. Heme oxygenase (HO)-1 cleaves heme to form biliverdin, carbon monoxide (CO) and iron (Fe2+). The anti-inflammatory properties of biliverdin and CO help to alleviate ischemia/reperfusion injury as well as acute and/or chronic allograft rejection. We investigated whether 5-ALA and Fe2+ exerts salutary effects in the setting of organ transplantation. METHODS: An in vitro mixed-lymphocyte reaction (MLR) assay and cardiac allotransplantation model (CBA to C57BL/10) were used to evaluate the effects of 5-ALA and Fe2+ on transplantation tolerance. RESULTS: Treatment with 5-ALA and sodium ferrous citrate (SFC) resulted in permanent acceptance in the murine cardiac allografts in a dose-, SFC- and HO-1-dependent manner. The number of graft-infiltrating CD8 T cells was lower and the survival response of recipient spleen T cells to donor-type alloantigens was less compared with control recipients; however, numbers of both regulatory T cells and dendritic cells were significantly increased in 5-ALA/SFC-treated recipients. CONCLUSIONS: Our findings show that 5-ALA/SFC inhibits T-cell proliferation in response to alloantigens and an increased number of regulatory cells, resulting in permanent cardiac allograft acceptance in mice. These findings highlight the major roles of CO and/or HO-1 in inducing tolerance and suggest that 5-ALA/SFC may be a clinically effective treatment for allograft rejection. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.	[Hou, Jiangang; Zhang, Qi; Fujino, Masayuki; Cai, Songjie; Li, Xiao-Kang] Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Tokyo 1578535, Japan; [Hou, Jiangang; Zhang, Qi; Xu, Jinhua; Zou, Hejian; Ding, Qiang] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Fujino, Masayuki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Takahashi, Kiwamu; Abe, Fuminori; Nakajima, Motowo; Tanaka, Tohru] SBI Pharmaceut Co Ltd, Tokyo, Japan	Li, XK (reprint author), Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ri-k@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20390349, 21659310, 2109739, 22/00830]; National Center for Child Health and Development [22-10, 24-1:756]	The authors have no conflicts of interest to disclose. The first two authors (J.H. and Q.Z.) contributed equally to this work. This study was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid 20390349, 21659310, 2109739 and 22/00830) and the National Center for Child Health and Development (22-10, 24-1:756).	Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Tsui TY, 2003, CIRCULATION, V107, P2623, DOI 10.1161/01.CIR.0000066911.03770.8D; Ezzelarab MB, 2013, AM J TRANSPLANT, V13, P1989, DOI 10.1111/ajt.12310; Liu Z, 2012, TRANSPLANTATION, V93, P1116, DOI 10.1097/TP.0b013e31824fd7cd; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9; Hou JG, 2013, AM J PHYSIOL-RENAL, V305, pF1149, DOI 10.1152/ajprenal.00275.2013; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Yolcu ES, 2011, J IMMUNOL, V187, P5901, DOI 10.4049/jimmunol.1003266; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Itoh M, 1999, J IMMUNOL, V162, P5317; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Ferris CD, 1999, NAT CELL BIOL, V1, P152; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643; Hara Y, 2007, TRANSPLANTATION, V84, P407, DOI 10.1097/01.tp.0000270324.28126.93; Heng Y, 2010, TRANSPL INT, V23, P1259, DOI 10.1111/j.1432-2277.2010.01119.x; Hsieh GR, 2007, TRANSPLANTATION, V84, P238, DOI 10.1097/01.tp.0000268509.60200.ea; KUTTY RK, 1988, ARCH BIOCHEM BIOPHYS, V260, P638, DOI 10.1016/0003-9861(88)90492-4; Moreau Aurélie, 2012, Transplant Res, V1, P13, DOI 10.1186/2047-1440-1-13; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Rocuts F, 2010, CELL TRANSPLANT, V19, P443, DOI 10.3727/096368909X484680; Schnickel GT, 2006, TRANSPLANT P, V38, P3259, DOI 10.1016/j.transproceed.2006.10.156; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15; Ullrich R, 2005, J HEART LUNG TRANSPL, V24, P1600, DOI 10.1016/j.healun.2004.11.009; Vachharajani TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1613; Wu YJL, 2013, CIRC-CARDIOVASC IMAG, V6, P965, DOI 10.1161/CIRCIMAGING.113.000674; Zhang L, 2009, AM J TRANSPLANT, V9, P2012, DOI 10.1111/j.1600-6143.2009.02735.x; Zhang N, 2010, IMMUNOL LETT, V127, P119, DOI 10.1016/j.imlet.2009.10.004; Zhang Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep03979; Zhen-Wei Xia, 2007, Pediatr Transplant, V11, P850, DOI 10.1111/j.1399-3046.2007.00701.x	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	FEB	2015	34	2					254	263		10.1016/j.healun.2014.09.037		10	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CC1DV	WOS:000350082300017		
J	Masaki, M; Tateuchi, H; Tsukagoshi, R; Ibuki, S; Ichihashi, N				Masaki, Mitsuhiro; Tateuchi, Hiroshige; Tsukagoshi, Rui; Ibuki, Satoko; Ichihashi, Noriaki			ELECTROMYOGRAPHIC ANALYSIS OF TRAINING TO SELECTIVELY STRENGTHEN THE LUMBAR MULTIFIDUS MUSCLE: EFFECTS OF DIFFERENT LIFTING DIRECTIONS AND WEIGHT LOADING OF THE EXTREMITIES DURING QUADRUPED UPPER AND LOWER EXTREMITY LIFTS	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Electromyography; Paraspinal Muscles; Exercise Therapy	LOW-BACK-PAIN; CROSS-SECTIONAL AREA; REHABILITATION EXERCISES; THERAPEUTIC EXERCISES; PARASPINAL MUSCLES; STABILIZING SYSTEM; TRUNK MUSCLES; SPINE; INSTABILITY; ACTIVATION	Objective: The lumbar multifidus muscle (LMF) is a lower back muscle that contributes to spinal stability. Several electromyographic analyses have evaluated LMF activity during various types of training. The present study examined the activity of the back muscles during quadruped upper and lower extremity lifts (QULELs) with different lifting direction and weight loading of extremities. Methods: Seventeen healthy men were included as subjects. The exercise conditions comprised raising the upper extremity of one side and the lower extremity of the opposite side in a quadruped position with different lifting direction and weight loading. The various combinations of lifts were modifications of conventional QULEL, in which the upper extremity is raised to 180 degrees shoulder flexion and the lower extremity to 0 degrees hip extension. The effects of different lifting directions and weight loading on LMF and lumbar erector spinae (LES) muscle activities were measured using surface electromyography. Results: The LMF activity and the LMF/LES activity ratio on the side of lower extremity lifting were higher during QULEL with the upper and lower extremities in abduction than during conventional QULEL. The LMF/LES activity ratio was lower during QULEL with weight loading on the upper and lower extremities than during conventional QULEL. Conclusion: The results of the present study suggest that QULEL with shoulder and hip abduction is more effective to selectively strengthen LMF on the side, where the lower extremity is lifted. Loading weight onto both the lifted upper and lower extremities during QULEL is disadvantageous as a selective LMF training method because the LMF/LES activity ratio is low.	[Masaki, Mitsuhiro; Tateuchi, Hiroshige; Ibuki, Satoko; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy Human Hlth Sci, Kyoto, Japan; [Tsukagoshi, Rui] Hyogo Univ Hlth Sci, Fac Rehabil, Dept Phys Therapy, Kobe, Hyogo, Japan	Masaki, M (reprint author), 53 Kawahara Cho, Kyoto 6068507, Japan.	masaki.mitsuhiro.27w@st.kyoto-u.ac.jp					Smith M, 2009, PHYS THER SPORT, V10, P45, DOI 10.1016/j.ptsp.2008.12.002; Hides JA, 1996, SPINE, V21, P2763, DOI 10.1097/00007632-199612010-00011; PANJABI MM, 1992, J SPINAL DISORD, V5, P383; COOPER RG, 1992, BRIT J RHEUMATOL, V31, P389; Ekstrom RA, 2007, J ORTHOP SPORT PHYS, V37, P754, DOI 10.2519/jospt.2007.2471; Barker KL, 2004, SPINE, V29, pE515, DOI 10.1097/01.brs.0000144405.11661.eb; PANJABI MM, 1992, J SPINAL DISORD, V5, P390; MacDonald D, 2010, SPINE, V35, P818, DOI 10.1097/BRS.0b013e3181bc98f1; Arokoski JPA, 1999, ARCH PHYS MED REHAB, V80, P842, DOI 10.1016/S0003-9993(99)90237-X; Hides J, 2008, J ORTHOP SPORT PHYS, V38, P101, DOI 10.2519/jospt.2008.2658; Hodges P, 2006, SPINE, V31, P2926, DOI 10.1097/01.brs.0000248453.51165.0b; Keller A, 2004, SPINE, V29, P3, DOI 10.1097/01.BRS.0000103946.26548.EB; Arokoski JP, 2001, ARCH PHYS MED REHAB, V82, P1089, DOI 10.1053/apmr.2001.23819; Drake JDM, 2006, J MANIP PHYSIOL THER, V29, P354, DOI 10.1016/j.jmpt.2006.04.011; Granata KP, 2000, SPINE, V25, P1398, DOI 10.1097/00007632-200006010-00012; Ng JKF, 2002, J ORTHOPAED RES, V20, P112, DOI 10.1016/S0736-0266(01)00067-5; Cools AM, 2007, AM J SPORT MED, V35, P1744, DOI 10.1177/0363546507303560; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; Danneels LA, 2000, EUR SPINE J, V9, P266, DOI 10.1007/s005860000190; Mengiardi B, 2006, RADIOLOGY, V240, P786, DOI 10.1148/radiol.2403050820; Jang JH, 2014, J PHYS THER SCI, V26, P135, DOI 10.1589/jpts.26.135; DEFOA JL, 1989, J ANAT, V163, P243; Ekstrom RA, 2008, J ORTHOP SPORT PHYS, V38, P736, DOI 10.2519/jospt.2008.2865; Kjaer P, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-2; Lin YH, 2001, SPINE, V26, P2362, DOI 10.1097/00007632-200111010-00013; Pirouzi Soraya, 2006, Spine (Phila Pa 1976), V31, pE999, DOI 10.1097/01.brs.0000250076.74366.9d; Tarnanen SP, 2008, ARCH PHYS MED REHAB, V89, P513, DOI 10.1016/j.apmr.2007.08.160; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; Vezina MJ, 2000, ARCH PHYS MED REHAB, V81, P1370, DOI 10.1053/apmr.2000.16349; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	FEB	2015	38	2					138	144		10.1016/j.jmpt.2014.07.008		7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	CB8XI	WOS:000349915200006		
J	Ogaya, S; Naito, H; Okita, Y; Iwata, A; Higuchi, Y; Fuchioka, S; Tanaka, M				Ogaya, S.; Naito, H.; Okita, Y.; Iwata, A.; Higuchi, Y.; Fuchioka, S.; Tanaka, M.			CONTRIBUTION OF MUSCLE TENSION FORCE TO MEDIAL KNEE CONTACT FORCE AT FAST WALKING SPEED	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Musculoskeletal simulation; fast walking; medial knee contact force	ADDUCTION MOMENT; LOWER-EXTREMITY; RECTUS FEMORIS; HUMAN MOVEMENT; GAIT; JOINT; OSTEOARTHRITIS; HIP; PREDICTION; STRATEGIES	Fast walking is considered as a factor that causes pain in patients suffering from knee disorders. This study examined the effect of walking speed on the medial knee contact force and identified contributions to the muscle tension on the medial knee contact force during fast walking using musculoskeletal simulation analysis. The muscle contribution to the medial knee contact force was calculated based on the joint angles and ground reaction force for the normal and fast walking experiments of seven subjects. The muscle force and joint reaction force were used to estimate the medial knee contact force. Results showed, in average, 70% increase in medial knee contact force at the first peak and 34% increase at the second peak with a fast walking speed, compared to when they walked at a normal walking speed. The remarkable increase in the first peak was mainly contributed by the increase in the quadriceps force resisting the external knee flexion moment. In contrast, the moderate increase of second peak was contributed by the increase in the gastrocnemius muscle force. These results suggest that the increase in medial knee contact force at fast walking speeds is caused by the increased muscle force.	[Ogaya, S.; Iwata, A.; Higuchi, Y.; Fuchioka, S.] Osaka Prefecture Univ, Dept Comprehens Rehabil, Div Phys Therapy, Osaka 5838555, Japan; [Ogaya, S.; Naito, H.; Tanaka, M.] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Div Bioengn, Osaka 5608531, Japan; [Okita, Y.] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan	Ogaya, S (reprint author), Osaka Prefecture Univ, Dept Comprehens Rehabil, Div Phys Therapy, Osaka 5838555, Japan.	ogaya@rehab.osakafu-u.ac.jp		Okita, Yusuke/0000-0003-0734-188X			Ae M, 1992, BIOMECHANISMS, V11, P23; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Sritharan P, 2012, J ORTHOP RES, V30, P1586, DOI 10.1002/jor.22082; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Saraswat P, 2010, J BIOMECH, V43, P1645, DOI 10.1016/j.jbiomech.2010.03.005; Henriksen M, 2006, KNEE, V13, P445, DOI 10.1016/j.knee.2006.08.005; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Nene A, 2004, GAIT POSTURE, V20, P1, DOI 10.1016/S0966-6362(03)00074-2; Kito N, 2010, CLIN BIOMECH, V25, P914, DOI 10.1016/j.clinbiomech.2010.06.008; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Schmitt LC, 2007, ARTHRIT RHEUM-ARTHR, V57, P1018, DOI 10.1002/art.22889; Mundermann A, 2004, ARTHRITIS RHEUM, V50, P1172, DOI 10.1002/art.20132; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Lin YC, 2010, J BIOMECH, V43, P945, DOI 10.1016/j.jbiomech.2009.10.048; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379; Kutzner I, 2011, J ORTHOP RES, V29, P1910, DOI 10.1002/jor.21477; Zeni JA, 2009, CLIN BIOMECH, V24, P372, DOI 10.1016/j.clinbiomech.2009.02.001; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; Correa TA, 2010, J BIOMECH, V43, P1618, DOI 10.1016/j.jbiomech.2010.02.008; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; LEDINGHAM J, 1993, ANN RHEUM DIS, V52, P520, DOI 10.1136/ard.52.7.520; Kim HJ, 2009, J ORTHOP RES, V27, P1326, DOI 10.1002/jor.20876; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Adouni M, 2012, J BIOMECH, V45, P2149, DOI 10.1016/j.jbiomech.2012.05.040; Simic M, 2011, ARTHRIT CARE RES, V63, P405, DOI 10.1002/acr.20380; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; De Groote F, 2009, COMPUT METHOD BIOMEC, V12, P563, DOI 10.1080/10255840902788587; Barr KM, 2010, GAIT POSTURE, V32, P363, DOI 10.1016/j.gaitpost.2010.06.010; BELL AL, 1990, J BIOMECH, V23, P617, DOI 10.1016/0021-9290(90)90054-7; Buchanan TS, 2004, J APPL BIOMECH, V20, P367; Cleather DJ, 2011, ANN BIOMED ENG, V39, P147, DOI 10.1007/s10439-010-0161-9; CORCOS DM, 1992, J ELECTROMYOGR KINES, V2, P59, DOI 10.1016/1050-6411(92)90017-D; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Kinney AL, 2013, J ORTHOP RES, V31, P434, DOI 10.1002/jor.22240; Ko SU, 2011, GAIT POSTURE, V33, P205, DOI 10.1016/j.gaitpost.2010.11.006; Kutzner I, 2011, J BIOMECH, V44, P1354, DOI 10.1016/j.jbiomech.2011.01.014; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006	49	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	FEB	2015	15	1							1550002	10.1142/S0219519415500025		13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CC0JX	WOS:000350022700003		
J	Yu, HL; Xie, L; Lv, C; Shao, W; Wang, Y; Wang, JW; Yu, WW				Yu, Hailong; Xie, Le; Lv, Chao; Shao, Wei; Wang, Yuan; Wang, Jinwu; Yu, Wenwei			A SYSTEM FOR UPPER LIMB REHABILITATION AND MOTOR FUNCTION EVALUATION	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Upper limb; stroke; rehabilitation; virtual reality	RANDOMIZED CONTROLLED-TRIAL; STROKE REHABILITATION; CONVENTIONAL THERAPY; ROBOT; IMPAIRMENT; EXOSKELETON; RECOVERY; BLIND	In the conventional upper-limb rehabilitation process, patients have to be relying on therapists to do the exercise and assessments. Using robotic rehabilitation devices, patients can practice independently and intensively with their upper paretic limb. In this study, we hypothesized that a multi-DOF passive mechanism coupled with multi-DOF 3D sensory feedback could provide: (1) safe and nature active exercise; (2) various combinations of degrees of freedom (DOF) for the training of different specific joints; (3) the possibility to realize ideal trajectory. In order to test the hypothesis, we designed a seven-DOF passive exoskeleton-based system for the upper extremity, integrated with virtual reality (VR) technology based 3D feedback. An experiment was done on six healthy subjects and three subjects with upper-limb impairment. All subjects did not experience any problems when handling the device during the intervention. Moreover, Fugl-Meyer Score of the upper extremity Assessment (FMA) scale showed that the three patients have increased the score by 19, 23 and 14, respectively. Wolf Motor Function Test (WMFT) scale showed that the three patients have increased their scores by 22, 22 and 14, respectively.	[Yu, Hailong; Xie, Le; Lv, Chao; Shao, Wei; Wang, Yuan] Shanghai Jiao Tong Univ, Natl Digital Mfg Technol Ctr, Shanghai 200030, Peoples R China; [Xie, Le] Shanghai Jiao Tong Univ, Inst Rehabil Engn, Shanghai 200030, Peoples R China; [Wang, Jinwu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Yu, Wenwei] Chiba Univ, Dept Med Syst Engn, Chiba, Japan	Xie, L (reprint author), Shanghai Jiao Tong Univ, Natl Digital Mfg Technol Ctr, Shanghai 200030, Peoples R China.	lexie@sjtu.edu.cn			national science & technology pillar program of China [2009BAI71B06]; Major program of national natural science foundation project of China [61190124, 61190120]; National nature science foundation of China [60873131]; national high technology research and development program of China [2006AA01Z310, 2009AA01Z313]	The work described in this paper was supported by key projects from the national science & technology pillar program of China (2009BAI71B06), Major program of national natural science foundation project of China (61190124, 61190120), National nature science foundation of China (60873131) and the project from national high technology research and development program of China (2006AA01Z310, 2009AA01Z313). We thank the participants and the therapists who assisted with the recruitment.	Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Carey LM, 2005, STROKE, V36, P625, DOI 10.1161/01.STR.0000155720.47711.83; Klein J, 2010, IEEE T ROBOT, V26, P710, DOI 10.1109/TRO.2010.2052170; Lo HS, 2012, MED ENG PHYS, V34, P261, DOI 10.1016/j.medengphy.2011.10.004; Rosati G, 2007, IEEE T NEUR SYS REH, V15, P560, DOI 10.1109/TNSRE.2007.908560; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Krebs HI, 2008, NEUROREHABILITATION, V23, P81; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91; Colombo R, 2005, IEEE T NEUR SYS REH, V13, P311, DOI 10.1109/TNSRE.2005.848352; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Kiguchi K, 2008, ROBOT AUTON SYST, V56, P678, DOI 10.1016/j.robot.2007.11.007; Loureiro R, 2003, AUTON ROBOT, V15, P35, DOI 10.1023/A:1024436732030; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Reinkensmeyer DJ, 2000, J REHABIL RES DEV, V37, P653; Sanchez RJ, 2006, IEEE T NEUR SYS REH, V14, P378, DOI 10.1109/TNSRE.2006.881553; Platz T, 2003, NERVENARZT, V74, P841, DOI 10.1007/s00115-003-1549-7; Arjunan SP, 2011, J MECH MED BIOL, V11, P581, DOI 10.1142/S0219519411003867; Baheux Kenji, 2005, Technol Health Care, V13, P245; Carignan C, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3697, DOI 10.1109/IROS.2009.5354834; Davis JZ, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/D91V-2NEY-6FL5-26Y2; Eschweiler J, 2014, J NEUROENG REHABIL, V11, P3; Krebs H., 2004, J NEUROENG REHABIL, V1, P5, DOI DOI 10.1186/1743-0003-1-5; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Muntner P, 2002, STROKE, V33, P1209, DOI 10.1161/01.STR.0000015031.57955.D1; Parasuraman S, 2011, J MECH MED BIOL, V11, P691, DOI 10.1142/S0219519411004368; Platz T, 2009, NEUROREHAB NEURAL RE, V23, P706, DOI 10.1177/1545968309335974; Ren Y, 2009, 2009 IEEE 11 INT C R, P761, DOI 10.1109/ICORR.2009.5209482; Schoone M, 2007, P IEEE 10 INT C REH, P477; Widjaja F, 2011, J MECH MED BIOL, V11, P1347, DOI 10.1142/S0219519411004344; Yu W, 2012, J MECH MED BIOL, V12	32	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	FEB	2015	15	1							1550010	10.1142/S0219519415500104		19	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CC0JX	WOS:000350022700011		
J	Zhao, N; Iramina, K				Zhao, Ning; Iramina, Keiji			A MATHEMATICAL COUPLED MODEL OF OXYGEN TRANSPORT IN THE MICROCIRCULATION: THE EFFECT OF CONVECTION-DIFFUSION ON OXYGEN TRANSPORT	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Porous medium; microcirculation; oxygen transport; convection-diffusion; solid deformation; fluid seepage	MIXTURE THEORY; SOLUTE TRANSPORT; TISSUE; CAPILLARIES; FLUID; MICROVASCULATURE; METABOLISM; SIMULATION; PRESSURE; VESSELS	This paper is aimed at examining the effect of convection-diffusion on oxygen transport at the micro-level. A coupled model of the convection-diffusion and molecular diffusion of oxygen is developed, and the solid deformation resulting from capillary fluctuations and the seepage of tissue fluid are incorporated into this model. The results indicate that (1) the oxygen concentration calculated from this coupled model is higher than that given by molecular diffusion models, both within the capillaries and tissue (maximum difference of 16%); (2) convection-diffusion has the greatest effect in tissue surrounding the middle of the capillary, and enhances the amount of oxygen transported to cells far from the oxygen source; (3) larger permeability coefficients or smaller diffusion coefficients produce a more obvious convection-diffusion effect; (4) a counter-current flow occurs near the inlet and outlet ends of the capillary. This model also provides a foundation for the study of how oxygen affects tumor growth.	[Zhao, Ning] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 8190395, Japan; [Iramina, Keiji] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Dept Informat, Nishi Ku, Fukuoka 8190395, Japan	Zhao, N (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	zhaoning@bie.inf.kyushu-u.ac.jp					Chapman SJ, 2008, B MATH BIOL, V70, P2334, DOI 10.1007/s11538-008-9349-7; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Yao H, 2007, BIOMECH MODEL MECHAN, V6, P63, DOI 10.1007/s10237-006-0040-3; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pozrikidis C, 2003, ANN BIOMED ENG, V31, P181, DOI 10.1114/1.1540103; Pozrikidis C, 2010, J MATH BIOL, V60, P75, DOI 10.1007/s00285-009-0259-6; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457; Pittman RN, 2013, MICROCIRCULATION, V20, P117, DOI 10.1111/micc.12017; Bear J., 1988, DYNAMICS FLUIDS PORO; Caro CG, 2012, OXFORD MED PUBLICATI, P368; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Grinberg O, 2005, ADV EXP MED BIOL, V566, P127; Hall JE, 2010, GUYTON HALL TXB MED, P495; He Y, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412005101; Hellums JD, 1996, ANN BIOMED ENG, V24, P1; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044375; Mikelic A, 2006, NODEA-NONLINEAR DIFF, V13, P349, DOI 10.1007/s00030-006-4008-x; Morsi Y., 1999, J ARTIF ORGANS, V2, P163, DOI 10.1007/BF02480061; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Pittman RN, 2011, REGULATION TISSUE OX, P1; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Popel AS, 2003, ADV EXP MED BIOL, V530, P485; Salathe EP, 2003, J MATH BIOL, V46, P287, DOI 10.1007/s00285-002-0175-5; Schuff MM, 2013, J MATH BIOL, V66, P1179, DOI 10.1007/s00285-012-0528-7; Schuff MM, 2013, J MATH BIOL, V67, P1307, DOI 10.1007/s00285-012-0544-7; Sharma GC, 2004, COMPUT BIOL MED, V34, P633, DOI 10.1016/S0010-4825(03)00043-X; Skalak R, 1971, MECH MICROCIRCULATIO, P457; Titcombe MS, 2000, SIAM J APPL MATH, V60, P1767, DOI 10.1137/S0036139998343356; Wang P, 2010, ANN BIOMED ENG, V38, P2512, DOI 10.1007/s10439-010-0022-6; Yulianti K, 2012, ITB J SCI, V44, P164; Zhu Q, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/198145; ZWEIFACH BW, 1974, CIRC RES, V34, P858	36	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	FEB	2015	15	1							1550003	10.1142/S0219519415500037		26	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CC0JX	WOS:000350022700004		
J	Zhao, X; Liu, YJ; Ding, JL; Ren, XC; Bai, F; Zhang, MZ; Ma, LC; Wang, WX; Xie, JS; Qiao, AK				Zhao, Xi; Liu, Youjun; Ding, Jinli; Ren, Xiaochen; Bai, Fan; Zhang, Mingzi; Ma, Liancai; Wang, Wenxin; Xie, Jinsheng; Qiao, Aike			HEMODYNAMIC EFFECTS OF THE ANASTOMOSES IN THE MODIFIED BLALOCK-TAUSSIG SHUNT: A NUMERICAL STUDY USING A 0D/3D COUPLING METHOD	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						0D/3D coupling simulation; hemodynamics; modified BT shunts; anastomotic shape; computational fluid dynamics (CFD)	PULMONARY ARTERY SHUNTS; LEFT-HEART SYNDROME; FLOW-ANALYSIS; SIMULATIONS; CIRCULATION; VALIDATION	The modified Blalock-Taussig (BT) shunt is a palliative surgery which can help the tetralogy of Fallot (TOF) patient increase the blood oxygen saturation by interposing a systemic-to-pulmonary artery shunt. Two typical anastomotic shapes are frequently used in clinical practice: the end-to-side (ETS) and the side-to-side (STS) anastomosis. This paper examines the hemodynamic influence of the anastomotic shape in the modified BT shunt. Three models with different anastomotic shapes were reconstructed. The ETS anastomoses were applied in the first model. For the innominate artery (IA) and the pulmonary artery (PA) in the second model, the ETS and the STS anastomosis were applied, respectively. Finally, the STS anastomoses were applied in the third model. The 0D/3D coupling method was used to perform a numerical simulation by coupling the three-dimensional (3D) artery model with a zero-dimensional (0D) lumped parameter model for the cardiovascular system. The simulation results showed that the perfusion into the left and right PA in Model 1 was unbalanced. Swirling flow appeared in the shunt in Model 3, but the shunt flow rate in Model 3 was lower. The ETS anastomosis at the PA may cause unbalanced blood perfusion into the left and right PA. Conversely, the STS anastomosis can make the blood perfusion more balanced. Otherwise,the STS anastomosis at the IA could generate a swirling flow in the shunt which may provide a better hemodynamic environment while decreasing the pulmonary perfusion.	[Zhao, Xi; Liu, Youjun; Ren, Xiaochen; Bai, Fan; Ma, Liancai; Wang, Wenxin; Qiao, Aike] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China; [Ding, Jinli] Capital Med Univ, Dept Diagnost Radiol, Beijing You An Hosp, Beijing 100069, Peoples R China; [Zhang, Mingzi] Tohoku Univ, Inst Fluid Sci, Grad Sch Engn, Ohta Lab,Aoba Ku, Sendai, Miyagi 9808577, Japan; [Xie, Jinsheng] Capital Med Univ, Beijing An Zhen Hosp, Beijing 100029, Peoples R China	Liu, YJ (reprint author), Beijing Univ Technol, Coll Life Sci & Bioengn, 100 Pingleyuan, Beijing 100124, Peoples R China.	lyjlma@bjut.edu.cn			National Science Foundation of China [11172016, 11472022]; Natural Science Foundation of Beijing, China [KZ201210005006]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111103110012]	This research is supported by the National Science Foundation of China (11172016, 11472022), the Natural Science Foundation of Beijing, China (KZ201210005006), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20111103110012).	Anderson Robert H, 2005, Cardiol Young, V15 Suppl 1, P38, DOI 10.1017/S1047951105001010; Wong KKL, 2009, ANN BIOMED ENG, V37, P1495, DOI 10.1007/s10439-009-9709-y; Moghadam ME, 2013, J COMPUT PHYS, V244, P63, DOI 10.1016/j.jcp.2012.07.035; Kemp I, 2013, AUSTRALAS PHYS ENG S, V36, P363, DOI 10.1007/s13246-013-0213-1; Hsia TY, 2009, ANN THORAC SURG, V88, P830, DOI 10.1016/j.athoracsur.2009.05.051; Lagana K, 2005, J BIOMECH, V38, P1129, DOI 10.1016/j.jbiomech.2004.05.027; Zhan F, 2010, THROMB RES, V125, P413, DOI 10.1016/j.thromres.2009.02.011; BARNEA O, 1994, J AM COLL CARDIOL, V24, P1376; Fenton KN, 2003, ANN THORAC SURG, V76, P152, DOI 10.1016/S0003-4975(03)00168-1; Davies PF, 2011, ANTIOXID REDOX SIGN, V15, P1427, DOI 10.1089/ars.2010.3741; Ding ZF, 2010, EXP BIOL MED, V235, P506, DOI 10.1258/ebm.2009.009245; Stergiopulos N, 1996, AM J PHYSIOL-HEART C, V270, pH2050; Blagojevic M, 2014, VOJNOSANIT PREGL, V71, P285, DOI 10.2298/VSP1403285B; Bove EL, 2008, J THORAC CARDIOV SUR, V136, P312, DOI 10.1016/j.jtcvs.2007.04.078; Chandra S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024275; D'Ancona G, 2013, INTERACT CARDIOV TH, V17, P576, DOI 10.1093/icvts/ivt245; Ding J, 2013, J MED BIOMECH, V28, P1; Ding JL, 2013, INT J NUMER METH BIO, V29, P351, DOI 10.1002/cnm.2508; Ding JL, 2013, J MECH MED BIOL, V13; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02091; Jonas Richard A, 2009, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P39, DOI 10.1053/j.pcsu.2009.01.021; Mair R, 2003, J THORAC CARDIOV SUR, V126, P1378, DOI 10.1016/S0022-5223(03)00389-1; Migliavacca F, 2000, J BIOMECH, V33, P549, DOI 10.1016/S0021-9290(99)00219-5; Pennati G, 2001, J BIOMECH, V34, P23, DOI 10.1016/S0021-9290(00)00167-6; Sachweh J, 1998, EUR J CARDIO-THORAC, V14, P229, DOI 10.1016/S1010-7940(98)00185-7; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004747; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005688; Wong KKL, 2013, COMPUT MATH METHOD M, V2013; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Yuan SM, 2009, J CARDIAC SURG, V24, P101, DOI 10.1111/j.1540-8191.2008.00758.x; Zhan F, 2010, ASAIO J, V56, P172, DOI 10.1097/MAT.0b013e3181d0ea15	32	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	FEB	2015	15	1							1550017	10.1142/S0219519415500177		18	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CC0JX	WOS:000350022700018		
J	Ueshima, E; Yusa, Y				Ueshima, Eriko; Yusa, Yoichi			Antipredator behaviour in response to single or combined predator cues in the apple snail Pomacea canaliculata	JOURNAL OF MOLLUSCAN STUDIES			English	Article							FRESH-WATER SNAIL; MULTIPLE PREDATORS; ALARM RESPONSE; BODY-SIZE; LYMNAEA-STAGNALIS; SHELL MORPHOLOGY; AVOIDANCE; PREY; AMPULLARIIDAE; RECOGNITION	The documentation of antipredator behaviour associated with different risk levels (threat-sensitive predator avoidance), different predators (predator-specific avoidance) or combined predators (multiple predator avoidance) in freshwater caenogastropods is limited. We studied the antipredator behaviour of predator-naive hatchlings of the invasive apple snail Pomacea canaliculata to chemical cues from the common carp (Cyprinus carpio), Reeve's turtle (Mauremys reevesii) and crushed conspecifics in three laboratory experiments. First, we tested the snails' responses of crawling out of the water and self-burial in the sand to odour from a single nonfeeding predator or crushed conspecifics. A greater proportion of snails responded to odour from crushed conspecifics than to turtle or carp odours. Second, we studied the snails' responses to cues simulating a single feeding predator. When combined with cues from crushed conspecifics, snails tended to bury themselves in the sand in response to the turtle odour whereas they tended to crawl above the waterline in response to the carp odour. Third, we compared the snails' responses to single or combined predator cues. In the presence of cues from crushed conspecifics, the snails' responses to the combined odours from turtle and carp were more similar to the responses associated with the carp odour than to those associated with the turtle odour. Overall, these experiments indicate that P. canaliculata hatchlings show fine-tuned innate antipredator behaviour.	[Ueshima, Eriko; Yusa, Yoichi] Nara Womens Univ, Fac Sci, Nara 6308506, Japan	Yusa, Y (reprint author), Nara Womens Univ, Fac Sci, Nara 6308506, Japan.	yusa@cc.nara-wu.ac.jp					Aizaki K, 2009, J ETHOL, V27, P175, DOI 10.1007/s10164-008-0103-2; Aizaki K, 2010, MALACOLOGIA, V52, P21, DOI 10.4002/040.052.0102; ALEXANDER JE, 1991, OECOLOGIA, V87, P435, DOI 10.1007/BF00634603; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Kats LB, 1998, ECOSCIENCE, V5, P361; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Covich AP, 2010, HYDROBIOLOGIA, V653, P191, DOI 10.1007/s10750-010-0354-0; Turner AM, 2006, ANIM BEHAV, V72, P1443, DOI 10.1016/j.anbehav.2006.05.010; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; Bernot RJ, 2001, OECOLOGIA, V129, P139, DOI 10.1007/s004420100705; Turner AM, 2008, ANIM BEHAV, V76, P1211, DOI 10.1016/j.anbehav.2008.06.005; Turner AM, 1999, OECOLOGIA, V118, P242, DOI 10.1007/s004420050724; Chivers DP, 1998, ECOSCIENCE, V5, P338; Yamanishi Y, 2012, BIOL INVASIONS, V14, P1343, DOI 10.1007/s10530-011-0158-9; Yusa Y, 2006, BIOL INVASIONS, V8, P137, DOI 10.1007/s10530-004-1790-4; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; Carlsson N, 2004, FRESHWATER BIOL, V49, P1269, DOI 10.1111/j.1365-2427.2004.01269.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Dalesman S, 2006, ANIM BEHAV, V71, P789, DOI 10.1016/j.anbehav.2005.05.028; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Dreon MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015059; Grafen A, 2002, MODERN STAT LIFE SCI; Hara A, 2015, BIOL INVASIONS, V17, P63, DOI 10.1007/s10530-014-0703-4; Harvell C. D., 1999, ECOLOGY EVOLUTION IN; Hazlett BA, 2007, BEHAVIOUR, V144, P847, DOI 10.1163/156853907781476409; Hoverman JT, 2007, OECOLOGIA, V154, P551, DOI 10.1007/s00442-007-0847-3; Ichinose K, 2003, ECOL RES, V18, P213, DOI 10.1046/j.1440-1703.2003.00548.x; Ichinose K, 2002, J CHEM ECOL, V28, P2017, DOI 10.1023/A:1020749911877; Joshi R. C., 2006, GLOBAL ADV ECOLOGY M; Lakowitz T, 2008, FRESHWATER BIOL, V53, P2184, DOI 10.1111/j.1365-2427.2008.02045.x; McCarthy TM, 2000, FRESHWATER BIOL, V44, P387, DOI 10.1046/j.1365-2427.2000.00576.x; McGINNIS S.M, 2006, FIELD GUIDE FRESHWAT; Ojima Hisae, 2013, Plankton & Benthos Research, V8, P38; Rochette R, 1998, ECOSCIENCE, V5, P353; SNYDER NFR, 1971, BEHAVIOUR, V40, P175, DOI 10.1163/156853971X00384; Turner AM, 2000, OIKOS, V88, P148, DOI 10.1034/j.1600-0706.2000.880117.x; Xu WB, 2014, J MOLLUS STUD, V80, P117, DOI 10.1093/mollus/eyt054; Yoshie H, 2011, FRESHWATER BIOL, V56, P302, DOI 10.1111/j.1365-2427.2010.02497.x; Yoshie H, 2008, APPL ENTOMOL ZOOL, V43, P475, DOI 10.1303/aez.2008.475; Yusa Yoichi, 2006, P345	41	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0260-1230	1464-3766		J MOLLUS STUD	J. Molluscan Stud.	FEB	2015	81		1				51	57		10.1093/mollus/eyu057		7	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CC0VE	WOS:000350054900005		
J	Azuma, N; Miranda, RM; Goshima, S; Abe, S				Azuma, Noriko; Miranda, Richard M.; Goshima, Seiji; Abe, Syuiti			Phylogeography of Neptune whelk (Neptunea arthritica) suggests sex-biased impact of tributyltin pollution and overfishing around northern Japan	JOURNAL OF MOLLUSCAN STUDIES			English	Article							MITOCHONDRIAL-DNA; GASTROPODA BUCCINIDAE; POPULATION-STRUCTURE; IMPOSEX; SIZE; PHYLOGENIES; SEQUENCES; HOKKAIDO; MOLLUSCA; WATERS	The Neptune whelk, Neptunea arthritica, is a sublittoral snail from Pacific waters that is a food resource and supports a commercially important fishery in northern Japan. This species showed a severe decline during the 1970s and 1980s, possibly because of overfishing, imposex caused by tributyltin (TBT) pollution and parasite infection. In the present study, we investigated genetic variation among the populations of N. arthritica from eight localities in northern Japan, including Hokkaido and Aomori, using a mitochondrial DNA (mtDNA) marker, a partial sequence of the cytochrome c oxidase subunit I (COI) gene. We also addressed the evolutionary history of N. arthritica and human impact on the population genetic profiles of this species. The parsimony network showed 14 COI haplotypes separated into two groups (Groups A and B), with an intermediate haplotype connecting both groups. Among eight populations, six were fixed for only one or two haplotypes, and no geographic-genetic correlation was found; they were probably affected by random drift. These results contrasted with those from previous microsatellite analysis, which indicated that geographic structure was the result of restricted gene flow between populations. Our results suggested that N. arthritica diverged into Groups A and B during the Pliocene; however, recent TBT pollution and size-selective fishing pressure have reduced genetic diversity and concealed the natural population structure. The present study also suggested that human impact may cause longstanding and possibly irreversible modification of ecosystems, particularly for species forming discrete and relatively small local populations, such as N. arthritica. Thus, the combined use of mtDNA and microsatellite genetic data provides a powerful tool to investigate the health of biodiversity in molluscs.	[Azuma, Noriko; Goshima, Seiji] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Miranda, Richard M.] Univ Austral Chile, Sede Puerto Montt, Region De Los L, Chile; [Abe, Syuiti] Iwate Univ, Dept Revitalizat Sanriku Reg, Sanriku Fisheries Res Ctr, Kamaishi, Iwate 0260001, Japan	Azuma, N (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	nazu@fish.hokudai.ac.jp			MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku	This work was partly supported by MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku. The authors thank Enago (www.enago.jp) and editor David Reid for the English language review.	Amano Kazutaka, 1997, Paleontological Research, V1, P274; Amano Kazutaka, 2007, Fossils (Tokyo), P6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.2307/2410325; Bigatti G, 2009, MAR POLLUT BULL, V58, P695, DOI 10.1016/j.marpolbul.2009.01.001; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; CHINZEI K, 1978, VELIGER, V21, P155; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Kendall NW, 2013, OIKOS, V122, P411, DOI 10.1111/j.1600-0706.2012.20319.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Wright S, 1943, GENETICS, V28, P114; Avise JC., 2000, PHYLOGEOGRAPHY HIST; Azuma Noriko, 2011, Plankton & Benthos Research, V6, P42; Blackmore G, 2000, J MOLLUS STUD, V66, P1, DOI 10.1093/mollus/66.1.1; COLSON L., 2004, MOL ECOL, V13, P2223; EXCOFFIER L, 1992, GENETICS, V131, P479; Freeland J., 2005, MOL ECOLOGY; Fujinaga Katsuaki, 2003, Memoirs of the Graduate School of Fisheries Sciences Hokkaido University, V50, P1; FUJINAGA K., 1996, JAPANESE J ECOLOGY, V44, P331; Fujinaga K, 2006, FISHERIES SCI, V72, P995, DOI 10.1111/j.1444-2906.2006.01248.x; Gibbs PE, 1996, J MOLLUS STUD, V62, P403, DOI 10.1093/mollus/62.4.403; Hou L, 2013, CHINESE SCI BULL, V58, P2315, DOI 10.1007/s11434-013-5922-z; HUGHES R.N., 1986, FUNCTIONAL BIOL MARI; Ilano AS, 2003, J MAR BIOL ASSOC UK, V83, P1287, DOI 10.1017/S0025315403008683; KASHIMA K., 1996, LAGUNA, V3, P33; Kawai Kei, 1994, Venus the Japanese Journal of Malacology, V53, P105; Koizumi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033986; Lombardo RC, 2010, J MOLLUS STUD, V76, P317, DOI 10.1093/mollus/eyq015; Miranda RM, 2009, MAR BIOL RES, V5, P268, DOI 10.1080/17451000802419422; MIRANDA R.M., 2007, AQUACULTURE SCI, V55, P9; Miranda RM, 2008, MAR BIOL RES, V4, P224, DOI 10.1080/17451000701881706; MIZUSHIMA T., 2003, FISHERIES AQUATIC LI; Nakano Tomoyuki, 2010, Venus (Tokyo), V68, P121; OKUTANI T., 2000, MARINE MOLLUSCS JAPA; OTUKA Y, 1939, J GEOLOGICAL SOC JAP, V44, P23; Pavoni B, 2007, MAR POLLUT BULL, V55, P505, DOI 10.1016/j.marpolbul.2007.09.012; Power AJ, 2001, J MAR BIOL ASSOC UK, V81, P243; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWE R., 2003, TRENDS ECOL EVOL, V18, P567; Suzuki K, 2002, FISHERIES SCI, V68, P87, DOI 10.1046/j.1444-2906.2002.00393.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; WoRMS Editorial Board, 2014, WORLD REGISTER MARIN	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0260-1230	1464-3766		J MOLLUS STUD	J. Molluscan Stud.	FEB	2015	81		1				131	138		10.1093/mollus/eyu068		8	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CC0VE	WOS:000350054900012		
J	Iwata, Y; Sakurai, Y; Shaw, P				Iwata, Yoko; Sakurai, Yasunori; Shaw, Paul			Dimorphic sperm-transfer strategies and alternative mating tactics in loliginid squid	JOURNAL OF MOLLUSCAN STUDIES			English	Article							SPERMATOPHORIC REACTION; MOLLUSCA CEPHALOPODA; REPRODUCTIVE-SYSTEM; COMPETITION GAMES; AFRICAN WATERS; IMPLANTATION; OCTOPOTEUTHIDAE; BEHAVIORS; BLEEKERI; BEETLES	Animal species usually have a single sperm-storage site in the female body, but females of the squid Heterololigo bleekeri possess two distinct sperm-storage sites simultaneously. Use of two sperm-storage sites correlates with alternative male mating behaviours: large consorts guard females and place spermatophores inside the oviduct just before spawning, whereas small 'sneaker' males place spermatophores on the membrane around the female's mouth within the arm crown, where a seminal receptacle is present. Previous work showed that spermatophore and sperm morphology diverge between consort and sneaker males. Here we show novel dichotomous adaptations in the sperm-transfer strategy of males of this squid, associated with the use of two distinct sperm-storage sites on females. The spermatangia ejaculated from spermatophores were clearly dimorphic: all spermatangia ejaculated from spermatophores smaller than 12 mm from small sneaker males were drop-shaped, whereas all spermatangia from spermatophores longer than 12 mm from larger consort males were rope-shaped. In addition, the dropshaped spermatangia were distinct in having a spine on their base, which might reduce the risk of it being shed from the female's body surface. Our findings suggest that existence of alternative spermstorage sites, and related biological and environmental factors, lead to the evolution of divergent spermtransfer strategies.	[Iwata, Yoko] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Sakurai, Yasunori] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Shaw, Paul] Aberystwyth Univ, IBERS, Aberystwyth SY23 3DA, Dyfed, Wales	Iwata, Y (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan.	iwayou@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [18789001]; European Commission [PIIF-GA-2008-220611]; Japan Society for the Promotion of Science	We thank A. Gange, V. Jansen, A. Takahashi, Y. Watanuki and R. Yanagimachi for comments and K. Ito for collecting samples. We greatly appreciate two anonymous reviewers and Associate Editor J. Voight helped to improve the manuscript. This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18789001), the European Commission (PIIF-GA-2008-220611) and the Japan Society for the Promotion of Science Fellowship to YI.	EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Marian JEAR, 2012, J MORPHOL, V273, P248, DOI 10.1002/jmor.11020; Pearson GA, 1998, ECOLOGY, V79, P1725; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Simmons LW, 1999, P ROY SOC B-BIOL SCI, V266, P145; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; Kotiaho JS, 2001, BEHAV ECOL, V12, P553, DOI 10.1093/beheco/12.5.553; Bolstad K.S.R., 2011, Marine Biodiversity Records, V4, DOI 10.1017/S175526721000120X; BORNDT M.-L., 2002, MARINE ECOLOGY PROGR, V226, P273; Drew GA, 1919, J MORPHOL, V32, P379, DOI 10.1002/jmor.1050320205; Hanlon RT, 1996, CEPHALOPOD BEHAV; Hirohashi Noritaka, 2013, Communicative & Integrative Biology, V6, pe26729, DOI 10.4161/cib.26729; Hirohashi N, 2013, CURR BIOL, V23, P775, DOI 10.1016/j.cub.2013.03.040; Hoving HJT, 2007, BIOL BULL-US, V212, P177; Hoving HJT, 2010, MAR BIOL, V157, P393, DOI 10.1007/s00227-009-1326-7; Hoving HJT, 2009, J EXP MAR BIOL ECOL, V372, P75, DOI 10.1016/j.jembe.2009.02.008; Hoving HJT, 2004, J ZOOL, V264, P153, DOI 10.1017/S0952836904005710; Hoving HJT, 2008, AFR J MAR SCI, V30, P603, DOI 10.2989/AJMS.2008.30.3.13.647; Iwata Y, 2007, MAR ECOL PROG SER, V345, P141, DOI 10.3354/meps06971; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Levitan D. R., 1998, SPERM COMPETITION SE, P175, DOI 10.1016/B978-012100543-6/50031-3; MANN T, 1966, NATURE, V211, P1279, DOI 10.1038/2111279a0; Marian JEAR, 2012, ZOOMORPHOLOGY, V131, P293, DOI 10.1007/s00435-012-0165-0; Marian JEAR, 2012, BIOL J LINN SOC, V105, P711, DOI 10.1111/j.1095-8312.2011.01832.x; Marian JEAR, 2011, J MOLLUS STUD, V77, P98, DOI 10.1093/mollus/eyq038; Naud MJ, 2006, MAR BIOL, V148, P559, DOI 10.1007/s00227-005-0109-z; Sato N, 2010, J ZOOL, V282, P151, DOI 10.1111/j.1469-7998.2010.00733.x; TAKAHAMA H, 1991, J MORPHOL, V207, P241, DOI 10.1002/jmor.1052070303	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0260-1230	1464-3766		J MOLLUS STUD	J. Molluscan Stud.	FEB	2015	81		1				147	151		10.1093/mollus/eyu072		5	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CC0VE	WOS:000350054900014		
J	Goto, T; Nagao, K; Ishida, Y; Tomotake, Y; Ichikawa, T				Goto, Takaharu; Nagao, Kan; Ishida, Yuichi; Tomotake, Yoritoki; Ichikawa, Tetsuo			Influence of Matrix Attachment Installation Load on Movement and Resultant Forces in Implant Overdentures	JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY			English	Article						Implant overdenture; attachment; installation load; denture movement	PATIENT SATISFACTION; IN-VITRO; CLINICAL-TRIAL; MANDIBULAR OVERDENTURES; PROSTHETIC ASPECTS; BAR ATTACHMENTS; BALL; COMPLICATIONS; MAGNET	PurposeThis in vitro study investigated the effect of attachment installation conditions on the load transfer and denture movements of implant overdentures, and aims to clarify the differences among the three types of attachments, namely ball, Locator, and magnet attachments. Materials and MethodsThree types of attachments, namely ball, Locator, and magnetic attachments were used. An acrylic resin mandibular edentulous model with two implants placed in the bilateral canine regions and removable overdenture were prepared. The two implants and bilateral molar ridges were connected to three-axis load-cell transducers, and a universal testing machine was used to apply a 50 N vertical force to each site of the occlusal table in the first molar region. The denture movement was measured using a G(2) motion sensor. Three installation conditions, namely, the application of 0, 50, and 100 N loads were used to install each attachment on the denture base. The load transfer and denture movement were then evaluated. ResultsThe resultant force decreased with increasing installation load for all attachments. In particular, the resultant force on implants on the loading side of the Locator attachment significantly decreased when the installation load was increased from 0 to 50 N, and that for magnetic attachment significantly decreased when the installation load was increased from 50 to 100 N. For the residual ridges on the loading side, the direction of the forces for all attachments changed to downward with increasing installation load. Furthermore, the yaw Euler angle increased with increasing installation load for the magnetic attachment. ConclusionsSubject to the limitations of this study, the use of any installation load greater than 0 N is recommended for the installation of ball and Locator attachments on a denture base. Regarding magnetic attachments, our results also recommend installation on a denture base using any installation load greater than 0 N, and suggest that the resultant force acting on the implant can be decreased by increasing the installation load; however, a large installation load of 100 N should be avoided when installing the attachment on the denture base to avoid increasing the denture movement.	[Goto, Takaharu; Nagao, Kan; Ishida, Yuichi; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Hlth Biosci, Dept Oral Maxillofacial Prosthodont & Oral Implan, Tokushima 7708504, Japan	Goto, T (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Oral Maxillofacial Prosthodont & Oral Implan, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	tak510@tokushima-u.ac.jp					Maeda Y, 2008, CLIN ORAL IMPLAN RES, V19, P271, DOI 10.1111/j.1600-0501.2007.01425.x; MacEntee MI, 2005, J PROSTHET DENT, V93, P28, DOI 10.1016/j.prosdent.2004.10.013; JACOBSON TE, 1983, J PROSTHET DENT, V49, P306, DOI 10.1016/0022-3913(83)90267-6; Tokuhisa M, 2003, INT J PROSTHODONT, V16, P128; Cune M, 2005, INT J PROSTHODONT, V18, P99; Evtimovska E, 2009, J PROSTHODONT, V18, P479, DOI 10.1111/j.1532-849X.2009.00474.x; DEBOEVER JA, 1978, J PROSTHET DENT, V40, P326, DOI 10.1016/0022-3913(78)90042-2; Goodacre CJ, 2003, J PROSTHET DENT, V90, P121, DOI 10.1016/S0022-3913(03)00212-9; Alsabeeha NHM, 2009, INT J PROSTHODONT, V22, P429; Heckmann SM, 2001, CLIN ORAL IMPLAN RES, V12, P640, DOI 10.1034/j.1600-0501.2001.120613.x; Naert I, 2004, INT J PROSTHODONT, V17, P401; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; FIELDS HW, 1986, J DENT RES, V65, P135, DOI 10.1177/00220345860650020901; Andreiotelli M, 2010, INT J PROSTHODONT, V23, P195; Burns D R, 2000, J Prosthodont, V9, P37, DOI 10.1111/j.1532-849X.2000.00037.x; Chikunov Igor, 2008, J Prosthodont, V17, P141, DOI 10.1111/j.1532-849X.2007.00261.x; Chung Kwok-Hung, 2004, J Prosthodont, V13, P221; Feine J S, 2002, Int J Prosthodont, V15, P413; Gonda T, 2004, J ORAL REHABIL, V31, P1001, DOI 10.1111/j.1365-2842.2004.01324.x; Ichikawa T, 1996, INT J PROSTHODONT, V9, P394; Kaires AK, 1958, J PROSTHET DENT, V8, P340, DOI 10.1016/0022-3913(58)90167-7; Kawano F, 1987, ANN JPN PROSTHODONT, V31, P726; MericskeStern R, 1996, CLIN ORAL IMPLAN RES, V7, P387, DOI 10.1034/j.1600-0501.1996.070413.x; Mericske-Stern R, 1998, INT J ORAL MAX IMPL, V13, P36; Naert I, 1999, J ORAL REHABIL, V26, P195, DOI 10.1046/j.1365-2842.1999.00369.x; Naert I E, 1997, Clin Oral Investig, V1, P81, DOI 10.1007/s007840050016; vansKampen F, 2003, CLIN ORAL IMPLAN RES, V14, P720; Yoda N, 2008, PROSTHODONT RES PRAC, V7, P258, DOI 10.2186/prp.7.258	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-941X	1532-849X		J PROSTHODONT	J. Prosthodont.	FEB	2015	24	2					156	163		10.1111/jopr.12177		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CC2CI	WOS:000350152100010		
J	Kato, H; Izumiyama, M				Kato, Hiroyuki; Izumiyama, Masahiro			IMPAIRED MOTOR CONTROL DUE TO PROPRIOCEPTIVE SENSORY LOSS IN A PATIENT WITH CEREBRAL INFARCTION LOCALIZED TO THE POSTCENTRAL GYRUS	JOURNAL OF REHABILITATION MEDICINE			English	Article						proprioception; motor control; functional MRI; diffusion tensor imaging; stroke; rehabilitation	STROKE; MOVEMENTS; HAND	Objective: Most rehabilitative interventions following stroke emphasize the improvement of motor deficits but rarely address sensory function and sensorimotor control. We report here a case of cerebral infarction localized to the postcentral gyrus that presented with severe impairment of motor control due to profound proprioceptive sensory loss. We attempted to demonstrate the mechanism for the motor impairment using functional magnetic resonance imaging (fMRI). Case report: A 70-year-old woman developed abrupt loss of motor control of the right hand, concomitant with the loss of proprioception of the hand. An fMRI was conducted 12 days after stroke onset. Movement of the unaffected hand activated the normal sensorimotor network in the brain, including the contralateral primary sensorimotor cortex, supplementary motor areas, and ipsilateral cerebellum. However, movement of the affected hand activated only the contralateral primary motor cortex and activation of the cerebral sensorimotor network was severely depressed. Diffusion tensor tractography revealed that the corticospinal tracts were intact. Intensive rehabilitation and the use of visual support enabled the patient to live an independent life. Conclusion: Loss of motor control may occur even with a normal corticospinal tract when proprioception is severely impaired by dysfunction of the sensorimotor network in the brain.	[Kato, Hiroyuki] Int Univ Hlth & Welf Hosp, Dept Neurol, Nasushiobara 3292763, Japan; [Izumiyama, Masahiro] Sendai Nakae Hosp, Dept Neurol, Sendai, Miyagi, Japan	Kato, H (reprint author), Int Univ Hlth & Welf Hosp, Dept Neurol, 537-3 Iguchi, Nasushiobara 3292763, Japan.	katoh@iuhw.ac.jp			Japan Society for the Promotion of Science [25350615]	The authors would like to thank Mr Katsuhiro Aki at the MRI section of Sendai Nakae Hospital for his help in performing the fMRI studies, and Ms Saika Kanno (occupational therapist) and Ms Yuka Kohno (speech therapist) at the rehabilitation section of Sendai Nakae Hospital for their expert rehabilitative evaluations. This study was supported by Grant-in-Aid for Scientific Research (25350615), Japan Society for the Promotion of Science.	SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Kato H, 2002, STROKE, V33, P2032, DOI 10.1161/01.STR.0000021903.52901.97; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Laufer Y, 2011, NEUROREHAB NEURAL RE, V25, P799, DOI 10.1177/1545968310397205; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Hsu HY, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-26; JEANNEROD M, 1984, BRAIN, V107, P899, DOI 10.1093/brain/107.3.899; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; SHARP FR, 1994, ARCH NEUROL-CHICAGO, V51, P1103	10	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	FEB	2015	47	2					187	190		10.2340/16501977-1900		4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CC0DR	WOS:000350006500013		
J	Ideta, A; Aoyagi, Y; Tsuchiya, K; Nakamura, Y; Hayama, K; Shirasawa, A; Sakaguchi, K; Tominaga, N; Nishimiya, Y; Tsuda, S				Ideta, Atsushi; Aoyagi, Yoshito; Tsuchiya, Kanami; Nakamura, Yuuki; Hayama, Kou; Shirasawa, Atsushi; Sakaguchi, Kenichiro; Tominaga, Naomi; Nishimiya, Yoshiyuki; Tsuda, Sakae			Prolonging hypothermic storage (4 C) of bovine embryos with fish antifreeze protein	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Antifreeze protein; Bovine embryo; Nonfreezing preservation	NOTCHED-FIN EELPOUT; IN-VITRO; PRESERVATION; TEMPERATURE; CELLS; GLYCOPEPTIDES; ISOFORM; KNER; ICE	Embryos obtained via superovulation are necessary for mammalian artificial reproduction, and viability is a key determinant of success. Nonfreezing storage at 4 C is possible, but currently used storage solutions can maintain embryo viability for only 24-48 h. Here we found that 10 mg/ml antifreeze protein (AFP) dissolved in culture medium 199 with 20% (v/v) fetal bovine serum and 25 mM HEPES could keep bovine embryos alive for 10 days at 4 C. We used a recombinant AFP isolated from the notched-fin eelpout (Zoarces elongatus Kner). Photomicroscopy indicated that the AFP embryo interaction was enhanced at 37 C. Embryos pre-warmed with the APP solution at 37 C for 60 min maintained high viability, whereas those that were not pre-warmed could live no longer than 7 days. Thus, short-term storage of bovine embryos was achieved by a combination of APP-containing medium and controlled pre-warming.	[Ideta, Atsushi; Aoyagi, Yoshito; Tsuchiya, Kanami; Nakamura, Yuuki; Hayama, Kou; Shirasawa, Atsushi; Sakaguchi, Kenichiro; Tominaga, Naomi] Zennoh Embryo Transfer ET Ctr, Res & Dev Grp, Kamishihoro, Hokkaido 0801407, Japan; [Nishimiya, Yoshiyuki; Tsuda, Sakae] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Kamishihoro, Hokkaido 0628517, Japan	Ideta, A (reprint author), Zennoh Embryo Transfer ET Ctr, Res & Dev Grp, Kamishihoro, Hokkaido 0801407, Japan.	ideta-atsushi@zennoh.or.jp					WILMUT I, 1973, VET REC, V92, P686; Ideta A, 2007, CLONING STEM CELLS, V9, P571, DOI 10.1089/clo.2007.0017; Garnham CP, 2012, FEBS LETT, V586, P3876, DOI 10.1016/j.febslet.2012.09.017; [Anonymous], 2013, IATA DANG GOODS REG; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Davies PL, 2002, PHILOS T ROY SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; O'Neil L, 1998, CRYOBIOLOGY, V37, P59, DOI 10.1006/cryo.1998.2098; Arav A., 1993, Cryobiology, V30, P621; Baguisi A, 1997, THERIOGENOLOGY, V48, P1017, DOI 10.1016/S0093-691X(97)00328-2; Duncker BP, 1995, CRYOBIOLOGY, V32, P521, DOI 10.1006/cryo.1995.1054; Hirano Y, 2008, ANAL CHEM, V80, P9349, DOI 10.1021/ac8018334; Hirano Y, 2008, CRYOBIOLOGY, V57, P46, DOI 10.1016/j.cryobiol.2008.05.006; Ideta A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01173; Kamijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073643; Kumeta H, 2013, J BIOMOL NMR, V55, P225, DOI 10.1007/s10858-012-9703-9; Mugano JA, 1995, CRYOBIOLOGY, V32, P556; Nishigai M, 2003, J REPROD DEVELOP, V49, P23; Nishimiya Y, 2008, SYNTHESIOLOGY, V1, P7; Riley JM, 2009, BIOTECHNOL BIOENG, V103, P241, DOI 10.1002/bit.22274; Robertson I, 2010, MANUAL INT EMBRYO TR, VFourth, P86; RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N; RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7; RUBINSKY B, 1990, BIOCHEM BIOPH RES CO, V173, P1369, DOI 10.1016/S0006-291X(05)80939-8; Shah G, 1999, Dev Biol Stand, V99, P17	29	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					1	6				6	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800001		
J	Takahashi, N; Yamaguchi, E; Kawabata, Y; Kono, T				Takahashi, Nozomi; Yamaguchi, Eito; Kawabata, Yukiko; Kono, Tomohiro			Deleting maternal Gtl2 leads to growth enhancement and decreased expression of stem cell markers in teratoma	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Dlk1-Dio3 domain; Genomic imprinting; miRNA; Noncoding RNA; Teratoma	IMPRINTED NONCODING RNA; TUMOR-SUPPRESSOR; MOUSE; TARGETS; CLUSTER; CANCER; REGION; GENES; MEG3; DIFFERENTIATION	The distal region of mouse chromosome 12 harbors the Dlk1-Dio3 domain, is essential for normal development and encodes maternally expressed noncoding RNAs (ncRNAs), including Gtl2 as well as paternally expressed proteins. Gtl2 works as a tumor suppressor in several types of human cancer cell lines; however, whether this reflects its function in vivo is unknown. Deleting Gtl2 from the maternal allele (Gtl2((-/+))) results in loss of expression of Gtl2 and decreased expression of downstream ncRNAs, including many miRNAs. To determine the role of ncRNAs in tumorigenesis, we induced teratomas by engrafting E6.5 embryos (wildtype or Gtl2((-/+))) under the kidney capsule of scid mice. Some teratomas derived from the Gtl2((-/+)) embryos exhibited hypertrophic growth, suggesting that ncRNAs, including Gtl2, may act as tumor suppressors in vivo. Microarray analysis of miRNAs expressed by Gtl2((-/+)) teratomas revealed decreased expression of 28 miRNAs encoded by the Dlk1-Dio3 domain, low expression of embryonic stem cell-specific miRNAs and dysregulation of miRNAs involved in tumorigenesis. This study suggests that downregulation of ncRNAs in the Dlk1-Dio3 domain leads to enhanced teratoma growth and repression of stem cell markers.	[Takahashi, Nozomi; Yamaguchi, Eito; Kawabata, Yukiko; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo 1560054, Japan	Kono, T (reprint author), Tokyo Univ Agr, Dept Biosci, Tokyo 1560054, Japan.	tomohiro@nodai.ac.jp			Research Fellowships for Young Scientists of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank K Hata and K Nakabayashi (National Research Institute for Child Health and Development, Japan) for technical advice. This study was supported by Research Fellowships for Young Scientists of the Japan Society for the Promotion of Science to N.T. and Grants-in-Aid for Scientific Research on Priority Areas, and for Scientific Research A from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TK.	Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.04.043; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Li ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1681; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Schmidt JV, 2000, GENE DEV, V14, P1997; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108	28	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					7	12				6	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800002		
J	Honsho, K; Hirose, M; Hatori, M; Yasmin, L; Izu, H; Matoba, S; Togayachi, S; Miyoshi, H; Sankai, T; Ogura, A; Honda, A				Honsho, Kimiko; Hirose, Michiko; Hatori, Masanori; Yasmin, Lubna; Izu, Haruna; Matoba, Shogo; Togayachi, Sumie; Miyoshi, Hiroyuki; Sankai, Tadashi; Ogura, Atsuo; Honda, Arata			Naive-like conversion enhances the difference in innate in vitro differentiation capacity between rabbit ES cells and iPS cells	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Embryonic stem cells (ESCs); Induced pluripotent stem cells (iPSCs); Naive; Neural differentiation; Rabbit	PLURIPOTENT STEM-CELLS; LINES; GENERATION; DERIVATION; EMBRYOS; MODELS	Quality evaluation of pluripotent stem cells using appropriate animal models needs to be improved for human regenerative medicine. Previously, we demonstrated that although the in vitro neural differentiating capacity of rabbit induced pluripotent stem cells (iPSCs) can be mitigated by improving their baseline level of pluripotency, i.e., by converting them into the so-called "naive-like" state, the effect after such conversion of rabbit embryonic stem cells (ESCs) remains to be elucidated. Here we found that naive-like conversion enhanced the differences in innate in vitro differentiation capacity between ESCs and iPSCs. Naive-like rabbit ESCs exhibited several features indicating pluripotency, including the capacity for teratoma formation. They differentiated into mature oligodendrocytes much more effectively (3.3-7.2 times) than naive-like iPSCs. This suggests an inherent variation in differentiation potential in vitro among PSC lines. When naive-like ESCs were injected into preimplantation rabbit embryos, although they contributed efficiently to forming the inner cell mass of blastocysts, no chimeric pups were obtained. Thus, in vitro neural differentiation following naive-like conversion is a promising option for determining the quality of PSCs without the need to demonstrate chimeric contribution. These results provide an opportunity to evaluate which pluripotent stem cells or treatments are best suited for therapeutic use.	[Honsho, Kimiko; Izu, Haruna; Honda, Arata] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8891692, Japan; [Hirose, Michiko; Hatori, Masanori; Matoba, Shogo; Togayachi, Sumie; Miyoshi, Hiroyuki; Ogura, Atsuo; Honda, Arata] RIKEN, BioResource Ctr, Ibaraki 3050074, Japan; [Yasmin, Lubna; Sankai, Tadashi] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Ibaraki 3050843, Japan	Ogura, A (reprint author), RIKEN, BioResource Ctr, Ibaraki 3050074, Japan.	ogura@rtc.riken.go.jp; a-honda@med.miyazaki-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Ministry of Education, Culture, Sports, Science and Technology; PRESTO of the Japan Science and Technology Agency; Sumitomo Foundation	This work was supported by the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology, PRESTO of the Japan Science and Technology Agency and a grant for basic science research projects from Sumitomo Foundation.	Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Osteil P, 2013, BIOL OPEN, V2, P613, DOI 10.1242/bio.20134242; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Zakhartchenko V, 2011, BIOL REPROD, V84, P229, DOI 10.1095/biolreprod.110.087098; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Honda A, 2013, J BIOL CHEM, V288, P26157, DOI 10.1074/jbc.M113.502492; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Mallon BS, 2014, STEM CELL RES, V12, P376, DOI 10.1016/j.scr.2013.11.010; Shiomi Masashi, 2004, J Atheroscler Thromb, V11, P184; Streckfuss-Bomeke K, 2013, EUR HEART J, V34, P2618, DOI 10.1093/eurheartj/ehs203; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Takashima Y., CELL STEM C IN PRESS; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095329	30	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					13	19				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800003		
J	Yamamura, T; Wakabayashi, Y; Ohkura, S; Navarro, VM; Okamura, H				Yamamura, Takashi; Wakabayashi, Yoshihiro; Ohkura, Satoshi; Navarro, Victor M.; Okamura, Hiroaki			Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and lutemizing hormone secretion in goats	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						GnRH pulse generator; Goat; NK1R agonist; NK2R agonist; NK3R agonist	CENTRAL-NERVOUS-SYSTEM; ARCUATE NUCLEUS; SUBSTANCE-P; TACHYKININ RECEPTORS; KISSPEPTIN NEURONS; KISSPEPTIN/NEUROKININ B/DYNORPHIN; MORPHOLOGIC EVIDENCE; RAT HYPOTHALAMUS; NEUROPEPTIDE-Y; BINDING-SITES	Recent evidence suggests that neurokinin B (NKB), a member of the neurokinin (tachykinin) peptide family, plays a pivotal role in gonadotropin-releasing hormone (GnRH) pulse generation. Three types of neurokinin receptors (NKRs), NK1R, NK2R and NK3R, are found in the brain. Although NKB preferentially binds to NK3R, other NKRs are possibly also involved in NKB action. The present study examined the effects of intravenous administration of the NKR subtype-selective agonists GR73632 (NK1R), GR64349 (NK2R), and senktide (NK3R) on GnRH pulse generator activity and luteinizing hormone (LH) secretion. Multiple-unit activity (MUA) was monitored in ovariectomized goats (n = 5) implanted with recording electrodes. Characteristic increases in MUA (MUA volleys) were considered GnRH pulse generator activity. Although three NKR agonists dose-dependently induced an MUA volley and an accompanying increase in LH secretion, the efficacy in inducing the volley markedly differed. As little as 10 nmol of senktide induced an MUA volley in all goats, whereas a dose of 1000 nmol was only effective for the NK1R and NK2R agonists in two and four goats, respectively. When the treatment failed to evoke an MUA volley, no apparent change was observed in the MBA or LH secretion. Similar effects of the NK2R and NK3R agonists were observed in the presence of estradiol. The results demonstrated that NK3R plays a predominant role in GnRH pulse generation and suggested that the contributions of NK1R and NK2R to this mechanism may be few, if any, in goats.	[Yamamura, Takashi; Wakabayashi, Yoshihiro; Okamura, Hiroaki] Natl Inst Agrobiol Sci, Anim Physiol Res Unit, Ibaraki 3058602, Japan; [Ohkura, Satoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Navarro, Victor M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Navarro, Victor M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Okamura, H (reprint author), Natl Inst Agrobiol Sci, Anim Physiol Res Unit, Ibaraki 3058602, Japan.	hokamu@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan (Research Program on Innovative Technologies for Animal Breeding, Reproduction and Vaccine Development) [REP-2001]; Japan Society for the Promotion of Science [25871109, 26870842]	We are grateful to Drs S Oishi and N Fujii at Kyoto University for providing senktide. We thank Drs GR Merriam and KW Wachter for the PULSAR computer program. The LH radioimmunoassay and LIT pulse analysis were performed at the Nagoya University Radioisotope Center and the Nagoya University Information Technology Center, respectively. This study was supported in part by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Research Program on Innovative Technologies for Animal Breeding, Reproduction and Vaccine Development, REP-2001) and by Grants-in-Aid for Young Scientists (B) 26870842 (TY) and 25871109 (YW) from the Japan Society for the Promotion of Science. The authors wish to thank Ms Y Sakairi for her invaluable technical assistance throughout the study.	Amstalden M, 2010, J NEUROENDOCRINOL, V22, P1, DOI 10.1111/j.1365-2826.2009.01930.x; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Grachev P, 2012, ENDOCRINOLOGY, V153, P4894, DOI 10.1210/en.2012-1574; Dupre SM, 2010, CURR BIOL, V20, P829, DOI 10.1016/j.cub.2010.02.066; MORI Y, 1984, J REPROD FERTIL, V72, P223; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Kinsey-Jones JS, 2008, ENDOCRINOLOGY, V149, P1004, DOI 10.1210/en.2007-1505; de Croft S, 2013, ENDOCRINOLOGY, V154, P2750, DOI 10.1210/en.2013-1231; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; Wakabayashi Y, 2013, J REPROD DEVELOP, V59, P40; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Maeda K, 2010, BRAIN RES, V1364, P103, DOI 10.1016/j.brainres.2010.10.026; Goodman RL, 2013, ENDOCRINOLOGY, V154, P4259, DOI 10.1210/en.2013-1331; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Chan YM, 2011, J CLIN ENDOCR METAB, V96, pE908, DOI 10.1210/jc.2010-3046; MERRIAM GR, 1982, AM J PHYSIOL, V243, pE310; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; MAGGI CA, 1995, GEN PHARMACOL, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Almeida TA, 2004, CURR MED CHEM, V11, P2045; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; OHKURA S, 1991, J NEUROENDOCRINOL, V3, P503, DOI 10.1111/j.1365-2826.1991.tb00310.x; Navarro VM, 2012, J NEUROSCI, V32, P2388, DOI 10.1523/JNEUROSCI.4288-11.2012; BUCK SH, 1986, PEPTIDES, V7, P1109, DOI 10.1016/0196-9781(86)90141-5; DEAL MJ, 1992, J MED CHEM, V35, P4195, DOI 10.1021/jm00100a027; de Lange RPJ, 2008, BRAIN RES, V1212, P35, DOI 10.1016/j.brainres.2008.03.018; Ding YQ, 1996, J COMP NEUROL, V364, P290; Hrabovszky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072369; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; KALRA PS, 1992, ENDOCRINOLOGY, V131, P1195, DOI 10.1210/en.131.3.1195; Karsch F J., 1984, REPROD MAMMALS, V3, P1; Knobil E, 1980, Recent Prog Horm Res, V36, P53; Krajewski SJ, 2010, NEUROSCIENCE, V166, P680, DOI 10.1016/j.neuroscience.2009.12.053; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; LARSEN PJ, 1992, J HISTOCHEM CYTOCHEM, V40, P487; LARSEN PJ, 1992, PEPTIDES, V13, P705, DOI 10.1016/0196-9781(92)90176-4; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Navarro VM, 2013, ADV EXP MED BIOL, V784, P325, DOI 10.1007/978-1-4614-6199-9_15; Noritake K, 2011, J REPROD DEVELOP, V57, P409, DOI 10.1262/jrd.11-002S; Ohkura S, 2004, ENDOCRINOLOGY, V145, P3239, DOI 10.1210/en.2003-1516; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Okamura H, 2013, ANIM SCI J, V84, P369, DOI 10.1111/asj.12056; Reichard GA, 2002, BIOORG MED CHEM LETT, V12, P2355, DOI 10.1016/S0960-894X(02)00462-6; Ruka KA, 2013, ENDOCRINOLOGY, V154, P2761, DOI 10.1210/en.2013-1268; Sakamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081017; SEABROOK GR, 1995, EUR J PHARMACOL, V273, P113, DOI 10.1016/0014-2999(94)00681-V; SHAMGOCHIAN MD, 1992, ENDOCRINOLOGY, V131, P871, DOI 10.1210/en.131.2.871; Shughrue PJ, 1996, J COMP NEUROL, V372, P395; TSURUO Y, 1983, BRAIN RES, V289, P1, DOI 10.1016/0006-8993(83)90002-1; Nakahara T, 2013, J REPROD DEVELOP, V59, P479, DOI 10.1262/jrd.2013-046; VIJAYAN E, 1979, ENDOCRINOLOGY, V105, P64; Wakabayashi Y, 2012, 42 SOC NEUR ANN M NE	55	3	3	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					20	29				10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800004		
J	Tanabe, M; Tamura, H; Taketani, T; Okada, M; Lee, L; Tamura, I; Maekawa, R; Asada, H; Yamagata, Y; Sugino, N				Tanabe, Manabu; Tamura, Hiroshi; Taketani, Toshiaki; Okada, Maki; Lee, Lifa; Tamura, Isao; Maekawa, Ryo; Asada, Hiromi; Yamagata, Yoshiaki; Sugino, Norihiro			Melatonin protects the integrity of granulosa cells by reducing oxidative stress in nuclei, mitochondria, and plasma membranes in mice	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Granulosa cells; Melatonin; Oxidative stress; Reactive oxygen species	INDUCED DNA-DAMAGE; RAT LUTEAL CELLS; HYDROGEN-PEROXIDE; CORPUS-LUTEUM; PROGESTERONE PRODUCTION; BRAIN MITOCHONDRIA; REACTIVE OXYGEN; FREE-RADICALS; IN-VITRO; ANTIOXIDANT	Melatonin protects luteinized granulosa cells (GCs) from oxidative stress in the follicle during ovulation. However, it is unclear in which cellular components (e.g., nuclei, mitochondria, or plasma membranes) melatonin works as an antioxidant. GCs from immature (3 wks) ICR mice were incubated with hydrogen peroxide (H2O2; 0.01, 0.1, 1, 10 mM) in the presence or absence of melatonin (100 mu g/ml) for 2 h. DNA damage was assessed by fluorescence-based immunocytochemistry using specific antibodies for 8-hydroxydeoxyguanosine (8-OHdG), an indicator of oxidative guanine base damage in DNA, and for histone H2AX phosphorylation (gamma H2AX), a marker of double-strand breaks of DNA. Mitochondrial function was assessed by the fluorescence intensity of MitoTracker Red probes, which diffuse across the membrane and accumulate in mitochondria with active membrane potentials. Lipid peroxidation of plasma membranes was analyzed by measuring hexanoyl-lysine (HEL), a oxidative stress marker for lipid peroxidation. Apoptosis of GCs was assessed by nuclear fragmentation using DAPI staining, and apoptotic activities were evaluated by caspase-3/7 activities. H2O2 treatment significantly increased the fluorescence intensities of 8-OHdG and gamma H2AX, reduced the intensity of MitoTracker Red in the mitochondria, increased HEL concentrations in GCs, and enhanced the number of apoptotic cells and caspase-3/7 activities. All these changes were significantly decreased by melatonin treatment. Melatonin reduced oxidative stress-induced DNA damage, mitochondrial dysfunction, lipid peroxidation, and apoptosis in GCs, suggesting that melatonin protects GCs by reducing oxidative stress of cellular components including nuclei, mitochondria, and plasma membranes. Melatonin helps to maintain the integrity of GCs as an antioxidant in the preovulatory follicle.	[Tanabe, Manabu; Tamura, Hiroshi; Taketani, Toshiaki; Okada, Maki; Lee, Lifa; Tamura, Isao; Maekawa, Ryo; Asada, Hiromi; Yamagata, Yoshiaki; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 7558505, Japan	Sugino, N (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 7558505, Japan.	sugino@yamaguchi-u.ac.jp			JSPS KAKENHI Grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan [24592471, 24791704, 24791705, 25293343, 25462559, 25462560, 25861495, 26670726, 26861328, 26861329, 26861330, 26462492]	This work was supported in part by JSPS KAKENHI Grants 24592471, 24791704, 24791705, 25293343, 25462559, 25462560, 25861495, 26670726, 26861328, 26861329, 26861330, and 26462492 for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aganval A, 2005, REPROD BIOL ENDOCRIN, V3, P28; Akbulut KG, 2009, J PINEAL RES, V47, P308, DOI 10.1111/j.1600-079X.2009.00715.x; Akbulut KG, 2012, AGING CLIN EXP RES, V24, P15, DOI 10.3275/7568; Tang XL, 2009, BIOL PHARM BULL, V32, P1399; Ronen-Fuhrmann T, 1998, ENDOCRINOLOGY, V139, P303, DOI 10.1210/en.139.1.303; Martin M, 2000, FASEB J, V14, P1677; Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x; Mishra DP, 2007, PROSTAG OTH LIPID M, V83, P75, DOI 10.1016/j.prostaglandins.2006.10.002; Wu J, 2011, TOXICOL LETT, V202, P168, DOI 10.1016/j.toxlet.2011.01.029; Wang FW, 2013, J CELL BIOCHEM, V114, P2346, DOI 10.1002/jcb.24582; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x; Mah LJ, 2010, EPIGENETICS-US, V5, P129; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Lopez A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Tamura H, 2008, J PINEAL RES, V44, P280, DOI [10.1111/j.1600-079X.2007.00524.x, 10.1111/j.1600-079X.2007.00524.X]; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Denault Jean-Bernard, 2008, V414, P191; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; BEHRMAN HR, 1991, ENDOCRINOLOGY, V128, P2958; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; Erenberk U, 2014, DRUG CHEM TOXICOL, V37, P233, DOI 10.3109/01480545.2013.838777; Gubory AI- KH, 2004, REPRODUCTION, V128, P767; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HICKEY GJ, 1988, ENDOCRINOLOGY, V122, P1426; KODAMAN PH, 1994, ENDOCRINOLOGY, V135, P2723, DOI 10.1210/en.135.6.2723; Mayo JC, 2002, CELL MOL LIFE SCI, V59, P1706, DOI 10.1007/PL00012498; Milczarek R, 2010, J PINEAL RES, V49, P149, DOI 10.1111/j.1600-079X.2010.00779.x; Nagy IZ, 2001, ANN NY ACAD SCI, V928, P187; Nakamura Y, 2003, FERTIL STERIL, V80, P1012, DOI 10.1016/S0015-0282(03)01008-2; Niles LP, 1999, MOL CELL ENDOCRINOL, V156, P107, DOI 10.1016/S0303-7207(99)00135-5; Reiter Russel J, 2008, Interdiscip Toxicol, V1, P137, DOI 10.2478/v10102-010-0030-2; SAWADA M, 1991, ENDOCRINOLOGY, V128, P2992; Soares JM, 2003, J PHARMACOL EXP THER, V306, P694, DOI 10.1124/jpet.103.049916; Sun FY, 2002, J PINEAL RES, V33, P48, DOI 10.1034/j.1600-079X.2002.01891.x; Taketani T, 2011, J PINEAL RES, V51, P207, DOI 10.1111/j.1600-079X.2011.00878.x; Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5; Tamura H, 2014, J OBSTET GYNAECOL RE, V40, P1, DOI 10.1111/jog.12177; Tamura H, 2013, ENDOCR J, V60, P1; Wu HJ, 2013, MUTAT RES-GEN TOX EN, V752, P57, DOI 10.1016/j.mrgentox.2013.01.005; WU XM, 1993, ENDOCRINOLOGY, V133, P491, DOI 10.1210/en.133.2.491; Yamamoto HA, 2002, TOXICOLOGY, V179, P29, DOI 10.1016/S0300-483X(02)00244-5	55	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					35	41				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800006		
J	Sakumoto, R; Hayashi, KG; Hosoe, M; Iga, K; Kizaki, K; Okuda, K				Sakumoto, Ryosuke; Hayashi, Ken-Go; Hosoe, Misa; Iga, Kosuke; Kizaki, Keiichiro; Okuda, Kiyoshi			Gene expression profiles in the bovine corpus luteum (CL) during the estrous cycle and pregnancy: Possible roles of chemokines in regulating CL function during pregnancy	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Chemokines; Corpus luteum; Cow; Microarray analysis; Pregnancy	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORPORA-LUTEA; OVARIAN-FUNCTION; MESSENGER-RNA; PROGESTERONE; RECEPTORS; OXYTOCIN; COW; PROSTAGLANDIN-F2-ALPHA; EOSINOPHILS	To determine functional differences between the corpus luteum (CL) of the estrous cycle and pregnancy in cows, gene expression profiles were compared using a 15 K bovine oligo DNA microarray. In the pregnant CL at days 20-25,40-45 and 150-160, the expressions of 138, 265 and 455 genes differed by a factor of > 2-fold (P < 0.05) from their expressions in the cyclic CL (days 10-12 of the estrous cycle). Messenger RNA expressions of chemokines (eotaxin, lymphotactin and ENA-78) and their receptors (CCR3, XCRI and CXCR2) were validated by quantitative real-time PCR. Transcripts of eotaxin were more abundant in the CL at days 40-45 and 150-160 of pregnancy than in the cyclic CL (P < 0.01). In contrast, the mRNA expressions of lymphotactin, ENA-78 and XCRI were lower in the CL of pregnancy (P < 0.05). Messenger RNAs of CCR3 and CXCR2 were similarly detected both in the cyclic and pregnant CL. Tissue protein levels of eotaxin were significantly higher in the CL at days 150-160 of pregnancy than in the CL at other stages, whereas the lymphotactin protein levels in the CL at days 20-25 of pregnancy were lower (P < 0.05) Immunohistochemical staining showed that CCR3 was expressed in the luteal cells and that XCR1 was expressed in both the luteal cells and endothelial cells. Collectively, the different gene expression profiles may contribute to functional differences between the cyclic and pregnant CL, and chemokines including eotaxin and lymphotactin may regulate CL function during pregnancy in cows.	[Sakumoto, Ryosuke; Hayashi, Ken-Go; Hosoe, Misa] Natl Inst Agrobiol Sci, Anim Physiol Res Unit, Ibaraki 3050901, Japan; [Iga, Kosuke] NARO, Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan; [Kizaki, Keiichiro] Iwate Univ, Vet Physiol Lab, Morioka, Iwate 0208550, Japan; [Okuda, Kiyoshi] Okayama Univ, Reprod Physiol Lab, Okayama 7008530, Japan	Sakumoto, R (reprint author), Natl Inst Agrobiol Sci, Anim Physiol Res Unit, Ibaraki 3050901, Japan.	sakumoto@affrc.go.jp			Japanese Society for the Promotion of Science (JSPS) [25780276]; Ministry of Agriculture, Forestry and Fisheries of Japan [REP1001]	This research was supported by Grants-in-Aid for Scientific Research (No. 25780276) from the Japanese Society for the Promotion of Science (JSPS) and for the Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development (REP1001) from the Ministry of Agriculture, Forestry and Fisheries of Japan. The authors thank the staff of the National Institute of Livestock and Grassland Sciences, Japan, for their skilled technical assistance.	Wasielak M, 2008, MOL REPROD DEV, V75, P1208, DOI 10.1002/mrd.20862; Shirasuna K, 2012, DOMEST ANIM ENDOCRIN, V43, P198, DOI 10.1016/j.domaniend.2012.03.007; Yang L, 2010, J DAIRY SCI, V93, P1000, DOI 10.3168/jds.2009-2529; Nitta A, 2011, REPRODUCTION, V142, P879, DOI 10.1530/REP-11-0157; Bukulmez O, 2000, HUM REPROD UPDATE, V6, P1, DOI 10.1093/humupd/6.1.1; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Magata F, 2012, J REPROD DEVELOP, V58, P445, DOI 10.1262/jrd.2011-049; Niswender GD, 2000, PHYSIOL REV, V80, P1; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Fields MJ, 1996, THERIOGENOLOGY, V45, P1295, DOI 10.1016/0093-691X(96)00099-4; Oliveira JF, 2008, ENDOCRINOLOGY, V149, P1252, DOI 10.1210/en.2007-0863; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Aust G, 2000, MOL HUM REPROD, V6, P1085, DOI 10.1093/molehr/6.12.1085; Farin C E, 1989, J Reprod Fertil Suppl, V37, P181; FIELDS MJ, 1980, ENDOCRINOLOGY, V107, P869; HARRISON LM, 1987, J REPROD FERTIL, V79, P539; Haworth JD, 1998, BIOL REPROD, V58, P169, DOI 10.1095/biolreprod58.1.169; Henson MC, 1998, HUM REPROD UPDATE, V4, P389, DOI 10.1093/humupd/4.4.389; Hughes AL, 1999, IMMUNOGENETICS, V49, P115, DOI 10.1007/s002510050470; Kizaki K, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-6; Luo WX, 2011, ENDOCRINOLOGY, V152, P2797, DOI 10.1210/en.2010-1247; MCDONALD LE, 1953, AM J VET RES, V14, P539; MORI T, 1990, AM J REPROD IMMUNOL, V24, P80; OSHEA JD, 1989, J REPROD FERTIL, V85, P483; OSHEA JD, 1988, J REPROD FERTIL, V83, P107; PARKINSON TJ, 1992, J REPROD FERTIL, V94, P161; Pate J L, 2003, Reprod Suppl, V61, P207; Penny LA, 1998, BIOL REPROD, V59, P1464, DOI 10.1095/biolreprod59.6.1464; Sakumoto R, 2006, DOMEST ANIM ENDOCRIN, V31, P246, DOI 10.1016/j.domaniend.2005.11.001; Sakumoto R, 2014, REPROD BIOL, V14, P115, DOI 10.1016/j.repbio.2013.12.003; Sakumoto R, 2010, J REPROD DEVELOP, V56, P219; Sawyer H R, 1995, J Reprod Fertil Suppl, V49, P97; Schams D, 2004, REPROD DOMEST ANIM, V39, P241, DOI 10.1111/j.1439-0531.2004.00509.x; STORMSHAK F, 1961, J DAIRY SCI, V44, P310; Townson DH, 2002, BIOL REPROD, V66, P361, DOI 10.1095/biolreprod66.2.361; Townson David H, 2003, Reprod Biol Endocrinol, V1, P94, DOI 10.1186/1477-7827-1-94; Ushizawa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005814; Vogel B, 2005, VET IMMUNOL IMMUNOP, V107, P67, DOI 10.1016/j.vetimm.2005.03.013; WATHES DC, 1984, J REPROD FERTIL, V71, P551; Wong KHH, 2002, ENDOCRINOLOGY, V143, P784, DOI 10.1210/en.143.3.784; YUAN W, 1993, J ANIM SCI, V71, P481	41	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					42	48				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800007		
J	Ghanem, ME; Tezuka, E; Devkota, B; Izaike, Y; Osawa, T				Ghanem, Mohamed Elshabrawy; Tezuka, Erisa; Devkota, Bhuminand; Izaike, Yoshiaki; Osawa, Takeshi			Persistence of uterine bacterial infection, and its associations with endometritis and ovarian function in postpartum dairy cows	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Bacterial infection; Cows; Endometritis; Prolonged luteal phase	REPRODUCTIVE-PERFORMANCE; HOLSTEIN COWS; ARCANOBACTERIUM-PYOGENES; SUBCLINICAL ENDOMETRITIS; RETAINED PLACENTA; CATTLE; DISEASE; HEALTH; PROGESTERONE; PARTURITION	We investigated the relationship between the persistence of uterine bacterial infections with cytologically determined endometritis and ovarian function in 65 postpartum Holstein cows. Vaginal mucus discharges were collected, and endometrial smear samples (n = 130) were collected for cytological and bacteriological examinations from the cows at weeks 5 and 7 postpartum (pp). Blood samples were collected at weeks 3, 5 and 7 pp to determine plasma progesterone concentrations to monitor ovarian activity. According to the bacteriological examination, cows were classified into four groups. The first group (n = 32; 49%) comprised cows negative for bacteria at weeks 5 and 7 pp. The second group (n = 11; 17%) comprised cows with bacterial infections at week 5 pp but that were clear of infection at week 7 pp. The third group (n = 12; 19%) comprised cows without bacteria at week 5 pp but that acquired an infection by week 7 pp. The fourth group (n = 10; 15%) comprised cows with bacterial infections at weeks 5 and 7 pp (persistence of infection). A positive correlation (P < 0.001) was noted between the severity of cytologically determined endometritis, purulent vaginal discharge and the persistence of infection. Cows with persistent infections had a significantly (P < 0.01) prolonged luteal phase compared with cows without infection. In conclusion, the prevalence of cytologically determined endometritis and prolonged luteal phase were significantly increased in cows with persistent infections.	[Ghanem, Mohamed Elshabrawy; Tezuka, Erisa; Devkota, Bhuminand; Izaike, Yoshiaki; Osawa, Takeshi] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 0208550, Japan; [Ghanem, Mohamed Elshabrawy] Suez Canal Univ, Fac Vet Med, Dept Theriogenol, Ismailia, Egypt	Osawa, T (reprint author), Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 0208550, Japan.	osawa@cc.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS [21580385]	The authors thank the members of the Laboratory of Theriogenology and Laboratory of Food Animal Medicine, Iwate University, for their help during sample collection. The first author was supported by a Fellowship from the Japan Society for the Promotion of Science (JSPS). This research work was supported by a Grant-in-Aid for Scientific Research (No. 21580385 to TO) from JSPS.	LeBlanc SJ, 2008, VET J, V176, P102, DOI [10.1016/j.tvjl.2007.12.019, 10.1016/j.tvj1.2007.12.019]; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Miller ANA, 2007, THERIOGENOLOGY, V68, P972, DOI 10.1016/j.theriogenoloy.2007.07.013; Shrestha HK, 2004, THERIOGENOLOGY, V61, P637, DOI 10.1016/S0093-691X(03)00233-4; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; DOHMEN MJW, 1995, THERIOGENOLOGY, V43, P1379, DOI 10.1016/0093-691X(95)00123-P; Azawi OI, 2008, ANIM REPROD SCI, V105, P187, DOI 10.1016/j.anireprosci.2008.01.010; Sheldon IM, 2004, ANIM REPROD SCI, V82-3, P295, DOI 10.1016/j.anireprosci.2004.04.006; Kaneko K, 2008, J VET MED SCI, V70, P77, DOI 10.1292/jvms.70.77; Zerbe H, 2001, VET MICROBIOL, V79, P351, DOI 10.1016/S0378-1135(00)00368-0; McDougall S, 2007, ANIM REPROD SCI, V99, P9, DOI 10.1016/j.anireprosci.2006.03.017; Dubuc J, 2010, J DAIRY SCI, V93, P5225, DOI 10.3168/jds.2010-3428; Kasimanickam R, 2004, THERIOGENOLOGY, V62, P9, DOI 10.1016/j.theriogenology.2003.03.001; BEKANA M, 1994, J VET MED A, V41, P663; Bacha B, 2010, TROP ANIM HEALTH PRO, V42, P397, DOI 10.1007/s11250-009-9433-5; Senosy WS, 2009, THERIOGENOLOGY, V72, P1153, DOI 10.1016/j.theriogenology.2009.07.007; Westermann S, 2010, THERIOGENOLOGY, V74, P1248, DOI 10.1016/j.theriogenology.2010.05.028; Bondurant RH, 1999, J ANIM SCI, V77, P101; Barlund CS, 2008, THERIOGENOLOGY, V69, P714, DOI [10.1016/j.theriogenology.2007.12.005, 10.1016/j.thefiogenology.2007.12.005]; FARIN PW, 1989, THERIOGENOLOGY, V31, P979, DOI 10.1016/0093-691X(89)90481-0; Huszenicza G, 1999, REPROD DOMEST ANIM, V34, P237, DOI 10.1111/j.1439-0531.1999.tb01246.x; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Lewis GS, 1997, J DAIRY SCI, V80, P984, DOI 10.3168/jds.S0022-0302(97)76024-7; Hansen PJ, 2013, J ANIM SCI, V91, P1639, DOI 10.2527/jas.2012-5934; Konigsson K, 2001, REPROD DOMEST ANIM, V36, P247, DOI 10.1046/j.1439-0531.2001.00289.x; Kafi M, 2012, THERIOGENOLOGY, V77, P421, DOI 10.1016/j.theriogenology.2011.08.016; Donofrio G, 2008, REPRODUCTION, V136, P361, DOI 10.1530/REP-08-0171; Foldi J, 2006, ANIM REPROD SCI, V96, P265, DOI 10.1016/j.anireprosci.2006.08.006; LeBlanc SJ, 2002, J DAIRY SCI, V85, P2223, DOI 10.3168/jds.S0022-0302(02)74302-6; POYSER NL, 1995, PROSTAG LEUKOTR ESS, V53, P147, DOI 10.1016/0952-3278(95)90115-9; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; BORSBERRY S, 1989, VET REC, V124, P217; Brooks GF, 2007, JAWETZ MELNICK ADELB, P306; Ghanem M, 2008, REPROD DOMEST ANIM, V43, P346, DOI 10.1111/j.1439-0531.2007.00913.x; HOLT LC, 1989, J DAIRY SCI, V72, P533, DOI 10.3168/jds.S0022-0302(89)79137-2; HUSSAIN AM, 1989, J VET MED B, V36, P641; HUSSAIN AM, 1990, THERIOGENOLOGY, V34, P291, DOI 10.1016/0093-691X(90)90522-U; Jadon RS, 2005, ANIM REPROD SCI, V88, P215, DOI 10.1016/j.anireprosci.2004.12.006; Lincke A, 2007, BERL MUNCH TIERARZTL, V120, P245; Long NM, 2009, PROF ANIM SCI, V25, P481; Oguri T, 2011, CLIN MICROBIOLOGY HD, P97; Opsomer G, 1996, VET QUART, V18, P68; RUDER CA, 1981, THERIOGENOLOGY, V15, P573, DOI 10.1016/0093-691X(81)90060-1; Runciman DJ, 2008, AUST VET J, V86, P205, DOI 10.1111/j.1751-0813.2008.00301.x; Seals RC, 2002, J ANIM SCI, V80, P1068; Shamsuddin M, 2006, TROP ANIM HEALTH PRO, V38, P85, DOI 10.1007/s11250-006-4249-z; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Silva E, 2008, VET MICROBIOL, V132, P111, DOI 10.1016/j.vetmic.2008.04.033; Silva N, 1998, REV BRAS REPROD ANIM, V23, P410; Smith B.I., 2002, COMP CONT VET ED, V24, P74; STEVENSON JS, 1979, J ANIM SCI, V48, P570; Subandrio AL, 2000, THERIOGENOLOGY, V53, P1591, DOI 10.1016/S0093-691X(00)00300-9	53	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					54	60				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800009		
J	Yanagawa, Y; Matsuura, Y; Suzuki, M; Saga, SI; Okuyama, H; Fukui, D; Bando, G; Nagano, M; Katagiri, S; Takahashi, Y; Tsubota, T				Yanagawa, Yojiro; Matsuura, Yukiko; Suzuki, Masatsugu; Saga, Shin-ichi; Okuyama, Hideto; Fukui, Daisuke; Bando, Gen; Nagano, Masashi; Katagiri, Seiji; Takahashi, Yoshiyuki; Tsubota, Toshio			Accessory corpora lutea formation in pregnant Hokkaido sika deer (Cervus nippon yesoensis) investigated by examination of ovarian dynamics and steroid hormone concentrations	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Accessory corpus luteum; Estradiol; Follicular wave; Progesterone; Sika deer	RED DEER; ESTROUS-CYCLE; IMMUNOHISTOCHEMICAL LOCALIZATION; CORPUS-LUTEUM; DAIRY-CATTLE; ELAPHUS; WAPITI; SEASON; HINDS; EWES	Generally, sika deer conceive a single fetus, but approximately 80% of pregnant females have two corpora lutea (CLs). The function of the accessory CL (ACL) is unknown; moreover, the process of ACL formation is unclear, and understanding this is necessary to know its role. To elucidate the process of ACL formation, the ovarian dynamics of six adult Hokkaido sika deer females were examined ultrasonographically together with peripheral estradiol-17 beta and progesterone concentrations. ACLs formed in three females that conceived at the first estrus of the breeding season, but not in those females that conceived at the second estrus. After copulation, postconception ovulation of the dominant follicle of the first wave is induced by an increase in estradiol-17 beta, which leads to formation of an ACL. A relatively low concentration of progesterone after the first estrus of the breeding season is considered to be responsible for the increase in estradiol-17 beta after copulation.	[Yanagawa, Yojiro; Nagano, Masashi; Takahashi, Yoshiyuki] Hokkaido Univ, Lab Theriogenol, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Matsuura, Yukiko] Hokkaido Res Ctr Forestry, Sapporo, Hokkaido 0628516, Japan; [Matsuura, Yukiko] Forest Prod Res Inst, Sapporo, Hokkaido 0628516, Japan; [Suzuki, Masatsugu] Gifu Univ, Lab Zoo & Wildlife Med, Dept Vet Med, Fac Appl Biol Sci, Gifu 5011193, Japan; [Saga, Shin-ichi; Okuyama, Hideto; Fukui, Daisuke; Bando, Gen] Asahiyama Zool Pk, Hoakkaido 0788205, Japan; [Katagiri, Seiji] Rakuno Gakuen Univ, Sch Vet Med, Dept Large Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan; [Tsubota, Toshio] Hokkaido Univ, Grad Sch Vet Med, Lab Wildlife Biol, Sapporo, Hokkaido 0600818, Japan	Yanagawa, Y (reprint author), Hokkaido Univ, Lab Theriogenol, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan.	yoji-y@vetmed.hokudai.ac.jp			Inui Memorial Trust for Research on Animal Science	We thank Dr H Igota, Mr J Igota, Mr A Ohsawa, and Mr S Nakahara for providing captive deer and helping with transportation. We are also indebted to Dr M Matsui for his advice on ultrasono-graphic examination. We would like to thank Dr A Miyamoto for providing the estradiol-17 beta antibody. This work was supported by the Inui Memorial Trust for Research on Animal Science.	MEYER HHD, 1990, J STEROID BIOCHEM, V35, P263, DOI 10.1016/0022-4731(90)90283-X; KOIKE H, 1985, J ARCHAEOL SCI, V12, P443, DOI 10.1016/0305-4403(85)90004-4; Hildebrandt TB, 2011, ANIM REPROD SCI, V124, P176, DOI 10.1016/j.anireprosci.2010.08.027; GUINNESS F, 1971, J REPROD FERTIL, V27, P427; Vanholder T, 2006, REPROD NUTR DEV, V46, P105, DOI 10.1051/rnd:2006003; Niswender GD, 2000, PHYSIOL REV, V80, P1; SPENCER TE, 1995, ENDOCRINOLOGY, V136, P4932, DOI 10.1210/en.136.11.4932; Asher GW, 1999, ADV DEER BIOL, P148; Bartlewski PM, 1999, ANIM REPROD SCI, V57, P67, DOI 10.1016/S0378-4320(99)00060-3; Bartlewski PM, 2001, REPROD FERT DEVELOP, V13, P133, DOI 10.1071/RD00092; Bergfelt D. R., 2011, Equine reproduction, Volume 2, P2055; Braun Joachim, 1994, Journal of Reproduction and Development, V40, P141; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; DAUPHINE TC, 1978, CAN J ZOOL, V56, P1684, DOI 10.1139/z78-232; Demmers KJ, 2000, J REPROD FERTIL, V118, P387, DOI 10.1530/reprod/118.2.387; DOUGLAS MJW, 1966, J MAMMAL, V47, P152, DOI 10.2307/1378103; Ginther OJ, 2008, J EQUINE VET SCI, V28, P454, DOI 10.1016/j.jevs.2008.07.008; GUINNESS FE, 1978, J ANIM ECOL, V47, P817, DOI 10.2307/3673; HALAZON GEORGE C., 1956, TRANS N AMER WILDLIFE CONF, V21, P545; Hermes R, 2000, ZOO BIOL, V19, P369, DOI 10.1002/1098-2361(2000)19:5<369::AID-ZOO7>3.0.CO;2-K; Kelly R. W., 1985, Biology of deer production. Proceedings of the International Conference held at Dunedin, New Zealand, 13-18 February 1983., P181; KELLY RW, 1978, NEW ZEAL J ZOOL, V5, P817; LEADERWILLIAMS N, 1983, J REPROD FERTIL, V67, P247; Liu BT, 2002, ZOOL SCI, V19, P1033, DOI 10.2108/zsj.19.1033; Lueders I, 2010, REPRODUCTION, V140, P777, DOI 10.1530/REP-10-0022; Matsuura Y, 2004, JPN J VET RES, V51, P167; Matsuura Yukiko, 2004, Mammal Study, V29, P15, DOI 10.3106/mammalstudy.29.15; Matsuura Y, 2004, ECOL RES, V19, P397, DOI 10.1111/j.1440-1703.2004.00650.x; McCorkell R, 2006, THERIOGENOLOGY, V65, P540, DOI 10.1016/j.theriogenology.2005.05.049; McCorkell R, 2007, THERIOGENOLOGY, V67, P1224, DOI 10.1016/j.theriogenology.2007.01.007; McCorkell RB, 2004, THERIOGENOLOGY, V61, P473, DOI 10.1016/S0093-691X(03)00247-4; Stevenson J., 2007, CURRENT THERAPY LARG, P258; Suzuki M, 1996, J VET MED SCI, V58, P505; SUZUKI M, 1993, DEV AN VET, V26, P356; SUZUKI M, 1992, Journal of the Mammalogical Society of Japan, V17, P11; SUZUKI M, 1993, J VET MED SCI, V55, P833; Webb R, 1999, ANIM SCI, V68, P257; Wiltbank MC, 2000, J DAIRY SCI, V83, P2998; YAMAUCHI S, 1984, Japanese Journal of Animal Reproduction, V30, P162; Yanagawa Y, 2008, JPN J VET RES, V56, P139; Yanagawa Y, 2009, J REPROD DEVELOP, V55, P143, DOI 10.1262/jrd.20113	41	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					61	66				6	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800010		
J	Hirata, R; Hojo, T; Sano, M; Hayashi, N; Okuda, K				Hirata, Rei; Hojo, Takuo; Sano, Masahiro; Hayashi, Nobuyoshi; Okuda, Kiyoshi			Potential role of hCG in apoptosis of human luteinized granulosa cells	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Human chorionic gonadotropin; Human luteinized granulosa cell; Progesterone; Survival factor	HUMAN CORPUS-LUTEUM; HUMAN CHORIONIC-GONADOTROPIN; OXIDE INDUCES APOPTOSIS; IN-VITRO; PROGESTERONE-RECEPTOR; EARLY-PREGNANCY; CORPORA-LUTEA; RAT; EXPRESSION; DEATH	The corpus luteum (CL) forms after ovulation and acts as a temporary endocrine gland that produces progesterone (P4), a hormone that is essential for implantation and maintenance of pregnancy in mammals. In pregnant women, human chorionic gonadotropin (hCG) secreted by the conceptus prevents luteolysis. hCG also increases the survival of cultured human luteinized granulosa cells (hLGCs). To clarify the maintenance mechanism of the human CL, we investigated the effects of hCG and P4 receptor antagonists, onapristone (OP) and RU486, on the viability of hLGCs. With the patients' consent, hLGCs were isolated from follicular aspirates for in vitro fertilization. The cells were cultured with hCG (0.1, 1, 10, 100 IU/ml), OP (10, 25, 50, 100 mu M), RU486 (100 mu M), P4 (1, 10, 25, 50 mu M) or some combination of the four for 24 h. Cell viability was significantly increased by hCG (100 IU/ml) and significantly decreased by OP (100 mu M) compared with the control. Cells treated with hCG and OP together were significantly less viable than the control and OP-treated cells. The combined treatment also significantly increased CASP3 activity and cleaved CASP3 protein expression. Furthermore, P4 addition reversed the reduction in cell viability caused by the combination of hCG and OP treatment. The overall findings suggest that hCG cooperates with P4 to increase survival of hLGCs and to induce apoptosis when P4 action supported by hCG is attenuated in the human CL.	[Hirata, Rei; Hojo, Takuo; Sano, Masahiro; Okuda, Kiyoshi] Okayama Univ, Reprod Physiol Lab, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Hirata, Rei; Hayashi, Nobuyoshi] Okayama Couples Clin, Okayama 7011152, Japan	Okuda, K (reprint author), Okayama Univ, Reprod Physiol Lab, Grad Sch Environm & Life Sci, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp					Okuda K, 2004, BIOL REPROD, V71, P2065, DOI 10.1095/biolreprod.104.028076; KLEINHITPASS L, 1991, NUCLEIC ACIDS RES, V19, P1227, DOI 10.1093/nar/19.6.1227; Sugino N, 2000, J CLIN ENDOCR METAB, V85, P4379, DOI 10.1210/jc.85.11.4379; Rung E, 2005, BIOL REPROD, V72, P538, DOI 10.1095/biolreprod.104.033878; Kumazawa Y, 2005, MOL HUM REPROD, V11, P161, DOI 10.1093/molehr/gah146; Pru JK, 2001, MOL ENDOCRINOL, V15, P845, DOI 10.1210/me.15.6.845; Friberg PA, 2009, BIOL REPROD, V80, P1160, DOI 10.1095/biolreprod.108.073932; Vega M, 2000, MOL HUM REPROD, V6, P681, DOI 10.1093/molehr/6.8.681; Shikone T, 1996, J CLIN ENDOCR METAB, V81, P2376, DOI 10.1210/jc.81.6.2376; Wan H, 2007, J LEUKOCYTE BIOL, V82, P926, DOI 10.1189/jlb.0207092; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Peluso JJ, 2001, BIOL REPROD, V65, P94, DOI 10.1095/biolreprod65.1.94; BUHR MM, 1987, J ANIM SCI, V65, P1027; Chen SU, 2010, J CLIN ENDOCR METAB, V95, P3982, DOI 10.1210/jc.2009-2596; Eiger W, 2000, STEROIDS, V65, P713; Engmann L, 2006, J CLIN ENDOCR METAB, V91, P4962, DOI 10.1210/jc.2006-1128; Gaytan F, 1998, BIOL REPROD, V59, P417, DOI 10.1095/biolreprod59.2.417; HANSON FW, 1971, J CLIN ENDOCR METAB, V32, P211; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Korzekwa AJ, 2006, J REPROD DEVELOP, V52, P353, DOI 10.1262/jrd.17092; Liu J, 2010, MOL ENDOCRINOL, V24, P1203, DOI 10.1210/me.2009-0325; Makrigiannakis A, 2000, ANN NY ACAD SCI, V900, P16; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Myers M, 2007, ENDOCRINOLOGY, V148, P5769, DOI 10.1210/en.2007-0742; Okuda Kiyoshi, 1998, Journal of Reproduction and Development, V44, P79, DOI 10.1262/jrd.44.79; OONK RB, 1989, J BIOL CHEM, V264, P21934; OSNES T, 1993, SCAND J CLIN LAB INV, V53, P757, DOI 10.3109/00365519309092582; Park DW, 2003, FERTIL STERIL, V80, P993, DOI 10.1016/S0015-0282(03)01118-X; PATE JL, 1982, MOL CELL ENDOCRINOL, V28, P551, DOI 10.1016/0303-7207(82)90146-0; Port CB, 2000, J REPROD FERTIL, V119, P93, DOI 10.1530/reprod/119.1.93; Sugino N, 1996, ENDOCRINOLOGY, V137, P749, DOI 10.1210/en.137.2.749; Sun GW, 1999, J HISTOCHEM CYTOCHEM, V47, P1433; Tanaka M, 2000, J REPROD FERTIL, V120, P239, DOI 10.1530/reprod/120.2.239; Vaskivuo TE, 2002, MOL CELL ENDOCRINOL, V194, P191, DOI 10.1016/S0303-7207(02)00087-4; Yuan W, 1997, J CLIN ENDOCR METAB, V82, P3148, DOI 10.1210/jc.82.9.3148	36	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	FEB	2015	61	1					67	73				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CC1EA	WOS:000350082800011		
J	Mokhtari, P; Takemoto, H; Nishimura, R; Kato, H				Mokhtari, Parham; Takemoto, Hironori; Nishimura, Ryouichi; Kato, Hiroaki			Frequency and amplitude estimation of the first peak of head-related transfer functions from individual pinna anthropometry	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							MEDIAN PLANE	The first (lowest) peak of head-related transfer functions (HRTFs) is known to be a concha depth resonance and a spectral cue in human sound localization. However, there is still no established model to estimate its center-frequency F-1 and amplitude A(1) from pinna anthropometry. Here, with geometries of 38 pinnae measured and their median-plane HRTFs calculated by numerical simulation, linear regression models were evaluated in estimating F-1 and A(1) from 25 concha depth and aperture measurements. F-1 was best estimated (correlation coefficient r = 0.84, mean absolute error MAE = 118 Hz) by lateral distances from the base of the posterior cavum concha to the outer surface of the antitragus and antihelix (longest measures of concha depth). A(1) was best estimated (r = 0.83, MAE = 0.84 dB) by the lateral distance from the ear-canal entrance to the side of the cheek near the anterior notch (shortest measure of concha depth) and by the equivalent diameter of the concha aperture. These results suggest that the first resonance's quarter-wavelength corresponds to the longest lateral extent of the concha and that its energy lost to the surrounding air depends on the concha aperture and the cavum concha's shortest lateral depth. (C) 2015 Acoustical Society of America.	[Mokhtari, Parham; Takemoto, Hironori; Nishimura, Ryouichi; Kato, Hiroaki] Natl Inst Informat & Commun Technol, Seika, Kyoto 6190289, Japan	Mokhtari, P (reprint author), Natl Inst Informat & Commun Technol, 3-5 Hikaridai, Seika, Kyoto 6190289, Japan.	parham@nict.go.jp					Algazi VR, 2001, PROCEEDINGS OF THE 2001 IEEE WORKSHOP ON THE APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS, P99, DOI 10.1109/ASPAA.2001.969552; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; Iida K, 2007, APPL ACOUST, V68, P835, DOI 10.1016/j.apacoust.2006.07.016; Takemoto H, 2010, J ACOUST SOC AM, V128, P3724, DOI 10.1121/1.3502470; Blauert J., 1997, SPATIAL HEARING PSYC, P36; Iida K, 2014, J ACOUST SOC AM, V136, P317, DOI 10.1121/1.4880856; Ishii Y., 2013, POW EL APPL EPE 15 E, P1; Kahana Y, 2006, J SOUND VIB, V292, P148, DOI 10.1016/j.jsv.2005.07.048; Mokhtari P., 2014, P 39 IEEE INT C AC S, P8267; Mokhtari P., 2010, P 20 INT C AC ICA SY, P1; Mokhtari P, 2010, IEEE T AUDIO SPEECH, V18, P1068, DOI 10.1109/TASL.2009.2035036; Mokhtari P., 2011, PRINCIPLES APPL SPAT, P205; Mokhtari P., 2008, P AUT M AC SOC JAP F, P611; Mokhtari P., 2013, P AUT M AC SOC JAP T, P861; Pierce A D, 1989, ACOUSTICS INTRO ITS, P180; SHAW EAG, 1968, J ACOUST SOC AM, V44, P240, DOI 10.1121/1.1911059; Takemoto H, 2012, J ACOUST SOC AM, V132, P3832, DOI 10.1121/1.4765083; TERANISH.R, 1968, J ACOUST SOC AM, V44, P257, DOI 10.1121/1.1911061	18	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	FEB	2015	137	2					690	701		10.1121/1.4906160		12	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CC0KO	WOS:000350024600031		
J	Shi, C; Kajikawa, Y				Shi, Chuang; Kajikawa, Yoshinobu			A convolution model for computing the far-field directivity of a parametric loudspeaker array	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							GAUSSIAN BEAMS; SOUND	This paper describes a method to compute the far-field directivity of a parametric loudspeaker array (PLA), whereby the steerable parametric loudspeaker can be implemented when phased array techniques are applied. The convolution of the product directivity and the Westervelt's directivity is suggested, substituting for the past practice of using the product directivity only. Computed directivity of a PLA using the proposed convolution model achieves significant improvement in agreement to measured directivity at a negligible computational cost. (C) 2015 Acoustical Society of America.	[Shi, Chuang; Kajikawa, Yoshinobu] Kansai Univ, Dept Elect & Elect Engn, Suita, Osaka 5648680, Japan	Shi, C (reprint author), Kansai Univ, Dept Elect & Elect Engn, 3-3-35 Yamatecho, Suita, Osaka 5648680, Japan.	r148005@kansai-u.ac.jp			MEXT	This work is supported by MEXT-Supported Program for the Strategic Research Foundation at Private University, 2013-2017.	Kamakura T, 2000, J ACOUST SOC AM, V107, P3035, DOI 10.1121/1.429332; Kamakura T, 2013, ULTRASONICS, V53, P432, DOI 10.1016/j.ultras.2012.08.008; WEN JJ, 1988, J ACOUST SOC AM, V83, P1752, DOI 10.1121/1.396508; BENNETT MB, 1975, J ACOUST SOC AM, V57, P562, DOI 10.1121/1.380484; BERKTAY HO, 1965, J SOUND VIB, V2, P435, DOI 10.1016/0022-460X(65)90122-7; BERKTAY HO, 1974, J ACOUST SOC AM, V55, P539, DOI 10.1121/1.1914533; DARVENNES CM, 1990, J ACOUST SOC AM, V87, P1955, DOI 10.1121/1.399322; FOX PD, 2005, P IEEE UFFC 2005 S, P1984; Hamilton M. F., 1998, NONLINEAR ACOUSTICS, P233; Kamakura T., 1984, Proceedings of the 10th International Symposium on Nonlinear Acoustics; Kite T. D., 1998, P 16 ICA 135 M ASA S, P1091; MOFFETT MB, 1977, J ACOUST SOC AM, V61, P325, DOI 10.1121/1.381310; MUIR TG, 1972, J ACOUST SOC AM, V52, P1481, DOI 10.1121/1.1913264; Sayin U, 2013, J ACOUST SOC AM, V134, P1899, DOI 10.1121/1.4817905; SHI C, 2013, P 38 INT C AC SPEECH, P31; Shi C, 2012, J ACOUST SOC AM, V131, P1938, DOI 10.1121/1.3682035; Shi C, 2014, IEICE T FUND ELECTR, VE97A, P1859, DOI 10.1587/transfun.E97.A.1859; Shi C., 2013, P M AC, V19; Shi CA, 2011, IEEE T ULTRASON FERR, V58, P437, DOI 10.1109/TUFFC.2011.1821; Tanaka N, 2011, J ACOUST SOC AM, V129, P165, DOI 10.1121/1.3514543; Tanaka N, 2010, J ACOUST SOC AM, V127, P3526, DOI 10.1121/1.3409483; WESTERVELT PJ, 1963, J ACOUST SOC AM, V35, P535, DOI 10.1121/1.1918525; YONEYAMA M, 1983, J ACOUST SOC AM, V73, P1532, DOI 10.1121/1.389414; Zheng M, 1999, J SOUND VIB, V228, P177, DOI 10.1006/jsvi.1999.2408	24	1	1	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	FEB	2015	137	2					777	784		10.1121/1.4906163		8	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CC0KO	WOS:000350024600039		
J	Ishikawa-Takata, K; Nagaya, M; Nakazawa, M; Ohta, T				Ishikawa-Takata, Kazuko; Nagaya, Masahiro; Nakazawa, Makoto; Ohta, Toshiki			EXERCISE WITHOUT DIGESTIVE ENZYME SUPPLEMENTATION WORSENS NUTRITIONAL STATUS OF FRAIL OLDER WOMEN	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Ishikawa-Takata, Kazuko] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Nagaya, Masahiro] Geriatr Hlth Serv Facil, Luminous Obu, Aichi, Japan; [Nakazawa, Makoto] Aichi Rehabil Hosp, Nagoya, Aichi, Japan; [Ohta, Toshiki] Nagoya Heart Ctr, Nagoya, Aichi, Japan	Ishikawa-Takata, K (reprint author), Natl Inst Hlth & Nutr, Tokyo 162, Japan.				Comprehensive Research on Aging and Health, Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare	This work was supported by a Comprehensive Research on Aging and Health, Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare.	Volkert D, 2011, INT J VITAM NUTR RES, V81, P109, DOI 10.1024/0300-9831/a000061; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Collin C, 1988, Int Disabil Stud, V10, P61; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Milne AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub3; Shibata H, 1999, GERIATR MED, V37, P1355; Yamada T, 2005, DIGESTIVE ORGAN IMMU, V42, P137	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	FEB	2015	63	2					386	388		10.1111/jgs.13263		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CB8PP	WOS:000349893300028		
J	Okumiya, K; Fujisawa, M; Sakamoto, R; Wada, T; Chen, WL; Imai, H; Ishimoto, Y; Kimura, Y; Fukutomi, E; Sasiwongsaroj, K; Kato, E; Tanaka, M; Hirosaki, M; Kasahara, Y; Nakatsuka, M; Nose, M; Ishine, M; Yamamoto, N; Otsuka, K; Matsubayashi, K				Okumiya, Kiyohito; Fujisawa, Michiko; Sakamoto, Ryota; Wada, Taizo; Chen, Wen-Ling; Imai, Hissei; Ishimoto, Yasuko; Kimura, Yumi; Fukutomi, Eriko; Sasiwongsaroj, Kwanchit; Kato, Emiko; Tanaka, Mire; Hirosaki, Mayumi; Kasahara, Yoriko; Nakatsuka, Masahiro; Nose, Mitsuhiro; Ishine, Masayuki; Yamamoto, Naomune; Otsuka, Kuniaki; Matsubayashi, Kozo			EFFECT OF EARLY DIAGNOSIS AND LIFESTYLE MODIFICATION ON DEPRESSIVE SYMPTOMS IN COMMUNITY-DWELLING ELDERLY ADULTS WITH GLUCOSE INTOLERANCE: 5-YEAR LONGITUDINAL STUDY	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							DIABETES-MELLITUS; PEOPLE		[Okumiya, Kiyohito; Fujisawa, Michiko; Wada, Taizo; Ishimoto, Yasuko; Kimura, Yumi; Sasiwongsaroj, Kwanchit; Nose, Mitsuhiro; Matsubayashi, Kozo] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan; [Okumiya, Kiyohito] Res Inst Human & Nat, Kyoto, Japan; [Sakamoto, Ryota] Kyoto Univ, Ctr Southeast Asian Studies, Hakubi Ctr Adv Res, Kyoto, Japan; [Chen, Wen-Ling; Imai, Hissei; Fukutomi, Eriko; Kato, Emiko; Tanaka, Mire] Kyoto Univ, Sch Publ Hlth, Dept Field Med, Kyoto, Japan; [Hirosaki, Mayumi] Kansai Univ, Fac Hlth & Well Being, Sakai, Osaka, Japan; [Kasahara, Yoriko] Kanto Gakuin Univ, Coll Nursing, Yokohama, Kanagawa, Japan; [Nakatsuka, Masahiro] Sakakibara Hakuho Hosp, Tsu, Mie, Japan; [Ishine, Masayuki] Yasugi Clin, Hamada, Shimane, Japan; [Yamamoto, Naomune] Aino Hosp, Dept Internal Med, Osaka, Japan; [Otsuka, Kuniaki] Tokyo Womens Med Univ, Tokyo, Japan	Okumiya, K (reprint author), Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan.						Matsubayashi K, 2012, GERIATR GERONTOL INT, V12, P5, DOI 10.1111/j.1447-0594.2011.00738.x; Kimbro LB, 2014, J AM GERIATR SOC, V62, P1017, DOI 10.1111/jgs.12833; Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137; desJonge P, 2006, DIABETOLOGIA, V49, P2627; Matsubayashi K, 1996, LANCET, V347, P60, DOI 10.1016/S0140-6736(96)91592-5; Okumiya K, 2008, J AM GERIATR SOC, V56, P767, DOI 10.1111/j.1532-5415.2008.01617.x; Okumiya K, 2014, J AM GERIATR SOC, V63, P190; Okumiya K, 2012, GERIATR GERONTOL INT, V12, P755, DOI 10.1111/j.1447-0594.2012.00854.x; Okumiya K, 2005, GERIATR GERONTOL INT, V5, P267, DOI DOI 10.1111/J.1447-0594.2005.00300.X; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	FEB	2015	63	2					393	395		10.1111/jgs.13269		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CB8PP	WOS:000349893300032		
J	Sakakibara, R; Doi, H; Sato, M; Hirai, S; Masaka, T; Kishi, M; Tsuyusaki, Y; Tateno, A; Tateno, F; Aiba, Y; Ogata, T; Suzuki, Y				Sakakibara, Ryuji; Doi, Hirokazu; Sato, Mitsutoshi; Hirai, Shigekazu; Masaka, Tohru; Kishi, Masahiko; Tsuyusaki, Yohei; Tateno, Akihiko; Tateno, Fuyuki; Aiba, Yosuke; Ogata, Tsuyoshi; Suzuki, Yasuo			NIZATIDINE AMELIORATES SLOW TRANSIT CONSTIPATION IN PARKINSON'S DISEASE	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Sakakibara, Ryuji; Kishi, Masahiko; Tsuyusaki, Yohei; Tateno, Akihiko; Tateno, Fuyuki; Ogata, Tsuyoshi] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Chiba, Japan; [Doi, Hirokazu; Hirai, Shigekazu; Masaka, Tohru] Toho Univ, Sakura Med Ctr, Pharmaceut Unit, Sakura, Chiba, Japan; [Sato, Mitsutoshi] Toho Univ, Fac Pharmaceut Sci, Dept Pharmacol & Toxicol, Funabashi, Chiba 274, Japan; [Aiba, Yosuke; Suzuki, Yasuo] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Gastroenterol, Sakura, Chiba, Japan	Sakakibara, R (reprint author), Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Chiba, Japan.						HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Doi H, 2014, MOVEMENT DISORD, V29, P562, DOI 10.1002/mds.25777; Sakakibara R, 2014, PARKINSONISM RELAT D, V20, P267, DOI 10.1016/j.parkreldis.2013.11.001; Doi H, 2012, J NEUROL SCI, V319, P86, DOI 10.1016/j.jns.2012.05.010; Tateno F, 2011, PARKINSONISM RELAT D, V17, P662, DOI 10.1016/j.parkreldis.2011.06.002; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P2429, DOI 10.1210/jc.2003-031517; Futagami S, 2012, DIGESTION, V86, P114, DOI 10.1159/000339111; PIPER DW, 1995, J GASTROEN HEPATOL, V10, P205, DOI 10.1111/j.1440-1746.1995.tb01079.x; Sakakibara R, 2011, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011/924605; UEKI S, 1993, J PHARMACOL EXP THER, V264, P152	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	FEB	2015	63	2					399	401		10.1111/jgs.13279		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CB8PP	WOS:000349893300035		
J	Nakajima, M; Mizooka, M; Tazuma, S				Nakajima, Masamitsu; Mizooka, Masafumi; Tazuma, Susumu			BLACK HAIRY TONGUE TREATED WITH ORAL ANTIBIOTICS: A CASE REPORT	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Nakajima, Masamitsu; Mizooka, Masafumi; Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan; [Nakajima, Masamitsu] Hiroshima Int Univ, Fac Hlth Sci, Hiroshima, Japan	Nakajima, M (reprint author), Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan.						SARTI GM, 1990, AM FAM PHYSICIAN, V41, P1751; Korber A, 2006, NEW ENGL J MED, V354, P67, DOI 10.1056/NEJMicm050117; Thompson DF, 2010, PHARMACOTHERAPY, V30, P585, DOI 10.1592/phco.30.6.585; Kannan S, 2014, J AM GERIATR SOC, V62, P992, DOI 10.1111/jgs.12813; Kobayashi K, 2010, DERMATOL RES PRACT, V2010; Sheikh Z, 2011, LANCET, V377, P1183, DOI 10.1016/S0140-6736(10)60930-0; Swinburne G, 1939, J LARYNGOL OTOL, V54, P386; Tobe M, 1955, KOKUBYO GAKKAI ZASSH, V3, P111; Vano-Galvan S, 2008, CLEV CLIN J MED, V75, P847, DOI 10.3949/ccjm.75a.08023	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	FEB	2015	63	2					412	413		10.1111/jgs.13260		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CB8PP	WOS:000349893300042		
J	Tachibana, K; Takayanagi, K; Akimoto, A; Ueda, K; Shinkai, Y; Umezawa, M; Takeda, K				Tachibana, Ken; Takayanagi, Kohei; Akimoto, Ayame; Ueda, Kouji; Shinkai, Yusuke; Umezawa, Masakazu; Takeda, Ken			Prenatal diesel exhaust exposure disrupts the DNA methylation profile in the brain of mouse offspring	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Brain; DNA methylation; Diesel exhaust; Prenatal exposure	EPIGENETIC TRANSGENERATIONAL ACTIONS; PARTICULATE AIR-POLLUTION; IN-UTERO EXPOSURE; DEVELOPMENTAL ORIGINS; LOCOMOTOR-ACTIVITY; MUTATION-RATES; DISEASE; PARTICLES; MICE; NEUROINFLAMMATION	Prenatal diesel exhaust (DE) exposure is associated with detrimental health effects in offspring. Although previous reports suggest that DE exposure affects the brain of offspring in the developmental period, the molecular events associated with the health effects have largely remained unclear. We hypothesized that the DNA methylation state would be disrupted by prenatal DE exposure. In the present study, the authors examined the genome-wide DNA methylation state of the gene promoter and bioinformatically analyzed the obtained data to identify the molecular events related to disrupted DNA methylation, Pregnant C57BL/6J mice were exposed to DE (DEP; 0.1 mg/m(3)) in an inhalation chamber on gestational days 0-16. Brains were collected from 1-day-old and 21-day-old offspring. The genomewide DNA methylation state of the brain genome was analyzed by methylation-specific DNA immunoprecipitation and subsequent promoter tiling array analysis. The genes in which the DNA methylation level was affected by prenatal DE exposure were bioinformatically categorized using Gene Ontology (GO). Differentially methylated DNA regions were detected in all chromosomes in brains collected from both 1-day-old and 21-day-old offspring. Altered DNA methylation was observed independently of the presence of CpG island. Bioinformatic interpretation using GO terms showed that differentially methylated genes with CpG islands in their promoter were commonly enriched in neuronal differentiation and neurogenesis. The results suggest that prenatal DE exposure causes genome-wide disruption of DNA methylation in the brain. Disrupted DNA methylation would disturb neuronal development in the developmental period and may be associated with health and disease in later life.	[Tachibana, Ken; Takayanagi, Kohei; Akimoto, Ayame; Ueda, Kouji; Shinkai, Yusuke; Umezawa, Masakazu; Takeda, Ken] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hygien Chem, Noda, Chiba 2788510, Japan; [Tachibana, Ken; Umezawa, Masakazu; Takeda, Ken] Tokyo Univ Sci, Ctr Environm Hlth Sci Next Generat, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Tachibana, K (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hygien Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tachibana@nichiyaku.ac.jp			JSPS KAKENHI [22710067]; Ministry of Health, Labour and Welfare of Japan; Strategic Research Foundation at Private Universities	We thank the graduate and undergraduate students at the Takeda laboratory for their help with the experiments. We also thank Dr. Masaya Ohtsu (Tokyo University of Science) for helpful discussion. This work was supported in part by a JSPS KAKENHI Grant, Number 22710067 (Ken Tachibana); a MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015 (Ken Takeda); and a Grant-in-Aid for the Health and Labour Science Research Grant, Research on the Risk of Chemical Substances, from the Ministry of Health, Labour and Welfare of Japan (Ken Takeda).	Li Ying-Ji, 2010, Inflammation & Allergy Drug Targets, V9, P300; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Yamagishi N, 2012, INHAL TOXICOL, V24, P459, DOI 10.3109/08958378.2012.688225; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Peters S, 2013, INT J CANCER, V132, P2975, DOI 10.1002/ijc.27972; Amir RE, 1999, NAT GENET, V23, P185; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Roth TL, 2009, BBA-GEN SUBJECTS, V1790, P869, DOI 10.1016/j.bbagen.2009.06.009; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; CROSFILL ML, 1961, J PHYSIOL-LONDON, V158, P1; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Tucker KL, 2001, NEURON, V30, P649, DOI 10.1016/S0896-6273(01)00325-7; Liu J, 2008, TOXICOL SCI, V102, P76, DOI 10.1093/toxsci/kfm290; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Kilburn KH, 2000, ARCH ENVIRON HEALTH, V55, P11; Wick P, 2010, ENVIRON HEALTH PERSP, V118, P432, DOI 10.1289/ehp.0901200; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Rajamani KT, 2013, AUTISM RES, V6, P248, DOI 10.1002/aur.1287; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Win-Shwe TT, 2012, NANOTOXICOLOGY, V6, P543, DOI 10.3109/17435390.2011.590904; Chen RZ, 1998, NATURE, V395, P89; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Gurjar BR, 2008, ATMOS ENVIRON, V42, P1593, DOI 10.1016/j.atmosenv.2007.10.048; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Cruts B, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-4; Donaldson Ken, 2005, Part Fibre Toxicol, V2, P10, DOI 10.1186/1743-8977-2-10; Jost J P, 1993, EXS, V64, P425; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Ritz C, 2011, MUTAT RES-FUND MOL M, V712, P55, DOI [10.1016/j.mrfmmm.2011.03.007, 10.1016/j.mrfmmm.2011.04.007]; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Umezawa M, 2012, J TOXICOL SCI, V37, P1247; Watanabe N, 2001, ENVIRON HEALTH PERSP, V109, P111	53	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					1	11				11	Toxicology	Toxicology	CB5GB	WOS:000349654400001		
J	Mokudai, T; Kanno, T; Niwano, Y				Mokudai, Takayuki; Kanno, Taro; Niwano, Yoshimi			Involvement of reactive oxygen species in the cytotoxic effect of acid-electrolyzed water	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Acid-electrolyzed water; Mouse fibroblast; Cytotoxicity; Reactive oxygen species	HYPOCHLOROUS ACID; OXIDIZING WATER; ESCHERICHIA-COLI; DISINFECTION; EFFICIENCY; REDUCTION; TOXICITY; BACTERIA; CELLS	Acid-electrolyzed water (AEW) is commonly used as a disinfectant in the agricultural and medical fields. Although several studies have been conducted to examine its toxicity in vitro and in vivo, the cytotoxic mechanism of AEW has never been verified. The purpose of the present study was to elucidate the underlying mechanism by which AEW exerts its in vitro cytotoxic effect. Mouse fibroblasts treated with AEW experienced dilution rate-dependent cytotoxic effects in the 100% confluent phase as well as in the mitotic phase. The levels of intracellular reactive oxygen species (ROS) increased significantly in fully-confluent cells treated with undiluted and four times diluted AEW. In both of these treatments, cytotoxicity was also observed. It is thus concluded that the in vitro cytotoxicity of AEW is attributable to increased intracellular ROS. Additionally, the ROS responsible for these effects appears to be, at least in part, hydroxyl radical because the increase in intracellular ROS was attenuated by post-treatment with dimethyl sulfoxide, a hydroxyl radical scavenger, and with the antioxidant polyphenol, proanthocyanidin.	[Mokudai, Takayuki; Kanno, Taro; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan	Niwano, Y (reprint author), Tohoku Univ, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	niwano@m.tohoku.ac.jp			Japan Science and Technology Agency (JST) A-STEP [241FT0011]	This work was supported by a grant from the Japan Science and Technology Agency (JST) A-STEP (No. 241FT0011).	ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548; Lu ZH, 2010, J FOOD PROTECT, V73, P483; Fabrizio KA, 2004, MEAT SCI, V68, P463, DOI 10.1016/j.meatsci.2004.04.013; Rahman SME, 2011, FOOD MICROBIOL, V28, P484, DOI 10.1016/j.fm.2010.10.006; Cao W, 2009, INT J FOOD MICROBIOL, V130, P88, DOI 10.1016/j.ijfoodmicro.2008.12.021; Guentzel JL, 2008, FOOD MICROBIOL, V25, P36, DOI 10.1016/j.fm.2007.08.003; Kiura H, 2002, J MICROBIOL METH, V49, P285, DOI 10.1016/S0167-7012(01)00385-2; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; HURST JK, 1991, EUR J BIOCHEM, V202, P1275, DOI 10.1111/j.1432-1033.1991.tb16500.x; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Al-Haq MM, 2005, FOOD SCI TECHNOL RES, V11, P135, DOI 10.3136/fstr.11.135; Tanaka N, 2000, ARTIF ORGANS, V24, P921, DOI 10.1046/j.1525-1594.2000.06611.x; RAMOS CL, 1992, J BIOL CHEM, V267, P8307; Rahman SME, 2010, INT J FOOD MICROBIOL, V139, P147, DOI 10.1016/j.ijfoodmicro.2010.03.020; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Northcutt J, 2007, POULTRY SCI, V86, P2239; Feliciano L, 2012, J FOOD SCI, V77, pM182, DOI 10.1111/j.1750-3841.2012.02633.x; Gomi K, 2010, QUINTESSENCE INT, V41, pE166; Hotta K., 2000, INTENS CARE MED, V7, P97; Kubota A, 2009, SURG TODAY, V39, P514, DOI 10.1007/s00595-008-3914-4; Lee JH, 2004, J GASTROEN HEPATOL, V19, P897, DOI 10.1111/j.1400-1746.2004.03375.x; Mokudai T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046392; Morita C, 2011, ARCH ORAL BIOL, V56, P359, DOI 10.1016/j.archoralbio.2010.10.016; Nagamatsu Y, 2001, Dent Mater J, V20, P148; Nisola GM, 2011, J ENVIRON SCI HEAL A, V46, P263, DOI 10.1080/10934529.2011.535428; Okubo K, 1999, Kansenshogaku Zasshi, V73, P1025; Oomori T, 2000, ANAL SCI, V16, P365, DOI 10.2116/analsci.16.365; Park YB, 2009, J FOOD SCI, V74, pM185, DOI 10.1111/j.1750-3841.2009.01139.x; Rodriguez-Garcia O, 2011, J FOOD PROTECT, V74, P1552, DOI 10.4315/0362-028X.JFP-11-047; Sharma RR, 2003, INT J FOOD MICROBIOL, V86, P231, DOI 10.1016/S0168-1605(02)00549-4	31	2	2	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					13	19				7	Toxicology	Toxicology	CB5GB	WOS:000349654400002		
J	Yamazaki-Hashimoto, Y; Nakamura, Y; Ohara, H; Cao, X; Kitahara, K; Izumi-Nakaseko, H; Ando, K; Yamazaki, H; Ikeda, T; Yamazaki, J; Sugiyama, A				Yamazaki-Hashimoto, Yukiko; Nakamura, Yuji; Ohara, Hiroshi; Cao, Xin; Kitahara, Ken; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Yamazaki, Hiroshi; Ikeda, Takanori; Yamazaki, Junichi; Sugiyama, Atsushi			Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Fluvoxamine; Long QT syndrome; Arrhythmia; I-Kr; SSRI	TORSADES-DE-POINTES; IN-VIVO EXPERIMENTS; DEPRESSED-PATIENTS; PLASMA-CONCENTRATIONS; PROKINETIC AGENTS; ANTI-DEPRESSANTS; HUMANIZED LIVER; CHIMERIC MICE; PROLONGATION; PHARMACOKINETICS	Fluvoxamine is one of the typical selective serotonin-reuptake inhibitors. While its combined use with QT-prolonging drugs has been contraindicated because of the increase in plasma concentrations of such drugs, information is still limited whether fluvoxamine by itself may directly prolong the QT interval. We examined electropharmacological effects of fluvoxamine together with its pharmacokinetic profile by using the halothane-anesthetized dogs (n = 4). Fluvoxamine was intravenously administered in three escalating doses of 0.1, 1 and 10 mg/kg over 10 min with a pause of 20 min between the doses. The low dose provided therapeutic plasma drug concentration, whereas the middle and high doses attained approximately 10 and 100 times of the therapeutic ones, respectively. Supra-therapeutic concentration of fluvoxamine exerted the negative chronotropic, inotropic and hypotensive effects; and suppressed the atrioventricular nodal and intraventricular conductions, indicating inhibitory actions on Ca2+ and Na+ channels, whereas it delayed the repolarization in a reverse use-dependent manner, reflecting characteristics of rapidly activating delayed rectifier K+ current channel-blocking property. Fluvoxamine prolonged the terminal repolarization phase at 100 times higher concentration than the therapeutic, indicating its proarrhythmic potential. Thus, fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.	[Yamazaki-Hashimoto, Yukiko; Nakamura, Yuji; Ohara, Hiroshi; Cao, Xin; Kitahara, Ken; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Sugiyama, Atsushi] Toho Univ, Fac Med, Dept Pharmacol, Ota Ku, Tokyo 1438540, Japan; [Yamazaki-Hashimoto, Yukiko; Ohara, Hiroshi; Kitahara, Ken; Ikeda, Takanori; Yamazaki, Junichi] Toho Univ, Fac Med, Dept Internal Med, Div Cardiovasc Med,Ota Ku, Tokyo 1438541, Japan; [Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan	Sugiyama, A (reprint author), Toho Univ, Fac Med, Dept Pharmacol, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	atsushi.sugiyama@med.toho-u.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Culture, Sports, Science, and Technology in Japan [25460344, S1101016]; Japan Science and Technology Agency [A52116907E]; Toho University Joint Research Fund [H25-3, H26-2]	This study was supported in part by Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (#25460344, #S1101016), Japan Science and Technology Agency (#A52116907E), and Toho University Joint Research Fund (H25-3, H26-2). The authors thank Professor M. Hone for his useful advice, Dr. N. Murayama, Mr. Y. Sugiyama and Miss S. Shida for their technical supports, and Ms. M. Nakatani for proofreading the manuscript.	Kanjanauthai S, 2008, INT J CARDIOL, V131, pE33, DOI 10.1016/j.ijcard.2007.08.006; Granfors MT, 2004, CLIN PHARMACOL THER, V75, P331, DOI 10.1016/j.clpt.2003.12.005; Wenzel-Seifert K, 2011, DTSCH ARZTEBL INT, V108, P687, DOI 10.3238/arztebl.2011.0687; Beach SR, 2014, J CLIN PSYCHIAT, V75, pE441, DOI 10.4088/JCP.13r08672; Carlsson L, 1997, J PHARMACOL EXP THER, V282, P220; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; CLAASSEN V, 1983, BRIT J CLIN PHARMACO, V15, pS349; de Boer Rudolf A, 2005, BMC Emerg Med, V5, P5, DOI 10.1186/1471-227X-5-5; DEWILDE JE, 1983, BRIT J CLIN PHARMACO, V15, pS427; DEWILDE JEM, 1982, J AFFECT DISORDERS, V4, P249, DOI 10.1016/0165-0327(82)90009-X; Emoto C, 2009, XENOBIOTICA, V39, P227, DOI 10.1080/00498250802668863; GUELFI JD, 1983, BRIT J CLIN PHARMACO, V15, pS411; Ishigooka J., 1993, CLIN EVAL, V21, P441; Kise H, 2010, BASIC CLIN PHARMACOL, V106, P288, DOI 10.1111/j.1742-7843.2009.00477.x; KLOK CJ, 1981, ACTA PSYCHIAT SCAND, V64, P1, DOI 10.1111/j.1600-0447.1981.tb00756.x; Kogut Christopher, 2013, Ther Adv Drug Saf, V4, P189, DOI 10.1177/2042098613492366; MANET P, 1993, THERAPIE, V48, P62; Milnes JT, 2003, BRIT J PHARMACOL, V139, P887, DOI 10.1038/sj.bjp.0705335; Mitsumori Y, 2010, CARDIOVASC TOXICOL, V10, P275, DOI 10.1007/s12012-010-9084-9; Nia AM, 2012, EUR J CLIN PHARMACOL, V68, P109, DOI 10.1007/s00228-011-1091-7; Ohtani H, 2001, BIOL PHARM BULL, V24, P550, DOI 10.1248/bpb.24.550; Okayasu H, 2012, PHARMACOPSYCHIATRY, V45, P279, DOI 10.1055/s-0032-1308969; Omori IM, 2009, J PSYCHOPHARMACOL, V23, P539, DOI 10.1177/0269881108089876; ROBINSON JF, 1982, BRIT J CLIN PHARMACO, V14, P805; de la Torre BR, 2001, THER DRUG MONIT, V23, P435, DOI 10.1097/00007691-200108000-00019; ROOS JC, 1983, BRIT J CLIN PHARMACO, V15, pS439; SALETU B, 1977, J NEURAL TRANSM, V41, P17, DOI 10.1007/BF01252962; Sato N., 1995, JPN PHARMACOL THER, V23, P637; Singh P., 2014, CASE REP MED, V2014, P1, DOI [10.1155/2014/296463, DOI 10.1155/2014/917846, 10.1155/2014/917846]; Sugiyama A, 1998, TOXICOL APPL PHARM, V152, P261, DOI 10.1006/taap.1998.8494; Sugiyama A, 2008, BRIT J PHARMACOL, V154, P1528, DOI 10.1038/bjp.2008.240; Sugiyama A, 2004, J PHARMACOL SCI, V96, P436, DOI 10.1254/jphs.FPJ04025X; Sugiyama A, 2002, JPN J PHARMACOL, V88, P414, DOI 10.1254/jjp.88.414; Tsukada A, 2013, REGUL TOXICOL PHARM, V65, P316, DOI 10.1016/j.yrtph.2013.01.008; VANDEWATER A, 1989, J PHARMACOL METHOD, V22, P207, DOI 10.1016/0160-5402(89)90015-6; Wilting I, 2006, AM J PSYCHIAT, V163, P325, DOI 10.1176/appi.ajp.163.2.325; WOUTERS W, 1983, ARCH INT PHARMACOD T, V263, P197; Yamashita M, 2014, REGUL TOXICOL PHARM, V70, P214, DOI 10.1016/j.yrtph.2014.06.028	39	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					33	42				10	Toxicology	Toxicology	CB5GB	WOS:000349654400004		
J	Kawaguchi, S; Kuwahara, R; Kohara, Y; Uchida, Y; Oku, Y; Yamashita, K				Kawaguchi, Shinichiro; Kuwahara, Rika; Kohara, Yumi; Uchida, Yutaro; Oku, Yushi; Yamashita, Kimihiro			Oral exposure to low-dose of nonylphenol impairs memory performance in Sprague-Dawley rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Nonylphenol; Endocrine disruptors; Learning and memory; Behavior; Central nervous system; Rat	ELEVATED PLUS-MAZE; BISPHENOL-A; ESTROUS-CYCLE; FEMALE RATS; NUCLEUS-ACCUMBENS; ENVIRONMENTAL ESTROGEN; BEHAVIORAL ALTERATIONS; HIPPOCAMPAL-NEURONS; PERINATAL EXPOSURE; PASSIVE-AVOIDANCE	Nonylphenol ethoxylate (NPE) is a non-ionic surfactant, that is degraded to short-chain NPE and 4-nonylphenol (NP) by bacteria in the environment. NP, one of the most common environmental endocrine disruptors, exhibits weak estrogen-like activity. In this study, we investigated whether oral administration of NP (at 0.5 and 5 mg/kg doses) affects spatial learning and memory, general activity, emotionality, and fear-motivated learning and memory in male and female Sprague-Dawley (SD) rats. SD rats of both sexes were evaluated using a battery of behavioral tests, including an appetite-motivated maze test (MAZE test) that was used to assess spatial learning and memory. In the MAZE test, the time required to reach the reward in male rats treated with 0.5 mg/kg NP group and female rats administered 5 mg/kg NP was significantly longer than that for control animals of the corresponding sex. In other behavioral tests, no significant differences were observed between the control group and either of the NP-treated groups of male rats. In female rats, inner and ambulation values for animals administered 0.5 mg/kg NP were significantly higher than those measured in control animals in open-field test, while the latency in the group treated with 5 mg/kg NP was significantly shorter compared to the control group in step-through passive avoidance test. This study indicates that oral administration of a low-dose of NP slightly impairs spatial learning and memory performance in male and female rats, and alters emotionality and fear-motivated learning and memory in female rats only.	[Kawaguchi, Shinichiro] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 8528521, Japan; [Kuwahara, Rika] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kohara, Yumi; Uchida, Yutaro; Oku, Yushi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Yamashita, Kimihiro] Nagasaki Univ, Div Environm Chem & Ecotoxicol, Inst Environm Studies, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan	Yamashita, K (reprint author), Nagasaki Univ, Div Environm Chem & Ecotoxicol, Inst Environm Studies, Grad Sch Fisheries Sci & Environm Studies, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kimihiro@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22510069]	This study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22510069).	Aly HAA, 2012, TOXICOL APPL PHARM, V261, P134, DOI 10.1016/j.taap.2012.02.015; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Inagaki T, 2012, ENDOCRINOLOGY, V153, P3357, DOI 10.1210/en.2012-1121; Nishihara T, 2000, J HEALTH SCI, V46, P282; Chapin RE, 1999, TOXICOL SCI, V52, P80, DOI 10.1093/toxsci/52.1.80; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253; Jie X, 2010, BIRTH DEFECTS RES B, V89, P418, DOI 10.1002/bdrb.20268; Kuwahara R, 2013, J PHARMACOL SCI, V123, P132, DOI 10.1254/jphs.13093FP; Xu XH, 2011, TOXICOL APPL PHARM, V255, P221, DOI 10.1016/j.taap.2011.06.022; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Phan A, 2012, NEUROPSYCHOPHARMACOL, V37, P2299, DOI 10.1038/npp.2012.82; Ferguson SA, 2000, NEUROTOXICOL TERATOL, V22, P583, DOI 10.1016/S0892-0362(00)00071-4; Nagao T, 2001, REPROD TOXICOL, V15, P293, DOI 10.1016/S0890-6238(01)00123-X; Morgan MA, 2001, HORM BEHAV, V40, P472, DOI 10.1006/hbeh.2001.1716; Komatsu T, 2008, EXP GERONTOL, V43, P339, DOI 10.1016/j.exger.2008.01.008; Goodman YD, 1996, J NEUROCHEM, V66, P1836; McEwen B, 2001, P NATL ACAD SCI USA, V98, P7093, DOI 10.1073/pnas.121146898; Ying GG, 2002, ENVIRON INT, V28, P215, DOI 10.1016/S0160-4120(02)00017-X; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Galeeva A, 2001, BEHAV BRAIN RES, V119, P41, DOI 10.1016/S0166-4328(00)00341-7; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Zalko D, 2003, DRUG METAB DISPOS, V31, P168, DOI 10.1124/dmd.31.2.168; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1598, DOI 10.1038/sj.npp.1300713; Negishi T, 2004, ENVIRON HEALTH PERSP, V112, P1159, DOI 10.1289/ehp.6961; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Cunny HC, 1997, REGUL TOXICOL PHARM, V26, P172, DOI 10.1006/rtph.1997.1154; Flynn KM, 2002, NEUROTOXICOLOGY, V23, P87, DOI 10.1016/S0161-813X(02)00007-4; Frye CA, 2005, BRAIN RES, V1036, P101, DOI 10.1016/j.brainres.2004.12.014; Gao QH, 2013, TOXICOL LETT, V218, P137, DOI 10.1016/j.toxlet.2013.01.016; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Kuwahara R, 2014, CELL MOL NEUROBIOL, V34, P333, DOI 10.1007/s10571-013-0017-6; Lee PC, 1996, B ENVIRON CONTAM TOX, V57, P341; Mao Z, 2011, INT J MOL SCI, V12, P114, DOI 10.3390/ijms12010114; Matsunaga H, 2010, J NEUROCHEM, V114, P1333, DOI 10.1111/j.1471-4159.2010.06847.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Noda S., 2006, J TOXICOL PATHOL, V18, P203, DOI 10.1293/tox.18.203; Obata T, 2000, NEUROSCI LETT, V296, P41, DOI 10.1016/S0304-3940(00)01619-0; Obata T, 2001, BBA-GEN SUBJECTS, V1568, P171, DOI 10.1016/S0304-4165(01)00214-8; Odum J, 2000, TOXICOL SCI, V56, P400, DOI 10.1093/toxsci/56.2.400; Pompili A, 2010, BEHAV BRAIN RES, V213, P10, DOI 10.1016/j.bbr.2010.04.018; PRADOALCALA RA, 1985, PHARMACOL BIOCHEM BE, V22, P243, DOI 10.1016/0091-3057(85)90385-5; STEFANSKI R, 1993, NEUROPHARMACOLOGY, V32, P987, DOI 10.1016/0028-3908(93)90063-9; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; van Goethem NP, 2012, BEHAV BRAIN RES, V232, P323, DOI 10.1016/j.bbr.2012.03.023	46	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					43	53				11	Toxicology	Toxicology	CB5GB	WOS:000349654400005		
J	Ochi, M; Kawai, Y; Tanaka, Y; Toyoda, H				Ochi, Masanori; Kawai, Yoshiko; Tanaka, Yoshiyuki; Toyoda, Hiromu			Characterization of nicardipine hydrochloride-induced cell injury in human vascular endothelial cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Nicardipine hydrochloride; Autophagy; Cytotoxicity; Vascular injury; Endothelial cells	AUTOPHAGY; HYPERTENSION; PATHWAYS; CALCIUM; DEATH	Nicardipine hydrochloride (NIC), a dihydropyridine calcium-channel blocking agent, has been widely used for the treatment of hypertension. Especially, nicardipine hydrochloride injection is used as first-line therapy for emergency treatment of abnormally high blood pressure. Although NIC has an attractive pharmacological profile, one of the dose-limiting factors of NIC is severe peripheral vascular injury after intravenous injection. The goal of this study was to better understand and thereby reduce NIC-mediated vascular injury. Here, we investigated the mechanism of NIC-induced vascular injury using human dermal microvascular endothelial cells (HMVECs). NIC decreased cell viability and increased percent of dead cells in a dose-dependent manner (10-30 mu g/mL). Although cell membrane injury was not significant over 9 hr exposure, significant changes of cell morphology and increases in vacuoles in HMVECs were observed within 30 min of NIC exposure (30 mu g/mL). Autophagosome labeling with monodansylcadaverine revealed increased autophagosomes in the NIC-treated cells, whereas caspase 3/7 activity was not increased in the NIC-treated cells (30 mu g/mL). Additionally, NIC-induced reduction of cell viability was inhibited by 3-methyladenine, an inhibitor of autophagosome formation. These findings suggest that NIC causes severe peripheral venous irritation via induction of autophagic cell death and that inhibition of autophagy could contribute to the reduction of NIC-induced vascular injury.	[Ochi, Masanori; Tanaka, Yoshiyuki; Toyoda, Hiromu] Sawai Pharmaceut Co Ltd, Dept Biol Res, Yodogawa Ku, Osaka 5320003, Japan; [Kawai, Yoshiko] Osaka Univ Pharmaceut Sci, Lab Pharmacol, Takatsuki, Osaka 5691094, Japan	Ochi, M (reprint author), Sawai Pharmaceut Co Ltd, Dept Biol Res, Yodogawa Ku, 2-30,Miyahara 5 Chome, Osaka 5320003, Japan.	m.ochi@sawai.co.jp					Aki T, 2008, J PHARMACOL SCI, V106, P415, DOI 10.1254/jphs.FP0072035; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; WALLIN JD, 1988, AM J MED, V85, P331, DOI 10.1016/0002-9343(88)90582-7; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Demarchi F, 2007, AUTOPHAGY, V3, P235; Hagiwara K, 2003, NEUROSCI RES, V46, P493, DOI 10.1016/S0168-0102(03)00126-3; Kongara Sameera, 2012, Front Oncol, V2, P171, DOI 10.3389/fonc.2012.00171; Sane AT, 1997, BIOCHEM CELL BIOL, V75, P359; SORKIN EM, 1987, DRUGS, V33, P296, DOI 10.2165/00003495-198733040-00002; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; Thomberry NA, 1998, SCIENCE, V281, P1312; Weedon D, 1979, Am J Dermatopathol, V1, P133; Wisnoskey BJ, 2004, AM J PHYSIOL-CELL PH, V287, pC345, DOI 10.1152/ajpcell.00473.2003; YEH CJG, 1981, J IMMUNOL METHODS, V43, P269, DOI 10.1016/0022-1759(81)90174-5; Yuasa Tetsuya, 1997, Journal of Dermatology (Tokyo), V24, P466	18	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					71	76				6	Toxicology	Toxicology	CB5GB	WOS:000349654400007		
J	Kaneko, MAN; Hirota, M; Kouzuki, H; Mori, M				Kaneko, Maki Aiba Nee; Hirota, Morihiko; Kouzuki, Hirokazu; Mori, Masaaki			Prediction of genotoxic potential of cosmetic ingredients by an in silico battery system consisting of a combination of an expert rule-based system and a statistics-based system	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Mutagenicity; Genotoxicity; In silico; Cosmetic ingredient; INCI; Decision tree	CHEMICAL-STRUCTURE; SALMONELLA MUTAGENICITY; MICRONUCLEUS ASSAY; QSAR ANALYSIS; CARCINOGENS; VITRO; TESTS; PHENOLPHTHALEIN; TOXICOLOGY; CELLS	Genotoxicity is the most commonly used endpoint to predict the carcinogenicity of chemicals. The International Conference on Harmonization (ICH) M7 Guideline on Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk offers guidance on (quantitative) structure-activity relationship ((Q)SAR) methodologies that predict the outcome of bacterial mutagenicity assay for actual and potential impurities. We examined the effectiveness of the (Q)SAR approach with the combination of DEREK NEXUS as an expert rule-based system and ADMEWorks as a statistics-based system for the prediction of not only mutagenic potential in the Ames test, but also genotoxic potential in mutagenicity and clastogenicity tests, using a data set of 342 chemicals extracted from the literature. The prediction of mutagenic potential or genotoxic potential by DEREK NEXUS or ADMEWorks showed high values of sensitivity and concordance, while prediction by the combination of DEREK NEXUS and ADME Works (battery system) showed the highest values of sensitivity and concordance among the three methods, but the lowest value of specificity. The number of false negatives was reduced with the battery system. We also separately predicted the mutagenic potential and genotoxic potential of 41 cosmetic ingredients listed in the International Nomenclature of Cosmetic Ingredients (INCI) among the 342 chemicals. Although specificity was low with the battery system, sensitivity and concordance were high. These results suggest that the battery system consisting of DEREK NEXUS and ADMEWorks is useful for prediction of genotoxic potential of chemicals, including cosmetic ingredients.	[Kaneko, Maki Aiba Nee; Hirota, Morihiko; Kouzuki, Hirokazu; Mori, Masaaki] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan	Mori, M (reprint author), Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	masaaki.mori@to.shiseido.co.jp					Akagi A, 1998, FOOD CHEM TOXICOL, V36, P1065, DOI 10.1016/S0278-6915(98)00077-5; AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281; HAYASHI M, 1990, MUTAT RES, V245, P245, DOI 10.1016/0165-7992(90)90153-B; Sobol Z, 2012, MUTAT RES-GEN TOX EN, V746, P29, DOI 10.1016/j.mrgentox.2012.02.005; Martins IF, 2012, J CHEM INF MODEL, V52, P1686, DOI 10.1021/ci300124c; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; Hillebrecht A, 2011, CHEM RES TOXICOL, V24, P843, DOI 10.1021/tx2000398; Pearlstein RA, 2003, BIOORG MED CHEM LETT, V13, P1829, DOI 10.1016/S0960-894X(03)00196-3; Li HY, 2011, BIOPHARM DRUG DISPOS, V32, P333, DOI 10.1002/bdd.762; White AC, 2003, MUTAT RES-GEN TOX EN, V539, P77, DOI 10.1016/S1383-5718(03)00135-9; Naven RT, 2010, EXPERT OPIN DRUG MET, V6, P797, DOI 10.1517/17425255.2010.495118; Fukushima S, 2005, CARCINOGENESIS, V26, P1835, DOI 10.1093/carcin/bgi160; Mekenyan OG, 2004, CURR PHARM DESIGN, V10, P1273, DOI 10.2174/1381612043452596; Myshkin E, 2012, CHEM BIOL DRUG DES, V80, P406, DOI 10.1111/j.1747-0285.2012.01411.x; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; ASHBY J, 1988, MUTAT RES, V204, P17, DOI 10.1016/0165-1218(88)90114-0; Greene N, 1999, SAR QSAR ENVIRON RES, V10, P299, DOI 10.1080/10629369908039182; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z; Sutter A, 2013, REGUL TOXICOL PHARM, V67, P39, DOI 10.1016/j.yrtph.2013.05.001; Contrera JF, 2003, REGUL TOXICOL PHARM, V38, P243, DOI 10.1016/S0273-2300(03)00071-0; ASHBY J, 1991, MUTAT RES, V257, P229, DOI 10.1016/0165-1110(91)90003-E; Bley K, 2012, TOXICOL PATHOL, V40, P847, DOI 10.1177/0192623312444471; DeGroot AC, 1997, CONTACT DERMATITIS, V37, P145; Dieter M.P., 1990, NIH PUBLICATION, V89-2824; Dieter M.P., 1990, TECHNICAL REPORT SER, V369; Dunnick JK, 1996, CANCER RES, V56, P4922; Hayashi M., 2007, ALTERN ANIMAL TEST E, V14, P9; Hayashi M, 2005, MUTAT RES-GEN TOX EN, V588, P129, DOI 10.1016/j.mrgentox.2005.09.009; HAYASHI M, 1988, FOOD CHEM TOXICOL, V26, P487, DOI 10.1016/0278-6915(88)90001-4; Herbold B, 1998, MUTAT RES-GEN TOX EN, V412, P167, DOI 10.1016/S1383-5718(97)00189-7; Hosea NA, 2013, MOL PHARMACEUT, V10, P1207, DOI 10.1021/mp300482w; IARC, 2000, SOM ANT ANT DRUGS OT, V76, P385; ICH, 1995, GUID SPEC ASP REG GE; ICH, 2011, GUID GEN TEST DAT IN; ICH M7, 2014, ASS CONTR DNA REACT; IPCS, 2014, ALPH METH ALC INCHEM; Ishidate M, 1998, MUTAT RES-FUND MOL M, V404, P167, DOI 10.1016/S0027-5107(98)00110-9; Klauning J. E., 2008, CASARETT DOULLS TOXI; Matsushima T, 1999, MUTAGENESIS, V14, P569, DOI 10.1093/mutage/14.6.569; Mori Masaaki, 1999, Journal of Toxicological Sciences, V24, P217; Morita T, 2012, MUTAT RES-GEN TOX EN, V741, P32, DOI 10.1016/j.mrgentox.2011.10.005; MORTELMANS K, 1986, ENVIRON MOL MUTAGEN, V8, P1, DOI 10.1002/em.2860080802; Nagabhushan M, 1986, Nutr Cancer, V8, P201; OECD, 1997, BACT REV MUT TEST TE; OECD, 2013, IS CHICK EYE TEST ME; OECD, 1997, IN VITR MAMM CHROM A; OECD, 2014, IN VITR MAMM CHROM A; OECD, 2014, IN VITR MAMM CELL MI, V487; OECD, 2004, IN VITR 3T3 NRU PHOT; OECD, 2013, BOV CORN OP PERM TES; OECD, 2013, IN VITR SKIN IRR REC; Organisation for Economic Cooperation and Development (OECD), 1997, IN VITR MAMM CELL GE; Organisation for Economic Co-operation and Development (OECD), 2004, SKIN ABS IN VITR MET; Belsito D, 2012, FOOD CHEM TOXICOL, V50, pS52, DOI 10.1016/j.fct.2011.10.042; Peters C. A., 1940, J CHEM EDUC, V17, P525; PURCHASE IFH, 1978, BRIT J CANCER, V37, P873, DOI 10.1038/bjc.1978.132; SCCS, 2014, COLIPA NO B007; Scognamiglio J, 2012, FOOD CHEM TOXICOL, V50, pS124, DOI 10.1016/j.fct.2011.10.010; Sugimura T, 1976, FUNDAMENTALS CANCER, P191; Thybaud Veronique, 2003, Mutation Research, V540, P141, DOI 10.1016/j.mrgentox.2003.07.004; Tsutsui T, 1997, INT J CANCER, V73, P697; Wanchana S, 2003, PHARMACEUT RES, V20, P1401, DOI 10.1023/A:1025702009611; WITT KL, 1995, MUTAT RES-GENET TOX, V341, P151, DOI 10.1016/0165-1218(95)90005-5; Worth A., 2011, EUR SCI TECHNICAL RE; Zeiger E., 2001, GENETIC TOXICOLOGY C, P29, DOI 10.1201/9780203904237.ch2	66	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					77	98				22	Toxicology	Toxicology	CB5GB	WOS:000349654400008		
J	Itoh, S; Nagata, M; Hattori, C; Takasaki, W				Itoh, Satoru; Nagata, Mayumi; Hattori, Chiharu; Takasaki, Wataru			Effect of buprenorphine on genotoxicity evaluation of chemicals by the rat liver micronucleus test with partial hepatectomy	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Liver; Micronucleus test; Partial hepatectomy; Analgesic drug; Buprenorphine		In the view of animal welfare considerations, we investigated the suitability of modifying the rat liver micronucleus test with partial hepatectomy to include administration of an analgesic drug to minimize pain and distress as much as possible. The effects of the analgesic, buprenorphine, on the genotoxicity evaluation of structural chromosome aberration inducers (cyclophosphamide, diethylnitrosamine and 1,2-dimethylhydrazine) and numerical chromosome aberration inducers (colchicine and carbendazim) were examined. The genotoxicants were given orally to 8-week-old male F344 rats a day before or after partial hepatectomy and hepatocytes were isolated 4 days after the partial hepatectomy. Buprenorphine was injected subcutaneously twice a day with at least a 6-hr interval for 2 days from just after partial hepatectomy. As results, buprenorphine caused neither change in clinical signs (except for one animal death) nor increase in the incidence of micronucleated hepatocytes of vehicle treated animals. In the case of concomitant treatment of buprenorphine and a genotoxicant, one out of 8 animals died in each group given buprenorphine with cyclophosphamide, carbendazim or colchicine (lower dose level only). Slight changes in clinical signs were noted in the group given buprenorphine with cyclophosphamide or carbendazim. A statistically significant increase in the incidence of micronucleated hepatocytes was obtained in concomitant treatment of buprenorphine and genotoxicant compared with genotoxicant alone for 1,2-dimethylhydrazine, colchicine and carbendazim. It is concluded that use of buprenorphine as an analgesic drug to minimize pain and distress for rats that are given partial hepatectomy is not appropriate under the present experimental conditions, because it could enhance the general toxicity and genotoxicity of the test chemical.	[Itoh, Satoru; Nagata, Mayumi; Hattori, Chiharu; Takasaki, Wataru] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan	Itoh, S (reprint author), Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kitakasai, Tokyo 1348630, Japan.	itoh.satoru.n5@daiichisankyo.co.jp					TATES AD, 1980, MUTAT RES, V74, P11, DOI 10.1016/0165-1161(80)90187-9; Igarashi M, 1997, MUTAT RES-GEN TOX EN, V391, P49, DOI 10.1016/S0165-1218(97)00031-1; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Kobayashi K, 1998, DRUG METAB DISPOS, V26, P818; BRADE WP, 1985, CANCER TREAT REV, V12, P1, DOI 10.1016/0305-7372(85)90011-8; HIYAMA T, 1982, FOLIA PHARMACOL JPN, V79, P147, DOI 10.1254/fpj.79.147; Itoh S, 2012, MUTAT RES-GEN TOX EN, V747, P98, DOI 10.1016/j.mrgentox.2012.04.007; Uno Y.T., 2014, MUTAT RES IN PRESS	8	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	FEB	2015	40	1					109	114				6	Toxicology	Toxicology	CB5GB	WOS:000349654400010		
J	Hamamoto, S; Okuma, T; Yamamoto, A; Kageyama, K; Ueki, A; Matsuoka, T; Miki, Y				Hamamoto, Shinichi; Okuma, Tomohisa; Yamamoto, Akira; Kageyama, Ken; Ueki, Ai; Matsuoka, Toshiyuki; Miki, Yukio			Combination Radiofrequency Ablation and Local Injection of the Immunostimulant Bacillus Calmette-Guerin Induces Antitumor Immunity in the Lung and at a Distant VX2 Tumor in a Rabbit Model	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							BLADDER-CANCER; HEPATOCELLULAR-CARCINOMA; IN-SITU; CELLS; ANTIGEN; BCG; INFILTRATION; LYMPHOCYTES; ACTIVATION; THERAPY	Purpose: To evaluate whether the combination of radiofrequency (RF) ablation and local injection of the immunostimulant Mycobacterium bovis bacillus Calmette Guerin (BCG) induces systemic antitumor immunity. Materials and Methods: Japanese White rabbits with lung and auricle VX2 tumors were randomized into three groups: control (n = 8; no treatment), RF ablation only (n = 8; RF ablation to the lung tumor), and RF ablation with local BCG injection into the lung tumor (n = 8). Treatments were performed 1 week after tumor implantation. Survival was evaluated with Kaplan Meier method and log-rank test. Weekly mean volume and specific growth rate (SGR) of auricle tumors were calculated, and comparisons were made by Mann Whitney test. Results: Median survival of control, RF-only, and RF/BCG groups were 23, 41.5, and 103.5 days, respectively. Survival was significantly prolonged in the RF-only and RF/BCG groups compared with the control group (P=.034 and P =.003, respectively), but no significant difference was found between the RF-only and RF/BCG groups (P=.279). Only in the RF/BCG group was mean auricle tumor volume decreased 5 weeks after implantation. No significant difference in SGR was found between the control and RF-only groups (P=.959), but SGR in the RF/BCG group, was significantly lower than in the control group (P=.005). Conclusions: The combination of RF ablation and local injection of BCG resulted in distant tumor suppression compared with the control group, whereas RF ablation alone did not produce this effect. Therefore, the combination of RF ablation-and local injection of BCG may induce systemic antitumor immunity.	[Hamamoto, Shinichi; Okuma, Tomohisa; Yamamoto, Akira; Kageyama, Ken; Ueki, Ai; Matsuoka, Toshiyuki; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Radiol, Abeno Ku, Osaka 5458585, Japan	Yamamoto, A (reprint author), Osaka City Univ, Grad Sch Med, Dept Radiol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.						Akaza H, 2003, JPN J CLIN ONCOL, V33, P382, DOI 10.1093/jjco/hyg073; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Dromi SA, 2009, RADIOLOGY, V251, P58, DOI 10.1148/radiol.2511072175; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Nakamoto Y, 2011, CLIN EXP IMMUNOL, V163, P165, DOI 10.1111/j.1365-2249.2010.04246.x; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Wissniowski TT, 2003, CANCER RES, V63, P6496; Hamamoto S, 2013, RADIOLOGY, V267, P405, DOI 10.1148/radiol.13120249; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Sapre N, 2013, BJU INT, V112, P852, DOI 10.1111/bju.12261; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Fujiwara S, 2012, J IMMUNOTHER, V35, P513, DOI 10.1097/CJI.0b013e3182619cb4; Kawamura N, 2014, METHODS MOL BIOL, V1139, P145, DOI 10.1007/978-1-4939-0345-0_13; Lima L, BJU INT IN PRESS; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Waitz R, 2009, RADIOLOGY, V251, P1, DOI 10.1148/radiol.2511082215; Zhang XH, 2002, CANCER BIOTHER RADIO, V17, P601, DOI 10.1089/108497802320970217	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	FEB	2015	26	2					271	278		10.1016/j.jvir.2014.09.002		8	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CB6MZ	WOS:000349742400021		
J	Sugimoto, K; Moriyasu, F; Kobayashi, Y; Kasuya, K; Nagakawa, Y; Tsuchida, A; Hara, T; Iobe, H; Oshiro, H				Sugimoto, Katsutoshi; Moriyasu, Fuminori; Kobayashi, Yoshiyuki; Kasuya, Kazuhiko; Nagakawa, Yuichi; Tsuchida, Akihiko; Hara, Takeshi; Iobe, Hiroaki; Oshiro, Hisashi			Assessment of Various Types of US Findings after Irreversible Electroporation in Porcine Liver: Comparison with Radiofrequency Ablation	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							SHEAR-WAVE ELASTOGRAPHY; RADIOLOGIC-PATHOLOGICAL CORRELATION; HEPATOCELLULAR-CARCINOMA; HEPATIC-TUMORS; METASTASES; ACCURACY; EFFICACY	Purpose: To assess various ultrasound (US) findings, including B-mode, shear-wave elastography (SWE), and contrastenhanced US, in accurately assessing ablation Inargins after irreversible electroporation (IRE) based on radiologic pathologic correlation, and to compare these findings between IRE and radiofrequency (RF) ablation. Materials and Methods: IRE (n = 9) and RF ablation (n = 3) were performed in-vivo in three pig livers. Each ablation zone was imaged by each method immediately after the procedure and 90 minutes later. Ablation zones were evaluated based on gross pathologic and histopathologic findings in samples from animals euthanized 2 hours after the last ablation. The characteristics and dimensions of the histologic ablation zones were qualitatively and quantitatively compared against each US finding. Results: In B-mode US at 90 minutes after IRE, the ablation zones appeared as hyperechoic areas with a peripheral hyperechoic rim, showing excellent correlation (12 = 0.905, P < .0001) with gross pathologic findings: SWE showed that tissue stiffness in the IRE ablation zones increased over time. Contrast-enhanced US depicted the IRE ablation zones as hypovascular areas in the portal phase, and showed the highest correlation (r2 = 0.923, P < .0001) with gross pathologic findings. The RF ablation zones were clearly visualized by B-mode US. SWE showed that tissue stiffness after RF ablation was higher than after IRE. Contrast-enhanced US depicted the RF ablation zones as avascular areas. Conclusions: IRE and RF ablation zones can be most accurately predicted by portal-phase contrast-enhanced US measurements obtained imMediately after ablation.	[Sugimoto, Katsutoshi; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Kasuya, Kazuhiko; Nagakawa, Yuichi; Tsuchida, Akihiko] Tokyo Med Univ, Dept Gastrointestinal & Pediat Surg, Shinjuku Ku, Tokyo 1600023, Japan; [Iobe, Hiroaki; Oshiro, Hisashi] Tokyo Med Univ, Dept Anat Pathol, Shinjuku Ku, Tokyo 1600023, Japan; [Kobayashi, Yoshiyuki] Tokyo Med Univ, Hachioji Med Ctr, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Hara, Takeshi] Gifu Univ, Dept Intelligent Image Informat, Grad Sch Med, Gifu, Japan	Sugimoto, K (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	sugimoto@tokyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26865030, 24590242]; Tokyo Medical University Cancer Research Foundation	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 26865030 to K.S. and no. 24590242 to H.O.) and the Tokyo Medical University Cancer Research Foundation.	Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; Au JT, 2013, SURGERY, V153, P787, DOI 10.1016/j.surg.2012.11.022; Appelbaum L, 2012, RADIOLOGY, V262, P117, DOI 10.1148/radiol.11110475; Hudson JM, 2013, ULTRASOUND MED BIOL, V39, P950, DOI 10.1016/j.ultrasmedbio.2012.12.011; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Morimoto M, 2002, HEPATOLOGY, V35, P1467, DOI 10.1053/jhep.2002.33635; Hosein PJ, 2014, J VASC INTERV RADIOL, V25, P1233, DOI 10.1016/j.jvir.2014.04.007; Wu J, 2013, CHINESE J CANCER RES, V25, P143, DOI 10.3978/j.issn.1000-9604.2013.01.02; Dollinger M, 2014, J VASC INTERV RADIOL, V25, P1589, DOI 10.1016/j.jvir.2014.06.026; Honjo M, 2014, J ULTRAS MED, V33, P61, DOI 10.7863/ultra.33.1.61; Shunichi S, 2009, ULTRASOUND MED BIOL, V35, P1819, DOI 10.1016/j.ultrasmedbio.2009.05.013; Sugimoto K, 2014, WORLD J GASTROENTERO, V20, P11850, DOI 10.3748/wjg.v20.i33.11850; Sugimoto K, 2014, KANZO, V55, P290; Sugimoto K, 2014, J MED ULTRA IN PRESS; WARNER AE, 1990, AM J PHYSIOL, V258, pL1; Wu HP, 2014, RADIOLOGY, V270, P107, DOI 10.1148/radiol.13121999	19	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	FEB	2015	26	2					279	287		10.1016/j.jvir.2014.11.007		9	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CB6MZ	WOS:000349742400022		
J	Hashimoto, T; Kato, N; Kondo, Y; Hirano, K; Higashigawa, T; Chino, S				Hashimoto, Takashi; Kato, Noriyuki; Kondo, Yuka; Hirano, Koji; Higashigawa, Takatoshi; Chino, Shuji			Treatment of a Ruptured Chronic Aortic Dissection Using Stent-Graft Placement and Coil Embolization	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter							COMPLICATIONS		[Hashimoto, Takashi; Kato, Noriyuki; Higashigawa, Takatoshi; Chino, Shuji] Mie Univ Hosp, Dept Radiol, Tsu, Mie 5148507, Japan; [Kondo, Yuka; Hirano, Koji] Mie Univ Hosp, Dept Cardiovasc Surg, Tsu, Mie 5148507, Japan	Hashimoto, T (reprint author), Mie Univ Hosp, Dept Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.						Kang WC, 2011, J THORAC CARDIOV SUR, V142, P1074, DOI 10.1016/j.jtcvs.2011.03.008; Kolbel T, 2013, J ENDOVASC THER, V20, P484, DOI 10.1583/13-4318.1; Eggebrecht H, 2005, CURR OPIN CARDIOL, V20, P477, DOI 10.1097/01.hco.0000181481.86025.a6; San Norberto EM, 2011, J VASC SURG, V54, P201	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	FEB	2015	26	2					288	290		10.1016/j.jvir.2014.10.004		3	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CB6MZ	WOS:000349742400023		
J	Mehedi, IM; Kubota, T; Al-Saggaf, UM				Mehedi, Ibrahim Mustafa; Kubota, Takashi; Al-Saggaf, Ubaid M.			3-Dimensional advanced solution for lunar descent and landing	JOURNAL OF VIBROENGINEERING			English	Article						lunar landing; 3-D modeling; advanced solution	POWERED-DESCENT; GUIDANCE; OPTIMIZATION	A 3-dimensional advanced guidance scheme is necessary to perform a successful precise lunar landing mission. This paper outlines a 3-dimensional comparison of different methods of solution of motion control equations for guidance scheme of lunar descent. It also proposes a 3-dimensional advanced solution that allows a full depiction for a descent vehicle motion from orbital states down to the final landing event. In the conventional 2-dimensional methods of solution, some inadequate assumptions exist that limit the validity of the solutions. The proposed research solves those problems and eventually allows a complete representation of the descent module motion for successful pinpoint lunar landing.	[Mehedi, Ibrahim Mustafa; Al-Saggaf, Ubaid M.] King Abdulaziz Univ, CEIES, Jeddah, Saudi Arabia; [Mehedi, Ibrahim Mustafa; Al-Saggaf, Ubaid M.] King Abdulaziz Univ, Dept Elect & Comp Engn, Jeddah, Saudi Arabia; [Kubota, Takashi] Univ Tokyo, Tokyo, Japan	Mehedi, IM (reprint author), King Abdulaziz Univ, CEIES, Jeddah, Saudi Arabia.	imehedi@kau.edu.sa; kubota@isas.jaxa.jp; usaggaf@kau.edu.sa	Mehedi, Ibrahim/B-1537-2014		Center of Excellence in Intelligent Engineering Systems (CEIES), King Abdulaziz University, Jeddah	This article was funded by the Center of Excellence in Intelligent Engineering Systems (CEIES), King Abdulaziz University, Jeddah. Therefore, the authors acknowledge with thanks CEIES financial support.	Acikmese B, 2011, AUTOMATICA, V47, P341, DOI 10.1016/j.automatica.2010.10.037; Ackmese B., 2007, AIAA J GUIDANCE CONT, V30, P1353; Sturm JF, 2002, OPTIM METHOD SOFTW, V17, P1105, DOI 10.1080/1055678021000045123; Miele A, 2001, ACTA ASTRONAUT, V49, P59, DOI 10.1016/S0094-5765(01)00007-8; Topcu U, 2007, J SPACECRAFT ROCKETS, V44, P324, DOI 10.2514/1.25023; Sturm JF, 1999, OPTIM METHOD SOFTW, V11-2, P625, DOI 10.1080/10556789908805766; Blackmore L, 2010, J GUID CONTROL DYNAM, V33, P1161, DOI 10.2514/1.47202; Braun RD, 2007, J SPACECRAFT ROCKETS, V44, P310, DOI 10.2514/1.25116; Cheng R., 1964, LUNAR MISSIONS EXPLO, P308; CHENG RK, 1966, J SPACECRAFT ROCKETS, V3, P1569, DOI 10.2514/3.28709; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Kenji U., 2002, 23 INT S SPAC TECHN, V1, P977; Klumpp R., 1974, AUTOMATICA, V10, P133; Klumpp R., 1971, TECHNICAL REPORT; Lutz T., 7 INT PLAN PROB WORK; Mattingley J., 2010, IEEE SIGNAL PROCESSI, V3, P1569; McInnes CR, 2003, J GUID CONTROL DYNAM, V26, P183, DOI 10.2514/2.5033; Mehedi IM, 2011, T JPN SOC AERONAUT S, V54, P98, DOI 10.2322/tjsass.54.98; Najson F, 2006, J GUID CONTROL DYNAM, V29, P955, DOI 10.2514/1.17715; Sostaric R., 2006, TECHNICAL REPORT; Steinfeld B., 2010, AIAA J SPACECRAFT RO, V47; Ueno S., 1998, 14 IFAC S AUT CONTR, P377; Xing-Long L., 2008, AUTOMATICA, V44, P1097; Ye Y., 1997, INTERIOR POINT ALGOR	24	0	0	JOURNAL VIBROENGINEERING	KAUNAS	GELIU RATAS 15 A, KAUNAS, LT-50282, LITHUANIA	1392-8716			J VIBROENG	J. Vibroeng.	FEB	2015	17	1					527	543				17	Engineering, Biomedical; Engineering, Mechanical	Engineering	CB7WI	WOS:000349838900046		
J	Morris, BJ; Donlon, TA; He, QM; Grove, JS; Masaki, KH; Elliott, A; Willcox, DC; Allsopp, R; Willcox, BJ				Morris, Brian J.; Donlon, Timothy A.; He, Qimei; Grove, John S.; Masaki, Kamal H.; Elliott, Ayako; Willcox, D. Craig; Allsopp, Richard; Willcox, Bradley J.			Genetic Analysis of TOR Complex Gene Variation With Human Longevity: A Nested Case-Control Study of American Men of Japanese Ancestry	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Genetic association analysis; Health span; Life span; Longevity; Target of rapamycin	GENOME-WIDE ASSOCIATION; MAMMALIAN LIFE-SPAN; BINDING PARTNER; EXTENDS LIFE; MTOR; RAPAMYCIN; EXPRESSION; PATHWAY; AGE; CENTENARIANS	The mechanistic target of rapamycin (mTOR) pathway is crucial for life span determination in model organisms. The aim of the present study was to test tagging single-nucleotide polymorphisms that captured most of the genetic variation across key TOR complex 1 (TORC1) and TOR complex 2 (TORC2) genes MTOR, RPTOR, and RICTOR and the important downstream effector gene RPS6KA1 for association with human longevity (defined as attainment of at least 95 years of age) as well as health span phenotypes. Subjects comprised a homogeneous population of American men of Japanese ancestry, well characterized for aging phenotypes and who have been followed for 48 years. The study used a nested case-control design involving 440 subjects aged 95 years and older and 374 controls. It found no association of 6 tagging single-nucleotide polymorphisms for MTOR, 61 for RPTOR, 7 for RICTOR, or 5 for RPS6KA1 with longevity. Of 40 aging-related phenotypes, no significant association with genotype was seen. Thus common genetic variation (minor allele frequency >= 10%) in MTOR, RPTOR, RICTOR, and RPS6KA1 is not associated with extreme old age or aging phenotypes in this population. Further research is needed to assess the potential genetic contribution of other mTOR pathway genes to human longevity, gene expression, upstream and downstream targets, and clinically relevant aging phenotypes.	[Morris, Brian J.; Donlon, Timothy A.; He, Qimei; Grove, John S.; Masaki, Kamal H.; Elliott, Ayako; Willcox, D. Craig; Willcox, Bradley J.] Kuakini Med Ctr, Dept Res, Honolulu Asia Aging Study, Honolulu Heart Program, Honolulu, HI 96817 USA; [Morris, Brian J.; Masaki, Kamal H.; Willcox, D. Craig; Willcox, Bradley J.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; [Morris, Brian J.] Univ Sydney, Basic & Clin Genom Lab, Sch Med Sci, Sydney, NSW 2006, Australia; [Grove, John S.] Univ Hawaii Manoa, John A Burns Sch Med, Publ Hlth Sci, Honolulu, HI 96822 USA; [Willcox, D. Craig] Okinawa Int Univ, Dept Human Welf, Ginowan, Okinawa, Japan; [Allsopp, Richard] Univ Hawaii, Inst Biogenesis Res, Honolulu, HI 96822 USA	Morris, BJ (reprint author), Kuakini Med Ctr, Dept Res, Honolulu Asia Aging Study, Honolulu Heart Program, HPM-9,347 North Kuakini St, Honolulu, HI 96817 USA.	brian.morris@sydney.edu.au			National Heart, Lung, and Blood Institute [NO1-HC-05102]; National Institute on Aging [NO1-AG-4-2149, U01-AG-019349, R01-AG-038707, R01-AG-027060]; Hawaii Community Foundation [2004-0463]	This research was supported by the National Heart, Lung, and Blood Institute (contract NO1-HC-05102), the National Institute on Aging (contract NO1-AG-4-2149; and grants U01-AG-019349, R01-AG-038707, and R01-AG-027060), and the Hawaii Community Foundation (grant 2004-0463).	Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Passtoors WM, 2013, AGING CELL, V12, P24, DOI 10.1111/acel.12015; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Sarbassov DD, 2004, CURR BIOL, V14, P1296; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; Mendelsohn AR, 2012, REJUV RES, V15, P334, DOI 10.1089/rej.2012.1347; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Banasik K, 2011, J CLIN ENDOCR METAB, V96, pE119, DOI 10.1210/jc.2010-0881; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Fadini GP, 2011, AGING CELL, V10, P10, DOI 10.1111/j.1474-9726.2010.00642.x; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Ganna A, 2013, HUM GENET, V132, P553, DOI 10.1007/s00439-013-1267-6; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Tazearslan C, 2012, J GERONTOL A-BIOL, V67, P376, DOI 10.1093/gerona/glr200; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056; Anson RM, 2012, J GERONTOL A-BIOL, V67, P347, DOI 10.1093/gerona/gls010; Arias E., 2008, UNITED STATES LIFE T, V61; Arias E., 2006, UNITED STATES LIFE T, V54; Bernstein AM, 2004, J GERONTOL A-BIOL, V59, P1195; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Kagan A, 1996, THE HONOLULU HEART P; Nordyke EC, 1984, PAPERS E W POPUL I, V91, P13; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P277, DOI 10.3389/fgene.2012.00277; Soerensen M, 2012, DAN MED J, V59; Statistical Analysis for the Social Sciences, 1990, STATISTICAL ANALYSIS; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox DC, 2007, AM J GERIAT PSYCHIAT, V15, P252, DOI 10.1097/JGP.0b013e31803190cc; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; Wu P, 2009, MECH AGEING DEV, V130, P602, DOI 10.1016/j.mad.2009.07.005	50	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	FEB	2015	70	2					133	142		10.1093/gerona/glu021		10	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CC1RR	WOS:000350121100001		
J	Matsuda, K; Hotta, T; Takifuji, K; Yokoyama, S; Watanabe, T; Mitani, Y; Ieda, J; Iwamoto, H; Mizumoto, Y; Yamaue, H				Matsuda, Kenji; Hotta, Tsukasa; Takifuji, Katsunari; Yokoyama, Shozo; Watanabe, Takashi; Mitani, Yasuyuki; Ieda, Junji; Iwamoto, Hiromitsu; Mizumoto, Yuki; Yamaue, Hiroki			Clinical characteristics of anastomotic leakage after an anterior resection for rectal cancer by assessing of the international classification on anastomotic leakage	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Anastomotic leakage; Rectal cancer; Clinical assessment; International classification on anastomotic leakage	PANCREATIC SURGERY ISGPS; PELVIC DRAINAGE; MESORECTAL EXCISION; MULTICENTER TRIAL; PERMANENT STOMA; RISK-FACTORS; DEFINITION	The International Study Group of Rectal Cancer (ISREC) has proposed a new definition of anastomotic leakage (AL) which was simply classified into three grades; however, these criteria have not been assessed well. The aims of this study are to assess the new definition and to show the clinical features of AL after an anterior resection for rectal cancer. Fifty consecutive patients developed AL after an anterior resection for rectal cancer was retrospectively assessed. AL was defined by the ISREC criteria. Twenty-seven (54 %) patients with AL were diagnosed by drain contents. The postoperative day of diagnosis for AL was later in grade A versus grades B and C (p = 0.038 vs p = 0.006, respectively). Permanent stoma (PS) was significantly more frequent in patients with grade C but not grade B compared to the patients with no AL (p < 0.001 and p = 0.171, respectively). In patients without diverting stoma, there was more serious grade of AL (p < 0.001). Differences were observed in the postoperative day of diagnosis, the creation rate of PS, and impact on diverting stoma after AL between each grade of leakage. The new classification was easy and reasonable to evaluate AL. As a result, it should be widely used in future studies.	[Matsuda, Kenji; Hotta, Tsukasa; Takifuji, Katsunari; Yokoyama, Shozo; Watanabe, Takashi; Mitani, Yasuyuki; Ieda, Junji; Iwamoto, Hiromitsu; Mizumoto, Yuki; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kulu Y, 2013, SURGERY, V153, P753, DOI 10.1016/j.surg.2013.02.007; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Merad F, 1999, SURGERY, V125, P529, DOI 10.1067/msy.1999.97700; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Yeh CY, 2005, ANN SURG, V241, P9, DOI 10.1097/01.sla.0000150067.99651.6a; Tsujinaka S, 2008, ANZ J SURG, V78, P461, DOI 10.1111/j.1445-2197.2008.04535.x; Peeters KCMJ, 2005, BRIT J SURG, V92, P211, DOI 10.1002/bjs.4806; Junginger T, 2010, DIS COLON RECTUM, V53, P1632, DOI 10.1007/DCR.0b013e3181ed0aae; Law WL, 2004, ANN SURG, V240, P260, DOI 10.1097/01.sla.0000133185.23514.32; Lindgren R, 2011, DIS COLON RECTUM, V54, P41, DOI 10.1007/DCR.0b013e3181fd2948; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Matthiessen P, 2004, Colorectal Dis, V6, P462, DOI 10.1111/j.1463-1318.2004.00657.x	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	FEB	2015	400	2					207	212		10.1007/s00423-015-1272-4		6	Surgery	Surgery	CC0PY	WOS:000350039200007		
J	Tomonaga, M; Sakamoto, N; Ishimatsu, Y; Kakugawa, T; Harada, T; Nakashima, S; Hara, A; Hara, S; Horai, Y; Kawakami, A; Mukae, H; Kohno, S				Tomonaga, Masaomi; Sakamoto, Noriho; Ishimatsu, Yuji; Kakugawa, Tomoyuki; Harada, Tatsuhiko; Nakashima, Shota; Hara, Atsuko; Hara, Shintaro; Horai, Yoshihiro; Kawakami, Atsushi; Mukae, Hiroshi; Kohno, Shigeru			Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies	LUNG			English	Article						Antisynthetase syndrome; Interstitial lung disease; Dermatomyositis; Polymyositis	INTERSTITIAL LUNG-DISEASE; ANTISYNTHETASE SYNDROME; POSITIVE PATIENTS; DERMATOMYOSITIS; POLYMYOSITIS; AUTOANTIBODIES; SURVIVAL; OUTCOMES	Anti-PL-7 is an anti-tRNA synthetase antibody, and interstitial lung disease (ILD) is the most frequent complication of anti-PL-7-associated antisynthetase syndrome. However, the features of ILD have not been fully elucidated. The present study retrospectively compares 7 and 15 patients who were positive for anti-PL-7 and anti-Jo-1 antibodies, respectively. The features of ILD did not significantly differ between the two groups, but the ratio of lymphocytes in bronchoalveolar lavage fluid was higher in the Jo-1 than in the PL-7 group. High-resolution computed tomography revealed nonspecific interstitial pneumonia in all patients in the PL-7 group and organizing pneumonia in four of the 15 patients in the Jo-1 group. These findings suggest that pulmonary complications slightly differ between patients expressing anti-PL-7 and anti-Jo-1 antibodies. Further studies are required to clarify the features of ILD associated with PL-7.	[Tomonaga, Masaomi; Sakamoto, Noriho; Ishimatsu, Yuji; Kakugawa, Tomoyuki; Harada, Tatsuhiko; Nakashima, Shota; Hara, Atsuko; Hara, Shintaro; Kohno, Shigeru] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan; [Horai, Yoshihiro; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 8528501, Japan; [Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan	Ishimatsu, Y (reprint author), Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	yuji-i@nagasaki-u.ac.jp					Aggarwal R, 2014, ANN RHEUM DIS, V73, P227, DOI 10.1136/annrheumdis-2012-201800; [American Thoracic Society International Consensus Statement American Thoracic Society (ATS) and the European Respiratory Society (ERS)], 2000, AM J RESP CRIT CARE, V161, P646; Hervier B, 2012, AUTOIMMUN REV, V12, P210, DOI 10.1016/j.autrev.2012.06.006; Marie I, 2012, AUTOIMMUN REV, V11, P739, DOI 10.1016/j.autrev.2012.01.006; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Marie I, 2013, EUR J INTERN MED, V24, P474, DOI 10.1016/j.ejim.2013.01.002; Ronnelid J, 2009, AUTOIMMUN REV, V9, P58, DOI 10.1016/j.autrev.2009.03.005; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Sakamoto N, 2004, RESP MED, V98, P213, DOI 10.1016/j.rmed.2003.09.015; Marie I, 2012, CURR RHEUMATOL REP, V14, P275, DOI 10.1007/s11926-012-0249-3; Ingegnoli F, 2012, AUTOIMMUN REV, V11, P335, DOI 10.1016/j.autrev.2011.09.007; Schnabel A, 2003, SEMIN ARTHRITIS RHEU, V32, P273, DOI 10.1053/sarh.2002.50012; Hervier B, 2011, EUR RESPIR J, V37, P714, DOI 10.1183/09031936.00104310; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Hamaguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060442; Hervier B, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0349-8; Marie I, 2013, ARTHRIT CARE RES, V65, P800, DOI 10.1002/acr.21895; Tillie-Leblond I, 2008, THORAX, V63, P53, DOI 10.1136/thx.2006.069237	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	FEB	2015	193	1					79	83		10.1007/s00408-014-9665-7		5	Respiratory System	Respiratory System	CB3VF	WOS:000349556500012		
J	Kosaka, K; Ohta, Y; Yokozawa, T				Kosaka, Kentaro; Ohta, Yoshihiro; Yokozawa, Tsutomu			uence of the Boron Moiety and Water on Suzuki-Miyaura Catalyst-Transfer Condensation Polymerization	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						catalyst-transfer condensation polymerization; palladium catalyst; polythiophenes; Suzuki polycondensation; triolborate	CHAIN-GROWTH POLYMERIZATION; ELECTROPHILIC DISPLACEMENT REACTIONS; CROSS-COUPLING POLYMERIZATION; TRANSFER POLYCONDENSATION; CONJUGATED POLYMERS; ARENEBORONIC ACIDS; MASS-SPECTROMETRY; MOLECULAR-WEIGHT; POLY(3-HEXYLTHIOPHENE); MECHANISM	Although water promotes Suzuki-Miyaura coupling reaction, it also induces side reactions such as deboronation and dehalogenation. Therefore, Suzuki-Miyaura polymerization of triolborate halothiophene monomer 1 with (Bu3PPd)-Bu-t(o-tolyl)Br (2) in dry tetrahydrofuran (THF) is investigated. However, the resultant poly(3-hexylthiophene) (P3HT) shows a broad molecular weight distribution and uncontrolled polymer ends. Model reactions of a number of boron reagents 3 with 2,5-dibromothiophene (4) in the presence or absence of water indicate that intramolecular transfer of the catalyst is hardly affected by the boron moiety of 3, whereas it is hindered in the absence of water. Indeed, polymerization of 1 with 2 in H2O/THF affords P3HT with a narrower molecular weight distribution and controlled tolyl/H ends, as compared to the reaction in dry THF.	[Kosaka, Kentaro; Ohta, Yoshihiro; Yokozawa, Tsutomu] Kanagawa Univ, Dept Mat & Life Chem, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan	Yokozawa, T (reprint author), Kanagawa Univ, Dept Mat & Life Chem, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan.	yokozt01@kanagawa-u.ac.jp			MEXT	The authors gratefully acknowledge funding from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2018. The authors also thank Prof. Junji Sakamoto at Osaka University for helpful discussion about the mechanism of dehalogenation in the Suzuki-Miyaura coupling reaction.	Grisorio R, 2014, POLYM CHEM-UK, V5, P4304, DOI 10.1039/c4py00028e; Senkovskyy V, 2010, MACROMOLECULES, V43, P10157, DOI 10.1021/ma1024889; Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b; Sheina EE, 2004, MACROMOLECULES, V37, P3526, DOI 10.1021/ma0357063; Jayakannan M, 2005, J POLYM SCI POL CHEM, V43, P1454, DOI 10.1002/pola.20618; Yamamoto Y, 2008, ANGEW CHEM INT EDIT, V47, P928, DOI 10.1002/anie.200704162; Okamoto K, 2011, POLYM CHEM-UK, V2, P2424, DOI 10.1039/c1py00171j; Senkovskyy V, 2009, J AM CHEM SOC, V131, P16445, DOI 10.1021/ja904885w; Yokoyama A, 2007, J AM CHEM SOC, V129, P7236, DOI 10.1021/ja070313v; Yokoyama A, 2004, MACROMOLECULES, V37, P1169, DOI 10.1021/ma035396o; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Handy ST, 2007, TETRAHEDRON LETT, V48, P8108, DOI 10.1016/j.tetlet.2007.09.114; Miyakoshi R, 2005, J AM CHEM SOC, V127, P17542, DOI 10.1021/ja0556880; Lee JK, 2012, MACROMOL RAPID COMM, V33, P938, DOI 10.1002/marc.201100686; Li C, 2010, CHEM REV, V110, P6817, DOI 10.1021/cr100052z; Dong CG, 2005, J AM CHEM SOC, V127, P10006, DOI 10.1021/ja052547p; Zhang HH, 2012, J AM CHEM SOC, V134, P13156, DOI 10.1021/ja302745t; Knapp DM, 2009, J AM CHEM SOC, V131, P6961, DOI 10.1021/ja901416p; Stefan MC, 2012, POLYM CHEM-UK, V3, P1693, DOI 10.1039/c1py00453k; Miyakoshi R, 2004, MACROMOL RAPID COMM, V25, P1663, DOI 10.1002/marc.200400281; Iovu MC, 2005, MACROMOLECULES, V38, P8649, DOI 10.1021/ma051122k; Bronstein HA, 2009, J AM CHEM SOC, V131, P12894, DOI 10.1021/ja9054977; Yokozawa T, 2011, MACROMOL RAPID COMM, V32, P801, DOI 10.1002/marc.201100037; Kiriy A, 2011, MACROMOL RAPID COMM, V32, P1503, DOI 10.1002/marc.201100316; Stambuli JP, 2004, J AM CHEM SOC, V126, P1184, DOI 10.1021/ja037928rn; Billingsley KL, 2006, ANGEW CHEM INT EDIT, V45, P3484, DOI 10.1002/anie.200600493; KUIVILA HG, 1964, J AM CHEM SOC, V86, P2666, DOI 10.1021/ja01067a031; Smeets A, 2009, MACROMOLECULES, V42, P7638, DOI 10.1021/ma901888h; Elmalem E, 2012, J AM CHEM SOC, V134, P17769, DOI 10.1021/ja3080677; Handy ST, 2007, J ORG CHEM, V72, P8496, DOI 10.1021/jo701709a; Billingsley K, 2007, J AM CHEM SOC, V129, P3358, DOI 10.1021/ja068577p; Bryan ZJ, 2013, MACROMOLECULES, V46, P8395, DOI 10.1021/ma401314x; Jayakannan M, 2001, MACROMOLECULES, V34, P5386, DOI 10.1021/ma0100403; Cao P, 2008, J ORG CHEM, V73, P7204, DOI 10.1021/jo801097v; Yokozawa T, 2013, CHEM COMMUN, V49, P8281, DOI 10.1039/c3cc43603a; KUIVILA HG, 1963, CAN J CHEM, V41, P3081, DOI 10.1139/v63-451; Carrer A, 2011, J ORG CHEM, V76, P2502, DOI 10.1021/jo102265b; Fischer C. S., 2012, J AM CHEM SOC, V135, P1148; Ghosez L, 2001, CAN J CHEM, V79, P1827, DOI 10.1139/cjc-79-11-1827; Hannah DR, 2000, BIOORGAN MED CHEM, V8, P739, DOI 10.1016/S0968-0896(00)00017-1; Miyaura N., 2008, METAL CATALYZED CROS, P41; Tyrrell E., 2003, SYNTHESIS-STUTTGART, V2003, P0469, DOI 10.1055/s-2003-37721; Urawa Y, 2002, J ORGANOMET CHEM, V653, P269, DOI 10.1016/S0022-328X(02)01175-0; Yokozawa T., 2010, CONJUGATED POLYM SYN, P35	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	FEB	2015	36	4					373	377		10.1002/marc.201400530		5	Polymer Science	Polymer Science	CB9YC	WOS:000349989400003		
J	Inokuchi, R; Ohashi-Fukuda, N; Nakamura, K; Wada, T; Gunshin, M; Kitsuta, Y; Nakajima, S; Yahagi, N				Inokuchi, Ryota; Ohashi-Fukuda, Naoko; Nakamura, Kensuke; Wada, Tomoki; Gunshin, Masataka; Kitsuta, Yoichi; Nakajima, Susumu; Yahagi, Naoki			Comparison of Intranasal and Intravenous Diazepam on Status Epilepticus in Stroke Patients A Retrospective Cohort Study	MEDICINE			English	Article							INFORMATION-SYSTEMS; RANDOMIZED-TRIAL; EPILEPSY; PHARMACOKINETICS; SEIZURES; JAPAN	Administering diazepam intravenously or rectally in an adult with status epilepticus can be difficult and time consuming. The aim of this study was to examine whether intranasal diazepam is an effective alternative to intravenous diazepam when treating status epilepticus. We undertook a retrospective cohort study based on the medical records of 19 stroke patients presenting with status epilepticus to our institution. We measured the time between arrival at the hospital, the intravenous or intranasal administration of diazepam, and the seizure termination. Intranasal diazepam was administered about 9 times faster than intravenous diazepam (1 vs 9.5 minutes, P = 0.001), resulting in about 3-fold reduction in the time to termination of seizure activity after arrival at the hospital (3 minutes compared with 9.5 minutes in the intravenous group, P = 0.030). No adverse effects of intranasal diazepam were evident from the medical records. Intranasal diazepam administration is safer, easier, and quicker than intravenous administration.	[Inokuchi, Ryota; Ohashi-Fukuda, Naoko; Nakamura, Kensuke; Wada, Tomoki; Gunshin, Masataka; Kitsuta, Yoichi; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inokuchir-icu@h.u-tokyo.ac.jp					Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; Hirsch LJ, 2011, NEUROLOGY, V76, P1932, DOI 10.1212/WNL.0b013e31821de7de; Ivaturi VD, 2009, ACTA NEUROL SCAND, V120, P353, DOI 10.1111/j.1600-0404.2009.01170.x; Ahmad S, 2006, LANCET, V367, P1591, DOI 10.1016/S0140-6736(06)68696-0; Agarwal SK, 2013, EPILEPSY RES, V105, P362, DOI 10.1016/j.eplepsyres.2013.02.018; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Wermeling DP, 2009, NEUROTHERAPEUTICS, V6, P352, DOI 10.1016/j.nurt.2009.01.002; Furtado MD, 2012, NEUROTOXICOLOGY, V33, P1476, DOI 10.1016/j.neuro.2012.09.001; Humphries Lesley K, 2013, J Pediatr Pharmacol Ther, V18, P79, DOI 10.5863/1551-6776-18.2.79; Inokuchi R, 2014, AM J EMERG MED, V32, P725, DOI 10.1016/j.ajem.2014.03.035; Inokuchi R, 2013, EMERG MED J, V30, P914, DOI 10.1136/emermed-2012-201869; Nair PP, 2011, J POSTGRAD MED, V57, P242, DOI 10.4103/0022-3859.81807; Shorvon S, 2013, EPILEPSIA, V54, P64, DOI 10.1111/epi.12281	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	7							e555	10.1097/MD.0000000000000555		4	Medicine, General & Internal	General & Internal Medicine	CC1QH	WOS:000350116000023		
J	Inoue, T; Ichikawa, H; Okumura, F; Mizushima, T; Nishie, H; Iwasaki, H; Anbe, K; Ozeki, T; Kachi, K; Fukusada, S; Suzuki, Y; Sano, H				Inoue, Tadahisa; Ichikawa, Hiroshi; Okumura, Fumihiro; Mizushima, Takashi; Nishie, Hirotada; Iwasaki, Hiroyasu; Anbe, Kaiki; Ozeki, Takanori; Kachi, Kenta; Fukusada, Shigeki; Suzuki, Yuta; Sano, Hitoshi			Local Administration of Amphotericin B and Percutaneous Endoscopic Necrosectomy for Refractory Fungal-Infected Walled-Off Necrosis A Case Report and Literature Review	MEDICINE			English	Review							PANCREATIC NECROSIS; NECROTIZING PANCREATITIS; MULTICENTER	Walled-off necrosis (WON) caused by fungal infection is very rare, and its treatment is more difficult than that of bacterial infection. We present the first case of a patient with refractory fungal-infected WON treated with percutaneous endoscopic necrosectomy and local administration of amphotericin B. A Japanese man in his 30s was hospitalized with severe necrotizing pancreatitis and multiple organ failure. Computed tomography imaging of the abdomen 1 month after the onset of pancreatitis revealed infected WON. Percutaneous drainage revealed purulent necrotic fluid, and culture of the fluid revealed the presence of Candida albicans and C glabrata. WON was treated by percutaneous endoscopic necrosectomy and local administration of amphotericin B. Consequently, the patient's condition improved, and Candida species were not detected in subsequent cultures. The combination of endoscopic necrosectomy with local administration of amphotericin B may be effective in treating refractory fungal-infected WON.	[Inoue, Tadahisa; Ichikawa, Hiroshi; Okumura, Fumihiro; Mizushima, Takashi; Nishie, Hirotada; Iwasaki, Hiroyasu; Anbe, Kaiki; Ozeki, Takanori; Kachi, Kenta; Fukusada, Shigeki; Suzuki, Yuta; Sano, Hitoshi] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Gifu, Japan	Inoue, T (reprint author), 5-161 Maebatacho, Tajimi, Gifu 5078522, Japan.	tinoue-tag@umin.ac.jp					Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Seifert H, 2009, GUT, V58, P1260, DOI 10.1136/gut.2008.163733; Yasuda I, 2013, ENDOSCOPY, V45, P627, DOI 10.1055/s-0033-1344027; van Santvoort HC, 2011, GASTROENTEROLOGY, V141, P1254, DOI 10.1053/j.gastro.2011.06.073; Werner J, 2005, GUT, V54, P426, DOI 10.1136/gut.2003.035907; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Harrison S, 2010, J GASTROINTEST SURG, V14, P245, DOI 10.1007/s11605-009-1100-7; Navarrete C, 2011, GASTROINTEST ENDOSC, V73, P609, DOI 10.1016/j.gie.2010.08.015; Yamamoto N, 2013, ENDOSCOPY, V45, pE44, DOI [10.1055/s-0032-1309927, 10.1055/s0032-1309927]; Zhu ES, 2013, ANTIMICROB AGENTS CH, V57, P6341, DOI 10.1128/AAC.00963-13; Zulfikaroglu B, 2004, SURG TODAY, V34, P466, DOI 10.1007/s00595-003-2716-y	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	6								10.1097/MD.0000000000000558		4	Medicine, General & Internal	General & Internal Medicine	CB6YF	WOS:000349772200038		
J	Iwase, T; Yamamoto, K; Ra, EM; Murotani, K; Matsui, S; Terasaki, H				Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Murotani, Kenta; Matsui, Shigeyuki; Terasaki, Hiroko			Diurnal Variations in Blood Flow at Optic Nerve Head and Choroid in Healthy Eyes Diurnal Variations in Blood Flow	MEDICINE			English	Article							OPEN-ANGLE GLAUCOMA; LASER SPECKLE FLOWGRAPHY; OCULAR PERFUSION-PRESSURE; NORMAL-TENSION GLAUCOMA; INTRAOCULAR-PRESSURE; 2-DIMENSIONAL MEASUREMENT; RETINITIS-PIGMENTOSA; CORNEAL TOPOGRAPHY; TISSUE CIRCULATION; NITRIC-OXIDE	To investigate the diurnal variations of the ocular blood flow in healthy eyes using laser speckle flowgraphy (LSFG), and to determine the relationship of the diurnal variations between the ocular blood flow and other ocular parameters. This prospective cross-sectional study was conducted at Nagoya University Hospital. We studied 13 healthy volunteers whose mean age was 33.5 +/- 7.6 years. The mean blur rate (MBR), expressing the relative blood flow, on the optic nerve head (ONH) and choroidal blood flow was determined by LSFG (LSFG-NAVI) every 3 hours from 6: 00 to 24: 00 hours. The intraocular pressure (IOP), choroidal thickness measured by enhanced depth imaging optical coherence tomography, systolic (SBP) and diastolic (DBP) blood pressure, and heart rate (HR) in the brachial artery were also recorded. We evaluated the diurnal variations of the parameters and compared the MBR to the other parameters using a linear mixed model. The diurnal variations of the MBR on the ONH varied significantly with a trough at 9: 00 hours and a peak at 24: 00 hours (P < 0.001, linear mixed model). The MBR of choroid also had significant diurnal variations with a trough at 15: 00 hours and a peak at 18: 00 hours (P = 0.001). The IOP (P < 0.001), choroidal thickness (P< 0.001), SBP (P = 0.005), DBP (P = 0.001), and HR (P< 0.001) also had significant diurnal variations. Although the diurnal variation of the MBR on the ONH was different from the other parameters, that on the choroid was significantly and positively correlated with the DBP (P = 0.002), mean arterial pressure (P = 0.023), and mean ocular perfusion pressure (P = 0.047). We found significant diurnal variations in the ONH and choroidal blood flow. Although the ONH blood flow had its own diurnal variation because of strong autoregulation, the choroidal blood flow was more likely affected by systemic circulatory factors because of poor autoregulation.	[Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Terasaki, Hiroko] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668560, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Showa Ku, Nagoya, Aichi, Japan; [Matsui, Shigeyuki] Nagoya Univ, Dept Biostat, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668560, Japan	Iwase, T (reprint author), Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668560, Japan.	tsuyoshiiwase@aol.com			 [26462635];  [23390401]	This work was supported by a Grant-in-Aid for Scientific Research (C) (26462635) (TI) and a Grant-in-Aid for Scientific Research (B) (23390401) (HT).	Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; KITAZAWA Y, 1975, AM J OPHTHALMOL, V79, P557; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Read SA, 2005, CORNEA, V24, P678, DOI 10.1097/01.ico.0000154385.43732.6e; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; HAYREH SS, 1995, EXP EYE RES, V61, P259, DOI 10.1016/S0014-4835(05)80121-6; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; Kiel JW, 1999, EXP EYE RES, V69, P413, DOI 10.1006/exer.1999.0717; Harper CL, 1996, BRIT J OPHTHALMOL, V80, P1068, DOI 10.1136/bjo.80.12.1068; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Okuno T, 2002, INVEST OPHTH VIS SCI, V43, P784; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; Fontana L, 1998, BRIT J OPHTHALMOL, V82, P731, DOI 10.1136/bjo.82.7.731; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; MAPSTONE R, 1985, ARCH OPHTHALMOL-CHIC, V103, P1485; Falsini B, 2011, INVEST OPHTH VIS SCI, V52, P1064, DOI 10.1167/iovs.10-5964; RIVA C, 1972, INVEST OPHTH VISUAL, V11, P936; Sehi M, 2005, INVEST OPHTH VIS SCI, V46, P4581, DOI 10.1167/iovs.050209; Avisar R, 2002, ANN PHARMACOTHER, V36, P992; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; LANGHAM ME, 1990, EYE, V4, P374; Okuno T, 2004, EYE, V18, P697, DOI 10.1038/sj.eye.6700749; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Weigert G, 2005, OPHTHALMOLOGY, V112, P1337, DOI 10.1016/j.ophtha.2005.03.016; Pillunat LE, 1997, EXP EYE RES, V64, P737, DOI 10.1006/exer.1996.0263; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; Chiba Naoki, 2011, Clin Ophthalmol, V5, P1549, DOI 10.2147/OPTH.S22097; FEKE GT, 1989, INVEST OPHTH VIS SCI, V30, P58; FLUGEL C, 1994, INVEST OPHTH VIS SCI, V35, P592; FlugelKoch C, 1996, OPHTHALMOLOGICA, V210, P296; Fujii H, 1996, ATARASHII GANKA, V13, P957; HALES JRS, 1973, PFLUG ARCH EUR J PHY, V344, P119, DOI 10.1007/BF00586546; HOULE ROLAND E., 1967, INVEST OPHTHALMOL, V6, P145; KIELY PM, 1982, AM J OPTOM PHYS OPT, V59, P976; PASZTOR E, 1973, Stroke, V4, P556; Pemp B, 2009, BRIT J OPHTHALMOL, V93, P486, DOI 10.1136/bjo.2008.148676; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P1752; Riva CE, 1978, AM J PHYSIOL, V234, P315; Schmidl D, 2013, INVEST OPHTH VIS SCI, V54, P1964, DOI 10.1167/iovs.12-11406; Takayama J, 2003, INVEST OPHTH VIS SCI, V44, P3977, DOI 10.1167/iovs.03-0024; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P297, DOI 10.1016/S0021-5155(97)00054-3; Wilson LB, 2006, INVEST OPHTH VIS SCI, V47, P1778, DOI 10.1167/iovs.05-0869; Yokoyama Yu, 2011, Clin Ophthalmol, V5, P1721, DOI 10.2147/OPTH.S23204	56	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	6								10.1097/MD.0000000000000519		10	Medicine, General & Internal	General & Internal Medicine	CB6YF	WOS:000349772200023		
J	Lin, HR; Otsubo, T; Imanaka, Y				Lin, Huei-Ru; Otsubo, Tetsuya; Imanaka, Yuichi			The Effects of Dementia and Long-Term Care Services on the Deterioration of Care- needs Levels of the Elderly in Japan	MEDICINE			English	Article							COMMUNITY-BASED SERVICES; HOME; INSURANCE; IMPACT; PREDICTORS; DISABILITY; FRAILTY; SYSTEM; RISK	To investigate the associations between dementia, the use of long-term care (LTC) services, and the deterioration of care-needs levels of elderly persons in Japan. Using a retrospective cohort study, we analyzed 50,268 insurance beneficiaries aged 65 years and older who had utilized LTC services between 2010 and 2011 in Kyoto prefecture, Japan. Logistic regression analyses were used to identify predictors of care-needs level deterioration. Dementia, facility care services, the male sex, older age, and lower baseline care-needs levels were associated with care-needs level deterioration. The disparity between odds ratios of home care services, dementia diagnoses, and facility care services on care-needs level deterioration diminished with increasing baseline care-needs levels. The other risk factors of care-needs level deterioration showed stronger associations as care-needs levels and age increased. The effects of baseline care-needs levels and dementia should be considered when developing LTC policies.	[Lin, Huei-Ru; Otsubo, Tetsuya; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Kyoto 6068501, Japan	Imanaka, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	imanaka-y@umin.net			Otsuka Toshimi Scholarship Foundation (Osaka, Japan)	Huei-Ru Lin is a recipient of a scholarship from Otsuka Toshimi Scholarship Foundation (Osaka, Japan). Other 2 authors have no funding and conflicts of interest to disclose.	Olivares-Tirado P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-239; Klein BEK, 2005, ARCH GERONTOL GERIAT, V41, P141, DOI 10.1016/j.archger.2005.01.002; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Luck T, 2012, AM J GERIAT PSYCHIAT, V20, P943, DOI 10.1097/JGP.0b013e31825c09bc; Arling G, 2013, MED CARE, V51, P575, DOI 10.1097/MLR.0b013e31828d4d4a; Langa KM, 2004, ALZ DIS ASSOC DIS, V18, P90, DOI 10.1097/01.wad.0000126620.73791.3e; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Carpenter G Iain, 2006, BMC Geriatr, V6, P7, DOI 10.1186/1471-2318-6-7; Fukuma M, 2010, J JPN ASS RURAL MED, V58, P516; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Health and Welfare Bureau for the Elderly, LONG TERM CAR ELD 20; Health and Welfare Bureau for the Elderly, 2013, OP LONG TERM CAR INS; Ho HK, 2002, GERIATR GERONTOL INT, V2, P80, DOI 10.1046/j.1444-1586.2002.00026.x; Ishibashi T, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-224; Kashiwagi M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-1; Kato Gohei, 2009, BMC Geriatr, V9, P58, DOI 10.1186/1471-2318-9-58; Kim Jung-Nim, 2012, J Rural Med, V7, P6, DOI 10.2185/jrm.7.6; Koike S, 2013, HEALTH POLICY, V110, P94, DOI 10.1016/j.healthpol.2012.12.011; Matsuda S, 2009, ASIAN PACIFIC J DIS, V3, P75; Ministry of Health Labour and Welfare, 2006, ANN HLTH LAB WELF RE; Ministry of Health Labour and Welfare, 2010, STAT APPL ADM NURS H; Murtaugh CM, 2011, J AGING HEALTH, V23, P554, DOI 10.1177/0898264310389491; National Collaborating Centre for Mental H. National Institute for Health and Clinical Excellence, 2007, GUID DEM NICE SCIE G; Norton MJ, 2010, AGING MENT HEALTH, V14, P303, DOI 10.1080/13607860903167879; Rakowski DA, 2006, CLIN J AM SOC NEPHRO, V1, P1000, DOI 10.2215/CJN.00470705; Tomita N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-345; World Health Organization, 2011, W PACIFIC COUNTR HLT	29	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	7							e525	10.1097/MD.0000000000000525		7	Medicine, General & Internal	General & Internal Medicine	CC1QH	WOS:000350116000009		
J	Okuchi, S; Okada, T; Yamamoto, A; Kanagaki, M; Fushimi, Y; Okada, T; Yamauchi, M; Kataoka, M; Arakawa, Y; Takahashi, JC; Minamiguchi, S; Miyamoto, S; Togashi, K				Okuchi, Sachi; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Yamauchi, Moritaka; Kataoka, Masako; Arakawa, Yoshiki; Takahashi, Jun C.; Minamiguchi, Sachiko; Miyamoto, Susumu; Togashi, Kaori			Grading Meningioma A Comparative Study of Thallium-SPECT and FDG-PET	MEDICINE			English	Article							INTRACRANIAL MENINGIOMAS; ANAPLASTIC MENINGIOMA; MALIGNANT MENINGIOMA; TL-201 SPECT; INDEX; RECURRENCE; AGGRESSIVENESS; GLUCOSE	The purpose was to compare capability of fluorine-18 fluorodeoxyglucose (FDG)-PET and thallium-201 (Tl)-SPECT for grading meningioma. This retrospective study was conducted as a case-control study under approval by the institutional review board. In the hospital information system, 67 patients (22 men and 45 women) who had both FDG-PET and Tl-SPECT preoperative examinations were found with histopathologic diagnosis of meningioma. The maximum FDG uptake values of the tumors were measured, and they were standardized to the whole body (SUVmax) and normalized as gray matter ratio (SUVRmax). Mean and maximum Tl uptake ratios (TURmean and TURmax, respectively) of the tumors were measured and normalized as ratios to those of the contralateral normal brain. Receiver-operating characteristic curve analyses of the 4 indexes were conducted for differentiation between low-and high-grade meningiomas, and areas under the curves (AUCs) were compared. Correlation coefficients were calculated between these indexes and Ki-67. Fifty-six meningiomas were classified as grade I (low grade), and 11 were grade II or III (high grade). In all 4 indexes, a significant difference was observed between low-and high-grade meningiomas (P < 0.05). AUCs were 0.817 (SUVmax), 0.781 (SUVRmax), 0.810 (TURmean), and 0.831 (TURmax), and no significant difference was observed among the indexes. Their sensitivity and specificity were 72.7% to 90.9% and 71.4% to 87.5%, respectively. Correlation of the 4 indexes to Ki-67 was statistically significant, but coefficients were relatively low (0.273-0.355). Tl-SPECT, which can be used at hospitals without a cyclotron or an FDG distribution network, has high diagnostic capability of meningioma grades comparable to FDG-PET.	[Okuchi, Sachi; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Yamauchi, Moritaka; Kataoka, Masako; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Arakawa, Yoshiki; Takahashi, Jun C.] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Clin Pathol, Kyoto 6068507, Japan	Okada, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tomokada@kuhp.kyoto-u.ac.jp					Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5<649::AID-SIM371>3.0.CO;2-H; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; MAIER H, 1992, J NEUROSURG, V77, P616, DOI 10.3171/jns.1992.77.4.0616; Bruna J, 2007, NEUROPATHOLOGY, V27, P114, DOI 10.1111/j.1440-1789.2007.00750.x; Marosi C, 2008, CRIT REV ONCOL HEMAT, V67, P153, DOI 10.1016/j.critrevonc.2008.01.010; Hug EB, 2000, J NEURO-ONCOL, V48, P151, DOI 10.1023/A:1006434124794; Goyal LK, 2000, INT J RADIAT ONCOL, V46, P57, DOI 10.1016/S0360-3016(99)00349-1; TONAMI N, 1993, J NUCL MED, V34, P2089; Dziuk TW, 1998, J NEURO-ONCOL, V37, P177, DOI 10.1023/A:1005853720926; Kinuya K, 2003, ANN NUCL MED, V17, P463; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Arita H, 2012, J NEURO-ONCOL, V107, P379, DOI 10.1007/s11060-011-0759-2; ATKINS HL, 1977, J NUCL MED, V18, P133; Cremerius U, 1997, J NUCL MED, V38, P26; DICHIRO G, 1987, RADIOLOGY, V164, P521; Iuchi T, 1999, NEUROL RES, V21, P640; JINNOUCHI S, 1993, J NUCL MED, V34, P2091; Lee JW, 2009, EUR J NUCL MED MOL I, V36, P1574, DOI 10.1007/s00259-009-1133-x; Lippitz B, 1996, Acta Neurochir Suppl, V65, P108; Louis DN, 2007, WHO CLASSIFICATION T; Park Yong Sook, 2006, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V40, P428; Sugo Nobuo, 2000, Kaku Igaku, V37, P311; Takahashi JA, 2004, SURG NEUROL, V61, P155; Takahashi JA, 2004, SURG NEUROL, V61, P149, DOI 10.1016/S0090-3019(03)00575-5; Takeda T, 2011, NEURORADIOLOGY, V53, P867, DOI 10.1007/s00234-010-0822-2; Tedeschi E, 1996, EUR J NUCL MED, V23, P1478, DOI 10.1007/BF01254472; Torp SH, 2005, CLIN NEUROPATHOL, V24, P170	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	6								10.1097/MD.0000000000000549		6	Medicine, General & Internal	General & Internal Medicine	CB6YF	WOS:000349772200036		
J	Takase, H; Sugiura, T; Ohte, N; Dohi, Y				Takase, Hiroyuki; Sugiura, Tomonori; Ohte, Nobuyuki; Dohi, Yasuaki			Urinary Albumin as a Marker of Future Blood Pressure and Hypertension in the General Population	MEDICINE			English	Article							INCIDENT HYPERTENSION; CARDIOVASCULAR-DISEASE; LONG-TERM; RISK; JAPANESE; MICROALBUMINURIA; KIDNEY; ATHEROSCLEROSIS; VASODILATION; METAANALYSIS	We investigated whether urinary albumin could predict the development of hypertension and future increases in blood pressure in the normotensive general population. Normotensive subjects who visited our hospital for a physical checkup (n = 6205, men 61.8%, 53.4 +/- 11.4 years old) were enrolled in this study. Urine samples were collected for the measurement of albumin concentration, expressed as the ratio of urinary albumin to creatinine concentrations (UACR [mg/g Cr]). After the baseline examination, subjects were followed up for a median of 1089 days with the endpoint being the development of hypertension. Urinary albumin was in the normal range (UACR < 30mg/g Cr) in most subjects (97.5%). During the follow-up, hypertension developed in 1184 subjects (19.1%, 69.5 per 1000 person-years), with more men than women affected. The incidence of hypertension was increased across the quartiles of UACR by Kaplan-Meier analysis (log-rank, P < 0.0001) and the hazard ratio (lowest quartile [median UACR 1.14mg/g Cr] as reference) was 1.53 (95% confidence intervals 1.30-1.80) in the highest quartile (median UACR 8.87mg/g Cr). Multivariate Cox hazard analysis in which UACR was taken as a continuous variable identified UACR as a significant predictor of hypertension (hazard ratio 1.37, 95% CI 1.20-1.56). UACR was also an independent predictor of future increases in systolic blood pressure (P < 0.01). Urinary albumin is an independent predictor of hypertension and increases in blood pressure in the general population even in the normal range below the threshold defined for microalbuminuria.	[Takase, Hiroyuki] Enshu Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan; [Sugiura, Tomonori; Ohte, Nobuyuki; Dohi, Yasuaki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi 4678601, Japan	Sugiura, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tomosugi@med.nagoya-cu.ac.jp					American Diabetes Association, 2001, DIABETES CARE S1, V24, pS69; Mattix HJ, 2002, J AM SOC NEPHROL, V13; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; Ikeda A, 2009, AM J HYPERTENS, V22, P273, DOI 10.1038/ajh.2008.356; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; Fujiyoshi A, 2012, HYPERTENS RES, V35, P947, DOI 10.1038/hr.2012.87; Kestenbaum B, 2008, ANN INTERN MED, V148, P501; Campese V M, 2000, Kidney Int Suppl, V75, pS2; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155; KANNEL WB, 1993, J CARDIOVASC PHARM, V21, pS27; Fukuda M, 2004, KIDNEY INT, V65, P621, DOI 10.1111/j.1523-1755.2004.00419.x; Takase H, 2012, J HYPERTENS, V30, P505, DOI 10.1097/HJH.0b013e32834f6a1d; Imano H, 2009, STROKE, V40, P1571, DOI 10.1161/STROKEAHA.108.538629; BRENNER BM, 1988, AM J HYPERTENS, V1, P335; Dogra G, 2001, DIABETOLOGIA, V44, P593, DOI 10.1007/s001250051665; LAW CM, 1993, BRIT MED J, V306, P24; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Clausen P, 2001, CIRCULATION, V103, P1869; Ballermann Barbara J, 2007, J Am Soc Nephrol, V18, P2432, DOI 10.1681/ASN.2007060687; Forman JP, 2008, J AM SOC NEPHROL, V19, P1983, DOI 10.1681/ASN.2008010038; Kaplan NM, 2002, KAPLANS CLIN HYPERTE, P136; Kimura G, 2010, HYPERTENS RES, V33, P515, DOI 10.1038/hr.2010.47; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lazzara MJ, 2007, AM J PHYSIOL-RENAL, V292, pF430, DOI 10.1152/ajprenal.00010.2006; Murai S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03884; Rossi R, 2004, J AM COLL CARDIOL, V44, P1636, DOI 10.1016/j.jacc.2004.07.027; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Takashima N, 2012, J HYPERTENS, V30, P2299, DOI 10.1097/HJH.0b013e328359a9f7; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; Agodoa L, 2007, J HYPERTENS, V25, P951	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	6								10.1097/MD.0000000000000511		7	Medicine, General & Internal	General & Internal Medicine	CB6YF	WOS:000349772200018		
J	Takayama, K; Tanaka, A; Shibata, M; Muraoka, T; Ishikawa, S; Harimoto, K; Takeuchi, M				Takayama, Kei; Tanaka, Atsushi; Shibata, Masanori; Muraoka, Tadashi; Ishikawa, Sho; Harimoto, Kouzo; Takeuchi, Masaru			Evaluation of Microincision Vitrectomy Surgery Using Wide-Viewing System for Complications With Ocular Sarcoidosis	MEDICINE			English	Article							PARS-PLANA VITRECTOMY; EPIRETINAL MEMBRANE SURGERY; SUTURELESS VITRECTOMY; VITREOUS SURGERY; INTRAOCULAR INFLAMMATION; POSTERIOR UVEITIS; MANAGEMENT; 25-GAUGE; CORTICOSTEROIDS; SECONDARY	We evaluate the outcomes of microincision vitrectomy surgery (MIVS) using wide-viewing system for complications with ocular sarcoidosis resistance to medical treatment. Consecutive clinical records of 24 eyes (19 patients) with complications of ocular sarcoidosis underwent MIVS between April 2010 and December 2013 were retrospectively reviewed. MIVS and phacoemulsification were performed in 18 eyes and MIVS only in 6 eyes. Bestcorrected visual acuity (BCVA), inflammation scores in the anterior segment and in the posterior segment, and central retinal thickness (CRT) of eyes with cystoid macular edema (CME) before surgery and after 1 week, 1, 3, 6, and 12 months were evaluated. LogMAR (log of the minimum angle of resolution) converted from BCVA was improved in 83.3% after 12 months and 66.7% showed improvement of more than 2 lines. The mean LogMAR was significantly improved from 1.14 +/- 1.18 to 0.36 +/- 0.79 in all eyes and 0.83 +/- 0.86 to 0.23 +/- 0.41 in eyes with MIVS and phacoemulsification, although no improvement was observed in eyes with MIVS only. Significant decrease of the mean anterior inflammation score was observed after 1 month in eyes with MIVS only and after 12 months in eyes with MIVS and phacoemulsification, and the mean posterior inflammation scores decreased after 1 week in all eyes. In eyes with preoperative CME, mean CRT was significantly decreased from 1 week after surgery. There was no case in which ocular inflammation was exacerbated by surgical stress. Improvement of visual acuity and resolution of ocular inflammation could be achieved by MIVS using wide-viewing system for complications of ocular sarcoidosis.	[Takayama, Kei; Tanaka, Atsushi; Shibata, Masanori; Muraoka, Tadashi; Ishikawa, Sho; Harimoto, Kouzo; Takeuchi, Masaru] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama 3598513, Japan	Takeuchi, M (reprint author), Natl Def Med Coll, Dept Ophthalmol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	masatake@ndmc.ac.jp			Japan Society for the Promotion of Science [24592689]	This work was supported in part by Grant-in-Aid 24592689 for Scientific Research from the Japan Society for the Promotion of Science.	ALGVERE P, 1981, ACTA OPHTHALMOL, V59, P727; Androudi S, 2012, ACTA OPHTHALMOL, V90, pe409, DOI 10.1111/j.1755-3768.2011.02258.x; Sandali O, 2011, GRAEF ARCH CLIN EXP, V249, P1811, DOI 10.1007/s00417-011-1752-3; Rizzo S, 2006, GRAEF ARCH CLIN EXP, V244, P472, DOI 10.1007/s00417-005-0173-6; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Muhaya M, 1999, CLIN EXP IMMUNOL, V116, P410; Kiryu J, 2001, OPHTHALMOLOGY, V108, P1140, DOI 10.1016/S0161-6420(01)00558-9; Chalam KV, 2004, SURV OPHTHALMOL, V49, P437, DOI 10.1016/j.survophthal.2004.04.010; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1814, DOI 10.1016/S0161-6420(02)01119-3; Sakaguchi M, 1998, JPN J OPHTHALMOL, V42, P262, DOI 10.1016/S0021-5155(98)00016-1; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Moller DR, 1999, SARCOIDOSIS VASC DIF, V16, P24; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Wimpissinger B, 2008, BRIT J OPHTHALMOL, V92, P1483, DOI 10.1136/bjo.2008.140509; Au Eong Kah-Guan, 2002, Retina, V22, P130, DOI 10.1097/00006982-200202000-00032; Baughman RP, 2012, SARCOIDOSIS VASC DIF, V29, P26; Bovey EH, 2000, OCUL IMMUNOL INFLAMM, V8, P285, DOI 10.1076/ocii.8.4.285.6456; DUGEL PU, 1992, OPHTHALMOLOGY, V99, P1535; Hawkins WR, 2003, AM J OPHTHALMOL, V136, P1191, DOI 10.1016/j.ajo.2003.09.007; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; Ieki Yoshiaki, 2004, Ocul Immunol Inflamm, V12, P35, DOI 10.1076/ocii.12.1.35.28070; Kamei RRW, 2012, ARQ BRAS OFTALMOL, V75, P107, DOI 10.1590/S0004-27492012000200007; Kiryu J, 2003, JPN J OPHTHALMOL, V47, P479, DOI 10.1016/S0021-5155(03)00128-X; Kobayashi S, 2010, OPHTHAL SURG LAS IM, V41, P550, DOI 10.3928/15428877-20100726-03; LeHoang P, 2012, DEV OPHTHALMOL, V51, P7, DOI 10.1159/000336676; Lewis Shawn A, 2011, Ophthalmic Surg Lasers Imaging, V42, P107, DOI 10.3928/15428877-20101223-02; Sato Tatsuhiko, 2012, Clin Ophthalmol, V6, P1925, DOI 10.2147/OPTH.S37864; Schoenberger SD, 2011, OPHTHAL SURG LAS IM, V42, P474, DOI 10.3928/15428877-20110901-02; Scott RA, 2003, EYE, V17, P221, DOI 10.1038/sj.eye.6700299; Soheilian MM, 2013, OCUL IMMUNOL INFLAMM; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, P288, DOI 10.1007/BF00220702	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	7							e559	10.1097/MD.0000000000000559		6	Medicine, General & Internal	General & Internal Medicine	CC1QH	WOS:000350116000024		
J	Tano, S; Horiki, N; Omata, F; Tanaka, K; Hamada, Y; Katsurahara, M; Ninomiya, K; Nishikawa, K; Nojiri, K; Yamada, R; Inoue, H; Gabazza, EC; Katayama, N; Takei, Y				Tano, Shunsuke; Horiki, Noriyuki; Omata, Fumio; Tanaka, Kyosuke; Hamada, Yasuhiko; Katsurahara, Masaki; Ninomiya, Katsuhito; Nishikawa, Kenichiro; Nojiri, Keiichiro; Yamada, Reiko; Inoue, Hiroyuki; Gabazza, Esteban C.; Katayama, Naoyuki; Takei, Yoshiyuki			Second and Third-look Endoscopy for the Prevention of Post-ESD Bleeding	MEDICINE			English	Article							SUBMUCOSAL DISSECTION; RISK-FACTORS; 2ND-LOOK ENDOSCOPY; CLINICAL-OUTCOMES; LESIONS; ULCER	The efficacy of 2nd-look esophagogastroduodenoscopy (EGD) with endoscopic hemostatic therapy (EHT) for the prevention of postendoscopic submucosal dissection (ESD) clinical bleeding remains controversial. The aim of this study was to estimate post-ESD bleeding rate using 2nd and 3rd-look strategy, and to determine risk factors for clinical bleeding, and for EHT at 2nd and 3rd-look EGDs. Three hundred forty-four consecutive patients with early gastric cancer or adenoma underwent ESD from January 2006 through March 2012. Second and 3rd-look EGDs were performed on day 1 (D1) and day 7 (D7), respectively, with EHT as needed. Post-ESD clinical bleeding rate was 2.6% (95% confidence interval [CI] 1.2%-4.9%). For clinical bleeding, adjusted odds ratios (ORs) for age < 65 years and antithrombotic drug uses were 4.40 (95% CI 1.07-19.93) and 7.34 (95% CI 1.80-32.48), respectively. For D1 EHT, adjusted ORs of tumor location in the lower part of the stomach and maximum tumor diameter >= 60mm were 2.16 (95% CI 1.35-3.51) and 2.20 (95% CI 1.05-4.98), respectively. For D7 EHT, adjusted OR of D1 EHT was 4.65 (95% CI 1.56-20.0). Post-ESD clinical bleeding rate was relatively low using 2nd and 3rd-look strategy. Age <65 years and antithrombotic drug use are significant risk factors for clinical bleeding. Regarding EHT, tumor location in the lower part of the stomach and maximum diameter of resected specimen >= 60 mm are significant predictors for D1 EHT. D1 EHT in turn is a significant risk factor for D7 EHT. The efficacy of sequential strategy for preventing post-ESD bleeding is promising.	[Tano, Shunsuke; Horiki, Noriyuki; Tanaka, Kyosuke; Hamada, Yasuhiko; Katsurahara, Masaki] Mie Univ Hosp, Dept Endoscop Med, Tsu, Mie 5148507, Japan; [Tano, Shunsuke; Ninomiya, Katsuhito; Nishikawa, Kenichiro; Nojiri, Keiichiro; Yamada, Reiko; Inoue, Hiroyuki; Takei, Yoshiyuki] Mie Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Tsu, Mie 514, Japan; [Omata, Fumio] St Lukes Int Hosp, Dept Internal Med, Tokyo, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan	Tano, S (reprint author), Mie Univ Hosp, Dept Endoscop Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mchtanosh@clin.medic.mie-u.ac.jp					[Anonymous], 1998, GASTRIC CANC, V1, P10; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Park YM, 2011, SURG ENDOSC, V25, P2666, DOI 10.1007/s00464-011-1627-z; Mannen K, 2010, J GASTROENTEROL, V45, P30, DOI 10.1007/s00535-009-0137-4; Tsuji Y, 2010, WORLD J GASTROENTERO, V16, P2913, DOI 10.3748/wjg.v16.i23.2913; Draganov PV, 2013, GASTROINTEST ENDOSC, V78, P677, DOI 10.1016/j.gie.2013.07.033; Choi CW, 2014, SURG ENDOSC, V28, P2213, DOI 10.1007/s00464-014-3457-2; FORREST JAH, 1974, LANCET, V2, P394; Ryu HY, 2013, GASTROINTEST ENDOSC, V78, P285, DOI 10.1016/j.gie.2013.02.008; Takenaka R, 2008, GASTROINTEST ENDOSC, V68, P887, DOI 10.1016/j.gie.2008.03.1089; ASGE Standards of Practice Committee, 2009, GASTROINTEST ENDOSC, V70, P1060; Chiu PWY, 2006, ENDOSCOPY, V38, P726, DOI 10.1055/s-2006-925179; EGUCHI T, 2003, DIGEST ENDOSC, V15, P113, DOI DOI 10.1016/J.GIE.2005.08.026; Goto O, 2011, DIGEST DIS SCI, V57, P435; Jang JS, 2009, SCAND J GASTROENTERO, V44, P1370, DOI 10.3109/00365520903194609; Japanese Gastric Cancer Association, 2004, JAP GASTR CANC TREAT; KAMINISHI M, 1987, GASTROENTEROLOGY, V92, P1913; Loren L, 2012, AM J GASTROENTEROL, V107, P345; Takeuchi K, 1983, Nihon Shokakibyo Gakkai Zasshi, V80, P9	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	6								10.1097/MD.0000000000000491		6	Medicine, General & Internal	General & Internal Medicine	CB6YF	WOS:000349772200011		
J	Ebihara, M; Shirai, N; Sekimoto, S; Nakamura, T; Tsuchiyama, A; Matsuno, J; Matsumoto, T; Tanaka, M; Abe, M; Fujimura, A; Ishibashi, Y; Karouji, Y; Mukai, T; Okada, T; Uesugi, M; Yada, T				Ebihara, M.; Shirai, N.; Sekimoto, S.; Nakamura, T.; Tsuchiyama, A.; Matsuno, J.; Matsumoto, T.; Tanaka, M.; Abe, M.; Fujimura, A.; Ishibashi, Y.; Karouji, Y.; Mukai, T.; Okada, T.; Uesugi, M.; Yada, T.			Chemical and mineralogical compositions of two grains recovered from asteroid Itokawa	METEORITICS & PLANETARY SCIENCE			English	Article							ORDINARY CHONDRITES; HAYABUSA SAMPLES; DUST PARTICLES; ABUNDANCES; ELEMENTS; EARTH; REGOLITH; OLIVINE; HISTORY; ORIGIN	Two silicate grains (RB-QD04-0049 and RA-QD02-0064, whose estimated masses are 0.050g and 0.048g, respectively) recovered from the asteroid Itokawa by the Hayabusa spacecraft were studied for their mineralogical characteristics by synchrotron X-ray diffraction and synchrotron X-ray microtomography and further analyzed for their bulk chemical compositions by instrumental neutron activation analysis (INAA). According to X-ray tomography, RB-QD004-0049 is composed of olivine, high-Ca pyroxene, plagioclase, Ca-phosphate, and troilite, whereas RA-QD002-0064 entirely consists of olivine. INAA data are consistent with these mineral compositions except for rare earth elements (REEs). Although the grain RB-QD004-0049 contains measurable REEs, which seems to be consistent with the presence of Ca-phosphate, their abundances are anomalously high. Very low abundance of Co implies less than 0.1 mass% of metals in these two grains by calculation, which is in contrast to the result for the previously analyzed grain RA-QD02-0049 (Ebihara et al., 2011). FeO/Sc ratios of the grains fall within the range of those for ordinary chondrite olivines, implying that these grains are extraterrestrial in origin. FeO/MnO ratios also confirm this conclusion and further suggest that the Hayabusa grains analyzed in this study are similar to material found in LL chondrites rather than CK chondrites although olivines from LL and CK chondrites have similar Fa# (molar% of Fe relative to [Fe+Mg] in olivine) (similar to 30) to those of the Hayabusa grains including the two grains analyzed in this study.	[Ebihara, M.; Shirai, N.] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Sekimoto, S.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Nakamura, T.] Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan; [Tsuchiyama, A.; Matsuno, J.] Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan; [Matsumoto, T.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Tanaka, M.] Spring8, Natl Inst Mat Sci, Sayo, Hyogo 6795198, Japan; [Abe, M.; Fujimura, A.; Mukai, T.; Okada, T.; Yada, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Abe, M.; Ishibashi, Y.; Karouji, Y.; Okada, T.; Uesugi, M.; Yada, T.] Japan Aerosp Explorat Agcy, Lunar & Planetary Explorat Program Grp, Sagamihara, Kanagawa 2525210, Japan	Ebihara, M (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan.	ebihara-mitsuru@tmu.ac.jp			Kyoto University; MEXT [22224010]	INAA was made possible through a program for the cooperative use of KUR supported by Kyoto University. Careful and extensive reviews by M. Misawa and G. Herzog are highly appreciated. M. Zolensky and A. Rubin are also thanked for their helpful suggestions and comments. This work is partly supported by a Grant-in-Aids of MEXT (22224010 to ME).	ALLEN RO, 1973, GEOCHIM COSMOCHIM AC, V37, P1435, DOI 10.1016/0016-7037(73)90081-1; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; Eggins SM, 1998, EARTH PLANET SC LETT, V154, P53, DOI 10.1016/S0012-821X(97)00195-7; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; RUBIN AE, 1990, GEOCHIM COSMOCHIM AC, V54, P1217, DOI 10.1016/0016-7037(90)90148-E; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; CURTIS DB, 1979, GEOCHIM COSMOCHIM AC, V43, P1091, DOI 10.1016/0016-7037(79)90096-6; EBIHARA M, 1983, EARTH PLANET SC LETT, V63, P433, DOI 10.1016/0012-821X(83)90116-4; EBIHARA M, 1984, METEORITICS, V19, P69; Ebihara M, 2011, SCIENCE, V333, P1119, DOI 10.1126/science.1207865; JAHANBAG.IC, 1969, AM MINERAL, V54, P246; Jones J. H., 1995, HDB PHYS CONSTANTS R, V3, P73; Kallemeyn G. W., 1991, GEOCHIMICA COSMOCHIM, V55, P861; Kong P, 1997, GEOCHIM COSMOCHIM AC, V61, P2317, DOI 10.1016/S0016-7037(97)00087-2; Laul J. C., 1972, P 3 LUN SCI C, V2, P1181; Laul J. C., 1974, P 5 LUN SCI C GEOCH, V3, P1047; Lodders K, 1998, METEORIT PLANET SCI, V33, pA183; Mason B., 1970, SMITHSONIAN CONTRIBU, V3, P1; Mittlefehldt D. W., 2003, TREATISE GEOCHEMISTR, V1, P291; Nagao K, 2011, SCIENCE, V333, P1128, DOI 10.1126/science.1207785; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nakamura T., 2011, 42 LUN PLAN SCI C; Tsuchiyama A, 2014, METEORIT PLANET SCI, V49, P172, DOI 10.1111/maps.12177; Tsuchiyama A, 2013, GEOCHIM COSMOCHIM AC, V116, P5, DOI 10.1016/j.gca.2012.11.036; Wolf D, 2001, METEORIT PLANET SCI, V36, P559; Yurimoto H, 2011, SCIENCE, V333, P1116, DOI 10.1126/science.1207776	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	FEB	2015	50	2					243	254		10.1111/maps.12418		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CC1RL	WOS:000350120100005		
J	Kurotaki, D; Uede, T; Tamura, T				Kurotaki, Daisuke; Uede, Toshimitsu; Tamura, Tomohiko			Functions and development of red pulp macrophages	MICROBIOLOGY AND IMMUNOLOGY			English	Review						macrophage development; macrophage function; red pulp macrophages	TISSUE-RESIDENT MACROPHAGES; DENDRITIC CELLS; MONOCYTE DIFFERENTIATION; CIRCULATING MONOCYTES; REGULATORY FACTOR-4; GENE-EXPRESSION; YOLK-SAC; SPI-C; MOUSE; MICE	Macrophages are extremely heterogeneous mononuclear phagocytes widely distributed throughout the body. They play unique roles in each organ where they reside. Among macrophage subsets, red pulp macrophages (RPMs) that localize in the splenic red pulp, are critical for maintenance of blood homeostasis by actively phagocytosing injured and senescent erythrocytes and blood-borne particulates. Recent evidence indicates that RPMs are mainly generated during embryogenesis and are maintained during adult life. Furthermore, the cell-intrinsic and -extrinsic factors (namely, Spi-C, IRF8/4, heme oxygenase-1, and M-CSF) that regulate the development and survival of RPMs have been identified. Although the immunological properties of RPMs have yet to be elucidated fully, pioneering studies have demonstrated that these cells are capable of inducing differentiation of regulatory T cells via expression of transforming growth factor- and secrete a large amount of type I interferons during parasitic infections. In this review, we describe recent advances in understanding of the functions and development of RPMs.	[Kurotaki, Daisuke; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido 0600815, Japan	Kurotaki, D (reprint author), Yokohama City Univ, Grad Sch Med, Dept Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	kurotaki@yokohama-cu.ac.jp; tamurat@yokohama-cu.ac.jp			Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology	We thank Dr Junko Morimoto at The University of Tokushima and Dr Shigeyuki Kon at Hokkaido University for invaluable discussions and Dr Jun Nakabayashi at Yokohama City University for retrieving microarray data. This work was supported by Grants-in-Aids (KAKENHI) from the Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology to D.K. and T.T.	Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87; Yadava A, 1996, P NATL ACAD SCI USA, V93, P4595, DOI 10.1073/pnas.93.10.4595; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Tsujimura H, 2003, J IMMUNOL, V170, P1131; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Tamura T, 2005, J IMMUNOL, V174, P2573; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Kurotaki D, 2011, J IMMUNOL, V186, P2229, DOI 10.4049/jimmunol.1001345; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; den Haan JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00201; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Sasaki H, 2015, BLOOD, V125, P358, DOI 10.1182/blood-2014-02-557983; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; TAKAHASHI K, 1994, J LEUKOCYTE BIOL, V55, P581; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					55	62		10.1111/1348-0421.12228		8	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000001		
J	Tanaka, Y; Benno, Y				Tanaka, Yoshiki; Benno, Yoshimi			Application of a single-colony coculture technique to the isolation of hitherto unculturable gut bacteria	MICROBIOLOGY AND IMMUNOLOGY			English	Article						cocultivation; human gut; interbacterial communication; unculturable bacteria	SP NOV.; CULTIVATION; CULTURE; MICROORGANISMS; MICROBIOME; DIVERSITY; STRAIN; GROWTH; FLORA; IBD	Molecular studies have led to postulation of a relationship between gut microbiota and certain diseases. However, because studies of hitherto uncultured species in vivo are essential for characterizing the biology and pathogenic properties of gut bacteria, techniques for culturing and isolating such bacteria must be developed. Here, a technique is described that partially overcomes the obstacles that prevent detection of interbacterial communication in vitro and are thus responsible for the failure to culture certain bacterial species. For this purpose, a ring with a membrane filter at the bottom was designed and a relatively simple nutrient medium was used instead of conventional media. Gut bacteria were cocultivated in soft agar separated by the membrane filter to simulate interbacterial communication in vitro. Use of this soft agar coculture technique led to the successful isolation of hitherto uncultured bacteria and the demonstration of multistage interbacterial communication among gut bacteria in vitro. Cultivation and isolation of single colonies of bacteria that require other bacteria for growth will enhance efforts to better understand the physiological and pathogenic roles of gut microbiota.	[Tanaka, Yoshiki] Biofermin Pharmaceut, Biofermin Kobe Res Inst, Nishi Ku, Kobe, Hyogo 6512242, Japan; [Tanaka, Yoshiki; Benno, Yoshimi] RIKEN Innovat Ctr, Benno Lab, Wako, Saitama 3510198, Japan	Tanaka, Y (reprint author), Biofermin Pharmaceut, Biofermin Kobe Res Inst, Nishi Ku, 7-3-4 Higashi Machi, Kobe, Hyogo 6512242, Japan.	tanaka_yoshiki@biofermin.co.jp					Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Aoi Y, 2009, APPL ENVIRON MICROB, V75, P3826, DOI 10.1128/AEM.02542-08; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Bloomfield SF, 1998, MICROBIOL-UK, V144, P1; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; DELDOT T, 1993, SYST APPL MICROBIOL, V16, P380; AMANN RI, 1995, MICROBIOL REV, V59, P143; CALDWELL DR, 1966, APPL MICROBIOL, V14, P794; MITSUOKA T, 1965, ZENTBL BAKTERIOLOG P, V195, P455; Ohno M, 1999, BIOSCI BIOTECH BIOCH, V63, P1083, DOI 10.1271/bbb.63.1083; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Tanaka Y, 2004, INT J SYST EVOL MICR, V54, P955, DOI 10.1099/ijs.0.02750-0; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Tannock GW, 2008, MUCOSAL IMMUNOL, V1, pS15, DOI 10.1038/mi.2008.54; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Antunes LCM, 2005, ANAEROBE, V11, P295, DOI 10.1016/j.anaerobe.2005.03.003; ELLER C, 1971, Applied Microbiology, V22, P522; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; GRENIER D, 1992, INFECT IMMUN, V60, P5298; Guarner F, 2008, INFLAMM BOWEL DIS, V14, pS83, DOI 10.1002/ibd.20548; Kim Kwang, 2011, BMC Res Notes, V4, P437, DOI 10.1186/1756-0500-4-437; KOSEKI T, 1995, ORAL MICROBIOL IMMUN, V10, P271, DOI 10.1111/j.1399-302X.1995.tb00153.x; Nicols D., 2008, APPL ENVIRON MICROB, V74, P4889; Watsuji T. O., 2007, APPL ENVIRON MICROB, V73, P6159; Zengler K, 2005, METHOD ENZYMOL, V397, P124, DOI 10.1016/S0076-6879(05)97007-9	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					63	70		10.1111/1348-0421.12220		8	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000002		
J	Arimitsu, H; Sasaki, K; Iba, Y; Kurosawa, Y; Shimizu, T; Tsuji, T				Arimitsu, Hideyuki; Sasaki, Keiko; Iba, Yoshitaka; Kurosawa, Yoshikazu; Shimizu, Toshiyasu; Tsuji, Takao			Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2	MICROBIOLOGY AND IMMUNOLOGY			English	Article						monoclonal antibodies; neutralization; Shiga toxins	ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; PROTECT MICE; INFECTION; VACCINE; TYPE-2; ANTIBIOTICS; ENTEROTOXIN; VOLUNTEERS; BINDING	Shiga toxin 2 (Stx2)-specific mAb-producing hybridoma clones were generated from mice. Because mice tend to produce small amounts of B subunit (Stx2B)-specific antibodies at the polyclonal antibody level after immunization via the parenteral route, mice were immunized intranasally with Stx2 toxoids with a mutant heat-labile enterotoxin as a mucosal adjuvant; 11 different hybridoma clones were obtained in two trials. Six of them were A subunit (Stx2A)-specific whereas five were Stx2B-specific antibody-producing clones. The in vitro neutralization activity of Stx2B-specific mAbs against Stx2 was greater than that of Stx2A-specific mAbs on HeLa229 cells. Furthermore, even at low concentrations two of the Stx2B-specific mAbs (45 and 75D9) completely inhibited receptor binding and showed in vivo neutralization activity against a fivefold median lethal dose of Stx2 in mice. In western blot analysis, these Stx2B-specific neutralization antibodies did not react to three different mutant forms of Stx2, each amino acid residue of which was associated with receptor binding. Additionally, the nucleotide sequences of the V-H and V-L regions of clones 45 and 75D9 were determined. Our Stx2B-specific mAbs may be new candidates for the development of mouse-human chimeric Stx2-neutralizing antibodies which have fewer adverse effects than animal antibodies for enterohemorrhagic Escherichia coli infection.	[Arimitsu, Hideyuki; Sasaki, Keiko; Shimizu, Toshiyasu; Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 4701192, Japan; [Iba, Yoshitaka; Kurosawa, Yoshikazu] Fujita Hlth Univ, Innovat Ctr Adv Med, Toyoake, Aichi 4701192, Japan	Arimitsu, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Microbiol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	arimitsu@fujita-hu.ac.jp			JSPS KAKENHI [24590539]; Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare, Japan	This work was supported, in part, by grants from JSPS KAKENHI (Number 24590539), the Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Health and Labor Sciences Research Grants for Research on Global Health Issues from the Ministry of Health, Labor, and Welfare, Japan.	Connell TD, 2007, EXPERT REV VACCINES, V6, P821, DOI 10.1586/14760584.6.5.821; Matsushiro A, 1999, J BACTERIOL, V181, P2257; Bitzan M, 2009, ANTIMICROB AGENTS CH, V53, P3081, DOI 10.1128/AAC.01661-08; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; TESH VL, 1993, INFECT IMMUN, V61, P3392; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497; SCOTLAND SM, 1987, EPIDEMIOL INFECT, V99, P613; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128/AAC.00343-09; OSTROFF SM, 1989, J INFECT DIS, V160, P994; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; TAKEDA Y, 1993, MICROBIOL IMMUNOL, V37, P591; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Arimitsu H, 2013, MICROBIOL IMMUNOL, V57, P38, DOI 10.1111/j.1348-0421.2012.12004.x; Arimitsu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083577; Dowling TC, 2005, ANTIMICROB AGENTS CH, V49, P1808, DOI 10.1128/AAC.49.5.1808-1812.2005; Edwards AC, 1998, ESCHERICHIA COLI O15, P388; Iba Y, 1997, GENE, V194, P35, DOI 10.1016/S0378-1119(97)00101-7; Kimura T, 2002, HYBRIDOMA HYBRIDOM, V21, P161, DOI 10.1089/153685902760173872; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Nakao H, 1999, INFECT IMMUN, V67, P5717; Neri P, 2007, MICROBIOL IMMUNOL, V51, P581; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; PERERA LP, 1988, J CLIN MICROBIOL, V26, P2127; Sheoran AS, 2003, INFECT IMMUN, V71, P3125, DOI 10.1128/IAI.71.6.3125-3130.2003; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Tsuji T, 1997, IMMUNOLOGY, V90, P176, DOI 10.1046/j.1365-2567.1997.00156.x; Tsuji T, 2008, VACCINE, V26, P2092, DOI 10.1016/j.vaccine.2008.02.034; Tsuji T, 2008, VACCINE, V26, P469, DOI 10.1016/j.vaccine.2007.11.038; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					71	81		10.1111/1348-0421.12221		11	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000003		
J	Saekhow, P; Ikeda, H				Saekhow, Prayuth; Ikeda, Hidetoshi			Prevalence and genomic characterization of porcine parvoviruses detected in Chiangmai area of Thailand in 2011	MICROBIOLOGY AND IMMUNOLOGY			English	Article						genetic diversity; porcine parvovirus; prevalence	HIGHLY PREVALENT; GENETIC-ANALYSIS; IDENTIFICATION; HOKOVIRUS; PIGS; POPULATION; SEQUENCE; CHINA	Porcine parvovirus (PPV) causes reproductive failure in sows and has spread worldwide. Several new types of porcine parvoviruses have recently been identified in pig herds. The prevalence of five porcine parvoviruses in the Chiangmai area of Thailand was studied. The prevalence in 80 pigs was 53% for PPV (PPV-Kr or -NADL2 being the new abbreviations), 83% for PPV2 (CnP-PARV4), 73% for PPV3 (P-PARV4), 44% for PPV4 (PPV4), and 18% for PBo-likeV (PBoV7). Over 60% of the pigs carried more than three of the five porcine parvoviruses and occurrence together of the two pairs of viral genes, PPV1/PPV3 and PPV2/PBo-likeV were observed. Phylogenetic analyses for PPV2 and PPV3 indicated the existence of only two major clades of PPV2 and one major clade of PPV3.	[Saekhow, Prayuth; Ikeda, Hidetoshi] Nippon Vet & Life Sci Univ, Grad Sch Vet Med & Life Sci, Lab Vet Hyg, Musashino, Tokyo 1808602, Japan; [Saekhow, Prayuth] Chiang Mai Univ, Dept Vet Biosci & Publ Hlth, Fac Vet Med, Chiang Mai 50100, Thailand	Ikeda, H (reprint author), Nippon Vet & Life Sci Univ, Grad Sch Vet Med & Life Sci, Lab Vet Hyg, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	hikeda@nvlu.ac.jp			Ministry of Health, Labor and Welfare [H20-Shokuhin-Ippan-014]	We thank Dr. Yoshikazu Tanaka for his advice and help. This study was supported in part by Grant-in-Aids for Scientific Research from the Ministry of Health, Labor and Welfare (H20-Shokuhin-Ippan-014).	Adlhoch C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-171; Adlhoch C, 2013, EMERG INFECT DIS, V19, P2060, DOI 10.3201/eid1912.130891; Xiao CT, 2012, VET MICROBIOL, V160, P290, DOI 10.1016/j.vetmic.2012.05.038; Tummaruk P, 2012, TROP ANIM HEALTH PRO, V44, P983, DOI 10.1007/s11250-011-9999-6; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Xiao CT, 2013, VET MICROBIOL, V161, P325, DOI 10.1016/j.vetmic.2012.07.038; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Ogawa H, 2009, J VIROL METHODS, V160, P210, DOI 10.1016/j.jviromet.2009.05.010; Hijikata M, 2001, JPN J INFECT DIS, V54, P244; Wang F, 2010, VIRUS GENES, V41, P305, DOI 10.1007/s11262-010-0506-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Cadar D, 2011, ARCH VIROL, V156, P2233, DOI 10.1007/s00705-011-1125-6; Cadar D, 2011, VIRUS GENES, V43, P376, DOI 10.1007/s11262-011-0650-4; Cartwright S. F., 1967, VET REC, V81, P196; Huang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-333; Li B, 2012, J VIROL, V86, P1899, DOI 10.1128/JVI.06771-11; Li SB, 2013, ARCH VIROL, V158, P1987, DOI 10.1007/s00705-013-1690-y; Pan YY, 2012, ARCH VIROL, V157, P1785, DOI 10.1007/s00705-012-1350-7; Saekhow P., 2014, MICROBIOL IMMUNOL, V58, P361; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Streck AF, 2013, ARCH VIROL, V158, P1173, DOI 10.1007/s00705-013-1603-0; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3201/eid1603.090746, 10.3210/eid1603.090746]; Xiao C. T., 2013, PLOS ONE, V8; Xiao CT, 2013, INFECT GENET EVOL, V16, P369, DOI 10.1016/j.meegid.2013.03.017; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0; Zhang HB, 2011, EPIDEMIOL INFECT, V139, P1581, DOI 10.1017/S0950268811000847	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					82	88		10.1111/1348-0421.12218		7	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000004		
J	Shiota, T; Li, TC; Yoshizaki, S; Kato, T; Wakita, T; Ishii, K				Shiota, Tomoyuki; Li, Tian-Cheng; Yoshizaki, Sayaka; Kato, Takanobu; Wakita, Takaji; Ishii, Koji			Establishment of hepatitis E virus infection-permissive and -non-permissive human hepatoma PLC/PRF/5 subclones	MICROBIOLOGY AND IMMUNOLOGY			English	Article						attachment; cloning cell lines; hepatitis E virus; non-permissive	NON-B-HEPATITIS; CELL-CULTURE; CDNA-CLONE; FULMINANT-HEPATITIS; VIRAL GENOME; NON-A; HEV; STRAIN; PARTICLES; CHINA	PLC/PRF/5 cells show limited permissiveness, meaning that almost all subclones are permissive; however, some subclones do not exhibit permissiveness for hepatitis E virus (HEV) infection. In this study, the single-cell cloning of PLC/PRF/5 was performed and heterogeneous subclones characterized. Notably, the efficiency of intracellular virus replication did not correlate with the permissiveness for HEV infection. However, as well as binding permissive subclones, virus-like particles bound non-permissive subclones on various levels, suggesting that these subclones have some deficiencies in the attachment and entry steps of infection. Our data would be useful for investigating the HEV life cycle.	[Shiota, Tomoyuki; Li, Tian-Cheng; Yoshizaki, Sayaka; Kato, Takanobu; Wakita, Takaji; Ishii, Koji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan	Ishii, K (reprint author), Natl Inst Infect Dis, Dept Virol 2, Gakuen 4-7-1, Tokyo 2080011, Japan.	kishii@nih.go.jp			Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by grants-in-aid from the Ministry of Health, Labour, and Welfare, Japan, and from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1002/hep.510230622; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; KANE MA, 1984, JAMA-J AM MED ASSOC, V252, P3140, DOI 10.1001/jama.252.22.3140; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Li TC, 1997, J VIROL, V71, P7207; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Magden J, 2001, J VIROL, V75, P6249, DOI 10.1128/JVI.75.14.6249-6255.2001; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Agrawal S, 2001, VIROLOGY, V282, P87, DOI 10.1006/viro.2000.0819; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Li TC, 2005, EMERG INFECT DIS, V11, P1958; ARANKALLE VA, 1988, LANCET, V1, P550; Cordoba L, 2012, J GEN VIROL, V93, P2183, DOI 10.1099/vir.0.043711-0; Emerson S. U., 2005, VIRUS TAXONOMY, P853; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JV1.00046-06; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Huang RT, 1999, CLIN DIAGN LAB IMMUN, V6, P729; HUANG RT, 1995, J MED VIROL, V47, P299, DOI 10.1002/jmv.1890470402; HUANG RT, 1992, J GEN VIROL, V73, P1143, DOI 10.1099/0022-1317-73-5-1143; KAZACHKOV YA, 1992, ARCH VIROL, V127, P399, DOI 10.1007/BF01309603; Khuroo M S, 1991, Indian J Gastroenterol, V10, P96; Kwon HM, 2011, VET MICROBIOL, V147, P310, DOI 10.1016/j.vetmic.2010.07.016; MCCLAIN DS, 1994, VIROLOGY, V198, P690, DOI 10.1006/viro.1994.1081; Meng J, 1997, J CLIN MICROBIOL, V35, P1373; Shiota T, 2013, J VIROL, V87, P6031, DOI 10.1128/JVI.00444-13; Takahashi K., 2010, KANZO, V51, P536; Tam AW, 1997, VIROLOGY, V238, P94, DOI 10.1006/viro.1997.8817; TSAREV SA, 1994, J MED VIROL, V43, P135, DOI 10.1002/jmv.1890430207; Wei SJ, 2000, J MED VIROL, V61, P311, DOI 10.1002/1096-9071(200007)61:3<311::AID-JMV5>3.0.CO;2-H; Yamada K, 2009, J GEN VIROL, V90, P457, DOI 10.1099/vir.0.007559-0; Zhu YM, 2013, VET MICROBIOL, V166, P405, DOI 10.1016/j.vetmic.2013.06.021	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					89	94		10.1111/1348-0421.12219		6	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000005		
J	Takeshima, K; Sato, K; Nabekura, T; Nagamune, K; Hamada, H; Yoshikawa, H; Shibuya, A; Shibuya, K				Takeshima, Kinuko; Sato, Kazuki; Nabekura, Tsukasa; Nagamune, Kisaburo; Hamada, Hiromi; Yoshikawa, Hiroyuki; Shibuya, Akira; Shibuya, Kazuko			Increased CD11b(+) Gr-1(+) cell population in the placenta after infection with Toxoplasma gondii	MICROBIOLOGY AND IMMUNOLOGY			English	Article						CD11b(+) Gr-1(+) cell; flow cytometry analysis; placenta	INFLAMMATORY MONOCYTES; MICE; RECRUITMENT; NEUTROPHILS; RESISTANCE; GAMMA	Toxoplasma gondii is an obligate intracellular protozoan pathogen that can cross the placenta, resulting in congenital toxoplasmosis with severe fetal brain abnormalities. The molecular mechanisms of immune responses against T. gondii infection in the placenta have largely remained unclear. An analytical method for characterizing phenotypes of immune cells in the placenta by flow cytometry was established and it was found that numbers of CD11b(+) Gr-1(+) cells in the placenta increased significantly after T. gondii infection. These results suggest that innate immune responses play an important role in immunity against T. gondii infection via the feto-maternal interface.	[Takeshima, Kinuko; Sato, Kazuki; Nabekura, Tsukasa; Shibuya, Akira; Shibuya, Kazuko] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; [Takeshima, Kinuko; Hamada, Hiromi; Yoshikawa, Hiroyuki] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058575, Japan; [Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan; [Shibuya, Akira] Univ Tsukuba, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Tsukuba, Ibaraki 3058575, Japan; [Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan	Shibuya, K (reprint author), Univ Tsukuba, Fac Med, Dept Immunol, 1-1-1 Tennohdai, Tsukuba, Ibaraki 3058575, Japan.	kazukos@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This research was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to A.S and K.S).	Abdallah Abi, 2012, INFECT IMMUN, V80, P768; WONG SY, 1994, CLIN INFECT DIS, V18, P853; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Coombes JL, 2013, P NATL ACAD SCI USA, V110, pE1913, DOI 10.1073/pnas.1220272110; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; MCCABE R, 1988, NEW ENGL J MED, V318, P313, DOI 10.1056/NEJM198802043180509; Shiono Y, 2007, PARASITOL INT, V56, P141, DOI 10.1016/j.parint.2007.01.008; WONG SY, 1993, J CLIN MICROBIOL, V31, P2952	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					95	98		10.1111/1348-0421.12225		4	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000006		
J	Miyazawa, K; Yoda, K; Kawase, M; Harata, G; He, F				Miyazawa, Kenji; Yoda, Kazutoyo; Kawase, Manabu; Harata, Gaku; He, Fang			Influence of orally administered Lactobacillus GG on respiratory immune response in a murine model of diet-induced obesity	MICROBIOLOGY AND IMMUNOLOGY			English	Article						intestinal microbiota; Lactobacillus GG; obesity; respiratory immunity	PLACEBO-CONTROLLED TRIAL; ATTENDING DAY-CARE; RHAMNOSUS GG; INTESTINAL MICROBIOTA; VIRUS INFECTION; GASSERI TMC0356; PROTECTS MICE; DOUBLE-BLIND; PROBIOTICS; CHILDREN	Mice with diet-induced obesity were fed with Lactobacillus rhamnosus GG (LGG) suspended in saline or saline alone (control mice). Pulmonary mRNA expression of IFN-; IFN- receptor 1; CD247 antigen; killer cell lectin-like receptor subfamily K, member 1; TNF-; IL-12 receptor 1 and IL-2 receptor , and the proportion of Lactobacillales in feces were significantly greater in the LGG group than in the control mice (P<0.05 and P<0.01, respectively). These results suggest that LGG alters the respiratory immunity of obese subjects through having a potent impact on intestinal immunity.	[Miyazawa, Kenji; Yoda, Kazutoyo; Kawase, Manabu; Harata, Gaku; He, Fang] Takanashi Milk Prod, Tech Res Lab, Yokohama, Kanagawa 2410023, Japan	Yoda, K (reprint author), Takanashi Milk Prod, Tech Res Lab, Yokohama, Kanagawa 2410023, Japan.	k-yoda@takanashi-milk.co.jp			Japanese Ministry of Agriculture, Forestry and Fisheries	This work was supported by a grant from the Japanese Ministry of Agriculture, Forestry and Fisheries. We thank T. Hisada (NCIMB group, TechnoSuruga Laboratory Co., Ltd) for his assistance and technique of T-RFLP analysis of fecal samples. We thank H. Kawasaki and S. Takayama (LA center, Oriental Yeast Co., Ltd) for their excellent technique in the animal experiments. The authors would like to thank Enago (www.enago.jp) for the English language review.	Yoda K, 2012, J APPL MICROBIOL, V113, P155, DOI 10.1111/j.1365-2672.2012.05316.x; Kumpu M, 2013, J MED VIROL, V85, P1632, DOI 10.1002/jmv.23623; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Horvath A, 2011, ALIMENT PHARM THER, V33, P1302, DOI 10.1111/j.1365-2036.2011.04665.x; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Hojsak I, 2010, CLIN NUTR, V29, P312, DOI 10.1016/j.clnu.2009.09.008; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Smith AG, 2007, J NUTR, V137, P1236; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Hatakka K, 2001, BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kumpu M, 2012, EUR J CLIN NUTR, V66, P1020, DOI 10.1038/ejcn.2012.62; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Benno Y., 1996, NUTR TODAY, V31, p12S, DOI 10.1097/00017285-199611001-00004; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Iliev ID, 2008, SCAND J IMMUNOL, V67, P370, DOI 10.1111/j.1365-3083.2008.02080.x; Jain S, 2011, CLIN INFECT DIS, V53, P422, DOI 10.1093/cid/cir448; Kawase M, 2011, FEMS IMMUNOL MED MIC, V64, P280; Kubota A, 2009, MICROBIOL IMMUNOL, V53, P198, DOI 10.1111/j.1348-0421.2009.00113.x; Miyazawa K, 2012, MICROBIOL IMMUNOL, V56, P847, DOI 10.1111/j.1348-0421.2012.00512.x; Thang CL, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-20; Villena J., 2013, PROBIOTICS IMMUNOBIO, P365; World Health Organization [WHO], 2014, OB OV	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	FEB	2015	59	2					99	103		10.1111/1348-0421.12226		5	Immunology; Microbiology	Immunology; Microbiology	CC1XZ	WOS:000350140000007		
J	Nakamoto, H; Nakayama, K; Emoto, N; Kajiya, F				Nakamoto, Hiroshi; Nakayama, Kazuhiko; Emoto, Noriaki; Kajiya, Fumihiko			The Short-Term Effects of C-Peptide on the Early Diabetes-Related Ultrastructural Changes to the Podocyte Slit Diaphragm of Glomeruli in Rats	MICROCIRCULATION			English	Article						C-peptide; diabetes; diaphragm; electron microscopy; immunofluorescence; slit podocyte	CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; PROXIMAL TUBULE; NEPHROPATHY; PROTEINURIA; NEPHRIN; INSULIN; IDDM	ObjectiveThis study aimed to investigate the structural changes in the slit diaphragm, caused by early diabetes, and the nephroprotective effect of C-peptide. MethodsStreptozotocin-induced type 1 diabetic Wistar rats were divided into control, control plus C-peptide, early diabetes, and early diabetes plus C-peptide groups. C-peptide was infused into rats for one day. The slit diaphragm component proteins podocin, CD2AP, and nephrin, were stained immunofluorescently and their distribution quantitatively analyzed by determining the overlapping area ratio. The interfoot process gap length was measured from electron microscopic images. ResultsDiabetic duration correlated best with the area ratio of podocin and CD2AP (r=0.626), followed by other protein combinations, showing progressive change in the slit diaphragm structure. C-peptide-treatment did not alter area ratios. The interfoot process gap length was wider in diabetic rats (p<0.05) and did not narrow with C-peptide-treatment in either control or diabetic rats (both p<0.05). ConclusionsDiabetes widened the interfoot process gap length and distorted the slit diaphragm structure progressively and heterogeneously in rats with early diabetes; this was not altered by C-peptide-treatment. The nephroprotective effect of C-peptide in decreasing the glomerular filtration rate appears to be functional rather than structural.	[Nakamoto, Hiroshi; Kajiya, Fumihiko] Kawasaki Med Univ, Dept Med Engn & Syst Cardiol, Kurashiki, Okayama 7010192, Japan; [Nakamoto, Hiroshi] Kawasaki Univ Med Welf, Dept Clin Engn, Kurashiki, Okayama, Japan; [Nakayama, Kazuhiko; Emoto, Noriaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Emoto, Noriaki] Kobe Pharmaceut Univ, Kobe, Hyogo, Japan	Nakamoto, H (reprint author), Kawasaki Med Univ, Dept Med Engn & Syst Cardiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hershey@me.kawasaki-m.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [B20300163, 23650278]; Kawasaki Welfare University [C13]	Most of this work was presented at the Scientific Sessions of the American Heart Association in 2012. We acknowledge the students of the Department of Clinical Engineering at Kawasaki Junior College, viz., Keiichi Etoh, Hiroki Iwashita, and Hironori Manabe, and those at Kawasaki Welfare University, viz., Ken Harada, Yuka Hirota, and Akira Higuchi. We also acknowledge the students of the Department of Clinical Pharmacy at Kobe Pharmaceutical University, viz., Yuki Murai, Yu-ka Okada, Keiko Fujiki, and Takuya Okano. This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (B20300163 and Challenging Exploratory Research 23650278) and was also supported by a grant from Kawasaki Welfare University (2013-2014, C13).	ALLEN F, 1976, KIDNEY INT, V9, P8, DOI 10.1038/ki.1976.2; Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562; Kang JJ, 2008, HYPERTENSION, V51, P1597, DOI 10.1161/HYPERTENSIONAHA.107.107268; De Nicola L, 2006, KIDNEY INT, V69, P538, DOI 10.1038/sj.ki.5000085; Sipos A, 2007, KIDNEY INT, V72, P1188, DOI 10.1038/sj.ki.5002461; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; BJORN SF, 1995, DIABETOLOGIA, V38, P1197, DOI 10.1007/BF00422369; Berg UB, 1998, DIABETOLOGIA, V41, P1047, DOI 10.1007/s001250051029; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Flynn ER, 2013, J DIABETES COMPLICAT, V27, P538, DOI 10.1016/j.jdiacomp.2013.07.002; Nordquist L, 2009, AM J PHYSIOL-RENAL, V297, pF1265, DOI 10.1152/ajprenal.00228.2009; Hallan SI, 2010, J NEPHROL, V23, P147; Hills CE, 2009, CLIN SCI, V116, P565, DOI 10.1042/CS20080441; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Forst T, 1998, J CLIN INVEST, V101, P2036, DOI 10.1172/JCI2147; Hills CE, 2010, AM J NEPHROL, V31, P389, DOI 10.1159/000289864; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Nakamoto H, 2004, METABOLISM, V53, P335, DOI 10.1016/j.metabol.2003.10.014; Nakamoto H, 2013, MICROCIRCULATION, V20, P425, DOI 10.1111/micc.12043; Nordquist L, 2008, AM J PHYSIOL-REG I, V294, pR836, DOI 10.1152/ajpregu.00811.2007; Rasband WS, 1997, IMAGEJ; Russo LM, 2007, KIDNEY INT, V72, P1195, DOI 10.1038/sj.ki.5002528; Samnegard B, 2001, KIDNEY INT, V60, P1258, DOI 10.1046/j.1523-1755.2001.00964.x; Sjoquist M, 1998, KIDNEY INT, V54, P758, DOI 10.1046/j.1523-1755.1998.00074.x; Smoyer WE, 1997, AM J PHYSIOL-RENAL, V273, pF150; Thelle K, 2006, KIDNEY INT, V69, P1333, DOI 10.1038/sj.ki.5000272; Toyota E, 2004, KIDNEY INT, V66, P855, DOI 10.1111/j.1523-1755.2004.00816.x; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Wahren J, 2007, DIABETOLOGIA, V50, P503, DOI 10.1007/s00125-006-0559-y; Wahren J, 2004, EXP DIABESITY RES, V5, P15, DOI 10.1080/15438600490424479; Wahren J, 1996, J INTERN MED, V240, P115, DOI 10.1046/j.1365-2796.1996.19841000.x; Yamamoto T, 2001, KIDNEY INT, V60, P364, DOI 10.1046/j.1523-1755.2001.00808.x	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	FEB	2015	22	2					122	132		10.1111/micc.12185		11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CB9UE	WOS:000349977800003		
J	Li, W; Sasaki, A; Oozu, H; Aoki, K; Kakushima, K; Kataoka, Y; Nishiyama, A; Sugii, N; Wakabayashi, H; Tsutsui, K; Natori, K; Iwai, H				Li, Wei; Sasaki, Akito; Oozu, Hideyuki; Aoki, Katsuaki; Kakushima, Kuniyuki; Kataoka, Yoshinori; Nishiyama, Akira; Sugii, Nobuyuki; Wakabayashi, Hitoshi; Tsutsui, Kazuo; Natori, Kenji; Iwai, Hiroshi			Improvement of charge/discharge performance for lithium ion batteries with tungsten trioxide electrodes	MICROELECTRONICS RELIABILITY			English	Article						Tungsten trioxide electrode; Charge/discharge performance; Electron conduction; Crystalline structure	OXIDE FILMS; ELECTROCHEMICAL CHARACTERISTICS; WO3; ANODE	Although a large amount of research on Li ion transportation has been carried out with the aim of improving the properties of lithium ion batteries, there has been little detailed research on electron conduction. Hence, we have been focusing on improving the charge/discharge performance of lithium ion batteries by increasing the electron conductivity of the electrodes. The electron conductivity of crystalline tungsten trioxide (WO3) was found to be increased by N-2 annealing owing to the generation of oxygen vacancies. It was clarified that increasing the conductivity of the electrodes can improve the performance of lithium ion batteries, particularly their charge/discharge speed and reversibility. Additionally, the best performance was observed in a sample subjected to high-temperature annealing at 700 degrees C in N-2 ambient, which decreased the resistivity of the WO3 electrode by five orders of magnitude and simultaneously changed the monoclinic crystalline structure into a cubiclike structure into which Li ions are more easily intercalated. Therefore, to enhance the charge/discharge performance of lithium ion batteries, electron conduction should be a focus of research. Crystalline WO3 was also demonstrated to be a promising material for electrodes since oxygen vacancy generation can be induced by a simple annealing treatment, improving the electron conduction and Li ion transportation. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Wei; Kakushima, Kuniyuki; Kataoka, Yoshinori; Nishiyama, Akira; Sugii, Nobuyuki; Wakabayashi, Hitoshi; Tsutsui, Kazuo; Iwai, Hiroshi] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect & Appl Phys, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Sasaki, Akito; Oozu, Hideyuki; Aoki, Katsuaki] Toshiba Mat Co LTD, Isogo Ku, Yokohama, Kanagawa 2358522, Japan; [Natori, Kenji; Iwai, Hiroshi] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Li, W (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect & Appl Phys, Midori Ku, 4259-S2-20 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	li.w.ad@m.titech.ac.jp			China Scholarship Council in Japan	The author Wei Li wants to thank China Scholarship Council for supporting her study in Japan.	Zhao HL, 2008, ELECTROCHIM ACTA, V53, P7079, DOI 10.1016/j.electacta.2008.05.038; Li NC, 2001, J POWER SOURCES, V97-8, P240, DOI 10.1016/S0378-7753(01)00760-1; Lee SH, 2001, ELECTROCHIM ACTA, V46, P3415, DOI 10.1016/S0013-4686(01)00541-2; Fan XY, 2010, J ALLOY COMPD, V493, P77, DOI 10.1016/j.jallcom.2009.12.179; Valova E, 2010, J ELECTROCHEM SOC, V157, pD309, DOI 10.1149/1.3356001; Etacheri V, 2011, ENERG ENVIRON SCI, V4, P3243, DOI 10.1039/c1ee01598b; Wang YQ, 2012, J AM CHEM SOC, V134, P7874, DOI 10.1021/ja301266w; Stankova NE, 2005, APPL SURF SCI, V247, P401, DOI 10.1016/j.apsusc.2005.01.057; Armstrong AR, 1996, NATURE, V381, P499, DOI 10.1038/381499a0; HOLLINGER G, 1976, PHYS REV LETT, V37, P1564, DOI 10.1103/PhysRevLett.37.1564; ZHONG Q, 1992, PHYS REV B, V46, P2554, DOI 10.1103/PhysRevB.46.2554; Parkinson MF, 2014, ELECTROCHIM ACTA, V125, P71, DOI 10.1016/j.electacta.2014.01.080; SCROSATI B, 1995, NATURE, V373, P557, DOI 10.1038/373557a0; DANIEL MF, 1988, J SOLID STATE CHEM, V73, P127, DOI 10.1016/0022-4596(88)90062-X; Granqvist CG, 1999, ELECTROCHIM ACTA, V44, P3005, DOI 10.1016/S0013-4686(99)00016-X; Koningsberger D., 1988, XRAY ABSORPTION PRIN; Li W, MICROELECTR IN PRESS; Ozer N, 1997, THIN SOLID FILMS, V304, P310, DOI 10.1016/S0040-6090(97)00218-6; Pauporte T, 2004, J ELECTROCHEM SOC, V151, pH21, DOI 10.1149/1.1631285; Wang CK, 2013, CERAM INT, V39, P4293, DOI 10.1016/j.ceramint.2012.11.010; Yamada H, 1999, MATER RES BULL, V34, P955, DOI 10.1016/S0025-5408(99)00090-2	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0026-2714			MICROELECTRON RELIAB	Microelectron. Reliab.	FEB	2015	55	2					402	406		10.1016/j.microrel.2014.11.002		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CB6GD	WOS:000349724600016		
J	Li, W; Sasaki, A; Oozu, H; Aoki, K; Kakushima, K; Kataoka, Y; Nishiyama, A; Sugii, N; Wakabayashi, H; Tsutsui, K; Natori, K; Iwai, H				Li, Wei; Sasaki, Akito; Oozu, Hideyuki; Aoki, Katsuaki; Kakushima, Kuniyuki; Kataoka, Yoshinori; Nishiyama, Akira; Sugii, Nobuyuki; Wakabayashi, Hitoshi; Tsutsui, Kazuo; Natori, Kenji; Iwai, Hiroshi			Electron transport mechanism of tungsten trioxide powder thin film studied by investigating effect of annealing on resistivity	MICROELECTRONICS RELIABILITY			English	Article						Electron transport mechanism; Monoclinic tungsten trioxide powder thin film; Resistivity; Activation energy	LITHIUM; OXIDE; SEMICONDUCTOR	We report a new approach for improving the recharging and discharging speed of lithium ion batteries based on understanding of the electron conduction mechanism of tungsten trioxide (WO3) powder thin films fabricated from nanoparticles and used in lithium ion battery electrodes. Resistivity measurements are carried out after annealing in N-2 or 5% O-2 + 95% N-2 ambient. Annealing in N-2 ambient decreases the resistivity owing to the increased number of oxygen vacancies in the WO3 thin film. Fitting results obtained from the resistivity are used to propose the simultaneous existence of two types of electron conduction mechanism, band conduction and nearest-neighbor hopping (NNH) conduction, contributing to electron conduction in WO3 thin films. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Wei; Kakushima, Kuniyuki; Kataoka, Yoshinori; Nishiyama, Akira; Sugii, Nobuyuki; Wakabayashi, Hitoshi; Tsutsui, Kazuo; Iwai, Hiroshi] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect & Appl Phys, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Sasaki, Akito; Oozu, Hideyuki; Aoki, Katsuaki] Toshiba Mat Co LTD, Isogo Ku, Yokohama, Kanagawa 2358522, Japan; [Natori, Kenji; Iwai, Hiroshi] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Li, W (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect & Appl Phys, Midori Ku, 4259-S2-20 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	li.w.ad@m.titech.ac.jp			China Scholarship Council in Japan	The author Wei Li wants to thank China Scholarship Council for supporting her study in Japan.	Al Mohammad A, 2002, THIN SOLID FILMS, V408, P302, DOI 10.1016/S0040-6090(02)00090-1; Ambily S, 1998, MATER LETT, V34, P124, DOI 10.1016/S0167-577X(97)00151-1; Lee SH, 2001, ELECTROCHIM ACTA, V46, P3415, DOI 10.1016/S0013-4686(01)00541-2; Nomura K, 2004, APPL PHYS LETT, V85, P1993, DOI 10.1063/1.1788897; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; Yu D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216802; CONWELL EM, 1956, PHYS REV, V103, P51, DOI 10.1103/PhysRev.103.51; Dillon AC, 2008, THIN SOLID FILMS, V516, P794, DOI 10.1016/j.tsf.2007.06.177; Yu AS, 1998, J SOLID STATE ELECTR, V2, P394, DOI 10.1007/s100080050116; Huang K, 2012, NANO ENERGY, V1, P172, DOI 10.1016/j.nanoen.2011.08.005; Parkinson MF, 2014, ELECTROCHIM ACTA, V125, P71, DOI 10.1016/j.electacta.2014.01.080; Sato T, 2000, PHYS REV B, V61, P12970, DOI 10.1103/PhysRevB.61.12970; Jun JH, 2009, SENSOR ACTUAT B-CHEM, V140, P412, DOI 10.1016/j.snb.2009.05.019; KUMAGAI N, 1994, SOLID STATE IONICS, V70, P451, DOI 10.1016/0167-2738(94)90353-0	14	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0026-2714			MICROELECTRON RELIAB	Microelectron. Reliab.	FEB	2015	55	2					407	410		10.1016/j.microrel.2014.10.012		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CB6GD	WOS:000349724600017		
J	Naoe, T				Naoe, Takuya			Case study: Root cause of fluorine detection during TiN ARC layer corrosion of AlSiCu metal lines	MICROELECTRONICS RELIABILITY			English	Article						ARC; TiN; Corrosion; Fluorine; SOG; TEOS oxide	SILICATE GLASS; STABILITY	The present study examines the cause of fluorine detection during the corrosion of the TiN antireflection coat (ARC) layer of AlSiCu metal lines. When a crack is generated in the tetraethyl orthosilicate (TEOS) oxide or spin-on-glass (SOG) film of an LSI device, the corrosion of the TiN ARC layer (TiOxNy-oxidation) may occur due to residual moisture inside the device. In this case, concentrated fluorine is detected around the corroded TiN ARC layer by energy-dispersive X-ray spectroscopy (EDX) analysis. Fluorine concentration was correlated with the degree of corrosion on the TiN ARC layer, suggesting the contribution of fluorine to the corrosion of this layer. When a wider distribution of fluorine concentrations was evaluated, however, the concentration of fluorine and the degree of corrosion on the TiN ARC layer did not match; instead, a higher concentration of fluorine was observed near the crack of the TEOS oxide film. The corroded TiN ARC layer of the sample was then removed, and the Al line of the underlying layer was observed. Etching was observed on the Al line surface where a high concentration of fluorine was detected. More specifically, EDX analysis detected that fluorine reacted with the Al line in the underlying layer after diffusion through the TiOxNy film, causing decreased film density due to the corrosion of the TiN ARC layer. (C) 2014 Elsevier Ltd. All rights reserved.	Ricoh Elect Devices Co Ltd, Ikeda, Osaka 5638501, Japan	Naoe, T (reprint author), Ricoh Elect Devices Co Ltd, 13-1 Himemuro Cho, Ikeda, Osaka 5638501, Japan.	takuya_naoe@e-devices.ricoh.co.jp					Avasarala B, 2010, ELECTROCHIM ACTA, V55, P9024, DOI 10.1016/j.electacta.2010.08.035; Barbieri TJ, 2006, ISTFA 2006, P461; Choi JH, 1995, VIMIC C JUN 27 29, P397; Endou M, 2012, Japan patent, Patent No. [JP 5072780, 5072780]; Fortin V, 2001, VIMIC C SEPT 25 26, P513; Gambion J, 1996, VMIC C JUN 18 20; Kim SE, 1999, APPL PHYS LETT, V75, P1902, DOI 10.1063/1.124866; Li WD, 1997, MATER RES SOC SYMP P, V476, P261; McVeigh M, 2008, ISTFA 2008: CONFERENCE PROCEEDINGS FROM THE 34TH INTERNATIONAL SYMPOSIUM FOR TESTING AND FAILURE ANALYSIS, P449, DOI 10.1361/cp2008istfa449; MONTERO I, 1991, SURF SCI, V251, P1038, DOI 10.1016/0039-6028(91)91147-P; Passemard G, 1997, MICROELECTRON ENG, V33, P335, DOI 10.1016/S0167-9317(96)00062-7; WILLIAMS R, 1975, J APPL PHYS, V46, P695, DOI 10.1063/1.321632	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0026-2714			MICROELECTRON RELIAB	Microelectron. Reliab.	FEB	2015	55	2					411	417		10.1016/j.microrel.2014.11.007		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CB6GD	WOS:000349724600018		
J	Yamamoto, T; Chen, WF; Yamamoto, N; Yoshimatsu, H; Tashiro, K; Koshima, I				Yamamoto, Takumi; Chen, Wei F.; Yamamoto, Nana; Yoshimatsu, Hidehiko; Tashiro, Kensuke; Koshima, Isao			TECHNICAL SIMPLIFICATION OF THE SUPERMICROSURGICAL SIDE-TO-END LYMPHATICOVENULAR ANASTOMOSIS USING THE PARACHUTE TECHNIQUE	MICROSURGERY			English	Article							INDOCYANINE-GREEN-LYMPHOGRAPHY; LOWER-EXTREMITY-LYMPHEDEMA; INTRAVASCULAR STENTING METHOD; DERMAL BACKFLOW PATTERNS; SUBCLINICAL LYMPHEDEMA; PATIENT; SAFE	BackgroundSupermicrosurgical side-to-end (S-E) lymphaticovenular anastomosis (LVA) is the most favorable anastomotic configuration for the treatment of lymphedema because it creates antegrade and retrograde lymph flow while preserves the native lymph flow. However, it is technically demanding and its successful performance has been limited only to the experienced LVA surgeons. This study aimed to evaluate the applicability of parachute technique in S-E LVA and its potential in decreasing the technical complexity of the procedure. MethodsBetween April 2010 and July 2011, S-E LVAs were performed in 14 patients with bilateral lower limb lymphedema with either the conventional technique or the parachute technique. To exclude interoperator variability of LVAs, only limbs in which S-E LVAs performed by one surgeon were included. Feasibility, anastomotic patency, operative times, and treatment efficacy of both techniques were retrospectively compared. ResultsThirty-seven S-E LVAs were performed by the surgeon; 17 LVAs with parachute technique in seven limbs and 20 LVAs with the conventional technique in seven limbs. Both groups demonstrated 100% anastomotic patency. Time required to perform the S-E anastomosis using the parachute technique was significantly shorter than when the conventional technique was used (8.6 +/- 3.7 vs. 11.3 +/- 3.1 minutes, P = 0.025). Both groups showed similar postoperative reduction in lymphedema indices (19.9 +/- 8.2 vs. 18.9 +/- 10.0, P = 0.841). Conclusions: The parachute technique simplifies the supermicrosurgical S-E LVA while maintaining efficacy comparable to the conventional technique. (c) 2014 Wiley Periodicals, Inc. Microsurgery, 2014. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:129-134, 2015.	[Yamamoto, Takumi; Yamamoto, Nana; Yoshimatsu, Hidehiko; Tashiro, Kensuke; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan; [Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp			Takeda Science Foundation	Grant sponsor: Takeda Science Foundation.	Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, P587, DOI 10.1016/j.bjps.2013.10.044; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, pE142, DOI 10.1016/j.bjps.2013.12.045; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2014, ANN PLAS SURG, V73, P46, DOI 10.1097/SAP.0b013e31826caff1; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; Yamamoto T, 2014, VASC ENDOVASC SURG, V48, P139, DOI 10.1177/1538574413510979; Yamamoto T, 2014, MICROSURG, V34, P308, DOI 10.1002/micr.22187; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Auba C, 2012, MICROSURG, V32, P261, DOI 10.1002/micr.20980; Koshima I, 2000, J RECONSTR MICROSURG, V16, P432; Nanashima A, 2012, HEPATO-GASTROENTEROL, V59, P1000, DOI 10.5754/hge12058; Narushima M, 2010, PLAST RECONSTR SURG, V125, P935, DOI 10.1097/PRS.0b013e3181cb64da; Narushima M, 2008, ANN PLAS SURG, V60, P41, DOI 10.1097/SAP.0b013e3181804bdb38; Ochi M, 1994, Kyobu Geka, V47, P360; Okamoto K, 2011, HEPATO-GASTROENTEROL, V58, P1025; YAMADA Y, 1969, Nagoya Journal of Medical Science, V32, P1; Yamamoto T, 2013, ANN PLAS SURG, V71, P538, DOI 10.1097/SAP.0b013e318250f0a0; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059523; Yamamoto T, 2013, J VASC SURG VEN 0718; Yamamoto T, 2012, J JPN COLL ANGIOL, V52, P327; Yamamoto T, 2014, MICROSURG, V34, P404, DOI 10.1002/micr.22215; Yamamoto T, 2014, ANN PLAS SURG, V73, P706, DOI 10.1097/SAP.0b013e318285875f; Yamamoto T, 2013, ANN PLAS SURG, V71, P591, DOI 10.1097/SAP.0b013e318255168a; Yamamoto T, 2013, PLAST RECONSTR SURG, V132, p472E, DOI 10.1097/PRS.0b013e31829acdd0; Yoshimi F, 2002, HEPATO-GASTROENTEROL, V49, P1213	33	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	FEB	2015	35	2					129	134		10.1002/micr.22272		6	Surgery	Surgery	CC1ZH	WOS:000350143500007		
J	Sekiguchi, H; Motomiya, M; Sakurai, K; Matsumoto, D; Funakoshi, T; Iwasaki, N				Sekiguchi, Hirotake; Motomiya, Makoto; Sakurai, Keisuke; Matsumoto, Dai; Funakoshi, Tadanao; Iwasaki, Norimasa			BRACHIAL ARTERY PERFORATOR-BASED PROPELLER FLAP COVERAGE FOR PREVENTION OF READHESION AFTER ULNAR NERVE NEUROLYSIS	MICROSURGERY			English	Article							CARPAL-TUNNEL-SYNDROME; ANTERIOR SUBMUSCULAR TRANSPOSITION; RECURRENT COMPRESSIVE NEUROPATHY; CLINICAL-APPLICATIONS; FAILED DECOMPRESSION; MEDIAN NERVE; ELBOW TRAUMA; RECONSTRUCTION; REGENERATION; DEFECTS	It is difficult for most plastic and orthopaedic surgeons to treat nerve dysfunction related to neural adhesion because the pathophysiology and suitable treatment have not been clarified. In the current report, we describe our experience of surgical treatment for adhesive ulnar neuropathy. A 58-year-old male complained of pain radiating to the ulnar nerve-innervated area during elbow and wrist motion caused by adhesive ulnar neuropathy after complex open trauma of the elbow joint. The patient obtained a good clinical outcome by surgical neurolysis of the ulnar nerve combined with a brachial artery perforator-based propeller flap to cover the soft tissue defect after resection of the scar tissue and to prevent readhesion of the ulnar nerve. This flap may be a useful option for ulnar nerve coverage after neurolysis without microvascular anastomosis in specific cases. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:158-162, 2015.	[Sekiguchi, Hirotake; Motomiya, Makoto; Matsumoto, Dai] Kushiro Rosai Hosp Hand Ctr, Dept Orthopaed Surg, Kushiro, Hokkaido, Japan; [Motomiya, Makoto; Funakoshi, Tadanao; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido 0608638, Japan; [Sakurai, Keisuke] Kushiro Rosai Hosp, Dept Plast Surg, Kushiro, Hokkaido, Japan	Motomiya, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Orthoped Surg, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	motomiya530126@yahoo.co.jp					Ayestaray B, 2011, ANN CHIR PLAST ESTH, V56, P90, DOI 10.1016/j.anplas.2010.11.004; Varitimidis SE, 2001, J HAND SURG-AM, V26A, P296, DOI 10.1053/jhsu.2001.22528; Siemionow M, 2013, MICROSURG, V33, P318, DOI 10.1002/micr.22104; HYAKUSOKU H, 1991, BRIT J PLAST SURG, V44, P53, DOI 10.1016/0007-1226(91)90179-N; Dahlin LB, 2010, J PLAST SURG HAND SU, V44, P4, DOI 10.3109/02844310903528697; Chaput B, 2014, ANN CHIR PLAST ESTH, V59, P65, DOI 10.1016/j.anplas.2013.05.004; GABEL GT, 1990, J BONE JOINT SURG AM, V72A, P213; Shin R, 2007, J BONE JOINT SURG AM, V89A, P1108, DOI 10.2106/JBJS.F.00594; Caputo AE, 2000, J HAND SURG-AM, V25A, P544, DOI 10.1053/jhsu.2000.6005; Bartels RHMA, 2004, J BONE JOINT SURG BR, V86B, P998, DOI 10.1302/0301-620X.86B7.14877; Palmer BA, 2010, J HAND SURG-AM, V35A, P153, DOI 10.1016/j.jhsa.2009.11.004; Yamamoto T, 2014, MICROSURG, V34, P145, DOI 10.1002/micr.22135; Dahlin LB, 2002, SCAND J PLAST RECONS, V36, P172; Faierman E, 2001, J HAND SURG-AM, V26A, P675, DOI 10.1053/jhsu.2001.26186; Murakami M, 2012, J PLAST RECONSTR AES, V65, P1418, DOI 10.1016/j.bjps.2012.03.013; ROGERS MR, 1991, CLIN ORTHOP RELAT R, P193; Vogel RB, 2004, BRIT J PLAST SURG, V57, P311, DOI 10.1016/j.bjps.2004.02.027; Kilic A, 2013, MICROSURG, V33, P367, DOI 10.1002/micr.22101; Broudy A S, 1978, J Hand Surg Am, V3, P85; Ono S, 2011, J HAND SURG-AM, V36A, P853, DOI 10.1016/j.jhsa.2010.12.021; Prantl L, 2008, J PLAST RECONSTR AES, V61, P546, DOI 10.1016/j.bjps.2007.05.015; Varitimidis SE, 2000, J HAND SURG-BRIT EUR, V25B, P271, DOI 10.1054/jhsb.2000.0379	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	FEB	2015	35	2					158	162		10.1002/micr.22303		5	Surgery	Surgery	CC1ZH	WOS:000350143500012		
J	Kawano, A; Ota, S; Oide, T; Matsushima, J; Suzuki, M; Iwamoto, M; Kishimoto, T; Kitagawa, M; Araki, N; Misawa, S; Kuwabara, S; Sakaida, E; Nakaseko, C				Kawano, Asuka; Ota, Satoshi; Oide, Takashi; Matsushima, Jun; Suzuki, Masaki; Iwamoto, Masami; Kishimoto, Takashi; Kitagawa, Moto; Araki, Nobuyuki; Misawa, Sonoko; Kuwabara, Satoshi; Sakaida, Emiko; Nakaseko, Chiaki			POEMS Syndrome: A Study of Five Autopsy Cases With Emphasis on the Significance of Subcutaneous Calciphylaxis	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kawano, Asuka; Ota, Satoshi; Oide, Takashi; Matsushima, Jun; Suzuki, Masaki; Iwamoto, Masami; Kishimoto, Takashi; Kitagawa, Moto; Araki, Nobuyuki; Misawa, Sonoko; Kuwabara, Satoshi; Sakaida, Emiko; Nakaseko, Chiaki] Chiba Univ, Sch Med, Chiba 280, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		11	6A	6A				1	Pathology	Pathology	CB3BF	WOS:000349502200012		
J	Wakasa, T; Ikeda, T; Takeuchi, M; Ishibashi-Ueda, H; Kanayama, N; Tamura, N; Matsuda, Y; Yoshimatsu, J				Wakasa, Tomoko; Ikeda, Tomoaki; Takeuchi, Makoto; Ishibashi-Ueda, Hatsue; Kanayama, Naohiro; Tamura, Naoaki; Matsuda, Yoshio; Yoshimatsu, Jun			Maternal Death Analysis in Japan: An Autopsy-Based Study (2011-2013)	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kindai Hosp, Nara Hosp, Fac Med, Ikoma, Japan; Mie Univ, Sch Med, Tsu, Mie 514, Japan; Osaka Med Ctr Maternal & Child Hlth, Izumi, Japan; Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; Int Univ Hlth & Welf Hosp, Nasushiobara, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		31	12A	12A				1	Pathology	Pathology	CB3BF	WOS:000349502200032		
J	Athanasou, N; Inagaki, Y; Kashima, T; Hookway, E; Tanaka, Y; Hassan, A; Oppermann, U				Athanasou, Nicholas; Inagaki, Yusuke; Kashima, Takeshi; Hookway, Edward; Tanaka, Yasuhito; Hassan, Andrew; Oppermann, Udo			Dentine Matrix Protein (DMP-1): A Marker of Bone Formation and Mineralization in Soft Tissue Tumours	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Oxford, Nuffield Orthopaed Ctr, Oxford, England; Nara Med Univ, Kashihara, Nara 634, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		41	14A	14A				1	Pathology	Pathology	CB3BF	WOS:000349502200042		
J	Fukunaga, M				Fukunaga, Masaharu			Composite Hemangioendothelioma: A Clinicopathologic Study of Nine Cases	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ Daisan Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		55	17A	17A				1	Pathology	Pathology	CB3BF	WOS:000349502200056		
J	Kohashi, K; Yamamoto, H; Yamada, Y; Oda, Y				Kohashi, Kenichi; Yamamoto, Hidetaka; Yamada, Yuichi; Oda, Yoshinao			Expressions of Core Subunits of SWI/SNF Chromatin Remodeling Complex in SMARCB1/INI1-Deficient Tumors	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kohashi, Kenichi; Yamamoto, Hidetaka; Yamada, Yuichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		66	20A	20A				1	Pathology	Pathology	CB3BF	WOS:000349502200067		
J	Konishi, E; Nakashima, Y; Mano, M; Tomita, Y; Yanagisawa, A				Konishi, Eiichi; Nakashima, Yasuaki; Mano, Masayuki; Tomita, Yasuhiko; Yanagisawa, Akio			Clinicopathological Prognostic Factors of Primary Central Chondrosarcoma: Analysis of 182 Cases By Numerical Score on Histology	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kyoto Prefectural Univ Med, Kyoto, Japan; Kyoto Univ Hosp, Kyoto 606, Japan; Osaka Natl Hosp, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		67	20A	20A				1	Pathology	Pathology	CB3BF	WOS:000349502200068		
J	Motoi, T; Kato, I; Yoshida, A; Ikegami, M; Horiguchi, S; Goto, T; Hishima, T				Motoi, Toru; Kato, Ikuna; Yoshida, Akihiko; Ikegami, Masachika; Horiguchi, Shinichiro; Goto, Takahiro; Hishima, Tsunekazu			Fibroma of Tendon Sheath With Fasciitis-Like Pattern Lacks USP6 Rearrangement and Is Genetically Distinct From Nodular Fasciitis: A Chromogenic In Situ Hybridization Study	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Tokyo, Japan; Natl Canc Ctr Cent Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		75	22A	22A				1	Pathology	Pathology	CB3BF	WOS:000349502200076		
J	Yamamoto, H; Taguchi, K; Yoshida, A; Kohashi, K; Oda, Y				Yamamoto, Hidetaka; Taguchi, Kenichi; Yoshida, Akihiko; Kohashi, Kenichi; Oda, Yoshinao			ALK and ROS1 Expression in Inflammatory Myofibroblastic Tumor	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kyushu Univ, Fukuoka 812, Japan; Kyushu Canc Ctr, Fukuoka, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		104	29A	29A				1	Pathology	Pathology	CB3BF	WOS:000349502200105		
J	Eberle, C; Piscuoglio, S; Rakha, E; Yamaguchi, R; Ng, C; Weigelt, B; Reis-Filho, J; Ellis, I				Eberle, Carey; Piscuoglio, Salvatore; Rakha, Emad; Yamaguchi, Rin; Ng, Charlotte; Weigelt, Britta; Reis-Filho, Jorge; Ellis, Ian			Massively Parallel Sequencing Analysis of Infiltrating Epitheliosis of the Breast	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Nottingham, Nottingham NG7 2RD, England; Kurume Univ, Med Ctr, Kurume, Fukuoka 830, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		158	42A	42A				1	Pathology	Pathology	CB3BF	WOS:000349502200159		
J	Fusco, N; Martelotto, L; Ng, C; Fuhrmann, L; Cyrta, J; Guerini-Rocco, E; Sakr, R; Yim, E; Marchio, C; Lim, R; Piscuoglio, S; Vincent-Salomon, A; Badve, S; Ichihara, S; Ellis, I; Reis, J; Weigelt, B				Fusco, Nicola; Martelotto, Luciano; Ng, Charlotte; Fuhrmann, Laetitia; Cyrta, Joanna; Guerini-Rocco, Elena; Sakr, Rita; Yim, Elizabeth; Marchio, Caterina; Lim, Raymond; Piscuoglio, Salvatore; Vincent-Salomon, Anne; Badve, Sunil; Ichihara, Shu; Ellis, Ian; Reis-Filho, Jorge; Weigelt, Britta			Genetic Events in the Progression of Adenoid Cystic Carcinomas of the Breast To High-Grade Triple-Negative Breast Cancers	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Inst Curie, Paris, France; Indiana Univ Sch Med, Indianapolis, IN 46202 USA; Nagoya Med Ctr, Nagoya, Aichi, Japan; Univ Nottingham, Nottingham NG7 2RD, England								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		170	45A	45A				1	Pathology	Pathology	CB3BF	WOS:000349502200171		
J	Guerini-Rocco, E; Piscuoglio, S; Ng, C; Akram, M; Sakr, R; Fusco, N; Ichihara, S; Vincent-Salomon, A; Ellis, I; Weigelt, B; Wen, YH; Schnitt, S; Reis, J				Guerini-Rocco, Elena; Piscuoglio, Salvatore; Ng, Charlotte; Akram, Muzaffar; Sakr, Rita; Fusco, Nicola; Ichihara, Shu; Vincent-Salomon, Anne; Ellis, Ian; Weigelt, Britta; Wen, Yong Hannah; Schnitt, Stuart; Reis-Filho, Jorge			Massively Parallel Sequencing Reveals That Microglandular Adenosis Is a Clonal Neoplastic Lesion of Triple-Negative Phenotype	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Nagoya Med Ctr, Nagoya, Aichi, Japan; Inst Curie, Paris, France; Univ Nottingham, Nottingham NG7 2RD, England; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		179	47A	47A				1	Pathology	Pathology	CB3BF	WOS:000349502200180		
J	Nitta, H; Kelly, B; Zhang, WJ; Farrell, M; Dennis, E; Masuda, S				Nitta, Hiroaki; Kelly, Brian; Zhang, Wenjun; Farrell, Mike; Dennis, Eslie; Masuda, Shinobu			Micro-Intratumoral Heterogeneity and Multiple Tumor Cell Subtypes of HER2-Positive, ER-Positive Breast Cancers	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Ventana Med Syst Inc, Tucson, AZ USA; Nihon Univ, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		219	58A	58A				1	Pathology	Pathology	CB3BF	WOS:000349502200220		
J	Hiroshima, K; Wu, D; Hasegawa, M; Sekine, Y; Ozaki, D; Yusa, T; Tada, Y; Shimada, H; Tagawa, M				Hiroshima, Kenzo; Wu, Di; Hasegawa, Mizue; Sekine, Yasuo; Ozaki, Daisuke; Yusa, Toshikazu; Tada, Yuji; Shimada, Hideaki; Tagawa, Masatoshi			Usefulness of FISH Analysis Combined With Immunofluorescence in the Cytological Diagnosis of Mesothelioma in Serosal Effusions	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Tokyo Womens Med Univ, Yachiyo, Japan; Chiba Rosai Hosp, Ichihara, Chiba, Japan; Chiba Univ, Chiba, Japan; Toho Univ, Tokyo, Japan; Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		360	93A	93A				1	Pathology	Pathology	CB3BF	WOS:000349502200361		
J	Goto, K				Goto, Keisuke			Immunohistochemistry for CD117 Is Effective in Distinguishing Cutaneous Adnexal Tumors With Apocrine/Eccrine or Sebaceous Differentiation From Other Non-Merkel Cell Epithelial Tumors of the Skin	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Goto, Keisuke] Kainan Hosp, Yatomi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		469	120A	121A				2	Pathology	Pathology	CB3BF	WOS:000349502200469		
J	Kondo, T; Nakazawa, T; Akaishi, J; Mochizuki, K; Oishi, N; Itoh, K; Katoh, R				Kondo, Tetsuo; Nakazawa, Tadao; Akaishi, Junko; Mochizuki, Kunio; Oishi, Naoki; Itoh, Koichi; Katoh, Ryohei			Clinical Impact of the Minor Proportion of Poorly Differentiated Component in Thyroid Carcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Yamanashi, Japan; Ito Hop, Shibuya Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		533	136A	136A				1	Pathology	Pathology	CB3BF	WOS:000349502200533		
J	Oishi, N; Kondo, T; Nakazawa, T; Mochizuki, K; Kasai, K; Inoue, T; Tahara, I; Wang, J; Yabuta, T; Hirokawa, M; Miyauchi, A; Katoh, R				Oishi, Naoki; Kondo, Tetsuo; Nakazawa, Tadao; Mochizuki, Kunio; Kasai, Kazunari; Inoue, Tomohiro; Tahara, Ippei; Wang, Jieying; Yabuta, Tomonori; Hirokawa, Mitsuyoshi; Miyauchi, Akira; Katoh, Ryohei			BRAF and TERT Promoter Mutations in Papillary Thyroid Carcinoma of Young Age	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Yamanashi, Japan; Kuma Hosp, Kobe, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		546	139A	139A				1	Pathology	Pathology	CB3BF	WOS:000349502200546		
J	Osamura, R; Matsuda, M; Inomoto, C; Kajiwara, H				Osamura, Robert; Matsuda, Midori; Inomoto, Chie; Kajiwara, Hiroshi			High Immunohistochemical Expression of Heat Shock Protein90 in the Metastatic NET/NEC in the Liver: A Next Generation Target?	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Int Univ Hlth & Welf, Tokyo, Japan; Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		547	139A	140A				2	Pathology	Pathology	CB3BF	WOS:000349502200547		
J	Osamura, R; Matsuda, M; Inomoto, C; Kajiwara, H; Matsuno, A; Teramoto, A				Osamura, Robert; Matsuda, Midori; Inomoto, Chie; Kajiwara, Hiroshi; Matsuno, Akira; Teramoto, Akira			Immunohistochemical Detection of Therapeutic Biomarkers, SSTR2; SSTR5 and p-mTOR, in Various Human Pituitary Adenomas	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Int Univ Hlth & Welf, Mita Hosp, Tokyo, Japan; Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; Teikyo Univ, Sch Med, Tokyo 173, Japan; Tokyo Rosai Occupat Dis & Injuries Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		548	140A	140A				1	Pathology	Pathology	CB3BF	WOS:000349502200548		
J	Kowano, S; Kojima, M; Sugimoto, M; Takahashi, S; Saito, N; Atsushi-Ochiai				Kowano, Shingo; Kojima, Motohiro; Sugimoto, Motokazu; Takahashi, Shinichiro; Saito, Norio; Atsushi-Ochiai			Correlation Between the Elastic Modulus of Colorectal Cancer Tissue and Clinicopathological and Histological Findings	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kowano, Shingo; Kojima, Motohiro; Sugimoto, Motokazu; Takahashi, Shinichiro; Saito, Norio; Atsushi-Ochiai] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		661	168A	168A				1	Pathology	Pathology	CB3BF	WOS:000349502200661		
J	Kojima, M; Puppa, G; Richard, K; Basturk, O; Frankel, W; Vieth, M; Lugli, A; Sheahan, K; Yeh, M; Lauwers, G; Risio, M; Shimazaki, H; Iwaya, K; Kage, M; Akiba, J; Ohkura, Y; Hortguchi, S; Shomori, K; Kushima, R; Nomura, S; Ajioka, Y; Adsay, V; Ochiai, A				Kojima, Motohiro; Puppa, Giacomo; Richard, Kirsch; Basturk, Olca; Frankel, Wendy; Vieth, Michael; Lugli, Alessandro; Sheahan, Kieran; Yeh, Matthew; Lauwers, Greg; Risio, Mauro; Shimazaki, Hideyuki; Iwaya, Keichi; Kage, Masayoshi; Akiba, Jun; Ohkura, Yasuo; Hortguchi, Shinichiro; Shomori, Kohei; Kushima, Ryoji; Nomura, Shogo; Ajioka, Yoichi; Adsay, Volkan; Ochiai, Atsushi			Construction of an Objective Pathological Diagnostic System of Blood and Lymphatic Vessel Invasion	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Canc Ctr Hosp East, Chiba, Japan; Hop Cantonal Univ Geneva, Geneva, Switzerland; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; Klinikum Bayreuth, Bayreuth, Germany; Univ Bern, Bern, Switzerland; St Vincents Univ Hosp, Dublin 4, Ireland; Univ Washington, Sch Med, Seattle, WA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Inst Canc Res & Treatment, Turin, Italy; Natl Def Med Coll, Saitama, Japan; Kurume Univ Scool Med, Fukuoka, Japan; Kyorin Univ, Grad Sch Med, Tokyo, Japan; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; Sanin Rosai Hosp, Tottori, Japan; Shiga Univ Med Sci Hosp, Shiga, Japan; Niigata Univ, Niigata, Japan; Emory Univ, Sch Med, Atlanta, GA USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		673	171A	171A				1	Pathology	Pathology	CB3BF	WOS:000349502201011		
J	Maruyama, Y; Uehara, T; Daikuhara, S; Ota, H				Maruyama, Yasuhiro; Uehara, Takeshi; Daikuhara, Seiichi; Ota, Hiroyoshi			CD44v9 Is Expressed in Human Duodenal Carcinoma and CD44v9-Positive Cancer Cells Exhibit Stem Cell-Like Features	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Maruyama, Yasuhiro; Uehara, Takeshi; Daikuhara, Seiichi; Ota, Hiroyoshi] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		703	178A	179A				2	Pathology	Pathology	CB3BF	WOS:000349502201041		
J	Nomura, R; Saito, T; Mitomi, H; Hidaka, Y; Lee, SY; Watanabe, S; Yao, T				Nomura, Ryosuke; Saito, Tsuyoshi; Mitomi, Hiroyuki; Hidaka, Yasuhiro; Lee, Se-yong; Watanabe, Sumio; Yao, Takashi			GNAS Mutation as an Alternative Mechanism of Activation of the Wnt/beta-Catenin Signaling Pathway in Gastric Adenocarcinoma of the Fundic Gland Type	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Juntendo Univ, Sch Med, Tokyo 113, Japan; Dokkyo Univ, Sch Med, Mibu, Tochigi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		716	181A	182A				2	Pathology	Pathology	CB3BF	WOS:000349502201054		
J	Karram, S; Faraj, S; Fujita, K; Munari, E; Shih, IM; Chaux, A; Netto, G				Karram, Sarah; Faraj, Sheila; Fujita, Kazutoshi; Munari, Enrico; Shih, Ie-Ming; Chaux, Alcides; Netto, George			Immunohistochemical Expression of ARID1a in Upper Tract Urothelial Carcinomas: A Tissue Microarray Study of 99 Cases	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Osaka Univ, Osaka, Japan; Norte Univ, Sch Med, Asuncion, Paraguay								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		929	233A	233A				1	Pathology	Pathology	CB3BF	WOS:000349502201267		
J	Maeda, D; Akiyama, Y				Maeda, Daichi; Akiyama, Yoshiyuki			HunnerType (Classic) Interstitial Cystitis Is a Distinct Inflammatory Disorder Characterized By Epithelial Denudation and Pancystitis With Frequent Expansion of Clonal B-Cells	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Akita Univ, Grad Sch Med, Akita 010, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		960	241A	241A				1	Pathology	Pathology	CB3BF	WOS:000349502201298		
J	Morikawa, T; Makise, N; Ichimura, T; Fukayama, M				Morikawa, Teppei; Makise, Naohiro; Ichimura, Takashi; Fukayama, Masashi			MAGE-A Expression, Immune Microenvironment and Prognosis in Upper Urinary Tract Carcinoma	MODERN PATHOLOGY			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Morikawa, Teppei; Makise, Naohiro; Ichimura, Takashi; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28			2		980	246A	246A				1	Pathology	Pathology	CB3BF	WOS:000349502201318		
